Citrus Sinensis ID: 005940
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 668 | 2.2.26 [Sep-21-2011] | |||||||
| Q9SR87 | 693 | Probable L-type lectin-do | yes | no | 0.920 | 0.887 | 0.540 | 0.0 | |
| Q9M020 | 688 | Lectin-domain containing | no | no | 0.941 | 0.914 | 0.520 | 0.0 | |
| Q66GN2 | 691 | Lectin-domain containing | no | no | 0.926 | 0.895 | 0.513 | 0.0 | |
| Q9M021 | 682 | L-type lectin-domain cont | no | no | 0.964 | 0.944 | 0.506 | 1e-174 | |
| Q9M345 | 677 | L-type lectin-domain cont | no | no | 0.956 | 0.943 | 0.482 | 1e-166 | |
| Q9SZD5 | 669 | L-type lectin-domain cont | no | no | 0.931 | 0.929 | 0.472 | 1e-164 | |
| O80939 | 675 | L-type lectin-domain cont | no | no | 0.883 | 0.874 | 0.488 | 1e-160 | |
| O81292 | 674 | L-type lectin-domain cont | no | no | 0.905 | 0.897 | 0.476 | 1e-159 | |
| O81291 | 669 | L-type lectin-domain cont | no | no | 0.911 | 0.910 | 0.484 | 1e-158 | |
| Q9M2S4 | 684 | L-type lectin-domain cont | no | no | 0.880 | 0.859 | 0.490 | 1e-157 |
| >sp|Q9SR87|LRK61_ARATH Probable L-type lectin-domain containing receptor kinase VI.1 OS=Arabidopsis thaliana GN=LECRK61 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 654 bits (1687), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 340/629 (54%), Positives = 446/629 (70%), Gaps = 14/629 (2%)
Query: 21 IVAQSQSSSFIFQGFNGGATNLSLQGAEIIK-PSGALKLTNRSRYVIGHAFYVKPIQMFD 79
++A++ ++ F F GF T++ +GA I+ + L+LTNR + V G AFY KPI++ +
Sbjct: 27 VLAEATTAKFTFIGFKENQTDIQTEGASTIQHDNDLLRLTNRKQNVTGTAFYRKPIRLRE 86
Query: 80 TSASPSPNASSFSTTFVFEISTPRSGRGGHGLAFLLAPSTKLPGAQPEHYLGILNSTNNG 139
+ S SFST+FVF I G GG G F L+P+ PGA+ YLG+LN TNNG
Sbjct: 87 LTNSSDIKVCSFSTSFVFVILPSSPGNGGFGFTFTLSPTPNRPGAESAQYLGLLNRTNNG 146
Query: 140 EPSNHILIVEFDTVNGFNDKAENQGNHVGIGINTMFSNRSEPASYYINGTDHKEEMTLES 199
PSNH+ VEFDTV GF D A+ +GNH+G+ N + SN EP YY + D KE+ LES
Sbjct: 147 NPSNHVFAVEFDTVQGFKDGADRRGNHIGLNFNNLSSNVQEPLIYY-DTEDRKEDFQLES 205
Query: 200 GEPIQAWIEYDGEQKVLNVTISPAEIG-KPMRPLISFGVN-LTGYIKETMYVGFSASTG- 256
GEPI+ I+YDG + LNVTI P + KP +PLIS V+ L+ +K+ MYVGF+A+TG
Sbjct: 206 GEPIRVLIDYDGSSETLNVTIYPTRLEFKPKKPLISRRVSELSEIVKDEMYVGFTAATGK 265
Query: 257 EKSSSHYILGWSFSLNGVAPA---LNVSELPKPPKEKEPSSYNPKILALIVSLCLVTFLL 313
++SS+HY++GWSFS G P L +S LP PP+ YN +++ LIV+L +VT +L
Sbjct: 266 DQSSAHYVMGWSFSSCGENPMADWLEISRLPPPPRLSNKKGYNSQVIVLIVALSIVTLVL 325
Query: 314 LGTLVFFLIY-RKWSNSETLEDWEKDCPHRFRYKDLYAATKGFKESEVIGIGGFGSVYKG 372
L L F++Y R+ +TLEDWE D PHRFRY+DLY ATK FKESE+IG GGFG VY+G
Sbjct: 326 LVLLFIFVMYKRRIQEEDTLEDWEIDYPHRFRYRDLYLATKKFKESEIIGTGGFGIVYRG 385
Query: 373 VLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEYI 432
L ++ G +AVKKIT NSLQG+REF AEIESLGRL HKNLVNL GWCK KN+LLL+Y+YI
Sbjct: 386 NL-SSSGPIAVKKITSNSLQGVREFMAEIESLGRLGHKNLVNLQGWCKHKNELLLIYDYI 444
Query: 433 PNGSLDTLLFKP--KDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALID 490
PNGSLD+LL++ ++G VL W+ RF I+KGIASGLLYLHEEWEQ+V+HRDVKPSN LID
Sbjct: 445 PNGSLDSLLYQTPRRNGIVLPWDVRFEIIKGIASGLLYLHEEWEQIVVHRDVKPSNVLID 504
Query: 491 AEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEV 550
+MNA+LGDFGLARLY+ G + TT +VGT GY+APELT+ GK ST+SDVFA+G+LLLE+
Sbjct: 505 EDMNAKLGDFGLARLYERGTLTQTTKIVGTLGYMAPELTRNGKGSTASDVFAFGVLLLEI 564
Query: 551 ATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSYVVKEMELVLKLGLMCSH-KTQ 609
G +P + + L +WV E H G IL V D L SS+ +E +L L +GL+C H K +
Sbjct: 565 VCGNKPTNAENFFLADWVMEFHTNGGILCVVDQNLGSSFNGREAKLALVVGLLCCHQKPK 624
Query: 610 FRPTMRQVMRYLSGEKQL-RFNNDWGSID 637
FRP+MR V+RYL+GE+ + + + +WG D
Sbjct: 625 FRPSMRMVLRYLNGEENVPQIDENWGFSD 653
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9M020|LRK63_ARATH Lectin-domain containing receptor kinase VI.3 OS=Arabidopsis thaliana GN=LECRK63 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 651 bits (1679), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 337/647 (52%), Positives = 447/647 (69%), Gaps = 18/647 (2%)
Query: 8 ALFLLFFFFIRLN-IVAQSQSSSFIFQGFNGGATNLSLQGAEIIKPSGALKLTNRSRYVI 66
LFLL R ++ + FIF+GF+G +N+ GA IK G L+LT+R+ V
Sbjct: 3 VLFLLLTIPTRAQRTTTETPKTEFIFRGFSGNQSNIVTTGAATIKLDGLLRLTDRNSNVT 62
Query: 67 GHAFYVKPIQMFDTSASPSPNAS--SFSTTFVFEISTPRSGRGGHGLAFLLAPSTKLPGA 124
G +FY KP+++ +T+ S S N++ SFST+FVF I S GG G F L+P+ GA
Sbjct: 63 GTSFYHKPVRLLETNTS-STNSTIRSFSTSFVFVIIPTSSSNGGFGFTFTLSPTPDRTGA 121
Query: 125 QPEHYLGILNSTNNGEPSNHILIVEFDTVNGFNDKAENQGNHVGIGINTMFSNRSEPASY 184
+ YLG+LN N+G +NH+ VEFDTV GF D A+ GNH+G+ N++ S+ EP Y
Sbjct: 122 ESAQYLGLLNKANDGNSTNHVFAVEFDTVQGFKDGADRTGNHIGLNFNSLTSDVQEPVVY 181
Query: 185 YIN-GTDHKEEMTLESGEPIQAWIEYDGEQKVLNVTISPAEI-GKPMRPLISFGV-NLTG 241
Y N + KE+ L+SG+PI+A ++YDG + LN+T+ PA + +P+RPLIS V L+
Sbjct: 182 YDNEDPNRKEDFPLQSGDPIRAILDYDGPTQTLNLTVYPANLKSRPVRPLISRPVPKLSQ 241
Query: 242 YIKETMYVGFSASTG-EKSSSHYILGWSFSLNGVAPALNVSEL---PKPP-KEKEPSSYN 296
++E MYVGF+A+TG ++SS+HY++GWSFS G + +L P+PP + YN
Sbjct: 242 IVQEEMYVGFTAATGRDQSSAHYVMGWSFSSGGDLLTEDTLDLLELPRPPPNTAKKRGYN 301
Query: 297 PKILALIVSLCLVTFLLLGTLVFFLIYRK-WSNSETLEDWEKDCPHRFRYKDLYAATKGF 355
++LALIV+L VT +LL L FF++Y+K E LEDWE + PHR RYKDLYAAT GF
Sbjct: 302 SQVLALIVALSGVTVILLALLFFFVMYKKRLQQGEVLEDWEINHPHRLRYKDLYAATDGF 361
Query: 356 KESEVIGIGGFGSVYKGVLPT-TGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVN 414
KE+ ++G GGFG+V++G L + + ++AVKKIT NS+QG+REF AEIESLGRLRHKNLVN
Sbjct: 362 KENRIVGTGGFGTVFRGNLSSPSSDQIAVKKITPNSMQGVREFIAEIESLGRLRHKNLVN 421
Query: 415 LHGWCKQKNDLLLVYEYIPNGSLDTLLF-KPKD-GSVLDWEQRFNIVKGIASGLLYLHEE 472
L GWCKQKNDLLL+Y+YIPNGSLD+LL+ +P+ G VL W RF I KGIASGLLYLHEE
Sbjct: 422 LQGWCKQKNDLLLIYDYIPNGSLDSLLYSRPRQSGVVLSWNARFKIAKGIASGLLYLHEE 481
Query: 473 WEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPELTQTG 532
WE+VVIHRD+KPSN LI+ +MN RLGDFGLARLY+ G +TT VVGT GY+APEL + G
Sbjct: 482 WEKVVIHRDIKPSNVLIEDDMNPRLGDFGLARLYERGSQSNTTVVVGTIGYMAPELARNG 541
Query: 533 KASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSYVVK 592
K+S++SDVFA+G+LLLE+ +GRRP SG L +WV E H G IL DP L Y
Sbjct: 542 KSSSASDVFAFGVLLLEIVSGRRPTDSGTFFLADWVMELHARGEILHAVDPRLGFGYDGV 601
Query: 593 EMELVLKLGLMCSH-KTQFRPTMRQVMRYLSGEKQL-RFNNDWGSID 637
E L L +GL+C H + RP+MR V+RYL+G+ + +NDWG D
Sbjct: 602 EARLALVVGLLCCHQRPTSRPSMRTVLRYLNGDDDVPEIDNDWGYSD 648
|
Involved in negative regulation of abscisic acid response in seed germination. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q66GN2|LRK64_ARATH Lectin-domain containing receptor kinase VI.4 OS=Arabidopsis thaliana GN=LECRK64 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 641 bits (1654), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 325/633 (51%), Positives = 434/633 (68%), Gaps = 14/633 (2%)
Query: 18 RLNIVAQSQSSSFIFQGFNGGATNLSLQGAEIIKPSGALKLTNRSRYVIGHAFYVKPIQM 77
R ++ ++ FIF GF G + + +QG I +G L+LT+R+ V+G AFY KP+++
Sbjct: 18 RAHVATTETTTEFIFHGFKGNQSEIHMQGDSTITSNGLLRLTDRNSDVVGTAFYHKPVRL 77
Query: 78 FDTSASPSPNASSFSTTFVFEISTPRSGRGGHGLAFLLAPSTKLPGAQPEHYLGILNSTN 137
D S S + SFST+F+F I + + GG G F L+P+ A PE Y+G+LN N
Sbjct: 78 LD-SNSTNTTVRSFSTSFIFIIPSSSTSNGGFGFTFTLSPTPNRTDADPEQYMGLLNERN 136
Query: 138 NGEPSNHILIVEFDTVNGFNDKAENQGNHVGIGINTMFSNRSEPASYYINGTDHKEEMTL 197
+G SNH+ VEFDTV GF D GNH+G+ N++ S+ EP +Y+ N KEE L
Sbjct: 137 DGNSSNHVFAVEFDTVQGFKDGTNRIGNHIGLNFNSLSSDVQEPVAYFNNNDSQKEEFQL 196
Query: 198 ESGEPIQAWIEYDGEQKVLNVTISPAEIG-KPMRPLISFGV-NLTGYIKETMYVGFSAST 255
SGEPIQ +++Y G K LN+T+ P +G KP PLIS V L+ + + M+VGF+A+T
Sbjct: 197 VSGEPIQVFLDYHGPTKTLNLTVYPTRLGYKPRIPLISREVPKLSDIVVDEMFVGFTAAT 256
Query: 256 GE--KSSSHYILGWSFSLNG---VAPALNVSELPKPPKEK-EPSSYNPKILALIVSLCLV 309
G +SS+HY++GWSF+ G +A L++S+LP PP K + YN K++ALIV+L V
Sbjct: 257 GRHGQSSAHYVMGWSFASGGEHPLAAMLDISQLPPPPPNKAKKRGYNGKVIALIVALSTV 316
Query: 310 TFLLLGTLVFFLIYRK-WSNSETLEDWEKDCPHRFRYKDLYAATKGFKESEVIGIGGFGS 368
++L L F++Y+K E LEDWE D PHRFRY+DLY AT+GFKE+ V+G GGFG
Sbjct: 317 ISIMLVLLFLFMMYKKRMQQEEILEDWEIDHPHRFRYRDLYKATEGFKENRVVGTGGFGI 376
Query: 369 VYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLV 428
VY+G + ++ ++AVKKIT NS+QG+REF AEIESLGRLRHKNLVNL GWCK +NDLLL+
Sbjct: 377 VYRGNIRSSSDQIAVKKITPNSMQGVREFVAEIESLGRLRHKNLVNLQGWCKHRNDLLLI 436
Query: 429 YEYIPNGSLDTLLF-KPK-DGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSN 486
Y+YIPNGSLD+LL+ KP+ G+VL W RF I KGIASGLLYLHEEWEQ+VIHRDVKPSN
Sbjct: 437 YDYIPNGSLDSLLYSKPRRSGAVLSWNARFQIAKGIASGLLYLHEEWEQIVIHRDVKPSN 496
Query: 487 ALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGIL 546
LID++MN RLGDFGLARLY+ G TT VVGT GY+APEL + G +S++SDVFA+G+L
Sbjct: 497 VLIDSDMNPRLGDFGLARLYERGSQSCTTVVVGTIGYMAPELARNGNSSSASDVFAFGVL 556
Query: 547 LLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSYVVKEMELVLKLGLMCS- 605
LLE+ +GR+P SG + +WV E G IL DP L S Y E L L +GL+C
Sbjct: 557 LLEIVSGRKPTDSGTFFIADWVMELQASGEILSAIDPRLGSGYDEGEARLALAVGLLCCH 616
Query: 606 HKTQFRPTMRQVMRYLSGEKQL-RFNNDWGSID 637
HK + RP MR V+RYL+ ++ + +++WG D
Sbjct: 617 HKPESRPLMRMVLRYLNRDEDVPEIHDNWGYSD 649
|
Involved in negative regulation of abscisic acid response in seed germination. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9M021|LRK62_ARATH L-type lectin-domain containing receptor kinase VI.2 OS=Arabidopsis thaliana GN=LECRK62 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 612 bits (1577), Expect = e-174, Method: Compositional matrix adjust.
Identities = 336/664 (50%), Positives = 446/664 (67%), Gaps = 20/664 (3%)
Query: 19 LNIVAQSQSSSFIFQGFNGGATNLSLQGAEIIKPSGALKLTNRSRYVIGHAFYVKPIQMF 78
+++ AQ +++F F+GFNG + + ++GA +IKP G L+LT+R V G AFY KP+++
Sbjct: 22 VHVRAQRTTTNFAFRGFNGNQSKIRIEGAAMIKPDGLLRLTDRKSNVTGTAFYHKPVRLL 81
Query: 79 DTSASPSPNASSFSTTFVFEISTPRSGRGGHGLAFLLAPSTKLPGAQPEHYLGILNSTNN 138
+ + S + SFST+FVF I S G G F L+P+ A YLG+ N NN
Sbjct: 82 NRN-STNVTIRSFSTSFVFVIIPSSSSNKGFGFTFTLSPTPYRLNAGSAQYLGVFNKENN 140
Query: 139 GEPSNHILIVEFDTVNG-FNDKAENQGNHVGIGINTMFSNRSEPASYYINGTDH--KEEM 195
G+P NH+ VEFDTV G +D + GN +G+ N+ S+ EP YY N DH KE+
Sbjct: 141 GDPRNHVFAVEFDTVQGSRDDNTDRIGNDIGLNYNSRTSDLQEPVVYY-NNDDHNKKEDF 199
Query: 196 TLESGEPIQAWIEYDGEQKVLNVTISPAEIG-KPMRPLISFGV-NLTGYIKETMYVGFSA 253
LESG PIQA +EYDG ++LNVT+ PA +G KP +PLIS V L ++E MYVGF+A
Sbjct: 200 QLESGNPIQALLEYDGATQMLNVTVYPARLGFKPTKPLISQHVPKLLEIVQEEMYVGFTA 259
Query: 254 STGE-KSSSHYILGWSFSLNG---VAPALNVSELPKPPKEK-EPSSYNPKILALIVSLCL 308
STG+ +SS+HY++GWSFS G +A L +SELP PP K + N +++ +IV+L
Sbjct: 260 STGKGQSSAHYVMGWSFSSGGERPIADVLILSELPPPPPNKAKKEGLNSQVIVMIVALSA 319
Query: 309 VTFLLLGTLVFFLIYRK-WSNSETLEDWEKDCPHRFRYKDLYAATKGFKESEVIGIGGFG 367
V ++L L FF++Y+K ETLEDWE D P R RY+DLY AT GFK++ +IG GGFG
Sbjct: 320 VMLVMLVLLFFFVMYKKRLGQEETLEDWEIDHPRRLRYRDLYVATDGFKKTGIIGTGGFG 379
Query: 368 SVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLL 427
+V+KG LP + +AVKKI +S QG+REF AEIESLG+LRHKNLVNL GWCK KNDLLL
Sbjct: 380 TVFKGKLPNSD-PIAVKKIIPSSRQGVREFVAEIESLGKLRHKNLVNLQGWCKHKNDLLL 438
Query: 428 VYEYIPNGSLDTLLFK--PKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPS 485
+Y+YIPNGSLD+LL+ + G+VL W RF I KGIASGLLYLHEEWE++VIHRDVKPS
Sbjct: 439 IYDYIPNGSLDSLLYTVPRRSGAVLSWNARFQIAKGIASGLLYLHEEWEKIVIHRDVKPS 498
Query: 486 NALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGI 545
N LID++MN RLGDFGLARLY+ G + TT +VGT GY+APEL++ G S++SDVFA+G+
Sbjct: 499 NVLIDSKMNPRLGDFGLARLYERGTLSETTALVGTIGYMAPELSRNGNPSSASDVFAFGV 558
Query: 546 LLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSYVVKEMELVLKLGLMCS 605
LLLE+ GR+P SG LV+WV E H G IL DP L S Y E L L +GL+C
Sbjct: 559 LLLEIVCGRKPTDSGTFFLVDWVMELHANGEILSAIDPRLGSGYDGGEARLALAVGLLCC 618
Query: 606 H-KTQFRPTMRQVMRYLSGEKQL-RFNNDWGSIDYRQGFDEFSSRTFDEISTGTFKSSHR 663
H K RP+MR V+RYL+GE+ + +++WG + EF S+ +S+ +
Sbjct: 619 HQKPASRPSMRIVLRYLNGEENVPEIDDEWGY--SKSSRSEFGSKLVGYVSSTSITRVSS 676
Query: 664 SSSI 667
+S I
Sbjct: 677 TSRI 680
|
Involved in negative regulation of abscisic acid response in seed germination. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9M345|LRK42_ARATH L-type lectin-domain containing receptor kinase IV.2 OS=Arabidopsis thaliana GN=LECRK42 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 587 bits (1512), Expect = e-166, Method: Compositional matrix adjust.
Identities = 319/661 (48%), Positives = 441/661 (66%), Gaps = 22/661 (3%)
Query: 21 IVAQSQSSSFIFQGFNGGATNLSLQGAEIIKPSGALKLTNRSRYVIGHAFYVKPIQMFDT 80
+++ SQ+ +F + GF+ T++SLQG + P+G LKLTN S GHAF + I+ D
Sbjct: 18 MISSSQNLNFTYNGFHPPLTDISLQGLATVTPNGLLKLTNTSVQKTGHAFCTERIRFKD- 76
Query: 81 SASPSPNASSFSTTFVFEISTPRSGRGGHGLAFLLAPSTKLPGAQPEHYLGILNSTNNGE 140
S + N SSFSTTFVF I + GHG+AF++AP+ LP A P Y+G+ N +NNG
Sbjct: 77 --SQNGNVSSFSTTFVFAIHSQIPTLSGHGIAFVVAPTLGLPFALPSQYIGLFNISNNGN 134
Query: 141 PSNHILIVEFDTVNGFNDKAENQGNHVGIGINTMFSNRSEPASYYINGTDHKEEMTLESG 200
+NHI VEFDT+ ++ + NHVGI +N + S A Y + D + ++L S
Sbjct: 135 DTNHIFAVEFDTIQS-SEFGDPNDNHVGIDLNGLRSANYSTAGYR-DDHDKFQNLSLISR 192
Query: 201 EPIQAWIEYDGEQKVLNVTISPAEIGKPMRPLISFGVNLTGYIKETMYVGFSASTGEKSS 260
+ IQ WI+YD ++VT++P + KP +PL+S+ +L+ + E MYVGFS++TG S
Sbjct: 193 KRIQVWIDYDNRSHRIDVTVAPFDSDKPRKPLVSYVRDLSSILLEDMYVGFSSATGSVLS 252
Query: 261 SHYILGWSFSLNGVAPALNVSELPKPPK-EKEPSSYNPKILALIVSLCLVTFLLLGTLVF 319
H+++GWSF LNG AP L++S+LPK P+ E S KI ++SL L+ ++ L F
Sbjct: 253 EHFLVGWSFRLNGEAPMLSLSKLPKLPRFEPRRISEFYKIGMPLISLSLIFSIIF--LAF 310
Query: 320 FLIYRKWSNSETLEDWEKDC-PHRFRYKDLYAATKGFKESEVIGIGGFGSVYKGVLPTTG 378
+++ RK E L+DWE + +RFR+K+LY ATKGFKE +++G GGFG VY+G+LPTT
Sbjct: 311 YIVRRKKKYEEELDDWETEFGKNRFRFKELYHATKGFKEKDLLGSGGFGRVYRGILPTTK 370
Query: 379 GEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEYIPNGSLD 438
EVAVK+++ +S QGM+EF AEI S+GR+ H+NLV L G+C+++ +LLLVY+Y+PNGSLD
Sbjct: 371 LEVAVKRVSHDSKQGMKEFVAEIVSIGRMSHRNLVPLLGYCRRRGELLLVYDYMPNGSLD 430
Query: 439 TLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLG 498
L+ + + LDW+QR I+KG+ASGL YLHEEWEQVVIHRDVK SN L+DA+ N RLG
Sbjct: 431 KYLYNNPE-TTLDWKQRSTIIKGVASGLFYLHEEWEQVVIHRDVKASNVLLDADFNGRLG 489
Query: 499 DFGLARLYDHGGMPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPI- 557
DFGLARLYDHG P TT+VVGT GY+APE ++TG+A+T++DV+A+G LLEV +GRRPI
Sbjct: 490 DFGLARLYDHGSDPQTTHVVGTLGYLAPEHSRTGRATTTTDVYAFGAFLLEVVSGRRPIE 549
Query: 558 ---GSGD-LLLVEWVRECHQLGRILDVADPLLNSS-YVVKEMELVLKLGLMCSHKT-QFR 611
S D LLVEWV G I++ DP L SS Y ++E+E+VLKLGL+CSH + R
Sbjct: 550 FHSASDDTFLLVEWVFSLWLRGNIMEAKDPKLGSSGYDLEEVEMVLKLGLLCSHSDPRAR 609
Query: 612 PTMRQVMRYLSGEKQL----RFNNDWGSIDYRQGFDEFSSRTFDEISTGTFKSSHRSSSI 667
P+MRQV++YL G+ L + GS+ G D FS + ST FK SSI
Sbjct: 610 PSMRQVLQYLRGDMALPELTPLDLSAGSVMNLGGRDGFSGIAMTDFST-VFKGFTGGSSI 668
Query: 668 V 668
Sbjct: 669 A 669
|
Required during pollen development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SZD5|LRK59_ARATH L-type lectin-domain containing receptor kinase V.9 OS=Arabidopsis thaliana GN=LECRK59 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 578 bits (1491), Expect = e-164, Method: Compositional matrix adjust.
Identities = 309/654 (47%), Positives = 423/654 (64%), Gaps = 32/654 (4%)
Query: 22 VAQSQSSSFIFQGFNGGATNLSLQGAEIIKPSGALKLTNRSRYVIGHAFYVKPIQMFDTS 81
++QS+ F GFNG + S G I G +KLTN S + GH FY P++
Sbjct: 20 LSQSEEGEF---GFNGYLYDNS--GIAITNSKGLMKLTNSSEFSYGHVFYNSPVRF---K 71
Query: 82 ASPSPNASSFSTTFVFEISTPRSGRGGHGLAFLLAPSTKLPGAQPEHYLGILNSTNNGEP 141
SP+ SSFSTTFVF I + + GHGLAF+++P+ LP + YLG+ N TNNG+P
Sbjct: 72 NSPNGTVSSFSTTFVFAIVSNVNALDGHGLAFVISPTKGLPYSSSSQYLGLFNLTNNGDP 131
Query: 142 SNHILIVEFDTVNG--FNDKAENQGNHVGIGINTMFSNRSEPASYYINGTDHKEEMTLES 199
SNHI+ VEFDT F+D NHVGI IN++ S ++ A YY + + + L +
Sbjct: 132 SNHIVAVEFDTFQNQEFDDM---DNNHVGIDINSLSSEKASTAGYYEDDDGTFKNIRLIN 188
Query: 200 GEPIQAWIEYDGEQKVLNVTISPAEIGKPMRPLISFGVNLTGYIKETMYVGFSASTGEKS 259
+PIQAWIEYD ++ LNVTI P + KP PL+S +L+ Y+ ++MYVGF+++TG
Sbjct: 189 QKPIQAWIEYDSSRRQLNVTIHPIHLPKPKIPLLSLTKDLSPYLFDSMYVGFTSATGRLR 248
Query: 260 SSHYILGWSFSLNGVAPALNVSELPKPPKEKEPSSYNPKILALIVSLCLVTFLLLGTLVF 319
SSHYILGW+F LNG A +++S LPK P++ +S KILA+ +SL + L+ T+ +
Sbjct: 249 SSHYILGWTFKLNGTASNIDISRLPKLPRDSRSTSVK-KILAISLSLTSLAILVFLTISY 307
Query: 320 FLIYRKWSNSETLEDWEKDC-PHRFRYKDLYAATKGFKESEVIGIGGFGSVYKGVLPTTG 378
L ++ E LEDWE PHRF YKDLY ATKGF+ SE++G GGFG VYKG L T+
Sbjct: 308 MLFLKRKKLMEVLEDWEVQFGPHRFAYKDLYIATKGFRNSELLGKGGFGKVYKGTLSTSN 367
Query: 379 GEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEYIPNGSLD 438
++AVKK++ +S QGMREF AEI ++GRLRH NLV L G+C++K +L LVY+ +P GSLD
Sbjct: 368 MDIAVKKVSHDSRQGMREFVAEIATIGRLRHPNLVRLLGYCRRKGELYLVYDCMPKGSLD 427
Query: 439 TLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLG 498
L+ + S LDW QRF I+K +ASGL YLH +W QV+IHRD+KP+N L+D MN +LG
Sbjct: 428 KFLYHQPEQS-LDWSQRFKIIKDVASGLCYLHHQWVQVIIHRDIKPANVLLDDSMNGKLG 486
Query: 499 DFGLARLYDHGGMPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPI- 557
DFGLA+L +HG P T+NV GTFGYI+PEL++TGKASTSSDVFA+GIL+LE+ GRRP+
Sbjct: 487 DFGLAKLCEHGFDPQTSNVAGTFGYISPELSRTGKASTSSDVFAFGILMLEITCGRRPVL 546
Query: 558 ----GSGDLLLVEWVRECHQLGRILDVADPLL--NSSYVVKEMELVLKLGLMCSHKT-QF 610
+++L +WV +C + IL V D + + Y+ +++ LVLKLGL CSH
Sbjct: 547 PRASSPSEMVLTDWVLDCWE-DDILQVVDERVKQDDKYLEEQVALVLKLGLFCSHPVAAV 605
Query: 611 RPTMRQVMRYLSGEKQLRFNNDWGSIDYR------QGFDEFSSRTFDEISTGTF 658
RP+M V+++L G QL NN + + R +GF E + + S T
Sbjct: 606 RPSMSSVIQFLDGVAQLP-NNLFDIVKARENVGAIEGFGEAAESLAEPCSVATL 658
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O80939|LRK41_ARATH L-type lectin-domain containing receptor kinase IV.1 OS=Arabidopsis thaliana GN=LECRK41 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 565 bits (1456), Expect = e-160, Method: Compositional matrix adjust.
Identities = 303/620 (48%), Positives = 410/620 (66%), Gaps = 30/620 (4%)
Query: 23 AQSQSSSFIFQ-GFNGGATNLSLQGAEIIKPSGALKLTNRSRYVIGHAFYVKPIQMFDTS 81
+ SQS +F + GFN T+LS+QG + P+G LKLTN + GHAFY KPI+ D
Sbjct: 20 SSSQSLNFAYNNGFNP-PTDLSIQGITTVTPNGLLKLTNTTVQKTGHAFYTKPIRFKD-- 76
Query: 82 ASPSPNASSFSTTFVFEISTPRSGRGGHGLAFLLAPSTKLPGAQPEHYLGILNSTNNGEP 141
SP+ SSFST+FVF I + + GHG+AF++AP+ LP P Y+G+ N NNG
Sbjct: 77 -SPNGTVSSFSTSFVFAIHSQIAILSGHGIAFVVAPNASLPYGNPSQYIGLFNLANNGNE 135
Query: 142 SNHILIVEFDTV--NGFNDKAENQGNHVGIGINTMFSNRSEPASYYINGTDHKEEMTLES 199
+NH+ VE DT+ FND +N HVGI IN++ S +S PA Y+ K +TL S
Sbjct: 136 TNHVFAVELDTILSTEFNDTNDN---HVGIDINSLKSVQSSPAGYWDEKGQFKN-LTLIS 191
Query: 200 GEPIQAWIEYDGEQKVLNVTISPAEIGKPMRPLISFGVNLTGYIKETMYVGFSASTGEKS 259
+P+Q W++YDG ++VT++P KP RPL++ +L+ + + MYVGFS++TG
Sbjct: 192 RKPMQVWVDYDGRTNKIDVTMAPFNEDKPTRPLVTAVRDLSSVLLQDMYVGFSSATGSVL 251
Query: 260 SSHYILGWSFSLNGVAPALNVSELPKPPKEKEPSSYNPKILALI--VSLCLVTFLLLGTL 317
S HYILGWSF LN AP L +S LPK P+ + PK ++ + + L++ L+ +
Sbjct: 252 SEHYILGWSFGLNEKAPPLALSRLPKLPR------FEPKRISEFYKIGMPLISLFLIFSF 305
Query: 318 VFFLIY----RKWSNSETLEDWEKDCPHRFRYKDLYAATKGFKESEVIGIGGFGSVYKGV 373
+F + Y R+ E E ++ +RFR+KDLY ATKGFKE ++G GGFGSVYKGV
Sbjct: 306 IFLVCYIVRRRRKFAEELEEWEKEFGKNRFRFKDLYYATKGFKEKGLLGTGGFGSVYKGV 365
Query: 374 LPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEYIP 433
+P T E+AVK+++ S QGM+EF AEI S+GR+ H+NLV L G+C+++ +LLLVY+Y+P
Sbjct: 366 MPGTKLEIAVKRVSHESRQGMKEFVAEIVSIGRMSHRNLVPLLGYCRRRGELLLVYDYMP 425
Query: 434 NGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEM 493
NGSLD L+ + L+W+QR ++ G+ASGL YLHEEWEQVVIHRDVK SN L+D E+
Sbjct: 426 NGSLDKYLYNTPE-VTLNWKQRIKVILGVASGLFYLHEEWEQVVIHRDVKASNVLLDGEL 484
Query: 494 NARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATG 553
N RLGDFGLARLYDHG P TT+VVGT GY+APE T+TG+A+ ++DVFA+G LLEVA G
Sbjct: 485 NGRLGDFGLARLYDHGSDPQTTHVVGTLGYLAPEHTRTGRATMATDVFAFGAFLLEVACG 544
Query: 554 RRPI-----GSGDLLLVEWVRECHQLGRILDVADPLLNSSYVVKEMELVLKLGLMCSHKT 608
RRPI LLV+WV G IL DP + S KE+E+VLKLGL+CSH
Sbjct: 545 RRPIEFQQETDETFLLVDWVFGLWNKGDILAAKDPNMGSECDEKEVEMVLKLGLLCSHSD 604
Query: 609 -QFRPTMRQVMRYLSGEKQL 627
+ RP+MRQV+ YL G+ +L
Sbjct: 605 PRARPSMRQVLHYLRGDAKL 624
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O81292|LRK43_ARATH L-type lectin-domain containing receptor kinase IV.3 OS=Arabidopsis thaliana GN=LECRK43 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 561 bits (1446), Expect = e-159, Method: Compositional matrix adjust.
Identities = 301/632 (47%), Positives = 419/632 (66%), Gaps = 27/632 (4%)
Query: 23 AQSQSSSFIFQGFNGGATNLSLQGAEIIKPSGALKLTNRSRYVIGHAFYVKPIQMFDTSA 82
+ SQS +F + F+ TN+S+QG + +G LKLT+++ GHAFY +PI+ D
Sbjct: 22 SSSQSLNFTYNSFHRPPTNISIQGIATVTSNGILKLTDKTVISTGHAFYTEPIRFKD--- 78
Query: 83 SPSPNASSFSTTFVFEISTPRSGRGGHGLAFLLAPSTKLPGAQPEHYLGILNSTNNGEPS 142
SP+ SSFSTTFV I + GHG+AF +AP+ L A YLG+ +STNNG +
Sbjct: 79 SPNDTVSSFSTTFVIGIYSGIPTISGHGMAFFIAPNPVLSSAMASQYLGLFSSTNNGNDT 138
Query: 143 NHILIVEFDTVNG--FNDKAENQGNHVGIGINTMFSNRSEPASYYINGTDHKEEMTLESG 200
NHIL VEFDT+ F+D +N HVGI IN++ S +S Y+ + + +TL S
Sbjct: 139 NHILAVEFDTIMNPEFDDTNDN---HVGININSLTSVKSSLVGYW-DEINQFNNLTLISR 194
Query: 201 EPIQAWIEYDGEQKVLNVTISPAEIGKPMRPLISFGVNLTGYIKETMYVGFSASTGEKSS 260
+ +Q W++YD ++VT++P KP + L+S +L+ + MY+GFSA+TG S
Sbjct: 195 KRMQVWVDYDDRTNQIDVTMAPFGEVKPRKALVSVVRDLSSVFLQDMYLGFSAATGYVLS 254
Query: 261 SHYILGWSFSLNG-VAPALNVSELPKPPKEKEPSSYNP--KILALIVSLCLVTFLLLGTL 317
H++ GWSF + G AP L +S++PK P+ P+S K + SL L+ L + +L
Sbjct: 255 EHFVFGWSFMVKGKTAPPLTLSKVPKFPRVG-PTSLQRFYKNRMPLFSLLLIPVLFVVSL 313
Query: 318 VF---FLIYRKWSNSETLEDWEKDC-PHRFRYKDLYAATKGFKESEVIGIGGFGSVYKGV 373
+F F++ R+ +E EDWE + +R R+KDLY ATKGFK+ +++G GGFG VY+GV
Sbjct: 314 IFLVRFIVRRRRKFAEEFEDWETEFGKNRLRFKDLYYATKGFKDKDLLGSGGFGRVYRGV 373
Query: 374 LPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEYIP 433
+PTT E+AVK+++ S QG++EF AEI S+GR+ H+NLV L G+C+++++LLLVY+Y+P
Sbjct: 374 MPTTKKEIAVKRVSNESRQGLKEFVAEIVSIGRMSHRNLVPLLGYCRRRDELLLVYDYMP 433
Query: 434 NGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEM 493
NGSLD L+ + + LDW+QRFN++ G+ASGL YLHEEWEQVVIHRD+K SN L+DAE
Sbjct: 434 NGSLDKYLYDCPEVT-LDWKQRFNVIIGVASGLFYLHEEWEQVVIHRDIKASNVLLDAEY 492
Query: 494 NARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATG 553
N RLGDFGLARL DHG P TT VVGT+GY+AP+ +TG+A+T++DVFA+G+LLLEVA G
Sbjct: 493 NGRLGDFGLARLCDHGSDPQTTRVVGTWGYLAPDHVRTGRATTATDVFAFGVLLLEVACG 552
Query: 554 RRPI-----GSGDLLLVEWVRECHQLGRILDVADPLLNSSYVVKEMELVLKLGLMCSHKT 608
RRPI +LLV+ V G ILD DP L S Y +E+E VLKLGL+CSH
Sbjct: 553 RRPIEIEIESDESVLLVDSVFGFWIEGNILDATDPNLGSVYDQREVETVLKLGLLCSHSD 612
Query: 609 -QFRPTMRQVMRYLSGEKQLRFNNDWGSIDYR 639
Q RPTMRQV++YL G+ L D +D+R
Sbjct: 613 PQVRPTMRQVLQYLRGDATL---PDLSPLDFR 641
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O81291|LRK44_ARATH L-type lectin-domain containing receptor kinase IV.4 OS=Arabidopsis thaliana GN=LECRK44 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 560 bits (1442), Expect = e-158, Method: Compositional matrix adjust.
Identities = 306/632 (48%), Positives = 426/632 (67%), Gaps = 23/632 (3%)
Query: 9 LFLLFFF-FIRLNIVAQSQSSSFIFQGFNGGATNLSLQGAEIIKPSGALKLTNRSRYVIG 67
LF +FF F ++ + SQ F + GF T++S+ G I P+G LKLTN + G
Sbjct: 6 LFTIFFLSFFWQSLKSSSQIIDFTYNGFRPPPTDISILGIATITPNGLLKLTNTTMQSTG 65
Query: 68 HAFYVKPIQMFDTSASPSPNASSFSTTFVFEISTPRSGRGGHGLAFLLAPSTKLPGAQPE 127
HAFY KPI+ D SP+ SSFSTTFVF I + HG+AF++AP+ +LP P
Sbjct: 66 HAFYTKPIRFKD---SPNGTVSSFSTTFVFAIHSQIPI--AHGMAFVIAPNPRLPFGSPL 120
Query: 128 HYLGILNSTNNGEPSNHILIVEFDTVNG--FNDKAENQGNHVGIGINTMFSNRSEPASYY 185
YLG+ N TNNG NH+ VE DT+ FND NHVGI IN++ S +S PA Y+
Sbjct: 121 QYLGLFNVTNNGNVRNHVFAVELDTIMNIEFND---TNNNHVGIDINSLNSVKSSPAGYW 177
Query: 186 INGTDHKEEMTLESGEPIQAWIEYDGEQKVLNVTISPAEIGKPMRPLISFGVNLTGYIKE 245
+ D +TL S + +Q W+++DG +++VT++P KP +PL+S +L+ + +
Sbjct: 178 -DENDQFHNLTLISSKRMQVWVDFDGPTHLIDVTMAPFGEVKPRKPLVSIVRDLSSVLLQ 236
Query: 246 TMYVGFSASTGEKSSSHYILGWSFSLNGVAPALNVSELPK-PPKEKEPSSYNP--KILAL 302
M+VGFS++TG S ++LGWSF +NG A L +S+LP+ P + +P+ K
Sbjct: 237 DMFVGFSSATGNIVSEIFVLGWSFGVNGEAQPLALSKLPRLPVWDLKPTRVYRFYKNWVP 296
Query: 303 IVSLCLVTFLLLGTLVFFLIYRKWSNSETLEDWEKDC-PHRFRYKDLYAATKGFKESEVI 361
++SL L+ FLL+ LV F++ R+ +E +EDWE + +R R+KDLY ATKGFK+ ++
Sbjct: 297 LISLLLIPFLLIIFLVRFIMKRRRKFAEEVEDWETEFGKNRLRFKDLYYATKGFKDKNIL 356
Query: 362 GIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNLHGWCKQ 421
G GGFGSVYKG++P T E+AVK+++ S QG++EF AEI S+G++ H+NLV L G+C++
Sbjct: 357 GSGGFGSVYKGIMPKTKKEIAVKRVSNESRQGLKEFVAEIVSIGQMSHRNLVPLVGYCRR 416
Query: 422 KNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRD 481
+++LLLVY+Y+PNGSLD L+ + + LDW+QRF ++ G+AS L YLHEEWEQVVIHRD
Sbjct: 417 RDELLLVYDYMPNGSLDKYLYNSPEVT-LDWKQRFKVINGVASALFYLHEEWEQVVIHRD 475
Query: 482 VKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPELTQTGKASTSSDVF 541
VK SN L+DAE+N RLGDFGLA+L DHG P TT VVGT+GY+AP+ +TG+A+T++DVF
Sbjct: 476 VKASNVLLDAELNGRLGDFGLAQLCDHGSDPQTTRVVGTWGYLAPDHIRTGRATTTTDVF 535
Query: 542 AYGILLLEVATGRRPI----GSGD-LLLVEWVRECHQLGRILDVADPLLNSSYVVKEMEL 596
A+G+LLLEVA GRRPI SG+ ++LV+WV ILD DP L S Y KE+E+
Sbjct: 536 AFGVLLLEVACGRRPIEINNQSGERVVLVDWVFRFWMEANILDAKDPNLGSEYDQKEVEM 595
Query: 597 VLKLGLMCSHKTQF-RPTMRQVMRYLSGEKQL 627
VLKLGL+CSH RPTMRQV++YL G+ L
Sbjct: 596 VLKLGLLCSHSDPLARPTMRQVLQYLRGDAML 627
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9M2S4|LRKS4_ARATH L-type lectin-domain containing receptor kinase S.4 OS=Arabidopsis thaliana GN=LECRKS4 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 555 bits (1429), Expect = e-157, Method: Compositional matrix adjust.
Identities = 297/606 (49%), Positives = 405/606 (66%), Gaps = 18/606 (2%)
Query: 30 FIFQGFNGGATNLSLQGAEIIKPSGALKLTNRSRYVIGHAFYVKPIQMFDTSASPSPNAS 89
F F GF + NL+L G I P+GA++LT ++ VIGHAFY PI+ + A
Sbjct: 26 FSFIGFKKASPNLTLNGVAEIAPTGAIRLTTETQRVIGHAFYSLPIRFKPIGVN---RAL 82
Query: 90 SFSTTFVFEISTPRSGRGGHGLAFLLAPSTKLPGAQPEHYLGILNSTNNGEPSNHILIVE 149
SFST+F + GGHGLAF + P+ L G+ P YLG+LNS+ S+H VE
Sbjct: 83 SFSTSFAIAMVPEFVTLGGHGLAFAITPTPDLRGSLPSQYLGLLNSSRVNF-SSHFFAVE 141
Query: 150 FDTVNGFNDKAENQGNHVGIGINTMFSNRSEPASYYINGTDHKEEMTLESGEPIQAWIEY 209
FDTV + N NHVGI IN+M S+ S PA Y++ + K+E+ L+ G IQAWI+Y
Sbjct: 142 FDTVRDLEFEDIND-NHVGIDINSMESSISTPAGYFLANS-TKKELFLDGGRVIQAWIDY 199
Query: 210 DGEQKVLNVTISPAEIGKPMRPLISFGVNLTGYIKETMYVGFSASTGEKSSSHYILGWSF 269
D +K L+V +SP KP L+S+ V+L+ + + MYVGFSASTG +SSHYILGW+F
Sbjct: 200 DSNKKRLDVKLSPFS-EKPKLSLLSYDVDLSSVLGDEMYVGFSASTGLLASSHYILGWNF 258
Query: 270 SLNGVAPALNVSELPKPPKEKEPSSYNPKILALIVSLCLVTFLLLGTLVF--FLIYRKWS 327
+++G A +L++ LP+ P + + L L VSL L + L+ LV + RK
Sbjct: 259 NMSGEAFSLSLPSLPRIPSSIKKRKKKRQSLILGVSL-LCSLLIFAVLVAASLFVVRKVK 317
Query: 328 NSETLEDWEKDC-PHRFRYKDLYAATKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKI 386
+ + +E+WE D PHRF Y++L AT GF + E++G GGFG VYKG LP + VAVK+I
Sbjct: 318 DEDRVEEWELDFGPHRFSYRELKKATNGFGDKELLGSGGFGKVYKGKLPGSDEFVAVKRI 377
Query: 387 TRNSLQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKD 446
+ S QG+REF +E+ S+G LRH+NLV L GWC++++DLLLVY+++PNGSLD LF
Sbjct: 378 SHESRQGVREFMSEVSSIGHLRHRNLVQLLGWCRRRDDLLLVYDFMPNGSLDMYLFDENP 437
Query: 447 GSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLY 506
+L W+QRF I+KG+ASGLLYLHE WEQ VIHRD+K +N L+D+EMN R+GDFGLA+LY
Sbjct: 438 EVILTWKQRFKIIKGVASGLLYLHEGWEQTVIHRDIKAANVLLDSEMNGRVGDFGLAKLY 497
Query: 507 DHGGMPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSG----DL 562
+HG P T VVGTFGY+APELT++GK +TS+DV+A+G +LLEVA GRRPI + +L
Sbjct: 498 EHGSDPGATRVVGTFGYLAPELTKSGKLTTSTDVYAFGAVLLEVACGRRPIETSALPEEL 557
Query: 563 LLVEWVRECHQLGRILDVADPLLNSSYVVKEMELVLKLGLMCSHKT-QFRPTMRQVMRYL 621
++V+WV Q G I DV D LN + +E+ +V+KLGL+CS+ + + RPTMRQV+ YL
Sbjct: 558 VMVDWVWSRWQSGDIRDVVDRRLNGEFDEEEVVMVIKLGLLCSNNSPEVRPTMRQVVMYL 617
Query: 622 SGEKQL 627
EKQ
Sbjct: 618 --EKQF 621
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 668 | ||||||
| 332083027 | 668 | lectin receptor-like kinase [Gossypium h | 0.970 | 0.970 | 0.632 | 0.0 | |
| 224139244 | 660 | predicted protein [Populus trichocarpa] | 0.944 | 0.956 | 0.649 | 0.0 | |
| 224087800 | 660 | predicted protein [Populus trichocarpa] | 0.964 | 0.975 | 0.628 | 0.0 | |
| 224139246 | 660 | predicted protein [Populus trichocarpa] | 0.974 | 0.986 | 0.633 | 0.0 | |
| 255571419 | 675 | kinase, putative [Ricinus communis] gi|2 | 0.988 | 0.977 | 0.610 | 0.0 | |
| 359481281 | 1435 | PREDICTED: uncharacterized protein LOC10 | 0.956 | 0.445 | 0.624 | 0.0 | |
| 449483730 | 670 | PREDICTED: lectin-domain containing rece | 0.971 | 0.968 | 0.579 | 0.0 | |
| 449440249 | 670 | PREDICTED: lectin-domain containing rece | 0.971 | 0.968 | 0.579 | 0.0 | |
| 449440251 | 667 | PREDICTED: probable L-type lectin-domain | 0.977 | 0.979 | 0.571 | 0.0 | |
| 449483726 | 667 | PREDICTED: probable L-type lectin-domain | 0.977 | 0.979 | 0.571 | 0.0 |
| >gi|332083027|gb|AEE00746.1| lectin receptor-like kinase [Gossypium hirsutum] | Back alignment and taxonomy information |
|---|
Score = 832 bits (2150), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 414/655 (63%), Positives = 515/655 (78%), Gaps = 7/655 (1%)
Query: 11 LLFFFFIRLNIVAQSQSSSFIFQGFNGGATNLSLQGAEIIKPSGALKLTNRSRYVIGHAF 70
L F+FI ++AQ + ++FIF GFN L+L GA I PSGAL+LTN SR IGHAF
Sbjct: 3 FLLFWFIFFPVIAQPRPTNFIFHGFNRSEPKLTLDGASIRSPSGALELTNDSRDAIGHAF 62
Query: 71 YVKPIQMFDTSASPSPNASSFSTTFVFEISTPRSGRGGHGLAFLLAPSTKLPGAQPEHYL 130
Y +PIQM D +SPSP +SSFSTTFV I TP SGRGGHGLAF L+PS + PGA PEHY+
Sbjct: 63 YSEPIQMLDDKSSPSPKSSSFSTTFVLAIVTPSSGRGGHGLAFTLSPSKQFPGALPEHYM 122
Query: 131 GILNSTNNGEPSNHILIVEFDTVNGFNDKAENQGNHVGIGINTMFSNRSEPASYYINGTD 190
GI NS +G SNHI+ VEFDTVNG+ND+ +++GNHVGI INTM+SN +EPA+YY+N T+
Sbjct: 123 GIFNSETDGSSSNHIVAVEFDTVNGYNDRLDSKGNHVGININTMYSNATEPAAYYVNNTE 182
Query: 191 HKEEMTLESGEPIQAWIEYDGEQKVLNVTISPAEIGKPMRPLISFGVNLTGYIKETMYVG 250
KE+M LESG+ IQAWIEYDG +NVTI P + KP +PLIS ++LT +++ETMYVG
Sbjct: 183 LKEDMILESGDAIQAWIEYDG--NFVNVTICPFHLNKPSKPLISHPIDLTPFVQETMYVG 240
Query: 251 FSASTGEKSSSHYILGWSFSLNGVAPALNVSELP-KPPKEKEPSSYNPKILALIVSLCLV 309
FSASTG+KSSSHYILGWSFS NG A LN S +P P K+ + SS++ +++ LIV+L V
Sbjct: 241 FSASTGQKSSSHYILGWSFSTNGTAAQLNTSRIPMAPSKQNDGSSFDTRVIGLIVALSTV 300
Query: 310 TFLLLGTLVFFLIYRKWSNSETLEDWEKDCPHRFRYKDLYAATKGFKESEVIGIGGFGSV 369
T LLLG L++F +Y++ + E LEDWE DCPHRFR KDLYAAT+GF+ SE+IG+GGF +V
Sbjct: 301 TVLLLGILIYFTLYKRNAKYEDLEDWELDCPHRFRCKDLYAATRGFQLSEIIGVGGFAAV 360
Query: 370 YKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVY 429
YKGVLPTTG EVAVKKIT++S+QG+REF AEIESLGRLRHKNLV L GWCK+KNDLLLVY
Sbjct: 361 YKGVLPTTGTEVAVKKITQSSIQGLREFVAEIESLGRLRHKNLVYLQGWCKRKNDLLLVY 420
Query: 430 EYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALI 489
+YIPNGSL +LLF + G VL WE+RFNI+KGIA+GLLYLHEEWE VVIHRDVK SN LI
Sbjct: 421 DYIPNGSLYSLLFNQEQGFVLSWEKRFNIIKGIAAGLLYLHEEWELVVIHRDVKSSNVLI 480
Query: 490 DAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLE 549
DA+MNARLGDFGLARLYDHG HTTN+VGT GYIAPEL + GKASTSSDVFAYG+LLLE
Sbjct: 481 DADMNARLGDFGLARLYDHGTDSHTTNIVGTVGYIAPELARNGKASTSSDVFAYGVLLLE 540
Query: 550 VATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSYVVKEMELVLKLGLMCSH-KT 608
+ GR+P+ S + LV+WV ECHQ+G ILD DP LNSSYV +E++LVL LGL+CSH K
Sbjct: 541 IVCGRKPVDSRNFFLVDWVIECHQMGHILDAMDPKLNSSYVTEEVKLVLLLGLLCSHPKP 600
Query: 609 QFRPTMRQVMRYLSGEKQLRFNNDWGSIDYRQGFDEFSSRTFDEISTGTFKSSHR 663
+ RP+M +++RYL+G++++ ++W + D DE + + +S+ + S+R
Sbjct: 601 EVRPSMSKIVRYLNGDERIPSIDNWEAFDSS---DETYLKFLETVSSDSITKSYR 652
|
Source: Gossypium hirsutum Species: Gossypium hirsutum Genus: Gossypium Family: Malvaceae Order: Malvales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224139244|ref|XP_002323017.1| predicted protein [Populus trichocarpa] gi|222867647|gb|EEF04778.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 823 bits (2126), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 415/639 (64%), Positives = 506/639 (79%), Gaps = 8/639 (1%)
Query: 3 MGNSSALFLLFFFFIRLNIVAQSQSSSFIFQGFNGGATNLSLQGAEIIKPSGALKLTNRS 62
M ++ LFLL+ F ++++ ++QS FIF GFN NL++ GA IIKPSG L+LTN++
Sbjct: 1 MASTICLFLLYMF---ISMIVEAQSVEFIFNGFNESEKNLTIDGASIIKPSGLLRLTNKT 57
Query: 63 RYVIGHAFYVKPIQMFDTSASPSPNASSFSTTFVFEISTPRSGRGGHGLAFLLAPSTKLP 122
+Y +GHAFY KPIQM DTS++ SPNASSFSTTFVF+I +P+ G+GGHGLAF LAPS + P
Sbjct: 58 QYAVGHAFYSKPIQMLDTSSNSSPNASSFSTTFVFQIVSPK-GKGGHGLAFALAPSNQFP 116
Query: 123 GAQPEHYLGILNSTNNGEPSNHILIVEFDTVNGFNDKAENQGNHVGIGINTMFSNRSEPA 182
GA EHYLG+ N +NNG+ SNHI VEFDTVNGFN+ ++ +GNHVG+ IN+M S S A
Sbjct: 117 GAAAEHYLGLFNPSNNGDSSNHIFAVEFDTVNGFNENSDTEGNHVGVNINSMRSKSSRAA 176
Query: 183 SYYINGT-DHKEEMTLESGEPIQAWIEYDGEQKVLNVTISPAEIGKPMRPLISFGVNLTG 241
SY + D EE+TLESGEPIQAWIEYDG K+++VTI P E +P+RPLISF V+L+
Sbjct: 177 SYREDDNPDRYEELTLESGEPIQAWIEYDGAAKLVSVTIGPMEKSRPIRPLISFPVDLSA 236
Query: 242 YIKETMYVGFSASTGEKSSSHYILGWSFSLNGV-APALNVSELPKPP-KEKEPSSYNPKI 299
+K+ MY GFS+STG+K+SSHYILGWSFS A LN+S LP+ P E+ SS+ P +
Sbjct: 237 VVKDNMYAGFSSSTGKKTSSHYILGWSFSTEKAGARPLNLSLLPRAPISEESSSSFQPSV 296
Query: 300 LALIVSLCLVTFLLLGTLVFFLIYRKWSNSETLEDWEKDCPHRFRYKDLYAATKGFKESE 359
+A+I SLC VT +L L+F +YR W SE LEDWE DCPHRFRY+DL+ ATKGFK+SE
Sbjct: 297 IAIIASLCGVTTILFAILLFHAVYRNWPQSEALEDWEVDCPHRFRYQDLHTATKGFKKSE 356
Query: 360 VIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNLHGWC 419
+IG GGFG+VYKG LPT G EVAVK+IT NS+QG+R F AEIESLGRLRHKNLVNL GWC
Sbjct: 357 IIGAGGFGAVYKGRLPTNGNEVAVKRITTNSIQGLRGFTAEIESLGRLRHKNLVNLQGWC 416
Query: 420 KQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIH 479
K+ NDLLLVY+YIPNGSL LLF + VL WEQRFNIVKGIA+GLLYLHEEWEQVVIH
Sbjct: 417 KRNNDLLLVYDYIPNGSLAGLLFSRGNNFVLSWEQRFNIVKGIAAGLLYLHEEWEQVVIH 476
Query: 480 RDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPELTQTGKASTSSD 539
RDVK SN LIDA MN RLGDFGLARLYDHG M HTTN+VGT GYIAPEL +TG+ASTSSD
Sbjct: 477 RDVKSSNVLIDAGMNGRLGDFGLARLYDHGTMSHTTNIVGTIGYIAPELARTGQASTSSD 536
Query: 540 VFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSYVVKEMELVLK 599
V+AYGILLLEVA GR+P+ + + +L ++V ECHQ GR+LD ADP LNS++VVKEME+VL
Sbjct: 537 VYAYGILLLEVACGRKPVETSNFILTDFVIECHQKGRVLDAADPELNSAFVVKEMEVVLG 596
Query: 600 LGLMCS-HKTQFRPTMRQVMRYLSGEKQLRFNNDWGSID 637
LGL+CS HK + RPTMR+V+RYL+ E++L +D GS D
Sbjct: 597 LGLLCSHHKPKARPTMREVIRYLNWEEKLPVIDDLGSSD 635
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224087800|ref|XP_002308233.1| predicted protein [Populus trichocarpa] gi|222854209|gb|EEE91756.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 818 bits (2114), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 409/651 (62%), Positives = 501/651 (76%), Gaps = 7/651 (1%)
Query: 21 IVAQSQSSSFIFQGFNGGATNLSLQGAEIIKPSGALKLTNRSRYVIGHAFYVKPIQMFDT 80
+VA++Q F+F GFNG NL+L IIKPSG L+LTN+++ +GHAFY + +QM +
Sbjct: 1 MVAEAQDVEFLFNGFNGSEANLTLDKVSIIKPSGLLRLTNKTQNAVGHAFYSEKVQMLNR 60
Query: 81 SASPSPNASSFSTTFVFEISTPRSGRGGHGLAFLLAPSTKLPGAQPEHYLGILNSTNNGE 140
S+S SPNASSFST FVF+I +P G GG G AF L+PS +LPGA+ HYLG+ NSTN+G
Sbjct: 61 SSSSSPNASSFSTAFVFQIISPSKGEGGFGFAFTLSPSDRLPGAEARHYLGLFNSTNDGS 120
Query: 141 PSNHILIVEFDTVNGFNDKAENQGNHVGIGINTMFSNRSEPASYY--INGTDHKEEMTLE 198
SN+I VEFDTVNGFN ++ GNHVGI IN++ S +PASY +N D EE+ L+
Sbjct: 121 SSNYIFAVEFDTVNGFNKSTDSVGNHVGININSVDSKAGKPASYNDDVNRLDSFEELVLD 180
Query: 199 SGEPIQAWIEYDGEQKVLNVTISPAEIGKPMRPLISFGVNLTGYIKETMYVGFSASTGEK 258
SG+PIQAW+EY+G K NVTI+P + GKP++PLISF +L+ Y++E MYVGFSASTG K
Sbjct: 181 SGKPIQAWVEYNGVTKCTNVTIAPMDHGKPIQPLISFPQDLSTYVREDMYVGFSASTGNK 240
Query: 259 SSSHYILGWSFSLNGVAPALNVSELPKPPKEKEPSSYNPKILALIVSLCLVTFLLLGTLV 318
+SSHYILGWSFS G AP LN+S LP +EK SS+ P ++ +I SLC VT LL L
Sbjct: 241 ASSHYILGWSFSTKGEAPPLNLSRLPIALQEKNSSSFRPSVIVIIASLCGVTTLLFVILF 300
Query: 319 FFLIYR-KWSNSETLEDWEKDCPHRFRYKDLYAATKGFKESEVIGIGGFGSVYKGVLPTT 377
F +Y+ KW SE LEDWE +CPHRFRY+DLY ATKGFK+SE+IG+GGFG+VYKG LPT
Sbjct: 301 FLTVYKIKWRQSEALEDWELECPHRFRYQDLYTATKGFKKSEIIGVGGFGAVYKGRLPTN 360
Query: 378 GGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEYIPNGSL 437
G EVAVKKI NS+QG+REF AEIESLGRLRHKNLVNL GWCK+ NDLLLVY++IPNGSL
Sbjct: 361 GNEVAVKKINNNSIQGLREFTAEIESLGRLRHKNLVNLQGWCKKNNDLLLVYDFIPNGSL 420
Query: 438 DTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARL 497
LLF + VL WEQRFNIVKG+A+GLLYLHEEWEQVVIHRDVK N LIDAEMN RL
Sbjct: 421 AGLLFSRINNFVLSWEQRFNIVKGVAAGLLYLHEEWEQVVIHRDVKSGNVLIDAEMNGRL 480
Query: 498 GDFGLARLYDHGGMPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPI 557
GDFGLARLYDHG M HTTN+VGT GY+APELT+TG++STSSDV+AYGILLLEVA GR+P+
Sbjct: 481 GDFGLARLYDHGTMSHTTNIVGTIGYLAPELTRTGQSSTSSDVYAYGILLLEVACGRKPV 540
Query: 558 GSGDLLLVEWVRECHQLGRILDVADPLLNSSYVVKEMELVLKLGLMCSH-KTQFRPTMRQ 616
+ + +L++ V E HQ+GRI+D ADP LNS++VVKEMELVL LGL+CSH K + RPTMRQ
Sbjct: 541 ETSNFILIDSVIEYHQMGRIIDAADPKLNSAFVVKEMELVLGLGLLCSHRKPKARPTMRQ 600
Query: 617 VMRYLSGEKQLRFNNDWGSIDYRQGFDEFSSRTFDEISTGTFKSSHRSSSI 667
V RYL+ E +L +D GS D +G +F + +S+ T S+ SSSI
Sbjct: 601 VTRYLNWEDKLPVIDDLGSPDSLRGSTKFMEVS---VSSNTITGSYPSSSI 648
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224139246|ref|XP_002323018.1| predicted protein [Populus trichocarpa] gi|222867648|gb|EEF04779.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 817 bits (2111), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 420/663 (63%), Positives = 511/663 (77%), Gaps = 12/663 (1%)
Query: 3 MGNSSALFLLFFFFIRLNIVAQSQSSSFIFQGFNGGATNLSLQGAEIIKPSGALKLTNRS 62
M ++ LFLL+ F ++++ ++QS FIF GFN NL++ GA IIKPSG L+LTN++
Sbjct: 1 MASTICLFLLYMF---ISMIVEAQSVEFIFNGFNESEKNLTIDGASIIKPSGLLRLTNKT 57
Query: 63 RYVIGHAFYVKPIQMFDTSASPSPNASSFSTTFVFEISTPRSGRGGHGLAFLLAPSTKLP 122
+Y +GHAFY KPIQM DTS++ SPNASSFSTTFVF+I +P+ G+GGHGLAF LAPS + P
Sbjct: 58 QYAVGHAFYSKPIQMLDTSSNSSPNASSFSTTFVFQIVSPK-GKGGHGLAFALAPSNQFP 116
Query: 123 GAQPEHYLGILNSTNNGEPSNHILIVEFDTVNGFNDKAENQGNHVGIGINTMFSNRSEPA 182
GA EHYLG+ N +NNG+ SNHI VEFDTVNGFN+ ++ +GNHVG+ IN+M S S A
Sbjct: 117 GAAAEHYLGLFNPSNNGDSSNHIFAVEFDTVNGFNENSDTEGNHVGVNINSMRSKSSRAA 176
Query: 183 SYYINGT-DHKEEMTLESGEPIQAWIEYDGEQKVLNVTISPAEIGKPMRPLISFGVNLTG 241
SY + D EE+TLESGEPIQAWIEYDG K+++VTI P E +P+RPLISF V+L+
Sbjct: 177 SYREDDNPDRYEELTLESGEPIQAWIEYDGAAKLVSVTIGPMEKSRPIRPLISFPVDLSA 236
Query: 242 YIKETMYVGFSASTGEKSSSHYILGWSFSLNGV-APALNVSELPKPP-KEKEPSSYNPKI 299
+K+ MY GFS+STG+K+SSHYILGWSFS A LN+S LP+ P E+ SS+ P +
Sbjct: 237 VVKDNMYAGFSSSTGKKTSSHYILGWSFSTEKAGARPLNLSLLPRAPISEESSSSFQPSV 296
Query: 300 LALIVSLCLVTFLLLGTLVFFLIYRKWSNSETLEDWEKDCPHRFRYKDLYAATKGFKESE 359
+A+I SLC VT +L L F +YR W SE LEDWE DCPHRFRY+DL+ ATKGFK+SE
Sbjct: 297 IAIIASLCGVTTILFAILFFHAVYRNWPQSEALEDWEVDCPHRFRYQDLHTATKGFKKSE 356
Query: 360 VIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNLHGWC 419
+IG GGFG+VYKG LPT G EVAVK+IT NS+QG+R F AEIESLGRLRHKNLVNL GWC
Sbjct: 357 IIGAGGFGAVYKGRLPTNGNEVAVKRITPNSIQGLRGFTAEIESLGRLRHKNLVNLQGWC 416
Query: 420 KQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIH 479
K+ NDLLLVY+YIPNG L LLF + VL WEQRFNIVK IA+GLLYLHEEWEQVVIH
Sbjct: 417 KRNNDLLLVYDYIPNGCLAGLLFSRGNNFVLSWEQRFNIVKDIAAGLLYLHEEWEQVVIH 476
Query: 480 RDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPELTQTGKASTSSD 539
RDVK SN LIDA MN RLGDFGLARLYDHG M HTTN+VGT GYIAPEL +TG+ASTSSD
Sbjct: 477 RDVKSSNVLIDAGMNGRLGDFGLARLYDHGTMSHTTNIVGTIGYIAPELARTGQASTSSD 536
Query: 540 VFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSYVVKEMELVLK 599
V+AYGILLLEVA GR+P+ + + +L ++V ECHQ GR+LD ADP LNS++VVKEME+VL
Sbjct: 537 VYAYGILLLEVACGRKPVETSNFILTDFVIECHQKGRVLDAADPELNSAFVVKEMEVVLG 596
Query: 600 LGLMCS-HKTQFRPTMRQVMRYLSGEKQLRFNNDWGSIDYRQGFDEFSSRTFDEISTGTF 658
LGL+CS HK + RPTMR+V+RYL+ E++L +D GS D SSR E+S
Sbjct: 597 LGLLCSHHKPKARPTMREVIRYLNWEEKLPVIDDLGSSDSPCR----SSRYMGEVSIEMI 652
Query: 659 KSS 661
SS
Sbjct: 653 TSS 655
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255571419|ref|XP_002526657.1| kinase, putative [Ricinus communis] gi|223533957|gb|EEF35679.1| kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 804 bits (2077), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 408/668 (61%), Positives = 508/668 (76%), Gaps = 8/668 (1%)
Query: 3 MGNSSALFLLFFFFIRLNIVAQSQSSSFIFQGFNGGATNLSLQGAEIIKPSGALKLTNRS 62
M SS +++F F+ IV Q+QS F F GFNG L+L A + KPSGAL+LTN++
Sbjct: 1 MAASSMNSVVWFIFLLYTIVDQAQSEEFTFNGFNGKEKLLALDRASVFKPSGALRLTNKT 60
Query: 63 RYVIGHAFYVKPIQMFDTSASPSPNASSFSTTFVFEISTPRSGRGGHGLAFLLAPSTKLP 122
+ IGHAFY IQMF+ + SPN +SF TTFVF I P SG GG G F L+P++++P
Sbjct: 61 KNAIGHAFYSNTIQMFNKT---SPNPTSFQTTFVFSIVPPASGEGGFGFGFALSPTSQIP 117
Query: 123 GAQPEHYLGILNSTNNGEPSNHILIVEFDTVNGFNDKAENQGNHVGIGINTMFSNRSEPA 182
GA HYLG+ N+ NNGE +NHI VEFDTV GFN+ + GNH+GI IN+M SN ++ A
Sbjct: 118 GAAAGHYLGLFNNLNNGESTNHIFAVEFDTVKGFNETGDTTGNHIGININSMDSNETQAA 177
Query: 183 SYYINGTDHKEE-MTLESGEPIQAWIEYDGEQKVLNVTISPAEIGKPMRPLISF-GVNLT 240
+Y I+ D +E+ + L G+PIQAW+EYDG +KV+ VTI P KP+ PLI+F G+NL+
Sbjct: 178 AY-ISVNDTREDGLNLHDGKPIQAWVEYDGAKKVVTVTICPMGQPKPVIPLINFTGLNLS 236
Query: 241 GYIKETMYVGFSASTGEKSSSHYILGWSFSLNGVAPALNVSELPKPPKEKEPSSYNPKIL 300
+KE YVGFSASTGE +SSHYILGWSFS G APALN+ ELP PP EK+ SS++ ++
Sbjct: 237 EIVKENTYVGFSASTGENASSHYILGWSFSTTGAAPALNLDELPMPPDEKDSSSFSRTVV 296
Query: 301 ALIVSLCLVTFLLLGTLVFFLIYRKWSNSETLEDWEKDCPHRFRYKDLYAATKGFKESEV 360
ALI +LC++ LL+G L+ +Y+ + E+LEDWE +CPHRF Y+DLY ATKGFKESE+
Sbjct: 297 ALISALCVMAVLLIGILLCLTLYKSMATFESLEDWELECPHRFGYRDLYTATKGFKESEI 356
Query: 361 IGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNLHGWCK 420
IG+GGFG VYK V+ G EVAVKKITRNS+QG++EF+AEIESLGRLRHK+LVNL GWCK
Sbjct: 357 IGVGGFGIVYKAVMRNDGNEVAVKKITRNSVQGLKEFSAEIESLGRLRHKHLVNLQGWCK 416
Query: 421 QKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHR 480
++NDL LVY+YIPNGSLD+LLF PK+ SVL W+QRFNIVKGIA+GLLYLHEEW+QVVIHR
Sbjct: 417 RENDLFLVYDYIPNGSLDSLLFHPKNNSVLSWDQRFNIVKGIAAGLLYLHEEWDQVVIHR 476
Query: 481 DVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPELTQTGKASTSSDV 540
DVK SN LIDAEMN RLGDFGLARLYDHG HTT+VVGT GYIAPEL +TGKASTSSDV
Sbjct: 477 DVKSSNVLIDAEMNGRLGDFGLARLYDHGINSHTTSVVGTIGYIAPELARTGKASTSSDV 536
Query: 541 FAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSYVVKEMELVLKL 600
FAYG+LLLEVATGRRPIGSG +LV+WV EC Q+G+ILD DP LNS+Y +E+ELVL+L
Sbjct: 537 FAYGVLLLEVATGRRPIGSGQFILVDWVLECQQVGKILDAVDPNLNSNYTAEEVELVLEL 596
Query: 601 GLMCSHK-TQFRPTMRQVMRYLSGEKQLRFNNDWGSIDYRQGFDEFSSRTFDEISTGTFK 659
GL+C+H+ + RP+MRQV YL+G+ +L DWGS + E +SR +
Sbjct: 597 GLLCAHQNSDSRPSMRQVTTYLNGDYKLPVIEDWGSYESHH-LSEINSRLLKLSNCEMTS 655
Query: 660 SSHRSSSI 667
+S+RSSSI
Sbjct: 656 TSYRSSSI 663
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359481281|ref|XP_002267556.2| PREDICTED: uncharacterized protein LOC100267833 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 759 bits (1961), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 412/660 (62%), Positives = 491/660 (74%), Gaps = 21/660 (3%)
Query: 19 LNIVAQSQSSS--FIFQGFNGGATNLSLQGAEIIKPSGALKLTNRSRYVIGHAFYVKPIQ 76
+N AQSQSSS F++ GFN N +L+GA IIKPSGALKLTNRSR VIGHAFY PI
Sbjct: 774 VNGAAQSQSSSLDFVYNGFNRTEKNFTLKGATIIKPSGALKLTNRSRDVIGHAFYPDPIN 833
Query: 77 MFDTSASPSPNASSFSTTFVFEISTPRSGRGGHGLAFLLAPSTKLPGAQPEHYLGILNST 136
+ ++S + S ++SF + + S GG+GLAFLL+PST L GA H+LGILNST
Sbjct: 834 LLNSSNNISSFSTSFVFSII----PSGSDGGGYGLAFLLSPSTDLQGADSGHFLGILNST 889
Query: 137 NNGEPSNHILIVEFDTVNGFNDKAENQGNHVGIGINTMFSNRSEPASYYINGTDHKEEMT 196
N+G+ SNHI VEFDTVNG N+ ++GNHVGI IN M S SEPASYY+N TD KEE+
Sbjct: 890 NDGDESNHIFAVEFDTVNGHNEGKSSEGNHVGININKMDSIASEPASYYVNDTDKKEEVN 949
Query: 197 LESGEPIQAWIEY-DGEQKVLNVTISPAEI-GKPMRPLISFGVNLTGYIKETMYVGFSAS 254
L+SG IQAWI+Y DG V+NVTI+P + KPM+PL+S + L G + +MYVGFSAS
Sbjct: 950 LDSGH-IQAWIDYADG---VVNVTIAPLSVPDKPMKPLMSKEIELPGVVTNSMYVGFSAS 1005
Query: 255 TGEKSSSHYILGWSFSLNGVAPALNVSELPKPPKEKEPSSYNPKILALIVSLCLVTFLLL 314
TGE+ SSHYILGWSF +NG A LN+S LP PP E + SS + I LI L ++ L+
Sbjct: 1006 TGEERSSHYILGWSFCINGTARPLNLSILPVPPIETDSSSLHTGIKVLITGLAVI-LLVF 1064
Query: 315 GTLVFFLIYRKWSNSETLEDWEKDCPHRFRYKDLYAATKGFKESEVIGIGGFGSVYKGVL 374
G + L+YR+ E LEDWE D PHRFRYKDLY +TKGFK SEVIG+GGF +VYKGVL
Sbjct: 1065 GAWLIRLLYRRKMKPEDLEDWELDYPHRFRYKDLYTSTKGFKVSEVIGVGGFATVYKGVL 1124
Query: 375 PTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEYIPN 434
PT G EVAVKKI +N GMREFAAEIESLGRLRHKNLVNL GWCK KNDLLLVY+YIPN
Sbjct: 1125 PTNGNEVAVKKIVQNLTHGMREFAAEIESLGRLRHKNLVNLQGWCKHKNDLLLVYDYIPN 1184
Query: 435 GSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMN 494
GSLD+LLF P D VL W+QRF I++GIA+GLLYLHEEWE+VVIHRDVK SN LID++MN
Sbjct: 1185 GSLDSLLFHPPDNFVLSWDQRFKILRGIAAGLLYLHEEWEKVVIHRDVKASNVLIDSDMN 1244
Query: 495 ARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGR 554
RLGDFGLARLYDHG HTT+VVGT GYIAPELT+TGKASTSSDVFAYG+LLLEVA G+
Sbjct: 1245 GRLGDFGLARLYDHGKNSHTTSVVGTIGYIAPELTRTGKASTSSDVFAYGVLLLEVACGK 1304
Query: 555 RPIGSGD------LLLVEWVRECHQLGRILDVADPLLNSSYVVKEMELVLKLGLMCSH-K 607
RPI D +L++WV EC+Q G+ILD DP +NS YVV+E+ELVL+LGL CSH +
Sbjct: 1305 RPIRPADSQSSDHFILMDWVFECYQAGQILDAVDPRMNSVYVVEEVELVLRLGLFCSHPR 1364
Query: 608 TQFRPTMRQVMRYLSGEKQLRFNNDWGSIDYRQGFDEFSSRTFDEISTGTFKSSHRSSSI 667
+ RPTMRQV RYLS + L +DW + D + F + S R +ST T SS RSSS+
Sbjct: 1365 PEARPTMRQVTRYLSRDDPLPIVDDWAAPDSSR-FSDISPRFLQIVSTDTITSSCRSSSV 1423
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449483730|ref|XP_004156672.1| PREDICTED: lectin-domain containing receptor kinase VI.4-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 753 bits (1945), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 391/675 (57%), Positives = 498/675 (73%), Gaps = 26/675 (3%)
Query: 1 MEMGNSSALFLLFFFFIRLNIVAQSQSSSFIFQGFNGGATNLSLQGAEIIKPSGALKLTN 60
M MG S ++ FF++ + V +SF+ GFN + L QGA I +PSG L+LT+
Sbjct: 1 MAMGFSLPCLVILFFYVAVLCV----QASFVCHGFNNSSMLLD-QGASI-EPSGLLRLTD 54
Query: 61 RSRYVIGHAFYVKPIQMFDTSASPSPNASSFSTTFVFEISTPRSGRG-GHGLAFLLAPST 119
S+YVIG AFY + MFD + P + SSFST+FVF I SG G+GLAF++APST
Sbjct: 55 SSQYVIGRAFYPETQLMFDIKSEPVSDVSSFSTSFVFAIVPSSSGPPVGYGLAFVMAPST 114
Query: 120 KLPGAQPEHYLGILNSTNNGEPSNHILIVEFDTVNGFNDKAENQGNHVGIGINTMFSNRS 179
+ P A EHYLG+ N +NNG+PSNHI VEFDTVNG +D+ +GNHVGI N + S+ S
Sbjct: 115 QFPDAASEHYLGLFNPSNNGDPSNHIFAVEFDTVNGHDDETNFKGNHVGINKNGVRSSAS 174
Query: 180 EPASYYINGTDHKEEMTLESGEPIQAWIEYDGEQKVLNVTISPAEIGKPMRPLISFGVNL 239
E A Y G+D K E+ L++G+ IQAWI+YDG KV+NVTI+PA + +P PLIS+ +NL
Sbjct: 175 ESAEYSDYGSDVKTEVYLDTGDLIQAWIDYDGHSKVVNVTIAPASVIRPTEPLISYPINL 234
Query: 240 TGYIKETMYVGFSASTGEKSSSHYILGWSFSLNGVAPALNVSELPKPPKEKEPS-----S 294
T + E M+VGFSASTG+++S HYI GWSF++N AP L+VS+LP P K + P +
Sbjct: 235 TSVLNERMFVGFSASTGKETSFHYISGWSFAINESAPQLDVSQLPPPLKVQSPPPSSPST 294
Query: 295 YNPKILALIVSLCLVTFLLLGTLVFFLIYRKWSNSETLEDWEKDCPHRFRYKDLYAATKG 354
+NP + ++ L +T +L+ L I+R+ E LE+WE+DCPHRF Y+DLY ATKG
Sbjct: 295 FNPLVTVVVPILSAMTLMLI--LFLASIFRRRLRGENLEEWERDCPHRFSYRDLYKATKG 352
Query: 355 FKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVN 414
FK+SE+IG GGFGSVY+GVLP+TG E+AVKKITRN+ QGMREFAAEIESLGRLRHKNLVN
Sbjct: 353 FKDSELIGSGGFGSVYRGVLPSTGCEIAVKKITRNASQGMREFAAEIESLGRLRHKNLVN 412
Query: 415 LHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWE 474
L GWCK++NDLLLVY+Y+PNGSLD+LL+ PKD VL+WEQR NI+KG+A GLLYLHEEWE
Sbjct: 413 LQGWCKKQNDLLLVYDYVPNGSLDSLLYHPKDNLVLNWEQRINILKGVAGGLLYLHEEWE 472
Query: 475 QVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPELTQTGKA 534
QVVIHRDVKPSN LID MNARL DFGLARLYDH + HTT+VVGT GYI+PEL +TGKA
Sbjct: 473 QVVIHRDVKPSNILIDISMNARLSDFGLARLYDHDQISHTTSVVGTIGYISPELARTGKA 532
Query: 535 STSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSYVVKEM 594
S ++DVFAYG+L+LE+A GRRP+ S +LV+WV EC++ GR+LD ADP LN Y + EM
Sbjct: 533 SKTTDVFAYGVLILEMACGRRPLESDIFILVDWVMECYEKGRVLDAADPKLNGIYDMVEM 592
Query: 595 ELVLKLGLMCSH-KTQFRPTMRQVMRYLSGEKQ-LRFN-NDWGSIDYR--QGFDEF---S 646
E+VLKLGL+CSH + RP+MRQV R+L+GE Q L F+ + + I ++ GF +F S
Sbjct: 593 EMVLKLGLLCSHYNPESRPSMRQVTRFLNGEDQILAFDPSPYSQITFQSSSGFTQFIPPS 652
Query: 647 SRTFDEISTGTFKSS 661
SRT ST +F SS
Sbjct: 653 SRT----STASFLSS 663
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449440249|ref|XP_004137897.1| PREDICTED: lectin-domain containing receptor kinase VI.4-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 753 bits (1944), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 391/675 (57%), Positives = 498/675 (73%), Gaps = 26/675 (3%)
Query: 1 MEMGNSSALFLLFFFFIRLNIVAQSQSSSFIFQGFNGGATNLSLQGAEIIKPSGALKLTN 60
M MG S ++ FF++ + V +SF+ GFN + L QGA I +PSG L+LT+
Sbjct: 1 MAMGFSLPCLVILFFYVAVLCV----QASFVCHGFNNSSMLLD-QGASI-EPSGLLRLTD 54
Query: 61 RSRYVIGHAFYVKPIQMFDTSASPSPNASSFSTTFVFEISTPRSGRG-GHGLAFLLAPST 119
S+YVIG AFY + MFD + P + SSFST+FVF I SG G+GLAF++APST
Sbjct: 55 SSQYVIGRAFYPETQLMFDIKSEPVSDVSSFSTSFVFAIVPSSSGPPVGYGLAFVMAPST 114
Query: 120 KLPGAQPEHYLGILNSTNNGEPSNHILIVEFDTVNGFNDKAENQGNHVGIGINTMFSNRS 179
+ P A EHYLG+ N +NNG+PSNHI VEFDTVNG +D+ +GNHVGI N + S+ S
Sbjct: 115 QFPDAASEHYLGLFNPSNNGDPSNHIFAVEFDTVNGHDDETNFKGNHVGINKNGVRSSAS 174
Query: 180 EPASYYINGTDHKEEMTLESGEPIQAWIEYDGEQKVLNVTISPAEIGKPMRPLISFGVNL 239
E A Y G+D K E+ L++G+ IQAWI+YDG KV+NVTI+PA + +P PLIS+ +NL
Sbjct: 175 ESAEYSDYGSDVKTEVYLDTGDLIQAWIDYDGRSKVVNVTIAPASVIRPTEPLISYPINL 234
Query: 240 TGYIKETMYVGFSASTGEKSSSHYILGWSFSLNGVAPALNVSELPKPPKEKEPS-----S 294
T + E M+VGFSASTG+++S HYI GWSF++N AP L+VS+LP P K + P +
Sbjct: 235 TSVLNERMFVGFSASTGKETSFHYISGWSFAINESAPQLDVSQLPPPLKVQSPPPSSPST 294
Query: 295 YNPKILALIVSLCLVTFLLLGTLVFFLIYRKWSNSETLEDWEKDCPHRFRYKDLYAATKG 354
+NP + ++ L +T +L+ L I+R+ E LE+WE+DCPHRF Y+DLY ATKG
Sbjct: 295 FNPLVTVVVPILSAMTLMLI--LFLASIFRRRLRGENLEEWERDCPHRFSYRDLYKATKG 352
Query: 355 FKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVN 414
FK+SE+IG GGFGSVY+GVLP+TG E+AVKKITRN+ QGMREFAAEIESLGRLRHKNLVN
Sbjct: 353 FKDSELIGSGGFGSVYRGVLPSTGCEIAVKKITRNASQGMREFAAEIESLGRLRHKNLVN 412
Query: 415 LHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWE 474
L GWCK++NDLLLVY+Y+PNGSLD+LL+ PKD VL+WEQR NI+KG+A GLLYLHEEWE
Sbjct: 413 LQGWCKKQNDLLLVYDYVPNGSLDSLLYHPKDNLVLNWEQRINILKGVAGGLLYLHEEWE 472
Query: 475 QVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPELTQTGKA 534
QVVIHRDVKPSN LID MNARL DFGLARLYDH + HTT+VVGT GYI+PEL +TGKA
Sbjct: 473 QVVIHRDVKPSNILIDISMNARLSDFGLARLYDHDQISHTTSVVGTIGYISPELARTGKA 532
Query: 535 STSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSYVVKEM 594
S ++DVFAYG+L+LE+A GRRP+ S +LV+WV EC++ GR+LD ADP LN Y + EM
Sbjct: 533 SKTTDVFAYGVLILEMACGRRPLESDIFILVDWVMECYEKGRVLDAADPKLNGIYDMVEM 592
Query: 595 ELVLKLGLMCSH-KTQFRPTMRQVMRYLSGEKQ-LRFN-NDWGSIDYR--QGFDEF---S 646
E+VLKLGL+CSH + RP+MRQV R+L+GE Q L F+ + + I ++ GF +F S
Sbjct: 593 EMVLKLGLLCSHYNPESRPSMRQVTRFLNGEDQILAFDPSPYSQITFQSSSGFTQFIPPS 652
Query: 647 SRTFDEISTGTFKSS 661
SRT ST +F SS
Sbjct: 653 SRT----STASFLSS 663
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449440251|ref|XP_004137898.1| PREDICTED: probable L-type lectin-domain containing receptor kinase VI.1-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 744 bits (1922), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 382/669 (57%), Positives = 487/669 (72%), Gaps = 16/669 (2%)
Query: 1 MEMGNSSALFLLFFFFIRLNIVAQSQSSSFIFQGFNGGATNLSLQGAEIIKPSGALKLTN 60
M + AL +F FF A + SSFI+ GFN T+L +GA ++KP GAL+LTN
Sbjct: 1 MAIAAHLALLSVFIFF-----EAHALPSSFIYPGFNN--TSLDREGASVVKPYGALRLTN 53
Query: 61 RSRYVIGHAFYVKPIQMFDTSASPSPNASSFSTTFVFEISTPRSGRGGHGLAFLLAPSTK 120
S+ VIGHAF+ +MF+ S+ SPN SFSTTFVF I G+GG+GLAF +APSTK
Sbjct: 54 ISQNVIGHAFHPTSFRMFEQSSDSSPNVLSFSTTFVFAIEPSSPGQGGYGLAFAIAPSTK 113
Query: 121 LPGAQPEHYLGILNSTNNGEPSNHILIVEFDTVNGFNDKAENQGNHVGIGINTMFSNRSE 180
GA HYLG+ NS+NNG PSNHI +EFDTVNG ++ +GNHVGI IN + S S+
Sbjct: 114 FSGAGSGHYLGLFNSSNNGNPSNHIFAIEFDTVNGHGEERNTKGNHVGIDINDISSVTSK 173
Query: 181 PASYYINGTDHKEEMTLESGEPIQAWIEYDGEQKVLNVTISPAEIG-KPMRPLISFGVNL 239
PASY G H+ ++ ++SG+PI W+EYDG +K++NVTI+P + KP + L+S+ ++L
Sbjct: 174 PASYSDYGEAHEHDLQMDSGDPIIVWVEYDGPKKIVNVTIAPLKHKRKPTKSLLSYPIDL 233
Query: 240 TGYIKETMYVGFSASTGEKSSSHYILGWSFSLNGVAPALNVSELPKPPKEKEPSSYNPKI 299
++KE M+VGFSASTG+K+SSHYILGWSF++N AP L+ S LP PPKE++P S +P
Sbjct: 234 KPFLKEQMFVGFSASTGDKTSSHYILGWSFAMNEPAPPLDYSLLPNPPKEQDPPSSSPNS 293
Query: 300 LALIVSLCLVTFLLLGTLVFFLIYRKWSNSETLEDWEKDCPHRFRYKDLYAATKGFKESE 359
+ + +LG YRK ++E LEDWE+DCPHRF Y DLY ATKGFK SE
Sbjct: 294 RYKVFVAVVSVIAILGIFFLAFWYRKTWHTERLEDWERDCPHRFHYTDLYTATKGFKSSE 353
Query: 360 VIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNLHGWC 419
+IGIGGFGSVYKG + +TG E+AVK++ RNS QGM+EFAAEIESLGRLRHKNLVNL GWC
Sbjct: 354 LIGIGGFGSVYKGQIRSTGIEIAVKRVRRNSGQGMKEFAAEIESLGRLRHKNLVNLQGWC 413
Query: 420 KQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIH 479
K+KNDLL+VY+YIPNGSL +LL+ PK+ +L+W+QRFNI+KGIA+GLLYLHEEWEQVVIH
Sbjct: 414 KKKNDLLIVYDYIPNGSLYSLLYHPKNNIILNWKQRFNILKGIAAGLLYLHEEWEQVVIH 473
Query: 480 RDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPELTQTGKASTSSD 539
RDVKPSN LIDA+MN RL DFGLAR YDH HTT VVGT GYIAPEL +TGKAS S+D
Sbjct: 474 RDVKPSNVLIDADMNPRLSDFGLARQYDHDEASHTTGVVGTIGYIAPELVRTGKASKSTD 533
Query: 540 VFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSYVVKEMELVLK 599
VF YG+LLLEVA GR+P+ S + +LV+WV E ++ G+IL+ ADP LN Y +EM++VL
Sbjct: 534 VFGYGVLLLEVACGRKPLKSDNFILVDWVMEQYEKGKILEAADPKLNWEYEAEEMKMVLV 593
Query: 600 LGLMCSHK-TQFRPTMRQVMRYLSGEKQLRFNNDWGSIDYRQGFDEFSSRTFDEISTGTF 658
LGL CSH+ + RPTMR+VMR L G+ ++ W D Q + + +SR + IS
Sbjct: 594 LGLHCSHQIAEARPTMRRVMRILDGDDKIAAVEGW---DCSQSYSKSNSRMTEVISA--- 647
Query: 659 KSSHRSSSI 667
+S+RSSSI
Sbjct: 648 -TSYRSSSI 655
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449483726|ref|XP_004156671.1| PREDICTED: probable L-type lectin-domain containing receptor kinase VI.1-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 743 bits (1919), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 382/669 (57%), Positives = 486/669 (72%), Gaps = 16/669 (2%)
Query: 1 MEMGNSSALFLLFFFFIRLNIVAQSQSSSFIFQGFNGGATNLSLQGAEIIKPSGALKLTN 60
M + AL +F FF A + SSFI+ GFN T+L +GA ++KP GAL+LTN
Sbjct: 1 MAIAAHLALLSVFIFF-----EAHAVPSSFIYPGFNN--TSLDREGASVVKPYGALRLTN 53
Query: 61 RSRYVIGHAFYVKPIQMFDTSASPSPNASSFSTTFVFEISTPRSGRGGHGLAFLLAPSTK 120
S+ VIGHAF+ +MF+ S+ SPN SFSTTFVF I G+GG+GLAF +APSTK
Sbjct: 54 ISQNVIGHAFHPTSFRMFEQSSDSSPNVLSFSTTFVFAIEPSSPGQGGYGLAFAIAPSTK 113
Query: 121 LPGAQPEHYLGILNSTNNGEPSNHILIVEFDTVNGFNDKAENQGNHVGIGINTMFSNRSE 180
GA HYLG+ NS+NNG PSNHI +EFDTVNG ++ +GNHVGI IN + S S+
Sbjct: 114 FSGAGSGHYLGLFNSSNNGNPSNHIFAIEFDTVNGHGEERNTKGNHVGIDINDISSVTSK 173
Query: 181 PASYYINGTDHKEEMTLESGEPIQAWIEYDGEQKVLNVTISPAEIG-KPMRPLISFGVNL 239
PASY G H+ ++ ++SG+PI W+EYDG +K++NVTI+P + KP + L+S+ ++L
Sbjct: 174 PASYSDYGEAHEHDLQMDSGDPIIVWVEYDGPKKIVNVTIAPLKHKRKPTKSLLSYPIDL 233
Query: 240 TGYIKETMYVGFSASTGEKSSSHYILGWSFSLNGVAPALNVSELPKPPKEKEPSSYNPKI 299
++KE M+VGFSASTG+K+SSHYILGWSF++N AP L+ S LP PPKE++P S +P
Sbjct: 234 KPFLKEQMFVGFSASTGDKTSSHYILGWSFAMNEPAPPLDYSLLPNPPKEQDPPSSSPNS 293
Query: 300 LALIVSLCLVTFLLLGTLVFFLIYRKWSNSETLEDWEKDCPHRFRYKDLYAATKGFKESE 359
+ + +LG YRK ++E LEDWE+DCPHRF Y DLY ATKGFK SE
Sbjct: 294 RYKVFVAVVSVIAILGIFFLAFWYRKTWHTERLEDWERDCPHRFHYTDLYTATKGFKSSE 353
Query: 360 VIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNLHGWC 419
+IGIGGFGSVYKG + +TG E+AVK++ RNS QGM+EFAAEIESLGRLRHKNLVNL GWC
Sbjct: 354 LIGIGGFGSVYKGQIRSTGIEIAVKRVRRNSGQGMKEFAAEIESLGRLRHKNLVNLQGWC 413
Query: 420 KQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIH 479
K+KNDLL+VY+YIPNGSL +LL+ PK+ +L+W+QRFNI+KGIA+GLLYLHEEWEQVVIH
Sbjct: 414 KKKNDLLIVYDYIPNGSLYSLLYHPKNNIILNWKQRFNILKGIAAGLLYLHEEWEQVVIH 473
Query: 480 RDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPELTQTGKASTSSD 539
RDVKPSN LIDA+MN RL DFGLAR YDH HTT VVGT GYIAPEL +TGKAS S+D
Sbjct: 474 RDVKPSNVLIDADMNPRLSDFGLARQYDHDEASHTTGVVGTIGYIAPELVRTGKASKSTD 533
Query: 540 VFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSYVVKEMELVLK 599
VF YG+LLLEVA GR+P+ S + +LV+WV E ++ G+IL+ ADP LN Y +EM++VL
Sbjct: 534 VFGYGVLLLEVACGRKPLKSDNFILVDWVMEQYEKGKILEAADPKLNWEYEAEEMKMVLV 593
Query: 600 LGLMCSHK-TQFRPTMRQVMRYLSGEKQLRFNNDWGSIDYRQGFDEFSSRTFDEISTGTF 658
LGL CSH+ + RPTMR+VMR L G+ ++ W D Q + + SR + IS
Sbjct: 594 LGLHCSHQIAEARPTMRRVMRILDGDDKIAAVEGW---DCSQSYSKSISRMTEVISA--- 647
Query: 659 KSSHRSSSI 667
+S+RSSSI
Sbjct: 648 -TSYRSSSI 655
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 668 | ||||||
| TAIR|locus:2097613 | 693 | AT3G08870 [Arabidopsis thalian | 0.932 | 0.898 | 0.503 | 8.1e-163 | |
| TAIR|locus:2149810 | 691 | LECRKA4.3 "lectin receptor kin | 0.934 | 0.903 | 0.475 | 4.9e-156 | |
| TAIR|locus:2149795 | 688 | LECRKA4.2 "lectin receptor kin | 0.941 | 0.914 | 0.480 | 1e-155 | |
| TAIR|locus:2149780 | 682 | LECRKA4.1 "lectin receptor kin | 0.932 | 0.913 | 0.479 | 2.9e-151 | |
| TAIR|locus:2084375 | 677 | AT3G53810 [Arabidopsis thalian | 0.514 | 0.508 | 0.547 | 6.2e-142 | |
| TAIR|locus:2040681 | 675 | RLK "receptor lectin kinase" [ | 0.456 | 0.451 | 0.575 | 3.4e-141 | |
| TAIR|locus:2119936 | 669 | AT4G29050 [Arabidopsis thalian | 0.902 | 0.901 | 0.449 | 1.3e-137 | |
| TAIR|locus:2133239 | 669 | AT4G02420 [Arabidopsis thalian | 0.453 | 0.452 | 0.569 | 2.8e-137 | |
| TAIR|locus:2099941 | 684 | AT3G55550 [Arabidopsis thalian | 0.860 | 0.840 | 0.468 | 1.1e-135 | |
| TAIR|locus:2020608 | 666 | AT1G70110 [Arabidopsis thalian | 0.869 | 0.872 | 0.445 | 2.7e-132 |
| TAIR|locus:2097613 AT3G08870 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1585 (563.0 bits), Expect = 8.1e-163, P = 8.1e-163
Identities = 322/639 (50%), Positives = 420/639 (65%)
Query: 40 TNLSLQGAEIIK-PSGALKLTNRSRYVIGHAFYVKPIQMFDTXXXXXXXXXXXXXXXVFE 98
T++ +GA I+ + L+LTNR + V G AFY KPI++ + VF
Sbjct: 46 TDIQTEGASTIQHDNDLLRLTNRKQNVTGTAFYRKPIRLRELTNSSDIKVCSFSTSFVFV 105
Query: 99 ISTPRSGRGGHGLAFLLAPSTKLPGAQPEHYLGILNSTNNGEPSNHILIVEFDTVNGFND 158
I G GG G F L+P+ PGA+ YLG+LN TNNG PSNH+ VEFDTV GF D
Sbjct: 106 ILPSSPGNGGFGFTFTLSPTPNRPGAESAQYLGLLNRTNNGNPSNHVFAVEFDTVQGFKD 165
Query: 159 KAENQGNHVGIGINTMFSNRSEPASYYINGTDHKEEMTLESGEPIQAWIEYDGEQKVLNV 218
A+ +GNH+G+ N + SN EP YY + D KE+ LESGEPI+ I+YDG + LNV
Sbjct: 166 GADRRGNHIGLNFNNLSSNVQEPLIYY-DTEDRKEDFQLESGEPIRVLIDYDGSSETLNV 224
Query: 219 TISPAEIG-KPMRPLISFGVN-LTGYIKETMYVGFSASTG-EKSSSHYILGWSFSLNGVA 275
TI P + KP +PLIS V+ L+ +K+ MYVGF+A+TG ++SS+HY++GWSFS G
Sbjct: 225 TIYPTRLEFKPKKPLISRRVSELSEIVKDEMYVGFTAATGKDQSSAHYVMGWSFSSCGEN 284
Query: 276 PA---LNVXXXXXXXXXXXXXXYNPKILAXXXXXXXXXXXXXXXXXXXXIY-RKWSNSET 331
P L + YN +++ +Y R+ +T
Sbjct: 285 PMADWLEISRLPPPPRLSNKKGYNSQVIVLIVALSIVTLVLLVLLFIFVMYKRRIQEEDT 344
Query: 332 LEDWEKDCPHRFRYKDLYAATKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSL 391
LEDWE D PHRFRY+DLY ATK FKESE+IG GGFG VY+G L ++ G +AVKKIT NSL
Sbjct: 345 LEDWEIDYPHRFRYRDLYLATKKFKESEIIGTGGFGIVYRGNL-SSSGPIAVKKITSNSL 403
Query: 392 QGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEYIPNGSLDTLLFK-PK-DGSV 449
QG+REF AEIESLGRL HKNLVNL GWCK KN+LLL+Y+YIPNGSLD+LL++ P+ +G V
Sbjct: 404 QGVREFMAEIESLGRLGHKNLVNLQGWCKHKNELLLIYDYIPNGSLDSLLYQTPRRNGIV 463
Query: 450 LDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHG 509
L W+ RF I+KGIASGLLYLHEEWEQ+V+HRDVKPSN LID +MNA+LGDFGLARLY+ G
Sbjct: 464 LPWDVRFEIIKGIASGLLYLHEEWEQIVVHRDVKPSNVLIDEDMNAKLGDFGLARLYERG 523
Query: 510 GMPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVR 569
+ TT +VGT GY+APELT+ GK ST+SDVFA+G+LLLE+ G +P + + L +WV
Sbjct: 524 TLTQTTKIVGTLGYMAPELTRNGKGSTASDVFAFGVLLLEIVCGNKPTNAENFFLADWVM 583
Query: 570 ECHQLGRILDVADPLLNSSYVVKEMELVLKLGLMCSH-KTQFRPTMRQVMRYLSGEKQL- 627
E H G IL V D L SS+ +E +L L +GL+C H K +FRP+MR V+RYL+GE+ +
Sbjct: 584 EFHTNGGILCVVDQNLGSSFNGREAKLALVVGLLCCHQKPKFRPSMRMVLRYLNGEENVP 643
Query: 628 RFNNDWGSIDYRQGFDEFSSRTFDEISTGTFKSSHRSSS 666
+ + +WG D + D+ S +S+ SS+ SS
Sbjct: 644 QIDENWGFSDSSR--DDHKSNVVGYVSSDRASSSNTFSS 680
|
|
| TAIR|locus:2149810 LECRKA4.3 "lectin receptor kinase a4.3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1521 (540.5 bits), Expect = 4.9e-156, P = 4.9e-156
Identities = 304/640 (47%), Positives = 407/640 (63%)
Query: 40 TNLSLQGAEIIKPSGALKLTNRSRYVIGHAFYVKPIQMFDTXXXXXXXXXXXXXXXVFEI 99
+ + +QG I +G L+LT+R+ V+G AFY KP+++ D+ +F I
Sbjct: 40 SEIHMQGDSTITSNGLLRLTDRNSDVVGTAFYHKPVRLLDSNSTNTTVRSFSTSF-IFII 98
Query: 100 STPRSGRGGHGLAFLLAPSTKLPGAQPEHYLGILNSTNNGEPSNHILIVEFDTVNGFNDK 159
+ + GG G F L+P+ A PE Y+G+LN N+G SNH+ VEFDTV GF D
Sbjct: 99 PSSSTSNGGFGFTFTLSPTPNRTDADPEQYMGLLNERNDGNSSNHVFAVEFDTVQGFKDG 158
Query: 160 AENQGNHVGIGINTMFSNRSEPASYYINGTDHKEEMTLESGEPIQAWIEYDGEQKVLNVT 219
GNH+G+ N++ S+ EP +Y+ N KEE L SGEPIQ +++Y G K LN+T
Sbjct: 159 TNRIGNHIGLNFNSLSSDVQEPVAYFNNNDSQKEEFQLVSGEPIQVFLDYHGPTKTLNLT 218
Query: 220 ISPAEIG-KPMRPLISFGV-NLTGYIKETMYVGFSASTGE--KSSSHYILGWSFSLNG-- 273
+ P +G KP PLIS V L+ + + M+VGF+A+TG +SS+HY++GWSF+ G
Sbjct: 219 VYPTRLGYKPRIPLISREVPKLSDIVVDEMFVGFTAATGRHGQSSAHYVMGWSFASGGEH 278
Query: 274 -VAPALNVXXXXXXX-XXXXXXXYNPKILAXXXXXXXXXXXXXXXXXXXXIYRK-WSNSE 330
+A L++ YN K++A +Y+K E
Sbjct: 279 PLAAMLDISQLPPPPPNKAKKRGYNGKVIALIVALSTVISIMLVLLFLFMMYKKRMQQEE 338
Query: 331 TLEDWEKDCPHRFRYKDLYAATKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNS 390
LEDWE D PHRFRY+DLY AT+GFKE+ V+G GGFG VY+G + ++ ++AVKKIT NS
Sbjct: 339 ILEDWEIDHPHRFRYRDLYKATEGFKENRVVGTGGFGIVYRGNIRSSSDQIAVKKITPNS 398
Query: 391 LQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEYIPNGSLDTLLF-KPK-DGS 448
+QG+REF AEIESLGRLRHKNLVNL GWCK +NDLLL+Y+YIPNGSLD+LL+ KP+ G+
Sbjct: 399 MQGVREFVAEIESLGRLRHKNLVNLQGWCKHRNDLLLIYDYIPNGSLDSLLYSKPRRSGA 458
Query: 449 VLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDH 508
VL W RF I KGIASGLLYLHEEWEQ+VIHRDVKPSN LID++MN RLGDFGLARLY+
Sbjct: 459 VLSWNARFQIAKGIASGLLYLHEEWEQIVIHRDVKPSNVLIDSDMNPRLGDFGLARLYER 518
Query: 509 GGMPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWV 568
G TT VVGT GY+APEL + G +S++SDVFA+G+LLLE+ +GR+P SG + +WV
Sbjct: 519 GSQSCTTVVVGTIGYMAPELARNGNSSSASDVFAFGVLLLEIVSGRKPTDSGTFFIADWV 578
Query: 569 RECHQLGRILDVADPLLNSSYVVKEMELVLKLGLMCSH-KTQFRPTMRQVMRYLSGEKQL 627
E G IL DP L S Y E L L +GL+C H K + RP MR V+RYL+ ++ +
Sbjct: 579 MELQASGEILSAIDPRLGSGYDEGEARLALAVGLLCCHHKPESRPLMRMVLRYLNRDEDV 638
Query: 628 -RFNNDWGSIDYRQGFDEFSSRTFDEISTGTFKSSHRSSS 666
+++WG D + + S+ IS+ SSH +S
Sbjct: 639 PEIHDNWGYSDSSR--TDLGSKLVGYISSDRASSSHSHTS 676
|
|
| TAIR|locus:2149795 LECRKA4.2 "lectin receptor kinase a4.1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1518 (539.4 bits), Expect = 1.0e-155, P = 1.0e-155
Identities = 312/649 (48%), Positives = 413/649 (63%)
Query: 40 TNLSLQGAEIIKPSGALKLTNRSRYVIGHAFYVKPIQMFDTXXXXXXXXXXXXXXX-VFE 98
+N+ GA IK G L+LT+R+ V G +FY KP+++ +T VF
Sbjct: 36 SNIVTTGAATIKLDGLLRLTDRNSNVTGTSFYHKPVRLLETNTSSTNSTIRSFSTSFVFV 95
Query: 99 ISTPRSGRGGHGLAFLLAPSTKLPGAQPEHYLGILNSTNNGEPSNHILIVEFDTVNGFND 158
I S GG G F L+P+ GA+ YLG+LN N+G +NH+ VEFDTV GF D
Sbjct: 96 IIPTSSSNGGFGFTFTLSPTPDRTGAESAQYLGLLNKANDGNSTNHVFAVEFDTVQGFKD 155
Query: 159 KAENQGNHVGIGINTMFSNRSEPASYYIN-GTDHKEEMTLESGEPIQAWIEYDGEQKVLN 217
A+ GNH+G+ N++ S+ EP YY N + KE+ L+SG+PI+A ++YDG + LN
Sbjct: 156 GADRTGNHIGLNFNSLTSDVQEPVVYYDNEDPNRKEDFPLQSGDPIRAILDYDGPTQTLN 215
Query: 218 VTISPAEI-GKPMRPLISFGV-NLTGYIKETMYVGFSASTG-EKSSSHYILGWSFSLNG- 273
+T+ PA + +P+RPLIS V L+ ++E MYVGF+A+TG ++SS+HY++GWSFS G
Sbjct: 216 LTVYPANLKSRPVRPLISRPVPKLSQIVQEEMYVGFTAATGRDQSSAHYVMGWSFSSGGD 275
Query: 274 --VAPALNVXXXXXXX-XXXXXXXYNPKILAXXXXXXXXXXXXXXXXXXXXIYRK-WSNS 329
L++ YN ++LA +Y+K
Sbjct: 276 LLTEDTLDLLELPRPPPNTAKKRGYNSQVLALIVALSGVTVILLALLFFFVMYKKRLQQG 335
Query: 330 ETLEDWEKDCPHRFRYKDLYAATKGFKESEVIGIGGFGSVYKGVLPT-TGGEVAVKKITR 388
E LEDWE + PHR RYKDLYAAT GFKE+ ++G GGFG+V++G L + + ++AVKKIT
Sbjct: 336 EVLEDWEINHPHRLRYKDLYAATDGFKENRIVGTGGFGTVFRGNLSSPSSDQIAVKKITP 395
Query: 389 NSLQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEYIPNGSLDTLLF-KPKD- 446
NS+QG+REF AEIESLGRLRHKNLVNL GWCKQKNDLLL+Y+YIPNGSLD+LL+ +P+
Sbjct: 396 NSMQGVREFIAEIESLGRLRHKNLVNLQGWCKQKNDLLLIYDYIPNGSLDSLLYSRPRQS 455
Query: 447 GSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLY 506
G VL W RF I KGIASGLLYLHEEWE+VVIHRD+KPSN LI+ +MN RLGDFGLARLY
Sbjct: 456 GVVLSWNARFKIAKGIASGLLYLHEEWEKVVIHRDIKPSNVLIEDDMNPRLGDFGLARLY 515
Query: 507 DHGGMPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVE 566
+ G +TT VVGT GY+APEL + GK+S++SDVFA+G+LLLE+ +GRRP SG L +
Sbjct: 516 ERGSQSNTTVVVGTIGYMAPELARNGKSSSASDVFAFGVLLLEIVSGRRPTDSGTFFLAD 575
Query: 567 WVRECHQLGRILDVADPLLNSSYVVKEMELVLKLGLMCSH-KTQFRPTMRQVMRYLSGEK 625
WV E H G IL DP L Y E L L +GL+C H + RP+MR V+RYL+G+
Sbjct: 576 WVMELHARGEILHAVDPRLGFGYDGVEARLALVVGLLCCHQRPTSRPSMRTVLRYLNGDD 635
Query: 626 QL-RFNNDWGSIDYRQG-----FDEFSSRTFDEISTGTFKSSHRSSSIV 668
+ +NDWG D + F+ + S S +F + SSS V
Sbjct: 636 DVPEIDNDWGYSDSSRSDLGSNFEGYVSSDRASSSVPSFSVTRVSSSSV 684
|
|
| TAIR|locus:2149780 LECRKA4.1 "lectin receptor kinase a4.1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1476 (524.6 bits), Expect = 2.9e-151, P = 2.9e-151
Identities = 308/643 (47%), Positives = 401/643 (62%)
Query: 40 TNLSLQGAEIIKPSGALKLTNRSRYVIGHAFYVKPIQMFDTXXXXXXXXXXXXXXXVFEI 99
+ + ++GA +IKP G L+LT+R V G AFY KP+++ + VF I
Sbjct: 43 SKIRIEGAAMIKPDGLLRLTDRKSNVTGTAFYHKPVRLLNRNSTNVTIRSFSTSF-VFVI 101
Query: 100 STPRSGRGGHGLAFLLAPSTKLPGAQPEHYLGILNSTNNGEPSNHILIVEFDTVNGF-ND 158
S G G F L+P+ A YLG+ N NNG+P NH+ VEFDTV G +D
Sbjct: 102 IPSSSSNKGFGFTFTLSPTPYRLNAGSAQYLGVFNKENNGDPRNHVFAVEFDTVQGSRDD 161
Query: 159 KAENQGNHVGIGINTMFSNRSEPASYYINGTDH--KEEMTLESGEPIQAWIEYDGEQKVL 216
+ GN +G+ N+ S+ EP YY N DH KE+ LESG PIQA +EYDG ++L
Sbjct: 162 NTDRIGNDIGLNYNSRTSDLQEPVVYY-NNDDHNKKEDFQLESGNPIQALLEYDGATQML 220
Query: 217 NVTISPAEIG-KPMRPLISFGV-NLTGYIKETMYVGFSASTGE-KSSSHYILGWSFSLNG 273
NVT+ PA +G KP +PLIS V L ++E MYVGF+ASTG+ +SS+HY++GWSFS G
Sbjct: 221 NVTVYPARLGFKPTKPLISQHVPKLLEIVQEEMYVGFTASTGKGQSSAHYVMGWSFSSGG 280
Query: 274 VAPALNVXXXXXXX----XXXXXXXYNPKILAXXXXXXXXXXXXXXXXXXXXIYRK-WSN 328
P +V N +++ +Y+K
Sbjct: 281 ERPIADVLILSELPPPPPNKAKKEGLNSQVIVMIVALSAVMLVMLVLLFFFVMYKKRLGQ 340
Query: 329 SETLEDWEKDCPHRFRYKDLYAATKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITR 388
ETLEDWE D P R RY+DLY AT GFK++ +IG GGFG+V+KG LP + +AVKKI
Sbjct: 341 EETLEDWEIDHPRRLRYRDLYVATDGFKKTGIIGTGGFGTVFKGKLPNSD-PIAVKKIIP 399
Query: 389 NSLQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEYIPNGSLDTLLFK-PK-D 446
+S QG+REF AEIESLG+LRHKNLVNL GWCK KNDLLL+Y+YIPNGSLD+LL+ P+
Sbjct: 400 SSRQGVREFVAEIESLGKLRHKNLVNLQGWCKHKNDLLLIYDYIPNGSLDSLLYTVPRRS 459
Query: 447 GSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLY 506
G+VL W RF I KGIASGLLYLHEEWE++VIHRDVKPSN LID++MN RLGDFGLARLY
Sbjct: 460 GAVLSWNARFQIAKGIASGLLYLHEEWEKIVIHRDVKPSNVLIDSKMNPRLGDFGLARLY 519
Query: 507 DHGGMPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVE 566
+ G + TT +VGT GY+APEL++ G S++SDVFA+G+LLLE+ GR+P SG LV+
Sbjct: 520 ERGTLSETTALVGTIGYMAPELSRNGNPSSASDVFAFGVLLLEIVCGRKPTDSGTFFLVD 579
Query: 567 WVRECHQLGRILDVADPLLNSSYVVKEMELVLKLGLMCSH-KTQFRPTMRQVMRYLSGEK 625
WV E H G IL DP L S Y E L L +GL+C H K RP+MR V+RYL+GE+
Sbjct: 580 WVMELHANGEILSAIDPRLGSGYDGGEARLALAVGLLCCHQKPASRPSMRIVLRYLNGEE 639
Query: 626 QL-RFNNDWGSIDYRQGFDEFSSRTFDEISTGTFKSSHRSSSI 667
+ +++WG + EF S+ +S+ + +S I
Sbjct: 640 NVPEIDDEWGYS--KSSRSEFGSKLVGYVSSTSITRVSSTSRI 680
|
|
| TAIR|locus:2084375 AT3G53810 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 955 (341.2 bits), Expect = 6.2e-142, Sum P(2) = 6.2e-142
Identities = 196/358 (54%), Positives = 256/358 (71%)
Query: 322 IYRKWSNSETLEDWEKDC-PHRFRYKDLYAATKGFKESEVIGIGGFGSVYKGVLPTTGGE 380
+ RK E L+DWE + +RFR+K+LY ATKGFKE +++G GGFG VY+G+LPTT E
Sbjct: 313 VRRKKKYEEELDDWETEFGKNRFRFKELYHATKGFKEKDLLGSGGFGRVYRGILPTTKLE 372
Query: 381 VAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEYIPNGSLDTL 440
VAVK+++ +S QGM+EF AEI S+GR+ H+NLV L G+C+++ +LLLVY+Y+PNGSLD
Sbjct: 373 VAVKRVSHDSKQGMKEFVAEIVSIGRMSHRNLVPLLGYCRRRGELLLVYDYMPNGSLDKY 432
Query: 441 LFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDF 500
L+ + + LDW+QR I+KG+ASGL YLHEEWEQVVIHRDVK SN L+DA+ N RLGDF
Sbjct: 433 LYNNPE-TTLDWKQRSTIIKGVASGLFYLHEEWEQVVIHRDVKASNVLLDADFNGRLGDF 491
Query: 501 GLARLYDHGGMPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPI--- 557
GLARLYDHG P TT+VVGT GY+APE ++TG+A+T++DV+A+G LLEV +GRRPI
Sbjct: 492 GLARLYDHGSDPQTTHVVGTLGYLAPEHSRTGRATTTTDVYAFGAFLLEVVSGRRPIEFH 551
Query: 558 -GSGD-LLLVEWVRECHQLGRILDVADPLLNSS-YVVKEMELVLKLGLMCSHKT-QFRPT 613
S D LLVEWV G I++ DP L SS Y ++E+E+VLKLGL+CSH + RP+
Sbjct: 552 SASDDTFLLVEWVFSLWLRGNIMEAKDPKLGSSGYDLEEVEMVLKLGLLCSHSDPRARPS 611
Query: 614 MRQVMRYLSGEKQLR----FNNDWGSIDYRQGFDEFSSRTFDEISTGTFKSSHRSSSI 667
MRQV++YL G+ L + GS+ G D FS + ST FK SSI
Sbjct: 612 MRQVLQYLRGDMALPELTPLDLSAGSVMNLGGRDGFSGIAMTDFST-VFKGFTGGSSI 668
|
|
| TAIR|locus:2040681 RLK "receptor lectin kinase" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 914 (326.8 bits), Expect = 3.4e-141, Sum P(2) = 3.4e-141
Identities = 180/313 (57%), Positives = 233/313 (74%)
Query: 322 IYRKWSNSETLEDWEKDC-PHRFRYKDLYAATKGFKESEVIGIGGFGSVYKGVLPTTGGE 380
+ R+ +E LE+WEK+ +RFR+KDLY ATKGFKE ++G GGFGSVYKGV+P T E
Sbjct: 313 VRRRRKFAEELEEWEKEFGKNRFRFKDLYYATKGFKEKGLLGTGGFGSVYKGVMPGTKLE 372
Query: 381 VAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEYIPNGSLDTL 440
+AVK+++ S QGM+EF AEI S+GR+ H+NLV L G+C+++ +LLLVY+Y+PNGSLD
Sbjct: 373 IAVKRVSHESRQGMKEFVAEIVSIGRMSHRNLVPLLGYCRRRGELLLVYDYMPNGSLDKY 432
Query: 441 LFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDF 500
L+ + + L+W+QR ++ G+ASGL YLHEEWEQVVIHRDVK SN L+D E+N RLGDF
Sbjct: 433 LYNTPEVT-LNWKQRIKVILGVASGLFYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDF 491
Query: 501 GLARLYDHGGMPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIG-- 558
GLARLYDHG P TT+VVGT GY+APE T+TG+A+ ++DVFA+G LLEVA GRRPI
Sbjct: 492 GLARLYDHGSDPQTTHVVGTLGYLAPEHTRTGRATMATDVFAFGAFLLEVACGRRPIEFQ 551
Query: 559 -SGD--LLLVEWVRECHQLGRILDVADPLLNSSYVVKEMELVLKLGLMCSHKT-QFRPTM 614
D LLV+WV G IL DP + S KE+E+VLKLGL+CSH + RP+M
Sbjct: 552 QETDETFLLVDWVFGLWNKGDILAAKDPNMGSECDEKEVEMVLKLGLLCSHSDPRARPSM 611
Query: 615 RQVMRYLSGEKQL 627
RQV+ YL G+ +L
Sbjct: 612 RQVLHYLRGDAKL 624
|
|
| TAIR|locus:2119936 AT4G29050 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1347 (479.2 bits), Expect = 1.3e-137, P = 1.3e-137
Identities = 282/628 (44%), Positives = 384/628 (61%)
Query: 46 GAEIIKPSGALKLTNRSRYVIGHAFYVKPIQMFDTXXXXXXXXXXXXXXXVFEISTPRSG 105
G I G +KLTN S + GH FY P++ ++ VF I + +
Sbjct: 39 GIAITNSKGLMKLTNSSEFSYGHVFYNSPVRFKNSPNGTVSSFSTTF---VFAIVSNVNA 95
Query: 106 RGGHGLAFLLAPSTKLPGAQPEHYLGILNSTNNGEPSNHILIVEFDTV-NGFNDKAENQG 164
GHGLAF+++P+ LP + YLG+ N TNNG+PSNHI+ VEFDT N D +N
Sbjct: 96 LDGHGLAFVISPTKGLPYSSSSQYLGLFNLTNNGDPSNHIVAVEFDTFQNQEFDDMDN-- 153
Query: 165 NHVGIGINTMFSNRSEPASYYINGTDHKEEMTLESGEPIQAWIEYDGEQKVLNVTISPAE 224
NHVGI IN++ S ++ A YY + + + L + +PIQAWIEYD ++ LNVTI P
Sbjct: 154 NHVGIDINSLSSEKASTAGYYEDDDGTFKNIRLINQKPIQAWIEYDSSRRQLNVTIHPIH 213
Query: 225 IGKPMRPLISFGVNLTGYIKETMYVGFSASTGEKSSSHYILGWSFSLNGVAPALNVXXXX 284
+ KP PL+S +L+ Y+ ++MYVGF+++TG SSHYILGW+F LNG A +++
Sbjct: 214 LPKPKIPLLSLTKDLSPYLFDSMYVGFTSATGRLRSSHYILGWTFKLNGTASNIDISRLP 273
Query: 285 XXXXXXXXXXYNPKILAXXXXXXXXXXXXXXXXXXXXIYRKWSNSETLEDWEKDC-PHRF 343
KILA ++ E LEDWE PHRF
Sbjct: 274 KLPRDSRSTSVK-KILAISLSLTSLAILVFLTISYMLFLKRKKLMEVLEDWEVQFGPHRF 332
Query: 344 RYKDLYAATKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIES 403
YKDLY ATKGF+ SE++G GGFG VYKG L T+ ++AVKK++ +S QGMREF AEI +
Sbjct: 333 AYKDLYIATKGFRNSELLGKGGFGKVYKGTLSTSNMDIAVKKVSHDSRQGMREFVAEIAT 392
Query: 404 LGRLRHKNLVNLHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIA 463
+GRLRH NLV L G+C++K +L LVY+ +P GSLD L+ + S LDW QRF I+K +A
Sbjct: 393 IGRLRHPNLVRLLGYCRRKGELYLVYDCMPKGSLDKFLYHQPEQS-LDWSQRFKIIKDVA 451
Query: 464 SGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGY 523
SGL YLH +W QV+IHRD+KP+N L+D MN +LGDFGLA+L +HG P T+NV GTFGY
Sbjct: 452 SGLCYLHHQWVQVIIHRDIKPANVLLDDSMNGKLGDFGLAKLCEHGFDPQTSNVAGTFGY 511
Query: 524 IAPELTQTGKASTSSDVFAYGILLLEVATGRRPI-----GSGDLLLVEWVRECHQLGRIL 578
I+PEL++TGKASTSSDVFA+GIL+LE+ GRRP+ +++L +WV +C + IL
Sbjct: 512 ISPELSRTGKASTSSDVFAFGILMLEITCGRRPVLPRASSPSEMVLTDWVLDCWE-DDIL 570
Query: 579 DVADPLL--NSSYVVKEMELVLKLGLMCSHKTQ-FRPTMRQVMRYLSGEKQLRFNNDWGS 635
V D + + Y+ +++ LVLKLGL CSH RP+M V+++L G QL NN +
Sbjct: 571 QVVDERVKQDDKYLEEQVALVLKLGLFCSHPVAAVRPSMSSVIQFLDGVAQLP-NNLFDI 629
Query: 636 IDYRQ------GFDEFSSRTFDEISTGT 657
+ R+ GF E + + S T
Sbjct: 630 VKARENVGAIEGFGEAAESLAEPCSVAT 657
|
|
| TAIR|locus:2133239 AT4G02420 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 926 (331.0 bits), Expect = 2.8e-137, Sum P(2) = 2.8e-137
Identities = 177/311 (56%), Positives = 236/311 (75%)
Query: 324 RKWSNSETLEDWEKDC-PHRFRYKDLYAATKGFKESEVIGIGGFGSVYKGVLPTTGGEVA 382
R+ +E +EDWE + +R R+KDLY ATKGFK+ ++G GGFGSVYKG++P T E+A
Sbjct: 318 RRRKFAEEVEDWETEFGKNRLRFKDLYYATKGFKDKNILGSGGFGSVYKGIMPKTKKEIA 377
Query: 383 VKKITRNSLQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEYIPNGSLDTLLF 442
VK+++ S QG++EF AEI S+G++ H+NLV L G+C+++++LLLVY+Y+PNGSLD L+
Sbjct: 378 VKRVSNESRQGLKEFVAEIVSIGQMSHRNLVPLVGYCRRRDELLLVYDYMPNGSLDKYLY 437
Query: 443 KPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGL 502
+ + LDW+QRF ++ G+AS L YLHEEWEQVVIHRDVK SN L+DAE+N RLGDFGL
Sbjct: 438 NSPEVT-LDWKQRFKVINGVASALFYLHEEWEQVVIHRDVKASNVLLDAELNGRLGDFGL 496
Query: 503 ARLYDHGGMPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIG---- 558
A+L DHG P TT VVGT+GY+AP+ +TG+A+T++DVFA+G+LLLEVA GRRPI
Sbjct: 497 AQLCDHGSDPQTTRVVGTWGYLAPDHIRTGRATTTTDVFAFGVLLLEVACGRRPIEINNQ 556
Query: 559 SGD-LLLVEWVRECHQLGRILDVADPLLNSSYVVKEMELVLKLGLMCSHKTQF-RPTMRQ 616
SG+ ++LV+WV ILD DP L S Y KE+E+VLKLGL+CSH RPTMRQ
Sbjct: 557 SGERVVLVDWVFRFWMEANILDAKDPNLGSEYDQKEVEMVLKLGLLCSHSDPLARPTMRQ 616
Query: 617 VMRYLSGEKQL 627
V++YL G+ L
Sbjct: 617 VLQYLRGDAML 627
|
|
| TAIR|locus:2099941 AT3G55550 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1329 (472.9 bits), Expect = 1.1e-135, P = 1.1e-135
Identities = 279/595 (46%), Positives = 380/595 (63%)
Query: 41 NLSLQGAEIIKPSGALKLTNRSRYVIGHAFYVKPIQMFDTXXXXXXXXXXXXXXXVF-EI 99
NL+L G I P+GA++LT ++ VIGHAFY PI+ + E
Sbjct: 37 NLTLNGVAEIAPTGAIRLTTETQRVIGHAFYSLPIRFKPIGVNRALSFSTSFAIAMVPEF 96
Query: 100 STPRSGRGGHGLAFLLAPSTKLPGAQPEHYLGILNSTNNGEPSNHILIVEFDTVNGFNDK 159
T GGHGLAF + P+ L G+ P YLG+LNS+ S+H VEFDTV +
Sbjct: 97 VT----LGGHGLAFAITPTPDLRGSLPSQYLGLLNSSRVNF-SSHFFAVEFDTVRDLEFE 151
Query: 160 AENQGNHVGIGINTMFSNRSEPASYYI-NGTDHKEEMTLESGEPIQAWIEYDGEQKVLNV 218
N NHVGI IN+M S+ S PA Y++ N T K+E+ L+ G IQAWI+YD +K L+V
Sbjct: 152 DIND-NHVGIDINSMESSISTPAGYFLANST--KKELFLDGGRVIQAWIDYDSNKKRLDV 208
Query: 219 TISPAEIGKPMRPLISFGVNLTGYIKETMYVGFSASTGEKSSSHYILGWSFSLNGVAPAL 278
+SP KP L+S+ V+L+ + + MYVGFSASTG +SSHYILGW+F+++G A +L
Sbjct: 209 KLSPFS-EKPKLSLLSYDVDLSSVLGDEMYVGFSASTGLLASSHYILGWNFNMSGEAFSL 267
Query: 279 NVXXXXXX-XXXXXXXXYNPKILAXXXXXXXXXXXXXXXXXXXXIYRKWSNSETLEDWEK 337
++ ++ + RK + + +E+WE
Sbjct: 268 SLPSLPRIPSSIKKRKKKRQSLILGVSLLCSLLIFAVLVAASLFVVRKVKDEDRVEEWEL 327
Query: 338 DC-PHRFRYKDLYAATKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMRE 396
D PHRF Y++L AT GF + E++G GGFG VYKG LP + VAVK+I+ S QG+RE
Sbjct: 328 DFGPHRFSYRELKKATNGFGDKELLGSGGFGKVYKGKLPGSDEFVAVKRISHESRQGVRE 387
Query: 397 FAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRF 456
F +E+ S+G LRH+NLV L GWC++++DLLLVY+++PNGSLD LF +L W+QRF
Sbjct: 388 FMSEVSSIGHLRHRNLVQLLGWCRRRDDLLLVYDFMPNGSLDMYLFDENPEVILTWKQRF 447
Query: 457 NIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTN 516
I+KG+ASGLLYLHE WEQ VIHRD+K +N L+D+EMN R+GDFGLA+LY+HG P T
Sbjct: 448 KIIKGVASGLLYLHEGWEQTVIHRDIKAANVLLDSEMNGRVGDFGLAKLYEHGSDPGATR 507
Query: 517 VVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSG----DLLLVEWVRECH 572
VVGTFGY+APELT++GK +TS+DV+A+G +LLEVA GRRPI + +L++V+WV
Sbjct: 508 VVGTFGYLAPELTKSGKLTTSTDVYAFGAVLLEVACGRRPIETSALPEELVMVDWVWSRW 567
Query: 573 QLGRILDVADPLLNSSYVVKEMELVLKLGLMCSHKT-QFRPTMRQVMRYLSGEKQ 626
Q G I DV D LN + +E+ +V+KLGL+CS+ + + RPTMRQV+ YL EKQ
Sbjct: 568 QSGDIRDVVDRRLNGEFDEEEVVMVIKLGLLCSNNSPEVRPTMRQVVMYL--EKQ 620
|
|
| TAIR|locus:2020608 AT1G70110 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1297 (461.6 bits), Expect = 2.7e-132, P = 2.7e-132
Identities = 267/600 (44%), Positives = 364/600 (60%)
Query: 41 NLSLQGAEIIKPSGALKLTNRSRYVIGHAFYVKPIQMFDTXXXXXXXXXXXXXXXVFEIS 100
N+ G+ I +G ++LTN + G FY ++ ++ VF I
Sbjct: 33 NMYTSGSAYINNNGLIRLTNSTPQTTGQVFYNDQLRFKNSVNGTVSSFSTTF---VFSIE 89
Query: 101 TPRSGRGGHGLAFLLAPSTKLPGAQPEHYLGILNSTNNGEPSNHILIVEFDTV--NGFND 158
GG+G+AF++ P+ L P YLG+ N +N G+P NHI+ VE DT F D
Sbjct: 90 FHNGIYGGYGIAFVICPTRDLSPTFPTTYLGLFNRSNMGDPKNHIVAVELDTKVDQQFED 149
Query: 159 KAENQGNHVGIGINTMFSNRSEPASYYI-NGTDHKEEMTLESGEPIQAWIEYDGEQKVLN 217
K NHVGI INT+ S+ A YY+ NGT + L SG+P+Q WIEYD +QK +N
Sbjct: 150 K---DANHVGIDINTLVSDTVALAGYYMDNGTFRS--LLLNSGQPMQIWIEYDSKQKQIN 204
Query: 218 VTISPAEIGKPMRPLISFGVNLTGYIKETMYVGFSASTGEKSSSHYILGWSFSLNGVAPA 277
VT+ P + KP PL+S +L+ Y+ E MYVGF+++TG+ ++SHYILGW+F +NG P
Sbjct: 205 VTLHPLYVPKPKIPLLSLEKDLSPYLLELMYVGFTSTTGDLTASHYILGWTFKMNGTTPD 264
Query: 278 LNVXXXXXXXXXXXXXXYNPK-ILAXXXXXXXXXXXXXXXXXXXXIYRKWSNSETLEDWE 336
++ +P IL ++ E LEDWE
Sbjct: 265 IDPSRLPKIPRYNQPWIQSPNGILTISLTVSGVIILIILSLSLWLFLKRKKLLEVLEDWE 324
Query: 337 KDC-PHRFRYKDLYAATKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMR 395
PHRF +KDL+ ATKGFK++EV+G GGFG VYKG LP + E+AVK ++ +S QGMR
Sbjct: 325 VQFGPHRFAFKDLHIATKGFKDTEVLGKGGFGKVYKGTLPVSNVEIAVKMVSHDSRQGMR 384
Query: 396 EFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQR 455
EF AEI ++GRLRH NLV L G+C+ K +L LVY+ + GSLD L+ + G+ LDW QR
Sbjct: 385 EFIAEIATIGRLRHPNLVRLQGYCRHKGELYLVYDCMAKGSLDKFLYHQQTGN-LDWSQR 443
Query: 456 FNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTT 515
F I+K +ASGL YLH++W QV+IHRD+KP+N L+DA MNA+LGDFGLA+L DHG P T+
Sbjct: 444 FKIIKDVASGLYYLHQQWVQVIIHRDIKPANILLDANMNAKLGDFGLAKLCDHGTDPQTS 503
Query: 516 NVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPI----GSGDLLLVEWVREC 571
+V GT GYI+PEL++TGKAST SDVFA+GI++LE+A GR+PI +++L +WV EC
Sbjct: 504 HVAGTLGYISPELSRTGKASTRSDVFAFGIVMLEIACGRKPILPRASQREMVLTDWVLEC 563
Query: 572 HQLGRILDVADPLLNSSYVVKEMELVLKLGLMCSHKTQ-FRPTMRQVMRYLSGEKQLRFN 630
+ I+ V D + YV ++ LVLKLGL CSH RP M V++ L QL N
Sbjct: 564 WENEDIMQVLDHKIGQEYVEEQAALVLKLGLFCSHPVAAIRPNMSSVIQLLDSVAQLPHN 623
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q9SR87 | LRK61_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.5405 | 0.9206 | 0.8874 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.946 |
| 3rd Layer | 2.7.11 | 0.963 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | eugene3.00161171 | hypothetical protein (661 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 668 | |||
| cd06899 | 236 | cd06899, lectin_legume_LecRK_Arcelin_ConA, legume | 3e-92 | |
| pfam00139 | 231 | pfam00139, Lectin_legB, Legume lectin domain | 5e-89 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-54 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 8e-50 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-49 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 6e-45 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 3e-44 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 3e-42 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 4e-42 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 7e-42 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 3e-37 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-32 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 7e-32 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-31 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 7e-31 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 9e-31 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 5e-30 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 7e-30 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 1e-29 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-29 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 6e-29 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 8e-29 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-28 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 3e-28 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 8e-28 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 8e-28 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-27 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-27 | |
| cd01951 | 223 | cd01951, lectin_L-type, legume lectins | 6e-27 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 8e-27 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-26 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-26 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 4e-26 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 6e-26 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 7e-26 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 1e-25 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 3e-25 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 3e-25 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-25 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 7e-25 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 1e-24 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 1e-24 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 1e-24 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-24 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-24 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-24 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 4e-24 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 5e-24 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 7e-24 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 9e-24 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 1e-23 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 2e-23 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-23 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-23 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 3e-23 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 3e-23 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 3e-23 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 3e-23 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 6e-23 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 7e-23 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 8e-23 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 1e-22 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 2e-22 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 2e-22 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 3e-22 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 4e-22 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 4e-22 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 8e-22 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 1e-21 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 2e-21 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 5e-21 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 6e-21 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 6e-21 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 6e-21 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 6e-21 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 7e-21 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 8e-21 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-20 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-20 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 3e-20 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 3e-20 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 3e-20 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 4e-20 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 4e-20 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 5e-20 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 5e-20 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 6e-20 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 8e-20 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 9e-20 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 1e-19 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 1e-19 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 2e-19 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 2e-19 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-19 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-19 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-19 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 3e-19 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 5e-19 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 5e-19 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 5e-19 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 6e-19 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 7e-19 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 7e-19 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 8e-19 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 1e-18 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 3e-18 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 3e-18 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 4e-18 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 4e-18 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 5e-18 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 6e-18 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 6e-18 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 6e-18 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 7e-18 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 7e-18 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 9e-18 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 1e-17 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-17 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-17 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 3e-17 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 3e-17 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 3e-17 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 4e-17 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 4e-17 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 4e-17 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 4e-17 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 5e-17 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 6e-17 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 6e-17 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 8e-17 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 9e-17 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 1e-16 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 1e-16 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-16 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-16 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-16 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-16 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 2e-16 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-16 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 3e-16 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 3e-16 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 3e-16 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 3e-16 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 3e-16 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 4e-16 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 5e-16 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 5e-16 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 5e-16 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 5e-16 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 6e-16 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 6e-16 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 6e-16 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 8e-16 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 8e-16 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 9e-16 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 1e-15 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-15 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 2e-15 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-15 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 3e-15 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 3e-15 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 4e-15 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 5e-15 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 5e-15 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 5e-15 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 5e-15 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 5e-15 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 6e-15 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 6e-15 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 7e-15 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 7e-15 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 9e-15 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 1e-14 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-14 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 2e-14 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 2e-14 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 3e-14 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 3e-14 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 3e-14 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 4e-14 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 4e-14 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 4e-14 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 5e-14 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 5e-14 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 7e-14 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 7e-14 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 7e-14 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 8e-14 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 8e-14 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 9e-14 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 9e-14 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 1e-13 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 1e-13 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 1e-13 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 1e-13 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 1e-13 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-13 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 2e-13 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-13 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 2e-13 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-13 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 3e-13 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 3e-13 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 4e-13 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 4e-13 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 4e-13 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 5e-13 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 5e-13 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 6e-13 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 6e-13 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 6e-13 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 7e-13 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 7e-13 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 1e-12 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 1e-12 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-12 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 1e-12 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-12 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 2e-12 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-12 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 2e-12 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-12 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 3e-12 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 3e-12 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 3e-12 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 3e-12 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 5e-12 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 5e-12 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 7e-12 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 8e-12 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 8e-12 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 8e-12 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 9e-12 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 1e-11 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 1e-11 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 1e-11 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 2e-11 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-11 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 3e-11 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 3e-11 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 3e-11 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 3e-11 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 4e-11 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 4e-11 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 7e-11 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 7e-11 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 7e-11 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 7e-11 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 7e-11 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 8e-11 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 8e-11 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 9e-11 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 1e-10 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 1e-10 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 1e-10 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 1e-10 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 1e-10 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 2e-10 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-10 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 3e-10 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 3e-10 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 3e-10 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 4e-10 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 6e-10 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 6e-10 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 7e-10 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 8e-10 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 8e-10 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 8e-10 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 9e-10 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 1e-09 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 1e-09 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 1e-09 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 1e-09 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-09 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 2e-09 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 2e-09 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 2e-09 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 2e-09 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 3e-09 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 3e-09 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 3e-09 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 9e-09 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 1e-08 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 1e-08 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 2e-08 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 3e-08 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 3e-08 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 5e-08 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 7e-08 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 3e-07 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 4e-07 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 4e-07 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 1e-06 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 2e-06 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 4e-06 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 7e-06 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 1e-05 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 5e-05 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 6e-05 | |
| cd07308 | 218 | cd07308, lectin_leg-like, legume-like lectins: ERG | 6e-04 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 8e-04 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 0.001 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 0.002 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 0.003 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 0.003 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 0.003 |
| >gnl|CDD|173887 cd06899, lectin_legume_LecRK_Arcelin_ConA, legume lectins, lectin-like receptor kinases, arcelin, concanavalinA, and alpha-amylase inhibitor | Back alignment and domain information |
|---|
Score = 285 bits (731), Expect = 3e-92
Identities = 113/249 (45%), Positives = 154/249 (61%), Gaps = 18/249 (7%)
Query: 29 SFIFQGFNGGATNLSLQGAEIIKPSGALKLTNRSRYV--IGHAFYVKPIQMFDTSASPSP 86
SF F GF+ +NL+LQG I +GAL+LTN + +G A Y KP++++D S +
Sbjct: 2 SFNFNGFSSDQSNLTLQGDATISSNGALQLTNDTSPASSVGRALYSKPVRLWD---STTG 58
Query: 87 NASSFSTTFVFEISTPRSGRGGHGLAFLLAPSTKLPGAQPEHYLGILNSTNNGEPSNHIL 146
+SFST+F F I+ P GG GLAF LAP+ LP A YLG+ NS+NNG SNHI+
Sbjct: 59 KVASFSTSFSFSITPPNPSLGGDGLAFFLAPTDSLPPASSGGYLGLFNSSNNGNSSNHIV 118
Query: 147 IVEFDTV--NGFNDKAENQGNHVGIGINTMFSNRSEPASYYINGTDHKEEMTLESGEPIQ 204
VEFDT F D NHVGI +N++ S A Y+ + L+SG+P+Q
Sbjct: 119 AVEFDTFQNPEFGDP---DDNHVGIDVNSL---VSVKAGYWDDDGGK-----LKSGKPMQ 167
Query: 205 AWIEYDGEQKVLNVTISPAEIGKPMRPLISFGVNLTGYIKETMYVGFSASTGEKSSSHYI 264
AWI+YD K L+VT++ + + KP +PL+S+ V+L+ + E +YVGFSASTG + HYI
Sbjct: 168 AWIDYDSSSKRLSVTLAYSGVAKPKKPLLSYPVDLSKVLPEEVYVGFSASTGLLTELHYI 227
Query: 265 LGWSFSLNG 273
L WSFS NG
Sbjct: 228 LSWSFSSNG 236
|
This alignment model includes the legume lectins (also known as agglutinins), the arcelin (also known as phytohemagglutinin-L) family of lectin-like defense proteins, the LecRK family of lectin-like receptor kinases, concanavalinA (ConA), and an alpha-amylase inhibitor. Arcelin is a major seed glycoprotein discovered in kidney beans (Phaseolus vulgaris) that has insecticidal properties and protects the seeds from predation by larvae of various bruchids. Arcelin is devoid of monosaccharide binding properties and lacks a key metal-binding loop that is present in other members of this family. Phytohaemagglutinin (PHA) is a lectin found in plants, especially beans, that affects cell metabolism by inducing mitosis and by altering the permeability of the cell membrane to various proteins. PHA agglutinates most mammalian red blood cell types by binding glycans on the cell surface. Medically, PHA is used as a mitogen to trigger cell division in T-lymphocytes and to activate latent HIV-1 from human peripheral lymphocytes. Plant L-type lectins are primarily found in the seeds of leguminous plants where they constitute about 10% of the total soluble protein of the seed extracts. They are synthesized during seed development several weeks after flowering and transported to the vacuole where they become condensed into specialized vesicles called protein bodies. L-type lectins have a dome-shaped beta-barrel carbohydrate recognition domain with a curved seven-stranded beta-sheet referred to as the "front face" and a flat six-stranded beta-sheet referred to as the "back face". This domain homodimerizes so that adjacent back sheets form a contiguous 12-stranded sheet and homotetramers occur by a back-to-back association of these homodimers. Though L-type lectins exhibit both sequence and structural similarity to one another, their carbohydrate binding specificities differ widely. Length = 236 |
| >gnl|CDD|215744 pfam00139, Lectin_legB, Legume lectin domain | Back alignment and domain information |
|---|
Score = 276 bits (709), Expect = 5e-89
Identities = 118/248 (47%), Positives = 153/248 (61%), Gaps = 20/248 (8%)
Query: 26 QSSSFIFQGFNGGATNLSLQGAEIIKPSGALKLTNRSRYVIGHAFYVKPIQMFDTSASPS 85
+ SF + GF+ +NL+LQG + P+G L+LTN + G A Y KPI+++D+S
Sbjct: 1 STVSFNYNGFSNV-SNLTLQGDATVLPNGLLQLTNVTNNSAGRALYSKPIRLWDSSTG-- 57
Query: 86 PNASSFSTTFVFEIS-TPRSGRGGHGLAFLLAPSTKLPGAQPEHYLGILNSTNNGEPSNH 144
+SFST+FVF I P+S GG GLAF LAPS PGA YLG+ NS+NNG SNH
Sbjct: 58 -KVASFSTSFVFAIKNIPKSTNGGDGLAFFLAPSGTQPGASSGGYLGLFNSSNNGNSSNH 116
Query: 145 ILIVEFDTV--NGFNDKAENQGNHVGIGINTMFSNRSEPASYYINGTDHKEEMTLESGEP 202
I+ VEFDT FND NHVGI +N++ S SE AS + L SG+P
Sbjct: 117 IVAVEFDTFLNPEFNDI---DDNHVGIDVNSIISVASESAS--------FVPLDLNSGKP 165
Query: 203 IQAWIEYDGEQKVLNVTISPAEIGKPMRPLISFGVNLTGYIKETMYVGFSASTGEKSSSH 262
IQ WI+YDG K L+VT++ KP RPL+S V+L+ + E +YVGFSASTG + SH
Sbjct: 166 IQVWIDYDGSSKRLSVTLAY--PNKPKRPLLSASVDLSTVLPEWVYVGFSASTGGATESH 223
Query: 263 YILGWSFS 270
Y+L WSFS
Sbjct: 224 YVLSWSFS 231
|
Length = 231 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 187 bits (477), Expect = 1e-54
Identities = 86/269 (31%), Positives = 126/269 (46%), Gaps = 19/269 (7%)
Query: 355 FKESEVIGIGGFGSVYKGVLPTTGGEVAVKKI---TRNSLQGMREFAAEIESLGRLRHKN 411
++ +G G FG+VYK TG VAVK + + S + EI L RL H N
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQT-ARREIRILRRLSHPN 59
Query: 412 LVNLHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHE 471
+V L + K+ L LV EY G L L + G L ++ I I GL YLH
Sbjct: 60 IVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSR---GGPLSEDEAKKIALQILRGLEYLHS 116
Query: 472 EWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPELTQT 531
+IHRD+KP N L+D ++ DFGLA+ T VGT Y+APE+
Sbjct: 117 NG---IIHRDLKPENILLDENGVVKIADFGLAKKLLKSS-SSLTTFVGTPWYMAPEVLLG 172
Query: 532 GK-ASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSYV 590
G DV++ G++L E+ TG +P SG+ +L + LG L+ +P +S
Sbjct: 173 GNGYGPKVDVWSLGVILYELLTG-KPPFSGENILDQLQLIRRILGPPLEFDEPKWSS--G 229
Query: 591 VKEM-ELVLKLGLMCSHKTQFRPTMRQVM 618
+E +L+ K + RPT +++
Sbjct: 230 SEEAKDLIKK---CLNKDPSKRPTAEEIL 255
|
Length = 260 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 172 bits (438), Expect = 8e-50
Identities = 74/192 (38%), Positives = 104/192 (54%), Gaps = 9/192 (4%)
Query: 361 IGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMRE-FAAEIESLGRLRHKNLVNLHGWC 419
+G GGFG+VY TG +VA+K I + + E EIE L +L H N+V L+G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 420 KQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIH 479
+ +N L LV EY GSL LL + + L ++ I+ I GL YLH +IH
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENEGK--LSEDEILRILLQILEGLEYLH---SNGIIH 115
Query: 480 RDVKPSNALIDA-EMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPE-LTQTGKASTS 537
RD+KP N L+D+ +L DFGL++L T +VGT Y+APE L G S
Sbjct: 116 RDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKT-IVGTPAYMAPEVLLGKGYYSEK 174
Query: 538 SDVFAYGILLLE 549
SD+++ G++L E
Sbjct: 175 SDIWSLGVILYE 186
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 173 bits (442), Expect = 1e-49
Identities = 75/203 (36%), Positives = 112/203 (55%), Gaps = 9/203 (4%)
Query: 355 FKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFA-AEIESLGRLRHKNLV 413
++ E +G G FG VY TG VA+K I + ++ RE EI+ L +L+H N+V
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 414 NLHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEW 473
L+ + ++ L LV EY G L LL K G + + E RF ++ I S L YLH +
Sbjct: 61 RLYDVFEDEDKLYLVMEYCEGGDLFDLL--KKRGRLSEDEARF-YLRQILSALEYLHSKG 117
Query: 474 EQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPELTQTGK 533
++HRD+KP N L+D + + +L DFGLAR D G T VGT Y+APE+
Sbjct: 118 ---IVHRDLKPENILLDEDGHVKLADFGLARQLDPGEK--LTTFVGTPEYMAPEVLLGKG 172
Query: 534 ASTSSDVFAYGILLLEVATGRRP 556
+ D+++ G++L E+ TG+ P
Sbjct: 173 YGKAVDIWSLGVILYELLTGKPP 195
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 160 bits (408), Expect = 6e-45
Identities = 78/274 (28%), Positives = 127/274 (46%), Gaps = 25/274 (9%)
Query: 356 KESEVIGIGGFGSVYKGVL----PTTGGEVAVKKITRN-SLQGMREFAAEIESLGRLRHK 410
+ +G G FG VYKG L EVAVK + + S Q + EF E + +L H
Sbjct: 2 TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHP 61
Query: 411 NLVNLHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLH 470
N+V L G C ++ L++V EY+P G L L + L + IA G+ YL
Sbjct: 62 NIVKLLGVCTEEEPLMIVMEYMPGGDLLDYL-RKNRPKELSLSDLLSFALQIARGMEYLE 120
Query: 471 EEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPELTQ 530
+ IHRD+ N L+ + ++ DFGL+R ++APE +
Sbjct: 121 ---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLK 177
Query: 531 TGKASTSSDVFAYGILLLEVAT-GRRP-IGSGDLLLVEWVRECHQLGRILDVADPLLNSS 588
GK ++ SDV+++G+LL E+ T G P G + ++E++++ ++L + P
Sbjct: 178 EGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKKGYRLPK------PPNCPP 231
Query: 589 YVVKEMELVLKLGLMC-SHKTQFRPTMRQVMRYL 621
+ K M L C + + RPT +++ L
Sbjct: 232 ELYKLM-------LQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 158 bits (403), Expect = 3e-44
Identities = 79/274 (28%), Positives = 128/274 (46%), Gaps = 26/274 (9%)
Query: 356 KESEVIGIGGFGSVYKGVLPTTGG----EVAVKKITRN-SLQGMREFAAEIESLGRLRHK 410
+ +G G FG VYKG L GG EVAVK + + S Q + EF E + +L H
Sbjct: 2 TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHP 61
Query: 411 NLVNLHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLH 470
N+V L G C ++ L +V EY+ G L + L K + L + IA G+ YL
Sbjct: 62 NVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRP--KLSLSDLLSFALQIARGMEYLE 119
Query: 471 EEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPELTQ 530
+ IHRD+ N L+ + ++ DFGL+R ++APE +
Sbjct: 120 ---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLK 176
Query: 531 TGKASTSSDVFAYGILLLEVAT-GRRP-IGSGDLLLVEWVRECHQLGRILDVADPLLNSS 588
GK ++ SDV+++G+LL E+ T G +P G + ++E+++ ++L + P
Sbjct: 177 EGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKNGYRLPQ------PPNCPP 230
Query: 589 YVVKEMELVLKLGLMC-SHKTQFRPTMRQVMRYL 621
+ M L C + + RPT +++ L
Sbjct: 231 ELYDLM-------LQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 153 bits (389), Expect = 3e-42
Identities = 82/284 (28%), Positives = 132/284 (46%), Gaps = 44/284 (15%)
Query: 359 EVIGIGGFGSVYKGVLPTTGG---EVAVKKITRN-SLQGMREFAAEIESLGRLRHKNLVN 414
+ +G G FG VYKG L G EVAVK + + S + ++F E + +L H N+V
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 415 LHGWCKQKNDLLLVYEYIPNGSLDTLL------FKPKDGSVLDWEQRFNIVKGIASGLLY 468
L G C ++ L LV EY+ G L L F + S L + + IA G+ Y
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 469 LHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYI---- 524
L + +HRD+ N L+ ++ ++ DFGL+R T G +
Sbjct: 121 LA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKK----TGGKLPIRW 173
Query: 525 -APELTQTGKASTSSDVFAYGILLLEVAT-GRRP---IGSGDLLLVEWVRECHQLGRILD 579
APE + G ++ SDV+++G+LL E+ T G P + + ++L E++R+ ++L
Sbjct: 174 MAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVL--EYLRKGYRL----- 226
Query: 580 VADPLLNSSYVVKEM-ELVLKLGLMC-SHKTQFRPTMRQVMRYL 621
P Y E+ EL+L C + RPT +++ L
Sbjct: 227 -PKP----EYCPDELYELMLS----CWQLDPEDRPTFSELVERL 261
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 152 bits (387), Expect = 4e-42
Identities = 80/276 (28%), Positives = 124/276 (44%), Gaps = 35/276 (12%)
Query: 359 EVIGIGGFGSVYKGVL----PTTGGEVAVKKITRN-SLQGMREFAAEIESLGRLRHKNLV 413
+ +G G FG VYKG L T +VAVK + S + EF E + +L H N+V
Sbjct: 5 KKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIV 64
Query: 414 NLHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEW 473
L G C Q L +V EY+P G L L K G L + + IA G+ YL
Sbjct: 65 RLLGVCTQGEPLYIVTEYMPGGDLLDFL--RKHGEKLTLKDLLQMALQIAKGMEYLE--- 119
Query: 474 EQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYI-----APEL 528
+ +HRD+ N L+ + ++ DFGL+R G + APE
Sbjct: 120 SKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDD----YYRKRGGGKLPIKWMAPES 175
Query: 529 TQTGKASTSSDVFAYGILLLEVAT-GRRPI-GSGDLLLVEWVRECHQLGRILDVADPLLN 586
+ GK ++ SDV+++G+LL E+ T G +P G + ++E + + ++L R P
Sbjct: 176 LKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLEDGYRLPR------PENC 229
Query: 587 SSYVVKEMELVLKLGLMCSHKT-QFRPTMRQVMRYL 621
+ + M L C + RPT +++ L
Sbjct: 230 PDELYELM-------LQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 152 bits (386), Expect = 7e-42
Identities = 66/209 (31%), Positives = 112/209 (53%), Gaps = 15/209 (7%)
Query: 355 FKESEVIGIGGFGSVYKGVLPTTGGEVAVKKI--TRNSLQGMREFAAEIESLGRLRHKNL 412
+ E++G G FGSVY + TG +AVK + + +S + + EI L L+H N+
Sbjct: 2 WTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNI 61
Query: 413 VNLHG--WCKQKNDLLLVYEYIPNGSLDTLL--FKPKDGSVLDWEQRFNIVKGIASGLLY 468
V +G ++KN L + EY+ GSL +LL F V+ +++ + I GL Y
Sbjct: 62 VRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVI---RKY--TRQILEGLAY 116
Query: 469 LHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTN-VVGTFGYIAPE 527
LH ++HRD+K +N L+D++ +L DFG A+ T V GT ++APE
Sbjct: 117 LHS---NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPE 173
Query: 528 LTQTGKASTSSDVFAYGILLLEVATGRRP 556
+ + + ++D+++ G ++E+ATG+ P
Sbjct: 174 VIRGEEYGRAADIWSLGCTVIEMATGKPP 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 138 bits (351), Expect = 3e-37
Identities = 71/205 (34%), Positives = 110/205 (53%), Gaps = 11/205 (5%)
Query: 355 FKESEVIGIGGFGSVYKGVLPTTGGEVAVKKI--TRNSLQGMREFAAEIESLGRLRHKNL 412
++ ++IG G FG VYKG+ TG VA+K+I + + ++ EI+ L L+H N+
Sbjct: 2 YQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNI 61
Query: 413 VNLHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEE 472
V G + + L ++ EY NGSL ++ K V + GL YLH
Sbjct: 62 VKYIGSIETSDSLYIILEYAENGSLRQII-KKFGP--FPESLVAVYVYQVLQGLAYLH-- 116
Query: 473 WEQVVIHRDVKPSNALIDAEMNARLGDFGLA-RLYDHGGMPHTTNVVGTFGYIAPELTQT 531
EQ VIHRD+K +N L + +L DFG+A +L D + VVGT ++APE+ +
Sbjct: 117 -EQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDAS--VVGTPYWMAPEVIEM 173
Query: 532 GKASTSSDVFAYGILLLEVATGRRP 556
AST+SD+++ G ++E+ TG P
Sbjct: 174 SGASTASDIWSLGCTVIELLTGNPP 198
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 2e-32
Identities = 68/208 (32%), Positives = 103/208 (49%), Gaps = 19/208 (9%)
Query: 355 FKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVN 414
F+ E IG GGFG VYK TG EVA+K I S + + EI+ L + +H N+V
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61
Query: 415 LHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFN------IVKGIASGLLY 468
+G +K++L +V E+ GSL LL Q + K + GL Y
Sbjct: 62 YYGSYLKKDELWIVMEFCSGGSLKDLL--------KSTNQTLTESQIAYVCKELLKGLEY 113
Query: 469 LHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPEL 528
LH +IHRD+K +N L+ ++ +L DFGL+ +T VGT ++APE+
Sbjct: 114 LH---SNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTM--VGTPYWMAPEV 168
Query: 529 TQTGKASTSSDVFAYGILLLEVATGRRP 556
+D+++ GI +E+A G+ P
Sbjct: 169 INGKPYDYKADIWSLGITAIELAEGKPP 196
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 127 bits (319), Expect = 7e-32
Identities = 74/216 (34%), Positives = 107/216 (49%), Gaps = 19/216 (8%)
Query: 354 GFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKI---TRNSLQGMREFAAEIESLGRLRH- 409
++ +G G FG VY VA+K + + + + F EI+ L L H
Sbjct: 1 SYRILRKLGEGSFGEVYLARDRK---LVALKVLAKKLESKSKEVERFLREIQILASLNHP 57
Query: 410 KNLVNLHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYL 469
N+V L+ + + + L LV EY+ GSL+ LL K L + I+ I S L YL
Sbjct: 58 PNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYL 117
Query: 470 HEEWEQVVIHRDVKPSNALIDAEMN-ARLGDFGLARLYDHGGMPHTTN-----VVGTFGY 523
H + +IHRD+KP N L+D + +L DFGLA+L G + VGT GY
Sbjct: 118 H---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGY 174
Query: 524 IAPEL---TQTGKASTSSDVFAYGILLLEVATGRRP 556
+APE+ AS+SSD+++ GI L E+ TG P
Sbjct: 175 MAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPP 210
|
Length = 384 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 122 bits (309), Expect = 2e-31
Identities = 65/216 (30%), Positives = 105/216 (48%), Gaps = 29/216 (13%)
Query: 355 FKESEVIGIGGFGSVYKGVLPTTGGE-VAVKKITRNSLQGM----REFA-AEIESLGRLR 408
++ + IG G FG VY V + G+ +K+I L M RE A E++ L +L
Sbjct: 2 YEIIKQIGKGSFGKVYL-VRRKSDGKLYVLKEI---DLSNMSEKEREDALNEVKILKKLN 57
Query: 409 HKNLVNLHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGS-------VLDW-EQRFNIVK 460
H N++ + ++K L +V EY G L + K K +LDW Q
Sbjct: 58 HPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQ------ 111
Query: 461 GIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGT 520
+ L YLH + ++HRD+KP N + + +LGDFG++++ + VVGT
Sbjct: 112 -LCLALKYLHS---RKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSS-TVDLAKTVVGT 166
Query: 521 FGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRP 556
Y++PEL Q + SD+++ G +L E+ T + P
Sbjct: 167 PYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHP 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 7e-31
Identities = 65/199 (32%), Positives = 104/199 (52%), Gaps = 8/199 (4%)
Query: 355 FKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVN 414
F +G G FG V++G+ VA+K + + L ++F E+++L RLRHK+L++
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRV-RVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLIS 66
Query: 415 LHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWE 474
L C + ++ E + GSL L P +G VL ++ +A G+ YL E
Sbjct: 67 LFAVCSVGEPVYIITELMEKGSLLAFLRSP-EGQVLPVASLIDMACQVAEGMAYLE---E 122
Query: 475 QVVIHRDVKPSNALIDAEMNARLGDFGLARLY-DHGGMPHTTNVVGTFGYIAPELTQTGK 533
Q IHRD+ N L+ ++ ++ DFGLARL + + + + + APE G
Sbjct: 123 QNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI--PYKWTAPEAASHGT 180
Query: 534 ASTSSDVFAYGILLLEVAT 552
ST SDV+++GILL E+ T
Sbjct: 181 FSTKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 9e-31
Identities = 74/268 (27%), Positives = 123/268 (45%), Gaps = 28/268 (10%)
Query: 360 VIGIGGFGSVYKGVLPTTGGEVAVKKITRNS-LQGMREFAAEIESLGRLRHKNLVNLHGW 418
V+G G G VYK TG A+KKI + + ++ E+++L +V +G
Sbjct: 8 VLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGA 67
Query: 419 CKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIAS----GLLYLHEEWE 474
++ ++ +V EY+ GSL LL K E ++ IA GL YLH +
Sbjct: 68 FYKEGEISIVLEYMDGGSLADLLKKVGKIP----EP---VLAYIARQILKGLDYLHTKRH 120
Query: 475 QVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPELTQTGKA 534
IHRD+KPSN LI+++ ++ DFG++++ ++ T VGT Y++PE Q
Sbjct: 121 I--IHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTF-VGTVTYMSPERIQGESY 177
Query: 535 STSSDVFAYGILLLEVATGRRPI---GSGDLLLVEWVRECHQLGRILDVADPLLNSSYVV 591
S ++D+++ G+ LLE A G+ P G + I D P L +
Sbjct: 178 SYAADIWSLGLTLLECALGKFPFLPPGQPSF----FELMQA----ICDGPPPSLPAEEFS 229
Query: 592 KEMELVLKLGLMCSHKTQFRPTMRQVMR 619
E + L K RP+ ++++
Sbjct: 230 PEFRDFISACLQKDPKK--RPSAAELLQ 255
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 5e-30
Identities = 80/239 (33%), Positives = 112/239 (46%), Gaps = 47/239 (19%)
Query: 361 IGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMRE-----FAAEIESLGRLRHKNLVNL 415
IG G +G VYK TG VA+KKI ++ +E EI+ L +LRH N+V L
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKI---RMENEKEGFPITAIREIKLLQKLRHPNIVRL 63
Query: 416 HGWC--KQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNI--VKGIA----SGLL 467
K K + +V+EY+ + L LL P E +F +K GL
Sbjct: 64 KEIVTSKGKGSIYMVFEYMDH-DLTGLLDSP--------EVKFTESQIKCYMKQLLEGLQ 114
Query: 468 YLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPE 527
YLH ++HRD+K SN LI+ + +L DFGLAR Y TN V T Y PE
Sbjct: 115 YLHS---NGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPE 171
Query: 528 L----TQTGKASTSSDVFAYGILLLEVATGRRPI--GSGDLLLVEWVRECHQLGRILDV 580
L T+ G D+++ G +L E+ G +PI GS +L QL +I ++
Sbjct: 172 LLLGATRYG---PEVDMWSVGCILAELFLG-KPIFQGSTEL---------EQLEKIFEL 217
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 7e-30
Identities = 70/206 (33%), Positives = 111/206 (53%), Gaps = 18/206 (8%)
Query: 361 IGIGGFGSVYKGVLPTTGGEVAVK--KITRNSLQGMREFAAEIESLGRLRHKNLVNLHGW 418
IG G FG VY V TG +AVK +I N + ++E A E++ L L+H NLV +G
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGV 67
Query: 419 CKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWE--QRFNIVKGIASGLLYLHEEWEQV 476
+ + + EY G+L+ LL + G +LD + + + GL YLH
Sbjct: 68 EVHREKVYIFMEYCSGGTLEELL---EHGRILDEHVIRVY--TLQLLEGLAYLHS---HG 119
Query: 477 VIHRDVKPSNALIDAEMNARLGDFGLA-RLYDHGGMPHTT--NVVGTFGYIAPELTQTGK 533
++HRD+KP+N +D +LGDFG A +L ++ ++ GT Y+APE+ GK
Sbjct: 120 IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGK 179
Query: 534 AS---TSSDVFAYGILLLEVATGRRP 556
++D+++ G ++LE+ATG+RP
Sbjct: 180 GKGHGRAADIWSLGCVVLEMATGKRP 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 1e-29
Identities = 76/277 (27%), Positives = 122/277 (44%), Gaps = 27/277 (9%)
Query: 355 FKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMRE-----FAAEIESLGRLRH 409
++ E IG G FG+V K + G + K+I M E +E+ L L+H
Sbjct: 2 YEVLETIGKGSFGTVRKVRRKSDGKILVWKEI---DYGNMTEKEKQQLVSEVNILRELKH 58
Query: 410 KNLVNLHGWC--KQKNDLLLVYEYIPNGSLDTLLFK-PKDGSVLDWEQRFNIVKGIASGL 466
N+V + + L +V EY G L L+ K K+ ++ E + I+ + L
Sbjct: 59 PNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLAL 118
Query: 467 LYLH--EEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYI 524
H + V+HRD+KP+N +DA N +LGDFGLA++ H T VGT Y+
Sbjct: 119 YECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKT-YVGTPYYM 177
Query: 525 APELTQTGKASTSSDVFAYGILLLEVATGRRPI-GSGDLLLVEWVRECHQLGRILDVADP 583
+PE SD+++ G L+ E+ P L L ++E G+ + P
Sbjct: 178 SPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKE----GKFRRI--P 231
Query: 584 LLNSSYVVKEMELVLKLGLMCSHKTQFRPTMRQVMRY 620
SS E+ V+K L RP+ ++++
Sbjct: 232 YRYSS----ELNEVIKSMLNVDPDK--RPSTEELLQL 262
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 2e-29
Identities = 69/208 (33%), Positives = 110/208 (52%), Gaps = 19/208 (9%)
Query: 359 EVIGIGGFGSVYKGVLPTTGGE---VAVKKITRNSLQGMR-EFAAEIESLGRLRHKNLVN 414
+VIG G FG V +G L G + VA+K + S R +F E +G+ H N++
Sbjct: 10 KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIR 69
Query: 415 LHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWE 474
L G + ++++ EY+ NGSLD L + DG Q +++GIASG+ YL E
Sbjct: 70 LEGVVTKSRPVMIITEYMENGSLDKFL-RENDGK-FTVGQLVGMLRGIASGMKYLS---E 124
Query: 475 QVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYI-----APELT 529
+HRD+ N L+++ + ++ DFGL+R + +TT G I APE
Sbjct: 125 MNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKG----GKIPIRWTAPEAI 180
Query: 530 QTGKASTSSDVFAYGILLLEVAT-GRRP 556
K +++SDV+++GI++ EV + G RP
Sbjct: 181 AYRKFTSASDVWSFGIVMWEVMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 6e-29
Identities = 69/211 (32%), Positives = 104/211 (49%), Gaps = 16/211 (7%)
Query: 356 KESEVIGIGGFGSVYKGVL-PT---TGGEVAVKKITRNS-LQGMREFAAEIESLGRLRHK 410
K + +G G FG V P TG +VAVK + + Q +F EIE L L H+
Sbjct: 7 KFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHE 66
Query: 411 NLVNLHGWC--KQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLY 468
N+V G C L L+ EY+P+GSL L + +D ++ ++ I G+ Y
Sbjct: 67 NIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQ--INLKRLLLFSSQICKGMDY 124
Query: 469 LHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVG---TFGYIA 525
L Q IHRD+ N L+++E ++ DFGLA++ + G F Y A
Sbjct: 125 LGS---QRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY-A 180
Query: 526 PELTQTGKASTSSDVFAYGILLLEVATGRRP 556
PE +T K S++SDV+++G+ L E+ T P
Sbjct: 181 PECLRTSKFSSASDVWSFGVTLYELFTYGDP 211
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 8e-29
Identities = 76/236 (32%), Positives = 106/236 (44%), Gaps = 40/236 (16%)
Query: 359 EVIGIGGFGSVYKGVLPTTGGEVAVKKI---------TRNSLQGMREFAAEIESLGRLRH 409
E +G G +G VYK TG VA+KKI +L+ EI L L+H
Sbjct: 5 EKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALR-------EISLLKELKH 57
Query: 410 KNLVNLHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIA----SG 465
N+V L + L LV+EY L L K N++K I G
Sbjct: 58 PNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSP------NLIKSIMYQLLRG 110
Query: 466 LLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIA 525
L Y H ++HRD+KP N LI+ + +L DFGLAR + +T VV T Y A
Sbjct: 111 LAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVV-TLWYRA 166
Query: 526 PE-LTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDV 580
PE L + ST+ D+++ G + E+ TG +P+ GD E QL +I +
Sbjct: 167 PEILLGSKHYSTAVDIWSVGCIFAEMITG-KPLFPGD-------SEIDQLFKIFQI 214
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (291), Expect = 1e-28
Identities = 72/220 (32%), Positives = 105/220 (47%), Gaps = 15/220 (6%)
Query: 361 IGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAA--EIESLGRLRHKNLVNLHGW 418
IG G +G VYK TG VA+KKI A EI+ L L H N++ L
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66
Query: 419 CKQKNDLLLVYEYIPNGSLDTLLFKPKDGS--VLDWEQRFNIVKGIASGLLYLHEEWEQV 476
+ K DL LV+E+ +DT L+K L + + + GL + H
Sbjct: 67 FRHKGDLYLVFEF-----MDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHG--- 118
Query: 477 VIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPELTQTGKAST 536
++HRD+KP N LI+ E +L DFGLAR + P+T VV T Y APEL K +
Sbjct: 119 ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVV-TRWYRAPELLLGDKGYS 177
Query: 537 SS-DVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLG 575
+ D+++ G + E+ + RRP+ G + + + LG
Sbjct: 178 TPVDIWSVGCIFAELLS-RRPLFPGKSEIDQLFKIFRTLG 216
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 3e-28
Identities = 71/204 (34%), Positives = 102/204 (50%), Gaps = 20/204 (9%)
Query: 358 SEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNLHG 417
IG G FG V G G +VAVK + +S + F AE + LRH NLV L G
Sbjct: 11 GATIGKGEFGDVMLGDY--RGQKVAVKCLKDDS-TAAQAFLAEASVMTTLRHPNLVQLLG 67
Query: 418 WCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVV 477
Q N L +V EY+ GSL L + + +V+ Q+ + G+ YL E+
Sbjct: 68 VVLQGNPLYIVTEYMAKGSLVDYL-RSRGRAVITLAQQLGFALDVCEGMEYLE---EKNF 123
Query: 478 IHRDVKPSNALIDAEMNARLGDFGLARL----YDHGGMPHTTNVVGTFGYIAPELTQTGK 533
+HRD+ N L+ ++ A++ DFGLA+ D G +P + APE + K
Sbjct: 124 VHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLP--------VKWTAPEALREKK 175
Query: 534 ASTSSDVFAYGILLLEV-ATGRRP 556
ST SDV+++GILL E+ + GR P
Sbjct: 176 FSTKSDVWSFGILLWEIYSFGRVP 199
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 8e-28
Identities = 67/200 (33%), Positives = 97/200 (48%), Gaps = 12/200 (6%)
Query: 361 IGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFA---AEIESLGRLRHKNLVNLHG 417
+G G FG V TG A+K + + + +E E L R+ H +V LH
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLH- 59
Query: 418 WCKQ-KNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQV 476
+ Q + L LV EY P G L + L K+G + RF + I L YLH
Sbjct: 60 YAFQTEEKLYLVLEYAPGGELFSHL--SKEGRFSEERARFYAAE-IVLALEYLHS---LG 113
Query: 477 VIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPELTQTGKAST 536
+I+RD+KP N L+DA+ + +L DFGLA+ G T GT Y+APE+
Sbjct: 114 IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS-RTNTFCGTPEYLAPEVLLGKGYGK 172
Query: 537 SSDVFAYGILLLEVATGRRP 556
+ D ++ G+LL E+ TG+ P
Sbjct: 173 AVDWWSLGVLLYEMLTGKPP 192
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 8e-28
Identities = 69/198 (34%), Positives = 101/198 (51%), Gaps = 10/198 (5%)
Query: 359 EVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMRE-FAAEIESLGRLRHKNLVNLHG 417
E IG G FG VYKGVL EVAVK ++ F E E L + H N+V L G
Sbjct: 1 EKIGKGNFGDVYKGVL-KGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIG 59
Query: 418 WCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVV 477
C QK + +V E +P GSL T L K K+ L ++ + A+G+ YL +
Sbjct: 60 VCVQKQPIYIVMELVPGGSLLTFLRKKKNR--LTVKKLLQMSLDAAAGMEYLE---SKNC 114
Query: 478 IHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTF--GYIAPELTQTGKAS 535
IHRD+ N L+ ++ DFG++R + GG+ ++ + + APE G+ +
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMSR-EEEGGIYTVSDGLKQIPIKWTAPEALNYGRYT 173
Query: 536 TSSDVFAYGILLLEVATG 553
+ SDV++YGILL E +
Sbjct: 174 SESDVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 2e-27
Identities = 74/264 (28%), Positives = 121/264 (45%), Gaps = 21/264 (7%)
Query: 360 VIGIGGFGSVYKGVLPTTGGEVAVKKITRNS-LQGMREFAAEIESLGRLRHKNLVNLHGW 418
+G G G V K + TG +AVK I ++ E++ L + +V +G
Sbjct: 8 ELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGA 67
Query: 419 CKQKNDLLLVYEYIPNGSLDTLL---FKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQ 475
D+ + EY+ GSLD +L +L I + GL YLHE+ +
Sbjct: 68 FYNNGDISICMEYMDGGSLDKILKEVQGRIPERILG-----KIAVAVLKGLTYLHEKHK- 121
Query: 476 VVIHRDVKPSNALIDAEMNARLGDFGLA-RLYDHGGMPHTTNVVGTFGYIAPELTQTGKA 534
+IHRDVKPSN L+++ +L DFG++ +L + VGT Y+APE Q
Sbjct: 122 -IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAK----TFVGTSSYMAPERIQGNDY 176
Query: 535 STSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSYVVKEM 594
S SD+++ G+ L+E+ATGR P + L I++ P L S +
Sbjct: 177 SVKSDIWSLGLSLIELATGRFPYPPEN---DPPDGIFELLQYIVNEPPPRLPSGKFSPDF 233
Query: 595 ELVLKLGLMCSHKTQFRPTMRQVM 618
+ + L L+ + RP+ ++++
Sbjct: 234 QDFVNLCLIKDPRE--RPSYKELL 255
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 2e-27
Identities = 73/235 (31%), Positives = 105/235 (44%), Gaps = 23/235 (9%)
Query: 359 EVIGIGGFGSVYKGVLPTTGGEVAVK--KITRNSLQGMREFAAEIESLGRLRHKNLVNLH 416
V+G G +G V K TG VA+K K + + + E++ L +LRH+N+VNL
Sbjct: 7 GVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLK 66
Query: 417 GWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQV 476
++K L LV+EY+ L+ L P L + + + + + Y H
Sbjct: 67 EAFRRKGRLYLVFEYVERTLLELLEASPGG---LPPDAVRSYIWQLLQAIAYCHS---HN 120
Query: 477 VIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPEL----TQTG 532
+IHRD+KP N L+ +L DFG AR T+ V T Y APEL T G
Sbjct: 121 IIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNYG 180
Query: 533 KASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNS 587
K DV+A G ++ E+ G P+ GD + QL I PL S
Sbjct: 181 KP---VDVWAIGCIMAELLDG-EPLFPGD-------SDIDQLYLIQKCLGPLPPS 224
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173886 cd01951, lectin_L-type, legume lectins | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 6e-27
Identities = 65/246 (26%), Positives = 93/246 (37%), Gaps = 27/246 (10%)
Query: 28 SSFIFQGF-NGGATNLSLQG-AEIIKPSGALKLTNRSRYVIGHAFYVKPIQMFDTSASPS 85
+S F F N +N L G A + SG L+LT + G A+Y PI +
Sbjct: 1 TSLNFSNFSNNNQSNWQLNGSATLTTDSGVLRLTPDTGNQAGSAWYKTPIDL-------- 52
Query: 86 PNASSFSTTFVFEISTPRSGRGGHGLAFLLAPSTKLPGAQPEHYLGILNSTNNGEPSNHI 145
+ F+TTF F + T G G+AF+L G G +
Sbjct: 53 --SKDFTTTFKFYLGTK-GTNGADGIAFVLQNDPAGALGGGG---GGGGLGYGG--IGNS 104
Query: 146 LIVEFDTV-NGFNDKAENQGNHVGIGINTMFSNRSEPASYYINGTDHKEEMTLESGEPIQ 204
+ VEFDT N N+ + GNH I I+ + + + + G
Sbjct: 105 VAVEFDTYKNDDNN--DPNGNH--ISIDVNGNGNNTALATSLGSASLPN--GTGLGNEHT 158
Query: 205 AWIEYDGEQKVLNVTISPAEIGKPMRPLISFGVNLTGYIKETMYVGFSASTGEKSSSHYI 264
I YD L V + I+ V+L Y GF+ASTG ++ H I
Sbjct: 159 VRITYDPTTNTLTVYLDNGST--LTSLDITIPVDLIQLGPTKAYFGFTASTGGLTNLHDI 216
Query: 265 LGWSFS 270
L WSF+
Sbjct: 217 LNWSFT 222
|
The L-type (legume-type) lectins are a highly diverse family of carbohydrate binding proteins that generally display no enzymatic activity toward the sugars they bind. This family includes arcelin, concanavalinA, the lectin-like receptor kinases, the ERGIC-53/VIP36/EMP46 type1 transmembrane proteins, and an alpha-amylase inhibitor. L-type lectins have a dome-shaped beta-barrel carbohydrate recognition domain with a curved seven-stranded beta-sheet referred to as the "front face" and a flat six-stranded beta-sheet referred to as the "back face". This domain homodimerizes so that adjacent back sheets form a contiguous 12-stranded sheet and homotetramers occur by a back-to-back association of these homodimers. Though L-type lectins exhibit both sequence and structural similarity to one another, their carbohydrate binding specificities differ widely. Length = 223 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 8e-27
Identities = 68/254 (26%), Positives = 112/254 (44%), Gaps = 25/254 (9%)
Query: 354 GFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKIT------RNSLQGMREFAAEIESLGRL 407
F+ VIG G FG V T A+K + + S++ + E L L
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLN---ERRILQEL 57
Query: 408 RHKNLVNLHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQ-RFNIVKGIASGL 466
H LVNL + + ++ LV + + G L L + EQ +F I + I L
Sbjct: 58 NHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQ---KVKFSEEQVKFWICE-IVLAL 113
Query: 467 LYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAP 526
YLH + +IHRD+KP N L+D + + + DF +A + TT+ GT GY+AP
Sbjct: 114 EYLHS---KGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTL--TTSTSGTPGYMAP 168
Query: 527 ELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLN 586
E+ S + D ++ G+ E G+RP + + +R + AD L
Sbjct: 169 EVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIR------AKQETADVLYP 222
Query: 587 SSYVVKEMELVLKL 600
+++ + ++ + KL
Sbjct: 223 ATWSTEAIDAINKL 236
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 2e-26
Identities = 70/212 (33%), Positives = 119/212 (56%), Gaps = 18/212 (8%)
Query: 356 KESEVIGIGGFGSVYKGVLPTTGGE---VAVKKITRN-SLQGMREFAAEIESLGRLRHKN 411
K EVIG G FG V +G L G VA+K + + + R+F +E +G+ H N
Sbjct: 7 KIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPN 66
Query: 412 LVNLHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDG--SVLDWEQRFNIVKGIASGLLYL 469
+++L G + ++++ E++ NG+LD+ L + DG +V+ Q +++GIA+G+ YL
Sbjct: 67 IIHLEGVVTKSRPVMIITEFMENGALDSFL-RQNDGQFTVI---QLVGMLRGIAAGMKYL 122
Query: 470 HEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLAR-LYDHGGMPHTTNVVG---TFGYIA 525
E +HRD+ N L+++ + ++ DFGL+R L D P T+ +G + A
Sbjct: 123 S---EMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTA 179
Query: 526 PELTQTGKASTSSDVFAYGILLLEVAT-GRRP 556
PE K +++SDV++YGI++ EV + G RP
Sbjct: 180 PEAIAYRKFTSASDVWSYGIVMWEVMSYGERP 211
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 69/241 (28%), Positives = 109/241 (45%), Gaps = 30/241 (12%)
Query: 355 FKESEVIGIGGFGSVYKGVLPTTGGEVAVK---KITRNSLQGMREFAAEIESLGRL-RHK 410
FK ++IG G F +V T E A+K K + ++ E E L RL H
Sbjct: 3 FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHP 62
Query: 411 NLVNLHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLH 470
++ L+ + + +L V EY PNG L + + LD + I L YLH
Sbjct: 63 GIIKLYYTFQDEENLYFVLEYAPNGELLQYI---RKYGSLDEKCTRFYAAEILLALEYLH 119
Query: 471 EEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMP------------------ 512
+ +IHRD+KP N L+D +M+ ++ DFG A++ D P
Sbjct: 120 S---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNR 176
Query: 513 -HTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPI-GSGDLLLVEWVRE 570
+ VGT Y++PEL A SSD++A G ++ ++ TG+ P GS + L + + +
Sbjct: 177 RRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILK 236
Query: 571 C 571
Sbjct: 237 L 237
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 4e-26
Identities = 82/239 (34%), Positives = 124/239 (51%), Gaps = 31/239 (12%)
Query: 355 FKESEVIGIGGFGSVYKGVLPTTGGEVAVKKI-TRNSLQGM-----REFAAEIESLGRLR 408
++E IG G +G+VYK TG VA+KK+ S +G+ RE A ++ L
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIAL-LKQLESFE 59
Query: 409 HKNLVNL----HGW-CKQKNDLLLVYEYIPNGSLDTLLFK-PKDGSVLDWEQRFNIVKGI 462
H N+V L HG ++ L LV+E++ + L T L K PK G L E ++++ +
Sbjct: 60 HPNIVRLLDVCHGPRTDRELKLTLVFEHV-DQDLATYLSKCPKPG--LPPETIKDLMRQL 116
Query: 463 ASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFG 522
G+ +LH ++HRD+KP N L+ ++ ++ DFGLAR+Y M T+ VV T
Sbjct: 117 LRGVDFLHS---HRIVHRDLKPQNILVTSDGQVKIADFGLARIYSF-EMALTSVVV-TLW 171
Query: 523 YIAPE-LTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDV 580
Y APE L Q+ A T D+++ G + E+ RRP+ G E QL +I DV
Sbjct: 172 YRAPEVLLQSSYA-TPVDMWSVGCIFAELFR-RRPLFRGT-------SEADQLDKIFDV 221
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 6e-26
Identities = 64/205 (31%), Positives = 113/205 (55%), Gaps = 12/205 (5%)
Query: 359 EVIGIGGFGSVYKGVLPTTGGE---VAVKKITRNSLQGMR-EFAAEIESLGRLRHKNLVN 414
+VIG G FG V++G+L G + VA+K + + R +F +E +G+ H N++
Sbjct: 11 KVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIR 70
Query: 415 LHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWE 474
L G + +++ EY+ NG+LD L + DG + Q +++GIA+G+ YL +
Sbjct: 71 LEGVVTKFKPAMIITEYMENGALDKYL-RDHDGEFSSY-QLVGMLRGIAAGMKYLS---D 125
Query: 475 QVVIHRDVKPSNALIDAEMNARLGDFGLARLY--DHGGMPHTTNVVGTFGYIAPELTQTG 532
+HRD+ N L+++ + ++ DFGL+R+ D G T+ + APE
Sbjct: 126 MNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYR 185
Query: 533 KASTSSDVFAYGILLLEVAT-GRRP 556
K +++SDV+++GI++ EV + G RP
Sbjct: 186 KFTSASDVWSFGIVMWEVMSFGERP 210
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 7e-26
Identities = 84/232 (36%), Positives = 123/232 (53%), Gaps = 28/232 (12%)
Query: 355 FKESEVIGIGGFGSVYKGVLPTTGGEVAVKKIT-RNSLQGMREFAA-EIESLGRLRHKNL 412
+ + E IG G +G VYKG TG VA+KKI + +G+ A EI L L+H N+
Sbjct: 2 YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNI 61
Query: 413 VNLHGWCKQKNDLLLVYEYIP---NGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYL 469
V L Q++ L L++E++ LD+L PK +D E + + I G+L+
Sbjct: 62 VCLQDVLMQESRLYLIFEFLSMDLKKYLDSL---PKGQY-MDAELVKSYLYQILQGILFC 117
Query: 470 HEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMP---HTTNVVGTFGYIAP 526
H + V+HRD+KP N LID + +L DFGLAR + G+P +T VV T Y AP
Sbjct: 118 HS---RRVLHRDLKPQNLLIDNKGVIKLADFGLARAF---GIPVRVYTHEVV-TLWYRAP 170
Query: 527 E-LTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRI 577
E L + + ST D+++ G + E+AT ++P+ GD E QL RI
Sbjct: 171 EVLLGSPRYSTPVDIWSIGTIFAEMAT-KKPLFHGD-------SEIDQLFRI 214
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 1e-25
Identities = 63/197 (31%), Positives = 97/197 (49%), Gaps = 7/197 (3%)
Query: 361 IGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNLHGWCK 420
+G G FG V++G+ T VAVK + ++ ++F AE + + +LRH L+ L+ C
Sbjct: 14 LGAGQFGEVWEGLWNNTT-PVAVKTLKPGTMD-PKDFLAEAQIMKKLRHPKLIQLYAVCT 71
Query: 421 QKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHR 480
+ + +V E + GSL L + G L Q ++ +ASG+ YL Q IHR
Sbjct: 72 LEEPIYIVTELMKYGSLLEYL-QGGAGRALKLPQLIDMAAQVASGMAYLE---AQNYIHR 127
Query: 481 DVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPELTQTGKASTSSDV 540
D+ N L+ ++ DFGLAR+ + APE + S SDV
Sbjct: 128 DLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDV 187
Query: 541 FAYGILLLEVAT-GRRP 556
+++GILL E+ T GR P
Sbjct: 188 WSFGILLTEIVTYGRMP 204
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 3e-25
Identities = 62/209 (29%), Positives = 109/209 (52%), Gaps = 14/209 (6%)
Query: 356 KESEVIGIGGFGSVYKGVLPTTGGEVAVKKIT-----RNSLQGMREFAAEIESLGRLRHK 410
++ E++G G FGSVY+G+ G AVK+++ + + +++ EI L +L+H
Sbjct: 3 RKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHP 62
Query: 411 NLVNLHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLH 470
N+V G +++++L + E +P GSL LL K + I GL YLH
Sbjct: 63 NIVQYLGTEREEDNLYIFLELVPGGSLAKLL---KKYGSFPEPVIRLYTRQILLGLEYLH 119
Query: 471 EEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPE-LT 529
+ + +HRD+K +N L+D +L DFG+A+ + G+ ++APE +
Sbjct: 120 D---RNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSF--AKSFKGSPYWMAPEVIA 174
Query: 530 QTGKASTSSDVFAYGILLLEVATGRRPIG 558
Q G ++D+++ G +LE+ATG+ P
Sbjct: 175 QQGGYGLAADIWSLGCTVLEMATGKPPWS 203
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 3e-25
Identities = 67/202 (33%), Positives = 99/202 (49%), Gaps = 17/202 (8%)
Query: 361 IGIGGFGSVYKGV-LPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNLHGWC 419
+G G FG V+ G TT +VAVK + ++ F E + + +LRH LV L+ C
Sbjct: 14 LGAGQFGEVWMGTWNGTT--KVAVKTLKPGTMS-PEAFLQEAQIMKKLRHDKLVQLYAVC 70
Query: 420 KQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIH 479
++ + +V EY+ GSL L +G L Q ++ IA G+ YL + IH
Sbjct: 71 SEEEPIYIVTEYMSKGSLLDFLKSG-EGKKLRLPQLVDMAAQIAEGMAYLE---SRNYIH 126
Query: 480 RDVKPSNALIDAEMNARLGDFGLARLY-DHGGMPHTTNVVGT---FGYIAPELTQTGKAS 535
RD+ N L+ + ++ DFGLARL D G + APE G+ +
Sbjct: 127 RDLAARNILVGENLVCKIADFGLARLIEDDEYTARE----GAKFPIKWTAPEAANYGRFT 182
Query: 536 TSSDVFAYGILLLEVAT-GRRP 556
SDV+++GILL E+ T GR P
Sbjct: 183 IKSDVWSFGILLTEIVTYGRVP 204
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 4e-25
Identities = 94/339 (27%), Positives = 149/339 (43%), Gaps = 39/339 (11%)
Query: 302 LIVSLCLVTFLLLGTLVFFLIYRKWSNSETL-----ED--WE-----KDCPHRFRYKDLY 349
++ L FL+L + F ++ + N+ L ED WE D+
Sbjct: 630 FYITCTLGAFLVLALVAFGFVFIRGRNNLELKRVENEDGTWELQFFDSKVSKSITINDIL 689
Query: 350 AATKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITR-NSLQGMREFAAEIESLGRLR 408
++ K E VI G G+ YKG G + VK+I NS+ EI +G+L+
Sbjct: 690 SSLK---EENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSS-----EIADMGKLQ 741
Query: 409 HKNLVNLHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLY 468
H N+V L G C+ + L++EYI +L +L L WE+R I GIA L +
Sbjct: 742 HPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVL------RNLSWERRRKIAIGIAKALRF 795
Query: 469 LHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPEL 528
LH V+ ++ P +ID + L RL G + T + Y+APE
Sbjct: 796 LHCRCSPAVVVGNLSPEKIIIDGKDEPHL------RLSLPGLLCTDTKCFISSAYVAPET 849
Query: 529 TQTGKASTSSDVFAYGILLLEVATGRRP--IGSG-DLLLVEWVRECHQLGRILDVADPLL 585
+T + SD++ +G++L+E+ TG+ P G +VEW R C+ + DP +
Sbjct: 850 RETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSI 909
Query: 586 NSSYVVKEMELV--LKLGLMCSH-KTQFRPTMRQVMRYL 621
V + E+V + L L C+ RP V++ L
Sbjct: 910 RGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTL 948
|
Length = 968 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 7e-25
Identities = 66/204 (32%), Positives = 102/204 (50%), Gaps = 12/204 (5%)
Query: 355 FKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAA--EIESLGRL-RHKN 411
+K + +G G FGSVY TG VA+KK+ + E E++SL +L H N
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKK-KFYSWEECMNLREVKSLRKLNEHPN 59
Query: 412 LVNLHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHE 471
+V L ++ ++L V+EY+ G+L L K + G +I+ I GL ++H+
Sbjct: 60 IVKLKEVFRENDELYFVFEYM-EGNLYQL-MKDRKGKPFSESVIRSIIYQILQGLAHIHK 117
Query: 472 EWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPE-LTQ 530
HRD+KP N L+ ++ DFGLAR P T+ V T Y APE L +
Sbjct: 118 ---HGFFHRDLKPENLLVSGPEVVKIADFGLAREIR--SRPPYTDYVSTRWYRAPEILLR 172
Query: 531 TGKASTSSDVFAYGILLLEVATGR 554
+ S+ D++A G ++ E+ T R
Sbjct: 173 STSYSSPVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 65/204 (31%), Positives = 101/204 (49%), Gaps = 11/204 (5%)
Query: 355 FKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVN 414
+K E IG G G VYK TG EVA+KK+ Q EI + +H N+V+
Sbjct: 21 YKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRK-QNKELIINEILIMKDCKHPNIVD 79
Query: 415 LHGWCKQKNDLLLVYEYIPNGSL-DTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEW 473
+ ++L +V EY+ GSL D + ++ Q + + + GL YLH
Sbjct: 80 YYDSYLVGDELWVVMEYMDGGSLTDIITQNFVR---MNEPQIAYVCREVLQGLEYLHS-- 134
Query: 474 EQVVIHRDVKPSNALIDAEMNARLGDFGL-ARLYDHGGMPHTTNVVGTFGYIAPELTQTG 532
Q VIHRD+K N L+ + + +L DFG A+L ++ VVGT ++APE+ +
Sbjct: 135 -QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNS--VVGTPYWMAPEVIKRK 191
Query: 533 KASTSSDVFAYGILLLEVATGRRP 556
D+++ GI+ +E+A G P
Sbjct: 192 DYGPKVDIWSLGIMCIEMAEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 1e-24
Identities = 69/205 (33%), Positives = 103/205 (50%), Gaps = 9/205 (4%)
Query: 355 FKESEVIGIGGFGSVYKGVLPTTGGEVAVKKIT-RNSLQGMREFAA-EIESLGRLRHKNL 412
F+ IG G FG V+K V A+K+I + RE A E L +L +
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61
Query: 413 VNLHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEE 472
+ + K L +V EY NG L LL K + G L +Q + I GL +LH
Sbjct: 62 IRYYESFLDKGKLNIVMEYAENGDLHKLL-KMQRGRPLPEDQVWRFFIQILLGLAHLHS- 119
Query: 473 WEQVVIHRDVKPSNALIDAEMNARLGDFGLAR-LYDHGGMPHTTNVVGTFGYIAPELTQT 531
+ ++HRD+K N +DA N ++GD G+A+ L D+ +T +VGT Y++PEL +
Sbjct: 120 --KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT--IVGTPYYLSPELCED 175
Query: 532 GKASTSSDVFAYGILLLEVATGRRP 556
+ SDV+A G++L E TG+ P
Sbjct: 176 KPYNEKSDVWALGVVLYECCTGKHP 200
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 103 bits (260), Expect = 1e-24
Identities = 69/203 (33%), Positives = 95/203 (46%), Gaps = 24/203 (11%)
Query: 361 IGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQ------GMREFAAEIESLGRLRHKNLVN 414
IG G +G V+K TG VA+KK + +RE I L +L+H NLVN
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALRE----IRMLKQLKHPNLVN 64
Query: 415 LHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWE 474
L ++K L LV+EY + L+ L P+ + I+ + + H+
Sbjct: 65 LIEVFRRKRKLHLVFEYCDHTVLNELEKNPRG---VPEHLIKKIIWQTLQAVNFCHK--- 118
Query: 475 QVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPEL----TQ 530
IHRDVKP N LI + +L DFG AR+ G + T+ V T Y APEL TQ
Sbjct: 119 HNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDY-TDYVATRWYRAPELLVGDTQ 177
Query: 531 TGKASTSSDVFAYGILLLEVATG 553
G DV+A G + E+ TG
Sbjct: 178 YG---PPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 64/199 (32%), Positives = 100/199 (50%), Gaps = 10/199 (5%)
Query: 359 EVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNLHGW 418
E +G G +GSVYK + TG VA+K + ++E EI L + +V +G
Sbjct: 9 EKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE--DLQEIIKEISILKQCDSPYIVKYYGS 66
Query: 419 CKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVI 478
+ DL +V EY GS+ ++ L E+ I+ GL YLH I
Sbjct: 67 YFKNTDLWIVMEYCGAGSVSDIM--KITNKTLTEEEIAAILYQTLKGLEYLHS---NKKI 121
Query: 479 HRDVKPSNALIDAEMNARLGDFGLA-RLYDHGGMPHTTNVVGTFGYIAPELTQTGKASTS 537
HRD+K N L++ E A+L DFG++ +L D M V+GT ++APE+ Q +
Sbjct: 122 HRDIKAGNILLNEEGQAKLADFGVSGQLTD--TMAKRNTVIGTPFWMAPEVIQEIGYNNK 179
Query: 538 SDVFAYGILLLEVATGRRP 556
+D+++ GI +E+A G+ P
Sbjct: 180 ADIWSLGITAIEMAEGKPP 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 103 bits (260), Expect = 2e-24
Identities = 70/231 (30%), Positives = 108/231 (46%), Gaps = 37/231 (16%)
Query: 361 IGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMRE---FAA--EIESLGRLRHKNLVNL 415
+G G + VYK TG VA+KKI + ++ F A EI+ L L+H N++ L
Sbjct: 8 LGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGL 67
Query: 416 HGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRF------NIVKGIASGLLYL 469
K+++ LV+E++ L+ ++ KD S+ + + GL YL
Sbjct: 68 LDVFGHKSNINLVFEFME-TDLEKVI---KDKSI-----VLTPADIKSYMLMTLRGLEYL 118
Query: 470 HEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPELT 529
H W ++HRD+KP+N LI ++ +L DFGLAR + T VV T Y APEL
Sbjct: 119 HSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV-TRWYRAPELL 174
Query: 530 QTGKASTSS-DVFAYGILLLEVATGRRPI--GSGDLLLVEWVRECHQLGRI 577
+ D+++ G + E+ R P G D+ QLG+I
Sbjct: 175 FGARHYGVGVDMWSVGCIFAELLL-RVPFLPGDSDI---------DQLGKI 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 60/201 (29%), Positives = 101/201 (50%), Gaps = 11/201 (5%)
Query: 361 IGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNLHGWCK 420
+G G FG VYK TG A K I S + + +F EI+ L +H N+V L+
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 421 QKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHR 480
+N L ++ E+ G+LD+++ + + G L Q + + + L +LH VIHR
Sbjct: 73 YENKLWILIEFCDGGALDSIMLELERG--LTEPQIRYVCRQMLEALNFLH---SHKVIHR 127
Query: 481 DVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPEL--TQTGKAS--- 535
D+K N L+ + + +L DFG++ T +GT ++APE+ +T K +
Sbjct: 128 DLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDT-FIGTPYWMAPEVVACETFKDNPYD 186
Query: 536 TSSDVFAYGILLLEVATGRRP 556
+D+++ GI L+E+A P
Sbjct: 187 YKADIWSLGITLIELAQMEPP 207
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 4e-24
Identities = 72/210 (34%), Positives = 113/210 (53%), Gaps = 24/210 (11%)
Query: 360 VIGIGGFGSVYKGVLPTTGGE---VAVKKITRNSLQGMR-EFAAEIESLGRLRHKNLVNL 415
VIG G FG V G L G VA+K + + R +F +E +G+ H N+++L
Sbjct: 11 VIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHL 70
Query: 416 HGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDG--SVLDWEQRFNIVKGIASGLLYLHEEW 473
G + +++V EY+ NGSLD L + DG +V+ Q +++GIASG+ YL
Sbjct: 71 EGVVTKSKPVMIVTEYMENGSLDAFL-RKHDGQFTVI---QLVGMLRGIASGMKYLS--- 123
Query: 474 EQVVIHRDVKPSNALIDAEMNARLGDFGLAR-LYDHGGMPHTTNVVGTFGYI-----APE 527
+ +HRD+ N L+++ + ++ DFGL+R L D +TT G I APE
Sbjct: 124 DMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTT----RGGKIPIRWTAPE 179
Query: 528 LTQTGKASTSSDVFAYGILLLEVAT-GRRP 556
K +++SDV++YGI++ EV + G RP
Sbjct: 180 AIAYRKFTSASDVWSYGIVMWEVMSYGERP 209
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 5e-24
Identities = 73/204 (35%), Positives = 110/204 (53%), Gaps = 11/204 (5%)
Query: 355 FKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAA-EIESLGRLRHKNLV 413
FK+ E +G G + +VYKG TTG VA+K+I ++ +G A EI + L+H+N+V
Sbjct: 2 FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIV 61
Query: 414 NLHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEW 473
LH +N L+LV+EY+ + L + LD + + G+ + HE
Sbjct: 62 RLHDVIHTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHE-- 118
Query: 474 EQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTT--NVVGTFGYIAPE-LTQ 530
V+HRD+KP N LI+ +L DFGLAR + G+P T N V T Y AP+ L
Sbjct: 119 -NRVLHRDLKPQNLLINKRGELKLADFGLARAF---GIPVNTFSNEVVTLWYRAPDVLLG 174
Query: 531 TGKASTSSDVFAYGILLLEVATGR 554
+ STS D+++ G ++ E+ TGR
Sbjct: 175 SRTYSTSIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 101 bits (255), Expect = 7e-24
Identities = 70/242 (28%), Positives = 105/242 (43%), Gaps = 43/242 (17%)
Query: 355 FKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQG------MREFAAEIESLGRLR 408
+K IG G G V+K TG VA+KK+ L+G +RE I++L +
Sbjct: 2 YKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALRE----IKALQACQ 57
Query: 409 HKNLVNLHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQR---FNIVKGIA-- 463
H +V L + +LV EY+P L VL E+R VK
Sbjct: 58 HPYVVKLLDVFPHGSGFVLVMEYMP-SDL---------SEVLRDEERPLPEAQVKSYMRM 107
Query: 464 --SGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTF 521
G+ Y+H ++HRD+KP+N LI A+ ++ DFGLARL+ ++ V T
Sbjct: 108 LLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATR 164
Query: 522 GYIAPEL---TQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRIL 578
Y APEL + K D++A G + E+ G P+ G+ + QL +
Sbjct: 165 WYRAPELLYGAR--KYDPGVDLWAVGCIFAELLNG-SPLFPGE-------NDIEQLAIVF 214
Query: 579 DV 580
Sbjct: 215 RT 216
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 9e-24
Identities = 67/240 (27%), Positives = 112/240 (46%), Gaps = 25/240 (10%)
Query: 358 SEVIGIGGFGSVYKGVLPTTGGE-----VAVKKITRNSLQGMR-EFAAEIESLGRLRHKN 411
E +G G FG VYKG L VA+K + N+ ++ EF E E + L+H N
Sbjct: 10 LEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPN 69
Query: 412 LVNLHGWCKQKNDLLLVYEYIPNGSLDTLLFK--PKDG-----------SVLDWEQRFNI 458
+V L G C ++ +++EY+ +G L L + P S LD +I
Sbjct: 70 IVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHI 129
Query: 459 VKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARL-YDHGGMPHTTNV 517
IA+G+ YL +HRD+ N L+ + ++ DFGL+R Y +
Sbjct: 130 AIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKS 186
Query: 518 VGTFGYIAPELTQTGKASTSSDVFAYGILLLEV-ATGRRP-IGSGDLLLVEWVRECHQLG 575
+ ++ PE GK +T SD++++G++L E+ + G +P G + ++E +R L
Sbjct: 187 LLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRSRQLLP 246
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 1e-23
Identities = 62/204 (30%), Positives = 100/204 (49%), Gaps = 10/204 (4%)
Query: 359 EVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQ-GMREFAAEIESLGRLRHKNLVNLHG 417
EVIG+G VY + +VA+K+I Q + E E++++ + H N+V +
Sbjct: 7 EVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYT 66
Query: 418 WCKQKNDLLLVYEYIPNGS-LDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQV 476
++L LV Y+ GS LD + G LD ++K + GL YLH
Sbjct: 67 SFVVGDELWLVMPYLSGGSLLDIMKSSYPRG-GLDEAIIATVLKEVLKGLEYLHS---NG 122
Query: 477 VIHRDVKPSNALIDAEMNARLGDFGL-ARLYDHGGMPHT--TNVVGTFGYIAPELTQTGK 533
IHRD+K N L+ + + ++ DFG+ A L D G VGT ++APE+ +
Sbjct: 123 QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVH 182
Query: 534 ASTS-SDVFAYGILLLEVATGRRP 556
+D++++GI +E+ATG P
Sbjct: 183 GYDFKADIWSFGITAIELATGAAP 206
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 84/255 (32%), Positives = 113/255 (44%), Gaps = 43/255 (16%)
Query: 355 FKESEVIGIGGFGSVYKGVLPTTGGEVAVKKIT-RNSLQGMREFAA-EIESLGRLRHKNL 412
++ +G G FG VYK TG VA+KKI N G A EI+ L +L+H N+
Sbjct: 10 YEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNV 69
Query: 413 VNL-------HGWCKQKNDLLLVYEYIP--NGSLDTLLFKPKDGSV-LDWEQRFNIVKGI 462
V L K K VY P + L LL P SV L Q + +
Sbjct: 70 VPLIDMAVERPD--KSKRKRGSVYMVTPYMDHDLSGLLENP---SVKLTESQIKCYMLQL 124
Query: 463 ASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYD-------HGGMPHT- 514
G+ YLHE ++HRD+K +N LID + ++ DFGLAR YD GG T
Sbjct: 125 LEGINYLHE---NHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTR 181
Query: 515 --TNVVGTFGYIAPELT-QTGKASTSSDVFAYGILLLEVATGRRPI--GSGDLLLVEWVR 569
TN+V T Y PEL + +T+ D++ G + E+ T RRPI G D+
Sbjct: 182 KYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFT-RRPILQGKSDI------- 233
Query: 570 ECHQLGRILDVADPL 584
QL I +
Sbjct: 234 --DQLHLIFKLCGTP 246
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 64/214 (29%), Positives = 112/214 (52%), Gaps = 25/214 (11%)
Query: 359 EVIGIGGFGSVYKGVLPTTGGEVAVKKITRNS---------LQGMRE-FAAEIESLGRLR 408
E+IG G +G VY + TTG +AVK++ + + M + +EIE+L L
Sbjct: 7 ELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLD 66
Query: 409 HKNLVNLHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLY 468
H N+V G+ + L + EY+P GS+ + L G + RF + + GL Y
Sbjct: 67 HLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTY--GRFEEQLVRF-FTEQVLEGLAY 123
Query: 469 LHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLAR----LYDHGGMPHTTNVVGTFGYI 524
LH + ++HRD+K N L+DA+ ++ DFG+++ +YD+ ++ G+ ++
Sbjct: 124 LH---SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDND---QNMSMQGSVFWM 177
Query: 525 APELTQTGKASTSS--DVFAYGILLLEVATGRRP 556
APE+ + S+ D+++ G ++LE+ GRRP
Sbjct: 178 APEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 84/233 (36%), Positives = 114/233 (48%), Gaps = 31/233 (13%)
Query: 355 FKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNS-LQGMREFAA-EIESLGRLRHKNL 412
+++ E IG G +G VYK TG VA+KKI + +G+ A EI L L H N+
Sbjct: 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNI 60
Query: 413 VNLHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKG----IASGLLY 468
V L +N L LV+E+ LD L K D S L ++K + G+ Y
Sbjct: 61 VRLLDVVHSENKLYLVFEF-----LDLDLKKYMDSSPLTGLDP-PLIKSYLYQLLQGIAY 114
Query: 469 LHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMP---HTTNVVGTFGYIA 525
H V+HRD+KP N LID E +L DFGLAR + G+P +T VV T Y A
Sbjct: 115 CHS---HRVLHRDLKPQNLLIDREGALKLADFGLARAF---GVPVRTYTHEVV-TLWYRA 167
Query: 526 PELTQTGKA-STSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRI 577
PE+ + ST D+++ G + E+ RRP+ GD E QL RI
Sbjct: 168 PEILLGSRQYSTPVDIWSIGCIFAEMVN-RRPLFPGD-------SEIDQLFRI 212
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99.8 bits (249), Expect = 3e-23
Identities = 67/216 (31%), Positives = 112/216 (51%), Gaps = 17/216 (7%)
Query: 355 FKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQG-MREFAAEIESLGRLRH---K 410
++ E+IG G +G+VY+G TG VA+K I ++ + + E+ L +LR
Sbjct: 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPP 62
Query: 411 NLVNLHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFN--IVKGIASGLLY 468
N+ +G + L ++ EY GS+ TL+ K G + +++ I++ + L Y
Sbjct: 63 NITKYYGSYLKGPRLWIIMEYAEGGSVRTLM---KAGPI---AEKYISVIIREVLVALKY 116
Query: 469 LHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPEL 528
+H+ VIHRD+K +N L+ N +L DFG+A L + +T VGT ++APE+
Sbjct: 117 IHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRST-FVGTPYWMAPEV 172
Query: 529 TQTGKA-STSSDVFAYGILLLEVATGRRPIGSGDLL 563
GK T +D+++ GI + E+ATG P D
Sbjct: 173 ITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAF 208
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 99.8 bits (249), Expect = 3e-23
Identities = 78/214 (36%), Positives = 109/214 (50%), Gaps = 27/214 (12%)
Query: 359 EVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGM-REFAA-EIESLGRLRHKNLVNLH 416
++G G +G V K TG VA+KK + M ++ A EI L +LRH+NLVNL
Sbjct: 7 GLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLI 66
Query: 417 GWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQR-----FNIVKGIASGLLYLHE 471
++K L LV+E++ + LD L P LD E R F I++GI + H
Sbjct: 67 EVFRRKKRLYLVFEFVDHTVLDDLEKYPNG---LD-ESRVRKYLFQILRGIE----FCH- 117
Query: 472 EWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPEL--- 528
+IHRD+KP N L+ +L DFG AR G + T+ V T Y APEL
Sbjct: 118 --SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVY-TDYVATRWYRAPELLVG 174
Query: 529 -TQTGKASTSSDVFAYGILLLEVATGRRPIGSGD 561
T+ G+A D++A G L+ E+ TG P+ GD
Sbjct: 175 DTKYGRA---VDIWAVGCLVTEMLTG-EPLFPGD 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 3e-23
Identities = 69/222 (31%), Positives = 113/222 (50%), Gaps = 24/222 (10%)
Query: 350 AATKGFKESE---VIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMR-EFAAEIESLG 405
+A K E E IG G G+VYK + TG A+K I N +R + EIE L
Sbjct: 68 SAAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILR 127
Query: 406 RLRHKNLVNLHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRF--NIVKGIA 463
+ H N+V H ++ ++ E++ GSL+ G+ + +++F ++ + I
Sbjct: 128 DVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLE--------GTHI-ADEQFLADVARQIL 178
Query: 464 SGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGY 523
SG+ YLH + ++HRD+KPSN LI++ N ++ DFG++R+ M + VGT Y
Sbjct: 179 SGIAYLHR---RHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQ-TMDPCNSSVGTIAY 234
Query: 524 IAPE-----LTQTGKASTSSDVFAYGILLLEVATGRRPIGSG 560
++PE L + D+++ G+ +LE GR P G G
Sbjct: 235 MSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVG 276
|
Length = 353 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99.6 bits (249), Expect = 3e-23
Identities = 66/208 (31%), Positives = 100/208 (48%), Gaps = 19/208 (9%)
Query: 355 FKESEVIGIGGFGSVYKGVLPTTGGEVAVKKIT-RNSLQGMREFAAEIESLGRLRHKNLV 413
F E IG G FG VYK + T VA+K I + + + EI+ L + R +
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYIT 62
Query: 414 NLHGWCKQKN-DLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEE 472
+G K L ++ EY GS LL KP LD I++ + GL YLH
Sbjct: 63 KYYG-SFLKGSKLWIIMEYCGGGSCLDLL-KP---GKLDETYIAFILREVLLGLEYLH-- 115
Query: 473 WEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTN----VVGTFGYIAPEL 528
E+ IHRD+K +N L+ E + +L DFG++ G + T + VGT ++APE+
Sbjct: 116 -EEGKIHRDIKAANILLSEEGDVKLADFGVS-----GQLTSTMSKRNTFVGTPFWMAPEV 169
Query: 529 TQTGKASTSSDVFAYGILLLEVATGRRP 556
+ +D+++ GI +E+A G P
Sbjct: 170 IKQSGYDEKADIWSLGITAIELAKGEPP 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 99.1 bits (247), Expect = 6e-23
Identities = 69/201 (34%), Positives = 104/201 (51%), Gaps = 15/201 (7%)
Query: 361 IGIGGFGSV----YKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNLH 416
+G G FGSV Y + TG VAVKK+ ++ + +R+F EIE L L+H N+V
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71
Query: 417 GWC--KQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWE 474
G C + +L LV EY+P GSL L K ++ LD + I G+ YL
Sbjct: 72 GVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRER--LDHRKLLLYASQICKGMEYLG---S 126
Query: 475 QVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVG---TFGYIAPELTQT 531
+ +HRD+ N L+++E ++GDFGL ++ + G F Y APE
Sbjct: 127 KRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWY-APESLTE 185
Query: 532 GKASTSSDVFAYGILLLEVAT 552
K S +SDV+++G++L E+ T
Sbjct: 186 SKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 98.2 bits (245), Expect = 7e-23
Identities = 69/205 (33%), Positives = 101/205 (49%), Gaps = 14/205 (6%)
Query: 361 IGIGGFGSVYKGVLPTTGG---EVAVKKITRN-SLQGMREFAAEIESLGRLRHKNLVNLH 416
+G G FGSV KGV G EVAVK + + G +EF E + +L H +V L
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 417 GWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQV 476
G CK + L+LV E P G L L K ++ V D + + +A G+ YL +
Sbjct: 63 GVCKGEP-LMLVMELAPLGPLLKYLKKRREIPVSDLK---ELAHQVAMGMAYLES---KH 115
Query: 477 VIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTF--GYIAPELTQTGKA 534
+HRD+ N L+ A++ DFG++R G + G + + APE GK
Sbjct: 116 FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKF 175
Query: 535 STSSDVFAYGILLLEVAT-GRRPIG 558
S+ SDV++YG+ L E + G +P G
Sbjct: 176 SSKSDVWSYGVTLWEAFSYGAKPYG 200
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 97.8 bits (244), Expect = 8e-23
Identities = 67/210 (31%), Positives = 102/210 (48%), Gaps = 22/210 (10%)
Query: 359 EVIGIGGFGSVYKGVLPTTGGE---VAVKKITRNSLQG-MREFAAEIESLGRLRHKNLVN 414
+ +G G FG V +G T+GG+ VAVK + + L M +F E + L H+NL+
Sbjct: 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIR 60
Query: 415 LHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVL-----DWEQRFNIVKGIASGLLYL 469
L+G L++V E P GSL L K G L D+ + IA+G+ YL
Sbjct: 61 LYGVVLTHP-LMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQ------IANGMRYL 113
Query: 470 HEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTT--NVVGTFGYIAPE 527
+ IHRD+ N L+ ++ ++GDFGL R + ++ F + APE
Sbjct: 114 ES---KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPE 170
Query: 528 LTQTGKASTSSDVFAYGILLLEVAT-GRRP 556
+T S +SDV+ +G+ L E+ T G P
Sbjct: 171 SLRTRTFSHASDVWMFGVTLWEMFTYGEEP 200
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 98.3 bits (245), Expect = 1e-22
Identities = 65/222 (29%), Positives = 105/222 (47%), Gaps = 32/222 (14%)
Query: 359 EVIGIGGFGSVYKGVLPTTGGE-----VAVKKITRNSLQGMRE-FAAEIESLGRLRHKNL 412
+G G FG V+ G E VAVK + + R+ F E E L +H+N+
Sbjct: 11 RELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENI 70
Query: 413 VNLHGWCKQKNDLLLVYEYIPNGSLDTLL-----------FKPKDGSVLDWEQRFNIVKG 461
V +G C + + ++V+EY+ +G L+ L L Q I
Sbjct: 71 VKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQ 130
Query: 462 IASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLAR------LYDHGGMPHTT 515
IASG++YL Q +HRD+ N L+ ++ ++GDFG++R Y GG HT
Sbjct: 131 IASGMVYLA---SQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGG--HTM 185
Query: 516 NVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVAT-GRRP 556
+ ++ PE K +T SDV+++G++L E+ T G++P
Sbjct: 186 LPI---RWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 98.0 bits (244), Expect = 2e-22
Identities = 84/233 (36%), Positives = 114/233 (48%), Gaps = 31/233 (13%)
Query: 355 FKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNS-LQGMREFAA-EIESLGRLRHKNL 412
F++ E IG G +G VYK TG VA+KKI ++ +G+ A EI L L H N+
Sbjct: 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 61
Query: 413 VNLHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKG----IASGLLY 468
V L +N L LV+E+ L L K D S L ++K + GL +
Sbjct: 62 VKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASPLS-GIPLPLIKSYLFQLLQGLAF 115
Query: 469 LHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMP---HTTNVVGTFGYIA 525
H V+HRD+KP N LI+ E +L DFGLAR + G+P +T VV T Y A
Sbjct: 116 CHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAF---GVPVRTYTHEVV-TLWYRA 168
Query: 526 PE-LTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRI 577
PE L ST+ D+++ G + E+ T RR + GD E QL RI
Sbjct: 169 PEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGD-------SEIDQLFRI 213
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 96.8 bits (241), Expect = 2e-22
Identities = 65/206 (31%), Positives = 101/206 (49%), Gaps = 11/206 (5%)
Query: 356 KESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNL 415
E V+G G +G VY +T +A+K+I + ++ EI L+H+N+V
Sbjct: 11 GERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQY 70
Query: 416 HGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNI-VKGIASGLLYLHEEWE 474
G + + E +P GSL LL + K G + D EQ K I GL YLH +
Sbjct: 71 LGSDSENGFFKIFMEQVPGGSLSALL-RSKWGPLKDNEQTIIFYTKQILEGLKYLH---D 126
Query: 475 QVVIHRDVKPSNALIDAEMNA-RLGDFGLA-RLYDHGGMPHTTNVVGTFGYIAPELTQTG 532
++HRD+K N L++ ++ DFG + RL G P T GT Y+APE+ G
Sbjct: 127 NQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRL--AGINPCTETFTGTLQYMAPEVIDKG 184
Query: 533 KA--STSSDVFAYGILLLEVATGRRP 556
+D+++ G ++E+ATG+ P
Sbjct: 185 PRGYGAPADIWSLGCTIVEMATGKPP 210
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 97.1 bits (242), Expect = 3e-22
Identities = 67/210 (31%), Positives = 100/210 (47%), Gaps = 12/210 (5%)
Query: 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKI-TRNSLQGMREFAAEIESLGRLRHKN 411
+ E +G G GSV K L TG A+K I T + ++ E+E +
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60
Query: 412 LVNLHGWC--KQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRF-NIVKGIASGLLY 468
+V +G + + + + EY GSLD++ K K E+ I + + GL Y
Sbjct: 61 IVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSY 120
Query: 469 LHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLA-RLYDHGGMPHTTNVVGTFGYIAPE 527
LH + +IHRD+KPSN L+ + +L DFG++ L + T GT Y+APE
Sbjct: 121 LHS---RKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFT----GTSFYMAPE 173
Query: 528 LTQTGKASTSSDVFAYGILLLEVATGRRPI 557
Q S +SDV++ G+ LLEVA R P
Sbjct: 174 RIQGKPYSITSDVWSLGLTLLEVAQNRFPF 203
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 96.1 bits (240), Expect = 4e-22
Identities = 62/204 (30%), Positives = 95/204 (46%), Gaps = 11/204 (5%)
Query: 361 IGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFA---AEIESLGRLRHKNLVNLHG 417
+G+GGFG V + + A+K + + + + +E E L H +V L+
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 418 WCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVV 477
K K + ++ EY G L T+L G ++ RF + + YLH + +
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTILRD--RGLFDEYTARF-YIACVVLAFEYLHN---RGI 114
Query: 478 IHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPELTQTGKASTS 537
I+RD+KP N L+D+ +L DFG A+ G T GT Y+APE+ S
Sbjct: 115 IYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWT--FCGTPEYVAPEIILNKGYDFS 172
Query: 538 SDVFAYGILLLEVATGRRPIGSGD 561
D ++ GILL E+ TGR P G D
Sbjct: 173 VDYWSLGILLYELLTGRPPFGEDD 196
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 96.1 bits (239), Expect = 4e-22
Identities = 64/217 (29%), Positives = 108/217 (49%), Gaps = 20/217 (9%)
Query: 355 FKESEVIGIGGFGSVYKGVLPTTGGEVAVKKIT--RNSLQG----MREFAAEIESLGRLR 408
+ + + +G G F S Y+ TG +AVK++T RN+ + EI + RL
Sbjct: 2 WLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLN 61
Query: 409 HKNLVNLHGWCKQKNDLLLVYEYIPNGSLDTLL--FKPKDGSVLDWEQRFNIVKGIASGL 466
H +++ + G + + L E++ GS+ LL + +V+ N + + GL
Sbjct: 62 HPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVI-----INYTEQLLRGL 116
Query: 467 LYLHEEWEQVVIHRDVKPSNALIDAE-MNARLGDFGLA-RLYDH--GGMPHTTNVVGTFG 522
YLH E +IHRDVK +N LID+ R+ DFG A RL G ++GT
Sbjct: 117 SYLH---ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIA 173
Query: 523 YIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGS 559
++APE+ + + S DV++ G +++E+AT + P +
Sbjct: 174 FMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNA 210
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 95.4 bits (237), Expect = 8e-22
Identities = 73/225 (32%), Positives = 114/225 (50%), Gaps = 26/225 (11%)
Query: 352 TKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKI---TRNSLQGMREFAA---EIESLG 405
TKG EV+G G +G+VY G L G +AVK++ T N L +E+ E++ L
Sbjct: 3 TKG----EVLGKGAYGTVYCG-LTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLK 57
Query: 406 RLRHKNLVNLHGWCKQKNDLLLVYEYIPNGSLDTLL--FKPKDGSVLDWEQRFNIVKGIA 463
L+H N+V G C N + + E++P GS+ ++L F P V ++ K I
Sbjct: 58 SLKHVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVF---CKYT--KQIL 112
Query: 464 SGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHT-----TNVV 518
G+ YLH V+HRD+K +N ++ +L DFG AR G+ T ++
Sbjct: 113 DGVAYLH---NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMH 169
Query: 519 GTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLL 563
GT ++APE+ SD+++ G + E+ATG+ P+ S D L
Sbjct: 170 GTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRL 214
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 94.9 bits (236), Expect = 1e-21
Identities = 63/205 (30%), Positives = 103/205 (50%), Gaps = 10/205 (4%)
Query: 361 IGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNLHGWCK 420
+G G +G VY+GV VAVK + ++++ + EF E + ++H NLV L G C
Sbjct: 14 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 72
Query: 421 QKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHR 480
++ ++ E++ G+L L + + ++ + I+S + YL ++ IHR
Sbjct: 73 REPPFYIITEFMTYGNLLDYL-RECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHR 128
Query: 481 DVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTF--GYIAPELTQTGKASTSS 538
D+ N L+ ++ DFGL+RL G +T + F + APE K S S
Sbjct: 129 DLAARNCLVGENHLVKVADFGLSRLMT--GDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 186
Query: 539 DVFAYGILLLEVAT-GRRPIGSGDL 562
DV+A+G+LL E+AT G P DL
Sbjct: 187 DVWAFGVLLWEIATYGMSPYPGIDL 211
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 2e-21
Identities = 64/192 (33%), Positives = 95/192 (49%), Gaps = 7/192 (3%)
Query: 359 EVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMR-EFAAEIESLGRLRHKNLVNLHG 417
E++G G FG V+KG L VAVK + Q ++ +F +E L + H N+V L G
Sbjct: 1 ELLGKGNFGEVFKGTLKDKT-PVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIG 59
Query: 418 WCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVV 477
C Q+ + +V E +P G + L K KD L +Q A+G+ YL +
Sbjct: 60 VCTQRQPIYIVMELVPGGDFLSFLRKKKDE--LKTKQLVKFALDAAAGMAYLE---SKNC 114
Query: 478 IHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPELTQTGKASTS 537
IHRD+ N L+ ++ DFG++R D G + + APE G+ S+
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSE 174
Query: 538 SDVFAYGILLLE 549
SDV++YGILL E
Sbjct: 175 SDVWSYGILLWE 186
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 93.2 bits (232), Expect = 5e-21
Identities = 61/222 (27%), Positives = 101/222 (45%), Gaps = 34/222 (15%)
Query: 355 FKESE-----VIGIGGFGSVYKGVLPTTGG----EVAVKKITRNS-LQGMREFAAEIESL 404
KE+E V+G G FG+VYKGV G VA+K + + + +E E +
Sbjct: 4 LKETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVM 63
Query: 405 GRLRHKNLVNLHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIAS 464
+ H ++V L G C + L+ + +P G L + KD + + N IA
Sbjct: 64 ASVDHPHVVRLLGICLSSQ-VQLITQLMPLGCLLDYVRNHKDN--IGSQYLLNWCVQIAK 120
Query: 465 GLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARL---------YDHGGMPHTT 515
G+ YL E + ++HRD+ N L+ + ++ DFGLA+L + G +P
Sbjct: 121 GMSYLEE---KRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVP--- 174
Query: 516 NVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVAT-GRRP 556
++A E + SDV++YG+ + E+ T G +P
Sbjct: 175 -----IKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKP 211
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 94.0 bits (234), Expect = 6e-21
Identities = 80/242 (33%), Positives = 110/242 (45%), Gaps = 56/242 (23%)
Query: 361 IGIGGFGSVYKGVLPTTGGEVAVKKITRN------SLQGMREFAAEIESLGRLRHKNLVN 414
IG G +G VY+ T+G VA+KK+ + + +RE I L LRH N+V
Sbjct: 15 IGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLRE----ITLLLNLRHPNIVE 70
Query: 415 LH----GWCKQKNDLLLVYEYIPNGSLDTLLFKPKD-GSVLDWEQR-FNI--VKGIA--- 463
L G K + + LV EY +D S+LD F+ VK +
Sbjct: 71 LKEVVVG--KHLDSIFLVMEYCE-----------QDLASLLDNMPTPFSESQVKCLMLQL 117
Query: 464 -SGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFG 522
GL YLHE + +IHRD+K SN L+ + ++ DFGLAR Y P T VV T
Sbjct: 118 LRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVV-TLW 173
Query: 523 YIAPEL-----TQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRI 577
Y APEL T T T+ D++A G +L E+ +P+ G E QL I
Sbjct: 174 YRAPELLLGCTTYT----TAIDMWAVGCILAELLAH-KPLLPGK-------SEIEQLDLI 221
Query: 578 LD 579
+
Sbjct: 222 IQ 223
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.9 bits (234), Expect = 6e-21
Identities = 70/241 (29%), Positives = 105/241 (43%), Gaps = 55/241 (22%)
Query: 354 GFKESEVIGIGGFGSVYKGVL--PTTGGEVAVKKI--TRNSLQGMREFAA-EIESLGRLR 408
++ IG G +G VYK G E A+KK + G+ + A EI L L+
Sbjct: 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELK 60
Query: 409 HKNLVNLHGWCKQKND--LLLVYEY-------------------IPNGSLDTLLFKPKDG 447
H+N+V+L + D + L+++Y IP + +LL++
Sbjct: 61 HENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQ---- 116
Query: 448 SVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNAR----LGDFGLA 503
I +G+ YLH W V+HRD+KP+N L+ E R +GD GLA
Sbjct: 117 --------------ILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLA 159
Query: 504 RLYDHGGMP--HTTNVVGTFGYIAPELTQTGKASTSS-DVFAYGILLLEVATGRRPIGSG 560
RL++ P VV T Y APEL + T + D++A G + E+ T PI G
Sbjct: 160 RLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-LEPIFKG 218
Query: 561 D 561
Sbjct: 219 R 219
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 94.2 bits (235), Expect = 6e-21
Identities = 77/232 (33%), Positives = 119/232 (51%), Gaps = 30/232 (12%)
Query: 361 IGIGGFGSVYKGVLPTTGGEVAVKKIT---RNSLQGMREFAAEIESLGRLR-HKNLVNLH 416
+G G +G V+K + T VA+KKI RN+ R F EI L L H N+V L
Sbjct: 15 LGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFR-EIMFLQELGDHPNIVKLL 73
Query: 417 GWCKQKN--DLLLVYEYIPNGSLDTLLFKP-KDGSVLDWEQRFNIVKGIASGLLYLHEEW 473
K +N D+ LV+EY+ +T L + + D +R+ I+ + L Y+H
Sbjct: 74 NVIKAENDKDIYLVFEYM-----ETDLHAVIRANILEDVHKRY-IMYQLLKALKYIHS-- 125
Query: 474 EQVVIHRDVKPSNALIDAEMNARLGDFGLAR----LYDHGGMPHTTNVVGTFGYIAPE-L 528
VIHRD+KPSN L++++ +L DFGLAR L ++ P T+ V T Y APE L
Sbjct: 126 -GNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEIL 184
Query: 529 TQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDV 580
+ + + D+++ G +L E+ G +P+ G L +QL +I++V
Sbjct: 185 LGSTRYTKGVDMWSVGCILGEMLLG-KPLFPGTSTL-------NQLEKIIEV 228
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 92.5 bits (230), Expect = 6e-21
Identities = 62/213 (29%), Positives = 100/213 (46%), Gaps = 16/213 (7%)
Query: 352 TKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAA------EIESLG 405
FK + IG G F VYK + G VA+KK+ + M + A EI+ L
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKV---QIFEMMDAKARQDCLKEIDLLK 57
Query: 406 RLRHKNLVNLHGWCKQKNDLLLVYEYIPNGSLDTLL--FKPKDGSVLDWEQRFNIVKGIA 463
+L H N++ + N+L +V E G L ++ FK K ++ + +
Sbjct: 58 QLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFK-KQKRLIPERTIWKYFVQLC 116
Query: 464 SGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGY 523
S L ++H + ++HRD+KP+N I A +LGD GL R + ++VGT Y
Sbjct: 117 SALEHMHS---KRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT-AAHSLVGTPYY 172
Query: 524 IAPELTQTGKASTSSDVFAYGILLLEVATGRRP 556
++PE + SD+++ G LL E+A + P
Sbjct: 173 MSPERIHENGYNFKSDIWSLGCLLYEMAALQSP 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 93.1 bits (231), Expect = 7e-21
Identities = 73/245 (29%), Positives = 122/245 (49%), Gaps = 38/245 (15%)
Query: 361 IGIGGFGSVY----KGVLPTTGGE-VAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNL 415
+G G FG V+ + PT VAVK + +L ++F E E L L+H+++V
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72
Query: 416 HGWCKQKNDLLLVYEYIPNGSLDTLLF------------KPKDGS-VLDWEQRFNIVKGI 462
+G C + L++V+EY+ +G L+ L +P+ L Q +I I
Sbjct: 73 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 132
Query: 463 ASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLAR------LYDHGGMPHTTN 516
ASG++YL Q +HRD+ N L+ A + ++GDFG++R Y GG HT
Sbjct: 133 ASGMVYLA---SQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGG--HTML 187
Query: 517 VVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVAT-GRRP-IGSGDLLLVEWVRECHQL 574
+ ++ PE K +T SDV+++G++L E+ T G++P + ++ EC
Sbjct: 188 PI---RWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVI----ECITQ 240
Query: 575 GRILD 579
GR+L+
Sbjct: 241 GRVLE 245
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 92.8 bits (231), Expect = 8e-21
Identities = 55/214 (25%), Positives = 97/214 (45%), Gaps = 33/214 (15%)
Query: 361 IGIGGFGSVYKGVL-----PTTGGEVAVKKITRN-SLQGMREFAAEIESLGRLRHKNLVN 414
+G G FG VY+G+ VA+K + N S++ EF E + ++V
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 415 LHGWCKQKNDLLLVYEYIPNGSLDTLL--FKPKD-----GSVLDWEQRFNIVKGIASGLL 467
L G L+V E + G L + L +P+ ++ + IA G+
Sbjct: 74 LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133
Query: 468 YLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLAR-LYDH--------GGMPHTTNVV 518
YL + +HRD+ N ++ ++ ++GDFG+ R +Y+ G +P
Sbjct: 134 YLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLP------ 184
Query: 519 GTFGYIAPELTQTGKASTSSDVFAYGILLLEVAT 552
++APE + G +T SDV+++G++L E+AT
Sbjct: 185 --VRWMAPESLKDGVFTTKSDVWSFGVVLWEMAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 91.9 bits (228), Expect = 2e-20
Identities = 72/208 (34%), Positives = 99/208 (47%), Gaps = 18/208 (8%)
Query: 355 FKESEVIGIGGFGSV----YKGVLPTTGGEVAVKKITRNSLQGMRE-FAAEIESLGRLRH 409
K+ V+G G FG V Y TG VAVK + R Q + EI L L H
Sbjct: 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYH 65
Query: 410 KNLVNLHGWCKQKND--LLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLL 467
+N+V G C ++ L L+ EY+P GSL L K K L+ Q + I G+
Sbjct: 66 ENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHK----LNLAQLLLFAQQICEGMA 121
Query: 468 YLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVG---TFGYI 524
YLH Q IHRD+ N L+D + ++GDFGLA+ G + G F Y
Sbjct: 122 YLHS---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY- 177
Query: 525 APELTQTGKASTSSDVFAYGILLLEVAT 552
A E + K S +SDV+++G+ L E+ T
Sbjct: 178 AVECLKENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 2e-20
Identities = 62/199 (31%), Positives = 93/199 (46%), Gaps = 9/199 (4%)
Query: 361 IGIGGFGSVYKGVLPTTGGEVAVKKITRNSL---QGMREFAAEIESLGRLRHKNLVNLHG 417
+G GGFG V + TG A KK+ + L +G + E + L ++ + +V+L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 418 WCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVV 477
+ K+DL LV + G L ++ + + F + I GL +LH+ +
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQ-IICGLEHLHQRR---I 116
Query: 478 IHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPELTQTGKASTS 537
++RD+KP N L+D N R+ D GLA G GT GY+APE+ Q S
Sbjct: 117 VYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGR--AGTPGYMAPEVLQGEVYDFS 174
Query: 538 SDVFAYGILLLEVATGRRP 556
D FA G L E+ GR P
Sbjct: 175 VDWFALGCTLYEMIAGRSP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 3e-20
Identities = 69/206 (33%), Positives = 104/206 (50%), Gaps = 9/206 (4%)
Query: 354 GFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSL-QGMREFAA-EIESLGRLRHKN 411
FK + +G G +GSVYK + A+K++ S+ Q RE A EI L + H N
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 412 LVNLHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQR-FNIVKGIASGLLYLH 470
+++ N L +V EY P G L + K K L EQ + I + GL LH
Sbjct: 61 IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH 120
Query: 471 EEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPELTQ 530
E Q ++HRD+K +N L+ A ++GD G++++ M T +GT Y+APE+ +
Sbjct: 121 E---QKILHRDLKSANILLVANDLVKIGDLGISKVLK-KNMAKT--QIGTPHYMAPEVWK 174
Query: 531 TGKASTSSDVFAYGILLLEVATGRRP 556
S SD+++ G LL E+AT P
Sbjct: 175 GRPYSYKSDIWSLGCLLYEMATFAPP 200
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 90.4 bits (224), Expect = 3e-20
Identities = 70/210 (33%), Positives = 101/210 (48%), Gaps = 22/210 (10%)
Query: 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNL 412
K K + IG G FG V G G +VAVK I ++ + F AE + +LRH NL
Sbjct: 6 KELKLLQTIGKGEFGDVMLG--DYRGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNL 61
Query: 413 VNLHG-WCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHE 471
V L G ++K L +V EY+ GSL L + + SVL + + + YL
Sbjct: 62 VQLLGVIVEEKGGLYIVTEYMAKGSLVDYL-RSRGRSVLGGDCLLKFSLDVCEAMEYLEA 120
Query: 472 EWEQVVIHRDVKPSNALIDAEMNARLGDFGLAR----LYDHGGMPHTTNVVGTFGYIAPE 527
+HRD+ N L+ + A++ DFGL + D G +P + APE
Sbjct: 121 ---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLP--------VKWTAPE 169
Query: 528 LTQTGKASTSSDVFAYGILLLEVAT-GRRP 556
+ K ST SDV+++GILL E+ + GR P
Sbjct: 170 ALREKKFSTKSDVWSFGILLWEIYSFGRVP 199
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 90.4 bits (224), Expect = 3e-20
Identities = 57/202 (28%), Positives = 96/202 (47%), Gaps = 8/202 (3%)
Query: 356 KESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNL 415
+ IG G FG V+ G +VA+K I R +F E + + +L H LV L
Sbjct: 7 TLVQEIGSGQFGLVWLGYW-LEKRKVAIKTI-REGAMSEEDFIEEAQVMMKLSHPKLVQL 64
Query: 416 HGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQ 475
+G C +++ + LV+E++ +G L L + + G E + + G+ YL
Sbjct: 65 YGVCTERSPICLVFEFMEHGCLSDYL-RAQRGK-FSQETLLGMCLDVCEGMAYLE---SS 119
Query: 476 VVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPELTQTGKAS 535
VIHRD+ N L+ ++ DFG+ R +T + +PE+ K S
Sbjct: 120 NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYS 179
Query: 536 TSSDVFAYGILLLEV-ATGRRP 556
+ SDV+++G+L+ EV + G+ P
Sbjct: 180 SKSDVWSFGVLMWEVFSEGKTP 201
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 4e-20
Identities = 77/218 (35%), Positives = 109/218 (50%), Gaps = 25/218 (11%)
Query: 355 FKESEVIGIGGFGSVYKGVLPTTGGEVAVKKIT-RNSLQGMREFAA-EIESLGRLRHKNL 412
+++ E IG G +G VYK T +A+KKI +G+ A EI L ++H N+
Sbjct: 4 YEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNI 63
Query: 413 VNLHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKG----IASGLLY 468
V L + L LV+EY LD L K D S D+ + ++K I G+ Y
Sbjct: 64 VRLQDVVHSEKRLYLVFEY-----LDLDLKKHMDSSP-DFAKNPRLIKTYLYQILRGIAY 117
Query: 469 LHEEWEQVVIHRDVKPSNALIDAEMNA-RLGDFGLARLYDHGGMP---HTTNVVGTFGYI 524
H V+HRD+KP N LID NA +L DFGLAR + G+P T VV T Y
Sbjct: 118 CHS---HRVLHRDLKPQNLLIDRRTNALKLADFGLARAF---GIPVRTFTHEVV-TLWYR 170
Query: 525 APE-LTQTGKASTSSDVFAYGILLLEVATGRRPIGSGD 561
APE L + ST D+++ G + E+ ++P+ GD
Sbjct: 171 APEILLGSRHYSTPVDIWSVGCIFAEMVN-QKPLFPGD 207
|
Length = 294 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 90.8 bits (225), Expect = 4e-20
Identities = 73/232 (31%), Positives = 116/232 (50%), Gaps = 29/232 (12%)
Query: 361 IGIGGFGSVYKGVLPTTGGEVAVKKI-TRNSLQGM-----REFAAEIESLGRLRHKNLVN 414
IG+G +G+VYK P +G VA+K + + + G+ RE A ++ L H N+V
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVAL-LKRLEAFDHPNIVR 66
Query: 415 LHGWC-----KQKNDLLLVYEYIPNGSLDTLLFK-PKDGSVLDWEQRFNIVKGIASGLLY 468
L C ++ + LV+E++ + L T L K P G L E ++++ GL +
Sbjct: 67 LMDVCATSRTDRETKVTLVFEHV-DQDLRTYLDKVPPPG--LPAETIKDLMRQFLRGLDF 123
Query: 469 LHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPEL 528
LH ++HRD+KP N L+ + +L DFGLAR+Y T VV T Y APE+
Sbjct: 124 LHA---NCIVHRDLKPENILVTSGGQVKLADFGLARIYSC--QMALTPVVVTLWYRAPEV 178
Query: 529 TQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDV 580
+T D+++ G + E+ R+P+ G+ E QLG+I D+
Sbjct: 179 LLQSTYATPVDMWSVGCIFAEMFR-RKPLFCGN-------SEADQLGKIFDL 222
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 5e-20
Identities = 71/216 (32%), Positives = 107/216 (49%), Gaps = 22/216 (10%)
Query: 360 VIGIGGFGSVYKGVLPTTGGEVAVKKI-TRNSLQGMREFAA-EIESLGRLRHKNLVNLH- 416
IG G +G VYK TG VA+KK+ N +G A EI+ L +L H+N+VNL
Sbjct: 14 QIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKE 73
Query: 417 ---------GWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSV-LDWEQRFNIVKGIASGL 466
+ K K LV+EY+ + + L + G V + + +K + GL
Sbjct: 74 IVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLL----ESGLVHFSEDHIKSFMKQLLEGL 129
Query: 467 LYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAP 526
Y H+ + +HRD+K SN L++ + +L DFGLARLY+ TN V T Y P
Sbjct: 130 NYCHK---KNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLWYRPP 186
Query: 527 ELTQTGKASTSS-DVFAYGILLLEVATGRRPIGSGD 561
EL + + DV++ G +L E+ T ++PI +
Sbjct: 187 ELLLGEERYGPAIDVWSCGCILGELFT-KKPIFQAN 221
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 89.9 bits (223), Expect = 5e-20
Identities = 75/269 (27%), Positives = 127/269 (47%), Gaps = 31/269 (11%)
Query: 361 IGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNLHGWCK 420
+G G FG V+ G +VA+K I ++ +F E + + +L H LV L+G C
Sbjct: 12 LGSGQFGVVHLGKWRAQI-KVAIKAINEGAMS-EEDFIEEAKVMMKLSHPKLVQLYGVCT 69
Query: 421 QKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHR 480
Q+ L +V E++ NG L L + + L + ++ + + G+ YL IHR
Sbjct: 70 QQKPLYIVTEFMENGCL--LNYLRQRQGKLSKDMLLSMCQDVCEGMEYLE---RNSFIHR 124
Query: 481 DVKPSNALIDAEMNARLGDFGLAR--LYDHGGMPHTTNVVGTF--GYIAPELTQTGKAST 536
D+ N L+ + ++ DFG+ R L D +T++ F + PE+ K S+
Sbjct: 125 DLAARNCLVSSTGVVKVSDFGMTRYVLDDE----YTSSSGAKFPVKWSPPEVFNFSKYSS 180
Query: 537 SSDVFAYGILLLEVAT-GRRPIGS-GDLLLVEWVRECHQLGRILDVADPLLNSSYVVKEM 594
SDV+++G+L+ EV T G+ P + +VE + +L R P L S V + M
Sbjct: 181 KSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYR------PKLASMTVYEVM 234
Query: 595 ELVLKLGLMCSH-KTQFRPTMRQVMRYLS 622
C H K + RPT +++R ++
Sbjct: 235 -------YSCWHEKPEGRPTFAELLRAIT 256
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 89.4 bits (222), Expect = 6e-20
Identities = 74/272 (27%), Positives = 124/272 (45%), Gaps = 39/272 (14%)
Query: 361 IGIGGFGSV----YKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNLH 416
+G G FG V ++G + +VA+K I ++ +F E + + +L H NLV L+
Sbjct: 12 LGSGQFGVVHLGKWRGKI-----DVAIKMIREGAMS-EDDFIEEAKVMMKLSHPNLVQLY 65
Query: 417 GWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQV 476
G C ++ + +V EY+ NG L L + K L E ++ + + YL
Sbjct: 66 GVCTKQRPIFIVTEYMANGCLLNYLRERK--GKLGTEWLLDMCSDVCEAMEYLE---SNG 120
Query: 477 VIHRDVKPSNALIDAEMNARLGDFGLAR--LYDHGGMPHTTNVVGT---FGYIAPELTQT 531
IHRD+ N L+ + ++ DFGLAR L D T+ GT + PE+
Sbjct: 121 FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDD-----QYTSSQGTKFPVKWAPPEVFDY 175
Query: 532 GKASTSSDVFAYGILLLEVAT-GRRPIGS-GDLLLVEWVRECHQLGRILDVADPLLNSSY 589
+ S+ SDV+++G+L+ EV + G+ P + +VE V ++L R P L +
Sbjct: 176 SRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYR------PKLAPTE 229
Query: 590 VVKEMELVLKLGLMCSHKTQFRPTMRQVMRYL 621
V M K + RP ++++ L
Sbjct: 230 VYTIM------YSCWHEKPEDRPAFKKLLSQL 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 8e-20
Identities = 62/202 (30%), Positives = 101/202 (50%), Gaps = 8/202 (3%)
Query: 356 KESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNL 415
K + +G G FG V+ G +VA+K + + S+ F AE + +L+H LV L
Sbjct: 9 KLVKKLGAGQFGEVWMGYYNGHT-KVAIKSLKQGSMS-PEAFLAEANLMKQLQHPRLVRL 66
Query: 416 HGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQ 475
+ Q+ + ++ EY+ NGSL L K +G L + ++ IA G+ ++ +
Sbjct: 67 YAVVTQE-PIYIITEYMENGSLVDFL-KTPEGIKLTINKLIDMAAQIAEGMAFIER---K 121
Query: 476 VVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPELTQTGKAS 535
IHRD++ +N L+ + ++ DFGLARL + + APE G +
Sbjct: 122 NYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFT 181
Query: 536 TSSDVFAYGILLLEVAT-GRRP 556
SDV+++GILL E+ T GR P
Sbjct: 182 IKSDVWSFGILLTEIVTYGRIP 203
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 9e-20
Identities = 65/211 (30%), Positives = 112/211 (53%), Gaps = 20/211 (9%)
Query: 360 VIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMRE---------FAAEIESLGRLRHK 410
+IG G FGSVY G+ ++G +AVK++ S+ + A EI L L+H+
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 411 NLVNLHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLH 470
N+V G + L + EY+P GS+ LL G+ + R N V+ I GL YLH
Sbjct: 67 NIVQYLGSSLDADHLNIFLEYVPGGSVAALL--NNYGAFEETLVR-NFVRQILKGLNYLH 123
Query: 471 EEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTN-----VVGTFGYIA 525
+ +IHRD+K +N L+D + ++ DFG+++ + + TN + G+ ++A
Sbjct: 124 ---NRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMA 180
Query: 526 PELTQTGKASTSSDVFAYGILLLEVATGRRP 556
PE+ + + +D+++ G L++E+ TG+ P
Sbjct: 181 PEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 89.9 bits (224), Expect = 1e-19
Identities = 77/251 (30%), Positives = 116/251 (46%), Gaps = 43/251 (17%)
Query: 344 RYKDLYAATKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITR---NSLQGMREFAAE 400
RY+ L + IG G +G V V TG +VA+KKI+ + + R E
Sbjct: 1 RYELL----------KPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRIL-RE 49
Query: 401 IESLGRLRHKNLVNLH-----GWCKQKNDLLLVYEYIPNGSLDTLLFKP-KDGSVLDWEQ 454
I+ L LRH+N++ L + ND+ +V E ++T L K K L +
Sbjct: 50 IKLLRHLRHENIIGLLDILRPPSPEDFNDVYIVTEL-----METDLHKVIKSPQPLT-DD 103
Query: 455 RFN-IVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARL--YDHGGM 511
+ I GL YLH VIHRD+KPSN L+++ + ++ DFGLAR D
Sbjct: 104 HIQYFLYQILRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEK 160
Query: 512 PHTTNVVGTFGYIAPELTQTGKA-STSSDVFAYGILLLEVATGRRPIGSG-DLLLVEWVR 569
T V T Y APEL + + + D+++ G + E+ T R+P+ G D +
Sbjct: 161 GFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLT-RKPLFPGRDYI------ 213
Query: 570 ECHQLGRILDV 580
QL I++V
Sbjct: 214 --DQLNLIVEV 222
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 89.2 bits (221), Expect = 1e-19
Identities = 61/199 (30%), Positives = 98/199 (49%), Gaps = 14/199 (7%)
Query: 359 EVIGIGGFGSVYKGVLPTTGGEVAVKKITRN-SLQGMREFAAEIESLGRLRHKNLVNLHG 417
E++G G G+VYK T +AVK I + +++ ++ +E+E L + ++ +G
Sbjct: 7 EILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYG 66
Query: 418 WCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVV 477
+N + + E++ GSLD P+ VL I + GL YL W +
Sbjct: 67 AFFVENRISICTEFMDGGSLDVYRKIPE--HVLG-----RIAVAVVKGLTYL---WSLKI 116
Query: 478 IHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPELTQTGKASTS 537
+HRDVKPSN L++ +L DFG++ + VGT Y+APE +
Sbjct: 117 LHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS---IAKTYVGTNAYMAPERISGEQYGIH 173
Query: 538 SDVFAYGILLLEVATGRRP 556
SDV++ GI +E+A GR P
Sbjct: 174 SDVWSLGISFMELALGRFP 192
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 2e-19
Identities = 74/234 (31%), Positives = 117/234 (50%), Gaps = 17/234 (7%)
Query: 359 EVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNLHGW 418
E+IG G FG+V +G TG +VAVK I + + F E + +L HKNLV L G
Sbjct: 12 EIIGEGEFGAVLQG--EYTGQKVAVKNIKCDVTA--QAFLEETAVMTKLHHKNLVRLLGV 67
Query: 419 CKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVI 478
N L +V E + G+L L + + +++ Q +A G+ YL + ++
Sbjct: 68 ILH-NGLYIVMELMSKGNLVNFL-RTRGRALVSVIQLLQFSLDVAEGMEYLES---KKLV 122
Query: 479 HRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPELTQTGKASTSS 538
HRD+ N L+ + A++ DFGLAR+ G N + APE + K S+ S
Sbjct: 123 HRDLAARNILVSEDGVAKVSDFGLARVGSMG----VDNSKLPVKWTAPEALKHKKFSSKS 178
Query: 539 DVFAYGILLLEV-ATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSYVV 591
DV++YG+LL EV + GR P + ++ V+EC + G ++ + YV+
Sbjct: 179 DVWSYGVLLWEVFSYGRAPYPK---MSLKEVKECVEKGYRMEPPEGCPADVYVL 229
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 88.5 bits (220), Expect = 2e-19
Identities = 62/207 (29%), Positives = 97/207 (46%), Gaps = 18/207 (8%)
Query: 361 IGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFA---AEIESLGRLRHKNLVNLHG 417
I G +G V+ +TG A+K I + + + E + L + + +V L+
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLY- 59
Query: 418 WCKQ-KNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQV 476
+ Q K +L LV EY+P G L +LL ++ LD + + I L YLH
Sbjct: 60 YSFQGKKNLYLVMEYLPGGDLASLL---ENVGSLDEDVARIYIAEIVLALEYLHS---NG 113
Query: 477 VIHRDVKPSNALIDAEMNARLGDFGLAR-------LYDHGGMPHTTNVVGTFGYIAPELT 529
+IHRD+KP N LID+ + +L DFGL++ + + +VGT YIAPE+
Sbjct: 114 IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVI 173
Query: 530 QTGKASTSSDVFAYGILLLEVATGRRP 556
S + D ++ G +L E G P
Sbjct: 174 LGQGHSKTVDWWSLGCILYEFLVGIPP 200
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 2e-19
Identities = 66/216 (30%), Positives = 106/216 (49%), Gaps = 26/216 (12%)
Query: 356 KESEVIGIGGFGSVYKGVLPTTG--GEVAVKKITRNSLQG-MREFAAEIESLGRL-RHKN 411
K +VIG G FG V K + G + A+K++ + + R+FA E+E L +L H N
Sbjct: 10 KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPN 69
Query: 412 LVNLHGWCKQKNDLLLVYEYIPNGSLDTLLFKPK-------------DGSVLDWEQRFNI 458
++NL G C+ + L L EY P+G+L L K + S L +Q +
Sbjct: 70 IINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 129
Query: 459 VKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVV 518
+A G+ YL ++ IHRD+ N L+ A++ DFGL+R G + +
Sbjct: 130 AADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSR----GQEVYVKKTM 182
Query: 519 GTFG--YIAPELTQTGKASTSSDVFAYGILLLEVAT 552
G ++A E +T+SDV++YG+LL E+ +
Sbjct: 183 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 2e-19
Identities = 62/197 (31%), Positives = 99/197 (50%), Gaps = 8/197 (4%)
Query: 361 IGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNLHGWCK 420
+G G FG V+ G T VA+K + ++ F E + + +LRH+ LV L+
Sbjct: 14 LGQGCFGEVWMGTWNGTT-RVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVS 71
Query: 421 QKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHR 480
++ + +V EY+ GSL L K + G L Q ++ IASG+ Y+ +HR
Sbjct: 72 EE-PIYIVTEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHR 126
Query: 481 DVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPELTQTGKASTSSDV 540
D++ +N L+ + ++ DFGLARL + + APE G+ + SDV
Sbjct: 127 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 186
Query: 541 FAYGILLLEVAT-GRRP 556
+++GILL E+ T GR P
Sbjct: 187 WSFGILLTELTTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 88.6 bits (219), Expect = 2e-19
Identities = 73/240 (30%), Positives = 117/240 (48%), Gaps = 33/240 (13%)
Query: 361 IGIGGFGSVYKGVLPTTGGE-----VAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNL 415
+G G FG V+ E VAVK + S ++F E E L L+H+++V
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72
Query: 416 HGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWE----------QRFNIVKGIASG 465
+G C + + L++V+EY+ +G L+ L +VL E Q +I + IA+G
Sbjct: 73 YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAG 132
Query: 466 LLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLAR------LYDHGGMPHTTNVVG 519
++YL Q +HRD+ N L+ + ++GDFG++R Y GG HT +
Sbjct: 133 MVYLA---SQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGG--HTMLPI- 186
Query: 520 TFGYIAPELTQTGKASTSSDVFAYGILLLEVAT-GRRPIGSGDLLLVEWVRECHQLGRIL 578
++ PE K +T SDV++ G++L E+ T G++P L V EC GR+L
Sbjct: 187 --RWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQ---LSNNEVIECITQGRVL 241
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.7 bits (218), Expect = 3e-19
Identities = 70/211 (33%), Positives = 96/211 (45%), Gaps = 18/211 (8%)
Query: 359 EVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRL-RHKNLVNLHG 417
EVIG G +G VYK TG VA+K I E E L + H N+ +G
Sbjct: 12 EVIGEGTYGKVYKARHKKTGQLVAIK-IMDIIEDEEEEIKEEYNILRKYSNHPNIATFYG 70
Query: 418 WCKQKND------LLLVYEYIPNGSLDTLLFKPKD-GSVLDWEQRFNIVKGIASGLLYLH 470
+KN L LV E GS+ L+ + G L E I++ GL YLH
Sbjct: 71 AFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLH 130
Query: 471 EEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPELT- 529
E VIHRD+K N L+ +L DFG++ D T +GT ++APE+
Sbjct: 131 E---NKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNT-FIGTPYWMAPEVIA 186
Query: 530 --QTGKAS--TSSDVFAYGILLLEVATGRRP 556
+ AS SDV++ GI +E+A G+ P
Sbjct: 187 CDEQPDASYDARSDVWSLGITAIELADGKPP 217
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.0 bits (216), Expect = 5e-19
Identities = 61/205 (29%), Positives = 95/205 (46%), Gaps = 9/205 (4%)
Query: 355 FKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVN 414
++ + IG G +G VYK TG VA+K I EI L RH N+V
Sbjct: 5 YELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVA 64
Query: 415 LHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWE 474
G +++ L +V EY GSL +++ G L Q + + GL YLH E
Sbjct: 65 YFGSYLRRDKLWIVMEYCGGGSLQD-IYQVTRGP-LSELQIAYVCRETLKGLAYLH---E 119
Query: 475 QVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPELTQ---T 531
IHRD+K +N L+ + + +L DFG++ + + +GT ++APE+
Sbjct: 120 TGKIHRDIKGANILLTEDGDVKLADFGVSAQLTA-TIAKRKSFIGTPYWMAPEVAAVERK 178
Query: 532 GKASTSSDVFAYGILLLEVATGRRP 556
G D++A GI +E+A + P
Sbjct: 179 GGYDGKCDIWALGITAIELAELQPP 203
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.5 bits (220), Expect = 5e-19
Identities = 76/241 (31%), Positives = 116/241 (48%), Gaps = 37/241 (15%)
Query: 355 FKESEVIGIGGFGSVYKGVLPTTGGEVAVKKIT--RNSLQGMREFAAEIESLGRLRHKNL 412
++ IG G +G V TG +VA+KKI+ + R EI+ L R +H+N+
Sbjct: 7 YQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLR-EIKILRRFKHENI 65
Query: 413 VNLHGWCK-----QKNDLLLVYEYIPNGSLDTLLFKPKDGSVL--DWEQRFNIVKGIASG 465
+ + + ND+ +V E ++T L+K L D Q F + I G
Sbjct: 66 IGILDIIRPPSFESFNDVYIVQEL-----METDLYKLIKTQHLSNDHIQYF--LYQILRG 118
Query: 466 LLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARL----YDHGGMPHTTNVVGTF 521
L Y+H V+HRD+KPSN L++ + ++ DFGLAR+ +DH G T V T
Sbjct: 119 LKYIHS---ANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGF--LTEYVATR 173
Query: 522 GYIAPELTQTGKA-STSSDVFAYGILLLEVATGRRPIGSG-DLLLVEWVRECHQLGRILD 579
Y APE+ K + + D+++ G +L E+ + RP+ G D L HQL IL
Sbjct: 174 WYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSN-RPLFPGKDYL--------HQLNLILG 224
Query: 580 V 580
V
Sbjct: 225 V 225
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 5e-19
Identities = 63/211 (29%), Positives = 109/211 (51%), Gaps = 9/211 (4%)
Query: 355 FKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAA--EIESLGRLRHKNL 412
+++ V+G G FG V+ V +K+I + AA E + L L H N+
Sbjct: 2 YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNI 61
Query: 413 VNLHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEE 472
+ + + L++V EY P G+L + K + S+LD + I+ LL LH
Sbjct: 62 IEYYENFLEDKALMIVMEYAPGGTLAEYIQK-RCNSLLDEDT---ILHFFVQILLALHHV 117
Query: 473 WEQVVIHRDVKPSNALIDA-EMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPELTQT 531
++++HRD+K N L+D +M ++GDFG++++ +T VVGT YI+PEL +
Sbjct: 118 HTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYT--VVGTPCYISPELCEG 175
Query: 532 GKASTSSDVFAYGILLLEVATGRRPIGSGDL 562
+ SD++A G +L E+A+ +R + +L
Sbjct: 176 KPYNQKSDIWALGCVLYELASLKRAFEAANL 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 87.5 bits (217), Expect = 6e-19
Identities = 71/218 (32%), Positives = 107/218 (49%), Gaps = 36/218 (16%)
Query: 359 EVIGIGGFGSVYKGVLPTTGGEVAVKKIT-RNSLQGMREFAA-EIESLGRLRHKNLVNLH 416
E IG G +G+V+K T VA+K++ + +G+ A EI L L+HKN+V L+
Sbjct: 6 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLY 65
Query: 417 GWCKQKNDLLLVYEYIP----------NGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGL 466
L LV+EY NG +D + K S + F ++KG+A
Sbjct: 66 DVLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVK----SFM-----FQLLKGLA--- 113
Query: 467 LYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMP---HTTNVVGTFGY 523
+ H V+HRD+KP N LI+ +L DFGLAR + G+P ++ VV T Y
Sbjct: 114 -FCHS---HNVLHRDLKPQNLLINKNGELKLADFGLARAF---GIPVRCYSAEVV-TLWY 165
Query: 524 IAPELTQTGKA-STSSDVFAYGILLLEVATGRRPIGSG 560
P++ K STS D+++ G + E+A RP+ G
Sbjct: 166 RPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPG 203
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 86.9 bits (215), Expect = 7e-19
Identities = 65/200 (32%), Positives = 95/200 (47%), Gaps = 11/200 (5%)
Query: 361 IGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQ---GMREFAAEIESLGRLRHKNLVNLHG 417
+G GGFG V + TG A KK+ + L+ G + E E L ++ +VNL
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 418 WCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSV-LDWEQRFNIVKGIASGLLYLHEEWEQV 476
+ K L LV + G L ++ G L+ E+ + I G+L+LH
Sbjct: 61 AFESKTHLCLVMSLMNGGDLKYHIYNV--GERGLEMERVIHYSAQITCGILHLHS---MD 115
Query: 477 VIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPELTQTGKAST 536
+++RD+KP N L+D + N RL D GLA + G T GT GY+APE+ + S
Sbjct: 116 IVYRDMKPENVLLDDQGNCRLSDLGLA-VELKDGKT-ITQRAGTNGYMAPEILKEEPYSY 173
Query: 537 SSDVFAYGILLLEVATGRRP 556
D FA G + E+ GR P
Sbjct: 174 PVDWFAMGCSIYEMVAGRTP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 86.5 bits (214), Expect = 7e-19
Identities = 83/272 (30%), Positives = 129/272 (47%), Gaps = 45/272 (16%)
Query: 361 IGIGGFGSV----YKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNLH 416
+G G FG V ++G +VA+K I S+ EF E + + +L H+ LV L+
Sbjct: 12 LGTGQFGVVKYGKWRGQY-----DVAIKMIKEGSMS-EDEFIEEAKVMMKLSHEKLVQLY 65
Query: 417 GWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQV 476
G C ++ + +V EY+ NG L L + Q + K + G+ YL E +Q
Sbjct: 66 GVCTKQRPIYIVTEYMSNGCLLNYLREHGKR--FQPSQLLEMCKDVCEGMAYL--ESKQ- 120
Query: 477 VIHRDVKPSNALIDAEMNARLGDFGLAR--LYDHGGMPHTTNVVGTF--GYIAPELTQTG 532
IHRD+ N L+D + ++ DFGL+R L D +T++V F + PE+
Sbjct: 121 FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDE----YTSSVGSKFPVRWSPPEVLLYS 176
Query: 533 KASTSSDVFAYGILLLEVAT-GRRPIGSGDLL----LVEWVRECHQLGRILDVADPLLNS 587
K S+ SDV+A+G+L+ EV + G+ P + VE V + +L R P L S
Sbjct: 177 KFSSKSDVWAFGVLMWEVYSLGKMPY---ERFNNSETVEKVSQGLRLYR------PHLAS 227
Query: 588 SYVVKEMELVLKLGLMCSH-KTQFRPTMRQVM 618
V M C H K + RPT +Q++
Sbjct: 228 EKVYAIM-------YSCWHEKAEERPTFQQLL 252
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 8e-19
Identities = 74/232 (31%), Positives = 113/232 (48%), Gaps = 28/232 (12%)
Query: 361 IGIGGFGSVYKGVLPTTGGE-VAVKKI-TRNSLQGM-----REFAAEIESLGRLRHKNLV 413
IG G +G V+K GG VA+K++ + +GM RE A + L H N+V
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAV-LRHLETFEHPNVV 67
Query: 414 NLHGWCK-----QKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLY 468
L C ++ L LV+E++ + L T L K + V E +++ + GL +
Sbjct: 68 RLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPT-ETIKDMMFQLLRGLDF 125
Query: 469 LHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPEL 528
LH V+HRD+KP N L+ + +L DFGLAR+Y T+VV T Y APE+
Sbjct: 126 LHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA--LTSVVVTLWYRAPEV 180
Query: 529 TQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDV 580
+T D+++ G + E+ R+P+ G + QLG+ILDV
Sbjct: 181 LLQSSYATPVDLWSVGCIFAEMFR-RKPLFRGS-------SDVDQLGKILDV 224
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 1e-18
Identities = 60/197 (30%), Positives = 97/197 (49%), Gaps = 8/197 (4%)
Query: 361 IGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNLHGWCK 420
+G G FG V+ G +VAVK + ++ F E + + +LRH LV L+
Sbjct: 14 LGNGQFGEVWMGTWNGNT-KVAVKTLKPGTMSP-ESFLEEAQIMKKLRHDKLVQLYAVVS 71
Query: 421 QKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHR 480
++ + +V EY+ GSL L K +G L ++ +A+G+ Y+ IHR
Sbjct: 72 EE-PIYIVTEYMSKGSLLDFL-KDGEGRALKLPNLVDMAAQVAAGMAYIER---MNYIHR 126
Query: 481 DVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPELTQTGKASTSSDV 540
D++ +N L+ + ++ DFGLARL + + APE G+ + SDV
Sbjct: 127 DLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 186
Query: 541 FAYGILLLEVAT-GRRP 556
+++GILL E+ T GR P
Sbjct: 187 WSFGILLTELVTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 3e-18
Identities = 64/194 (32%), Positives = 95/194 (48%), Gaps = 9/194 (4%)
Query: 359 EVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSL--QGMREFAAEIESLGRLRHKNLVNLH 416
E IG G FG V+ G L VAVK R +L +F E L + H N+V L
Sbjct: 1 ERIGRGNFGEVFSGRLRADNTPVAVKS-CRETLPPDLKAKFLQEARILKQYSHPNIVRLI 59
Query: 417 GWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQV 476
G C QK + +V E + G D L F +G L ++ +V+ A+G+ YL +
Sbjct: 60 GVCTQKQPIYIVMELVQGG--DFLTFLRTEGPRLKVKELIQMVENAAAGMEYLE---SKH 114
Query: 477 VIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGT-FGYIAPELTQTGKAS 535
IHRD+ N L+ + ++ DFG++R + G T + + APE G+ S
Sbjct: 115 CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYS 174
Query: 536 TSSDVFAYGILLLE 549
+ SDV+++GILL E
Sbjct: 175 SESDVWSFGILLWE 188
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 3e-18
Identities = 65/204 (31%), Positives = 100/204 (49%), Gaps = 11/204 (5%)
Query: 355 FKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQG-MREFAAEIESLGRLRHKNLV 413
F + E IG G FG V+KG+ T VA+K I + + + EI L + +
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 414 NLHGWCKQKNDLLLVYEYIPNGS-LDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEE 472
+G + L ++ EY+ GS LD L P D Q ++K I GL YLH E
Sbjct: 66 KYYGSYLKGTKLWIIMEYLGGGSALDLLRAGP-----FDEFQIATMLKEILKGLDYLHSE 120
Query: 473 WEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPELTQTG 532
+ IHRD+K +N L+ + + +L DFG+A + T VGT ++APE+ Q
Sbjct: 121 KK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT-FVGTPFWMAPEVIQQS 176
Query: 533 KASTSSDVFAYGILLLEVATGRRP 556
+ +D+++ GI +E+A G P
Sbjct: 177 AYDSKADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 4e-18
Identities = 63/212 (29%), Positives = 111/212 (52%), Gaps = 19/212 (8%)
Query: 355 FKESEVIGIGGFGSVYKGVLPTTGGEVAVKKIT--RNSLQGMREFAA---EIESLGRLRH 409
++ +++G G FG VY TG E+AVK++ +S + +E A EI+ L L+H
Sbjct: 4 WRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQH 63
Query: 410 KNLVNLHGWCKQKNDLLLVY-EYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLY 468
+ +V +G C + ++ L ++ EY+P GS+ L G++ + R + I G+ Y
Sbjct: 64 ERIVQYYG-CLRDDETLSIFMEYMPGGSVKDQL--KAYGALTETVTR-KYTRQILEGVEY 119
Query: 469 LHEEWEQVVIHRDVKPSNALIDAEMNARLGDFG----LARLYDHGGMPHTTNVVGTFGYI 524
LH +++HRD+K +N L D+ N +LGDFG L + G + V GT ++
Sbjct: 120 LHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKS--VTGTPYWM 174
Query: 525 APELTQTGKASTSSDVFAYGILLLEVATGRRP 556
+PE+ +DV++ G ++E+ T + P
Sbjct: 175 SPEVISGEGYGRKADVWSVGCTVVEMLTEKPP 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 4e-18
Identities = 66/234 (28%), Positives = 113/234 (48%), Gaps = 25/234 (10%)
Query: 359 EVIGIGGFGSVYKGVLPTTGGE----VAVKKITR-NSLQGMREFAAEIESLGRLRHKNLV 413
E +G FG +YKG L G + VA+K + N+ Q EF E + L H N+V
Sbjct: 11 EELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIV 70
Query: 414 NLHGWCKQKNDLLLVYEYIPNGSLDTLLF-----------KPKDGSV---LDWEQRFNIV 459
L G Q+ + +++EY+ G L L +DG+V LD +I
Sbjct: 71 CLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIA 130
Query: 460 KGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLAR-LYDHGGMPHTTNVV 518
IA+G+ YL + +H+D+ N LI +++ ++ D GL+R +Y +
Sbjct: 131 IQIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSL 187
Query: 519 GTFGYIAPELTQTGKASTSSDVFAYGILLLEVAT-GRRP-IGSGDLLLVEWVRE 570
++ PE GK S+ SD++++G++L E+ + G +P G + ++E VR+
Sbjct: 188 LPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRK 241
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 5e-18
Identities = 62/211 (29%), Positives = 101/211 (47%), Gaps = 9/211 (4%)
Query: 360 VIGIGGFGSVYKGVLPTTGGEVAVKKI--TRNSLQGMREFAAEIESLGRLRHKNLVNLHG 417
V+G G FG V K++ TR S + R+ EI L L+H N++ +
Sbjct: 7 VLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYN 66
Query: 418 WCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVV 477
N LL+ EY G+L + + + G + + E + I S + Y+H+ +
Sbjct: 67 HFMDDNTLLIEMEYANGGTLYDKIVR-QKGQLFEEEMVLWYLFQIVSAVSYIHKA---GI 122
Query: 478 IHRDVKPSNALIDAEMNARLGDFGLAR-LYDHGGMPHTTNVVGTFGYIAPELTQTGKAST 536
+HRD+K N + +LGDFG+++ L M T VVGT Y++PEL Q K +
Sbjct: 123 LHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET--VVGTPYYMSPELCQGVKYNF 180
Query: 537 SSDVFAYGILLLEVATGRRPIGSGDLLLVEW 567
SD++A G +L E+ T +R + + L +
Sbjct: 181 KSDIWALGCVLYELLTLKRTFDATNPLNLVV 211
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 6e-18
Identities = 72/269 (26%), Positives = 127/269 (47%), Gaps = 26/269 (9%)
Query: 361 IGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMR-EFAAEIESLGRLRHKNLVNLHGWC 419
+G G GSV K TG +A K + + +R + E++ + R +V+ +G
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAF 72
Query: 420 KQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIH 479
+N++ + E++ GSLD + K G + E I + GL YL+ ++H
Sbjct: 73 LNENNICMCMEFMDCGSLDRIY---KKGGPIPVEILGKIAVAVVEGLTYLYNVHR--IMH 127
Query: 480 RDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTT--NVVGTFGYIAPELTQTGKASTS 537
RD+KPSN L+++ +L DFG++ G + ++ VGT Y++PE Q GK +
Sbjct: 128 RDIKPSNILVNSRGQIKLCDFGVS-----GELINSIADTFVGTSTYMSPERIQGGKYTVK 182
Query: 538 SDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLG------RILDVADPLLNSSYVV 591
SDV++ GI ++E+A G+ P ++ + +G +I+ P L SS
Sbjct: 183 SDVWSLGISIIELALGKFPFAFSNIDDDG---QDDPMGILDLLQQIVQEPPPRLPSSDFP 239
Query: 592 KEMELVLKLGLMCSHKT-QFRPTMRQVMR 619
+++ + C K RPT +Q+
Sbjct: 240 EDLRDFVDA---CLLKDPTERPTPQQLCA 265
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 6e-18
Identities = 59/200 (29%), Positives = 91/200 (45%), Gaps = 15/200 (7%)
Query: 361 IGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFA---AEIESLGRLRHK-NLVNLH 416
I G FGSVY +TG A+K + ++ + + AE + + L+
Sbjct: 4 ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLY 63
Query: 417 GWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQV 476
+ K+ L LV EY+ G +L+ K G DW +++ + + G+ LH+
Sbjct: 64 YSFQSKDYLYLVMEYLNGGDCASLI-KTLGGLPEDWAKQY--IAEVVLGVEDLHQRG--- 117
Query: 477 VIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPELTQTGKAST 536
+IHRD+KP N LID + +L DFGL+R G VGT Y+APE
Sbjct: 118 IIHRDIKPENLLIDQTGHLKLTDFGLSRN---GLEN--KKFVGTPDYLAPETILGVGDDK 172
Query: 537 SSDVFAYGILLLEVATGRRP 556
SD ++ G ++ E G P
Sbjct: 173 MSDWWSLGCVIFEFLFGYPP 192
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 84.1 bits (209), Expect = 6e-18
Identities = 60/211 (28%), Positives = 98/211 (46%), Gaps = 25/211 (11%)
Query: 355 FKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFA---AEIESLGRLRHKN 411
F+ + +G G FG V +G A+K +++ + +++ E L +RH
Sbjct: 3 FEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPF 62
Query: 412 LVNLHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKG------IASG 465
LVNL+G + ++L LV EY+P G L + L K RF +
Sbjct: 63 LVNLYGSFQDDSNLYLVMEYVPGGELFSHLRK---------SGRFPEPVARFYAAQVVLA 113
Query: 466 LLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIA 525
L YLH +++RD+KP N L+D++ ++ DFG A+ T + GT Y+A
Sbjct: 114 LEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVK----GRTYTLCGTPEYLA 166
Query: 526 PELTQTGKASTSSDVFAYGILLLEVATGRRP 556
PE+ + + D +A GIL+ E+ G P
Sbjct: 167 PEIILSKGYGKAVDWWALGILIYEMLAGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 83.6 bits (206), Expect = 7e-18
Identities = 62/197 (31%), Positives = 98/197 (49%), Gaps = 8/197 (4%)
Query: 361 IGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNLHGWCK 420
+G G FG V+ G T +VA+K + ++ F E + + +LRH LV L+
Sbjct: 14 LGQGCFGEVWMGTWNGTT-KVAIKTLKPGTMMP-EAFLQEAQIMKKLRHDKLVPLYAVVS 71
Query: 421 QKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHR 480
++ + +V E++ GSL L K DG L Q ++ IA G+ Y+ IHR
Sbjct: 72 EE-PIYIVTEFMGKGSLLDFL-KEGDGKYLKLPQLVDMAAQIADGMAYIER---MNYIHR 126
Query: 481 DVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPELTQTGKASTSSDV 540
D++ +N L+ + ++ DFGLARL + + APE G+ + SDV
Sbjct: 127 DLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 186
Query: 541 FAYGILLLEVAT-GRRP 556
+++GILL E+ T GR P
Sbjct: 187 WSFGILLTELVTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 7e-18
Identities = 63/213 (29%), Positives = 104/213 (48%), Gaps = 26/213 (12%)
Query: 359 EVIGIGGFGSVYKGVLPTTGGEV--AVKKITR-NSLQGMREFAAEIESLGRL-RHKNLVN 414
+VIG G FG V + ++ G ++ A+K + S R+FA E+E L +L H N++N
Sbjct: 8 DVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIIN 67
Query: 415 LHGWCKQKNDLLLVYEYIPNGSLDTLLFKPK-------------DGSVLDWEQRFNIVKG 461
L G C+ + L + EY P G+L L K + S L +Q
Sbjct: 68 LLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASD 127
Query: 462 IASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTF 521
+A+G+ YL E + IHRD+ N L+ + +++ DFGL+R G + +G
Sbjct: 128 VATGMQYLSE---KQFIHRDLAARNVLVGENLASKIADFGLSR----GEEVYVKKTMGRL 180
Query: 522 G--YIAPELTQTGKASTSSDVFAYGILLLEVAT 552
++A E +T SDV+++G+LL E+ +
Sbjct: 181 PVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 9e-18
Identities = 74/264 (28%), Positives = 123/264 (46%), Gaps = 21/264 (7%)
Query: 360 VIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIES--LGRLRHKNLVNL-H 416
V+G G +G V T G + +KK+ + AAE E+ L +L+H N+V
Sbjct: 7 VVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRE 66
Query: 417 GWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQV 476
W + L +V + G L L K + G +L Q IA L YLHE+
Sbjct: 67 SWEGEDGLLYIVMGFCEGGDLYHKL-KEQKGKLLPENQVVEWFVQIAMALQYLHEKH--- 122
Query: 477 VIHRDVKPSNALIDAEMNARLGDFGLAR-LYDHGGMPHTTNVVGTFGYIAPELTQTGKAS 535
++HRD+K N + ++GD G+AR L + M T ++GT Y++PEL +
Sbjct: 123 ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMAST--LIGTPYYMSPELFSNKPYN 180
Query: 536 TSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSYVVKEME 595
SDV+A G + E+AT + + D+ + + RI++ P + Y + E
Sbjct: 181 YKSDVWALGCCVYEMATLKHAFNAKDMNSLVY--------RIIEGKLPPMPKDYSPELGE 232
Query: 596 LVLKLGLMCSHKTQFRPTMRQVMR 619
L+ M S + + RP+++ ++R
Sbjct: 233 LIAT---MLSKRPEKRPSVKSILR 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.6 bits (207), Expect = 1e-17
Identities = 76/211 (36%), Positives = 106/211 (50%), Gaps = 27/211 (12%)
Query: 355 FKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAA--EIESLGRLRHKNL 412
+K+ + +G G + +VYKG TG VA+K+I +G F A E L L+H N+
Sbjct: 7 YKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGA-PFTAIREASLLKDLKHANI 65
Query: 413 VNLHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKD--GSVLDWEQ----RFNIVKGIASGL 466
V LH K L LV+EY LDT L + D G L F +++G+A
Sbjct: 66 VTLHDIIHTKKTLTLVFEY-----LDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLA--- 117
Query: 467 LYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTT--NVVGTFGYI 524
Y H+ + V+HRD+KP N LI +L DFGLAR +P T N V T Y
Sbjct: 118 -YCHQ---RRVLHRDLKPQNLLISERGELKLADFGLARA---KSVPSKTYSNEVVTLWYR 170
Query: 525 APE-LTQTGKASTSSDVFAYGILLLEVATGR 554
P+ L + + STS D++ G + E+ATGR
Sbjct: 171 PPDVLLGSTEYSTSLDMWGVGCIFYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 83.2 bits (205), Expect = 1e-17
Identities = 79/276 (28%), Positives = 124/276 (44%), Gaps = 38/276 (13%)
Query: 355 FKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQG-MREFAAEIESLGRLRHKNLV 413
F + E IG G FG V+KG+ T VA+K I + + + EI L + +
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 414 NLHGWCKQKNDLLLVYEYIPNGS-LDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEE 472
+G + L ++ EY+ GS LD L P LD Q I++ I GL YLH E
Sbjct: 66 KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP-----LDETQIATILREILKGLDYLHSE 120
Query: 473 WEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHT----TNVVGTFGYIAPEL 528
+ IHRD+K +N L+ +L DFG+A G + T VGT ++APE+
Sbjct: 121 KK---IHRDIKAANVLLSEHGEVKLADFGVA-----GQLTDTQIKRNTFVGTPFWMAPEV 172
Query: 529 TQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVAD---PLL 585
+ + +D+++ GI +E+A G P E H + + + P L
Sbjct: 173 IKQSAYDSKADIWSLGITAIELAKGEPPHS-----------ELHPMKVLFLIPKNNPPTL 221
Query: 586 NSSYVVKEMELVLKLGLMCSHKT-QFRPTMRQVMRY 620
+Y E V C +K FRPT ++++++
Sbjct: 222 EGNYSKPLKEFVEA----CLNKEPSFRPTAKELLKH 253
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 2e-17
Identities = 56/197 (28%), Positives = 97/197 (49%), Gaps = 7/197 (3%)
Query: 361 IGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNLHGWCK 420
+G G FG V+ G + +VAVK + ++ ++ F E + L+H LV L+
Sbjct: 14 LGAGQFGEVWMGYYNNST-KVAVKTLKPGTMS-VQAFLEEANLMKTLQHDKLVRLYAVVT 71
Query: 421 QKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHR 480
++ + ++ EY+ GSL L K +G + + + IA G+ Y+ + IHR
Sbjct: 72 KEEPIYIITEYMAKGSLLDFL-KSDEGGKVLLPKLIDFSAQIAEGMAYIER---KNYIHR 127
Query: 481 DVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPELTQTGKASTSSDV 540
D++ +N L+ + ++ DFGLAR+ + + APE G + SDV
Sbjct: 128 DLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDV 187
Query: 541 FAYGILLLEVAT-GRRP 556
+++GILL E+ T G+ P
Sbjct: 188 WSFGILLYEIVTYGKIP 204
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 3e-17
Identities = 61/215 (28%), Positives = 104/215 (48%), Gaps = 22/215 (10%)
Query: 353 KGFKESEVIGIGGFGSVYKGVLPTTGGE---VAVKKITRN-SLQGMREFAAEIESLGRLR 408
K K ++G G FG + +G L VA+ + S + R F AE +LG+
Sbjct: 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFD 64
Query: 409 HKNLVNLHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLY 468
H N+V L G + N +++V EY+ NG+LD+ L K +G L Q ++ G+ASG+ Y
Sbjct: 65 HSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRK-HEGQ-LVAGQLMGMLPGLASGMKY 122
Query: 469 LHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFG------ 522
L E +H+ + L+++++ ++ F + + T
Sbjct: 123 LS---EMGYVHKGLAAHKVLVNSDLVCKISGFR------RLQEDKSEAIYTTMSGKSPVL 173
Query: 523 YIAPELTQTGKASTSSDVFAYGILLLEV-ATGRRP 556
+ APE Q S++SDV+++GI++ EV + G RP
Sbjct: 174 WAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 3e-17
Identities = 65/201 (32%), Positives = 99/201 (49%), Gaps = 10/201 (4%)
Query: 361 IGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREF-AAEIES--LGRLRHKNLVNLHG 417
+G GGFG V + TG A KK+ + L+ + + A +E L ++ + +V+L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 418 WCKQKNDLLLVYEYIPNGSLDTLLFK-PKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQV 476
+ K DL LV + G L ++ ++ + I SGL +LH+ +
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQ---RR 117
Query: 477 VIHRDVKPSNALIDAEMNARLGDFGLA-RLYDHGGMPHTTNVVGTFGYIAPELTQTGKAS 535
+I+RD+KP N L+D + N R+ D GLA L D G T GT G++APEL Q +
Sbjct: 118 IIYRDLKPENVLLDNDGNVRISDLGLAVELKD--GQSKTKGYAGTPGFMAPELLQGEEYD 175
Query: 536 TSSDVFAYGILLLEVATGRRP 556
S D FA G+ L E+ R P
Sbjct: 176 FSVDYFALGVTLYEMIAARGP 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 3e-17
Identities = 58/211 (27%), Positives = 94/211 (44%), Gaps = 15/211 (7%)
Query: 354 GFKESEVIGIGGFGSVYKGVLP---TTGGE--VAVKKI-TRNSLQGMREFAAEIESLGRL 407
+E +G G FG V+ GGE V VK + EF E++ +L
Sbjct: 6 NLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKL 65
Query: 408 RHKNLVNLHGWCKQKNDLLLVYEYIPNGSLDTLLF--KPKDGSV----LDWEQRFNIVKG 461
HKN+V L G C++ ++ EY G L L K KD + L +Q+ +
Sbjct: 66 SHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQ 125
Query: 462 IASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTF 521
IA G+ +L +HRD+ N L+ ++ ++ L++ + N +
Sbjct: 126 IALGMDHLS---NARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPL 182
Query: 522 GYIAPELTQTGKASTSSDVFAYGILLLEVAT 552
++APE Q ST SDV+++G+L+ EV T
Sbjct: 183 RWLAPEAVQEDDFSTKSDVWSFGVLMWEVFT 213
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 4e-17
Identities = 65/215 (30%), Positives = 103/215 (47%), Gaps = 23/215 (10%)
Query: 361 IGIGGFGSVYKGVLPTTGGE------VAVKKITRNSL-QGMREFAAEIESLGRLRHKNLV 413
+G G FG VY+G G VAVK + + + Q +EF E + H N+V
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62
Query: 414 NLHGWCKQKNDLLLVYEYIPNGSLDTLLFKPK----DGSVLDWEQRFNIVKGIASGLLYL 469
L G C ++ E + G L + L + +L ++ +I +A G +YL
Sbjct: 63 KLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL 122
Query: 470 HEEWEQV-VIHRDVKPSNALI-----DAEMNARLGDFGLAR-LYDHGGMPHTTNVVGTFG 522
EQ+ IHRD+ N L+ DA+ ++GDFGLAR +Y +
Sbjct: 123 ----EQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVR 178
Query: 523 YIAPELTQTGKASTSSDVFAYGILLLEVAT-GRRP 556
++APE GK +T SDV+++G+L+ E+ T G++P
Sbjct: 179 WMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQP 213
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 4e-17
Identities = 63/207 (30%), Positives = 101/207 (48%), Gaps = 20/207 (9%)
Query: 361 IGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQ--GMREFAAEIESLGRLRHKNLVNLHGW 418
+G G +GSVYK + TG +A+K+I R L + E++ L + +V+ +G
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEI-RLELDESKFNQIIMELDILHKAVSPYIVDFYGA 67
Query: 419 CKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVI 478
+ + + EY+ GSLD L + + I + GL +L EE +I
Sbjct: 68 FFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN--II 125
Query: 479 HRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHT---TNVVGTFGYIAPE------LT 529
HRDVKP+N L++ +L DFG++ G + + TN +G Y+APE
Sbjct: 126 HRDVKPTNVLVNGNGQVKLCDFGVS-----GNLVASLAKTN-IGCQSYMAPERIKSGGPN 179
Query: 530 QTGKASTSSDVFAYGILLLEVATGRRP 556
Q + SDV++ G+ +LE+A GR P
Sbjct: 180 QNPTYTVQSDVWSLGLSILEMALGRYP 206
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 82.8 bits (205), Expect = 4e-17
Identities = 71/231 (30%), Positives = 109/231 (47%), Gaps = 30/231 (12%)
Query: 361 IGIGGFGSVYKGVLPTTGGEVAVKKITR---NSLQGMREFAAEIESLGRLRHKNLVNLHG 417
IG G +G V T +VA+KKI N + R EI+ L L H+N++ +
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLR-EIKLLRHLDHENVIAIKD 71
Query: 418 WCK-----QKNDLLLVYEYIPNGSLDTLLFKP-KDGSVLDWEQRFNIVKGIASGLLYLHE 471
ND+ +VYE +DT L + + L + + + GL Y+H
Sbjct: 72 IMPPPHREAFNDVYIVYEL-----MDTDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHS 126
Query: 472 EWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPE-LTQ 530
V+HRD+KPSN L++A + ++ DFGLAR G T VV T Y APE L
Sbjct: 127 ---ANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVV-TRWYRAPELLLN 182
Query: 531 TGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVREC-HQLGRILDV 580
+ +T+ DV++ G + E+ GR+P+ G ++ HQL I ++
Sbjct: 183 CSEYTTAIDVWSVGCIFAEL-LGRKPLFPG--------KDYVHQLKLITEL 224
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 4e-17
Identities = 66/212 (31%), Positives = 103/212 (48%), Gaps = 14/212 (6%)
Query: 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGM---REFAAEIESLGRLRH 409
K F+ +G GG+G V+ TG VA+K++ ++ L + R E + L +
Sbjct: 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKS 60
Query: 410 KNLVNLHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYL 469
+ LV L + L L EY+P G TLL G + + RF + + + + L
Sbjct: 61 EWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLL--NNLGVLSEDHARFYMAEMFEA-VDAL 117
Query: 470 HEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPELT 529
HE IHRD+KP N LIDA + +L DFGL++ G + + +VVG+ Y+APE+
Sbjct: 118 HE---LGYIHRDLKPENFLIDASGHIKLTDFGLSK----GIVTYANSVVGSPDYMAPEVL 170
Query: 530 QTGKASTSSDVFAYGILLLEVATGRRPIGSGD 561
+ + D ++ G +L E G P SG
Sbjct: 171 RGKGYDFTVDYWSLGCMLYEFLCGFPPF-SGS 201
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 5e-17
Identities = 64/228 (28%), Positives = 106/228 (46%), Gaps = 33/228 (14%)
Query: 377 TGGEVAVKKITRNSLQGMREFA---AEIESLGRLRHKNLVNLHGWCKQKNDLLL-VYEYI 432
TG EVA+K + ++ + + A E RL H N+V L + LL V+EY+
Sbjct: 2 TGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYV 61
Query: 433 PNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALI--- 489
P +L +L DG L + ++ + L H Q ++HRD+KP N ++
Sbjct: 62 PGRTLREVL--AADG-ALPAGETGRLMLQVLDALACAHN---QGIVHRDLKPQNIMVSQT 115
Query: 490 DAEMNARLGDFGLARL------YDHGGMPHTTNVVGTFGYIAPELTQTGKASTSSDVFAY 543
+A++ DFG+ L D + TT V+GT Y APE + + +SD++A+
Sbjct: 116 GVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAW 175
Query: 544 GILLLEVATGR-------------RPIGSGDLLLVEWVRECHQLGRIL 578
G++ LE TG+ + + D+ L W+ H LG++L
Sbjct: 176 GLIFLECLTGQRVVQGASVAEILYQQLSPVDVSLPPWI-AGHPLGQVL 222
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 81.3 bits (200), Expect = 6e-17
Identities = 66/213 (30%), Positives = 104/213 (48%), Gaps = 26/213 (12%)
Query: 359 EVIGIGGFGSVYKGVLPTTGGEV--AVKKITR-NSLQGMREFAAEIESLGRL-RHKNLVN 414
+VIG G FG V K + G + A+K++ S R+FA E+E L +L H N++N
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60
Query: 415 LHGWCKQKNDLLLVYEYIPNGSLDTLLFKPK-------------DGSVLDWEQRFNIVKG 461
L G C+ + L L EY P+G+L L K + S L +Q +
Sbjct: 61 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120
Query: 462 IASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTF 521
+A G+ YL + + IHRD+ N L+ A++ DFGL+R G + +G
Sbjct: 121 VARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSR----GQEVYVKKTMGRL 173
Query: 522 G--YIAPELTQTGKASTSSDVFAYGILLLEVAT 552
++A E +T+SDV++YG+LL E+ +
Sbjct: 174 PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 6e-17
Identities = 61/207 (29%), Positives = 100/207 (48%), Gaps = 10/207 (4%)
Query: 355 FKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFA---AEIESLGRLRHKN 411
F+ + IG G F VY+ G VA+KK+ L + A EI+ L +L H N
Sbjct: 4 FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 63
Query: 412 LVNLHGWCKQKNDLLLVYEYIPNGSLDTLL--FKPKDGSVLDWEQRFNIVKGIASGLLYL 469
++ + + N+L +V E G L ++ FK K ++ + + + S L ++
Sbjct: 64 VIKYYASFIEDNELNIVLELADAGDLSRMIKHFK-KQKRLIPEKTVWKYFVQLCSALEHM 122
Query: 470 HEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPELT 529
H + V+HRD+KP+N I A +LGD GL R + ++VGT Y++PE
Sbjct: 123 HS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFS-SKTTAAHSLVGTPYYMSPERI 178
Query: 530 QTGKASTSSDVFAYGILLLEVATGRRP 556
+ SD+++ G LL E+A + P
Sbjct: 179 HENGYNFKSDIWSLGCLLYEMAALQSP 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 8e-17
Identities = 65/223 (29%), Positives = 106/223 (47%), Gaps = 38/223 (17%)
Query: 361 IGIGGFGSVY----KGVLPTTGGE-VAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNL 415
+G G FG V+ +LP VAVK + S ++F E E L L+H+++V
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 416 HGWCKQKNDLLLVYEYIPNGSLDTLL-FKPKDGSVLD-----------WEQRFNIVKGIA 463
+G C + LL+V+EY+ +G L+ L D +L Q I IA
Sbjct: 73 YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132
Query: 464 SGLLY---LHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLAR------LYDHGGMPHT 514
SG++Y LH +HRD+ N L+ + ++GDFG++R Y GG
Sbjct: 133 SGMVYLASLH------FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGG---- 182
Query: 515 TNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVAT-GRRP 556
+ ++ PE K +T SD++++G++L E+ T G++P
Sbjct: 183 -RTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 80.9 bits (199), Expect = 9e-17
Identities = 63/204 (30%), Positives = 100/204 (49%), Gaps = 11/204 (5%)
Query: 355 FKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQG-MREFAAEIESLGRLRHKNLV 413
F + E IG G FG VYKG+ T VA+K I + + + EI L + +
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65
Query: 414 NLHGWCKQKNDLLLVYEYIPNGS-LDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEE 472
+G + L ++ EY+ GS LD L P + + + I++ I GL YLH E
Sbjct: 66 RYYGSYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIA-----TILREILKGLDYLHSE 120
Query: 473 WEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPELTQTG 532
+ IHRD+K +N L+ + + +L DFG+A + T VGT ++APE+ +
Sbjct: 121 RK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT-FVGTPFWMAPEVIKQS 176
Query: 533 KASTSSDVFAYGILLLEVATGRRP 556
+D+++ GI +E+A G P
Sbjct: 177 AYDFKADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 81.2 bits (201), Expect = 1e-16
Identities = 65/238 (27%), Positives = 111/238 (46%), Gaps = 29/238 (12%)
Query: 355 FKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNS--LQGMREFAAEIESLGRLRHKNL 412
+K E IG G +G V + +G +VA+KKI + E++ L +H N+
Sbjct: 7 YKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNI 66
Query: 413 VNLHGWCKQK----NDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLY 468
+ + + D+ +V + + + L ++ + + + + F + + GL Y
Sbjct: 67 IAIRDILRPPGADFKDVYVVMDLMES-DLHHIIHSDQPLT-EEHIRYF--LYQLLRGLKY 122
Query: 469 LHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLY-----DHGGMPHTTNVVGTFGY 523
+H VIHRD+KPSN L++ + R+GDFG+AR +H T V T Y
Sbjct: 123 IHS---ANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKY--FMTEYVATRWY 177
Query: 524 IAPELTQT-GKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDV 580
APEL + + +T+ D+++ G + E+ GRR + G + HQL IL V
Sbjct: 178 RAPELLLSLPEYTTAIDMWSVGCIFAEM-LGRRQLFPGKNYV-------HQLKLILSV 227
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 80.3 bits (199), Expect = 1e-16
Identities = 56/175 (32%), Positives = 89/175 (50%), Gaps = 23/175 (13%)
Query: 364 GGFGSVYKGVLPTTGGEVAVKKIT-RNSLQG-----MREFAAEIESLGRLRHKNLVNLH- 416
G +G VY+ TG VA+KK+ +G +RE I L +L+H N+V +
Sbjct: 16 GTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLRE----INILLKLQHPNIVTVKE 71
Query: 417 ---GWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEW 473
G + + +V EY+ + L +L+ + L E + ++ + SG+ +LH+ W
Sbjct: 72 VVVG--SNLDKIYMVMEYVEH-DLKSLM-ETMKQPFLQSEVKC-LMLQLLSGVAHLHDNW 126
Query: 474 EQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPEL 528
++HRD+K SN L++ ++ DFGLAR Y P+T VV T Y APEL
Sbjct: 127 ---ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVV-TLWYRAPEL 177
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 2e-16
Identities = 55/207 (26%), Positives = 101/207 (48%), Gaps = 8/207 (3%)
Query: 359 EVIGIGGFGSVYKGVLPTTGGEVAVKKI--TRNSLQGMREFAAEIESLGRLRHKNLVNLH 416
+ IG G FG +Y + +K+I T+ ++ E+ L +++H N+V
Sbjct: 6 KKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFF 65
Query: 417 GWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQV 476
++ L +V EY G L + + + G + +Q + I+ GL ++H+ +
Sbjct: 66 ASFQENGRLFIVMEYCDGGDLMKRINRQR-GVLFSEDQILSWFVQISLGLKHIHD---RK 121
Query: 477 VIHRDVKPSNALIDAE-MNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPELTQTGKAS 535
++HRD+K N + M A+LGDFG+AR + M VGT Y++PE+ Q +
Sbjct: 122 ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS-MELAYTCVGTPYYLSPEICQNRPYN 180
Query: 536 TSSDVFAYGILLLEVATGRRPIGSGDL 562
+D+++ G +L E+ T + P +L
Sbjct: 181 NKTDIWSLGCVLYELCTLKHPFEGNNL 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 2e-16
Identities = 61/219 (27%), Positives = 104/219 (47%), Gaps = 19/219 (8%)
Query: 359 EVIGIGGFGSVYKGVLPTTGGE--VAVKKITRNSL---QGMREFAAEIESL--------G 405
E +G G FG VYK V G+ +A+K+I ++ + RE I +
Sbjct: 6 EHLGSGAFGCVYK-VRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKE 64
Query: 406 RLRHKNLVNLHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKD-GSVLDWEQRFNIVKGIAS 464
+LRH N+V + + + L +V + I L K+ E+ +NI +
Sbjct: 65 QLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVL 124
Query: 465 GLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYI 524
L YLH+E + ++HRD+ P+N ++ + + DFGLA+ T+VVGT Y
Sbjct: 125 ALRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFGLAK--QKQPESKLTSVVGTILYS 180
Query: 525 APELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLL 563
PE+ + +DV+A+G +L ++ T + P S ++L
Sbjct: 181 CPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNML 219
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 2e-16
Identities = 66/200 (33%), Positives = 97/200 (48%), Gaps = 13/200 (6%)
Query: 359 EVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAA-EIESLGRLRHKNLVNLHG 417
E +G G + +V+KG T VA+K+I +G A E+ L L+H N+V LH
Sbjct: 12 EKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHD 71
Query: 418 WCKQKNDLLLVYEYIPNGSLDTLLFKPKD--GSVLDWEQRFNIVKGIASGLLYLHEEWEQ 475
L LV+EY LD L + D G+++ + I GL Y H +
Sbjct: 72 IVHTDKSLTLVFEY-----LDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHR---R 123
Query: 476 VVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPE-LTQTGKA 534
V+HRD+KP N LI+ +L DFGLAR ++ VV T Y P+ L + +
Sbjct: 124 KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDVLLGSSEY 182
Query: 535 STSSDVFAYGILLLEVATGR 554
ST D++ G + E+A+GR
Sbjct: 183 STQIDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 2e-16
Identities = 67/227 (29%), Positives = 110/227 (48%), Gaps = 24/227 (10%)
Query: 355 FKESE-----VIGIGGFGSVYKGVLPTTGGE----VAVKKIT-RNSLQGMREFAAEIESL 404
KE+E ++G G FG+V+KG+ G VA+K I R+ Q +E + ++
Sbjct: 4 LKETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAM 63
Query: 405 GRLRHKNLVNLHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIAS 464
G L H +V L G C + L LV + P GSL + + +D LD ++ N IA
Sbjct: 64 GSLDHAYIVRLLGICPGAS-LQLVTQLSPLGSLLDHVRQHRDS--LDPQRLLNWCVQIAK 120
Query: 465 GLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGT-FGY 523
G+ YL E ++HR++ N L+ ++ ++ DFG+A L + + T +
Sbjct: 121 GMYYLEE---HRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKW 177
Query: 524 IAPELTQTGKASTSSDVFAYGILLLEVAT-------GRRPIGSGDLL 563
+A E G+ + SDV++YG+ + E+ + G RP DLL
Sbjct: 178 MALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLL 224
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 80.1 bits (198), Expect = 2e-16
Identities = 69/233 (29%), Positives = 103/233 (44%), Gaps = 43/233 (18%)
Query: 343 FRYKDLYAATKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQ-GMREFAAEI 401
F +DL K+ IG G FG+V K + +G +AVK+I + + ++
Sbjct: 1 FTAEDL-------KDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDL 53
Query: 402 ESLGRLRH-KNLVNLHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRF--NI 458
+ + R +V +G ++ D + E + + SLD +K + + I
Sbjct: 54 DVVMRSSDCPYIVKFYGALFREGDCWICMELM-DISLD-KFYKYVYEVL---KSVIPEEI 108
Query: 459 VKGIA----SGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGL--------ARLY 506
+ IA L YL EE + +IHRDVKPSN L+D N +L DFG+ A+
Sbjct: 109 LGKIAVATVKALNYLKEELK--IIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTR 166
Query: 507 DHGGMPHTTNVVGTFGYIAPELTQTGKAS---TSSDVFAYGILLLEVATGRRP 556
D G P Y+APE SDV++ GI L EVATG+ P
Sbjct: 167 DAGCRP----------YMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFP 209
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 2e-16
Identities = 67/215 (31%), Positives = 103/215 (47%), Gaps = 32/215 (14%)
Query: 352 TKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAA---------EIE 402
T + + + +G+G FG V TG VA+KKI M+ F+ E++
Sbjct: 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKI-------MKPFSTPVLAKRTYRELK 61
Query: 403 SLGRLRHKNLVNLHG-WCKQKNDLLLVYEYIPNGSLDTLL-FKPKDGSVLDWEQRFNIVK 460
L LRH+N+++L + D+ V E + L LL +P + + Q F +
Sbjct: 62 LLKHLRHENIISLSDIFISPLEDIYFVTELLGT-DLHRLLTSRPLEKQFI---QYF--LY 115
Query: 461 GIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGT 520
I GL Y+H V+HRD+KPSN LI+ + ++ DFGLAR+ D P T V T
Sbjct: 116 QILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARIQD----PQMTGYVST 168
Query: 521 FGYIAPELTQT-GKASTSSDVFAYGILLLEVATGR 554
Y APE+ T K D+++ G + E+ G+
Sbjct: 169 RYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 3e-16
Identities = 59/201 (29%), Positives = 98/201 (48%), Gaps = 11/201 (5%)
Query: 361 IGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNLHGWCK 420
+G G FG VYK TG A K I S + + ++ EIE L H +V L G
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79
Query: 421 QKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHR 480
L ++ E+ P G++D ++ + G L Q I + + L YLH +IHR
Sbjct: 80 WDGKLWIMIEFCPGGAVDAIMLELDRG--LTEPQIQVICRQMLEALQYLH---SMKIIHR 134
Query: 481 DVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPE--LTQTGKAST-- 536
D+K N L+ + + +L DFG++ + + + +GT ++APE + +T K +
Sbjct: 135 DLKAGNVLLTLDGDIKLADFGVSA-KNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYD 193
Query: 537 -SSDVFAYGILLLEVATGRRP 556
+D+++ GI L+E+A P
Sbjct: 194 YKADIWSLGITLIEMAQIEPP 214
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 3e-16
Identities = 61/211 (28%), Positives = 107/211 (50%), Gaps = 15/211 (7%)
Query: 355 FKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRN--SLQGMREFAA---EIESLGRLRH 409
++ +++G G FG VY TG E+A K++ + S + +E +A EI+ L L+H
Sbjct: 4 WRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQH 63
Query: 410 KNLVNLHGWCKQKND--LLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLL 467
+ +V +G + + + L + EY+P GS+ L K L + I G+
Sbjct: 64 ERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQL---KAYGALTESVTRKYTRQILEGMS 120
Query: 468 YLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHT--TNVVGTFGYIA 525
YLH +++HRD+K +N L D+ N +LGDFG ++ M T +V GT +++
Sbjct: 121 YLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMS 177
Query: 526 PELTQTGKASTSSDVFAYGILLLEVATGRRP 556
PE+ +DV++ G ++E+ T + P
Sbjct: 178 PEVISGEGYGRKADVWSLGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 79.7 bits (197), Expect = 3e-16
Identities = 74/234 (31%), Positives = 107/234 (45%), Gaps = 34/234 (14%)
Query: 361 IGIGGFGSVYKGVLPTTGGEVAVKKI-TRNSLQGMREFA-AEIESLGRLRHKNLVNLHGW 418
IG G FG V+K T VA+KK+ N +G A EI+ L L+H+N+VNL
Sbjct: 20 IGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 79
Query: 419 C--------KQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLH 470
C + K LV+E+ + L LL L ++ ++K + +GL Y+H
Sbjct: 80 CRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKK--VMKMLLNGLYYIH 136
Query: 471 EEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLY---DHGGMPHTTNVVGTFGYIAPE 527
++HRD+K +N LI + +L DFGLAR + + TN V T Y PE
Sbjct: 137 R---NKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPE 193
Query: 528 L----TQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRI 577
L G D++ G ++ E+ T R PI G+ E HQL I
Sbjct: 194 LLLGERDYGPP---IDMWGAGCIMAEMWT-RSPIMQGN-------TEQHQLTLI 236
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 3e-16
Identities = 68/219 (31%), Positives = 104/219 (47%), Gaps = 33/219 (15%)
Query: 355 FKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITR--NSLQGMR---EFAAEIESLGRLRH 409
K +V+G G FG+VYKG+ G V + + N G + EF E + + H
Sbjct: 9 LKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDH 68
Query: 410 KNLVNLHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKD--GSVLDWEQRFNIVKGIASGLL 467
+LV L G C + LV + +P+G L + + KD GS L N IA G++
Sbjct: 69 PHLVRLLGVCLSPT-IQLVTQLMPHGCLLDYVHEHKDNIGSQL----LLNWCVQIAKGMM 123
Query: 468 YLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLY---------DHGGMPHTTNVV 518
YL E + ++HRD+ N L+ + + ++ DFGLARL D G MP
Sbjct: 124 YLEE---RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMP------ 174
Query: 519 GTFGYIAPELTQTGKASTSSDVFAYGILLLEVAT-GRRP 556
++A E K + SDV++YG+ + E+ T G +P
Sbjct: 175 --IKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKP 211
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 3e-16
Identities = 64/198 (32%), Positives = 100/198 (50%), Gaps = 13/198 (6%)
Query: 361 IGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAA-EIESLGRLRHKNLVNLHGWC 419
+G G + +V+KG T VA+K+I +G A E+ L L+H N+V LH
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII 72
Query: 420 KQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIH 479
+ L LV+EY+ + D + G+++ + + GL Y H+ + ++H
Sbjct: 73 HTERCLTLVFEYLDS---DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHK---RKILH 126
Query: 480 RDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTT--NVVGTFGYIAPE-LTQTGKAST 536
RD+KP N LI+ + +L DFGLAR +P T N V T Y P+ L + + ST
Sbjct: 127 RDLKPQNLLINEKGELKLADFGLARA---KSVPTKTYSNEVVTLWYRPPDVLLGSTEYST 183
Query: 537 SSDVFAYGILLLEVATGR 554
D++ G +L E+ATGR
Sbjct: 184 PIDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 4e-16
Identities = 59/207 (28%), Positives = 103/207 (49%), Gaps = 15/207 (7%)
Query: 359 EVIGIGGFGSVYKGVLPTTGGEVAVKKITRN--SLQGMREFAA---EIESLGRLRHKNLV 413
+++G G FG VY TG E+AVK++ + S + +E A EI+ L L H+ +V
Sbjct: 8 KLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIV 67
Query: 414 NLHGWCK--QKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHE 471
+G + + L + E++P GS+ L K L + I G+ YLH
Sbjct: 68 QYYGCLRDPMERTLSIFMEHMPGGSIKDQL---KSYGALTENVTRKYTRQILEGVSYLHS 124
Query: 472 EWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHT--TNVVGTFGYIAPELT 529
+++HRD+K +N L D+ N +LGDFG ++ + T +V GT +++PE+
Sbjct: 125 ---NMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVI 181
Query: 530 QTGKASTSSDVFAYGILLLEVATGRRP 556
+D+++ G ++E+ T + P
Sbjct: 182 SGEGYGRKADIWSVGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 5e-16
Identities = 67/200 (33%), Positives = 97/200 (48%), Gaps = 17/200 (8%)
Query: 361 IGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAA-EIESLGRLRHKNLVNLHGWC 419
+G G + +VYKG T VA+K+I +G A E+ L L+H N+V LH
Sbjct: 14 LGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII 73
Query: 420 KQKNDLLLVYEYIPNGSLDTLLFKPKD--GSVLDWEQRFNIVKGIASGLLYLHEEWEQVV 477
+ L LV+EY LD L + D G+ ++ + + GL Y H + V
Sbjct: 74 HTEKSLTLVFEY-----LDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHR---RKV 125
Query: 478 IHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTT--NVVGTFGYIAPE-LTQTGKA 534
+HRD+KP N LI+ +L DFGLAR +P T N V T Y P+ L +
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLARA---KSIPTKTYSNEVVTLWYRPPDILLGSTDY 182
Query: 535 STSSDVFAYGILLLEVATGR 554
ST D++ G + E++TGR
Sbjct: 183 STQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 5e-16
Identities = 59/211 (27%), Positives = 104/211 (49%), Gaps = 15/211 (7%)
Query: 355 FKESEVIGIGGFGSVYKGVLPTTGGEVAVKKI-----TRNSLQGMREFAAEIESLGRLRH 409
++ +++G G FG VY TG E+AVK++ ++ + + + EI+ L LRH
Sbjct: 4 WRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRH 63
Query: 410 KNLVNLHGWCK--QKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLL 467
+V +G + ++ L + EY+P GS+ L K L + I G+
Sbjct: 64 DRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQL---KAYGALTENVTRRYTRQILQGVS 120
Query: 468 YLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHT--TNVVGTFGYIA 525
YLH +++HRD+K +N L D+ N +LGDFG ++ M T +V GT +++
Sbjct: 121 YLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMS 177
Query: 526 PELTQTGKASTSSDVFAYGILLLEVATGRRP 556
PE+ +DV++ ++E+ T + P
Sbjct: 178 PEVISGEGYGRKADVWSVACTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 5e-16
Identities = 67/233 (28%), Positives = 110/233 (47%), Gaps = 25/233 (10%)
Query: 359 EVIGIGGFGSVYKG-VLPTTGGE----VAVKKITRNSLQGMRE-FAAEIESLGRLRHKNL 412
E +G FG VYKG + T GE VA+K + + +RE F E RL+H N+
Sbjct: 11 EELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNI 70
Query: 413 VNLHGWCKQKNDLLLVYEYIPNGSLDTLLF--KPKDG-----------SVLDWEQRFNIV 459
V L G ++ L +++ Y + L L P S L+ +IV
Sbjct: 71 VCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIV 130
Query: 460 KGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLAR-LYDHGGMPHTTNVV 518
IA+G+ +L V+H+D+ N L+ ++N ++ D GL R +Y N +
Sbjct: 131 TQIAAGMEFLSSHH---VVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSL 187
Query: 519 GTFGYIAPELTQTGKASTSSDVFAYGILLLEV-ATGRRP-IGSGDLLLVEWVR 569
+++PE GK S SD+++YG++L EV + G +P G + ++E +R
Sbjct: 188 LPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIR 240
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 5e-16
Identities = 60/205 (29%), Positives = 100/205 (48%), Gaps = 9/205 (4%)
Query: 355 FKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAA---EIESLGRLRHKN 411
F++ V+G GGFG V + TG A KK+ + ++ + + E + L ++ +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61
Query: 412 LVNLHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHE 471
+V+L + K+ L LV + G L ++ + + F + I GL LH+
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAE-ICCGLEDLHQ 120
Query: 472 EWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPELTQT 531
E +++RD+KP N L+D + R+ D GLA G VGT GY+APE+ +
Sbjct: 121 E---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT--IKGRVGTVGYMAPEVVKN 175
Query: 532 GKASTSSDVFAYGILLLEVATGRRP 556
+ + S D +A G LL E+ G+ P
Sbjct: 176 ERYTFSPDWWALGCLLYEMIAGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 6e-16
Identities = 63/209 (30%), Positives = 107/209 (51%), Gaps = 19/209 (9%)
Query: 355 FKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMR-EFAAEIESLGRLRHKNLV 413
F++ +G G G V K + +G +A K I +R + E++ L +V
Sbjct: 3 FEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIV 62
Query: 414 NLHGWCKQKNDLLLVYEYIPNGSLDTLLFK----PKDGSVLDWEQRFNIVKGIASGLLYL 469
+G ++ + E++ GSLD +L K P++ +L I + GL YL
Sbjct: 63 GFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEN--ILG-----KISIAVLRGLTYL 115
Query: 470 HEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLA-RLYDHGGMPHTTNVVGTFGYIAPEL 528
E+ + ++HRDVKPSN L+++ +L DFG++ +L D M ++ VGT Y++PE
Sbjct: 116 REKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID--SMANS--FVGTRSYMSPER 169
Query: 529 TQTGKASTSSDVFAYGILLLEVATGRRPI 557
Q + SD+++ G+ L+E+A GR PI
Sbjct: 170 LQGTHYTVQSDIWSLGLSLVEMAIGRYPI 198
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 6e-16
Identities = 59/212 (27%), Positives = 96/212 (45%), Gaps = 27/212 (12%)
Query: 355 FKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMRE---FAAEIESLGRLRHKN 411
+ + +G G FG V+ + A+K + + +++ E L + H
Sbjct: 3 LERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPF 62
Query: 412 LVNLHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKG------IASG 465
++ L + L ++ EY+P G L F S L RF+ G I
Sbjct: 63 IIRLFWTEHDQRFLYMLMEYVPGGEL----F-----SYLRNSGRFSNSTGLFYASEIVCA 113
Query: 466 LLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLAR-LYDHGGMPHTTNVVGTFGYI 524
L YLH + +++RD+KP N L+D E + +L DFG A+ L D T + GT Y+
Sbjct: 114 LEYLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD-----RTWTLCGTPEYL 165
Query: 525 APELTQTGKASTSSDVFAYGILLLEVATGRRP 556
APE+ Q+ + + D +A GIL+ E+ G P
Sbjct: 166 APEVIQSKGHNKAVDWWALGILIYEMLVGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 6e-16
Identities = 66/205 (32%), Positives = 100/205 (48%), Gaps = 19/205 (9%)
Query: 360 VIGIGGFGSVYKGVLPTTGGEVAVKKITRNS-LQG------MREFAAEIESLGRLRHKNL 412
V+G G FG V L T AVK + ++ LQ M E + +L +H L
Sbjct: 2 VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTE--KRVLALAG-KHPFL 58
Query: 413 VNLHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQ-RFNIVKGIASGLLYLHE 471
LH + K+ L V EY+ G L +F + D + RF + I GL +LHE
Sbjct: 59 TQLHSCFQTKDRLFFVMEYVNGGDL---MFHIQRSGRFDEPRARFYAAE-IVLGLQFLHE 114
Query: 472 EWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPELTQT 531
+ +I+RD+K N L+D+E + ++ DFG+ + GG+ T+ GT YIAPE+
Sbjct: 115 ---RGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV-TTSTFCGTPDYIAPEILSY 170
Query: 532 GKASTSSDVFAYGILLLEVATGRRP 556
+ D +A G+LL E+ G+ P
Sbjct: 171 QPYGPAVDWWALGVLLYEMLAGQSP 195
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 8e-16
Identities = 62/241 (25%), Positives = 102/241 (42%), Gaps = 19/241 (7%)
Query: 324 RKWSNSETLEDWEKDC--PHRFRYKDLYAATKGFKESEVIGI---GGFGSVYKGVLPTTG 378
++ E+L C P A+ + ++ G G V+ + T
Sbjct: 59 DYDADEESLSPQTDVCQEPCETT-SSSDPASVVRMQYNILSSLTPGSEGEVF---VCTKH 114
Query: 379 GEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEYIPNGSLD 438
G+ KK+ ++ G + EI+ L + H+ ++NL + K+ + +V +P D
Sbjct: 115 GDEQRKKVIVKAVTGGKTPGREIDILKTISHRAIINLIHAYRWKSTVCMV---MPKYKCD 171
Query: 439 TLLFKPKDG-SVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARL 497
LF D L EQ I + + L YLH + +IHRDVK N +D NA L
Sbjct: 172 --LFTYVDRSGPLPLEQAITIQRRLLEALAYLHG---RGIIHRDVKTENIFLDEPENAVL 226
Query: 498 GDFGLA-RLYDHGGMPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRP 556
GDFG A +L H P GT +PEL +D+++ G++L E++
Sbjct: 227 GDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVT 286
Query: 557 I 557
+
Sbjct: 287 L 287
|
Length = 392 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 8e-16
Identities = 66/217 (30%), Positives = 98/217 (45%), Gaps = 14/217 (6%)
Query: 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMRE---FAAEIESLGRLRH 409
K F ++G G FG V TG A+K + ++ L F E + L
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS 60
Query: 410 KNLVNLHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYL 469
+ L + K++L LV EY P G L +LL + +D D Q + +A +L +
Sbjct: 61 PWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFY-----LAELVLAI 115
Query: 470 HEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPELT 529
H + +HRD+KP N LID + +L DFG A M ++ VGT YIAPE+
Sbjct: 116 HSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVL 175
Query: 530 QT----GKAS--TSSDVFAYGILLLEVATGRRPIGSG 560
T GK + D ++ G++ E+ GR P G
Sbjct: 176 TTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEG 212
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 9e-16
Identities = 60/197 (30%), Positives = 97/197 (49%), Gaps = 8/197 (4%)
Query: 361 IGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNLHGWCK 420
+G G FG V+ +VAVK + S+ + F AE + L+H LV LH
Sbjct: 14 LGAGQFGEVWMATY-NKHTKVAVKTMKPGSMS-VEAFLAEANVMKTLQHDKLVKLHA-VV 70
Query: 421 QKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHR 480
K + ++ E++ GSL L K +GS + + IA G+ ++ + + IHR
Sbjct: 71 TKEPIYIITEFMAKGSLLDFL-KSDEGSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHR 126
Query: 481 DVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPELTQTGKASTSSDV 540
D++ +N L+ A + ++ DFGLAR+ + + APE G + SDV
Sbjct: 127 DLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDV 186
Query: 541 FAYGILLLEVAT-GRRP 556
+++GILL+E+ T GR P
Sbjct: 187 WSFGILLMEIVTYGRIP 203
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 1e-15
Identities = 60/216 (27%), Positives = 95/216 (43%), Gaps = 29/216 (13%)
Query: 361 IGIGGFGSVYK----GVLPTTGGE-VAVKKITRN-SLQGMREFAAEIESLGRLRHKNLVN 414
IG G FG V++ G+LP VAVK + S +F E + H N+V
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 415 LHGWCKQKNDLLLVYEYIPNGSLDTLL-------------------FKPKDGSVLDWEQR 455
L G C + L++EY+ G L+ L + L ++
Sbjct: 73 LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132
Query: 456 FNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLAR-LYDHGGMPHT 514
I K +A+G+ YL E + +HRD+ N L+ M ++ DFGL+R +Y +
Sbjct: 133 LCIAKQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189
Query: 515 TNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEV 550
N ++ PE + +T SDV+AYG++L E+
Sbjct: 190 ENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEI 225
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 2e-15
Identities = 59/201 (29%), Positives = 99/201 (49%), Gaps = 14/201 (6%)
Query: 361 IGIGGFGSV----YKGVLPTTGGEVAVKKIT-RNSLQGMREFAAEIESLGRLRHKNLVNL 415
+G G FG V Y TG +VAVK + + + + EIE L L H+N+V
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71
Query: 416 HGWCKQK--NDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEW 473
G C + N + L+ E++P+GSL L P++ + ++ +Q+ I G+ YL
Sbjct: 72 KGICTEDGGNGIKLIMEFLPSGSLKEYL--PRNKNKINLKQQLKYAVQICKGMDYLGS-- 127
Query: 474 EQVVIHRDVKPSNALIDAEMNARLGDFGLARLY--DHGGMPHTTNVVGTFGYIAPELTQT 531
+ +HRD+ N L+++E ++GDFGL + D ++ + APE
Sbjct: 128 -RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQ 186
Query: 532 GKASTSSDVFAYGILLLEVAT 552
K +SDV+++G+ L E+ T
Sbjct: 187 SKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 2e-15
Identities = 67/206 (32%), Positives = 101/206 (49%), Gaps = 19/206 (9%)
Query: 359 EVIGIGGFGSVYKGVLPTTGGEVAVKKITRNS-LQG------MREFAAEIESLGRLRHKN 411
+V+G G FG V L T A+K + ++ LQ M E I +L +H
Sbjct: 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTE--KRILALAA-KHPF 57
Query: 412 LVNLHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQ-RFNIVKGIASGLLYLH 470
L LH + K+ L V EY+ G L +F+ + D + RF + + L++LH
Sbjct: 58 LTALHCCFQTKDRLFFVMEYVNGGDL---MFQIQRSRKFDEPRSRFYAAE-VTLALMFLH 113
Query: 471 EEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPELTQ 530
VI+RD+K N L+DAE + +L DFG+ + G+ TT GT YIAPE+ Q
Sbjct: 114 R---HGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVT-TTTFCGTPDYIAPEILQ 169
Query: 531 TGKASTSSDVFAYGILLLEVATGRRP 556
+ S D +A G+L+ E+ G+ P
Sbjct: 170 ELEYGPSVDWWALGVLMYEMMAGQPP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 2e-15
Identities = 57/204 (27%), Positives = 94/204 (46%), Gaps = 8/204 (3%)
Query: 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNL 412
K + E IG G G+VY + TG EVA+K++ EI + +H N+
Sbjct: 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNI 78
Query: 413 VNLHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEE 472
VN ++L +V EY+ GSL ++ + + +D Q + + L +LH
Sbjct: 79 VNYLDSYLVGDELWVVMEYLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHS- 133
Query: 473 WEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPELTQTG 532
VIHRD+K N L+ + + +L DFG +T +VGT ++APE+
Sbjct: 134 --NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST-MVGTPYWMAPEVVTRK 190
Query: 533 KASTSSDVFAYGILLLEVATGRRP 556
D+++ GI+ +E+ G P
Sbjct: 191 AYGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 3e-15
Identities = 61/210 (29%), Positives = 96/210 (45%), Gaps = 29/210 (13%)
Query: 359 EVIGIGGFGSVYKGVLPTTGGE---VAVKKITR-NSLQGMREFAAEIESLGRLRHKNLVN 414
VIG G FG VY G L + G+ AVK + R L+ + +F E + H N+++
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60
Query: 415 LHGWCKQKNDL-LLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEW 473
L G C L+V Y+ +G L + + F + +A G+ YL
Sbjct: 61 LLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGL--QVAKGMEYLAS-- 116
Query: 474 EQVVIHRDVKPSNALIDAEMNARLGDFGLAR-LYD----------HGGMPHTTNVVGTFG 522
+ +HRD+ N ++D ++ DFGLAR +YD +P
Sbjct: 117 -KKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLP--------VK 167
Query: 523 YIAPELTQTGKASTSSDVFAYGILLLEVAT 552
++A E QT K +T SDV+++G+LL E+ T
Sbjct: 168 WMALESLQTQKFTTKSDVWSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 75.9 bits (186), Expect = 3e-15
Identities = 79/278 (28%), Positives = 126/278 (45%), Gaps = 28/278 (10%)
Query: 355 FKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRL-RHKNLV 413
F+ E++G G +G VYKG TG ++A K+ + E EI L + H+N+
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTG-QLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIA 66
Query: 414 NLHGWCKQKN------DLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLL 467
+G +KN L LV E+ GS+ T L K G+ L E I + I GL
Sbjct: 67 TYYGAFIKKNPPGMDDQLWLVMEFCGAGSV-TDLIKNTKGNTLKEEWIAYICREILRGLS 125
Query: 468 YLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPE 527
+LH+ VIHRD+K N L+ +L DFG++ D + +GT ++APE
Sbjct: 126 HLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDR-TVGRRNTFIGTPYWMAPE 181
Query: 528 LTQTGKASTS-----SDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVAD 582
+ + + SD+++ GI +E+A G P+ + L I
Sbjct: 182 VIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCD--------MHPMRALFLIPRNPA 233
Query: 583 PLLNSSYVVKEMELVLKLGLMCSHKTQFRPTMRQVMRY 620
P L S K+ + ++ L+ +H RPT Q+M++
Sbjct: 234 PRLKSKKWSKKFQSFIESCLVKNHSQ--RPTTEQLMKH 269
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 4e-15
Identities = 64/212 (30%), Positives = 104/212 (49%), Gaps = 17/212 (8%)
Query: 349 YAATKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAA--EIESLGR 406
+ A + E +G G + +VYKG+ G VA+K I+ + +G+ F A E L
Sbjct: 1 FGAATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGV-PFTAIREASLLKG 59
Query: 407 LRHKNLVNLHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQR---FNIVKGIA 463
L+H N+V LH K L V+EY+ ++ P G + + R F +++G+A
Sbjct: 60 LKHANIVLLHDIIHTKETLTFVFEYMHTDLAQYMIQHP--GGLHPYNVRLFMFQLLRGLA 117
Query: 464 SGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGY 523
Y+H Q ++HRD+KP N LI +L DFGLAR +++ VV T Y
Sbjct: 118 ----YIHG---QHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV-TLWY 169
Query: 524 IAPE-LTQTGKASTSSDVFAYGILLLEVATGR 554
P+ L S++ D++ G + +E+ G+
Sbjct: 170 RPPDVLLGATDYSSALDIWGAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 5e-15
Identities = 77/249 (30%), Positives = 110/249 (44%), Gaps = 38/249 (15%)
Query: 355 FKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLR-----H 409
+ IG G G VYK TG +AVK++ R G +E I L L H
Sbjct: 17 LENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRT---GNKEENKRI--LMDLDVVLKSH 71
Query: 410 --KNLVNLHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDG---SVLDWEQRFNIVKGIAS 464
+V +G+ +D+ + E + + LD LL + + +L + I
Sbjct: 72 DCPYIVKCYGYFITDSDVFICME-LMSTCLDKLLKRIQGPIPEDILG-----KMTVAIVK 125
Query: 465 GLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLA-RLYDHGGMPHTTNVVGTFGY 523
L YL E+ VIHRDVKPSN L+DA N +L DFG++ RL D T + G Y
Sbjct: 126 ALHYLKEK--HGVIHRDVKPSNILLDASGNVKLCDFGISGRLVD--SKAKTRS-AGCAAY 180
Query: 524 IAPEL----TQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILD 579
+APE K +DV++ GI L+E+ATG+ P + E L +IL
Sbjct: 181 MAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKT-------EFEVLTKILQ 233
Query: 580 VADPLLNSS 588
P L +
Sbjct: 234 EEPPSLPPN 242
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 5e-15
Identities = 71/220 (32%), Positives = 97/220 (44%), Gaps = 42/220 (19%)
Query: 359 EVIGIGGFGSVYKGVLPTTGGEVAVKKI--TRNSLQGMREFAAEIESLGRLRH-KNLVNL 415
E +G G +G V K TG +AVK+I T NS Q + +++ R V
Sbjct: 7 EELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNS-QEQKRLLMDLDISMRSVDCPYTVTF 65
Query: 416 HGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRF------NIVKGIASGLLYL 469
+G ++ D+ + E + + SLD K V D I I L YL
Sbjct: 66 YGALFREGDVWICMEVM-DTSLDKFYKK-----VYDKGLTIPEDILGKIAVSIVKALEYL 119
Query: 470 HEEWEQVVIHRDVKPSNALIDAEMNARLGDFG--------LARLYDHGGMPHTTNVVGTF 521
H + VIHRDVKPSN LI+ +L DFG +A+ D G P
Sbjct: 120 HSKLS--VIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTIDAGCKP--------- 168
Query: 522 GYIAPE-----LTQTGKASTSSDVFAYGILLLEVATGRRP 556
Y+APE L Q G SDV++ GI ++E+ATGR P
Sbjct: 169 -YMAPERINPELNQKG-YDVKSDVWSLGITMIELATGRFP 206
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 5e-15
Identities = 67/220 (30%), Positives = 109/220 (49%), Gaps = 13/220 (5%)
Query: 355 FKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMR-EFAAEIESLGRLRHKNLV 413
F++ +G G G V+K +G +A K I +R + E++ L +V
Sbjct: 7 FEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 66
Query: 414 NLHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVK-GIASGLLYLHEE 472
+G ++ + E++ GSLD +L K G + EQ V + GL YL E+
Sbjct: 67 GFYGAFYSDGEISICMEHMDGGSLDQVL--KKAGRIP--EQILGKVSIAVIKGLTYLREK 122
Query: 473 WEQVVIHRDVKPSNALIDAEMNARLGDFGLA-RLYDHGGMPHTTNVVGTFGYIAPELTQT 531
+ ++HRDVKPSN L+++ +L DFG++ +L D + VGT Y++PE Q
Sbjct: 123 HK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SMANSFVGTRSYMSPERLQG 176
Query: 532 GKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVREC 571
S SD+++ G+ L+E+A GR PI D +E + C
Sbjct: 177 THYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGC 216
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 5e-15
Identities = 66/241 (27%), Positives = 103/241 (42%), Gaps = 49/241 (20%)
Query: 355 FKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMRE---FAAEIESLGRLRHKN 411
F+ E +G G FG V TG A+K + + + M++ A E L L H
Sbjct: 20 FEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPF 79
Query: 412 LVNLHGWCKQKNDLLLVYEYIPNGSLDTLLFK----PKDGS-------VLDWEQRFNIVK 460
+VN+ + +N + + E++ G L T L K P D + VL +E
Sbjct: 80 IVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFE------- 132
Query: 461 GIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLA-RLYDHGGMPHTTNVVG 519
YLH + +I+RD+KP N L+D + + ++ DFG A ++ D T + G
Sbjct: 133 -------YLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD-----RTFTLCG 177
Query: 520 TFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRP------------IGSGDLLLVEW 567
T Y+APE+ Q+ + D + G+LL E G P I +G L W
Sbjct: 178 TPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNW 237
Query: 568 V 568
Sbjct: 238 F 238
|
Length = 329 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 75.9 bits (186), Expect = 5e-15
Identities = 57/204 (27%), Positives = 95/204 (46%), Gaps = 8/204 (3%)
Query: 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNL 412
K + E IG G G+V+ + TG EVA+K+I EI + L++ N+
Sbjct: 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNI 78
Query: 413 VNLHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEE 472
VN ++L +V EY+ GSL ++ + + +D Q + + L +LH
Sbjct: 79 VNFLDSFLVGDELFVVMEYLAGGSLTDVVTE----TCMDEAQIAAVCRECLQALEFLHAN 134
Query: 473 WEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPELTQTG 532
VIHRD+K N L+ + + +L DFG +T +VGT ++APE+
Sbjct: 135 Q---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRST-MVGTPYWMAPEVVTRK 190
Query: 533 KASTSSDVFAYGILLLEVATGRRP 556
D+++ GI+ +E+ G P
Sbjct: 191 AYGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 6e-15
Identities = 68/251 (27%), Positives = 112/251 (44%), Gaps = 21/251 (8%)
Query: 355 FKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSL---QGMREFAAEIESLGRLRHKN 411
F+ + IG G F VY+ VA+KK+ + + ++ EI+ L +L H N
Sbjct: 4 FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPN 63
Query: 412 LVNLHGWCKQKNDLLLVYEYIPNGSLDTLL--FKPKDGSVLDWEQRFNIVKGIASGLLYL 469
++ + N+L +V E G L ++ FK K ++ + + S + ++
Sbjct: 64 VIKYLDSFIEDNELNIVLELADAGDLSQMIKYFK-KQKRLIPERTVWKYFVQLCSAVEHM 122
Query: 470 HEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTT---NVVGTFGYIAP 526
H + V+HRD+KP+N I A +LGD GL R + TT ++VGT Y++P
Sbjct: 123 HS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFS----SKTTAAHSLVGTPYYMSP 175
Query: 527 ELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLN 586
E + SD+++ G LL E+A + P + L ++ Q PL
Sbjct: 176 ERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDY-----PPLPT 230
Query: 587 SSYVVKEMELV 597
Y K ELV
Sbjct: 231 EHYSEKLRELV 241
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 76.1 bits (187), Expect = 6e-15
Identities = 89/303 (29%), Positives = 131/303 (43%), Gaps = 40/303 (13%)
Query: 359 EVIGIGGFGSVYKGVLPTTGGEVAVKKITRNS-LQG------MREFAAEIESLGRLRHKN 411
V+G G FG V L +G AVK + ++ LQ M E I SL R H
Sbjct: 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTE--KRILSLAR-NHPF 57
Query: 412 LVNLHGWCKQKND-LLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLH 470
L L+ C Q D L V E++ G L +F + D + I S L++LH
Sbjct: 58 LTQLY-CCFQTPDRLFFVMEFVNGGDL---MFHIQKSRRFDEARARFYAAEITSALMFLH 113
Query: 471 EEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPELTQ 530
++ +I+RD+K N L+D E + +L DFG+ + G T+ GT YIAPE+ Q
Sbjct: 114 DKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKT-TSTFCGTPDYIAPEILQ 169
Query: 531 TGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSYV 590
S D +A G+LL E+ G P E E IL+ D ++ +++
Sbjct: 170 EMLYGPSVDWWAMGVLLYEMLCGHAPF--------EAENEDDLFEAILN--DEVVYPTWL 219
Query: 591 VKEMELVLKLGLMCSHKTQFRPTMRQVMRYLSGEKQLRFNN-----DWGSIDYRQGFDEF 645
++ +LK M PTMR L GE+ + + DW ++ RQ F
Sbjct: 220 SQDAVDILK-AFMTK-----NPTMRLGSLTLGGEEAILRHPFFKELDWEKLNRRQIEPPF 273
Query: 646 SSR 648
R
Sbjct: 274 RPR 276
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 75.9 bits (186), Expect = 7e-15
Identities = 61/203 (30%), Positives = 100/203 (49%), Gaps = 11/203 (5%)
Query: 361 IGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMR-EFAAEIESLGRLRHKNLVNLHGWC 419
+G G G V K +G +A K I +R + E++ L +V +G
Sbjct: 13 LGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 72
Query: 420 KQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIH 479
++ + E++ GSLD +L K+ + E + + GL YL E+ + ++H
Sbjct: 73 YSDGEISICMEHMDGGSLDQVL---KEAKRIPEEILGKVSIAVLRGLAYLREKHQ--IMH 127
Query: 480 RDVKPSNALIDAEMNARLGDFGLA-RLYDHGGMPHTTNVVGTFGYIAPELTQTGKASTSS 538
RDVKPSN L+++ +L DFG++ +L D + VGT Y++PE Q S S
Sbjct: 128 RDVKPSNILVNSRGEIKLCDFGVSGQLID----SMANSFVGTRSYMSPERLQGTHYSVQS 183
Query: 539 DVFAYGILLLEVATGRRPIGSGD 561
D+++ G+ L+E+A GR PI D
Sbjct: 184 DIWSMGLSLVELAIGRYPIPPPD 206
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 7e-15
Identities = 66/217 (30%), Positives = 103/217 (47%), Gaps = 22/217 (10%)
Query: 355 FKESEVIGIGGFGSVYKGVLPTTGGEVAVK--KITRNSLQGMREFAAEIESLGRL-RHKN 411
F+ EV+G G +G VYKG TG A+K +T + + E EI L + H+N
Sbjct: 18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEE---EIKLEINMLKKYSHHRN 74
Query: 412 LVNLHGWCKQK------NDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASG 465
+ +G +K + L LV E+ GS+ T L K G+ L + I + I G
Sbjct: 75 IATYYGAFIKKSPPGHDDQLWLVMEFCGAGSV-TDLVKNTKGNALKEDWIAYICREILRG 133
Query: 466 LLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIA 525
L +LH VIHRD+K N L+ +L DFG++ D + +GT ++A
Sbjct: 134 LAHLHA---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDR-TVGRRNTFIGTPYWMA 189
Query: 526 PELTQTGKASTS-----SDVFAYGILLLEVATGRRPI 557
PE+ + + SD+++ GI +E+A G P+
Sbjct: 190 PEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPL 226
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 9e-15
Identities = 64/211 (30%), Positives = 96/211 (45%), Gaps = 17/211 (8%)
Query: 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKIT---RNSLQGMREFAAEIESLGRLRH 409
K F + IG G FG+VY VA+KK++ + S + ++ E+ L +LRH
Sbjct: 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH 74
Query: 410 KNLVNLHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYL 469
N + G +++ LV EY + D L K L + + G GL YL
Sbjct: 75 PNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP---LQEVEIAAVTHGALQGLAYL 131
Query: 470 HEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPEL- 528
H +IHRDVK N L+ +LGDFG A + M VGT ++APE+
Sbjct: 132 HS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASI-----MAPANXFVGTPYWMAPEVI 183
Query: 529 --TQTGKASTSSDVFAYGILLLEVATGRRPI 557
G+ DV++ GI +E+A + P+
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIELAERKPPL 214
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 1e-14
Identities = 64/208 (30%), Positives = 97/208 (46%), Gaps = 11/208 (5%)
Query: 349 YAATKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAA--EIESLGR 406
+ +++ E +G G + +VYKG G VA+K I +G F A E L
Sbjct: 1 FGKADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGT-PFTAIREASLLKG 59
Query: 407 LRHKNLVNLHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGL 466
L+H N+V LH K L LV+EY+ D + K L E + + GL
Sbjct: 60 LKHANIVLLHDIIHTKETLTLVFEYV---HTDLCQYMDKHPGGLHPENVKLFLFQLLRGL 116
Query: 467 LYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAP 526
Y+H+ + ++HRD+KP N LI +L DFGLAR ++ VV T Y P
Sbjct: 117 SYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVV-TLWYRPP 172
Query: 527 E-LTQTGKASTSSDVFAYGILLLEVATG 553
+ L + + ST D++ G + +E+ G
Sbjct: 173 DVLLGSTEYSTCLDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 1e-14
Identities = 59/205 (28%), Positives = 95/205 (46%), Gaps = 9/205 (4%)
Query: 355 FKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQ---GMREFAAEIESLGRLRHKN 411
F++ V+G GGFG V + TG A K++ + ++ G E + L ++ +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61
Query: 412 LVNLHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHE 471
+VNL + K+ L LV + G L ++ + + E+ I GL LH
Sbjct: 62 VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPG-FEEERALFYAAEILCGLEDLHR 120
Query: 472 EWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPELTQT 531
E ++RD+KP N L+D + R+ D GLA G VGT GY+APE+
Sbjct: 121 E---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES--IRGRVGTVGYMAPEVLNN 175
Query: 532 GKASTSSDVFAYGILLLEVATGRRP 556
+ + S D + G L+ E+ G+ P
Sbjct: 176 QRYTLSPDYWGLGCLIYEMIEGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 2e-14
Identities = 67/278 (24%), Positives = 118/278 (42%), Gaps = 28/278 (10%)
Query: 361 IGIGGFGSVYKGVLPT--TGGEVAVKKITRNS-LQGMREFAAEIESLGRLRHKNLVNLHG 417
IG G FG V G + V VK++ ++ F E++ L H N++ G
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62
Query: 418 WCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRF--NIVKGIASGLLYLHEEWEQ 475
C + LLV E+ P G L L + ++ + +ASGLL+LH +
Sbjct: 63 QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH---QA 119
Query: 476 VVIHRDVKPSNALIDAEMNARLGDFGLA-RLYDHGGMPHTTNVVGTFGYIAPELTQ---- 530
IH D+ N + A+++ ++GD+GLA Y ++APEL +
Sbjct: 120 DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQ 179
Query: 531 ---TGKASTSSDVFAYGILLLEVAT-GRRPIG--SGDLLLVEWVRECHQLGRILDVADPL 584
+ S++++ G+ + E+ T +P S + +L + VRE + + + P
Sbjct: 180 DLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVRE-----QDIKLPKPQ 234
Query: 585 LNSSYVVKEMELVLKLGLMCSHKTQFRPTMRQVMRYLS 622
L+ Y + E++ C + RPT +V L+
Sbjct: 235 LDLKYSDRWYEVM----QFCWLDPETRPTAEEVHELLT 268
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 2e-14
Identities = 63/210 (30%), Positives = 96/210 (45%), Gaps = 13/210 (6%)
Query: 355 FKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKN--- 411
F+ +VIG G FG V + T A+K + + + E A E L + +
Sbjct: 3 FEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQW 62
Query: 412 LVNLHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHE 471
+ LH + +N L LV +Y G L TLL K +D D + + IA +L +H
Sbjct: 63 ITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFY-----IAEMVLAIHS 117
Query: 472 EWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPELTQT 531
+ +HRD+KP N L+D + RL DFG + G ++ VGT YI+PE+ Q
Sbjct: 118 IHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQA 177
Query: 532 -----GKASTSSDVFAYGILLLEVATGRRP 556
GK D ++ G+ + E+ G P
Sbjct: 178 MEDGMGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 3e-14
Identities = 71/251 (28%), Positives = 111/251 (44%), Gaps = 38/251 (15%)
Query: 344 RYKDLYAATKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIES 403
RY DL +G G G V+ V VAVKKI Q ++ EI+
Sbjct: 6 RYMDLRP----------LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKI 55
Query: 404 LGRLRHKNLVNLH-----GWCKQKNDLLLVYE----YIPNGSLDTLLFKPKDGSVLDWEQ 454
+ RL H N+V ++ D+ + E YI ++T L + L E
Sbjct: 56 IRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEH 115
Query: 455 RFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAE-MNARLGDFGLARL----YDHG 509
+ + GL Y+H V+HRD+KP+N I+ E + ++GDFGLAR+ Y H
Sbjct: 116 ARLFMYQLLRGLKYIHS---ANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHK 172
Query: 510 GMPHTTNVVGTFGYIAPELTQTGKASTSS-DVFAYGILLLEVATGRRPIGSGDLLLVEWV 568
G + + + T Y +P L + T + D++A G + E+ TG +P+ +G
Sbjct: 173 G--YLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTG-KPLFAGA------- 222
Query: 569 RECHQLGRILD 579
E Q+ IL+
Sbjct: 223 HELEQMQLILE 233
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 3e-14
Identities = 59/201 (29%), Positives = 98/201 (48%), Gaps = 11/201 (5%)
Query: 361 IGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNLHGWCK 420
+G G FG VYK TG A K I S + + ++ EI+ L H N+V L
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72
Query: 421 QKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHR 480
+N+L ++ E+ G++D ++ + + L Q + K L YLH E +IHR
Sbjct: 73 YENNLWILIEFCAGGAVDAVMLELE--RPLTEPQIRVVCKQTLEALNYLH---ENKIIHR 127
Query: 481 DVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPE--LTQTGKAST-- 536
D+K N L + + +L DFG++ + + + +GT ++APE + +T K
Sbjct: 128 DLKAGNILFTLDGDIKLADFGVSA-KNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYD 186
Query: 537 -SSDVFAYGILLLEVATGRRP 556
+DV++ GI L+E+A P
Sbjct: 187 YKADVWSLGITLIEMAQIEPP 207
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 3e-14
Identities = 54/196 (27%), Positives = 95/196 (48%), Gaps = 8/196 (4%)
Query: 361 IGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNLHGWCK 420
IG G G V TG +VAVKK+ Q E+ + H+N+V+++
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL 89
Query: 421 QKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHR 480
++L +V E++ G+L ++ + ++ EQ + + L YLH Q VIHR
Sbjct: 90 VGDELWVVMEFLEGGALTDIVTHTR----MNEEQIATVCLSVLRALSYLHN---QGVIHR 142
Query: 481 DVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPELTQTGKASTSSDV 540
D+K + L+ ++ +L DFG +P ++VGT ++APE+ T D+
Sbjct: 143 DIKSDSILLTSDGRIKLSDFGFCAQVSKE-VPKRKSLVGTPYWMAPEVISRLPYGTEVDI 201
Query: 541 FAYGILLLEVATGRRP 556
++ GI+++E+ G P
Sbjct: 202 WSLGIMVIEMIDGEPP 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 4e-14
Identities = 53/183 (28%), Positives = 87/183 (47%), Gaps = 14/183 (7%)
Query: 381 VAVKKITRNSLQGMR-EFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEYIPNGSLDT 439
VAVK + + + R +F EI+ + RL++ N++ L G C + L ++ EY+ NG L+
Sbjct: 47 VAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQ 106
Query: 440 LLFKPKDGSVL---------DWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALID 490
L + + S + IASG+ YL +HRD+ N L+
Sbjct: 107 FLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLA---SLNFVHRDLATRNCLVG 163
Query: 491 AEMNARLGDFGLAR-LYDHGGMPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLE 549
++ DFG++R LY V ++A E GK +T+SDV+A+G+ L E
Sbjct: 164 NHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWE 223
Query: 550 VAT 552
+ T
Sbjct: 224 MFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 72.8 bits (179), Expect = 4e-14
Identities = 74/289 (25%), Positives = 130/289 (44%), Gaps = 44/289 (15%)
Query: 359 EVIGIGGFGSVYKGVL-----PTTGGEVAVKKITRNSL-QGMREFAAEIESLGRL-RHKN 411
+ +G G FG V K P VAVK + ++ + + + +E+E + + +HKN
Sbjct: 18 KPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 77
Query: 412 LVNLHGWCKQKNDLLLVYEYIPNGSLDTLL--FKPK------DGSVLDWEQ--RFNIVK- 460
++NL G C Q+ L +V EY +G+L L +P D E + ++V
Sbjct: 78 IINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSF 137
Query: 461 --GIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLAR-LYDHGGMPHTTNV 517
+A G+ +L + IHRD+ N L+ + ++ DFGLAR ++ TTN
Sbjct: 138 AYQVARGMEFLAS---KKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNG 194
Query: 518 VGTFGYIAPELTQTGKASTSSDVFAYGILLLEVAT-GRRPIGSGDL-LLVEWVRECHQLG 575
++APE + SDV+++G+LL E+ T G P + L + ++E +++
Sbjct: 195 RLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEGYRM- 253
Query: 576 RILDVADPLLNSSYVVKEMELVLKLGLMCS---HKTQFRPTMRQVMRYL 621
+ N + +E+ LM RPT +Q++ L
Sbjct: 254 ------EKPQNCT---QEL-----YHLMRDCWHEVPSQRPTFKQLVEDL 288
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 73.6 bits (180), Expect = 4e-14
Identities = 62/211 (29%), Positives = 97/211 (45%), Gaps = 17/211 (8%)
Query: 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKIT---RNSLQGMREFAAEIESLGRLRH 409
K F + IG G FG+VY T VA+KK++ + S + ++ E++ L R++H
Sbjct: 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKH 84
Query: 410 KNLVNLHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYL 469
N + G +++ LV EY + D L K L + I G GL YL
Sbjct: 85 PNSIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKP---LQEVEIAAITHGALQGLAYL 141
Query: 470 HEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPEL- 528
H +IHRD+K N L+ +L DFG A + + VGT ++APE+
Sbjct: 142 HS---HNMIHRDIKAGNILLTEPGQVKLADFGSASI-----ASPANSFVGTPYWMAPEVI 193
Query: 529 --TQTGKASTSSDVFAYGILLLEVATGRRPI 557
G+ DV++ GI +E+A + P+
Sbjct: 194 LAMDEGQYDGKVDVWSLGITCIELAERKPPL 224
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 5e-14
Identities = 67/260 (25%), Positives = 121/260 (46%), Gaps = 36/260 (13%)
Query: 355 FKESEVIGIGGFGSVYKGVLP---TTGGEVAVK--KITRNSLQGMREFAAEIESLGRLRH 409
K +++G G FGSV +G L + +VAVK K+ ++ + EF +E + H
Sbjct: 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDH 60
Query: 410 KNLVNLHGWCKQKNDL------LLVYEYIPNGSLDTLLFKPKDGSV---LDWEQRFNIVK 460
N++ L G C + + L +++ ++ +G L + L + G + L + +
Sbjct: 61 PNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMV 120
Query: 461 GIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLAR------LYDHG---GM 511
IA G+ YL + IHRD+ N ++ +M + DFGL++ Y G M
Sbjct: 121 DIALGMEYLSN---RNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKM 177
Query: 512 PHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVAT-GRRPI-GSGDLLLVEWVR 569
P +IA E ++ SDV+A+G+ + E+AT G+ P G + + +++R
Sbjct: 178 P--------VKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLR 229
Query: 570 ECHQLGRILDVADPLLNSSY 589
++L + D D L + Y
Sbjct: 230 HGNRLKQPEDCLDELYDLMY 249
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 5e-14
Identities = 65/204 (31%), Positives = 94/204 (46%), Gaps = 22/204 (10%)
Query: 361 IGIGGFGSVYKGVLPTTGGEVAVKKIT---RNSLQGMREFAAEIESLGRLRHKNLVNLHG 417
IG G FG+VY T VA+KK++ + S + ++ E+ L +LRH N + G
Sbjct: 23 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKG 82
Query: 418 WCKQKNDLLLVYEYIPNGSLDTL--LFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQ 475
+++ LV EY + D L KP L + I G GL YLH
Sbjct: 83 CYLREHTAWLVMEYCLGSASDILEVHKKP-----LQEVEIAAICHGALQGLAYLHS---H 134
Query: 476 VVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPEL---TQTG 532
IHRD+K N L+ +L DFG A L P + VGT ++APE+ G
Sbjct: 135 ERIHRDIKAGNILLTEPGTVKLADFGSASLVS----PANS-FVGTPYWMAPEVILAMDEG 189
Query: 533 KASTSSDVFAYGILLLEVATGRRP 556
+ DV++ GI +E+A R+P
Sbjct: 190 QYDGKVDVWSLGITCIELAE-RKP 212
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 7e-14
Identities = 55/197 (27%), Positives = 90/197 (45%), Gaps = 10/197 (5%)
Query: 358 SEVIGIGGFGSVYKGVLPTTGGE---VAVKKITRNSLQGMRE-FAAEIESLGRLRHKNLV 413
IG G FG VY+GV + E VAVK + +RE F E + + H ++V
Sbjct: 11 GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIV 70
Query: 414 NLHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEW 473
L G + N + +V E P G L + L K LD +++ L YL
Sbjct: 71 KLIGVITE-NPVWIVMELAPLGELRSYLQVNKYS--LDLASLILYSYQLSTALAYLES-- 125
Query: 474 EQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPELTQTGK 533
+ +HRD+ N L+ + +LGDFGL+R + + ++APE +
Sbjct: 126 -KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRR 184
Query: 534 ASTSSDVFAYGILLLEV 550
+++SDV+ +G+ + E+
Sbjct: 185 FTSASDVWMFGVCMWEI 201
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 72.8 bits (179), Expect = 7e-14
Identities = 71/237 (29%), Positives = 110/237 (46%), Gaps = 36/237 (15%)
Query: 361 IGIGGFGSV----YKGVLPTTGGEVAVKKITR---NSLQGMREFAAEIESLGRLR-HKNL 412
+G G +G V VA+KKIT + R E++ L R HKN+
Sbjct: 8 LGQGAYGIVCSARNAETSEEET--VAIKKITNVFSKKILAKRALR-ELKLLRHFRGHKNI 64
Query: 413 VNLHG----WCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVL-DWEQRFNIVKGIASGLL 467
L+ + N+L L YE + L ++ + G L D + I + I GL
Sbjct: 65 TCLYDMDIVFPGNFNELYL-YEELMEADLHQII---RSGQPLTDAHFQSFIYQ-ILCGLK 119
Query: 468 YLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHG---GMPHTTNVVGTFGYI 524
Y+H V+HRD+KP N L++A+ ++ DFGLAR + T V T Y
Sbjct: 120 YIHS---ANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYR 176
Query: 525 APELTQTGKASTSS-DVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDV 580
APE+ + ++ T + DV++ G +L E+ GR+P+ G ++V QL +IL V
Sbjct: 177 APEIMLSFQSYTKAIDVWSVGCILAEL-LGRKPVFKGK----DYV---DQLNQILQV 225
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 7e-14
Identities = 60/220 (27%), Positives = 99/220 (45%), Gaps = 34/220 (15%)
Query: 360 VIGIGGFGSVYKGVLPTTGGE-----VAVKKITRN-SLQGMREFAAEIESLGRLRHKNLV 413
+G G FG VY+G+ G+ VAVK + + S Q +F E + + H+N+V
Sbjct: 13 ALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIV 72
Query: 414 NLHGWCKQKNDLLLVYEYIPNGSLDTLLF----KPKDGSVLDWEQRFNIVKGIASGLLYL 469
L G ++ ++ E + G L + L +P+ S L + + +A G YL
Sbjct: 73 RLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYL 132
Query: 470 HEEWEQVVIHRDVKPSNALID---AEMNARLGDFGLAR------LYDHGG---MPHTTNV 517
E IHRD+ N L+ A++ DFG+AR Y GG +P
Sbjct: 133 EENH---FIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLP----- 184
Query: 518 VGTFGYIAPELTQTGKASTSSDVFAYGILLLEV-ATGRRP 556
++ PE G ++ +DV+++G+LL E+ + G P
Sbjct: 185 ---IKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMP 221
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 8e-14
Identities = 59/207 (28%), Positives = 98/207 (47%), Gaps = 11/207 (5%)
Query: 359 EVIGIGGFGSVYKGVLPTTGGEVAVKKITRNS--LQGMREFAAEIESLGRLRHKN--LVN 414
+V+G G FG V L G AVK + ++ + E + + L +N L +
Sbjct: 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTH 60
Query: 415 LHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWE 474
L+ + K L V E++ G L+F +D D + I GL +LH +
Sbjct: 61 LYCTFQTKEHLFFVMEFLNGGD---LMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKG- 116
Query: 475 QVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPELTQTGKA 534
+I+RD+K N ++D + + ++ DFG+ + G +T GT YIAPE+ Q K
Sbjct: 117 --IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAST-FCGTPDYIAPEILQGLKY 173
Query: 535 STSSDVFAYGILLLEVATGRRPIGSGD 561
+ S D +++G+LL E+ G+ P D
Sbjct: 174 TFSVDWWSFGVLLYEMLIGQSPFHGDD 200
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.1 bits (180), Expect = 8e-14
Identities = 74/239 (30%), Positives = 98/239 (41%), Gaps = 43/239 (17%)
Query: 360 VIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMRE----FAAEIESLGRLRHKNLVNL 415
VIG G FG V+ TG A+K + R S R AE + L +V L
Sbjct: 8 VIGRGAFGEVWLVRDKDTGQVYAMKVL-RKSDMIKRNQIAHVRAERDILADADSPWIVKL 66
Query: 416 HGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQ-RFNIVKGIASGLLYLHEEWE 474
+ + + L LV EY+P G L LL + KD V E RF I A +L L +
Sbjct: 67 YYSFQDEEHLYLVMEYMPGGDLMNLLIR-KD--VFPEETARFYI----AELVLALDSVHK 119
Query: 475 QVVIHRDVKPSNALIDAEMNARLGDFGLA------------------RLYDHGGMPHTTN 516
IHRD+KP N LIDA+ + +L DFGL L+ + +
Sbjct: 120 LGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRD 179
Query: 517 ----------VVGTFGYIAPE-LTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLL 564
VGT YIAPE L T D ++ G++L E+ G P S L
Sbjct: 180 HKQRRVRANSTVGTPDYIAPEVLRGTP-YGLECDWWSLGVILYEMLYGFPPFYSDTLQE 237
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 9e-14
Identities = 54/197 (27%), Positives = 98/197 (49%), Gaps = 10/197 (5%)
Query: 361 IGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNLHGWCK 420
IG G G V +TG +VAVKK+ Q E+ + +H N+V ++
Sbjct: 27 IGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYL 86
Query: 421 QKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHR 480
++L +V E++ G+L ++ + ++ EQ + + L +LH Q VIHR
Sbjct: 87 VGDELWVVMEFLEGGALTDIVTHTR----MNEEQIATVCLAVLKALSFLHA---QGVIHR 139
Query: 481 DVKPSNALIDAEMNARLGDFGL-ARLYDHGGMPHTTNVVGTFGYIAPELTQTGKASTSSD 539
D+K + L+ ++ +L DFG A++ +P ++VGT ++APE+ T D
Sbjct: 140 DIKSDSILLTSDGRVKLSDFGFCAQVSKE--VPRRKSLVGTPYWMAPEVISRLPYGTEVD 197
Query: 540 VFAYGILLLEVATGRRP 556
+++ GI+++E+ G P
Sbjct: 198 IWSLGIMVIEMVDGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 9e-14
Identities = 65/210 (30%), Positives = 98/210 (46%), Gaps = 19/210 (9%)
Query: 360 VIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIES-----LGRLRHKNLVN 414
VIG G FG V G AVK + + ++ +E I + L ++H LV
Sbjct: 2 VIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKE-QKHIMAERNVLLKNVKHPFLVG 60
Query: 415 LHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWE 474
LH + + L V +Y+ G L L + + S + RF + IAS L YLH
Sbjct: 61 LHYSFQTADKLYFVLDYVNGGELFFHLQRER--SFPEPRARFYAAE-IASALGYLHS--- 114
Query: 475 QVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPH---TTNVVGTFGYIAPELTQT 531
+I+RD+KP N L+D++ + L DFGL + G+ H T+ GT Y+APE+ +
Sbjct: 115 LNIIYRDLKPENILLDSQGHVVLTDFGLCK----EGIEHSKTTSTFCGTPEYLAPEVLRK 170
Query: 532 GKASTSSDVFAYGILLLEVATGRRPIGSGD 561
+ D + G +L E+ G P S D
Sbjct: 171 QPYDRTVDWWCLGAVLYEMLYGLPPFYSRD 200
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 1e-13
Identities = 61/203 (30%), Positives = 92/203 (45%), Gaps = 17/203 (8%)
Query: 361 IGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQ---GMREFAAEIESLGRLRHKNLVNLHG 417
IG G FG+VY T VAVKK++ + Q ++ E++ L +L+H N + G
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 418 WCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVV 477
+++ LV EY + D L K L + I G GL YLH +
Sbjct: 89 CYLKEHTAWLVMEYCLGSASDLLEVHKKP---LQEVEIAAITHGALQGLAYLHS---HNM 142
Query: 478 IHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPEL---TQTGKA 534
IHRD+K N L+ +L DFG A + VGT ++APE+ G+
Sbjct: 143 IHRDIKAGNILLTEPGQVKLADFGSASK-----SSPANSFVGTPYWMAPEVILAMDEGQY 197
Query: 535 STSSDVFAYGILLLEVATGRRPI 557
DV++ GI +E+A + P+
Sbjct: 198 DGKVDVWSLGITCIELAERKPPL 220
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 1e-13
Identities = 65/229 (28%), Positives = 105/229 (45%), Gaps = 20/229 (8%)
Query: 360 VIGIGGFGSVYKGVLPTTGGEVAVKKI--TRNSLQGMREFAAEIESLGRLRHKNLVNLHG 417
V+G G +G V K T VA+KK + + + E++ L L+ +N+V L
Sbjct: 8 VVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKE 67
Query: 418 WCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQR--FNIVKGIASGLLYLHEEWEQ 475
+++ L LV+EY+ L+ L P +G + + + ++K I H +
Sbjct: 68 AFRRRGKLYLVFEYVEKNMLELLEEMP-NGVPPEKVRSYIYQLIKAI-------HWCHKN 119
Query: 476 VVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPELTQTGKAS 535
++HRD+KP N LI +L DFG AR G + T V T Y +PEL
Sbjct: 120 DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYG 179
Query: 536 TSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPL 584
+ D+++ G +L E++ G +P+ G+ E QL I V PL
Sbjct: 180 KAVDMWSVGCILGELSDG-QPLFPGE-------SEIDQLFTIQKVLGPL 220
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 1e-13
Identities = 64/208 (30%), Positives = 102/208 (49%), Gaps = 24/208 (11%)
Query: 360 VIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNLHGWC 419
+IG GGFG VY TG A+K + + ++ M++ E +L +LV+ G C
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIK-MKQ--GETLALNERIMLSLVST-GDC 56
Query: 420 ----------KQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYL 469
+ L + + + G L L + G + E RF + I GL ++
Sbjct: 57 PFIVCMTYAFHTPDKLCFILDLMNGGDLHYHL--SQHGVFSEKEMRFYATE-IILGLEHM 113
Query: 470 HEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPELT 529
H + V++RD+KP+N L+D + R+ D GLA + PH + VGT GY+APE+
Sbjct: 114 HNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSK-KKPHAS--VGTHGYMAPEVL 167
Query: 530 QTGKA-STSSDVFAYGILLLEVATGRRP 556
Q G A +S+D F+ G +L ++ G P
Sbjct: 168 QKGTAYDSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 1e-13
Identities = 72/237 (30%), Positives = 111/237 (46%), Gaps = 26/237 (10%)
Query: 355 FKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITR--NSLQGMREFAAEIESLGRLRHKNL 412
+K EVIG G +G V + TG +VA+KKI + EI+ L LRH ++
Sbjct: 2 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDI 61
Query: 413 VN-----LHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLL 467
V L ++ D+ +V+E + L ++ K D + Q F + + L
Sbjct: 62 VEIKHIMLPPSRREFKDIYVVFELM-ESDLHQVI-KANDDLTPEHHQFF--LYQLLRALK 117
Query: 468 YLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLAR--LYDHGGMPHTTNVVGTFGYIA 525
Y+H V HRD+KP N L +A+ ++ DFGLAR D T+ V T Y A
Sbjct: 118 YIHT---ANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRA 174
Query: 526 PELTQT--GKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDV 580
PEL + K + + D+++ G + EV TG +P+ G ++ HQL I D+
Sbjct: 175 PELCGSFFSKYTPAIDIWSIGCIFAEVLTG-KPLFPGKNVV-------HQLDLITDL 223
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 1e-13
Identities = 52/196 (26%), Positives = 94/196 (47%), Gaps = 8/196 (4%)
Query: 361 IGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNLHGWCK 420
IG G G V +G +VAVK + Q E+ + +H+N+V ++
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYL 88
Query: 421 QKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHR 480
+L ++ E++ G+L ++ + + L+ EQ + + + L YLH Q VIHR
Sbjct: 89 VGEELWVLMEFLQGGALTDIVSQTR----LNEEQIATVCESVLQALCYLHS---QGVIHR 141
Query: 481 DVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPELTQTGKASTSSDV 540
D+K + L+ + +L DFG +P ++VGT ++APE+ T D+
Sbjct: 142 DIKSDSILLTLDGRVKLSDFGFCAQISKD-VPKRKSLVGTPYWMAPEVISRTPYGTEVDI 200
Query: 541 FAYGILLLEVATGRRP 556
++ GI+++E+ G P
Sbjct: 201 WSLGIMVIEMVDGEPP 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 2e-13
Identities = 52/207 (25%), Positives = 101/207 (48%), Gaps = 13/207 (6%)
Query: 361 IGIGGFGSVYKGVL---PTTGGEVAVKKI--TRNSLQGMREFAAEIESLGRLRHKNLVNL 415
IG G FG K +L G + +K+I ++ S + E E+ L ++H N+V
Sbjct: 8 IGEGSFG---KAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQY 64
Query: 416 HGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQ 475
++ +L +V +Y G L + + G + +Q + I L ++H+ +
Sbjct: 65 QESFEENGNLYIVMDYCEGGDLYKKINAQR-GVLFPEDQILDWFVQICLALKHVHD---R 120
Query: 476 VVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPELTQTGKAS 535
++HRD+K N + + +LGDFG+AR+ + + +GT Y++PE+ + +
Sbjct: 121 KILHRDIKSQNIFLTKDGTIKLGDFGIARVL-NSTVELARTCIGTPYYLSPEICENRPYN 179
Query: 536 TSSDVFAYGILLLEVATGRRPIGSGDL 562
SD++A G +L E+ T + +G++
Sbjct: 180 NKSDIWALGCVLYEMCTLKHAFEAGNM 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 2e-13
Identities = 58/204 (28%), Positives = 92/204 (45%), Gaps = 22/204 (10%)
Query: 360 VIGIGGFGSVYKGVLPTTGGE-----VAVKKITRNSLQGMRE-FAAEIESLGRL-RHKNL 412
+G G FG V + VAVK + + RE +E++ + L H+N+
Sbjct: 42 TLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENI 101
Query: 413 VNLHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEE 472
VNL G C +L++ EY G L L + ++ S L E + +A G+ +L
Sbjct: 102 VNLLGACTIGGPILVITEYCCYGDLLNFLRRKRE-SFLTLEDLLSFSYQVAKGMAFLAS- 159
Query: 473 WEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVV---GTF---GYIAP 526
+ IHRD+ N L+ ++ DFGLAR + + +N V ++AP
Sbjct: 160 --KNCIHRDLAARNVLLTHGKIVKICDFGLAR-----DIMNDSNYVVKGNARLPVKWMAP 212
Query: 527 ELTQTGKASTSSDVFAYGILLLEV 550
E + SDV++YGILL E+
Sbjct: 213 ESIFNCVYTFESDVWSYGILLWEI 236
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 71.3 bits (174), Expect = 2e-13
Identities = 56/204 (27%), Positives = 94/204 (46%), Gaps = 8/204 (3%)
Query: 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNL 412
K + E IG G G+VY + TG EVA+K++ EI + ++ N+
Sbjct: 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNI 78
Query: 413 VNLHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEE 472
VN ++L +V EY+ GSL ++ + + +D Q + + L +LH
Sbjct: 79 VNYLDSYLVGDELWVVMEYLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALDFLHS- 133
Query: 473 WEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPELTQTG 532
VIHRD+K N L+ + + +L DFG +T +VGT ++APE+
Sbjct: 134 --NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST-MVGTPYWMAPEVVTRK 190
Query: 533 KASTSSDVFAYGILLLEVATGRRP 556
D+++ GI+ +E+ G P
Sbjct: 191 AYGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 2e-13
Identities = 52/188 (27%), Positives = 89/188 (47%), Gaps = 21/188 (11%)
Query: 381 VAVKKITRNSLQGMR-EFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEYIPNGSLDT 439
VAVK + ++ + R +F E++ L RL+ N++ L G C ++ L ++ EY+ NG L+
Sbjct: 49 VAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQ 108
Query: 440 LL--------------FKPKDGS--VLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVK 483
L P + + ++ IASG+ YL +HRD+
Sbjct: 109 FLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLS---SLNFVHRDLA 165
Query: 484 PSNALIDAEMNARLGDFGLAR-LYDHGGMPHTTNVVGTFGYIAPELTQTGKASTSSDVFA 542
N L+ + ++ DFG++R LY V ++A E GK +T+SDV+A
Sbjct: 166 TRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWA 225
Query: 543 YGILLLEV 550
+G+ L E+
Sbjct: 226 FGVTLWEI 233
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 2e-13
Identities = 58/205 (28%), Positives = 94/205 (45%), Gaps = 9/205 (4%)
Query: 355 FKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAA---EIESLGRLRHKN 411
F+ V+G GGFG V + TG A KK+ + ++ + A E L ++ +
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF 61
Query: 412 LVNLHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHE 471
+V+L + K+ L LV + G L ++ + D ++ + GL L
Sbjct: 62 VVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGN-PGFDEQRAIFYAAELCCGLEDLQR 120
Query: 472 EWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPELTQT 531
E +++RD+KP N L+D + R+ D GLA G VGT GY+APE+
Sbjct: 121 E---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG--ETVRGRVGTVGYMAPEVINN 175
Query: 532 GKASTSSDVFAYGILLLEVATGRRP 556
K + S D + G L+ E+ G+ P
Sbjct: 176 EKYTFSPDWWGLGCLIYEMIQGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 3e-13
Identities = 59/206 (28%), Positives = 106/206 (51%), Gaps = 18/206 (8%)
Query: 359 EVIGIGGFGSVY--KGVLPTTGGEVAVKKITRNSLQGMRE---FAAEIESLGRLRHKNLV 413
+V+G G FG V+ + + G++ K+ + + +R+ E + L + H +V
Sbjct: 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIV 61
Query: 414 NLHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQ--RFNIVKGIASGLLYLHE 471
LH + + L L+ +++ G L T L K V+ E+ +F + + +A L +LH
Sbjct: 62 KLHYAFQTEGKLYLILDFLRGGDLFTRLSK----EVMFTEEDVKFYLAE-LALALDHLHS 116
Query: 472 EWEQVVIHRDVKPSNALIDAEMNARLGDFGLAR-LYDHGGMPHTTNVVGTFGYIAPELTQ 530
+I+RD+KP N L+D E + +L DFGL++ DH + GT Y+APE+
Sbjct: 117 ---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE--KKAYSFCGTVEYMAPEVVN 171
Query: 531 TGKASTSSDVFAYGILLLEVATGRRP 556
+ S+D +++G+L+ E+ TG P
Sbjct: 172 RRGHTQSADWWSFGVLMFEMLTGSLP 197
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 3e-13
Identities = 52/196 (26%), Positives = 93/196 (47%), Gaps = 8/196 (4%)
Query: 361 IGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNLHGWCK 420
IG G G V + ++G VAVKK+ Q E+ + +H+N+V ++
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 421 QKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHR 480
++L +V E++ G+L ++ + ++ EQ + + L LH Q VIHR
Sbjct: 88 VGDELWVVMEFLEGGALTDIVTHTR----MNEEQIAAVCLAVLKALSVLH---AQGVIHR 140
Query: 481 DVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPELTQTGKASTSSDV 540
D+K + L+ + +L DFG +P ++VGT ++APEL D+
Sbjct: 141 DIKSDSILLTHDGRVKLSDFGFCAQVSK-EVPRRKSLVGTPYWMAPELISRLPYGPEVDI 199
Query: 541 FAYGILLLEVATGRRP 556
++ GI+++E+ G P
Sbjct: 200 WSLGIMVIEMVDGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 70.9 bits (173), Expect = 4e-13
Identities = 52/158 (32%), Positives = 81/158 (51%), Gaps = 14/158 (8%)
Query: 409 HKNLVNLHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLY 468
H LV LH + ++ L V EY+ G D + + + + RF + I+ L Y
Sbjct: 55 HPFLVGLHSCFQTESRLFFVIEYVNGG--DLMFHMQRQRKLPEEHARFYSAE-ISLALNY 111
Query: 469 LHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMP--HTTNVVGTFGYIAP 526
LHE + +I+RD+K N L+D+E + +L D+G+ + G P T+ GT YIAP
Sbjct: 112 LHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCK---EGLRPGDTTSTFCGTPNYIAP 165
Query: 527 ELTQTGKASTSSDVFAYGILLLEVATGRRP---IGSGD 561
E+ + S D +A G+L+ E+ GR P +GS D
Sbjct: 166 EILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSD 203
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 4e-13
Identities = 58/205 (28%), Positives = 100/205 (48%), Gaps = 18/205 (8%)
Query: 361 IGIGGFGSVYKGV--LPTTGGEVAVKKITRNSLQGMR-EFAAEIESLGRLRHKNLVNLHG 417
+G G FG V KGV + +VA+K + + + +R E E E + +L + +V + G
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62
Query: 418 WCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVK---GIASGLLYLHEEWE 474
C+ + L+LV E G L+ L KD + N+V+ ++ G+ YL
Sbjct: 63 VCEAEA-LMLVMEMASGGPLNKFLSGKKDEITVS-----NVVELMHQVSMGMKYLEG--- 113
Query: 475 QVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTF--GYIAPELTQTG 532
+ +HRD+ N L+ + A++ DFGL++ + G + + APE
Sbjct: 114 KNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFR 173
Query: 533 KASTSSDVFAYGILLLEV-ATGRRP 556
K S+ SDV++YGI + E + G++P
Sbjct: 174 KFSSRSDVWSYGITMWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 4e-13
Identities = 60/205 (29%), Positives = 97/205 (47%), Gaps = 9/205 (4%)
Query: 355 FKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAA---EIESLGRLRHKN 411
F+ V+G GGFG V + TG A KK+ + ++ + A E + L ++ +
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 61
Query: 412 LVNLHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHE 471
+V+L + K+ L LV + G L ++ + D E+ I GL LH
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPG-FDEERAVFYAAEITCGLEDLHR 120
Query: 472 EWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPELTQT 531
E +++RD+KP N L+D + R+ D GLA G VGT GY+APE+ +
Sbjct: 121 E---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET--IRGRVGTVGYMAPEVVKN 175
Query: 532 GKASTSSDVFAYGILLLEVATGRRP 556
+ + S D + G L+ E+ G+ P
Sbjct: 176 ERYTFSPDWWGLGCLIYEMIEGKSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 70.5 bits (172), Expect = 5e-13
Identities = 62/218 (28%), Positives = 107/218 (49%), Gaps = 21/218 (9%)
Query: 346 KDLYAATKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITR--NSLQGMREFAAEIES 403
K ++ + ++ +G G +GSV TG VAVKK++R S+ + E+
Sbjct: 10 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 69
Query: 404 LGRLRHKNLVNL------HGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFN 457
L ++H+N++ L ++ ND+ LV ++ L+ ++ K + D +F
Sbjct: 70 LKHMKHENVIGLLDVFTPARSLEEFNDVYLV-THLMGADLNNIV---KCQKLTDDHVQFL 125
Query: 458 IVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNV 517
I + I GL Y+H +IHRD+KPSN ++ + ++ DFGLAR D T
Sbjct: 126 IYQ-ILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD----EMTGY 177
Query: 518 VGTFGYIAPELTQTG-KASTSSDVFAYGILLLEVATGR 554
V T Y APE+ + + D+++ G ++ E+ TGR
Sbjct: 178 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 5e-13
Identities = 63/210 (30%), Positives = 97/210 (46%), Gaps = 15/210 (7%)
Query: 359 EVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMRE----FAAEIESLGRLRHKNLVN 414
+VIG G FG V + G AVK + + ++ +E A L L+H LV
Sbjct: 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60
Query: 415 LHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWE 474
LH + L V +Y+ G L ++ L+ RF + +AS + YLH
Sbjct: 61 LHYSFQTAEKLYFVLDYVNGGEL--FFHLQRERCFLEPRARFYAAE-VASAIGYLHS--- 114
Query: 475 QVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPH--TTNVVGTFGYIAPELTQTG 532
+I+RD+KP N L+D++ + L DFGL + G P T+ GT Y+APE+ +
Sbjct: 115 LNIIYRDLKPENILLDSQGHVVLTDFGLCK---EGVEPEETTSTFCGTPEYLAPEVLRKE 171
Query: 533 KASTSSDVFAYGILLLEVATGRRPIGSGDL 562
+ D + G +L E+ G P S D+
Sbjct: 172 PYDRTVDWWCLGAVLYEMLYGLPPFYSRDV 201
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 69.8 bits (170), Expect = 6e-13
Identities = 55/205 (26%), Positives = 96/205 (46%), Gaps = 10/205 (4%)
Query: 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNL 412
K + E IG G G+VY + TG EVA++++ EI + ++ N+
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNI 79
Query: 413 VNLHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEE 472
VN ++L +V EY+ GSL ++ + + +D Q + + L +LH
Sbjct: 80 VNYLDSYLVGDELWVVMEYLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHS- 134
Query: 473 WEQVVIHRDVKPSNALIDAEMNARLGDFGL-ARLYDHGGMPHTTNVVGTFGYIAPELTQT 531
VIHRD+K N L+ + + +L DFG A++ + +VGT ++APE+
Sbjct: 135 --NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE--QSKRSTMVGTPYWMAPEVVTR 190
Query: 532 GKASTSSDVFAYGILLLEVATGRRP 556
D+++ GI+ +E+ G P
Sbjct: 191 KAYGPKVDIWSLGIMAIEMIEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 6e-13
Identities = 64/207 (30%), Positives = 104/207 (50%), Gaps = 20/207 (9%)
Query: 360 VIGIGGFGSVYKGVLPTTGGE----VAVK-----KITRNSLQGMREFAAEIESLGRLRHK 410
V+G GG+G V++ V TG + A+K I RN + AE L ++H
Sbjct: 3 VLGKGGYGKVFQ-VRKVTGADTGKIFAMKVLKKATIVRNQ-KDTAHTKAERNILEAVKHP 60
Query: 411 NLVNLHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLH 470
+V+L + L L+ EY+ G L L ++G ++ F + + I+ L +LH
Sbjct: 61 FIVDLIYAFQTGGKLYLILEYLSGGELFMHL--EREGIFMEDTACFYLSE-ISLALEHLH 117
Query: 471 EEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGG-MPHTTNVVGTFGYIAPELT 529
+ Q +I+RD+KP N L+DA+ + +L DFGL + H G + HT GT Y+APE+
Sbjct: 118 Q---QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHT--FCGTIEYMAPEIL 172
Query: 530 QTGKASTSSDVFAYGILLLEVATGRRP 556
+ D ++ G L+ ++ TG P
Sbjct: 173 MRSGHGKAVDWWSLGALMYDMLTGAPP 199
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 6e-13
Identities = 67/251 (26%), Positives = 119/251 (47%), Gaps = 35/251 (13%)
Query: 325 KWSNSETLEDWEKDCPHRFRYKDLYAATKGFKESEVIGIGGFGSVYKGVLPTTGGE---- 380
K +S++ ++ ++ ++ +Y+D F +G G FG V +L T E
Sbjct: 11 KKKDSDSTKEPKRK--NKMKYED-------FNFIRTLGTGSFGRV---ILATYKNEDFPP 58
Query: 381 VAVKKITRNSLQGMREFA---AEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEYIPNGSL 437
VA+K+ ++ + ++ +E + L + H VNL+G K ++ L LV E++ G
Sbjct: 59 VAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEF 118
Query: 438 DTLLFKPKDGSVLDWEQRF-NIVKGIASGLLYLHEEWEQV--VIHRDVKPSNALIDAEMN 494
T L + K RF N V + + L E+ Q +++RD+KP N L+D +
Sbjct: 119 FTFLRRNK---------RFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGF 169
Query: 495 ARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGR 554
++ DFG A++ D T + GT YIAPE+ ++D + GI + E+ G
Sbjct: 170 IKMTDFGFAKVVD----TRTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGC 225
Query: 555 RPIGSGDLLLV 565
P + + LL+
Sbjct: 226 PPFYANEPLLI 236
|
Length = 340 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 7e-13
Identities = 64/222 (28%), Positives = 96/222 (43%), Gaps = 22/222 (9%)
Query: 346 KDLYAATKGFKESEVIGIGGFGSVYKGVLPTTGGEV-AVKKITRNSLQGMREFAAEIESL 404
L + F +VIG G FG V + V + +V A+K +++ + + A E
Sbjct: 36 TKLRMKAEDFDVIKVIGRGAFGEV-QLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEER 94
Query: 405 GRLRHKN---LVNLHGWCKQKNDLLLVYEYIPNGSLDTLLFK---PKDGSVLDWEQRFNI 458
+ H N +V LH + L +V EY+P G L L+ P+ W + +
Sbjct: 95 DIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPE-----KWARFY-- 147
Query: 459 VKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVV 518
A +L L IHRDVKP N L+D + +L DFG D GM V
Sbjct: 148 ---TAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAV 204
Query: 519 GTFGYIAPELTQT----GKASTSSDVFAYGILLLEVATGRRP 556
GT YI+PE+ ++ G D ++ G+ L E+ G P
Sbjct: 205 GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 70.0 bits (172), Expect = 7e-13
Identities = 67/246 (27%), Positives = 107/246 (43%), Gaps = 59/246 (23%)
Query: 359 EVIGIGGFGSVYKGVLPTTGGEVAVKKITR---NSLQGMREFAAEIESLGRLRHKNLVNL 415
+G G +G V TG +VA+KK++R +++ R + E+ L + H+N++
Sbjct: 21 SPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYR-ELRLLKHMDHENVI-- 77
Query: 416 HGWCKQKNDLLLVYEYIPNGSLDTL----LFKPKDGSVL----------DWEQRFNIVKG 461
LL V+ P SL+ L G+ L D +F +V
Sbjct: 78 --------GLLDVFT--PASSLEDFQDVYLVTHLMGADLNNIVKCQKLSDDHIQF-LVYQ 126
Query: 462 IASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTF 521
I GL Y+H +IHRD+KPSN ++ + ++ DFGLAR D T V T
Sbjct: 127 ILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGLARHTDD----EMTGYVATR 179
Query: 522 GYIAPEL-------TQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQL 574
Y APE+ QT D+++ G ++ E+ TG+ D + QL
Sbjct: 180 WYRAPEIMLNWMHYNQT------VDIWSVGCIMAELLTGKTLFPGSDHI--------DQL 225
Query: 575 GRILDV 580
RI+++
Sbjct: 226 KRIMNL 231
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 1e-12
Identities = 73/281 (25%), Positives = 120/281 (42%), Gaps = 34/281 (12%)
Query: 361 IGIGGFGSVYKGVLPT--TGGEVAVKKITRN-SLQGMREFAAEIESLGRLRHKNLVNLHG 417
IG G FG V G + + T +V VK++ + S+Q +F E + L+H NL+ G
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62
Query: 418 WCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRF--NIVKGIASGLLYLHEEWEQ 475
C + LLV E+ P G L L + ++ + + IA GLL+LH +
Sbjct: 63 QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH---KN 119
Query: 476 VVIHRDVKPSNALIDAEMNARLGDFGLARL-YDHGGMPHTTNVVGTFGYIAPELTQ---- 530
IH D+ N L+ A++ ++GD+GL+ Y + +IAPEL
Sbjct: 120 NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHG 179
Query: 531 ---TGKASTSSDVFAYGIL---LLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPL 584
+ S+V++ G+ L E+ + S + +L VRE + L + P
Sbjct: 180 NLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVRE-----QQLKLPKPR 234
Query: 585 LN---SSYVVKEMELVLKLGLMCSHKTQFRPTMRQVMRYLS 622
L S + M+ C + + RP+ +V LS
Sbjct: 235 LKLPLSDRWYEVMQF-------CWLQPEQRPSAEEVHLLLS 268
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 1e-12
Identities = 62/210 (29%), Positives = 96/210 (45%), Gaps = 13/210 (6%)
Query: 355 FKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKN--- 411
F+ +VIG G FG V + TG A+K + + + E A E L + +
Sbjct: 3 FEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRW 62
Query: 412 LVNLHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHE 471
+ NLH + +N+L LV +Y G L TLL K +D D + + +A +L +
Sbjct: 63 ITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFY-----LAEMVLAIDS 117
Query: 472 EWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPELTQ- 530
+ +HRD+KP N L+D + RL DFG G + VGT YI+PE+ Q
Sbjct: 118 VHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQA 177
Query: 531 ----TGKASTSSDVFAYGILLLEVATGRRP 556
G+ D ++ G+ + E+ G P
Sbjct: 178 MEDGKGRYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 1e-12
Identities = 52/202 (25%), Positives = 90/202 (44%), Gaps = 6/202 (2%)
Query: 360 VIGIGGFGSVYKGVLPTTGGEVAVKKIT-RNSLQGMREFAAEIESLGRLRHKNLVNLHGW 418
V+G G FG + + A+K+I S + + E L +++H N+V
Sbjct: 7 VVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKES 66
Query: 419 CKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVI 478
+ L +V EY G L + K + G + + + G+ ++HE + V+
Sbjct: 67 FEADGHLYIVMEYCDGGDLMQKI-KLQRGKLFPEDTILQWFVQMCLGVQHIHE---KRVL 122
Query: 479 HRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPELTQTGKASTSS 538
HRD+K N + +LGDFG ARL + VGT Y+ PE+ + + S
Sbjct: 123 HRDIKSKNIFLTQNGKVKLGDFGSARLLTS-PGAYACTYVGTPYYVPPEIWENMPYNNKS 181
Query: 539 DVFAYGILLLEVATGRRPIGSG 560
D+++ G +L E+ T + P +
Sbjct: 182 DIWSLGCILYELCTLKHPFQAN 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 1e-12
Identities = 61/217 (28%), Positives = 98/217 (45%), Gaps = 13/217 (5%)
Query: 355 FKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMRE---FAAEIESLGRLRHKN 411
F+ +VIG G FG V L A+K + + + E F E + L ++
Sbjct: 3 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQW 62
Query: 412 LVNLHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHE 471
+ LH + +N+L LV +Y G L TLL K +D D + + +A ++ +
Sbjct: 63 ITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFY-----LAEMVIAIDS 117
Query: 472 EWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPELTQT 531
+ +HRD+KP N L+D + RL DFG G ++ VGT YI+PE+ Q
Sbjct: 118 VHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQA 177
Query: 532 -----GKASTSSDVFAYGILLLEVATGRRPIGSGDLL 563
GK D ++ G+ + E+ G P + L+
Sbjct: 178 MEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLV 214
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-12
Identities = 60/221 (27%), Positives = 97/221 (43%), Gaps = 31/221 (14%)
Query: 360 VIGIGGFGSVYKGVLPTTGG-----EVAVKKITRNSLQG-MREFAAEIESLGRLRHKNLV 413
+G G FG V K G VAVK + N+ +R+ +E L ++ H +++
Sbjct: 7 TLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVI 66
Query: 414 NLHGWCKQKNDLLLVYEYIPNGSLDTLL-------------FKPKDGSVLDWEQRFNIVK 460
L+G C Q LLL+ EY GSL + L ++ S LD +
Sbjct: 67 KLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTM 126
Query: 461 G--------IASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLAR-LYDHGGM 511
G I+ G+ YL E ++HRD+ N L+ ++ DFGL+R +Y+
Sbjct: 127 GDLISFAWQISRGMQYLA---EMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSY 183
Query: 512 PHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVAT 552
+ ++A E +T SDV+++G+LL E+ T
Sbjct: 184 VKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 2e-12
Identities = 64/221 (28%), Positives = 98/221 (44%), Gaps = 31/221 (14%)
Query: 355 FKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESL---------- 404
F+ V+G G FG V TG A+K + + + R+ E+ESL
Sbjct: 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIA-RD---EVESLMCEKRIFETA 56
Query: 405 GRLRHKNLVNLHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIAS 464
RH LVNL + ++ + V EY G D ++ D V + +
Sbjct: 57 NSERHPFLVNLFACFQTEDHVCFVMEYAAGG--DLMMHIHTD--VFSEPRAVFYAACVVL 112
Query: 465 GLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPH---TTNVVGTF 521
GL YLHE +++RD+K N L+D E ++ DFGL + GM T+ GT
Sbjct: 113 GLQYLHE---NKIVYRDLKLDNLLLDTEGFVKIADFGLCK----EGMGFGDRTSTFCGTP 165
Query: 522 GYIAPELTQTGKASTSS-DVFAYGILLLEVATGRRPIGSGD 561
++APE+ T + T + D + G+L+ E+ G P GD
Sbjct: 166 EFLAPEVL-TETSYTRAVDWWGLGVLIYEMLVGESPF-PGD 204
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 2e-12
Identities = 64/208 (30%), Positives = 102/208 (49%), Gaps = 24/208 (11%)
Query: 360 VIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNLHGWC 419
+IG GGFG VY TG A+K + + ++ M++ E +L +LV+ G C
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIK-MKQ--GETLALNERIMLSLVST-GDC 56
Query: 420 ----------KQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYL 469
+ L + + + G L L + G + E RF + I GL ++
Sbjct: 57 PFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL--SQHGVFSEAEMRFYAAE-IILGLEHM 113
Query: 470 HEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPELT 529
H + V++RD+KP+N L+D + R+ D GLA + PH + VGT GY+APE+
Sbjct: 114 HNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSK-KKPHAS--VGTHGYMAPEVL 167
Query: 530 QTGKA-STSSDVFAYGILLLEVATGRRP 556
Q G A +S+D F+ G +L ++ G P
Sbjct: 168 QKGVAYDSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 2e-12
Identities = 51/182 (28%), Positives = 88/182 (48%), Gaps = 13/182 (7%)
Query: 381 VAVKKITRNSLQGMR-EFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEYIPNGSLDT 439
VAVK + ++ + R +F EI+ + RL+ N++ L C + L ++ EY+ NG L+
Sbjct: 49 VAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQ 108
Query: 440 LLFKPK--------DGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDA 491
L + + D + + + IASG+ YL +HRD+ N L+
Sbjct: 109 FLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLS---SLNFVHRDLATRNCLVGK 165
Query: 492 EMNARLGDFGLAR-LYDHGGMPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEV 550
++ DFG++R LY V +++ E GK +T+SDV+A+G+ L E+
Sbjct: 166 NYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEI 225
Query: 551 AT 552
T
Sbjct: 226 LT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-12
Identities = 45/150 (30%), Positives = 72/150 (48%), Gaps = 7/150 (4%)
Query: 412 LVNLHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHE 471
L LH + + L V EY+ G L ++ + Q I+ GL +LH
Sbjct: 63 LTQLHSCFQTVDRLYFVMEYVNGGDL---MYHIQQVGKFKEPQAVFYAAEISVGLFFLHR 119
Query: 472 EWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPELTQT 531
+ +I+RD+K N ++D+E + ++ DFG+ + + G+ T GT YIAPE+
Sbjct: 120 ---RGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVT-TRTFCGTPDYIAPEIIAY 175
Query: 532 GKASTSSDVFAYGILLLEVATGRRPIGSGD 561
S D +AYG+LL E+ G+ P D
Sbjct: 176 QPYGKSVDWWAYGVLLYEMLAGQPPFDGED 205
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 3e-12
Identities = 54/192 (28%), Positives = 84/192 (43%), Gaps = 24/192 (12%)
Query: 381 VAVKKITRNSLQGMR-EFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEYIPNGSLDT 439
VAVK + ++ R +F E++ L RL N+ L G C L ++ EY+ NG L+
Sbjct: 49 VAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQ 108
Query: 440 LLFK--PKDGSV------LDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDA 491
L K + + L + + IASG+ YL +HRD+ N L+
Sbjct: 109 FLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLE---SLNFVHRDLATRNCLVGK 165
Query: 492 EMNARLGDFGLAR------LYDHGGMPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGI 545
++ DFG++R Y G ++A E GK +T SDV+A+G+
Sbjct: 166 NYTIKIADFGMSRNLYSSDYYRVQG-----RAPLPIRWMAWESVLLGKFTTKSDVWAFGV 220
Query: 546 LLLEVAT-GRRP 556
L E+ T R
Sbjct: 221 TLWEILTLCREQ 232
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 3e-12
Identities = 60/215 (27%), Positives = 101/215 (46%), Gaps = 26/215 (12%)
Query: 361 IGIGGFGSVYKGVL-------PTTGGEVAVKKITRNSL-QGMREFAAEIESLGRL-RHKN 411
+G G FG V + P VAVK + N+ + + + +E+E + + +HKN
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79
Query: 412 LVNLHGWCKQKNDLLLVYEYIPNGSLDTLLFKPK--------DGSVLDWEQ-----RFNI 458
++NL G C Q+ L ++ EY G+L L + D + + EQ +
Sbjct: 80 IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139
Query: 459 VKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLAR-LYDHGGMPHTTNV 517
+A G+ YL + IHRD+ N L+ + ++ DFGLAR ++D T+N
Sbjct: 140 AYQVARGMEYLE---SRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNG 196
Query: 518 VGTFGYIAPELTQTGKASTSSDVFAYGILLLEVAT 552
++APE + SDV+++GIL+ E+ T
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 3e-12
Identities = 59/210 (28%), Positives = 99/210 (47%), Gaps = 17/210 (8%)
Query: 359 EVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQ-------GMREFAAEIESLGRLRHKN 411
+++G G FG V+ L T A+K + ++ + M E + SL H
Sbjct: 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVE--KRVLSLA-WEHPF 57
Query: 412 LVNLHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHE 471
L +L+ + K +L V EY+ G L +F + D + I GL +LH
Sbjct: 58 LTHLYCTFQTKENLFFVMEYLNGGDL---MFHIQSCHKFDLPRATFYAAEIICGLQFLHS 114
Query: 472 EWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPELTQT 531
+ +++RD+K N L+D + + ++ DFG+ + + G T GT YIAPE+
Sbjct: 115 KG---IVYRDLKLDNILLDTDGHIKIADFGMCK-ENMLGDAKTCTFCGTPDYIAPEILLG 170
Query: 532 GKASTSSDVFAYGILLLEVATGRRPIGSGD 561
K +TS D +++G+LL E+ G+ P D
Sbjct: 171 QKYNTSVDWWSFGVLLYEMLIGQSPFHGHD 200
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 3e-12
Identities = 64/230 (27%), Positives = 103/230 (44%), Gaps = 47/230 (20%)
Query: 342 RFRYKDLYAATKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITR---NSLQGMREFA 398
RY+DL +G G +G+V + TG +VA+KK+ R + L R +
Sbjct: 14 PDRYRDLKQ----------VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYR 63
Query: 399 AEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEYIPNGSLDTL----LFKPKDGSVLD--- 451
E+ L ++H+N++ L + + P+ SLD L P G+ L
Sbjct: 64 -ELRLLKHMKHENVIGL------------LDVFTPDLSLDRFHDFYLVMPFMGTDLGKLM 110
Query: 452 -----WEQRFN-IVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARL 505
E R +V + GL Y+H +IHRD+KP N ++ + ++ DFGLAR
Sbjct: 111 KHEKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQ 167
Query: 506 YDHGGMPHTTNVVGTFGYIAPELTQTGKASTSS-DVFAYGILLLEVATGR 554
D T V T Y APE+ T + D+++ G ++ E+ TG+
Sbjct: 168 TD----SEMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 5e-12
Identities = 51/151 (33%), Positives = 78/151 (51%), Gaps = 13/151 (8%)
Query: 409 HKNLVNLHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQ-RFNIVKGIASGLL 467
H LV LH + ++ L V E++ G L +F + L E RF + I+ L
Sbjct: 55 HPFLVGLHSCFQTESRLFFVIEFVSGGDL---MFHMQRQRKLPEEHARFYSAE-ISLALN 110
Query: 468 YLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMP--HTTNVVGTFGYIA 525
+LHE + +I+RD+K N L+DAE + +L D+G+ + G P T+ GT YIA
Sbjct: 111 FLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCK---EGIRPGDTTSTFCGTPNYIA 164
Query: 526 PELTQTGKASTSSDVFAYGILLLEVATGRRP 556
PE+ + S D +A G+L+ E+ GR P
Sbjct: 165 PEILRGEDYGFSVDWWALGVLMFEMMAGRSP 195
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 5e-12
Identities = 68/273 (24%), Positives = 123/273 (45%), Gaps = 39/273 (14%)
Query: 361 IGIGGFGSVYKGVL-------PTTGGEVAVKKITRN-SLQGMREFAAEIESLGRLRHKNL 412
+G G FG VY+G+ P T VA+K + S++ EF E + ++
Sbjct: 14 LGQGSFGMVYEGIAKGVVKDEPET--RVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 71
Query: 413 VNLHGWCKQKNDLLLVYEYIPNGSLDTLL--FKPKDG-----SVLDWEQRFNIVKGIASG 465
V L G Q L++ E + G L + L +P+ + ++ + IA G
Sbjct: 72 VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADG 131
Query: 466 LLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLAR-LYDHGGMPHTTNVVGTFGYI 524
+ YL+ +HRD+ N ++ + ++GDFG+ R +Y+ + ++
Sbjct: 132 MAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 188
Query: 525 APELTQTGKASTSSDVFAYGILLLEVAT-GRRPI-GSGDLLLVEWVRECHQLGRILDVAD 582
+PE + G +T SDV+++G++L E+AT +P G + ++ +V E G +LD D
Sbjct: 189 SPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVME----GGLLDKPD 244
Query: 583 PLLNSSYVVKEMELVLKLGLMCSHKTQFRPTMR 615
+++ +L MC Q+ P MR
Sbjct: 245 NC---------PDMLFELMRMC---WQYNPKMR 265
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 7e-12
Identities = 66/242 (27%), Positives = 116/242 (47%), Gaps = 19/242 (7%)
Query: 359 EVIGIGGFGSVYKGVLPTTGG--EVAVK--KITRNSLQGMREFAAEIESLGRLRHKNLVN 414
+ +G G FGSV +G L +VAVK KI + M +F +E + H N++
Sbjct: 5 KTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMR 64
Query: 415 LHGWCKQKNDL------LLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVK---GIASG 465
L G C Q + +++ ++ +G L + L + G + +VK IASG
Sbjct: 65 LIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASG 124
Query: 466 LLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGT-FGYI 524
+ YL + IHRD+ N +++ MN + DFGL++ +G + +I
Sbjct: 125 MEYLSS---KSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWI 181
Query: 525 APELTQTGKASTSSDVFAYGILLLEVAT-GRRPI-GSGDLLLVEWVRECHQLGRILDVAD 582
A E +T SDV+++G+ + E+AT G+ P G + + +++R+ ++L + D D
Sbjct: 182 AIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLKQPPDCLD 241
Query: 583 PL 584
L
Sbjct: 242 GL 243
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 8e-12
Identities = 49/147 (33%), Positives = 74/147 (50%), Gaps = 11/147 (7%)
Query: 412 LVNLHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHE 471
LV LH + + L LV EY+ G L +F + L E I L +LHE
Sbjct: 58 LVGLHSCFQTTSRLFLVIEYVNGGDL---MFHMQRQRKLPEEHARFYAAEICIALNFLHE 114
Query: 472 EWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMP--HTTNVVGTFGYIAPELT 529
+ +I+RD+K N L+DA+ + +L D+G+ + G P T+ GT YIAPE+
Sbjct: 115 ---RGIIYRDLKLDNVLLDADGHIKLTDYGMCK---EGLGPGDTTSTFCGTPNYIAPEIL 168
Query: 530 QTGKASTSSDVFAYGILLLEVATGRRP 556
+ + S D +A G+L+ E+ GR P
Sbjct: 169 RGEEYGFSVDWWALGVLMFEMMAGRSP 195
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.0 bits (164), Expect = 8e-12
Identities = 72/251 (28%), Positives = 108/251 (43%), Gaps = 54/251 (21%)
Query: 355 FKESEVIGIGGFGSVYKGVLPTTGGEVAVKK------ITRNSLQGMREFAAEIESLGRLR 408
F+ +VIG G FG V TG A+KK + + + +R AE + L
Sbjct: 3 FESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVR---AERDILAEAD 59
Query: 409 HKNLVNLHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLY 468
+ +V L+ + +N L L+ EY+P G + TLL K KD + E RF I A +L
Sbjct: 60 NPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMK-KDTFTEE-ETRFYI----AETILA 113
Query: 469 LHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGL------------ARLYDHGGMPHTT- 515
+ + IHRD+KP N L+DA+ + +L DFGL R+ H +
Sbjct: 114 IDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLD 173
Query: 516 ------------------------NVVGTFGYIAPE-LTQTGKASTSSDVFAYGILLLEV 550
+ VGT YIAPE QTG + D ++ G+++ E+
Sbjct: 174 FISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTG-YNKECDWWSLGVIMYEM 232
Query: 551 ATGRRPIGSGD 561
G P S +
Sbjct: 233 LVGYPPFCSDN 243
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 8e-12
Identities = 53/197 (26%), Positives = 90/197 (45%), Gaps = 25/197 (12%)
Query: 375 PTTGGEVAVKKITRNSLQ-GMREFAAEIESLGRL-RHKNLVNLHGWCKQKNDLLLVYEYI 432
P VAVK + ++ + + + +E+E + + +HKN++NL G C Q L ++ EY
Sbjct: 44 PKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYA 103
Query: 433 PNGSLDTLLFKPKDGSVLDWEQRFNIVK----------------GIASGLLYLHEEWEQV 476
G+L L + E ++I + +A G+ YL Q
Sbjct: 104 SKGNLREYLRARRP---PGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLA---SQK 157
Query: 477 VIHRDVKPSNALIDAEMNARLGDFGLAR-LYDHGGMPHTTNVVGTFGYIAPELTQTGKAS 535
IHRD+ N L+ ++ DFGLAR + + TTN ++APE +
Sbjct: 158 CIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYT 217
Query: 536 TSSDVFAYGILLLEVAT 552
SDV+++G+L+ E+ T
Sbjct: 218 HQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 9e-12
Identities = 70/254 (27%), Positives = 115/254 (45%), Gaps = 28/254 (11%)
Query: 350 AATKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRH 409
+ K +K +IG G FG VY+ + T +VA+KK+ ++ RE + L H
Sbjct: 63 SPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLI----MKNLNH 118
Query: 410 KNLVNLHGW----CKQKND----LLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVK- 460
N++ L + C +KN+ L +V E+IP + ++ L +VK
Sbjct: 119 INIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALP----LFLVKL 174
Query: 461 ---GIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNA-RLGDFGLARLYDHGGMPHTTN 516
+ L Y+H ++ + HRD+KP N LID + +L DFG A+ G +
Sbjct: 175 YSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNL-LAGQRSVSY 230
Query: 517 VVGTFGYIAPELT-QTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLG 575
+ F Y APEL +T D+++ G ++ E+ G PI SG + + VR LG
Sbjct: 231 ICSRF-YRAPELMLGATNYTTHIDLWSLGCIIAEMILG-YPIFSGQSSVDQLVRIIQVLG 288
Query: 576 RILDVADPLLNSSY 589
+ +N +Y
Sbjct: 289 TPTEDQLKEMNPNY 302
|
Length = 440 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 1e-11
Identities = 45/144 (31%), Positives = 76/144 (52%), Gaps = 11/144 (7%)
Query: 416 HGWC--KQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQ-RFNIVKGIASGLLYLHEE 472
H +C + K L V EY+ G L +F + D + RF + I GL +LH++
Sbjct: 60 HLFCTFQTKEHLFFVMEYLNGGDL---MFHIQSSGRFDEARARFYAAE-IICGLQFLHKK 115
Query: 473 WEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPELTQTG 532
+I+RD+K N L+D + + ++ DFG+ + + G + GT YIAPE+ +
Sbjct: 116 G---IIYRDLKLDNVLLDKDGHIKIADFGMCKE-NMNGEGKASTFCGTPDYIAPEILKGQ 171
Query: 533 KASTSSDVFAYGILLLEVATGRRP 556
K + S D +++G+LL E+ G+ P
Sbjct: 172 KYNESVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 1e-11
Identities = 58/225 (25%), Positives = 103/225 (45%), Gaps = 31/225 (13%)
Query: 348 LYAATKGFKESEVIGIGGFGSVYKGVL----PTTGGEVAVKKITRN-SLQGMREFAAEIE 402
+ + S+++ G FG ++ G+L P EV VK + + S + E
Sbjct: 1 IAISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESC 60
Query: 403 SLGRLRHKNLVNLHGWCKQKNDLLLV-YEYIPNGSLDTLLFKPKDGSV-----LDWEQRF 456
L L H+N++ + C + + V Y Y+ G+L L + + G L +Q
Sbjct: 61 LLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLV 120
Query: 457 NIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLAR---------LYD 507
++ IA G+ YLH+ + VIH+D+ N +ID E+ ++ D L+R L D
Sbjct: 121 HMAIQIACGMSYLHK---RGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGD 177
Query: 508 HGGMPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVAT 552
+ P ++A E + S++SDV+++G+LL E+ T
Sbjct: 178 NENRP--------VKWMALESLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 1e-11
Identities = 63/246 (25%), Positives = 108/246 (43%), Gaps = 45/246 (18%)
Query: 361 IGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMRE------------FAA--EIESLGR 406
+G G +G V K TG VA+KK+ + F E++ +
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76
Query: 407 LRHKNLVNLHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFN-IVKGIASG 465
++H+N++ L + + + LV + + + L K D + E + I+ I +G
Sbjct: 77 IKHENIMGLVDVYVEGDFINLVMDI-----MASDLKKVVDRKIRLTESQVKCILLQILNG 131
Query: 466 LLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHT----------- 514
L LH+ + +HRD+ P+N I+++ ++ DFGLAR Y + T
Sbjct: 132 LNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRRE 188
Query: 515 --TNVVGTFGYIAPELTQTGKASTSS-DVFAYGILLLEVATGRRPIGSGDLLLVEWVREC 571
T+ V T Y APEL + + D+++ G + E+ TG +P+ G+ E
Sbjct: 189 EMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTG-KPLFPGE-------NEI 240
Query: 572 HQLGRI 577
QLGRI
Sbjct: 241 DQLGRI 246
|
Length = 335 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 2e-11
Identities = 59/215 (27%), Positives = 92/215 (42%), Gaps = 20/215 (9%)
Query: 359 EVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKN---LVNL 415
+VIG G FG V ++ A+K +++ + + A E + N +V L
Sbjct: 49 KVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL 108
Query: 416 HGWCKQKNDLLLVYEYIPNGSLDTLLFK---PKDGSVLDWEQRFNIVKGIASGLLYLHEE 472
+ L +V EY+P G L L+ P+ W + + A +L L
Sbjct: 109 FCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEK-----WAKFYT-----AEVVLALDAI 158
Query: 473 WEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPELTQT- 531
+IHRDVKP N L+D + +L DFG D GM VGT YI+PE+ ++
Sbjct: 159 HSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQ 218
Query: 532 ---GKASTSSDVFAYGILLLEVATGRRPIGSGDLL 563
G D ++ G+ L E+ G P + L+
Sbjct: 219 GGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLV 253
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 74/287 (25%), Positives = 126/287 (43%), Gaps = 42/287 (14%)
Query: 361 IGIGGFGSVYKGVL-------PTTGGEVAVKKITRNSLQ-GMREFAAEIESLGRL-RHKN 411
+G G FG V P +VAVK + ++ + + + +E+E + + +HKN
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85
Query: 412 LVNLHGWCKQKNDLLLVYEYIPNGSLDTLL-----------FKPKDGSV--LDWEQRFNI 458
++NL G C Q L ++ EY G+L L + P L ++ +
Sbjct: 86 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145
Query: 459 VKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDH-GGMPHTTNV 517
+A G+ YL + IHRD+ N L+ + ++ DFGLAR H TTN
Sbjct: 146 AYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 202
Query: 518 VGTFGYIAPELTQTGKASTSSDVFAYGILLLEVAT-GRRPI-GSGDLLLVEWVRECHQLG 575
++APE + SDV+++G+LL E+ T G P G L + ++E H++
Sbjct: 203 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMD 262
Query: 576 RILDVADPLLNSSYVVKEMELVLKLGLMCSHKT-QFRPTMRQVMRYL 621
+ S E+ ++++ C H RPT +Q++ L
Sbjct: 263 K----------PSNCTNELYMMMR---DCWHAVPSQRPTFKQLVEDL 296
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 3e-11
Identities = 49/151 (32%), Positives = 71/151 (47%), Gaps = 9/151 (5%)
Query: 412 LVNLHGWCKQKND-LLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLH 470
L LH C Q D L V EY+ G L ++ + IA GL +LH
Sbjct: 63 LTQLHS-CFQTMDRLYFVMEYVNGGDL---MYHIQQVGKFKEPHAVFYAAEIAIGLFFLH 118
Query: 471 EEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPELTQ 530
+ +I+RD+K N ++DAE + ++ DFG+ + GG T GT YIAPE+
Sbjct: 119 S---KGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKT-TRTFCGTPDYIAPEIIA 174
Query: 531 TGKASTSSDVFAYGILLLEVATGRRPIGSGD 561
S D +A+G+LL E+ G+ P D
Sbjct: 175 YQPYGKSVDWWAFGVLLYEMLAGQPPFDGED 205
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 3e-11
Identities = 56/194 (28%), Positives = 92/194 (47%), Gaps = 19/194 (9%)
Query: 375 PTTGGEVAVKKITRNSL-QGMREFAAEIESLGRL-RHKNLVNLHGWCKQKNDLLLVYEYI 432
P VAVK + ++ + + + +E+E + + +HKN++NL G C Q L ++ EY
Sbjct: 41 PNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYA 100
Query: 433 PNGSLDTLLFKPK--------DGSVLDWEQ-----RFNIVKGIASGLLYLHEEWEQVVIH 479
G+L L + D L EQ + +A G+ YL Q IH
Sbjct: 101 SKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLA---SQKCIH 157
Query: 480 RDVKPSNALIDAEMNARLGDFGLAR-LYDHGGMPHTTNVVGTFGYIAPELTQTGKASTSS 538
RD+ N L+ + ++ DFGLAR +++ TTN ++APE + S
Sbjct: 158 RDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQS 217
Query: 539 DVFAYGILLLEVAT 552
DV+++G+LL E+ T
Sbjct: 218 DVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 3e-11
Identities = 63/230 (27%), Positives = 106/230 (46%), Gaps = 29/230 (12%)
Query: 361 IGIGGFGSVYKGVLPTTGGEVAVKKITR--NSLQGMREFAAEIESLGRLRHKNLVNL--- 415
+G G +GSV +VAVKK++R SL R E+ L ++H+N++ L
Sbjct: 23 VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDV 82
Query: 416 ---HGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEE 472
+ N++ LV + L+ ++ K + D +F ++ + GL Y+H
Sbjct: 83 FTPATSIENFNEVYLVTNLM-GADLNNIV---KCQKLSDEHVQF-LIYQLLRGLKYIHSA 137
Query: 473 WEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPELTQTG 532
+IHRD+KPSN ++ + R+ DFGLAR D T V T Y APE+
Sbjct: 138 G---IIHRDLKPSNVAVNEDCELRILDFGLARQADD----EMTGYVATRWYRAPEIMLNW 190
Query: 533 -KASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVA 581
+ + D+++ G ++ E+ G+ D + QL RI++V
Sbjct: 191 MHYNQTVDIWSVGCIMAELLKGKALFPGNDYI--------DQLKRIMEVV 232
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 3e-11
Identities = 61/210 (29%), Positives = 93/210 (44%), Gaps = 17/210 (8%)
Query: 359 EVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMRE----FAAEIESLGRLRHKNLVN 414
+VIG G FG V G AVK + + + +E A L ++H LV
Sbjct: 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 415 LHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWE 474
LH + L V +++ G L ++ S + RF + IAS L YLH
Sbjct: 61 LHYSFQTTEKLYFVLDFVNGGEL--FFHLQRERSFPEPRARFYAAE-IASALGYLHS--- 114
Query: 475 QVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPH---TTNVVGTFGYIAPELTQT 531
+++RD+KP N L+D++ + L DFGL + G+ TT GT Y+APE+ +
Sbjct: 115 INIVYRDLKPENILLDSQGHVVLTDFGLCK----EGIAQSDTTTTFCGTPEYLAPEVIRK 170
Query: 532 GKASTSSDVFAYGILLLEVATGRRPIGSGD 561
+ D + G +L E+ G P D
Sbjct: 171 QPYDNTVDWWCLGAVLYEMLYGLPPFYCRD 200
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 4e-11
Identities = 65/236 (27%), Positives = 110/236 (46%), Gaps = 22/236 (9%)
Query: 349 YAATKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITR---NSLQGMREFAAEIESLG 405
+ K +++ + IG G G V G VAVKK++R N R + E+ L
Sbjct: 17 FTVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYR-ELVLLK 75
Query: 406 RLRHKNLVNL-HGWCKQKN-----DLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIV 459
+ HKN+++L + + QK+ D+ LV E + + + LD E+ ++
Sbjct: 76 CVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHME------LDHERMSYLL 129
Query: 460 KGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVG 519
+ G+ +LH +IHRD+KPSN ++ ++ ++ DFGLAR M T V
Sbjct: 130 YQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFM--MTPYVV 184
Query: 520 TFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLG 575
T Y APE+ + D+++ G ++ E+ G I G + +W + QLG
Sbjct: 185 TRYYRAPEVILGMGYKENVDIWSVGCIMGELVKG-SVIFQGTDHIDQWNKVIEQLG 239
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 4e-11
Identities = 68/253 (26%), Positives = 110/253 (43%), Gaps = 63/253 (24%)
Query: 355 FKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIES----LGRLRHK 410
F + + IGIG FG V T A+K + R + MR AA +++ L ++
Sbjct: 3 FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTL-RKADVLMRNQAAHVKAERDILAEADNE 61
Query: 411 NLVNLHGWCKQKNDLLLVYEYIPNGSLDTLLFK----PKDGSVLDWEQRFNIVKGIASGL 466
+V L+ + K++L V +YIP G + +LL + +D + RF I + + +
Sbjct: 62 WVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLA------RFYIAE-LTCAI 114
Query: 467 LYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGL---------ARLYDHGGMP----- 512
+H+ IHRD+KP N LID + + +L DFGL ++ Y G
Sbjct: 115 ESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSM 171
Query: 513 ------------------------HTT----NVVGTFGYIAPE-LTQTGKASTSSDVFAY 543
H ++VGT YIAPE L +TG + D ++
Sbjct: 172 EPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGY-TQLCDWWSV 230
Query: 544 GILLLEVATGRRP 556
G++L E+ G+ P
Sbjct: 231 GVILYEMLVGQPP 243
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 7e-11
Identities = 49/181 (27%), Positives = 79/181 (43%), Gaps = 18/181 (9%)
Query: 404 LGRLRHKNLVNLHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIA 463
L + H +++ + +V +P+ S D + K L +Q I K I
Sbjct: 111 LQNVNHPSVIRMKDTLVSGAITCMV---LPHYSSDLYTYLTKRSRPLPIDQALIIEKQIL 167
Query: 464 SGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGY 523
GL YLH Q +IHRDVK N I+ +GD G A+ P + GT
Sbjct: 168 EGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQF--PVVAPAFLGLAGTVET 222
Query: 524 IAPELTQTGKASTSSDVFAYGILLLEV-----ATGRRPIGSGDLLLVEWVRECH-QLGRI 577
APE+ K ++ +D+++ GI+L E+ P + + E+V+ CH L +I
Sbjct: 223 NAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPE----EYVKSCHSHLLKI 278
Query: 578 L 578
+
Sbjct: 279 I 279
|
Length = 357 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 7e-11
Identities = 66/216 (30%), Positives = 95/216 (43%), Gaps = 27/216 (12%)
Query: 359 EVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRL-----RHKNLV 413
E IG G +G VYK G AVK L + + EIE+ + H N+V
Sbjct: 28 ETIGKGTYGKVYKVTNKKDGSLAAVK-----ILDPISDVDEEIEAEYNILQSLPNHPNVV 82
Query: 414 NLHGWCKQKN-----DLLLVYEYIPNGSLDTLLFKP--KDGSVLDWEQRFNIVKGIASGL 466
+G + + L LV E GS+ T L K G LD I+ G GL
Sbjct: 83 KFYGMFYKADKLVGGQLWLVLELCNGGSV-TELVKGLLICGQRLDEAMISYILYGALLGL 141
Query: 467 LYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAP 526
+LH +IHRDVK +N L+ E +L DFG++ + T+ VGT ++AP
Sbjct: 142 QHLHN---NRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS-VGTPFWMAP 197
Query: 527 ELTQTGKASTSS-----DVFAYGILLLEVATGRRPI 557
E+ + S DV++ GI +E+ G P+
Sbjct: 198 EVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPL 233
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 7e-11
Identities = 74/283 (26%), Positives = 128/283 (45%), Gaps = 44/283 (15%)
Query: 359 EVIGIGGFGSVYKGVLPTTGG-------EVAVK---KITRNSLQGMREFAAEIESLGRLR 408
E +G G F ++KG+ G EV +K K RN + E AA + S +L
Sbjct: 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFE-AASMMS--QLS 57
Query: 409 HKNLVNLHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLY 468
HK+LV +G C ++ ++V EY+ GSLDT L K K+ + W + + K +A L +
Sbjct: 58 HKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISW--KLEVAKQLAWALHF 115
Query: 469 LHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTN---VVGTFGYIA 525
L ++ + H +V N L+ E + + G+ +L D G ++ ++
Sbjct: 116 LE---DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLERIPWVP 172
Query: 526 PELTQTGKA-STSSDVFAYGILLLEVATG-RRPIGSGD----LLLVEWVRECHQLGRILD 579
PE + + S ++D +++G L E+ +G +P+ + D L E + HQL
Sbjct: 173 PECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYE---DRHQL----- 224
Query: 580 VADPLLNSSYVVKEMELVLKLGLMCSHKTQFRPTMRQVMRYLS 622
P K EL + ++ FRP+ R ++R L+
Sbjct: 225 ---P------APKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 7e-11
Identities = 63/206 (30%), Positives = 99/206 (48%), Gaps = 20/206 (9%)
Query: 361 IGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKN------LVN 414
IG G FG VY+ T A+K +++ + +E A I L +V
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 415 LHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWE 474
L + +DL LV +Y+ G L L K+G + +F I + + + L +LH+
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHL--QKEGRFSEDRAKFYIAELVLA-LEHLHK--- 114
Query: 475 QVVIHRDVKPSNALIDAEMNARLGDFGLAR--LYDHGGMPHTTNV-VGTFGYIAPELTQT 531
+++RD+KP N L+DA + L DFGL++ L D+ TTN GT Y+APE+
Sbjct: 115 YDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK----TTNTFCGTTEYLAPEVLLD 170
Query: 532 GKASTSS-DVFAYGILLLEVATGRRP 556
K T D ++ G+L+ E+ G P
Sbjct: 171 EKGYTKHVDFWSLGVLVFEMCCGWSP 196
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 7e-11
Identities = 45/147 (30%), Positives = 72/147 (48%), Gaps = 8/147 (5%)
Query: 412 LVNLHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHE 471
LV LH + L L+ +Y+ G L T L++ + E R I + I L +LH+
Sbjct: 67 LVTLHYAFQTDTKLHLILDYVNGGELFTHLYQ--REHFTESEVRVYIAE-IVLALDHLHQ 123
Query: 472 EWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPELTQT 531
+I+RD+K N L+D+E + L DFGL++ + + GT Y+APE+ +
Sbjct: 124 ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRG 180
Query: 532 GKASTSS--DVFAYGILLLEVATGRRP 556
G D ++ G+L E+ TG P
Sbjct: 181 GSGGHDKAVDWWSLGVLTFELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 8e-11
Identities = 61/232 (26%), Positives = 93/232 (40%), Gaps = 47/232 (20%)
Query: 361 IGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQG----MREFAAEIESLGRLRHKNLVNLH 416
IG GG G VY P VA+KKI R L + F E + L H +V ++
Sbjct: 10 IGKGGMGEVYLAYDPVCSRRVALKKI-REDLSENPLLKKRFLREAKIAADLIHPGIVPVY 68
Query: 417 GWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQR---------------FNIVKG 461
C + + YI +L +LL SV W++ +I
Sbjct: 69 SICSDGDPVYYTMPYIEGYTLKSLL-----KSV--WQKESLSKELAEKTSVGAFLSIFHK 121
Query: 462 IASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYD-------------- 507
I + + Y+H + V+HRD+KP N L+ + D+G A
Sbjct: 122 ICATIEYVHS---KGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDER 178
Query: 508 ---HGGMPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRP 556
+ M +VGT Y+APE AS S+D++A G++L ++ T P
Sbjct: 179 NICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFP 230
|
Length = 932 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 8e-11
Identities = 59/211 (27%), Positives = 97/211 (45%), Gaps = 30/211 (14%)
Query: 361 IGIGGFGSVYKGVLPTTGGE--VAVK--KITRNSLQGMREFAAEIESLGRLRHKNLVNLH 416
+G G FG+V KG+ E VAVK K N E E + +L + +V +
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 417 GWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQV 476
G C+ ++ +LV E G L+ L K K + + + +V ++ G+ YL E
Sbjct: 63 GICEAES-WMLVMELAELGPLNKFLQKNKHVTEKNITE---LVHQVSMGMKYLEE---TN 115
Query: 477 VIHRDVKPSNALIDAEMNARLGDFGLARLY----------DHGGMPHTTNVVGTFGYIAP 526
+HRD+ N L+ + A++ DFGL++ HG P + AP
Sbjct: 116 FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWP--------VKWYAP 167
Query: 527 ELTQTGKASTSSDVFAYGILLLEV-ATGRRP 556
E K S+ SDV+++G+L+ E + G++P
Sbjct: 168 ECMNYYKFSSKSDVWSFGVLMWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 9e-11
Identities = 58/217 (26%), Positives = 103/217 (47%), Gaps = 29/217 (13%)
Query: 355 FKESEVIGIGGFGSVYKGVLPTTGGE----VAVKKITR-NSLQGMREFAAEIESLGRLRH 409
FK+ +V+G G FG+VYKG+ G + VA+K++ S + +E E + + +
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68
Query: 410 KNLVNLHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYL 469
++ L G C + + L+ + +P G L + + KD + N IA G+ YL
Sbjct: 69 PHVCRLLGIC-LTSTVQLITQLMPFGCLLDYVREHKDNIGSQY--LLNWCVQIAKGMNYL 125
Query: 470 HEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLY---------DHGGMPHTTNVVGT 520
E + ++HRD+ N L+ + ++ DFGLA+L + G +P
Sbjct: 126 EE---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVP-------- 174
Query: 521 FGYIAPELTQTGKASTSSDVFAYGILLLEVAT-GRRP 556
++A E + SDV++YG+ + E+ T G +P
Sbjct: 175 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 211
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 1e-10
Identities = 72/260 (27%), Positives = 111/260 (42%), Gaps = 19/260 (7%)
Query: 314 LGTLVF---FLIYRKWSNSETLEDWEKDCPHRFRYKDLYAATKGFKESEVIGIGGFGSVY 370
L LV+ F RK N + + KD ++ R DL + ++ +VIG G FG V
Sbjct: 3 LDALVYDLDFPALRKNKNIDNFLNRYKDTINKIR--DLRMKAEDYEVVKVIGRGAFGEVQ 60
Query: 371 KGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKN---LVNLHGWCKQKNDLLL 427
+T A+K +++ + + A E + N +V L + L +
Sbjct: 61 LVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYM 120
Query: 428 VYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNA 487
V EY+P G L L+ + V + RF A +L L IHRDVKP N
Sbjct: 121 VMEYMPGGDLVNLM---SNYDVPEKWARFYT----AEVVLALDAIHSMGFIHRDVKPDNM 173
Query: 488 LIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPELTQT----GKASTSSDVFAY 543
L+D + +L DFG + GM VGT YI+PE+ ++ G D ++
Sbjct: 174 LLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSV 233
Query: 544 GILLLEVATGRRPIGSGDLL 563
G+ L E+ G P + L+
Sbjct: 234 GVFLYEMLVGDTPFYADSLV 253
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 1e-10
Identities = 54/206 (26%), Positives = 94/206 (45%), Gaps = 10/206 (4%)
Query: 355 FKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVN 414
F+ + IG G +G VYK TG A+K I + EI + +H N+V
Sbjct: 11 FELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVA 70
Query: 415 LHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWE 474
G +++ L + E+ GSL + S Q + + GL YLH + +
Sbjct: 71 YFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSES---QIAYVSRETLQGLYYLHSKGK 127
Query: 475 QVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPELT---QT 531
+HRD+K +N L+ + +L DFG++ + + +GT ++APE+ +
Sbjct: 128 ---MHRDIKGANILLTDNGHVKLADFGVSAQIT-ATIAKRKSFIGTPYWMAPEVAAVERK 183
Query: 532 GKASTSSDVFAYGILLLEVATGRRPI 557
G + D++A GI +E+A + P+
Sbjct: 184 GGYNQLCDIWAVGITAIELAELQPPM 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 1e-10
Identities = 67/224 (29%), Positives = 101/224 (45%), Gaps = 33/224 (14%)
Query: 355 FKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSL----QGMREFAAEIESLGRLRHK 410
F+ ++I G +G+VY T A+KKI + +L Q + F E + L +
Sbjct: 3 FETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFV-ERDILTFAENP 61
Query: 411 NLVNLHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQ-RFNIVKGIASGLLYL 469
+V++ + K L +V EY+ G TLL K+ L + R + + + L YL
Sbjct: 62 FVVSMFCSFETKRHLCMVMEYVEGGDCATLL---KNIGALPVDMARMYFAETVLA-LEYL 117
Query: 470 HEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTN------------- 516
H ++HRD+KP N LI + + +L DFGL+++ G M TTN
Sbjct: 118 HNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKI---GLMSLTTNLYEGHIEKDTREF 171
Query: 517 ----VVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRP 556
V GT YIAPE+ D +A GI+L E G P
Sbjct: 172 LDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVP 215
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 1e-10
Identities = 63/213 (29%), Positives = 103/213 (48%), Gaps = 21/213 (9%)
Query: 355 FKESEVIGIGGFGSVYKGVLPTTGGE----VAVKKITRN-SLQGMREFAAEIESLGRLRH 409
K+ +V+G G FG+VYKG+ G VA+K + N S + +E E + +
Sbjct: 9 LKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGS 68
Query: 410 KNLVNLHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKD--GS--VLDWEQRFNIVKGIASG 465
+ L G C + + LV + +P G L + + KD GS +L+W + IA G
Sbjct: 69 PYVCRLLGIC-LTSTVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQ------IAKG 121
Query: 466 LLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMP-HTTNVVGTFGYI 524
+ YL E ++HRD+ N L+ + + ++ DFGLARL D H ++
Sbjct: 122 MSYLEE---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWM 178
Query: 525 APELTQTGKASTSSDVFAYGILLLEVAT-GRRP 556
A E + + SDV++YG+ + E+ T G +P
Sbjct: 179 ALESILHRRFTHQSDVWSYGVTVWELMTFGAKP 211
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-10
Identities = 44/150 (29%), Positives = 71/150 (47%), Gaps = 7/150 (4%)
Query: 412 LVNLHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHE 471
L LH + + L V EY+ G L +++ + IA GL +LH
Sbjct: 63 LTQLHSCFQTMDRLYFVMEYVNGGDL---MYQIQQVGRFKEPHAVFYAAEIAIGLFFLHS 119
Query: 472 EWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPELTQT 531
+ +I+RD+K N ++D+E + ++ DFG+ + G+ T GT YIAPE+
Sbjct: 120 KG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVT-TKTFCGTPDYIAPEIIAY 175
Query: 532 GKASTSSDVFAYGILLLEVATGRRPIGSGD 561
S D +A+G+LL E+ G+ P D
Sbjct: 176 QPYGKSVDWWAFGVLLYEMLAGQAPFEGED 205
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-10
Identities = 64/207 (30%), Positives = 96/207 (46%), Gaps = 15/207 (7%)
Query: 359 EVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIES-----LGRLRHKNLV 413
+VIG G FG V AVK + + ++ +E I S L ++H LV
Sbjct: 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKE-EKHIMSERNVLLKNVKHPFLV 59
Query: 414 NLHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEW 473
LH + + L V +YI G L L ++ L+ RF + IAS L YLH
Sbjct: 60 GLHFSFQTADKLYFVLDYINGGELFYHL--QRERCFLEPRARFYAAE-IASALGYLHS-- 114
Query: 474 EQVVIHRDVKPSNALIDAEMNARLGDFGLARL-YDHGGMPHTTNVVGTFGYIAPELTQTG 532
+++RD+KP N L+D++ + L DFGL + +H G T+ GT Y+APE+
Sbjct: 115 -LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGT--TSTFCGTPEYLAPEVLHKQ 171
Query: 533 KASTSSDVFAYGILLLEVATGRRPIGS 559
+ D + G +L E+ G P S
Sbjct: 172 PYDRTVDWWCLGAVLYEMLYGLPPFYS 198
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 2e-10
Identities = 56/200 (28%), Positives = 89/200 (44%), Gaps = 10/200 (5%)
Query: 361 IGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNLHGWCK 420
+G G +G VYK TG AVK I EI + +H N+V G
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYL 76
Query: 421 QKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHR 480
+ L + EY GSL + S L Q + + GL YLH + + +HR
Sbjct: 77 SREKLWICMEYCGGGSLQDIYHVTGPLSEL---QIAYVCRETLQGLAYLHSKGK---MHR 130
Query: 481 DVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPELT---QTGKASTS 537
D+K +N L+ + +L DFG+A + + +GT ++APE+ + G +
Sbjct: 131 DIKGANILLTDNGDVKLADFGVAAKIT-ATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQL 189
Query: 538 SDVFAYGILLLEVATGRRPI 557
D++A GI +E+A + P+
Sbjct: 190 CDIWAVGITAIELAELQPPM 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 3e-10
Identities = 68/247 (27%), Positives = 103/247 (41%), Gaps = 53/247 (21%)
Query: 355 FKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVN 414
F+ +VIG G FG V + V G + KI R + +E A I R LV
Sbjct: 3 FESLKVIGRGAFGEV-RLVQKKDTGHIYAMKILRKADMLEKEQVAHI----RAERDILVE 57
Query: 415 LHG-WC-------KQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGL 466
G W + K +L L+ E++P G + TLL K KD ++ + +F I A +
Sbjct: 58 ADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMK-KD-TLSEEATQFYI----AETV 111
Query: 467 LYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLA-------RLYDHGGMPHTT---- 515
L + + IHRD+KP N L+DA+ + +L DFGL R + + H
Sbjct: 112 LAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDF 171
Query: 516 -----------------------NVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVAT 552
+ VGT YIAPE+ + D ++ G+++ E+
Sbjct: 172 SFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLI 231
Query: 553 GRRPIGS 559
G P S
Sbjct: 232 GYPPFCS 238
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 3e-10
Identities = 62/226 (27%), Positives = 96/226 (42%), Gaps = 15/226 (6%)
Query: 359 EVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFA---AEIESLGRLRHKNLVNL 415
+++G G FG V TG A+K + + + E A E L RH L L
Sbjct: 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 60
Query: 416 HGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQ 475
+ + L V EY G L F V ++ I S L YLH E
Sbjct: 61 KYSFQTHDRLCFVMEYANGGEL---FFHLSRERVFSEDRARFYGAEIVSALDYLHSEKN- 116
Query: 476 VVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPELTQTGKAS 535
V++RD+K N ++D + + ++ DFGL + G T GT Y+APE+ +
Sbjct: 117 -VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT-FCGTPEYLAPEVLEDNDYG 174
Query: 536 TSSDVFAYGILLLEVATGRRPIGSGD------LLLVEWVRECHQLG 575
+ D + G+++ E+ GR P + D L+L+E +R L
Sbjct: 175 RAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLS 220
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.5 bits (150), Expect = 3e-10
Identities = 63/234 (26%), Positives = 97/234 (41%), Gaps = 37/234 (15%)
Query: 355 FKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFA---AEIESLGRLRHKN 411
FK+ +++G G G V+ L TG A+K + + + + E E L L H
Sbjct: 3 FKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPF 62
Query: 412 LVNLHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHE 471
L L+ + + L LV +Y P G L LL + + + RF + + L YLH
Sbjct: 63 LPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAE-VLLALEYLHL 121
Query: 472 EWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMP------------------- 512
+++RD+KP N L+ + L DF L++ D P
Sbjct: 122 ---LGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPS 178
Query: 513 ---------HTTNVVGTFGYIAPELTQTGKASTSS-DVFAYGILLLEVATGRRP 556
+ + VGT YIAPE+ +G S+ D + GILL E+ G P
Sbjct: 179 ETFSEEPSFRSNSFVGTEEYIAPEVI-SGDGHGSAVDWWTLGILLYEMLYGTTP 231
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 4e-10
Identities = 50/170 (29%), Positives = 84/170 (49%), Gaps = 28/170 (16%)
Query: 466 LLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLY------DHGGMPHTTNVVG 519
LL +H + +IHRD+K +N L+ + +LGDFG +++Y D G G
Sbjct: 153 LLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVG-----RTFCG 207
Query: 520 TFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILD 579
T Y+APE+ + S +D+F+ G+LL E+ T +RP ++ E V GR
Sbjct: 208 TPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENM---EEVMHKTLAGRY-- 262
Query: 580 VADPLLNSSYVVKEMELVLKLGLMCSHKTQFRPTMRQVMR------YLSG 623
DPL S + EM+ ++ L+ S + RP+ +++ ++SG
Sbjct: 263 --DPLPPS--ISPEMQEIVTA-LLSSDPKR-RPSSSKLLNMPICKLFISG 306
|
Length = 496 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 6e-10
Identities = 60/213 (28%), Positives = 102/213 (47%), Gaps = 19/213 (8%)
Query: 355 FKESEVIGIGGFGSVY---KGVLPTTGGEVAVKKITRNSL----QGMREFAAEIESLGRL 407
F+ +V+G G +G V+ K TG A+K + + +L + + E L +
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHV 61
Query: 408 RHKN-LVNLHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKG-IASG 465
R LV LH + + L L+ +Y+ G + T L++ + S E G I
Sbjct: 62 RQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFS----EDEVRFYSGEIILA 117
Query: 466 LLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIA 525
L +LH+ +++RD+K N L+D+E + L DFGL++ + T + GT Y+A
Sbjct: 118 LEHLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMA 174
Query: 526 PEL--TQTGKASTSSDVFAYGILLLEVATGRRP 556
PE+ + G + D ++ GIL+ E+ TG P
Sbjct: 175 PEIIRGKGGHGK-AVDWWSLGILIFELLTGASP 206
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 6e-10
Identities = 66/228 (28%), Positives = 108/228 (47%), Gaps = 36/228 (15%)
Query: 355 FKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQ-------GMREFA-----AEIE 402
+++ E IG G +G VYK TG VA+KK TR + +RE + +E
Sbjct: 3 YEKLEKIGEGTYGKVYKARDKNTGKLVALKK-TRLEMDEEGIPPTALREISLLQMLSESI 61
Query: 403 SLGRL-RHKNLVNLHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKD------GSVLDWEQR 455
+ RL +++ +G K L LV+EY LD+ L K D G L +
Sbjct: 62 YIVRLLDVEHVEEKNG----KPSLYLVFEY-----LDSDLKKFMDSNGRGPGRPLPAKTI 112
Query: 456 FNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNA-RLGDFGLARLYDHGGMPHT 514
+ + + G+ + H + V+HRD+KP N L+D + ++ D GL R + +T
Sbjct: 113 KSFMYQLLKGVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYT 169
Query: 515 TNVVGTFGYIAPE-LTQTGKASTSSDVFAYGILLLEVATGRRPIGSGD 561
+V T Y APE L + ST D+++ G + E++ ++P+ GD
Sbjct: 170 HEIV-TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSR-KQPLFPGD 215
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 7e-10
Identities = 67/236 (28%), Positives = 101/236 (42%), Gaps = 44/236 (18%)
Query: 361 IGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEI------ESLGRLRHKNLVN 414
+G G +GSV + TG +VA+KK++R F +EI L L+H N
Sbjct: 23 VGSGAYGSVCSAIDKRTGEKVAIKKLSR-------PFQSEIFAKRAYRELTLLKHMQHEN 75
Query: 415 LHGWC---------KQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASG 465
+ G + D LV Y + T L K G L ++ +V + G
Sbjct: 76 VIGLLDVFTSAVSGDEFQDFYLVMPY-----MQTDLQKIM-GHPLSEDKVQYLVYQMLCG 129
Query: 466 LLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIA 525
L Y+H +IHRD+KP N ++ + ++ DFGLAR D T V T Y A
Sbjct: 130 LKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLARHAD----AEMTGYVVTRWYRA 182
Query: 526 PELTQTGKASTSS-DVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDV 580
PE+ + D+++ G ++ E+ TG+ D L QL +IL V
Sbjct: 183 PEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL--------DQLTQILKV 230
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 8e-10
Identities = 66/249 (26%), Positives = 107/249 (42%), Gaps = 57/249 (22%)
Query: 355 FKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNS----------LQGMREFAAEIESL 404
F+ +VIG G FG V + V G V KI R + ++ R+ E +SL
Sbjct: 3 FESLKVIGRGAFGEV-RLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSL 61
Query: 405 GRLRHKNLVNLHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIAS 464
+V + + K +L L+ E++P G + TLL K KD ++ + E +F I A
Sbjct: 62 W------VVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMK-KD-TLTEEETQFYI----AE 109
Query: 465 GLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLA-------RLYDHGGMPHTT-- 515
+L + + IHRD+KP N L+D++ + +L DFGL R + + H+
Sbjct: 110 TVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPS 169
Query: 516 -------------------------NVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEV 550
+ VGT YIAPE+ + D ++ G+++ E+
Sbjct: 170 DFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEM 229
Query: 551 ATGRRPIGS 559
G P S
Sbjct: 230 LIGYPPFCS 238
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 8e-10
Identities = 60/220 (27%), Positives = 96/220 (43%), Gaps = 16/220 (7%)
Query: 359 EVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFA---AEIESLGRLRHKNLVNL 415
+++G G FG V TG A+K + + + E A E L RH L L
Sbjct: 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTAL 60
Query: 416 HGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQ 475
+ + L V EY G L L ++ + RF + I S L YLH
Sbjct: 61 KYSFQTHDRLCFVMEYANGGELFFHL--SRERVFSEDRARFYGAE-IVSALGYLHS---C 114
Query: 476 VVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPELTQTGKAS 535
V++RD+K N ++D + + ++ DFGL + G GT Y+APE+ +
Sbjct: 115 DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGAT-MKTFCGTPEYLAPEVLEDNDYG 173
Query: 536 TSSDVFAYGILLLEVATGRRPIGSGD------LLLVEWVR 569
+ D + G+++ E+ GR P + D L+L+E +R
Sbjct: 174 RAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIR 213
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 8e-10
Identities = 58/213 (27%), Positives = 98/213 (46%), Gaps = 18/213 (8%)
Query: 355 FKESEVIGIGGFGSVY--KGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGR--LRHK 410
F+ +V+G G +G V+ + V G++ K+ + + + E R L H
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 61
Query: 411 N----LVNLHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKG-IASG 465
LV LH + L L+ +YI G L T L + + EQ I G I
Sbjct: 62 RQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFK----EQEVQIYSGEIVLA 117
Query: 466 LLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIA 525
L +LH+ +I+RD+K N L+D+ + L DFGL++ + + + GT Y+A
Sbjct: 118 LEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMA 174
Query: 526 PELTQTGKA--STSSDVFAYGILLLEVATGRRP 556
P++ + G + D ++ G+L+ E+ TG P
Sbjct: 175 PDIVRGGDGGHDKAVDWWSMGVLMYELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 9e-10
Identities = 58/214 (27%), Positives = 100/214 (46%), Gaps = 33/214 (15%)
Query: 361 IGIGGFGSVYKGVLP-TTGGE----VAVKKITRN-SLQGMREFAAEIESLGRLRHKNLVN 414
+G G FG VY+G GE VAVK + + SL+ EF E + ++V
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73
Query: 415 LHGWCKQKNDLLLVYEYIPNGSLDTLL--FKPKD----GSVL-DWEQRFNIVKGIASGLL 467
L G + L+V E + +G L + L +P+ G ++ + IA G+
Sbjct: 74 LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 133
Query: 468 YLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLAR------LYDHGG---MPHTTNVV 518
YL+ + +HRD+ N ++ + ++GDFG+ R Y GG +P
Sbjct: 134 YLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLP------ 184
Query: 519 GTFGYIAPELTQTGKASTSSDVFAYGILLLEVAT 552
++APE + G +TSSD++++G++L E+ +
Sbjct: 185 --VRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 59.6 bits (145), Expect = 1e-09
Identities = 56/207 (27%), Positives = 92/207 (44%), Gaps = 34/207 (16%)
Query: 361 IGIGGFGSVYKGVLPTTGGEVAVKKITR--NSLQGMREFAAEIESLGRLR-HKNLVNLHG 417
IG G F V K TG A+K + + SL+ + EI++L RL H N++ L
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLR-EIQALRRLSPHPNILRLIE 65
Query: 418 WCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDW---------EQRF-NIVKGIASGLL 467
++++ G L L+F+ D ++ + E+R + + + L
Sbjct: 66 ---------VLFD-RKTGRL-ALVFELMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLD 114
Query: 468 YLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLAR-LYDHGGMPHTTNVVGTFGYIAP 526
++H + HRD+KP N LI + +L DFG R +Y P+ T + T Y AP
Sbjct: 115 HMHRNG---IFHRDIKPENILIKDD-ILKLADFGSCRGIYSKP--PY-TEYISTRWYRAP 167
Query: 527 E-LTQTGKASTSSDVFAYGILLLEVAT 552
E L G D++A G + E+ +
Sbjct: 168 ECLLTDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 1e-09
Identities = 63/210 (30%), Positives = 95/210 (45%), Gaps = 25/210 (11%)
Query: 361 IGIGGFGSVYKGVLP--TTGGEVAVKKI--TRNSLQGMREFAAEIESLGRLRHKNLVNLH 416
+G G +G VYK E A+K+I T S+ RE A L L+H N++ L
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIAL----LRELKHPNVIALQ 64
Query: 417 GWCKQKND--LLLVYEYIPNGSLDTLLFK-----PKDGSVLDWEQRFNIVKGIASGLLYL 469
+D + L+++Y + + F K L +++ I G+ YL
Sbjct: 65 KVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYL 124
Query: 470 HEEWEQVVIHRDVKPSNALIDAEMNAR----LGDFGLARLYDHGGMP--HTTNVVGTFGY 523
H W V+HRD+KP+N L+ E R + D G ARL++ P VV TF Y
Sbjct: 125 HANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWY 181
Query: 524 IAPELTQTGKASTSS-DVFAYGILLLEVAT 552
APEL + T + D++A G + E+ T
Sbjct: 182 RAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 60.5 bits (146), Expect = 1e-09
Identities = 44/187 (23%), Positives = 88/187 (47%), Gaps = 19/187 (10%)
Query: 383 VKKITRNSLQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLV--------YEYIPN 434
+ K + + + EI +LGRL H+N++ + + + + ++ Y ++ +
Sbjct: 196 IAKRVKAGSRAAIQLENEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYD 255
Query: 435 GSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMN 494
+ D KD +L + R I+K + + Y+H+ + +IHRD+K N ++ +
Sbjct: 256 EAFDW-----KDRPLL-KQTR-AIMKQLLCAVEYIHD---KKLIHRDIKLENIFLNCDGK 305
Query: 495 ARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLE-VATG 553
LGDFG A ++ VGT +PE+ +D+++ G++LL+ ++
Sbjct: 306 IVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHD 365
Query: 554 RRPIGSG 560
PIG G
Sbjct: 366 FCPIGDG 372
|
Length = 501 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-09
Identities = 62/255 (24%), Positives = 105/255 (41%), Gaps = 63/255 (24%)
Query: 355 FKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFA---AEIESLGRLRHKN 411
F + + +GIG FG V T A+K + + + + A AE + L ++
Sbjct: 3 FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEW 62
Query: 412 LVNLHGWCKQKNDLLLVYEYIPNGSLDTLLFK----PKDGSVLDWEQRFNIVKGIASGLL 467
+V L+ + K++L V +YIP G + +LL + P+D + RF I + + +
Sbjct: 63 VVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLA------RFYIAE-LTCAVE 115
Query: 468 YLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGL---------ARLYDHGGMPHTT--- 515
+H+ IHRD+KP N LID + + +L DFGL ++ Y G
Sbjct: 116 SVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMD 172
Query: 516 ----------------------------------NVVGTFGYIAPELTQTGKASTSSDVF 541
++VGT YIAPE+ + D +
Sbjct: 173 FSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWW 232
Query: 542 AYGILLLEVATGRRP 556
+ G++L E+ G+ P
Sbjct: 233 SVGVILYEMLVGQPP 247
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 2e-09
Identities = 60/202 (29%), Positives = 87/202 (43%), Gaps = 16/202 (7%)
Query: 361 IGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFA---AEIESLGRLRHKNLVNLHG 417
IG G FG V + T A+K I + + E AE L ++ +V L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 418 WCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKG---IASGLLYLHEEWE 474
+ L LV +I G L L + E RF++ + A L L +
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHLQR---------EGRFDLSRARFYTAELLCALENLHK 111
Query: 475 QVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPELTQTGKA 534
VI+RD+KP N L+D + + L DFGL +L + T GT Y+APEL
Sbjct: 112 FNVIYRDLKPENILLDYQGHIALCDFGLCKL-NMKDDDKTNTFCGTPEYLAPELLLGHGY 170
Query: 535 STSSDVFAYGILLLEVATGRRP 556
+ + D + G+LL E+ TG P
Sbjct: 171 TKAVDWWTLGVLLYEMLTGLPP 192
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 2e-09
Identities = 65/233 (27%), Positives = 98/233 (42%), Gaps = 62/233 (26%)
Query: 361 IGIGGFGSVYKGVLP--TTGGEVAVKKI--TRNSLQGMREFAAEIESLGRLRHKNLVNLH 416
+G G +G VYK + A+K+I T S+ RE A L L+H N+++L
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIAL----LRELKHPNVISLQ 64
Query: 417 GWCKQKND--LLLVYEY-----------------------IPNGSLDTLLFKPKDGSVLD 451
D + L+++Y +P G + +LL++
Sbjct: 65 KVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQ-------- 116
Query: 452 WEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNAR----LGDFGLARLYD 507
I G+ YLH W V+HRD+KP+N L+ E R + D G ARL++
Sbjct: 117 ----------ILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFN 163
Query: 508 HGGMP--HTTNVVGTFGYIAPELTQTGKASTSS-DVFAYGILLLEVATGRRPI 557
P VV TF Y APEL + T + D++A G + E+ T PI
Sbjct: 164 SPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTS-EPI 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 2e-09
Identities = 55/208 (26%), Positives = 91/208 (43%), Gaps = 14/208 (6%)
Query: 359 EVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFA---AEIESLGRLRHKNLVNL 415
+++G G FG V +G A+K + + + E A E L RH L +L
Sbjct: 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL 60
Query: 416 HGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQ 475
+ K+ L V EY+ G L F V ++ I S L YLH
Sbjct: 61 KYSFQTKDRLCFVMEYVNGGEL---FFHLSRERVFSEDRTRFYGAEIVSALDYLHS---G 114
Query: 476 VVIHRDVKPSNALIDAEMNARLGDFGLAR--LYDHGGMPHTTNVVGTFGYIAPELTQTGK 533
+++RD+K N ++D + + ++ DFGL + + D M GT Y+APE+ +
Sbjct: 115 KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATM---KTFCGTPEYLAPEVLEDND 171
Query: 534 ASTSSDVFAYGILLLEVATGRRPIGSGD 561
+ D + G+++ E+ GR P + D
Sbjct: 172 YGRAVDWWGLGVVMYEMMCGRLPFYNQD 199
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 2e-09
Identities = 62/253 (24%), Positives = 102/253 (40%), Gaps = 59/253 (23%)
Query: 355 FKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFA---AEIESLGRLRHKN 411
F + + +GIG FG V T A+K + + + + A AE + L ++
Sbjct: 3 FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEW 62
Query: 412 LVNLHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHE 471
+V L+ + K++L V +YIP G + +LL + + RF I A L +
Sbjct: 63 VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRM--EVFPEVLARFYI----AELTLAIES 116
Query: 472 EWEQVVIHRDVKPSNALIDAEMNARLGDFGL---------ARLYDHGG------------ 510
+ IHRD+KP N LID + + +L DFGL ++ Y G
Sbjct: 117 VHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDL 176
Query: 511 ---------------------------MPHTTNVVGTFGYIAPELTQTGKASTSSDVFAY 543
+ H+ +VGT YIAPE+ + D ++
Sbjct: 177 WDDVSNCRCGDRLKTLEQRATKQHQRCLAHS--LVGTPNYIAPEVLLRKGYTQLCDWWSV 234
Query: 544 GILLLEVATGRRP 556
G++L E+ G+ P
Sbjct: 235 GVILFEMLVGQPP 247
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 2e-09
Identities = 60/227 (26%), Positives = 100/227 (44%), Gaps = 37/227 (16%)
Query: 355 FKESEVIGIGGFGSVYKGVLPT---TGGEVAVK--KITRNSLQGMREFAAEIESLGRLRH 409
F ++G G FGSV + L + + +VAVK K S + EF E + H
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 410 KNL-----VNLHGWCKQKNDL-LLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNI----- 458
N+ V+L K + + +++ ++ +G L T L + G E+ F +
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIG-----EEPFTLPLQTL 115
Query: 459 ---VKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARL-----YDHGG 510
+ IASG+ YL + IHRD+ N +++ M + DFGL++ Y G
Sbjct: 116 VRFMIDIASGMEYLSS---KNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQG 172
Query: 511 MPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVAT-GRRP 556
V ++A E +T SDV+A+G+ + E+ T G+ P
Sbjct: 173 CASKLPV----KWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTP 215
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 3e-09
Identities = 57/204 (27%), Positives = 95/204 (46%), Gaps = 19/204 (9%)
Query: 361 IGIGGFGSVYKGVLPTTGGEVAVKKITR--NSLQGMREFAAEIESLGRLRHKNLVNL--- 415
IG G FG V+ P G VA+KK+ +L + E++ L +H N+++
Sbjct: 8 IGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDI 67
Query: 416 ----HGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHE 471
H ++ + V + L ++ P+ S D + F + I GL YLH
Sbjct: 68 LQPPHIDPFEE---IYVVTELMQSDLHKIIVSPQPLSS-DHVKVF--LYQILRGLKYLHS 121
Query: 472 EWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPELTQT 531
++HRD+KP N L+++ ++ DFGLAR+ + H T V T Y APE+
Sbjct: 122 AG---ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMG 178
Query: 532 GKASTSS-DVFAYGILLLEVATGR 554
+ TS+ D+++ G + E+ R
Sbjct: 179 SRHYTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 3e-09
Identities = 61/209 (29%), Positives = 98/209 (46%), Gaps = 31/209 (14%)
Query: 361 IGIGGFGSVYKGVLPTTGGEVAVKKI--TRNSL----QGMREFAAEIES---LGRLRHKN 411
+G G F ++YKGVL V L R+ A E+ + +L HK+
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 412 LVNLHGWC-KQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLH 470
LV L+G C + +N ++V EY+ G LD L + K+ L W + ++ K +AS L YL
Sbjct: 63 LVKLYGVCVRDEN--IMVEEYVKFGPLDVFLHREKNNVSLHW--KLDVAKQLASALHYLE 118
Query: 471 EEWEQVVIHRDVKPSNALIDAEMNARLGDFG----LARLYDHG-GMPHTTNV--VGTFGY 523
++ ++H +V N L+ AR G +L D G + + V +
Sbjct: 119 ---DKKLVHGNVCGKNILV-----ARYGLNEGYVPFIKLSDPGIPITVLSREERVERIPW 170
Query: 524 IAPELTQTGKASTSS--DVFAYGILLLEV 550
IAPE + G+AS + D +++G LLE+
Sbjct: 171 IAPECIRNGQASLTIAADKWSFGTTLLEI 199
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 3e-09
Identities = 61/222 (27%), Positives = 96/222 (43%), Gaps = 20/222 (9%)
Query: 359 EVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFA---AEIESLGRLRHKNLVNL 415
+++G G FG V TG A+K + + + E A E L RH L L
Sbjct: 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 60
Query: 416 HGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQ 475
+ + L V EY G L F V E+ I S L YLH +
Sbjct: 61 KYAFQTHDRLCFVMEYANGGEL---FFHLSRERVFTEERARFYGAEIVSALEYLHS---R 114
Query: 476 VVIHRDVKPSNALIDAEMNARLGDFGLAR--LYDHGGMPHTTNVVGTFGYIAPELTQTGK 533
V++RD+K N ++D + + ++ DFGL + + D M GT Y+APE+ +
Sbjct: 115 DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM---KTFCGTPEYLAPEVLEDND 171
Query: 534 ASTSSDVFAYGILLLEVATGRRPIGSGD------LLLVEWVR 569
+ D + G+++ E+ GR P + D L+L+E +R
Sbjct: 172 YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIR 213
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 9e-09
Identities = 65/217 (29%), Positives = 93/217 (42%), Gaps = 27/217 (12%)
Query: 359 EVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLR-HKNLVNLHG 417
E IG G +G V+K VL G A KI E AE L L H N+V +G
Sbjct: 24 ETIGKGTYGKVFK-VLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYG 82
Query: 418 WCKQKN-----DLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFN------IVKGIASGL 466
+K+ L LV E GS+ L+ L +R I+ GL
Sbjct: 83 MYYKKDVKNGDQLWLVLELCNGGSVTDLV-----KGFLKRGERMEEPIIAYILHEALMGL 137
Query: 467 LYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAP 526
+LH IHRDVK +N L+ E +L DFG++ + T+ VGT ++AP
Sbjct: 138 QHLHV---NKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS-VGTPFWMAP 193
Query: 527 ELTQTGKASTSS-----DVFAYGILLLEVATGRRPIG 558
E+ + S+ DV++ GI +E+ G P+
Sbjct: 194 EVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLA 230
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 56.4 bits (137), Expect = 1e-08
Identities = 42/156 (26%), Positives = 66/156 (42%), Gaps = 26/156 (16%)
Query: 409 HKNLVNLHGWCKQKNDLLLVYEYIPNGSL-DTLLFKPKDGSVLDWEQRFNIVKGIASGLL 467
+ N + L+ +L+ +YI +G L D L + K L + I++ + L
Sbjct: 68 NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGK----LSEAEVKKIIRQLVEALN 123
Query: 468 YLHEEWEQVVIHRDVKPSNALIDAEMN-ARLGDFGLAR------LYDHGGMPHTTNVVGT 520
LH + +IH D+K N L D + L D+GL + YD GT
Sbjct: 124 DLH---KHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCYD-----------GT 169
Query: 521 FGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRP 556
Y +PE + S D +A G+L E+ TG+ P
Sbjct: 170 LDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHP 205
|
Length = 267 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 1e-08
Identities = 47/168 (27%), Positives = 80/168 (47%), Gaps = 21/168 (12%)
Query: 399 AEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEYIPNGSLDT---------LLFKPKDGSV 449
+E+ L H +V K + LLL+ EY G L+ L F+ + +
Sbjct: 114 SELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGL 173
Query: 450 LDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLY-DH 508
L ++ IV L L E + ++HRD+K +N + +LGDFG ++ Y D
Sbjct: 174 LFYQ----IV-------LALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDS 222
Query: 509 GGMPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRP 556
+ ++ GT Y+APEL + + S +D+++ G++L E+ T RP
Sbjct: 223 VSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRP 270
|
Length = 478 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 2e-08
Identities = 53/196 (27%), Positives = 89/196 (45%), Gaps = 11/196 (5%)
Query: 361 IGIGGFGSVY--KGVLPTTGGEVAV-KKITRNSLQGMREFAAEIES--LGRLRHKNLVNL 415
+G G FG+VY K + V K+I L A E+ L +L H +V
Sbjct: 8 LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKF 67
Query: 416 HGWCKQKNDLLLVYEYIPNGSLDTLLFKPK-DGSVLDWEQRFNIVKGIASGLLYLHEEWE 474
H +++ ++ EY LD L + K G L Q + G+ Y+H+
Sbjct: 68 HASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQ--- 124
Query: 475 QVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPELTQTGKA 534
+ ++HRD+K N + + ++GDFG++RL G T GT Y++PE +
Sbjct: 125 RRILHRDLKAKNIFLKNNL-LKIGDFGVSRLL-MGSCDLATTFTGTPYYMSPEALKHQGY 182
Query: 535 STSSDVFAYGILLLEV 550
+ SD+++ G +L E+
Sbjct: 183 DSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 3e-08
Identities = 47/151 (31%), Positives = 72/151 (47%), Gaps = 15/151 (9%)
Query: 361 IGIGGFGSVYKGVLPTTGGEVAVK------KITRNSLQGMREFAAEIESLGRLRHKNLVN 414
I G FG VY G AVK I +N + ++ AE ++L + +V+
Sbjct: 12 ISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQ---AERDALALSKSPFIVH 68
Query: 415 LHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWE 474
L+ + N++ LV EY+ G + +LL D E + +A L YLH
Sbjct: 69 LYYSLQSANNVYLVMEYLIGGDVKSLLHI---YGYFDEEMAVKYISEVALALDYLHR--- 122
Query: 475 QVVIHRDVKPSNALIDAEMNARLGDFGLARL 505
+IHRD+KP N LI E + +L DFGL+++
Sbjct: 123 HGIIHRDLKPDNMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 55.9 bits (134), Expect = 3e-08
Identities = 60/236 (25%), Positives = 107/236 (45%), Gaps = 22/236 (9%)
Query: 349 YAATKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITR---NSLQGMREFAAEIESLG 405
+ K ++ + IG G G V VA+KK++R N R + E+ +
Sbjct: 13 FTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR-ELVLMK 71
Query: 406 RLRHKNLVNL-HGWCKQK-----NDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIV 459
+ HKN+++L + + QK D+ LV E + + + LD E+ ++
Sbjct: 72 CVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQME------LDHERMSYLL 125
Query: 460 KGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVG 519
+ G+ +LH +IHRD+KPSN ++ ++ ++ DFGLAR M T V
Sbjct: 126 YQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM--MTPYVV 180
Query: 520 TFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLG 575
T Y APE+ + D+++ G ++ E+ + + G + +W + QLG
Sbjct: 181 TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVR-HKILFPGRDYIDQWNKVIEQLG 235
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 5e-08
Identities = 58/210 (27%), Positives = 98/210 (46%), Gaps = 26/210 (12%)
Query: 359 EVIGIGGFGSVYKGVL--------PTTGGEVAVKKITRNSLQGMREFA-AEIESLGRLR- 408
E +G G +Y G+L E +K I + R+ + A E+ +R
Sbjct: 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQ 60
Query: 409 --HKNLVNLHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGL 466
HK++V L+G C + + ++V E++ G LD LF + VL +F + K +AS L
Sbjct: 61 VSHKHIVLLYGVCVRDVENIMVEEFVEFGPLD--LFMHRKSDVLTTPWKFKVAKQLASAL 118
Query: 467 LYLHEEWEQVVIHRDVKPSNALIDAE-MNARLGDFGLARLYDHGGMPHTT----NVVGTF 521
YL ++ ++H +V N L+ E ++ G F +L D G+P T V
Sbjct: 119 SYLE---DKDLVHGNVCTKNILLAREGIDGECGPF--IKLSD-PGIPITVLSRQECVERI 172
Query: 522 GYIAPELTQTGKA-STSSDVFAYGILLLEV 550
+IAPE + K S ++D +++G L E+
Sbjct: 173 PWIAPECVEDSKNLSIAADKWSFGTTLWEI 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 7e-08
Identities = 60/236 (25%), Positives = 107/236 (45%), Gaps = 22/236 (9%)
Query: 349 YAATKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITR---NSLQGMREFAAEIESLG 405
+ K ++ + IG G G V VA+KK++R N R + E+ +
Sbjct: 20 FTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYR-ELVLMK 78
Query: 406 RLRHKNLVNL-HGWCKQKN-----DLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIV 459
+ HKN++ L + + QK+ D+ +V E + + + LD E+ ++
Sbjct: 79 CVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQME------LDHERMSYLL 132
Query: 460 KGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVG 519
+ G+ +LH +IHRD+KPSN ++ ++ ++ DFGLAR M T V
Sbjct: 133 YQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM--MTPYVV 187
Query: 520 TFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLG 575
T Y APE+ + D+++ G ++ E+ G + G + +W + QLG
Sbjct: 188 TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG-GVLFPGTDHIDQWNKVIEQLG 242
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 3e-07
Identities = 41/151 (27%), Positives = 75/151 (49%), Gaps = 10/151 (6%)
Query: 404 LGRLRHKNLVNLHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIA 463
+ ++ H +L +HG C + ++ ++V E++ +G LD L K K + W + + + +A
Sbjct: 70 MSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAW--KITVAQQLA 127
Query: 464 SGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHG---GMPHTTNVVGT 520
S L YL ++ ++H +V N L+ A + G +L D G V
Sbjct: 128 SALSYLE---DKNLVHGNVCAKNILL-ARLGLAEGTSPFIKLSDPGVSFTALSREERVER 183
Query: 521 FGYIAPELTQTGKA-STSSDVFAYGILLLEV 550
+IAPE G + ST++D +++G LLE+
Sbjct: 184 IPWIAPECVPGGNSLSTAADKWSFGTTLLEI 214
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 53.2 bits (127), Expect = 4e-07
Identities = 79/314 (25%), Positives = 134/314 (42%), Gaps = 59/314 (18%)
Query: 344 RYKDLYAATKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMRE-----FA 398
+Y D + ++ + IG G FG V+ T K I S +G++E
Sbjct: 4 KYDDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAI---SYRGLKEREKSQLV 60
Query: 399 AEIESLGRLRHKNLVNL--HGWCKQKNDLLLVYEYIPNGSLD-------TLLFKPKDGSV 449
E+ + L+HKN+V K L ++ E+ G L + K ++ ++
Sbjct: 61 IEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAI 120
Query: 450 LDWEQRFNIVKGIASGLLYLHEEWE----QVVIHRDVKPSNAL----------IDAEMN- 494
+D I + + L Y H + + V+HRD+KP N I A+ N
Sbjct: 121 VD------ITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANN 174
Query: 495 ------ARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPELT--QTGKASTSSDVFAYGIL 546
A++GDFGL++ M H+ VGT Y +PEL +T SD++A G +
Sbjct: 175 LNGRPIAKIGDFGLSKNIGIESMAHS--CVGTPYYWSPELLLHETKSYDDKSDMWALGCI 232
Query: 547 LLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSYVVKEMELVLKLGLMCSH 606
+ E+ +G+ P + + + +L R D+ P+ S KE+ +++K L S
Sbjct: 233 IYELCSGKTPFHKAN----NFSQLISELKRGPDL--PIKGKS---KELNILIKNLLNLSA 283
Query: 607 KTQFRPTMRQVMRY 620
K RP+ Q + Y
Sbjct: 284 KE--RPSALQCLGY 295
|
Length = 1021 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 4e-07
Identities = 50/205 (24%), Positives = 94/205 (45%), Gaps = 21/205 (10%)
Query: 361 IGIGGFGSVYKGVL--PTTGGEVAVKKITRN-SLQGMREFAAEIESLGRLRHKNLVNLHG 417
IG G FG V + T V VK++ N S + EF + + L+H N++ G
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62
Query: 418 WCKQKNDLLLVYEYIPNGSLDTLL----FKPKDGSVLDWEQRFNIVKGIASGLLYLHEEW 473
C + LLV+EY G L + L + ++ +L ++ + IA+G+ ++H
Sbjct: 63 QCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQR---MACEIAAGVTHMH--- 116
Query: 474 EQVVIHRDVKPSNALIDAEMNARLGDFGLA-RLYDHGGMPHTTNVVGTFGYIAPELTQ-- 530
+ +H D+ N + +++ ++GD+G+ Y + + ++APEL
Sbjct: 117 KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEF 176
Query: 531 -----TGKASTSSDVFAYGILLLEV 550
T + + S+V+A G+ L E+
Sbjct: 177 HGGLITAEQTKPSNVWALGVTLWEL 201
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 1e-06
Identities = 46/158 (29%), Positives = 72/158 (45%), Gaps = 21/158 (13%)
Query: 355 FKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFA---AEIESLGRLRHKN 411
F +VIG G FG V TG A+K + ++ + + A AE + L
Sbjct: 3 FHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPW 62
Query: 412 LVNLHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWE------QRFNIVKGIASG 465
+V+L+ + L L+ E++P G L T+L K ++ RF + A
Sbjct: 63 VVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIK--------YDTFSEDVTRFYM----AEC 110
Query: 466 LLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLA 503
+L + + IHRD+KP N LID + +L DFGL+
Sbjct: 111 VLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLS 148
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 2e-06
Identities = 61/228 (26%), Positives = 101/228 (44%), Gaps = 45/228 (19%)
Query: 343 FRYKDLYAATKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITR---NSLQGMREFAA 399
RY++L + IG G G V TG VA+KK++R N R +
Sbjct: 16 KRYQNL----------KPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYR- 64
Query: 400 EIESLGRLRHKNLVN-LHGWCKQK-----NDLLLVYEYIPNGSLDTLLFKPKDGSV---- 449
E+ + + HKN++ L+ + QK D+ LV E + D ++
Sbjct: 65 ELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELM-------------DANLCQVI 111
Query: 450 ---LDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLY 506
LD E+ ++ + G+ +LH +IHRD+KPSN ++ ++ ++ DFGLAR
Sbjct: 112 QMDLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA 168
Query: 507 DHGGMPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGR 554
M T V T Y APE+ + D+++ G ++ E+ G
Sbjct: 169 GTSFM--MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 4e-06
Identities = 61/231 (26%), Positives = 102/231 (44%), Gaps = 32/231 (13%)
Query: 346 KDLYAATKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLG 405
+D+ +T+ FK ++G G FG V + AV KI RN + R+ EI+ +
Sbjct: 122 EDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAV-KIVRNVPKYTRDAKIEIQFME 180
Query: 406 RLRHKNLVNLHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGS-VLDWEQR---FN---- 457
++R + + + L+ + Y N + + PK G +LDW + F+
Sbjct: 181 KVRQADPAD-------RFPLMKIQRYFQNETGHMCIVMPKYGPCLLDWIMKHGPFSHRHL 233
Query: 458 --IVKGIASGLLYLHEEWEQVVIHRDVKPSNAL-------IDAEMNARL-GDFGLARLYD 507
I+ L Y H E ++H D+KP N L +D N L D R+ D
Sbjct: 234 AQIIFQTGVALDYFHTELH--LMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICD 291
Query: 508 HGGM---PHT-TNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGR 554
GG H+ T +V T Y +PE+ S+D+++ G ++ E+ TG+
Sbjct: 292 LGGCCDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGK 342
|
Length = 467 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 7e-06
Identities = 31/97 (31%), Positives = 44/97 (45%), Gaps = 3/97 (3%)
Query: 458 IVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNV 517
I + + + YLHE +IHRD+K N I+ + LGDFG A
Sbjct: 187 IERSVLRAIQYLHE---NRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGW 243
Query: 518 VGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGR 554
GT APEL + D+++ GI+L E+AT
Sbjct: 244 AGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 47.7 bits (114), Expect = 1e-05
Identities = 56/247 (22%), Positives = 93/247 (37%), Gaps = 46/247 (18%)
Query: 348 LYAATKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFA---AEIESL 404
L K F++ + K T VAVKKI +S + EI +
Sbjct: 3 LTLIGKCFED------LMIVHLAKHK--PTNTLVAVKKINLDS-CSKEDLKLLQQEIITS 53
Query: 405 GRLRHKNLVNLHGWCKQKNDLLLVYEYIPNGSLDTLL---FKPKDG---SVLDWEQRFNI 458
+L+H N++ ++L +V + GS + LL F +G + I
Sbjct: 54 RQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFP--EGLPELAIA-----FI 106
Query: 459 VKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMP------ 512
+K + + L Y+H + IHR VK S+ L+ + L + G
Sbjct: 107 LKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHD 163
Query: 513 HTTNVVGTFGYIAPELTQ------TGKASTSSDVFAYGILLLEVATGRRPIGSGD--LLL 564
+ V +++PE+ Q K SD+++ GI E+A G P +L
Sbjct: 164 FPKSSVKNLPWLSPEVLQQNLQGYNEK----SDIYSVGITACELANGHVPFKDMPATQML 219
Query: 565 VEWVREC 571
+E VR
Sbjct: 220 LEKVRGT 226
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 5e-05
Identities = 31/104 (29%), Positives = 51/104 (49%), Gaps = 6/104 (5%)
Query: 450 LDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHG 509
L Q + + + S + Y+H E +IHRD+K N L++ + LGDFG A + G
Sbjct: 257 LGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFG-AACFARG 312
Query: 510 --GMPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVA 551
P + GT APE+ + S D+++ G+++ E A
Sbjct: 313 SWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAA 356
|
Length = 461 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 6e-05
Identities = 55/210 (26%), Positives = 90/210 (42%), Gaps = 40/210 (19%)
Query: 433 PNGSLDTLLFKPKDGSV-LDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDA 491
+ S D+ + + S LD + +A G+ +L + IHRDV N L+
Sbjct: 191 SSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLAS---KNCIHRDVAARNVLLTD 247
Query: 492 EMNARLGDFGLARLYDHGGMPHTTNVVG-----TFGYIAPELTQTGKASTSSDVFAYGIL 546
A++ DFGLAR M + VV ++APE + SDV++YGIL
Sbjct: 248 GRVAKICDFGLARDI----MNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGIL 303
Query: 547 LLEV-ATGRRPIGSGDLLLVE-----WVRECHQLGRILDVADPLLNSSYVVKEMELVLKL 600
L E+ + G+ P +LV V+ +Q+ R + E+ ++K
Sbjct: 304 LWEIFSLGKSPYPG---ILVNSKFYKMVKRGYQMSR----------PDFAPPEIYSIMK- 349
Query: 601 GLMC--SHKTQFRPTMRQVMRYLSGEKQLR 628
MC T+ RPT Q+ + + ++QL
Sbjct: 350 --MCWNLEPTE-RPTFSQISQLI--QRQLG 374
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173892 cd07308, lectin_leg-like, legume-like lectins: ERGIC-53, ERGL, VIP36, VIPL, EMP46, and EMP47 | Back alignment and domain information |
|---|
Score = 41.6 bits (98), Expect = 6e-04
Identities = 50/233 (21%), Positives = 76/233 (32%), Gaps = 54/233 (23%)
Query: 43 SLQGAEIIKPSGALKLTNRSRYVIGHAFYVKPIQMFDTSASPSPNASSFSTTFVFEISTP 102
++ G+ +I ++LT G + PI F F I
Sbjct: 23 TVGGSTVIT-KNYIRLTPDVPSQSGSLWSRVPIPA-----------KDFEIEVEFSIHGG 70
Query: 103 RSGRGGHGLAFLL----APSTKLPGAQPEHYLGI---LNSTNNGEPSNHILIVEFDTVNG 155
SG GG G AF L G P+ + G+ ++ +N F +++
Sbjct: 71 -SGLGGDGFAFWYTEEPGSDGPLFGG-PDKFKGLAIFFDTYDNDG-------KGFPSISV 121
Query: 156 F-NDKAENQGNHVGIGINTMFSNRS--EPASYYINGTDHKEEMTLESGEPIQAWIEYDGE 212
F ND G ++ E AS + + S P I Y
Sbjct: 122 FLND---------GTKSYDYETDGEKLELASCSLKFRN--------SNAPTTLRISYLNN 164
Query: 213 QKVLNVTISPAEIGKPMRPLISFGVNLTGYIKETMYVGFSASTGEKSSSHYIL 265
+++T S K F V + Y GFSA TG+ S +H IL
Sbjct: 165 TLKVDITYSEGNNWK-----ECFTVEDVILPSQG-YFGFSAQTGDLSDNHDIL 211
|
The legume-like (leg-like) lectins are eukaryotic intracellular sugar transport proteins with a carbohydrate recognition domain similar to that of the legume lectins. This domain binds high-mannose-type oligosaccharides for transport from the endoplasmic reticulum to the Golgi complex. These leg-like lectins include ERGIC-53, ERGL, VIP36, VIPL, EMP46, EMP47, and the UIP5 (ULP1-interacting protein 5) precursor protein. Leg-like lectins have different intracellular distributions and dynamics in the endoplasmic reticulum-Golgi system of the secretory pathway and interact with N-glycans of glycoproteins in a calcium-dependent manner, suggesting a role in glycoprotein sorting and trafficking. L-type lectins have a dome-shaped beta-barrel carbohydrate recognition domain with a curved seven-stranded beta-sheet referred to as the "front face" and a flat six-stranded beta-sheet referred to as the "back face". This domain homodimerizes so that adjacent back sheets form a contiguous 12-stranded sheet and homotetramers occur by a back-to-back association of these homodimers. Though L-type lectins exhibit both sequence and structural similarity to one another, their carbohydrate binding specificities differ widely. Length = 218 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 8e-04
Identities = 28/81 (34%), Positives = 42/81 (51%), Gaps = 11/81 (13%)
Query: 478 IHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVG---TF---GYIAPELTQT 531
+HRD+ N LI ++ DFGLAR + +N + TF ++APE
Sbjct: 261 VHRDLAARNVLICEGKLVKICDFGLAR-----DIMRDSNYISKGSTFLPLKWMAPESIFN 315
Query: 532 GKASTSSDVFAYGILLLEVAT 552
+T SDV+++GILL E+ T
Sbjct: 316 NLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 0.001
Identities = 29/79 (36%), Positives = 42/79 (53%), Gaps = 11/79 (13%)
Query: 478 IHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVG---TF---GYIAPELTQT 531
+HRD+ N L+ ++ DFGLAR + H +N V TF ++APE
Sbjct: 259 VHRDLAARNVLLAQGKIVKICDFGLAR-----DIMHDSNYVSKGSTFLPVKWMAPESIFD 313
Query: 532 GKASTSSDVFAYGILLLEV 550
+T SDV++YGILL E+
Sbjct: 314 NLYTTLSDVWSYGILLWEI 332
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.002
Identities = 24/74 (32%), Positives = 38/74 (51%), Gaps = 1/74 (1%)
Query: 478 IHRDVKPSNALIDAEMNARLGDFGLAR-LYDHGGMPHTTNVVGTFGYIAPELTQTGKAST 536
IHRD+ N L+ ++ DFGLAR +Y + ++APE +T
Sbjct: 196 IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFDKVYTT 255
Query: 537 SSDVFAYGILLLEV 550
SDV+++G+LL E+
Sbjct: 256 QSDVWSFGVLLWEI 269
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 0.003
Identities = 29/86 (33%), Positives = 43/86 (50%), Gaps = 7/86 (8%)
Query: 359 EVIGIGGFGSVYKGVLPTTGGE-----VAVKKITRNSLQGMRE-FAAEIESLGRL-RHKN 411
+ +G G FG V + G E VAVK + ++ RE +E++ L L +HKN
Sbjct: 44 KTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKN 103
Query: 412 LVNLHGWCKQKNDLLLVYEYIPNGSL 437
+VNL G C +L++ EY G L
Sbjct: 104 IVNLLGACTHGGPVLVITEYCCYGDL 129
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.003
Identities = 24/76 (31%), Positives = 39/76 (51%), Gaps = 1/76 (1%)
Query: 478 IHRDVKPSNALIDAEMNARLGDFGLAR-LYDHGGMPHTTNVVGTFGYIAPELTQTGKAST 536
IHRD+ N L+ ++ DFGLAR +Y + ++APE +T
Sbjct: 195 IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFDKVYTT 254
Query: 537 SSDVFAYGILLLEVAT 552
SDV+++G+LL E+ +
Sbjct: 255 QSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.003
Identities = 32/106 (30%), Positives = 49/106 (46%), Gaps = 4/106 (3%)
Query: 446 DGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLAR- 504
D LD E + +A G+ +L + IHRD+ N L+ ++ DFGLAR
Sbjct: 207 DELALDTEDLLSFSYQVAKGMSFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARD 263
Query: 505 LYDHGGMPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEV 550
+ + N ++APE + SDV++YGILL E+
Sbjct: 264 IRNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEI 309
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 668 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06899 | 236 | lectin_legume_LecRK_Arcelin_ConA legume lectins, l | 100.0 | |
| PF00139 | 236 | Lectin_legB: Legume lectin domain; InterPro: IPR00 | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd01951 | 223 | lectin_L-type legume lectins. The L-type (legume-t | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.98 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.98 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.98 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.98 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.97 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.97 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.97 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.97 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.97 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.97 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.96 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.96 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.96 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.96 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.96 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.96 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.95 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.95 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.95 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.95 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.94 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.94 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.93 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.93 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.93 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.93 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.92 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.92 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.9 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.9 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.88 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.88 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.88 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.86 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.85 | |
| cd07308 | 218 | lectin_leg-like legume-like lectins: ERGIC-53, ERG | 99.85 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.82 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.81 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.81 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.8 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.79 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.79 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.78 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.78 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.76 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.75 | |
| cd06901 | 248 | lectin_VIP36_VIPL VIP36 and VIPL type 1 transmembr | 99.72 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.72 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.71 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.7 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.69 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.69 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.69 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.68 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.67 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.66 | |
| cd06902 | 225 | lectin_ERGIC-53_ERGL ERGIC-53 and ERGL type 1 tran | 99.65 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.61 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.57 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.56 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.51 | |
| cd06903 | 215 | lectin_EMP46_EMP47 EMP46 and EMP47 type 1 transmem | 99.49 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.43 | |
| PF03388 | 229 | Lectin_leg-like: Legume-like lectin family; InterP | 99.42 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.4 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.4 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.27 | |
| KOG3839 | 351 | consensus Lectin VIP36, involved in the transport | 99.27 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.26 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.26 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.21 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.16 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.09 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.02 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.0 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.98 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.97 | |
| KOG3838 | 497 | consensus Mannose lectin ERGIC-53, involved in gly | 98.82 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.82 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.74 | |
| cd06900 | 255 | lectin_VcfQ VcfQ bacterial pilus biogenesis protei | 98.63 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.52 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.47 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.47 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.47 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.43 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.37 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.37 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.23 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.17 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.17 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.14 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.0 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 97.97 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.93 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.91 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.83 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.77 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.69 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.66 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.55 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.43 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.42 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.42 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.39 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.34 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.2 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.09 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 96.95 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 96.7 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 96.64 | |
| PLN02236 | 344 | choline kinase | 96.61 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 96.44 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.38 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.27 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.25 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 95.76 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 95.64 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 95.58 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 95.47 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 95.2 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 95.18 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-56 Score=472.05 Aligned_cols=284 Identities=48% Similarity=0.796 Sum_probs=251.8
Q ss_pred CCcccchhhHHHHhcCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCchhHHHHHHHHHHHhcccccCceeEeee
Q 005940 339 CPHRFRYKDLYAATKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNLHGW 418 (668)
Q Consensus 339 ~~~~f~~~el~~at~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~ 418 (668)
..+.|+++++..||++|+..++||+|+||.||+|.+. ++..||||++.....+..++|.+|++++.+++|||+|+|+||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~-~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGy 139 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLS-DGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGY 139 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEEC-CCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEE
Confidence 4678999999999999999999999999999999995 458999998877654315679999999999999999999999
Q ss_pred ecccC-ceEEEEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEE
Q 005940 419 CKQKN-DLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARL 497 (668)
Q Consensus 419 ~~~~~-~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl 497 (668)
|.+.+ +.+||||||++|+|+++|+..... .|+|.+|++|+.++|+||+|||+.+.++|+||||||+|||||+++++||
T Consensus 140 C~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKl 218 (361)
T KOG1187|consen 140 CLEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKL 218 (361)
T ss_pred EecCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEc
Confidence 99998 499999999999999999854433 8999999999999999999999998889999999999999999999999
Q ss_pred EeecCceeccC-CCCCcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC----chhHHHHHHHHH
Q 005940 498 GDFGLARLYDH-GGMPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSG----DLLLVEWVRECH 572 (668)
Q Consensus 498 ~DfGla~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~----~~~l~~~~~~~~ 572 (668)
+|||+|+.... ........ .||.+|+|||+...+..++|+|||||||+|+||+||++|.+.. +..+.+|++...
T Consensus 219 sDFGLa~~~~~~~~~~~~~~-~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~ 297 (361)
T KOG1187|consen 219 SDFGLAKLGPEGDTSVSTTV-MGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLL 297 (361)
T ss_pred cCccCcccCCccccceeeec-CCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHH
Confidence 99999976554 22211111 7999999999999999999999999999999999999988742 455899999999
Q ss_pred hcCccccccCcccC-CcccH-HHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhccCc
Q 005940 573 QLGRILDVADPLLN-SSYVV-KEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSGEK 625 (668)
Q Consensus 573 ~~~~~~~~~d~~l~-~~~~~-~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~~~ 625 (668)
..+++.+++|+.+. ..+.. ++++++..++++|.+. |++||+|.||++.|+...
T Consensus 298 ~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~ 353 (361)
T KOG1187|consen 298 EEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGIL 353 (361)
T ss_pred HCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence 99999999999987 55664 7899999999999998 999999999999995543
|
|
| >cd06899 lectin_legume_LecRK_Arcelin_ConA legume lectins, lectin-like receptor kinases, arcelin, concanavalinA, and alpha-amylase inhibitor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-53 Score=426.19 Aligned_cols=233 Identities=46% Similarity=0.796 Sum_probs=209.2
Q ss_pred eeEEeCCCCCCCCCeEEeCceeeCCCCcEEccCCC--CceEEEEEeeCceecccCCCCCCCCeeeeEEEEEEEEeCCCCC
Q 005940 28 SSFIFQGFNGGATNLSLQGAEIIKPSGALKLTNRS--RYVIGHAFYVKPIQMFDTSASPSPNASSFSTTFVFEISTPRSG 105 (668)
Q Consensus 28 ~~f~~~~f~~~~~~l~~~g~a~~~~~~~~~lt~~~--~~~~G~~~y~~p~~l~~~~~~~~~~~~sF~t~F~f~i~~~~~~ 105 (668)
++|+|++|.....+++++|+|.+..++.|+||++. .+++|||+|++||+||+ ..+++++||+|+|+|.|.+++..
T Consensus 1 ~~f~f~~f~~~~~~l~l~G~A~~~~~~~i~LT~~~~~~~~~G~v~y~~pi~l~~---~~~~~~~sFst~F~F~i~~~~~~ 77 (236)
T cd06899 1 LSFNFNGFSSDQSNLTLQGDATISSNGALQLTNDTSPASSVGRALYSKPVRLWD---STTGKVASFSTSFSFSITPPNPS 77 (236)
T ss_pred CceecCCCCCCCCCEEEecceEcCCCCeEEecCCCCCCcceEEEEeCCCEEeec---CCCCCceeEEEEEEEEEEcCCCC
Confidence 47999999876679999999999768999999998 89999999999999999 78899999999999999988767
Q ss_pred CCCCceEEEEcCCCCCCCCCCCCcccccccCCCCCCCccEEEEEeecccCCCCCCCCCCCeeeeecCCcccccccCCccc
Q 005940 106 RGGHGLAFLLAPSTKLPGAQPEHYLGILNSTNNGEPSNHILIVEFDTVNGFNDKAENQGNHVGIGINTMFSNRSEPASYY 185 (668)
Q Consensus 106 ~~g~GlaF~l~p~~~~~~~~~~~~lGl~~~~~~~~~~~~~~aVEfDt~~n~~d~~~~~~~Hvgid~~s~~s~~~~~~~~~ 185 (668)
.+||||||||+|+...+.++.|++||+++.+++++..+++|||||||++|.++ .||++||||||+|++.|..+..+..
T Consensus 78 ~~gdGlAF~i~~~~~~~~~~~G~~lG~~~~~~~~~~~~~~vAVEFDT~~n~~~-~D~~~nHigIdvn~~~S~~~~~~~~- 155 (236)
T cd06899 78 LGGDGLAFFLAPTDSLPPASSGGYLGLFNSSNNGNSSNHIVAVEFDTFQNPEF-GDPDDNHVGIDVNSLVSVKAGYWDD- 155 (236)
T ss_pred CCCCeEEEEEecCCCCCCCCCcceeeeecCCCCCCcccceEEEEeecccCccc-CCCCCCeEEEEcCCcccceeecccc-
Confidence 88999999999987656578899999999888777889999999999999321 3499999999999998887765542
Q ss_pred cCCCCCccccccCCCCcEEEEEEEeCCcceEEEEEEeCCCCCCCCcceeeeeccccccccceeeeeecccCCcccceeee
Q 005940 186 INGTDHKEEMTLESGEPIQAWIEYDGEQKVLNVTISPAEIGKPMRPLISFGVNLTGYIKETMYVGFSASTGEKSSSHYIL 265 (668)
Q Consensus 186 ~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~V~~~~~~~~~p~~~~ls~~~dLs~~l~~~~~vGFsastG~~~~~~~i~ 265 (668)
....|.+|+.++|||+||+..++|+|+|++.+..+|..|+|+..+||+.+|+++|||||||+||...|.|+|+
T Consensus 156 -------~~~~l~~g~~~~v~I~Y~~~~~~L~V~l~~~~~~~~~~~~ls~~vdL~~~l~~~~~vGFSasTG~~~~~h~i~ 228 (236)
T cd06899 156 -------DGGKLKSGKPMQAWIDYDSSSKRLSVTLAYSGVAKPKKPLLSYPVDLSKVLPEEVYVGFSASTGLLTELHYIL 228 (236)
T ss_pred -------ccccccCCCeEEEEEEEcCCCCEEEEEEEeCCCCCCcCCEEEEeccHHHhCCCceEEEEEeEcCCCcceEEEE
Confidence 1345789999999999999999999999988877899999999999999999999999999999999999999
Q ss_pred ccccccc
Q 005940 266 GWSFSLN 272 (668)
Q Consensus 266 ~w~F~~~ 272 (668)
+|+|++.
T Consensus 229 sWsF~s~ 235 (236)
T cd06899 229 SWSFSSN 235 (236)
T ss_pred EEEEEcC
Confidence 9999874
|
This alignment model includes the legume lectins (also known as agglutinins), the arcelin (also known as phytohemagglutinin-L) family of lectin-like defense proteins, the LecRK family of lectin-like receptor kinases, concanavalinA (ConA), and an alpha-amylase inhibitor. Arcelin is a major seed glycoprotein discovered in kidney beans (Phaseolus vulgaris) that has insecticidal properties and protects the seeds from predation by larvae of various bruchids. Arcelin is devoid of monosaccharide binding properties and lacks a key metal-binding loop that is present in other members of this family. Phytohaemagglutinin (PHA) is a lectin found in plants, especially beans, that affects cell metabolism by inducing mitosis and by altering the permeability of the cell membrane to various proteins. PHA agglutinates most mammalian red blood cell types by bindin |
| >PF00139 Lectin_legB: Legume lectin domain; InterPro: IPR001220 Legume lectins are one of the largest lectin families with more than 70 lectins reported | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-51 Score=410.47 Aligned_cols=231 Identities=42% Similarity=0.765 Sum_probs=202.9
Q ss_pred ceeEEeCCCCCCCCCeEEeCceeeCCCCcEEccCCCC-ceEEEEEeeCceecccCCCCCCCCeeeeEEEEEEEEeCC--C
Q 005940 27 SSSFIFQGFNGGATNLSLQGAEIIKPSGALKLTNRSR-YVIGHAFYVKPIQMFDTSASPSPNASSFSTTFVFEISTP--R 103 (668)
Q Consensus 27 ~~~f~~~~f~~~~~~l~~~g~a~~~~~~~~~lt~~~~-~~~G~~~y~~p~~l~~~~~~~~~~~~sF~t~F~f~i~~~--~ 103 (668)
+++|+|+.| .+..++++.|+|.+..+|.|+||++.. +++|||+|++||+||| +.++.++||+|+|+|.|... .
T Consensus 1 ~~~F~~~~F-~~~~~~~l~G~A~~~~~~~l~LT~~~~~~~~G~~~y~~pi~l~d---~~~~~~~sF~t~F~f~i~~~~~~ 76 (236)
T PF00139_consen 1 SVSFSFPSF-SNSSNLTLNGDASISSNGSLQLTPDSTNNQAGRAWYNNPIQLWD---STTGNVASFSTSFSFSITNGPGS 76 (236)
T ss_dssp EEEEEESSB-TTGTTEEEEETEEEETTSEEESSTBETSSEEEEEEESSEEESBE---TTTTEBEEEEEEEEEEEEESSSS
T ss_pred CceEEcCCC-CCCCceEEEeeEEeccCCeEEcCCCCCCCcEEEEEECCcEEEeC---CCCcceeeeeeEEEEEEeccCCC
Confidence 368999999 335899999999996689999999888 9999999999999999 88888999999999999632 4
Q ss_pred CCCCCCceEEEEcCCCCCCCCCCCCcccccccCCCCCCCccEEEEEeecccC--CCCCCCCCCCeeeeecCCcccccccC
Q 005940 104 SGRGGHGLAFLLAPSTKLPGAQPEHYLGILNSTNNGEPSNHILIVEFDTVNG--FNDKAENQGNHVGIGINTMFSNRSEP 181 (668)
Q Consensus 104 ~~~~g~GlaF~l~p~~~~~~~~~~~~lGl~~~~~~~~~~~~~~aVEfDt~~n--~~d~~~~~~~Hvgid~~s~~s~~~~~ 181 (668)
...+||||||||+|+...+.++.|++||+++.+.++...++.|||||||++| ++| |++||||||+|++.|..+.+
T Consensus 77 ~~~~~dGlAFvi~~~~~~~~~~~g~~lG~~~~~~~~~~~~~~vAVEFDT~~N~~~~d---~~~nHIgI~~n~~~s~~~~~ 153 (236)
T PF00139_consen 77 SNNGGDGLAFVIQPDPNLPGGSSGGYLGLFNSSTDGNGINNSVAVEFDTYKNPEYND---PDDNHIGIDVNSVVSNKTAS 153 (236)
T ss_dssp SSS-BEEEEEEEEETTSSTTTSSGGGTTTSSSSSTTGGGGCEEEEEEETSTCGGGTT---TSSSEEEEEESSSSESEEEE
T ss_pred CccCCCceEEEEecCcccccCCCCCccCccccccCCCccCcEEEEEEeeeecccccc---cCCCEEEEECCCCccccccc
Confidence 5778999999999988777778999999999887777788999999999997 456 88999999999999999877
Q ss_pred CccccCCCCCccccccCCCCcEEEEEEEeCCcceEEEEEEeCCCCCCCCcceeeeeccccccccceeeeeecccCCcccc
Q 005940 182 ASYYINGTDHKEEMTLESGEPIQAWIEYDGEQKVLNVTISPAEIGKPMRPLISFGVNLTGYIKETMYVGFSASTGEKSSS 261 (668)
Q Consensus 182 ~~~~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~V~~~~~~~~~p~~~~ls~~~dLs~~l~~~~~vGFsastG~~~~~ 261 (668)
++++ .....++.+|+.++|||+||+..++|+|++.... .+|..|+|+..+||+.+|+++|||||||+||...|.
T Consensus 154 ~~~~-----~~~~~~l~~g~~~~v~I~Yd~~~~~L~V~l~~~~-~~~~~~~l~~~vdL~~~l~~~v~vGFsasTG~~~~~ 227 (236)
T PF00139_consen 154 AGYY-----SSPSFSLSDGKWHTVWIDYDASTKRLSVYLDDNS-SKPSSPVLSVNVDLSAVLPEQVYVGFSASTGGSYQT 227 (236)
T ss_dssp ---------EEEEHHHGTTSEEEEEEEEETTTTEEEEEEEETT-TTSEEEEEEEE--HHHHSCSEEEEEEEEEESSSSEE
T ss_pred cccc-----ccccccccCCcEEEEEEEEcCCccEEEEEEeccc-CCCcceeEEEEEchHHhcCCCcEEEEEeecCCCcce
Confidence 7654 2346788999999999999999999999999874 689999999999999999999999999999999999
Q ss_pred eeeeccccc
Q 005940 262 HYILGWSFS 270 (668)
Q Consensus 262 ~~i~~w~F~ 270 (668)
|.|++|+|+
T Consensus 228 h~I~sW~F~ 236 (236)
T PF00139_consen 228 HDILSWSFS 236 (236)
T ss_dssp EEEEEEEEE
T ss_pred EEEEEEEeC
Confidence 999999995
|
Leguminous plant lectins resemble each other in their physicochemical properties although they differ in their carbohydrate specificities. They consist of two or four subunits with relative molecular mass of 30 kDa and each subunit has one carbohydrate-binding site. The interaction with sugars requires tightly bound calcium and manganese ions. The structural similarities of these lectins are reported by the primary structural analyses and X-ray crystallographic studies. X-ray studies have shown that the folding of the polypeptide chains in the region of the carbohydrate-binding sites is also similar, despite differences in the primary sequences. The carbohydrate-binding sites of these lectins consist of two conserved amino acids on beta pleated sheets. One of these loops contains transition metals, calcium and manganese, which keep the amino acid residues of the sugar-binding site at the required positions. Amino acid sequences of this loop play an important role in the carbohydrate-binding specificities of these lectins. These lectins bind either glucose/mannose or galactose. The exact function of legume lectins is not known but they may be involved in the attachment of nitrogen-fixing bacteria to legumes and in the protection against pathogens. Some legume lectins are proteolytically processed to produce two chains, beta (which corresponds to the N-terminal) and alpha (C-terminal) (IPR000985 from INTERPRO). The lectin concanavalin A (conA) from jack bean is exceptional in that the two chains are transposed and ligated (by formation of a new peptide bond). The N terminus of mature conA thus corresponds to that of the alpha chain and the C terminus to the beta chain.; GO: 0005488 binding; PDB: 1VLN_B 2GDF_C 2JE9_C 2JEC_C 1DGL_B 2P37_B 2CWM_A 2P34_D 2OW4_A 3IPV_B .... |
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-45 Score=383.82 Aligned_cols=251 Identities=34% Similarity=0.517 Sum_probs=205.0
Q ss_pred cceeeeecCcEEEEEEEeCCCCcE-EEEEEEecCCch--hHHHHHHHHHHHhcccccCceeEeeeecccC-ceEEEEEec
Q 005940 357 ESEVIGIGGFGSVYKGVLPTTGGE-VAVKKITRNSLQ--GMREFAAEIESLGRLRHKNLVNLHGWCKQKN-DLLLVYEYI 432 (668)
Q Consensus 357 ~~~~lG~G~~g~Vy~~~~~~~~~~-vavK~~~~~~~~--~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~-~~~lV~E~~ 432 (668)
..+.||+|+||+||+|.+. |.. ||||++...... ..++|.+|+.+|.+++|||||+++|.|.+.. .+++|||||
T Consensus 45 ~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~ 122 (362)
T KOG0192|consen 45 IEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYM 122 (362)
T ss_pred hhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeC
Confidence 3456999999999999994 556 999999765432 2569999999999999999999999999887 799999999
Q ss_pred CCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCc-eEecCCCCCCEEECCCC-CEEEEeecCceeccCCC
Q 005940 433 PNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQV-VIHRDVKPSNALIDAEM-NARLGDFGLARLYDHGG 510 (668)
Q Consensus 433 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~-ivHrDLkp~NIll~~~~-~~kl~DfGla~~~~~~~ 510 (668)
++|+|.++|+.. ....+++..+++++.|||+||.|||+ .+ ||||||||+||||+.++ ++||+|||+++......
T Consensus 123 ~~GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~---~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~ 198 (362)
T KOG0192|consen 123 PGGSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHS---EGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK 198 (362)
T ss_pred CCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhc---CCCeeecccChhhEEEcCCCCEEEECCCccceeecccc
Confidence 999999999753 46789999999999999999999999 67 99999999999999997 99999999998766532
Q ss_pred CCcccccccCCcccCccccc--CCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCcccCCc
Q 005940 511 MPHTTNVVGTFGYIAPELTQ--TGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSS 588 (668)
Q Consensus 511 ~~~~~~~~gt~~y~aPE~~~--~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 588 (668)
...+...||..|||||++. ...++.|+|||||||++|||+||+.||..... ...+......... |.+...
T Consensus 199 -~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~--~~~~~~v~~~~~R-----p~~p~~ 270 (362)
T KOG0192|consen 199 -TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP--VQVASAVVVGGLR-----PPIPKE 270 (362)
T ss_pred -ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH--HHHHHHHHhcCCC-----CCCCcc
Confidence 2233368999999999999 56899999999999999999999999986543 2222222212211 111111
Q ss_pred ccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhccCc
Q 005940 589 YVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSGEK 625 (668)
Q Consensus 589 ~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~~~ 625 (668)
....+..++..||+. |++||++.+|+..|+...
T Consensus 271 ----~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~ 304 (362)
T KOG0192|consen 271 ----CPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIM 304 (362)
T ss_pred ----CCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHH
Confidence 234456666789998 999999999999998553
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-44 Score=363.77 Aligned_cols=250 Identities=29% Similarity=0.414 Sum_probs=207.4
Q ss_pred cceeeeecCcEEEEEEEeCCCCcEEEEEEEecCC-chhHHHHHHHHHHHhcccccCceeEeeeecccC-ceEEEEEecCC
Q 005940 357 ESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNS-LQGMREFAAEIESLGRLRHKNLVNLHGWCKQKN-DLLLVYEYIPN 434 (668)
Q Consensus 357 ~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~-~~~lV~E~~~~ 434 (668)
..+.||+|..|+|||+.++.+++.+|+|.+.... ....+++.+|++++++.+||+||.++|.|..++ +.+++||||.+
T Consensus 83 ~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYMDg 162 (364)
T KOG0581|consen 83 RLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYMDG 162 (364)
T ss_pred hhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhcCC
Confidence 4678999999999999999999999999995443 345678999999999999999999999999988 59999999999
Q ss_pred CChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCCCCcc
Q 005940 435 GSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHT 514 (668)
Q Consensus 435 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 514 (668)
|||+.++.. .+.+++...-+|+.+|++||.|||+ +++|+||||||+|||++.+|++||||||.++.+.+. ..
T Consensus 163 GSLd~~~k~---~g~i~E~~L~~ia~~VL~GL~YLh~--~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS---~a 234 (364)
T KOG0581|consen 163 GSLDDILKR---VGRIPEPVLGKIARAVLRGLSYLHE--ERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS---IA 234 (364)
T ss_pred CCHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhh--ccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh---hc
Confidence 999999953 3569999999999999999999996 399999999999999999999999999999987765 34
Q ss_pred cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCcccCCcccHHHH
Q 005940 515 TNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSYVVKEM 594 (668)
Q Consensus 515 ~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 594 (668)
...+||..|||||.+.++.|+.++||||||+.++|+++|+.|+........+|..-+. .+.+-..|.+....-.+|
T Consensus 235 ~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~---~Iv~~ppP~lP~~~fS~e- 310 (364)
T KOG0581|consen 235 NTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLC---AIVDEPPPRLPEGEFSPE- 310 (364)
T ss_pred ccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHH---HHhcCCCCCCCcccCCHH-
Confidence 5579999999999999999999999999999999999999999764221222222111 122223355544422233
Q ss_pred HHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 595 ELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 595 ~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
+..+...|++. |.+||+.+|+++|
T Consensus 311 --f~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 311 --FRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred --HHHHHHHHhcCCcccCCCHHHHhcC
Confidence 44555689888 9999999999986
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=359.77 Aligned_cols=200 Identities=31% Similarity=0.530 Sum_probs=183.1
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecC--CchhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEE
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRN--SLQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYE 430 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 430 (668)
.+|...+.||+|.|++||+|+++.++.+||||.+.+. ..+..+-+..|+.+|+.++|||||++++++...+.+|||||
T Consensus 10 ~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVME 89 (429)
T KOG0595|consen 10 GDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVME 89 (429)
T ss_pred ccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEE
Confidence 5688888999999999999999999999999999877 44556678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCC------CCEEEEeecCce
Q 005940 431 YIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAE------MNARLGDFGLAR 504 (668)
Q Consensus 431 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~------~~~kl~DfGla~ 504 (668)
||.+|+|.++++. .+.+++.....++.|||.||++||+ ++|+||||||.||||+.. -.+||+|||+|+
T Consensus 90 yC~gGDLs~yi~~---~~~l~e~t~r~Fm~QLA~alq~L~~---~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR 163 (429)
T KOG0595|consen 90 YCNGGDLSDYIRR---RGRLPEATARHFMQQLASALQFLHE---NNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFAR 163 (429)
T ss_pred eCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCcceEEeccCCCCCCCceEEecccchhh
Confidence 9999999999964 3469999999999999999999999 999999999999999875 458999999999
Q ss_pred eccCCCCCcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 005940 505 LYDHGGMPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSG 560 (668)
Q Consensus 505 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~ 560 (668)
.+..+.. ....+|++-|||||++..++|+-|+|+||.|+++||+++|+.||+..
T Consensus 164 ~L~~~~~--a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~ 217 (429)
T KOG0595|consen 164 FLQPGSM--AETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAE 217 (429)
T ss_pred hCCchhH--HHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCcccc
Confidence 9886554 34469999999999999999999999999999999999999999754
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-43 Score=374.60 Aligned_cols=249 Identities=29% Similarity=0.448 Sum_probs=206.1
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCc---hhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEE
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSL---QGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVY 429 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 429 (668)
..|...+.||+|||+.||.++...+|+.||+|++.+... ...+...+||++.++|+|||||+++++|++.+..|+|.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 468889999999999999999988999999999987433 34577889999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCC
Q 005940 430 EYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHG 509 (668)
Q Consensus 430 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~ 509 (668)
|+|++++|.++++ .++.+++.+++.++.||+.||.|||+ .+|+|||||..|+||+++.++||||||||..+...
T Consensus 98 ELC~~~sL~el~K---rrk~ltEpEary~l~QIv~GlkYLH~---~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~ 171 (592)
T KOG0575|consen 98 ELCHRGSLMELLK---RRKPLTEPEARYFLRQIVEGLKYLHS---LGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD 171 (592)
T ss_pred EecCCccHHHHHH---hcCCCCcHHHHHHHHHHHHHHHHHHh---cCceecccchhheeecCcCcEEecccceeeeecCc
Confidence 9999999999995 45779999999999999999999999 99999999999999999999999999999988865
Q ss_pred CCCcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCcccCCcc
Q 005940 510 GMPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSY 589 (668)
Q Consensus 510 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 589 (668)
... ....+||+.|+|||++....++..+||||+||+||-|+.|++||+..+.. + ......... -.+.. .
T Consensus 172 ~Er-k~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vk--e-ty~~Ik~~~------Y~~P~-~ 240 (592)
T KOG0575|consen 172 GER-KKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVK--E-TYNKIKLNE------YSMPS-H 240 (592)
T ss_pred ccc-cceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHH--H-HHHHHHhcC------ccccc-c
Confidence 433 34469999999999999999999999999999999999999999864211 1 111111111 11111 1
Q ss_pred cHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 005940 590 VVKEMELVLKLGLMCSHKTQFRPTMRQVMRY 620 (668)
Q Consensus 590 ~~~~~~~l~~l~~~C~~~p~~RPs~~evl~~ 620 (668)
-..+...|+. .++..+|.+||++++|+.+
T Consensus 241 ls~~A~dLI~--~lL~~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 241 LSAEAKDLIR--KLLRPNPSERPSLDEVLDH 269 (592)
T ss_pred cCHHHHHHHH--HHhcCCcccCCCHHHHhcC
Confidence 2223333322 2445559999999999965
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=373.40 Aligned_cols=251 Identities=32% Similarity=0.485 Sum_probs=208.3
Q ss_pred ccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCchhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEEecCCC
Q 005940 356 KESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEYIPNG 435 (668)
Q Consensus 356 ~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~g 435 (668)
...+.||+|-||.||.|.+. ....||+|.+..... ..+.|.+|+++|++|+|+|||+++|+|..++.+|||||||+.|
T Consensus 209 ~l~~~LG~G~FG~V~~g~~~-~~~~vavk~ik~~~m-~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~G 286 (468)
T KOG0197|consen 209 KLIRELGSGQFGEVWLGKWN-GSTKVAVKTIKEGSM-SPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKG 286 (468)
T ss_pred HHHHHhcCCccceEEEEEEc-CCCcccceEEecccc-ChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccC
Confidence 34688999999999999994 345899999987643 3478999999999999999999999999988999999999999
Q ss_pred ChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCCCCccc
Q 005940 436 SLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTT 515 (668)
Q Consensus 436 sL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 515 (668)
+|.++|.. ..+..+...+.+.++.|||+||+||++ +++|||||-++||||+++..+||+|||+|+...++......
T Consensus 287 sLl~yLr~-~~~~~l~~~~Ll~~a~qIaeGM~YLes---~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~~ 362 (468)
T KOG0197|consen 287 SLLDYLRT-REGGLLNLPQLLDFAAQIAEGMAYLES---KNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTASE 362 (468)
T ss_pred cHHHHhhh-cCCCccchHHHHHHHHHHHHHHHHHHh---CCccchhhhhhheeeccCceEEEcccccccccCCCceeecC
Confidence 99999974 456789999999999999999999999 99999999999999999999999999999976665544444
Q ss_pred ccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHHHhcCccccccCcccCCcccHHHH
Q 005940 516 NVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVAT-GRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSYVVKEM 594 (668)
Q Consensus 516 ~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 594 (668)
...-+..|.|||.+..++++.|||||||||+||||+| |+.|+.... ..+.+....+..++. -|.. +.
T Consensus 363 ~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~ms--n~ev~~~le~GyRlp---~P~~-------CP 430 (468)
T KOG0197|consen 363 GGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMS--NEEVLELLERGYRLP---RPEG-------CP 430 (468)
T ss_pred CCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCC--HHHHHHHHhccCcCC---CCCC-------CC
Confidence 4455678999999999999999999999999999999 999987542 222222222222211 1222 23
Q ss_pred HHHHHHHhhcCCC-CCCCCCHHHHHHHhccC
Q 005940 595 ELVLKLGLMCSHK-TQFRPTMRQVMRYLSGE 624 (668)
Q Consensus 595 ~~l~~l~~~C~~~-p~~RPs~~evl~~L~~~ 624 (668)
..+.+|+..||+. |++|||++.+...|+..
T Consensus 431 ~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~ 461 (468)
T KOG0197|consen 431 DEVYELMKSCWHEDPEDRPTFETLREVLEDF 461 (468)
T ss_pred HHHHHHHHHHhhCCcccCCCHHHHHHHHHHh
Confidence 4567788999998 99999999988887654
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-43 Score=340.49 Aligned_cols=259 Identities=26% Similarity=0.398 Sum_probs=209.0
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecC--CchhHHHHHHHHHHHhcccccCceeEeee-ecccCc-eEEE
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRN--SLQGMREFAAEIESLGRLRHKNLVNLHGW-CKQKND-LLLV 428 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~-~~~~~~-~~lV 428 (668)
.+|.+.++||+|.||+|||+....+|..+|.|.+.-. +.+..++...|+.+|++|+|||||+++++ +.+..+ ++||
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 3578899999999999999999999999999998743 34566789999999999999999999994 444555 8999
Q ss_pred EEecCCCChhhhhcCC-CCCCCccHHHHHHHHHHHHHHHHHhhhccCC-ceEecCCCCCCEEECCCCCEEEEeecCceec
Q 005940 429 YEYIPNGSLDTLLFKP-KDGSVLDWEQRFNIVKGIASGLLYLHEEWEQ-VVIHRDVKPSNALIDAEMNARLGDFGLARLY 506 (668)
Q Consensus 429 ~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~-~ivHrDLkp~NIll~~~~~~kl~DfGla~~~ 506 (668)
||||..|+|..+++.. +.++.+++..+|+++.|++.||..+|+.+.+ -|+||||||.||+|+.+|.+||||||+++.+
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l 178 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL 178 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence 9999999999999653 3456799999999999999999999986543 4899999999999999999999999999988
Q ss_pred cCCCCCcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCcccC
Q 005940 507 DHGGMPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLN 586 (668)
Q Consensus 507 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 586 (668)
..... .....+||+.||+||.+....|+.||||||+||++|||+.-+.||.+.. +....+. ...+. -|.+.
T Consensus 179 ~s~~t-fA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n--~~~L~~K-I~qgd-----~~~~p 249 (375)
T KOG0591|consen 179 SSKTT-FAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDN--LLSLCKK-IEQGD-----YPPLP 249 (375)
T ss_pred cchhH-HHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCccccc--HHHHHHH-HHcCC-----CCCCc
Confidence 76443 3455799999999999999999999999999999999999999998652 2221121 22222 23343
Q ss_pred CcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhcc
Q 005940 587 SSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSG 623 (668)
Q Consensus 587 ~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~ 623 (668)
.+...+++. .|+.+|... |+.||+.-.+++.+..
T Consensus 250 ~~~YS~~l~---~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 250 DEHYSTDLR---ELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred HHHhhhHHH---HHHHHHccCCcccCCCcchHHHHHHH
Confidence 344444444 445578776 9999996666665554
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=344.10 Aligned_cols=250 Identities=28% Similarity=0.409 Sum_probs=196.8
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCch-------hHHHHHHHHHHHhcccccCceeEeeeecccCce
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQ-------GMREFAAEIESLGRLRHKNLVNLHGWCKQKNDL 425 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-------~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~ 425 (668)
+.|...+.||+|+||.|-+|..+.+++.||||++.+.... ......+|+++|++|+|||||++++++......
T Consensus 172 d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~ 251 (475)
T KOG0615|consen 172 DYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSS 251 (475)
T ss_pred ceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCce
Confidence 4567789999999999999999999999999999764221 223457999999999999999999999999999
Q ss_pred EEEEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCC---CCEEEEeecC
Q 005940 426 LLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAE---MNARLGDFGL 502 (668)
Q Consensus 426 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~---~~~kl~DfGl 502 (668)
|+||||+++|.|.+.+- ..+.+.+.....+++|++.|+.|||+ +||+||||||+||||..+ ..+||+|||+
T Consensus 252 YmVlE~v~GGeLfd~vv---~nk~l~ed~~K~~f~Qll~avkYLH~---~GI~HRDiKPeNILl~~~~e~~llKItDFGl 325 (475)
T KOG0615|consen 252 YMVLEYVEGGELFDKVV---ANKYLREDLGKLLFKQLLTAVKYLHS---QGIIHRDIKPENILLSNDAEDCLLKITDFGL 325 (475)
T ss_pred EEEEEEecCccHHHHHH---hccccccchhHHHHHHHHHHHHHHHH---cCcccccCCcceEEeccCCcceEEEecccch
Confidence 99999999999999985 34557788888999999999999999 999999999999999766 7799999999
Q ss_pred ceeccCCCCCcccccccCCcccCcccccCCCC---CcchhHHHHHHHHHHHHhCCCCCCCC--chhHHHHHHHHHhcCcc
Q 005940 503 ARLYDHGGMPHTTNVVGTFGYIAPELTQTGKA---STSSDVFAYGILLLEVATGRRPIGSG--DLLLVEWVRECHQLGRI 577 (668)
Q Consensus 503 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~sDV~S~Gvvl~elltG~~p~~~~--~~~l~~~~~~~~~~~~~ 577 (668)
|+....+. .....|||+.|.|||++.++.. ..+.|+||+||+||-++||..||... +..+.+ ....++.
T Consensus 326 AK~~g~~s--fm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~e----QI~~G~y 399 (475)
T KOG0615|consen 326 AKVSGEGS--FMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKE----QILKGRY 399 (475)
T ss_pred hhccccce--ehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHH----HHhcCcc
Confidence 99876443 3455799999999999977543 35889999999999999999999754 221222 2222222
Q ss_pred ccccCcccCCcccHHHHHHHHHHHhhcCC-CCCCCCCHHHHHHH
Q 005940 578 LDVADPLLNSSYVVKEMELVLKLGLMCSH-KTQFRPTMRQVMRY 620 (668)
Q Consensus 578 ~~~~d~~l~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~~ 620 (668)
.. .|..-.+ --++...+..+++. +|+.||++.|+|++
T Consensus 400 ~f--~p~~w~~----Iseea~dlI~~mL~VdP~~R~s~~eaL~h 437 (475)
T KOG0615|consen 400 AF--GPLQWDR----ISEEALDLINWMLVVDPENRPSADEALNH 437 (475)
T ss_pred cc--cChhhhh----hhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence 21 1111111 11233344445555 59999999999985
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-41 Score=326.38 Aligned_cols=261 Identities=27% Similarity=0.300 Sum_probs=205.1
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCc--hhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEE
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSL--QGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYE 430 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 430 (668)
+.|+...++|+|+||.|||++++++|+.||||++..... ...+-.++|+++|++|+|+|+|.++..|..+..++||+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 357778899999999999999999999999999965433 334557899999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCC
Q 005940 431 YIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGG 510 (668)
Q Consensus 431 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~ 510 (668)
||+..-|+++=+. ...++...+.+++.|++.|+.|+|+ ++++||||||+||||+.++.+||||||.|+.+.. .
T Consensus 82 ~~dhTvL~eLe~~---p~G~~~~~vk~~l~Q~l~ai~~cHk---~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~-p 154 (396)
T KOG0593|consen 82 YCDHTVLHELERY---PNGVPSELVKKYLYQLLKAIHFCHK---NNCIHRDIKPENILITQNGVVKLCDFGFARTLSA-P 154 (396)
T ss_pred ecchHHHHHHHhc---cCCCCHHHHHHHHHHHHHHhhhhhh---cCeecccCChhheEEecCCcEEeccchhhHhhcC-C
Confidence 9988767665432 2348889999999999999999999 9999999999999999999999999999998874 2
Q ss_pred CCcccccccCCcccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCC-chhHHHHHHHHHhc--Ccccccc-----
Q 005940 511 MPHTTNVVGTFGYIAPELTQT-GKASTSSDVFAYGILLLEVATGRRPIGSG-DLLLVEWVRECHQL--GRILDVA----- 581 (668)
Q Consensus 511 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~S~Gvvl~elltG~~p~~~~-~~~l~~~~~~~~~~--~~~~~~~----- 581 (668)
....+.++.|.+|.|||.+.+ .+|....||||.||++.||++|..-|.+. |....--+...... .+..+++
T Consensus 155 gd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~ 234 (396)
T KOG0593|consen 155 GDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPF 234 (396)
T ss_pred cchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCc
Confidence 334677889999999998877 78999999999999999999999888653 22222111111110 0111111
Q ss_pred -----CcccCC-----cccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 582 -----DPLLNS-----SYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 582 -----d~~l~~-----~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
-|.... .-.+.-...++.++..|++. |++|++-+|++.+
T Consensus 235 F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H 284 (396)
T KOG0593|consen 235 FHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHH 284 (396)
T ss_pred eeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence 111111 11112234778888999998 9999999999865
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=334.04 Aligned_cols=203 Identities=31% Similarity=0.448 Sum_probs=183.3
Q ss_pred hcCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCc---hhHHHHHHHHHHHhcccccCceeEeeeecccCceEEE
Q 005940 352 TKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSL---QGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLV 428 (668)
Q Consensus 352 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV 428 (668)
.++|+..++||+|+||+||.++.+++++.+|+|++++... ...+...+|..+|.+++||.||+++-.|++++.+|||
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 4678999999999999999999999999999999987543 3456788999999999999999999999999999999
Q ss_pred EEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccC
Q 005940 429 YEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDH 508 (668)
Q Consensus 429 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~ 508 (668)
+||+.||.|..+|.+ ...+++..+.-++.+|+.||.|||+ .+|+||||||+|||||++|+++|+|||+++....
T Consensus 104 ld~~~GGeLf~hL~~---eg~F~E~~arfYlaEi~lAL~~LH~---~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~ 177 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQR---EGRFSEDRARFYLAEIVLALGYLHS---KGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLK 177 (357)
T ss_pred EeccCCccHHHHHHh---cCCcchhHHHHHHHHHHHHHHHHHh---CCeeeccCCHHHeeecCCCcEEEeccccchhccc
Confidence 999999999999963 3568899888999999999999999 9999999999999999999999999999995444
Q ss_pred CCCCcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCc
Q 005940 509 GGMPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGD 561 (668)
Q Consensus 509 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~ 561 (668)
.. ..+...+||+.|||||++.+..++..+|.||+|+++|||++|..||...+
T Consensus 178 ~~-~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~ 229 (357)
T KOG0598|consen 178 DG-DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAED 229 (357)
T ss_pred CC-CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCcc
Confidence 32 23444799999999999999999999999999999999999999997654
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=364.74 Aligned_cols=258 Identities=29% Similarity=0.468 Sum_probs=213.5
Q ss_pred CcccceeeeecCcEEEEEEEeCC-----CCcEEEEEEEecCCch-hHHHHHHHHHHHhcccccCceeEeeeecccCceEE
Q 005940 354 GFKESEVIGIGGFGSVYKGVLPT-----TGGEVAVKKITRNSLQ-GMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLL 427 (668)
Q Consensus 354 ~f~~~~~lG~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~-~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l 427 (668)
+....+.||+|+||+||+|.... +...||||.++..... ..++|++|++++..|+|||||+|+|.|.+++.+++
T Consensus 487 ~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~M 566 (774)
T KOG1026|consen 487 DIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCM 566 (774)
T ss_pred heeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEE
Confidence 44557889999999999998632 3357999999877665 77899999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhcCCC-------CC----CCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEE
Q 005940 428 VYEYIPNGSLDTLLFKPK-------DG----SVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNAR 496 (668)
Q Consensus 428 V~E~~~~gsL~~~l~~~~-------~~----~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~k 496 (668)
|+|||..|+|.++|.... .+ .+|+..+.+.|+.|||.||.||-+ +.+|||||-.+|+|+.++..+|
T Consensus 567 vFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~---~~FVHRDLATRNCLVge~l~VK 643 (774)
T KOG1026|consen 567 VFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSS---HHFVHRDLATRNCLVGENLVVK 643 (774)
T ss_pred EEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh---CcccccchhhhhceeccceEEE
Confidence 999999999999996422 12 238899999999999999999999 9999999999999999999999
Q ss_pred EEeecCceeccCCCCC-cccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHHHhc
Q 005940 497 LGDFGLARLYDHGGMP-HTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVAT-GRRPIGSGDLLLVEWVRECHQL 574 (668)
Q Consensus 497 l~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~l~~~~~~~~~~ 574 (668)
|+|||++|..-..+.- ......-..+|||||.+..+++|++||||||||+|||+++ |+.|+.+.. .+.|.+..+.
T Consensus 644 IsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glS---n~EVIe~i~~ 720 (774)
T KOG1026|consen 644 ISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLS---NQEVIECIRA 720 (774)
T ss_pred ecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccc---hHHHHHHHHc
Confidence 9999999965433322 2223345679999999999999999999999999999999 999986532 2234455566
Q ss_pred CccccccCcccCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhccCcC
Q 005940 575 GRILDVADPLLNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSGEKQ 626 (668)
Q Consensus 575 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~~~~ 626 (668)
++++...+ .....+..|++.||+. |++||+++||-..|+...+
T Consensus 721 g~lL~~Pe---------~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~ 764 (774)
T KOG1026|consen 721 GQLLSCPE---------NCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQ 764 (774)
T ss_pred CCcccCCC---------CCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHh
Confidence 66544322 2335677888999999 9999999999999987653
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=366.45 Aligned_cols=270 Identities=29% Similarity=0.481 Sum_probs=223.7
Q ss_pred cccchhhHHHHhcCc---------ccceeeeecCcEEEEEEEeCCCC---cEEEEEEEecCCc-hhHHHHHHHHHHHhcc
Q 005940 341 HRFRYKDLYAATKGF---------KESEVIGIGGFGSVYKGVLPTTG---GEVAVKKITRNSL-QGMREFAAEIESLGRL 407 (668)
Q Consensus 341 ~~f~~~el~~at~~f---------~~~~~lG~G~~g~Vy~~~~~~~~---~~vavK~~~~~~~-~~~~~f~~Ei~~l~~l 407 (668)
..++|+|-..|-+.| .+.++||.|.||.||+|.++..+ ..||||.++.... +...+|+.|+.||.++
T Consensus 608 DP~TYEDPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQF 687 (996)
T KOG0196|consen 608 DPHTYEDPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQF 687 (996)
T ss_pred CCccccCccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccC
Confidence 457888887776554 56789999999999999997655 4699999987644 5668999999999999
Q ss_pred cccCceeEeeeecccCceEEEEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCE
Q 005940 408 RHKNLVNLHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNA 487 (668)
Q Consensus 408 ~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NI 487 (668)
.||||++|.|........++|.|||+||+|+.+|+. ....+++.|...++++||.||.||-+ .++|||||-++||
T Consensus 688 dHPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~--~DGqftviQLVgMLrGIAsGMkYLsd---m~YVHRDLAARNI 762 (996)
T KOG0196|consen 688 DHPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQ--NDGQFTVIQLVGMLRGIASGMKYLSD---MNYVHRDLAARNI 762 (996)
T ss_pred CCCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhh--cCCceEeehHHHHHHHHHHHhHHHhh---cCchhhhhhhhhe
Confidence 999999999999999999999999999999999964 34569999999999999999999998 9999999999999
Q ss_pred EECCCCCEEEEeecCceeccCCCCCccccccc--CCcccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCC-chh
Q 005940 488 LIDAEMNARLGDFGLARLYDHGGMPHTTNVVG--TFGYIAPELTQTGKASTSSDVFAYGILLLEVAT-GRRPIGSG-DLL 563 (668)
Q Consensus 488 ll~~~~~~kl~DfGla~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~-~~~ 563 (668)
|++.+..+|++|||++|.++++.....+..-| +.+|.|||.+...+.|.++|||||||+|||+++ |.+||-+. +..
T Consensus 763 LVNsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQd 842 (996)
T KOG0196|consen 763 LVNSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD 842 (996)
T ss_pred eeccceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHH
Confidence 99999999999999999887665333332223 468999999999999999999999999999887 99998543 333
Q ss_pred HHHHHHHHHhcCccccccCcccCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhccCcCCC
Q 005940 564 LVEWVRECHQLGRILDVADPLLNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSGEKQLR 628 (668)
Q Consensus 564 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~~~~~~ 628 (668)
.++.+.+- ++...+.++...|.+|++.||+. -.+||.+.||+..|.+.-.-|
T Consensus 843 VIkaIe~g-------------yRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP 895 (996)
T KOG0196|consen 843 VIKAIEQG-------------YRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNP 895 (996)
T ss_pred HHHHHHhc-------------cCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCc
Confidence 33322222 22223344556788999999998 789999999999998654444
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-40 Score=335.02 Aligned_cols=261 Identities=28% Similarity=0.421 Sum_probs=204.6
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCchhHHHHHHHHHHHhcccccCceeEeeeecccC--ceEEEEE
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNLHGWCKQKN--DLLLVYE 430 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~--~~~lV~E 430 (668)
.++...+.||+|.||.||++...++|...|||.+........+.+.+|+++|.+++|||||+.+|...... .+++.||
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE 96 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME 96 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence 35666889999999999999998889999999987764444677899999999999999999999855444 6899999
Q ss_pred ecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECC-CCCEEEEeecCceeccC-
Q 005940 431 YIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDA-EMNARLGDFGLARLYDH- 508 (668)
Q Consensus 431 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~-~~~~kl~DfGla~~~~~- 508 (668)
|+++|+|.+++.... + .|++..+.++.+||++||.|||+ ++|+||||||+||||+. ++.+||+|||+++....
T Consensus 97 y~~~GsL~~~~~~~g-~-~l~E~~v~~ytr~iL~GL~ylHs---~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~ 171 (313)
T KOG0198|consen 97 YAPGGSLSDLIKRYG-G-KLPEPLVRRYTRQILEGLAYLHS---KGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESK 171 (313)
T ss_pred ccCCCcHHHHHHHcC-C-CCCHHHHHHHHHHHHHHHHHHHh---CCEeccCcccceEEEeCCCCeEEeccCccccccccc
Confidence 999999999996432 2 79999999999999999999998 99999999999999999 79999999999987763
Q ss_pred -CCCCcccccccCCcccCcccccCCC-CCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCcccC
Q 005940 509 -GGMPHTTNVVGTFGYIAPELTQTGK-ASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLN 586 (668)
Q Consensus 509 -~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 586 (668)
..........||+.|||||++..+. ...++||||+||++.||+||+.||... ....+++........ -|.+.
T Consensus 172 ~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-~~~~~~~~~ig~~~~-----~P~ip 245 (313)
T KOG0198|consen 172 GTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-FEEAEALLLIGREDS-----LPEIP 245 (313)
T ss_pred cccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-cchHHHHHHHhccCC-----CCCCC
Confidence 2222234578999999999998643 345999999999999999999999753 222333332222221 12222
Q ss_pred CcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhccCcCCC
Q 005940 587 SSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSGEKQLR 628 (668)
Q Consensus 587 ~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~~~~~~ 628 (668)
.. -.++...+ ...|... |++|||+++++++.-.....+
T Consensus 246 ~~-ls~~a~~F---l~~C~~~~p~~Rpta~eLL~hpf~~~~~~ 284 (313)
T KOG0198|consen 246 DS-LSDEAKDF---LRKCFKRDPEKRPTAEELLEHPFLKQNSI 284 (313)
T ss_pred cc-cCHHHHHH---HHHHhhcCcccCcCHHHHhhChhhhcccc
Confidence 22 22334433 4478887 999999999999865544333
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=337.77 Aligned_cols=202 Identities=34% Similarity=0.461 Sum_probs=179.9
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCc--hhHHHHHHHHHHHhcccccCceeEeeeeccc--CceEEE
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSL--QGMREFAAEIESLGRLRHKNLVNLHGWCKQK--NDLLLV 428 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~--~~~~lV 428 (668)
+.|+..++||+|.||.||||++..+|+.||+|+++.+.. ....-..+||.+|++|.||||++|.+...+. +.+|||
T Consensus 117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV 196 (560)
T KOG0600|consen 117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV 196 (560)
T ss_pred HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence 356678899999999999999999999999999987653 3345567899999999999999999998766 789999
Q ss_pred EEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccC
Q 005940 429 YEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDH 508 (668)
Q Consensus 429 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~ 508 (668)
+|||+. +|.-++. ..+-.++..++..+++||+.||.|+|+ ++|+|||||.+|||||.+|.+||+|||||+++..
T Consensus 197 FeYMdh-DL~GLl~--~p~vkft~~qIKc~mkQLl~Gl~~cH~---~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~ 270 (560)
T KOG0600|consen 197 FEYMDH-DLSGLLS--SPGVKFTEPQIKCYMKQLLEGLEYCHS---RGVLHRDIKGSNILIDNNGVLKIADFGLARFYTP 270 (560)
T ss_pred Eecccc-hhhhhhc--CCCcccChHHHHHHHHHHHHHHHHHhh---cCeeeccccccceEEcCCCCEEeccccceeeccC
Confidence 999976 7777774 345679999999999999999999999 9999999999999999999999999999998887
Q ss_pred CCCCcccccccCCcccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 005940 509 GGMPHTTNVVGTFGYIAPELTQT-GKASTSSDVFAYGILLLEVATGRRPIGSG 560 (668)
Q Consensus 509 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~S~Gvvl~elltG~~p~~~~ 560 (668)
......+..+-|.+|.|||.+.+ ..|+.+.|+||.||||.||+.|+..|.+.
T Consensus 271 ~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~ 323 (560)
T KOG0600|consen 271 SGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGR 323 (560)
T ss_pred CCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCc
Confidence 76666777788999999998876 47999999999999999999999988765
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=344.97 Aligned_cols=265 Identities=27% Similarity=0.408 Sum_probs=205.2
Q ss_pred hHHHHhcCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCC--chhHHHHHHHHHHHhcccccCceeEeeeecccCc
Q 005940 347 DLYAATKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNS--LQGMREFAAEIESLGRLRHKNLVNLHGWCKQKND 424 (668)
Q Consensus 347 el~~at~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~ 424 (668)
+.....+.+.....||+|.||+||+|.|- ..||||++..+. .+..+.|++|+..+++-||.||+-+.|||.+.+.
T Consensus 386 ~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh---GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~ 462 (678)
T KOG0193|consen 386 EWEIPPEEVLLGERIGSGSFGTVYRGRWH---GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL 462 (678)
T ss_pred ccccCHHHhhccceeccccccceeecccc---cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce
Confidence 33333445567889999999999999993 479999997653 4577899999999999999999999999998877
Q ss_pred eEEEEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCce
Q 005940 425 LLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLAR 504 (668)
Q Consensus 425 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~ 504 (668)
.+|..+|++.+|..+|+. ....+...+.+.|++|||+|+.|||. ++|||||||..||||.+++.+||+|||++.
T Consensus 463 -AIiTqwCeGsSLY~hlHv--~etkfdm~~~idIAqQiaqGM~YLHA---K~IIHrDLKSnNIFl~~~~kVkIgDFGLat 536 (678)
T KOG0193|consen 463 -AIITQWCEGSSLYTHLHV--QETKFDMNTTIDIAQQIAQGMDYLHA---KNIIHRDLKSNNIFLHEDLKVKIGDFGLAT 536 (678)
T ss_pred -eeeehhccCchhhhhccc--hhhhhhHHHHHHHHHHHHHhhhhhhh---hhhhhhhccccceEEccCCcEEEeccccee
Confidence 999999999999999974 34679999999999999999999999 999999999999999999999999999997
Q ss_pred eccCCCC-CcccccccCCcccCcccccCC---CCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccc
Q 005940 505 LYDHGGM-PHTTNVVGTFGYIAPELTQTG---KASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDV 580 (668)
Q Consensus 505 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~---~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~ 580 (668)
.-..... ......-|...|||||+++.+ .+++.+||||||||+|||+||..||.......+-| .. ++-.-.
T Consensus 537 vk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIif--mV---GrG~l~ 611 (678)
T KOG0193|consen 537 VKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIF--MV---GRGYLM 611 (678)
T ss_pred eeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEE--Ee---cccccC
Confidence 5432211 112233567789999998764 57899999999999999999999997432221111 11 111111
Q ss_pred cCcccCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhccCcC-CC
Q 005940 581 ADPLLNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSGEKQ-LR 628 (668)
Q Consensus 581 ~d~~l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~~~~-~~ 628 (668)
.|..... ....+.+.+|...||.. +++||.+.+|+..|+...+ +|
T Consensus 612 pd~s~~~---s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~~p 658 (678)
T KOG0193|consen 612 PDLSKIR---SNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPSLP 658 (678)
T ss_pred ccchhhh---ccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhccc
Confidence 1221111 12233445555689998 9999999999998877655 55
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=380.59 Aligned_cols=258 Identities=30% Similarity=0.512 Sum_probs=216.1
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCchhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEEec
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEYI 432 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~ 432 (668)
..+...++||+|+||.||+|++..++..||||++...... ...|++++++++|||||+++|+|.+.+..++||||+
T Consensus 690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~ 765 (968)
T PLN00113 690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYI 765 (968)
T ss_pred hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCC
Confidence 4577788999999999999999888999999998654322 135688999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCCCC
Q 005940 433 PNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMP 512 (668)
Q Consensus 433 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~~~ 512 (668)
++|+|.++++ .++|.++.+++.|+++||+|||..+.++|+||||||+||+++.++.+++. ||.+......
T Consensus 766 ~~g~L~~~l~------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~--- 835 (968)
T PLN00113 766 EGKNLSEVLR------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD--- 835 (968)
T ss_pred CCCcHHHHHh------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC---
Confidence 9999999994 28999999999999999999997666899999999999999999988876 6665433221
Q ss_pred cccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC---chhHHHHHHHHHhcCccccccCcccCC--
Q 005940 513 HTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSG---DLLLVEWVRECHQLGRILDVADPLLNS-- 587 (668)
Q Consensus 513 ~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~---~~~l~~~~~~~~~~~~~~~~~d~~l~~-- 587 (668)
....++..|+|||++.+..++.++|||||||++|||+||+.||+.. ...+.+|++............|+.+..
T Consensus 836 --~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 913 (968)
T PLN00113 836 --TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDV 913 (968)
T ss_pred --CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCC
Confidence 2236789999999999999999999999999999999999998543 345778887766555555666776643
Q ss_pred cccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhccCcC
Q 005940 588 SYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSGEKQ 626 (668)
Q Consensus 588 ~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~~~~ 626 (668)
....+++..+.+++..|++. |++||+|+||++.|+....
T Consensus 914 ~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~ 953 (968)
T PLN00113 914 SVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR 953 (968)
T ss_pred CccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence 34556777888999999998 9999999999999987654
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-39 Score=334.64 Aligned_cols=252 Identities=28% Similarity=0.422 Sum_probs=204.7
Q ss_pred hcCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCc---hhHHHHHHHHHHHhcc-cccCceeEeeeecccCceEE
Q 005940 352 TKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSL---QGMREFAAEIESLGRL-RHKNLVNLHGWCKQKNDLLL 427 (668)
Q Consensus 352 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~l 427 (668)
.++|...+.||+|+|++|++|+.+.++++||||++.+.-. ...+-...|-.+|.+| .||.|++|+-.|+++..+|+
T Consensus 72 ~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYF 151 (604)
T KOG0592|consen 72 PNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYF 151 (604)
T ss_pred hhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEE
Confidence 4678888999999999999999999999999999976532 2334566788999999 79999999999999999999
Q ss_pred EEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceecc
Q 005940 428 VYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYD 507 (668)
Q Consensus 428 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~ 507 (668)
|+||+++|.|.++|++. +.+++.....++.+|+.||.|||+ .|||||||||+|||||+|+++||.|||-|+.+.
T Consensus 152 vLe~A~nGdll~~i~K~---Gsfde~caR~YAAeIldAleylH~---~GIIHRDlKPENILLd~dmhikITDFGsAK~l~ 225 (604)
T KOG0592|consen 152 VLEYAPNGDLLDLIKKY---GSFDETCARFYAAEILDALEYLHS---NGIIHRDLKPENILLDKDGHIKITDFGSAKILS 225 (604)
T ss_pred EEEecCCCcHHHHHHHh---CcchHHHHHHHHHHHHHHHHHHHh---cCceeccCChhheeEcCCCcEEEeeccccccCC
Confidence 99999999999999753 459999999999999999999999 999999999999999999999999999999875
Q ss_pred CCCCC------------cccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcC
Q 005940 508 HGGMP------------HTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLG 575 (668)
Q Consensus 508 ~~~~~------------~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~ 575 (668)
..... ....++||..|.+||++..+..+..+|+|+|||+||+|+.|..||......+.- .
T Consensus 226 ~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliF--------q 297 (604)
T KOG0592|consen 226 PSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIF--------Q 297 (604)
T ss_pred hhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHH--------H
Confidence 33211 124479999999999999999999999999999999999999999765433221 1
Q ss_pred ccccccCcccCCcccHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHh
Q 005940 576 RILDVADPLLNSSYVVKEMELVLKLGLMCSHKTQFRPTMRQVMRYL 621 (668)
Q Consensus 576 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~p~~RPs~~evl~~L 621 (668)
+++++ +-.+...+...-..++.+ .+..+|.+|++.+||.+|.
T Consensus 298 kI~~l-~y~fp~~fp~~a~dLv~K---LLv~dp~~Rlt~~qIk~Hp 339 (604)
T KOG0592|consen 298 KIQAL-DYEFPEGFPEDARDLIKK---LLVRDPSDRLTSQQIKAHP 339 (604)
T ss_pred HHHHh-cccCCCCCCHHHHHHHHH---HHccCccccccHHHHhhCc
Confidence 11111 222233344333333333 3456699999999999875
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=343.34 Aligned_cols=242 Identities=29% Similarity=0.463 Sum_probs=202.1
Q ss_pred cceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCchhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEEecCCCC
Q 005940 357 ESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEYIPNGS 436 (668)
Q Consensus 357 ~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gs 436 (668)
..+-||.|+.|.||+|++ .++.||||+++.-. ..+|+-|++|+|+||+.+.|.|.....+|+|||||+.|.
T Consensus 128 ELeWlGSGaQGAVF~Grl--~netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~Gq 198 (904)
T KOG4721|consen 128 ELEWLGSGAQGAVFLGRL--HNETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQ 198 (904)
T ss_pred hhhhhccCcccceeeeec--cCceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEEeeecccccc
Confidence 356799999999999999 57899999874321 257899999999999999999999999999999999999
Q ss_pred hhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCCCCcccc
Q 005940 437 LDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTN 516 (668)
Q Consensus 437 L~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~ 516 (668)
|.++|+ .+.+++-.....+..+||.||.|||. +.|||||||.-||||..+..+||+|||-++..... ...+.
T Consensus 199 L~~VLk---a~~~itp~llv~Wsk~IA~GM~YLH~---hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~--STkMS 270 (904)
T KOG4721|consen 199 LYEVLK---AGRPITPSLLVDWSKGIAGGMNYLHL---HKIIHRDLKSPNILISYDDVVKISDFGTSKELSDK--STKMS 270 (904)
T ss_pred HHHHHh---ccCccCHHHHHHHHHHhhhhhHHHHH---hhHhhhccCCCceEeeccceEEeccccchHhhhhh--hhhhh
Confidence 999995 45678888899999999999999999 99999999999999999999999999999876543 33456
Q ss_pred cccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCcccCCcccHHHHHH
Q 005940 517 VVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSYVVKEMEL 596 (668)
Q Consensus 517 ~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~ 596 (668)
++||..|||||++++...++|.||||||||||||+||..||.+-+..-+-| - +-...|.......+.+-
T Consensus 271 FaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIw--G---------VGsNsL~LpvPstcP~G 339 (904)
T KOG4721|consen 271 FAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIW--G---------VGSNSLHLPVPSTCPDG 339 (904)
T ss_pred hhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEE--e---------ccCCcccccCcccCchH
Confidence 799999999999999999999999999999999999999996533221111 1 11122222333344455
Q ss_pred HHHHHhhcCCC-CCCCCCHHHHHHHhccCcC
Q 005940 597 VLKLGLMCSHK-TQFRPTMRQVMRYLSGEKQ 626 (668)
Q Consensus 597 l~~l~~~C~~~-p~~RPs~~evl~~L~~~~~ 626 (668)
+..|+..||+. |..||++++|+.||+...+
T Consensus 340 fklL~Kqcw~sKpRNRPSFrqil~HldIa~p 370 (904)
T KOG4721|consen 340 FKLLLKQCWNSKPRNRPSFRQILLHLDIASP 370 (904)
T ss_pred HHHHHHHHHhcCCCCCccHHHHHHHHhhcCH
Confidence 66777799998 9999999999999998764
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=336.98 Aligned_cols=259 Identities=25% Similarity=0.364 Sum_probs=200.0
Q ss_pred hcCcccceeeeecCcEEEEEEEeC-----CCCcEEEEEEEecCCc-hhHHHHHHHHHHHhcc-cccCceeEeeeecccC-
Q 005940 352 TKGFKESEVIGIGGFGSVYKGVLP-----TTGGEVAVKKITRNSL-QGMREFAAEIESLGRL-RHKNLVNLHGWCKQKN- 423 (668)
Q Consensus 352 t~~f~~~~~lG~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~-~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~- 423 (668)
.++|.+.++||+|+||.||+|.+. .++..||||++..... ...+.+.+|++++.++ +||||++++++|...+
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG 85 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence 357888999999999999999752 3346799999875432 3456789999999999 8999999999987644
Q ss_pred ceEEEEEecCCCChhhhhcCCCC---------------------------------------------------------
Q 005940 424 DLLLVYEYIPNGSLDTLLFKPKD--------------------------------------------------------- 446 (668)
Q Consensus 424 ~~~lV~E~~~~gsL~~~l~~~~~--------------------------------------------------------- 446 (668)
..++||||+++|+|.+++.....
T Consensus 86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (338)
T cd05102 86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD 165 (338)
T ss_pred ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence 58899999999999999864211
Q ss_pred --CCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCCC-CcccccccCCcc
Q 005940 447 --GSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGM-PHTTNVVGTFGY 523 (668)
Q Consensus 447 --~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y 523 (668)
...+++..+++++.||++||.|||+ .+|+||||||+|||++.++.+||+|||+++....... .......++..|
T Consensus 166 ~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y 242 (338)
T cd05102 166 LWKSPLTMEDLICYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW 242 (338)
T ss_pred cccCCCCHHHHHHHHHHHHHHHHHHHH---CCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccc
Confidence 1348889999999999999999998 9999999999999999999999999999986543221 112233456789
Q ss_pred cCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHHHhcCccccccCcccCCcccHHHHHHHHHHHh
Q 005940 524 IAPELTQTGKASTSSDVFAYGILLLEVAT-GRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSYVVKEMELVLKLGL 602 (668)
Q Consensus 524 ~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~ 602 (668)
+|||++.+..++.++|||||||++|||++ |..||....... . .......+.. ....... ...+..++.
T Consensus 243 ~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~-~-~~~~~~~~~~-----~~~~~~~----~~~l~~li~ 311 (338)
T cd05102 243 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE-E-FCQRLKDGTR-----MRAPENA----TPEIYRIML 311 (338)
T ss_pred cCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH-H-HHHHHhcCCC-----CCCCCCC----CHHHHHHHH
Confidence 99999988899999999999999999997 999997543211 1 1111111111 1111111 134567777
Q ss_pred hcCCC-CCCCCCHHHHHHHhccC
Q 005940 603 MCSHK-TQFRPTMRQVMRYLSGE 624 (668)
Q Consensus 603 ~C~~~-p~~RPs~~evl~~L~~~ 624 (668)
.|++. |++||++.||++.|+..
T Consensus 312 ~cl~~dp~~RPs~~el~~~l~~~ 334 (338)
T cd05102 312 ACWQGDPKERPTFSALVEILGDL 334 (338)
T ss_pred HHccCChhhCcCHHHHHHHHHHH
Confidence 89987 99999999999999864
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-39 Score=337.85 Aligned_cols=249 Identities=25% Similarity=0.384 Sum_probs=209.2
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCchhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEEec
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEYI 432 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~ 432 (668)
..|....+||+|+-|.||.+....+++.||||++........+-+.+|+.+|+..+|+|||++++.+..+++++.|||||
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym 352 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM 352 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence 35677789999999999999998899999999998877666677889999999999999999999999899999999999
Q ss_pred CCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCCCC
Q 005940 433 PNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMP 512 (668)
Q Consensus 433 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~~~ 512 (668)
++|+|.+++. ...+++.++..|++++++||+|||. ++|+|||||.+||||+.++.+||+|||+|..+.....
T Consensus 353 ~ggsLTDvVt----~~~~~E~qIA~Icre~l~aL~fLH~---~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~- 424 (550)
T KOG0578|consen 353 EGGSLTDVVT----KTRMTEGQIAAICREILQGLKFLHA---RGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS- 424 (550)
T ss_pred CCCchhhhhh----cccccHHHHHHHHHHHHHHHHHHHh---cceeeeccccceeEeccCCcEEEeeeeeeeccccccC-
Confidence 9999999984 3459999999999999999999999 9999999999999999999999999999998876554
Q ss_pred cccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCcccCC-cccH
Q 005940 513 HTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNS-SYVV 591 (668)
Q Consensus 513 ~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~-~~~~ 591 (668)
.+...+||+.|||||+.....|.+|.||||||++++||+-|+.||-..+....-|... ..+ -|.+.. +.-.
T Consensus 425 KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa--~ng------~P~lk~~~klS 496 (550)
T KOG0578|consen 425 KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA--TNG------TPKLKNPEKLS 496 (550)
T ss_pred ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHh--hcC------CCCcCCccccC
Confidence 4555799999999999999999999999999999999999999996544332222221 111 122211 1122
Q ss_pred HHHHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 592 KEMELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 592 ~~~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
.+ +..+...|+.. +++||+++|+|+|
T Consensus 497 ~~---~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 497 PE---LKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred HH---HHHHHHHHhhcchhcCCCHHHHhcC
Confidence 33 33444588887 9999999999986
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=334.16 Aligned_cols=199 Identities=31% Similarity=0.439 Sum_probs=177.1
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCchhHHH--HHHHHHHHhccc-ccCceeEeeeecccC-ceEEE
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMRE--FAAEIESLGRLR-HKNLVNLHGWCKQKN-DLLLV 428 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~--f~~Ei~~l~~l~-H~nIv~l~g~~~~~~-~~~lV 428 (668)
++|...++||.|.||.||+|+.+.+++.||||++.++... .++ =++|+..|++|+ ||||+++.+.+.+.+ .+++|
T Consensus 10 ~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s-~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fV 88 (538)
T KOG0661|consen 10 DRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFV 88 (538)
T ss_pred HHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc-HHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeee
Confidence 5788899999999999999999999999999999776443 233 358999999998 999999999998887 99999
Q ss_pred EEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccC
Q 005940 429 YEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDH 508 (668)
Q Consensus 429 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~ 508 (668)
||||+ .+|.+++..+ ++.+++..+..|+.||++||+|+|. +|+.||||||+|||+..+..+||+|||+||....
T Consensus 89 fE~Md-~NLYqLmK~R--~r~fse~~irnim~QilqGL~hiHk---~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~S 162 (538)
T KOG0661|consen 89 FEFMD-CNLYQLMKDR--NRLFSESDIRNIMYQILQGLAHIHK---HGFFHRDLKPENILISGNDVIKIADFGLAREVRS 162 (538)
T ss_pred HHhhh-hhHHHHHhhc--CCcCCHHHHHHHHHHHHHHHHHHHh---cCcccccCChhheEecccceeEeccccccccccc
Confidence 99995 5999999643 7889999999999999999999999 9999999999999999999999999999998765
Q ss_pred CCCCcccccccCCcccCccccc-CCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 005940 509 GGMPHTTNVVGTFGYIAPELTQ-TGKASTSSDVFAYGILLLEVATGRRPIGSG 560 (668)
Q Consensus 509 ~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDV~S~Gvvl~elltG~~p~~~~ 560 (668)
. +..+.++.|.+|.|||++. .+.|+.+.|+|++|||++|+.+-+.-|.+.
T Consensus 163 k--pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~ 213 (538)
T KOG0661|consen 163 K--PPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGA 213 (538)
T ss_pred C--CCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCC
Confidence 3 3467789999999999865 567899999999999999999999888654
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=324.26 Aligned_cols=251 Identities=25% Similarity=0.347 Sum_probs=199.6
Q ss_pred CcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCc---hhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEE
Q 005940 354 GFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSL---QGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYE 430 (668)
Q Consensus 354 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 430 (668)
.|+..+.||+|+||.||+|.+..+++.||+|.+.+... .....+.+|++++.+++|+||+++++.+.+.+..++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 36778999999999999999988999999999875432 233467899999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCC
Q 005940 431 YIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGG 510 (668)
Q Consensus 431 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~ 510 (668)
|+++|+|..++... ....+++.++..++.|++.||.|||+ .+|+||||||+||++++++.+||+|||++.......
T Consensus 81 ~~~~g~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~---~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05631 81 IMNGGDLKFHIYNM-GNPGFDEQRAIFYAAELCCGLEDLQR---ERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE 156 (285)
T ss_pred ecCCCcHHHHHHhh-CCCCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC
Confidence 99999999888532 23468999999999999999999999 999999999999999999999999999998764332
Q ss_pred CCcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchh-HHHHHHHHHhcCccccccCcccCCcc
Q 005940 511 MPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLL-LVEWVRECHQLGRILDVADPLLNSSY 589 (668)
Q Consensus 511 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~-l~~~~~~~~~~~~~~~~~d~~l~~~~ 589 (668)
......||..|+|||++.+..++.++|||||||++|||++|+.||...... ..+-+........ ......+
T Consensus 157 --~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~------~~~~~~~ 228 (285)
T cd05631 157 --TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQ------EEYSEKF 228 (285)
T ss_pred --eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhccc------ccCCccC
Confidence 123347899999999999999999999999999999999999999754321 1111111111100 0111122
Q ss_pred cHHHHHHHHHHHhhcCCC-CCCCCC-----HHHHHHH
Q 005940 590 VVKEMELVLKLGLMCSHK-TQFRPT-----MRQVMRY 620 (668)
Q Consensus 590 ~~~~~~~l~~l~~~C~~~-p~~RPs-----~~evl~~ 620 (668)
. ..+..+...|+.. |++||+ +++++++
T Consensus 229 s----~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 261 (285)
T cd05631 229 S----EDAKSICRMLLTKNPKERLGCRGNGAAGVKQH 261 (285)
T ss_pred C----HHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence 2 2344566678886 999997 8888874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=325.73 Aligned_cols=261 Identities=26% Similarity=0.398 Sum_probs=201.6
Q ss_pred cCcccceeeeecCcEEEEEEEeCC----------------CCcEEEEEEEecCC-chhHHHHHHHHHHHhcccccCceeE
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPT----------------TGGEVAVKKITRNS-LQGMREFAAEIESLGRLRHKNLVNL 415 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~----------------~~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l 415 (668)
++|...++||+|+||.||+|.+.. ++..||+|.+.... .....+|.+|++++.+++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 467888999999999999998632 23479999987653 3345679999999999999999999
Q ss_pred eeeecccCceEEEEEecCCCChhhhhcCCC----------------CCCCccHHHHHHHHHHHHHHHHHhhhccCCceEe
Q 005940 416 HGWCKQKNDLLLVYEYIPNGSLDTLLFKPK----------------DGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIH 479 (668)
Q Consensus 416 ~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~----------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH 479 (668)
++++.+.+..++||||+++|+|.+++.... ....++|.++++++.||+.||.|||+ .+|+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~ivH 161 (304)
T cd05096 85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSS---LNFVH 161 (304)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHH---CCccc
Confidence 999999999999999999999999885321 11357899999999999999999998 99999
Q ss_pred cCCCCCCEEECCCCCEEEEeecCceeccCCCCC-cccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHh--CCCC
Q 005940 480 RDVKPSNALIDAEMNARLGDFGLARLYDHGGMP-HTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVAT--GRRP 556 (668)
Q Consensus 480 rDLkp~NIll~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt--G~~p 556 (668)
|||||+|||++.++.+||+|||+++........ ......++..|+|||++..+.++.++|||||||++|||++ +..|
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p 241 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP 241 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence 999999999999999999999999865443221 1223345788999999988899999999999999999987 5567
Q ss_pred CCCC-chhHHHHHHHHHhcCcc-ccccCcccCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhcc
Q 005940 557 IGSG-DLLLVEWVRECHQLGRI-LDVADPLLNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSG 623 (668)
Q Consensus 557 ~~~~-~~~l~~~~~~~~~~~~~-~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~ 623 (668)
|... .....+.+......... .....+ .. ....+..++..|+.. |++||+++||.+.|+.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~----~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 242 YGELTDEQVIENAGEFFRDQGRQVYLFRP---PP----CPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred CCcCCHHHHHHHHHHHhhhccccccccCC---CC----CCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 7543 22333333332221111 111111 11 123466777899997 9999999999998863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=331.90 Aligned_cols=251 Identities=26% Similarity=0.379 Sum_probs=199.6
Q ss_pred HhcCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecC----Cc-hhHHHHHHHHHHHhccc-ccCceeEeeeecccCc
Q 005940 351 ATKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRN----SL-QGMREFAAEIESLGRLR-HKNLVNLHGWCKQKND 424 (668)
Q Consensus 351 at~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~-~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~~~ 424 (668)
...+|...+.||+|.||+|++|.+..++..||+|++.+. .. ...+.+.+|+.++++++ ||||++++.++.....
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~ 94 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK 94 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence 346889999999999999999999989999999987664 11 23345667999999999 9999999999999999
Q ss_pred eEEEEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCC-CCEEEEeecCc
Q 005940 425 LLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAE-MNARLGDFGLA 503 (668)
Q Consensus 425 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~-~~~kl~DfGla 503 (668)
.++||||+.+|.|.+++.. ...+.+....++++|++.|++|||+ ++|+||||||+||||+.+ +++||+|||++
T Consensus 95 ~~ivmEy~~gGdL~~~i~~---~g~l~E~~ar~~F~Qlisav~y~H~---~gi~HRDLK~ENilld~~~~~~Kl~DFG~s 168 (370)
T KOG0583|consen 95 IYIVMEYCSGGDLFDYIVN---KGRLKEDEARKYFRQLISAVAYCHS---RGIVHRDLKPENILLDGNEGNLKLSDFGLS 168 (370)
T ss_pred EEEEEEecCCccHHHHHHH---cCCCChHHHHHHHHHHHHHHHHHHh---CCEeeCCCCHHHEEecCCCCCEEEeccccc
Confidence 9999999999999999963 4668889999999999999999999 999999999999999999 99999999999
Q ss_pred eeccCCCCCcccccccCCcccCcccccCCC-CC-cchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCcccccc
Q 005940 504 RLYDHGGMPHTTNVVGTFGYIAPELTQTGK-AS-TSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVA 581 (668)
Q Consensus 504 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~ 581 (668)
.... .........+||+.|+|||++.+.. |. .++||||+||+||.|++|+.||+..+.... .+. ...+.
T Consensus 169 ~~~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l--~~k-i~~~~----- 239 (370)
T KOG0583|consen 169 AISP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNL--YRK-IRKGE----- 239 (370)
T ss_pred cccC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHH--HHH-HhcCC-----
Confidence 9874 1222344569999999999999876 74 899999999999999999999986432221 111 11111
Q ss_pred CcccCCcccHHHHHHHHHHHhhcCC-CCCCCCCHHHHHHH
Q 005940 582 DPLLNSSYVVKEMELVLKLGLMCSH-KTQFRPTMRQVMRY 620 (668)
Q Consensus 582 d~~l~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~~ 620 (668)
..+.......+.. .+...|+. +|.+|+++.+|+++
T Consensus 240 -~~~p~~~~S~~~~---~Li~~mL~~~P~~R~t~~~i~~h 275 (370)
T KOG0583|consen 240 -FKIPSYLLSPEAR---SLIEKMLVPDPSTRITLLEILEH 275 (370)
T ss_pred -ccCCCCcCCHHHH---HHHHHHcCCCcccCCCHHHHhhC
Confidence 1111111022222 23334444 59999999999954
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-39 Score=334.07 Aligned_cols=248 Identities=28% Similarity=0.371 Sum_probs=203.9
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecC--CchhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEE
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRN--SLQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYE 430 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 430 (668)
++|.+.+.||+|.||.||||+.+.+.+.||+|.+.+. ..+..+.+.+|++++++|+||||+.+++||+...++++|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 5788889999999999999999999999999999764 33556789999999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCC
Q 005940 431 YIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGG 510 (668)
Q Consensus 431 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~ 510 (668)
|+.+ +|..+|. ..+.++++++..|+.|++.||.|||+ .+|+|||+||.||||+.++.+|+||||+|+......
T Consensus 82 ~a~g-~L~~il~---~d~~lpEe~v~~~a~~LVsaL~yLhs---~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t 154 (808)
T KOG0597|consen 82 YAVG-DLFTILE---QDGKLPEEQVRAIAYDLVSALYYLHS---NRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNT 154 (808)
T ss_pred hhhh-hHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHh---cCcccccCCcceeeecCCCceeechhhhhhhcccCc
Confidence 9976 9999995 34569999999999999999999999 999999999999999999999999999999876543
Q ss_pred CCcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCcccCCccc
Q 005940 511 MPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSYV 590 (668)
Q Consensus 511 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 590 (668)
...+...||+-|||||...++.|+..+|+||+||++||+++|++||-.. .+...++....+ +........
T Consensus 155 -~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~--si~~Lv~~I~~d-------~v~~p~~~S 224 (808)
T KOG0597|consen 155 -SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR--SITQLVKSILKD-------PVKPPSTAS 224 (808)
T ss_pred -eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH--HHHHHHHHHhcC-------CCCCccccc
Confidence 2345578999999999999999999999999999999999999999542 222223322221 111111222
Q ss_pred HHHHHHHHHHHhhcC-CCCCCCCCHHHHHHHh
Q 005940 591 VKEMELVLKLGLMCS-HKTQFRPTMRQVMRYL 621 (668)
Q Consensus 591 ~~~~~~l~~l~~~C~-~~p~~RPs~~evl~~L 621 (668)
. .+..+..-.+ ++|.+|-+..+++.|=
T Consensus 225 ~----~f~nfl~gLL~kdP~~RltW~~Ll~Hp 252 (808)
T KOG0597|consen 225 S----SFVNFLQGLLIKDPAQRLTWTDLLGHP 252 (808)
T ss_pred H----HHHHHHHHHhhcChhhcccHHHHhcCh
Confidence 2 2222333334 4599999999998764
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=335.01 Aligned_cols=253 Identities=26% Similarity=0.329 Sum_probs=201.2
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCC---chhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEE
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNS---LQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVY 429 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 429 (668)
++|++.+.||+|+||.||+|++..+++.||||++.+.. ....+.+..|++++.+++||||+++++.+...+..++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 36888999999999999999998889999999997642 234567889999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCC
Q 005940 430 EYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHG 509 (668)
Q Consensus 430 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~ 509 (668)
||+++|+|.+++.. ...+++.++..++.||+.||.|||+ .+|+||||||+||+++.++.+||+|||+++....
T Consensus 81 e~~~g~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~- 153 (333)
T cd05600 81 EYVPGGDFRTLLNN---LGVLSEDHARFYMAEMFEAVDALHE---LGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT- 153 (333)
T ss_pred eCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCCEEEEeCcCCccccc-
Confidence 99999999999953 3468999999999999999999998 9999999999999999999999999999986543
Q ss_pred CCCcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCcccCCcc
Q 005940 510 GMPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSY 589 (668)
Q Consensus 510 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 589 (668)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...+... ............. .+.... .
T Consensus 154 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~--~~~~i~~~~~~~~--~~~~~~-~ 225 (333)
T cd05600 154 ---YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNE--TWENLKYWKETLQ--RPVYDD-P 225 (333)
T ss_pred ---ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHH--HHHHHHhcccccc--CCCCCc-c
Confidence 2234578999999999998899999999999999999999999997543211 1111111111111 111100 0
Q ss_pred cHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 590 VVKEMELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 590 ~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
.......+..+...|+.+ |++||+++|++++
T Consensus 226 ~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 226 RFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred ccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 000112334455577777 8899999999987
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-38 Score=319.93 Aligned_cols=261 Identities=25% Similarity=0.342 Sum_probs=204.9
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCc-hhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEEe
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSL-QGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEY 431 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~ 431 (668)
+.|...++||.|..++||+|.....++.||||++..+.. ...+.+.+|+..++.++||||++++..|..+.++++||.|
T Consensus 26 ~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpf 105 (516)
T KOG0582|consen 26 KDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPF 105 (516)
T ss_pred cceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehh
Confidence 578889999999999999999988899999999976533 3468899999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCCC
Q 005940 432 IPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGM 511 (668)
Q Consensus 432 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~~ 511 (668)
|.+||+.++++..-. ..+++..+..|++++++||.|||. +|.||||||+.||||+++|.+||+|||..-.+.....
T Consensus 106 Ma~GS~ldIik~~~~-~Gl~E~~Ia~iLre~LkaL~YLH~---~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~ 181 (516)
T KOG0582|consen 106 MAGGSLLDIIKTYYP-DGLEEASIATILREVLKALDYLHQ---NGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGD 181 (516)
T ss_pred hcCCcHHHHHHHHcc-ccccHHHHHHHHHHHHHHHHHHHh---cCceecccccccEEEcCCCcEEEcCceeeeeecccCc
Confidence 999999999964332 339999999999999999999999 9999999999999999999999999998765544332
Q ss_pred Ccc---cccccCCcccCcccccC--CCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCcccC
Q 005940 512 PHT---TNVVGTFGYIAPELTQT--GKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLN 586 (668)
Q Consensus 512 ~~~---~~~~gt~~y~aPE~~~~--~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 586 (668)
... ...+||+.|||||++.. ..|+.|+||||||+..+||++|..||.... .++......+..-. ...-..+.
T Consensus 182 R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~p--PmkvLl~tLqn~pp-~~~t~~~~ 258 (516)
T KOG0582|consen 182 RQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYP--PMKVLLLTLQNDPP-TLLTSGLD 258 (516)
T ss_pred eeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCC--hHHHHHHHhcCCCC-CcccccCC
Confidence 221 44689999999999543 468999999999999999999999997542 22222222221111 00000111
Q ss_pred CcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 587 SSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 587 ~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
.+.+..--..+.++.-.|+.. |++||++.+++++
T Consensus 259 ~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh 293 (516)
T KOG0582|consen 259 KDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH 293 (516)
T ss_pred hHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence 111111122455666688887 9999999999975
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=324.41 Aligned_cols=254 Identities=28% Similarity=0.424 Sum_probs=200.9
Q ss_pred cCcccceeeeecCcEEEEEEEeC---CCCcEEEEEEEecCCc-hhHHHHHHHHHHHhcccccCceeEeeeecccCceEEE
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLP---TTGGEVAVKKITRNSL-QGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLV 428 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~---~~~~~vavK~~~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV 428 (668)
++|++.+.||+|+||.||+|.+. ..+..||+|.+..... ...+.|.+|+.++++++||||+++++++...+..++|
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 84 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV 84 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence 56888999999999999999874 3456899999876533 3446789999999999999999999999999999999
Q ss_pred EEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccC
Q 005940 429 YEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDH 508 (668)
Q Consensus 429 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~ 508 (668)
|||+++|+|++++... ...+++.+++.++.|++.||+|||+ ++++||||||+||+++.++.+|++|||.+.....
T Consensus 85 ~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~i~~al~~lH~---~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~ 159 (266)
T cd05064 85 TEYMSNGALDSFLRKH--EGQLVAGQLMGMLPGLASGMKYLSE---MGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKS 159 (266)
T ss_pred EEeCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHH---CCEeeccccHhhEEEcCCCcEEECCCcccccccc
Confidence 9999999999999632 3468999999999999999999998 9999999999999999999999999998765432
Q ss_pred CCCCcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHHHhcCccccccCcccCC
Q 005940 509 GGMPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVAT-GRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNS 587 (668)
Q Consensus 509 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 587 (668)
..........++..|+|||.+.++.++.++|||||||++||+++ |+.||...... +.... ....... ....
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~--~~~~~-~~~~~~~-----~~~~ 231 (266)
T cd05064 160 EAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ--DVIKA-VEDGFRL-----PAPR 231 (266)
T ss_pred cchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH--HHHHH-HHCCCCC-----CCCC
Confidence 22111222345678999999998999999999999999999775 99999754321 11111 1111111 1111
Q ss_pred cccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhcc
Q 005940 588 SYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSG 623 (668)
Q Consensus 588 ~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~ 623 (668)
.+ ...+..+...|++. |++||+++||.+.|+.
T Consensus 232 ~~----~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~ 264 (266)
T cd05064 232 NC----PNLLHQLMLDCWQKERGERPRFSQIHSILSK 264 (266)
T ss_pred CC----CHHHHHHHHHHcCCCchhCCCHHHHHHHHHh
Confidence 11 23456677789998 9999999999998865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=322.71 Aligned_cols=262 Identities=23% Similarity=0.276 Sum_probs=202.1
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCC--chhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEE
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNS--LQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYE 430 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 430 (668)
++|++.+.||+|+||.||+|+++.+++.||+|++.... ....+.+.+|++++++++|+||+++++.+...+..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 46889999999999999999998889999999987542 2334678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCC
Q 005940 431 YIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGG 510 (668)
Q Consensus 431 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~ 510 (668)
|++++.+..+.. ....+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 154 (287)
T cd07848 81 YVEKNMLELLEE---MPNGVPPEKVRSYIYQLIKAIHWCHK---NDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS 154 (287)
T ss_pred cCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEEeeccCcccccccc
Confidence 999887776553 23458999999999999999999998 999999999999999999999999999998765443
Q ss_pred CCcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhH--HH-----------HHHHHHhcCcc
Q 005940 511 MPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLL--VE-----------WVRECHQLGRI 577 (668)
Q Consensus 511 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l--~~-----------~~~~~~~~~~~ 577 (668)
........|+..|+|||++.+..++.++|||||||++|||++|+.||......- .. +..........
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd07848 155 NANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRF 234 (287)
T ss_pred cccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchh
Confidence 333344578999999999988889999999999999999999999997542111 00 00000000000
Q ss_pred ccccCcccCCcc------cHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 578 LDVADPLLNSSY------VVKEMELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 578 ~~~~d~~l~~~~------~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
.....+...... .......+..+...|++. |++||+++|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h 284 (287)
T cd07848 235 HGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH 284 (287)
T ss_pred cccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 000001110000 000123466777788887 9999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-38 Score=300.39 Aligned_cols=262 Identities=27% Similarity=0.365 Sum_probs=201.9
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCch--hHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEE
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQ--GMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYE 430 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 430 (668)
.+|...++||+|.||.||+|++..+|+.||||++...... ......+|++.|+.++|+||+.+++.|-+.+.+-||+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 3567788999999999999999999999999999765433 23467899999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCC
Q 005940 431 YIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGG 510 (668)
Q Consensus 431 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~ 510 (668)
||+ .+|+..++. ....++-.++..++.++++||+|||+ ..|+||||||.|+|+++++.+||+|||+|+.+....
T Consensus 82 fm~-tdLe~vIkd--~~i~l~pa~iK~y~~m~LkGl~y~H~---~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~ 155 (318)
T KOG0659|consen 82 FMP-TDLEVVIKD--KNIILSPADIKSYMLMTLKGLAYCHS---KWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN 155 (318)
T ss_pred ecc-ccHHHHhcc--cccccCHHHHHHHHHHHHHHHHHHHh---hhhhcccCCccceEEcCCCcEEeecccchhccCCCC
Confidence 996 589999953 45679999999999999999999999 999999999999999999999999999999887654
Q ss_pred CCcccccccCCcccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCC-chhHHHHHHHHHhcCc------ccc---
Q 005940 511 MPHTTNVVGTFGYIAPELTQT-GKASTSSDVFAYGILLLEVATGRRPIGSG-DLLLVEWVRECHQLGR------ILD--- 579 (668)
Q Consensus 511 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~S~Gvvl~elltG~~p~~~~-~~~l~~~~~~~~~~~~------~~~--- 579 (668)
... +..+-|.+|.|||.+.+ .+|+...||||.|||+.||+-|..-|.+. |......+........ +..
T Consensus 156 ~~~-~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpd 234 (318)
T KOG0659|consen 156 RIQ-THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPD 234 (318)
T ss_pred ccc-ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCcccccccc
Confidence 433 33378999999998876 46899999999999999999988666433 3222222222221111 111
Q ss_pred ------ccCcccCCcccHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHh
Q 005940 580 ------VADPLLNSSYVVKEMELVLKLGLMCSHKTQFRPTMRQVMRYL 621 (668)
Q Consensus 580 ------~~d~~l~~~~~~~~~~~l~~l~~~C~~~p~~RPs~~evl~~L 621 (668)
...+.++.-+...--..+-.++.+..-+|.+|.++.|++++=
T Consensus 235 Y~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~ 282 (318)
T KOG0659|consen 235 YVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHP 282 (318)
T ss_pred HHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcch
Confidence 111222222222122233344445566699999999999763
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=319.48 Aligned_cols=249 Identities=33% Similarity=0.551 Sum_probs=192.9
Q ss_pred cceeeeecCcEEEEEEEeC----CCCcEEEEEEEecCC-chhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEEe
Q 005940 357 ESEVIGIGGFGSVYKGVLP----TTGGEVAVKKITRNS-LQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEY 431 (668)
Q Consensus 357 ~~~~lG~G~~g~Vy~~~~~----~~~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~ 431 (668)
..+.||.|.||.||+|.+. ..+..|+||.+.... .+..++|.+|++.+++++||||++++|+|...+..++|+||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 4678999999999999996 335689999996543 34478999999999999999999999999988889999999
Q ss_pred cCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCCC
Q 005940 432 IPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGM 511 (668)
Q Consensus 432 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~~ 511 (668)
+++|+|.++|... ....+++.+++.|+.||++||.|||+ .+++|+||+++||++++++.+||+|||++........
T Consensus 83 ~~~g~L~~~L~~~-~~~~~~~~~~~~i~~~i~~~l~~Lh~---~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~ 158 (259)
T PF07714_consen 83 CPGGSLDDYLKSK-NKEPLSEQQRLSIAIQIAEALSYLHS---NNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK 158 (259)
T ss_dssp -TTEBHHHHHHHT-CTTTSBHHHHHHHHHHHHHHHHHHHH---TTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred ccccccccccccc-cccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccccc
Confidence 9999999999743 34679999999999999999999999 8999999999999999999999999999987733221
Q ss_pred -CcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHHHhcCccccccCcccCCcc
Q 005940 512 -PHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVAT-GRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSY 589 (668)
Q Consensus 512 -~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 589 (668)
...........|+|||.+....++.++||||||+++|||++ |+.|+...+. .++.... ......... ..+
T Consensus 159 ~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~--~~~~~~~-~~~~~~~~~-----~~~ 230 (259)
T PF07714_consen 159 YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDN--EEIIEKL-KQGQRLPIP-----DNC 230 (259)
T ss_dssp EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCH--HHHHHHH-HTTEETTSB-----TTS
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccc--ccccccc-cccccceec-----cch
Confidence 12223456778999999988889999999999999999999 7888865422 2222232 222222111 111
Q ss_pred cHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHh
Q 005940 590 VVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYL 621 (668)
Q Consensus 590 ~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L 621 (668)
...+..++..|+.. |++||++++|++.|
T Consensus 231 ----~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 231 ----PKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp ----BHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ----hHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 13355677799987 99999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd01951 lectin_L-type legume lectins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=309.15 Aligned_cols=204 Identities=29% Similarity=0.409 Sum_probs=169.0
Q ss_pred CCeEEeCceeeCC-CCcEEccCCCCceEEEEEeeCceecccCCCCCCCCeeeeEEEEEEEEeCCCCCCCCCceEEEEcCC
Q 005940 40 TNLSLQGAEIIKP-SGALKLTNRSRYVIGHAFYVKPIQMFDTSASPSPNASSFSTTFVFEISTPRSGRGGHGLAFLLAPS 118 (668)
Q Consensus 40 ~~l~~~g~a~~~~-~~~~~lt~~~~~~~G~~~y~~p~~l~~~~~~~~~~~~sF~t~F~f~i~~~~~~~~g~GlaF~l~p~ 118 (668)
.++.+.|+|.+.. ++.|+||++..+++|+++|++||++|. +|+|+|+|.|.+.. ..+||||||+|+|.
T Consensus 14 ~~~~~~G~A~~~~~~~~l~Lt~~~~~~~G~~~~~~~i~~~~----------~F~~~F~f~i~~~~-~~~gdG~aF~l~~~ 82 (223)
T cd01951 14 SNWQLNGSATLTTDSGVLRLTPDTGNQAGSAWYKTPIDLSK----------DFTTTFKFYLGTKG-TNGADGIAFVLQND 82 (223)
T ss_pred hhcEEcccEEecCCCCEEEECCCCCCcEEEEEECCcEeccC----------CEEEEEEEEEeCCC-CCCCCcEEEEEecC
Confidence 6899999999975 789999999999999999999999986 79999999999864 56899999999997
Q ss_pred CCCCCCCCC--CcccccccCCCCCCCccEEEEEeecccCCCCCCCCCCCeeeeecCCccccc--ccCCccccCCCCCccc
Q 005940 119 TKLPGAQPE--HYLGILNSTNNGEPSNHILIVEFDTVNGFNDKAENQGNHVGIGINTMFSNR--SEPASYYINGTDHKEE 194 (668)
Q Consensus 119 ~~~~~~~~~--~~lGl~~~~~~~~~~~~~~aVEfDt~~n~~d~~~~~~~Hvgid~~s~~s~~--~~~~~~~~~~~~~~~~ 194 (668)
...+.+.++ ++||+ ...++.+||||||++|. +.+||+.||||||+|+..+.. .....+. ..+
T Consensus 83 ~~~~~~~~g~~~~lG~-------~~~~~~~aVefDT~~N~-~~~dp~~~higi~~n~~~~~~~~~~~~~~~------~~~ 148 (223)
T cd01951 83 PAGALGGGGGGGGLGY-------GGIGNSVAVEFDTYKND-DNNDPNGNHISIDVNGNGNNTALATSLGSA------SLP 148 (223)
T ss_pred CCCccccCCCCCccCc-------cccCCeEEEEEeccccC-CCCCCCCCEEEEEcCCCCCCccccccccee------eCC
Confidence 755555555 78887 34567899999999993 223499999999999997642 1111111 011
Q ss_pred cccCCCCcEEEEEEEeCCcceEEEEEEeCCCCCCCCcceeeeeccccccccceeeeeecccCCcccceeeeccccc
Q 005940 195 MTLESGEPIQAWIEYDGEQKVLNVTISPAEIGKPMRPLISFGVNLTGYIKETMYVGFSASTGEKSSSHYILGWSFS 270 (668)
Q Consensus 195 ~~l~~g~~~~~~I~Y~~~~~~l~V~~~~~~~~~p~~~~ls~~~dLs~~l~~~~~vGFsastG~~~~~~~i~~w~F~ 270 (668)
....+|+.++|||+||+..++|+|++.+... |..+.++.++||+..++++|||||||+||...+.|.|++|+|+
T Consensus 149 ~~~~~g~~~~v~I~Y~~~~~~L~v~l~~~~~--~~~~~l~~~~~l~~~~~~~~yvGFTAsTG~~~~~h~V~~wsf~ 222 (223)
T cd01951 149 NGTGLGNEHTVRITYDPTTNTLTVYLDNGST--LTSLDITIPVDLIQLGPTKAYFGFTASTGGLTNLHDILNWSFT 222 (223)
T ss_pred CccCCCCEEEEEEEEeCCCCEEEEEECCCCc--cccccEEEeeeecccCCCcEEEEEEcccCCCcceeEEEEEEec
Confidence 2222399999999999999999999987654 6778999999999999999999999999999999999999996
|
The L-type (legume-type) lectins are a highly diverse family of carbohydrate binding proteins that generally display no enzymatic activity toward the sugars they bind. This family includes arcelin, concanavalinA, the lectin-like receptor kinases, the ERGIC-53/VIP36/EMP46 type1 transmembrane proteins, and an alpha-amylase inhibitor. L-type lectins have a dome-shaped beta-barrel carbohydrate recognition domain with a curved seven-stranded beta-sheet referred to as the "front face" and a flat six-stranded beta-sheet referred to as the "back face". This domain homodimerizes so that adjacent back sheets form a contiguous 12-stranded sheet and homotetramers occur by a back-to-back association of these homodimers. Though L-type lectins exhibit both sequence and structural similarity to one another, their carbohydrate binding specificities differ widely. |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=319.42 Aligned_cols=246 Identities=19% Similarity=0.269 Sum_probs=196.2
Q ss_pred ceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCchh---HHHHHHHHHHHhcccccCceeEeeeecc----cCceEEEEE
Q 005940 358 SEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQG---MREFAAEIESLGRLRHKNLVNLHGWCKQ----KNDLLLVYE 430 (668)
Q Consensus 358 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~---~~~f~~Ei~~l~~l~H~nIv~l~g~~~~----~~~~~lV~E 430 (668)
...||+|++|.||+|.+ +|+.||||++....... .+.|.+|++++++++||||++++|++.+ ....++|||
T Consensus 25 ~~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~E 102 (283)
T PHA02988 25 SVLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILE 102 (283)
T ss_pred CeEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEE
Confidence 46799999999999998 68899999997653322 5678899999999999999999999866 346899999
Q ss_pred ecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCC
Q 005940 431 YIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGG 510 (668)
Q Consensus 431 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~ 510 (668)
|+++|+|.+++.. ...++|...++++.|++.||.|||+ ..+++||||||+||++++++.+||+|||+++......
T Consensus 103 y~~~g~L~~~l~~---~~~~~~~~~~~i~~~i~~~l~~lH~--~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~ 177 (283)
T PHA02988 103 YCTRGYLREVLDK---EKDLSFKTKLDMAIDCCKGLYNLYK--YTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP 177 (283)
T ss_pred eCCCCcHHHHHhh---CCCCChhHHHHHHHHHHHHHHHHHh--cCCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc
Confidence 9999999999963 3468999999999999999999997 2478899999999999999999999999998654322
Q ss_pred CCcccccccCCcccCcccccC--CCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCcccCCc
Q 005940 511 MPHTTNVVGTFGYIAPELTQT--GKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSS 588 (668)
Q Consensus 511 ~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 588 (668)
....|+..|+|||++.+ +.++.++|||||||++|||++|+.||...+.. +........... +.+...
T Consensus 178 ----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~--~~~~~i~~~~~~-----~~~~~~ 246 (283)
T PHA02988 178 ----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTK--EIYDLIINKNNS-----LKLPLD 246 (283)
T ss_pred ----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHH--HHHHHHHhcCCC-----CCCCCc
Confidence 22367889999999876 67899999999999999999999999764321 222222111111 111111
Q ss_pred ccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhccCc
Q 005940 589 YVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSGEK 625 (668)
Q Consensus 589 ~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~~~ 625 (668)
+ ...+..+...|++. |++||+++||++.|+...
T Consensus 247 ~----~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~ 280 (283)
T PHA02988 247 C----PLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK 280 (283)
T ss_pred C----cHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 2 22455667789997 999999999999997643
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=331.73 Aligned_cols=203 Identities=28% Similarity=0.394 Sum_probs=177.8
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCC---chhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEE
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNS---LQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVY 429 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 429 (668)
++|+..+.||+|+||+||++....+++.||||++.+.. ......+..|+.++.+++|+||+++++.+.+....++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 46888999999999999999998889999999997642 233456788999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCC
Q 005940 430 EYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHG 509 (668)
Q Consensus 430 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~ 509 (668)
||+++|+|.+++.+ ...+++.++..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 81 E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~---~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~ 154 (363)
T cd05628 81 EFLPGGDMMTLLMK---KDTLTEEETQFYIAETVLAIDSIHQ---LGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKA 154 (363)
T ss_pred cCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEecCCCHHHeEECCCCCEEEeeccCccccccc
Confidence 99999999999963 3468999999999999999999998 99999999999999999999999999999754321
Q ss_pred CCC----------------------------------cccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCC
Q 005940 510 GMP----------------------------------HTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRR 555 (668)
Q Consensus 510 ~~~----------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~ 555 (668)
... .....+||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~ 234 (363)
T cd05628 155 HRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (363)
T ss_pred ccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCC
Confidence 100 0123479999999999998899999999999999999999999
Q ss_pred CCCCCc
Q 005940 556 PIGSGD 561 (668)
Q Consensus 556 p~~~~~ 561 (668)
||....
T Consensus 235 Pf~~~~ 240 (363)
T cd05628 235 PFCSET 240 (363)
T ss_pred CCCCCC
Confidence 997543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-38 Score=356.32 Aligned_cols=257 Identities=28% Similarity=0.463 Sum_probs=207.9
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCc-----EEEEEEEecC-CchhHHHHHHHHHHHhcccccCceeEeeeecccCceE
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGG-----EVAVKKITRN-SLQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLL 426 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~-----~vavK~~~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~ 426 (668)
.+....+.||+|.||.||.|...+... .||||.+.+. +.+...+|.+|..+|++++|||||+++|.|.+.+..+
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~ 771 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPL 771 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcE
Confidence 344567889999999999999865443 3999999775 4566789999999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhcCCCC----CCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecC
Q 005940 427 LVYEYIPNGSLDTLLFKPKD----GSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGL 502 (668)
Q Consensus 427 lV~E~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGl 502 (668)
+++|||++|+|..+|++.+. ...|+....+.++.|||+|+.||++ +++|||||.++|+||++...+||+|||+
T Consensus 772 i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~---~~fvHRDLAaRNCLL~~~r~VKIaDFGl 848 (1025)
T KOG1095|consen 772 ILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLES---KHFVHRDLAARNCLLDERRVVKIADFGL 848 (1025)
T ss_pred EEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHh---CCCcCcchhhhheeecccCcEEEcccch
Confidence 99999999999999975422 4568999999999999999999999 9999999999999999999999999999
Q ss_pred ceeccCCCC-CcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCc-hhHHHHHHHHHhcCcccc
Q 005940 503 ARLYDHGGM-PHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVAT-GRRPIGSGD-LLLVEWVRECHQLGRILD 579 (668)
Q Consensus 503 a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~-~~l~~~~~~~~~~~~~~~ 579 (668)
|+.+..... .......-...|||||.+..+.++.|+|||||||++||++| |..||.... ..+.. .....+++.
T Consensus 849 ArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~---~~~~ggRL~- 924 (1025)
T KOG1095|consen 849 ARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLL---DVLEGGRLD- 924 (1025)
T ss_pred hHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHH---HHHhCCccC-
Confidence 994433322 22222233568999999999999999999999999999999 999997542 22221 122233211
Q ss_pred ccCcccCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhccCc
Q 005940 580 VADPLLNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSGEK 625 (668)
Q Consensus 580 ~~d~~l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~~~ 625 (668)
.|.. +.+.+.+|++.||+. |++||++..|++.+....
T Consensus 925 --~P~~-------CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~ 962 (1025)
T KOG1095|consen 925 --PPSY-------CPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAIS 962 (1025)
T ss_pred --CCCC-------CChHHHHHHHHHccCChhhCccHHHHHhhhhhhh
Confidence 2222 335667999999998 999999999999876554
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-37 Score=325.03 Aligned_cols=201 Identities=29% Similarity=0.393 Sum_probs=178.2
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCC-chhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEEe
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNS-LQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEY 431 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~ 431 (668)
++|+..+.||+|+||.||++++..++..+|+|.+.... ....+.+.+|++++++++||||+++++++...+..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 84 (331)
T cd06649 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 84 (331)
T ss_pred ccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeec
Confidence 67899999999999999999998889999999987653 23456799999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCCC
Q 005940 432 IPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGM 511 (668)
Q Consensus 432 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~~ 511 (668)
+++|+|.+++.. ...+++..+..++.|++.||.|||+ ..+|+||||||+||+++.++.+||+|||++.......
T Consensus 85 ~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~--~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 158 (331)
T cd06649 85 MDGGSLDQVLKE---AKRIPEEILGKVSIAVLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM- 158 (331)
T ss_pred CCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHhh--cCCEEcCCCChhhEEEcCCCcEEEccCcccccccccc-
Confidence 999999999953 3458999999999999999999997 2469999999999999999999999999997654322
Q ss_pred CcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCc
Q 005940 512 PHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGD 561 (668)
Q Consensus 512 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~ 561 (668)
.....|+..|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 159 --~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~ 206 (331)
T cd06649 159 --ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPD 206 (331)
T ss_pred --cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 233468999999999998889999999999999999999999996543
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=316.87 Aligned_cols=254 Identities=26% Similarity=0.369 Sum_probs=204.4
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCchhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEEec
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEYI 432 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~ 432 (668)
.+|...++||+|++|.||+|.+...++.||+|++.... ...+++.+|++++++++|+||++++++|...+..++||||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 84 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc-hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence 35778899999999999999998889999999987543 34567899999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCCCC
Q 005940 433 PNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMP 512 (668)
Q Consensus 433 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~~~ 512 (668)
++++|.+++... ....+++..++.++.|++.||+|||+ .+++||||||+||++++++.+||+|||++.........
T Consensus 85 ~~~~L~~~~~~~-~~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~ 160 (263)
T cd05052 85 TYGNLLDYLREC-NRQEVNAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT 160 (263)
T ss_pred CCCcHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccCcceEEEcCCCcEEeCCCccccccccceee
Confidence 999999998532 34568999999999999999999998 99999999999999999999999999999876543322
Q ss_pred cccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHHHhcCccccccCcccCCcccH
Q 005940 513 HTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVAT-GRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSYVV 591 (668)
Q Consensus 513 ~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 591 (668)
......++..|+|||.+.+..++.++|||||||++|||++ |..||...+.. +......... .+......+
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~--~~~~~~~~~~------~~~~~~~~~- 231 (263)
T cd05052 161 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS--QVYELLEKGY------RMERPEGCP- 231 (263)
T ss_pred ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHHHCCC------CCCCCCCCC-
Confidence 2222334668999999988899999999999999999998 99998754321 2111111111 111111122
Q ss_pred HHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhcc
Q 005940 592 KEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSG 623 (668)
Q Consensus 592 ~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~ 623 (668)
..+..+...|+.. |++||++.++++.|+.
T Consensus 232 ---~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~ 261 (263)
T cd05052 232 ---PKVYELMRACWQWNPSDRPSFAEIHQAFET 261 (263)
T ss_pred ---HHHHHHHHHHccCCcccCCCHHHHHHHHHh
Confidence 3355666789887 9999999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=319.92 Aligned_cols=263 Identities=29% Similarity=0.404 Sum_probs=201.7
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCchhHHHHHHHHHHHhc--ccccCceeEeeeecccC----ceE
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGR--LRHKNLVNLHGWCKQKN----DLL 426 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~--l~H~nIv~l~g~~~~~~----~~~ 426 (668)
...+..++||+|+||.||||.+ +++.||||++.. +..+.|.+|-+|.+. ++|+||+++++.-+... +++
T Consensus 210 ~pl~l~eli~~Grfg~V~KaqL--~~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eyw 284 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQL--DNRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYW 284 (534)
T ss_pred CchhhHHHhhcCccceeehhhc--cCceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCcccccee
Confidence 4556678999999999999999 579999999954 455678888877765 58999999999876555 899
Q ss_pred EEEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhcc------CCceEecCCCCCCEEECCCCCEEEEee
Q 005940 427 LVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEW------EQVVIHRDVKPSNALIDAEMNARLGDF 500 (668)
Q Consensus 427 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~------~~~ivHrDLkp~NIll~~~~~~kl~Df 500 (668)
||+||.++|+|.++|. ...++|....+|+..+++||+|||++. +++|+|||||++||||..|+++.|+||
T Consensus 285 LVt~fh~kGsL~dyL~----~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDF 360 (534)
T KOG3653|consen 285 LVTEFHPKGSLCDYLK----ANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADF 360 (534)
T ss_pred EEeeeccCCcHHHHHH----hccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecc
Confidence 9999999999999995 467999999999999999999999864 678999999999999999999999999
Q ss_pred cCceeccCCCCC-cccccccCCcccCcccccCCC------CCcchhHHHHHHHHHHHHhCCCCCCCC-------------
Q 005940 501 GLARLYDHGGMP-HTTNVVGTFGYIAPELTQTGK------ASTSSDVFAYGILLLEVATGRRPIGSG------------- 560 (668)
Q Consensus 501 Gla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~------~~~~sDV~S~Gvvl~elltG~~p~~~~------------- 560 (668)
|+|..+..+... +....+||.+|||||++.+.- .-.+.||||+|.|||||++.-..+..+
T Consensus 361 GLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~ev 440 (534)
T KOG3653|consen 361 GLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEV 440 (534)
T ss_pred ceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHh
Confidence 999988765432 334579999999999986532 235799999999999999965433110
Q ss_pred -chhHHHHHHHHH-hcCccccccCcccCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhccCcCCC
Q 005940 561 -DLLLVEWVRECH-QLGRILDVADPLLNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSGEKQLR 628 (668)
Q Consensus 561 -~~~l~~~~~~~~-~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~~~~~~ 628 (668)
...-.+-+++.. .......+.|..... ..+..+.+....||.. ++.|-|+.=|.+.+....-+.
T Consensus 441 G~hPt~e~mq~~VV~kK~RP~~p~~W~~h----~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~ 507 (534)
T KOG3653|consen 441 GNHPTLEEMQELVVRKKQRPKIPDAWRKH----AGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLW 507 (534)
T ss_pred cCCCCHHHHHHHHHhhccCCCChhhhhcC----ccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccC
Confidence 111112222222 112222222222221 4567788888899987 999999998888877665333
|
|
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=332.74 Aligned_cols=253 Identities=27% Similarity=0.335 Sum_probs=202.9
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCC---chhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEE
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNS---LQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVY 429 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 429 (668)
++|...+.||+|+||.||+|....+++.||||++.... ......+..|++++..++|+||+++++.+.+++..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 46888999999999999999998889999999997542 234567889999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCC
Q 005940 430 EYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHG 509 (668)
Q Consensus 430 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~ 509 (668)
||+++++|.+++... ..+++..+..++.||+.||.|||+ .+|+||||||+||+++.++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~---~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 154 (350)
T cd05573 81 EYMPGGDLMNLLIRK---DVFPEETARFYIAELVLALDSVHK---LGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKA 154 (350)
T ss_pred cCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEeecCCCCccCccc
Confidence 999999999999632 568999999999999999999999 99999999999999999999999999999866543
Q ss_pred C----------------------------CCcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCc
Q 005940 510 G----------------------------MPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGD 561 (668)
Q Consensus 510 ~----------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~ 561 (668)
. ........||..|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~ 234 (350)
T cd05573 155 KDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT 234 (350)
T ss_pred CcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCC
Confidence 3 112234578999999999999899999999999999999999999997654
Q ss_pred hhHHHHHHHHHhcCccccccCcccCCcccHHHHHHHHHHHhhcCCCCCCCCC-HHHHHHH
Q 005940 562 LLLVEWVRECHQLGRILDVADPLLNSSYVVKEMELVLKLGLMCSHKTQFRPT-MRQVMRY 620 (668)
Q Consensus 562 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~p~~RPs-~~evl~~ 620 (668)
.. .............. -+.. ...+ . .+..+...|+.+|++||+ ++|++++
T Consensus 235 ~~--~~~~~i~~~~~~~~--~p~~-~~~~-~---~~~~li~~ll~dp~~R~~s~~~ll~h 285 (350)
T cd05573 235 LQ--ETYNKIINWKESLR--FPPD-PPVS-P---EAIDLICRLLCDPEDRLGSFEEIKSH 285 (350)
T ss_pred HH--HHHHHHhccCCccc--CCCC-CCCC-H---HHHHHHHHHccChhhcCCCHHHHhcC
Confidence 21 11111111111010 0111 1112 2 233444567778999999 9999987
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=326.88 Aligned_cols=245 Identities=24% Similarity=0.321 Sum_probs=200.2
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCC---chhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEE
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNS---LQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVY 429 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 429 (668)
++|...+.||+|+||.||+|++..+++.||||++.+.. ....+.+.+|+.++++++||||+++++.+.+++..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 56888999999999999999998889999999997542 234567889999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCC
Q 005940 430 EYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHG 509 (668)
Q Consensus 430 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~ 509 (668)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 98 e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 171 (329)
T PTZ00263 98 EFVVGGELFTHLRK---AGRFPNDVAKFYHAELVLAFEYLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR 171 (329)
T ss_pred cCCCCChHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHEEECCCCCEEEeeccCceEcCCC
Confidence 99999999999953 3458899999999999999999999 99999999999999999999999999999876542
Q ss_pred CCCcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCcccCCcc
Q 005940 510 GMPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSY 589 (668)
Q Consensus 510 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 589 (668)
. ....||+.|+|||++.+..++.++|||||||++|||++|+.||...... +.... ...+.. .+....
T Consensus 172 ~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~--~~~~~-i~~~~~------~~p~~~ 238 (329)
T PTZ00263 172 T----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPF--RIYEK-ILAGRL------KFPNWF 238 (329)
T ss_pred c----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHH--HHHHH-HhcCCc------CCCCCC
Confidence 2 2357899999999999888999999999999999999999999754321 11111 111111 111112
Q ss_pred cHHHHHHHHHHHhhcCCC-CCCCCC-----HHHHHHH
Q 005940 590 VVKEMELVLKLGLMCSHK-TQFRPT-----MRQVMRY 620 (668)
Q Consensus 590 ~~~~~~~l~~l~~~C~~~-p~~RPs-----~~evl~~ 620 (668)
+ ..+..+...|++. |++||+ +++++++
T Consensus 239 ~----~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 239 D----GRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred C----HHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 2 2234555678876 999986 7888876
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=323.10 Aligned_cols=245 Identities=23% Similarity=0.294 Sum_probs=199.5
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCC---chhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEE
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNS---LQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVY 429 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 429 (668)
++|+..+.||+|+||.||+|....+++.||+|++.... ....+.+.+|++++++++||||+++++.+.+....++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 36888999999999999999998889999999997542 234467889999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCC
Q 005940 430 EYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHG 509 (668)
Q Consensus 430 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~ 509 (668)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~ 154 (291)
T cd05612 81 EYVPGGELFSYLRN---SGRFSNSTGLFYASEIVCALEYLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR 154 (291)
T ss_pred eCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEEEecCcchhccCC
Confidence 99999999999953 3468999999999999999999999 99999999999999999999999999999866432
Q ss_pred CCCcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCcccCCcc
Q 005940 510 GMPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSY 589 (668)
Q Consensus 510 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 589 (668)
.....|++.|+|||++.+..++.++|||||||++|||++|+.||...... +....... .+. .+....
T Consensus 155 ----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~--~~~~~i~~-~~~------~~~~~~ 221 (291)
T cd05612 155 ----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPF--GIYEKILA-GKL------EFPRHL 221 (291)
T ss_pred ----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHh-CCc------CCCccC
Confidence 22346899999999998888999999999999999999999999764321 11111111 111 111112
Q ss_pred cHHHHHHHHHHHhhcCCC-CCCCCC-----HHHHHHH
Q 005940 590 VVKEMELVLKLGLMCSHK-TQFRPT-----MRQVMRY 620 (668)
Q Consensus 590 ~~~~~~~l~~l~~~C~~~-p~~RPs-----~~evl~~ 620 (668)
+ ..+..+...|+.. |.+||+ ++|++++
T Consensus 222 ~----~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 222 D----LYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred C----HHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 2 2344556678776 999995 8888865
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=331.26 Aligned_cols=255 Identities=26% Similarity=0.384 Sum_probs=199.8
Q ss_pred cCcccceeeeecCcEEEEEEEe-----CCCCcEEEEEEEecCC-chhHHHHHHHHHHHhcc-cccCceeEeeeecccCce
Q 005940 353 KGFKESEVIGIGGFGSVYKGVL-----PTTGGEVAVKKITRNS-LQGMREFAAEIESLGRL-RHKNLVNLHGWCKQKNDL 425 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~-----~~~~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~ 425 (668)
++|+..++||+|+||.||+|++ .+++..||||++.... ....+.+.+|++++..+ +||||++++++|...+..
T Consensus 35 ~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~ 114 (375)
T cd05104 35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPT 114 (375)
T ss_pred HHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcc
Confidence 4688899999999999999974 3345689999986543 33456788999999999 899999999999999999
Q ss_pred EEEEEecCCCChhhhhcCCC------------------------------------------------------------
Q 005940 426 LLVYEYIPNGSLDTLLFKPK------------------------------------------------------------ 445 (668)
Q Consensus 426 ~lV~E~~~~gsL~~~l~~~~------------------------------------------------------------ 445 (668)
++||||+++|+|.+++....
T Consensus 115 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (375)
T cd05104 115 LVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSY 194 (375)
T ss_pred eeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccccee
Confidence 99999999999999985321
Q ss_pred ------------CCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCCCC-
Q 005940 446 ------------DGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMP- 512 (668)
Q Consensus 446 ------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~~~- 512 (668)
....++|..+++++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++........
T Consensus 195 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 271 (375)
T cd05104 195 IDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYV 271 (375)
T ss_pred cccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCchhhEEEECCCcEEEecCccceeccCccccc
Confidence 11257899999999999999999998 99999999999999999999999999999866443221
Q ss_pred cccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCc--hhHHHHHHHHHhcCccccccCcccCCcc
Q 005940 513 HTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVAT-GRRPIGSGD--LLLVEWVRECHQLGRILDVADPLLNSSY 589 (668)
Q Consensus 513 ~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~--~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 589 (668)
......++..|+|||.+.+..++.++|||||||++|||++ |..||.... ....+++. .+.... .+ ..
T Consensus 272 ~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~----~~~~~~--~~----~~ 341 (375)
T cd05104 272 VKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIK----EGYRML--SP----EC 341 (375)
T ss_pred ccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHH----hCccCC--CC----CC
Confidence 1122345668999999998899999999999999999998 888886532 12222211 111000 01 11
Q ss_pred cHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhcc
Q 005940 590 VVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSG 623 (668)
Q Consensus 590 ~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~ 623 (668)
.+ ..+..++..|++. |++||++.||++.|+.
T Consensus 342 ~~---~~l~~li~~cl~~dP~~RPs~~eil~~l~~ 373 (375)
T cd05104 342 AP---SEMYDIMKSCWDADPLKRPTFKQIVQLIEQ 373 (375)
T ss_pred CC---HHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence 12 2355666789987 9999999999999985
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-38 Score=334.42 Aligned_cols=254 Identities=30% Similarity=0.415 Sum_probs=202.1
Q ss_pred cceeeeecCcEEEEEEEeCCCCc---E-EEEEEEec---CCchhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEE
Q 005940 357 ESEVIGIGGFGSVYKGVLPTTGG---E-VAVKKITR---NSLQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVY 429 (668)
Q Consensus 357 ~~~~lG~G~~g~Vy~~~~~~~~~---~-vavK~~~~---~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 429 (668)
..++||+|+||.||+|++...+. . ||||.... .......+|.+|++++++++|||||+++|++..+..+++||
T Consensus 161 l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ivm 240 (474)
T KOG0194|consen 161 LGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLMLVM 240 (474)
T ss_pred ccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEEEE
Confidence 35899999999999999865432 3 89998875 23566789999999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCC
Q 005940 430 EYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHG 509 (668)
Q Consensus 430 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~ 509 (668)
|+|+||+|+++|.+ ....++..++++++.+.|+||+|||+ .+++||||-++|+|++.++.+||+|||+++....-
T Consensus 241 El~~gGsL~~~L~k--~~~~v~~~ek~~~~~~AA~Gl~YLh~---k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~~ 315 (474)
T KOG0194|consen 241 ELCNGGSLDDYLKK--NKKSLPTLEKLRFCYDAARGLEYLHS---KNCIHRDIAARNCLYSKKGVVKISDFGLSRAGSQY 315 (474)
T ss_pred EecCCCcHHHHHHh--CCCCCCHHHHHHHHHHHHhHHHHHHH---CCCcchhHhHHHheecCCCeEEeCccccccCCcce
Confidence 99999999999964 33369999999999999999999999 99999999999999999999999999998865421
Q ss_pred CCCcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCchh-HHHHHHHHHhcCccccccCcccCC
Q 005940 510 GMPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVAT-GRRPIGSGDLL-LVEWVRECHQLGRILDVADPLLNS 587 (668)
Q Consensus 510 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~-l~~~~~~~~~~~~~~~~~d~~l~~ 587 (668)
.... ....-+.+|+|||.+..+.++.++|||||||++||+++ |..||.+.... +..++. ..+.... ..
T Consensus 316 ~~~~-~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~---~~~~r~~------~~ 385 (474)
T KOG0194|consen 316 VMKK-FLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIV---KNGYRMP------IP 385 (474)
T ss_pred eecc-ccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHH---hcCccCC------CC
Confidence 1111 11134678999999999999999999999999999999 89999765322 222221 1111111 11
Q ss_pred cccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhccCcCCC
Q 005940 588 SYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSGEKQLR 628 (668)
Q Consensus 588 ~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~~~~~~ 628 (668)
...+.++. .+...||.. |++||+|.++.+.|+......
T Consensus 386 ~~~p~~~~---~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~ 424 (474)
T KOG0194|consen 386 SKTPKELA---KVMKQCWKKDPEDRPTMSTIKKKLEALEKKK 424 (474)
T ss_pred CCCHHHHH---HHHHHhccCChhhccCHHHHHHHHHHHHhcc
Confidence 13344444 444478887 999999999999998776444
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=332.16 Aligned_cols=254 Identities=25% Similarity=0.354 Sum_probs=196.5
Q ss_pred CcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCC---chhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEE
Q 005940 354 GFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNS---LQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYE 430 (668)
Q Consensus 354 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 430 (668)
.|...++||+|+||+||+|++..+++.||||++.+.. ....+.+..|++++++++|+||+++++.+.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 5788999999999999999999999999999997643 2345678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCC
Q 005940 431 YIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGG 510 (668)
Q Consensus 431 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~ 510 (668)
|+++|+|.+++.. ...+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++.+....
T Consensus 82 ~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~aL~~LH~---~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~ 155 (381)
T cd05626 82 YIPGGDMMSLLIR---MEVFPEVLARFYIAELTLAIESVHK---MGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTH 155 (381)
T ss_pred cCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCcHHHEEECCCCCEEEeeCcCCccccccc
Confidence 9999999999853 3458899999999999999999998 999999999999999999999999999986432100
Q ss_pred C----------------------------------------------CcccccccCCcccCcccccCCCCCcchhHHHHH
Q 005940 511 M----------------------------------------------PHTTNVVGTFGYIAPELTQTGKASTSSDVFAYG 544 (668)
Q Consensus 511 ~----------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~G 544 (668)
. .......||..|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (381)
T cd05626 156 NSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVG 235 (381)
T ss_pred ccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehh
Confidence 0 001234799999999999888899999999999
Q ss_pred HHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCcccCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 545 ILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 545 vvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
|++|||++|+.||...+..... ............ +. ....+.+....+.++ +|... +..||+++|++++
T Consensus 236 ~il~elltG~~Pf~~~~~~~~~--~~i~~~~~~~~~--~~-~~~~s~~~~dli~~l--l~~~~~~~~R~~~~~~l~h 305 (381)
T cd05626 236 VILFEMLVGQPPFLAPTPTETQ--LKVINWENTLHI--PP-QVKLSPEAVDLITKL--CCSAEERLGRNGADDIKAH 305 (381)
T ss_pred hHHHHHHhCCCCCcCCCHHHHH--HHHHccccccCC--CC-CCCCCHHHHHHHHHH--ccCcccccCCCCHHHHhcC
Confidence 9999999999999754322111 111111111111 10 012233333333332 34433 5669999999987
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=329.46 Aligned_cols=254 Identities=26% Similarity=0.334 Sum_probs=201.8
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCc---hhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEE
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSL---QGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVY 429 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 429 (668)
++|...+.||+|+||.||++....+++.||+|++..... +..+.+..|+.+++.++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 468899999999999999999998999999999976432 34467889999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCC
Q 005940 430 EYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHG 509 (668)
Q Consensus 430 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~ 509 (668)
||+++|+|.+++... ...+++..+..++.||+.||.|||+ .+|+||||||+||+++.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~lH~---~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~ 155 (330)
T cd05601 81 EYQPGGDLLSLLNRY--EDQFDEDMAQFYLAELVLAIHSVHQ---MGYVHRDIKPENVLIDRTGHIKLADFGSAARLTAN 155 (330)
T ss_pred CCCCCCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence 999999999999632 3468999999999999999999999 99999999999999999999999999999876554
Q ss_pred CCCcccccccCCcccCccccc------CCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCc
Q 005940 510 GMPHTTNVVGTFGYIAPELTQ------TGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADP 583 (668)
Q Consensus 510 ~~~~~~~~~gt~~y~aPE~~~------~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~ 583 (668)
.........||..|+|||++. ...++.++|||||||++|||++|+.||...... ................+.
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~--~~~~~i~~~~~~~~~~~~ 233 (330)
T cd05601 156 KMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSA--KTYNNIMNFQRFLKFPED 233 (330)
T ss_pred CceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHH--HHHHHHHcCCCccCCCCC
Confidence 333333457899999999986 456789999999999999999999999754321 112222222111111111
Q ss_pred ccCCcccHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 005940 584 LLNSSYVVKEMELVLKLGLMCSHKTQFRPTMRQVMRY 620 (668)
Q Consensus 584 ~l~~~~~~~~~~~l~~l~~~C~~~p~~RPs~~evl~~ 620 (668)
... ..+ +..+...|+.+|++||++++++++
T Consensus 234 ---~~~-~~~---~~~li~~ll~~p~~R~t~~~l~~h 263 (330)
T cd05601 234 ---PKV-SSD---FLDLIQSLLCGQKERLGYEGLCCH 263 (330)
T ss_pred ---CCC-CHH---HHHHHHHHccChhhCCCHHHHhCC
Confidence 011 222 333444566689999999999975
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=326.49 Aligned_cols=242 Identities=24% Similarity=0.276 Sum_probs=195.0
Q ss_pred eeeeecCcEEEEEEEeCCCCcEEEEEEEecCC---chhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEEecCCC
Q 005940 359 EVIGIGGFGSVYKGVLPTTGGEVAVKKITRNS---LQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEYIPNG 435 (668)
Q Consensus 359 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~g 435 (668)
+.||+|+||.||++....+++.||||++.+.. ......+..|++++++++||||+++++.+...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999998899999999997642 233456788999999999999999999999999999999999999
Q ss_pred ChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCCCCccc
Q 005940 436 SLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTT 515 (668)
Q Consensus 436 sL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 515 (668)
+|.+++.. ...+++.++..++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||+++...... ....
T Consensus 81 ~L~~~l~~---~~~~~~~~~~~~~~qi~~~L~~lH~---~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~-~~~~ 153 (323)
T cd05571 81 ELFFHLSR---ERVFSEDRARFYGAEIVSALGYLHS---CDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG-ATMK 153 (323)
T ss_pred cHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC-Cccc
Confidence 99999853 3468999999999999999999999 999999999999999999999999999987532221 1223
Q ss_pred ccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCcccCCcccHHHHH
Q 005940 516 NVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSYVVKEME 595 (668)
Q Consensus 516 ~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~ 595 (668)
...||+.|+|||++.+..++.++|||||||++|||++|+.||...+.... ........ ..+......
T Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~---~~~~~~~~------~~~p~~~~~---- 220 (323)
T cd05571 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL---FELILMEE------IRFPRTLSP---- 220 (323)
T ss_pred ceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHH---HHHHHcCC------CCCCCCCCH----
Confidence 45799999999999988999999999999999999999999975432211 11111111 111122222
Q ss_pred HHHHHHhhcCCC-CCCCC-----CHHHHHHH
Q 005940 596 LVLKLGLMCSHK-TQFRP-----TMRQVMRY 620 (668)
Q Consensus 596 ~l~~l~~~C~~~-p~~RP-----s~~evl~~ 620 (668)
.+..+...|++. |++|| ++++++++
T Consensus 221 ~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 221 EAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred HHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence 234455577776 99999 89999875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=340.19 Aligned_cols=259 Identities=22% Similarity=0.265 Sum_probs=208.6
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCchhHHHHHHHHHHHhccc-ccCceeEeee-ecc------cCc
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLR-HKNLVNLHGW-CKQ------KND 424 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~-H~nIv~l~g~-~~~------~~~ 424 (668)
.++.+.+.|.+|||+.||.+.+...+.+||+|++-..++...+...+|+++|++|+ |+|||.+++. ... .-+
T Consensus 37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~E 116 (738)
T KOG1989|consen 37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWE 116 (738)
T ss_pred EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeE
Confidence 45677899999999999999998777999999988778888999999999999998 9999999993 221 236
Q ss_pred eEEEEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCce
Q 005940 425 LLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLAR 504 (668)
Q Consensus 425 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~ 504 (668)
.+|.||||++|+|-+++....... |++.++++|+.|+++|+++||. +..+|||||||-+||||..+++.||||||-|.
T Consensus 117 vllLmEyC~gg~Lvd~mn~Rlq~~-lte~eVLkIf~dv~~AVa~mH~-~~pPiIHRDLKiENvLls~~g~~KLCDFGSat 194 (738)
T KOG1989|consen 117 VLLLMEYCKGGSLVDFMNTRLQTR-LTEDEVLKIFYDVCEAVAAMHY-LKPPIIHRDLKIENVLLSADGNYKLCDFGSAT 194 (738)
T ss_pred EEeehhhccCCcHHHHHHHHHhcc-CChHHHHHHHHHHHHHHHHHhc-CCCccchhhhhhhheEEcCCCCEEeCcccccc
Confidence 899999999999999997544333 9999999999999999999997 56789999999999999999999999999987
Q ss_pred eccCCCC-Cc-------ccccccCCcccCcccc---cCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHh
Q 005940 505 LYDHGGM-PH-------TTNVVGTFGYIAPELT---QTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQ 573 (668)
Q Consensus 505 ~~~~~~~-~~-------~~~~~gt~~y~aPE~~---~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~ 573 (668)
..-.... .. .....-|+.|+|||++ .+...++|+|||+|||+||-|+....||+...
T Consensus 195 t~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg------------ 262 (738)
T KOG1989|consen 195 TKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESG------------ 262 (738)
T ss_pred cccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCc------------
Confidence 5433221 11 1112458999999976 45678999999999999999999999998642
Q ss_pred cCccccccCcccCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhccCcCCC
Q 005940 574 LGRILDVADPLLNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSGEKQLR 628 (668)
Q Consensus 574 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~~~~~~ 628 (668)
...+++-.+.-.-.+....++..|+..|++. |++||++.||+..+......+
T Consensus 263 ---~laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~ 315 (738)
T KOG1989|consen 263 ---KLAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKP 315 (738)
T ss_pred ---ceeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCC
Confidence 1222222222222234556667777789888 999999999999998776555
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=323.27 Aligned_cols=201 Identities=28% Similarity=0.400 Sum_probs=177.3
Q ss_pred hcCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCC-chhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEE
Q 005940 352 TKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNS-LQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYE 430 (668)
Q Consensus 352 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 430 (668)
.++|+..++||+|+||.||++.+..++..+|+|++.... ......+.+|++++++++|+||++++++|...+..++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 367899999999999999999998889999999887643 2345678999999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCC
Q 005940 431 YIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGG 510 (668)
Q Consensus 431 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~ 510 (668)
|+++|+|.+++.. ...+++..+..++.|++.||.|||+ ..+++||||||+||+++.++.+||+|||++.......
T Consensus 84 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~~l~~~l~~lH~--~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~ 158 (333)
T cd06650 84 HMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 158 (333)
T ss_pred cCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHh--cCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhc
Confidence 9999999999953 3458899999999999999999997 2479999999999999999999999999987654321
Q ss_pred CCcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 005940 511 MPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSG 560 (668)
Q Consensus 511 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~ 560 (668)
.....|+..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 159 ---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~ 205 (333)
T cd06650 159 ---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPP 205 (333)
T ss_pred ---cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 22346899999999998888999999999999999999999999754
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=316.48 Aligned_cols=201 Identities=30% Similarity=0.432 Sum_probs=173.5
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCc-hhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEEe
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSL-QGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEY 431 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~ 431 (668)
++|...++||+|+||.||+|....++..||+|++..... .....+.+|++++++++||||+++++++..++..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 468889999999999999999988899999999865432 2345678999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCCC
Q 005940 432 IPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGM 511 (668)
Q Consensus 432 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~~ 511 (668)
++ |+|.+++.. .+..+++..+..++.||+.||+|||+ ++|+||||||+||+++.++.+||+|||+++.......
T Consensus 85 ~~-~~l~~~l~~--~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~ 158 (288)
T cd07871 85 LD-SDLKQYLDN--CGNLMSMHNVKIFMFQLLRGLSYCHK---RKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK 158 (288)
T ss_pred CC-cCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCc
Confidence 97 489888853 23458899999999999999999998 9999999999999999999999999999986543221
Q ss_pred CcccccccCCcccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 005940 512 PHTTNVVGTFGYIAPELTQT-GKASTSSDVFAYGILLLEVATGRRPIGSG 560 (668)
Q Consensus 512 ~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~S~Gvvl~elltG~~p~~~~ 560 (668)
......++..|+|||++.+ ..++.++||||+||++|||++|+.||...
T Consensus 159 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~ 207 (288)
T cd07871 159 -TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGS 207 (288)
T ss_pred -cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 1233467899999998765 56899999999999999999999999754
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=319.09 Aligned_cols=255 Identities=27% Similarity=0.461 Sum_probs=203.2
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCC-----cEEEEEEEecCCc-hhHHHHHHHHHHHhcccccCceeEeeeecccCceE
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTG-----GEVAVKKITRNSL-QGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLL 426 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~-----~~vavK~~~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~ 426 (668)
++|+..+.||+|+||.||+|.+...+ ..||+|.+..... ....+|.+|++++++++||||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 36778899999999999999875544 5799999865432 34567899999999999999999999999989999
Q ss_pred EEEEecCCCChhhhhcCCCC-------------CCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCC
Q 005940 427 LVYEYIPNGSLDTLLFKPKD-------------GSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEM 493 (668)
Q Consensus 427 lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~ 493 (668)
++|||+++++|.+++..... ...+++..++.++.|++.||.|||+ .+++||||||+||++++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~---~~i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSS---HHFVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccccceEEEcCCC
Confidence 99999999999999864221 1458899999999999999999998 9999999999999999999
Q ss_pred CEEEEeecCceeccCCCC-CcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCch-hHHHHHHH
Q 005940 494 NARLGDFGLARLYDHGGM-PHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVAT-GRRPIGSGDL-LLVEWVRE 570 (668)
Q Consensus 494 ~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~-~l~~~~~~ 570 (668)
.+||+|||+++....... .......++..|+|||.+.++.++.++|||||||++|||++ |..||..... .+...
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~--- 238 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEM--- 238 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH---
Confidence 999999999986543321 12233456788999999988899999999999999999998 9999865432 22221
Q ss_pred HHhcCccccccCcccCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhcc
Q 005940 571 CHQLGRILDVADPLLNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSG 623 (668)
Q Consensus 571 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~ 623 (668)
........ .... ....+..+...|+.. |++||+++||+++|+.
T Consensus 239 -i~~~~~~~-----~~~~----~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 239 -IRSRQLLP-----CPED----CPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred -HHcCCcCC-----Cccc----CCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 11111111 1111 124466777799998 9999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=314.29 Aligned_cols=254 Identities=28% Similarity=0.408 Sum_probs=202.8
Q ss_pred hcCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCchhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEEe
Q 005940 352 TKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEY 431 (668)
Q Consensus 352 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~ 431 (668)
.++|+..+.||+|++|.||+|.+. +++.||+|.+.... ...+++.+|++++++++|+||+++++++...+..++||||
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTEL 82 (261)
T ss_pred hhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeec
Confidence 356888999999999999999974 46789999987544 3356789999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCCC
Q 005940 432 IPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGM 511 (668)
Q Consensus 432 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~~ 511 (668)
+++++|.+++.... +..+++.++..++.|++.||.|||+ .+++||||||+||++++++.+||+|||+++.......
T Consensus 83 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (261)
T cd05068 83 MKYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEA---QNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIY 158 (261)
T ss_pred ccCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCCcceEEEcCCCCEEECCcceEEEccCCcc
Confidence 99999999996432 4568999999999999999999998 9999999999999999999999999999987764322
Q ss_pred CcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHHHhcCccccccCcccCCccc
Q 005940 512 PHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVAT-GRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSYV 590 (668)
Q Consensus 512 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 590 (668)
........+..|+|||++.+..++.++||||||+++|||++ |+.||....... ........... + . .
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~~~~~~~~~----~-~----~ 226 (261)
T cd05068 159 EAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAE---VLQQVDQGYRM----P-C----P 226 (261)
T ss_pred cccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHH---HHHHHHcCCCC----C-C----C
Confidence 22222233458999999988899999999999999999999 999986543211 11111111100 0 0 0
Q ss_pred HHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhcc
Q 005940 591 VKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSG 623 (668)
Q Consensus 591 ~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~ 623 (668)
......+..++..|++. |++||+++++++.|+.
T Consensus 227 ~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 227 PGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred CcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 11124466777789887 9999999999999875
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=311.46 Aligned_cols=251 Identities=27% Similarity=0.421 Sum_probs=200.2
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCchhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEEec
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEYI 432 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~ 432 (668)
++|...+.||+|+||.||++.++ .+..+|+|.+.... ...++|.+|++++++++||||++++++|......++||||+
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~ 81 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFM 81 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEec-cCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcC
Confidence 35777899999999999999885 45689999886543 23467889999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCCCC
Q 005940 433 PNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMP 512 (668)
Q Consensus 433 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~~~ 512 (668)
++|+|.+++... ...+++..++.++.|++.||.|||+ .+++||||||+||+++.++.+||+|||+++........
T Consensus 82 ~~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~ 156 (256)
T cd05114 82 ENGCLLNYLRQR--QGKLSKDMLLSMCQDVCEGMEYLER---NSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT 156 (256)
T ss_pred CCCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHH---CCccccccCcceEEEcCCCeEEECCCCCccccCCCcee
Confidence 999999998632 2358999999999999999999998 99999999999999999999999999999865433322
Q ss_pred cccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHHHhcCccccccCcccCCcccH
Q 005940 513 HTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVAT-GRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSYVV 591 (668)
Q Consensus 513 ~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 591 (668)
......++..|+|||++....++.++||||||+++|||++ |+.||...+.. +.+......... ..+.. .
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~--~~~~~i~~~~~~---~~~~~----~- 226 (256)
T cd05114 157 SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNY--EVVEMISRGFRL---YRPKL----A- 226 (256)
T ss_pred ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHHHCCCCC---CCCCC----C-
Confidence 2223345668999999988889999999999999999999 89999654321 111221111111 11111 1
Q ss_pred HHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhc
Q 005940 592 KEMELVLKLGLMCSHK-TQFRPTMRQVMRYLS 622 (668)
Q Consensus 592 ~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~ 622 (668)
...+..++..|+.. |++||+++++++.|.
T Consensus 227 --~~~~~~li~~c~~~~p~~Rps~~~l~~~l~ 256 (256)
T cd05114 227 --SMTVYEVMYSCWHEKPEGRPTFAELLRAIT 256 (256)
T ss_pred --CHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 13456777789988 999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-37 Score=327.26 Aligned_cols=247 Identities=28% Similarity=0.443 Sum_probs=191.7
Q ss_pred CcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCc-hhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEEec
Q 005940 354 GFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSL-QGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEYI 432 (668)
Q Consensus 354 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~ 432 (668)
+|+..++||+|+||.||+|++..+++.||||++..... ...+.+.+|++++++++|+||+++++++...+..++||||+
T Consensus 75 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 154 (353)
T PLN00034 75 ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFM 154 (353)
T ss_pred HHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecC
Confidence 45567889999999999999988899999999865433 34567899999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCCCC
Q 005940 433 PNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMP 512 (668)
Q Consensus 433 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~~~ 512 (668)
++|+|.... ..++..+..++.||+.||.|||+ .+|+||||||+|||+++++.+||+|||+++.......
T Consensus 155 ~~~~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~- 223 (353)
T PLN00034 155 DGGSLEGTH-------IADEQFLADVARQILSGIAYLHR---RHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD- 223 (353)
T ss_pred CCCcccccc-------cCCHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCEEEcccccceecccccc-
Confidence 999986533 35677888999999999999998 9999999999999999999999999999987654321
Q ss_pred cccccccCCcccCcccccC-----CCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCcccCC
Q 005940 513 HTTNVVGTFGYIAPELTQT-----GKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNS 587 (668)
Q Consensus 513 ~~~~~~gt~~y~aPE~~~~-----~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 587 (668)
......||..|+|||++.. ...+.++|||||||++|||++|+.||..... .+|......... . ..+....
T Consensus 224 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~--~~~~~~~~~~~~-~--~~~~~~~ 298 (353)
T PLN00034 224 PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQ--GDWASLMCAICM-S--QPPEAPA 298 (353)
T ss_pred cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCC--ccHHHHHHHHhc-c--CCCCCCC
Confidence 1233578999999998743 2335689999999999999999999974321 112111111000 0 0011111
Q ss_pred cccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 588 SYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 588 ~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
.+. ..+..+...|++. |++||+++||+++
T Consensus 299 ~~~----~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 299 TAS----REFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred ccC----HHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 112 2345666688887 9999999999986
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=323.65 Aligned_cols=249 Identities=29% Similarity=0.435 Sum_probs=209.6
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCc-hhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEEe
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSL-QGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEY 431 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~ 431 (668)
..|+..++||+|.||.||||.+..+++.||+|++..+.. ...++..+|+.+|.+++++||.+++|.+..+..++++|||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 456677899999999999999999999999999976544 4567889999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCCC
Q 005940 432 IPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGM 511 (668)
Q Consensus 432 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~~ 511 (668)
|.+|++.+.|. .+..+.+..+.-|++++..||.|||. ++.+|||||+.|||+..++.+||+|||.+..+.....
T Consensus 93 ~~gGsv~~lL~---~~~~~~E~~i~~ilre~l~~l~ylH~---~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~ 166 (467)
T KOG0201|consen 93 CGGGSVLDLLK---SGNILDEFEIAVILREVLKGLDYLHS---EKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK 166 (467)
T ss_pred hcCcchhhhhc---cCCCCccceeeeehHHHHHHhhhhhh---cceecccccccceeEeccCcEEEEecceeeeeechhh
Confidence 99999999994 34556888889999999999999999 9999999999999999999999999999988776554
Q ss_pred CcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCcccCCcccH
Q 005940 512 PHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSYVV 591 (668)
Q Consensus 512 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 591 (668)
.. ..++||+.|||||++....|+.|+||||||++++||++|..|+..... + .-.-.+.+-..|.+.+.+.
T Consensus 167 rr-~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hP--m------rvlflIpk~~PP~L~~~~S- 236 (467)
T KOG0201|consen 167 RR-KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHP--M------RVLFLIPKSAPPRLDGDFS- 236 (467)
T ss_pred cc-ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCc--c------eEEEeccCCCCCccccccC-
Confidence 33 567999999999999988999999999999999999999999964321 0 0011122333455555333
Q ss_pred HHHHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 592 KEMELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 592 ~~~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
.-+.+++.+|+.. |+.||++.+++++
T Consensus 237 ---~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 237 ---PPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred ---HHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 3355566689998 9999999999975
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=330.12 Aligned_cols=253 Identities=26% Similarity=0.333 Sum_probs=197.7
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCC---chhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEE
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNS---LQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVY 429 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 429 (668)
++|+..++||+|+||.||+|++..+++.||||++.... ......+.+|++++..++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 47889999999999999999998889999999997542 234456788999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCC
Q 005940 430 EYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHG 509 (668)
Q Consensus 430 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~ 509 (668)
||+++|+|.+++.. ...+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||++......
T Consensus 81 E~~~~g~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 154 (364)
T cd05599 81 EYLPGGDMMTLLMK---KDTFTEEETRFYIAETILAIDSIHK---LGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKS 154 (364)
T ss_pred CCCCCcHHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEeecccceecccc
Confidence 99999999999953 3458999999999999999999999 99999999999999999999999999998754321
Q ss_pred CCC-------------------------------------cccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHh
Q 005940 510 GMP-------------------------------------HTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVAT 552 (668)
Q Consensus 510 ~~~-------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt 552 (668)
... .....+||+.|+|||++....++.++|||||||++|||++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~ 234 (364)
T cd05599 155 HRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLV 234 (364)
T ss_pred ccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhc
Confidence 100 0012468999999999998899999999999999999999
Q ss_pred CCCCCCCCchhHHHHHHHHHhcCccccccCcccCCcccHHHHHHHHHHHhhcCCCCCCCCC---HHHHHHH
Q 005940 553 GRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSYVVKEMELVLKLGLMCSHKTQFRPT---MRQVMRY 620 (668)
Q Consensus 553 G~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~p~~RPs---~~evl~~ 620 (668)
|+.||...+.. +................. .... +++..+ ...|+.+|.+|++ ++|++++
T Consensus 235 G~~Pf~~~~~~--~~~~~i~~~~~~~~~~~~---~~~s-~~~~~l---i~~ll~~p~~R~~~~~~~~ll~h 296 (364)
T cd05599 235 GYPPFCSDNPQ--ETYRKIINWKETLQFPDE---VPLS-PEAKDL---IKRLCCEAERRLGNNGVNEIKSH 296 (364)
T ss_pred CCCCCCCCCHH--HHHHHHHcCCCccCCCCC---CCCC-HHHHHH---HHHHccCHhhcCCCCCHHHHhcC
Confidence 99999765322 111111111111111110 0112 233333 3345557888887 9999886
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=312.19 Aligned_cols=252 Identities=25% Similarity=0.444 Sum_probs=203.2
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCchhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEEec
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEYI 432 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~ 432 (668)
++|+..++||+|++|.||+|... ++..||+|.+.... ...+.+.+|+.++++++|+||+++++.+...+..+++|||+
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05072 6 ESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM 83 (261)
T ss_pred HHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence 46888999999999999999974 56789999986543 23578899999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCCCC
Q 005940 433 PNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMP 512 (668)
Q Consensus 433 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~~~ 512 (668)
++++|.+++... ....+++.+++.++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++.........
T Consensus 84 ~~~~L~~~l~~~-~~~~~~~~~~~~~~~~l~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05072 84 AKGSLLDFLKSD-EGGKVLLPKLIDFSAQIAEGMAYIER---KNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT 159 (261)
T ss_pred CCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhhEEecCCCcEEECCCccceecCCCcee
Confidence 999999999642 34568999999999999999999998 99999999999999999999999999999876543322
Q ss_pred cccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCch-hHHHHHHHHHhcCccccccCcccCCccc
Q 005940 513 HTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVAT-GRRPIGSGDL-LLVEWVRECHQLGRILDVADPLLNSSYV 590 (668)
Q Consensus 513 ~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~-~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 590 (668)
......++..|+|||++..+.++.++|||||||++|||++ |+.||..... ....++ ...... +.. ..++
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~----~~~~~~----~~~-~~~~ 230 (261)
T cd05072 160 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSAL----QRGYRM----PRM-ENCP 230 (261)
T ss_pred ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHH----HcCCCC----CCC-CCCC
Confidence 2233345678999999988889999999999999999998 9999965422 222211 111100 111 1111
Q ss_pred HHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhcc
Q 005940 591 VKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSG 623 (668)
Q Consensus 591 ~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~ 623 (668)
..+..++..|+.. |++||+++++.+.|+.
T Consensus 231 ----~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 231 ----DELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred ----HHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 2355677789887 9999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=316.36 Aligned_cols=253 Identities=30% Similarity=0.479 Sum_probs=207.3
Q ss_pred hcCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCchhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEEe
Q 005940 352 TKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEY 431 (668)
Q Consensus 352 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~ 431 (668)
..+|+..++||.|++|.||+|.+.. +..+++|.+.........++..|+.+++.++|+||+++++++......++||||
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 83 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL 83 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence 4568889999999999999999976 889999999877665677899999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCCC
Q 005940 432 IPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGM 511 (668)
Q Consensus 432 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~~ 511 (668)
+++++|.+++... .+..+++.+++.++.||+.||.|||+ .+++||||||+||++++++.+||+|||.+........
T Consensus 84 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~ 159 (261)
T cd05148 84 MEKGSLLAFLRSP-EGQVLPVASLIDMACQVAEGMAYLEE---QNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY 159 (261)
T ss_pred cccCCHHHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccCcceEEEcCCceEEEccccchhhcCCccc
Confidence 9999999999643 34568999999999999999999998 9999999999999999999999999999987654322
Q ss_pred CcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCch-hHHHHHHHHHhcCccccccCcccCCcc
Q 005940 512 PHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVAT-GRRPIGSGDL-LLVEWVRECHQLGRILDVADPLLNSSY 589 (668)
Q Consensus 512 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~-~l~~~~~~~~~~~~~~~~~d~~l~~~~ 589 (668)
. .....++..|+|||.+..+.++.++||||||+++|||++ |+.||..... ....... .... .....
T Consensus 160 ~-~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~---~~~~------~~~~~-- 227 (261)
T cd05148 160 L-SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQIT---AGYR------MPCPA-- 227 (261)
T ss_pred c-ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHH---hCCc------CCCCC--
Confidence 1 123345678999999988889999999999999999998 8999965431 1222111 1111 11111
Q ss_pred cHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhcc
Q 005940 590 VVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSG 623 (668)
Q Consensus 590 ~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~ 623 (668)
.....+..++.+|+.. |++||+++++++.|+.
T Consensus 228 --~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 228 --KCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred --CCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 1123456777789887 9999999999999975
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=333.90 Aligned_cols=258 Identities=27% Similarity=0.376 Sum_probs=199.7
Q ss_pred cCcccceeeeecCcEEEEEEEeCC-----CCcEEEEEEEecCC-chhHHHHHHHHHHHhcc-cccCceeEeeeecccCce
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPT-----TGGEVAVKKITRNS-LQGMREFAAEIESLGRL-RHKNLVNLHGWCKQKNDL 425 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~ 425 (668)
++|+..+.||+|+||.||+|++.. ++..||||++.... ....+.+.+|+++++.+ +|+||++++++|...+..
T Consensus 38 ~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~ 117 (374)
T cd05106 38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPV 117 (374)
T ss_pred HHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCe
Confidence 468889999999999999998533 33579999997543 33456788999999999 899999999999999999
Q ss_pred EEEEEecCCCChhhhhcCCC------------------------------------------------------------
Q 005940 426 LLVYEYIPNGSLDTLLFKPK------------------------------------------------------------ 445 (668)
Q Consensus 426 ~lV~E~~~~gsL~~~l~~~~------------------------------------------------------------ 445 (668)
++||||+++|+|.+++....
T Consensus 118 ~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (374)
T cd05106 118 LVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDS 197 (374)
T ss_pred EEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccccc
Confidence 99999999999999885321
Q ss_pred -------CCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCCCC-ccccc
Q 005940 446 -------DGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMP-HTTNV 517 (668)
Q Consensus 446 -------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~~~-~~~~~ 517 (668)
....+++.++++++.||+.||.|||+ ++|+||||||+||++++++.+||+|||+++........ .....
T Consensus 198 ~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~---~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~ 274 (374)
T cd05106 198 KDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLAS---KNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNA 274 (374)
T ss_pred cchhccCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCC
Confidence 11247889999999999999999998 99999999999999999999999999999865443221 11223
Q ss_pred ccCCcccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHHHhcCccccccCcccCCcccHHHHHH
Q 005940 518 VGTFGYIAPELTQTGKASTSSDVFAYGILLLEVAT-GRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSYVVKEMEL 596 (668)
Q Consensus 518 ~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~ 596 (668)
.++..|+|||++.++.++.++|||||||++|||++ |+.||....... .. ........ .+.... ..+ ..
T Consensus 275 ~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~-~~-~~~~~~~~-----~~~~~~-~~~---~~ 343 (374)
T cd05106 275 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS-KF-YKMVKRGY-----QMSRPD-FAP---PE 343 (374)
T ss_pred CCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH-HH-HHHHHccc-----CccCCC-CCC---HH
Confidence 35668999999988899999999999999999997 999996532111 11 11111110 011111 111 23
Q ss_pred HHHHHhhcCCC-CCCCCCHHHHHHHhccC
Q 005940 597 VLKLGLMCSHK-TQFRPTMRQVMRYLSGE 624 (668)
Q Consensus 597 l~~l~~~C~~~-p~~RPs~~evl~~L~~~ 624 (668)
+..+...|++. |++||++.+|++.|+..
T Consensus 344 l~~li~~cl~~dp~~RPs~~~l~~~l~~~ 372 (374)
T cd05106 344 IYSIMKMCWNLEPTERPTFSQISQLIQRQ 372 (374)
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 55666789987 99999999999999764
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=318.10 Aligned_cols=202 Identities=30% Similarity=0.401 Sum_probs=173.0
Q ss_pred hcCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCc-hhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEE
Q 005940 352 TKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSL-QGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYE 430 (668)
Q Consensus 352 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 430 (668)
.++|...++||+|+||.||+|....+++.||||++..... .....+.+|++++++++||||+++++++......++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 4679999999999999999999988899999999875432 223467789999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCC
Q 005940 431 YIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGG 510 (668)
Q Consensus 431 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~ 510 (668)
|++ ++|.+++.. ....+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||+++......
T Consensus 84 ~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 157 (303)
T cd07869 84 YVH-TDLCQYMDK--HPGGLHPENVKLFLFQLLRGLSYIHQ---RYILHRDLKPQNLLISDTGELKLADFGLARAKSVPS 157 (303)
T ss_pred CCC-cCHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECCCCcceeccCCC
Confidence 995 677777743 23458899999999999999999999 999999999999999999999999999997654322
Q ss_pred CCcccccccCCcccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 005940 511 MPHTTNVVGTFGYIAPELTQT-GKASTSSDVFAYGILLLEVATGRRPIGSG 560 (668)
Q Consensus 511 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~S~Gvvl~elltG~~p~~~~ 560 (668)
. ......++..|+|||++.+ ..++.++||||+||++|||++|+.||...
T Consensus 158 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 207 (303)
T cd07869 158 H-TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGM 207 (303)
T ss_pred c-cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 1 2233468899999998765 45789999999999999999999999754
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=310.50 Aligned_cols=259 Identities=25% Similarity=0.368 Sum_probs=208.4
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecC---CchhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEE
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRN---SLQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVY 429 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 429 (668)
.+|...++||+|+||.||+|+...+++.||||.+... .......+.+|++++++++||||+++++++...+..++|+
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 4788899999999999999999888999999987642 2334467889999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCC-CCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccC
Q 005940 430 EYIPNGSLDTLLFKPK-DGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDH 508 (668)
Q Consensus 430 E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~ 508 (668)
||+++++|.+++.... ....+++.+++.++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 9999999998885322 23568999999999999999999998 9999999999999999999999999999987654
Q ss_pred CCCCcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCcccCCc
Q 005940 509 GGMPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSS 588 (668)
Q Consensus 509 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 588 (668)
... ......++..|+|||.+.+...+.++|+||||+++|||++|+.||........++........ .+...
T Consensus 159 ~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~------~~~~~-- 229 (267)
T cd08228 159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCD------YPPLP-- 229 (267)
T ss_pred hhH-HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCC------CCCCC--
Confidence 321 122346788999999998888899999999999999999999999654433333333222111 11111
Q ss_pred ccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhccC
Q 005940 589 YVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSGE 624 (668)
Q Consensus 589 ~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~~ 624 (668)
.......+..+...|++. |++||++.+|++.|+..
T Consensus 230 -~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 230 -TEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred -hhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 111224456677789987 99999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=324.49 Aligned_cols=258 Identities=24% Similarity=0.380 Sum_probs=202.3
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCc----EEEEEEEecCC-chhHHHHHHHHHHHhcccccCceeEeeeecccCceEE
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGG----EVAVKKITRNS-LQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLL 427 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~----~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l 427 (668)
.+|+..+.||+|+||.||+|++..++. .||+|++.... ....+++..|+.+++.++||||++++|+|... ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 468899999999999999999865555 38999986543 34557899999999999999999999999764 5789
Q ss_pred EEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceecc
Q 005940 428 VYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYD 507 (668)
Q Consensus 428 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~ 507 (668)
|+||+++|+|.+++.. ....+++..+++++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||+++...
T Consensus 86 v~e~~~~g~l~~~l~~--~~~~~~~~~~~~~~~qi~~~L~~LH~---~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~ 160 (316)
T cd05108 86 ITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLEE---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 160 (316)
T ss_pred eeecCCCCCHHHHHHh--ccccCCHHHHHHHHHHHHHHHHHHHh---cCeeccccchhheEecCCCcEEEcccccccccc
Confidence 9999999999999963 23458899999999999999999998 999999999999999999999999999998765
Q ss_pred CCCCCc-ccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHHHhcCccccccCccc
Q 005940 508 HGGMPH-TTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVAT-GRRPIGSGDLLLVEWVRECHQLGRILDVADPLL 585 (668)
Q Consensus 508 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 585 (668)
...... .....++..|+|||++.+..++.++|||||||++|||++ |+.||...... ++ .......... ..+
T Consensus 161 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~--~~-~~~~~~~~~~--~~~-- 233 (316)
T cd05108 161 ADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS--EI-SSILEKGERL--PQP-- 233 (316)
T ss_pred CCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH--HH-HHHHhCCCCC--CCC--
Confidence 433211 112234678999999998899999999999999999998 99999754322 11 1111111111 011
Q ss_pred CCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhccCcCCC
Q 005940 586 NSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSGEKQLR 628 (668)
Q Consensus 586 ~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~~~~~~ 628 (668)
..+. ..+..++..|+.. |++||++.++++.|......+
T Consensus 234 -~~~~----~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~ 272 (316)
T cd05108 234 -PICT----IDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 272 (316)
T ss_pred -CCCC----HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCC
Confidence 1111 2355677789887 999999999999988765444
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-37 Score=298.17 Aligned_cols=200 Identities=29% Similarity=0.433 Sum_probs=183.3
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCc---hhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEE
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSL---QGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVY 429 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 429 (668)
.+|+..+.||.|+||.|.+++.+.+|..+|+|++++... +..+...+|.++|+.+.||+++++.+.|.+.+.+|+||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 467889999999999999999999999999999987654 34456789999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCC
Q 005940 430 EYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHG 509 (668)
Q Consensus 430 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~ 509 (668)
||+++|-|..+|++ .+.+++....-++.||+.||.|||+ ..|++|||||+|||||.+|.+||.|||.|+.....
T Consensus 124 eyv~GGElFS~Lrk---~~rF~e~~arFYAAeivlAleylH~---~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r 197 (355)
T KOG0616|consen 124 EYVPGGELFSYLRK---SGRFSEPHARFYAAEIVLALEYLHS---LDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR 197 (355)
T ss_pred eccCCccHHHHHHh---cCCCCchhHHHHHHHHHHHHHHHHh---cCeeeccCChHHeeeccCCcEEEEeccceEEecCc
Confidence 99999999999964 3469999999999999999999999 99999999999999999999999999999987642
Q ss_pred CCCcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCch
Q 005940 510 GMPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDL 562 (668)
Q Consensus 510 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~ 562 (668)
+-..|||+.|+|||+++...+..++|.|+|||++|||+.|..||.....
T Consensus 198 ----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~ 246 (355)
T KOG0616|consen 198 ----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP 246 (355)
T ss_pred ----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh
Confidence 4567999999999999999999999999999999999999999976543
|
|
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=332.77 Aligned_cols=253 Identities=24% Similarity=0.342 Sum_probs=196.5
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCc---hhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEE
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSL---QGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVY 429 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 429 (668)
.+|.+.+.||+|+||.||++....+++.||||++.+... .....+.+|++++++++|+||+++++.+.+++.+++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 368899999999999999999988999999999865322 23456889999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCC
Q 005940 430 EYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHG 509 (668)
Q Consensus 430 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~ 509 (668)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+|..+...
T Consensus 81 E~~~~g~L~~~i~~---~~~~~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~ 154 (376)
T cd05598 81 DYIPGGDMMSLLIR---LGIFEEDLARFYIAELTCAIESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 154 (376)
T ss_pred eCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccc
Confidence 99999999999953 3458889999999999999999998 99999999999999999999999999998533100
Q ss_pred C------------------------------------------CCcccccccCCcccCcccccCCCCCcchhHHHHHHHH
Q 005940 510 G------------------------------------------MPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILL 547 (668)
Q Consensus 510 ~------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl 547 (668)
. ........||+.|+|||++.+..++.++|||||||++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil 234 (376)
T cd05598 155 HDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 234 (376)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeecccee
Confidence 0 0001234799999999999988999999999999999
Q ss_pred HHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCcccCCcccHHHHHHHHHHHhhcCCCCCCCC---CHHHHHHH
Q 005940 548 LEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSYVVKEMELVLKLGLMCSHKTQFRP---TMRQVMRY 620 (668)
Q Consensus 548 ~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~p~~RP---s~~evl~~ 620 (668)
|||++|+.||...+.. ++............. +. ......+....+. .|+.+|++|+ ++.|++++
T Consensus 235 yell~G~~Pf~~~~~~--~~~~~i~~~~~~~~~--~~-~~~~s~~~~~li~----~l~~~p~~R~~~~t~~ell~h 301 (376)
T cd05598 235 YEMLVGQPPFLADTPA--ETQLKVINWETTLHI--PS-QAKLSREASDLIL----RLCCGAEDRLGKNGADEIKAH 301 (376)
T ss_pred eehhhCCCCCCCCCHH--HHHHHHhccCccccC--CC-CCCCCHHHHHHHH----HHhcCHhhcCCCCCHHHHhCC
Confidence 9999999999765422 111111111111110 11 1122333332222 3445799999 89999987
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=337.91 Aligned_cols=252 Identities=22% Similarity=0.282 Sum_probs=202.5
Q ss_pred CcccceeeeecCcEEEEEEEeCCC-CcEEEEEEEecCCchhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEEec
Q 005940 354 GFKESEVIGIGGFGSVYKGVLPTT-GGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEYI 432 (668)
Q Consensus 354 ~f~~~~~lG~G~~g~Vy~~~~~~~-~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~ 432 (668)
.|...+.||+|++|.||+|....+ +..||+|.+..........+..|+++++.++||||++++++|...+..|+||||+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 488899999999999999998766 6789999876666555667889999999999999999999999999999999999
Q ss_pred CCCChhhhhcCC-CCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCCC
Q 005940 433 PNGSLDTLLFKP-KDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGM 511 (668)
Q Consensus 433 ~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~~ 511 (668)
++|+|.+++... .....+++..+..++.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+++.......
T Consensus 148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~---~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 224 (478)
T PTZ00267 148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHS---RKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS 224 (478)
T ss_pred CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh---CCEEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence 999999988532 234568999999999999999999999 9999999999999999999999999999987654322
Q ss_pred -CcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCcccCCccc
Q 005940 512 -PHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSYV 590 (668)
Q Consensus 512 -~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 590 (668)
......+||+.|+|||++.+..++.++|||||||++|||++|+.||...+.. +....... +... + ......
T Consensus 225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~--~~~~~~~~-~~~~----~-~~~~~s 296 (478)
T PTZ00267 225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQR--EIMQQVLY-GKYD----P-FPCPVS 296 (478)
T ss_pred cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHh-CCCC----C-CCccCC
Confidence 1233457999999999999889999999999999999999999999754321 11222111 1111 1 111111
Q ss_pred HHHHHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 591 VKEMELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 591 ~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
..+..+...|+.. |++||++++++++
T Consensus 297 ----~~~~~li~~~L~~dP~~Rps~~~~l~~ 323 (478)
T PTZ00267 297 ----SGMKALLDPLLSKNPALRPTTQQLLHT 323 (478)
T ss_pred ----HHHHHHHHHHhccChhhCcCHHHHHhC
Confidence 2345556678887 9999999999753
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=328.97 Aligned_cols=254 Identities=24% Similarity=0.298 Sum_probs=198.7
Q ss_pred HhcCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCC---chhHHHHHHHHHHHhcccccCceeEeeeecccCceEE
Q 005940 351 ATKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNS---LQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLL 427 (668)
Q Consensus 351 at~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l 427 (668)
..++|+..++||+|+||.||++....+++.||+|++.+.. ....+.+..|+.+++.++||||+++++++.+....++
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 3467899999999999999999998899999999997532 2234557889999999999999999999999999999
Q ss_pred EEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceecc
Q 005940 428 VYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYD 507 (668)
Q Consensus 428 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~ 507 (668)
||||+++|+|.+++.. ..+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||++....
T Consensus 121 v~Ey~~gg~L~~~l~~----~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~ 193 (370)
T cd05596 121 VMEYMPGGDLVNLMSN----YDIPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMD 193 (370)
T ss_pred EEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEcCCCCEEEEeccceeecc
Confidence 9999999999999852 347888899999999999999999 999999999999999999999999999998765
Q ss_pred CCCCCcccccccCCcccCcccccCC----CCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCc
Q 005940 508 HGGMPHTTNVVGTFGYIAPELTQTG----KASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADP 583 (668)
Q Consensus 508 ~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~ 583 (668)
...........||+.|+|||++... .++.++|||||||++|||++|+.||...+.. ................+.
T Consensus 194 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~--~~~~~i~~~~~~~~~~~~ 271 (370)
T cd05596 194 ANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV--GTYSKIMDHKNSLTFPDD 271 (370)
T ss_pred CCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHH--HHHHHHHcCCCcCCCCCc
Confidence 4333233345799999999988653 4789999999999999999999999765322 111111111111111010
Q ss_pred ccCCcccHHHHHHHHHHHhhcCCC-CCC--CCCHHHHHHH
Q 005940 584 LLNSSYVVKEMELVLKLGLMCSHK-TQF--RPTMRQVMRY 620 (668)
Q Consensus 584 ~l~~~~~~~~~~~l~~l~~~C~~~-p~~--RPs~~evl~~ 620 (668)
... ..+ +..+...|+.. |++ ||+++|++++
T Consensus 272 ---~~~-s~~---~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 272 ---IEI-SKQ---AKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred ---CCC-CHH---HHHHHHHHccChhhccCCCCHHHHhcC
Confidence 011 222 33444566666 766 9999999887
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-37 Score=323.65 Aligned_cols=242 Identities=24% Similarity=0.287 Sum_probs=193.9
Q ss_pred eeeeecCcEEEEEEEeCCCCcEEEEEEEecCC---chhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEEecCCC
Q 005940 359 EVIGIGGFGSVYKGVLPTTGGEVAVKKITRNS---LQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEYIPNG 435 (668)
Q Consensus 359 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~g 435 (668)
+.||+|+||.||++....++..||+|++.... ......+..|++++++++||||+++++.+...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 46999999999999998889999999997642 234456788999999999999999999999999999999999999
Q ss_pred ChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCCCCccc
Q 005940 436 SLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTT 515 (668)
Q Consensus 436 sL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 515 (668)
+|..++.. ...+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++...... ....
T Consensus 81 ~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~~~ 153 (323)
T cd05595 81 ELFFHLSR---ERVFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-ATMK 153 (323)
T ss_pred cHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEEcCCCCEEecccHHhccccCCC-Cccc
Confidence 99988853 3468999999999999999999998 999999999999999999999999999987532221 1223
Q ss_pred ccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCcccCCcccHHHHH
Q 005940 516 NVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSYVVKEME 595 (668)
Q Consensus 516 ~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~ 595 (668)
...||..|+|||++.++.++.++|||||||++|||++|+.||...+.... ..... ... ..+...+..
T Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~--~~~~~-~~~------~~~p~~~~~---- 220 (323)
T cd05595 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL--FELIL-MEE------IRFPRTLSP---- 220 (323)
T ss_pred cccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHH--HHHHh-cCC------CCCCCCCCH----
Confidence 35789999999999988999999999999999999999999975432211 11111 111 111122222
Q ss_pred HHHHHHhhcCCC-CCCCC-----CHHHHHHH
Q 005940 596 LVLKLGLMCSHK-TQFRP-----TMRQVMRY 620 (668)
Q Consensus 596 ~l~~l~~~C~~~-p~~RP-----s~~evl~~ 620 (668)
.+..+...|+.. |++|| ++++++++
T Consensus 221 ~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h 251 (323)
T cd05595 221 EAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 251 (323)
T ss_pred HHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence 234555578776 99998 89999875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=321.67 Aligned_cols=200 Identities=31% Similarity=0.445 Sum_probs=170.0
Q ss_pred CcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecC--CchhHHHHHHHHHHHhcccccCceeEeeeeccc-----CceE
Q 005940 354 GFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRN--SLQGMREFAAEIESLGRLRHKNLVNLHGWCKQK-----NDLL 426 (668)
Q Consensus 354 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~-----~~~~ 426 (668)
+|+..++||+|+||.||+|+...++..||||++... .......+.+|++++++++||||+++++++... ...|
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 477889999999999999999889999999998643 223445788999999999999999999988533 2479
Q ss_pred EEEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceec
Q 005940 427 LVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLY 506 (668)
Q Consensus 427 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~ 506 (668)
+||||+. ++|.+++.. ...+++..+..++.||++||.|||+ .+|+||||||+|||++.++.+||+|||+++..
T Consensus 81 lv~e~~~-~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~ 153 (338)
T cd07859 81 VVFELME-SDLHQVIKA---NDDLTPEHHQFFLYQLLRALKYIHT---ANVFHRDLKPKNILANADCKLKICDFGLARVA 153 (338)
T ss_pred EEEecCC-CCHHHHHHh---cccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCcEEEccCcccccc
Confidence 9999995 689888852 3458999999999999999999999 99999999999999999999999999999865
Q ss_pred cCCCC--CcccccccCCcccCcccccC--CCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 005940 507 DHGGM--PHTTNVVGTFGYIAPELTQT--GKASTSSDVFAYGILLLEVATGRRPIGSG 560 (668)
Q Consensus 507 ~~~~~--~~~~~~~gt~~y~aPE~~~~--~~~~~~sDV~S~Gvvl~elltG~~p~~~~ 560 (668)
..... .......||..|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 154 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~ 211 (338)
T cd07859 154 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGK 211 (338)
T ss_pred ccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCC
Confidence 32221 11234578999999998865 67899999999999999999999999654
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=328.26 Aligned_cols=206 Identities=26% Similarity=0.350 Sum_probs=179.0
Q ss_pred HHHhcCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCC---chhHHHHHHHHHHHhcccccCceeEeeeecccCce
Q 005940 349 YAATKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNS---LQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDL 425 (668)
Q Consensus 349 ~~at~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~ 425 (668)
....++|+..+.||+|+||.||++.+..+++.+|+|++.+.. ....+.+.+|+.+++.++||||+++++.+..+...
T Consensus 39 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~ 118 (370)
T cd05621 39 QMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYL 118 (370)
T ss_pred CCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEE
Confidence 334578999999999999999999998889999999997532 22345678999999999999999999999999999
Q ss_pred EEEEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCcee
Q 005940 426 LLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARL 505 (668)
Q Consensus 426 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~ 505 (668)
++||||+++|+|.+++.. ..+++.++..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||++..
T Consensus 119 ~lv~Ey~~gg~L~~~l~~----~~~~~~~~~~~~~qil~aL~~LH~---~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~ 191 (370)
T cd05621 119 YMVMEYMPGGDLVNLMSN----YDVPEKWAKFYTAEVVLALDAIHS---MGLIHRDVKPDNMLLDKHGHLKLADFGTCMK 191 (370)
T ss_pred EEEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEECCCCCEEEEeccccee
Confidence 999999999999999952 247889999999999999999999 9999999999999999999999999999987
Q ss_pred ccCCCCCcccccccCCcccCcccccCC----CCCcchhHHHHHHHHHHHHhCCCCCCCCc
Q 005940 506 YDHGGMPHTTNVVGTFGYIAPELTQTG----KASTSSDVFAYGILLLEVATGRRPIGSGD 561 (668)
Q Consensus 506 ~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~sDV~S~Gvvl~elltG~~p~~~~~ 561 (668)
.............||+.|+|||++... .++.++||||+||++|||++|+.||...+
T Consensus 192 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~ 251 (370)
T cd05621 192 MDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADS 251 (370)
T ss_pred cccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCC
Confidence 654333233445799999999998653 37889999999999999999999997543
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-37 Score=319.97 Aligned_cols=206 Identities=30% Similarity=0.422 Sum_probs=181.7
Q ss_pred HHhcCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCc---hhHHHHHHHHHHHhcccccCceeEeeeecccCceE
Q 005940 350 AATKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSL---QGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLL 426 (668)
Q Consensus 350 ~at~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~ 426 (668)
...++|+.+.+||+|+||.||+|+-+.+|..+|+|++.+... ...+..++|-.+|....++.||+|+-.|++...+|
T Consensus 138 ~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LY 217 (550)
T KOG0605|consen 138 LSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLY 217 (550)
T ss_pred CCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeE
Confidence 345789999999999999999999999999999999988654 34566789999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceec
Q 005940 427 LVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLY 506 (668)
Q Consensus 427 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~ 506 (668)
|||||++||++..+|. ....|++.....++.+++.|+.-||+ .|+|||||||+|+|||..|++||+||||+..+
T Consensus 218 LiMEylPGGD~mTLL~---~~~~L~e~~arfYiaE~vlAI~~iH~---~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl 291 (550)
T KOG0605|consen 218 LIMEYLPGGDMMTLLM---RKDTLTEDWARFYIAETVLAIESIHQ---LGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGL 291 (550)
T ss_pred EEEEecCCccHHHHHH---hcCcCchHHHHHHHHHHHHHHHHHHH---cCcccccCChhheeecCCCCEeeccccccchh
Confidence 9999999999999995 34579999999999999999999999 99999999999999999999999999998633
Q ss_pred cCC----------------------CCC-----cc-------------------cccccCCcccCcccccCCCCCcchhH
Q 005940 507 DHG----------------------GMP-----HT-------------------TNVVGTFGYIAPELTQTGKASTSSDV 540 (668)
Q Consensus 507 ~~~----------------------~~~-----~~-------------------~~~~gt~~y~aPE~~~~~~~~~~sDV 540 (668)
... ... .. -..+||+.|||||++.+..|+..+|.
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDw 371 (550)
T KOG0605|consen 292 DKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDW 371 (550)
T ss_pred hhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccH
Confidence 210 000 00 11379999999999999999999999
Q ss_pred HHHHHHHHHHHhCCCCCCCCc
Q 005940 541 FAYGILLLEVATGRRPIGSGD 561 (668)
Q Consensus 541 ~S~Gvvl~elltG~~p~~~~~ 561 (668)
||+|||+|||+.|.+||...+
T Consensus 372 WSLG~ImyEmLvGyPPF~s~t 392 (550)
T KOG0605|consen 372 WSLGCIMYEMLVGYPPFCSET 392 (550)
T ss_pred HHHHHHHHHHHhCCCCCCCCC
Confidence 999999999999999997653
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=316.54 Aligned_cols=261 Identities=26% Similarity=0.320 Sum_probs=192.3
Q ss_pred cCcccceeeeecCcEEEEEEEeCC-CCcEEEEEEEecCCc--hhHHHHHHHHHHHhcc---cccCceeEeeeec-----c
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPT-TGGEVAVKKITRNSL--QGMREFAAEIESLGRL---RHKNLVNLHGWCK-----Q 421 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~-~~~~vavK~~~~~~~--~~~~~f~~Ei~~l~~l---~H~nIv~l~g~~~-----~ 421 (668)
++|+..+.||+|+||.||+|.+.. ++..||+|++..... .....+.+|+.+++++ +||||++++++|. .
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 368889999999999999999853 467899999865432 2234566777777665 6999999999985 3
Q ss_pred cCceEEEEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeec
Q 005940 422 KNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFG 501 (668)
Q Consensus 422 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfG 501 (668)
....++||||++ ++|.+++... ....+++.++..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~---~~iiH~dlkp~Nil~~~~~~~kl~Dfg 155 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKV-PEPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFG 155 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEEcCCCCEEEcccc
Confidence 456899999996 6899988632 23458999999999999999999999 999999999999999999999999999
Q ss_pred CceeccCCCCCcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCc-hhHHHHHHHHHhcCc---c
Q 005940 502 LARLYDHGGMPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGD-LLLVEWVRECHQLGR---I 577 (668)
Q Consensus 502 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~-~~l~~~~~~~~~~~~---~ 577 (668)
+++...... ......|+..|+|||.+....++.++|||||||++|||++|+.||.... ......+........ .
T Consensus 156 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~ 233 (290)
T cd07862 156 LARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 233 (290)
T ss_pred ceEeccCCc--ccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhc
Confidence 998765432 2334578999999999988889999999999999999999999997542 222222211110000 0
Q ss_pred -------ccccCcccCC---cccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 578 -------LDVADPLLNS---SYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 578 -------~~~~d~~l~~---~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
.....+.... ......-..+..+...|++. |++||++.|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~h 287 (290)
T cd07862 234 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 287 (290)
T ss_pred hhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence 0000000000 00001112345667788887 9999999999964
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-37 Score=313.38 Aligned_cols=254 Identities=30% Similarity=0.465 Sum_probs=203.0
Q ss_pred cCcccceeeeecCcEEEEEEEeCCC---CcEEEEEEEecCCc-hhHHHHHHHHHHHhcccccCceeEeeeecccCceEEE
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTT---GGEVAVKKITRNSL-QGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLV 428 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV 428 (668)
++|+..+.||+|+||.||+|.+... ...||||.+..... ....+|..|+.++++++|+||+++++++...+..++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 5688899999999999999998643 45799999875433 3456789999999999999999999999999999999
Q ss_pred EEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccC
Q 005940 429 YEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDH 508 (668)
Q Consensus 429 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~ 508 (668)
|||+++++|.+++.. ....+++.++++++.|++.||.|||+ .+|+||||||+||++++++.+||+|||+++....
T Consensus 84 ~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~Lh~---~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 158 (266)
T cd05033 84 TEYMENGSLDKFLRE--NDGKFTVGQLVGMLRGIASGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRRLED 158 (266)
T ss_pred EEcCCCCCHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCCEEECccchhhcccc
Confidence 999999999999953 23468999999999999999999998 9999999999999999999999999999987752
Q ss_pred CCCC-cccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCc-hhHHHHHHHHHhcCccccccCccc
Q 005940 509 GGMP-HTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVAT-GRRPIGSGD-LLLVEWVRECHQLGRILDVADPLL 585 (668)
Q Consensus 509 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~-~~l~~~~~~~~~~~~~~~~~d~~l 585 (668)
.... ......++..|+|||.+.+..++.++||||||+++|||++ |..||.... ..+.+.+ ...... +.
T Consensus 159 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~----~~~~~~----~~- 229 (266)
T cd05033 159 SEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAV----EDGYRL----PP- 229 (266)
T ss_pred cccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHH----HcCCCC----CC-
Confidence 2211 1122345678999999988889999999999999999998 999986432 2222211 111100 10
Q ss_pred CCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhccC
Q 005940 586 NSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSGE 624 (668)
Q Consensus 586 ~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~~ 624 (668)
.. .....+..++..|++. |++||+++||+++|+..
T Consensus 230 ~~----~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 230 PM----DCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred CC----CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 01 1123466778899987 99999999999999753
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=311.07 Aligned_cols=203 Identities=32% Similarity=0.445 Sum_probs=176.1
Q ss_pred HhcCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEec--CCchhHHHHHHHHHHHhcccccCceeEeeeecc-----cC
Q 005940 351 ATKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITR--NSLQGMREFAAEIESLGRLRHKNLVNLHGWCKQ-----KN 423 (668)
Q Consensus 351 at~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~--~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~-----~~ 423 (668)
....|...+.||+|+||.|+.++++.+|+.||||++.+ ...-..++-.+|+++|++++|+||+.+.+.+.. -+
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~ 99 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN 99 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence 34556667899999999999999999999999999973 344456778899999999999999999998854 35
Q ss_pred ceEEEEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCc
Q 005940 424 DLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLA 503 (668)
Q Consensus 424 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla 503 (668)
..|+|+|+| ..+|.++++ .+..|+..+...+++|+++||.|+|+ .+|+||||||+|++++.+..+||+|||+|
T Consensus 100 DvYiV~elM-etDL~~iik---~~~~L~d~H~q~f~YQiLrgLKyiHS---AnViHRDLKPsNll~n~~c~lKI~DFGLA 172 (359)
T KOG0660|consen 100 DVYLVFELM-ETDLHQIIK---SQQDLTDDHAQYFLYQILRGLKYIHS---ANVIHRDLKPSNLLLNADCDLKICDFGLA 172 (359)
T ss_pred eeEEehhHH-hhHHHHHHH---cCccccHHHHHHHHHHHHHhcchhhc---ccccccccchhheeeccCCCEEeccccce
Confidence 789999999 678999995 34559999999999999999999999 99999999999999999999999999999
Q ss_pred eeccCCCC-CcccccccCCcccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 005940 504 RLYDHGGM-PHTTNVVGTFGYIAPELTQT-GKASTSSDVFAYGILLLEVATGRRPIGSG 560 (668)
Q Consensus 504 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~S~Gvvl~elltG~~p~~~~ 560 (668)
+..+.... ...+..+.|.+|.|||++.+ ..|+.+.||||.|||+.||++|+.-|.+.
T Consensus 173 R~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~ 231 (359)
T KOG0660|consen 173 RYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGK 231 (359)
T ss_pred eeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCC
Confidence 98864311 22356788999999997654 67999999999999999999999988654
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=319.97 Aligned_cols=251 Identities=24% Similarity=0.295 Sum_probs=196.7
Q ss_pred CcccceeeeecCcEEEEEEEeC---CCCcEEEEEEEecCC----chhHHHHHHHHHHHhccc-ccCceeEeeeecccCce
Q 005940 354 GFKESEVIGIGGFGSVYKGVLP---TTGGEVAVKKITRNS----LQGMREFAAEIESLGRLR-HKNLVNLHGWCKQKNDL 425 (668)
Q Consensus 354 ~f~~~~~lG~G~~g~Vy~~~~~---~~~~~vavK~~~~~~----~~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~ 425 (668)
+|+..++||+|+||.||++... .++..||+|++.+.. ....+.+..|+.++.+++ |+||+++++++...+..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 4788999999999999998763 467899999997532 233456788999999995 99999999999999999
Q ss_pred EEEEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCcee
Q 005940 426 LLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARL 505 (668)
Q Consensus 426 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~ 505 (668)
++||||+++|+|.+++.. +..+++.++..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++.
T Consensus 81 ~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~ 154 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQ---RDNFSEDEVRFYSGEIILALEHLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLSKE 154 (332)
T ss_pred EEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCcEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence 999999999999999853 3458999999999999999999998 9999999999999999999999999999986
Q ss_pred ccCCCCCcccccccCCcccCcccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCc-hhHHHHHHHHHhcCccccccCc
Q 005940 506 YDHGGMPHTTNVVGTFGYIAPELTQTG-KASTSSDVFAYGILLLEVATGRRPIGSGD-LLLVEWVRECHQLGRILDVADP 583 (668)
Q Consensus 506 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDV~S~Gvvl~elltG~~p~~~~~-~~l~~~~~~~~~~~~~~~~~d~ 583 (668)
.............||..|+|||++.+. .++.++|||||||++|||++|+.||.... ......+...... .++
T Consensus 155 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~------~~~ 228 (332)
T cd05614 155 FLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILK------CDP 228 (332)
T ss_pred ccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhc------CCC
Confidence 544333333446799999999998765 47889999999999999999999996431 1111111111111 112
Q ss_pred ccCCcccHHHHHHHHHHHhhcCCC-CCCCC-----CHHHHHHH
Q 005940 584 LLNSSYVVKEMELVLKLGLMCSHK-TQFRP-----TMRQVMRY 620 (668)
Q Consensus 584 ~l~~~~~~~~~~~l~~l~~~C~~~-p~~RP-----s~~evl~~ 620 (668)
.+..... ..+..+...|+.. |++|| ++++++++
T Consensus 229 ~~~~~~~----~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 229 PFPSFIG----PEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred CCCCCCC----HHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 2222222 2234555678887 99999 78899876
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=306.73 Aligned_cols=250 Identities=30% Similarity=0.425 Sum_probs=204.1
Q ss_pred CcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecC--CchhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEEe
Q 005940 354 GFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRN--SLQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEY 431 (668)
Q Consensus 354 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~ 431 (668)
+|...+.||+|++|.||+|+...++..|++|.+... .....+++.+|++++++++||||+++++.+.+.+..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 477789999999999999999888999999998653 334567889999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCCC
Q 005940 432 IPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGM 511 (668)
Q Consensus 432 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~~ 511 (668)
+++++|.+++... ....+++.+++.++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||+++.......
T Consensus 81 ~~~~~L~~~l~~~-~~~~~~~~~~~~i~~~l~~al~~lH~---~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~ 156 (256)
T cd08529 81 AENGDLHKLLKMQ-RGRPLPEDQVWRFFIQILLGLAHLHS---KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN 156 (256)
T ss_pred CCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEEeCCCCEEEcccccceeccCccc
Confidence 9999999999642 34578999999999999999999998 9999999999999999999999999999987654332
Q ss_pred CcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCcccCCcccH
Q 005940 512 PHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSYVV 591 (668)
Q Consensus 512 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 591 (668)
. .....|+..|+|||+..++.++.++|||||||++|||++|+.||...+.. ..... ...+.. +.+...+
T Consensus 157 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~-~~~~~~-----~~~~~~~-- 225 (256)
T cd08529 157 F-ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQG--ALILK-IIRGVF-----PPVSQMY-- 225 (256)
T ss_pred h-hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH--HHHHH-HHcCCC-----CCCcccc--
Confidence 2 22346788999999999888999999999999999999999999755421 11111 111111 1111111
Q ss_pred HHHHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 592 KEMELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 592 ~~~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
...+..+...|++. |++||++.+++++
T Consensus 226 --~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 226 --SQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred --CHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 23456677789887 9999999999975
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=329.75 Aligned_cols=202 Identities=27% Similarity=0.405 Sum_probs=175.4
Q ss_pred CcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCC---chhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEE
Q 005940 354 GFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNS---LQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYE 430 (668)
Q Consensus 354 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 430 (668)
.|...++||+|+||.||+|....+++.||+|++.+.. ....+.+.+|++++++++|+||+++++.+.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 5788999999999999999998899999999997643 2345678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCC
Q 005940 431 YIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGG 510 (668)
Q Consensus 431 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~ 510 (668)
|+++|+|.+++.. ...+++.....++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||++..+....
T Consensus 82 ~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~al~~lH~---~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~ 155 (382)
T cd05625 82 YIPGGDMMSLLIR---MGIFPEDLARFYIAELTCAVESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (382)
T ss_pred CCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEEeECCCCccccccc
Confidence 9999999999853 2458889999999999999999999 999999999999999999999999999975331100
Q ss_pred ----------------------------------------------CCcccccccCCcccCcccccCCCCCcchhHHHHH
Q 005940 511 ----------------------------------------------MPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYG 544 (668)
Q Consensus 511 ----------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~G 544 (668)
.......+||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (382)
T cd05625 156 DSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG 235 (382)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEech
Confidence 0001124689999999999988999999999999
Q ss_pred HHHHHHHhCCCCCCCCc
Q 005940 545 ILLLEVATGRRPIGSGD 561 (668)
Q Consensus 545 vvl~elltG~~p~~~~~ 561 (668)
|++|||++|+.||...+
T Consensus 236 vil~elltG~~Pf~~~~ 252 (382)
T cd05625 236 VILYEMLVGQPPFLAQT 252 (382)
T ss_pred HHHHHHHhCCCCCCCCC
Confidence 99999999999997643
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=309.58 Aligned_cols=247 Identities=30% Similarity=0.420 Sum_probs=195.4
Q ss_pred eeeeecCcEEEEEEEeCCCCcEEEEEEEecCC-chhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEEecCCCCh
Q 005940 359 EVIGIGGFGSVYKGVLPTTGGEVAVKKITRNS-LQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEYIPNGSL 437 (668)
Q Consensus 359 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL 437 (668)
++||+|+||.||+|++..+++.+|+|.+.... .+....+.+|++++++++|+||++++++|......++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 46999999999999998889999999886543 34456799999999999999999999999999999999999999999
Q ss_pred hhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCCCCcc-cc
Q 005940 438 DTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHT-TN 516 (668)
Q Consensus 438 ~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~-~~ 516 (668)
.+++.. .+..+++.+++.++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++........... ..
T Consensus 81 ~~~~~~--~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 155 (252)
T cd05084 81 LTFLRT--EGPRLKVKELIQMVENAAAGMEYLES---KHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGM 155 (252)
T ss_pred HHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccchheEEEcCCCcEEECccccCcccccccccccCCC
Confidence 999953 23468999999999999999999998 9999999999999999999999999999876543221111 11
Q ss_pred cccCCcccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHHHhcCccccccCcccCCcccHHHHH
Q 005940 517 VVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVAT-GRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSYVVKEME 595 (668)
Q Consensus 517 ~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~ 595 (668)
...+..|+|||.+.++.++.++|||||||++|||++ |..||....... .......... ....... ..
T Consensus 156 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~---~~~~~~~~~~-----~~~~~~~----~~ 223 (252)
T cd05084 156 KQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQ---TREAIEQGVR-----LPCPELC----PD 223 (252)
T ss_pred CCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHH---HHHHHHcCCC-----CCCcccC----CH
Confidence 123457999999998899999999999999999998 888886432211 1111111100 0111111 23
Q ss_pred HHHHHHhhcCCC-CCCCCCHHHHHHHhc
Q 005940 596 LVLKLGLMCSHK-TQFRPTMRQVMRYLS 622 (668)
Q Consensus 596 ~l~~l~~~C~~~-p~~RPs~~evl~~L~ 622 (668)
.+..+...|++. |++||++.||++.|+
T Consensus 224 ~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 224 AVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 456677789887 999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=327.87 Aligned_cols=203 Identities=28% Similarity=0.378 Sum_probs=176.2
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCC---chhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEE
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNS---LQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVY 429 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 429 (668)
++|...++||+|+||.||++....+++.||||++.+.. ....+.+.+|++++++++||||+++++++.+....|+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 46888999999999999999999899999999986542 234567889999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCC
Q 005940 430 EYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHG 509 (668)
Q Consensus 430 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~ 509 (668)
||+++|+|.+++.. ...+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 E~~~gg~L~~~l~~---~~~~~~~~~~~~~~ql~~aL~~LH~---~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~ 154 (377)
T cd05629 81 EFLPGGDLMTMLIK---YDTFSEDVTRFYMAECVLAIEAVHK---LGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQ 154 (377)
T ss_pred eCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEECCCCCEEEeecccccccccc
Confidence 99999999999953 3468899999999999999999999 99999999999999999999999999999633210
Q ss_pred CC------------C----------------------------------cccccccCCcccCcccccCCCCCcchhHHHH
Q 005940 510 GM------------P----------------------------------HTTNVVGTFGYIAPELTQTGKASTSSDVFAY 543 (668)
Q Consensus 510 ~~------------~----------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~ 543 (668)
.. . .....+||+.|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 234 (377)
T cd05629 155 HDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSL 234 (377)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEec
Confidence 00 0 0012469999999999998899999999999
Q ss_pred HHHHHHHHhCCCCCCCCc
Q 005940 544 GILLLEVATGRRPIGSGD 561 (668)
Q Consensus 544 Gvvl~elltG~~p~~~~~ 561 (668)
||++|||++|+.||...+
T Consensus 235 Gvil~elltG~~Pf~~~~ 252 (377)
T cd05629 235 GAIMFECLIGWPPFCSEN 252 (377)
T ss_pred chhhhhhhcCCCCCCCCC
Confidence 999999999999997543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=311.69 Aligned_cols=258 Identities=23% Similarity=0.422 Sum_probs=201.2
Q ss_pred HhcCcccceeeeecCcEEEEEEEeC-----CCCcEEEEEEEecCC-chhHHHHHHHHHHHhcccccCceeEeeeecccCc
Q 005940 351 ATKGFKESEVIGIGGFGSVYKGVLP-----TTGGEVAVKKITRNS-LQGMREFAAEIESLGRLRHKNLVNLHGWCKQKND 424 (668)
Q Consensus 351 at~~f~~~~~lG~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~ 424 (668)
++++|+..+.||+|++|.||+|.+. ..+..||||++.... .....+|.+|+.++++++|+||+++++++.....
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4567999999999999999999864 234679999986433 2345678999999999999999999999999999
Q ss_pred eEEEEEecCCCChhhhhcCCCC-------CCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEE
Q 005940 425 LLLVYEYIPNGSLDTLLFKPKD-------GSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARL 497 (668)
Q Consensus 425 ~~lV~E~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl 497 (668)
.++||||+++++|.+++..... ...+++.+++.++.|++.||.|||+ .+++||||||+||++++++.+||
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCcchheEEEcCCCCEEE
Confidence 9999999999999999854221 2346889999999999999999998 99999999999999999999999
Q ss_pred EeecCceeccCCCCCc-ccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHHHhcC
Q 005940 498 GDFGLARLYDHGGMPH-TTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVAT-GRRPIGSGDLLLVEWVRECHQLG 575 (668)
Q Consensus 498 ~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~l~~~~~~~~~~~ 575 (668)
+|||+++......... .....++..|+|||.+..+.++.++|||||||++|||++ |..||...... +... .....
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~--~~~~-~~~~~ 237 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNE--QVLR-FVMEG 237 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH--HHHH-HHHcC
Confidence 9999987654332211 112345778999999988889999999999999999999 78888654321 1111 11111
Q ss_pred ccccccCcccCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhcc
Q 005940 576 RILDVADPLLNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSG 623 (668)
Q Consensus 576 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~ 623 (668)
.... ..... ...+..++.+|++. |++||++.|+++.|+.
T Consensus 238 ~~~~-----~~~~~----~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 238 GLLD-----KPDNC----PDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred CcCC-----CCCCC----CHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 1111 11111 23456777789887 9999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=307.95 Aligned_cols=251 Identities=29% Similarity=0.439 Sum_probs=199.5
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCchhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEEec
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEYI 432 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~ 432 (668)
++|...+.||+|++|.||+|.+. .+..+|+|.+..... ..++|.+|+.++++++||||++++++|......++||||+
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~aik~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM-SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYM 81 (256)
T ss_pred HHeEEeeEecCcccceEEEEEec-CCCcEEEEEcCCCcc-cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcC
Confidence 35777899999999999999884 355799999875432 3467899999999999999999999999888999999999
Q ss_pred CCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCCCC
Q 005940 433 PNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMP 512 (668)
Q Consensus 433 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~~~ 512 (668)
++|+|.+++... ...+++.+++.++.||+.||+|||+ .+++|+||||+||+++.++.+||+|||+++........
T Consensus 82 ~~~~l~~~i~~~--~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~ 156 (256)
T cd05113 82 SNGCLLNYLREH--GKRFQPSQLLEMCKDVCEGMAYLES---KQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT 156 (256)
T ss_pred CCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccCcceEEEcCCCCEEECCCccceecCCCcee
Confidence 999999999532 2368999999999999999999998 99999999999999999999999999999866543322
Q ss_pred cccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHHHhcCccccccCcccCCcccH
Q 005940 513 HTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVAT-GRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSYVV 591 (668)
Q Consensus 513 ~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 591 (668)
......++..|+|||.+..+.++.++|||||||++|||++ |+.||...... +.......... . .....
T Consensus 157 ~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~--~~~~~~~~~~~-~-----~~~~~--- 225 (256)
T cd05113 157 SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNS--ETVEKVSQGLR-L-----YRPHL--- 225 (256)
T ss_pred ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHH--HHHHHHhcCCC-C-----CCCCC---
Confidence 2222345678999999988889999999999999999999 99998654321 11111111111 0 01111
Q ss_pred HHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhc
Q 005940 592 KEMELVLKLGLMCSHK-TQFRPTMRQVMRYLS 622 (668)
Q Consensus 592 ~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~ 622 (668)
....+..+...|++. |++||++.+|++.|+
T Consensus 226 -~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 226 -ASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred -CCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 124556777789987 999999999998874
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=319.13 Aligned_cols=245 Identities=24% Similarity=0.331 Sum_probs=193.6
Q ss_pred cccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCC---chhHHHHHHHHHHH---hcccccCceeEeeeecccCceEEE
Q 005940 355 FKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNS---LQGMREFAAEIESL---GRLRHKNLVNLHGWCKQKNDLLLV 428 (668)
Q Consensus 355 f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~f~~Ei~~l---~~l~H~nIv~l~g~~~~~~~~~lV 428 (668)
|++.+.||+|+||.||+|.+..+++.||||++.+.. ....+.+..|++++ ++++||||+++++++...+..|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 567899999999999999998889999999997542 22345566666655 567899999999999999999999
Q ss_pred EEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccC
Q 005940 429 YEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDH 508 (668)
Q Consensus 429 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~ 508 (668)
|||+++++|..++.. ..+++.+++.++.||+.||.|||+ .+|+||||||+||+++.++.+||+|||+++....
T Consensus 81 ~E~~~~~~L~~~~~~----~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05589 81 MEYAAGGDLMMHIHT----DVFSEPRAVFYAACVVLGLQYLHE---NKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG 153 (324)
T ss_pred EcCCCCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHh---CCeEecCCCHHHeEECCCCcEEeCcccCCccCCC
Confidence 999999999988842 359999999999999999999998 9999999999999999999999999999875432
Q ss_pred CCCCcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCcccCCc
Q 005940 509 GGMPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSS 588 (668)
Q Consensus 509 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 588 (668)
.. .......|+..|+|||++.+..++.++|||||||++|||++|+.||...+.. +....... .. ......
T Consensus 154 ~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~--~~~~~i~~-~~------~~~p~~ 223 (324)
T cd05589 154 FG-DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEE--EVFDSIVN-DE------VRYPRF 223 (324)
T ss_pred CC-CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHH--HHHHHHHh-CC------CCCCCC
Confidence 22 1223457899999999999889999999999999999999999999765322 11111111 11 111111
Q ss_pred ccHHHHHHHHHHHhhcCCC-CCCCC-----CHHHHHHH
Q 005940 589 YVVKEMELVLKLGLMCSHK-TQFRP-----TMRQVMRY 620 (668)
Q Consensus 589 ~~~~~~~~l~~l~~~C~~~-p~~RP-----s~~evl~~ 620 (668)
.. ..+..+...|++. |++|| ++++++++
T Consensus 224 ~~----~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~ 257 (324)
T cd05589 224 LS----REAISIMRRLLRRNPERRLGSGEKDAEDVKKQ 257 (324)
T ss_pred CC----HHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence 22 2234556678876 99999 67888775
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=322.71 Aligned_cols=242 Identities=24% Similarity=0.282 Sum_probs=194.7
Q ss_pred eeeeecCcEEEEEEEeCCCCcEEEEEEEecCC---chhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEEecCCC
Q 005940 359 EVIGIGGFGSVYKGVLPTTGGEVAVKKITRNS---LQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEYIPNG 435 (668)
Q Consensus 359 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~g 435 (668)
++||+|+||.||++....+++.||+|++.+.. ......+..|++++++++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999998899999999997642 234567889999999999999999999999999999999999999
Q ss_pred ChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCCCCccc
Q 005940 436 SLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTT 515 (668)
Q Consensus 436 sL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 515 (668)
+|..++.. ...+++.++..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++...... ....
T Consensus 81 ~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~-~~~~ 153 (328)
T cd05593 81 ELFFHLSR---ERVFSEDRTRFYGAEIVSALDYLHS---GKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA-ATMK 153 (328)
T ss_pred CHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEecccCHHHeEECCCCcEEEecCcCCccCCCcc-cccc
Confidence 99988853 3468999999999999999999998 999999999999999999999999999987543221 1223
Q ss_pred ccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCcccCCcccHHHHH
Q 005940 516 NVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSYVVKEME 595 (668)
Q Consensus 516 ~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~ 595 (668)
...||+.|+|||++.+..++.++|||||||++|||++|+.||...+.. +....... . +..+......
T Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~--~~~~~~~~-~------~~~~p~~~~~---- 220 (328)
T cd05593 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--KLFELILM-E------DIKFPRTLSA---- 220 (328)
T ss_pred cccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHH--HHHHHhcc-C------CccCCCCCCH----
Confidence 457999999999998888999999999999999999999999754321 11111111 1 1112122222
Q ss_pred HHHHHHhhcCCC-CCCCC-----CHHHHHHH
Q 005940 596 LVLKLGLMCSHK-TQFRP-----TMRQVMRY 620 (668)
Q Consensus 596 ~l~~l~~~C~~~-p~~RP-----s~~evl~~ 620 (668)
.+..+...|+.. |++|| +++|++++
T Consensus 221 ~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 221 DAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred HHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 234455577776 99997 89999976
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=319.94 Aligned_cols=240 Identities=26% Similarity=0.291 Sum_probs=192.8
Q ss_pred eeecCcEEEEEEEeCCCCcEEEEEEEecC---CchhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEEecCCCCh
Q 005940 361 IGIGGFGSVYKGVLPTTGGEVAVKKITRN---SLQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEYIPNGSL 437 (668)
Q Consensus 361 lG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL 437 (668)
||+|+||.||+|.+..+++.||+|++.+. .......+..|++++++++||||+++++++...+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 69999999999999888999999999753 233456788999999999999999999999999999999999999999
Q ss_pred hhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCCCCccccc
Q 005940 438 DTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNV 517 (668)
Q Consensus 438 ~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~ 517 (668)
.+++.. ...+++..+..++.||+.||.|||+ .+|+||||||+||+++.++.+||+|||+++...... ......
T Consensus 81 ~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~~ 153 (312)
T cd05585 81 FHHLQR---EGRFDLSRARFYTAELLCALENLHK---FNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD-DKTNTF 153 (312)
T ss_pred HHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHeEECCCCcEEEEECcccccCccCC-Cccccc
Confidence 999953 3458999999999999999999998 999999999999999999999999999998543222 223345
Q ss_pred ccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCcccCCcccHHHHHHH
Q 005940 518 VGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSYVVKEMELV 597 (668)
Q Consensus 518 ~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l 597 (668)
.||+.|+|||++.+..++.++|||||||++|||++|+.||...+.. +........ . ..+....+ . .+
T Consensus 154 ~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~--~~~~~~~~~-~------~~~~~~~~-~---~~ 220 (312)
T cd05585 154 CGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVN--EMYRKILQE-P------LRFPDGFD-R---DA 220 (312)
T ss_pred cCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHH--HHHHHHHcC-C------CCCCCcCC-H---HH
Confidence 7999999999999889999999999999999999999999754321 222222111 1 11111222 2 23
Q ss_pred HHHHhhcCCC-CCCCCC---HHHHHHH
Q 005940 598 LKLGLMCSHK-TQFRPT---MRQVMRY 620 (668)
Q Consensus 598 ~~l~~~C~~~-p~~RPs---~~evl~~ 620 (668)
..+...|+.. |++||+ +.|++++
T Consensus 221 ~~li~~~L~~dp~~R~~~~~~~e~l~h 247 (312)
T cd05585 221 KDLLIGLLSRDPTRRLGYNGAQEIKNH 247 (312)
T ss_pred HHHHHHHcCCCHHHcCCCCCHHHHHcC
Confidence 4555678887 999975 6777665
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=319.00 Aligned_cols=257 Identities=26% Similarity=0.343 Sum_probs=197.9
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCC---chhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEE
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNS---LQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVY 429 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 429 (668)
++|++.+.||+|+||.||++....+++.||+|++.+.. ....+.+.+|+.++..++|+||+++++.+.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 46888999999999999999998889999999997532 223456889999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCC
Q 005940 430 EYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHG 509 (668)
Q Consensus 430 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~ 509 (668)
||+++|+|.+++.+ ....+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||++......
T Consensus 81 e~~~g~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (331)
T cd05597 81 DYYVGGDLLTLLSK--FEDRLPEDMARFYLAEMVLAIDSVHQ---LGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD 155 (331)
T ss_pred ecCCCCcHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHh---CCeEECCCCHHHEEECCCCCEEEEECCceeecCCC
Confidence 99999999999953 23468999999999999999999999 99999999999999999999999999999876544
Q ss_pred CCCcccccccCCcccCcccccC-----CCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCcc
Q 005940 510 GMPHTTNVVGTFGYIAPELTQT-----GKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPL 584 (668)
Q Consensus 510 ~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 584 (668)
.........||+.|+|||++.. +.++.++|||||||++|||++|+.||..... .+............... +.
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~--~~~~~~i~~~~~~~~~~-~~ 232 (331)
T cd05597 156 GTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL--VETYGKIMNHKEHFQFP-PD 232 (331)
T ss_pred CCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCH--HHHHHHHHcCCCcccCC-Cc
Confidence 3333333568999999999863 4578899999999999999999999975432 12222222111111111 11
Q ss_pred cCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 585 LNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 585 l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
..... +++..++.- ++|... +..||++++++++
T Consensus 233 -~~~~~-~~~~~li~~-ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 233 -VTDVS-EEAKDLIRR-LICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred -cCCCC-HHHHHHHHH-HccCcccccCCCCHHHHhcC
Confidence 11122 233333332 234433 4569999999988
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=336.04 Aligned_cols=258 Identities=24% Similarity=0.313 Sum_probs=204.0
Q ss_pred HHHHhcCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCC--chhHHHHHHHHHHHhcccccCceeEeeeecccC--
Q 005940 348 LYAATKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNS--LQGMREFAAEIESLGRLRHKNLVNLHGWCKQKN-- 423 (668)
Q Consensus 348 l~~at~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~-- 423 (668)
.....++|.+.++||+|+||+||+|.+..+++.||||++.... ......+.+|+.++..++|+||+++++.+....
T Consensus 27 ~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~ 106 (496)
T PTZ00283 27 AKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPR 106 (496)
T ss_pred ccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceeccccc
Confidence 3344578999999999999999999998899999999987643 344567889999999999999999988764332
Q ss_pred ------ceEEEEEecCCCChhhhhcCC-CCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEE
Q 005940 424 ------DLLLVYEYIPNGSLDTLLFKP-KDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNAR 496 (668)
Q Consensus 424 ------~~~lV~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~k 496 (668)
.+++||||+++|+|.+++... .....+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+|
T Consensus 107 ~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~---~~IiHrDLKP~NILl~~~~~vk 183 (496)
T PTZ00283 107 NPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHS---KHMIHRDIKSANILLCSNGLVK 183 (496)
T ss_pred CcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEeCCCCEE
Confidence 368999999999999998532 234568999999999999999999999 9999999999999999999999
Q ss_pred EEeecCceeccCCCC-CcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcC
Q 005940 497 LGDFGLARLYDHGGM-PHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLG 575 (668)
Q Consensus 497 l~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~ 575 (668)
|+|||+++.+..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...+. .+....... +
T Consensus 184 L~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~--~~~~~~~~~-~ 260 (496)
T PTZ00283 184 LGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENM--EEVMHKTLA-G 260 (496)
T ss_pred EEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH--HHHHHHHhc-C
Confidence 999999987643221 122345799999999999988999999999999999999999999975432 222222211 1
Q ss_pred ccccccCcccCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 576 RILDVADPLLNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 576 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
... + +....+ ..+..+...|++. |++||++.+++++
T Consensus 261 ~~~----~-~~~~~~----~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 261 RYD----P-LPPSIS----PEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred CCC----C-CCCCCC----HHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 111 1 111122 2345666688887 9999999999875
|
|
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=310.63 Aligned_cols=250 Identities=26% Similarity=0.399 Sum_probs=198.3
Q ss_pred CcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCchhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEEecC
Q 005940 354 GFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEYIP 433 (668)
Q Consensus 354 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~ 433 (668)
+|+..+.||+|++|.||+|.++ ++..+|+|.+.+... ...+|.+|++++++++|+||+++++++...+..++||||++
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA 82 (256)
T ss_pred HcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence 5777899999999999999885 467899999865432 33578899999999999999999999999999999999999
Q ss_pred CCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCCCCc
Q 005940 434 NGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPH 513 (668)
Q Consensus 434 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 513 (668)
+++|.+++... ...+++..++.++.|++.||+|||+ .+++||||||+||++++++.+||+|||+++.........
T Consensus 83 ~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~ 157 (256)
T cd05059 83 NGCLLNYLRER--KGKLGTEWLLDMCSDVCEAMEYLES---NGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTS 157 (256)
T ss_pred CCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHH---CCcccccccHhhEEECCCCcEEECCcccceecccccccc
Confidence 99999999632 2368999999999999999999998 999999999999999999999999999998654332222
Q ss_pred ccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHHHhcCccccccCcccCCcccHH
Q 005940 514 TTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVAT-GRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSYVVK 592 (668)
Q Consensus 514 ~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 592 (668)
.....++..|+|||.+.+..++.++||||||+++|||++ |+.||...+.. +....... . ........
T Consensus 158 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~~~~~~~~-~-----~~~~~~~~---- 225 (256)
T cd05059 158 SQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNS--EVVESVSA-G-----YRLYRPKL---- 225 (256)
T ss_pred cCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHH--HHHHHHHc-C-----CcCCCCCC----
Confidence 222234557999999988899999999999999999999 88998654321 11111111 1 01111111
Q ss_pred HHHHHHHHHhhcCCC-CCCCCCHHHHHHHhc
Q 005940 593 EMELVLKLGLMCSHK-TQFRPTMRQVMRYLS 622 (668)
Q Consensus 593 ~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~ 622 (668)
....+..++..|++. |++||++.|+++.|.
T Consensus 226 ~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l~ 256 (256)
T cd05059 226 APTEVYTIMYSCWHEKPEDRPAFKKLLSQLT 256 (256)
T ss_pred CCHHHHHHHHHHhcCChhhCcCHHHHHHHhC
Confidence 123466778899987 999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=311.27 Aligned_cols=251 Identities=26% Similarity=0.365 Sum_probs=200.6
Q ss_pred CcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCc---hhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEE
Q 005940 354 GFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSL---QGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYE 430 (668)
Q Consensus 354 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 430 (668)
+|+..++||+|+||.||++....+++.||||++..... .....+.+|++++++++|+||+++++.+..++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 47788999999999999999988899999999975432 223457789999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCC
Q 005940 431 YIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGG 510 (668)
Q Consensus 431 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~ 510 (668)
|+++|+|.+++... ....+++..+..++.|++.||.|||+ .+++||||||+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05605 81 LMNGGDLKFHIYNM-GNPGFDEERAVFYAAEITCGLEDLHR---ERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE 156 (285)
T ss_pred ccCCCcHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHH---CCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCC
Confidence 99999999888532 23468999999999999999999999 899999999999999999999999999998764332
Q ss_pred CCcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchh-HHHHHHHHHhcCccccccCcccCCcc
Q 005940 511 MPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLL-LVEWVRECHQLGRILDVADPLLNSSY 589 (668)
Q Consensus 511 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~-l~~~~~~~~~~~~~~~~~d~~l~~~~ 589 (668)
. .....|+..|+|||++.+..++.++||||+||++|||++|+.||...+.. ..+.+........ ......+
T Consensus 157 ~--~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~------~~~~~~~ 228 (285)
T cd05605 157 T--IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQ------EEYSEKF 228 (285)
T ss_pred c--cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcc------cccCccc
Confidence 2 12347899999999998888999999999999999999999999754321 1111111111110 1111111
Q ss_pred cHHHHHHHHHHHhhcCCC-CCCCC-----CHHHHHHH
Q 005940 590 VVKEMELVLKLGLMCSHK-TQFRP-----TMRQVMRY 620 (668)
Q Consensus 590 ~~~~~~~l~~l~~~C~~~-p~~RP-----s~~evl~~ 620 (668)
...+..++..|+.. |++|| ++++++++
T Consensus 229 ----~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 229 ----SEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred ----CHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 23345667789887 99999 88898776
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=324.73 Aligned_cols=261 Identities=25% Similarity=0.296 Sum_probs=202.4
Q ss_pred hhhHHHHhcCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCC---chhHHHHHHHHHHHhcccccCceeEeeeecc
Q 005940 345 YKDLYAATKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNS---LQGMREFAAEIESLGRLRHKNLVNLHGWCKQ 421 (668)
Q Consensus 345 ~~el~~at~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~ 421 (668)
..++....++|...+.||+|+||.||++.+..+++.+|+|++.+.. ....+.+.+|+.+++.++||||+++++.+.+
T Consensus 35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (371)
T cd05622 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 114 (371)
T ss_pred HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 4445556689999999999999999999999999999999986532 2234567889999999999999999999999
Q ss_pred cCceEEEEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeec
Q 005940 422 KNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFG 501 (668)
Q Consensus 422 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfG 501 (668)
....++||||+++|+|.+++.. ..++...+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NIll~~~~~ikL~DfG 187 (371)
T cd05622 115 DRYLYMVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFG 187 (371)
T ss_pred CCEEEEEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHH---CCEEeCCCCHHHEEECCCCCEEEEeCC
Confidence 9999999999999999999852 247888899999999999999999 999999999999999999999999999
Q ss_pred CceeccCCCCCcccccccCCcccCcccccCC----CCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCcc
Q 005940 502 LARLYDHGGMPHTTNVVGTFGYIAPELTQTG----KASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRI 577 (668)
Q Consensus 502 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~ 577 (668)
+++..............||+.|+|||++... .++.++|||||||++|||++|+.||...+.. ............
T Consensus 188 ~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~--~~~~~i~~~~~~ 265 (371)
T cd05622 188 TCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV--GTYSKIMNHKNS 265 (371)
T ss_pred ceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHH--HHHHHHHcCCCc
Confidence 9987654433333456799999999998653 3789999999999999999999999765422 111222111111
Q ss_pred ccccCcccCCcccHHHHHHHHHHHhhcCCC-CC--CCCCHHHHHHHh
Q 005940 578 LDVADPLLNSSYVVKEMELVLKLGLMCSHK-TQ--FRPTMRQVMRYL 621 (668)
Q Consensus 578 ~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~-p~--~RPs~~evl~~L 621 (668)
....+. .... .+ +..+...|+.+ +. .||+++|++++.
T Consensus 266 ~~~~~~---~~~s-~~---~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 266 LTFPDD---NDIS-KE---AKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred ccCCCc---CCCC-HH---HHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 111111 1112 22 23334456655 33 389999999875
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=304.75 Aligned_cols=259 Identities=26% Similarity=0.385 Sum_probs=209.4
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecC---CchhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEE
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRN---SLQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVY 429 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 429 (668)
++|+..+.||+|++|.||+|....+++.||+|.+... .....+.+.+|++++++++|+|++++++.+...+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 5788999999999999999999888999999988642 2234568899999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCC-CCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccC
Q 005940 430 EYIPNGSLDTLLFKP-KDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDH 508 (668)
Q Consensus 430 E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~ 508 (668)
||+++++|.+++... ..+..+++.+++.++.|++.||.|||+ .+++||||||+||+++.++.++|+|||+++....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHS---KRIMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHh---CCEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 999999999998532 234568999999999999999999998 9999999999999999999999999999986654
Q ss_pred CCCCcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCcccCCc
Q 005940 509 GGMPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSS 588 (668)
Q Consensus 509 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 588 (668)
... ......++..|+|||.+.+..++.++|||||||++|||++|+.||........+....... +.. +....
T Consensus 159 ~~~-~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~-----~~~~~- 230 (267)
T cd08224 159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEK-CDY-----PPLPA- 230 (267)
T ss_pred CCc-ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhc-CCC-----CCCCh-
Confidence 322 1223468889999999988889999999999999999999999996554333333322221 111 11111
Q ss_pred ccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhccC
Q 005940 589 YVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSGE 624 (668)
Q Consensus 589 ~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~~ 624 (668)
......+..+...|+.. |++||++.+|++.|+..
T Consensus 231 --~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~ 265 (267)
T cd08224 231 --DHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM 265 (267)
T ss_pred --hhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence 11223455677789987 99999999999999764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=310.62 Aligned_cols=246 Identities=26% Similarity=0.346 Sum_probs=193.7
Q ss_pred eeecCcEEEEEEEeCCCCcEEEEEEEecCCc---hhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEEecCCCCh
Q 005940 361 IGIGGFGSVYKGVLPTTGGEVAVKKITRNSL---QGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEYIPNGSL 437 (668)
Q Consensus 361 lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL 437 (668)
||+|+||+||++.+..+++.||+|++.+... ...+.+..|++++++++|+||+++.+++..+...++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 6999999999999988899999999975432 2345678899999999999999999999999999999999999999
Q ss_pred hhhhcCC-CCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCCCCcccc
Q 005940 438 DTLLFKP-KDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTN 516 (668)
Q Consensus 438 ~~~l~~~-~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~ 516 (668)
..++... .....+++..+..++.||+.||.|||+ .+|+||||||+||+++.++.+||+|||++........ ....
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~-~~~~ 156 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQ---RRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS-KTKG 156 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc-cccc
Confidence 9887532 234568999999999999999999999 9999999999999999999999999999987654332 2234
Q ss_pred cccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhH-HHHHHHHHhcCccccccCcccCCcccHHHHH
Q 005940 517 VVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLL-VEWVRECHQLGRILDVADPLLNSSYVVKEME 595 (668)
Q Consensus 517 ~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l-~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~ 595 (668)
..||..|+|||++.+..++.++|||||||++|||++|+.||...+... ........... .......+. .
T Consensus 157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~------~~~~~~~~~----~ 226 (280)
T cd05608 157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILND------SVTYPDKFS----P 226 (280)
T ss_pred cCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhccc------CCCCcccCC----H
Confidence 578999999999999999999999999999999999999997542211 11111111000 001111112 2
Q ss_pred HHHHHHhhcCCC-CCCCC-----CHHHHHHH
Q 005940 596 LVLKLGLMCSHK-TQFRP-----TMRQVMRY 620 (668)
Q Consensus 596 ~l~~l~~~C~~~-p~~RP-----s~~evl~~ 620 (668)
.+..+...|++. |++|| ++++++++
T Consensus 227 ~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 227 ASKSFCEALLAKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred HHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence 344555678776 99999 77888864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=324.35 Aligned_cols=245 Identities=24% Similarity=0.323 Sum_probs=197.5
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCC-cEEEEEEEecCC---chhHHHHHHHHHHHhcccccCceeEeeeecccCceEEE
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTG-GEVAVKKITRNS---LQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLV 428 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~-~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV 428 (668)
++|...+.||+|+||.||+|.+..++ ..||+|++.+.. ....+.+..|+++++.++||||+++++++.+.+..++|
T Consensus 30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 109 (340)
T PTZ00426 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV 109 (340)
T ss_pred hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEE
Confidence 46888999999999999999875544 689999986542 23456788999999999999999999999999999999
Q ss_pred EEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccC
Q 005940 429 YEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDH 508 (668)
Q Consensus 429 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~ 508 (668)
|||+++|+|.+++.. ...+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 110 ~Ey~~~g~L~~~i~~---~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~ 183 (340)
T PTZ00426 110 LEFVIGGEFFTFLRR---NKRFPNDVGCFYAAQIVLIFEYLQS---LNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT 183 (340)
T ss_pred EeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEccCCCHHHEEECCCCCEEEecCCCCeecCC
Confidence 999999999999953 3458999999999999999999999 9999999999999999999999999999987643
Q ss_pred CCCCcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCcccCCc
Q 005940 509 GGMPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSS 588 (668)
Q Consensus 509 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 588 (668)
. .....||+.|+|||++.+..++.++|||||||++|||++|+.||...+.... ......+.. .+...
T Consensus 184 ~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~---~~~i~~~~~------~~p~~ 250 (340)
T PTZ00426 184 R----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLI---YQKILEGII------YFPKF 250 (340)
T ss_pred C----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHH---HHHHhcCCC------CCCCC
Confidence 2 2235789999999999888899999999999999999999999976543211 111111111 11111
Q ss_pred ccHHHHHHHHHHHhhcCCC-CCCC-----CCHHHHHHH
Q 005940 589 YVVKEMELVLKLGLMCSHK-TQFR-----PTMRQVMRY 620 (668)
Q Consensus 589 ~~~~~~~~l~~l~~~C~~~-p~~R-----Ps~~evl~~ 620 (668)
.+. + +..+...|+.. |++| |++++++++
T Consensus 251 ~~~-~---~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 251 LDN-N---CKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred CCH-H---HHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 222 2 33455567776 8888 489999876
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=325.19 Aligned_cols=193 Identities=25% Similarity=0.308 Sum_probs=170.4
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCchhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEEec
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEYI 432 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~ 432 (668)
.+|++.+.||+|+||.||++.+..+++.||+|+... +.+.+|++++++|+||||+++++++......++|+|++
T Consensus 92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~ 165 (391)
T PHA03212 92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRY 165 (391)
T ss_pred CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecC
Confidence 579999999999999999999999999999997532 34678999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCCCC
Q 005940 433 PNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMP 512 (668)
Q Consensus 433 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~~~ 512 (668)
. ++|..++.. ...+++..++.++.||+.||.|||+ .+|+||||||+||+++.++.+||+|||+++........
T Consensus 166 ~-~~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~ylH~---~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~ 238 (391)
T PHA03212 166 K-TDLYCYLAA---KRNIAICDILAIERSVLRAIQYLHE---NRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINAN 238 (391)
T ss_pred C-CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHhEEEcCCCCEEEEeCCccccccccccc
Confidence 5 788888743 3458999999999999999999999 89999999999999999999999999999754332222
Q ss_pred cccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 005940 513 HTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIG 558 (668)
Q Consensus 513 ~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~ 558 (668)
......||+.|+|||++.+..++.++|||||||++|||++|+.|+.
T Consensus 239 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~ 284 (391)
T PHA03212 239 KYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLF 284 (391)
T ss_pred ccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcC
Confidence 3334579999999999998899999999999999999999998864
|
|
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=310.65 Aligned_cols=256 Identities=27% Similarity=0.475 Sum_probs=203.1
Q ss_pred hcCcccceeeeecCcEEEEEEEeCCCCc---EEEEEEEecCC-chhHHHHHHHHHHHhcccccCceeEeeeecccCceEE
Q 005940 352 TKGFKESEVIGIGGFGSVYKGVLPTTGG---EVAVKKITRNS-LQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLL 427 (668)
Q Consensus 352 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~---~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l 427 (668)
+++|+..+.||+|++|.||+|+++.+++ .+++|++.... ....+++.+|++++++++|+||+++.+++...+..++
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 3568888999999999999999865554 79999987553 3445789999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceecc
Q 005940 428 VYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYD 507 (668)
Q Consensus 428 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~ 507 (668)
||||+++++|.+++.. ....+++.++..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++....
T Consensus 84 v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~ 158 (268)
T cd05063 84 ITEYMENGALDKYLRD--HDGEFSSYQLVGMLRGIAAGMKYLSD---MNYVHRDLAARNILVNSNLECKVSDFGLSRVLE 158 (268)
T ss_pred EEEcCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhhEEEcCCCcEEECCCccceecc
Confidence 9999999999999953 23568999999999999999999998 999999999999999999999999999998665
Q ss_pred CCCCCccc--ccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHHHhcCccccccCcc
Q 005940 508 HGGMPHTT--NVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVAT-GRRPIGSGDLLLVEWVRECHQLGRILDVADPL 584 (668)
Q Consensus 508 ~~~~~~~~--~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 584 (668)
........ ....+..|+|||++..+.++.++|||||||++|||++ |+.||..... .++.......... +.
T Consensus 159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~--~~~~~~i~~~~~~-----~~ 231 (268)
T cd05063 159 DDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN--HEVMKAINDGFRL-----PA 231 (268)
T ss_pred cccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH--HHHHHHHhcCCCC-----CC
Confidence 43221111 1223457999999988889999999999999999997 9999965432 1222222111111 11
Q ss_pred cCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhccC
Q 005940 585 LNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSGE 624 (668)
Q Consensus 585 l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~~ 624 (668)
. ... ...+..++..|++. |++||++.+|++.|+..
T Consensus 232 ~-~~~----~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 232 P-MDC----PSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred C-CCC----CHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 1 111 23456777889987 99999999999999753
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=307.52 Aligned_cols=259 Identities=26% Similarity=0.386 Sum_probs=206.8
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCC---chhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEE
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNS---LQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVY 429 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 429 (668)
.+|+..+.||+|++|.||++....++..++||.+.... .....++.+|++++++++|+||+++++++...+..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 46788899999999999999988889999999886532 234568899999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCC-CCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccC
Q 005940 430 EYIPNGSLDTLLFKP-KDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDH 508 (668)
Q Consensus 430 E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~ 508 (668)
||+++++|.+++... .....+++.+++.++.||+.||.|||+ .+++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 999999999988532 234568999999999999999999998 9999999999999999999999999999886644
Q ss_pred CCCCcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCcccCCc
Q 005940 509 GGMPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSS 588 (668)
Q Consensus 509 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 588 (668)
... ......++..|+|||++.+...+.++||||||+++|||++|..||.........+..... ....+.....
T Consensus 159 ~~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~------~~~~~~~~~~ 231 (267)
T cd08229 159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIE------QCDYPPLPSD 231 (267)
T ss_pred CCc-ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhh------cCCCCCCCcc
Confidence 322 122346888999999998888999999999999999999999999654332222222211 1111222111
Q ss_pred ccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhccC
Q 005940 589 YVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSGE 624 (668)
Q Consensus 589 ~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~~ 624 (668)
.. ...+..+...|+.. |++||+|.+|++.++..
T Consensus 232 ~~---~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 232 HY---SEELRQLVNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred cc---cHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence 11 22355666688886 99999999999988753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=313.51 Aligned_cols=257 Identities=23% Similarity=0.375 Sum_probs=201.2
Q ss_pred HhcCcccceeeeecCcEEEEEEEeCC-----CCcEEEEEEEecCCc-hhHHHHHHHHHHHhcccccCceeEeeeecccCc
Q 005940 351 ATKGFKESEVIGIGGFGSVYKGVLPT-----TGGEVAVKKITRNSL-QGMREFAAEIESLGRLRHKNLVNLHGWCKQKND 424 (668)
Q Consensus 351 at~~f~~~~~lG~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~ 424 (668)
++++|...+.||+|++|.||+|.+.. .+..|++|.+..... .....|..|+.++++++|+||+++++++.+...
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 34678899999999999999999976 567899998865432 334678999999999999999999999999889
Q ss_pred eEEEEEecCCCChhhhhcCCCC----CCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCC---CEEE
Q 005940 425 LLLVYEYIPNGSLDTLLFKPKD----GSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEM---NARL 497 (668)
Q Consensus 425 ~~lV~E~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~---~~kl 497 (668)
.++||||+++++|.+++..... ...++|.++++++.||+.||+|||+ .+++||||||+||+++.++ .+||
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEE---NHFIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccchheEEEeccCCCcceEe
Confidence 9999999999999999864321 2358999999999999999999999 8999999999999998764 5999
Q ss_pred EeecCceeccCCCCC-cccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHHHhcC
Q 005940 498 GDFGLARLYDHGGMP-HTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVAT-GRRPIGSGDLLLVEWVRECHQLG 575 (668)
Q Consensus 498 ~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~l~~~~~~~~~~~ 575 (668)
+|||+++........ .......+..|+|||++.+..++.++|||||||++|||++ |+.||...... +.........
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~--~~~~~~~~~~ 238 (277)
T cd05036 161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ--EVMEFVTGGG 238 (277)
T ss_pred ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHHHcCC
Confidence 999999876432211 1112233568999999988899999999999999999997 99999754321 1111111111
Q ss_pred ccccccCcccCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhc
Q 005940 576 RILDVADPLLNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLS 622 (668)
Q Consensus 576 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~ 622 (668)
+. ...... ...+..++..|+.. |++||++.+|+++|+
T Consensus 239 ~~------~~~~~~----~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 239 RL------DPPKGC----PGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred cC------CCCCCC----CHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 11 011111 13456677789987 999999999999986
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=306.09 Aligned_cols=253 Identities=31% Similarity=0.433 Sum_probs=201.3
Q ss_pred cccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCchhHH--HHHHHHHHHhcccccCceeEeeeecccCceEEEEEec
Q 005940 355 FKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMR--EFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEYI 432 (668)
Q Consensus 355 f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~--~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~ 432 (668)
|+..+.||+|+||+||++....+++.+|+|++......... ....|+.++++++|+||+++++++......++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 56789999999999999999998999999999887654332 3456999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCCCC
Q 005940 433 PNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMP 512 (668)
Q Consensus 433 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~~~ 512 (668)
++++|.+++. ....+++..++.++.|+++||.|||+ .+++|+||||+||++++++.++|+|||.+..... ...
T Consensus 81 ~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~Lh~---~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~-~~~ 153 (260)
T PF00069_consen 81 PGGSLQDYLQ---KNKPLSEEEILKIAYQILEALAYLHS---KGIVHRDIKPENILLDENGEVKLIDFGSSVKLSE-NNE 153 (260)
T ss_dssp TTEBHHHHHH---HHSSBBHHHHHHHHHHHHHHHHHHHH---TTEEESSBSGGGEEESTTSEEEESSGTTTEESTS-TTS
T ss_pred cccccccccc---cccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccc-ccc
Confidence 9999999996 34568999999999999999999999 9999999999999999999999999999986521 223
Q ss_pred cccccccCCcccCccccc-CCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCcccCCcccH
Q 005940 513 HTTNVVGTFGYIAPELTQ-TGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSYVV 591 (668)
Q Consensus 513 ~~~~~~gt~~y~aPE~~~-~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 591 (668)
......++..|+|||++. ....+.++||||+|+++|+|++|+.||......-............... ........
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~- 229 (260)
T PF00069_consen 154 NFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPS---SSQQSREK- 229 (260)
T ss_dssp EBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHH---HTTSHTTS-
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccc---cccccchh-
Confidence 344567899999999998 7889999999999999999999999998652111111111111111110 00000000
Q ss_pred HHHHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 592 KEMELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 592 ~~~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
...+..+...|++. |++||++.+++++
T Consensus 230 --~~~l~~li~~~l~~~p~~R~~~~~l~~~ 257 (260)
T PF00069_consen 230 --SEELRDLIKKMLSKDPEQRPSAEELLKH 257 (260)
T ss_dssp --HHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred --HHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 14556666678887 9999999999874
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=316.84 Aligned_cols=242 Identities=26% Similarity=0.358 Sum_probs=192.4
Q ss_pred eeeeecCcEEEEEEEeC---CCCcEEEEEEEecCC----chhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEEe
Q 005940 359 EVIGIGGFGSVYKGVLP---TTGGEVAVKKITRNS----LQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEY 431 (668)
Q Consensus 359 ~~lG~G~~g~Vy~~~~~---~~~~~vavK~~~~~~----~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~ 431 (668)
++||+|+||.||++... .+++.||||++.+.. ......+.+|++++++++||||+++++++..++..|+||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 67999999999999863 467899999997532 23345678899999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCCC
Q 005940 432 IPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGM 511 (668)
Q Consensus 432 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~~ 511 (668)
+++++|.+++.. ...+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 154 (323)
T cd05584 82 LSGGELFMHLER---EGIFMEDTACFYLSEISLALEHLHQ---QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG- 154 (323)
T ss_pred CCCchHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCC-
Confidence 999999999853 3457888999999999999999999 999999999999999999999999999987543222
Q ss_pred CcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCcccCCcccH
Q 005940 512 PHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSYVV 591 (668)
Q Consensus 512 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 591 (668)
.......||..|+|||++.+..++.++|||||||++|||++|+.||...+.. ........ +.. .+.....
T Consensus 155 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~--~~~~~~~~-~~~------~~~~~~~- 224 (323)
T cd05584 155 TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRK--KTIDKILK-GKL------NLPPYLT- 224 (323)
T ss_pred CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHH--HHHHHHHc-CCC------CCCCCCC-
Confidence 1223457899999999998888999999999999999999999999765322 11111111 111 1111112
Q ss_pred HHHHHHHHHHhhcCCC-CCCCC-----CHHHHHHH
Q 005940 592 KEMELVLKLGLMCSHK-TQFRP-----TMRQVMRY 620 (668)
Q Consensus 592 ~~~~~l~~l~~~C~~~-p~~RP-----s~~evl~~ 620 (668)
..+..+...|+.. |++|| ++++++++
T Consensus 225 ---~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h 256 (323)
T cd05584 225 ---PEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH 256 (323)
T ss_pred ---HHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence 2344555678877 99999 89998875
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=310.09 Aligned_cols=255 Identities=26% Similarity=0.415 Sum_probs=199.2
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCc----EEEEEEEecCCc-hhHHHHHHHHHHHhcccccCceeEeeeecccCceEE
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGG----EVAVKKITRNSL-QGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLL 427 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~----~vavK~~~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l 427 (668)
.+|+..+.||+|+||.||+|.+..++. .+++|.+..... ....++..|+.+++++.||||+++++++.. ...++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence 467778999999999999999876665 477777754432 344678889999999999999999999864 45789
Q ss_pred EEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceecc
Q 005940 428 VYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYD 507 (668)
Q Consensus 428 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~ 507 (668)
++||+++|+|.+++.. ....++|..++.++.||+.||.|||+ .+++||||||+||++++++.+||+|||+++...
T Consensus 86 i~e~~~~gsL~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~lH~---~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~ 160 (279)
T cd05111 86 VTQLSPLGSLLDHVRQ--HRDSLDPQRLLNWCVQIAKGMYYLEE---HRMVHRNLAARNILLKSDSIVQIADFGVADLLY 160 (279)
T ss_pred EEEeCCCCcHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHH---CCEeccccCcceEEEcCCCcEEEcCCccceecc
Confidence 9999999999999963 33568999999999999999999998 999999999999999999999999999998664
Q ss_pred CCCCC-cccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCchh-HHHHHHHHHhcCccccccCcc
Q 005940 508 HGGMP-HTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVAT-GRRPIGSGDLL-LVEWVRECHQLGRILDVADPL 584 (668)
Q Consensus 508 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~-l~~~~~~~~~~~~~~~~~d~~ 584 (668)
..... ......++..|+|||.+.++.++.++|||||||++|||++ |+.||...... ..++ ...+... ..+.
T Consensus 161 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~----~~~~~~~--~~~~ 234 (279)
T cd05111 161 PDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDL----LEKGERL--AQPQ 234 (279)
T ss_pred CCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH----HHCCCcC--CCCC
Confidence 33221 2233456778999999988899999999999999999998 99999754322 2222 1111111 1111
Q ss_pred cCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhccCcC
Q 005940 585 LNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSGEKQ 626 (668)
Q Consensus 585 l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~~~~ 626 (668)
. +. ..+..++..|+.. |++||++.|+++.|.....
T Consensus 235 ~---~~----~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~ 270 (279)
T cd05111 235 I---CT----IDVYMVMVKCWMIDENVRPTFKELANEFTRMAR 270 (279)
T ss_pred C---CC----HHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence 1 11 2344566688887 9999999999999877543
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=307.43 Aligned_cols=251 Identities=25% Similarity=0.389 Sum_probs=200.4
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCc-----hhHHHHHHHHHHHhcccccCceeEeeeecccCceEE
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSL-----QGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLL 427 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-----~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l 427 (668)
++|...+.||+|++|.||++....++..+|+|.+..... ...+.+.+|++++++++||||+++++++......++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 578899999999999999999988899999999865422 234578899999999999999999999999999999
Q ss_pred EEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceecc
Q 005940 428 VYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYD 507 (668)
Q Consensus 428 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~ 507 (668)
|+||+++++|.+++.. ...+++..+..++.|++.||.|||+ .+++||||+|+||+++++++++|+|||+++...
T Consensus 82 v~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~ 155 (263)
T cd06625 82 FMEYMPGGSVKDQLKA---YGALTETVTRKYTRQILEGVEYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQ 155 (263)
T ss_pred EEEECCCCcHHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence 9999999999999853 3458899999999999999999998 999999999999999999999999999998654
Q ss_pred CCCCCcc--cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCccc
Q 005940 508 HGGMPHT--TNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLL 585 (668)
Q Consensus 508 ~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 585 (668)
....... ....++..|+|||.+.+..++.++||||||+++|||++|+.||...+.... ......... .+.+
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~--~~~~~~~~~-----~~~~ 228 (263)
T cd06625 156 TICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAA--IFKIATQPT-----NPQL 228 (263)
T ss_pred ccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHH--HHHHhccCC-----CCCC
Confidence 3221111 234678899999999988899999999999999999999999965432211 111111111 1111
Q ss_pred CCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 586 NSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 586 ~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
....+ ..+..+...|+.. |++||+++|++++
T Consensus 229 ~~~~~----~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 229 PSHVS----PDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred CccCC----HHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 12222 2344555678876 9999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=313.39 Aligned_cols=255 Identities=25% Similarity=0.410 Sum_probs=200.3
Q ss_pred cCcccceeeeecCcEEEEEEEeC----CCCcEEEEEEEecCC-chhHHHHHHHHHHHhcccccCceeEeeeecccCceEE
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLP----TTGGEVAVKKITRNS-LQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLL 427 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~----~~~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l 427 (668)
.+|+..++||+|+||.||+|.+. ..+..+++|.+.... .+...++.+|++++++++||||+++++++......++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 35777899999999999999852 345789999987533 3445688999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhcCCC--------------CCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCC
Q 005940 428 VYEYIPNGSLDTLLFKPK--------------DGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEM 493 (668)
Q Consensus 428 V~E~~~~gsL~~~l~~~~--------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~ 493 (668)
||||+++++|.+++.... ....+++.+++.++.|++.||.|||+ ++++||||||+||++++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSS---HFFVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---cCeehhccccceEEEcCCC
Confidence 999999999999985321 12358899999999999999999998 9999999999999999999
Q ss_pred CEEEEeecCceeccCCCC-CcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCch-hHHHHHHH
Q 005940 494 NARLGDFGLARLYDHGGM-PHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVAT-GRRPIGSGDL-LLVEWVRE 570 (668)
Q Consensus 494 ~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~-~l~~~~~~ 570 (668)
.+||+|||+++....... .......++..|+|||++.++.++.++|||||||++|||++ |..||..... .+.+.
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~--- 238 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEM--- 238 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHH---
Confidence 999999999986543321 11223345678999999988889999999999999999998 9989865322 22221
Q ss_pred HHhcCccccccCcccCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhcc
Q 005940 571 CHQLGRILDVADPLLNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSG 623 (668)
Q Consensus 571 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~ 623 (668)
........ ....++ ..+..+..+|++. |++||++.+|+++|+.
T Consensus 239 -~~~~~~~~-----~~~~~~----~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 239 -VRKRQLLP-----CSEDCP----PRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred -HHcCCcCC-----CCCCCC----HHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 11111111 111122 2345666789987 9999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=305.72 Aligned_cols=257 Identities=24% Similarity=0.354 Sum_probs=203.4
Q ss_pred hHHHHhcCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCchhHHHHHHHHHHHhcccccCceeEeeeecccCceE
Q 005940 347 DLYAATKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLL 426 (668)
Q Consensus 347 el~~at~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~ 426 (668)
|++.+++++.....||+|+||.||+|++..++..|++|.+........+.+.+|++++++++|+||+++++++...+..+
T Consensus 2 ~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 81 (268)
T cd06624 2 EYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFK 81 (268)
T ss_pred CcccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEE
Confidence 34456777777889999999999999998888999999998777667788999999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhcCCCCCCCc--cHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECC-CCCEEEEeecCc
Q 005940 427 LVYEYIPNGSLDTLLFKPKDGSVL--DWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDA-EMNARLGDFGLA 503 (668)
Q Consensus 427 lV~E~~~~gsL~~~l~~~~~~~~l--~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~-~~~~kl~DfGla 503 (668)
+|+||+++++|.+++.... ..+ ++..+..++.||+.||+|||+ .+|+||||||+||+++. ++.+||+|||++
T Consensus 82 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~h~dl~p~nil~~~~~~~~~l~dfg~~ 156 (268)
T cd06624 82 IFMEQVPGGSLSALLRSKW--GPLKDNEQTIIFYTKQILEGLKYLHD---NQIVHRDIKGDNVLVNTYSGVVKISDFGTS 156 (268)
T ss_pred EEEecCCCCCHHHHHHHhc--ccCCCcHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCeEEEecchhh
Confidence 9999999999999996422 234 888899999999999999998 99999999999999986 678999999998
Q ss_pred eeccCCCCCcccccccCCcccCcccccCCC--CCcchhHHHHHHHHHHHHhCCCCCCCCchhH-HHHHHHHHhcCccccc
Q 005940 504 RLYDHGGMPHTTNVVGTFGYIAPELTQTGK--ASTSSDVFAYGILLLEVATGRRPIGSGDLLL-VEWVRECHQLGRILDV 580 (668)
Q Consensus 504 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l-~~~~~~~~~~~~~~~~ 580 (668)
........ ......++..|+|||++.... ++.++||||||+++|||++|+.||...+... ..+......
T Consensus 157 ~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~------- 228 (268)
T cd06624 157 KRLAGINP-CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFK------- 228 (268)
T ss_pred eecccCCC-ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhc-------
Confidence 76543221 222345789999999986643 7889999999999999999999996432211 111111000
Q ss_pred cCcccCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 581 ADPLLNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 581 ~d~~l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
..+.+.... ...+..+...|++. |++||++.|++++
T Consensus 229 ~~~~~~~~~----~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 229 IHPEIPESL----SAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred cCCCCCccc----CHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 011111111 13345666789987 9999999999875
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=309.54 Aligned_cols=254 Identities=27% Similarity=0.445 Sum_probs=202.3
Q ss_pred cCcccceeeeecCcEEEEEEEeCC-----CCcEEEEEEEecCCch-hHHHHHHHHHHHhcccccCceeEeeeecccCceE
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPT-----TGGEVAVKKITRNSLQ-GMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLL 426 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~-~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~ 426 (668)
+.|.+.+.||+|+||.||+|.+.. ++..||||.+...... ..+.+.+|++++++++|+||+++++++......+
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 457888999999999999998743 3578999999765444 4578999999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhcCCC-----------CCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCE
Q 005940 427 LVYEYIPNGSLDTLLFKPK-----------DGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNA 495 (668)
Q Consensus 427 lV~E~~~~gsL~~~l~~~~-----------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~ 495 (668)
+||||+++++|.+++.... ....+++.++..++.|++.||.|||+ .+++||||||+||+++.++.+
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLAS---QHFVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhh---CCeeccccccceEEEcCCCeE
Confidence 9999999999999996421 23458999999999999999999998 899999999999999999999
Q ss_pred EEEeecCceeccCCCC-CcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCch-hHHHHHHHHH
Q 005940 496 RLGDFGLARLYDHGGM-PHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVAT-GRRPIGSGDL-LLVEWVRECH 572 (668)
Q Consensus 496 kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~-~l~~~~~~~~ 572 (668)
||+|||+++....... .......++..|+|||++..+.++.++|||||||++|||++ |+.||...+. ...+.+
T Consensus 162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~---- 237 (280)
T cd05049 162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECI---- 237 (280)
T ss_pred EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH----
Confidence 9999999986533221 11223345778999999999999999999999999999998 9999865432 222221
Q ss_pred hcCccccccCcccCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhc
Q 005940 573 QLGRILDVADPLLNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLS 622 (668)
Q Consensus 573 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~ 622 (668)
..+..... .... ...+..+...|+.. |++||+++||++.|+
T Consensus 238 ~~~~~~~~-----~~~~----~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 238 TQGRLLQR-----PRTC----PSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred HcCCcCCC-----CCCC----CHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 11111111 1111 13455667788887 999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=322.94 Aligned_cols=251 Identities=26% Similarity=0.388 Sum_probs=207.7
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecC--CchhHHHHHHHHHHHhcccccCceeEeeeecccCc-eEEEE
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRN--SLQGMREFAAEIESLGRLRHKNLVNLHGWCKQKND-LLLVY 429 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~-~~lV~ 429 (668)
++|...+++|+|+||.++..+++.++..+++|.+... .....+...+|+.++++++|||||.+.+.+.+++. .++||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 4678899999999999999999989999999998654 33445577899999999999999999999998888 99999
Q ss_pred EecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCC
Q 005940 430 EYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHG 509 (668)
Q Consensus 430 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~ 509 (668)
+||+||+|.+.+.+.+ +..+++.++.+++.|++.|+.|||+ ..|+|||||+.|||++.+..+||+|||+|+.+...
T Consensus 84 ~Y~eGg~l~~~i~~~k-~~~f~E~~i~~~~~Q~~~av~ylH~---~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~ 159 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQK-GVLFPEERILKWFVQILLAVNYLHE---NRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE 159 (426)
T ss_pred eecCCCCHHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHh---hhhhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence 9999999999997433 6779999999999999999999998 99999999999999999999999999999988765
Q ss_pred CCCcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCcccCCcc
Q 005940 510 GMPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSY 589 (668)
Q Consensus 510 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 589 (668)
.. ....++||+.||.||++.+..|..|+|||||||++|||++-+++|...+.. ..+.+..+.. .+| +...+
T Consensus 160 ~~-~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~--~Li~ki~~~~-----~~P-lp~~y 230 (426)
T KOG0589|consen 160 DS-LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMS--ELILKINRGL-----YSP-LPSMY 230 (426)
T ss_pred hh-hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchH--HHHHHHhhcc-----CCC-CCccc
Confidence 42 334578999999999999999999999999999999999999999765421 1111111111 111 21222
Q ss_pred cHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 590 VVKEMELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 590 ~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
. ..+..++..|+.. |+.||++.+++.+
T Consensus 231 -s---~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 231 -S---SELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred -c---HHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 2 3344455577777 9999999999987
|
|
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=309.65 Aligned_cols=258 Identities=28% Similarity=0.460 Sum_probs=205.5
Q ss_pred cCcccceeeeecCcEEEEEEEeC-----CCCcEEEEEEEecCCchhHHHHHHHHHHHhcccccCceeEeeeecccCceEE
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLP-----TTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLL 427 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l 427 (668)
.+|...+.||+|+||.||+|... .++..+++|.+........+.+.+|++++++++|+||+++++++......++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 35777899999999999999853 2345699999877766666789999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhcCCC-------------CCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCC
Q 005940 428 VYEYIPNGSLDTLLFKPK-------------DGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMN 494 (668)
Q Consensus 428 V~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~ 494 (668)
||||+++++|.+++.... ....++|..++.++.||+.||+|||+ .+|+||||||+||+++.++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLAS---QHFVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccCcceEEEccCCc
Confidence 999999999999985422 12358999999999999999999998 99999999999999999999
Q ss_pred EEEEeecCceeccCCCC-CcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHHH
Q 005940 495 ARLGDFGLARLYDHGGM-PHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVAT-GRRPIGSGDLLLVEWVRECH 572 (668)
Q Consensus 495 ~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~l~~~~~~~~ 572 (668)
+||+|||+++....... .......++..|+|||.+....++.++|||||||++|||++ |+.||...... + ..+..
T Consensus 162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~--~-~~~~~ 238 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT--E-VIECI 238 (291)
T ss_pred EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--H-HHHHH
Confidence 99999999976543321 11223456788999999988889999999999999999998 99998654321 1 11112
Q ss_pred hcCccccccCcccCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhccCc
Q 005940 573 QLGRILDVADPLLNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSGEK 625 (668)
Q Consensus 573 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~~~ 625 (668)
..+..... ... ....+..+...|++. |++||++++|++.|+...
T Consensus 239 ~~~~~~~~-----~~~----~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~ 283 (291)
T cd05094 239 TQGRVLER-----PRV----CPKEVYDIMLGCWQREPQQRLNIKEIYKILHALG 283 (291)
T ss_pred hCCCCCCC-----Ccc----CCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHH
Confidence 22221111 111 123456777789887 999999999999998774
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=307.33 Aligned_cols=254 Identities=25% Similarity=0.347 Sum_probs=200.3
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCchhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEEec
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEYI 432 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~ 432 (668)
.+|++.+.||+|+||.||+|+...+++.||+|++..........+.+|+.++++++|+||+++++.+..++..++|+||+
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~ 88 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYC 88 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCC
Confidence 46888999999999999999998889999999997665555567889999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCCCC
Q 005940 433 PNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMP 512 (668)
Q Consensus 433 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~~~ 512 (668)
++++|.+++.. ...+++.++..++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||++........
T Consensus 89 ~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~- 161 (267)
T cd06646 89 GGGSLQDIYHV---TGPLSELQIAYVCRETLQGLAYLHS---KGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIA- 161 (267)
T ss_pred CCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCCEEECcCccceeeccccc-
Confidence 99999999853 3468999999999999999999998 9999999999999999999999999999986643221
Q ss_pred cccccccCCcccCccccc---CCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCcccCCcc
Q 005940 513 HTTNVVGTFGYIAPELTQ---TGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSY 589 (668)
Q Consensus 513 ~~~~~~gt~~y~aPE~~~---~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 589 (668)
......++..|+|||.+. ...++.++|||||||++|||++|+.|+...... ........ .....+.....
T Consensus 162 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~-----~~~~~~~~-~~~~~~~~~~~- 234 (267)
T cd06646 162 KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPM-----RALFLMSK-SNFQPPKLKDK- 234 (267)
T ss_pred ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchh-----hhheeeec-CCCCCCCCccc-
Confidence 123346888999999874 345788999999999999999999998543211 00000000 00011111110
Q ss_pred cHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHh
Q 005940 590 VVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYL 621 (668)
Q Consensus 590 ~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L 621 (668)
......+..+...|+.. |++||++++|+++|
T Consensus 235 -~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 235 -TKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred -cccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 01123455666788887 99999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=311.96 Aligned_cols=264 Identities=27% Similarity=0.382 Sum_probs=199.3
Q ss_pred cCcccceeeeecCcEEEEEEEe----CCCCcEEEEEEEecCCchhHHHHHHHHHHHhcccccCceeEeeeecc--cCceE
Q 005940 353 KGFKESEVIGIGGFGSVYKGVL----PTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNLHGWCKQ--KNDLL 426 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~----~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~--~~~~~ 426 (668)
+.|+..+.||+|+||.||++.. ..++..||+|++........+.|.+|++++++++||||+++++++.. ....+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 4678889999999999999984 34678999999987766667889999999999999999999998753 34689
Q ss_pred EEEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceec
Q 005940 427 LVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLY 506 (668)
Q Consensus 427 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~ 506 (668)
+|+||+++++|.+++.. ....+++..++.++.|++.||+|||+ .+++||||||+||++++++.+||+|||+++..
T Consensus 84 lv~e~~~~~~L~~~l~~--~~~~l~~~~~~~~~~~l~~aL~~LH~---~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~ 158 (284)
T cd05081 84 LVMEYLPYGSLRDYLQK--HRERLDHRKLLLYASQICKGMEYLGS---KRYVHRDLATRNILVESENRVKIGDFGLTKVL 158 (284)
T ss_pred EEEEecCCCCHHHHHHh--cCcCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCCHhhEEECCCCeEEECCCcccccc
Confidence 99999999999999953 23468999999999999999999998 99999999999999999999999999999876
Q ss_pred cCCCCCc--ccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCc-------c
Q 005940 507 DHGGMPH--TTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGR-------I 577 (668)
Q Consensus 507 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~-------~ 577 (668)
....... .....++..|+|||++.+..++.++|||||||++|||++|..|+........ ........ +
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~ 235 (284)
T cd05081 159 PQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFM---RMMGNDKQGQMIVYHL 235 (284)
T ss_pred cCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhh---hhcccccccccchHHH
Confidence 5432211 1112234569999999888899999999999999999998877643221111 00000000 0
Q ss_pred ccccCcccCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhccC
Q 005940 578 LDVADPLLNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSGE 624 (668)
Q Consensus 578 ~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~~ 624 (668)
.+.................+..++..|+.. |++||+++||++.|+..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 236 IELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 000000000000011123466777789987 99999999999998754
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=327.14 Aligned_cols=259 Identities=24% Similarity=0.330 Sum_probs=201.3
Q ss_pred hcCcccceeeeecCcEEEEEEEeCCC-----CcEEEEEEEecCCc-hhHHHHHHHHHHHhccc-ccCceeEeeeecccCc
Q 005940 352 TKGFKESEVIGIGGFGSVYKGVLPTT-----GGEVAVKKITRNSL-QGMREFAAEIESLGRLR-HKNLVNLHGWCKQKND 424 (668)
Q Consensus 352 t~~f~~~~~lG~G~~g~Vy~~~~~~~-----~~~vavK~~~~~~~-~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~~~ 424 (668)
.++|.+.++||+|+||.||+|++... +..||||++..... ...+.+..|+++++++. ||||++++++|.+.+.
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~ 115 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP 115 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence 35788899999999999999986322 34699999975433 34467899999999996 9999999999999999
Q ss_pred eEEEEEecCCCChhhhhcCCC-----------------------------------------------------------
Q 005940 425 LLLVYEYIPNGSLDTLLFKPK----------------------------------------------------------- 445 (668)
Q Consensus 425 ~~lV~E~~~~gsL~~~l~~~~----------------------------------------------------------- 445 (668)
.++||||+++|+|.++|.+..
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (400)
T cd05105 116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK 195 (400)
T ss_pred eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence 999999999999999885321
Q ss_pred ----------------------------------CCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECC
Q 005940 446 ----------------------------------DGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDA 491 (668)
Q Consensus 446 ----------------------------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~ 491 (668)
....+++.+++.++.||+.||.|||+ .+|+||||||+||+++.
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivH~dikp~Nill~~ 272 (400)
T cd05105 196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLAS---KNCVHRDLAARNVLLAQ 272 (400)
T ss_pred hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChHhEEEeC
Confidence 01247889999999999999999998 99999999999999999
Q ss_pred CCCEEEEeecCceeccCCCC-CcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHH
Q 005940 492 EMNARLGDFGLARLYDHGGM-PHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVAT-GRRPIGSGDLLLVEWVR 569 (668)
Q Consensus 492 ~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~l~~~~~ 569 (668)
++.+||+|||+++....... .......++..|+|||.+.+..++.++|||||||++|||++ |..||...... ....
T Consensus 273 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~--~~~~ 350 (400)
T cd05105 273 GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVD--STFY 350 (400)
T ss_pred CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchh--HHHH
Confidence 99999999999986643221 11223356788999999988889999999999999999997 99998643211 1111
Q ss_pred HHHhcCccccccCcccCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhccC
Q 005940 570 ECHQLGRILDVADPLLNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSGE 624 (668)
Q Consensus 570 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~~ 624 (668)
.....+.. ....... ...+..++..|+.. |++||++.+|.+.|+..
T Consensus 351 ~~~~~~~~-----~~~~~~~----~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l 397 (400)
T cd05105 351 NKIKSGYR-----MAKPDHA----TQEVYDIMVKCWNSEPEKRPSFLHLSDIVESL 397 (400)
T ss_pred HHHhcCCC-----CCCCccC----CHHHHHHHHHHCccCHhHCcCHHHHHHHHHHH
Confidence 11111110 1111111 23456677789987 99999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=290.60 Aligned_cols=264 Identities=25% Similarity=0.273 Sum_probs=211.3
Q ss_pred HHhcCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCchhHHHHHHHHHHHhcccccCceeEeeeeccc-----Cc
Q 005940 350 AATKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNLHGWCKQK-----ND 424 (668)
Q Consensus 350 ~at~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~-----~~ 424 (668)
...++|.+.++||+|||+.||+++...+++.+|+|++.....+..+..+.|++..++++|||++++++++..+ .+
T Consensus 18 In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~ 97 (302)
T KOG2345|consen 18 INNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHE 97 (302)
T ss_pred EcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCcee
Confidence 3457899999999999999999998888999999999888878888999999999999999999999998543 35
Q ss_pred eEEEEEecCCCChhhhhcCCCC-CCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCc
Q 005940 425 LLLVYEYIPNGSLDTLLFKPKD-GSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLA 503 (668)
Q Consensus 425 ~~lV~E~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla 503 (668)
.||+++|...|+|.+.+...+. +..+++.++++|+.+|++||.+||+ ...+++||||||.|||+.+.+.++|.|||.+
T Consensus 98 ~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~-~~~~yAH~DiKP~NILls~~~~~vl~D~GS~ 176 (302)
T KOG2345|consen 98 AYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHE-KEPPYAHRDIKPANILLSDSGLPVLMDLGSA 176 (302)
T ss_pred EEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhc-cCCcccccCCCcceeEecCCCceEEEeccCc
Confidence 8999999999999999865443 4579999999999999999999998 2345999999999999999999999999998
Q ss_pred eeccCCCC--------CcccccccCCcccCcccccC---CCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHH
Q 005940 504 RLYDHGGM--------PHTTNVVGTFGYIAPELTQT---GKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECH 572 (668)
Q Consensus 504 ~~~~~~~~--------~~~~~~~gt~~y~aPE~~~~---~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~ 572 (668)
....-... ........|..|.|||.+.- ...++++|||||||+||+|+.|..||+. ...
T Consensus 177 ~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~----------~~~ 246 (302)
T KOG2345|consen 177 TQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFER----------IYQ 246 (302)
T ss_pred cccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchH----------Hhh
Confidence 75432111 11122357899999998753 4568999999999999999999999963 122
Q ss_pred hcCcccc-ccCcccCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhccC
Q 005940 573 QLGRILD-VADPLLNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSGE 624 (668)
Q Consensus 573 ~~~~~~~-~~d~~l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~~ 624 (668)
+.+.+.- +..+.+...-...-.+.+.++..+|++. |.+||++.+++..+...
T Consensus 247 ~GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L 300 (302)
T KOG2345|consen 247 QGGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL 300 (302)
T ss_pred cCCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence 3333322 2222332222222446677888899998 99999999999988653
|
|
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=306.76 Aligned_cols=252 Identities=27% Similarity=0.440 Sum_probs=199.4
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCchhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEEec
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEYI 432 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~ 432 (668)
++|++.++||+|++|.||+|... ++..+|+|.+..... ..+.+.+|+.++++++|+|++++++++. ....+++|||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~ 82 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYM 82 (260)
T ss_pred HHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEec
Confidence 46788899999999999999875 567899999876443 3467899999999999999999999885 45689999999
Q ss_pred CCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCCCC
Q 005940 433 PNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMP 512 (668)
Q Consensus 433 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~~~ 512 (668)
++++|.+++... ....+++.+++.++.|++.||.|||+ .+++||||||+||++++++.++|+|||++.........
T Consensus 83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05070 83 SKGSLLDFLKDG-EGRALKLPNLVDMAAQVAAGMAYIER---MNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT 158 (260)
T ss_pred CCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCccceEEEeCCceEEeCCceeeeeccCcccc
Confidence 999999999642 33568999999999999999999999 99999999999999999999999999999876543322
Q ss_pred cccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHHHhcCccccccCcccCCcccH
Q 005940 513 HTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVAT-GRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSYVV 591 (668)
Q Consensus 513 ~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 591 (668)
......++..|+|||++.+..++.++||||||+++|||++ |..||...+.. +.......... ......
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~--~~~~~~~~~~~------~~~~~~--- 227 (260)
T cd05070 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNR--EVLEQVERGYR------MPCPQD--- 227 (260)
T ss_pred cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHH--HHHHHHHcCCC------CCCCCc---
Confidence 2222345678999999988889999999999999999999 88898654321 11111111111 111111
Q ss_pred HHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhcc
Q 005940 592 KEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSG 623 (668)
Q Consensus 592 ~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~ 623 (668)
....+..+...|+.. |++||+++++.+.|+.
T Consensus 228 -~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 228 -CPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred -CCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 123466777789887 9999999999998864
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=319.56 Aligned_cols=259 Identities=30% Similarity=0.428 Sum_probs=207.7
Q ss_pred cccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCchh-HHHHHHHHHHHhcccccCceeEeeeecccCceEEEEEecC
Q 005940 355 FKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQG-MREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEYIP 433 (668)
Q Consensus 355 f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~-~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~ 433 (668)
..+.++||+|-||.|.++... .+..||||.++...... .++|.+|+++|.+|+||||++|+|.|..++.+++|+|||+
T Consensus 540 L~~~ekiGeGqFGEVhLCeve-g~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYmE 618 (807)
T KOG1094|consen 540 LRFKEKIGEGQFGEVHLCEVE-GPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYME 618 (807)
T ss_pred eehhhhhcCcccceeEEEEec-CceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHHh
Confidence 466789999999999999983 36899999998876554 4899999999999999999999999999999999999999
Q ss_pred CCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCCC-C
Q 005940 434 NGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGM-P 512 (668)
Q Consensus 434 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~~-~ 512 (668)
+|+|.+++.... ...+.-....+|+.||+.||+||.+ .+++||||.++|+|++.++++||+|||++|.+-.+.. .
T Consensus 619 nGDLnqFl~ahe-apt~~t~~~vsi~tqiasgmaYLes---~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~ 694 (807)
T KOG1094|consen 619 NGDLNQFLSAHE-LPTAETAPGVSICTQIASGMAYLES---LNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYR 694 (807)
T ss_pred cCcHHHHHHhcc-CcccccchhHHHHHHHHHHHHHHHh---hchhhccccccceeecCcccEEecCcccccccccCCcee
Confidence 999999996432 2225667778899999999999999 9999999999999999999999999999996554433 2
Q ss_pred cccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHH--hCCCCCCCC-chhHHHHHHHHHhcCccc-cccCcccCCc
Q 005940 513 HTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVA--TGRRPIGSG-DLLLVEWVRECHQLGRIL-DVADPLLNSS 588 (668)
Q Consensus 513 ~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ell--tG~~p~~~~-~~~l~~~~~~~~~~~~~~-~~~d~~l~~~ 588 (668)
.....+-+.+|||||.+..++.+.++|||+||+.+||++ |..+||+.. +...++-.-.....+... -...|..
T Consensus 695 vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~P~~--- 771 (807)
T KOG1094|consen 695 VQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLSRPPA--- 771 (807)
T ss_pred eecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceeccCCCc---
Confidence 233456678999999999999999999999999999975 588999753 333333333333222111 1111222
Q ss_pred ccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhccCc
Q 005940 589 YVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSGEK 625 (668)
Q Consensus 589 ~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~~~ 625 (668)
....+.++++.||.. .++||+++++..+|..+.
T Consensus 772 ----cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~~ 805 (807)
T KOG1094|consen 772 ----CPQGLYELMLRCWRRESEQRPSFEQLHLFLQEDA 805 (807)
T ss_pred ----CcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHhc
Confidence 234566888999998 789999999999987653
|
|
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=307.27 Aligned_cols=252 Identities=28% Similarity=0.420 Sum_probs=200.1
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCchhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEEec
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEYI 432 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~ 432 (668)
.+|...++||+|++|.||+|++.. ...||+|++..... ..++|..|++++++++|+||+++++.+.+ ...++||||+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~-~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~ 82 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 82 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecC-CceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcC
Confidence 468889999999999999999864 45799999875432 34678999999999999999999998754 5689999999
Q ss_pred CCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCCCC
Q 005940 433 PNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMP 512 (668)
Q Consensus 433 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~~~ 512 (668)
++|+|.+++... ....+++.+++.++.|++.||+|||+ .+++||||||+||++++++.+||+|||.++........
T Consensus 83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~ 158 (262)
T cd05071 83 SKGSLLDFLKGE-MGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 158 (262)
T ss_pred CCCcHHHHHhhc-cccCCCHHHHHHHHHHHHHHHHHHHH---CCccccccCcccEEEcCCCcEEeccCCceeeccccccc
Confidence 999999999632 23568999999999999999999998 99999999999999999999999999999876544332
Q ss_pred cccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHHHhcCccccccCcccCCcccH
Q 005940 513 HTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVAT-GRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSYVV 591 (668)
Q Consensus 513 ~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 591 (668)
......++..|+|||+..++.++.++|||||||++|||++ |..||....... ......... .... ..
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~---~~~~~~~~~-----~~~~----~~ 226 (262)
T cd05071 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE---VLDQVERGY-----RMPC----PP 226 (262)
T ss_pred cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHH---HHHHHhcCC-----CCCC----cc
Confidence 2223456778999999988889999999999999999999 888886543211 111111111 0011 11
Q ss_pred HHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhcc
Q 005940 592 KEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSG 623 (668)
Q Consensus 592 ~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~ 623 (668)
+....+..+...|++. |++||++.++++.|+.
T Consensus 227 ~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~ 259 (262)
T cd05071 227 ECPESLHDLMCQCWRKEPEERPTFEYLQAFLED 259 (262)
T ss_pred ccCHHHHHHHHHHccCCcccCCCHHHHHHHHHH
Confidence 2234566788899987 9999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=316.15 Aligned_cols=241 Identities=24% Similarity=0.322 Sum_probs=189.2
Q ss_pred eeeeecCcEEEEEEEeCCCCcEEEEEEEecCC---chhHHHHHHHHHHHhcc-cccCceeEeeeecccCceEEEEEecCC
Q 005940 359 EVIGIGGFGSVYKGVLPTTGGEVAVKKITRNS---LQGMREFAAEIESLGRL-RHKNLVNLHGWCKQKNDLLLVYEYIPN 434 (668)
Q Consensus 359 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~E~~~~ 434 (668)
++||+|+||.||+|.+..+++.||||++.... ....+.+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999998889999999997542 22344556677777654 799999999999999999999999999
Q ss_pred CChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCCCCcc
Q 005940 435 GSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHT 514 (668)
Q Consensus 435 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 514 (668)
|+|..++.. ...+++.++..++.||+.||.|||+ .+|+||||||+||+++.++.+||+|||+++...... ...
T Consensus 81 g~L~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~---~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~~ 153 (316)
T cd05592 81 GDLMFHIQS---SGRFDEARARFYAAEIICGLQFLHK---KGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GKA 153 (316)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Ccc
Confidence 999999853 3458999999999999999999999 999999999999999999999999999998654322 223
Q ss_pred cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCcccCCcccHHHH
Q 005940 515 TNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSYVVKEM 594 (668)
Q Consensus 515 ~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 594 (668)
....||..|+|||++.+..++.++|||||||++|||++|+.||...+... ...... .. .+.+..... .
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~--~~~~i~-~~------~~~~~~~~~-~-- 221 (316)
T cd05592 154 STFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDE--LFDSIL-ND------RPHFPRWIS-K-- 221 (316)
T ss_pred ccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHH--HHHHHH-cC------CCCCCCCCC-H--
Confidence 34578999999999998889999999999999999999999997654221 111111 11 111111122 2
Q ss_pred HHHHHHHhhcCCC-CCCCCCHH-HHHH
Q 005940 595 ELVLKLGLMCSHK-TQFRPTMR-QVMR 619 (668)
Q Consensus 595 ~~l~~l~~~C~~~-p~~RPs~~-evl~ 619 (668)
.+..+...|+.. |++||++. ++++
T Consensus 222 -~~~~ll~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05592 222 -EAKDCLSKLFERDPTKRLGVDGDIRQ 247 (316)
T ss_pred -HHHHHHHHHccCCHHHcCCChHHHHc
Confidence 234455578877 99999875 5554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=318.87 Aligned_cols=245 Identities=26% Similarity=0.313 Sum_probs=193.9
Q ss_pred eeeeecCcEEEEEEEeCCCCcEEEEEEEecCC---chhHHHHHHHHHHHhcc-cccCceeEeeeecccCceEEEEEecCC
Q 005940 359 EVIGIGGFGSVYKGVLPTTGGEVAVKKITRNS---LQGMREFAAEIESLGRL-RHKNLVNLHGWCKQKNDLLLVYEYIPN 434 (668)
Q Consensus 359 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~E~~~~ 434 (668)
+.||+|+||.||++.+..+++.||+|++.+.. ....+.+..|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 46999999999999998889999999997642 23445677899888877 799999999999999999999999999
Q ss_pred CChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCCCCcc
Q 005940 435 GSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHT 514 (668)
Q Consensus 435 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 514 (668)
|+|..++.. ...+++..+..++.||+.||.|||+ .+|+||||||+||+++.++.+||+|||+++...... ...
T Consensus 81 ~~L~~~~~~---~~~l~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~-~~~ 153 (329)
T cd05618 81 GDLMFHMQR---QRKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG-DTT 153 (329)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCC-Ccc
Confidence 999988853 3468999999999999999999998 999999999999999999999999999997543221 122
Q ss_pred cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC------chhHHHHHHHHHhcCccccccCcccCCc
Q 005940 515 TNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSG------DLLLVEWVRECHQLGRILDVADPLLNSS 588 (668)
Q Consensus 515 ~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~------~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 588 (668)
....||..|+|||++.+..++.++|||||||++|||++|+.||... .....++..+....... .+...
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~------~~p~~ 227 (329)
T cd05618 154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI------RIPRS 227 (329)
T ss_pred ccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCC------CCCCC
Confidence 3457899999999999989999999999999999999999999521 11223333333222211 11112
Q ss_pred ccHHHHHHHHHHHhhcCCC-CCCCCC------HHHHHHH
Q 005940 589 YVVKEMELVLKLGLMCSHK-TQFRPT------MRQVMRY 620 (668)
Q Consensus 589 ~~~~~~~~l~~l~~~C~~~-p~~RPs------~~evl~~ 620 (668)
.. ..+..+...|+.. |++||+ +.+++++
T Consensus 228 ~~----~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05618 228 LS----VKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 262 (329)
T ss_pred CC----HHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence 22 2344555678876 999998 5777665
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=309.50 Aligned_cols=258 Identities=27% Similarity=0.434 Sum_probs=204.6
Q ss_pred cCcccceeeeecCcEEEEEEEeC-----CCCcEEEEEEEecCCchhHHHHHHHHHHHhcccccCceeEeeeecccCceEE
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLP-----TTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLL 427 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l 427 (668)
++|.+.+.||+|+||.||++... .++..+|+|.+........+.+..|++++++++|+||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 84 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 46888899999999999999852 3445799999987666667789999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhcCCC----------CCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEE
Q 005940 428 VYEYIPNGSLDTLLFKPK----------DGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARL 497 (668)
Q Consensus 428 V~E~~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl 497 (668)
||||+++++|.+++.... ....+++.+++.++.|++.||+|||+ .+++||||||+||++++++.+||
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~---~~i~H~dlkp~Nili~~~~~~kl 161 (288)
T cd05093 85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLAS---QHFVHRDLATRNCLVGENLLVKI 161 (288)
T ss_pred EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccCcceEEEccCCcEEe
Confidence 999999999999985322 12358999999999999999999998 99999999999999999999999
Q ss_pred EeecCceeccCCCC-CcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHHHhcC
Q 005940 498 GDFGLARLYDHGGM-PHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVAT-GRRPIGSGDLLLVEWVRECHQLG 575 (668)
Q Consensus 498 ~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~l~~~~~~~~~~~ 575 (668)
+|||+++....... .......++..|+|||.+.+..++.++|||||||++|||++ |..||...... +. ......+
T Consensus 162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~--~~-~~~i~~~ 238 (288)
T cd05093 162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN--EV-IECITQG 238 (288)
T ss_pred ccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--HH-HHHHHcC
Confidence 99999986543221 11222345778999999988889999999999999999998 89998654321 11 1111212
Q ss_pred ccccccCcccCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhccCc
Q 005940 576 RILDVADPLLNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSGEK 625 (668)
Q Consensus 576 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~~~ 625 (668)
.... .....+ ..+..+...|++. |.+||+++||.+.|+...
T Consensus 239 ~~~~-----~~~~~~----~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~ 280 (288)
T cd05093 239 RVLQ-----RPRTCP----KEVYDLMLGCWQREPHMRLNIKEIHSLLQNLA 280 (288)
T ss_pred CcCC-----CCCCCC----HHHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence 1111 111122 2366777789987 999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-37 Score=290.00 Aligned_cols=248 Identities=27% Similarity=0.382 Sum_probs=205.0
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCc---hhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEE
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSL---QGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVY 429 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 429 (668)
++|++.+.||+|-||.||.|+.+.++-.||+|++.+... +..+++.+|+++.+.|+||||+++++|+.+....||++
T Consensus 22 ~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLil 101 (281)
T KOG0580|consen 22 DDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLIL 101 (281)
T ss_pred hhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEE
Confidence 578889999999999999999999999999999977543 23468899999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCC
Q 005940 430 EYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHG 509 (668)
Q Consensus 430 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~ 509 (668)
||.++|.|...|.. .....+++.....++.|+|.||.|+|. ++|+||||||+|+|++.++..||+|||.+.....
T Consensus 102 Eya~~gel~k~L~~-~~~~~f~e~~~a~Yi~q~A~Al~y~h~---k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~- 176 (281)
T KOG0580|consen 102 EYAPRGELYKDLQE-GRMKRFDEQRAATYIKQLANALLYCHL---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS- 176 (281)
T ss_pred EecCCchHHHHHHh-cccccccccchhHHHHHHHHHHHHhcc---CCcccCCCCHHHhccCCCCCeeccCCCceeecCC-
Confidence 99999999999973 345668999999999999999999998 9999999999999999999999999999876542
Q ss_pred CCCcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCcccCCcc
Q 005940 510 GMPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSY 589 (668)
Q Consensus 510 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 589 (668)
..+...+||..|.+||...+..++...|+|++|++.||++.|.+||+.... .+.++.-+-.+..+|. ..
T Consensus 177 --~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~------~etYkrI~k~~~~~p~---~i 245 (281)
T KOG0580|consen 177 --NKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSH------SETYKRIRKVDLKFPS---TI 245 (281)
T ss_pred --CCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhh------HHHHHHHHHccccCCc---cc
Confidence 345567999999999999999999999999999999999999999975431 1112211222333331 12
Q ss_pred cHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 590 VVKEMELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 590 ~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
..+.. .+...|... |.+|....||+++
T Consensus 246 -s~~a~---dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 246 -SGGAA---DLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred -ChhHH---HHHHHHhccCccccccHHHHhhh
Confidence 22222 233356555 9999999999976
|
|
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-36 Score=318.10 Aligned_cols=259 Identities=25% Similarity=0.356 Sum_probs=199.6
Q ss_pred cCcccceeeeecCcEEEEEEEeCC-----CCcEEEEEEEecCCc-hhHHHHHHHHHHHhcc-cccCceeEeeeecc-cCc
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPT-----TGGEVAVKKITRNSL-QGMREFAAEIESLGRL-RHKNLVNLHGWCKQ-KND 424 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~-~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~-~~~ 424 (668)
++|++.+.||+|+||.||+|.... +++.||+|++..... ...+.+..|+.++.++ +|+||++++++|.. ...
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~ 86 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGP 86 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCC
Confidence 468889999999999999997533 346899999875432 3346788899999999 79999999998864 456
Q ss_pred eEEEEEecCCCChhhhhcCCCC----------------------------------------------------------
Q 005940 425 LLLVYEYIPNGSLDTLLFKPKD---------------------------------------------------------- 446 (668)
Q Consensus 425 ~~lV~E~~~~gsL~~~l~~~~~---------------------------------------------------------- 446 (668)
.+++|||+++++|.+++.....
T Consensus 87 ~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (337)
T cd05054 87 LMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELY 166 (337)
T ss_pred EEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHh
Confidence 8899999999999998853211
Q ss_pred CCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCCCC-cccccccCCcccC
Q 005940 447 GSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMP-HTTNVVGTFGYIA 525 (668)
Q Consensus 447 ~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~a 525 (668)
...++|.++..++.||+.||.|||+ .+|+||||||+||++++++.+||+|||+++.+...... ......++..|+|
T Consensus 167 ~~~l~~~~~~~~~~qi~~aL~~lH~---~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~a 243 (337)
T cd05054 167 KEPLTLEDLISYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA 243 (337)
T ss_pred hcCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccC
Confidence 1368999999999999999999998 99999999999999999999999999999876433221 1223355678999
Q ss_pred cccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHHHhcCccccccCcccCCcccHHHHHHHHHHHhhc
Q 005940 526 PELTQTGKASTSSDVFAYGILLLEVAT-GRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSYVVKEMELVLKLGLMC 604 (668)
Q Consensus 526 PE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C 604 (668)
||++.+..++.++|||||||++|||++ |..||...... +............. ... .....+..++..|
T Consensus 244 PE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~--~~~~~~~~~~~~~~-----~~~----~~~~~~~~l~~~c 312 (337)
T cd05054 244 PESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQID--EEFCRRLKEGTRMR-----APE----YATPEIYSIMLDC 312 (337)
T ss_pred cHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCcc--HHHHHHHhccCCCC-----CCc----cCCHHHHHHHHHH
Confidence 999999999999999999999999998 99998643211 11111111111110 001 1123466777889
Q ss_pred CCC-CCCCCCHHHHHHHhccCc
Q 005940 605 SHK-TQFRPTMRQVMRYLSGEK 625 (668)
Q Consensus 605 ~~~-p~~RPs~~evl~~L~~~~ 625 (668)
++. |++||++.||+++|+...
T Consensus 313 l~~~p~~RPs~~ell~~l~~~~ 334 (337)
T cd05054 313 WHNNPEDRPTFSELVEILGDLL 334 (337)
T ss_pred ccCChhhCcCHHHHHHHHHHHH
Confidence 987 999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=306.81 Aligned_cols=246 Identities=27% Similarity=0.376 Sum_probs=196.6
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCC-chhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEEe
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNS-LQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEY 431 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~ 431 (668)
++|+..++||+|++|.||+|.+..+++.||+|++.... ....+++.+|++++++++||||+++++.+...+..++||||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 35778899999999999999998889999999987653 34456789999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCCC
Q 005940 432 IPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGM 511 (668)
Q Consensus 432 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~~ 511 (668)
+++++|..+. .+++..+..++.|++.||.|||+ .+|+|+||||+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~- 149 (279)
T cd06619 81 MDGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWS---LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI- 149 (279)
T ss_pred CCCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHH---CCEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc-
Confidence 9999997653 36788899999999999999998 999999999999999999999999999998654322
Q ss_pred CcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchh-----HHHHHHHHHhcCccccccCcccC
Q 005940 512 PHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLL-----LVEWVRECHQLGRILDVADPLLN 586 (668)
Q Consensus 512 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~-----l~~~~~~~~~~~~~~~~~d~~l~ 586 (668)
.....++..|+|||++.+..++.++||||||+++|||++|+.||...... ...+.. ..... ..+.+.
T Consensus 150 --~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~-~~~~~-----~~~~~~ 221 (279)
T cd06619 150 --AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQ-CIVDE-----DPPVLP 221 (279)
T ss_pred --ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHH-HHhcc-----CCCCCC
Confidence 23357899999999999888999999999999999999999999642110 011111 11101 011111
Q ss_pred CcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 587 SSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 587 ~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
..... ..+..++..|++. |++||+++|++++
T Consensus 222 ~~~~~---~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 222 VGQFS---EKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred CCcCC---HHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 11111 2345666688887 9999999999986
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=315.07 Aligned_cols=259 Identities=27% Similarity=0.399 Sum_probs=203.6
Q ss_pred HhcCcccceeeeecCcEEEEEEEeCCC-----CcEEEEEEEecCC-chhHHHHHHHHHHHhcc-cccCceeEeeeecccC
Q 005940 351 ATKGFKESEVIGIGGFGSVYKGVLPTT-----GGEVAVKKITRNS-LQGMREFAAEIESLGRL-RHKNLVNLHGWCKQKN 423 (668)
Q Consensus 351 at~~f~~~~~lG~G~~g~Vy~~~~~~~-----~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~ 423 (668)
..++|+..+.||+|+||.||++.+... ...+|+|.+.... .+...++.+|++++.++ +|+||+++++++...+
T Consensus 10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 89 (293)
T cd05053 10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEG 89 (293)
T ss_pred CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCC
Confidence 345788899999999999999987533 3679999987542 34456788999999999 7999999999999999
Q ss_pred ceEEEEEecCCCChhhhhcCC-------------CCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEEC
Q 005940 424 DLLLVYEYIPNGSLDTLLFKP-------------KDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALID 490 (668)
Q Consensus 424 ~~~lV~E~~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~ 490 (668)
..+++|||+++|+|.+++... .....+++..++.++.|++.||.|||+ .+|+||||||+||+++
T Consensus 90 ~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivH~dlkp~Nil~~ 166 (293)
T cd05053 90 PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLAS---KKCIHRDLAARNVLVT 166 (293)
T ss_pred CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH---CCccccccceeeEEEc
Confidence 999999999999999998532 224568999999999999999999998 9999999999999999
Q ss_pred CCCCEEEEeecCceeccCCCCC-cccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHH
Q 005940 491 AEMNARLGDFGLARLYDHGGMP-HTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVAT-GRRPIGSGDLLLVEWV 568 (668)
Q Consensus 491 ~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~l~~~~ 568 (668)
.++.+||+|||+++........ ......++..|+|||.+.+..++.++|||||||++|||++ |..||...... + .
T Consensus 167 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--~-~ 243 (293)
T cd05053 167 EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE--E-L 243 (293)
T ss_pred CCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHH--H-H
Confidence 9999999999999876543221 1222345678999999988889999999999999999998 99998654321 1 1
Q ss_pred HHHHhcCccccccCcccCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhccC
Q 005940 569 RECHQLGRILDVADPLLNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSGE 624 (668)
Q Consensus 569 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~~ 624 (668)
........... . .......+..+...|+.. |++||+++|+++.|+..
T Consensus 244 ~~~~~~~~~~~-----~----~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~ 291 (293)
T cd05053 244 FKLLKEGYRME-----K----PQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM 291 (293)
T ss_pred HHHHHcCCcCC-----C----CCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHh
Confidence 11111111110 0 111123466777889987 99999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=306.00 Aligned_cols=246 Identities=28% Similarity=0.376 Sum_probs=192.4
Q ss_pred eeecCcEEEEEEEeCCCCcEEEEEEEecCCc---hhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEEecCCCCh
Q 005940 361 IGIGGFGSVYKGVLPTTGGEVAVKKITRNSL---QGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEYIPNGSL 437 (668)
Q Consensus 361 lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL 437 (668)
||+|+||.||++..+.+++.||+|++..... ...+.+..|++++++++||||+++++.+..+...++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 6999999999999988899999999865322 2234556799999999999999999999999999999999999999
Q ss_pred hhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCCCCccccc
Q 005940 438 DTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNV 517 (668)
Q Consensus 438 ~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~ 517 (668)
.+++.. .....+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.++|+|||++....... .....
T Consensus 81 ~~~~~~-~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~--~~~~~ 154 (277)
T cd05607 81 KYHIYN-VGERGLEMERVIHYSAQITCGILHLHS---MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK--TITQR 154 (277)
T ss_pred HHHHHh-ccccCCCHHHHHHHHHHHHHHHHHHHH---CCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc--eeecc
Confidence 988853 233458999999999999999999998 999999999999999999999999999998765432 22334
Q ss_pred ccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhH--HHHHHHHHhcCccccccCcccCCcccHHHHH
Q 005940 518 VGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLL--VEWVRECHQLGRILDVADPLLNSSYVVKEME 595 (668)
Q Consensus 518 ~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l--~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~ 595 (668)
.|+..|+|||++.+..++.++||||+||++|||++|+.||....... .+....... ..+ .. ....+. +
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~-~~~----~~-~~~~~~-~--- 224 (277)
T cd05607 155 AGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLE-DEV----KF-EHQNFT-E--- 224 (277)
T ss_pred CCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhc-ccc----cc-ccccCC-H---
Confidence 68999999999988889999999999999999999999997542211 111111111 110 00 001122 2
Q ss_pred HHHHHHhhcCCC-CCCCCCHHHHHHHhc
Q 005940 596 LVLKLGLMCSHK-TQFRPTMRQVMRYLS 622 (668)
Q Consensus 596 ~l~~l~~~C~~~-p~~RPs~~evl~~L~ 622 (668)
.+..+...|+.. |++||+++|+++.+.
T Consensus 225 ~~~~li~~~L~~~P~~R~~~~~~~~~~~ 252 (277)
T cd05607 225 ESKDICRLFLAKKPEDRLGSREKNDDPR 252 (277)
T ss_pred HHHHHHHHHhccCHhhCCCCccchhhhh
Confidence 244555678876 999999988765444
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=316.75 Aligned_cols=247 Identities=25% Similarity=0.314 Sum_probs=195.0
Q ss_pred CcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCC---chhHHHHHHHHHHHhcccc-cCceeEeeeecccCceEEEE
Q 005940 354 GFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNS---LQGMREFAAEIESLGRLRH-KNLVNLHGWCKQKNDLLLVY 429 (668)
Q Consensus 354 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H-~nIv~l~g~~~~~~~~~lV~ 429 (668)
+|+..+.||+|+||.||+|....+++.||||++.+.. ....+.+..|.+++..++| ++|+++++++...+..|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 4788999999999999999998888999999997542 2345678889999999976 56888999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCC
Q 005940 430 EYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHG 509 (668)
Q Consensus 430 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~ 509 (668)
||+++|+|.+++.. ...+++.++..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 81 E~~~~g~L~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05587 81 EYVNGGDLMYHIQQ---VGKFKEPHAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG 154 (324)
T ss_pred cCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEEcCCCCEEEeecCcceecCCC
Confidence 99999999999853 3458999999999999999999999 99999999999999999999999999998753322
Q ss_pred CCCcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCcccCCcc
Q 005940 510 GMPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSY 589 (668)
Q Consensus 510 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 589 (668)
. .......||..|+|||++.+..++.++|||||||++|||++|+.||...+.... ...... .. ..+....
T Consensus 155 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~--~~~i~~-~~------~~~~~~~ 224 (324)
T cd05587 155 G-KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDEL--FQSIME-HN------VSYPKSL 224 (324)
T ss_pred C-CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHH--HHHHHc-CC------CCCCCCC
Confidence 1 122345789999999999988899999999999999999999999976532211 111111 11 1111122
Q ss_pred cHHHHHHHHHHHhhcCCC-CCCCCCH-----HHHHHH
Q 005940 590 VVKEMELVLKLGLMCSHK-TQFRPTM-----RQVMRY 620 (668)
Q Consensus 590 ~~~~~~~l~~l~~~C~~~-p~~RPs~-----~evl~~ 620 (668)
+. .+..+...|++. |++||+. ++++++
T Consensus 225 ~~----~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 257 (324)
T cd05587 225 SK----EAVSICKGLLTKHPAKRLGCGPTGERDIREH 257 (324)
T ss_pred CH----HHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 22 234555677776 9999976 666654
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=311.21 Aligned_cols=263 Identities=30% Similarity=0.417 Sum_probs=198.0
Q ss_pred cccceeeeecCcEEEEEEEe----CCCCcEEEEEEEecCCc-hhHHHHHHHHHHHhcccccCceeEeeeeccc--CceEE
Q 005940 355 FKESEVIGIGGFGSVYKGVL----PTTGGEVAVKKITRNSL-QGMREFAAEIESLGRLRHKNLVNLHGWCKQK--NDLLL 427 (668)
Q Consensus 355 f~~~~~lG~G~~g~Vy~~~~----~~~~~~vavK~~~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~--~~~~l 427 (668)
|...+.||+|+||+||++.. ..++..||+|.+..... .....|.+|++++++++||||++++++|... ...++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL 85 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence 37789999999999988653 34677899999876533 3456788999999999999999999998653 35889
Q ss_pred EEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceecc
Q 005940 428 VYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYD 507 (668)
Q Consensus 428 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~ 507 (668)
||||+++++|.+++.. ..+++.+++.++.|++.||.|||+ .+|+||||||+||++++++.+||+|||+++...
T Consensus 86 v~e~~~~~~l~~~~~~----~~l~~~~~~~i~~~l~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~ 158 (283)
T cd05080 86 IMEYVPLGSLRDYLPK----HKLNLAQLLLFAQQICEGMAYLHS---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 158 (283)
T ss_pred EecCCCCCCHHHHHHH----cCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccChheEEEcCCCcEEEeecccccccC
Confidence 9999999999999953 349999999999999999999998 999999999999999999999999999998765
Q ss_pred CCCCC--cccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHH---hcCccccccC
Q 005940 508 HGGMP--HTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECH---QLGRILDVAD 582 (668)
Q Consensus 508 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~---~~~~~~~~~d 582 (668)
..... ......++..|+|||++.....+.++||||||+++|||++|+.|+........+...... ......+..+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (283)
T cd05080 159 EGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLE 238 (283)
T ss_pred CcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhh
Confidence 43221 112234566799999998888999999999999999999999998643221111110000 0001111111
Q ss_pred cccCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhccC
Q 005940 583 PLLNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSGE 624 (668)
Q Consensus 583 ~~l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~~ 624 (668)
..............+..+...|++. |++||++++|++.|+..
T Consensus 239 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~ 281 (283)
T cd05080 239 RGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM 281 (283)
T ss_pred cCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence 1111111111224566777789997 99999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=310.93 Aligned_cols=255 Identities=26% Similarity=0.358 Sum_probs=195.7
Q ss_pred HhcCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCch--------------hHHHHHHHHHHHhcccccCceeEe
Q 005940 351 ATKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQ--------------GMREFAAEIESLGRLRHKNLVNLH 416 (668)
Q Consensus 351 at~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--------------~~~~f~~Ei~~l~~l~H~nIv~l~ 416 (668)
.-+.|...+.||+|.||.|-+|....+++.||||++.+.... ..+...+|+.+|++|+|||||+|+
T Consensus 95 ~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~Li 174 (576)
T KOG0585|consen 95 QLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLI 174 (576)
T ss_pred ehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEE
Confidence 347899999999999999999999999999999999664221 135788999999999999999999
Q ss_pred eeeccc--CceEEEEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCC
Q 005940 417 GWCKQK--NDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMN 494 (668)
Q Consensus 417 g~~~~~--~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~ 494 (668)
....+. +.+|||+|||..|.+... ......++..+.++++++++.||.|||. ++|+||||||+|+||+++++
T Consensus 175 EvLDDP~s~~~YlVley~s~G~v~w~---p~d~~els~~~Ar~ylrDvv~GLEYLH~---QgiiHRDIKPsNLLl~~~g~ 248 (576)
T KOG0585|consen 175 EVLDDPESDKLYLVLEYCSKGEVKWC---PPDKPELSEQQARKYLRDVVLGLEYLHY---QGIIHRDIKPSNLLLSSDGT 248 (576)
T ss_pred EeecCcccCceEEEEEeccCCccccC---CCCcccccHHHHHHHHHHHHHHHHHHHh---cCeeccccchhheEEcCCCc
Confidence 998764 579999999998877543 2333449999999999999999999999 99999999999999999999
Q ss_pred EEEEeecCceeccCCCCC----cccccccCCcccCcccccCCC----CCcchhHHHHHHHHHHHHhCCCCCCCCchhHHH
Q 005940 495 ARLGDFGLARLYDHGGMP----HTTNVVGTFGYIAPELTQTGK----ASTSSDVFAYGILLLEVATGRRPIGSGDLLLVE 566 (668)
Q Consensus 495 ~kl~DfGla~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~----~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~ 566 (668)
+||+|||.+.....+... .....+||+.|+|||.+.++. ...+.||||+||.||.|+.|+.||-... .
T Consensus 249 VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~--~-- 324 (576)
T KOG0585|consen 249 VKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDF--E-- 324 (576)
T ss_pred EEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccch--H--
Confidence 999999999876433211 223468999999999887743 3678999999999999999999996531 1
Q ss_pred HHHHHHhcCccccccCcccCCcccHHHHHHHHHHHhhc-CCCCCCCCCHHHHHHHhc
Q 005940 567 WVRECHQLGRILDVADPLLNSSYVVKEMELVLKLGLMC-SHKTQFRPTMRQVMRYLS 622 (668)
Q Consensus 567 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C-~~~p~~RPs~~evl~~L~ 622 (668)
.+.+. .++...+.-...+++-+.+..|.+.+ .++|++|.+..+|..|.-
T Consensus 325 --~~l~~-----KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpw 374 (576)
T KOG0585|consen 325 --LELFD-----KIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPW 374 (576)
T ss_pred --HHHHH-----HHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecce
Confidence 11111 11112221111112223333333444 455999999999998864
|
|
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=313.76 Aligned_cols=257 Identities=30% Similarity=0.431 Sum_probs=199.9
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCc--EEEEEEEecC-CchhHHHHHHHHHHHhcc-cccCceeEeeeecccCceEEE
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGG--EVAVKKITRN-SLQGMREFAAEIESLGRL-RHKNLVNLHGWCKQKNDLLLV 428 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~--~vavK~~~~~-~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV 428 (668)
++|++.+.||+|+||.||+|.+..++. .+++|.+... .....+.|.+|++++.++ +||||+++++++...+..++|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 468889999999999999999876654 4788887643 334456789999999999 799999999999999999999
Q ss_pred EEecCCCChhhhhcCCC-------------CCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCE
Q 005940 429 YEYIPNGSLDTLLFKPK-------------DGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNA 495 (668)
Q Consensus 429 ~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~ 495 (668)
+||+++++|.+++.... ....+++.+++.++.|++.||+|||+ .+|+||||||+||++++++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSE---KQFIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCcCCcceEEECCCCeE
Confidence 99999999999995422 11358899999999999999999998 999999999999999999999
Q ss_pred EEEeecCceeccCCCCCcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHHHhc
Q 005940 496 RLGDFGLARLYDHGGMPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVAT-GRRPIGSGDLLLVEWVRECHQL 574 (668)
Q Consensus 496 kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~l~~~~~~~~~~ 574 (668)
||+|||++....... .......+..|+|||++....++.++|||||||++|||++ |..||...... +.......
T Consensus 159 kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~--~~~~~~~~- 233 (297)
T cd05089 159 KIADFGLSRGEEVYV--KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCA--ELYEKLPQ- 233 (297)
T ss_pred EECCcCCCcccccee--ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHHhc-
Confidence 999999987433211 1111233567999999988889999999999999999997 99999754321 11111111
Q ss_pred CccccccCcccCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhccCcC
Q 005940 575 GRILDVADPLLNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSGEKQ 626 (668)
Q Consensus 575 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~~~~ 626 (668)
+. .+.....++ ..+..++..|+.. |.+||+++++++.|+....
T Consensus 234 ~~-----~~~~~~~~~----~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~ 277 (297)
T cd05089 234 GY-----RMEKPRNCD----DEVYELMRQCWRDRPYERPPFAQISVQLSRMLE 277 (297)
T ss_pred CC-----CCCCCCCCC----HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 10 111111122 2355677789988 9999999999999876543
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=314.36 Aligned_cols=204 Identities=28% Similarity=0.374 Sum_probs=177.8
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCC---chhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEE
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNS---LQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVY 429 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 429 (668)
++|...++||+|+||.||++++..+++.||+|++.+.. ....+.+.+|+.++..++|+||+++++++.+.+..|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46889999999999999999998889999999987532 223456788999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCC
Q 005940 430 EYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHG 509 (668)
Q Consensus 430 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~ 509 (668)
||+++|+|.+++.. ....+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 81 Ey~~gg~L~~~l~~--~~~~l~~~~~~~~~~qi~~~L~~lH~---~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 155 (331)
T cd05624 81 DYYVGGDLLTLLSK--FEDRLPEDMARFYIAEMVLAIHSIHQ---LHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD 155 (331)
T ss_pred eCCCCCcHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence 99999999999963 23468999999999999999999998 99999999999999999999999999999876544
Q ss_pred CCCcccccccCCcccCcccccC-----CCCCcchhHHHHHHHHHHHHhCCCCCCCCc
Q 005940 510 GMPHTTNVVGTFGYIAPELTQT-----GKASTSSDVFAYGILLLEVATGRRPIGSGD 561 (668)
Q Consensus 510 ~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDV~S~Gvvl~elltG~~p~~~~~ 561 (668)
.........||..|+|||++.+ +.++.++|||||||++|||++|+.||...+
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~ 212 (331)
T cd05624 156 GTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAES 212 (331)
T ss_pred CceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCC
Confidence 3333334579999999998865 467889999999999999999999997543
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=320.23 Aligned_cols=248 Identities=27% Similarity=0.385 Sum_probs=202.9
Q ss_pred CcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCC---chhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEE
Q 005940 354 GFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNS---LQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYE 430 (668)
Q Consensus 354 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 430 (668)
-|...+-||.|+-|.|-+|++..+|+.+|||++.+.. ......+..|+-+|+-+.|||++++++.++++.++|||.|
T Consensus 13 pwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlE 92 (786)
T KOG0588|consen 13 PWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLE 92 (786)
T ss_pred ceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEE
Confidence 4666788999999999999999999999999997652 1233567789999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCC
Q 005940 431 YIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGG 510 (668)
Q Consensus 431 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~ 510 (668)
|+++|-|.++|- .++.+++.+..+++.||+.|+.|+|. .+|+||||||+|+|||.++++||+|||+|.....+.
T Consensus 93 yv~gGELFdylv---~kG~l~e~eaa~ff~QIi~gv~yCH~---~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gk 166 (786)
T KOG0588|consen 93 YVPGGELFDYLV---RKGPLPEREAAHFFRQILDGVSYCHA---FNICHRDLKPENLLLDVKNNIKIADFGMASLEVPGK 166 (786)
T ss_pred ecCCchhHHHHH---hhCCCCCHHHHHHHHHHHHHHHHHhh---hcceeccCCchhhhhhcccCEeeeccceeecccCCc
Confidence 999999999995 34669999999999999999999999 999999999999999999999999999999876665
Q ss_pred CCcccccccCCcccCcccccCCCC-CcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCcccCCcc
Q 005940 511 MPHTTNVVGTFGYIAPELTQTGKA-STSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSY 589 (668)
Q Consensus 511 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 589 (668)
.. ...||.+.|.+||++.+.+| ..++||||+|||||.|++|+.||+++. +... ....+.+.+. + ....
T Consensus 167 lL--eTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdN--ir~L-LlKV~~G~f~-M-----Ps~I 235 (786)
T KOG0588|consen 167 LL--ETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDN--IRVL-LLKVQRGVFE-M-----PSNI 235 (786)
T ss_pred cc--cccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCcc--HHHH-HHHHHcCccc-C-----CCcC
Confidence 43 34599999999999999887 689999999999999999999998543 2111 1222222211 1 1122
Q ss_pred cHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHh
Q 005940 590 VVKEMELVLKLGLMCSHKTQFRPTMRQVMRYL 621 (668)
Q Consensus 590 ~~~~~~~l~~l~~~C~~~p~~RPs~~evl~~L 621 (668)
..+.+.|+. .|..-+|+.|-+++||++|-
T Consensus 236 -s~eaQdLLr--~ml~VDp~~RiT~~eI~kHP 264 (786)
T KOG0588|consen 236 -SSEAQDLLR--RMLDVDPSTRITTEEILKHP 264 (786)
T ss_pred -CHHHHHHHH--HHhccCccccccHHHHhhCc
Confidence 233333333 24555699999999999974
|
|
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=311.73 Aligned_cols=256 Identities=26% Similarity=0.365 Sum_probs=200.1
Q ss_pred CcccceeeeecCcEEEEEEEeCC-----CCcEEEEEEEecCCc-hhHHHHHHHHHHHhcccccCceeEeeeecccCceEE
Q 005940 354 GFKESEVIGIGGFGSVYKGVLPT-----TGGEVAVKKITRNSL-QGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLL 427 (668)
Q Consensus 354 ~f~~~~~lG~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l 427 (668)
+|+..+.||+|+||.||+|+... ....+++|.+..... ...+++.+|+.+++.++||||+++++.|...+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 46778999999999999998642 225688888865543 345678999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhcCCC---------------------CCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCC
Q 005940 428 VYEYIPNGSLDTLLFKPK---------------------DGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSN 486 (668)
Q Consensus 428 V~E~~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~N 486 (668)
++||+++++|.+++.... ....+++.+++.++.|++.||.|||+ .+++||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~---~~ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAE---MKLVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHH---CCeehhhhhhhe
Confidence 999999999999985321 12358899999999999999999998 999999999999
Q ss_pred EEECCCCCEEEEeecCceeccCCCC-CcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCchhH
Q 005940 487 ALIDAEMNARLGDFGLARLYDHGGM-PHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVAT-GRRPIGSGDLLL 564 (668)
Q Consensus 487 Ill~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~l 564 (668)
|++++++.+||+|||+++....... .......++..|+|||.+.+..++.++||||||+++|||++ |+.||......
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~- 236 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE- 236 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHH-
Confidence 9999999999999999986533221 11222345678999999988889999999999999999998 99999654311
Q ss_pred HHHHHHHHhcCccccccCcccCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhccC
Q 005940 565 VEWVRECHQLGRILDVADPLLNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSGE 624 (668)
Q Consensus 565 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~~ 624 (668)
.+++....... ....... ...+..++..|+.. |++||+++|+++.|+..
T Consensus 237 --~~~~~~~~~~~-----~~~~~~~----~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~ 286 (290)
T cd05045 237 --RLFNLLKTGYR-----MERPENC----SEEMYNLMLTCWKQEPDKRPTFADISKELEKM 286 (290)
T ss_pred --HHHHHHhCCCC-----CCCCCCC----CHHHHHHHHHHccCCcccCCCHHHHHHHHHHH
Confidence 11222211110 1111111 13456777899987 99999999999999865
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=305.38 Aligned_cols=254 Identities=25% Similarity=0.429 Sum_probs=203.0
Q ss_pred cCcccceeeeecCcEEEEEEEeCCC-----CcEEEEEEEecCC-chhHHHHHHHHHHHhcccccCceeEeeeecccCceE
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTT-----GGEVAVKKITRNS-LQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLL 426 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~-----~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~ 426 (668)
++|.+.+.||+|+||.||+|..... +..||+|.+.... ......+.+|+.+++.++|+||+++++++......+
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~ 85 (277)
T cd05032 6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTL 85 (277)
T ss_pred HHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcE
Confidence 5788899999999999999987543 3789999986543 244567889999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhcCCC-------CCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEe
Q 005940 427 LVYEYIPNGSLDTLLFKPK-------DGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGD 499 (668)
Q Consensus 427 lV~E~~~~gsL~~~l~~~~-------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~D 499 (668)
+||||+++|+|.+++.... ....++|..++.++.|++.||.|||+ .+++||||||+||+++.++.+||+|
T Consensus 86 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~di~p~nill~~~~~~kl~d 162 (277)
T cd05032 86 VVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAA---KKFVHRDLAARNCMVAEDLTVKIGD 162 (277)
T ss_pred EEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccChheEEEcCCCCEEECC
Confidence 9999999999999986422 12357899999999999999999998 9999999999999999999999999
Q ss_pred ecCceeccCCCC-CcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCch-hHHHHHHHHHhcCc
Q 005940 500 FGLARLYDHGGM-PHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVAT-GRRPIGSGDL-LLVEWVRECHQLGR 576 (668)
Q Consensus 500 fGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~-~l~~~~~~~~~~~~ 576 (668)
||+++....... .......++..|+|||.+..+.++.++|||||||++|||++ |+.||...+. ...++. ....
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~----~~~~ 238 (277)
T cd05032 163 FGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFV----IDGG 238 (277)
T ss_pred cccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHH----hcCC
Confidence 999986544322 12233456789999999988889999999999999999998 9999865432 222211 1121
Q ss_pred cccccCcccCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhc
Q 005940 577 ILDVADPLLNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLS 622 (668)
Q Consensus 577 ~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~ 622 (668)
... ..... ...+..++..|++. |++||++.++++.|+
T Consensus 239 ~~~-----~~~~~----~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 239 HLD-----LPENC----PDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred CCC-----CCCCC----CHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 111 11112 23566777899987 999999999999886
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=303.20 Aligned_cols=254 Identities=26% Similarity=0.370 Sum_probs=192.1
Q ss_pred eeeeecCcEEEEEEEeCC--CCcEEEEEEEecCCc-hhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEEecCCC
Q 005940 359 EVIGIGGFGSVYKGVLPT--TGGEVAVKKITRNSL-QGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEYIPNG 435 (668)
Q Consensus 359 ~~lG~G~~g~Vy~~~~~~--~~~~vavK~~~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~g 435 (668)
+.||+|+||.||+|.+.. ++..+|+|+++.... .....+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 368999999999998643 345799998865442 33457889999999999999999999999999999999999999
Q ss_pred ChhhhhcCCC--CCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCCCC-
Q 005940 436 SLDTLLFKPK--DGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMP- 512 (668)
Q Consensus 436 sL~~~l~~~~--~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~~~- 512 (668)
+|.+++.... ....+++..+..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||+++........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK---NNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH---CCEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 9999996422 22356788888999999999999998 99999999999999999999999999999754432221
Q ss_pred cccccccCCcccCcccccCC-------CCCcchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHHHhcCccccccCcc
Q 005940 513 HTTNVVGTFGYIAPELTQTG-------KASTSSDVFAYGILLLEVAT-GRRPIGSGDLLLVEWVRECHQLGRILDVADPL 584 (668)
Q Consensus 513 ~~~~~~gt~~y~aPE~~~~~-------~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 584 (668)
......++..|+|||++... .++.++||||||+++|||++ |+.||......-. ... ..........++.
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~-~~~--~~~~~~~~~~~~~ 234 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQV-LTY--TVREQQLKLPKPR 234 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHH-HHH--HhhcccCCCCCCc
Confidence 12234567889999987542 35789999999999999996 9999965432111 111 1111122222333
Q ss_pred cCCcccHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhc
Q 005940 585 LNSSYVVKEMELVLKLGLMCSHKTQFRPTMRQVMRYLS 622 (668)
Q Consensus 585 l~~~~~~~~~~~l~~l~~~C~~~p~~RPs~~evl~~L~ 622 (668)
+..... ..+..+..+|+.+|++||+++||++.|+
T Consensus 235 ~~~~~~----~~~~~l~~~c~~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 235 LKLPLS----DRWYEVMQFCWLQPEQRPSAEEVHLLLS 268 (269)
T ss_pred cCCCCC----hHHHHHHHHHhcCcccCCCHHHHHHHhc
Confidence 322222 2344566688877999999999999875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=321.54 Aligned_cols=200 Identities=26% Similarity=0.415 Sum_probs=172.6
Q ss_pred CcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecC--CchhHHHHHHHHHHHhcccccCceeEeeeecccC-----ceE
Q 005940 354 GFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRN--SLQGMREFAAEIESLGRLRHKNLVNLHGWCKQKN-----DLL 426 (668)
Q Consensus 354 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~-----~~~ 426 (668)
+|+..++||+|+||.||++.+..+++.||||++... .....+++.+|+++++.++|+||+++++++.... ..|
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 477889999999999999999888999999998653 2234567889999999999999999999998766 789
Q ss_pred EEEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceec
Q 005940 427 LVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLY 506 (668)
Q Consensus 427 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~ 506 (668)
+|+||+. ++|.+.+.. ...+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++..
T Consensus 81 lv~e~~~-~~l~~~~~~---~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~ 153 (372)
T cd07853 81 VVTELMQ-SDLHKIIVS---PQPLSSDHVKVFLYQILRGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVE 153 (372)
T ss_pred EEeeccc-cCHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChHHEEECCCCCEEeccccceeec
Confidence 9999996 578777742 3468999999999999999999999 99999999999999999999999999999876
Q ss_pred cCCCCCcccccccCCcccCcccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 005940 507 DHGGMPHTTNVVGTFGYIAPELTQTG-KASTSSDVFAYGILLLEVATGRRPIGSG 560 (668)
Q Consensus 507 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDV~S~Gvvl~elltG~~p~~~~ 560 (668)
............++..|+|||++.+. .++.++|||||||++|||++|+.||...
T Consensus 154 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 208 (372)
T cd07853 154 EPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQ 208 (372)
T ss_pred ccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCC
Confidence 54433333345678999999988764 4789999999999999999999999754
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=310.87 Aligned_cols=250 Identities=24% Similarity=0.361 Sum_probs=202.6
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCchhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEEec
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEYI 432 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~ 432 (668)
.+|...+.||+|++|.||+|....+++.|++|.+........+.+.+|+.++++++|+||+++++.+......++||||+
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~ 99 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence 57888999999999999999988889999999998766666678899999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCCCC
Q 005940 433 PNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMP 512 (668)
Q Consensus 433 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~~~ 512 (668)
++++|.+++.. ..+++.++..++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||++........
T Consensus 100 ~~~~L~~~~~~----~~~~~~~~~~i~~ql~~aL~~LH~---~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~- 171 (296)
T cd06654 100 AGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS- 171 (296)
T ss_pred CCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCEEECccccchhcccccc-
Confidence 99999999842 348899999999999999999998 9999999999999999999999999999886543221
Q ss_pred cccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCcccCCcccHH
Q 005940 513 HTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSYVVK 592 (668)
Q Consensus 513 ~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 592 (668)
......++..|+|||.+.+...+.++|||||||++|||++|+.||...+.. ..+ ........ +.+. ....
T Consensus 172 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~-~~~-~~~~~~~~------~~~~--~~~~ 241 (296)
T cd06654 172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL-RAL-YLIATNGT------PELQ--NPEK 241 (296)
T ss_pred ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHH-HhH-HHHhcCCC------CCCC--Cccc
Confidence 122346888999999998888899999999999999999999999754321 111 11111110 1110 0111
Q ss_pred HHHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 593 EMELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 593 ~~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
-...+..+...|+.. |++||++++|+++
T Consensus 242 ~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 242 LSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred cCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 113355666788886 9999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=322.23 Aligned_cols=203 Identities=29% Similarity=0.398 Sum_probs=177.3
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCC---chhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEE
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNS---LQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVY 429 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 429 (668)
++|+..+.||+|+||.||++....+++.||+|++.... ......+..|+.++.+++|+||+++++.+.+.+..++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 36888999999999999999998899999999997532 234567888999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCC
Q 005940 430 EYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHG 509 (668)
Q Consensus 430 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~ 509 (668)
||+++|+|.+++.. ...+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 81 E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~~L~~lH~---~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~ 154 (360)
T cd05627 81 EFLPGGDMMTLLMK---KDTLSEEATQFYIAETVLAIDAIHQ---LGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKA 154 (360)
T ss_pred eCCCCccHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEccCCCHHHEEECCCCCEEEeeccCCcccccc
Confidence 99999999999953 3458999999999999999999999 99999999999999999999999999998754321
Q ss_pred CC----------------------------------CcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCC
Q 005940 510 GM----------------------------------PHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRR 555 (668)
Q Consensus 510 ~~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~ 555 (668)
.. ......+||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~ 234 (360)
T cd05627 155 HRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (360)
T ss_pred cccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCC
Confidence 10 00123479999999999999899999999999999999999999
Q ss_pred CCCCCc
Q 005940 556 PIGSGD 561 (668)
Q Consensus 556 p~~~~~ 561 (668)
||....
T Consensus 235 Pf~~~~ 240 (360)
T cd05627 235 PFCSET 240 (360)
T ss_pred CCCCCC
Confidence 997543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-36 Score=315.18 Aligned_cols=242 Identities=27% Similarity=0.325 Sum_probs=188.0
Q ss_pred eeeeecCcEEEEEEEeCCCCcEEEEEEEecCCc---hhHHHHHHHHH-HHhcccccCceeEeeeecccCceEEEEEecCC
Q 005940 359 EVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSL---QGMREFAAEIE-SLGRLRHKNLVNLHGWCKQKNDLLLVYEYIPN 434 (668)
Q Consensus 359 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~f~~Ei~-~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~ 434 (668)
++||+|+||.||+|++..+++.||+|++.+... ....++..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 469999999999999988899999999975432 22344555554 57889999999999999999999999999999
Q ss_pred CChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCCCCcc
Q 005940 435 GSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHT 514 (668)
Q Consensus 435 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 514 (668)
|+|..++.. ...+++.++..++.||+.||.|||+ .+|+||||||+||+++.++.+||+|||+++...... ...
T Consensus 81 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~~L~~lH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~ 153 (321)
T cd05603 81 GELFFHLQR---ERCFLEPRARFYAAEVASAIGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE-ETT 153 (321)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC-Ccc
Confidence 999988853 3458888999999999999999998 999999999999999999999999999987532221 123
Q ss_pred cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCcccCCcccHHHH
Q 005940 515 TNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSYVVKEM 594 (668)
Q Consensus 515 ~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 594 (668)
....||+.|+|||++.+..++.++|||||||++|||++|+.||...+.. ........ .. . .+.... .
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--~~~~~i~~-~~-~-----~~~~~~----~ 220 (321)
T cd05603 154 STFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVS--QMYDNILH-KP-L-----QLPGGK----T 220 (321)
T ss_pred ccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHH--HHHHHHhc-CC-C-----CCCCCC----C
Confidence 3457899999999998888999999999999999999999999765422 11111111 11 1 111111 1
Q ss_pred HHHHHHHhhcCCC-CCCCCCH----HHHHHH
Q 005940 595 ELVLKLGLMCSHK-TQFRPTM----RQVMRY 620 (668)
Q Consensus 595 ~~l~~l~~~C~~~-p~~RPs~----~evl~~ 620 (668)
..+..+...|++. |.+||+. .|++++
T Consensus 221 ~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~ 251 (321)
T cd05603 221 VAACDLLVGLLHKDQRRRLGAKADFLEIKNH 251 (321)
T ss_pred HHHHHHHHHHccCCHhhcCCCCCCHHHHhCC
Confidence 2345566678887 9999875 355543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-36 Score=315.79 Aligned_cols=242 Identities=26% Similarity=0.347 Sum_probs=192.9
Q ss_pred eeeeecCcEEEEEEEeCCCCcEEEEEEEecCC---chhHHHHHHHHHHHhcc-cccCceeEeeeecccCceEEEEEecCC
Q 005940 359 EVIGIGGFGSVYKGVLPTTGGEVAVKKITRNS---LQGMREFAAEIESLGRL-RHKNLVNLHGWCKQKNDLLLVYEYIPN 434 (668)
Q Consensus 359 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~E~~~~ 434 (668)
++||+|+||.||+|++..+++.||||++.+.. ....+.+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46999999999999998889999999997642 23445677899998876 799999999999999999999999999
Q ss_pred CChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCCCCcc
Q 005940 435 GSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHT 514 (668)
Q Consensus 435 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 514 (668)
|+|..++.. ...+++..+..++.||+.||.|||+ .+|+||||||+||+++.++.+||+|||+++....... ..
T Consensus 81 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~-~~ 153 (321)
T cd05591 81 GDLMFQIQR---SRKFDEPRSRFYAAEVTLALMFLHR---HGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV-TT 153 (321)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEeecccceecccCCc-cc
Confidence 999988853 3458999999999999999999999 9999999999999999999999999999986433221 22
Q ss_pred cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCcccCCcccHHHH
Q 005940 515 TNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSYVVKEM 594 (668)
Q Consensus 515 ~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 594 (668)
....||..|+|||++.+..++.++|||||||++|||++|+.||...+.. +....... ... ....... .
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~--~~~~~i~~-~~~------~~p~~~~-~-- 221 (321)
T cd05591 154 TTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNED--DLFESILH-DDV------LYPVWLS-K-- 221 (321)
T ss_pred cccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHH--HHHHHHHc-CCC------CCCCCCC-H--
Confidence 3457899999999999889999999999999999999999999765322 11111111 110 1111112 2
Q ss_pred HHHHHHHhhcCCC-CCCCC-------CHHHHHHH
Q 005940 595 ELVLKLGLMCSHK-TQFRP-------TMRQVMRY 620 (668)
Q Consensus 595 ~~l~~l~~~C~~~-p~~RP-------s~~evl~~ 620 (668)
.+..+...|+.. |++|| ++++++++
T Consensus 222 -~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 222 -EAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred -HHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 234455577776 99999 88888866
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-36 Score=306.71 Aligned_cols=254 Identities=24% Similarity=0.399 Sum_probs=198.1
Q ss_pred cccceeeeecCcEEEEEEEeCCCC---cEEEEEEEecCC--chhHHHHHHHHHHHhcccccCceeEeeeecccCc-----
Q 005940 355 FKESEVIGIGGFGSVYKGVLPTTG---GEVAVKKITRNS--LQGMREFAAEIESLGRLRHKNLVNLHGWCKQKND----- 424 (668)
Q Consensus 355 f~~~~~lG~G~~g~Vy~~~~~~~~---~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~----- 424 (668)
|...+.||+|+||.||+|.+..++ ..||+|++.... ....+.+.+|++.++.++|+||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 456789999999999999986433 689999987543 3345689999999999999999999999865544
Q ss_pred -eEEEEEecCCCChhhhhcCCC---CCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEee
Q 005940 425 -LLLVYEYIPNGSLDTLLFKPK---DGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDF 500 (668)
Q Consensus 425 -~~lV~E~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~Df 500 (668)
.++++||+++|+|..++.... ....+++..++.++.|++.||.|||+ .+++||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSN---RNFIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHh---CCeeccccchheEEECCCCeEEECCc
Confidence 799999999999999985322 23468999999999999999999998 99999999999999999999999999
Q ss_pred cCceeccCCCCC-cccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHHHhcCccc
Q 005940 501 GLARLYDHGGMP-HTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVAT-GRRPIGSGDLLLVEWVRECHQLGRIL 578 (668)
Q Consensus 501 Gla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~l~~~~~~~~~~~~~~ 578 (668)
|+++........ ......++..|+|||.+....++.++|||||||++|||++ |..||...+.. +....... +..
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~--~~~~~~~~-~~~- 233 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH--EIYDYLRH-GNR- 233 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHc-CCC-
Confidence 999876543321 1122345678999999988889999999999999999999 88888654321 11211111 111
Q ss_pred cccCcccCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhcc
Q 005940 579 DVADPLLNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSG 623 (668)
Q Consensus 579 ~~~d~~l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~ 623 (668)
......+ ...+..++..|+.. |++||++.||++.|+.
T Consensus 234 ----~~~~~~~----~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~ 271 (273)
T cd05035 234 ----LKQPEDC----LDELYDLMYSCWRADPKDRPTFTKLREVLEN 271 (273)
T ss_pred ----CCCCcCC----CHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence 1111112 23456666789887 9999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-36 Score=302.95 Aligned_cols=246 Identities=29% Similarity=0.429 Sum_probs=196.1
Q ss_pred eeeeecCcEEEEEEEeCCCCcEEEEEEEecCCc-hhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEEecCCCCh
Q 005940 359 EVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSL-QGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEYIPNGSL 437 (668)
Q Consensus 359 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL 437 (668)
++||+|+||.||+|... ++..+|+|++..... .....+.+|++++++++||||++++++|...+..++||||+++++|
T Consensus 1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 79 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDF 79 (250)
T ss_pred CccCCCCCceEEEEEec-CCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcH
Confidence 36899999999999874 678999999876543 3345788999999999999999999999999999999999999999
Q ss_pred hhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCCCCccccc
Q 005940 438 DTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNV 517 (668)
Q Consensus 438 ~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~ 517 (668)
.+++.. ....+++..++.++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++..............
T Consensus 80 ~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~---~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 154 (250)
T cd05085 80 LSFLRK--KKDELKTKQLVKFALDAAAGMAYLES---KNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLK 154 (250)
T ss_pred HHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccChheEEEcCCCeEEECCCccceeccccccccCCCC
Confidence 999853 23458999999999999999999998 9999999999999999999999999999986554332222223
Q ss_pred ccCCcccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHHHhcCccccccCcccCCcccHHHHHH
Q 005940 518 VGTFGYIAPELTQTGKASTSSDVFAYGILLLEVAT-GRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSYVVKEMEL 596 (668)
Q Consensus 518 ~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~ 596 (668)
.++..|+|||++.++.++.++||||||+++||+++ |..||....... ............ .... ....
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~---~~~~~~~~~~~~-----~~~~----~~~~ 222 (250)
T cd05085 155 QIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQ---AREQVEKGYRMS-----CPQK----CPDD 222 (250)
T ss_pred CCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHH---HHHHHHcCCCCC-----CCCC----CCHH
Confidence 44678999999988899999999999999999998 999996543221 111111111111 1111 1245
Q ss_pred HHHHHhhcCCC-CCCCCCHHHHHHHhc
Q 005940 597 VLKLGLMCSHK-TQFRPTMRQVMRYLS 622 (668)
Q Consensus 597 l~~l~~~C~~~-p~~RPs~~evl~~L~ 622 (668)
+..++..|+.. |++||++.|+++.|.
T Consensus 223 ~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 223 VYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred HHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 66777789887 999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=302.61 Aligned_cols=253 Identities=24% Similarity=0.378 Sum_probs=189.6
Q ss_pred eeeecCcEEEEEEEeCC--CCcEEEEEEEecCCc-hhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEEecCCCC
Q 005940 360 VIGIGGFGSVYKGVLPT--TGGEVAVKKITRNSL-QGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEYIPNGS 436 (668)
Q Consensus 360 ~lG~G~~g~Vy~~~~~~--~~~~vavK~~~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gs 436 (668)
.||+|+||.||+|.... ....+++|.+..... .....|.+|+++++.++|+||+++++.|......++||||+++|+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 58999999999997532 334788888765432 345678899999999999999999999999999999999999999
Q ss_pred hhhhhcCCCC--CCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCCC-Cc
Q 005940 437 LDTLLFKPKD--GSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGM-PH 513 (668)
Q Consensus 437 L~~~l~~~~~--~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~~-~~ 513 (668)
|.+++..... ....++...+.++.||+.||+|||+ ++|+||||||+||++++++.+||+|||+++....... ..
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (269)
T cd05042 82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ---ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT 158 (269)
T ss_pred HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHh---cCEecccccHhheEecCCCcEEEeccccccccccchheec
Confidence 9999964322 2345788889999999999999998 9999999999999999999999999999875433221 11
Q ss_pred ccccccCCcccCcccccC-------CCCCcchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHHHhcCccccccCccc
Q 005940 514 TTNVVGTFGYIAPELTQT-------GKASTSSDVFAYGILLLEVAT-GRRPIGSGDLLLVEWVRECHQLGRILDVADPLL 585 (668)
Q Consensus 514 ~~~~~gt~~y~aPE~~~~-------~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 585 (668)
.....++..|+|||++.. ..++.++|||||||++|||++ |..||....... -...... .......++.+
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~--~~~~~~~-~~~~~~~~~~~ 235 (269)
T cd05042 159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ--VLKQVVR-EQDIKLPKPQL 235 (269)
T ss_pred cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHH--HHHHHhh-ccCccCCCCcc
Confidence 122345678999998643 356789999999999999999 788886542211 1111111 11122223333
Q ss_pred CCcccHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhc
Q 005940 586 NSSYVVKEMELVLKLGLMCSHKTQFRPTMRQVMRYLS 622 (668)
Q Consensus 586 ~~~~~~~~~~~l~~l~~~C~~~p~~RPs~~evl~~L~ 622 (668)
...+. ..+..+..+|+.+|++||+++||++.|.
T Consensus 236 ~~~~~----~~~~~~~~~~~~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 236 DLKYS----DRWYEVMQFCWLDPETRPTAEEVHELLT 268 (269)
T ss_pred cccCC----HHHHHHHHHHhcCcccccCHHHHHHHhc
Confidence 22222 3344556688888999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=307.17 Aligned_cols=262 Identities=25% Similarity=0.351 Sum_probs=203.6
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCC----------------cEEEEEEEecCCc-hhHHHHHHHHHHHhcccccCceeE
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTG----------------GEVAVKKITRNSL-QGMREFAAEIESLGRLRHKNLVNL 415 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~----------------~~vavK~~~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l 415 (668)
.+|+..++||+|+||.||++.+...+ ..||+|++..... ...+++.+|++++++++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~ 84 (296)
T cd05051 5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARL 84 (296)
T ss_pred hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence 56888999999999999999875433 4589999876543 445788999999999999999999
Q ss_pred eeeecccCceEEEEEecCCCChhhhhcCCC--------CCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCE
Q 005940 416 HGWCKQKNDLLLVYEYIPNGSLDTLLFKPK--------DGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNA 487 (668)
Q Consensus 416 ~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~--------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NI 487 (668)
+++|..++..++++||+++++|.+++.... ....+++..++.++.|++.||+|||+ .+++||||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~---~~i~H~dlkp~Ni 161 (296)
T cd05051 85 LGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLES---LNFVHRDLATRNC 161 (296)
T ss_pred EEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHH---cCccccccchhce
Confidence 999999999999999999999999986432 12368999999999999999999998 9999999999999
Q ss_pred EECCCCCEEEEeecCceeccCCCC-CcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHh--CCCCCCCCc-hh
Q 005940 488 LIDAEMNARLGDFGLARLYDHGGM-PHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVAT--GRRPIGSGD-LL 563 (668)
Q Consensus 488 ll~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt--G~~p~~~~~-~~ 563 (668)
+++.++.++|+|||+++....... .......++..|+|||++..+.++.++|||||||++|||++ |..||.... ..
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~ 241 (296)
T cd05051 162 LVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQ 241 (296)
T ss_pred eecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChHH
Confidence 999999999999999986543322 12233456778999999988889999999999999999998 677876432 22
Q ss_pred HHHHHHHHHhcCccccccCcccCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhcc
Q 005940 564 LVEWVRECHQLGRILDVADPLLNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSG 623 (668)
Q Consensus 564 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~ 623 (668)
................... ........+..++..|+.. |++||++.||++.|+.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~------~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~ 296 (296)
T cd05051 242 VIENAGHFFRDDGRQIYLP------RPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR 296 (296)
T ss_pred HHHHHHhccccccccccCC------CccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence 2222222211111111110 0111123567778889887 9999999999999863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=319.32 Aligned_cols=243 Identities=24% Similarity=0.281 Sum_probs=193.6
Q ss_pred eeeeecCcEEEEEEEeCCCCcEEEEEEEecCC---chhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEEecCCC
Q 005940 359 EVIGIGGFGSVYKGVLPTTGGEVAVKKITRNS---LQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEYIPNG 435 (668)
Q Consensus 359 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~g 435 (668)
+.||+|+||.||++....++..||+|++.+.. ......+..|++++..++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999998899999999997642 234456788999999999999999999999999999999999999
Q ss_pred ChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCCCCccc
Q 005940 436 SLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTT 515 (668)
Q Consensus 436 sL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 515 (668)
+|..++.. ...+++.++..++.||+.||.|||+ ..+|+||||||+|||++.++.+||+|||+++...... ....
T Consensus 81 ~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~--~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~~~ 154 (325)
T cd05594 81 ELFFHLSR---ERVFSEDRARFYGAEIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG-ATMK 154 (325)
T ss_pred cHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh--cCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCC-cccc
Confidence 99998853 3468999999999999999999996 2699999999999999999999999999987543221 1223
Q ss_pred ccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCcccCCcccHHHHH
Q 005940 516 NVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSYVVKEME 595 (668)
Q Consensus 516 ~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~ 595 (668)
...||..|+|||++.+..++.++|||||||++|||++|+.||...+... .... ..... ..+......
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~--~~~~-i~~~~------~~~p~~~~~---- 221 (325)
T cd05594 155 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK--LFEL-ILMEE------IRFPRTLSP---- 221 (325)
T ss_pred cccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHH--HHHH-HhcCC------CCCCCCCCH----
Confidence 3579999999999998899999999999999999999999997543211 1111 11111 111122222
Q ss_pred HHHHHHhhcCCC-CCCCC-----CHHHHHHH
Q 005940 596 LVLKLGLMCSHK-TQFRP-----TMRQVMRY 620 (668)
Q Consensus 596 ~l~~l~~~C~~~-p~~RP-----s~~evl~~ 620 (668)
.+..+...|+.. |++|+ ++++++++
T Consensus 222 ~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 222 EAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred HHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 234455577776 99996 99999876
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=314.49 Aligned_cols=204 Identities=28% Similarity=0.375 Sum_probs=176.7
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCC---chhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEE
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNS---LQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVY 429 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 429 (668)
++|...++||+|+||.||+++++.+++.+|+|++.+.. ....+.+..|+.++..++|+||+++++.+.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 46888999999999999999998889999999986532 223345888999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCC
Q 005940 430 EYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHG 509 (668)
Q Consensus 430 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~ 509 (668)
||+++|+|.+++.+ ....+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||++......
T Consensus 81 ey~~~g~L~~~l~~--~~~~l~~~~~~~~~~qi~~al~~lH~---~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~ 155 (332)
T cd05623 81 DYYVGGDLLTLLSK--FEDRLPEDMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMED 155 (332)
T ss_pred eccCCCcHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEECCCCCEEEeecchheecccC
Confidence 99999999999963 23468999999999999999999999 99999999999999999999999999999765443
Q ss_pred CCCcccccccCCcccCccccc-----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCc
Q 005940 510 GMPHTTNVVGTFGYIAPELTQ-----TGKASTSSDVFAYGILLLEVATGRRPIGSGD 561 (668)
Q Consensus 510 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~ 561 (668)
.........||+.|+|||++. .+.++.++|||||||++|||++|+.||...+
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~ 212 (332)
T cd05623 156 GTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAES 212 (332)
T ss_pred CcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCC
Confidence 332333457999999999886 3467899999999999999999999997543
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=305.45 Aligned_cols=254 Identities=29% Similarity=0.401 Sum_probs=198.9
Q ss_pred HHhcCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCchhHHHHHHHHHHHhcc-cccCceeEeeeeccc------
Q 005940 350 AATKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRL-RHKNLVNLHGWCKQK------ 422 (668)
Q Consensus 350 ~at~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~------ 422 (668)
.++..|+..+.||+|+||.||+|....+++.||+|++.... ....++.+|+.++.++ +|+||+++++++...
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 45677888999999999999999998889999999987654 3346788999999998 699999999998643
Q ss_pred CceEEEEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecC
Q 005940 423 NDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGL 502 (668)
Q Consensus 423 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGl 502 (668)
...++||||+++++|.+++... ....+++..+..++.|++.||+|||+ .+|+||||||+||++++++.+||+|||+
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~LH~---~~ivh~dl~~~nili~~~~~~~l~Dfg~ 157 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGV 157 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHEEECCCCCEEEccCCC
Confidence 4589999999999999998642 24568999999999999999999999 9999999999999999999999999999
Q ss_pred ceeccCCCCCcccccccCCcccCccccc-----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCcc
Q 005940 503 ARLYDHGGMPHTTNVVGTFGYIAPELTQ-----TGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRI 577 (668)
Q Consensus 503 a~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~ 577 (668)
++...... .......|+..|+|||++. ...++.++|||||||++|||++|+.||...+..... .. ... ..
T Consensus 158 ~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~-~~-~~~-~~- 232 (272)
T cd06637 158 SAQLDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRAL-FL-IPR-NP- 232 (272)
T ss_pred ceeccccc-ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHH-HH-Hhc-CC-
Confidence 98764332 2233457889999999885 335788999999999999999999999654321111 11 011 10
Q ss_pred ccccCcccCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 578 LDVADPLLNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 578 ~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
.+.+..... ...+..+...|+.. |.+||+++|++++
T Consensus 233 ----~~~~~~~~~---~~~~~~li~~~l~~~p~~Rpt~~~il~~ 269 (272)
T cd06637 233 ----APRLKSKKW---SKKFQSFIESCLVKNHSQRPTTEQLMKH 269 (272)
T ss_pred ----CCCCCCCCc---CHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence 111111111 12355666788886 9999999999874
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=301.67 Aligned_cols=254 Identities=25% Similarity=0.388 Sum_probs=196.3
Q ss_pred ccceeeeecCcEEEEEEEeCCCCc--EEEEEEEecC--CchhHHHHHHHHHHHhcccccCceeEeeeeccc------Cce
Q 005940 356 KESEVIGIGGFGSVYKGVLPTTGG--EVAVKKITRN--SLQGMREFAAEIESLGRLRHKNLVNLHGWCKQK------NDL 425 (668)
Q Consensus 356 ~~~~~lG~G~~g~Vy~~~~~~~~~--~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~------~~~ 425 (668)
.+.++||+|+||.||+|.+..++. .+|+|.+... .....+.+..|++++++++|+||++++++|... ...
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 81 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP 81 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence 457889999999999999866654 6999988654 334567889999999999999999999987432 246
Q ss_pred EEEEEecCCCChhhhhcCC---CCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecC
Q 005940 426 LLVYEYIPNGSLDTLLFKP---KDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGL 502 (668)
Q Consensus 426 ~lV~E~~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGl 502 (668)
++++||+++|+|.+++... .....+++..+..++.|++.||+|||+ .+|+||||||+||++++++.+||+|||+
T Consensus 82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~ 158 (272)
T cd05075 82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSS---KSFIHRDLAARNCMLNENMNVCVADFGL 158 (272)
T ss_pred EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhheEEcCCCCEEECCCCc
Confidence 8999999999999887422 123458999999999999999999998 9999999999999999999999999999
Q ss_pred ceeccCCCCCc-ccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHHHhcCccccc
Q 005940 503 ARLYDHGGMPH-TTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVAT-GRRPIGSGDLLLVEWVRECHQLGRILDV 580 (668)
Q Consensus 503 a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~l~~~~~~~~~~~~~~~~ 580 (668)
++......... .....++..|+|||+.....++.++|||||||++|||++ |+.||...+.. +. .+....+....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--~~-~~~~~~~~~~~- 234 (272)
T cd05075 159 SKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENS--EI-YDYLRQGNRLK- 234 (272)
T ss_pred ccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHH--HH-HHHHHcCCCCC-
Confidence 98765432211 122345678999999998889999999999999999999 88898653221 11 12222221111
Q ss_pred cCcccCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhccC
Q 005940 581 ADPLLNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSGE 624 (668)
Q Consensus 581 ~d~~l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~~ 624 (668)
....+ ...+..++..|++. |++||++.+|++.|+..
T Consensus 235 ----~~~~~----~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 235 ----QPPDC----LDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred ----CCCCC----CHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 11111 23356777789887 99999999999998753
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-36 Score=316.96 Aligned_cols=245 Identities=26% Similarity=0.312 Sum_probs=194.8
Q ss_pred eeeeecCcEEEEEEEeCCCCcEEEEEEEecCC---chhHHHHHHHHHHHhcc-cccCceeEeeeecccCceEEEEEecCC
Q 005940 359 EVIGIGGFGSVYKGVLPTTGGEVAVKKITRNS---LQGMREFAAEIESLGRL-RHKNLVNLHGWCKQKNDLLLVYEYIPN 434 (668)
Q Consensus 359 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~E~~~~ 434 (668)
++||+|+||.||++.+..+++.||||++.+.. ....+.+..|..++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46999999999999998899999999997642 23445688899999998 699999999999999999999999999
Q ss_pred CChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCCCCcc
Q 005940 435 GSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHT 514 (668)
Q Consensus 435 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 514 (668)
|+|.+++.. ...+++..+..++.||+.||.|||+ .+|+||||||+||+++.++.+||+|||+++...... ...
T Consensus 81 g~L~~~~~~---~~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~-~~~ 153 (329)
T cd05588 81 GDLMFHMQR---QRKLPEEHARFYSAEISLALNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG-DTT 153 (329)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEECcCccccccccCC-Ccc
Confidence 999988853 3469999999999999999999998 999999999999999999999999999987532211 122
Q ss_pred cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC------chhHHHHHHHHHhcCccccccCcccCCc
Q 005940 515 TNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSG------DLLLVEWVRECHQLGRILDVADPLLNSS 588 (668)
Q Consensus 515 ~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~------~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 588 (668)
....||..|+|||++.+..++.++|||||||++|||++|+.||... .....++..+....... .+...
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~------~~p~~ 227 (329)
T cd05588 154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQI------RIPRS 227 (329)
T ss_pred ccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCC------CCCCC
Confidence 3457899999999999889999999999999999999999999631 11222333333322211 11122
Q ss_pred ccHHHHHHHHHHHhhcCCC-CCCCCC------HHHHHHH
Q 005940 589 YVVKEMELVLKLGLMCSHK-TQFRPT------MRQVMRY 620 (668)
Q Consensus 589 ~~~~~~~~l~~l~~~C~~~-p~~RPs------~~evl~~ 620 (668)
.. ..+..+...|+.. |.+||+ +++++++
T Consensus 228 ~~----~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05588 228 LS----VKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH 262 (329)
T ss_pred CC----HHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence 22 2234555677776 999987 7788765
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=314.82 Aligned_cols=247 Identities=24% Similarity=0.322 Sum_probs=195.1
Q ss_pred CcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCc---hhHHHHHHHHHHHhcc-cccCceeEeeeecccCceEEEE
Q 005940 354 GFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSL---QGMREFAAEIESLGRL-RHKNLVNLHGWCKQKNDLLLVY 429 (668)
Q Consensus 354 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~ 429 (668)
+|+..+.||+|+||.||+|.+..+++.||||++.+... ...+.+..|.+++..+ +|++|+++++++...+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 47788999999999999999988899999999976432 2334567788888877 5899999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCC
Q 005940 430 EYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHG 509 (668)
Q Consensus 430 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~ 509 (668)
||+++|+|.+++.. ...+++.++..++.||+.||.|||+ .+|+||||||+|||+++++.+||+|||+++.....
T Consensus 81 E~~~~g~L~~~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~ 154 (323)
T cd05616 81 EYVNGGDLMYQIQQ---VGRFKEPHAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD 154 (323)
T ss_pred cCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCEEecCCCHHHeEECCCCcEEEccCCCceecCCC
Confidence 99999999998853 3458999999999999999999998 99999999999999999999999999999754322
Q ss_pred CCCcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCcccCCcc
Q 005940 510 GMPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSY 589 (668)
Q Consensus 510 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 589 (668)
.. ......||+.|+|||++.++.++.++|||||||++|||++|+.||...+.... ...... .. ..+....
T Consensus 155 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~--~~~i~~-~~------~~~p~~~ 224 (323)
T cd05616 155 GV-TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL--FQSIME-HN------VAYPKSM 224 (323)
T ss_pred CC-ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHH--HHHHHh-CC------CCCCCcC
Confidence 21 22345789999999999999999999999999999999999999976542211 111111 11 1111122
Q ss_pred cHHHHHHHHHHHhhcCCC-CCCCCCH-----HHHHHH
Q 005940 590 VVKEMELVLKLGLMCSHK-TQFRPTM-----RQVMRY 620 (668)
Q Consensus 590 ~~~~~~~l~~l~~~C~~~-p~~RPs~-----~evl~~ 620 (668)
. ..+..+...|++. |++|++. ++++++
T Consensus 225 s----~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h 257 (323)
T cd05616 225 S----KEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 257 (323)
T ss_pred C----HHHHHHHHHHcccCHHhcCCCCCCCHHHHhcC
Confidence 2 2344556678776 9999984 677654
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=307.09 Aligned_cols=260 Identities=27% Similarity=0.403 Sum_probs=199.6
Q ss_pred cCcccceeeeecCcEEEEEEEeCCC--------------CcEEEEEEEecCC-chhHHHHHHHHHHHhcccccCceeEee
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTT--------------GGEVAVKKITRNS-LQGMREFAAEIESLGRLRHKNLVNLHG 417 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~--------------~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g 417 (668)
++|+..++||+|+||.||++..... ...||+|++.... ......|.+|++++++++|+|++++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 4788899999999999999987432 2358999987643 334567999999999999999999999
Q ss_pred eecccCceEEEEEecCCCChhhhhcCCC---------CCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEE
Q 005940 418 WCKQKNDLLLVYEYIPNGSLDTLLFKPK---------DGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNAL 488 (668)
Q Consensus 418 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~---------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIl 488 (668)
++...+..++||||+++++|.+++.... ....+++..++.++.|++.||+|||+ .+++||||||+||+
T Consensus 85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~Nil 161 (295)
T cd05097 85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLAS---LNFVHRDLATRNCL 161 (295)
T ss_pred EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHh---cCeeccccChhhEE
Confidence 9999999999999999999999985321 11247899999999999999999998 99999999999999
Q ss_pred ECCCCCEEEEeecCceeccCCCCC-cccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHh--CCCCCCCCc-hhH
Q 005940 489 IDAEMNARLGDFGLARLYDHGGMP-HTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVAT--GRRPIGSGD-LLL 564 (668)
Q Consensus 489 l~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt--G~~p~~~~~-~~l 564 (668)
+++++.+||+|||++......... ......++..|+|||++..+.++.++|||||||++|||++ |..||.... ...
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~ 241 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQV 241 (295)
T ss_pred EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHHH
Confidence 999999999999999765433211 1222345678999999988899999999999999999998 566775432 222
Q ss_pred HHHHHHHHhc-CccccccCcccCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhc
Q 005940 565 VEWVRECHQL-GRILDVADPLLNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLS 622 (668)
Q Consensus 565 ~~~~~~~~~~-~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~ 622 (668)
.....+.... ........+.. ....+.+++.+|+.. |++||+|++|++.|+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~-------~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 242 IENTGEFFRNQGRQIYLSQTPL-------CPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred HHHHHHhhhhccccccCCCCCC-------CCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 2222221111 11111111111 113567788899997 999999999999986
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-36 Score=319.94 Aligned_cols=203 Identities=28% Similarity=0.430 Sum_probs=180.7
Q ss_pred HhcCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCc---hhHHHHHHHHHHHhcc-cccCceeEeeeecccCceE
Q 005940 351 ATKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSL---QGMREFAAEIESLGRL-RHKNLVNLHGWCKQKNDLL 426 (668)
Q Consensus 351 at~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~ 426 (668)
.-++|...++||+|.||+|+++.++.+++.+|||+++++.. ...+..+.|.+++... +||.+++++..++.+.++|
T Consensus 366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~ 445 (694)
T KOG0694|consen 366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLF 445 (694)
T ss_pred cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEE
Confidence 34689999999999999999999999999999999988754 4456777888888877 4999999999999999999
Q ss_pred EEEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceec
Q 005940 427 LVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLY 506 (668)
Q Consensus 427 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~ 506 (668)
+||||+.||++..+.+ ...+++..+.-++..|+.||+|||+ ++|||||||.+|||||.+|.+||+|||+++..
T Consensus 446 fvmey~~Ggdm~~~~~----~~~F~e~rarfyaAev~l~L~fLH~---~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~ 518 (694)
T KOG0694|consen 446 FVMEYVAGGDLMHHIH----TDVFSEPRARFYAAEVVLGLQFLHE---NGIIYRDLKLDNLLLDTEGHVKIADFGLCKEG 518 (694)
T ss_pred EEEEecCCCcEEEEEe----cccccHHHHHHHHHHHHHHHHHHHh---cCceeeecchhheEEcccCcEEeccccccccc
Confidence 9999999999554442 3569999999999999999999999 99999999999999999999999999999854
Q ss_pred cCCCCCcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCc
Q 005940 507 DHGGMPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGD 561 (668)
Q Consensus 507 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~ 561 (668)
-.. ...+...+||+.|||||++.++.|+...|.|+|||+||||+.|..||.+++
T Consensus 519 m~~-g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gdd 572 (694)
T KOG0694|consen 519 MGQ-GDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDD 572 (694)
T ss_pred CCC-CCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCC
Confidence 321 224667899999999999999999999999999999999999999998654
|
|
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=305.83 Aligned_cols=255 Identities=27% Similarity=0.394 Sum_probs=200.7
Q ss_pred cCcccceeeeecCcEEEEEEEeC-----CCCcEEEEEEEecCCchhHHHHHHHHHHHhcccccCceeEeeeecccCceEE
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLP-----TTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLL 427 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l 427 (668)
+++...++||+|+||.||++... .++..+|+|.+........+.|.+|++++++++|+||+++++++......++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 45677899999999999999742 2456899999887766667889999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhcCCCC------------CCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCE
Q 005940 428 VYEYIPNGSLDTLLFKPKD------------GSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNA 495 (668)
Q Consensus 428 V~E~~~~gsL~~~l~~~~~------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~ 495 (668)
+|||+++++|.+++..... ...+++..++.++.|++.||+|||+ .+++||||||+||++++++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~~i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLAS---LHFVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHH---CCeecccccHhhEEEcCCCCE
Confidence 9999999999999864321 1358999999999999999999998 999999999999999999999
Q ss_pred EEEeecCceeccCCCCC-cccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHHHh
Q 005940 496 RLGDFGLARLYDHGGMP-HTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVAT-GRRPIGSGDLLLVEWVRECHQ 573 (668)
Q Consensus 496 kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~l~~~~~~~~~ 573 (668)
||+|||+++........ ......++..|+|||.+.+..++.++|||||||++|||++ |..||...... +.......
T Consensus 162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--~~~~~~~~ 239 (280)
T cd05092 162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNT--EAIECITQ 239 (280)
T ss_pred EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHH--HHHHHHHc
Confidence 99999999865432211 1122345678999999988889999999999999999998 89998643221 11111111
Q ss_pred cCccccccCcccCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhc
Q 005940 574 LGRILDVADPLLNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLS 622 (668)
Q Consensus 574 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~ 622 (668)
.... .....++ ..+..+...|++. |++||+++||.+.|+
T Consensus 240 -~~~~-----~~~~~~~----~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 240 -GREL-----ERPRTCP----PEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred -CccC-----CCCCCCC----HHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 1111 1111122 2345666789887 999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=313.21 Aligned_cols=241 Identities=24% Similarity=0.363 Sum_probs=189.9
Q ss_pred eeeeecCcEEEEEEEeCCCCcEEEEEEEecCC---chhHHHHHHHHHHHhcc-cccCceeEeeeecccCceEEEEEecCC
Q 005940 359 EVIGIGGFGSVYKGVLPTTGGEVAVKKITRNS---LQGMREFAAEIESLGRL-RHKNLVNLHGWCKQKNDLLLVYEYIPN 434 (668)
Q Consensus 359 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~E~~~~ 434 (668)
+.||+|+||.||+|.+..+++.||||++.... ....+.+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999998889999999997642 23345566788888764 899999999999999999999999999
Q ss_pred CChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCCCCcc
Q 005940 435 GSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHT 514 (668)
Q Consensus 435 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 514 (668)
|+|.+++.. ...+++.++..++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||+++...... ...
T Consensus 81 g~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~LH~---~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~ 153 (316)
T cd05619 81 GDLMFHIQS---CHKFDLPRATFYAAEIICGLQFLHS---KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD-AKT 153 (316)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCC-Cce
Confidence 999999853 3458999999999999999999998 999999999999999999999999999987543222 122
Q ss_pred cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCcccCCcccHHHH
Q 005940 515 TNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSYVVKEM 594 (668)
Q Consensus 515 ~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 594 (668)
....||..|+|||++.+..++.++|||||||++|||++|+.||...+.. +.... ..... +....... .
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~--~~~~~-i~~~~------~~~~~~~~-~-- 221 (316)
T cd05619 154 CTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEE--ELFQS-IRMDN------PCYPRWLT-R-- 221 (316)
T ss_pred eeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHH--HHHHH-HHhCC------CCCCccCC-H--
Confidence 3457899999999999888999999999999999999999999754321 11111 11111 11111122 2
Q ss_pred HHHHHHHhhcCCC-CCCCCCHH-HHHH
Q 005940 595 ELVLKLGLMCSHK-TQFRPTMR-QVMR 619 (668)
Q Consensus 595 ~~l~~l~~~C~~~-p~~RPs~~-evl~ 619 (668)
.+..+...|++. |++||++. ++++
T Consensus 222 -~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 222 -EAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred -HHHHHHHHHhccCHhhcCCChHHHHc
Confidence 233445577776 99999997 6655
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-36 Score=307.06 Aligned_cols=253 Identities=30% Similarity=0.497 Sum_probs=200.4
Q ss_pred CcccceeeeecCcEEEEEEEeCCCCc---EEEEEEEecC-CchhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEE
Q 005940 354 GFKESEVIGIGGFGSVYKGVLPTTGG---EVAVKKITRN-SLQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVY 429 (668)
Q Consensus 354 ~f~~~~~lG~G~~g~Vy~~~~~~~~~---~vavK~~~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 429 (668)
.|+..+.||+|+||.||+|.+..+++ .||||.+... .....++|..|+.++++++||||+++++++..+...++||
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 84 (269)
T cd05065 5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIIT 84 (269)
T ss_pred HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEE
Confidence 46778999999999999999876554 5999998764 3345678999999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCC
Q 005940 430 EYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHG 509 (668)
Q Consensus 430 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~ 509 (668)
||+++++|.+++.. ....+++.+++.++.|++.||.|||+ .+++||||||+||+++.++.+||+|||+++.....
T Consensus 85 e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~~l~~al~~lH~---~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 159 (269)
T cd05065 85 EFMENGALDSFLRQ--NDGQFTVIQLVGMLRGIAAGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 159 (269)
T ss_pred ecCCCCcHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccChheEEEcCCCcEEECCCccccccccC
Confidence 99999999999953 23568999999999999999999998 99999999999999999999999999998866443
Q ss_pred CCCcc-cc-cc--cCCcccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCch-hHHHHHHHHHhcCccccccCc
Q 005940 510 GMPHT-TN-VV--GTFGYIAPELTQTGKASTSSDVFAYGILLLEVAT-GRRPIGSGDL-LLVEWVRECHQLGRILDVADP 583 (668)
Q Consensus 510 ~~~~~-~~-~~--gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~-~l~~~~~~~~~~~~~~~~~d~ 583 (668)
..... .. .. .+..|+|||++..+.++.++|||||||++|||++ |..||...+. ...+++. ..... +
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~---~~~~~-----~ 231 (269)
T cd05065 160 TSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIE---QDYRL-----P 231 (269)
T ss_pred ccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHH---cCCcC-----C
Confidence 22111 11 11 2457999999998899999999999999999886 9999965432 2222221 11010 0
Q ss_pred ccCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhccC
Q 005940 584 LLNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSGE 624 (668)
Q Consensus 584 ~l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~~ 624 (668)
....+ ...+..++..|+.. |++||++++|++.|+..
T Consensus 232 -~~~~~----~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 232 -PPMDC----PTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred -CcccC----CHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 01111 23356677789987 99999999999998753
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=310.56 Aligned_cols=255 Identities=26% Similarity=0.389 Sum_probs=200.5
Q ss_pred CcccceeeeecCcEEEEEEEeCC-----CCcEEEEEEEecCCch-hHHHHHHHHHHHhcccccCceeEeeeecccCceEE
Q 005940 354 GFKESEVIGIGGFGSVYKGVLPT-----TGGEVAVKKITRNSLQ-GMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLL 427 (668)
Q Consensus 354 ~f~~~~~lG~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~-~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l 427 (668)
.|+..+.||+|+||.||+|.+.. .+..||+|++...... ..+.+.+|+.++.+++||||+++++++......++
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~ 85 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM 85 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence 46678899999999999998743 2468999999765433 34678899999999999999999999999999999
Q ss_pred EEEecCCCChhhhhcCCC-------------CCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCC
Q 005940 428 VYEYIPNGSLDTLLFKPK-------------DGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMN 494 (668)
Q Consensus 428 V~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~ 494 (668)
++||+++++|.+++.... ....+++..+++++.|++.||.|||+ .+|+||||||+||++++++.
T Consensus 86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~---~gi~H~dlkp~Nil~~~~~~ 162 (283)
T cd05091 86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSS---HHVVHKDLATRNVLVFDKLN 162 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH---cCccccccchhheEecCCCc
Confidence 999999999999984221 12358899999999999999999998 99999999999999999999
Q ss_pred EEEEeecCceeccCCCC-CcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHHH
Q 005940 495 ARLGDFGLARLYDHGGM-PHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVAT-GRRPIGSGDLLLVEWVRECH 572 (668)
Q Consensus 495 ~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~l~~~~~~~~ 572 (668)
+||+|||+++....... .......+++.|+|||.+..+.++.++|||||||++|||++ |..||..... .++.....
T Consensus 163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~--~~~~~~i~ 240 (283)
T cd05091 163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN--QDVIEMIR 240 (283)
T ss_pred eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHHH
Confidence 99999999886543321 11223345778999999988889999999999999999998 8888865432 22222222
Q ss_pred hcCccccccCcccCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhcc
Q 005940 573 QLGRILDVADPLLNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSG 623 (668)
Q Consensus 573 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~ 623 (668)
. ..... ....+. ..+..+...|++. |++||++++|++.|+.
T Consensus 241 ~-~~~~~-----~~~~~~----~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 241 N-RQVLP-----CPDDCP----AWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred c-CCcCC-----CCCCCC----HHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 2 11111 111222 3356777799988 9999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-36 Score=315.66 Aligned_cols=242 Identities=26% Similarity=0.341 Sum_probs=192.0
Q ss_pred eeeeecCcEEEEEEEeCCCCcEEEEEEEecCC---chhHHHHHHHHHHHhcc-cccCceeEeeeecccCceEEEEEecCC
Q 005940 359 EVIGIGGFGSVYKGVLPTTGGEVAVKKITRNS---LQGMREFAAEIESLGRL-RHKNLVNLHGWCKQKNDLLLVYEYIPN 434 (668)
Q Consensus 359 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~E~~~~ 434 (668)
++||+|+||.||+|.++.+++.||||++.+.. ....+.+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999998889999999997542 23446677888888876 699999999999999999999999999
Q ss_pred CChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCCCCcc
Q 005940 435 GSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHT 514 (668)
Q Consensus 435 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 514 (668)
|+|.+++.. ...+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 g~L~~~i~~---~~~l~~~~~~~~~~ql~~~L~~lH~---~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~-~~~ 153 (320)
T cd05590 81 GDLMFHIQK---SRRFDEARARFYAAEITSALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG-KTT 153 (320)
T ss_pred chHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC-Ccc
Confidence 999998853 3458999999999999999999998 999999999999999999999999999987543222 122
Q ss_pred cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCcccCCcccHHHH
Q 005940 515 TNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSYVVKEM 594 (668)
Q Consensus 515 ~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 594 (668)
....||+.|+|||++.+..++.++|||||||++|||++|+.||...+.. +..... ..... ......+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~--~~~~~i-~~~~~------~~~~~~~---- 220 (320)
T cd05590 154 STFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENED--DLFEAI-LNDEV------VYPTWLS---- 220 (320)
T ss_pred cccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH--HHHHHH-hcCCC------CCCCCCC----
Confidence 3457899999999999888999999999999999999999999765322 111111 11111 1111111
Q ss_pred HHHHHHHhhcCCC-CCCCCCH------HHHHHH
Q 005940 595 ELVLKLGLMCSHK-TQFRPTM------RQVMRY 620 (668)
Q Consensus 595 ~~l~~l~~~C~~~-p~~RPs~------~evl~~ 620 (668)
..+..+...|++. |++||++ ++++++
T Consensus 221 ~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h 253 (320)
T cd05590 221 QDAVDILKAFMTKNPTMRLGSLTLGGEEAILRH 253 (320)
T ss_pred HHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcC
Confidence 2334555677776 9999998 666654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=304.74 Aligned_cols=257 Identities=25% Similarity=0.398 Sum_probs=201.9
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCc----EEEEEEEecCCc-hhHHHHHHHHHHHhcccccCceeEeeeecccCceEE
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGG----EVAVKKITRNSL-QGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLL 427 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~----~vavK~~~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l 427 (668)
++|+..++||+|+||.||+|++..++. .||+|++..... ...+++.+|+.+++.++|+||++++++|.. ...++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~l 85 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQL 85 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcEE
Confidence 568889999999999999999766665 489999875433 345678899999999999999999999975 45789
Q ss_pred EEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceecc
Q 005940 428 VYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYD 507 (668)
Q Consensus 428 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~ 507 (668)
++||+++|+|.+++.. ....+++..++.++.|++.||+|||+ .+++||||||+||++++++.+||+|||+++...
T Consensus 86 ~~~~~~~g~l~~~l~~--~~~~~~~~~~~~~~~qi~~~L~~lH~---~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~ 160 (279)
T cd05109 86 VTQLMPYGCLLDYVRE--NKDRIGSQDLLNWCVQIAKGMSYLEE---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLD 160 (279)
T ss_pred EEEcCCCCCHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccccceEEEcCCCcEEECCCCceeecc
Confidence 9999999999999953 23468999999999999999999998 999999999999999999999999999998765
Q ss_pred CCCCC-cccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCchh-HHHHHHHHHhcCccccccCcc
Q 005940 508 HGGMP-HTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVAT-GRRPIGSGDLL-LVEWVRECHQLGRILDVADPL 584 (668)
Q Consensus 508 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~-l~~~~~~~~~~~~~~~~~d~~ 584 (668)
..... ......++..|+|||.+.++.++.++|||||||++|||++ |..||...... +..++. ......
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~----~~~~~~----- 231 (279)
T cd05109 161 IDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLE----KGERLP----- 231 (279)
T ss_pred cccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH----CCCcCC-----
Confidence 43221 1112234678999999988899999999999999999998 99998754322 222211 111110
Q ss_pred cCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhccCcCCC
Q 005940 585 LNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSGEKQLR 628 (668)
Q Consensus 585 l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~~~~~~ 628 (668)
....+ ...+..++..|+.. |++||++.++++.|+.....|
T Consensus 232 ~~~~~----~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~ 272 (279)
T cd05109 232 QPPIC----TIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP 272 (279)
T ss_pred CCccC----CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence 00111 12355667789887 999999999999998776554
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=304.53 Aligned_cols=252 Identities=24% Similarity=0.336 Sum_probs=201.0
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCchhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEEec
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEYI 432 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~ 432 (668)
+.|++.++||+|+||.||+|.+..++..+++|.+........+.+.+|++++++++|+||+++++.+...+..++||||+
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 91 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC 91 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence 56888999999999999999998889999999998877777788999999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCCCC
Q 005940 433 PNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMP 512 (668)
Q Consensus 433 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~~~ 512 (668)
++++|..++.. ....+++..+..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++....... .
T Consensus 92 ~~~~l~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~-~ 165 (292)
T cd06644 92 PGGAVDAIMLE--LDRGLTEPQIQVICRQMLEALQYLHS---MKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL-Q 165 (292)
T ss_pred CCCcHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHhc---CCeeecCCCcceEEEcCCCCEEEccCccceeccccc-c
Confidence 99999988753 23468999999999999999999998 999999999999999999999999999987643322 1
Q ss_pred cccccccCCcccCccccc-----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCcccCC
Q 005940 513 HTTNVVGTFGYIAPELTQ-----TGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNS 587 (668)
Q Consensus 513 ~~~~~~gt~~y~aPE~~~-----~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 587 (668)
......++..|+|||++. ...++.++|||||||++|||++|+.||...+. ............ ... ....
T Consensus 166 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~--~~~~~~~~~~~~-~~~---~~~~ 239 (292)
T cd06644 166 RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP--MRVLLKIAKSEP-PTL---SQPS 239 (292)
T ss_pred ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccH--HHHHHHHhcCCC-ccC---CCCc
Confidence 223346788999999874 34467899999999999999999999965432 111111111111 000 0011
Q ss_pred cccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 588 SYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 588 ~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
.+ ...+..+...|+.. |++||+++|++++
T Consensus 240 ~~----~~~~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 240 KW----SMEFRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred cc----CHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 11 12345566678887 9999999999874
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=303.23 Aligned_cols=252 Identities=28% Similarity=0.465 Sum_probs=201.0
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCchhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEEec
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEYI 432 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~ 432 (668)
+.|+..++||+|+||.||+|... +++.||+|.+..... ...++.+|+.++++++|+||+++++++. .+..+++|||+
T Consensus 6 ~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 82 (260)
T cd05067 6 ETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYM 82 (260)
T ss_pred HHceeeeeeccCccceEEeeecC-CCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcC
Confidence 56888999999999999999874 578899999876543 3467899999999999999999999874 45689999999
Q ss_pred CCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCCCC
Q 005940 433 PNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMP 512 (668)
Q Consensus 433 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~~~ 512 (668)
++++|.+++... .+..+++.+++.++.|++.||+|||+ .+++||||||+||+++.++.++|+|||++.........
T Consensus 83 ~~~~L~~~~~~~-~~~~~~~~~~~~i~~~i~~al~~LH~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05067 83 ENGSLVDFLKTP-EGIKLTINKLIDMAAQIAEGMAFIER---KNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYT 158 (260)
T ss_pred CCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecccccHHhEEEcCCCCEEEccCcceeecCCCCcc
Confidence 999999998643 34568999999999999999999998 99999999999999999999999999999876643322
Q ss_pred cccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHHHhcCccccccCcccCCcccH
Q 005940 513 HTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVAT-GRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSYVV 591 (668)
Q Consensus 513 ~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 591 (668)
......++..|+|||++....++.++||||||+++|||++ |+.||...+.. +....... ..... .....
T Consensus 159 ~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~~~~~~~~-~~~~~-----~~~~~-- 228 (260)
T cd05067 159 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNP--EVIQNLER-GYRMP-----RPDNC-- 228 (260)
T ss_pred cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChH--HHHHHHHc-CCCCC-----CCCCC--
Confidence 2233355678999999988889999999999999999999 99999654321 11111111 11111 11111
Q ss_pred HHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhcc
Q 005940 592 KEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSG 623 (668)
Q Consensus 592 ~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~ 623 (668)
...+..++.+|+.. |++||+++++.+.|+.
T Consensus 229 --~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 229 --PEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred --CHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 13466777789887 9999999999999874
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=302.03 Aligned_cols=248 Identities=33% Similarity=0.438 Sum_probs=201.0
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCchhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEEec
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEYI 432 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~ 432 (668)
++|+..+.||+|++|.||+|.. .++.||+|.+..... ..+++.+|+.++++++|+||+++++++......++||||+
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~--~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 82 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDY--RGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM 82 (256)
T ss_pred hhccceeeeecCCCceEEEEEe--cCcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence 5678899999999999999988 478999999976654 5678999999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCCCC
Q 005940 433 PNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMP 512 (668)
Q Consensus 433 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~~~ 512 (668)
++++|.+++... ....+++..+..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||.++.......
T Consensus 83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lh~---~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~- 157 (256)
T cd05039 83 AKGSLVDYLRSR-GRAVITLAQQLGFALDVCEGMEYLEE---KNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD- 157 (256)
T ss_pred CCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHh---CCccchhcccceEEEeCCCCEEEcccccccccccccc-
Confidence 999999999632 23469999999999999999999998 9999999999999999999999999999987643221
Q ss_pred cccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHHHhcCccccccCcccCCcccH
Q 005940 513 HTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVAT-GRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSYVV 591 (668)
Q Consensus 513 ~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 591 (668)
....+..|+|||++..+.++.++||||||+++|||++ |+.||....... ........... .....+
T Consensus 158 ---~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~~~~~~~~~~-----~~~~~~-- 224 (256)
T cd05039 158 ---SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVPHVEKGYRM-----EAPEGC-- 224 (256)
T ss_pred ---cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHH---HHHHHhcCCCC-----CCccCC--
Confidence 2234668999999988889999999999999999998 999986543211 11111111111 111111
Q ss_pred HHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhcc
Q 005940 592 KEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSG 623 (668)
Q Consensus 592 ~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~ 623 (668)
...+..+...|+.. |++||+++|+++.|+.
T Consensus 225 --~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 225 --PPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred --CHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 23455666678886 9999999999999875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=303.50 Aligned_cols=246 Identities=25% Similarity=0.355 Sum_probs=191.7
Q ss_pred eeeecCcEEEEEEEeC--CCCcEEEEEEEecCCc-hhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEEecCCCC
Q 005940 360 VIGIGGFGSVYKGVLP--TTGGEVAVKKITRNSL-QGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEYIPNGS 436 (668)
Q Consensus 360 ~lG~G~~g~Vy~~~~~--~~~~~vavK~~~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gs 436 (668)
.||+|+||.||+|.+. ..+..||+|++..... ...++|.+|+.++++++|+||++++++|.. ...++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCC
Confidence 3899999999999874 3455799999876543 334679999999999999999999999864 57899999999999
Q ss_pred hhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCCCCc--c
Q 005940 437 LDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPH--T 514 (668)
Q Consensus 437 L~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~~~~--~ 514 (668)
|.+++.. ....+++..+++++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++.......... .
T Consensus 81 L~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05115 81 LNKFLSG--KKDEITVSNVVELMHQVSMGMKYLEG---KNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKAR 155 (257)
T ss_pred HHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHh---cCeeecccchheEEEcCCCcEEeccCCccccccCCccceecc
Confidence 9999853 24568999999999999999999998 899999999999999999999999999998654332211 1
Q ss_pred cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHHHhcCccccccCcccCCcccHHH
Q 005940 515 TNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVAT-GRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSYVVKE 593 (668)
Q Consensus 515 ~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 593 (668)
....++..|+|||++..+.++.++|||||||++||+++ |..||...... ++.... ..+.... ... ..
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~~~~~~-~~~~~~~-----~~~----~~ 223 (257)
T cd05115 156 SAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGP--EVMSFI-EQGKRLD-----CPA----EC 223 (257)
T ss_pred CCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHH--HHHHHH-HCCCCCC-----CCC----CC
Confidence 11233578999999988889999999999999999996 99999754321 222111 1111111 111 11
Q ss_pred HHHHHHHHhhcCCC-CCCCCCHHHHHHHhcc
Q 005940 594 MELVLKLGLMCSHK-TQFRPTMRQVMRYLSG 623 (668)
Q Consensus 594 ~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~ 623 (668)
...+..+...|+.. |++||++.+|.+.|+.
T Consensus 224 ~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~ 254 (257)
T cd05115 224 PPEMYALMKDCWIYKWEDRPNFAKVEERMRT 254 (257)
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHHHhh
Confidence 23445667789987 9999999999999875
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=312.86 Aligned_cols=242 Identities=27% Similarity=0.313 Sum_probs=188.3
Q ss_pred eeeeecCcEEEEEEEeCCCCcEEEEEEEecCCc---hhHHHHHHHHH-HHhcccccCceeEeeeecccCceEEEEEecCC
Q 005940 359 EVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSL---QGMREFAAEIE-SLGRLRHKNLVNLHGWCKQKNDLLLVYEYIPN 434 (668)
Q Consensus 359 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~f~~Ei~-~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~ 434 (668)
+.||+|+||+||+|.+..+++.||||++.+... ...+++..|.. +++.++||||+++++.+...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 469999999999999998999999999975422 22344555554 56789999999999999999999999999999
Q ss_pred CChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCCCCcc
Q 005940 435 GSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHT 514 (668)
Q Consensus 435 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 514 (668)
|+|..++.. ...+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 g~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~ 153 (323)
T cd05575 81 GELFFHLQR---ERSFPEPRARFYAAEIASALGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS-KTT 153 (323)
T ss_pred CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCC-Ccc
Confidence 999999853 3468999999999999999999998 999999999999999999999999999987543221 223
Q ss_pred cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCcccCCcccHHHH
Q 005940 515 TNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSYVVKEM 594 (668)
Q Consensus 515 ~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 594 (668)
....||..|+|||++.+..++.++|||||||++|||++|+.||...+.. +....... .. ..+.....
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~--~~~~~i~~-~~------~~~~~~~~---- 220 (323)
T cd05575 154 STFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTA--EMYDNILN-KP------LRLKPNIS---- 220 (323)
T ss_pred ccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHH--HHHHHHHc-CC------CCCCCCCC----
Confidence 3457899999999999889999999999999999999999999764321 11111111 11 11111222
Q ss_pred HHHHHHHhhcCCC-CCCCCCHH----HHHHH
Q 005940 595 ELVLKLGLMCSHK-TQFRPTMR----QVMRY 620 (668)
Q Consensus 595 ~~l~~l~~~C~~~-p~~RPs~~----evl~~ 620 (668)
..+..+...|++. |++||+++ |++++
T Consensus 221 ~~~~~li~~~l~~~p~~R~~~~~~~~~il~~ 251 (323)
T cd05575 221 VSARHLLEGLLQKDRTKRLGAKDDFLEIKNH 251 (323)
T ss_pred HHHHHHHHHHhhcCHHhCCCCCCCHHHHHcC
Confidence 2244555577776 99999874 66543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=302.39 Aligned_cols=251 Identities=28% Similarity=0.429 Sum_probs=198.0
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCchhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEEec
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEYI 432 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~ 432 (668)
++|...++||+|++|.||+|.+.. +..+|+|++.... ...+.+.+|++++++++|+|++++++++. .+..++||||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~-~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 82 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNG-TTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFM 82 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcC-CceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcC
Confidence 457788999999999999999854 4579999886543 23467889999999999999999999885 45689999999
Q ss_pred CCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCCCC
Q 005940 433 PNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMP 512 (668)
Q Consensus 433 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~~~ 512 (668)
++++|.+++... ....+++..+..++.|++.||.|||+ .+++|+||||+||++++++.+||+|||+++........
T Consensus 83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05069 83 GKGSLLDFLKEG-DGKYLKLPQLVDMAAQIADGMAYIER---MNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT 158 (260)
T ss_pred CCCCHHHHHhhC-CCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccCcceEEEcCCCeEEECCCccceEccCCccc
Confidence 999999999642 34458999999999999999999998 99999999999999999999999999999876543322
Q ss_pred cccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCch-hHHHHHHHHHhcCccccccCcccCCccc
Q 005940 513 HTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVAT-GRRPIGSGDL-LLVEWVRECHQLGRILDVADPLLNSSYV 590 (668)
Q Consensus 513 ~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~-~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 590 (668)
......++..|+|||....+.++.++||||||+++|||++ |+.||..... ....+. ..... +....
T Consensus 159 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~---~~~~~------~~~~~--- 226 (260)
T cd05069 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQV---ERGYR------MPCPQ--- 226 (260)
T ss_pred ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH---HcCCC------CCCCc---
Confidence 2223346678999999988889999999999999999999 8999865422 111111 11111 11111
Q ss_pred HHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhcc
Q 005940 591 VKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSG 623 (668)
Q Consensus 591 ~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~ 623 (668)
.....+..+...|+.. |++||++++|++.|+.
T Consensus 227 -~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 227 -GCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred -ccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 1123456666789887 9999999999999874
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=326.84 Aligned_cols=199 Identities=27% Similarity=0.411 Sum_probs=165.5
Q ss_pred hcCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCchhHHHHHHHHHHHhcccccCceeEeeeeccc--------C
Q 005940 352 TKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNLHGWCKQK--------N 423 (668)
Q Consensus 352 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~--------~ 423 (668)
.++|...++||+|+||.||+|.+..+++.||||++.... ....+|+.++++++|+||+++++++... .
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 140 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI 140 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence 467999999999999999999998889999999986543 2234799999999999999999876321 2
Q ss_pred ceEEEEEecCCCChhhhhcC-CCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCC-CEEEEeec
Q 005940 424 DLLLVYEYIPNGSLDTLLFK-PKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEM-NARLGDFG 501 (668)
Q Consensus 424 ~~~lV~E~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~-~~kl~DfG 501 (668)
.+++||||+++ +|.+++.. ...+..+++..+..++.||+.||+|||+ .+|+||||||+||||+.++ .+||+|||
T Consensus 141 ~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~---~~IiHrDLKp~NILl~~~~~~vkL~DFG 216 (440)
T PTZ00036 141 FLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHS---KFICHRDLKPQNLLIDPNTHTLKLCDFG 216 (440)
T ss_pred EEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCcCHHHEEEcCCCCceeeeccc
Confidence 36799999975 67666532 2234679999999999999999999999 9999999999999999765 69999999
Q ss_pred CceeccCCCCCcccccccCCcccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 005940 502 LARLYDHGGMPHTTNVVGTFGYIAPELTQT-GKASTSSDVFAYGILLLEVATGRRPIGSG 560 (668)
Q Consensus 502 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~S~Gvvl~elltG~~p~~~~ 560 (668)
+++....... .....||+.|+|||++.+ ..++.++|||||||++|||++|..||...
T Consensus 217 la~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~ 274 (440)
T PTZ00036 217 SAKNLLAGQR--SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQ 274 (440)
T ss_pred cchhccCCCC--cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 9987654322 233578999999998765 46899999999999999999999999754
|
|
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=303.69 Aligned_cols=202 Identities=34% Similarity=0.453 Sum_probs=173.5
Q ss_pred CcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCC--chhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEEe
Q 005940 354 GFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNS--LQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEY 431 (668)
Q Consensus 354 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~ 431 (668)
+|+..+.||+|++|.||+|+...++..||||++.... ....+.+.+|+.++++++||||+++++++..+...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4778899999999999999998889999999986532 22346788999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCCC
Q 005940 432 IPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGM 511 (668)
Q Consensus 432 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~~ 511 (668)
++ ++|.+++.....+..+++.++..++.||+.||.|||+ .+++||||||+||+++.++.+||+|||++.......
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~- 155 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHS---RRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV- 155 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCCHHHEEEcCCCcEEECcccceeecCCCc-
Confidence 97 6898888644444679999999999999999999998 999999999999999999999999999997654322
Q ss_pred CcccccccCCcccCcccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 005940 512 PHTTNVVGTFGYIAPELTQTG-KASTSSDVFAYGILLLEVATGRRPIGSG 560 (668)
Q Consensus 512 ~~~~~~~gt~~y~aPE~~~~~-~~~~~sDV~S~Gvvl~elltG~~p~~~~ 560 (668)
.......++..|+|||++.+. .++.++|||||||++|||+||+.||...
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~ 205 (285)
T cd07861 156 RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGD 205 (285)
T ss_pred ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 112233568899999987653 5789999999999999999999999754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=300.98 Aligned_cols=250 Identities=28% Similarity=0.383 Sum_probs=201.9
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCchhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEEec
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEYI 432 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~ 432 (668)
++|+..+.||+|++|.||+|.+..++..+++|.+..... .+++.+|++++++++|+||+++++++......++++||+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 80 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC 80 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence 578889999999999999999988789999999876533 678999999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCCCC
Q 005940 433 PNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMP 512 (668)
Q Consensus 433 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~~~ 512 (668)
++++|.+++.. .+..+++..+..++.|++.||.|||+ .+++||||+|+||+++.++.+||+|||++........
T Consensus 81 ~~~~L~~~l~~--~~~~l~~~~~~~~~~~l~~~l~~lh~---~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~- 154 (256)
T cd06612 81 GAGSVSDIMKI--TNKTLTEEEIAAILYQTLKGLEYLHS---NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA- 154 (256)
T ss_pred CCCcHHHHHHh--CccCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEECCCCcEEEcccccchhcccCcc-
Confidence 99999999853 34578999999999999999999998 8999999999999999999999999999987654331
Q ss_pred cccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCcccCCcccHH
Q 005940 513 HTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSYVVK 592 (668)
Q Consensus 513 ~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 592 (668)
......++..|+|||++.+..++.++||||||+++|||++|+.||........ .... .....+.+. ....
T Consensus 155 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~-----~~~~---~~~~~~~~~--~~~~ 224 (256)
T cd06612 155 KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRA-----IFMI---PNKPPPTLS--DPEK 224 (256)
T ss_pred ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhh-----hhhh---ccCCCCCCC--chhh
Confidence 22334578899999999888899999999999999999999999975322110 0000 000001111 0111
Q ss_pred HHHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 593 EMELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 593 ~~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
....+..+...|++. |++||+++||+++
T Consensus 225 ~~~~~~~~i~~~l~~~P~~Rps~~~il~~ 253 (256)
T cd06612 225 WSPEFNDFVKKCLVKDPEERPSAIQLLQH 253 (256)
T ss_pred cCHHHHHHHHHHHhcChhhCcCHHHHhcC
Confidence 113455666688876 9999999999874
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=298.06 Aligned_cols=250 Identities=26% Similarity=0.386 Sum_probs=200.9
Q ss_pred CcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCC--chhHHHHHHHHHHHhcccccCceeEeeeecc-cCceEEEEE
Q 005940 354 GFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNS--LQGMREFAAEIESLGRLRHKNLVNLHGWCKQ-KNDLLLVYE 430 (668)
Q Consensus 354 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~-~~~~~lV~E 430 (668)
+|+..+.||+|++|.||++....+++.+|+|++.... ....+.+.+|++++++++|+|++++++.+.. ....++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 4788999999999999999998888999999997543 2345678899999999999999999998764 446789999
Q ss_pred ecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCC
Q 005940 431 YIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGG 510 (668)
Q Consensus 431 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~ 510 (668)
|+++++|.+++... ....+++.+++.++.|++.||.|||+ .+++||||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~l~~~-~~~~l~~~~~~~~~~~l~~~l~~lH~---~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~ 156 (257)
T cd08223 81 FCEGGDLYHKLKEQ-KGKLLPENQVVEWFVQIAMALQYLHE---KHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC 156 (257)
T ss_pred ccCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence 99999999999632 34568999999999999999999998 999999999999999999999999999998764332
Q ss_pred CCcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCcccCCccc
Q 005940 511 MPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSYV 590 (668)
Q Consensus 511 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 590 (668)
. ......++..|+|||.+.++.++.++||||||++++||++|+.||...+.. .+...... +.. +.+....+
T Consensus 157 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~--~~~~~~~~-~~~-----~~~~~~~~ 227 (257)
T cd08223 157 D-MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMN--SLVYRIIE-GKL-----PPMPKDYS 227 (257)
T ss_pred C-ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH--HHHHHHHh-cCC-----CCCccccC
Confidence 2 223346889999999999888999999999999999999999999754422 22222221 111 11111122
Q ss_pred HHHHHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 591 VKEMELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 591 ~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
..+..+...|+.. |++||++.+++++
T Consensus 228 ----~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 228 ----PELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred ----HHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 3455666788877 9999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=302.96 Aligned_cols=251 Identities=25% Similarity=0.397 Sum_probs=193.9
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCC-----chhHHHHHHHHHHHhcccccCceeEeeeecc--cCce
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNS-----LQGMREFAAEIESLGRLRHKNLVNLHGWCKQ--KNDL 425 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~--~~~~ 425 (668)
.+|...+.||+|+||.||+|....++..|++|++.... .+..+.+.+|+.++++++|+||+++++++.+ ....
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 47888999999999999999998889999999986432 2334578899999999999999999998865 3567
Q ss_pred EEEEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCcee
Q 005940 426 LLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARL 505 (668)
Q Consensus 426 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~ 505 (668)
++++||+++++|.+++.. ...+++..++.++.|++.||.|||+ .+++||||||+||+++.++.+||+|||+++.
T Consensus 82 ~l~~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~LH~---~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~ 155 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKA---YGALTESVTRKYTRQILEGMSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKR 155 (266)
T ss_pred EEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEccCCCccc
Confidence 899999999999999953 3458999999999999999999998 9999999999999999999999999999986
Q ss_pred ccCCCC--CcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCc
Q 005940 506 YDHGGM--PHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADP 583 (668)
Q Consensus 506 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~ 583 (668)
...... .......++..|+|||++.+..++.++|||||||++|||++|+.||...+.. ..+...... ...+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~--~~~~~~~~~-----~~~~ 228 (266)
T cd06651 156 LQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAM--AAIFKIATQ-----PTNP 228 (266)
T ss_pred cccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchH--HHHHHHhcC-----CCCC
Confidence 543211 1122345788999999998888999999999999999999999999754211 111111111 1122
Q ss_pred ccCCcccHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 005940 584 LLNSSYVVKEMELVLKLGLMCSHKTQFRPTMRQVMRY 620 (668)
Q Consensus 584 ~l~~~~~~~~~~~l~~l~~~C~~~p~~RPs~~evl~~ 620 (668)
.+....+ ++... +..+|..+|++||+++||+++
T Consensus 229 ~~~~~~~-~~~~~---li~~~~~~p~~Rp~~~eil~h 261 (266)
T cd06651 229 QLPSHIS-EHARD---FLGCIFVEARHRPSAEELLRH 261 (266)
T ss_pred CCchhcC-HHHHH---HHHHhcCChhhCcCHHHHhcC
Confidence 2221112 22222 222334459999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-35 Score=303.08 Aligned_cols=250 Identities=26% Similarity=0.370 Sum_probs=197.5
Q ss_pred cccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCc---hhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEEe
Q 005940 355 FKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSL---QGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEY 431 (668)
Q Consensus 355 f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~ 431 (668)
|+..+.||+|+||+||+|.+..+++.+|+|.+..... .....+.+|++++++++|+||+++.+.+..++..++||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 6677899999999999999988899999999876432 2234578899999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCCC
Q 005940 432 IPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGM 511 (668)
Q Consensus 432 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~~ 511 (668)
+++++|.+++... ....+++..+..++.|++.||.|||+ .+|+||||||+||++++++.+||+|||++.......
T Consensus 82 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~ql~~~l~~lH~---~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~- 156 (285)
T cd05632 82 MNGGDLKFHIYNM-GNPGFEEERALFYAAEILCGLEDLHR---ENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE- 156 (285)
T ss_pred ccCccHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCCHHHEEECCCCCEEEecCCcceecCCCC-
Confidence 9999999888532 23469999999999999999999998 999999999999999999999999999997654322
Q ss_pred CcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhH-HHHHHHHHhcCccccccCcccCCccc
Q 005940 512 PHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLL-VEWVRECHQLGRILDVADPLLNSSYV 590 (668)
Q Consensus 512 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l-~~~~~~~~~~~~~~~~~d~~l~~~~~ 590 (668)
......|+..|+|||++.+..++.++|+|||||++|||++|+.||....... .+-+........ ......+.
T Consensus 157 -~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~ 229 (285)
T cd05632 157 -SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETE------EVYSAKFS 229 (285)
T ss_pred -cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccc------cccCccCC
Confidence 1233478999999999988889999999999999999999999997543211 111111111110 11111222
Q ss_pred HHHHHHHHHHHhhcCCC-CCCCCC-----HHHHHHH
Q 005940 591 VKEMELVLKLGLMCSHK-TQFRPT-----MRQVMRY 620 (668)
Q Consensus 591 ~~~~~~l~~l~~~C~~~-p~~RPs-----~~evl~~ 620 (668)
..+..+...|+.. |++||+ +++++++
T Consensus 230 ----~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 230 ----EEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred ----HHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence 2234566678887 999999 6666654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=305.20 Aligned_cols=261 Identities=26% Similarity=0.376 Sum_probs=199.6
Q ss_pred cCcccceeeeecCcEEEEEEEeCC----------------CCcEEEEEEEecCC-chhHHHHHHHHHHHhcccccCceeE
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPT----------------TGGEVAVKKITRNS-LQGMREFAAEIESLGRLRHKNLVNL 415 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~----------------~~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l 415 (668)
++|+..++||+|+||.||++.... ++..+|+|++.... ....++|.+|++++++++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 468889999999999999986432 33469999987543 3345689999999999999999999
Q ss_pred eeeecccCceEEEEEecCCCChhhhhcCCC--------CCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCE
Q 005940 416 HGWCKQKNDLLLVYEYIPNGSLDTLLFKPK--------DGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNA 487 (668)
Q Consensus 416 ~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~--------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NI 487 (668)
++++...+..++||||+++++|.+++.... ....+++.+++.++.|++.||+|||+ .+++||||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dlkp~Ni 161 (296)
T cd05095 85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSS---LNFVHRDLATRNC 161 (296)
T ss_pred EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHH---CCeecccCChheE
Confidence 999999999999999999999999986422 12357889999999999999999998 9999999999999
Q ss_pred EECCCCCEEEEeecCceeccCCCCC-cccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHh--CCCCCCCCc-hh
Q 005940 488 LIDAEMNARLGDFGLARLYDHGGMP-HTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVAT--GRRPIGSGD-LL 563 (668)
Q Consensus 488 ll~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt--G~~p~~~~~-~~ 563 (668)
+++.++.+||+|||+++........ ......++..|++||+...+.++.++|||||||++|||++ |..||.... ..
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~ 241 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ 241 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHH
Confidence 9999999999999999865433211 1222344678999999888889999999999999999998 677885432 11
Q ss_pred HHHHHHHHHhcCccccccCcccCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhc
Q 005940 564 LVEWVRECHQLGRILDVADPLLNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLS 622 (668)
Q Consensus 564 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~ 622 (668)
......+........ ...+.. .. ....+.+++.+|++. |++||++.||++.|+
T Consensus 242 ~~~~~~~~~~~~~~~-~~~~~~-~~----~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 242 VIENTGEFFRDQGRQ-VYLPKP-AL----CPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred HHHHHHHHHhhcccc-ccCCCC-CC----CCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 111111111111100 001111 11 124566778899997 999999999999886
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=295.45 Aligned_cols=201 Identities=27% Similarity=0.364 Sum_probs=173.4
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCch-h-HHHHHHHHHHHhcccccCceeEeeeec--ccCceEEE
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQ-G-MREFAAEIESLGRLRHKNLVNLHGWCK--QKNDLLLV 428 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~-~~~f~~Ei~~l~~l~H~nIv~l~g~~~--~~~~~~lV 428 (668)
++|+..++|++|.||.||+|+++.+++.||+|+++.+... + --.-++||.+|.+++|||||.+..... +-+..|+|
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V 155 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV 155 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence 4688899999999999999999999999999999754322 1 123468999999999999999988764 44579999
Q ss_pred EEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccC
Q 005940 429 YEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDH 508 (668)
Q Consensus 429 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~ 508 (668)
||||+. +|..++... ...+...+...++.|+++|++|||. ..|+|||||++|+|++..|.+||+|||+||.+..
T Consensus 156 Me~~Eh-DLksl~d~m--~q~F~~~evK~L~~QlL~glk~lH~---~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygs 229 (419)
T KOG0663|consen 156 MEYVEH-DLKSLMETM--KQPFLPGEVKTLMLQLLRGLKHLHD---NWILHRDLKTSNLLLSHKGILKIADFGLAREYGS 229 (419)
T ss_pred HHHHHh-hHHHHHHhc--cCCCchHHHHHHHHHHHHHHHHHhh---ceeEecccchhheeeccCCcEEecccchhhhhcC
Confidence 999965 888888533 3678899999999999999999999 9999999999999999999999999999998876
Q ss_pred CCCCcccccccCCcccCcccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 005940 509 GGMPHTTNVVGTFGYIAPELTQTG-KASTSSDVFAYGILLLEVATGRRPIGSG 560 (668)
Q Consensus 509 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDV~S~Gvvl~elltG~~p~~~~ 560 (668)
.. ...+..+-|.+|.|||.+.+. .|+++.|+||+|||+.||++++.-|.+.
T Consensus 230 p~-k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~ 281 (419)
T KOG0663|consen 230 PL-KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGK 281 (419)
T ss_pred Cc-ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCC
Confidence 53 345667889999999988764 6899999999999999999999888643
|
|
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=303.66 Aligned_cols=248 Identities=27% Similarity=0.409 Sum_probs=202.2
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCC-chhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEEe
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNS-LQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEY 431 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~ 431 (668)
++|+..+.||.|++|.||+|.+..+++.||+|.+.... ......+.+|++++++++|+||+++++.+.+....++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 36778899999999999999998889999999987653 34456788999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCCC
Q 005940 432 IPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGM 511 (668)
Q Consensus 432 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~~ 511 (668)
+++++|.+++.. ..+++..+..++.|++.||.|||+ .+++||||+|+||++++++.++|+|||+++......
T Consensus 81 ~~~~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~- 152 (274)
T cd06609 81 CGGGSCLDLLKP----GKLDETYIAFILREVLLGLEYLHE---EGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM- 152 (274)
T ss_pred eCCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEcccccceeecccc-
Confidence 999999999953 268999999999999999999998 999999999999999999999999999998776442
Q ss_pred CcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCcccCCc-cc
Q 005940 512 PHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSS-YV 590 (668)
Q Consensus 512 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~-~~ 590 (668)
.......++..|+|||++.+..++.++|||||||++|||++|+.||...+.. ........ . ..+.+... ++
T Consensus 153 ~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~--~~~~~~~~-~-----~~~~~~~~~~~ 224 (274)
T cd06609 153 SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPM--RVLFLIPK-N-----NPPSLEGNKFS 224 (274)
T ss_pred cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchH--HHHHHhhh-c-----CCCCCcccccC
Confidence 2223446888999999999888999999999999999999999999654321 11111111 1 11111111 22
Q ss_pred HHHHHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 591 VKEMELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 591 ~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
..+..+...|+.. |++||++++++++
T Consensus 225 ----~~~~~~l~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 225 ----KPFKDFVSLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred ----HHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 2344556678876 9999999999874
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=299.76 Aligned_cols=250 Identities=24% Similarity=0.359 Sum_probs=201.7
Q ss_pred CcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecC-CchhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEEec
Q 005940 354 GFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRN-SLQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEYI 432 (668)
Q Consensus 354 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~ 432 (668)
+|+..++||+|+||.||++....+++.+|+|.+... .....+.+.+|+.++++++|+||+++++.+..++..++||||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 477889999999999999999888999999998653 2344577889999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCCCC
Q 005940 433 PNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMP 512 (668)
Q Consensus 433 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~~~ 512 (668)
++++|.+++.. .....+++..++.++.|++.||.|||+ .+++|+||||+||++++++.++|+|||++........
T Consensus 81 ~~~~l~~~~~~-~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~- 155 (255)
T cd08219 81 DGGDLMQKIKL-QRGKLFPEDTILQWFVQMCLGVQHIHE---KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA- 155 (255)
T ss_pred CCCcHHHHHHh-ccCCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCcceEEECCCCcEEEcccCcceeeccccc-
Confidence 99999998853 234568999999999999999999998 9999999999999999999999999999986654321
Q ss_pred cccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCcccCCcccHH
Q 005940 513 HTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSYVVK 592 (668)
Q Consensus 513 ~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 592 (668)
......++..|+|||++.+..++.++|+||||+++|+|++|+.||...+... ....... +.... +....+
T Consensus 156 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~--~~~~~~~-~~~~~-----~~~~~~-- 225 (255)
T cd08219 156 YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKN--LILKVCQ-GSYKP-----LPSHYS-- 225 (255)
T ss_pred ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHH--HHHHHhc-CCCCC-----CCcccC--
Confidence 2233568889999999988889999999999999999999999997643221 1111111 11111 111122
Q ss_pred HHHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 593 EMELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 593 ~~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
..+..+...|+.. |++||++++|+..
T Consensus 226 --~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 226 --YELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred --HHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 2344556678876 9999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=302.91 Aligned_cols=250 Identities=26% Similarity=0.357 Sum_probs=199.0
Q ss_pred cccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCchhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEEecCC
Q 005940 355 FKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEYIPN 434 (668)
Q Consensus 355 f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~ 434 (668)
|+..+.||+|+||.||+|.+..++..+++|.+.....+..+.+.+|+++++.++|+||+++++.+...+..++|+||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 56678899999999999999888899999999877666778899999999999999999999999999999999999999
Q ss_pred CChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCCCCcc
Q 005940 435 GSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHT 514 (668)
Q Consensus 435 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 514 (668)
++|..++.. ....+++..+..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++....... ...
T Consensus 87 ~~l~~~~~~--~~~~l~~~~~~~~~~qi~~~L~~LH~---~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~-~~~ 160 (282)
T cd06643 87 GAVDAVMLE--LERPLTEPQIRVVCKQTLEALNYLHE---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-QRR 160 (282)
T ss_pred CcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCcccEEEccCCCEEEccccccccccccc-ccc
Confidence 999998853 23569999999999999999999999 999999999999999999999999999987654322 122
Q ss_pred cccccCCcccCccccc-----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCcccCCcc
Q 005940 515 TNVVGTFGYIAPELTQ-----TGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSY 589 (668)
Q Consensus 515 ~~~~gt~~y~aPE~~~-----~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 589 (668)
....++..|+|||++. ...++.++|||||||++|||++|+.||...+.. +.+........ .....+ ..+
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~--~~~~~~~~~~~-~~~~~~---~~~ 234 (282)
T cd06643 161 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPM--RVLLKIAKSEP-PTLAQP---SRW 234 (282)
T ss_pred ccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHH--HHHHHHhhcCC-CCCCCc---ccc
Confidence 3346889999999874 345678999999999999999999999654311 11111111111 111111 111
Q ss_pred cHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 590 VVKEMELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 590 ~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
. ..+..+...|++. |++||++.+++++
T Consensus 235 ~----~~~~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 235 S----SEFKDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred C----HHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 2 2345566689887 9999999999875
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-36 Score=312.55 Aligned_cols=255 Identities=30% Similarity=0.439 Sum_probs=198.3
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCc--EEEEEEEecC-CchhHHHHHHHHHHHhcc-cccCceeEeeeecccCceEEE
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGG--EVAVKKITRN-SLQGMREFAAEIESLGRL-RHKNLVNLHGWCKQKNDLLLV 428 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~--~vavK~~~~~-~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV 428 (668)
++|++.+.||+|+||.||+|.+..++. .+++|++... .....+.+.+|++++.++ +|+||+++++++...+..++|
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv 86 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 86 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence 578888999999999999999876665 4577776543 234456888999999999 899999999999999999999
Q ss_pred EEecCCCChhhhhcCCC-------------CCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCE
Q 005940 429 YEYIPNGSLDTLLFKPK-------------DGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNA 495 (668)
Q Consensus 429 ~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~ 495 (668)
|||+++++|.+++.... ....+++.+++.++.|++.||+|||+ .+++||||||+||+++.++.+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~gi~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVA 163 (303)
T ss_pred EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHh---CCccccccchheEEecCCCcE
Confidence 99999999999996432 12358999999999999999999998 999999999999999999999
Q ss_pred EEEeecCceeccCCCCCcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHHHhc
Q 005940 496 RLGDFGLARLYDHGGMPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVAT-GRRPIGSGDLLLVEWVRECHQL 574 (668)
Q Consensus 496 kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~l~~~~~~~~~~ 574 (668)
||+|||+++...... ......++..|+|||++....++.++|||||||++|||++ |..||...+.. +..... ..
T Consensus 164 kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--~~~~~~-~~ 238 (303)
T cd05088 164 KIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA--ELYEKL-PQ 238 (303)
T ss_pred EeCccccCcccchhh--hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChH--HHHHHH-hc
Confidence 999999986432111 1112234667999999988888999999999999999998 99999654321 111111 11
Q ss_pred CccccccCcccCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhccC
Q 005940 575 GRILDVADPLLNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSGE 624 (668)
Q Consensus 575 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~~ 624 (668)
.. ........+ ..+..+...|+.. |++||+++++++.|+..
T Consensus 239 ~~-----~~~~~~~~~----~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~ 280 (303)
T cd05088 239 GY-----RLEKPLNCD----DEVYDLMRQCWREKPYERPSFAQILVSLNRM 280 (303)
T ss_pred CC-----cCCCCCCCC----HHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 10 000111111 2345677789887 99999999999998754
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=304.21 Aligned_cols=253 Identities=27% Similarity=0.395 Sum_probs=199.2
Q ss_pred CcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecC-CchhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEEec
Q 005940 354 GFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRN-SLQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEYI 432 (668)
Q Consensus 354 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~ 432 (668)
+|+..+.||+|+||.||++.+..++..||+|.+... .......+.+|+.++++++|+||+++++.+...+..++||||+
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYM 81 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeec
Confidence 577889999999999999999888999999998754 2334568899999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCCCC
Q 005940 433 PNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMP 512 (668)
Q Consensus 433 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~~~ 512 (668)
++++|.+++........+++..+..++.|++.||.|||+ +.+++||||||+||+++.++.+||+|||++.......
T Consensus 82 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-- 157 (286)
T cd06622 82 DAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE--EHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL-- 157 (286)
T ss_pred CCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHh--cCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc--
Confidence 999999998643334578999999999999999999996 2589999999999999999999999999997654322
Q ss_pred cccccccCCcccCcccccCCC------CCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCcccC
Q 005940 513 HTTNVVGTFGYIAPELTQTGK------ASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLN 586 (668)
Q Consensus 513 ~~~~~~gt~~y~aPE~~~~~~------~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 586 (668)
.....++..|+|||.+.+.. ++.++|||||||++|||++|+.||................... .+.+.
T Consensus 158 -~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-----~~~~~ 231 (286)
T cd06622 158 -AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGD-----PPTLP 231 (286)
T ss_pred -cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcC-----CCCCC
Confidence 22346788999999885543 4789999999999999999999996543211111111111111 11222
Q ss_pred CcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 587 SSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 587 ~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
..+ ...+..+...|+.. |++||++++++++
T Consensus 232 ~~~----~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 232 SGY----SDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred ccc----CHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 222 23344566688886 9999999999975
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=312.65 Aligned_cols=242 Identities=26% Similarity=0.334 Sum_probs=193.7
Q ss_pred eeeeecCcEEEEEEEeCCCCcEEEEEEEecCC---chhHHHHHHHHHHHhcc-cccCceeEeeeecccCceEEEEEecCC
Q 005940 359 EVIGIGGFGSVYKGVLPTTGGEVAVKKITRNS---LQGMREFAAEIESLGRL-RHKNLVNLHGWCKQKNDLLLVYEYIPN 434 (668)
Q Consensus 359 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~E~~~~ 434 (668)
+.||+|+||.||+|.+..++..||||++.+.. ......+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999998889999999997642 23445677899999888 699999999999999999999999999
Q ss_pred CChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCCCCcc
Q 005940 435 GSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHT 514 (668)
Q Consensus 435 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 514 (668)
|+|..++.. ...+++.++..++.|++.||.|||+ .+|+||||||+||++++++.+||+|||+++...... ...
T Consensus 81 ~~L~~~~~~---~~~l~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~ 153 (318)
T cd05570 81 GDLMFHIQR---SGRFDEPRARFYAAEIVLGLQFLHE---RGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG-VTT 153 (318)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEccCCCHHHeEECCCCcEEecccCCCeecCcCC-Ccc
Confidence 999988853 3469999999999999999999998 999999999999999999999999999987533222 122
Q ss_pred cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCcccCCcccHHHH
Q 005940 515 TNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSYVVKEM 594 (668)
Q Consensus 515 ~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 594 (668)
....|+..|+|||++.+..++.++|||||||++|||++|+.||...+.. ..... ..... .......+
T Consensus 154 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~--~~~~~-i~~~~------~~~~~~~~---- 220 (318)
T cd05570 154 STFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDED--ELFQS-ILEDE------VRYPRWLS---- 220 (318)
T ss_pred cceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHH--HHHHH-HHcCC------CCCCCcCC----
Confidence 3357899999999999889999999999999999999999999754322 11111 11111 11111122
Q ss_pred HHHHHHHhhcCCC-CCCCCCH-----HHHHHH
Q 005940 595 ELVLKLGLMCSHK-TQFRPTM-----RQVMRY 620 (668)
Q Consensus 595 ~~l~~l~~~C~~~-p~~RPs~-----~evl~~ 620 (668)
..+..+...|++. |++||++ .+++++
T Consensus 221 ~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 221 KEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred HHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 2344566678877 9999999 888865
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=298.78 Aligned_cols=247 Identities=30% Similarity=0.453 Sum_probs=195.6
Q ss_pred eeeeecCcEEEEEEEeCCCC---cEEEEEEEecCCc-hhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEEecCC
Q 005940 359 EVIGIGGFGSVYKGVLPTTG---GEVAVKKITRNSL-QGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEYIPN 434 (668)
Q Consensus 359 ~~lG~G~~g~Vy~~~~~~~~---~~vavK~~~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~ 434 (668)
++||+|+||.||+|++...+ ..+|+|.+..... ...+++.+|+++++++.|+||+++++++. ....++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 46999999999999875544 6899999876554 34567899999999999999999999886 4568999999999
Q ss_pred CChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCCCCcc
Q 005940 435 GSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHT 514 (668)
Q Consensus 435 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 514 (668)
|+|.+++.. ...+++..++.++.|++.||+|||+ .+++||||||+||+++.++.+||+|||+++..........
T Consensus 80 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lh~---~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~ 153 (257)
T cd05060 80 GPLLKYLKK---RREIPVSDLKELAHQVAMGMAYLES---KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR 153 (257)
T ss_pred CcHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHhh---cCeeccCcccceEEEcCCCcEEeccccccceeecCCcccc
Confidence 999999963 2368999999999999999999998 9999999999999999999999999999987654332211
Q ss_pred --cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCch-hHHHHHHHHHhcCccccccCcccCCccc
Q 005940 515 --TNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVAT-GRRPIGSGDL-LLVEWVRECHQLGRILDVADPLLNSSYV 590 (668)
Q Consensus 515 --~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~-~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 590 (668)
....++..|+|||.+....++.++|||||||++|||++ |+.||...+. .+..++. . ..... .....
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~---~-~~~~~-----~~~~~- 223 (257)
T cd05060 154 ATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLE---S-GERLP-----RPEEC- 223 (257)
T ss_pred cccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHH---c-CCcCC-----CCCCC-
Confidence 11223567999999988899999999999999999998 9999975432 2222221 1 11111 11111
Q ss_pred HHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhccCc
Q 005940 591 VKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSGEK 625 (668)
Q Consensus 591 ~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~~~ 625 (668)
...+..++.+|+.. |++||++.+|++.|+...
T Consensus 224 ---~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 224 ---PQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred ---CHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 13455777789887 999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-37 Score=320.46 Aligned_cols=251 Identities=27% Similarity=0.385 Sum_probs=211.0
Q ss_pred ccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCchhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEEecCCC
Q 005940 356 KESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEYIPNG 435 (668)
Q Consensus 356 ~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~g 435 (668)
...++||-|.||.||.|+|+...-.||||.++.+.. ..++|++|..+|+.++|||+|+|+|.|..+..+|+|.|||..|
T Consensus 270 tMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtM-eveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~yG 348 (1157)
T KOG4278|consen 270 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMCYG 348 (1157)
T ss_pred eeeeccCCCcccceeeeeeeccceeeehhhhhhcch-hHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecccCc
Confidence 446899999999999999998889999999977654 4689999999999999999999999999999999999999999
Q ss_pred ChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCCCCccc
Q 005940 436 SLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTT 515 (668)
Q Consensus 436 sL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 515 (668)
+|.+||+. .++..++-...+.++.||+.||.||.. +++|||||-.+|+|+.++..+|++|||+++++..+......
T Consensus 349 NLLdYLRe-cnr~ev~avvLlyMAtQIsSaMeYLEk---knFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYTAHA 424 (1157)
T KOG4278|consen 349 NLLDYLRE-CNRSEVPAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYTAHA 424 (1157)
T ss_pred cHHHHHHH-hchhhcchhHHHHHHHHHHHHHHHHHH---hhhhhhhhhhhhccccccceEEeeccchhhhhcCCceeccc
Confidence 99999974 455668888889999999999999998 99999999999999999999999999999998765543333
Q ss_pred ccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHHHhcCccccccCcccCCcccHHHH
Q 005940 516 NVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVAT-GRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSYVVKEM 594 (668)
Q Consensus 516 ~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 594 (668)
...-...|.|||-+....++.|+|||+|||+||||.| |..||.+-+.. .+..+.+.+-.++ ....+.
T Consensus 425 GAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlS---qVY~LLEkgyRM~---------~PeGCP 492 (1157)
T KOG4278|consen 425 GAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS---QVYGLLEKGYRMD---------GPEGCP 492 (1157)
T ss_pred CccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHH---HHHHHHhcccccc---------CCCCCC
Confidence 3344668999999998999999999999999999998 99999754322 2333333322121 122334
Q ss_pred HHHHHHHhhcCCC-CCCCCCHHHHHHHhcc
Q 005940 595 ELVLKLGLMCSHK-TQFRPTMRQVMRYLSG 623 (668)
Q Consensus 595 ~~l~~l~~~C~~~-p~~RPs~~evl~~L~~ 623 (668)
..+.+|++.||+. |.+||++.|+-+.++.
T Consensus 493 pkVYeLMraCW~WsPsDRPsFaeiHqafEt 522 (1157)
T KOG4278|consen 493 PKVYELMRACWNWSPSDRPSFAEIHQAFET 522 (1157)
T ss_pred HHHHHHHHHHhcCCcccCccHHHHHHHHHH
Confidence 5678888999998 9999999999998864
|
|
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=313.39 Aligned_cols=242 Identities=25% Similarity=0.333 Sum_probs=190.2
Q ss_pred eeeeecCcEEEEEEEeCCCCcEEEEEEEecCC---chhHHHHHHHHHHHhcc-cccCceeEeeeecccCceEEEEEecCC
Q 005940 359 EVIGIGGFGSVYKGVLPTTGGEVAVKKITRNS---LQGMREFAAEIESLGRL-RHKNLVNLHGWCKQKNDLLLVYEYIPN 434 (668)
Q Consensus 359 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~E~~~~ 434 (668)
++||+|+||.||+|++..+++.||+|++.+.. ....+.+..|.+++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999999899999999997642 23345567788888764 899999999999999999999999999
Q ss_pred CChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCCCCcc
Q 005940 435 GSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHT 514 (668)
Q Consensus 435 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 514 (668)
|+|..++.. ...+++.++..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++...... ...
T Consensus 81 g~L~~~i~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~ 153 (316)
T cd05620 81 GDLMFHIQD---KGRFDLYRATFYAAEIVCGLQFLHS---KGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD-NRA 153 (316)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEeCccCCCeecccCC-Cce
Confidence 999998853 3458999999999999999999999 999999999999999999999999999987533222 123
Q ss_pred cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCcccCCcccHHHH
Q 005940 515 TNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSYVVKEM 594 (668)
Q Consensus 515 ~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 594 (668)
....||..|+|||++.+..++.++|||||||++|||++|+.||...+.. +. .+..... .+.+..... .+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~--~~-~~~~~~~------~~~~~~~~~-~~- 222 (316)
T cd05620 154 STFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED--EL-FESIRVD------TPHYPRWIT-KE- 222 (316)
T ss_pred eccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH--HH-HHHHHhC------CCCCCCCCC-HH-
Confidence 3457899999999999889999999999999999999999999755322 11 1111111 111111122 22
Q ss_pred HHHHHHHhhcCCC-CCCCCCHH-HHHHH
Q 005940 595 ELVLKLGLMCSHK-TQFRPTMR-QVMRY 620 (668)
Q Consensus 595 ~~l~~l~~~C~~~-p~~RPs~~-evl~~ 620 (668)
+..+...|++. |++||++. +++++
T Consensus 223 --~~~li~~~l~~dP~~R~~~~~~~~~h 248 (316)
T cd05620 223 --SKDILEKLFERDPTRRLGVVGNIRGH 248 (316)
T ss_pred --HHHHHHHHccCCHHHcCCChHHHHcC
Confidence 33455577776 99999984 66643
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=298.10 Aligned_cols=249 Identities=30% Similarity=0.464 Sum_probs=200.6
Q ss_pred eeeeecCcEEEEEEEeCCC---CcEEEEEEEecCCchh-HHHHHHHHHHHhcccccCceeEeeeecccCceEEEEEecCC
Q 005940 359 EVIGIGGFGSVYKGVLPTT---GGEVAVKKITRNSLQG-MREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEYIPN 434 (668)
Q Consensus 359 ~~lG~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~~~-~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~ 434 (668)
+.||+|+||.||+|..... +..|++|.+....... .+.+.+|++.+.+++|+||+++++++......++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 4699999999999999765 8899999997655433 67899999999999999999999999999999999999999
Q ss_pred CChhhhhcCCCC------CCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccC
Q 005940 435 GSLDTLLFKPKD------GSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDH 508 (668)
Q Consensus 435 gsL~~~l~~~~~------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~ 508 (668)
++|.+++..... ...+++.+++.++.|++.||.|||+ .+++||||||+||++++++.+||+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHc---CCcccCccCcceEEECCCCcEEEccccccccccc
Confidence 999999964321 3679999999999999999999998 9999999999999999999999999999987654
Q ss_pred CCC-CcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHHHhcCccccccCcccC
Q 005940 509 GGM-PHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVAT-GRRPIGSGDLLLVEWVRECHQLGRILDVADPLLN 586 (668)
Q Consensus 509 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 586 (668)
... .......++..|+|||.+....++.++||||+|+++|||++ |+.||...+.. +. .+........ ...
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~~-~~~~~~~~~~-----~~~ 229 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNE--EV-LEYLRKGYRL-----PKP 229 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHH--HH-HHHHHcCCCC-----CCC
Confidence 321 12233467889999999988889999999999999999999 69999765321 11 1111111111 111
Q ss_pred CcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhc
Q 005940 587 SSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLS 622 (668)
Q Consensus 587 ~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~ 622 (668)
... ...+..+...|++. |++||++.|++++|+
T Consensus 230 ~~~----~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 230 EYC----PDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred ccC----ChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 111 23455666788887 999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=301.58 Aligned_cols=251 Identities=24% Similarity=0.383 Sum_probs=195.7
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCC-----chhHHHHHHHHHHHhcccccCceeEeeeeccc--Cce
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNS-----LQGMREFAAEIESLGRLRHKNLVNLHGWCKQK--NDL 425 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~--~~~ 425 (668)
++|...++||+|+||.||+|.+..++..||||.+.... ....+.+.+|++++++++|+||+++++++.+. ..+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 47888999999999999999998889999999885422 23356788999999999999999999988653 467
Q ss_pred EEEEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCcee
Q 005940 426 LLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARL 505 (668)
Q Consensus 426 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~ 505 (668)
+++|||+++++|.+++.. ...+++..+++++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||+++.
T Consensus 82 ~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~ 155 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKS---YGALTENVTRKYTRQILEGVSYLHS---NMIVHRDIKGANILRDSVGNVKLGDFGASKR 155 (265)
T ss_pred EEEEEecCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEecCCCCEEECcCccccc
Confidence 899999999999999853 2347889999999999999999998 9999999999999999999999999999986
Q ss_pred ccCCCC--CcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCc
Q 005940 506 YDHGGM--PHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADP 583 (668)
Q Consensus 506 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~ 583 (668)
...... .......++..|+|||.+.+...+.++|||||||++|||++|+.||...+.... ..+..... ..+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~--~~~~~~~~-----~~~ 228 (265)
T cd06652 156 LQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAA--IFKIATQP-----TNP 228 (265)
T ss_pred cccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHH--HHHHhcCC-----CCC
Confidence 543211 112234688899999999888899999999999999999999999965422211 11111110 111
Q ss_pred ccCCcccHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 005940 584 LLNSSYVVKEMELVLKLGLMCSHKTQFRPTMRQVMRY 620 (668)
Q Consensus 584 ~l~~~~~~~~~~~l~~l~~~C~~~p~~RPs~~evl~~ 620 (668)
... ......+..+...|+.+|++||+++||+++
T Consensus 229 ~~~----~~~~~~~~~~i~~~l~~p~~Rp~~~~il~~ 261 (265)
T cd06652 229 VLP----PHVSDHCRDFLKRIFVEAKLRPSADELLRH 261 (265)
T ss_pred CCc----hhhCHHHHHHHHHHhcChhhCCCHHHHhcC
Confidence 121 122223334445666679999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=308.22 Aligned_cols=201 Identities=30% Similarity=0.444 Sum_probs=172.6
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCc-hhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEEe
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSL-QGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEY 431 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~ 431 (668)
++|...++||+|+||.||+|+...+++.||+|++..... .....+.+|++++++++|+||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 468889999999999999999988899999999875432 2334677899999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCCC
Q 005940 432 IPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGM 511 (668)
Q Consensus 432 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~~ 511 (668)
+++ +|.+++.. .+..+++..+..++.||+.||.|||+ .+|+||||||+||+++.++.+||+|||+++.......
T Consensus 86 ~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 159 (309)
T cd07872 86 LDK-DLKQYMDD--CGNIMSMHNVKIFLYQILRGLAYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK 159 (309)
T ss_pred CCC-CHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECccccceecCCCcc
Confidence 975 88888753 23458899999999999999999998 9999999999999999999999999999986543221
Q ss_pred CcccccccCCcccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 005940 512 PHTTNVVGTFGYIAPELTQT-GKASTSSDVFAYGILLLEVATGRRPIGSG 560 (668)
Q Consensus 512 ~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~S~Gvvl~elltG~~p~~~~ 560 (668)
......++..|+|||.+.+ ..++.++|||||||++|||++|+.||...
T Consensus 160 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~ 208 (309)
T cd07872 160 -TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGS 208 (309)
T ss_pred -ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 1223467899999998764 46789999999999999999999999754
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=311.98 Aligned_cols=261 Identities=26% Similarity=0.391 Sum_probs=203.8
Q ss_pred hcCcccceeeeecCcEEEEEEEeC-------CCCcEEEEEEEecCC-chhHHHHHHHHHHHhcc-cccCceeEeeeeccc
Q 005940 352 TKGFKESEVIGIGGFGSVYKGVLP-------TTGGEVAVKKITRNS-LQGMREFAAEIESLGRL-RHKNLVNLHGWCKQK 422 (668)
Q Consensus 352 t~~f~~~~~lG~G~~g~Vy~~~~~-------~~~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~ 422 (668)
..+|.+.+.||+|+||.||+++.. .++..||+|.+.... ....+++.+|+.+++.+ +||||+++++++...
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 93 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 93 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence 356788899999999999999752 234579999886543 34457889999999999 799999999999999
Q ss_pred CceEEEEEecCCCChhhhhcCCC-------------CCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEE
Q 005940 423 NDLLLVYEYIPNGSLDTLLFKPK-------------DGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALI 489 (668)
Q Consensus 423 ~~~~lV~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll 489 (668)
...++||||+++|+|.+++.... ....++|.+++.++.||+.||.|||+ .+++||||||+||++
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~---~givH~dlkp~Nili 170 (304)
T cd05101 94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLAS---QKCIHRDLAARNVLV 170 (304)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHH---CCeeecccccceEEE
Confidence 99999999999999999996432 12458899999999999999999998 999999999999999
Q ss_pred CCCCCEEEEeecCceeccCCCCC-cccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCchhHHHH
Q 005940 490 DAEMNARLGDFGLARLYDHGGMP-HTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVAT-GRRPIGSGDLLLVEW 567 (668)
Q Consensus 490 ~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~l~~~ 567 (668)
++++.+||+|||+++........ ......++..|+|||++.+..++.++||||||+++|||++ |..||.... ..++
T Consensus 171 ~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~--~~~~ 248 (304)
T cd05101 171 TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP--VEEL 248 (304)
T ss_pred cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC--HHHH
Confidence 99999999999999876543221 1222345678999999988889999999999999999998 788886432 2222
Q ss_pred HHHHHhcCccccccCcccCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhccCcCC
Q 005940 568 VRECHQLGRILDVADPLLNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSGEKQL 627 (668)
Q Consensus 568 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~~~~~ 627 (668)
......... .. .... ....+..+...|++. |++||++.||++.|+....+
T Consensus 249 ~~~~~~~~~-~~-----~~~~----~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~ 299 (304)
T cd05101 249 FKLLKEGHR-MD-----KPAN----CTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL 299 (304)
T ss_pred HHHHHcCCc-CC-----CCCC----CCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence 222221111 11 0011 123455677789997 99999999999999876544
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=310.21 Aligned_cols=256 Identities=25% Similarity=0.350 Sum_probs=200.8
Q ss_pred cCcccceeeeecCcEEEEEEEe-----CCCCcEEEEEEEecCC-chhHHHHHHHHHHHhcc-cccCceeEeeeecccCce
Q 005940 353 KGFKESEVIGIGGFGSVYKGVL-----PTTGGEVAVKKITRNS-LQGMREFAAEIESLGRL-RHKNLVNLHGWCKQKNDL 425 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~-----~~~~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~ 425 (668)
++|...+.||+|+||.||+++. ...+..||||++.... ....+.+.+|+++++++ +|+||++++++|...+..
T Consensus 35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 114 (302)
T cd05055 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPI 114 (302)
T ss_pred HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCce
Confidence 4688899999999999999975 2345589999987543 33456789999999999 799999999999999999
Q ss_pred EEEEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCcee
Q 005940 426 LLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARL 505 (668)
Q Consensus 426 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~ 505 (668)
++||||+++|+|.+++... ....+++.++..++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||+++.
T Consensus 115 ~lv~e~~~~~~L~~~i~~~-~~~~l~~~~~~~i~~~i~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~ 190 (302)
T cd05055 115 LVITEYCCYGDLLNFLRRK-RESFLTLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNVLLTHGKIVKICDFGLARD 190 (302)
T ss_pred EEEEEcCCCCcHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHH---CCeehhhhccceEEEcCCCeEEECCCccccc
Confidence 9999999999999999632 23448999999999999999999998 9999999999999999999999999999986
Q ss_pred ccCCCCC-cccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHHHhcCccccccCc
Q 005940 506 YDHGGMP-HTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVAT-GRRPIGSGDLLLVEWVRECHQLGRILDVADP 583 (668)
Q Consensus 506 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~ 583 (668)
....... ......++..|+|||.+..+.++.++|||||||++|||++ |..||...... +-..+....+...
T Consensus 191 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~--~~~~~~~~~~~~~----- 263 (302)
T cd05055 191 IMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVD--SKFYKLIKEGYRM----- 263 (302)
T ss_pred ccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCch--HHHHHHHHcCCcC-----
Confidence 5433211 1122345678999999988889999999999999999998 99998654211 1111111111100
Q ss_pred ccCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhcc
Q 005940 584 LLNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSG 623 (668)
Q Consensus 584 ~l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~ 623 (668)
...... ...+..++..|+.. |++||++.||++.|+.
T Consensus 264 ~~~~~~----~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~ 300 (302)
T cd05055 264 AQPEHA----PAEIYDIMKTCWDADPLKRPTFKQIVQLIGK 300 (302)
T ss_pred CCCCCC----CHHHHHHHHHHcCCCchhCcCHHHHHHHHHh
Confidence 000111 13456677789987 9999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=308.74 Aligned_cols=260 Identities=23% Similarity=0.384 Sum_probs=202.0
Q ss_pred HhcCcccceeeeecCcEEEEEEEeCC-----CCcEEEEEEEecCC-chhHHHHHHHHHHHhcccccCceeEeeeecccCc
Q 005940 351 ATKGFKESEVIGIGGFGSVYKGVLPT-----TGGEVAVKKITRNS-LQGMREFAAEIESLGRLRHKNLVNLHGWCKQKND 424 (668)
Q Consensus 351 at~~f~~~~~lG~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~ 424 (668)
..++|++.++||+|+||.||+|..+. .+..||+|.+.... ......+.+|+.++++++|+||+++++.+.....
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 35678999999999999999997642 24579999886543 2334568899999999999999999999999999
Q ss_pred eEEEEEecCCCChhhhhcCCCC-------CCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEE
Q 005940 425 LLLVYEYIPNGSLDTLLFKPKD-------GSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARL 497 (668)
Q Consensus 425 ~~lV~E~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl 497 (668)
.++||||+++|+|.+++..... ...+++..+..++.|++.||.|||+ ++|+||||||+||++++++.+||
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNA---KKFVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCCcCCCCChheEEEcCCCcEEE
Confidence 9999999999999999964221 2346778899999999999999998 99999999999999999999999
Q ss_pred EeecCceeccCCCCCc-ccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHHHhcC
Q 005940 498 GDFGLARLYDHGGMPH-TTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVAT-GRRPIGSGDLLLVEWVRECHQLG 575 (668)
Q Consensus 498 ~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~l~~~~~~~~~~~ 575 (668)
+|||+++......... .....++..|+|||.+.++.++.++|||||||++|||++ |..||...+.. +....... +
T Consensus 161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~--~~~~~~~~-~ 237 (288)
T cd05061 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE--QVLKFVMD-G 237 (288)
T ss_pred CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHc-C
Confidence 9999998654322211 122245678999999988889999999999999999999 78888653321 11111111 1
Q ss_pred ccccccCcccCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhccCc
Q 005940 576 RILDVADPLLNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSGEK 625 (668)
Q Consensus 576 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~~~ 625 (668)
... ..... ....+..++..|++. |++||++.++++.|+...
T Consensus 238 ~~~-----~~~~~----~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 238 GYL-----DQPDN----CPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred CCC-----CCCCC----CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 111 11111 124566777789988 999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=322.14 Aligned_cols=258 Identities=24% Similarity=0.363 Sum_probs=200.4
Q ss_pred cCcccceeeeecCcEEEEEEEeC-----CCCcEEEEEEEecCCc-hhHHHHHHHHHHHhccc-ccCceeEeeeecccCce
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLP-----TTGGEVAVKKITRNSL-QGMREFAAEIESLGRLR-HKNLVNLHGWCKQKNDL 425 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~-~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~ 425 (668)
++|...++||+|+||.||+|++. ..+..||||++..... ...+.+..|++++.++. ||||+++++.|...+..
T Consensus 37 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~ 116 (401)
T cd05107 37 DNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPI 116 (401)
T ss_pred HHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCc
Confidence 45777899999999999999863 2346899999976433 33457889999999997 99999999999999999
Q ss_pred EEEEEecCCCChhhhhcCCC------------------------------------------------------------
Q 005940 426 LLVYEYIPNGSLDTLLFKPK------------------------------------------------------------ 445 (668)
Q Consensus 426 ~lV~E~~~~gsL~~~l~~~~------------------------------------------------------------ 445 (668)
++|+||+++|+|.++++...
T Consensus 117 ~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (401)
T cd05107 117 YIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMK 196 (401)
T ss_pred EEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcch
Confidence 99999999999999986421
Q ss_pred -----------------------------------CCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEEC
Q 005940 446 -----------------------------------DGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALID 490 (668)
Q Consensus 446 -----------------------------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~ 490 (668)
....++|..++.++.||+.||.|||+ .+++||||||+|||++
T Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrdlkp~NiLl~ 273 (401)
T cd05107 197 GTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLAS---KNCVHRDLAARNVLIC 273 (401)
T ss_pred hhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhc---CCcCcccCCcceEEEe
Confidence 11247888899999999999999998 9999999999999999
Q ss_pred CCCCEEEEeecCceeccCCCC-CcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHH
Q 005940 491 AEMNARLGDFGLARLYDHGGM-PHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVAT-GRRPIGSGDLLLVEWV 568 (668)
Q Consensus 491 ~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~l~~~~ 568 (668)
+++.+||+|||+++....... .......++..|+|||.+....++.++|||||||++|||++ |+.||...... +..
T Consensus 274 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~--~~~ 351 (401)
T cd05107 274 EGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMN--EQF 351 (401)
T ss_pred CCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCch--HHH
Confidence 999999999999986543221 12223456788999999988889999999999999999998 88898643211 111
Q ss_pred HHHHhcCccccccCcccCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhccC
Q 005940 569 RECHQLGRILDVADPLLNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSGE 624 (668)
Q Consensus 569 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~~ 624 (668)
......+... ...... ...+..++..|++. |++||+++||++.|+..
T Consensus 352 ~~~~~~~~~~-----~~p~~~----~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~ 399 (401)
T cd05107 352 YNAIKRGYRM-----AKPAHA----SDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDL 399 (401)
T ss_pred HHHHHcCCCC-----CCCCCC----CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 1111111101 011111 13455666789997 99999999999999764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=304.96 Aligned_cols=253 Identities=30% Similarity=0.480 Sum_probs=199.9
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCC---cEEEEEEEecCC-chhHHHHHHHHHHHhcccccCceeEeeeecccCceEEE
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTG---GEVAVKKITRNS-LQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLV 428 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~---~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV 428 (668)
.+|++.+.||+|+||.||+|.+..++ ..+|+|.+.... ....+.|..|+.++++++||||+++++++...+..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 46778899999999999999875443 369999886543 23456889999999999999999999999999999999
Q ss_pred EEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccC
Q 005940 429 YEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDH 508 (668)
Q Consensus 429 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~ 508 (668)
|||+++++|.+++.. ....+++.+++.++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++.....
T Consensus 84 ~e~~~~~~L~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd05066 84 TEYMENGSLDAFLRK--HDGQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 158 (267)
T ss_pred EEcCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeehhhchhcEEECCCCeEEeCCCCccccccc
Confidence 999999999999963 23468999999999999999999998 9999999999999999999999999999987654
Q ss_pred CCCCcc--cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCch-hHHHHHHHHHhcCccccccCcc
Q 005940 509 GGMPHT--TNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVAT-GRRPIGSGDL-LLVEWVRECHQLGRILDVADPL 584 (668)
Q Consensus 509 ~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~-~l~~~~~~~~~~~~~~~~~d~~ 584 (668)
...... ....++..|+|||++.++.++.++|||||||++||+++ |..||..... ....++. ..... +.
T Consensus 159 ~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~---~~~~~-----~~ 230 (267)
T cd05066 159 DPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIE---EGYRL-----PA 230 (267)
T ss_pred ccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHh---CCCcC-----CC
Confidence 322111 11223567999999988889999999999999999886 9999965432 2222211 11010 11
Q ss_pred cCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhcc
Q 005940 585 LNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSG 623 (668)
Q Consensus 585 l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~ 623 (668)
.... ...+..+...|++. |++||+|.++++.|+.
T Consensus 231 -~~~~----~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 265 (267)
T cd05066 231 -PMDC----PAALHQLMLDCWQKDRNERPKFEQIVSILDK 265 (267)
T ss_pred -CCCC----CHHHHHHHHHHcccCchhCCCHHHHHHHHHh
Confidence 1111 23455677789987 9999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=302.12 Aligned_cols=253 Identities=30% Similarity=0.473 Sum_probs=202.3
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCchhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEEec
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEYI 432 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~ 432 (668)
++|.+.++||+|++|.||+|.+. ++..+|||.+..... ..+++.+|+.++++++|+||+++++++......++||||+
T Consensus 6 ~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 83 (261)
T cd05034 6 ESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTM-SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYM 83 (261)
T ss_pred hheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCcc-CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEecc
Confidence 57888999999999999999985 567899999875443 3467899999999999999999999999888999999999
Q ss_pred CCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCCCC
Q 005940 433 PNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMP 512 (668)
Q Consensus 433 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~~~ 512 (668)
++++|.+++... ....+++.++..++.|++.||.|||+ .+++|+||||+||++++++.+||+|||+++........
T Consensus 84 ~~~~L~~~i~~~-~~~~~~~~~~~~~~~~i~~al~~lh~---~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~ 159 (261)
T cd05034 84 SKGSLLDFLKSG-EGKKLRLPQLVDMAAQIAEGMAYLES---RNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYT 159 (261)
T ss_pred CCCCHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcchheEEEcCCCCEEECccccceeccchhhh
Confidence 999999999642 34568999999999999999999998 89999999999999999999999999999876543222
Q ss_pred cccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHHHhcCccccccCcccCCcccH
Q 005940 513 HTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVAT-GRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSYVV 591 (668)
Q Consensus 513 ~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 591 (668)
......++..|+|||.+.+..++.++||||||+++|||++ |+.||...+.. ........... .......
T Consensus 160 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~--~~~~~~~~~~~------~~~~~~~-- 229 (261)
T cd05034 160 AREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR--EVLEQVERGYR------MPRPPNC-- 229 (261)
T ss_pred hhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHcCCC------CCCCCCC--
Confidence 2223345678999999988889999999999999999999 99999654321 11111111100 0001111
Q ss_pred HHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhcc
Q 005940 592 KEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSG 623 (668)
Q Consensus 592 ~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~ 623 (668)
...+..++..|+.. |++||+++++.+.|+.
T Consensus 230 --~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 230 --PEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred --CHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 23456677788887 9999999999998874
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=307.56 Aligned_cols=200 Identities=29% Similarity=0.390 Sum_probs=176.2
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCC-chhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEEe
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNS-LQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEY 431 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~ 431 (668)
++|++.++||+|+||.||++.+..++..+|+|.+.... ....+++.+|++++++++||||+++++.|...+..++||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 36889999999999999999998889999999987543 23446788999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCCC
Q 005940 432 IPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGM 511 (668)
Q Consensus 432 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~~ 511 (668)
+++++|.+++.. ...+++..+..++.|+++||.|||+ ..+++||||||+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~- 154 (308)
T cd06615 81 MDGGSLDQVLKK---AGRIPENILGKISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM- 154 (308)
T ss_pred cCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh--hCCEEECCCChHHEEEecCCcEEEccCCCcccccccc-
Confidence 999999999963 2458999999999999999999997 2589999999999999999999999999987654322
Q ss_pred CcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 005940 512 PHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSG 560 (668)
Q Consensus 512 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~ 560 (668)
.....++..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 155 --~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~ 201 (308)
T cd06615 155 --ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPP 201 (308)
T ss_pred --cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCc
Confidence 23346889999999998888999999999999999999999998644
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=306.33 Aligned_cols=247 Identities=28% Similarity=0.417 Sum_probs=199.9
Q ss_pred CcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCC-chhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEEec
Q 005940 354 GFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNS-LQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEYI 432 (668)
Q Consensus 354 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~ 432 (668)
.|+..+.||+|++|.||+|.+..++..||+|.+.... ....+.+..|++++++++|+||+++++.+......++||||+
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence 4566788999999999999998888999999987543 344567899999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCCCC
Q 005940 433 PNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMP 512 (668)
Q Consensus 433 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~~~ 512 (668)
++++|.+++.. ..+++..+..++.|+++||.|||+ .+++|+||+|+||++++++.+||+|||++........
T Consensus 85 ~~~~L~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~---~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~- 156 (277)
T cd06642 85 GGGSALDLLKP----GPLEETYIATILREILKGLDYLHS---ERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI- 156 (277)
T ss_pred CCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhc---CCeeccCCChheEEEeCCCCEEEccccccccccCcch-
Confidence 99999998842 458999999999999999999998 9999999999999999999999999999986654321
Q ss_pred cccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCcccCCcccHH
Q 005940 513 HTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSYVVK 592 (668)
Q Consensus 513 ~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 592 (668)
......++..|+|||++.+..++.++|||||||++|||++|+.|+........ ... .... ..+.+...
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~--~~~-~~~~-----~~~~~~~~---- 224 (277)
T cd06642 157 KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRV--LFL-IPKN-----SPPTLEGQ---- 224 (277)
T ss_pred hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhH--Hhh-hhcC-----CCCCCCcc----
Confidence 12234678899999999988899999999999999999999999864322111 111 1111 11222221
Q ss_pred HHHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 593 EMELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 593 ~~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
....+..+...|++. |++||++.+|+++
T Consensus 225 ~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 225 YSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred cCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 223455666789887 9999999999985
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=304.05 Aligned_cols=250 Identities=27% Similarity=0.374 Sum_probs=197.7
Q ss_pred cccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCc---hhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEEe
Q 005940 355 FKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSL---QGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEY 431 (668)
Q Consensus 355 f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~ 431 (668)
|+..++||+|+||.||++.+..+++.||||.+..... ...+.+.+|+.++++++|+|++++++.+...+..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 6677899999999999999998999999999875432 2235677899999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCCC
Q 005940 432 IPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGM 511 (668)
Q Consensus 432 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~~ 511 (668)
+++++|.+++... ....+++.++..++.|++.||.|||+ .+|+||||||+||++++++.++|+|||++........
T Consensus 82 ~~g~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~---~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 157 (285)
T cd05630 82 MNGGDLKFHIYHM-GEAGFEEGRAVFYAAEICCGLEDLHQ---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT 157 (285)
T ss_pred cCCCcHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc
Confidence 9999999988532 23458999999999999999999998 9999999999999999999999999999976543321
Q ss_pred CcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHH-HHHHHHHhcCccccccCcccCCccc
Q 005940 512 PHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLV-EWVRECHQLGRILDVADPLLNSSYV 590 (668)
Q Consensus 512 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~-~~~~~~~~~~~~~~~~d~~l~~~~~ 590 (668)
.....|+..|+|||++.+..++.++|||||||++|||++|+.||........ +-....... .. ......+.
T Consensus 158 --~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~--~~----~~~~~~~~ 229 (285)
T cd05630 158 --IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE--VQ----EEYSEKFS 229 (285)
T ss_pred --ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhh--hh----hhcCccCC
Confidence 1234689999999999988999999999999999999999999975422111 111111110 00 11111222
Q ss_pred HHHHHHHHHHHhhcCCC-CCCCCC-----HHHHHHH
Q 005940 591 VKEMELVLKLGLMCSHK-TQFRPT-----MRQVMRY 620 (668)
Q Consensus 591 ~~~~~~l~~l~~~C~~~-p~~RPs-----~~evl~~ 620 (668)
..+..+...|++. |++||+ ++|++++
T Consensus 230 ----~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h 261 (285)
T cd05630 230 ----PDARSLCKMLLCKDPKERLGCQGGGAREVKEH 261 (285)
T ss_pred ----HHHHHHHHHHhhcCHHHccCCCCCchHHHHcC
Confidence 2244556678886 999999 8888874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-35 Score=297.03 Aligned_cols=251 Identities=27% Similarity=0.367 Sum_probs=204.1
Q ss_pred CcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecC--CchhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEEe
Q 005940 354 GFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRN--SLQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEY 431 (668)
Q Consensus 354 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~ 431 (668)
+|+..+.||.|+||.||.+....+++.+++|.+... .....+++.+|++++++++|+||+++++++.+.+..+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 478899999999999999999888999999998654 334567889999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCCC
Q 005940 432 IPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGM 511 (668)
Q Consensus 432 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~~ 511 (668)
+++++|.+++.... ...+++.++..++.|++.||.|||+ .+++||||+|+||++++++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~ 156 (256)
T cd08221 81 ANGGTLYDKIVRQK-GQLFEEEMVLWYLFQIVSAVSYIHK---AGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS 156 (256)
T ss_pred cCCCcHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHh---CCccccCCChHhEEEeCCCCEEECcCcceEEcccccc
Confidence 99999999996432 4568999999999999999999998 8999999999999999999999999999987654332
Q ss_pred CcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCcccCCcccH
Q 005940 512 PHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSYVV 591 (668)
Q Consensus 512 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 591 (668)
......++..|+|||.+.+...+.++||||||+++|||++|+.||...+. .+....... +..... ...+
T Consensus 157 -~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~--~~~~~~~~~-~~~~~~-----~~~~-- 225 (256)
T cd08221 157 -MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNP--LNLVVKIVQ-GNYTPV-----VSVY-- 225 (256)
T ss_pred -cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCH--HHHHHHHHc-CCCCCC-----cccc--
Confidence 22334688999999999888889999999999999999999999975432 222222221 111111 0111
Q ss_pred HHHHHHHHHHhhcCCC-CCCCCCHHHHHHHh
Q 005940 592 KEMELVLKLGLMCSHK-TQFRPTMRQVMRYL 621 (668)
Q Consensus 592 ~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L 621 (668)
...+..+...|++. |++||+++++++++
T Consensus 226 --~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 226 --SSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred --CHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 12345666688876 99999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=306.99 Aligned_cols=250 Identities=24% Similarity=0.358 Sum_probs=202.0
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCchhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEEec
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEYI 432 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~ 432 (668)
.+|...+.||+|++|.||+|....+++.||+|.+........+.+.+|+.+++.++|+||+++++++......++||||+
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 98 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 98 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeeccc
Confidence 57889999999999999999998889999999998766566677899999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCCCC
Q 005940 433 PNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMP 512 (668)
Q Consensus 433 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~~~ 512 (668)
++++|.+++.. ..+++.++..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++........
T Consensus 99 ~~~~L~~~~~~----~~~~~~~~~~~~~~l~~~L~~LH~---~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~- 170 (297)
T cd06656 99 AGGSLTDVVTE----TCMDEGQIAAVCRECLQALDFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS- 170 (297)
T ss_pred CCCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEECcCccceEccCCcc-
Confidence 99999999852 348899999999999999999998 9999999999999999999999999999986544322
Q ss_pred cccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCcccCCcccHH
Q 005940 513 HTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSYVVK 592 (668)
Q Consensus 513 ~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 592 (668)
......++..|+|||.+.++.++.++|||||||++|+|++|+.||...+..- ........+ .+.+. ....
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~--~~~~~~~~~------~~~~~--~~~~ 240 (297)
T cd06656 171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR--ALYLIATNG------TPELQ--NPER 240 (297)
T ss_pred CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcch--heeeeccCC------CCCCC--Cccc
Confidence 1223468889999999988889999999999999999999999996543210 000000000 01110 0011
Q ss_pred HHHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 593 EMELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 593 ~~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
....+..+...|+.. |++||++++|+++
T Consensus 241 ~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (297)
T cd06656 241 LSAVFRDFLNRCLEMDVDRRGSAKELLQH 269 (297)
T ss_pred cCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 112344566688887 9999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=299.45 Aligned_cols=245 Identities=25% Similarity=0.352 Sum_probs=192.7
Q ss_pred eeeecCcEEEEEEEe--CCCCcEEEEEEEecCC--chhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEEecCCC
Q 005940 360 VIGIGGFGSVYKGVL--PTTGGEVAVKKITRNS--LQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEYIPNG 435 (668)
Q Consensus 360 ~lG~G~~g~Vy~~~~--~~~~~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~g 435 (668)
.||+|+||.||+|.+ ..++..+|+|++.... ....+++..|+.++++++|+||+++++++.. ...++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCCC
Confidence 589999999999975 3467889999986543 2345789999999999999999999999864 5678999999999
Q ss_pred ChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCCCCc--
Q 005940 436 SLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPH-- 513 (668)
Q Consensus 436 sL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~~~~-- 513 (668)
+|.+++.. ...+++..+..++.|++.||+|||+ ++++||||||+||+++.++.+||+|||+++.........
T Consensus 81 ~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 154 (257)
T cd05116 81 PLNKFLQK---NKHVTEKNITELVHQVSMGMKYLEE---TNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKA 154 (257)
T ss_pred cHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeee
Confidence 99999953 2458999999999999999999998 999999999999999999999999999998765433211
Q ss_pred ccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHHHhcCccccccCcccCCcccHH
Q 005940 514 TTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVAT-GRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSYVVK 592 (668)
Q Consensus 514 ~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 592 (668)
.....++..|+|||.+....++.++|||||||++|||++ |+.||...... ++.... ..+... ......+
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--~~~~~i-~~~~~~-----~~~~~~~-- 224 (257)
T cd05116 155 KTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN--EVTQMI-ESGERM-----ECPQRCP-- 224 (257)
T ss_pred cCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHH-HCCCCC-----CCCCCCC--
Confidence 122234578999999988889999999999999999998 99999754322 222222 111111 1111222
Q ss_pred HHHHHHHHHhhcCCC-CCCCCCHHHHHHHhcc
Q 005940 593 EMELVLKLGLMCSHK-TQFRPTMRQVMRYLSG 623 (668)
Q Consensus 593 ~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~ 623 (668)
..+..+...|+.. |++||++.+|.+.|++
T Consensus 225 --~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 225 --PEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred --HHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 2345677789886 9999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=301.44 Aligned_cols=251 Identities=26% Similarity=0.437 Sum_probs=200.8
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCchhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEEec
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEYI 432 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~ 432 (668)
.+|+..+.||+|++|.||++.+. .+..+|+|.+..... ...+|.+|++++++++|||++++++++......++||||+
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFM 81 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcC
Confidence 46778899999999999999885 477899998865433 3457899999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCCCC
Q 005940 433 PNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMP 512 (668)
Q Consensus 433 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~~~ 512 (668)
++++|.+++.. ....+++..++.++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++.........
T Consensus 82 ~~~~L~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~ 156 (256)
T cd05112 82 EHGCLSDYLRA--QRGKFSQETLLGMCLDVCEGMAYLES---SNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYT 156 (256)
T ss_pred CCCcHHHHHHh--CccCCCHHHHHHHHHHHHHHHHHHHH---CCccccccccceEEEcCCCeEEECCCcceeecccCccc
Confidence 99999999853 23458999999999999999999998 89999999999999999999999999999865443222
Q ss_pred cccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHHHhcCccccccCcccCCcccH
Q 005940 513 HTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVAT-GRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSYVV 591 (668)
Q Consensus 513 ~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 591 (668)
......++.+|+|||.+.++.++.++||||||+++|||++ |+.||...... +......... ....+..
T Consensus 157 ~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~--~~~~~~~~~~---~~~~~~~------ 225 (256)
T cd05112 157 SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNS--EVVETINAGF---RLYKPRL------ 225 (256)
T ss_pred ccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHH--HHHHHHhCCC---CCCCCCC------
Confidence 2222345678999999988889999999999999999998 99999754321 1122211111 1111221
Q ss_pred HHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhc
Q 005940 592 KEMELVLKLGLMCSHK-TQFRPTMRQVMRYLS 622 (668)
Q Consensus 592 ~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~ 622 (668)
....+..++..|++. |++||+++||++.|.
T Consensus 226 -~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 226 -ASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred -CCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 124567788899987 999999999999873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=314.96 Aligned_cols=198 Identities=28% Similarity=0.355 Sum_probs=170.3
Q ss_pred hcCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecC--CchhHHHHHHHHHHHhcccccCceeEeeeecccC------
Q 005940 352 TKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRN--SLQGMREFAAEIESLGRLRHKNLVNLHGWCKQKN------ 423 (668)
Q Consensus 352 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~------ 423 (668)
.++|+..+.||+|+||.||++.+..++..||||++... .......+.+|+.++++++||||+++++++....
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 99 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ 99 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence 47899999999999999999999888999999998653 2334567889999999999999999999986443
Q ss_pred ceEEEEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCc
Q 005940 424 DLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLA 503 (668)
Q Consensus 424 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla 503 (668)
..|+||||+++ +|.+.+. ..+++..+..++.||+.||.|||+ .+|+||||||+||+++.++.+||+|||++
T Consensus 100 ~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~---~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a 170 (359)
T cd07876 100 DVYLVMELMDA-NLCQVIH-----MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLA 170 (359)
T ss_pred eeEEEEeCCCc-CHHHHHh-----ccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEecCCCc
Confidence 47999999965 5666553 237889999999999999999999 99999999999999999999999999999
Q ss_pred eeccCCCCCcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 005940 504 RLYDHGGMPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSG 560 (668)
Q Consensus 504 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~ 560 (668)
+...... ......||..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 171 ~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~ 225 (359)
T cd07876 171 RTACTNF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGT 225 (359)
T ss_pred cccccCc--cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence 7643322 123357899999999999889999999999999999999999999754
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-35 Score=302.60 Aligned_cols=257 Identities=26% Similarity=0.424 Sum_probs=202.0
Q ss_pred hcCcccceeeeecCcEEEEEEEeCC-----CCcEEEEEEEecCC-chhHHHHHHHHHHHhcccccCceeEeeeecccCce
Q 005940 352 TKGFKESEVIGIGGFGSVYKGVLPT-----TGGEVAVKKITRNS-LQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDL 425 (668)
Q Consensus 352 t~~f~~~~~lG~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~ 425 (668)
.++|+..+.||+|+||.||++.+.. ++..||+|++.... .+..+++.+|+.++++++||||++++++|......
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 3578889999999999999998742 56789999987543 34456799999999999999999999999999999
Q ss_pred EEEEEecCCCChhhhhcCCC-------------------CCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCC
Q 005940 426 LLVYEYIPNGSLDTLLFKPK-------------------DGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSN 486 (668)
Q Consensus 426 ~lV~E~~~~gsL~~~l~~~~-------------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~N 486 (668)
++||||+++|+|.+++.... ....+++.+++.++.|++.||.|||+ .+++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~---~~i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSE---RKFVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---CCeecccccHhh
Confidence 99999999999999996321 12357899999999999999999998 999999999999
Q ss_pred EEECCCCCEEEEeecCceeccCCCC-CcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCchhH
Q 005940 487 ALIDAEMNARLGDFGLARLYDHGGM-PHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVAT-GRRPIGSGDLLL 564 (668)
Q Consensus 487 Ill~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~l 564 (668)
|++++++.+||+|||++........ ........+..|+|||.+.++.++.++|||||||++|||++ |..||.....
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~-- 238 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAH-- 238 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH--
Confidence 9999999999999999886543221 11222344667999999988899999999999999999998 8888864321
Q ss_pred HHHHHHHHhcCccccccCcccCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhcc
Q 005940 565 VEWVRECHQLGRILDVADPLLNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSG 623 (668)
Q Consensus 565 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~ 623 (668)
.++... ...+..... .... ...+..++.+|++. |++||++.|+++.|+.
T Consensus 239 ~~~~~~-~~~~~~~~~-----~~~~----~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 239 EEVIYY-VRDGNVLSC-----PDNC----PLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred HHHHHH-HhcCCCCCC-----CCCC----CHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 122222 122221111 1111 23456677889987 9999999999999863
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=336.41 Aligned_cols=258 Identities=23% Similarity=0.302 Sum_probs=199.2
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCc---hhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEE
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSL---QGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVY 429 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 429 (668)
++|.+.++||+|+||.||+|++..+++.||||++..... ...++|.+|++++++++||||+++++++.+.+..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 478899999999999999999988899999999975422 33467899999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCC--------CCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeec
Q 005940 430 EYIPNGSLDTLLFKPK--------DGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFG 501 (668)
Q Consensus 430 E~~~~gsL~~~l~~~~--------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfG 501 (668)
||+++|+|.+++.... ....+++..+++++.||++||+|||+ .+|+||||||+||+++.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs---~GIIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHS---KGVLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHH---CCccccCCchheEEEcCCCCEEEEecC
Confidence 9999999999985311 12346778899999999999999999 999999999999999999999999999
Q ss_pred CceeccCCC-----------------CCcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhH
Q 005940 502 LARLYDHGG-----------------MPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLL 564 (668)
Q Consensus 502 la~~~~~~~-----------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l 564 (668)
+++...... ........||+.|+|||++.+..++.++|||||||++|||+||+.||...+...
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 998762111 001122469999999999999899999999999999999999999997543211
Q ss_pred HHHHHHHHhcCccccccCcccCCcccHHHHHHHHHHHhhcCCC-CCCCC-CHHHHHHHhcc
Q 005940 565 VEWVRECHQLGRILDVADPLLNSSYVVKEMELVLKLGLMCSHK-TQFRP-TMRQVMRYLSG 623 (668)
Q Consensus 565 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~-p~~RP-s~~evl~~L~~ 623 (668)
..+. ..+............+ ..+..++..|+.. |++|| +++++++.|+.
T Consensus 239 i~~~------~~i~~P~~~~p~~~iP----~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~ 289 (932)
T PRK13184 239 ISYR------DVILSPIEVAPYREIP----PFLSQIAMKALAVDPAERYSSVQELKQDLEP 289 (932)
T ss_pred hhhh------hhccChhhccccccCC----HHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 1110 0110000000000111 2345566678887 99995 56777776654
|
|
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=301.06 Aligned_cols=251 Identities=24% Similarity=0.350 Sum_probs=200.0
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCchhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEEec
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEYI 432 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~ 432 (668)
++|...+.||+|+||.||+|.+..+++.||+|.+..........+.+|+.+++.++||||+++++.+...+..++|+||+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 88 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC 88 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence 46788899999999999999998889999999997765555667889999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCCCC
Q 005940 433 PNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMP 512 (668)
Q Consensus 433 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~~~ 512 (668)
++++|.+++.. ...+++.+++.++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||++....... .
T Consensus 89 ~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~-~ 161 (267)
T cd06645 89 GGGSLQDIYHV---TGPLSESQIAYVSRETLQGLYYLHS---KGKMHRDIKGANILLTDNGHVKLADFGVSAQITATI-A 161 (267)
T ss_pred CCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECcceeeeEccCcc-c
Confidence 99999999853 3468999999999999999999999 899999999999999999999999999987654322 2
Q ss_pred cccccccCCcccCccccc---CCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCcccCC--
Q 005940 513 HTTNVVGTFGYIAPELTQ---TGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNS-- 587 (668)
Q Consensus 513 ~~~~~~gt~~y~aPE~~~---~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~-- 587 (668)
......|+..|+|||++. .+.++.++|||||||++|||++|+.||......... ..... .... .+....
T Consensus 162 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~--~~~~~-~~~~---~~~~~~~~ 235 (267)
T cd06645 162 KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL--FLMTK-SNFQ---PPKLKDKM 235 (267)
T ss_pred ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhH--Hhhhc-cCCC---CCcccccC
Confidence 223457899999999874 456789999999999999999999998643221111 11111 1110 111111
Q ss_pred cccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 588 SYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 588 ~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
.+. ..+..+...|+.. |++||++++|+++
T Consensus 236 ~~~----~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 236 KWS----NSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred CCC----HHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 111 2344566678877 9999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=297.00 Aligned_cols=254 Identities=26% Similarity=0.348 Sum_probs=204.6
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCchhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEEec
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEYI 432 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~ 432 (668)
++|+..+.||+|++|.||+|....++..+++|.+........+.+.+|++++++++||||+++++.+......+++|||+
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~ 82 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC 82 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence 57888999999999999999998888999999998766666788999999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCCCC
Q 005940 433 PNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMP 512 (668)
Q Consensus 433 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~~~ 512 (668)
++++|.+++.. ....+++.++..++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||++........
T Consensus 83 ~~~~l~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~- 156 (262)
T cd06613 83 GGGSLQDIYQV--TRGPLSELQIAYVCRETLKGLAYLHE---TGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA- 156 (262)
T ss_pred CCCcHHHHHHh--hccCCCHHHHHHHHHHHHHHHHHHHh---CCceecCCChhhEEECCCCCEEECccccchhhhhhhh-
Confidence 99999999853 23568999999999999999999998 9999999999999999999999999999886554221
Q ss_pred cccccccCCcccCcccccCC---CCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCcccCCcc
Q 005940 513 HTTNVVGTFGYIAPELTQTG---KASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSY 589 (668)
Q Consensus 513 ~~~~~~gt~~y~aPE~~~~~---~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 589 (668)
......++..|+|||.+... .++.++|||||||++|||++|+.||......... ..... ... ..+.+. .
T Consensus 157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~--~~~~~-~~~---~~~~~~--~ 228 (262)
T cd06613 157 KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRAL--FLISK-SNF---PPPKLK--D 228 (262)
T ss_pred ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHH--HHHHh-ccC---CCcccc--c
Confidence 22334678899999998766 7889999999999999999999999654321111 11111 100 011111 1
Q ss_pred cHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 590 VVKEMELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 590 ~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
.......+..+..+|+.. |.+||++.+|+.+
T Consensus 229 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 260 (262)
T cd06613 229 KEKWSPVFHDFIKKCLTKDPKKRPTATKLLQH 260 (262)
T ss_pred hhhhhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 112223466777889887 9999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=298.35 Aligned_cols=253 Identities=23% Similarity=0.341 Sum_probs=190.3
Q ss_pred eeeecCcEEEEEEEeCCC--CcEEEEEEEecCC-chhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEEecCCCC
Q 005940 360 VIGIGGFGSVYKGVLPTT--GGEVAVKKITRNS-LQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEYIPNGS 436 (668)
Q Consensus 360 ~lG~G~~g~Vy~~~~~~~--~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gs 436 (668)
.||+|+||.||+|..... ...+++|.+.... ....+.|.+|+.+++.++||||+++++.|......++||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 589999999999976332 2356777766543 3445789999999999999999999999999999999999999999
Q ss_pred hhhhhcCCCC-CCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCC-CCcc
Q 005940 437 LDTLLFKPKD-GSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGG-MPHT 514 (668)
Q Consensus 437 L~~~l~~~~~-~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~-~~~~ 514 (668)
|.+++..... ...+++..+..++.||+.||.|||+ .+++||||||+||+++.++.+||+|||++....... ....
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHK---HNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH---CCeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence 9999964322 2456778888999999999999998 999999999999999999999999999986432211 1112
Q ss_pred cccccCCcccCcccccC-------CCCCcchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHHHhcCccccccCcccC
Q 005940 515 TNVVGTFGYIAPELTQT-------GKASTSSDVFAYGILLLEVAT-GRRPIGSGDLLLVEWVRECHQLGRILDVADPLLN 586 (668)
Q Consensus 515 ~~~~gt~~y~aPE~~~~-------~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 586 (668)
....++..|+|||++.. ..++.++|||||||++|||++ |..||...+. .+....... +......++.+.
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~--~~~~~~~~~-~~~~~~~~~~~~ 235 (268)
T cd05086 159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD--REVLNHVIK-DQQVKLFKPQLE 235 (268)
T ss_pred cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHHh-hcccccCCCccC
Confidence 33467889999998743 245789999999999999997 5668754322 122222222 222333444444
Q ss_pred CcccHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhc
Q 005940 587 SSYVVKEMELVLKLGLMCSHKTQFRPTMRQVMRYLS 622 (668)
Q Consensus 587 ~~~~~~~~~~l~~l~~~C~~~p~~RPs~~evl~~L~ 622 (668)
..+.. .+..+..+|+.+|++||+++||++.|.
T Consensus 236 ~~~~~----~~~~l~~~c~~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 236 LPYSE----RWYEVLQFCWLSPEKRATAEEVHRLLT 267 (268)
T ss_pred CCCcH----HHHHHHHHHhhCcccCCCHHHHHHHhc
Confidence 33332 344455689988999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-35 Score=304.29 Aligned_cols=250 Identities=24% Similarity=0.381 Sum_probs=202.5
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCchhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEEec
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEYI 432 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~ 432 (668)
.+|+..+.||.|++|.||+|....+++.|++|.+........+.+.+|+++++.++|+||+++++++......++|+||+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 46888999999999999999998889999999997766566678899999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCCCC
Q 005940 433 PNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMP 512 (668)
Q Consensus 433 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~~~ 512 (668)
++++|.+++.. ..+++.++..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++........
T Consensus 99 ~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~---~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~- 170 (296)
T cd06655 99 AGGSLTDVVTE----TCMDEAQIAAVCRECLQALEFLHA---NQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS- 170 (296)
T ss_pred CCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEccCccchhcccccc-
Confidence 99999999842 358999999999999999999999 9999999999999999999999999999886543322
Q ss_pred cccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCcccCCcccHH
Q 005940 513 HTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSYVVK 592 (668)
Q Consensus 513 ~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 592 (668)
......++..|+|||.+.+..++.++|||||||++|||++|+.||...+.. .......... ...... .....
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~--~~~~~~~~~~-~~~~~~---~~~~~-- 242 (296)
T cd06655 171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPL--RALYLIATNG-TPELQN---PEKLS-- 242 (296)
T ss_pred cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhcC-CcccCC---cccCC--
Confidence 122346888999999998888999999999999999999999999764321 1111111111 100001 11112
Q ss_pred HHHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 593 EMELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 593 ~~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
..+..+...|+.. |++||++.+|+++
T Consensus 243 --~~~~~li~~~l~~dp~~Rpt~~~il~~ 269 (296)
T cd06655 243 --PIFRDFLNRCLEMDVEKRGSAKELLQH 269 (296)
T ss_pred --HHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 2344556688876 9999999999965
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=302.39 Aligned_cols=260 Identities=28% Similarity=0.387 Sum_probs=198.2
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCchhHHHHHHHHHHHh--cccccCceeEeeeecccC----ceE
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLG--RLRHKNLVNLHGWCKQKN----DLL 426 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~--~l~H~nIv~l~g~~~~~~----~~~ 426 (668)
+.....+.||+|.||.||+|.+ .|+.||||++...++ +.+.+|.++.+ .|||+||+.+++.-.... +++
T Consensus 211 rqI~L~e~IGkGRyGEVwrG~w--rGe~VAVKiF~srdE---~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLw 285 (513)
T KOG2052|consen 211 RQIVLQEIIGKGRFGEVWRGRW--RGEDVAVKIFSSRDE---RSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLW 285 (513)
T ss_pred heeEEEEEecCccccceeeccc--cCCceEEEEecccch---hhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEE
Confidence 4567789999999999999999 588999999965543 34555666655 579999999998764432 589
Q ss_pred EEEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhcc-----CCceEecCCCCCCEEECCCCCEEEEeec
Q 005940 427 LVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEW-----EQVVIHRDVKPSNALIDAEMNARLGDFG 501 (668)
Q Consensus 427 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~-----~~~ivHrDLkp~NIll~~~~~~kl~DfG 501 (668)
||.+|.++|||.++|. +..++-...++++..+|.||++||.+. ++.|.|||||++|||++.++.+.|+|+|
T Consensus 286 LvTdYHe~GSL~DyL~----r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLG 361 (513)
T KOG2052|consen 286 LVTDYHEHGSLYDYLN----RNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 361 (513)
T ss_pred EeeecccCCcHHHHHh----hccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeece
Confidence 9999999999999995 356999999999999999999999864 6889999999999999999999999999
Q ss_pred CceeccCCCC---CcccccccCCcccCcccccCCC------CCcchhHHHHHHHHHHHHhCC----------CCCCC---
Q 005940 502 LARLYDHGGM---PHTTNVVGTFGYIAPELTQTGK------ASTSSDVFAYGILLLEVATGR----------RPIGS--- 559 (668)
Q Consensus 502 la~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~------~~~~sDV~S~Gvvl~elltG~----------~p~~~--- 559 (668)
||...+.... ......+||.+|||||++...- .-..+||||||+|+||++..- .||.+
T Consensus 362 LAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp 441 (513)
T KOG2052|consen 362 LAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVP 441 (513)
T ss_pred eeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCC
Confidence 9987765421 1234468999999999986532 235699999999999997622 34432
Q ss_pred CchhHHHHHHHHHhcCccccccCcccCCc-ccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhccCcC
Q 005940 560 GDLLLVEWVRECHQLGRILDVADPLLNSS-YVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSGEKQ 626 (668)
Q Consensus 560 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~-~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~~~~ 626 (668)
.|....+ .++..-..++ .|.++.. .+.+.+..+.+++..||.. |..|-++-.|-+.|....+
T Consensus 442 ~DPs~ee-MrkVVCv~~~----RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 442 SDPSFEE-MRKVVCVQKL----RPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred CCCCHHH-Hhcceeeccc----CCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 1222111 1222212222 2333222 2456788899999999998 9999999998888876653
|
|
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-35 Score=299.18 Aligned_cols=240 Identities=25% Similarity=0.385 Sum_probs=187.8
Q ss_pred eeeeecCcEEEEEEEeCCC------------CcEEEEEEEecCCchhHHHHHHHHHHHhcccccCceeEeeeecccCceE
Q 005940 359 EVIGIGGFGSVYKGVLPTT------------GGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLL 426 (668)
Q Consensus 359 ~~lG~G~~g~Vy~~~~~~~------------~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~ 426 (668)
+.||+|+||.||+|++... ...|++|.+..........|.+|+.++++++||||+++++++..+...+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 4689999999999986422 2358999887665555668889999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCC-------EEEEe
Q 005940 427 LVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMN-------ARLGD 499 (668)
Q Consensus 427 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~-------~kl~D 499 (668)
+||||+++|+|+.++.. ....+++..+++++.||++||+|||+ .+|+||||||+|||++.++. +|++|
T Consensus 81 lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d 155 (262)
T cd05077 81 MVEEFVEFGPLDLFMHR--KSDVLTTPWKFKVAKQLASALSYLED---KDLVHGNVCTKNILLAREGIDGECGPFIKLSD 155 (262)
T ss_pred EEEecccCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHhhh---CCeECCCCCcccEEEecCCccCCCCceeEeCC
Confidence 99999999999998853 33568999999999999999999998 99999999999999987654 89999
Q ss_pred ecCceeccCCCCCcccccccCCcccCccccc-CCCCCcchhHHHHHHHHHHHH-hCCCCCCCCchhHHHHHHHHHhcCcc
Q 005940 500 FGLARLYDHGGMPHTTNVVGTFGYIAPELTQ-TGKASTSSDVFAYGILLLEVA-TGRRPIGSGDLLLVEWVRECHQLGRI 577 (668)
Q Consensus 500 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDV~S~Gvvl~ell-tG~~p~~~~~~~l~~~~~~~~~~~~~ 577 (668)
||++...... ....++..|+|||++. ...++.++|||||||++|||+ +|+.|+.......... ... ...
T Consensus 156 ~g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~---~~~-~~~ 226 (262)
T cd05077 156 PGIPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKER---FYE-GQC 226 (262)
T ss_pred CCCCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHH---HHh-cCc
Confidence 9998754322 2235788899999886 456899999999999999998 5888876433221111 111 110
Q ss_pred ccccCcccCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhc
Q 005940 578 LDVADPLLNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLS 622 (668)
Q Consensus 578 ~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~ 622 (668)
... .. .. ..+..++..|++. |++||++++|++.|+
T Consensus 227 -~~~-----~~-~~---~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 227 -MLV-----TP-SC---KELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred -cCC-----CC-Ch---HHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 000 11 11 2345667789987 999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-35 Score=301.94 Aligned_cols=261 Identities=26% Similarity=0.291 Sum_probs=199.7
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCC--chhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEE
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNS--LQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYE 430 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 430 (668)
++|+..+.||+|++|.||+|+++.+++.||+|++.... ....+.+.+|++++++++|+|++++++.+......++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 36888899999999999999998889999999986542 2234568899999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCC
Q 005940 431 YIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGG 510 (668)
Q Consensus 431 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~ 510 (668)
|+++++|..++.. ...+++.+++.++.|++.||.|||+ ++++||||||+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~ql~~~l~~LH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07847 81 YCDHTVLNELEKN---PRGVPEHLIKKIIWQTLQAVNFCHK---HNCIHRDVKPENILITKQGQIKLCDFGFARILTGPG 154 (286)
T ss_pred ccCccHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCChhhEEEcCCCcEEECccccceecCCCc
Confidence 9999999888742 3358999999999999999999999 999999999999999999999999999998765433
Q ss_pred CCcccccccCCcccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcC------------cc
Q 005940 511 MPHTTNVVGTFGYIAPELTQT-GKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLG------------RI 577 (668)
Q Consensus 511 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~------------~~ 577 (668)
. ......++..|+|||++.+ ..++.++||||||+++|||++|+.||......-..+........ ..
T Consensus 155 ~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (286)
T cd07847 155 D-DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQF 233 (286)
T ss_pred c-cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccc
Confidence 2 2223457889999998865 45789999999999999999999999754321111111100000 00
Q ss_pred -ccccCcccCCcccH-----HHHHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 578 -LDVADPLLNSSYVV-----KEMELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 578 -~~~~d~~l~~~~~~-----~~~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
.....+........ .....+..+...|++. |++||++.|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 234 FKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred cccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 00000110000000 0123456777789987 9999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=303.49 Aligned_cols=249 Identities=31% Similarity=0.456 Sum_probs=193.4
Q ss_pred eeeeecCcEEEEEEEeCCCCc--EEEEEEEecCC-chhHHHHHHHHHHHhcc-cccCceeEeeeecccCceEEEEEecCC
Q 005940 359 EVIGIGGFGSVYKGVLPTTGG--EVAVKKITRNS-LQGMREFAAEIESLGRL-RHKNLVNLHGWCKQKNDLLLVYEYIPN 434 (668)
Q Consensus 359 ~~lG~G~~g~Vy~~~~~~~~~--~vavK~~~~~~-~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~E~~~~ 434 (668)
+.||+|+||.||+|.+.+++. .+++|.+.... ....+.+.+|++++.++ +||||++++++|...+..++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 368999999999999977665 46888886432 34556889999999999 799999999999999999999999999
Q ss_pred CChhhhhcCCC-------------CCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeec
Q 005940 435 GSLDTLLFKPK-------------DGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFG 501 (668)
Q Consensus 435 gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfG 501 (668)
|+|.+++.... ....+++.+++.++.|++.||+|||+ .+++||||||+||++++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~---~~i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccccceEEEcCCCeEEECCCC
Confidence 99999986422 12358899999999999999999998 999999999999999999999999999
Q ss_pred CceeccCCCCCcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHHHhcCccccc
Q 005940 502 LARLYDHGGMPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVAT-GRRPIGSGDLLLVEWVRECHQLGRILDV 580 (668)
Q Consensus 502 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~l~~~~~~~~~~~~~~~~ 580 (668)
++....... .......+..|+|||++....++.++|||||||++|||++ |..||...+.. +....... ....
T Consensus 158 l~~~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~--~~~~~~~~-~~~~-- 230 (270)
T cd05047 158 LSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA--ELYEKLPQ-GYRL-- 230 (270)
T ss_pred Cccccchhh--hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHH--HHHHHHhC-CCCC--
Confidence 986432211 1111234567999999988889999999999999999997 99999654321 11111111 1000
Q ss_pred cCcccCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhccC
Q 005940 581 ADPLLNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSGE 624 (668)
Q Consensus 581 ~d~~l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~~ 624 (668)
......+ ..+..++..|+.. |.+||++.++++.|+..
T Consensus 231 ---~~~~~~~----~~~~~li~~~l~~~p~~Rps~~~il~~l~~~ 268 (270)
T cd05047 231 ---EKPLNCD----DEVYDLMRQCWREKPYERPSFAQILVSLNRM 268 (270)
T ss_pred ---CCCCcCC----HHHHHHHHHHcccChhhCCCHHHHHHHHHHh
Confidence 0111111 2456777789987 99999999999998754
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=309.73 Aligned_cols=258 Identities=27% Similarity=0.400 Sum_probs=201.2
Q ss_pred cCcccceeeeecCcEEEEEEEeCC-------CCcEEEEEEEecCC-chhHHHHHHHHHHHhcc-cccCceeEeeeecccC
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPT-------TGGEVAVKKITRNS-LQGMREFAAEIESLGRL-RHKNLVNLHGWCKQKN 423 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~-------~~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~ 423 (668)
++|.+.+.||+|+||.||++.... +...+|+|.+.... .....++..|+++++++ +|+||++++++|...+
T Consensus 18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 97 (307)
T cd05098 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 97 (307)
T ss_pred HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence 568889999999999999998632 23469999987543 34456788999999999 7999999999999999
Q ss_pred ceEEEEEecCCCChhhhhcCCCC-------------CCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEEC
Q 005940 424 DLLLVYEYIPNGSLDTLLFKPKD-------------GSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALID 490 (668)
Q Consensus 424 ~~~lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~ 490 (668)
..++||||+++|+|.+++..... ...++|.++++++.|++.||+|||+ .+++||||||+||+++
T Consensus 98 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~gi~H~dlkp~Nill~ 174 (307)
T cd05098 98 PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVT 174 (307)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH---CCcccccccHHheEEc
Confidence 99999999999999999964321 2358999999999999999999998 9999999999999999
Q ss_pred CCCCEEEEeecCceeccCCCCC-cccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHH
Q 005940 491 AEMNARLGDFGLARLYDHGGMP-HTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVAT-GRRPIGSGDLLLVEWV 568 (668)
Q Consensus 491 ~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~l~~~~ 568 (668)
.++.+||+|||+++........ ......++..|+|||.+.+..++.++|||||||++|||++ |..||..... .+..
T Consensus 175 ~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~--~~~~ 252 (307)
T cd05098 175 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV--EELF 252 (307)
T ss_pred CCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH--HHHH
Confidence 9999999999999865432211 1122234568999999988889999999999999999998 8888865432 2222
Q ss_pred HHHHhcCccccccCcccCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhccCc
Q 005940 569 RECHQLGRILDVADPLLNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSGEK 625 (668)
Q Consensus 569 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~~~ 625 (668)
..... ....+ .... ....+..+...|++. |++||++.+|++.|+...
T Consensus 253 ~~~~~-~~~~~-----~~~~----~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~ 300 (307)
T cd05098 253 KLLKE-GHRMD-----KPSN----CTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 300 (307)
T ss_pred HHHHc-CCCCC-----CCCc----CCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHH
Confidence 22211 11111 1111 123455667789987 999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=304.85 Aligned_cols=200 Identities=31% Similarity=0.453 Sum_probs=167.6
Q ss_pred CcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCc--hhHHHHHHHHHHHhcc---cccCceeEeeeecc-----cC
Q 005940 354 GFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSL--QGMREFAAEIESLGRL---RHKNLVNLHGWCKQ-----KN 423 (668)
Q Consensus 354 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~f~~Ei~~l~~l---~H~nIv~l~g~~~~-----~~ 423 (668)
+|.+.+.||+|+||.||+|.+..+++.||+|.+..... .....+..|+++++++ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 47788999999999999999998999999999865322 2223456677777665 69999999998854 34
Q ss_pred ceEEEEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCc
Q 005940 424 DLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLA 503 (668)
Q Consensus 424 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla 503 (668)
..++||||++ ++|.+++... ....+++.++..++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||++
T Consensus 81 ~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dikp~Nili~~~~~~kl~dfg~~ 155 (288)
T cd07863 81 KVTLVFEHVD-QDLRTYLDKV-PPPGLPAETIKDLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGQVKLADFGLA 155 (288)
T ss_pred eEEEEEcccc-cCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECccCcc
Confidence 5799999997 5888888532 23458999999999999999999999 99999999999999999999999999999
Q ss_pred eeccCCCCCcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 005940 504 RLYDHGGMPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSG 560 (668)
Q Consensus 504 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~ 560 (668)
+...... ......++..|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus 156 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~ 210 (288)
T cd07863 156 RIYSCQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGN 210 (288)
T ss_pred ccccCcc--cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCC
Confidence 8765322 123346889999999998888999999999999999999999999654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-35 Score=297.33 Aligned_cols=248 Identities=29% Similarity=0.407 Sum_probs=197.3
Q ss_pred eeeeecCcEEEEEEEeCC-CCc--EEEEEEEecCCc-hhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEEecCC
Q 005940 359 EVIGIGGFGSVYKGVLPT-TGG--EVAVKKITRNSL-QGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEYIPN 434 (668)
Q Consensus 359 ~~lG~G~~g~Vy~~~~~~-~~~--~vavK~~~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~ 434 (668)
++||+|++|.||+|.+.. .+. .||||.+..... ...+.+..|++++++++|+||+++++.+.. ...++|+||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999999854 232 699999987766 567789999999999999999999999988 889999999999
Q ss_pred CChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCCCC--
Q 005940 435 GSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMP-- 512 (668)
Q Consensus 435 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~~~-- 512 (668)
++|.+++..... ..++|..++.++.|++.||+|||+ .+++||||||+||+++.++.+||+|||+++........
T Consensus 80 ~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 155 (257)
T cd05040 80 GSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLES---KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYV 155 (257)
T ss_pred CcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHh---CCccccccCcccEEEecCCEEEecccccccccccccccee
Confidence 999999964322 568999999999999999999998 99999999999999999999999999999876543211
Q ss_pred cccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHHHhcCccccccCcccCCcccH
Q 005940 513 HTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVAT-GRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSYVV 591 (668)
Q Consensus 513 ~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 591 (668)
......++..|+|||++....++.++|||||||++|||++ |+.||...... +............. ....
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--~~~~~~~~~~~~~~-----~~~~--- 225 (257)
T cd05040 156 MEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGS--QILKKIDKEGERLE-----RPEA--- 225 (257)
T ss_pred cccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHhcCCcCC-----CCcc---
Confidence 1123456789999999998899999999999999999998 99999643221 11111111111110 0011
Q ss_pred HHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhc
Q 005940 592 KEMELVLKLGLMCSHK-TQFRPTMRQVMRYLS 622 (668)
Q Consensus 592 ~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~ 622 (668)
....+..++..|+.. |++||++.+|++.|.
T Consensus 226 -~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 226 -CPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred -CCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 123455677788887 999999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=295.38 Aligned_cols=248 Identities=27% Similarity=0.438 Sum_probs=199.3
Q ss_pred CcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCC-----chhHHHHHHHHHHHhcccccCceeEeeeecccCceEEE
Q 005940 354 GFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNS-----LQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLV 428 (668)
Q Consensus 354 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV 428 (668)
+|+..+.||+|++|.||+|+...++..|++|.+.... .+..+.+..|+.++++++|+||+++++++......+++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 3667889999999999999998789999999986543 23456789999999999999999999999999999999
Q ss_pred EEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccC
Q 005940 429 YEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDH 508 (668)
Q Consensus 429 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~ 508 (668)
+||+++++|.+++.. ...+++..+..++.|++.||+|||+ .+++|+||+|+||+++.++.+||+|||++.....
T Consensus 81 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~ 154 (258)
T cd06632 81 LELVPGGSLAKLLKK---YGSFPEPVIRLYTRQILLGLEYLHD---RNTVHRDIKGANILVDTNGVVKLADFGMAKQVVE 154 (258)
T ss_pred EEecCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence 999999999999953 2458999999999999999999998 9999999999999999999999999999887654
Q ss_pred CCCCcccccccCCcccCcccccCCC-CCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCcccCC
Q 005940 509 GGMPHTTNVVGTFGYIAPELTQTGK-ASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNS 587 (668)
Q Consensus 509 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 587 (668)
.. ......++..|++||.+.... ++.++|+||||+++|||++|+.||..... .+............ ....
T Consensus 155 ~~--~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~--~~~~~~~~~~~~~~-----~~~~ 225 (258)
T cd06632 155 FS--FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG--VAAVFKIGRSKELP-----PIPD 225 (258)
T ss_pred cc--cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcH--HHHHHHHHhcccCC-----CcCC
Confidence 33 223456888999999987766 89999999999999999999999976432 12222211111111 1111
Q ss_pred cccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 588 SYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 588 ~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
..+ ..+..+...|++. |++||++++++++
T Consensus 226 ~~~----~~~~~li~~~l~~~p~~Rp~~~~~l~~ 255 (258)
T cd06632 226 HLS----DEAKDFILKCLQRDPSLRPTAAELLEH 255 (258)
T ss_pred CcC----HHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence 112 2334556678876 9999999999874
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=314.66 Aligned_cols=193 Identities=27% Similarity=0.348 Sum_probs=167.7
Q ss_pred HhcCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCchhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEE
Q 005940 351 ATKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYE 430 (668)
Q Consensus 351 at~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 430 (668)
...+|.+.+.||+|+||.||+|+...++..||+|+..... ...|+.++++++|+||+++++++......++|+|
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~~------~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 137 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGT------TLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLP 137 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCccc------cHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEE
Confidence 3468999999999999999999998888999999754332 3468999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCC
Q 005940 431 YIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGG 510 (668)
Q Consensus 431 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~ 510 (668)
|+. ++|.+++.. ....+++..++.++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 138 ~~~-~~l~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~- 210 (357)
T PHA03209 138 HYS-SDLYTYLTK--RSRPLPIDQALIIEKQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA- 210 (357)
T ss_pred ccC-CcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEecCccccccccC-
Confidence 994 688888853 34568999999999999999999999 99999999999999999999999999999754322
Q ss_pred CCcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCC
Q 005940 511 MPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPI 557 (668)
Q Consensus 511 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~ 557 (668)
.......||..|+|||++.+..++.++|||||||++|||+++..|+
T Consensus 211 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 211 -PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred -cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 1223457899999999999889999999999999999999966554
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=303.30 Aligned_cols=197 Identities=28% Similarity=0.439 Sum_probs=166.6
Q ss_pred CcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCchhHHHHHHHHHHHhcccccCceeEeeeecccC-----ceEEE
Q 005940 354 GFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNLHGWCKQKN-----DLLLV 428 (668)
Q Consensus 354 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~-----~~~lV 428 (668)
.|...+++|.|+||.||+|....++++||||++-.+.... -.|+++|++++|||||+|+-+|.... ...||
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~k----nrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV 100 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYK----NRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV 100 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcC----cHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence 4566799999999999999999999999999986554322 26899999999999999999885322 34689
Q ss_pred EEecCCCChhhhhcCC-CCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCC-CCEEEEeecCceec
Q 005940 429 YEYIPNGSLDTLLFKP-KDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAE-MNARLGDFGLARLY 506 (668)
Q Consensus 429 ~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~-~~~kl~DfGla~~~ 506 (668)
|||||. +|.++++.. ..+..++...+.-+..||.+||+|||+ .+|+||||||.|+|+|.+ +.+||||||.|+.+
T Consensus 101 leymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~---~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L 176 (364)
T KOG0658|consen 101 LEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHS---HGICHRDIKPQNLLVDPDTGVLKICDFGSAKVL 176 (364)
T ss_pred HHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHh---cCcccCCCChheEEEcCCCCeEEeccCCcceee
Confidence 999975 888888532 234568888888899999999999999 999999999999999987 89999999999988
Q ss_pred cCCCCCcccccccCCcccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 005940 507 DHGGMPHTTNVVGTFGYIAPELTQT-GKASTSSDVFAYGILLLEVATGRRPIGSG 560 (668)
Q Consensus 507 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~S~Gvvl~elltG~~p~~~~ 560 (668)
..++.. .....|..|.|||.+.+ ..|+.+.||||.|||+.||+-|+.-|.+.
T Consensus 177 ~~~epn--iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~ 229 (364)
T KOG0658|consen 177 VKGEPN--ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGD 229 (364)
T ss_pred ccCCCc--eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCC
Confidence 876543 34567899999998876 46899999999999999999999988654
|
|
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=304.53 Aligned_cols=259 Identities=24% Similarity=0.339 Sum_probs=203.1
Q ss_pred hcCcccceeeeecCcEEEEEEEeCC----CCcEEEEEEEecCC-chhHHHHHHHHHHHhcccccCceeEeeeecc-cCce
Q 005940 352 TKGFKESEVIGIGGFGSVYKGVLPT----TGGEVAVKKITRNS-LQGMREFAAEIESLGRLRHKNLVNLHGWCKQ-KNDL 425 (668)
Q Consensus 352 t~~f~~~~~lG~G~~g~Vy~~~~~~----~~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~-~~~~ 425 (668)
.++|...++||+|+||.||+|.+.. .+..|++|++.... ....+.+.+|+.++++++|+||+++++++.. ....
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 84 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP 84 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence 4678889999999999999999865 25789999886543 3445678899999999999999999998866 4678
Q ss_pred EEEEEecCCCChhhhhcCCCCC-----CCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEee
Q 005940 426 LLVYEYIPNGSLDTLLFKPKDG-----SVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDF 500 (668)
Q Consensus 426 ~lV~E~~~~gsL~~~l~~~~~~-----~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~Df 500 (668)
++++||+++++|.+++...... ..+++.+++.++.|++.||+|||+ .+++||||||+||++++++.+||+||
T Consensus 85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~---~~i~H~di~p~nil~~~~~~~kl~d~ 161 (280)
T cd05043 85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHK---RGVIHKDIAARNCVIDEELQVKITDN 161 (280)
T ss_pred EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccCHhhEEEcCCCcEEECCC
Confidence 9999999999999998643322 569999999999999999999998 99999999999999999999999999
Q ss_pred cCceeccCCCCCc-ccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHHHhcCccc
Q 005940 501 GLARLYDHGGMPH-TTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVAT-GRRPIGSGDLLLVEWVRECHQLGRIL 578 (668)
Q Consensus 501 Gla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~l~~~~~~~~~~~~~~ 578 (668)
|+++.+....... .....++..|+|||++....++.++|||||||++||+++ |+.||...+. .++...........
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--~~~~~~~~~~~~~~ 239 (280)
T cd05043 162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP--FEMAAYLKDGYRLA 239 (280)
T ss_pred CCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH--HHHHHHHHcCCCCC
Confidence 9998654332211 122345678999999988889999999999999999999 9999975432 12222111111110
Q ss_pred cccCcccCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhccCc
Q 005940 579 DVADPLLNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSGEK 625 (668)
Q Consensus 579 ~~~d~~l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~~~ 625 (668)
....+ ...+..++.+|+.. |++||++.||++.|+...
T Consensus 240 ------~~~~~----~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~ 277 (280)
T cd05043 240 ------QPINC----PDELFAVMACCWALDPEERPSFSQLVQCLTDFH 277 (280)
T ss_pred ------CCCcC----CHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 01111 13456777899987 999999999999997643
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=310.75 Aligned_cols=247 Identities=25% Similarity=0.319 Sum_probs=193.6
Q ss_pred CcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCC---chhHHHHHHHHHHHhccc-ccCceeEeeeecccCceEEEE
Q 005940 354 GFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNS---LQGMREFAAEIESLGRLR-HKNLVNLHGWCKQKNDLLLVY 429 (668)
Q Consensus 354 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~lV~ 429 (668)
+|+..+.||+|+||.||+|....+++.||+|++.+.. ....+.+..|.+++..+. |++|+++++++...+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 3677899999999999999998899999999997642 233456778999998885 577888999999989999999
Q ss_pred EecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCC
Q 005940 430 EYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHG 509 (668)
Q Consensus 430 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~ 509 (668)
||+++|+|.+++.. ...+++.+++.++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 81 Ey~~~g~L~~~i~~---~~~l~~~~~~~i~~qi~~al~~lH~---~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~ 154 (323)
T cd05615 81 EYVNGGDLMYHIQQ---VGKFKEPQAVFYAAEISVGLFFLHR---RGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD 154 (323)
T ss_pred cCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEeccccccccCCC
Confidence 99999999999853 3459999999999999999999998 99999999999999999999999999998754322
Q ss_pred CCCcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCcccCCcc
Q 005940 510 GMPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSY 589 (668)
Q Consensus 510 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 589 (668)
.. ......||..|+|||++.++.++.++|||||||++|||++|+.||...+.. ........ .. ..+....
T Consensus 155 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~--~~~~~i~~-~~------~~~p~~~ 224 (323)
T cd05615 155 GV-TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDED--ELFQSIME-HN------VSYPKSL 224 (323)
T ss_pred Cc-cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHH--HHHHHHHh-CC------CCCCccC
Confidence 21 223356899999999999888999999999999999999999999765322 11111111 11 1111122
Q ss_pred cHHHHHHHHHHHhhcCCC-CCCCCCH-----HHHHHH
Q 005940 590 VVKEMELVLKLGLMCSHK-TQFRPTM-----RQVMRY 620 (668)
Q Consensus 590 ~~~~~~~l~~l~~~C~~~-p~~RPs~-----~evl~~ 620 (668)
. ..+..+...|++. |.+|++. +++.++
T Consensus 225 ~----~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h 257 (323)
T cd05615 225 S----KEAVSICKGLMTKHPSKRLGCGPEGERDIREH 257 (323)
T ss_pred C----HHHHHHHHHHcccCHhhCCCCCCCCHHHHhcC
Confidence 2 2234455577776 9999974 555554
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=303.21 Aligned_cols=239 Identities=23% Similarity=0.331 Sum_probs=186.2
Q ss_pred eeeecCcEEEEEEEeCCC------------------------CcEEEEEEEecCCchhHHHHHHHHHHHhcccccCceeE
Q 005940 360 VIGIGGFGSVYKGVLPTT------------------------GGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNL 415 (668)
Q Consensus 360 ~lG~G~~g~Vy~~~~~~~------------------------~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l 415 (668)
.||+|+||.||+|.+..+ ...|++|++.........+|.+|+.++++++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 689999999999986321 13589998876555556788899999999999999999
Q ss_pred eeeecccCceEEEEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCC--
Q 005940 416 HGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEM-- 493 (668)
Q Consensus 416 ~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~-- 493 (668)
+++|.+....++||||+++|+|+.++.. ....+++..+..++.||++||+|||+ ++|+||||||+||+++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~lH~---~~iiH~dlkp~Nill~~~~~~ 156 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRK--EKGRVPVAWKITVAQQLASALSYLED---KNLVHGNVCAKNILLARLGLA 156 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHc---CCccCCCCCcccEEEeccCcc
Confidence 9999999999999999999999999853 34568999999999999999999998 9999999999999997643
Q ss_pred -----CEEEEeecCceeccCCCCCcccccccCCcccCcccccC-CCCCcchhHHHHHHHHHHHH-hCCCCCCCCchhHHH
Q 005940 494 -----NARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPELTQT-GKASTSSDVFAYGILLLEVA-TGRRPIGSGDLLLVE 566 (668)
Q Consensus 494 -----~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~S~Gvvl~ell-tG~~p~~~~~~~l~~ 566 (668)
.+|++|||++...... ....++..|+|||.+.+ ..++.++|||||||++|||+ +|+.||.........
T Consensus 157 ~~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~ 231 (274)
T cd05076 157 EGTSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKE 231 (274)
T ss_pred cCccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHH
Confidence 3799999988643321 12356788999998865 56799999999999999995 699998654322111
Q ss_pred HHHHHHhcCccccccCcccCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhc
Q 005940 567 WVRECHQLGRILDVADPLLNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLS 622 (668)
Q Consensus 567 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~ 622 (668)
.. ..... ....... ..+..++..|+.. |++||++++|++.|.
T Consensus 232 ~~---~~~~~-------~~~~~~~----~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 232 RF---YEKKH-------RLPEPSC----KELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred HH---HHhcc-------CCCCCCC----hHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 11 11110 1111111 2355677789987 999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-35 Score=298.85 Aligned_cols=249 Identities=27% Similarity=0.459 Sum_probs=198.4
Q ss_pred CcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCch---------hHHHHHHHHHHHhcccccCceeEeeeecccCc
Q 005940 354 GFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQ---------GMREFAAEIESLGRLRHKNLVNLHGWCKQKND 424 (668)
Q Consensus 354 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---------~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~ 424 (668)
+|.....||+|++|.||+|....++..+|+|.+...... ..+.+..|+.++++++||||+++++++.+.+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 366778999999999999999888899999988654321 23568899999999999999999999999999
Q ss_pred eEEEEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCce
Q 005940 425 LLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLAR 504 (668)
Q Consensus 425 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~ 504 (668)
.++|+||+++++|.+++.. ...+++..+..++.|++.||.|||+ .+++||||+|+||++++++.+||+|||+++
T Consensus 81 ~~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~~l~~~l~~lH~---~~ivH~di~p~nil~~~~~~~~l~dfg~~~ 154 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNN---YGAFEETLVRNFVRQILKGLNYLHN---RGIIHRDIKGANILVDNKGGIKISDFGISK 154 (267)
T ss_pred cEEEEEecCCCCHHHHHHh---ccCccHHHHHHHHHHHHHHHHHHHh---cCcccccCCHHHEEEcCCCCEEecccCCCc
Confidence 9999999999999999953 3458999999999999999999998 899999999999999999999999999998
Q ss_pred eccCCCC-----CcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCcccc
Q 005940 505 LYDHGGM-----PHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILD 579 (668)
Q Consensus 505 ~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~ 579 (668)
....... .......|+..|+|||.+.+..++.++|||||||++|||++|+.||...+.. .-+.....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~------ 226 (267)
T cd06628 155 KLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQL--QAIFKIGE------ 226 (267)
T ss_pred ccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHH--HHHHHHhc------
Confidence 7653211 1112345788999999998888999999999999999999999999754321 11111111
Q ss_pred ccCcccCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 580 VADPLLNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 580 ~~d~~l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
...+.+....+ ..+..+...|++. |++||++.||+++
T Consensus 227 ~~~~~~~~~~~----~~~~~li~~~l~~~p~~Rp~~~~il~~ 264 (267)
T cd06628 227 NASPEIPSNIS----SEAIDFLEKTFEIDHNKRPTAAELLKH 264 (267)
T ss_pred cCCCcCCcccC----HHHHHHHHHHccCCchhCcCHHHHhhC
Confidence 11122222222 3344556688887 9999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-35 Score=301.01 Aligned_cols=247 Identities=28% Similarity=0.404 Sum_probs=202.1
Q ss_pred CcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCC-chhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEEec
Q 005940 354 GFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNS-LQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEYI 432 (668)
Q Consensus 354 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~ 432 (668)
.|+..++||.|+||.||+|.+..++..||+|.+.... ......+..|+.++++++|+||+++++.+.+....++||||+
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence 5677889999999999999998889999999987543 345678899999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCCCC
Q 005940 433 PNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMP 512 (668)
Q Consensus 433 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~~~ 512 (668)
++++|.+++.. ..+++.++..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++........
T Consensus 85 ~~~~L~~~i~~----~~l~~~~~~~~~~~l~~~l~~lh~---~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~- 156 (277)
T cd06640 85 GGGSALDLLRA----GPFDEFQIATMLKEILKGLDYLHS---EKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI- 156 (277)
T ss_pred CCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHh---CCccCcCCChhhEEEcCCCCEEEcccccceeccCCcc-
Confidence 99999999852 358899999999999999999998 9999999999999999999999999999987654332
Q ss_pred cccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCcccCCcccHH
Q 005940 513 HTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSYVVK 592 (668)
Q Consensus 513 ~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 592 (668)
......++..|+|||++.+...+.++|||||||++|||++|..||...... ...... ... ..+.+ ...
T Consensus 157 ~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~--~~~~~~-~~~-----~~~~~----~~~ 224 (277)
T cd06640 157 KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPM--RVLFLI-PKN-----NPPTL----TGE 224 (277)
T ss_pred ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChH--hHhhhh-hcC-----CCCCC----chh
Confidence 223346788999999998888999999999999999999999999654321 111110 000 01111 222
Q ss_pred HHHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 593 EMELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 593 ~~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
....+..+...|++. |++||++++++++
T Consensus 225 ~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 225 FSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred hhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 334566777899988 9999999999876
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=296.52 Aligned_cols=247 Identities=31% Similarity=0.421 Sum_probs=195.9
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCchhHHHHHHHHHHHhcccccCceeEeeeec-ccCceEEEEEe
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNLHGWCK-QKNDLLLVYEY 431 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~-~~~~~~lV~E~ 431 (668)
++|...+.||+|++|.||++.. .+..+|+|.+.... ..+.|.+|+.++++++|+|++++++++. ..+..++|+||
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~--~~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~ 81 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 81 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEE--cCCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEEC
Confidence 4678889999999999999987 47889999986543 3467899999999999999999999764 55678999999
Q ss_pred cCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCCC
Q 005940 432 IPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGM 511 (668)
Q Consensus 432 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~~ 511 (668)
+++++|.+++... ....+++..++.++.|++.||+|||+ .+++||||||+||++++++.+||+|||+++......
T Consensus 82 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~- 156 (256)
T cd05082 82 MAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEA---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ- 156 (256)
T ss_pred CCCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeccccchheEEEcCCCcEEecCCccceeccccC-
Confidence 9999999998632 33458999999999999999999998 999999999999999999999999999988654322
Q ss_pred CcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHHHhcCccccccCcccCCccc
Q 005940 512 PHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVAT-GRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSYV 590 (668)
Q Consensus 512 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 590 (668)
....++..|+|||++....++.++|||||||++|||++ |+.||...+. .+....... +.. +......
T Consensus 157 ---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~--~~~~~~~~~-~~~-----~~~~~~~- 224 (256)
T cd05082 157 ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL--KDVVPRVEK-GYK-----MDAPDGC- 224 (256)
T ss_pred ---CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHhc-CCC-----CCCCCCC-
Confidence 22344668999999988889999999999999999998 9999865432 122221111 110 1111111
Q ss_pred HHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhcc
Q 005940 591 VKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSG 623 (668)
Q Consensus 591 ~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~ 623 (668)
...+..+...|++. |++||++.++++.|+.
T Consensus 225 ---~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 225 ---PPVVYDVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred ---CHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 23455667788887 9999999999999875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=296.14 Aligned_cols=250 Identities=23% Similarity=0.393 Sum_probs=202.4
Q ss_pred CcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecC--CchhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEEe
Q 005940 354 GFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRN--SLQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEY 431 (668)
Q Consensus 354 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~ 431 (668)
+|+..+.||+|+||.+|++....+++.||+|++... .....+++.+|++++++++|+||+++++++...+..++|+||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 478899999999999999999888999999998753 233456889999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCCC
Q 005940 432 IPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGM 511 (668)
Q Consensus 432 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~~ 511 (668)
+++++|.+++... ....+++.+++.++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~~l~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~ 156 (256)
T cd08218 81 CEGGDLYKKINAQ-RGVLFPEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE 156 (256)
T ss_pred CCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchh
Confidence 9999999998532 23458899999999999999999998 9999999999999999999999999999986654321
Q ss_pred CcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCcccCCcccH
Q 005940 512 PHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSYVV 591 (668)
Q Consensus 512 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 591 (668)
......|+..|+|||++.++..+.++|||||||+++||++|+.||...+. .+.+.+... +.. +.....+.
T Consensus 157 -~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~--~~~~~~~~~-~~~-----~~~~~~~~- 226 (256)
T cd08218 157 -LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNM--KNLVLKIIR-GSY-----PPVSSHYS- 226 (256)
T ss_pred -hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCH--HHHHHHHhc-CCC-----CCCcccCC-
Confidence 12234578899999999888899999999999999999999999975432 222222221 111 11111111
Q ss_pred HHHHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 592 KEMELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 592 ~~~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
..+..+...|++. |++||++++|+++
T Consensus 227 ---~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 227 ---YDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred ---HHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 2355666688887 9999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-35 Score=302.00 Aligned_cols=253 Identities=25% Similarity=0.358 Sum_probs=201.9
Q ss_pred hcCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCchhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEEe
Q 005940 352 TKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEY 431 (668)
Q Consensus 352 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~ 431 (668)
.++|.+.+.||.|++|.||+|.+..++..+|+|.+........+.|..|++++++++|+||+++++.+..+...++||||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 35688899999999999999999888999999999877666678899999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCCC
Q 005940 432 IPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGM 511 (668)
Q Consensus 432 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~~ 511 (668)
+++++|.+++.. ....+++..+..++.|++.||.|||+ .+|+|+||||+||+++.++.++|+|||++........
T Consensus 84 ~~~~~L~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~ 158 (280)
T cd06611 84 CDGGALDSIMLE--LERGLTEPQIRYVCRQMLEALNFLHS---HKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ 158 (280)
T ss_pred cCCCcHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEECCCCCEEEccCccchhhccccc
Confidence 999999999853 23469999999999999999999999 9999999999999999999999999999876543221
Q ss_pred CcccccccCCcccCccccc-----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCcccC
Q 005940 512 PHTTNVVGTFGYIAPELTQ-----TGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLN 586 (668)
Q Consensus 512 ~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 586 (668)
......++..|+|||.+. ...++.++||||||+++|||++|+.||...+.. ........ ........+
T Consensus 159 -~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~-~~~~~~~~~--- 231 (280)
T cd06611 159 -KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM--RVLLKILK-SEPPTLDQP--- 231 (280)
T ss_pred -ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHH--HHHHHHhc-CCCCCcCCc---
Confidence 223346889999999874 344678999999999999999999999754321 11111111 111000000
Q ss_pred CcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 587 SSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 587 ~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
..+. ..+..+...|++. |++||++++|+++
T Consensus 232 ~~~~----~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 232 SKWS----SSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred ccCC----HHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 1111 2344566688887 9999999999875
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=304.93 Aligned_cols=253 Identities=28% Similarity=0.375 Sum_probs=202.3
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCC-chhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEEe
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNS-LQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEY 431 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~ 431 (668)
++|+..+.||+|++|+||++....++..||+|++.... ....+.+.+|+++++.++||||+++++.+......++||||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 46788899999999999999998889999999886543 34457889999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCCC
Q 005940 432 IPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGM 511 (668)
Q Consensus 432 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~~ 511 (668)
+++++|.+++.. ...+++..+..++.+++.||.|||+ ..+++||||||+||+++.++.++|+|||++.......
T Consensus 85 ~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~- 158 (284)
T cd06620 85 MDCGSLDRIYKK---GGPIPVEILGKIAVAVVEGLTYLYN--VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI- 158 (284)
T ss_pred CCCCCHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHH--hcCeeccCCCHHHEEECCCCcEEEccCCcccchhhhc-
Confidence 999999999853 3458999999999999999999996 2589999999999999999999999999987543322
Q ss_pred CcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCch---------hHHHHHHHHHhcCccccccC
Q 005940 512 PHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDL---------LLVEWVRECHQLGRILDVAD 582 (668)
Q Consensus 512 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~---------~l~~~~~~~~~~~~~~~~~d 582 (668)
.....|+..|+|||++.++.++.++|||||||++|||++|+.||..... .+.++........ .
T Consensus 159 --~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~ 230 (284)
T cd06620 159 --ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP------P 230 (284)
T ss_pred --cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhcc------C
Confidence 2234789999999999888899999999999999999999999974322 1122222221111 1
Q ss_pred cccCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhc
Q 005940 583 PLLNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLS 622 (668)
Q Consensus 583 ~~l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~ 622 (668)
+.+... +....+..+...|+.. |++||+++||+++.-
T Consensus 231 ~~~~~~---~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~ 268 (284)
T cd06620 231 PRLPSS---DFPEDLRDFVDACLLKDPTERPTPQQLCAMPP 268 (284)
T ss_pred CCCCch---hcCHHHHHHHHHHhcCCcccCcCHHHHhcCcc
Confidence 111111 0112345566678887 999999999998743
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=299.03 Aligned_cols=253 Identities=24% Similarity=0.363 Sum_probs=199.2
Q ss_pred cCcccceeeeecCcEEEEEEEeCCC---CcEEEEEEEecCC-chhHHHHHHHHHHHhcccccCceeEeeeecccCceEEE
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTT---GGEVAVKKITRNS-LQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLV 428 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~---~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV 428 (668)
++|...++||+|+||.||+|.+... ...|+||...... .+..+.+.+|+.++++++|+||++++++|.. ...++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv 84 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV 84 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence 4577889999999999999987543 3469999887654 4456789999999999999999999999875 457899
Q ss_pred EEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccC
Q 005940 429 YEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDH 508 (668)
Q Consensus 429 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~ 508 (668)
|||+++|+|.+++.. ....+++.+++.++.|++.||.|||+ .+++||||||+||+++.++.+||+|||+++....
T Consensus 85 ~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~l~~~l~~lH~---~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 159 (270)
T cd05056 85 MELAPLGELRSYLQV--NKYSLDLASLILYSYQLSTALAYLES---KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLED 159 (270)
T ss_pred EEcCCCCcHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccChheEEEecCCCeEEccCceeeeccc
Confidence 999999999999953 23458999999999999999999998 9999999999999999999999999999987654
Q ss_pred CCCCcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCchh-HHHHHHHHHhcCccccccCcccC
Q 005940 509 GGMPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVAT-GRRPIGSGDLL-LVEWVRECHQLGRILDVADPLLN 586 (668)
Q Consensus 509 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~-l~~~~~~~~~~~~~~~~~d~~l~ 586 (668)
..........++..|+|||.+....++.++||||||+++||+++ |..||...... ...+. ...... ...
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~---~~~~~~------~~~ 230 (270)
T cd05056 160 ESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRI---ENGERL------PMP 230 (270)
T ss_pred ccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH---HcCCcC------CCC
Confidence 43222222344568999999988889999999999999999986 99999754322 11111 111111 111
Q ss_pred CcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhccC
Q 005940 587 SSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSGE 624 (668)
Q Consensus 587 ~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~~ 624 (668)
...+ ..+..++..|+.. |++||++.++++.|+..
T Consensus 231 ~~~~----~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~ 265 (270)
T cd05056 231 PNCP----PTLYSLMTKCWAYDPSKRPRFTELKAQLSDI 265 (270)
T ss_pred CCCC----HHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 1222 2355566688877 99999999999998764
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=297.66 Aligned_cols=257 Identities=26% Similarity=0.398 Sum_probs=203.9
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCC-chhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEEe
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNS-LQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEY 431 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~ 431 (668)
++|+..+.||.|++|+||+|....++..+++|++.... ....+.+.+|+++++.++|+||+++++.+......++|+|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 46888999999999999999988888999999987543 23567899999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCCC
Q 005940 432 IPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGM 511 (668)
Q Consensus 432 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~~ 511 (668)
+++++|.+++........+++..+..++.|++.||.|||+ .+++||||||+||++++++.+||+|||++........
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~---~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~ 157 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHS---NGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD 157 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence 9999999999643333568999999999999999999998 9999999999999999999999999999886654332
Q ss_pred C---cccccccCCcccCcccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCcccCC
Q 005940 512 P---HTTNVVGTFGYIAPELTQTG-KASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNS 587 (668)
Q Consensus 512 ~---~~~~~~gt~~y~aPE~~~~~-~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 587 (668)
. ......|+..|+|||++... ..+.++|||||||++|||++|+.||...... .-........ .+.+..
T Consensus 158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~--~~~~~~~~~~------~~~~~~ 229 (267)
T cd06610 158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPM--KVLMLTLQND------PPSLET 229 (267)
T ss_pred ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChh--hhHHHHhcCC------CCCcCC
Confidence 2 12334688999999998776 7899999999999999999999999654221 1111111111 111111
Q ss_pred ccc-HHHHHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 588 SYV-VKEMELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 588 ~~~-~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
... ..-...+..+...|+.. |++||+++||+++
T Consensus 230 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 230 GADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH 264 (267)
T ss_pred ccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 110 01123445666688887 9999999999875
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=300.17 Aligned_cols=258 Identities=28% Similarity=0.397 Sum_probs=201.4
Q ss_pred cCcccceeeeecCcEEEEEEEeCC----CCcEEEEEEEecCCch-hHHHHHHHHHHHhcccccCceeEeeeecc--cCce
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPT----TGGEVAVKKITRNSLQ-GMREFAAEIESLGRLRHKNLVNLHGWCKQ--KNDL 425 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~----~~~~vavK~~~~~~~~-~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~--~~~~ 425 (668)
+.|+..+.||+|+||.||++.+.. ++..+|||++...... ..++|.+|++++++++|+||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 356678999999999999998643 3678999999766543 56789999999999999999999999977 5578
Q ss_pred EEEEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCcee
Q 005940 426 LLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARL 505 (668)
Q Consensus 426 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~ 505 (668)
++||||+++++|.+++.. ....+++..++.++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++..
T Consensus 84 ~lv~e~~~~~~l~~~l~~--~~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQR--HRDQINLKRLLLFSSQICKGMDYLGS---QRYIHRDLAARNILVESEDLVKISDFGLAKV 158 (284)
T ss_pred EEEEecCCCCCHHHHHHh--CccccCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHhEEEcCCCCEEEcccccccc
Confidence 999999999999999953 23369999999999999999999998 9999999999999999999999999999987
Q ss_pred ccCCCCCc--ccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHH------------HHHHHH
Q 005940 506 YDHGGMPH--TTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLV------------EWVREC 571 (668)
Q Consensus 506 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~------------~~~~~~ 571 (668)
........ .....++..|+|||.+....++.++||||||+++|||++|+.|+........ ....+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05038 159 LPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLEL 238 (284)
T ss_pred cccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHH
Confidence 65332111 1122445679999999888899999999999999999999999864321111 111111
Q ss_pred HhcCccccccCcccCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhccC
Q 005940 572 HQLGRILDVADPLLNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSGE 624 (668)
Q Consensus 572 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~~ 624 (668)
...... . .........+..++.+|++. |++||++.||+++|+..
T Consensus 239 ~~~~~~-------~--~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 239 LKEGER-------L--PRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHcCCc-------C--CCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 111100 0 00111124566778899987 99999999999999764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=310.56 Aligned_cols=245 Identities=24% Similarity=0.292 Sum_probs=192.7
Q ss_pred eeeeecCcEEEEEEEeCCCCcEEEEEEEecCC---chhHHHHHHHHHHHhcc-cccCceeEeeeecccCceEEEEEecCC
Q 005940 359 EVIGIGGFGSVYKGVLPTTGGEVAVKKITRNS---LQGMREFAAEIESLGRL-RHKNLVNLHGWCKQKNDLLLVYEYIPN 434 (668)
Q Consensus 359 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~E~~~~ 434 (668)
++||+|+||.||+|....+++.||+|++.+.. ....+.+..|+.++.++ +|+||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999998889999999997643 23446688999999888 699999999999999999999999999
Q ss_pred CChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCCCCcc
Q 005940 435 GSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHT 514 (668)
Q Consensus 435 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 514 (668)
|+|..++.. ...+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||+++...... ...
T Consensus 81 ~~L~~~~~~---~~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~ 153 (327)
T cd05617 81 GDLMFHMQR---QRKLPEEHARFYAAEICIALNFLHE---RGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG-DTT 153 (327)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEeCCCCEEEeccccceeccCCC-Cce
Confidence 999988853 3459999999999999999999999 999999999999999999999999999987533221 122
Q ss_pred cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC----chhHHHHHHHHHhcCccccccCcccCCccc
Q 005940 515 TNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSG----DLLLVEWVRECHQLGRILDVADPLLNSSYV 590 (668)
Q Consensus 515 ~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~----~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 590 (668)
....||+.|+|||++.+..++.++|||||||++|||++|+.||... .....++..+...... ..+....+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~------~~~p~~~~ 227 (327)
T cd05617 154 STFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKP------IRIPRFLS 227 (327)
T ss_pred ecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCC------CCCCCCCC
Confidence 3457999999999999889999999999999999999999999532 1122233333322211 11111222
Q ss_pred HHHHHHHHHHHhhcCCC-CCCCCC------HHHHHHH
Q 005940 591 VKEMELVLKLGLMCSHK-TQFRPT------MRQVMRY 620 (668)
Q Consensus 591 ~~~~~~l~~l~~~C~~~-p~~RPs------~~evl~~ 620 (668)
. .+..+...|+.. |++||+ +++++++
T Consensus 228 ~----~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 260 (327)
T cd05617 228 V----KASHVLKGFLNKDPKERLGCQPQTGFSDIKSH 260 (327)
T ss_pred H----HHHHHHHHHhccCHHHcCCCCCCCCHHHHHcC
Confidence 2 233444567766 999998 4677665
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-36 Score=314.84 Aligned_cols=242 Identities=26% Similarity=0.349 Sum_probs=191.1
Q ss_pred eeeeecCcEEEEEEEe---CCCCcEEEEEEEecCCc--hhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEEecC
Q 005940 359 EVIGIGGFGSVYKGVL---PTTGGEVAVKKITRNSL--QGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEYIP 433 (668)
Q Consensus 359 ~~lG~G~~g~Vy~~~~---~~~~~~vavK~~~~~~~--~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~ 433 (668)
+.||+|+||.||++.. ..+++.||+|++.+... .....+..|++++++++||||+++++++...+..|+||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999876 35678999999976432 233567789999999999999999999999999999999999
Q ss_pred CCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCCCCc
Q 005940 434 NGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPH 513 (668)
Q Consensus 434 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 513 (668)
+|+|.+++.+ ...+++..+..++.||+.||.|||+ .+|+||||||+||+++.++.+||+|||+++...... ..
T Consensus 82 ~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~-~~ 154 (318)
T cd05582 82 GGDLFTRLSK---EVMFTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE-KK 154 (318)
T ss_pred CCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC-Cc
Confidence 9999999853 3458999999999999999999999 999999999999999999999999999998654332 12
Q ss_pred ccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCcccCCcccHHH
Q 005940 514 TTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSYVVKE 593 (668)
Q Consensus 514 ~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 593 (668)
.....|+..|+|||++....++.++|||||||++|||++|+.||...+.. +....... ... .+....+ .
T Consensus 155 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~--~~~~~i~~-~~~------~~p~~~~-~- 223 (318)
T cd05582 155 AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRK--ETMTMILK-AKL------GMPQFLS-P- 223 (318)
T ss_pred eecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHH--HHHHHHHc-CCC------CCCCCCC-H-
Confidence 33457899999999998888899999999999999999999999754321 11111111 111 1111122 2
Q ss_pred HHHHHHHHhhcCCC-CCCCCC-----HHHHHHH
Q 005940 594 MELVLKLGLMCSHK-TQFRPT-----MRQVMRY 620 (668)
Q Consensus 594 ~~~l~~l~~~C~~~-p~~RPs-----~~evl~~ 620 (668)
.+..+...|++. |++||+ +++++++
T Consensus 224 --~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~ 254 (318)
T cd05582 224 --EAQSLLRALFKRNPANRLGAGPDGVEEIKRH 254 (318)
T ss_pred --HHHHHHHHHhhcCHhHcCCCCCCCHHHHhCC
Confidence 234555678876 999999 5556543
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=309.81 Aligned_cols=258 Identities=25% Similarity=0.350 Sum_probs=197.4
Q ss_pred cCcccceeeeecCcEEEEEEEeC-----CCCcEEEEEEEecCC-chhHHHHHHHHHHHhcc-cccCceeEeeeeccc-Cc
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLP-----TTGGEVAVKKITRNS-LQGMREFAAEIESLGRL-RHKNLVNLHGWCKQK-ND 424 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~-~~ 424 (668)
++|+..+.||+|+||.||+|.+. .+++.||||++.... ....+.+..|+.++.++ +|+||++++++|... ..
T Consensus 7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 86 (343)
T cd05103 7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 86 (343)
T ss_pred hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCc
Confidence 46888999999999999999742 356789999997643 23456788999999999 689999999988654 46
Q ss_pred eEEEEEecCCCChhhhhcCCCC----------------------------------------------------------
Q 005940 425 LLLVYEYIPNGSLDTLLFKPKD---------------------------------------------------------- 446 (668)
Q Consensus 425 ~~lV~E~~~~gsL~~~l~~~~~---------------------------------------------------------- 446 (668)
.++||||+++|+|.+++.....
T Consensus 87 ~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (343)
T cd05103 87 LMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA 166 (343)
T ss_pred eEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhh
Confidence 7899999999999999853210
Q ss_pred ------CCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCCC-Cccccccc
Q 005940 447 ------GSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGM-PHTTNVVG 519 (668)
Q Consensus 447 ------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~~-~~~~~~~g 519 (668)
...+++.++..++.|++.||+|||+ .+|+||||||+||++++++.+||+|||++........ .......+
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 243 (343)
T cd05103 167 EQEDLYKKVLTLEDLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL 243 (343)
T ss_pred hhhhhhhccCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCC
Confidence 1247889999999999999999998 9999999999999999999999999999986533211 11122345
Q ss_pred CCcccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHHHhcCccccccCcccCCcccHHHHHHHH
Q 005940 520 TFGYIAPELTQTGKASTSSDVFAYGILLLEVAT-GRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSYVVKEMELVL 598 (668)
Q Consensus 520 t~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~ 598 (668)
+..|+|||.+.+..++.++||||||+++|||++ |..||....... . .......+.... .....+ ..+.
T Consensus 244 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-~-~~~~~~~~~~~~-----~~~~~~----~~~~ 312 (343)
T cd05103 244 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-E-FCRRLKEGTRMR-----APDYTT----PEMY 312 (343)
T ss_pred CcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH-H-HHHHHhccCCCC-----CCCCCC----HHHH
Confidence 678999999988889999999999999999997 899986432111 1 111111111111 111111 2356
Q ss_pred HHHhhcCCC-CCCCCCHHHHHHHhccC
Q 005940 599 KLGLMCSHK-TQFRPTMRQVMRYLSGE 624 (668)
Q Consensus 599 ~l~~~C~~~-p~~RPs~~evl~~L~~~ 624 (668)
.++..|++. |++||++.||+++|+..
T Consensus 313 ~~~~~cl~~~p~~Rps~~eil~~l~~~ 339 (343)
T cd05103 313 QTMLDCWHGEPSQRPTFSELVEHLGNL 339 (343)
T ss_pred HHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 777789987 99999999999999764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=300.82 Aligned_cols=264 Identities=25% Similarity=0.333 Sum_probs=203.1
Q ss_pred cchhhHHHHhcCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCchhHHHHHHHHHHHhcc-cccCceeEeeeec-
Q 005940 343 FRYKDLYAATKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRL-RHKNLVNLHGWCK- 420 (668)
Q Consensus 343 f~~~el~~at~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~- 420 (668)
+.++.+..+.++|++.+.||+|+||.||++.+..+++.+|+|++.... ....++.+|+.+++++ +|+||+++++++.
T Consensus 8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 86 (286)
T cd06638 8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYK 86 (286)
T ss_pred EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence 445666677899999999999999999999998889999999886532 2235678899999999 6999999999883
Q ss_pred ----ccCceEEEEEecCCCChhhhhcCC-CCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCE
Q 005940 421 ----QKNDLLLVYEYIPNGSLDTLLFKP-KDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNA 495 (668)
Q Consensus 421 ----~~~~~~lV~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~ 495 (668)
..+..++||||+++++|.+++... ..+..+++..+..++.|++.||.|||+ .+++||||||+||+++.++.+
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nili~~~~~~ 163 (286)
T cd06638 87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHV---NKTIHRDVKGNNILLTTEGGV 163 (286)
T ss_pred cccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHh---CCccccCCCHHhEEECCCCCE
Confidence 345689999999999999987532 234568999999999999999999998 999999999999999999999
Q ss_pred EEEeecCceeccCCCCCcccccccCCcccCcccccC-----CCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHH
Q 005940 496 RLGDFGLARLYDHGGMPHTTNVVGTFGYIAPELTQT-----GKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRE 570 (668)
Q Consensus 496 kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~ 570 (668)
||+|||+++....... ......|+..|+|||++.. ..++.++|||||||++|||++|+.|+...... ... ..
T Consensus 164 kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~-~~~-~~ 240 (286)
T cd06638 164 KLVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPM-RAL-FK 240 (286)
T ss_pred EEccCCceeecccCCC-ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchh-HHH-hh
Confidence 9999999987654322 2223468999999998753 44788999999999999999999999654211 111 00
Q ss_pred HHhcCccccccCcccCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHh
Q 005940 571 CHQLGRILDVADPLLNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYL 621 (668)
Q Consensus 571 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L 621 (668)
.. ........++. .+. ..+..+...|++. |++||+++||++++
T Consensus 241 ~~-~~~~~~~~~~~---~~~----~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 241 IP-RNPPPTLHQPE---LWS----NEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred cc-ccCCCcccCCC---CcC----HHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 00 00001111111 111 2355666788876 99999999999864
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-35 Score=297.97 Aligned_cols=251 Identities=26% Similarity=0.452 Sum_probs=200.3
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCchhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEEec
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEYI 432 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~ 432 (668)
++|+..++||+|+||.||++.+. .+..+++|.+.... ...+.|.+|++++++++|+||+++++.+.+ ...+++|||+
T Consensus 6 ~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~ 82 (260)
T cd05073 6 ESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFM 82 (260)
T ss_pred cceeEEeEecCccceEEEEEEec-CCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeC
Confidence 56888999999999999999874 46679999886543 345678999999999999999999999887 7789999999
Q ss_pred CCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCCCC
Q 005940 433 PNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMP 512 (668)
Q Consensus 433 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~~~ 512 (668)
++++|.+++... ....+++.+++.++.|++.||.|||+ .+++||||||+||+++.++.+||+|||.+.........
T Consensus 83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 158 (260)
T cd05073 83 AKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT 158 (260)
T ss_pred CCCcHHHHHHhC-CccccCHHHHHHHHHHHHHHHHHHHh---CCccccccCcceEEEcCCCcEEECCCcceeeccCCCcc
Confidence 999999999643 34568999999999999999999998 89999999999999999999999999999876543332
Q ss_pred cccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCchh-HHHHHHHHHhcCccccccCcccCCccc
Q 005940 513 HTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVAT-GRRPIGSGDLL-LVEWVRECHQLGRILDVADPLLNSSYV 590 (668)
Q Consensus 513 ~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~-l~~~~~~~~~~~~~~~~~d~~l~~~~~ 590 (668)
......++..|+|||++..+.++.++|+|||||++||+++ |+.||...+.. +..+. ....... .....
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~----~~~~~~~-----~~~~~- 228 (260)
T cd05073 159 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRAL----ERGYRMP-----RPENC- 228 (260)
T ss_pred cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHH----hCCCCCC-----CcccC-
Confidence 2233345678999999988889999999999999999999 89999754322 22211 1111111 11111
Q ss_pred HHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhcc
Q 005940 591 VKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSG 623 (668)
Q Consensus 591 ~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~ 623 (668)
...+..+...|++. |++||++.++++.|+.
T Consensus 229 ---~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 229 ---PEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred ---CHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 23355666789887 9999999999999864
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=302.40 Aligned_cols=263 Identities=27% Similarity=0.323 Sum_probs=204.2
Q ss_pred cchhhHHHHhcCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCchhHHHHHHHHHHHhcc-cccCceeEeeeecc
Q 005940 343 FRYKDLYAATKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRL-RHKNLVNLHGWCKQ 421 (668)
Q Consensus 343 f~~~el~~at~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~ 421 (668)
+.+.++..++++|...+.||+|+||.||++....+++.+|+|++..... ...++.+|+.+++++ +|||++++++++..
T Consensus 12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~-~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~ 90 (291)
T cd06639 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD-VDEEIEAEYNILQSLPNHPNVVKFYGMFYK 90 (291)
T ss_pred hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccccc-HHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence 4556777788999999999999999999999988899999999865432 235677899999999 79999999999864
Q ss_pred c-----CceEEEEEecCCCChhhhhcCC-CCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCE
Q 005940 422 K-----NDLLLVYEYIPNGSLDTLLFKP-KDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNA 495 (668)
Q Consensus 422 ~-----~~~~lV~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~ 495 (668)
. +..++|+||+++++|.+++... ..+..+++..++.++.|++.||.|||+ .+++||||||+||+++.++.+
T Consensus 91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~nili~~~~~~ 167 (291)
T cd06639 91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHN---NRIIHRDVKGNNILLTTEGGV 167 (291)
T ss_pred ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEEcCCCCE
Confidence 3 3589999999999999988532 234568999999999999999999998 999999999999999999999
Q ss_pred EEEeecCceeccCCCCCcccccccCCcccCcccccCC-----CCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHH
Q 005940 496 RLGDFGLARLYDHGGMPHTTNVVGTFGYIAPELTQTG-----KASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRE 570 (668)
Q Consensus 496 kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~ 570 (668)
||+|||++........ ......|+..|+|||.+... .++.++|||||||++|||++|+.||...+... -+..
T Consensus 168 kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~--~~~~ 244 (291)
T cd06639 168 KLVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVK--TLFK 244 (291)
T ss_pred EEeecccchhcccccc-cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHH--HHHH
Confidence 9999999886543221 12234688899999987543 36889999999999999999999997543211 0111
Q ss_pred HHhcCccccccCcccCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 571 CHQLGRILDVADPLLNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 571 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
... .......++ .+....+..++..|++. |++||++.|++++
T Consensus 245 ~~~-~~~~~~~~~-------~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 245 IPR-NPPPTLLHP-------EKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred Hhc-CCCCCCCcc-------cccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 111 111111111 11123466677789887 9999999999975
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=313.58 Aligned_cols=199 Identities=26% Similarity=0.328 Sum_probs=171.0
Q ss_pred HhcCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCC--chhHHHHHHHHHHHhcccccCceeEeeeeccc------
Q 005940 351 ATKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNS--LQGMREFAAEIESLGRLRHKNLVNLHGWCKQK------ 422 (668)
Q Consensus 351 at~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~------ 422 (668)
..++|+..+.||+|+||.||++.+...++.||||++.... ....+.+.+|+.+++.++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 3478999999999999999999998889999999997542 23446788999999999999999999988543
Q ss_pred CceEEEEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecC
Q 005940 423 NDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGL 502 (668)
Q Consensus 423 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGl 502 (668)
...++||||+++ +|.+.+. ..+++..+..++.|+++||.|||+ .+|+||||||+||+++.++.+||+|||+
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~---~givHrDikp~Nill~~~~~~kl~Dfg~ 165 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGL 165 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHHEEECCCCCEEEeeCcc
Confidence 357999999965 6666663 238899999999999999999998 9999999999999999999999999999
Q ss_pred ceeccCCCCCcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 005940 503 ARLYDHGGMPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSG 560 (668)
Q Consensus 503 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~ 560 (668)
++...... ......||..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 166 ~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 221 (355)
T cd07874 166 ARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR 221 (355)
T ss_pred cccCCCcc--ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 98654332 223357899999999998888999999999999999999999999754
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=300.64 Aligned_cols=256 Identities=27% Similarity=0.396 Sum_probs=198.6
Q ss_pred cCcccceeeeecCcEEEEEEEe----CCCCcEEEEEEEecCC-chhHHHHHHHHHHHhcccccCceeEeeeeccc--Cce
Q 005940 353 KGFKESEVIGIGGFGSVYKGVL----PTTGGEVAVKKITRNS-LQGMREFAAEIESLGRLRHKNLVNLHGWCKQK--NDL 425 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~----~~~~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~--~~~ 425 (668)
+.|++.+.||+|+||.||++.+ ..++..||+|.+.... ....+.+.+|++++++++|+||+++++++... ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 4577889999999999999974 3467889999987543 34456799999999999999999999998765 568
Q ss_pred EEEEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCcee
Q 005940 426 LLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARL 505 (668)
Q Consensus 426 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~ 505 (668)
++||||+++++|.+++.+ ....++|..++.++.|++.||+|||+ .+++||||||+||+++.++.+||+|||+++.
T Consensus 84 ~lv~e~~~g~~L~~~l~~--~~~~~~~~~~~~i~~~i~~aL~~lH~---~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPR--NKNKINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLTKA 158 (284)
T ss_pred EEEEEccCCCCHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccchheEEEcCCCCEEECCCccccc
Confidence 999999999999999853 23468999999999999999999998 9999999999999999999999999999987
Q ss_pred ccCCCCC--cccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCch-------------hHHHHHHH
Q 005940 506 YDHGGMP--HTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDL-------------LLVEWVRE 570 (668)
Q Consensus 506 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~-------------~l~~~~~~ 570 (668)
....... ......++..|+|||++.+..++.++|||||||++|||++++.|...... ....++ .
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~ 237 (284)
T cd05079 159 IETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLV-R 237 (284)
T ss_pred cccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHH-H
Confidence 6543221 12234567789999999888899999999999999999998876532110 011111 1
Q ss_pred HHhcCccccccCcccCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhcc
Q 005940 571 CHQLGRILDVADPLLNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSG 623 (668)
Q Consensus 571 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~ 623 (668)
....+.... .... ....+..++..|++. |++||+++++++.|+.
T Consensus 238 ~~~~~~~~~-----~~~~----~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~ 282 (284)
T cd05079 238 VLEEGKRLP-----RPPN----CPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEA 282 (284)
T ss_pred HHHcCccCC-----CCCC----CCHHHHHHHHHHccCCcccCcCHHHHHHHHHh
Confidence 111111110 0111 123566777789887 9999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=298.60 Aligned_cols=257 Identities=25% Similarity=0.367 Sum_probs=201.6
Q ss_pred cCcccceeeeecCcEEEEEEEeCC-----CCcEEEEEEEecCCch-hHHHHHHHHHHHhcccccCceeEeeeecccCceE
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPT-----TGGEVAVKKITRNSLQ-GMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLL 426 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~-~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~ 426 (668)
++|+..+.||+|+||.||+|+.+. ....+++|.+...... ..+++..|++++++++|+||+++++++.+....+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 468889999999999999999743 3457999988765443 4678999999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhcCCCCC------CCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEee
Q 005940 427 LVYEYIPNGSLDTLLFKPKDG------SVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDF 500 (668)
Q Consensus 427 lV~E~~~~gsL~~~l~~~~~~------~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~Df 500 (668)
+||||+++|+|.+++.....+ ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.++|+||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~---~~i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSN---ARFVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhh---cCcccCcCccceEEEeCCCcEEEccc
Confidence 999999999999999643322 268999999999999999999998 89999999999999999999999999
Q ss_pred cCceeccCCCCCcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHHHhcCcccc
Q 005940 501 GLARLYDHGGMPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVAT-GRRPIGSGDLLLVEWVRECHQLGRILD 579 (668)
Q Consensus 501 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~l~~~~~~~~~~~~~~~ 579 (668)
|++...............++..|+|||.+.++..+.++||||||+++|||++ |..||...... ..+.. ........
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~--~~~~~-~~~~~~~~ 238 (275)
T cd05046 162 SLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDE--EVLNR-LQAGKLEL 238 (275)
T ss_pred ccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchH--HHHHH-HHcCCcCC
Confidence 9987544332222233456778999999988888999999999999999999 78888543211 11111 11111111
Q ss_pred ccCcccCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhcc
Q 005940 580 VADPLLNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSG 623 (668)
Q Consensus 580 ~~d~~l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~ 623 (668)
. ....++ ..+..++..|+.. |++||++.|+++.|..
T Consensus 239 ~----~~~~~~----~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~~ 275 (275)
T cd05046 239 P----VPEGCP----SRLYKLMTRCWAVNPKDRPSFSELVSALGE 275 (275)
T ss_pred C----CCCCCC----HHHHHHHHHHcCCCcccCCCHHHHHHHhcC
Confidence 0 011111 3466677789887 9999999999998863
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=318.94 Aligned_cols=194 Identities=25% Similarity=0.289 Sum_probs=169.1
Q ss_pred hcCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCchhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEEe
Q 005940 352 TKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEY 431 (668)
Q Consensus 352 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~ 431 (668)
..+|.+.+.||+|+||.||++.+..+++.||||.... ..+.+|++++++++|+||+++++++...+..++|||+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~ 241 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK 241 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 3478899999999999999999998899999996432 3456899999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCCC
Q 005940 432 IPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGM 511 (668)
Q Consensus 432 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~~ 511 (668)
+. ++|.+++.. ....++|.+++.++.||+.||.|||+ .+|+||||||+||||+.++.+||+|||+++.......
T Consensus 242 ~~-~~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~yLH~---~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~ 315 (461)
T PHA03211 242 YR-SDLYTYLGA--RLRPLGLAQVTAVARQLLSAIDYIHG---EGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS 315 (461)
T ss_pred cC-CCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHH---CCEEECcCCHHHEEECCCCCEEEcccCCceecccccc
Confidence 94 788888853 23469999999999999999999998 9999999999999999999999999999987643322
Q ss_pred C-cccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCC
Q 005940 512 P-HTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPI 557 (668)
Q Consensus 512 ~-~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~ 557 (668)
. ......||..|+|||++.+..++.++|||||||++|||++|..|+
T Consensus 316 ~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~l 362 (461)
T PHA03211 316 TPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASL 362 (461)
T ss_pred cccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCc
Confidence 1 122357999999999999889999999999999999999988665
|
|
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=296.77 Aligned_cols=246 Identities=32% Similarity=0.437 Sum_probs=195.3
Q ss_pred eeeeecCcEEEEEEEeCCCCcEEEEEEEecCCch-hHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEEecCCCCh
Q 005940 359 EVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQ-GMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEYIPNGSL 437 (668)
Q Consensus 359 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL 437 (668)
++||+|++|.||++.+.. ++.|++|++...... ....+.+|++++++++|+||+++++++......++||||+++++|
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l 79 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSL 79 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcH
Confidence 469999999999999976 899999998765443 557899999999999999999999999999999999999999999
Q ss_pred hhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCCCCcc-cc
Q 005940 438 DTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHT-TN 516 (668)
Q Consensus 438 ~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~-~~ 516 (668)
.+++.. ....+++..++.++.+++.||.|||+ .+++||||||+||+++.++.+||+|||++........... ..
T Consensus 80 ~~~l~~--~~~~~~~~~~~~~~~~~~~~l~~lH~---~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 154 (251)
T cd05041 80 LTFLRK--KKNRLTVKKLLQMSLDAAAGMEYLES---KNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGL 154 (251)
T ss_pred HHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHh---CCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceecccc
Confidence 999953 23468899999999999999999998 9999999999999999999999999999986543221111 11
Q ss_pred cccCCcccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHHHhcCccccccCcccCCcccHHHHH
Q 005940 517 VVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVAT-GRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSYVVKEME 595 (668)
Q Consensus 517 ~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~ 595 (668)
...+..|+|||.+.++.++.++|||||||++|||++ |..||....... .... ..... . ....... ..
T Consensus 155 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~--~~~~-~~~~~--~---~~~~~~~----~~ 222 (251)
T cd05041 155 KQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQ--TRER-IESGY--R---MPAPQLC----PE 222 (251)
T ss_pred CcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHH--HHHH-HhcCC--C---CCCCccC----CH
Confidence 233567999999988889999999999999999999 888886543211 1111 11110 0 0011111 23
Q ss_pred HHHHHHhhcCCC-CCCCCCHHHHHHHhc
Q 005940 596 LVLKLGLMCSHK-TQFRPTMRQVMRYLS 622 (668)
Q Consensus 596 ~l~~l~~~C~~~-p~~RPs~~evl~~L~ 622 (668)
.+..++..|+.. |++||++.||++.|+
T Consensus 223 ~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 223 EIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred HHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 456677788877 999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=294.36 Aligned_cols=249 Identities=27% Similarity=0.397 Sum_probs=200.7
Q ss_pred CcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCC--chhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEEe
Q 005940 354 GFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNS--LQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEY 431 (668)
Q Consensus 354 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~ 431 (668)
+|+..+.||+|++|.||++....+++.+|+|++.... .+..+.+.+|++++++++|+|++++++.+...+..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 4788899999999999999998899999999987643 34457889999999999999999999999989999999999
Q ss_pred cCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCC-CEEEEeecCceeccCCC
Q 005940 432 IPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEM-NARLGDFGLARLYDHGG 510 (668)
Q Consensus 432 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~-~~kl~DfGla~~~~~~~ 510 (668)
+++++|.+++... ....+++..+.+++.|++.||.|||+ ++++||||||+||+++.+. .+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lh~---~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (256)
T cd08220 81 APGGTLAEYIQKR-CNSLLDEDTILHFFVQILLALHHVHT---KLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS 156 (256)
T ss_pred CCCCCHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc
Confidence 9999999999632 24568999999999999999999998 9999999999999998654 58999999998765432
Q ss_pred CCcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCcccCCccc
Q 005940 511 MPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSYV 590 (668)
Q Consensus 511 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 590 (668)
. .....++..|+|||.+.....+.++||||||+++|||++|+.||...+.. ........ ...... ....
T Consensus 157 ~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~--~~~~~~~~-~~~~~~-----~~~~- 225 (256)
T cd08220 157 K--AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLP--ALVLKIMS-GTFAPI-----SDRY- 225 (256)
T ss_pred c--ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchH--HHHHHHHh-cCCCCC-----CCCc-
Confidence 2 22346788999999998888899999999999999999999999754321 22222211 111111 1111
Q ss_pred HHHHHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 591 VKEMELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 591 ~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
...+..+...|++. |++||+++|++++
T Consensus 226 ---~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 226 ---SPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred ---CHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 12345666788886 9999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=299.24 Aligned_cols=261 Identities=25% Similarity=0.278 Sum_probs=200.7
Q ss_pred CcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCC--chhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEEe
Q 005940 354 GFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNS--LQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEY 431 (668)
Q Consensus 354 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~ 431 (668)
+|+..+.||+|++|.||+|++..++..||+|++.... ....+.+.+|+.++++++|+||+++++++......++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 4778899999999999999998889999999987654 23456789999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCCC
Q 005940 432 IPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGM 511 (668)
Q Consensus 432 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~~ 511 (668)
+ +++|.+++.. ....+++.+++.++.||++||.|||+ .+++|+||||+||+++.++.++|+|||++........
T Consensus 81 ~-~~~L~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 154 (286)
T cd07832 81 M-PSDLSEVLRD--EERPLPEAQVKSYMRMLLKGVAYMHA---NGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP 154 (286)
T ss_pred c-CCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC
Confidence 9 9999999853 23569999999999999999999998 9999999999999999999999999999987655432
Q ss_pred CcccccccCCcccCcccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCch-hHHHHHHHHHhcCc------------c
Q 005940 512 PHTTNVVGTFGYIAPELTQTG-KASTSSDVFAYGILLLEVATGRRPIGSGDL-LLVEWVRECHQLGR------------I 577 (668)
Q Consensus 512 ~~~~~~~gt~~y~aPE~~~~~-~~~~~sDV~S~Gvvl~elltG~~p~~~~~~-~l~~~~~~~~~~~~------------~ 577 (668)
.......++..|+|||++.+. .++.++||||+||++|||++|+.||..... ....++........ .
T Consensus 155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T cd07832 155 RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDY 234 (286)
T ss_pred CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchh
Confidence 223345788999999988654 468999999999999999999877754321 11112111111000 0
Q ss_pred ccccCcccC----CcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 578 LDVADPLLN----SSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 578 ~~~~d~~l~----~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
.....+... .....+....+..+...|+.. |++||++++++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 235 NKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred hcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 000000000 000011124556666788887 9999999999986
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=303.84 Aligned_cols=260 Identities=30% Similarity=0.382 Sum_probs=199.9
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCc--hhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEE
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSL--QGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYE 430 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 430 (668)
++|+..++||+|++|.||+|.+..+++.||+|++..... ...+.+.+|++++++++|+||+++++++..++..++|+|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 468889999999999999999988899999998865332 234678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCC
Q 005940 431 YIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGG 510 (668)
Q Consensus 431 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~ 510 (668)
|+++++|.++... ...++|.+++.++.||+.||+|||+ .+++||||+|+||++++++.+||+|||++.......
T Consensus 81 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07846 81 FVDHTVLDDLEKY---PNGLDESRVRKYLFQILRGIEFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG 154 (286)
T ss_pred cCCccHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc
Confidence 9999999887742 2348999999999999999999998 899999999999999999999999999998765433
Q ss_pred CCcccccccCCcccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccc-----------
Q 005940 511 MPHTTNVVGTFGYIAPELTQT-GKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRIL----------- 578 (668)
Q Consensus 511 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~----------- 578 (668)
.......++..|+|||++.+ ..++.++||||||+++|||++|+.||..... ...+.......+...
T Consensus 155 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07846 155 -EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSD-IDQLYHIIKCLGNLIPRHQEIFQKNP 232 (286)
T ss_pred -cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCch-HHHHHHHHHHhCCCchhhHHHhccch
Confidence 22233467889999998765 4578899999999999999999999865432 111111110000000
Q ss_pred ---cccCcccCCcc-----cHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 579 ---DVADPLLNSSY-----VVKEMELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 579 ---~~~d~~l~~~~-----~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
....+...... .......+..++..|+.. |++||++++++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 283 (286)
T cd07846 233 LFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283 (286)
T ss_pred HhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence 00000000000 001124567788899987 9999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=296.20 Aligned_cols=238 Identities=27% Similarity=0.417 Sum_probs=188.3
Q ss_pred eeeeecCcEEEEEEEeCCCC----------cEEEEEEEecCCchhHHHHHHHHHHHhcccccCceeEeeeecccCceEEE
Q 005940 359 EVIGIGGFGSVYKGVLPTTG----------GEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLV 428 (668)
Q Consensus 359 ~~lG~G~~g~Vy~~~~~~~~----------~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV 428 (668)
+.||+|+||.||+|.+..++ ..+++|.+...... ...|.+|+.++++++|+||++++++|.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 46899999999999997655 35888877655433 6788999999999999999999999988 778999
Q ss_pred EEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCC-------CEEEEeec
Q 005940 429 YEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEM-------NARLGDFG 501 (668)
Q Consensus 429 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~-------~~kl~DfG 501 (668)
|||+++|+|.+++... ...+++..++.++.||+.||+|||+ ++|+||||||+||+++.++ .+||+|||
T Consensus 79 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg 153 (259)
T cd05037 79 EEYVKFGPLDVFLHRE--KNNVSLHWKLDVAKQLASALHYLED---KKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPG 153 (259)
T ss_pred EEcCCCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHhh---CCeecccCccceEEEecCccccCCceeEEeCCCC
Confidence 9999999999999642 2368999999999999999999998 9999999999999999887 79999999
Q ss_pred CceeccCCCCCcccccccCCcccCcccccCC--CCCcchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHHHhcCccc
Q 005940 502 LARLYDHGGMPHTTNVVGTFGYIAPELTQTG--KASTSSDVFAYGILLLEVAT-GRRPIGSGDLLLVEWVRECHQLGRIL 578 (668)
Q Consensus 502 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~l~~~~~~~~~~~~~~ 578 (668)
++..... .....++..|+|||++... .++.++|||||||++|||++ |..|+..... .++... .......
T Consensus 154 ~a~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~--~~~~~~-~~~~~~~ 225 (259)
T cd05037 154 IPITVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSS--SEKERF-YQDQHRL 225 (259)
T ss_pred ccccccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCc--hhHHHH-HhcCCCC
Confidence 9986543 1223567789999998776 78999999999999999999 5777754321 111111 1111100
Q ss_pred cccCcccCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhc
Q 005940 579 DVADPLLNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLS 622 (668)
Q Consensus 579 ~~~d~~l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~ 622 (668)
. .+ . ...+..++..|+.. |++||++.+|++.|+
T Consensus 226 ~--~~------~---~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 226 P--MP------D---CAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred C--CC------C---chHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0 00 0 14556777789887 999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-35 Score=311.06 Aligned_cols=198 Identities=27% Similarity=0.417 Sum_probs=171.0
Q ss_pred HhcCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCc--hhHHHHHHHHHHHhcccccCceeEeeeeccc------
Q 005940 351 ATKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSL--QGMREFAAEIESLGRLRHKNLVNLHGWCKQK------ 422 (668)
Q Consensus 351 at~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~------ 422 (668)
..++|...+.||+|+||.||+|.+..+++.||||++..... ...+.+.+|++++++++|+||+++++++...
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07878 13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF 92 (343)
T ss_pred hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence 34688999999999999999999988899999999875432 3345678899999999999999999987533
Q ss_pred CceEEEEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecC
Q 005940 423 NDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGL 502 (668)
Q Consensus 423 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGl 502 (668)
...++++|++ +++|.+++. ...+++..+..++.||+.||.|||+ .+|+||||||+||+++.++.+||+|||+
T Consensus 93 ~~~~~~~~~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivHrdikp~Nil~~~~~~~kl~Dfg~ 164 (343)
T cd07878 93 NEVYLVTNLM-GADLNNIVK----CQKLSDEHVQFLIYQLLRGLKYIHS---AGIIHRDLKPSNVAVNEDCELRILDFGL 164 (343)
T ss_pred CcEEEEeecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecccCChhhEEECCCCCEEEcCCcc
Confidence 4578999988 789988874 2358999999999999999999999 9999999999999999999999999999
Q ss_pred ceeccCCCCCcccccccCCcccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 005940 503 ARLYDHGGMPHTTNVVGTFGYIAPELTQT-GKASTSSDVFAYGILLLEVATGRRPIGSG 560 (668)
Q Consensus 503 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~S~Gvvl~elltG~~p~~~~ 560 (668)
++..... .....||..|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 165 ~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 219 (343)
T cd07878 165 ARQADDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGN 219 (343)
T ss_pred ceecCCC----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCC
Confidence 9876532 233578999999999876 56889999999999999999999999754
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=301.67 Aligned_cols=240 Identities=25% Similarity=0.396 Sum_probs=188.2
Q ss_pred eeeeecCcEEEEEEEeCCCCc-------EEEEEEEecCCchhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEEe
Q 005940 359 EVIGIGGFGSVYKGVLPTTGG-------EVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEY 431 (668)
Q Consensus 359 ~~lG~G~~g~Vy~~~~~~~~~-------~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~ 431 (668)
+.||+|+||.||+|.....+. ++++|.+........+++.+|+.+++.++|||++++++++......++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 469999999999998854443 4889988766555667889999999999999999999999998999999999
Q ss_pred cCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCC--------EEEEeecCc
Q 005940 432 IPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMN--------ARLGDFGLA 503 (668)
Q Consensus 432 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~--------~kl~DfGla 503 (668)
+++|+|.+++.. .+..+++..++.++.||+.||.|||+ .+|+||||||+||+++.++. ++++|||++
T Consensus 81 ~~~g~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~---~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~ 155 (258)
T cd05078 81 VKFGSLDTYLKK--NKNLINISWKLEVAKQLAWALHFLED---KGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS 155 (258)
T ss_pred CCCCcHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCccceEEEecccccccCCCceEEecccccc
Confidence 999999999963 23468999999999999999999998 99999999999999987765 589999988
Q ss_pred eeccCCCCCcccccccCCcccCcccccCC-CCCcchhHHHHHHHHHHHHhCC-CCCCCCchhHHHHHHHHHhcCcccccc
Q 005940 504 RLYDHGGMPHTTNVVGTFGYIAPELTQTG-KASTSSDVFAYGILLLEVATGR-RPIGSGDLLLVEWVRECHQLGRILDVA 581 (668)
Q Consensus 504 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDV~S~Gvvl~elltG~-~p~~~~~~~l~~~~~~~~~~~~~~~~~ 581 (668)
..... .....++..|+|||++.+. .++.++|||||||++|||++|. .|+...+.... .. .....
T Consensus 156 ~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~--~~-~~~~~------ 221 (258)
T cd05078 156 ITVLP-----KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKK--LQ-FYEDR------ 221 (258)
T ss_pred cccCC-----chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHH--HH-HHHcc------
Confidence 65432 2234678899999998764 5789999999999999999985 55543322111 11 11110
Q ss_pred CcccCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhc
Q 005940 582 DPLLNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLS 622 (668)
Q Consensus 582 d~~l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~ 622 (668)
..+..... ..+..++..|++. |++||+++++++.|+
T Consensus 222 -~~~~~~~~----~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 222 -HQLPAPKW----TELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred -ccCCCCCc----HHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 11111111 2355667788887 999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=314.97 Aligned_cols=246 Identities=27% Similarity=0.421 Sum_probs=200.9
Q ss_pred eeeeecCcEEEEEEEeCCCCcEEEEEEEecCCchhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEEecCCCChh
Q 005940 359 EVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEYIPNGSLD 438 (668)
Q Consensus 359 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~ 438 (668)
-+||+|.||+||.|++..+...+|||.+.....+..+-+..|+...++|+|+|||+++|.|.+++.+-+.||.+|||||.
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS 660 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS 660 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence 47999999999999999999999999998877777788999999999999999999999999999999999999999999
Q ss_pred hhhcCCCCCCCc--cHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECC-CCCEEEEeecCceeccCCCCCccc
Q 005940 439 TLLFKPKDGSVL--DWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDA-EMNARLGDFGLARLYDHGGMPHTT 515 (668)
Q Consensus 439 ~~l~~~~~~~~l--~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~-~~~~kl~DfGla~~~~~~~~~~~~ 515 (668)
++|.. .-+++ ++..+--+.+||++||.|||+ +.|||||||-.|||++. .|.+||+|||-++.+..- .+.+.
T Consensus 661 sLLrs--kWGPlKDNEstm~fYtkQILeGLkYLHe---n~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi-nP~TE 734 (1226)
T KOG4279|consen 661 SLLRS--KWGPLKDNESTMNFYTKQILEGLKYLHE---NKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI-NPCTE 734 (1226)
T ss_pred HHHHh--ccCCCccchhHHHHHHHHHHHHhhhhhh---cceeeccccCCcEEEeeccceEEecccccchhhccC-Ccccc
Confidence 99963 23445 778888899999999999998 99999999999999964 688999999998866532 34556
Q ss_pred ccccCCcccCcccccCC--CCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCcccCCcccHHH
Q 005940 516 NVVGTFGYIAPELTQTG--KASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSYVVKE 593 (668)
Q Consensus 516 ~~~gt~~y~aPE~~~~~--~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 593 (668)
.+.||..|||||++..+ .|..++|||||||.+.||.||++||-.-....... .+-+ +.-..|.+ +.+-
T Consensus 735 TFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAM----FkVG--myKvHP~i----Peel 804 (1226)
T KOG4279|consen 735 TFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAM----FKVG--MYKVHPPI----PEEL 804 (1226)
T ss_pred ccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhh----hhhc--ceecCCCC----cHHH
Confidence 67899999999999765 47899999999999999999999995432211111 1101 11112333 3333
Q ss_pred HHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 594 MELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 594 ~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
......+.+.|..+ |.+||+++++++-
T Consensus 805 saeak~FilrcFepd~~~R~sA~~LL~D 832 (1226)
T KOG4279|consen 805 SAEAKNFILRCFEPDPCDRPSAKDLLQD 832 (1226)
T ss_pred HHHHHHHHHHHcCCCcccCccHHHhccC
Confidence 44555667799988 9999999999963
|
|
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=311.23 Aligned_cols=241 Identities=26% Similarity=0.295 Sum_probs=185.8
Q ss_pred eeeeecCcEEEEEEEeCCCCcEEEEEEEecCCc---hhHHHHHHHH-HHHhcccccCceeEeeeecccCceEEEEEecCC
Q 005940 359 EVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSL---QGMREFAAEI-ESLGRLRHKNLVNLHGWCKQKNDLLLVYEYIPN 434 (668)
Q Consensus 359 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~f~~Ei-~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~ 434 (668)
+.||+|+||.||+|.+..+++.||+|++.+... ....++..|. .+++.++|+||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 469999999999999988899999999975422 2223444444 456788999999999999999999999999999
Q ss_pred CChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCCCCcc
Q 005940 435 GSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHT 514 (668)
Q Consensus 435 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 514 (668)
|+|.+++.. ...+++.....++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 ~~L~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~---~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~-~~~ 153 (325)
T cd05602 81 GELFYHLQR---ERCFLEPRARFYAAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN-GTT 153 (325)
T ss_pred CcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEEccCCCCcccccCC-CCc
Confidence 999999853 3457888888999999999999999 999999999999999999999999999997543222 123
Q ss_pred cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCcccCCcccHHHH
Q 005940 515 TNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSYVVKEM 594 (668)
Q Consensus 515 ~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 594 (668)
....||+.|+|||++.+..++.++|||||||++|||++|+.||...+.. +........ .. .+..... .
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--~~~~~i~~~-~~------~~~~~~~-~-- 221 (325)
T cd05602 154 STFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA--EMYDNILNK-PL------QLKPNIT-N-- 221 (325)
T ss_pred ccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHH--HHHHHHHhC-Cc------CCCCCCC-H--
Confidence 3457999999999999889999999999999999999999999754322 111111111 10 1111122 2
Q ss_pred HHHHHHHhhcCCC-CCCCCCHHHHHH
Q 005940 595 ELVLKLGLMCSHK-TQFRPTMRQVMR 619 (668)
Q Consensus 595 ~~l~~l~~~C~~~-p~~RPs~~evl~ 619 (668)
.+..+...|++. |.+||++.+.++
T Consensus 222 -~~~~li~~~l~~~p~~R~~~~~~~~ 246 (325)
T cd05602 222 -SARHLLEGLLQKDRTKRLGAKDDFM 246 (325)
T ss_pred -HHHHHHHHHcccCHHHCCCCCCCHH
Confidence 233444567776 999998774443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=294.52 Aligned_cols=263 Identities=26% Similarity=0.294 Sum_probs=197.9
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCch--hHHHHHHHHHHHhcccccC-ceeEeeeecccC------
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQ--GMREFAAEIESLGRLRHKN-LVNLHGWCKQKN------ 423 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~f~~Ei~~l~~l~H~n-Iv~l~g~~~~~~------ 423 (668)
..|...++||+|.||+||+|+.+.+|+.||+|+++....+ .......|+.++++|+|+| |++|++.+...+
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 3566678899999999999999999999999999876542 2345678999999999999 999999998776
Q ss_pred ceEEEEEecCCCChhhhhcCCCCC-CCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecC
Q 005940 424 DLLLVYEYIPNGSLDTLLFKPKDG-SVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGL 502 (668)
Q Consensus 424 ~~~lV~E~~~~gsL~~~l~~~~~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGl 502 (668)
.+++|+||+ .-+|..++...... ..++-..+..++.||++||+|||+ ++|+||||||.||||++++.+||+|||+
T Consensus 91 ~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~---~~IlHRDLKPQNlLi~~~G~lKlaDFGl 166 (323)
T KOG0594|consen 91 KLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHS---HGILHRDLKPQNLLISSSGVLKLADFGL 166 (323)
T ss_pred eEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHh---CCeecccCCcceEEECCCCcEeeeccch
Confidence 789999999 45899998643321 346678899999999999999999 9999999999999999999999999999
Q ss_pred ceeccCCCCCcccccccCCcccCcccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCC-chhHHHHHHHHHhcCc----
Q 005940 503 ARLYDHGGMPHTTNVVGTFGYIAPELTQTG-KASTSSDVFAYGILLLEVATGRRPIGSG-DLLLVEWVRECHQLGR---- 576 (668)
Q Consensus 503 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDV~S~Gvvl~elltG~~p~~~~-~~~l~~~~~~~~~~~~---- 576 (668)
|+...-+.. ..+..++|..|.|||++.+. .|+...||||+||++.||++++.-|.+. +.....-+.+......
T Consensus 167 Ara~~ip~~-~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~W 245 (323)
T KOG0594|consen 167 ARAFSIPMR-TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDW 245 (323)
T ss_pred HHHhcCCcc-cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCC
Confidence 996653322 24556889999999998876 6899999999999999999988888654 2222222222222111
Q ss_pred --cccccCcc--c---C-CcccHHH----HHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 577 --ILDVADPL--L---N-SSYVVKE----MELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 577 --~~~~~d~~--l---~-~~~~~~~----~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
.....+-. . . ......+ ......+...|++. |.+|.|++.+++|
T Consensus 246 p~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 246 PGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred CCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 01011100 0 0 0000010 12344555566666 9999999999986
|
|
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=307.16 Aligned_cols=200 Identities=23% Similarity=0.286 Sum_probs=167.7
Q ss_pred cceeeeec--CcEEEEEEEeCCCCcEEEEEEEecCC--chhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEEec
Q 005940 357 ESEVIGIG--GFGSVYKGVLPTTGGEVAVKKITRNS--LQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEYI 432 (668)
Q Consensus 357 ~~~~lG~G--~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~ 432 (668)
..++||+| +|++||++..+.+++.||+|++.... ....+.+.+|+++++.++||||++++++|..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 35789999 78999999999999999999997543 233456778999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCCCC
Q 005940 433 PNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMP 512 (668)
Q Consensus 433 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~~~ 512 (668)
++|+|.+++... ....+++..++.++.|++.||.|||+ .+|+||||||+||+++.++.+++.||+.+.........
T Consensus 82 ~~~~l~~~~~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~---~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~ 157 (327)
T cd08227 82 AYGSAKDLICTH-FMDGMSELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQR 157 (327)
T ss_pred CCCcHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCChhhEEEecCCcEEEcccchhhcccccccc
Confidence 999999998532 23458999999999999999999998 99999999999999999999999999865433211100
Q ss_pred ------cccccccCCcccCcccccC--CCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 005940 513 ------HTTNVVGTFGYIAPELTQT--GKASTSSDVFAYGILLLEVATGRRPIGSG 560 (668)
Q Consensus 513 ------~~~~~~gt~~y~aPE~~~~--~~~~~~sDV~S~Gvvl~elltG~~p~~~~ 560 (668)
......++..|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 213 (327)
T cd08227 158 LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDM 213 (327)
T ss_pred ccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCc
Confidence 0122356778999999875 45889999999999999999999999643
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=296.13 Aligned_cols=249 Identities=27% Similarity=0.408 Sum_probs=190.6
Q ss_pred eeeeecCcEEEEEEEeCC---CCcEEEEEEEecC-CchhHHHHHHHHHHHhcccccCceeEeeeec-ccCceEEEEEecC
Q 005940 359 EVIGIGGFGSVYKGVLPT---TGGEVAVKKITRN-SLQGMREFAAEIESLGRLRHKNLVNLHGWCK-QKNDLLLVYEYIP 433 (668)
Q Consensus 359 ~~lG~G~~g~Vy~~~~~~---~~~~vavK~~~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~-~~~~~~lV~E~~~ 433 (668)
+.||+|+||.||+|.+.. .+..+|+|++... .....+.+.+|+.+++.++||||++++++|. .++..++|+||++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 468999999999998643 2357999998543 3345678889999999999999999999875 4556899999999
Q ss_pred CCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCCC--
Q 005940 434 NGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGM-- 511 (668)
Q Consensus 434 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~~-- 511 (668)
+|+|.+++.. ....+++..++.++.|++.||.|||+ .+++||||||+||++++++.+||+|||+++.......
T Consensus 81 ~~~L~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~ 155 (262)
T cd05058 81 HGDLRNFIRS--ETHNPTVKDLIGFGLQVAKGMEYLAS---KKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYS 155 (262)
T ss_pred CCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccCcceEEEcCCCcEEECCccccccccCCccee
Confidence 9999999953 23446788889999999999999998 9999999999999999999999999999986543211
Q ss_pred -CcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhC-CCCCCCCchhHHHHHHHHHhcCccccccCcccCCcc
Q 005940 512 -PHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATG-RRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSY 589 (668)
Q Consensus 512 -~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG-~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 589 (668)
.......++..|+|||++....++.++|||||||++|||++| ..||...+. .+........... ......
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~--~~~~~~~~~~~~~------~~~~~~ 227 (262)
T cd05058 156 VHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDS--FDITVYLLQGRRL------LQPEYC 227 (262)
T ss_pred ecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHHhcCCCC------CCCCcC
Confidence 111233457789999999888899999999999999999995 455654321 1222222211110 111111
Q ss_pred cHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhccC
Q 005940 590 VVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSGE 624 (668)
Q Consensus 590 ~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~~ 624 (668)
...+..++..|++. |++||++.||++.|+..
T Consensus 228 ----~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~ 259 (262)
T cd05058 228 ----PDPLYEVMLSCWHPKPEMRPTFSELVSRIEQI 259 (262)
T ss_pred ----CHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 13456777789987 99999999999998754
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=302.47 Aligned_cols=258 Identities=27% Similarity=0.397 Sum_probs=200.1
Q ss_pred cCcccceeeeecCcEEEEEEEeC-------CCCcEEEEEEEecCC-chhHHHHHHHHHHHhcc-cccCceeEeeeecccC
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLP-------TTGGEVAVKKITRNS-LQGMREFAAEIESLGRL-RHKNLVNLHGWCKQKN 423 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~-------~~~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~ 423 (668)
.+|...++||+|+||.||+++.. .....+|+|++.... .....++.+|+++++++ +||||++++++|...+
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG 91 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC
Confidence 46778899999999999999752 234579999987543 34456788999999999 6999999999999989
Q ss_pred ceEEEEEecCCCChhhhhcCCC-------------CCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEEC
Q 005940 424 DLLLVYEYIPNGSLDTLLFKPK-------------DGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALID 490 (668)
Q Consensus 424 ~~~lV~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~ 490 (668)
..++||||+++|+|.+++.... ....++|.++.+++.|++.||.|||+ .+++||||||+||+++
T Consensus 92 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~gi~H~dlkp~Nill~ 168 (314)
T cd05099 92 PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLES---RRCIHRDLAARNVLVT 168 (314)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHH---CCeeeccccceeEEEc
Confidence 9999999999999999996422 12458999999999999999999998 9999999999999999
Q ss_pred CCCCEEEEeecCceeccCCCCC-cccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHH
Q 005940 491 AEMNARLGDFGLARLYDHGGMP-HTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVAT-GRRPIGSGDLLLVEWV 568 (668)
Q Consensus 491 ~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~l~~~~ 568 (668)
+++.+||+|||+++........ ......++..|+|||.+.++.++.++|||||||++|||++ |..||...... + .
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~--~-~ 245 (314)
T cd05099 169 EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVE--E-L 245 (314)
T ss_pred CCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHH--H-H
Confidence 9999999999999866432211 1112234467999999988889999999999999999999 88898654321 1 1
Q ss_pred HHHHhcCccccccCcccCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhccCc
Q 005940 569 RECHQLGRILDVADPLLNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSGEK 625 (668)
Q Consensus 569 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~~~ 625 (668)
.+........+ ..... ...+..++..|+.. |++||++.|+++.|....
T Consensus 246 ~~~~~~~~~~~-----~~~~~----~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~ 294 (314)
T cd05099 246 FKLLREGHRMD-----KPSNC----THELYMLMRECWHAVPTQRPTFKQLVEALDKVL 294 (314)
T ss_pred HHHHHcCCCCC-----CCCCC----CHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 11111111111 11111 12345677799987 999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=307.94 Aligned_cols=196 Identities=30% Similarity=0.386 Sum_probs=168.5
Q ss_pred eeeeecCcEEEEEEEeCCCCcEEEEEEEecCC---chhHHHHHHHHH-HHhcccccCceeEeeeecccCceEEEEEecCC
Q 005940 359 EVIGIGGFGSVYKGVLPTTGGEVAVKKITRNS---LQGMREFAAEIE-SLGRLRHKNLVNLHGWCKQKNDLLLVYEYIPN 434 (668)
Q Consensus 359 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~f~~Ei~-~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~ 434 (668)
+.||+|+||.||+|....+++.+|+|++.+.. .....++..|.. +++.++||||+++++.+...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46999999999999998899999999997542 223345556655 46778999999999999999999999999999
Q ss_pred CChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCCCCcc
Q 005940 435 GSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHT 514 (668)
Q Consensus 435 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 514 (668)
|+|..++.. ...+++.++..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~lH~---~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~-~~~ 153 (325)
T cd05604 81 GELFFHLQR---ERSFPEPRARFYAAEIASALGYLHS---INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS-DTT 153 (325)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCC-CCc
Confidence 999988853 3468999999999999999999998 999999999999999999999999999987532221 123
Q ss_pred cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCc
Q 005940 515 TNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGD 561 (668)
Q Consensus 515 ~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~ 561 (668)
....||..|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~ 200 (325)
T cd05604 154 TTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRD 200 (325)
T ss_pred ccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCC
Confidence 34579999999999999899999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=308.23 Aligned_cols=259 Identities=26% Similarity=0.379 Sum_probs=202.3
Q ss_pred cCcccceeeeecCcEEEEEEEeCC-------CCcEEEEEEEecCC-chhHHHHHHHHHHHhcc-cccCceeEeeeecccC
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPT-------TGGEVAVKKITRNS-LQGMREFAAEIESLGRL-RHKNLVNLHGWCKQKN 423 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~-------~~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~ 423 (668)
.+|.+.+.||+|+||.||++.... .+..||+|.+.... ....+++.+|+++++++ +|+||++++++|...+
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 91 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence 357888999999999999997532 12368999887543 34457899999999999 7999999999999999
Q ss_pred ceEEEEEecCCCChhhhhcCCC-------------CCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEEC
Q 005940 424 DLLLVYEYIPNGSLDTLLFKPK-------------DGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALID 490 (668)
Q Consensus 424 ~~~lV~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~ 490 (668)
..++++||+++|+|.+++.... ....++|.+++.++.|++.||.|||+ .+++||||||+||+++
T Consensus 92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~givH~dlkp~Nill~ 168 (334)
T cd05100 92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLAS---QKCIHRDLAARNVLVT 168 (334)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH---CCeeccccccceEEEc
Confidence 9999999999999999986422 22458899999999999999999998 9999999999999999
Q ss_pred CCCCEEEEeecCceeccCCCCC-cccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHH
Q 005940 491 AEMNARLGDFGLARLYDHGGMP-HTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVAT-GRRPIGSGDLLLVEWV 568 (668)
Q Consensus 491 ~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~l~~~~ 568 (668)
.++.+||+|||+++........ ......++..|+|||.+.+..++.++|||||||++|||++ |..||...+ ..++.
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~--~~~~~ 246 (334)
T cd05100 169 EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP--VEELF 246 (334)
T ss_pred CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCC--HHHHH
Confidence 9999999999999866543211 1122234567999999988889999999999999999998 888886543 22222
Q ss_pred HHHHhcCccccccCcccCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhccCcC
Q 005940 569 RECHQLGRILDVADPLLNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSGEKQ 626 (668)
Q Consensus 569 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~~~~ 626 (668)
...... ..... ...+ ...+..++..|++. |++||++.|+++.|+....
T Consensus 247 ~~~~~~-~~~~~-----~~~~----~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~ 295 (334)
T cd05100 247 KLLKEG-HRMDK-----PANC----THELYMIMRECWHAVPSQRPTFKQLVEDLDRVLT 295 (334)
T ss_pred HHHHcC-CCCCC-----CCCC----CHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhh
Confidence 222211 11111 1111 23455777789997 9999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=296.82 Aligned_cols=252 Identities=26% Similarity=0.406 Sum_probs=199.2
Q ss_pred CcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCC------chhHHHHHHHHHHHhcccccCceeEeeeecccCceEE
Q 005940 354 GFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNS------LQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLL 427 (668)
Q Consensus 354 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~------~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l 427 (668)
+|+..+.||+|++|.||+|....+++.+|+|++.... ....+.+..|++++++++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 4778899999999999999998889999999986533 1235688999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCC-CEEEEeecCceec
Q 005940 428 VYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEM-NARLGDFGLARLY 506 (668)
Q Consensus 428 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~-~~kl~DfGla~~~ 506 (668)
|+||+++++|.+++.. ...+++..+..++.|++.||.|||+ .+++|+||||+||+++.++ .+||+|||.+...
T Consensus 81 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~ql~~al~~LH~---~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~ 154 (268)
T cd06630 81 FVEWMAGGSVSHLLSK---YGAFKEAVIINYTEQLLRGLSYLHE---NQIIHRDVKGANLLIDSTGQRLRIADFGAAARL 154 (268)
T ss_pred EEeccCCCcHHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence 9999999999999853 3468999999999999999999999 9999999999999998876 5999999999876
Q ss_pred cCCCCC---cccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCch-hHHHHHHHHHhcCccccccC
Q 005940 507 DHGGMP---HTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDL-LLVEWVRECHQLGRILDVAD 582 (668)
Q Consensus 507 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~-~l~~~~~~~~~~~~~~~~~d 582 (668)
...... ......++..|+|||.+.+..++.++||||+|+++|||++|+.||...+. .......+...... .
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-----~ 229 (268)
T cd06630 155 AAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATT-----A 229 (268)
T ss_pred ccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCC-----C
Confidence 543211 12234678899999999888899999999999999999999999964321 11111111111000 1
Q ss_pred cccCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 583 PLLNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 583 ~~l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
+.. .......+..+...|+.. |++||++.|++++
T Consensus 230 ~~~----~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~ 264 (268)
T cd06630 230 PSI----PEHLSPGLRDVTLRCLELQPEDRPPSRELLKH 264 (268)
T ss_pred CCC----chhhCHHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence 111 111123455666788876 9999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=305.35 Aligned_cols=253 Identities=26% Similarity=0.325 Sum_probs=200.7
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCch---hHHHHHHHHHHHhcccccCceeEeeeecccCceEEEE
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQ---GMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVY 429 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 429 (668)
++|+..+.||+|++|.||+|....++..+|+|.+...... ..+.+..|++++++++|+||+++++.+......++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 3688899999999999999999888999999999765432 4567889999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCC
Q 005940 430 EYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHG 509 (668)
Q Consensus 430 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~ 509 (668)
||+.+++|.+++.. ..+..+++..+..++.|++.||+|||+ .+++||||||+||+++.++.++|+|||++......
T Consensus 81 e~~~~~~L~~~~~~-~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 156 (316)
T cd05574 81 DYCPGGELFRLLQR-QPGKCLSEEVARFYAAEVLLALEYLHL---LGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVE 156 (316)
T ss_pred EecCCCCHHHHHHh-CCCCccCHHHHHHHHHHHHHHHHHHHH---CCeeccCCChHHeEEcCCCCEEEeecchhhccccc
Confidence 99999999999863 234578999999999999999999998 99999999999999999999999999998755322
Q ss_pred CCC----------------------------cccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCc
Q 005940 510 GMP----------------------------HTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGD 561 (668)
Q Consensus 510 ~~~----------------------------~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~ 561 (668)
... ......|+..|+|||++.+..++.++||||||+++|||++|+.||...+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~ 236 (316)
T cd05574 157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN 236 (316)
T ss_pred ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCc
Confidence 110 1112367889999999988889999999999999999999999997543
Q ss_pred hhHHHHHHHHHhcCccccccCcccCCcccHHHHHHHHHHHhhcCCC-CCCCCC----HHHHHHH
Q 005940 562 LLLVEWVRECHQLGRILDVADPLLNSSYVVKEMELVLKLGLMCSHK-TQFRPT----MRQVMRY 620 (668)
Q Consensus 562 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs----~~evl~~ 620 (668)
... .+ ..... .. ...... ......+..+...|+.. |++||+ ++|++++
T Consensus 237 ~~~-~~-~~~~~-~~------~~~~~~--~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~ 289 (316)
T cd05574 237 RDE-TF-SNILK-KE------VTFPGS--PPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH 289 (316)
T ss_pred hHH-HH-HHHhc-CC------ccCCCc--cccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcC
Confidence 221 11 11111 11 011110 00223455666688877 999999 7777764
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=302.33 Aligned_cols=202 Identities=30% Similarity=0.427 Sum_probs=172.7
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCc-hhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEEe
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSL-QGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEY 431 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~ 431 (668)
++|...++||+|+||.||+|.+..+++.||+|.+..... .....+.+|+.++++++|+||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 468889999999999999999988899999999875432 2335677899999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCCC
Q 005940 432 IPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGM 511 (668)
Q Consensus 432 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~~ 511 (668)
++ ++|.+++.. ....+++..+..++.||+.||.|||+ .+|+||||||+||++++++.+||+|||++........
T Consensus 86 ~~-~~l~~~l~~--~~~~~~~~~~~~~~~qi~~aL~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 159 (301)
T cd07873 86 LD-KDLKQYLDD--CGNSINMHNVKLFLFQLLRGLNYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK 159 (301)
T ss_pred cc-cCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC
Confidence 97 589888853 23468899999999999999999999 9999999999999999999999999999976543221
Q ss_pred CcccccccCCcccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCc
Q 005940 512 PHTTNVVGTFGYIAPELTQT-GKASTSSDVFAYGILLLEVATGRRPIGSGD 561 (668)
Q Consensus 512 ~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~S~Gvvl~elltG~~p~~~~~ 561 (668)
......++..|+|||.+.+ ..++.++|||||||++|||++|+.||...+
T Consensus 160 -~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~ 209 (301)
T cd07873 160 -TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGST 209 (301)
T ss_pred -cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 1223356889999998765 357889999999999999999999997543
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=311.09 Aligned_cols=198 Identities=26% Similarity=0.331 Sum_probs=171.0
Q ss_pred hcCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCC--chhHHHHHHHHHHHhcccccCceeEeeeeccc------C
Q 005940 352 TKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNS--LQGMREFAAEIESLGRLRHKNLVNLHGWCKQK------N 423 (668)
Q Consensus 352 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~------~ 423 (668)
.++|...+.||+|+||.||++.+...++.||||++.... ....+.+.+|+.+++.++||||+++++.+... .
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~ 102 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 102 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence 468999999999999999999998889999999997542 33456788999999999999999999987543 3
Q ss_pred ceEEEEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCc
Q 005940 424 DLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLA 503 (668)
Q Consensus 424 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla 503 (668)
..|+||||+++ +|.+.+. ..+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||++
T Consensus 103 ~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a 173 (364)
T cd07875 103 DVYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLA 173 (364)
T ss_pred eEEEEEeCCCC-CHHHHHH-----hcCCHHHHHHHHHHHHHHHHHHhh---CCeecCCCCHHHEEECCCCcEEEEeCCCc
Confidence 57999999965 6777763 237889999999999999999998 99999999999999999999999999999
Q ss_pred eeccCCCCCcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 005940 504 RLYDHGGMPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSG 560 (668)
Q Consensus 504 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~ 560 (668)
+...... ......+|..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 174 ~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 228 (364)
T cd07875 174 RTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGT 228 (364)
T ss_pred cccCCCC--cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCC
Confidence 8654332 223357899999999999989999999999999999999999999754
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=296.84 Aligned_cols=254 Identities=26% Similarity=0.417 Sum_probs=197.1
Q ss_pred CcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCc----------hhHHHHHHHHHHHhcccccCceeEeeeecccC
Q 005940 354 GFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSL----------QGMREFAAEIESLGRLRHKNLVNLHGWCKQKN 423 (668)
Q Consensus 354 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----------~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~ 423 (668)
+|...+.||+|++|.||+|....+++.+|+|.+..... ...+.+..|+.++++++|+|++++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 46677899999999999999888899999998854211 12346788999999999999999999999999
Q ss_pred ceEEEEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCc
Q 005940 424 DLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLA 503 (668)
Q Consensus 424 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla 503 (668)
..++||||+++++|.+++... ..+++..+..++.|++.||.|||+ .+++||||+|+||+++.++.++|+|||++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~~~nil~~~~~~~~l~d~~~~ 155 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY---GRFEEQLVRFFTEQVLEGLAYLHS---KGILHRDLKADNLLVDADGICKISDFGIS 155 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhh---CCeeecCCChhhEEEcCCCeEEEeecccc
Confidence 999999999999999999532 468999999999999999999998 89999999999999999999999999999
Q ss_pred eeccCCCC-CcccccccCCcccCcccccCCC--CCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccc
Q 005940 504 RLYDHGGM-PHTTNVVGTFGYIAPELTQTGK--ASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDV 580 (668)
Q Consensus 504 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~--~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~ 580 (668)
+....... .......++..|+|||.+.... ++.++||||||+++||+++|..||...+.. ....+..... ....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~--~~~~~~~~~~-~~~~ 232 (272)
T cd06629 156 KKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI--AAMFKLGNKR-SAPP 232 (272)
T ss_pred ccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchH--HHHHHhhccc-cCCc
Confidence 86543221 1123346888999999887654 789999999999999999999999654322 1111111111 1111
Q ss_pred cCcccCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 581 ADPLLNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 581 ~d~~l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
+++.....+. ..+..+...|+.. |++||++++|+++
T Consensus 233 ~~~~~~~~~~----~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 233 IPPDVSMNLS----PVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred CCccccccCC----HHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 1111111222 3444555678876 9999999999985
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=292.65 Aligned_cols=252 Identities=30% Similarity=0.455 Sum_probs=200.3
Q ss_pred CcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCch--hHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEEe
Q 005940 354 GFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQ--GMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEY 431 (668)
Q Consensus 354 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~ 431 (668)
+|+..+.||+|++|.||+|....+++.|++|.+...... ..+.+..|+.++++++|+||+++++.+...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 477889999999999999999888999999998765543 667899999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCCC
Q 005940 432 IPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGM 511 (668)
Q Consensus 432 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~~ 511 (668)
+++++|.+++.. +..+++..+..++.|++.||.|||+ .+++|+||+|+||++++++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lh~---~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~ 154 (264)
T cd06626 81 CSGGTLEELLEH---GRILDEHVIRVYTLQLLEGLAYLHS---HGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTT 154 (264)
T ss_pred CCCCcHHHHHhh---cCCCChHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEcccccccccCCCCC
Confidence 999999999953 3458899999999999999999998 9999999999999999999999999999987654332
Q ss_pred Ccc---cccccCCcccCcccccCCC---CCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCccc
Q 005940 512 PHT---TNVVGTFGYIAPELTQTGK---ASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLL 585 (668)
Q Consensus 512 ~~~---~~~~gt~~y~aPE~~~~~~---~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 585 (668)
... ....++..|+|||++.... .+.++||||||+++|||++|+.||...+.. |......... ..+.+
T Consensus 155 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~---~~~~~~~~~~----~~~~~ 227 (264)
T cd06626 155 TMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNE---FQIMFHVGAG----HKPPI 227 (264)
T ss_pred cccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcch---HHHHHHHhcC----CCCCC
Confidence 211 1346788999999988766 789999999999999999999999654311 1111111110 11111
Q ss_pred CCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 586 NSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 586 ~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
.... .....+..+...|++. |++||+++|++++
T Consensus 228 ~~~~--~~~~~~~~li~~~l~~~p~~R~~~~~i~~~ 261 (264)
T cd06626 228 PDSL--QLSPEGKDFLDRCLESDPKKRPTASELLQH 261 (264)
T ss_pred Cccc--ccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 1111 0012334566688876 9999999999863
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=298.06 Aligned_cols=247 Identities=25% Similarity=0.412 Sum_probs=204.8
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCc---hhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEE
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSL---QGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVY 429 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 429 (668)
.+|++.+.||+|.||+|-++.....|+.||||.++++.. +.+-.+.+|++||..|+||||++++..|++++...+||
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM 132 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM 132 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence 467778899999999999999888899999999987644 44456789999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCC
Q 005940 430 EYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHG 509 (668)
Q Consensus 430 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~ 509 (668)
||..+|.|.+|+. .+..|++....++++||..|+.|+|. .+++|||||.+|||||.|+++||+|||++-++...
T Consensus 133 EYaS~GeLYDYiS---er~~LsErEaRhfFRQIvSAVhYCHk---nrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~ 206 (668)
T KOG0611|consen 133 EYASGGELYDYIS---ERGSLSEREARHFFRQIVSAVHYCHK---NRVVHRDLKLENILLDQNNNIKIADFGLSNLYADK 206 (668)
T ss_pred EecCCccHHHHHH---HhccccHHHHHHHHHHHHHHHHHHhh---ccceecccchhheeecCCCCeeeeccchhhhhccc
Confidence 9999999999995 35669999999999999999999998 99999999999999999999999999999988776
Q ss_pred CCCcccccccCCcccCcccccCCCC-CcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCcccCCc
Q 005940 510 GMPHTTNVVGTFGYIAPELTQTGKA-STSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSS 588 (668)
Q Consensus 510 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 588 (668)
.. .+.+||.+-|.+||++.+..| .+..|-||+||+||-|+.|..||++.+... .+++.. .+... .|.-.
T Consensus 207 kf--LqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~--lvrQIs-~GaYr---EP~~P-- 276 (668)
T KOG0611|consen 207 KF--LQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKR--LVRQIS-RGAYR---EPETP-- 276 (668)
T ss_pred cH--HHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHH--HHHHhh-ccccc---CCCCC--
Confidence 54 345799999999999998887 588999999999999999999998765332 122221 12221 12211
Q ss_pred ccHHHHHHHHHHHhhcCC-CCCCCCCHHHHHHHh
Q 005940 589 YVVKEMELVLKLGLMCSH-KTQFRPTMRQVMRYL 621 (668)
Q Consensus 589 ~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~~L 621 (668)
.+ ..-|+.|++. +|+.|-++++|..+.
T Consensus 277 ---Sd---A~gLIRwmLmVNP~RRATieDiAsHW 304 (668)
T KOG0611|consen 277 ---SD---ASGLIRWMLMVNPERRATIEDIASHW 304 (668)
T ss_pred ---ch---HHHHHHHHHhcCcccchhHHHHhhhh
Confidence 11 1233334444 599999999999885
|
|
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=298.22 Aligned_cols=257 Identities=25% Similarity=0.387 Sum_probs=201.1
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCc----EEEEEEEecCCc-hhHHHHHHHHHHHhcccccCceeEeeeecccCceEE
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGG----EVAVKKITRNSL-QGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLL 427 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~----~vavK~~~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l 427 (668)
.+|+..+.||+|+||.||+|.++.+++ .+|+|.+..... ....++.+|+.++++++|+||++++++|.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 467788999999999999999866554 589998876543 345788999999999999999999999987 78999
Q ss_pred EEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceecc
Q 005940 428 VYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYD 507 (668)
Q Consensus 428 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~ 507 (668)
|+||+++|+|.+++.. ....+++..++.++.|++.||+|||+ .+++||||||+||++++++.+||+|||+++...
T Consensus 86 v~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~LH~---~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~ 160 (279)
T cd05057 86 ITQLMPLGCLLDYVRN--HKDNIGSQYLLNWCVQIAKGMSYLEE---KRLVHRDLAARNVLVKTPQHVKITDFGLAKLLD 160 (279)
T ss_pred EEecCCCCcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHh---CCEEecccCcceEEEcCCCeEEECCCccccccc
Confidence 9999999999999963 23458999999999999999999998 999999999999999999999999999998765
Q ss_pred CCCCCcc-cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHHHhcCccccccCccc
Q 005940 508 HGGMPHT-TNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVAT-GRRPIGSGDLLLVEWVRECHQLGRILDVADPLL 585 (668)
Q Consensus 508 ~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 585 (668)
....... ....++..|+|||.+..+.++.++||||||+++||+++ |+.||...... ++..... ..... ..+.
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~~~~~~~-~~~~~--~~~~- 234 (279)
T cd05057 161 VDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAV--EIPDLLE-KGERL--PQPP- 234 (279)
T ss_pred CcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHH--HHHHHHh-CCCCC--CCCC-
Confidence 4322111 11223568999999988889999999999999999999 99999754321 2222111 11110 1111
Q ss_pred CCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhccCcCC
Q 005940 586 NSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSGEKQL 627 (668)
Q Consensus 586 ~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~~~~~ 627 (668)
... ..+..+...|+.. |++||++.++++.|+.....
T Consensus 235 --~~~----~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05057 235 --ICT----IDVYMVLVKCWMIDAESRPTFKELINEFSKMARD 271 (279)
T ss_pred --CCC----HHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhC
Confidence 111 2344556678876 99999999999999876433
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=294.02 Aligned_cols=254 Identities=25% Similarity=0.389 Sum_probs=202.0
Q ss_pred CcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCC--chhHHHHHHHHHHHhcccccCceeEeeeecc--cCceEEEE
Q 005940 354 GFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNS--LQGMREFAAEIESLGRLRHKNLVNLHGWCKQ--KNDLLLVY 429 (668)
Q Consensus 354 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~--~~~~~lV~ 429 (668)
+|+..+.||.|++|.||++.+..++..+|+|++.... ....+.+..|++++++++|+||+++++++.. ....+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 4778899999999999999998889999999986543 3445678899999999999999999998753 45679999
Q ss_pred EecCCCChhhhhcCC-CCCCCccHHHHHHHHHHHHHHHHHhhhcc--CCceEecCCCCCCEEECCCCCEEEEeecCceec
Q 005940 430 EYIPNGSLDTLLFKP-KDGSVLDWEQRFNIVKGIASGLLYLHEEW--EQVVIHRDVKPSNALIDAEMNARLGDFGLARLY 506 (668)
Q Consensus 430 E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~gL~yLH~~~--~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~ 506 (668)
||+++++|.+++... .....+++..++.++.||+.||.|||..+ ..+++|+||||+||+++.++.+||+|||++...
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 999999999998542 22457999999999999999999999321 289999999999999999999999999999877
Q ss_pred cCCCCCcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCcccC
Q 005940 507 DHGGMPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLN 586 (668)
Q Consensus 507 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 586 (668)
...... .....++..|+|||.+....++.++||||||+++|+|++|+.||...+.. ..... ...... +.+.
T Consensus 161 ~~~~~~-~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~~~~~-~~~~~~-----~~~~ 231 (265)
T cd08217 161 GHDSSF-AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQL--QLASK-IKEGKF-----RRIP 231 (265)
T ss_pred cCCccc-ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHH--HHHHH-HhcCCC-----CCCc
Confidence 654321 22346899999999998888999999999999999999999999765421 11111 111111 1111
Q ss_pred CcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 587 SSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 587 ~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
. .....+..+...|+.. |++||++++|+++
T Consensus 232 ~----~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 232 Y----RYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred c----ccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 1 1224456777788886 9999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=295.51 Aligned_cols=250 Identities=30% Similarity=0.472 Sum_probs=199.2
Q ss_pred ccceeeeecCcEEEEEEEeCCCC----cEEEEEEEecCCch-hHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEE
Q 005940 356 KESEVIGIGGFGSVYKGVLPTTG----GEVAVKKITRNSLQ-GMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYE 430 (668)
Q Consensus 356 ~~~~~lG~G~~g~Vy~~~~~~~~----~~vavK~~~~~~~~-~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 430 (668)
.+.+.||.|+||.||++.+...+ ..||+|++...... ..+.+..|++++.+++|+||+++++++.+.+..+++||
T Consensus 2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e 81 (258)
T smart00219 2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVME 81 (258)
T ss_pred cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEe
Confidence 45788999999999999997655 88999999765543 56789999999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCC
Q 005940 431 YIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGG 510 (668)
Q Consensus 431 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~ 510 (668)
|+++++|.+++.... ...+++.++..++.|++.||+|||+ .+++||||||+||+++.++.++|+|||+++......
T Consensus 82 ~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lh~---~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (258)
T smart00219 82 YMEGGDLLDYLRKNR-PKELSLSDLLSFALQIARGMEYLES---KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD 157 (258)
T ss_pred ccCCCCHHHHHHhhh-hccCCHHHHHHHHHHHHHHHHHHhc---CCeeecccccceEEEccCCeEEEcccCCceeccccc
Confidence 999999999996322 1228999999999999999999998 899999999999999999999999999998766543
Q ss_pred CCcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHHHhcCccccccCcccCCcc
Q 005940 511 MPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVAT-GRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSY 589 (668)
Q Consensus 511 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 589 (668)
........++..|+|||.+....++.++||||+|++++||++ |+.||...+. .+....... ...... ....
T Consensus 158 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~--~~~~~~~~~-~~~~~~-----~~~~ 229 (258)
T smart00219 158 YYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN--EEVLEYLKK-GYRLPK-----PENC 229 (258)
T ss_pred ccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHhc-CCCCCC-----CCcC
Confidence 222222346789999999988889999999999999999998 7888864322 111111111 111111 1111
Q ss_pred cHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHh
Q 005940 590 VVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYL 621 (668)
Q Consensus 590 ~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L 621 (668)
...+..+...|+.. |++||++.|+++.|
T Consensus 230 ----~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 230 ----PPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred ----CHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 23355666788887 99999999999865
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=298.46 Aligned_cols=203 Identities=28% Similarity=0.400 Sum_probs=171.8
Q ss_pred HhcCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCch-hHHHHHHHHHHHhcccccCceeEeeeecccCceEEEE
Q 005940 351 ATKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQ-GMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVY 429 (668)
Q Consensus 351 at~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 429 (668)
++++|...+.||+|+||.||+|....+++.||+|++...... ....+.+|+.++++++|+||+++++++..+...++|+
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 467899999999999999999999888999999998755332 2346778999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCC
Q 005940 430 EYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHG 509 (668)
Q Consensus 430 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~ 509 (668)
||+. ++|.+.+.. ....+++.++..++.|++.||.|||+ .+|+|+||||+||+++.++++||+|||+++.....
T Consensus 83 e~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 156 (291)
T cd07870 83 EYMH-TDLAQYMIQ--HPGGLHPYNVRLFMFQLLRGLAYIHG---QHILHRDLKPQNLLISYLGELKLADFGLARAKSIP 156 (291)
T ss_pred eccc-CCHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHHEEEcCCCcEEEeccccccccCCC
Confidence 9996 677666642 23457888999999999999999998 89999999999999999999999999999764332
Q ss_pred CCCcccccccCCcccCcccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 005940 510 GMPHTTNVVGTFGYIAPELTQTG-KASTSSDVFAYGILLLEVATGRRPIGSG 560 (668)
Q Consensus 510 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDV~S~Gvvl~elltG~~p~~~~ 560 (668)
.. ......++..|+|||.+.+. .++.++|||||||++|||++|+.||...
T Consensus 157 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~ 207 (291)
T cd07870 157 SQ-TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGV 207 (291)
T ss_pred CC-CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCc
Confidence 21 11223568899999988654 5788999999999999999999999754
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=321.49 Aligned_cols=203 Identities=23% Similarity=0.322 Sum_probs=168.0
Q ss_pred hHHHHhcCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCchhHHHHHHHHHHHhcccc------cCceeEeeeec
Q 005940 347 DLYAATKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRH------KNLVNLHGWCK 420 (668)
Q Consensus 347 el~~at~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H------~nIv~l~g~~~ 420 (668)
++...+++|++.++||+|+||+||+|.+..+++.||||+++... ...+++..|++++++++| .+++++++++.
T Consensus 123 ~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~ 201 (467)
T PTZ00284 123 DIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ 201 (467)
T ss_pred ccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence 34445678999999999999999999998889999999996532 233455667777777654 45889999886
Q ss_pred cc-CceEEEEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCC------
Q 005940 421 QK-NDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEM------ 493 (668)
Q Consensus 421 ~~-~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~------ 493 (668)
.. ...++|||++ +++|.+++.+ ...+++..+..|+.||+.||.|||+ +.+|+||||||+|||++.++
T Consensus 202 ~~~~~~~iv~~~~-g~~l~~~l~~---~~~l~~~~~~~i~~qi~~aL~yLH~--~~gIiHrDlKP~NILl~~~~~~~~~~ 275 (467)
T PTZ00284 202 NETGHMCIVMPKY-GPCLLDWIMK---HGPFSHRHLAQIIFQTGVALDYFHT--ELHLMHTDLKPENILMETSDTVVDPV 275 (467)
T ss_pred cCCceEEEEEecc-CCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHh--cCCeecCCCCHHHEEEecCCcccccc
Confidence 54 5789999988 7788888853 3469999999999999999999997 25999999999999998765
Q ss_pred ----------CEEEEeecCceeccCCCCCcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 005940 494 ----------NARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSG 560 (668)
Q Consensus 494 ----------~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~ 560 (668)
.+||+|||.+..... .....+||..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 276 ~~~~~~~~~~~vkl~DfG~~~~~~~----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~ 348 (467)
T PTZ00284 276 TNRALPPDPCRVRICDLGGCCDERH----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTH 348 (467)
T ss_pred cccccCCCCceEEECCCCccccCcc----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 499999998864332 223467999999999999999999999999999999999999999754
|
|
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=299.07 Aligned_cols=260 Identities=27% Similarity=0.347 Sum_probs=201.7
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCC--chhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEE
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNS--LQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYE 430 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 430 (668)
++|+..+.||+|++|.||+|.+..+++.||+|++.... ....+.+.+|++++++++|+||+++++.+...+..++|||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 36888999999999999999998889999999986532 2345678999999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCC
Q 005940 431 YIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGG 510 (668)
Q Consensus 431 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~ 510 (668)
|++++.+..++.. ...+++.++..++.||+.||.|||+ .+++||||+|+||++++++.+||+|||++.......
T Consensus 81 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 154 (288)
T cd07833 81 YVERTLLELLEAS---PGGLPPDAVRSYIWQLLQAIAYCHS---HNIIHRDIKPENILVSESGVLKLCDFGFARALRARP 154 (288)
T ss_pred cCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEEeeecccccCCCc
Confidence 9998877766642 3458999999999999999999998 999999999999999999999999999998776544
Q ss_pred CCcccccccCCcccCcccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHh-cCccc------cccC
Q 005940 511 MPHTTNVVGTFGYIAPELTQTG-KASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQ-LGRIL------DVAD 582 (668)
Q Consensus 511 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~-~~~~~------~~~d 582 (668)
........++..|+|||++.+. .++.++||||||+++|||++|+.||......-. .+.... .+... ...+
T Consensus 155 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 232 (288)
T cd07833 155 ASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQ--LYLIQKCLGPLPPSHQELFSSN 232 (288)
T ss_pred cccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHhCCCCHHHhhhcccC
Confidence 3233445778899999999887 789999999999999999999999975432111 111100 00000 0000
Q ss_pred cccCC--------------cccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 583 PLLNS--------------SYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 583 ~~l~~--------------~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
+.... .+.......+..++..|+.. |++||++++++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 285 (288)
T cd07833 233 PRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285 (288)
T ss_pred ccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence 00000 00111134566777789887 9999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=299.67 Aligned_cols=249 Identities=27% Similarity=0.447 Sum_probs=194.3
Q ss_pred eeeeecCcEEEEEEEeCCCC------cEEEEEEEecCC-chhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEEe
Q 005940 359 EVIGIGGFGSVYKGVLPTTG------GEVAVKKITRNS-LQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEY 431 (668)
Q Consensus 359 ~~lG~G~~g~Vy~~~~~~~~------~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~ 431 (668)
+.||+|+||.||+|++.... ..+|+|.+.... .....++.+|+.++++++||||++++++|......++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 36899999999999985433 679999886543 23456889999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCC----CCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCC-----CEEEEeecC
Q 005940 432 IPNGSLDTLLFKPK----DGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEM-----NARLGDFGL 502 (668)
Q Consensus 432 ~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~-----~~kl~DfGl 502 (668)
+++++|.+++.... ....+++.+++.++.|++.||.|||+ .+++|+||||+||+++.+. .+||+|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHh---CCcccCCCChheEEEecCCCCCCcceEECCccc
Confidence 99999999996422 23458999999999999999999998 8999999999999999887 899999999
Q ss_pred ceeccCCCC-CcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHHHhcCccccc
Q 005940 503 ARLYDHGGM-PHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVAT-GRRPIGSGDLLLVEWVRECHQLGRILDV 580 (668)
Q Consensus 503 a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~l~~~~~~~~~~~~~~~~ 580 (668)
++....... .......++..|+|||++.++.++.++|||||||++|||++ |+.||...... +...........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~--~~~~~~~~~~~~--- 232 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQ--EVLQHVTAGGRL--- 232 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHH--HHHHHHhcCCcc---
Confidence 976543221 11122345678999999999999999999999999999998 99998654321 111111111110
Q ss_pred cCcccCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhc
Q 005940 581 ADPLLNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLS 622 (668)
Q Consensus 581 ~d~~l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~ 622 (668)
..... ....+..+...|+.. |++||++++|++.|+
T Consensus 233 ---~~~~~----~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 233 ---QKPEN----CPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred ---CCccc----chHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 01111 123456677789887 999999999999886
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=333.49 Aligned_cols=257 Identities=23% Similarity=0.322 Sum_probs=197.5
Q ss_pred HHhcCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCC--chhHHHHHHHHHHHhcccccCceeEeeeecc--cCce
Q 005940 350 AATKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNS--LQGMREFAAEIESLGRLRHKNLVNLHGWCKQ--KNDL 425 (668)
Q Consensus 350 ~at~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~--~~~~ 425 (668)
...++|.+.++||+|+||+||++.+..++..+|+|.+.... ......|..|+.++++|+|||||++++++.. ...+
T Consensus 10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~l 89 (1021)
T PTZ00266 10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKL 89 (1021)
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEE
Confidence 34468999999999999999999999889999999987542 2345678999999999999999999998854 4568
Q ss_pred EEEEEecCCCChhhhhcCCC-CCCCccHHHHHHHHHHHHHHHHHhhhcc----CCceEecCCCCCCEEECCC--------
Q 005940 426 LLVYEYIPNGSLDTLLFKPK-DGSVLDWEQRFNIVKGIASGLLYLHEEW----EQVVIHRDVKPSNALIDAE-------- 492 (668)
Q Consensus 426 ~lV~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~gL~yLH~~~----~~~ivHrDLkp~NIll~~~-------- 492 (668)
||||||+++|+|.++|.... ....+++..++.|+.||+.||.|||+.. ..+|+||||||+||||+.+
T Consensus 90 yIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~ 169 (1021)
T PTZ00266 90 YILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKIT 169 (1021)
T ss_pred EEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccc
Confidence 99999999999999986422 2356999999999999999999999722 1459999999999999642
Q ss_pred ---------CCEEEEeecCceeccCCCCCcccccccCCcccCcccccC--CCCCcchhHHHHHHHHHHHHhCCCCCCCCc
Q 005940 493 ---------MNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPELTQT--GKASTSSDVFAYGILLLEVATGRRPIGSGD 561 (668)
Q Consensus 493 ---------~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDV~S~Gvvl~elltG~~p~~~~~ 561 (668)
..+||+|||++........ .....||+.|+|||++.. ..++.++|||||||+||||++|+.||...+
T Consensus 170 ~~~~n~ng~~iVKLsDFGlAr~l~~~s~--~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~ 247 (1021)
T PTZ00266 170 AQANNLNGRPIAKIGDFGLSKNIGIESM--AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKAN 247 (1021)
T ss_pred ccccccCCCCceEEccCCcccccccccc--ccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCC
Confidence 3489999999987643322 234578999999998854 457899999999999999999999997543
Q ss_pred hhHHHHHHHHHhcCccccccCcccCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 562 LLLVEWVRECHQLGRILDVADPLLNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 562 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
. ....+...... +.+...... ..+..++..|+.. |.+||++.|++++
T Consensus 248 ~-~~qli~~lk~~--------p~lpi~~~S---~eL~dLI~~~L~~dPeeRPSa~QlL~h 295 (1021)
T PTZ00266 248 N-FSQLISELKRG--------PDLPIKGKS---KELNILIKNLLNLSAKERPSALQCLGY 295 (1021)
T ss_pred c-HHHHHHHHhcC--------CCCCcCCCC---HHHHHHHHHHhcCChhHCcCHHHHhcc
Confidence 2 12222222111 111111111 2345566688887 9999999999953
|
|
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=302.45 Aligned_cols=254 Identities=26% Similarity=0.427 Sum_probs=197.9
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCc----EEEEEEEecCCc-hhHHHHHHHHHHHhcccccCceeEeeeecccCceEE
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGG----EVAVKKITRNSL-QGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLL 427 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~----~vavK~~~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l 427 (668)
++|+..+.||+|+||.||+|.+..++. .+|+|.+..... ....++.+|+.++++++||||++++++|... ..++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~ 85 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL 85 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence 457778999999999999999876665 478888865433 3345788999999999999999999999754 4679
Q ss_pred EEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceecc
Q 005940 428 VYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYD 507 (668)
Q Consensus 428 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~ 507 (668)
++||+++|+|.+++.. ....+++..++.++.|++.||.|||+ ++|+||||||+||+++.++.+||+|||+++...
T Consensus 86 v~e~~~~g~l~~~~~~--~~~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~ 160 (303)
T cd05110 86 VTQLMPHGCLLDYVHE--HKDNIGSQLLLNWCVQIAKGMMYLEE---RRLVHRDLAARNVLVKSPNHVKITDFGLARLLE 160 (303)
T ss_pred eehhcCCCCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHhh---cCeeccccccceeeecCCCceEEcccccccccc
Confidence 9999999999999853 23458999999999999999999998 999999999999999999999999999998765
Q ss_pred CCCCC-cccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCc-hhHHHHHHHHHhcCccccccCcc
Q 005940 508 HGGMP-HTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVAT-GRRPIGSGD-LLLVEWVRECHQLGRILDVADPL 584 (668)
Q Consensus 508 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~-~~l~~~~~~~~~~~~~~~~~d~~ 584 (668)
..... ......++..|+|||++.+..++.++|||||||++|||++ |+.||.... ....++ ........ .+
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~----~~~~~~~~--~~- 233 (303)
T cd05110 161 GDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDL----LEKGERLP--QP- 233 (303)
T ss_pred CcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH----HHCCCCCC--CC-
Confidence 33221 1222345678999999988889999999999999999997 999996532 222222 11111110 01
Q ss_pred cCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhccCc
Q 005940 585 LNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSGEK 625 (668)
Q Consensus 585 l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~~~ 625 (668)
..+. ..+..+...|+.. |++||+++++++.|+...
T Consensus 234 --~~~~----~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~ 269 (303)
T cd05110 234 --PICT----IDVYMVMVKCWMIDADSRPKFKELAAEFSRMA 269 (303)
T ss_pred --CCCC----HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 1111 2345666788876 999999999999998754
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=292.27 Aligned_cols=250 Identities=28% Similarity=0.457 Sum_probs=196.6
Q ss_pred CcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCc------hhHHHHHHHHHHHhcccccCceeEeeeecccCceEE
Q 005940 354 GFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSL------QGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLL 427 (668)
Q Consensus 354 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l 427 (668)
+|...+.||+|+||.||+|.. .+++.+|+|.+..... ...+.+.+|++++++++|+||++++++|.+.+..++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 79 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISI 79 (265)
T ss_pred CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEE
Confidence 467789999999999999987 4688999998864321 233568899999999999999999999999999999
Q ss_pred EEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceecc
Q 005940 428 VYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYD 507 (668)
Q Consensus 428 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~ 507 (668)
|+||+++++|.+++.+ ...+++..+..++.|++.||+|||+ .+++|+||+|+||++++++.+||+|||++....
T Consensus 80 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 153 (265)
T cd06631 80 FMEFVPGGSISSILNR---FGPLPEPVFCKYTKQILDGVAYLHN---NCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLA 153 (265)
T ss_pred EEecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcCHHhEEECCCCeEEeccchhhHhhh
Confidence 9999999999999953 2458899999999999999999998 899999999999999999999999999987643
Q ss_pred CCC-----CCcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccC
Q 005940 508 HGG-----MPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVAD 582 (668)
Q Consensus 508 ~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d 582 (668)
... ........++..|+|||++.+..++.++|||||||++|||++|+.||...+... ... ....... ..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~-~~~-~~~~~~~----~~ 227 (265)
T cd06631 154 WVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLA-AMF-YIGAHRG----LM 227 (265)
T ss_pred hccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHH-HHH-HhhhccC----CC
Confidence 211 111223468899999999988889999999999999999999999997543221 111 1111101 11
Q ss_pred cccCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 583 PLLNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 583 ~~l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
+.+...+. ..+..+...|++. |++||++.|++++
T Consensus 228 ~~~~~~~~----~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 262 (265)
T cd06631 228 PRLPDSFS----AAAIDFVTSCLTRDQHERPSALQLLRH 262 (265)
T ss_pred CCCCCCCC----HHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 22222222 3345566788886 9999999999863
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=313.78 Aligned_cols=196 Identities=27% Similarity=0.344 Sum_probs=169.7
Q ss_pred cCcccceeeeecCcEEEEEEEeCC--CCcEEEEEEEecCCchhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEE
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPT--TGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYE 430 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~--~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 430 (668)
.+|.+.+.||+|+||.||++.... .+..||+|.+... +.+.+|++++++++||||+++++++......++|||
T Consensus 92 ~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e 166 (392)
T PHA03207 92 MQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMP 166 (392)
T ss_pred CceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEeh
Confidence 468889999999999999997643 4578999988653 234679999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCC
Q 005940 431 YIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGG 510 (668)
Q Consensus 431 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~ 510 (668)
++. ++|.+++. ....+++.+++.++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 167 ~~~-~~l~~~l~---~~~~l~~~~~~~i~~ql~~aL~~LH~---~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~ 239 (392)
T PHA03207 167 KYK-CDLFTYVD---RSGPLPLEQAITIQRRLLEALAYLHG---RGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHP 239 (392)
T ss_pred hcC-CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEcCCCCEEEccCccccccCccc
Confidence 995 68888883 23569999999999999999999998 999999999999999999999999999998665432
Q ss_pred C-CcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 005940 511 M-PHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSG 560 (668)
Q Consensus 511 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~ 560 (668)
. .......||..|+|||++....++.++|||||||++|||++|+.||...
T Consensus 240 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~ 290 (392)
T PHA03207 240 DTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGK 290 (392)
T ss_pred ccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence 2 2223457999999999999889999999999999999999999999643
|
|
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=299.28 Aligned_cols=260 Identities=27% Similarity=0.388 Sum_probs=202.2
Q ss_pred cchhhHHHHhcCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCchhHHHHHHHHHHHhcc-cccCceeEeeeecc
Q 005940 343 FRYKDLYAATKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRL-RHKNLVNLHGWCKQ 421 (668)
Q Consensus 343 f~~~el~~at~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~ 421 (668)
.++.++..+...|+..+.||+|+||.||+|.+..+++.+|+|++.... ....++..|+.++.++ +|+||+++++++..
T Consensus 6 ~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 84 (282)
T cd06636 6 IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIK 84 (282)
T ss_pred hhhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhc
Confidence 355666667788999999999999999999998889999999986653 3346788999999998 69999999999853
Q ss_pred ------cCceEEEEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCE
Q 005940 422 ------KNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNA 495 (668)
Q Consensus 422 ------~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~ 495 (668)
....+++|||+++|+|.+++... ....+++..+..++.||+.||.|||+ .+++||||||+||++++++.+
T Consensus 85 ~~~~~~~~~~~iv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~---~~ivH~dl~~~nili~~~~~~ 160 (282)
T cd06636 85 KSPPGHDDQLWLVMEFCGAGSVTDLVKNT-KGNALKEDWIAYICREILRGLAHLHA---HKVIHRDIKGQNVLLTENAEV 160 (282)
T ss_pred ccccCCCCEEEEEEEeCCCCcHHHHHHHc-cCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCE
Confidence 45689999999999999998632 23458899999999999999999999 999999999999999999999
Q ss_pred EEEeecCceeccCCCCCcccccccCCcccCccccc-----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHH
Q 005940 496 RLGDFGLARLYDHGGMPHTTNVVGTFGYIAPELTQ-----TGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRE 570 (668)
Q Consensus 496 kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~ 570 (668)
+|+|||++........ ......|+..|+|||.+. ...++.++|||||||++|||++|+.||...... .-...
T Consensus 161 ~l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~--~~~~~ 237 (282)
T cd06636 161 KLVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPM--RALFL 237 (282)
T ss_pred EEeeCcchhhhhcccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHH--hhhhh
Confidence 9999999876543221 122346889999999875 345788999999999999999999999643211 00111
Q ss_pred HHhcCccccccCcccC-CcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 571 CHQLGRILDVADPLLN-SSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 571 ~~~~~~~~~~~d~~l~-~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
.. ....+... ..++ ..+..+...|++. |.+||++.|++++
T Consensus 238 ~~------~~~~~~~~~~~~~----~~~~~li~~cl~~~p~~Rp~~~ell~~ 279 (282)
T cd06636 238 IP------RNPPPKLKSKKWS----KKFIDFIEGCLVKNYLSRPSTEQLLKH 279 (282)
T ss_pred Hh------hCCCCCCcccccC----HHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence 11 11111111 1122 3455666789887 9999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=301.65 Aligned_cols=246 Identities=22% Similarity=0.311 Sum_probs=196.7
Q ss_pred cceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCchhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEEecCCCC
Q 005940 357 ESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEYIPNGS 436 (668)
Q Consensus 357 ~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gs 436 (668)
....||+|+||.||++....++..||+|++........+.+.+|+.+++.++||||+++++.+..++..++|+||+++++
T Consensus 25 ~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~ 104 (297)
T cd06659 25 NYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGA 104 (297)
T ss_pred hhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCC
Confidence 34579999999999999988899999999976555556778899999999999999999999999999999999999999
Q ss_pred hhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCCCCcccc
Q 005940 437 LDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTN 516 (668)
Q Consensus 437 L~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~ 516 (668)
|.+++.. ..+++.+++.++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++........ ....
T Consensus 105 L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~-~~~~ 176 (297)
T cd06659 105 LTDIVSQ----TRLNEEQIATVCESVLQALCYLHS---QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP-KRKS 176 (297)
T ss_pred HHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHeEEccCCcEEEeechhHhhcccccc-cccc
Confidence 9998742 458999999999999999999998 9999999999999999999999999999875543321 2233
Q ss_pred cccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCcccCCcccHHHHHH
Q 005940 517 VVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSYVVKEMEL 596 (668)
Q Consensus 517 ~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~ 596 (668)
..++..|+|||++.+..++.++|||||||++|||++|+.||...+.... ...... ..... ........ ..
T Consensus 177 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~--~~~~~~-~~~~~---~~~~~~~~----~~ 246 (297)
T cd06659 177 LVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQA--MKRLRD-SPPPK---LKNAHKIS----PV 246 (297)
T ss_pred eecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHhc-cCCCC---ccccCCCC----HH
Confidence 5688999999999888899999999999999999999999975432211 111111 11000 00001111 22
Q ss_pred HHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 597 VLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 597 l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
+..+...|++. |++||++++++++
T Consensus 247 l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 247 LRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred HHHHHHHHhcCCcccCcCHHHHhhC
Confidence 44555677776 9999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=301.63 Aligned_cols=245 Identities=25% Similarity=0.354 Sum_probs=195.9
Q ss_pred cceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCchhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEEecCCCC
Q 005940 357 ESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEYIPNGS 436 (668)
Q Consensus 357 ~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gs 436 (668)
....||+|+||.||++....++..||||++........+.+.+|+.++++++|+||+++++.+...+..++||||+++++
T Consensus 26 ~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~ 105 (292)
T cd06658 26 SFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGA 105 (292)
T ss_pred hhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCc
Confidence 34679999999999999988899999999977665666788999999999999999999999999999999999999999
Q ss_pred hhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCCCCcccc
Q 005940 437 LDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTN 516 (668)
Q Consensus 437 L~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~ 516 (668)
|.+++.. ..+++.++..++.||+.||.|||+ .+|+||||||+||+++.++.+||+|||++....... .....
T Consensus 106 L~~~~~~----~~l~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~-~~~~~ 177 (292)
T cd06658 106 LTDIVTH----TRMNEEQIATVCLSVLRALSYLHN---QGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV-PKRKS 177 (292)
T ss_pred HHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCEEEccCcchhhccccc-ccCce
Confidence 9998842 348999999999999999999999 899999999999999999999999999987654322 12233
Q ss_pred cccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCcccCCc-ccHHHHH
Q 005940 517 VVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSS-YVVKEME 595 (668)
Q Consensus 517 ~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~-~~~~~~~ 595 (668)
..|+..|+|||.+.+..++.++||||||+++|||++|+.||...+.... ...... ...+.+... ....+
T Consensus 178 ~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~--~~~~~~------~~~~~~~~~~~~~~~-- 247 (292)
T cd06658 178 LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQA--MRRIRD------NLPPRVKDSHKVSSV-- 247 (292)
T ss_pred eecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHh------cCCCccccccccCHH--
Confidence 5688999999999888899999999999999999999999975432111 111110 111111111 11122
Q ss_pred HHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 596 LVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 596 ~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
+..+...|+.. |++||+++|++++
T Consensus 248 -~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 248 -LRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred -HHHHHHHHccCChhHCcCHHHHhhC
Confidence 33444466666 9999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=293.63 Aligned_cols=254 Identities=26% Similarity=0.411 Sum_probs=200.1
Q ss_pred CcccceeeeecCcEEEEEEEeCC-CCcEEEEEEEecC----------CchhHHHHHHHHHHHhc-ccccCceeEeeeecc
Q 005940 354 GFKESEVIGIGGFGSVYKGVLPT-TGGEVAVKKITRN----------SLQGMREFAAEIESLGR-LRHKNLVNLHGWCKQ 421 (668)
Q Consensus 354 ~f~~~~~lG~G~~g~Vy~~~~~~-~~~~vavK~~~~~----------~~~~~~~f~~Ei~~l~~-l~H~nIv~l~g~~~~ 421 (668)
+|+..+.||+|+||.||+|.+.. .++.+|+|.+... ......++.+|+.++.+ ++|+||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47788999999999999999976 5788999987532 22334567889988875 799999999999999
Q ss_pred cCceEEEEEecCCCChhhhhcCC-CCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEee
Q 005940 422 KNDLLLVYEYIPNGSLDTLLFKP-KDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDF 500 (668)
Q Consensus 422 ~~~~~lV~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~Df 500 (668)
.+..++||||+++++|.+++... .....+++..+++++.|++.||.|||+ ..+++|+||||+||+++.++.+||+||
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~--~~~i~H~dl~~~nil~~~~~~~~l~df 158 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDF 158 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhcc--CCceeecCCCHHHEEECCCCcEEEecc
Confidence 99999999999999999887431 234568999999999999999999995 268999999999999999999999999
Q ss_pred cCceeccCCCCCcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccc
Q 005940 501 GLARLYDHGGMPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDV 580 (668)
Q Consensus 501 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~ 580 (668)
|++....... ......++..|+|||++.++.++.++||||||+++|||++|+.||...+.. ........ ....
T Consensus 159 g~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~--~~~~~~~~-~~~~-- 231 (269)
T cd08528 159 GLAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNML--SLATKIVE-AVYE-- 231 (269)
T ss_pred cceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHH--HHHHHHhh-ccCC--
Confidence 9998765433 233456889999999999888999999999999999999999999654322 11121111 1111
Q ss_pred cCcccCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhc
Q 005940 581 ADPLLNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLS 622 (668)
Q Consensus 581 ~d~~l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~ 622 (668)
+.....+ ...+..++..|+.. |++||++.||..+++
T Consensus 232 --~~~~~~~----~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 232 --PLPEGMY----SEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred --cCCcccC----CHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 1111111 13355666689887 999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-34 Score=294.55 Aligned_cols=247 Identities=28% Similarity=0.441 Sum_probs=199.7
Q ss_pred CcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCC-chhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEEec
Q 005940 354 GFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNS-LQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEYI 432 (668)
Q Consensus 354 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~ 432 (668)
-|+..++||+|+||.||+|....++..+|+|.+.... ....+.+.+|+.++++++|+||+++++++..+...++||||+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 3667889999999999999988888999999986543 234567889999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCCCC
Q 005940 433 PNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMP 512 (668)
Q Consensus 433 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~~~ 512 (668)
++++|.+++.. ..+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++........
T Consensus 85 ~~~~l~~~i~~----~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~- 156 (277)
T cd06641 85 GGGSALDLLEP----GPLDETQIATILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI- 156 (277)
T ss_pred CCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHcc---CCeecCCCCHHhEEECCCCCEEEeecccceecccchh-
Confidence 99999999842 358999999999999999999998 9999999999999999999999999999986654321
Q ss_pred cccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCcccCCcccHH
Q 005940 513 HTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSYVVK 592 (668)
Q Consensus 513 ~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 592 (668)
......++..|+|||.+.+...+.++|||||||++|||++|..|+...... .+...... .. .+.+....+
T Consensus 157 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~--~~~~~~~~-~~-----~~~~~~~~~-- 226 (277)
T cd06641 157 KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPM--KVLFLIPK-NN-----PPTLEGNYS-- 226 (277)
T ss_pred hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchH--HHHHHHhc-CC-----CCCCCcccC--
Confidence 222346788999999998888899999999999999999999999653321 11111111 11 111222222
Q ss_pred HHHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 593 EMELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 593 ~~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
..+..+...|++. |++||++.+++++
T Consensus 227 --~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 227 --KPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred --HHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 3345666789887 9999999999996
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-34 Score=295.08 Aligned_cols=258 Identities=29% Similarity=0.332 Sum_probs=201.4
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCc-hhHHHHHHHHHHHhcccccCceeEeeeecc--cCceEEEE
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSL-QGMREFAAEIESLGRLRHKNLVNLHGWCKQ--KNDLLLVY 429 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~--~~~~~lV~ 429 (668)
++|...+.||.|++|.||++.+..+++.+|+|.+..... ....++.+|++++++++||||++++++|.. .+..++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 367889999999999999999988899999999875433 445778999999999999999999998854 34689999
Q ss_pred EecCCCChhhhhcCC-CCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccC
Q 005940 430 EYIPNGSLDTLLFKP-KDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDH 508 (668)
Q Consensus 430 E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~ 508 (668)
||+++++|.+++... .....+++..+..++.||+.||.|||+ .+++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~---~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHS---RKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 999999999887431 234568999999999999999999998 9999999999999999999999999999875543
Q ss_pred CCCCcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCc---hhHHHHHHHHHhcCccccccCccc
Q 005940 509 GGMPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGD---LLLVEWVRECHQLGRILDVADPLL 585 (668)
Q Consensus 509 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~---~~l~~~~~~~~~~~~~~~~~d~~l 585 (668)
... ....++..|+|||.+.+..++.++|||||||++|||++|+.||.... ....+....... .......+...
T Consensus 158 ~~~---~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 233 (287)
T cd06621 158 SLA---GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVN-MPNPELKDEPG 233 (287)
T ss_pred ccc---ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhc-CCchhhccCCC
Confidence 221 23457889999999988899999999999999999999999997542 111222211111 11111111110
Q ss_pred CCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 586 NSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 586 ~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
. .......+..+...|+.. |++||++.||+++
T Consensus 234 ~---~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~ 266 (287)
T cd06621 234 N---GIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEH 266 (287)
T ss_pred C---CCchHHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence 0 011234566778899987 9999999999984
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=285.21 Aligned_cols=252 Identities=25% Similarity=0.370 Sum_probs=202.1
Q ss_pred hcCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCc--------hhHHHHHHHHHHHhccc-ccCceeEeeeeccc
Q 005940 352 TKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSL--------QGMREFAAEIESLGRLR-HKNLVNLHGWCKQK 422 (668)
Q Consensus 352 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--------~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~ 422 (668)
-++|...+.||.|..+.|-++.++.+++++|+|++..... .-.++-.+|+.+|+++. ||+|+++.+.++..
T Consensus 16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~ 95 (411)
T KOG0599|consen 16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESD 95 (411)
T ss_pred HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCc
Confidence 3567888999999999999999999999999999854321 12345568999999985 99999999999999
Q ss_pred CceEEEEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecC
Q 005940 423 NDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGL 502 (668)
Q Consensus 423 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGl 502 (668)
...++|+|.|+.|-|.++|. ..-.+++....+|++|+.+|+.|||. ..|+||||||+|||+|++.++||+|||.
T Consensus 96 sF~FlVFdl~prGELFDyLt---s~VtlSEK~tR~iMrqlfegVeylHa---~~IVHRDLKpENILlddn~~i~isDFGF 169 (411)
T KOG0599|consen 96 AFVFLVFDLMPRGELFDYLT---SKVTLSEKETRRIMRQLFEGVEYLHA---RNIVHRDLKPENILLDDNMNIKISDFGF 169 (411)
T ss_pred chhhhhhhhcccchHHHHhh---hheeecHHHHHHHHHHHHHHHHHHHH---hhhhhcccChhheeeccccceEEeccce
Confidence 99999999999999999995 34569999999999999999999999 9999999999999999999999999999
Q ss_pred ceeccCCCCCcccccccCCcccCcccccC------CCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCc
Q 005940 503 ARLYDHGGMPHTTNVVGTFGYIAPELTQT------GKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGR 576 (668)
Q Consensus 503 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~ 576 (668)
++.+..++ .....+||++|+|||.+.. ..|+...|+|++||+||-|+.|..||-.....++- .....++
T Consensus 170 a~~l~~Ge--kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlML---R~ImeGk 244 (411)
T KOG0599|consen 170 ACQLEPGE--KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLML---RMIMEGK 244 (411)
T ss_pred eeccCCch--hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHH---HHHHhcc
Confidence 99888765 3556799999999998754 35788999999999999999999999543222221 1122222
Q ss_pred cccccCcccCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 577 ILDVADPLLNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 577 ~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
.. .-.|... +-...+..+...|++- |.+|-|.+|+++|
T Consensus 245 yq-F~speWa-----dis~~~KdLIsrlLqVdp~~Ritake~LaH 283 (411)
T KOG0599|consen 245 YQ-FRSPEWA-----DISATVKDLISRLLQVDPTKRITAKEALAH 283 (411)
T ss_pred cc-cCCcchh-----hccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence 21 1112111 1112344555678876 9999999999975
|
|
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=301.23 Aligned_cols=196 Identities=28% Similarity=0.406 Sum_probs=160.5
Q ss_pred ceeeeecCcEEEEEEEeCC--CCcEEEEEEEecCCchhHHHHHHHHHHHhcccccCceeEeeeec--ccCceEEEEEecC
Q 005940 358 SEVIGIGGFGSVYKGVLPT--TGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNLHGWCK--QKNDLLLVYEYIP 433 (668)
Q Consensus 358 ~~~lG~G~~g~Vy~~~~~~--~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~--~~~~~~lV~E~~~ 433 (668)
..+||+|+||.||+|+... ++..||+|.+..... ...+.+|++++++++||||+++++++. .....++|+||++
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI--SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE 83 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCC--cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence 4689999999999999753 457899999865432 346778999999999999999999884 3557899999986
Q ss_pred CCChhhhhcCC------CCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEE----CCCCCEEEEeecCc
Q 005940 434 NGSLDTLLFKP------KDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALI----DAEMNARLGDFGLA 503 (668)
Q Consensus 434 ~gsL~~~l~~~------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll----~~~~~~kl~DfGla 503 (668)
+ +|.+++... .....+++..+..++.||+.||.|||+ .+|+||||||+||++ +.++.+||+|||++
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 84 H-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred C-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHh---CCEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 5 676666321 122358899999999999999999998 999999999999999 56678999999999
Q ss_pred eeccCCCC--CcccccccCCcccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 005940 504 RLYDHGGM--PHTTNVVGTFGYIAPELTQT-GKASTSSDVFAYGILLLEVATGRRPIGS 559 (668)
Q Consensus 504 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~S~Gvvl~elltG~~p~~~ 559 (668)
+....... .......+|..|+|||++.+ ..++.++|||||||++|||+||+.||..
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~ 218 (317)
T cd07867 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccc
Confidence 87654322 12234578999999998876 4578999999999999999999999964
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=292.32 Aligned_cols=246 Identities=31% Similarity=0.446 Sum_probs=196.1
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCchhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEEec
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEYI 432 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~ 432 (668)
++|.+.+.||+|+||.||+|.. +++.||+|.+.... ..+.+.+|+.++++++|||++++++++... ..++||||+
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~ 80 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELM 80 (254)
T ss_pred HHceeeeeeccCCCCceEeccc--CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECC
Confidence 4578889999999999999976 67889999986543 346788999999999999999999998764 479999999
Q ss_pred CCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCCCC
Q 005940 433 PNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMP 512 (668)
Q Consensus 433 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~~~ 512 (668)
++++|.+++... ....+++..++.++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++.......
T Consensus 81 ~~~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~al~~lH~---~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~-- 154 (254)
T cd05083 81 SKGNLVNFLRTR-GRALVSVIQLLQFSLDVAEGMEYLES---KKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV-- 154 (254)
T ss_pred CCCCHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccCcceEEEcCCCcEEECCCccceeccccC--
Confidence 999999999642 33468999999999999999999998 999999999999999999999999999997644321
Q ss_pred cccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHHHhcCccccccCcccCCcccH
Q 005940 513 HTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVAT-GRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSYVV 591 (668)
Q Consensus 513 ~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 591 (668)
.....+..|+|||++.++.++.++|||||||++|||++ |+.||...+.. +..... ..+.... ....+
T Consensus 155 --~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~--~~~~~~-~~~~~~~-----~~~~~-- 222 (254)
T cd05083 155 --DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLK--EVKECV-EKGYRME-----PPEGC-- 222 (254)
T ss_pred --CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHH--HHHHHH-hCCCCCC-----CCCcC--
Confidence 11234567999999988899999999999999999998 99999754322 111111 1111111 11111
Q ss_pred HHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhcc
Q 005940 592 KEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSG 623 (668)
Q Consensus 592 ~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~ 623 (668)
...+..+..+|++. |++||+++++++.|+.
T Consensus 223 --~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 223 --PADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred --CHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 23455677799987 9999999999999875
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-34 Score=296.80 Aligned_cols=201 Identities=32% Similarity=0.453 Sum_probs=171.4
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCch-hHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEEe
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQ-GMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEY 431 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~ 431 (668)
++|+..+.||+|++|.||+|..+.+++.||||.+...... ....+.+|++++++++|+||+++++++......++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 5788899999999999999999888999999998754322 234567899999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCCC
Q 005940 432 IPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGM 511 (668)
Q Consensus 432 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~~ 511 (668)
+++ +|.+++.. ....+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||+++.......
T Consensus 85 ~~~-~L~~~~~~--~~~~~~~~~~~~~~~ql~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 158 (291)
T cd07844 85 LDT-DLKQYMDD--CGGGLSMHNVRLFLFQLLRGLAYCHQ---RRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSK 158 (291)
T ss_pred CCC-CHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecccCCHHHEEEcCCCCEEECccccccccCCCCc
Confidence 974 89998853 23468999999999999999999998 9999999999999999999999999999875432211
Q ss_pred CcccccccCCcccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 005940 512 PHTTNVVGTFGYIAPELTQT-GKASTSSDVFAYGILLLEVATGRRPIGSG 560 (668)
Q Consensus 512 ~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~S~Gvvl~elltG~~p~~~~ 560 (668)
......++..|+|||.+.+ ..++.++||||+|+++|||++|+.||...
T Consensus 159 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~ 207 (291)
T cd07844 159 -TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGS 207 (291)
T ss_pred -cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 1122346788999998765 45789999999999999999999999654
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=297.43 Aligned_cols=199 Identities=30% Similarity=0.392 Sum_probs=169.7
Q ss_pred CcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCc--hhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEEe
Q 005940 354 GFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSL--QGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEY 431 (668)
Q Consensus 354 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~ 431 (668)
+|...+.||+|++|.||+|++..+|+.+|+|++..... .....+.+|++++++++|+||+++++++.+....++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 47778999999999999999998999999999865422 2235678899999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCCC
Q 005940 432 IPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGM 511 (668)
Q Consensus 432 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~~ 511 (668)
++ ++|.+++.. ....+++..++.++.||++||.|||+ .+++||||||+||+++.++.+||+|||+++.......
T Consensus 81 ~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~al~~LH~---~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 154 (284)
T cd07839 81 CD-QDLKKYFDS--CNGDIDPEIVKSFMFQLLKGLAFCHS---HNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR 154 (284)
T ss_pred CC-CCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCC
Confidence 97 578777743 23468999999999999999999998 9999999999999999999999999999986543221
Q ss_pred CcccccccCCcccCcccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCC
Q 005940 512 PHTTNVVGTFGYIAPELTQTG-KASTSSDVFAYGILLLEVATGRRPIGS 559 (668)
Q Consensus 512 ~~~~~~~gt~~y~aPE~~~~~-~~~~~sDV~S~Gvvl~elltG~~p~~~ 559 (668)
......++..|+|||++.+. .++.++|||||||++|||++|+.|+..
T Consensus 155 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~ 202 (284)
T cd07839 155 -CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP 202 (284)
T ss_pred -CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcC
Confidence 12234578899999988664 468999999999999999999998643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=305.51 Aligned_cols=251 Identities=25% Similarity=0.349 Sum_probs=204.4
Q ss_pred hcCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCch---hHHHHHHHHHHHhccc-ccCceeEeeeecccCceEE
Q 005940 352 TKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQ---GMREFAAEIESLGRLR-HKNLVNLHGWCKQKNDLLL 427 (668)
Q Consensus 352 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~l 427 (668)
...|...+.||+|.||.||+++.+.+|+.+|+|.+.+.... ..+.+..|+++|+++. |||||++.+.++.....++
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l 113 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL 113 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence 35688889999999999999999999999999999876543 3468899999999998 9999999999999999999
Q ss_pred EEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCC----CCEEEEeecCc
Q 005940 428 VYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAE----MNARLGDFGLA 503 (668)
Q Consensus 428 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~----~~~kl~DfGla 503 (668)
|||++.+|.|.+.+... .+++.....++.|++.++.|||+ .+|+||||||+|+|+... +.+|++|||++
T Consensus 114 vmEL~~GGeLfd~i~~~----~~sE~da~~~~~~il~av~~lH~---~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla 186 (382)
T KOG0032|consen 114 VMELCEGGELFDRIVKK----HYSERDAAGIIRQILEAVKYLHS---LGVVHRDLKPENLLLASKDEGSGRIKLIDFGLA 186 (382)
T ss_pred EEEecCCchHHHHHHHc----cCCHHHHHHHHHHHHHHHHHHHh---CCceeccCCHHHeeeccccCCCCcEEEeeCCCc
Confidence 99999999999999643 29999999999999999999999 999999999999999644 47999999999
Q ss_pred eeccCCCCCcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCc
Q 005940 504 RLYDHGGMPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADP 583 (668)
Q Consensus 504 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~ 583 (668)
..... .......+||+.|+|||++....++...||||+|+++|.|++|..||.......... ....++. +..++
T Consensus 187 ~~~~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~---~i~~~~~-~f~~~ 260 (382)
T KOG0032|consen 187 KFIKP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL---AILRGDF-DFTSE 260 (382)
T ss_pred eEccC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH---HHHcCCC-CCCCC
Confidence 98876 234556799999999999998999999999999999999999999997654222211 1122222 11122
Q ss_pred ccCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 584 LLNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 584 ~l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
... ...+.+.. +...|+.. |..|+++.++++|
T Consensus 261 ~w~--~is~~akd---~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 261 PWD--DISESAKD---FIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred Ccc--ccCHHHHH---HHHHhcccCcccCCCHHHHhcC
Confidence 221 11233333 33355554 9999999999997
|
|
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=310.68 Aligned_cols=241 Identities=24% Similarity=0.311 Sum_probs=185.3
Q ss_pred eeecCcEEEEEEEeCCCCcEEEEEEEecCCc---hhHHHHHHHHHHHhcc---cccCceeEeeeecccCceEEEEEecCC
Q 005940 361 IGIGGFGSVYKGVLPTTGGEVAVKKITRNSL---QGMREFAAEIESLGRL---RHKNLVNLHGWCKQKNDLLLVYEYIPN 434 (668)
Q Consensus 361 lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~f~~Ei~~l~~l---~H~nIv~l~g~~~~~~~~~lV~E~~~~ 434 (668)
||+|+||+||+|.+..+++.||||++.+... .....+..|..++.++ +||||+++++.+.+....++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 6999999999999988899999999975422 2233455677777665 699999999999999999999999999
Q ss_pred CChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCCCCcc
Q 005940 435 GSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHT 514 (668)
Q Consensus 435 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 514 (668)
|+|.+++.. ...+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 g~L~~~l~~---~~~~~~~~~~~~~~qil~al~~LH~---~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~-~~~ 153 (330)
T cd05586 81 GELFWHLQK---EGRFSEDRAKFYIAELVLALEHLHK---YDIVYRDLKPENILLDATGHIALCDFGLSKANLTDN-KTT 153 (330)
T ss_pred ChHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC-CCc
Confidence 999998853 3468999999999999999999999 999999999999999999999999999987543222 122
Q ss_pred cccccCCcccCcccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCcccCCcccHHH
Q 005940 515 TNVVGTFGYIAPELTQTG-KASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSYVVKE 593 (668)
Q Consensus 515 ~~~~gt~~y~aPE~~~~~-~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 593 (668)
....||..|+|||++.+. .++.++|||||||++|||++|+.||...+.. +... ....+. ..+......++
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~--~~~~-~i~~~~------~~~~~~~~~~~ 224 (330)
T cd05586 154 NTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQ--QMYR-NIAFGK------VRFPKNVLSDE 224 (330)
T ss_pred cCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHH--HHHH-HHHcCC------CCCCCccCCHH
Confidence 345799999999988754 4789999999999999999999999754322 1111 111111 11111111122
Q ss_pred HHHHHHHHhhcCCC-CCCCC----CHHHHHHH
Q 005940 594 MELVLKLGLMCSHK-TQFRP----TMRQVMRY 620 (668)
Q Consensus 594 ~~~l~~l~~~C~~~-p~~RP----s~~evl~~ 620 (668)
+..+...|+.. |++|| ++.|++++
T Consensus 225 ---~~~li~~~L~~~P~~R~~~~~~~~~ll~h 253 (330)
T cd05586 225 ---GRQFVKGLLNRNPQHRLGAHRDAVELKEH 253 (330)
T ss_pred ---HHHHHHHHcCCCHHHCCCCCCCHHHHhcC
Confidence 33445577776 99998 67777764
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-34 Score=298.06 Aligned_cols=255 Identities=24% Similarity=0.261 Sum_probs=198.4
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCc---hhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEE
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSL---QGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVY 429 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 429 (668)
++|+..+.||+|+||.||++.+..+++.|++|.+..... ...+.+.+|+++++.++|+||+++++.+..++..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 468889999999999999999998899999999876532 33467889999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCC
Q 005940 430 EYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHG 509 (668)
Q Consensus 430 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~ 509 (668)
||+++++|.+++.. ...+++..+..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||+++.....
T Consensus 81 e~~~g~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~ 154 (305)
T cd05609 81 EYVEGGDCATLLKN---IGALPVDMARMYFAETVLALEYLHN---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMS 154 (305)
T ss_pred ecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCchHHEEECCCCCEEEeeCCCccccCcC
Confidence 99999999999953 3468999999999999999999998 99999999999999999999999999998742111
Q ss_pred CC--------------CcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcC
Q 005940 510 GM--------------PHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLG 575 (668)
Q Consensus 510 ~~--------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~ 575 (668)
.. .......++..|+|||.+....++.++|+|||||++|||++|+.||...+.. ++.......
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~--~~~~~~~~~- 231 (305)
T cd05609 155 LTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE--ELFGQVISD- 231 (305)
T ss_pred ccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhc-
Confidence 00 0111235788999999998888999999999999999999999999754322 222221111
Q ss_pred ccccccCcccCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhcc
Q 005940 576 RILDVADPLLNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSG 623 (668)
Q Consensus 576 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~ 623 (668)
. ...+......+ ..+..++..|++. |++||++.++.+.|+.
T Consensus 232 ~---~~~~~~~~~~~----~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 232 D---IEWPEGDEALP----ADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred c---cCCCCccccCC----HHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 1 11111111111 2345666678887 9999996555554443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=294.52 Aligned_cols=252 Identities=28% Similarity=0.373 Sum_probs=202.1
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCc-hhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEEe
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSL-QGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEY 431 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~ 431 (668)
++|+..+.||+|++|.||++.+..+++.+++|++..... ...+++.+|++++++++||||+++++.+...+..++++||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 357778899999999999999988899999999877543 4456789999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCCC
Q 005940 432 IPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGM 511 (668)
Q Consensus 432 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~~ 511 (668)
+++++|.+++... ...+++..+.+++.|++.||.|||+ ..+++|+||||+||+++.++.+||+|||.+........
T Consensus 81 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lH~--~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~ 156 (265)
T cd06605 81 MDGGSLDKILKEV--QGRIPERILGKIAVAVLKGLTYLHE--KHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA 156 (265)
T ss_pred cCCCcHHHHHHHc--cCCCCHHHHHHHHHHHHHHHHHHcC--CCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh
Confidence 9999999999632 2568999999999999999999997 37999999999999999999999999999876543221
Q ss_pred CcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCc---hhHHHHHHHHHhcCccccccCcccCCc
Q 005940 512 PHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGD---LLLVEWVRECHQLGRILDVADPLLNSS 588 (668)
Q Consensus 512 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~---~~l~~~~~~~~~~~~~~~~~d~~l~~~ 588 (668)
....++..|+|||++.+..++.++||||||+++|||++|+.||...+ ....+......... .+.+...
T Consensus 157 ---~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~ 227 (265)
T cd06605 157 ---KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEP------PPRLPSG 227 (265)
T ss_pred ---hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCC------CCCCChh
Confidence 12568889999999988899999999999999999999999996542 22222222222111 1111111
Q ss_pred ccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 589 YVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 589 ~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
. ....+..+...|+.. |++||++.|++++
T Consensus 228 ~---~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 228 K---FSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred h---cCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 0 112345666678886 9999999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-34 Score=289.93 Aligned_cols=253 Identities=28% Similarity=0.408 Sum_probs=204.4
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCc-hhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEEe
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSL-QGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEY 431 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~ 431 (668)
++|+..+.||+|++|.||++++..+++.|+||++..... ...+++.+|++.+.+++|+||+++++++...+..++||||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 368889999999999999999988899999999977654 4567899999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCCC
Q 005940 432 IPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGM 511 (668)
Q Consensus 432 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~~ 511 (668)
+++++|.+++... ..+++..++.++.|+++||.|||+ ..+++||||+|+||+++.++.++|+|||.+........
T Consensus 81 ~~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lh~--~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~ 155 (264)
T cd06623 81 MDGGSLADLLKKV---GKIPEPVLAYIARQILKGLDYLHT--KRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLD 155 (264)
T ss_pred cCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhc--cCCCccCCCCHHHEEECCCCCEEEccCccceecccCCC
Confidence 9999999999532 568999999999999999999996 28999999999999999999999999999987654332
Q ss_pred CcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCch-hHHHHHHHHHhcCccccccCcccCCccc
Q 005940 512 PHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDL-LLVEWVRECHQLGRILDVADPLLNSSYV 590 (668)
Q Consensus 512 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~-~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 590 (668)
. .....++..|+|||.+.+..++.++||||||+++|||++|+.||...+. ...+....... .. .+.+....
T Consensus 156 ~-~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~-~~-----~~~~~~~~- 227 (264)
T cd06623 156 Q-CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICD-GP-----PPSLPAEE- 227 (264)
T ss_pred c-ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhc-CC-----CCCCCccc-
Confidence 2 2234678899999999988899999999999999999999999975431 11111111111 11 11111110
Q ss_pred HHHHHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 591 VKEMELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 591 ~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
....+..+...|+.. |++||++.|++++
T Consensus 228 --~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 228 --FSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred --CCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 123455566678877 9999999999985
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-34 Score=300.33 Aligned_cols=196 Identities=27% Similarity=0.405 Sum_probs=160.9
Q ss_pred ceeeeecCcEEEEEEEeC--CCCcEEEEEEEecCCchhHHHHHHHHHHHhcccccCceeEeeeecc--cCceEEEEEecC
Q 005940 358 SEVIGIGGFGSVYKGVLP--TTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNLHGWCKQ--KNDLLLVYEYIP 433 (668)
Q Consensus 358 ~~~lG~G~~g~Vy~~~~~--~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~--~~~~~lV~E~~~ 433 (668)
.++||+|+||.||+|... .++..||+|.+..... ...+.+|++++++++||||+++++++.. ....++||||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC--cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 468999999999999975 3567899999865432 3456789999999999999999998854 456889999985
Q ss_pred CCChhhhhcCCC------CCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEE----CCCCCEEEEeecCc
Q 005940 434 NGSLDTLLFKPK------DGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALI----DAEMNARLGDFGLA 503 (668)
Q Consensus 434 ~gsL~~~l~~~~------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll----~~~~~~kl~DfGla 503 (668)
++|.+++.... ....+++..+..++.||+.||.|||+ .+|+||||||+|||+ +.++.+||+|||++
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHh---CCEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 57877764221 12358999999999999999999998 999999999999999 45678999999999
Q ss_pred eeccCCCC--CcccccccCCcccCcccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCC
Q 005940 504 RLYDHGGM--PHTTNVVGTFGYIAPELTQTG-KASTSSDVFAYGILLLEVATGRRPIGS 559 (668)
Q Consensus 504 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~sDV~S~Gvvl~elltG~~p~~~ 559 (668)
+....... .......||+.|+|||++.+. .++.++||||+||++|||++|+.||..
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~ 218 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccC
Confidence 87654322 122345789999999988764 589999999999999999999999964
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=298.35 Aligned_cols=250 Identities=25% Similarity=0.373 Sum_probs=201.5
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCchhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEEec
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEYI 432 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~ 432 (668)
.+|...+.||+|+||.||++....++..|++|.+........+.+..|+.++++++|||++++++.|...+..++|+||+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 98 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL 98 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence 57888999999999999999988788999999987655555678899999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCCCC
Q 005940 433 PNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMP 512 (668)
Q Consensus 433 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~~~ 512 (668)
++++|.+++.. ..+++.++..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++........
T Consensus 99 ~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~---~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~- 170 (293)
T cd06647 99 AGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS- 170 (293)
T ss_pred CCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHh---CCEeeccCCHHHEEEcCCCCEEEccCcceeccccccc-
Confidence 99999999852 347899999999999999999998 9999999999999999999999999999876543322
Q ss_pred cccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCcccCCcccHH
Q 005940 513 HTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSYVVK 592 (668)
Q Consensus 513 ~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 592 (668)
......++..|+|||.+..+.++.++||||||+++||+++|+.||...+.. +.+......+. +... ....
T Consensus 171 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~--~~~~~~~~~~~------~~~~--~~~~ 240 (293)
T cd06647 171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPL--RALYLIATNGT------PELQ--NPEK 240 (293)
T ss_pred ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChh--hheeehhcCCC------CCCC--Cccc
Confidence 222346888999999998888999999999999999999999999754221 10111111110 1110 0111
Q ss_pred HHHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 593 EMELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 593 ~~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
....+..+...|+.. |++||++++++++
T Consensus 241 ~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 241 LSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred cCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 122355666789887 9999999999976
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-34 Score=295.16 Aligned_cols=201 Identities=33% Similarity=0.427 Sum_probs=172.4
Q ss_pred CcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCC--chhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEEe
Q 005940 354 GFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNS--LQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEY 431 (668)
Q Consensus 354 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~ 431 (668)
+|+..+.||.|++|.||+|+...++..||||++.... ......+.+|++++++++||||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4788899999999999999998889999999986543 22345788999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCCC
Q 005940 432 IPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGM 511 (668)
Q Consensus 432 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~~ 511 (668)
+. ++|.+++... .+..+++.++..++.|++.||+|||+ .+++||||+|+||+++.++.+||+|||++........
T Consensus 81 ~~-~~l~~~~~~~-~~~~l~~~~~~~~~~~i~~~l~~lh~---~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~ 155 (284)
T cd07860 81 LH-QDLKKFMDAS-PLSGIPLPLIKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 155 (284)
T ss_pred cc-cCHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEeeccchhhcccCcc
Confidence 95 6898888632 34568999999999999999999998 9999999999999999999999999999876543321
Q ss_pred CcccccccCCcccCcccccCCC-CCcchhHHHHHHHHHHHHhCCCCCCCC
Q 005940 512 PHTTNVVGTFGYIAPELTQTGK-ASTSSDVFAYGILLLEVATGRRPIGSG 560 (668)
Q Consensus 512 ~~~~~~~gt~~y~aPE~~~~~~-~~~~sDV~S~Gvvl~elltG~~p~~~~ 560 (668)
......++..|+|||++.+.. ++.++|||||||++|||+||+.||...
T Consensus 156 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~ 204 (284)
T cd07860 156 -TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 204 (284)
T ss_pred -ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 122335688999999876644 588999999999999999999999654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=296.69 Aligned_cols=245 Identities=26% Similarity=0.336 Sum_probs=199.6
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCC---chhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEE
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNS---LQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVY 429 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 429 (668)
++|+..+.||+|++|.||++.+..+++.+|+|++.... .+..+.+.+|++++++++||||+++++.+.+....++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 46888999999999999999998889999999987542 234567889999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCC
Q 005940 430 EYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHG 509 (668)
Q Consensus 430 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~ 509 (668)
||+++++|.+++.. ...+++..+..++.|++.||.|||+ .+++||||+|+||+++.++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~~~~---~~~l~~~~~~~~~~qil~~l~~lH~---~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 154 (290)
T cd05580 81 EYVPGGELFSHLRK---SGRFPEPVARFYAAQVVLALEYLHS---LDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR 154 (290)
T ss_pred ecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC
Confidence 99999999999953 2568999999999999999999999 99999999999999999999999999999876543
Q ss_pred CCCcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCcccCCcc
Q 005940 510 GMPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSY 589 (668)
Q Consensus 510 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 589 (668)
.....++..|+|||.+.+...+.++||||||+++|||++|+.||...+.. ...+....+. ..+....
T Consensus 155 ----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~~~~~~~------~~~~~~~ 221 (290)
T cd05580 155 ----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPI---QIYEKILEGK------VRFPSFF 221 (290)
T ss_pred ----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHhcCC------ccCCccC
Confidence 23346889999999998888899999999999999999999999765421 1111111111 1111122
Q ss_pred cHHHHHHHHHHHhhcCCC-CCCCC-----CHHHHHHH
Q 005940 590 VVKEMELVLKLGLMCSHK-TQFRP-----TMRQVMRY 620 (668)
Q Consensus 590 ~~~~~~~l~~l~~~C~~~-p~~RP-----s~~evl~~ 620 (668)
+ ..+..+...|+.. |++|| +++|++++
T Consensus 222 ~----~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~ 254 (290)
T cd05580 222 S----PDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNH 254 (290)
T ss_pred C----HHHHHHHHHHccCCHHHccCcccCCHHHHHcC
Confidence 2 2334555678876 99998 78888765
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-34 Score=295.43 Aligned_cols=260 Identities=29% Similarity=0.338 Sum_probs=198.7
Q ss_pred cccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCC--chhHHHHHHHHHHHhcccccCceeEeeeeccc--CceEEEEE
Q 005940 355 FKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNS--LQGMREFAAEIESLGRLRHKNLVNLHGWCKQK--NDLLLVYE 430 (668)
Q Consensus 355 f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~--~~~~lV~E 430 (668)
|++.++||+|++|.||+|+...++..+|+|++.... ....+.+.+|++++++++|+|++++++++... +..++|+|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 567889999999999999998889999999998763 33446788999999999999999999999887 88999999
Q ss_pred ecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCC
Q 005940 431 YIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGG 510 (668)
Q Consensus 431 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~ 510 (668)
|+++ +|.+++... ...+++.+++.++.||+.||+|||+ .+++|+||||+||++++++.+||+|||++.......
T Consensus 81 ~~~~-~l~~~~~~~--~~~~~~~~~~~i~~~i~~al~~LH~---~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~ 154 (287)
T cd07840 81 YMDH-DLTGLLDSP--EVKFTESQIKCYMKQLLEGLQYLHS---NGILHRDIKGSNILINNDGVLKLADFGLARPYTKRN 154 (287)
T ss_pred cccc-cHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCcHHHeEEcCCCCEEEccccceeeccCCC
Confidence 9974 888888532 2568999999999999999999998 899999999999999999999999999998776544
Q ss_pred CCcccccccCCcccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCchh-HHHHHHHHHhcC------ccccc--
Q 005940 511 MPHTTNVVGTFGYIAPELTQT-GKASTSSDVFAYGILLLEVATGRRPIGSGDLL-LVEWVRECHQLG------RILDV-- 580 (668)
Q Consensus 511 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~-l~~~~~~~~~~~------~~~~~-- 580 (668)
........++..|+|||.+.+ ..++.++||||||+++|||++|+.||...+.. ............ ...+.
T Consensus 155 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd07840 155 SADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPW 234 (287)
T ss_pred cccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchh
Confidence 323334467889999997654 45789999999999999999999999754321 111111111000 00000
Q ss_pred ---c------CcccCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 581 ---A------DPLLNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 581 ---~------d~~l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
. ...+...+...+...+..+...|+.. |++||++++++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 235 FENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred hhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 0 00000000011134567777888887 9999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-34 Score=296.66 Aligned_cols=260 Identities=25% Similarity=0.271 Sum_probs=197.0
Q ss_pred CcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCch-----hHHHHHHHHHHHhcccccCceeEeeeecccCceEEE
Q 005940 354 GFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQ-----GMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLV 428 (668)
Q Consensus 354 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-----~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV 428 (668)
+|+..+.||+|++|.||+|....+++.||||++...... ....+..|++++++++|+||+++++++.+....++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 477788999999999999999888999999999765432 335677899999999999999999999999999999
Q ss_pred EEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccC
Q 005940 429 YEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDH 508 (668)
Q Consensus 429 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~ 508 (668)
|||+ +++|.+++... ...+++..++.++.||++||.|||+ .+++||||||+||+++.++.+||+|||+++....
T Consensus 81 ~e~~-~~~L~~~i~~~--~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~ 154 (298)
T cd07841 81 FEFM-ETDLEKVIKDK--SIVLTPADIKSYMLMTLRGLEYLHS---NWILHRDLKPNNLLIASDGVLKLADFGLARSFGS 154 (298)
T ss_pred Eccc-CCCHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence 9999 99999999532 2369999999999999999999999 9999999999999999999999999999987654
Q ss_pred CCCCcccccccCCcccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCch-hHHHHHHHHHhc---------Ccc
Q 005940 509 GGMPHTTNVVGTFGYIAPELTQT-GKASTSSDVFAYGILLLEVATGRRPIGSGDL-LLVEWVRECHQL---------GRI 577 (668)
Q Consensus 509 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~-~l~~~~~~~~~~---------~~~ 577 (668)
... ......++..|+|||.+.+ ..++.++|||||||++|||++|..||...+. ....-....... ...
T Consensus 155 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (298)
T cd07841 155 PNR-KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSL 233 (298)
T ss_pred CCc-cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccc
Confidence 322 1222356788999998754 4578999999999999999999777754321 111111100000 000
Q ss_pred ccccCcccCCccc-----HHHHHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 578 LDVADPLLNSSYV-----VKEMELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 578 ~~~~d~~l~~~~~-----~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
............. ......+..++..|+.. |++||+++||+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 234 PDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred cccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 0000000000000 11124556777788887 9999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-34 Score=293.88 Aligned_cols=252 Identities=27% Similarity=0.356 Sum_probs=192.6
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCc-hhHHHHHHHHHH-HhcccccCceeEeeeecccCceEEEEE
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSL-QGMREFAAEIES-LGRLRHKNLVNLHGWCKQKNDLLLVYE 430 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~f~~Ei~~-l~~l~H~nIv~l~g~~~~~~~~~lV~E 430 (668)
++|++.+.||+|+||.||++++..+++.||+|++..... +...++..|+.+ ++.++|+||+++++++...+..+++||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 468889999999999999999988899999999876432 233455666665 556689999999999999999999999
Q ss_pred ecCCCChhhhhcCC-CCCCCccHHHHHHHHHHHHHHHHHhhhccCC-ceEecCCCCCCEEECCCCCEEEEeecCceeccC
Q 005940 431 YIPNGSLDTLLFKP-KDGSVLDWEQRFNIVKGIASGLLYLHEEWEQ-VVIHRDVKPSNALIDAEMNARLGDFGLARLYDH 508 (668)
Q Consensus 431 ~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~-~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~ 508 (668)
|++ |+|.+++... .....+++..++.++.||+.||.|||+ . +++||||||+||+++.++.+||+|||+++....
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 156 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHS---KLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVD 156 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhh---cCCeecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence 996 6888877532 234568999999999999999999998 5 899999999999999999999999999986543
Q ss_pred CCCCcccccccCCcccCcccccC----CCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCcc
Q 005940 509 GGMPHTTNVVGTFGYIAPELTQT----GKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPL 584 (668)
Q Consensus 509 ~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 584 (668)
.. ......++..|+|||.+.. ..++.++|+|||||++|||++|+.||......... ....... ..+.
T Consensus 157 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~-~~~~~~~------~~~~ 227 (283)
T cd06617 157 SV--AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQ-LKQVVEE------PSPQ 227 (283)
T ss_pred cc--ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHH-HHHHHhc------CCCC
Confidence 22 1223467889999998764 44688999999999999999999999643221111 1111111 1111
Q ss_pred cCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 585 LNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 585 l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
+.....+ ..+..+...|+.. |++||++++|+++
T Consensus 228 ~~~~~~~---~~l~~li~~~l~~~p~~Rp~~~~il~~ 261 (283)
T cd06617 228 LPAEKFS---PEFQDFVNKCLKKNYKERPNYPELLQH 261 (283)
T ss_pred CCccccC---HHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1111111 2345566678876 9999999999874
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=285.97 Aligned_cols=250 Identities=30% Similarity=0.431 Sum_probs=203.6
Q ss_pred CcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCchhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEEecC
Q 005940 354 GFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEYIP 433 (668)
Q Consensus 354 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~ 433 (668)
.|...+.||+|++|.||++....++..+++|++........+.+.+|++++++++|+|++++++++......++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 36778999999999999999988899999999987665567889999999999999999999999999999999999999
Q ss_pred CCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCCCCc
Q 005940 434 NGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPH 513 (668)
Q Consensus 434 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 513 (668)
+++|.+++... ...+++..+..++.|++.||.|||+ .+++||||+|+||++++++.++|+|||.+........
T Consensus 81 ~~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-- 153 (253)
T cd05122 81 GGSLKDLLKST--NQTLTESQIAYVCKELLKGLEYLHS---NGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA-- 153 (253)
T ss_pred CCcHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHhhc---CCEecCCCCHHHEEEccCCeEEEeecccccccccccc--
Confidence 99999998532 2568999999999999999999998 9999999999999999999999999999987655432
Q ss_pred ccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCcccCCcccHHH
Q 005940 514 TTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSYVVKE 593 (668)
Q Consensus 514 ~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 593 (668)
.....++..|+|||.+.....+.++||||||+++|||++|+.||...+.. ........ .......++. ..
T Consensus 154 ~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~-~~~~~~~~~~----~~--- 223 (253)
T cd05122 154 RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPM--KALFKIAT-NGPPGLRNPE----KW--- 223 (253)
T ss_pred ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchH--HHHHHHHh-cCCCCcCccc----cc---
Confidence 33456888999999998888999999999999999999999999754211 11111111 1111111110 00
Q ss_pred HHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 594 MELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 594 ~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
...+..+...|+.. |++||++.|++++
T Consensus 224 ~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 224 SDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred CHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 13355666688887 9999999999875
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=293.32 Aligned_cols=248 Identities=26% Similarity=0.313 Sum_probs=202.1
Q ss_pred CcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCc---hhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEE
Q 005940 354 GFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSL---QGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYE 430 (668)
Q Consensus 354 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 430 (668)
+|+..+.||.|+||.||+|.+..++..||+|.+.+... ...+.+.+|++++++++||||+++++.+......++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 57889999999999999999988899999999976432 346789999999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCC
Q 005940 431 YIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGG 510 (668)
Q Consensus 431 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~ 510 (668)
|+++++|.+++... ..+++.++..++.|+++||.|||+ .+++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lh~---~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 154 (258)
T cd05578 81 LLLGGDLRYHLSQK---VKFSEEQVKFWICEIVLALEYLHS---KGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT 154 (258)
T ss_pred CCCCCCHHHHHHhc---CCcCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc
Confidence 99999999999532 468999999999999999999998 999999999999999999999999999988665432
Q ss_pred CCcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCcccCCccc
Q 005940 511 MPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSYV 590 (668)
Q Consensus 511 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 590 (668)
......|+..|+|||++.+..++.++|+||||+++|+|++|+.||........++........ . +......+
T Consensus 155 --~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~----~~~~~~~~ 226 (258)
T cd05578 155 --LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETA--D----VLYPATWS 226 (258)
T ss_pred --cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhccc--c----ccCcccCc
Confidence 223346888999999998888999999999999999999999999765433333333322211 1 11111111
Q ss_pred HHHHHHHHHHHhhcCCC-CCCCCCH--HHHHH
Q 005940 591 VKEMELVLKLGLMCSHK-TQFRPTM--RQVMR 619 (668)
Q Consensus 591 ~~~~~~l~~l~~~C~~~-p~~RPs~--~evl~ 619 (668)
..+..+...|+.. |.+||+. +|+++
T Consensus 227 ----~~~~~~i~~~l~~~p~~R~~~~~~~l~~ 254 (258)
T cd05578 227 ----TEAIDAINKLLERDPQKRLGDNLKDLKN 254 (258)
T ss_pred ----HHHHHHHHHHccCChhHcCCccHHHHhc
Confidence 3445566678887 9999999 77664
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-34 Score=292.85 Aligned_cols=248 Identities=27% Similarity=0.426 Sum_probs=199.3
Q ss_pred CcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCC-chhHHHHHHHHHHHhccc---ccCceeEeeeecccCceEEEE
Q 005940 354 GFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNS-LQGMREFAAEIESLGRLR---HKNLVNLHGWCKQKNDLLLVY 429 (668)
Q Consensus 354 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~---H~nIv~l~g~~~~~~~~~lV~ 429 (668)
.|+..+.||+|+||.||+|.+..++..||+|.+.... .....++.+|++++++++ |||++++++++..+...++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 4777889999999999999998889999999987643 344567889999999997 999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCC
Q 005940 430 EYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHG 509 (668)
Q Consensus 430 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~ 509 (668)
||+++++|.+++.. ..+++..++.++.|++.||.|||+ .+++||||+|+||+++.++.++|+|||++......
T Consensus 82 e~~~~~~L~~~~~~----~~l~~~~~~~i~~~i~~~l~~lh~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06917 82 EYAEGGSVRTLMKA----GPIAEKYISVIIREVLVALKYIHK---VGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQN 154 (277)
T ss_pred ecCCCCcHHHHHHc----cCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence 99999999999853 268999999999999999999998 99999999999999999999999999999876544
Q ss_pred CCCcccccccCCcccCcccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCcccCCc
Q 005940 510 GMPHTTNVVGTFGYIAPELTQTG-KASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSS 588 (668)
Q Consensus 510 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 588 (668)
.. ......|+..|+|||.+.++ .++.++|||||||++|||++|+.||...+. ..+.... .....+.+...
T Consensus 155 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~--~~~~~~~------~~~~~~~~~~~ 225 (277)
T cd06917 155 SS-KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDA--FRAMMLI------PKSKPPRLEDN 225 (277)
T ss_pred cc-ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCCh--hhhhhcc------ccCCCCCCCcc
Confidence 32 22334688999999988754 468899999999999999999999975432 1111111 11111222221
Q ss_pred ccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 589 YVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 589 ~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
. ....+..++..|+.. |++||++.|++++
T Consensus 226 ~---~~~~~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 226 G---YSKLLREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred c---CCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence 1 123455666789987 9999999999874
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=291.02 Aligned_cols=250 Identities=23% Similarity=0.402 Sum_probs=200.1
Q ss_pred CcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCC--chhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEEe
Q 005940 354 GFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNS--LQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEY 431 (668)
Q Consensus 354 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~ 431 (668)
+|+..+.||+|++|.||+|....++..+|+|.+.... ....+.+.+|++++++++|+||+++++.+......++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 4778899999999999999999889999999986542 23446788999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCC-CEEEEeecCceeccCCC
Q 005940 432 IPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEM-NARLGDFGLARLYDHGG 510 (668)
Q Consensus 432 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~-~~kl~DfGla~~~~~~~ 510 (668)
+++++|.+++... ....+++..+..++.|++.||.|||+ .+++|+||||+||++++++ .+||+|||.+.......
T Consensus 81 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (257)
T cd08225 81 CDGGDLMKRINRQ-RGVLFSEDQILSWFVQISLGLKHIHD---RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM 156 (257)
T ss_pred CCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEEcCCCCeEEecccccchhccCCc
Confidence 9999999998632 23468999999999999999999998 9999999999999999885 46999999998665432
Q ss_pred CCcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCcccCCccc
Q 005940 511 MPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSYV 590 (668)
Q Consensus 511 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 590 (668)
. ......|+..|+|||+..+..++.++||||||+++|||++|+.||...+ ..+++.+.... ... + ......
T Consensus 157 ~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~--~~~~~~~~~~~-~~~----~-~~~~~~ 227 (257)
T cd08225 157 E-LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN--LHQLVLKICQG-YFA----P-ISPNFS 227 (257)
T ss_pred c-cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCcc--HHHHHHHHhcc-cCC----C-CCCCCC
Confidence 1 1223468889999999988889999999999999999999999997542 22333332221 111 1 111111
Q ss_pred HHHHHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 591 VKEMELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 591 ~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
..+..+...|+.. |++||+++||+++
T Consensus 228 ----~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 228 ----RDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred ----HHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 2344555678876 9999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=310.03 Aligned_cols=246 Identities=29% Similarity=0.389 Sum_probs=203.8
Q ss_pred CcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecC---CchhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEE
Q 005940 354 GFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRN---SLQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYE 430 (668)
Q Consensus 354 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 430 (668)
-|.+.+.||.|+||.||-+++..+.+.||||+++-. +.+..++++.|++.|++++|||++.+-|++..+...+||||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME 106 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME 106 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence 467788999999999999999999999999999654 34556789999999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCC
Q 005940 431 YIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGG 510 (668)
Q Consensus 431 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~ 510 (668)
|| -||-.+++. .-++++-+..+.-|+.+.+.||+|||+ .+.||||||+.||||++.+.+||+|||.|......
T Consensus 107 YC-lGSAsDlle--VhkKplqEvEIAAi~~gaL~gLaYLHS---~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA- 179 (948)
T KOG0577|consen 107 YC-LGSASDLLE--VHKKPLQEVEIAAITHGALQGLAYLHS---HNRIHRDIKAGNILLSEPGLVKLADFGSASIMAPA- 179 (948)
T ss_pred HH-hccHHHHHH--HHhccchHHHHHHHHHHHHHHHHHHHH---hhHHhhhccccceEecCCCeeeeccccchhhcCch-
Confidence 99 567777773 234679999999999999999999999 99999999999999999999999999999876543
Q ss_pred CCcccccccCCcccCccccc---CCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCcccCC
Q 005940 511 MPHTTNVVGTFGYIAPELTQ---TGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNS 587 (668)
Q Consensus 511 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 587 (668)
..++||+.|||||++. .+.|+-|.||||+||.-.||.-.++|+-..+. +......-+.. .|.+.
T Consensus 180 ----nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNA--MSALYHIAQNe------sPtLq- 246 (948)
T KOG0577|consen 180 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA--MSALYHIAQNE------SPTLQ- 246 (948)
T ss_pred ----hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchH--HHHHHHHHhcC------CCCCC-
Confidence 3468999999999864 57899999999999999999999999754321 11111111111 23332
Q ss_pred cccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHh
Q 005940 588 SYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYL 621 (668)
Q Consensus 588 ~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L 621 (668)
..+....+..+.-.|++. |.+|||.++++++-
T Consensus 247 --s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~ 279 (948)
T KOG0577|consen 247 --SNEWSDYFRNFVDSCLQKIPQERPTSEELLKHR 279 (948)
T ss_pred --CchhHHHHHHHHHHHHhhCcccCCcHHHHhhcc
Confidence 234456677788899998 99999999998764
|
|
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=296.86 Aligned_cols=247 Identities=29% Similarity=0.403 Sum_probs=196.2
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCC---chhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEE
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNS---LQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVY 429 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 429 (668)
+.|...+.||+|++|.||+|+...+++.||+|++.... .+..+++.+|++++++++||||++++++|...+..++|+
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 45888899999999999999998889999999986433 234467889999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCC
Q 005940 430 EYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHG 509 (668)
Q Consensus 430 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~ 509 (668)
||++ |+|.+++.. ....+++..+..++.|++.||.|||+ .+++||||+|+||+++.++.+||+|||++......
T Consensus 95 e~~~-g~l~~~~~~--~~~~l~~~~~~~~~~ql~~~L~~LH~---~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~ 168 (307)
T cd06607 95 EYCL-GSASDILEV--HKKPLQEVEIAAICHGALQGLAYLHS---HERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA 168 (307)
T ss_pred HhhC-CCHHHHHHH--cccCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcccEEECCCCCEEEeecCcceecCCC
Confidence 9996 677777642 23468999999999999999999998 99999999999999999999999999998765432
Q ss_pred CCCcccccccCCcccCccccc---CCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCcccC
Q 005940 510 GMPHTTNVVGTFGYIAPELTQ---TGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLN 586 (668)
Q Consensus 510 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 586 (668)
....++..|+|||++. .+.++.++||||||+++|||++|+.||...+.... ....... . .+.+.
T Consensus 169 -----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~--~~~~~~~-~-----~~~~~ 235 (307)
T cd06607 169 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA--LYHIAQN-D-----SPTLS 235 (307)
T ss_pred -----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHH--HHHHhcC-C-----CCCCC
Confidence 2346788999999874 45678999999999999999999999965432211 1111110 0 01111
Q ss_pred CcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHh
Q 005940 587 SSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYL 621 (668)
Q Consensus 587 ~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L 621 (668)
. ......+..+...|+.. |++||++.+|+++.
T Consensus 236 ~---~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 268 (307)
T cd06607 236 S---NDWSDYFRNFVDSCLQKIPQDRPSSEELLKHR 268 (307)
T ss_pred c---hhhCHHHHHHHHHHhcCChhhCcCHHHHhcCh
Confidence 1 11223466677789987 99999999999763
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-34 Score=294.29 Aligned_cols=202 Identities=33% Similarity=0.478 Sum_probs=173.4
Q ss_pred CcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCch-hHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEEec
Q 005940 354 GFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQ-GMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEYI 432 (668)
Q Consensus 354 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~ 432 (668)
+|+..++||.|++|.||+|++..++..||||++...... ..+.+.+|++++++++|+||+++++++...+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 578899999999999999999888999999998765432 3456778999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCCCC
Q 005940 433 PNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMP 512 (668)
Q Consensus 433 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~~~ 512 (668)
++ +|.+++........+++.++..++.|++.||.|||+ .+++||||||+||++++++.+||+|||++........
T Consensus 81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~- 155 (284)
T cd07836 81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHE---NRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN- 155 (284)
T ss_pred Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-
Confidence 85 888888543334568999999999999999999998 8999999999999999999999999999976543221
Q ss_pred cccccccCCcccCcccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 005940 513 HTTNVVGTFGYIAPELTQTG-KASTSSDVFAYGILLLEVATGRRPIGSG 560 (668)
Q Consensus 513 ~~~~~~gt~~y~aPE~~~~~-~~~~~sDV~S~Gvvl~elltG~~p~~~~ 560 (668)
......++..|++||++.+. .++.++|||||||++|||++|+.||...
T Consensus 156 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~ 204 (284)
T cd07836 156 TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGT 204 (284)
T ss_pred ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 12234568899999987653 5689999999999999999999999754
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=285.48 Aligned_cols=251 Identities=28% Similarity=0.418 Sum_probs=203.7
Q ss_pred CcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCc--hhHHHHHHHHHHHhcccccCceeEeeeeccc--CceEEEE
Q 005940 354 GFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSL--QGMREFAAEIESLGRLRHKNLVNLHGWCKQK--NDLLLVY 429 (668)
Q Consensus 354 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~--~~~~lV~ 429 (668)
+|+..+.||+|++|.||+|....++..|++|++..... ...+.+.+|++++++++|+||+++++.+... ...++|+
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 46778999999999999999988899999999876543 4567899999999999999999999999888 8899999
Q ss_pred EecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCC
Q 005940 430 EYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHG 509 (668)
Q Consensus 430 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~ 509 (668)
||+++++|.+++... ..+++.+++.++.|++.||+|||+ .+++|+||+|+||+++.++.++|+|||.+......
T Consensus 81 e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~---~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 154 (260)
T cd06606 81 EYVSGGSLSSLLKKF---GKLPEPVIRKYTRQILEGLAYLHS---NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDI 154 (260)
T ss_pred EecCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEcCCCCEEEcccccEEecccc
Confidence 999999999999532 379999999999999999999999 99999999999999999999999999999877654
Q ss_pred CCC-cccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCcccCCc
Q 005940 510 GMP-HTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSS 588 (668)
Q Consensus 510 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 588 (668)
... ......++..|+|||.+.....+.++||||||++++||++|+.||...+... ...+........ +.+...
T Consensus 155 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~-----~~~~~~ 228 (260)
T cd06606 155 ETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPM-AALYKIGSSGEP-----PEIPEH 228 (260)
T ss_pred cccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchH-HHHHhccccCCC-----cCCCcc
Confidence 321 1233568889999999988889999999999999999999999997654111 111111110111 111111
Q ss_pred ccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 589 YVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 589 ~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
. ...+..+..+|+.. |++||++.|++++
T Consensus 229 ~----~~~l~~~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 229 L----SEEAKDFLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred c----CHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence 1 23455666788887 9999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=293.43 Aligned_cols=249 Identities=23% Similarity=0.322 Sum_probs=200.6
Q ss_pred CcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCchhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEEecC
Q 005940 354 GFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEYIP 433 (668)
Q Consensus 354 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~ 433 (668)
.|...+.||+|++|.||++....+++.+++|++........+.+.+|+.++++++|+||+++++++...+..++|+||++
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~ 99 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE 99 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence 34556899999999999999888899999999876655566778999999999999999999999999999999999999
Q ss_pred CCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCCCCc
Q 005940 434 NGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPH 513 (668)
Q Consensus 434 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 513 (668)
+++|.+++.. ..+++..+..++.|++.||+|||+ .+++||||+|+||+++.++.++|+|||.+....... ..
T Consensus 100 ~~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~-~~ 171 (285)
T cd06648 100 GGALTDIVTH----TRMNEEQIATVCLAVLKALSFLHA---QGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEV-PR 171 (285)
T ss_pred CCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCChhhEEEcCCCcEEEcccccchhhccCC-cc
Confidence 9999999853 358999999999999999999998 999999999999999999999999999887554322 12
Q ss_pred ccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCcccCCcccHHH
Q 005940 514 TTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSYVVKE 593 (668)
Q Consensus 514 ~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 593 (668)
.....|+..|+|||.+.+..++.++||||||+++|||++|+.||...+. .......... . .+..... ...
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~--~~~~~~~~~~-~-----~~~~~~~--~~~ 241 (285)
T cd06648 172 RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPP--LQAMKRIRDN-L-----PPKLKNL--HKV 241 (285)
T ss_pred cccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCH--HHHHHHHHhc-C-----CCCCccc--ccC
Confidence 2334688999999999888899999999999999999999999865432 1222222111 1 1111100 001
Q ss_pred HHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 594 MELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 594 ~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
...+..+...|++. |++||++++++++
T Consensus 242 ~~~l~~li~~~l~~~p~~Rpt~~~il~~ 269 (285)
T cd06648 242 SPRLRSFLDRMLVRDPAQRATAAELLNH 269 (285)
T ss_pred CHHHHHHHHHHcccChhhCcCHHHHccC
Confidence 13456677788887 9999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-36 Score=283.20 Aligned_cols=252 Identities=26% Similarity=0.391 Sum_probs=199.2
Q ss_pred hcCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecC--CchhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEE
Q 005940 352 TKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRN--SLQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVY 429 (668)
Q Consensus 352 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 429 (668)
++.|+..+.||+|.|+.||++.+..+|+.+|+|.+... +....+++.+|+++.+.|+||||++|++...+.+..|+|+
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF 89 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 89 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence 45788889999999999999999999999999987532 3346688899999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCC---CCEEEEeecCceec
Q 005940 430 EYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAE---MNARLGDFGLARLY 506 (668)
Q Consensus 430 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~---~~~kl~DfGla~~~ 506 (668)
|+|.++.|..-+- .+...++...-..++||+++|.|+|. ++|+|||+||.|++|-+. --+||+|||+|..+
T Consensus 90 e~m~G~dl~~eIV---~R~~ySEa~aSH~~rQiLeal~yCH~---n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l 163 (355)
T KOG0033|consen 90 DLVTGGELFEDIV---AREFYSEADASHCIQQILEALAYCHS---NGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEV 163 (355)
T ss_pred ecccchHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHHHh---cCceeccCChhheeeeeccCCCceeecccceEEEe
Confidence 9999999966553 23557888889999999999999999 999999999999999543 34999999999988
Q ss_pred cCCCCCcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCc-hhHHHHHHHHHhcCccccccCccc
Q 005940 507 DHGGMPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGD-LLLVEWVRECHQLGRILDVADPLL 585 (668)
Q Consensus 507 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~-~~l~~~~~~~~~~~~~~~~~d~~l 585 (668)
..+ ......+||++|||||+++..+++..+|||+.||+||-|+.|+.||.+.+ ..+-+ ....+.. + +++..
T Consensus 164 ~~g--~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye----~I~~g~y-d-~~~~~ 235 (355)
T KOG0033|consen 164 NDG--EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYE----QIKAGAY-D-YPSPE 235 (355)
T ss_pred CCc--cccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHH----HHhcccc-C-CCCcc
Confidence 843 23455689999999999999999999999999999999999999997633 22222 1111111 1 12211
Q ss_pred CCcccHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 005940 586 NSSYVVKEMELVLKLGLMCSHKTQFRPTMRQVMRY 620 (668)
Q Consensus 586 ~~~~~~~~~~~l~~l~~~C~~~p~~RPs~~evl~~ 620 (668)
-.. -.++.+.++. .|+.-+|.+|-|+.|.+++
T Consensus 236 w~~-is~~Ak~Lvr--rML~~dP~kRIta~EAL~H 267 (355)
T KOG0033|consen 236 WDT-VTPEAKSLIR--RMLTVNPKKRITADEALKH 267 (355)
T ss_pred cCc-CCHHHHHHHH--HHhccChhhhccHHHHhCC
Confidence 111 2233333333 3455569999999998875
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=291.53 Aligned_cols=204 Identities=28% Similarity=0.398 Sum_probs=179.3
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCch---hHHHHHHHHHHHhcccccCceeEeeeecccCceEEEE
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQ---GMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVY 429 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 429 (668)
+.|+..+.||+|.-|+||++.+..++..+|+|++.+.... ...+...|-+||+.+.||.++.|++.++.....||+|
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m 156 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM 156 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence 3466688999999999999999988899999999886543 4456778999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCC
Q 005940 430 EYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHG 509 (668)
Q Consensus 430 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~ 509 (668)
|||+||+|..++++ +.++.+++..+.-++.+|+.||.|||. .|||+|||||+||||-++|++-|+||.|+......
T Consensus 157 eyCpGGdL~~Lrqk-Qp~~~fse~~aRFYaAEvl~ALEYLHm---lGivYRDLKPENILvredGHIMLsDFDLS~~~~~~ 232 (459)
T KOG0610|consen 157 EYCPGGDLHSLRQK-QPGKRFSESAARFYAAEVLLALEYLHM---LGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVS 232 (459)
T ss_pred ecCCCccHHHHHhh-CCCCccchhhHHHHHHHHHHHHHHHHh---hceeeccCCcceeEEecCCcEEeeeccccccCCCC
Confidence 99999999999874 567889999999999999999999999 99999999999999999999999999987533110
Q ss_pred --------------------------------C-C----------------------CcccccccCCcccCcccccCCCC
Q 005940 510 --------------------------------G-M----------------------PHTTNVVGTFGYIAPELTQTGKA 534 (668)
Q Consensus 510 --------------------------------~-~----------------------~~~~~~~gt~~y~aPE~~~~~~~ 534 (668)
. . ..+...+||-.|+|||++.+...
T Consensus 233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH 312 (459)
T KOG0610|consen 233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH 312 (459)
T ss_pred CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC
Confidence 0 0 01123479999999999999999
Q ss_pred CcchhHHHHHHHHHHHHhCCCCCCCC
Q 005940 535 STSSDVFAYGILLLEVATGRRPIGSG 560 (668)
Q Consensus 535 ~~~sDV~S~Gvvl~elltG~~p~~~~ 560 (668)
+.+.|.|+|||++|||+.|..||.+.
T Consensus 313 gsAVDWWtfGIflYEmLyG~TPFKG~ 338 (459)
T KOG0610|consen 313 GSAVDWWTFGIFLYEMLYGTTPFKGS 338 (459)
T ss_pred CchhhHHHHHHHHHHHHhCCCCcCCC
Confidence 99999999999999999999999765
|
|
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-34 Score=291.31 Aligned_cols=251 Identities=25% Similarity=0.391 Sum_probs=197.1
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecC-----CchhHHHHHHHHHHHhcccccCceeEeeeeccc--Cce
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRN-----SLQGMREFAAEIESLGRLRHKNLVNLHGWCKQK--NDL 425 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~--~~~ 425 (668)
.+|+..+.||+|++|.||+|.+..++..||+|.+... ..+..+.+.+|++++++++|+||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 4788899999999999999999888999999987532 223456788999999999999999999998654 458
Q ss_pred EEEEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCcee
Q 005940 426 LLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARL 505 (668)
Q Consensus 426 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~ 505 (668)
++++||+++++|.+++.. ...+++....+++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||+++.
T Consensus 82 ~~v~e~~~~~~L~~~~~~---~~~l~~~~~~~~~~~i~~al~~LH~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~ 155 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKA---YGALTENVTRRYTRQILQGVSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKR 155 (264)
T ss_pred EEEEEeCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEECccccccc
Confidence 899999999999999852 2358899999999999999999998 9999999999999999999999999999986
Q ss_pred ccCCCC--CcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCc
Q 005940 506 YDHGGM--PHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADP 583 (668)
Q Consensus 506 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~ 583 (668)
...... .......++..|+|||++.+...+.++|||||||++|||++|+.||...... +-+....... ..+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~~~-----~~~ 228 (264)
T cd06653 156 IQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAM--AAIFKIATQP-----TKP 228 (264)
T ss_pred cccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHH--HHHHHHHcCC-----CCC
Confidence 543211 1122346889999999998888999999999999999999999999754211 1111111111 112
Q ss_pred ccCCcccHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 005940 584 LLNSSYVVKEMELVLKLGLMCSHKTQFRPTMRQVMRY 620 (668)
Q Consensus 584 ~l~~~~~~~~~~~l~~l~~~C~~~p~~RPs~~evl~~ 620 (668)
.+..... ..+..+...|+..|..||+..+++.+
T Consensus 229 ~~p~~~~----~~~~~~i~~~l~~~~~r~~~~~~~~~ 261 (264)
T cd06653 229 MLPDGVS----DACRDFLKQIFVEEKRRPTAEFLLRH 261 (264)
T ss_pred CCCcccC----HHHHHHHHHHhcCcccCccHHHHhcC
Confidence 2222222 23445555788888999999998875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=312.27 Aligned_cols=248 Identities=28% Similarity=0.369 Sum_probs=202.3
Q ss_pred cceeeeecCcEEEEEEEeCCCCc---EEEEEEEecCCch-hHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEEec
Q 005940 357 ESEVIGIGGFGSVYKGVLPTTGG---EVAVKKITRNSLQ-GMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEYI 432 (668)
Q Consensus 357 ~~~~lG~G~~g~Vy~~~~~~~~~---~vavK~~~~~~~~-~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~ 432 (668)
..++||+|.||.|++|.|...+. .||||.++.+... .+.+|++|+.+|.+|+|+|+++|+|...+ ..+.+|+|++
T Consensus 114 l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELa 192 (1039)
T KOG0199|consen 114 LYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELA 192 (1039)
T ss_pred HHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhc
Confidence 35789999999999999965433 5999999877654 78899999999999999999999999987 6788999999
Q ss_pred CCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCCCC
Q 005940 433 PNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMP 512 (668)
Q Consensus 433 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~~~ 512 (668)
+.|||.+.|++ ..+..|.......++.|||.||.||.+ ++.|||||-.+|+||-..-.+||+||||.+.+..++..
T Consensus 193 plGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLes---krlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~ 268 (1039)
T KOG0199|consen 193 PLGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLES---KRLVHRDLAARNLLLASPRTVKICDFGLMRALGENEDM 268 (1039)
T ss_pred ccchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhhhheecccceeeeecccceeccCCCCcc
Confidence 99999999986 445678888899999999999999999 99999999999999999999999999999987655432
Q ss_pred ccc--ccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHHHhcCccccccCcccCCcc
Q 005940 513 HTT--NVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVAT-GRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSY 589 (668)
Q Consensus 513 ~~~--~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 589 (668)
... ...-...|+|||.++..+++.++|||+|||.+|||+| |+.||.+..... +++.+|..-+..-
T Consensus 269 Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~q------------IL~~iD~~erLpR 336 (1039)
T KOG0199|consen 269 YVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQ------------ILKNIDAGERLPR 336 (1039)
T ss_pred eEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHH------------HHHhccccccCCC
Confidence 211 1234568999999999999999999999999999999 888987543221 1111121111122
Q ss_pred cHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHh
Q 005940 590 VVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYL 621 (668)
Q Consensus 590 ~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L 621 (668)
...+.+.+..+++.||.. |++||++..|.+.+
T Consensus 337 Pk~csedIY~imk~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 337 PKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred CCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence 233457788899999998 99999999997443
|
|
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-34 Score=291.79 Aligned_cols=256 Identities=30% Similarity=0.379 Sum_probs=199.9
Q ss_pred HHhcCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCchhHHHHHHHHHHHhcc-cccCceeEeeeecccC-----
Q 005940 350 AATKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRL-RHKNLVNLHGWCKQKN----- 423 (668)
Q Consensus 350 ~at~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~----- 423 (668)
.++++|+..+.||+|++|.||+|....+++.+++|++..... ..+++.+|+.+++++ .|+||+++++++....
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence 356889999999999999999999988889999999876543 346789999999999 6999999999996544
Q ss_pred -ceEEEEEecCCCChhhhhcCCC-CCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeec
Q 005940 424 -DLLLVYEYIPNGSLDTLLFKPK-DGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFG 501 (668)
Q Consensus 424 -~~~lV~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfG 501 (668)
..++||||+++++|.+++.... .+..+++..+..++.|++.||.|||+ .+++|+||+|+||++++++.+||+|||
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~---~~i~H~~l~p~ni~~~~~~~~~l~d~~ 158 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHE---NKVIHRDIKGQNILLTKNAEVKLVDFG 158 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHHHEEEccCCeEEECCCc
Confidence 4899999999999999985422 24578999999999999999999998 999999999999999999999999999
Q ss_pred CceeccCCCCCcccccccCCcccCcccccC-----CCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCc
Q 005940 502 LARLYDHGGMPHTTNVVGTFGYIAPELTQT-----GKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGR 576 (668)
Q Consensus 502 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~ 576 (668)
++....... .......++..|+|||.+.. ..++.++|||||||++|||++|+.||...... .-..+..
T Consensus 159 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~~~~~~~---- 231 (275)
T cd06608 159 VSAQLDSTL-GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM--RALFKIP---- 231 (275)
T ss_pred cceecccch-hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchH--HHHHHhh----
Confidence 998654322 22233568899999998753 34678999999999999999999999643211 1111111
Q ss_pred cccccCcccCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 577 ILDVADPLLNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 577 ~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
....+.+.. .......+..+...|+.. |++||++.|++++
T Consensus 232 --~~~~~~~~~--~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~ 272 (275)
T cd06608 232 --RNPPPTLKS--PENWSKKFNDFISECLIKNYEQRPFMEELLEH 272 (275)
T ss_pred --ccCCCCCCc--hhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 101111111 111223455677789876 9999999999874
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-34 Score=299.11 Aligned_cols=203 Identities=28% Similarity=0.396 Sum_probs=170.2
Q ss_pred CcccceeeeecCcEEEEEEEeCC--CCcEEEEEEEecCC---chhHHHHHHHHHHHhcccccCceeEeeeeccc--CceE
Q 005940 354 GFKESEVIGIGGFGSVYKGVLPT--TGGEVAVKKITRNS---LQGMREFAAEIESLGRLRHKNLVNLHGWCKQK--NDLL 426 (668)
Q Consensus 354 ~f~~~~~lG~G~~g~Vy~~~~~~--~~~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~--~~~~ 426 (668)
+|+..++||+|++|.||+|.... ++..||+|.+.... ....+.+.+|+.++++++||||+++++++... ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 47788999999999999999987 78999999997743 33446778899999999999999999999887 7899
Q ss_pred EEEEecCCCChhhhhcCCC--CCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECC----CCCEEEEee
Q 005940 427 LVYEYIPNGSLDTLLFKPK--DGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDA----EMNARLGDF 500 (668)
Q Consensus 427 lV~E~~~~gsL~~~l~~~~--~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~----~~~~kl~Df 500 (668)
+||||+++ +|.+++.... ....+++..++.++.||+.||.|||+ .+|+||||||+||+++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHS---NWVLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHh---CCEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999975 6666653221 22368999999999999999999998 99999999999999999 899999999
Q ss_pred cCceeccCCCC--CcccccccCCcccCcccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 005940 501 GLARLYDHGGM--PHTTNVVGTFGYIAPELTQTG-KASTSSDVFAYGILLLEVATGRRPIGSG 560 (668)
Q Consensus 501 Gla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~sDV~S~Gvvl~elltG~~p~~~~ 560 (668)
|+++....... .......++..|+|||.+.+. .++.++|||||||++|||++|+.||...
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~ 219 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGR 219 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCC
Confidence 99987644322 112234678899999987654 5789999999999999999999999644
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=286.18 Aligned_cols=248 Identities=31% Similarity=0.480 Sum_probs=202.7
Q ss_pred CcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCc--hhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEEe
Q 005940 354 GFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSL--QGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEY 431 (668)
Q Consensus 354 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~ 431 (668)
+|+..+.||+|++|.||+++...+++.|++|.+..... ...+.+.+|++++++++|+|++++++++...+..+++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 47778999999999999999988889999999977654 4567899999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCCC
Q 005940 432 IPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGM 511 (668)
Q Consensus 432 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~~ 511 (668)
+++++|.+++.. ...+++..++.++.|++.||.|||+ .+++||||||+||+++.++.++|+|||++........
T Consensus 81 ~~~~~L~~~~~~---~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 154 (254)
T cd06627 81 AENGSLRQIIKK---FGPFPESLVAVYVYQVLQGLAYLHE---QGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK 154 (254)
T ss_pred CCCCcHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCHHHEEECCCCCEEEeccccceecCCCcc
Confidence 999999999853 2569999999999999999999998 9999999999999999999999999999987765432
Q ss_pred CcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCcccCCcccH
Q 005940 512 PHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSYVV 591 (668)
Q Consensus 512 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 591 (668)
. .....++..|+|||...+...+.++||||+|+++|||++|+.||...+.....|.. .. ... +.+....
T Consensus 155 ~-~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~--~~-~~~-----~~~~~~~-- 223 (254)
T cd06627 155 D-DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRI--VQ-DDH-----PPLPEGI-- 223 (254)
T ss_pred c-ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHH--hc-cCC-----CCCCCCC--
Confidence 1 23346788999999988877899999999999999999999999754422222111 11 111 1111111
Q ss_pred HHHHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 592 KEMELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 592 ~~~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
...+..+...|+.. |++||++.+++.+
T Consensus 224 --~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 251 (254)
T cd06627 224 --SPELKDFLMQCFQKDPNLRPTAKQLLKH 251 (254)
T ss_pred --CHHHHHHHHHHHhCChhhCcCHHHHhcC
Confidence 23445666788886 9999999999863
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=294.45 Aligned_cols=201 Identities=27% Similarity=0.348 Sum_probs=171.5
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCc--hhHHHHHHHHHHHhcccccCceeEeeeeccc--CceEEE
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSL--QGMREFAAEIESLGRLRHKNLVNLHGWCKQK--NDLLLV 428 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~--~~~~lV 428 (668)
++|+..+.||+|++|.||+|.+..+++.+++|.+..... .....+.+|+.++++++||||+++++++... ...++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 468888999999999999999988899999999975432 2234567899999999999999999998776 889999
Q ss_pred EEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccC
Q 005940 429 YEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDH 508 (668)
Q Consensus 429 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~ 508 (668)
|||++ ++|.+++... ...+++.+++.++.||+.||+|||+ .+++||||||+||+++.++.+||+|||+++....
T Consensus 85 ~e~~~-~~L~~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~---~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 158 (293)
T cd07843 85 MEYVE-HDLKSLMETM--KQPFLQSEVKCLMLQLLSGVAHLHD---NWILHRDLKTSNLLLNNRGILKICDFGLAREYGS 158 (293)
T ss_pred ehhcC-cCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHHHEEECCCCcEEEeecCceeeccC
Confidence 99997 5898888532 2368999999999999999999998 8999999999999999999999999999987654
Q ss_pred CCCCcccccccCCcccCcccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 005940 509 GGMPHTTNVVGTFGYIAPELTQTG-KASTSSDVFAYGILLLEVATGRRPIGSG 560 (668)
Q Consensus 509 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDV~S~Gvvl~elltG~~p~~~~ 560 (668)
... ......++..|+|||.+.+. ..+.++|+||||+++|||++|+.||...
T Consensus 159 ~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~ 210 (293)
T cd07843 159 PLK-PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGK 210 (293)
T ss_pred Ccc-ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 321 12234578899999988654 4689999999999999999999999754
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=312.04 Aligned_cols=246 Identities=23% Similarity=0.369 Sum_probs=194.2
Q ss_pred cceeeeecCcEEEEEEEeCCCCcEEEEEEEec----CCchhHHHHHHHHHHHhcccccCceeEeeeecccC--ceEEEEE
Q 005940 357 ESEVIGIGGFGSVYKGVLPTTGGEVAVKKITR----NSLQGMREFAAEIESLGRLRHKNLVNLHGWCKQKN--DLLLVYE 430 (668)
Q Consensus 357 ~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~----~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~--~~~lV~E 430 (668)
...+||+|+|-+||||.+..+|.+||--.++. ......+.|..|+.+|+.|+|+||++++..+.+.. ...+|.|
T Consensus 44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTE 123 (632)
T KOG0584|consen 44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITE 123 (632)
T ss_pred hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeee
Confidence 35689999999999999988898888554432 23355688999999999999999999999886554 4789999
Q ss_pred ecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCC-CCEEEEeecCceeccCC
Q 005940 431 YIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAE-MNARLGDFGLARLYDHG 509 (668)
Q Consensus 431 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~-~~~kl~DfGla~~~~~~ 509 (668)
.|..|+|..|+.+ .+.++...+..|++||++||.|||+ ..++|+|||||..||||+.+ |.+||||+|||......
T Consensus 124 L~TSGtLr~Y~kk---~~~vn~kaik~W~RQILkGL~yLHs-~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s 199 (632)
T KOG0584|consen 124 LFTSGTLREYRKK---HRRVNIKAIKSWCRQILKGLVYLHS-QDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS 199 (632)
T ss_pred cccCCcHHHHHHH---hccCCHHHHHHHHHHHHHHhhhhhc-CCCCccccccccceEEEcCCcCceeecchhHHHHhhcc
Confidence 9999999999964 3458888999999999999999998 46899999999999999987 88999999999987764
Q ss_pred CCCcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCcccCCcc
Q 005940 510 GMPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSY 589 (668)
Q Consensus 510 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 589 (668)
. ...+.||+.|||||+.. ..|.+..||||||++|+||+|+..||..... ..+..++.....+ ...+. ..
T Consensus 200 ~---aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n-~AQIYKKV~SGiK-P~sl~-----kV 268 (632)
T KOG0584|consen 200 H---AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTN-PAQIYKKVTSGIK-PAALS-----KV 268 (632)
T ss_pred c---cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCC-HHHHHHHHHcCCC-HHHhh-----cc
Confidence 3 23478999999999886 6899999999999999999999999975421 1222222222211 11111 11
Q ss_pred cHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 005940 590 VVKEMELVLKLGLMCSHKTQFRPTMRQVMRY 620 (668)
Q Consensus 590 ~~~~~~~l~~l~~~C~~~p~~RPs~~evl~~ 620 (668)
...|+. .++..|+...++||+++|+|++
T Consensus 269 ~dPevr---~fIekCl~~~~~R~sa~eLL~d 296 (632)
T KOG0584|consen 269 KDPEVR---EFIEKCLATKSERLSAKELLKD 296 (632)
T ss_pred CCHHHH---HHHHHHhcCchhccCHHHHhhC
Confidence 122333 4555898888899999999964
|
|
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=287.35 Aligned_cols=242 Identities=26% Similarity=0.340 Sum_probs=195.3
Q ss_pred eeecCcEEEEEEEeCCCCcEEEEEEEecCCc---hhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEEecCCCCh
Q 005940 361 IGIGGFGSVYKGVLPTTGGEVAVKKITRNSL---QGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEYIPNGSL 437 (668)
Q Consensus 361 lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL 437 (668)
||.|++|.||+++...+++.+|+|++.+... ...+.+.+|++++++++|+||+++++.+.++...++|+||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 6899999999999988899999999976432 3446789999999999999999999999999999999999999999
Q ss_pred hhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCCCCccccc
Q 005940 438 DTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNV 517 (668)
Q Consensus 438 ~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~ 517 (668)
.+++.+ ...+++.++..++.||+.||.|||+ .+++|+||||+||+++.++.+||+|||++....... .....
T Consensus 81 ~~~l~~---~~~l~~~~~~~~~~~i~~~l~~lH~---~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~~ 152 (262)
T cd05572 81 WTILRD---RGLFDEYTARFYIACVVLAFEYLHN---RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWTF 152 (262)
T ss_pred HHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--ccccc
Confidence 999953 2458999999999999999999998 999999999999999999999999999998765432 22234
Q ss_pred ccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCcccCCcccHHHHHHH
Q 005940 518 VGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSYVVKEMELV 597 (668)
Q Consensus 518 ~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l 597 (668)
.++..|++||.+....++.++|+||||+++|||++|..||...+....+........... ....... ...+
T Consensus 153 ~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~----~~~~ 223 (262)
T cd05572 153 CGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGK-----LEFPNYI----DKAA 223 (262)
T ss_pred cCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCC-----CCCCccc----CHHH
Confidence 678899999998888899999999999999999999999976543223333322211111 1111111 2345
Q ss_pred HHHHhhcCCC-CCCCCC-----HHHHHH
Q 005940 598 LKLGLMCSHK-TQFRPT-----MRQVMR 619 (668)
Q Consensus 598 ~~l~~~C~~~-p~~RPs-----~~evl~ 619 (668)
..+...|+.. |++||+ ++|+++
T Consensus 224 ~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 224 KDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred HHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 5666688876 999999 777776
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=290.31 Aligned_cols=254 Identities=24% Similarity=0.386 Sum_probs=195.7
Q ss_pred cccceeeeecCcEEEEEEEeCC---CCcEEEEEEEecCC--chhHHHHHHHHHHHhcccccCceeEeeeecccC------
Q 005940 355 FKESEVIGIGGFGSVYKGVLPT---TGGEVAVKKITRNS--LQGMREFAAEIESLGRLRHKNLVNLHGWCKQKN------ 423 (668)
Q Consensus 355 f~~~~~lG~G~~g~Vy~~~~~~---~~~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~------ 423 (668)
|.+.+.||+|+||.||+|.+.. ++..||||++.... ....+++.+|++++++++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 5567899999999999998643 46789999986542 344567889999999999999999999885432
Q ss_pred ceEEEEEecCCCChhhhhcCCC---CCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEee
Q 005940 424 DLLLVYEYIPNGSLDTLLFKPK---DGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDF 500 (668)
Q Consensus 424 ~~~lV~E~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~Df 500 (668)
..++++||+++|+|..++.... ....+++..++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSS---KNFIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccchhhEEEcCCCCEEECcc
Confidence 2478999999999998874221 12357899999999999999999998 89999999999999999999999999
Q ss_pred cCceeccCCCCC-cccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCchh-HHHHHHHHHhcCcc
Q 005940 501 GLARLYDHGGMP-HTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVAT-GRRPIGSGDLL-LVEWVRECHQLGRI 577 (668)
Q Consensus 501 Gla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~-l~~~~~~~~~~~~~ 577 (668)
|+++........ ......++..|++||.+....++.++|||||||++|||++ |+.||...+.. +..+.. .....
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~---~~~~~ 234 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLI---KGNRL 234 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHH---cCCcC
Confidence 999865433211 1122345678999999988888999999999999999999 88888654321 111111 11111
Q ss_pred ccccCcccCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhccC
Q 005940 578 LDVADPLLNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSGE 624 (668)
Q Consensus 578 ~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~~ 624 (668)
.... .....+..++..|+.. |++||++.|+++.|+..
T Consensus 235 ------~~~~----~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 235 ------KQPP----DCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred ------CCCC----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0101 1124567788899987 99999999999999753
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-34 Score=295.89 Aligned_cols=255 Identities=28% Similarity=0.345 Sum_probs=194.4
Q ss_pred CcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCc-hhHHHHHHHHHHHhccc-ccCceeEeeeecccCceEEEEEe
Q 005940 354 GFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSL-QGMREFAAEIESLGRLR-HKNLVNLHGWCKQKNDLLLVYEY 431 (668)
Q Consensus 354 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~lV~E~ 431 (668)
+|...++||+|+||.||++.+..+++.+|+|++..... .....+.+|+.++.++. |+||+++++++..++..+++|||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 45567889999999999999988899999999875432 34567889999999996 99999999999999999999999
Q ss_pred cCCCChhhhhcC--CCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCC
Q 005940 432 IPNGSLDTLLFK--PKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHG 509 (668)
Q Consensus 432 ~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~ 509 (668)
+. ++|.++... ......+++..+..++.|++.||+|||+ +.+++||||||+||+++.++.+||+|||+++.....
T Consensus 85 ~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~--~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 161 (288)
T cd06616 85 MD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS 161 (288)
T ss_pred cc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh--cCCeeccCCCHHHEEEccCCcEEEeecchhHHhccC
Confidence 86 455443311 1223568999999999999999999997 259999999999999999999999999999765432
Q ss_pred CCCcccccccCCcccCcccccCC---CCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCcccC
Q 005940 510 GMPHTTNVVGTFGYIAPELTQTG---KASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLN 586 (668)
Q Consensus 510 ~~~~~~~~~gt~~y~aPE~~~~~---~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 586 (668)
.. .....|+..|+|||.+.+. .++.++|||||||++|||++|+.||..... ..+...+... ...+.+.
T Consensus 162 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-~~~~~~~~~~------~~~~~~~ 232 (288)
T cd06616 162 IA--KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS-VFDQLTQVVK------GDPPILS 232 (288)
T ss_pred Cc--cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch-HHHHHhhhcC------CCCCcCC
Confidence 21 1233678899999998765 688999999999999999999999965431 1111111111 1112221
Q ss_pred CcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 587 SSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 587 ~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
..........+..+...|++. |++||++++|+++
T Consensus 233 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 233 NSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred CcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111111223456667789887 9999999999975
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=292.48 Aligned_cols=254 Identities=27% Similarity=0.388 Sum_probs=204.0
Q ss_pred HHhcCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCchhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEE
Q 005940 350 AATKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVY 429 (668)
Q Consensus 350 ~at~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 429 (668)
..++.|...+.||+|++|.||+|.+..++..+++|++..... ..+.+.+|++++++++|+|++++++.+......++|+
T Consensus 16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 94 (286)
T cd06614 16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVM 94 (286)
T ss_pred CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEE
Confidence 345678889999999999999999987899999999976554 5577889999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCC
Q 005940 430 EYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHG 509 (668)
Q Consensus 430 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~ 509 (668)
||+++++|.+++.... ..+++..++.++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++......
T Consensus 95 e~~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~---~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 169 (286)
T cd06614 95 EYMDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHS---QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKE 169 (286)
T ss_pred eccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCChhhEEEcCCCCEEECccchhhhhccc
Confidence 9999999999996422 479999999999999999999998 99999999999999999999999999998755432
Q ss_pred CCCcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCcccCCcc
Q 005940 510 GMPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSY 589 (668)
Q Consensus 510 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 589 (668)
.. ......++..|++||.+.+..++.++||||||+++|||++|+.||...+.... ...... .......++. .+
T Consensus 170 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~--~~~~~~-~~~~~~~~~~---~~ 242 (286)
T cd06614 170 KS-KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRA--LFLITT-KGIPPLKNPE---KW 242 (286)
T ss_pred hh-hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHh-cCCCCCcchh---hC
Confidence 21 22234578899999999888899999999999999999999999975432211 111111 1111111110 01
Q ss_pred cHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 590 VVKEMELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 590 ~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
+ ..+..+...|+.. |.+||++.+|+++
T Consensus 243 ~----~~l~~li~~~l~~~p~~Rpt~~~il~~ 270 (286)
T cd06614 243 S----PEFKDFLNKCLVKDPEKRPSAEELLQH 270 (286)
T ss_pred C----HHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 1 3355667789888 9999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=291.47 Aligned_cols=200 Identities=33% Similarity=0.418 Sum_probs=171.0
Q ss_pred cccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCc--hhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEEec
Q 005940 355 FKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSL--QGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEYI 432 (668)
Q Consensus 355 f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~ 432 (668)
|+..+.||.|++|.||+|.+..++..||+|++..... ...+.+.+|++++++++|+|++++++++.+.+..+++|||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 5678899999999999999988899999999875432 23457889999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCCCC
Q 005940 433 PNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMP 512 (668)
Q Consensus 433 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~~~ 512 (668)
+ ++|.+++.... ...+++..++.++.|+++||.|||+ .+++||||+|+||+++.++.++|+|||+++.......
T Consensus 81 ~-~~l~~~~~~~~-~~~~~~~~~~~~~~~i~~~L~~lH~---~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~- 154 (283)
T cd07835 81 D-LDLKKYMDSSP-LTGLDPPLIKSYLYQLLQGIAYCHS---HRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR- 154 (283)
T ss_pred C-cCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc-
Confidence 5 68999885322 2468999999999999999999998 8999999999999999999999999999976543221
Q ss_pred cccccccCCcccCcccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 005940 513 HTTNVVGTFGYIAPELTQTG-KASTSSDVFAYGILLLEVATGRRPIGSG 560 (668)
Q Consensus 513 ~~~~~~gt~~y~aPE~~~~~-~~~~~sDV~S~Gvvl~elltG~~p~~~~ 560 (668)
......++..|+|||++.+. .++.++||||||+++|||++|+.||...
T Consensus 155 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 203 (283)
T cd07835 155 TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGD 203 (283)
T ss_pred ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 11223568899999987654 4688999999999999999999999754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=292.58 Aligned_cols=264 Identities=29% Similarity=0.329 Sum_probs=196.6
Q ss_pred HHhcCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCc--hhHHHHHHHHHHHhcccccCceeEeeeecccC----
Q 005940 350 AATKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSL--QGMREFAAEIESLGRLRHKNLVNLHGWCKQKN---- 423 (668)
Q Consensus 350 ~at~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~---- 423 (668)
.+.++|++.+.||+|++|.||+|+++.+++.||+|++..... .....+.+|++++++++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 345789999999999999999999988899999999975432 23356778999999999999999999987654
Q ss_pred ------ceEEEEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEE
Q 005940 424 ------DLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARL 497 (668)
Q Consensus 424 ------~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl 497 (668)
..++|+||+++ +|...+.. ....+++.+++.++.|++.||+|||+ .+|+||||||+||++++++.+||
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~---~~i~H~dl~p~nili~~~~~~kl 157 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLES--GLVHFSEDHIKSFMKQLLEGLNYCHK---KNFLHRDIKCSNILLNNKGQIKL 157 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCcEEe
Confidence 78999999976 67676642 23468999999999999999999999 99999999999999999999999
Q ss_pred EeecCceeccCCCCCcccccccCCcccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCchh-HHHHHHHHHhcC
Q 005940 498 GDFGLARLYDHGGMPHTTNVVGTFGYIAPELTQT-GKASTSSDVFAYGILLLEVATGRRPIGSGDLL-LVEWVRECHQLG 575 (668)
Q Consensus 498 ~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~-l~~~~~~~~~~~ 575 (668)
+|||++...............++..|+|||.+.+ ...+.++|||||||++|||++|+.||...+.. ....+.+.....
T Consensus 158 ~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~ 237 (302)
T cd07864 158 ADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSP 237 (302)
T ss_pred CcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence 9999998765443222233356778999998754 45789999999999999999999999754311 111111111100
Q ss_pred cc---ccc--------cCc------ccCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 576 RI---LDV--------ADP------LLNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 576 ~~---~~~--------~d~------~l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
.. ... .++ .....+. .....+..+...|++. |++||++++|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 238 CPAVWPDVIKLPYFNTMKPKKQYRRRLREEFS-FIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred ChhhcccccccccccccccccccccchhhhcC-CCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 00 000 000 0000000 0013455666788887 9999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=290.94 Aligned_cols=250 Identities=26% Similarity=0.364 Sum_probs=208.1
Q ss_pred CcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCchhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEEecC
Q 005940 354 GFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEYIP 433 (668)
Q Consensus 354 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~ 433 (668)
-|.+.++||+|.||.|||+.++.+|..+|||++..++ ..+++..|+.++++++.|++|+++|.+.....+++|||||.
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s--DLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCG 111 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT--DLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCG 111 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc--hHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcC
Confidence 4677899999999999999999999999999987653 56889999999999999999999999999999999999999
Q ss_pred CCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCCCCc
Q 005940 434 NGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPH 513 (668)
Q Consensus 434 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 513 (668)
.|+..++++ ..+++|++.++..++++-+.||+|||. ..-+|||||+.||||+.+|.+||+|||.|..+.+.. ..
T Consensus 112 AGSiSDI~R--~R~K~L~E~EIs~iL~~TLKGL~YLH~---~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTM-AK 185 (502)
T KOG0574|consen 112 AGSISDIMR--ARRKPLSEQEISAVLRDTLKGLQYLHD---LKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTM-AK 185 (502)
T ss_pred CCcHHHHHH--HhcCCccHHHHHHHHHHHHhHHHHHHH---HHHHHhhcccccEEEcccchhhhhhccccchhhhhH-Hh
Confidence 999999995 356789999999999999999999998 888999999999999999999999999998766533 34
Q ss_pred ccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCcccCCcccHHH
Q 005940 514 TTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSYVVKE 593 (668)
Q Consensus 514 ~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 593 (668)
+..+.||+.|||||++..-.|..++||||+|+...||.-|+.||.+ ...+..+ --+..-..|..+ ...+.
T Consensus 186 RNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsD--IHPMRAI------FMIPT~PPPTF~--KPE~W 255 (502)
T KOG0574|consen 186 RNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSD--IHPMRAI------FMIPTKPPPTFK--KPEEW 255 (502)
T ss_pred hCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccc--cccccee------EeccCCCCCCCC--ChHhh
Confidence 4557899999999999988999999999999999999999999863 1111000 000111112221 22334
Q ss_pred HHHHHHHHhhcCCC-CCCCCCHHHHHHHh
Q 005940 594 MELVLKLGLMCSHK-TQFRPTMRQVMRYL 621 (668)
Q Consensus 594 ~~~l~~l~~~C~~~-p~~RPs~~evl~~L 621 (668)
...+..+...|+-. |++|-++-+++++-
T Consensus 256 S~~F~DFi~~CLiK~PE~R~TA~~L~~H~ 284 (502)
T KOG0574|consen 256 SSEFNDFIRSCLIKKPEERKTALRLCEHT 284 (502)
T ss_pred hhHHHHHHHHHhcCCHHHHHHHHHHhhhh
Confidence 55677777889877 99999999999873
|
|
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=287.06 Aligned_cols=249 Identities=26% Similarity=0.362 Sum_probs=202.8
Q ss_pred CcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCC--chhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEEe
Q 005940 354 GFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNS--LQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEY 431 (668)
Q Consensus 354 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~ 431 (668)
+|+..++||+|++|.||+++...+++.+++|.+.... .....++..|++++++++|+||+++++.+......++||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 4778899999999999999998889999999987543 23456788999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCC-CCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCC
Q 005940 432 IPNGSLDTLLFKPK-DGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGG 510 (668)
Q Consensus 432 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~ 510 (668)
+++++|.+++.+.. .+..+++..++.++.|++.||+|||+ .+++|+||+|+||++++++.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~---~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 157 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHE---QKILHRDLKSANILLVANDLVKIGDLGISKVLKKNM 157 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCcceEEEecCCcEEEeeccchhhhccCC
Confidence 99999999985422 23568999999999999999999998 999999999999999999999999999998766542
Q ss_pred CCcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCcccCCccc
Q 005940 511 MPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSYV 590 (668)
Q Consensus 511 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 590 (668)
.....++..|++||.+.+..++.++|+||||+++|||++|+.||...+..... .......... +.
T Consensus 158 ---~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~---~~~~~~~~~~-----~~---- 222 (256)
T cd08530 158 ---AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLR---YKVQRGKYPP-----IP---- 222 (256)
T ss_pred ---cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHhcCCCCC-----Cc----
Confidence 22245788999999998888999999999999999999999999765432111 1111111111 11
Q ss_pred HHHHHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 591 VKEMELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 591 ~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
......+..+...|++. |++||++.|++++
T Consensus 223 ~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 223 PIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred hhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 12223466677788876 9999999999975
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=299.97 Aligned_cols=261 Identities=25% Similarity=0.312 Sum_probs=195.5
Q ss_pred hcCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCC-chhHHHHHHHHHHHhcccccCceeEeeeeccc-----Cce
Q 005940 352 TKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNS-LQGMREFAAEIESLGRLRHKNLVNLHGWCKQK-----NDL 425 (668)
Q Consensus 352 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~-----~~~ 425 (668)
+++|++.++||+|++|.||+|++..+++.||||++.... ......+..|+.++++++|+||+++++++... ...
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 468999999999999999999998889999999986432 23456788999999999999999999987543 357
Q ss_pred EEEEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCcee
Q 005940 426 LLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARL 505 (668)
Q Consensus 426 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~ 505 (668)
++|+||++ ++|.+++. ...+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||++..
T Consensus 84 ~lv~e~~~-~~l~~~~~----~~~l~~~~~~~i~~ql~~aL~~LH~---~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~ 155 (336)
T cd07849 84 YIVQELME-TDLYKLIK----TQHLSNDHIQYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTNCDLKICDFGLARI 155 (336)
T ss_pred EEEehhcc-cCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEECCCCCEEECcccceee
Confidence 99999996 47877774 2458999999999999999999999 9999999999999999999999999999986
Q ss_pred ccCCCCC--cccccccCCcccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCchh-HHHHHHHHHhcCcc---c
Q 005940 506 YDHGGMP--HTTNVVGTFGYIAPELTQT-GKASTSSDVFAYGILLLEVATGRRPIGSGDLL-LVEWVRECHQLGRI---L 578 (668)
Q Consensus 506 ~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~-l~~~~~~~~~~~~~---~ 578 (668)
....... ......|+..|+|||.+.+ ..++.++|||||||++|||++|+.||...+.. ...+.......... .
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (336)
T cd07849 156 ADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLN 235 (336)
T ss_pred ccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHH
Confidence 5432211 1123468899999998654 46889999999999999999999999654321 11111111110000 0
Q ss_pred cccC-------------cccCC-cccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 579 DVAD-------------PLLNS-SYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 579 ~~~d-------------~~l~~-~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
...+ +.... .........+..++..|++. |++||++.|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 236 CIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred HhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0000 00000 00001123456777789887 9999999999987
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=295.52 Aligned_cols=252 Identities=28% Similarity=0.399 Sum_probs=197.8
Q ss_pred cccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCC---chhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEEe
Q 005940 355 FKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNS---LQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEY 431 (668)
Q Consensus 355 f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~ 431 (668)
|...+.||+|+||.||++++..++..+|+|++.... .+..+.+.+|++++++++|+|++++++++.+....++||||
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 106 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY 106 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence 667889999999999999998889999999987542 23346788999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCCC
Q 005940 432 IPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGM 511 (668)
Q Consensus 432 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~~ 511 (668)
++ |+|.+++.. ....++|.++..++.|++.||.|||+ .+++||||+|+||+++.++.+||+|||++......
T Consensus 107 ~~-g~l~~~~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~---~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~-- 178 (317)
T cd06635 107 CL-GSASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASIASPA-- 178 (317)
T ss_pred CC-CCHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcccEEECCCCCEEEecCCCccccCCc--
Confidence 96 577777742 24568999999999999999999998 99999999999999999999999999998754432
Q ss_pred CcccccccCCcccCccccc---CCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCcccCCc
Q 005940 512 PHTTNVVGTFGYIAPELTQ---TGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSS 588 (668)
Q Consensus 512 ~~~~~~~gt~~y~aPE~~~---~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 588 (668)
....++..|+|||++. .+.++.++|||||||++|||++|+.||...+.. ........... +.....
T Consensus 179 ---~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~--~~~~~~~~~~~------~~~~~~ 247 (317)
T cd06635 179 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM--SALYHIAQNES------PTLQSN 247 (317)
T ss_pred ---ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHH--HHHHHHHhccC------CCCCCc
Confidence 2346788999999873 456889999999999999999999998653211 11111111111 111111
Q ss_pred ccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhccCcCCC
Q 005940 589 YVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSGEKQLR 628 (668)
Q Consensus 589 ~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~~~~~~ 628 (668)
.....+..++..|++. |++||++.+|++++-.....+
T Consensus 248 ---~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~ 285 (317)
T cd06635 248 ---EWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRERP 285 (317)
T ss_pred ---cccHHHHHHHHHHccCCcccCcCHHHHHhChhhhccCc
Confidence 1123455667789987 999999999999865544333
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=291.35 Aligned_cols=261 Identities=24% Similarity=0.262 Sum_probs=193.4
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCc--hhHHHHHHHHHHHhccc-ccCceeEeeeecccCc-----
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSL--QGMREFAAEIESLGRLR-HKNLVNLHGWCKQKND----- 424 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~~~----- 424 (668)
++|+..+.||+|+||.||+|.+..+++.||+|++..... .....+.+|+.++++++ |+||+++++.+.....
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 468889999999999999999988899999999865432 23457888999999995 6999999999876655
Q ss_pred eEEEEEecCCCChhhhhcCCCC--CCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECC-CCCEEEEeec
Q 005940 425 LLLVYEYIPNGSLDTLLFKPKD--GSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDA-EMNARLGDFG 501 (668)
Q Consensus 425 ~~lV~E~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~-~~~~kl~DfG 501 (668)
.|+||||+++ +|.+++..... ...+++..++.++.||+.||.|||+ .+|+||||||+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~---~~i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHK---HGVMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChHHEEEecCCCeEEEeecc
Confidence 8999999985 78888753221 3568999999999999999999998 99999999999999998 8899999999
Q ss_pred CceeccCCCCCcccccccCCcccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhc-Ccccc
Q 005940 502 LARLYDHGGMPHTTNVVGTFGYIAPELTQT-GKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQL-GRILD 579 (668)
Q Consensus 502 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~-~~~~~ 579 (668)
+++....... ......+++.|+|||++.+ ..++.++||||||+++|||++|..||...+.. +........ .....
T Consensus 157 ~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~--~~~~~~~~~~~~~~~ 233 (295)
T cd07837 157 LGRAFSIPVK-SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSEL--QQLLHIFKLLGTPTE 233 (295)
T ss_pred cceecCCCcc-ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHH--HHHHHHHHHhCCCCh
Confidence 9986543221 1222356788999998765 45789999999999999999999999654321 111111110 00000
Q ss_pred ccC------------cccCC----cccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 580 VAD------------PLLNS----SYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 580 ~~d------------~~l~~----~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
... +.... .........+..+...|+.. |++||+++|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~ 291 (295)
T cd07837 234 QVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291 (295)
T ss_pred hhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 000 00000 00001123455666788887 9999999999874
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=290.87 Aligned_cols=202 Identities=29% Similarity=0.389 Sum_probs=169.6
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCc--hhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEE
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSL--QGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYE 430 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 430 (668)
++|+..+.||+|++|.||+|.+..+++.||+|++..... ...+.+.+|++++++++|+||+++++++......++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 468889999999999999999988899999999865432 334678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECC-CCCEEEEeecCceeccCC
Q 005940 431 YIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDA-EMNARLGDFGLARLYDHG 509 (668)
Q Consensus 431 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~-~~~~kl~DfGla~~~~~~ 509 (668)
|++ ++|.+++.. .....+++..+..++.||+.||+|||+ .+++||||+|+||+++. +..+||+|||++......
T Consensus 82 ~~~-~~l~~~~~~-~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~ 156 (294)
T PLN00009 82 YLD-LDLKKHMDS-SPDFAKNPRLIKTYLYQILRGIAYCHS---HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP 156 (294)
T ss_pred ccc-ccHHHHHHh-CCCCCcCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCcceEEEECCCCEEEEcccccccccCCC
Confidence 996 578777743 223346888899999999999999998 99999999999999985 457999999999765432
Q ss_pred CCCcccccccCCcccCcccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 005940 510 GMPHTTNVVGTFGYIAPELTQTG-KASTSSDVFAYGILLLEVATGRRPIGSG 560 (668)
Q Consensus 510 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDV~S~Gvvl~elltG~~p~~~~ 560 (668)
. .......++..|+|||++.+. .++.++|||||||++|||++|+.||...
T Consensus 157 ~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~ 207 (294)
T PLN00009 157 V-RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGD 207 (294)
T ss_pred c-cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 1 112234578899999988654 5789999999999999999999999754
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-33 Score=297.89 Aligned_cols=200 Identities=28% Similarity=0.378 Sum_probs=171.9
Q ss_pred HhcCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecC--CchhHHHHHHHHHHHhcccccCceeEeeeeccc------
Q 005940 351 ATKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRN--SLQGMREFAAEIESLGRLRHKNLVNLHGWCKQK------ 422 (668)
Q Consensus 351 at~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~------ 422 (668)
..++|+..+.||+|+||.||+|....+++.||||++.+. ......++.+|+.++++++|+||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 347899999999999999999999889999999998653 233456778899999999999999999988543
Q ss_pred CceEEEEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecC
Q 005940 423 NDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGL 502 (668)
Q Consensus 423 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGl 502 (668)
...++||||+. ++|.+.+.. .+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||+
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~~-----~l~~~~~~~~~~ql~~aL~~LH~---~gi~H~dlkp~Nil~~~~~~~kL~Dfg~ 164 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQM-----DLDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGL 164 (353)
T ss_pred CcEEEEEeccC-CCHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEccCcc
Confidence 35799999995 588887742 28899999999999999999999 9999999999999999999999999999
Q ss_pred ceeccCCCCCcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCc
Q 005940 503 ARLYDHGGMPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGD 561 (668)
Q Consensus 503 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~ 561 (668)
++....... .....++..|+|||.+.+..++.++|||||||++|+|++|+.||...+
T Consensus 165 ~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~ 221 (353)
T cd07850 165 ARTAGTSFM--MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTD 221 (353)
T ss_pred ceeCCCCCC--CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCC
Confidence 987654322 223467889999999998899999999999999999999999997543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-33 Score=288.15 Aligned_cols=258 Identities=28% Similarity=0.319 Sum_probs=198.6
Q ss_pred cccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCch--hHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEEec
Q 005940 355 FKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQ--GMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEYI 432 (668)
Q Consensus 355 f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~ 432 (668)
|+..+.||+|++|.||+|....+++.+++|++...... ....+..|++++++++|+||+++++++..+...++|+||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 56678999999999999999888999999998765332 4567889999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCCCC
Q 005940 433 PNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMP 512 (668)
Q Consensus 433 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~~~ 512 (668)
++ +|.+++.. ....+++.++..++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||.+....... .
T Consensus 81 ~~-~l~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-~ 153 (283)
T cd05118 81 DT-DLYKLIKD--RQRGLPESLIKSYLYQLLQGLAFCHS---HGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-R 153 (283)
T ss_pred CC-CHHHHHHh--hcccCCHHHHHHHHHHHHHHHHHHHH---CCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-c
Confidence 75 88888853 22568999999999999999999998 999999999999999999999999999998765543 1
Q ss_pred cccccccCCcccCcccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCccc------
Q 005940 513 HTTNVVGTFGYIAPELTQTG-KASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLL------ 585 (668)
Q Consensus 513 ~~~~~~gt~~y~aPE~~~~~-~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l------ 585 (668)
......++..|+|||.+.+. .++.++||||||+++|+|++|+.||...+.. ..........+.......+..
T Consensus 154 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd05118 154 PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEI-DQLFKIFRTLGTPDPEVWPKFTSLARN 232 (283)
T ss_pred cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHcCCCchHhcccchhhhhh
Confidence 22234578899999998776 7899999999999999999999999654321 111111000000000000000
Q ss_pred -----C-------CcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 586 -----N-------SSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 586 -----~-------~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
. ..........+..+...|++. |.+||++++++.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 233 YKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred hhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 0 000111234567788899987 9999999999874
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-33 Score=283.00 Aligned_cols=251 Identities=27% Similarity=0.449 Sum_probs=204.7
Q ss_pred CcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCc--hhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEEe
Q 005940 354 GFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSL--QGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEY 431 (668)
Q Consensus 354 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~ 431 (668)
+|+..+.||.|++|.||++.+..++..+++|++..... ...+++.+|++++++++|+|++++++.+......++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 47788999999999999999988899999999976543 4567789999999999999999999999988999999999
Q ss_pred cCCCChhhhhcCCC-CCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCC
Q 005940 432 IPNGSLDTLLFKPK-DGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGG 510 (668)
Q Consensus 432 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~ 510 (668)
+++++|.+++.... ....+++..+..++.+++.||.|||+ .+++|+||+|+||+++.++.++|+|||.+.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~---~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHS---RKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHh---CCEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 99999999996422 24679999999999999999999999 899999999999999999999999999998765543
Q ss_pred CCcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCcccCCccc
Q 005940 511 MPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSYV 590 (668)
Q Consensus 511 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 590 (668)
.......|+..|+|||......++.++||||+|+++++|++|+.||...+. .+....... ... +.+...+.
T Consensus 158 -~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~--~~~~~~~~~-~~~-----~~~~~~~~ 228 (258)
T cd08215 158 -DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENL--LELALKILK-GQY-----PPIPSQYS 228 (258)
T ss_pred -ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcH--HHHHHHHhc-CCC-----CCCCCCCC
Confidence 122334688899999999888899999999999999999999999975432 222222211 111 11111122
Q ss_pred HHHHHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 591 VKEMELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 591 ~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
..+..+...|+.. |++||+++|++++
T Consensus 229 ----~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 229 ----SELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred ----HHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 3455666788887 9999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-33 Score=287.27 Aligned_cols=257 Identities=24% Similarity=0.225 Sum_probs=192.0
Q ss_pred cccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCc-hhHHHHHHHHHHHhccc-ccCceeEeeeeccc--CceEEEEE
Q 005940 355 FKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSL-QGMREFAAEIESLGRLR-HKNLVNLHGWCKQK--NDLLLVYE 430 (668)
Q Consensus 355 f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~--~~~~lV~E 430 (668)
|+..++||+|+||.||+|....++..||+|++..... ........|+.++.++. |+|++++++++.+. +..++|+|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 5678899999999999999988899999999875422 22234457888999885 99999999999877 88999999
Q ss_pred ecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCC
Q 005940 431 YIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGG 510 (668)
Q Consensus 431 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~ 510 (668)
|++ ++|.+.+.. ....++|.+++.++.|++.||.|||+ .+++||||||+||+++. +.+||+|||+++......
T Consensus 81 ~~~-~~l~~~l~~--~~~~~~~~~~~~~~~qi~~~L~~LH~---~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~ 153 (282)
T cd07831 81 LMD-MNLYELIKG--RKRPLPEKRVKSYMYQLLKSLDHMHR---NGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKP 153 (282)
T ss_pred cCC-ccHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHH---CCceecccCHHHEEEcC-CCeEEEecccccccccCC
Confidence 996 578777743 23568999999999999999999998 99999999999999999 999999999998764332
Q ss_pred CCcccccccCCcccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCch-hHHHHHHHHHh-----------cCcc
Q 005940 511 MPHTTNVVGTFGYIAPELTQT-GKASTSSDVFAYGILLLEVATGRRPIGSGDL-LLVEWVRECHQ-----------LGRI 577 (668)
Q Consensus 511 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~-~l~~~~~~~~~-----------~~~~ 577 (668)
. .....++..|+|||++.. +..+.++|||||||++|||++|..||...+. ....+...... ....
T Consensus 154 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (282)
T cd07831 154 P--YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRH 231 (282)
T ss_pred C--cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhccccc
Confidence 2 123457889999997644 5578999999999999999999999965432 22222221110 0011
Q ss_pred ccccCcccCCc----ccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 578 LDVADPLLNSS----YVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 578 ~~~~d~~l~~~----~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
.....+..... ........+..+...|+.. |++||++++++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 232 MNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred ccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 11001100000 0011234566777788887 9999999999975
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=306.98 Aligned_cols=197 Identities=29% Similarity=0.376 Sum_probs=173.4
Q ss_pred CcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCchhHHHHHHHHHHHhccc-c-----cCceeEeeeecccCceEE
Q 005940 354 GFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLR-H-----KNLVNLHGWCKQKNDLLL 427 (668)
Q Consensus 354 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~-H-----~nIv~l~g~~~~~~~~~l 427 (668)
+|.+.+.||+|.||.|-||.+..+++.||||++++.. .-.++-..|+++|.+|+ | -|+|++++++..++++||
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci 265 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI 265 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence 7889999999999999999999999999999997654 33456678999999997 4 499999999999999999
Q ss_pred EEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCC--CCEEEEeecCcee
Q 005940 428 VYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAE--MNARLGDFGLARL 505 (668)
Q Consensus 428 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~--~~~kl~DfGla~~ 505 (668)
|+|.+ ..+|.++|+.. .-..++...+..|+.||+.||.+||+ .+|||+||||+||||.+. ..+||+|||.++.
T Consensus 266 VfELL-~~NLYellK~n-~f~Glsl~~ir~~~~Qil~~L~~L~~---l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~ 340 (586)
T KOG0667|consen 266 VFELL-STNLYELLKNN-KFRGLSLPLVRKFAQQILTALLFLHE---LGIIHCDLKPENILLKDPKRSRIKVIDFGSSCF 340 (586)
T ss_pred eehhh-hhhHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCChhheeeccCCcCceeEEecccccc
Confidence 99999 56999999743 34569999999999999999999998 999999999999999764 4699999999997
Q ss_pred ccCCCCCcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 005940 506 YDHGGMPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSG 560 (668)
Q Consensus 506 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~ 560 (668)
..+... ...-+..|.|||++.+.+|..+.||||||||+.||++|..-|.+.
T Consensus 341 ~~q~vy----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ 391 (586)
T KOG0667|consen 341 ESQRVY----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGD 391 (586)
T ss_pred cCCcce----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCC
Confidence 665332 456788999999999999999999999999999999998777554
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-34 Score=299.94 Aligned_cols=250 Identities=24% Similarity=0.384 Sum_probs=203.4
Q ss_pred ccceeeeecCcEEEEEEEeCCC--C--cEEEEEEEecC-CchhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEE
Q 005940 356 KESEVIGIGGFGSVYKGVLPTT--G--GEVAVKKITRN-SLQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYE 430 (668)
Q Consensus 356 ~~~~~lG~G~~g~Vy~~~~~~~--~--~~vavK~~~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 430 (668)
...++||+|-||.||+|+.... | -.||||..+.+ .....+.|++|..+|++++||||++|+|.|.+. ..++|||
T Consensus 392 tl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~WivmE 470 (974)
T KOG4257|consen 392 TLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMWIVME 470 (974)
T ss_pred cHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-ceeEEEe
Confidence 4467899999999999987432 2 35999988774 345678899999999999999999999999764 5899999
Q ss_pred ecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCC
Q 005940 431 YIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGG 510 (668)
Q Consensus 431 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~ 510 (668)
.++-|-|..+|.. +...|+......++.||+.||+|||+ ...|||||-.+|||+.+...+||+|||++|.++...
T Consensus 471 L~~~GELr~yLq~--nk~sL~l~tL~ly~~Qi~talaYLeS---krfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~ 545 (974)
T KOG4257|consen 471 LAPLGELREYLQQ--NKDSLPLRTLTLYCYQICTALAYLES---KRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDA 545 (974)
T ss_pred cccchhHHHHHHh--ccccchHHHHHHHHHHHHHHHHHHHh---hchhhhhhhhhheeecCcceeeecccchhhhccccc
Confidence 9999999999964 45568999999999999999999999 999999999999999999999999999999998776
Q ss_pred CCcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHHHhcCccccccCcccCCcc
Q 005940 511 MPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVAT-GRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSY 589 (668)
Q Consensus 511 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 589 (668)
.-......-+..|||||.+.-.+++.++|||-|||++|||+. |.+||.+-. ...+.-.+...-+..+
T Consensus 546 yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvk------------NsDVI~~iEnGeRlP~ 613 (974)
T KOG4257|consen 546 YYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVK------------NSDVIGHIENGERLPC 613 (974)
T ss_pred hhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCcccccc------------ccceEEEecCCCCCCC
Confidence 555554555778999999998999999999999999999988 999996421 1111111111111123
Q ss_pred cHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhcc
Q 005940 590 VVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSG 623 (668)
Q Consensus 590 ~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~ 623 (668)
++.+.-.+..++..||.. |.+||.+.|+...|..
T Consensus 614 P~nCPp~LYslmskcWayeP~kRPrftei~~~lsd 648 (974)
T KOG4257|consen 614 PPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSD 648 (974)
T ss_pred CCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHH
Confidence 333445667888899998 9999999999887754
|
|
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-33 Score=290.39 Aligned_cols=202 Identities=30% Similarity=0.416 Sum_probs=168.6
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCc--hhHHHHHHHHHHHhcccccCceeEeeeecccC-------
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSL--QGMREFAAEIESLGRLRHKNLVNLHGWCKQKN------- 423 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~------- 423 (668)
++|+..++||+|++|.||+|....+++.||||++..... .....+.+|++++++++||||++++++|....
T Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 91 (310)
T cd07865 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYK 91 (310)
T ss_pred hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCC
Confidence 468899999999999999999988899999999865432 22345678999999999999999999986543
Q ss_pred -ceEEEEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecC
Q 005940 424 -DLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGL 502 (668)
Q Consensus 424 -~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGl 502 (668)
..++||||+. ++|.+.+.. ....+++.+++.++.||+.||.|||+ .+++|+||||+||+++.++.+||+|||+
T Consensus 92 ~~~~lv~e~~~-~~l~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~ 165 (310)
T cd07865 92 GSFYLVFEFCE-HDLAGLLSN--KNVKFTLSEIKKVMKMLLNGLYYIHR---NKILHRDMKAANILITKDGILKLADFGL 165 (310)
T ss_pred ceEEEEEcCCC-cCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEECCCCcEEECcCCC
Confidence 4599999996 478887742 23468999999999999999999998 8999999999999999999999999999
Q ss_pred ceeccCCCCC---cccccccCCcccCcccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 005940 503 ARLYDHGGMP---HTTNVVGTFGYIAPELTQTG-KASTSSDVFAYGILLLEVATGRRPIGSG 560 (668)
Q Consensus 503 a~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~sDV~S~Gvvl~elltG~~p~~~~ 560 (668)
+......... ......++..|+|||++.+. .++.++||||||+++|||++|+.||...
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~ 227 (310)
T cd07865 166 ARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGN 227 (310)
T ss_pred cccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCC
Confidence 9866433221 11234578889999987654 3688999999999999999999999754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-33 Score=288.14 Aligned_cols=242 Identities=25% Similarity=0.314 Sum_probs=184.7
Q ss_pred eeeecCcEEEEEEEeCCCCcEEEEEEEecCCc---hhHHHHHHHHHHHh---cccccCceeEeeeecccCceEEEEEecC
Q 005940 360 VIGIGGFGSVYKGVLPTTGGEVAVKKITRNSL---QGMREFAAEIESLG---RLRHKNLVNLHGWCKQKNDLLLVYEYIP 433 (668)
Q Consensus 360 ~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~f~~Ei~~l~---~l~H~nIv~l~g~~~~~~~~~lV~E~~~ 433 (668)
.||+|+||.||++....+++.+|+|.+.+... .....+.+|..+++ ..+|+||+.+++.+...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 48999999999999988899999999865432 12233445544443 3479999999999999999999999999
Q ss_pred CCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCCCCc
Q 005940 434 NGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPH 513 (668)
Q Consensus 434 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 513 (668)
+++|.+++.. ...+++.++..++.|++.||.|||+ .+|+||||||+||++++++.++|+|||++.......
T Consensus 81 ~~~L~~~i~~---~~~l~~~~~~~i~~qi~~al~~lH~---~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~--- 151 (279)
T cd05633 81 GGDLHYHLSQ---HGVFSEKEMRFYATEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--- 151 (279)
T ss_pred CCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC---
Confidence 9999999853 3459999999999999999999999 999999999999999999999999999997654322
Q ss_pred ccccccCCcccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCcccCCcccHH
Q 005940 514 TTNVVGTFGYIAPELTQT-GKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSYVVK 592 (668)
Q Consensus 514 ~~~~~gt~~y~aPE~~~~-~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 592 (668)
.....|+..|+|||.+.+ ..++.++|||||||++|||++|+.||...+............ ..+..+...+.
T Consensus 152 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~------~~~~~~~~~~~-- 223 (279)
T cd05633 152 PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL------TVNVELPDSFS-- 223 (279)
T ss_pred ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhh------cCCcCCccccC--
Confidence 223468999999998864 457899999999999999999999996432211111111111 11112222222
Q ss_pred HHHHHHHHHhhcCCC-CCCCC-----CHHHHHHH
Q 005940 593 EMELVLKLGLMCSHK-TQFRP-----TMRQVMRY 620 (668)
Q Consensus 593 ~~~~l~~l~~~C~~~-p~~RP-----s~~evl~~ 620 (668)
..+..+...|++. |++|| +++|++++
T Consensus 224 --~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 224 --PELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred --HHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 2334455577776 99999 69999886
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=297.46 Aligned_cols=263 Identities=24% Similarity=0.336 Sum_probs=197.6
Q ss_pred hcCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCC--chhHHHHHHHHHHHhcccccCceeEeeeecc----cCce
Q 005940 352 TKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNS--LQGMREFAAEIESLGRLRHKNLVNLHGWCKQ----KNDL 425 (668)
Q Consensus 352 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~----~~~~ 425 (668)
..+|+..+.||+|++|.||+|....++..||+|++.... ....+.+..|+.++++++|+||+++++++.. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 367888999999999999999998899999999987643 2345677889999999999999999998753 3468
Q ss_pred EEEEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCcee
Q 005940 426 LLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARL 505 (668)
Q Consensus 426 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~ 505 (668)
++||||+. ++|.+++.. ...+++..+..++.||+.||.|||+ .+|+||||||+||++++++.+||+|||++..
T Consensus 84 ~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~ 156 (334)
T cd07855 84 YVVMDLME-SDLHHIIHS---DQPLTEEHIRYFLYQLLRGLKYIHS---ANVIHRDLKPSNLLVNEDCELRIGDFGMARG 156 (334)
T ss_pred EEEEehhh-hhHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEeccccccee
Confidence 99999995 689888853 3459999999999999999999998 9999999999999999999999999999986
Q ss_pred ccCCCCCc---ccccccCCcccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCchhH-HHHHHHHHhc------
Q 005940 506 YDHGGMPH---TTNVVGTFGYIAPELTQT-GKASTSSDVFAYGILLLEVATGRRPIGSGDLLL-VEWVRECHQL------ 574 (668)
Q Consensus 506 ~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l-~~~~~~~~~~------ 574 (668)
........ .....++..|+|||.+.. ..++.++|||||||++|||++|+.||...+... ...+......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~ 236 (334)
T cd07855 157 LSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVL 236 (334)
T ss_pred ecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhh
Confidence 64432211 123478899999998765 468899999999999999999999996543211 1111110000
Q ss_pred -----Cccc---cccCcccCC---cccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHh
Q 005940 575 -----GRIL---DVADPLLNS---SYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYL 621 (668)
Q Consensus 575 -----~~~~---~~~d~~l~~---~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L 621 (668)
..+. +........ .........+..+...|++. |++||++.+++++-
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~ 295 (334)
T cd07855 237 NRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHP 295 (334)
T ss_pred hhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhCh
Confidence 0000 000000000 00011234566777788887 99999999999863
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-33 Score=290.45 Aligned_cols=202 Identities=33% Similarity=0.408 Sum_probs=170.3
Q ss_pred hcCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCc--hhHHHHHHHHHHHhcccccCceeEeeeeccc--CceEE
Q 005940 352 TKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSL--QGMREFAAEIESLGRLRHKNLVNLHGWCKQK--NDLLL 427 (668)
Q Consensus 352 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~--~~~~l 427 (668)
.++|+..+.||+|+||.||+|.+..+++.||+|++..... .....+.+|+.++++++|+||+++++++... +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 3578999999999999999999988899999999865432 2233567899999999999999999998654 56899
Q ss_pred EEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceecc
Q 005940 428 VYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYD 507 (668)
Q Consensus 428 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~ 507 (668)
||||+. ++|.+++.. ....+++.+++.++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++....
T Consensus 86 v~e~~~-~~l~~~l~~--~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~ 159 (309)
T cd07845 86 VMEYCE-QDLASLLDN--MPTPFSESQVKCLMLQLLRGLQYLHE---NFIIHRDLKVSNLLLTDKGCLKIADFGLARTYG 159 (309)
T ss_pred EEecCC-CCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECccceeeecC
Confidence 999996 588888853 23568999999999999999999999 999999999999999999999999999998765
Q ss_pred CCCCCcccccccCCcccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 005940 508 HGGMPHTTNVVGTFGYIAPELTQT-GKASTSSDVFAYGILLLEVATGRRPIGSG 560 (668)
Q Consensus 508 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~S~Gvvl~elltG~~p~~~~ 560 (668)
.... ......++..|+|||.+.+ ..++.++||||+||++|||++|+.||...
T Consensus 160 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~ 212 (309)
T cd07845 160 LPAK-PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGK 212 (309)
T ss_pred CccC-CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCC
Confidence 4321 1222345788999998865 45789999999999999999999999754
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-33 Score=288.74 Aligned_cols=243 Identities=23% Similarity=0.315 Sum_probs=195.0
Q ss_pred ceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCchhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEEecCCCCh
Q 005940 358 SEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEYIPNGSL 437 (668)
Q Consensus 358 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL 437 (668)
..+||+|++|.||++....+++.||||++..........+.+|+.++++++|+||+++++.+...+..++||||+++++|
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 104 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 104 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence 46799999999999999888999999998765555667789999999999999999999999999999999999999999
Q ss_pred hhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCCCCccccc
Q 005940 438 DTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNV 517 (668)
Q Consensus 438 ~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~ 517 (668)
.+++.. ..+++..+..++.|++.||+|||+ .+++||||+|+||++++++.++|+|||++....... ......
T Consensus 105 ~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~---~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~-~~~~~~ 176 (292)
T cd06657 105 TDIVTH----TRMNEEQIAAVCLAVLKALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-PRRKSL 176 (292)
T ss_pred HHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEcccccceeccccc-cccccc
Confidence 998842 348999999999999999999998 899999999999999999999999999987654322 122335
Q ss_pred ccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCcccC--CcccHHHHH
Q 005940 518 VGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLN--SSYVVKEME 595 (668)
Q Consensus 518 ~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~--~~~~~~~~~ 595 (668)
.++..|+|||.+.+..++.++||||||+++|||++|..||...+.. +......... .+.+. ...+.
T Consensus 177 ~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~--~~~~~~~~~~------~~~~~~~~~~~~---- 244 (292)
T cd06657 177 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL--KAMKMIRDNL------PPKLKNLHKVSP---- 244 (292)
T ss_pred ccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhhC------CcccCCcccCCH----
Confidence 6889999999998888899999999999999999999999754321 1111111100 01110 11111
Q ss_pred HHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 596 LVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 596 ~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
.+..+...|+.. |.+||++.+++++
T Consensus 245 ~l~~li~~~l~~~P~~R~~~~~ll~~ 270 (292)
T cd06657 245 SLKGFLDRLLVRDPAQRATAAELLKH 270 (292)
T ss_pred HHHHHHHHHHhCCcccCcCHHHHhcC
Confidence 233455577776 9999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-33 Score=285.63 Aligned_cols=194 Identities=31% Similarity=0.449 Sum_probs=169.4
Q ss_pred eeecCcEEEEEEEeCCCCcEEEEEEEecCCc---hhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEEecCCCCh
Q 005940 361 IGIGGFGSVYKGVLPTTGGEVAVKKITRNSL---QGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEYIPNGSL 437 (668)
Q Consensus 361 lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL 437 (668)
||+|+||+||++....+++.+|+|.+..... ...+.+..|++++++++||||+++++.+...+..|+||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 6899999999999988899999999875432 2345677899999999999999999999999999999999999999
Q ss_pred hhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCCCCccccc
Q 005940 438 DTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNV 517 (668)
Q Consensus 438 ~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~ 517 (668)
.+++.... ...+++..++.++.|++.||.|||+ .+++||||+|+||+++.++.+||+|||++....... .....
T Consensus 81 ~~~l~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~---~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~--~~~~~ 154 (277)
T cd05577 81 KYHIYNVG-EPGFPEARAIFYAAQIICGLEHLHQ---RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK--KIKGR 154 (277)
T ss_pred HHHHHHcC-cCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEccCcchhhhccCC--ccccc
Confidence 99986432 2468999999999999999999998 999999999999999999999999999987654322 12234
Q ss_pred ccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 005940 518 VGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSG 560 (668)
Q Consensus 518 ~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~ 560 (668)
.++..|+|||++.++.++.++|||||||++|||++|+.||...
T Consensus 155 ~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 197 (277)
T cd05577 155 AGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQR 197 (277)
T ss_pred cCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCC
Confidence 6788999999998888999999999999999999999999654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-34 Score=306.47 Aligned_cols=201 Identities=35% Similarity=0.526 Sum_probs=177.9
Q ss_pred cccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCC-chhHHHHHHHHHHHhcccccCceeEeeeecccC------ceEE
Q 005940 355 FKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNS-LQGMREFAAEIESLGRLRHKNLVNLHGWCKQKN------DLLL 427 (668)
Q Consensus 355 f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~------~~~l 427 (668)
+.-.+.||+|+||.||+|+++.+|+.||||.++... ....+....|+++|++|+|+|||++.+.-+... ...+
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl 94 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL 94 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence 344678999999999999999999999999997643 334566789999999999999999999876543 5789
Q ss_pred EEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEEC--CCC--CEEEEeecCc
Q 005940 428 VYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALID--AEM--NARLGDFGLA 503 (668)
Q Consensus 428 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~--~~~--~~kl~DfGla 503 (668)
|||||.+|+|...|.++.+...|++.+.+.++.+++.||.|||+ ++|+||||||.||++- +++ -.||+|||.|
T Consensus 95 vmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrE---n~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A 171 (732)
T KOG4250|consen 95 VMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRE---NGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA 171 (732)
T ss_pred EEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHH---cCceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence 99999999999999988888899999999999999999999998 9999999999999993 223 4799999999
Q ss_pred eeccCCCCCcccccccCCcccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 005940 504 RLYDHGGMPHTTNVVGTFGYIAPELTQT-GKASTSSDVFAYGILLLEVATGRRPIGSG 560 (668)
Q Consensus 504 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~S~Gvvl~elltG~~p~~~~ 560 (668)
+.++++. .....+||..|.+||...+ +.++...|.|||||++||.+||..||.+.
T Consensus 172 rel~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~ 227 (732)
T KOG4250|consen 172 RELDDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPF 227 (732)
T ss_pred ccCCCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcC
Confidence 9988765 4566799999999999985 78899999999999999999999999754
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=287.80 Aligned_cols=252 Identities=27% Similarity=0.371 Sum_probs=193.3
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCc-hhHHHHHHHHHHHhccc-ccCceeEeeeecccCceEEEEE
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSL-QGMREFAAEIESLGRLR-HKNLVNLHGWCKQKNDLLLVYE 430 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~lV~E 430 (668)
++|...+.||+|++|.||+|.+..++..||||++..... ....++..|+.++.++. |+||++++++|......++|||
T Consensus 15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e 94 (296)
T cd06618 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICME 94 (296)
T ss_pred chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEee
Confidence 567889999999999999999987899999999976432 34456777887777775 9999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCC
Q 005940 431 YIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGG 510 (668)
Q Consensus 431 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~ 510 (668)
|++ ++|.+++.. ....+++..+..++.|++.||+|||+ ..+|+||||+|+||++++++.+||+|||++.......
T Consensus 95 ~~~-~~l~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~--~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~ 169 (296)
T cd06618 95 LMS-TCLDKLLKR--IQGPIPEDILGKMTVAIVKALHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSK 169 (296)
T ss_pred ccC-cCHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHh--hCCEecCCCcHHHEEEcCCCCEEECccccchhccCCC
Confidence 985 577777643 23478999999999999999999996 2589999999999999999999999999987654332
Q ss_pred CCcccccccCCcccCcccccCCC----CCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCcccC
Q 005940 511 MPHTTNVVGTFGYIAPELTQTGK----ASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLN 586 (668)
Q Consensus 511 ~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 586 (668)
. .....++..|+|||++.+.. ++.++||||||+++|||++|+.||...+.. .+......... . +...
T Consensus 170 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-~~~~~~~~~~~-~-----~~~~ 240 (296)
T cd06618 170 A--KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE-FEVLTKILQEE-P-----PSLP 240 (296)
T ss_pred c--ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH-HHHHHHHhcCC-C-----CCCC
Confidence 2 12235778999999987554 788999999999999999999999653221 11111111111 0 1111
Q ss_pred CcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 587 SSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 587 ~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
... .....+..+..+|++. |++||++++++++
T Consensus 241 ~~~--~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 241 PNE--GFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred CCC--CCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 000 1123456666789987 9999999999876
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-33 Score=284.62 Aligned_cols=245 Identities=27% Similarity=0.362 Sum_probs=193.4
Q ss_pred eeecCcEEEEEEEeCCCCcEEEEEEEecCCc---hhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEEecCCCCh
Q 005940 361 IGIGGFGSVYKGVLPTTGGEVAVKKITRNSL---QGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEYIPNGSL 437 (668)
Q Consensus 361 lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL 437 (668)
||+|++|.||++++..+++.+++|++..... ...+.+.+|++++++++|+||+++++.+..+...++|+||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 6899999999999988899999999876543 3456788999999999999999999999999999999999999999
Q ss_pred hhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCCC------
Q 005940 438 DTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGM------ 511 (668)
Q Consensus 438 ~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~~------ 511 (668)
.+++.+. ..+++..+..++.||+.||+|||+ .+++||||+|+||++++++.+||+|||++........
T Consensus 81 ~~~l~~~---~~~~~~~~~~i~~qi~~~L~~lH~---~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 154 (265)
T cd05579 81 ASLLENV---GSLDEDVARIYIAEIVLALEYLHS---NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDD 154 (265)
T ss_pred HHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH---cCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccc
Confidence 9999632 368999999999999999999998 9999999999999999999999999999876543321
Q ss_pred -CcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCcccCCccc
Q 005940 512 -PHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSYV 590 (668)
Q Consensus 512 -~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 590 (668)
.......++..|+|||.......+.++||||||+++|||++|+.||...... +....... +... .....
T Consensus 155 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~--~~~~~~~~-~~~~------~~~~~- 224 (265)
T cd05579 155 EKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPE--EIFQNILN-GKIE------WPEDV- 224 (265)
T ss_pred cccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHhc-CCcC------CCccc-
Confidence 1223346788999999998888999999999999999999999999754322 11222111 1110 00000
Q ss_pred HHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhc
Q 005940 591 VKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLS 622 (668)
Q Consensus 591 ~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~ 622 (668)
.....+..+...|++. |++||+++++.+.|+
T Consensus 225 -~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 225 -EVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred -cCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 0123445666678876 999999955555443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=311.99 Aligned_cols=252 Identities=28% Similarity=0.402 Sum_probs=203.2
Q ss_pred cccceeeeecCcEEEEEEEeCCCCc----EEEEEEEecC-CchhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEE
Q 005940 355 FKESEVIGIGGFGSVYKGVLPTTGG----EVAVKKITRN-SLQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVY 429 (668)
Q Consensus 355 f~~~~~lG~G~~g~Vy~~~~~~~~~----~vavK~~~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 429 (668)
....++||+|+||+||||.+-..++ +||||++... ..+...++++|+-+|.+|+|||+++|+|+|.... +.||.
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvt 776 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVT 776 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHH
Confidence 4557899999999999999854444 6999998654 4456789999999999999999999999998765 88999
Q ss_pred EecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCC
Q 005940 430 EYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHG 509 (668)
Q Consensus 430 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~ 509 (668)
+||+.|+|.++++. .+..+--...+.|+.|||+||.|||+ +.++||||-++|||+++-..+||.|||+++.....
T Consensus 777 q~mP~G~LlDyvr~--hr~~igsq~lLnw~~QIAkgM~YLe~---qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d 851 (1177)
T KOG1025|consen 777 QLMPLGCLLDYVRE--HRDNIGSQDLLNWCYQIAKGMKYLEE---QRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPD 851 (1177)
T ss_pred HhcccchHHHHHHH--hhccccHHHHHHHHHHHHHHHHHHHh---cchhhhhhhhhheeecCCCeEEEEecchhhccCcc
Confidence 99999999999964 44568888999999999999999998 99999999999999999999999999999988765
Q ss_pred CCCccc-ccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHHHhcCccccccCcccCC
Q 005940 510 GMPHTT-NVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVAT-GRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNS 587 (668)
Q Consensus 510 ~~~~~~-~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 587 (668)
...... ...-.+.|||=|.+....++.++|||||||.+||++| |.+|++.-. .+-+....+.+.. |
T Consensus 852 ~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~---~~eI~dlle~geR-------L-- 919 (1177)
T KOG1025|consen 852 EKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIP---AEEIPDLLEKGER-------L-- 919 (1177)
T ss_pred cccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCC---HHHhhHHHhcccc-------C--
Confidence 433222 2233567999999999999999999999999999999 999987532 2222223322221 1
Q ss_pred cccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhccC
Q 005940 588 SYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSGE 624 (668)
Q Consensus 588 ~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~~ 624 (668)
..++-....+..+++.||.. ++.||+++++...+..-
T Consensus 920 sqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ 957 (1177)
T KOG1025|consen 920 SQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRM 957 (1177)
T ss_pred CCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHH
Confidence 12222335577788899998 78899999999887643
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=285.57 Aligned_cols=257 Identities=27% Similarity=0.330 Sum_probs=193.4
Q ss_pred cccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCc--hhHHHHHHHHHHHhcc---cccCceeEeeeecccCc-----
Q 005940 355 FKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSL--QGMREFAAEIESLGRL---RHKNLVNLHGWCKQKND----- 424 (668)
Q Consensus 355 f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~f~~Ei~~l~~l---~H~nIv~l~g~~~~~~~----- 424 (668)
|++.+.||+|++|.||+|+++.++..+|+|++..... .....+.+|+.+++++ +|+|++++++.+.....
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 5678999999999999999987899999999964322 2234566788777666 59999999999987766
Q ss_pred eEEEEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCce
Q 005940 425 LLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLAR 504 (668)
Q Consensus 425 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~ 504 (668)
.+++|||++ ++|.+++... ....+++.+++.++.|++.||.|||+ .+++|+||+|+||+++.++.+||+|||++.
T Consensus 81 ~~l~~e~~~-~~l~~~l~~~-~~~~l~~~~~~~~~~~i~~al~~LH~---~~i~h~~l~~~nili~~~~~~~l~dfg~~~ 155 (287)
T cd07838 81 LTLVFEHVD-QDLATYLSKC-PKPGLPPETIKDLMRQLLRGVDFLHS---HRIVHRDLKPQNILVTSDGQVKIADFGLAR 155 (287)
T ss_pred eEEEehhcc-cCHHHHHHHc-cCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCChhhEEEccCCCEEEeccCcce
Confidence 899999997 5898888532 22458999999999999999999999 899999999999999999999999999998
Q ss_pred eccCCCCCcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCcc-------
Q 005940 505 LYDHGGMPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRI------- 577 (668)
Q Consensus 505 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~------- 577 (668)
....... .....++..|+|||.+.+..++.++|||||||++|||++|+.||..... .+......+....
T Consensus 156 ~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 231 (287)
T cd07838 156 IYSFEMA--LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSE--ADQLDKIFDVIGLPSEEEWP 231 (287)
T ss_pred eccCCcc--cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCCh--HHHHHHHHHHcCCCChHhcC
Confidence 7654322 1223578899999999888899999999999999999999999865321 1111111111000
Q ss_pred ------ccccCcccCC---cccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 578 ------LDVADPLLNS---SYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 578 ------~~~~d~~l~~---~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
.......... .....-...+..+...|+.. |++||+++|++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~ 284 (287)
T cd07838 232 RNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH 284 (287)
T ss_pred CCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence 0000000000 01111224556677789886 9999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=292.14 Aligned_cols=198 Identities=25% Similarity=0.304 Sum_probs=164.2
Q ss_pred eeeeec--CcEEEEEEEeCCCCcEEEEEEEecCC--chhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEEecCC
Q 005940 359 EVIGIG--GFGSVYKGVLPTTGGEVAVKKITRNS--LQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEYIPN 434 (668)
Q Consensus 359 ~~lG~G--~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~ 434 (668)
..||+| +||+||++.+..+++.||+|++.... ....+.+.+|+.+++.++||||++++++|..++..++|+||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 356666 99999999998899999999986532 33457788999999999999999999999999999999999999
Q ss_pred CChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCCCCc-
Q 005940 435 GSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPH- 513 (668)
Q Consensus 435 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~~~~- 513 (668)
++|.+++.... ...+++..+..++.|++.||.|||+ .+++||||||+||+++.++.+|++||+.+..........
T Consensus 84 ~~l~~~l~~~~-~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (328)
T cd08226 84 GSANSLLKTYF-PEGMSEALIGNILFGALRGLNYLHQ---NGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAK 159 (328)
T ss_pred CCHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccc
Confidence 99999986432 2458999999999999999999998 999999999999999999999999998654332211110
Q ss_pred -----ccccccCCcccCcccccCC--CCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 005940 514 -----TTNVVGTFGYIAPELTQTG--KASTSSDVFAYGILLLEVATGRRPIGSG 560 (668)
Q Consensus 514 -----~~~~~gt~~y~aPE~~~~~--~~~~~sDV~S~Gvvl~elltG~~p~~~~ 560 (668)
.....++..|+|||++.+. .++.++|||||||++|||++|+.||...
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~ 213 (328)
T cd08226 160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDM 213 (328)
T ss_pred ccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCc
Confidence 1112346679999998763 4789999999999999999999999754
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=281.56 Aligned_cols=244 Identities=22% Similarity=0.279 Sum_probs=186.9
Q ss_pred HHHhcCcccceee--eecCcEEEEEEEeCCCCcEEEEEEEecCCchhHHHHHHHHHHHhcc-cccCceeEeeeecccCce
Q 005940 349 YAATKGFKESEVI--GIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRL-RHKNLVNLHGWCKQKNDL 425 (668)
Q Consensus 349 ~~at~~f~~~~~l--G~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~ 425 (668)
....++|.+.+.+ |+|+||.||++..+.++..+|+|.+........ |+.....+ +|+||+++++.+...+..
T Consensus 10 ~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~~~~ 84 (267)
T PHA03390 10 VQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTLKGH 84 (267)
T ss_pred HHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecCCee
Confidence 3344566666666 999999999999988999999999875432211 22222222 699999999999999999
Q ss_pred EEEEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCC-CEEEEeecCce
Q 005940 426 LLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEM-NARLGDFGLAR 504 (668)
Q Consensus 426 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~-~~kl~DfGla~ 504 (668)
++||||+++++|.+++.. ...+++.++..++.|+++||.|||+ .+++||||||+||+++.++ .++|+|||++.
T Consensus 85 ~iv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~ 158 (267)
T PHA03390 85 VLIMDYIKDGDLFDLLKK---EGKLSEAEVKKIIRQLVEALNDLHK---HNIIHNDIKLENVLYDRAKDRIYLCDYGLCK 158 (267)
T ss_pred EEEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEEeCCCCeEEEecCccce
Confidence 999999999999999953 2379999999999999999999998 8999999999999999998 99999999988
Q ss_pred eccCCCCCcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchh---HHHHHHHHHhcCcccccc
Q 005940 505 LYDHGGMPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLL---LVEWVRECHQLGRILDVA 581 (668)
Q Consensus 505 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~---l~~~~~~~~~~~~~~~~~ 581 (668)
..... ....++..|+|||++.+..++.++||||||+++|||++|+.||...... ...+.... ....
T Consensus 159 ~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~---~~~~--- 227 (267)
T PHA03390 159 IIGTP-----SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ---QKKL--- 227 (267)
T ss_pred ecCCC-----ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh---cccC---
Confidence 65432 2236789999999998888999999999999999999999999744222 12222211 1101
Q ss_pred CcccCCcccHHHHHHHHHHHhhcCCC-CCCCCC-HHHHHHH
Q 005940 582 DPLLNSSYVVKEMELVLKLGLMCSHK-TQFRPT-MRQVMRY 620 (668)
Q Consensus 582 d~~l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs-~~evl~~ 620 (668)
+.. ...+ ..+..+...|++. |.+||+ ++|++++
T Consensus 228 -~~~-~~~~----~~~~~li~~~l~~~p~~R~~~~~~~l~h 262 (267)
T PHA03390 228 -PFI-KNVS----KNANDFVQSMLKYNINYRLTNYNEIIKH 262 (267)
T ss_pred -Ccc-cccC----HHHHHHHHHHhccChhhCCchHHHHhcC
Confidence 111 1122 2234444567776 999995 6999864
|
|
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=280.53 Aligned_cols=242 Identities=24% Similarity=0.251 Sum_probs=185.8
Q ss_pred eeeeecCcEEEEEEEeCCCCcEEEEEEEecCCc---hhHHHHHHHHHHH-hcccccCceeEeeeecccCceEEEEEecCC
Q 005940 359 EVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSL---QGMREFAAEIESL-GRLRHKNLVNLHGWCKQKNDLLLVYEYIPN 434 (668)
Q Consensus 359 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~f~~Ei~~l-~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~ 434 (668)
+.||+|++|.||+|....+++.||+|.+.+... .....+..|..++ ...+|+|++++++.+...+..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 568999999999999988899999999876432 2223445555544 455899999999999999999999999999
Q ss_pred CChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCCCCcc
Q 005940 435 GSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHT 514 (668)
Q Consensus 435 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 514 (668)
++|.+++.. ...+++..+..++.|++.||.|||+ .+++||||+|+||++++++.+||+|||+++.... .
T Consensus 82 ~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-----~ 150 (260)
T cd05611 82 GDCASLIKT---LGGLPEDWAKQYIAEVVLGVEDLHQ---RGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-----N 150 (260)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCcEEEeecccceeccc-----c
Confidence 999999953 3458999999999999999999999 9999999999999999999999999999875433 2
Q ss_pred cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCcccCCcccHHHH
Q 005940 515 TNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSYVVKEM 594 (668)
Q Consensus 515 ~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 594 (668)
....++..|+|||.+.+..++.++||||||+++|||++|..||...+... .... ....... ..+.....+ .
T Consensus 151 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--~~~~-~~~~~~~--~~~~~~~~~----~ 221 (260)
T cd05611 151 KKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDA--VFDN-ILSRRIN--WPEEVKEFC----S 221 (260)
T ss_pred ccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHH--HHHH-HHhcccC--CCCcccccC----C
Confidence 23467889999999988888999999999999999999999997543221 1111 1111111 011111111 2
Q ss_pred HHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 595 ELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 595 ~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
..+..++..|+.. |++||++.++.+.
T Consensus 222 ~~~~~~i~~~l~~~p~~R~~~~~~~~~ 248 (260)
T cd05611 222 PEAVDLINRLLCMDPAKRLGANGYQEI 248 (260)
T ss_pred HHHHHHHHHHccCCHHHccCCCcHHHH
Confidence 3455666688876 9999977544443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-33 Score=286.02 Aligned_cols=259 Identities=27% Similarity=0.353 Sum_probs=195.3
Q ss_pred cccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCc-hhHHHHHHHHHHHhccc-ccCceeEeeeecccCceEEEEEec
Q 005940 355 FKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSL-QGMREFAAEIESLGRLR-HKNLVNLHGWCKQKNDLLLVYEYI 432 (668)
Q Consensus 355 f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~lV~E~~ 432 (668)
|++.+.||+|++|.||+|+...+++.|+||++..... .......+|+..+++++ |+||+++++.+..++..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 5678899999999999999988889999999865432 22234557999999999 999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCCCC
Q 005940 433 PNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMP 512 (668)
Q Consensus 433 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~~~ 512 (668)
+|+|.+++.... ...+++.++..++.|++.+|.|||+ .+++|+||+|+||+++.++.++|+|||++........
T Consensus 81 -~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~---~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~- 154 (283)
T cd07830 81 -EGNLYQLMKDRK-GKPFSESVIRSIIYQILQGLAHIHK---HGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP- 154 (283)
T ss_pred -CCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEEcCCCCEEEeecccceeccCCCC-
Confidence 889998885322 3568999999999999999999998 9999999999999999999999999999986654321
Q ss_pred cccccccCCcccCccccc-CCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhH-H-------------HHHHHHHhcCcc
Q 005940 513 HTTNVVGTFGYIAPELTQ-TGKASTSSDVFAYGILLLEVATGRRPIGSGDLLL-V-------------EWVRECHQLGRI 577 (668)
Q Consensus 513 ~~~~~~gt~~y~aPE~~~-~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l-~-------------~~~~~~~~~~~~ 577 (668)
.....++..|+|||++. ...++.++|+||||++++||++|+.||......- . .|..........
T Consensus 155 -~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (283)
T cd07830 155 -YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKL 233 (283)
T ss_pred -cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccc
Confidence 22346788999999874 4457899999999999999999999986442111 1 011111000011
Q ss_pred ccccCcccC---CcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 578 LDVADPLLN---SSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 578 ~~~~d~~l~---~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
......... ..........+..++..|++. |++||+++|++.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 234 GFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred cccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 000000000 000011124566778889887 9999999999874
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=296.00 Aligned_cols=251 Identities=23% Similarity=0.344 Sum_probs=196.8
Q ss_pred hcCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEec--CCchhHHHHHHHHHHHhccc-ccCceeEeeeecccCceEEE
Q 005940 352 TKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITR--NSLQGMREFAAEIESLGRLR-HKNLVNLHGWCKQKNDLLLV 428 (668)
Q Consensus 352 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~--~~~~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~lV 428 (668)
.+.|++.++||+||-+.||++... +.+.+|+|++.. .+.+...-|.+|+..|.+|+ |.+|++|++|-..++.+|+|
T Consensus 360 g~~Yeilk~iG~GGSSkV~kV~~s-~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmv 438 (677)
T KOG0596|consen 360 GREYEILKQIGSGGSSKVFKVLNS-DKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMV 438 (677)
T ss_pred cchhhHHHhhcCCCcceeeeeecC-CCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEE
Confidence 457899999999999999999874 456788887643 34466788999999999996 99999999999999999999
Q ss_pred EEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccC
Q 005940 429 YEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDH 508 (668)
Q Consensus 429 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~ 508 (668)
|||- ..+|..+|.+. ......| .+..+.+|++.|+.++|. .+|||.||||.|+|+- .|.+||+|||+|..+..
T Consensus 439 mE~G-d~DL~kiL~k~-~~~~~~~-~lk~ywkqML~aV~~IH~---~gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~ 511 (677)
T KOG0596|consen 439 MECG-DIDLNKILKKK-KSIDPDW-FLKFYWKQMLLAVKTIHQ---HGIVHSDLKPANFLLV-KGRLKLIDFGIANAIQP 511 (677)
T ss_pred eecc-cccHHHHHHhc-cCCCchH-HHHHHHHHHHHHHHHHHH---hceeecCCCcccEEEE-eeeEEeeeechhcccCc
Confidence 9976 67999999643 2333445 778899999999999999 9999999999999984 56899999999998775
Q ss_pred CCC-CcccccccCCcccCcccccCC-----------CCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCc
Q 005940 509 GGM-PHTTNVVGTFGYIAPELTQTG-----------KASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGR 576 (668)
Q Consensus 509 ~~~-~~~~~~~gt~~y~aPE~~~~~-----------~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~ 576 (668)
+.. ......+||..||+||.+... +..+++||||+|||||+|+.|+.||..-. ..| .+
T Consensus 512 DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~---n~~-------aK 581 (677)
T KOG0596|consen 512 DTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII---NQI-------AK 581 (677)
T ss_pred cccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH---HHH-------HH
Confidence 543 234456899999999977432 25689999999999999999999996311 111 23
Q ss_pred cccccCcccCCcccH-HHHHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 577 ILDVADPLLNSSYVV-KEMELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 577 ~~~~~d~~l~~~~~~-~~~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
+..+.||.-.-+|.. .+-..++.++..|+.. |++||++.++|++
T Consensus 582 l~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 582 LHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred HHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 334445533222211 1112277888999997 9999999999986
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-33 Score=294.91 Aligned_cols=260 Identities=25% Similarity=0.333 Sum_probs=196.3
Q ss_pred hcCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecC--CchhHHHHHHHHHHHhcccccCceeEeeeeccc-----Cc
Q 005940 352 TKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRN--SLQGMREFAAEIESLGRLRHKNLVNLHGWCKQK-----ND 424 (668)
Q Consensus 352 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~-----~~ 424 (668)
.++|.+.+.||+|+||.||+|+...++..||||++... .......+..|+.++++++|+||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 45789999999999999999999889999999998653 223345677899999999999999999988643 35
Q ss_pred eEEEEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCce
Q 005940 425 LLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLAR 504 (668)
Q Consensus 425 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~ 504 (668)
.++|+||+. ++|.+++.. ...+++..+..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||+++
T Consensus 84 ~~lv~e~~~-~~L~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~---~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~ 156 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRS---SQTLSDDHCQYFLYQLLRGLKYIHS---ANVLHRDLKPSNLLLNANCDLKICDFGLAR 156 (337)
T ss_pred EEEEEeCCC-CCHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEECcCcccc
Confidence 899999996 688888853 3469999999999999999999998 999999999999999999999999999998
Q ss_pred eccCCCCCcccccccCCcccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCchhH-HHHHHHHHhc--------
Q 005940 505 LYDHGGMPHTTNVVGTFGYIAPELTQT-GKASTSSDVFAYGILLLEVATGRRPIGSGDLLL-VEWVRECHQL-------- 574 (668)
Q Consensus 505 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l-~~~~~~~~~~-------- 574 (668)
...... .......++..|+|||.+.. ..++.++|||||||++|||++|+.||...+... ..........
T Consensus 157 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (337)
T cd07858 157 TTSEKG-DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGF 235 (337)
T ss_pred ccCCCc-ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhh
Confidence 765432 12233467889999998764 468899999999999999999999996543110 0001110000
Q ss_pred ---Cc-------cccccCcccCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 575 ---GR-------ILDVADPLLNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 575 ---~~-------~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
.. .....++.... ........+..+...|++. |++||+++|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h 291 (337)
T cd07858 236 IRNEKARRYIRSLPYTPRQSFAR-LFPHANPLAIDLLEKMLVFDPSKRITVEEALAH 291 (337)
T ss_pred cCchhhhHHHHhcCcccccCHHH-HcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence 00 00000000000 0011123456777789887 9999999999988
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-33 Score=286.00 Aligned_cols=249 Identities=28% Similarity=0.391 Sum_probs=200.7
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCC---chhHHHHHHHHHHHhccc-ccCceeEeeeecccCceEEE
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNS---LQGMREFAAEIESLGRLR-HKNLVNLHGWCKQKNDLLLV 428 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~lV 428 (668)
++|...+.||+|++|.||+|+...++..||+|++.+.. ....+.+..|++++++++ |+||+++++++...+..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 46888999999999999999998889999999986532 234467889999999998 99999999999999999999
Q ss_pred EEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccC
Q 005940 429 YEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDH 508 (668)
Q Consensus 429 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~ 508 (668)
|||+++++|.+++.+ ...+++..++.++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 ~e~~~~~~L~~~l~~---~~~l~~~~~~~i~~ql~~~l~~Lh~---~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~ 154 (280)
T cd05581 81 LEYAPNGELLQYIRK---YGSLDEKCTRFYAAEILLALEYLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDP 154 (280)
T ss_pred EcCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEecCCccccccCC
Confidence 999999999999953 3369999999999999999999998 9999999999999999999999999999986654
Q ss_pred CCC-------------------CcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHH
Q 005940 509 GGM-------------------PHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVR 569 (668)
Q Consensus 509 ~~~-------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~ 569 (668)
... .......++..|+|||.......+.++||||||++++|+++|+.||...+.... ..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~--~~ 232 (280)
T cd05581 155 NSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLT--FQ 232 (280)
T ss_pred ccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHH--HH
Confidence 321 122234678899999999888899999999999999999999999975432111 11
Q ss_pred HHHhcCccccccCcccCCcccHHHHHHHHHHHhhcCCC-CCCCCCH----HHHHHH
Q 005940 570 ECHQLGRILDVADPLLNSSYVVKEMELVLKLGLMCSHK-TQFRPTM----RQVMRY 620 (668)
Q Consensus 570 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~----~evl~~ 620 (668)
..... ...+.... ...+..+...|++. |++||++ +|++++
T Consensus 233 ~~~~~-------~~~~~~~~----~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~ 277 (280)
T cd05581 233 KILKL-------EYSFPPNF----PPDAKDLIEKLLVLDPQDRLGVNEGYDELKAH 277 (280)
T ss_pred HHHhc-------CCCCCCcc----CHHHHHHHHHHhcCCHhhCCCcccCHHHHhcC
Confidence 11110 00111111 23455666788887 9999999 888764
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=285.71 Aligned_cols=256 Identities=17% Similarity=0.230 Sum_probs=181.2
Q ss_pred cCcccceeeeecCcEEEEEEEeCCC---CcEEEEEEEecCCchhH-----------HHHHHHHHHHhcccccCceeEeee
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTT---GGEVAVKKITRNSLQGM-----------REFAAEIESLGRLRHKNLVNLHGW 418 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~~~~-----------~~f~~Ei~~l~~l~H~nIv~l~g~ 418 (668)
++|.+.++||+|+||.||+|.+..+ +..+|+|+......... .....+...+..+.|+|++++++.
T Consensus 12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~ 91 (294)
T PHA02882 12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC 91 (294)
T ss_pred CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence 5789999999999999999998766 55677776433222110 112234455667789999999997
Q ss_pred ecccC----ceEEEEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCC
Q 005940 419 CKQKN----DLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMN 494 (668)
Q Consensus 419 ~~~~~----~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~ 494 (668)
+.... ..++++|++. .++.+.+.. ....++..+..++.|++.||.|||+ .+|+||||||+|||++.++.
T Consensus 92 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~---~~iiHrDiKp~Nill~~~~~ 164 (294)
T PHA02882 92 GSFKRCRMYYRFILLEKLV-ENTKEIFKR---IKCKNKKLIKNIMKDMLTTLEYIHE---HGISHGDIKPENIMVDGNNR 164 (294)
T ss_pred eeEecCCceEEEEEEehhc-cCHHHHHHh---hccCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCc
Confidence 65443 3467777764 356666532 2235788899999999999999998 99999999999999999999
Q ss_pred EEEEeecCceeccCCCC------CcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCc--hhHHH
Q 005940 495 ARLGDFGLARLYDHGGM------PHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGD--LLLVE 566 (668)
Q Consensus 495 ~kl~DfGla~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~--~~l~~ 566 (668)
++|+|||+++.+..... .......||+.|+|||+..+..++.++|||||||++|||++|+.||.... .....
T Consensus 165 ~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~ 244 (294)
T PHA02882 165 GYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIH 244 (294)
T ss_pred EEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHH
Confidence 99999999987643211 11223469999999999998899999999999999999999999997541 11111
Q ss_pred HHHHHHhcCccccccCcccCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhc
Q 005940 567 WVRECHQLGRILDVADPLLNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLS 622 (668)
Q Consensus 567 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~ 622 (668)
...... ..++. ...+.....+ ..+..+...|+.. |++||++.++++.|+
T Consensus 245 ~~~~~~-~~~~~---~~~~~~~~~~---~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 245 AAKCDF-IKRLH---EGKIKIKNAN---KFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred HhHHHH-HHHhh---hhhhccCCCC---HHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 111000 00000 0111001112 3455666688887 999999999998764
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=293.34 Aligned_cols=201 Identities=30% Similarity=0.446 Sum_probs=170.1
Q ss_pred hcCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecC--CchhHHHHHHHHHHHhcc-cccCceeEeeeeccc--CceE
Q 005940 352 TKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRN--SLQGMREFAAEIESLGRL-RHKNLVNLHGWCKQK--NDLL 426 (668)
Q Consensus 352 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~--~~~~ 426 (668)
.++|...+.||+|+||.||+|.+..++..+|+|++... .......+..|+.+++++ +|+||++++++|... ...+
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~ 85 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY 85 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence 45788899999999999999999888899999988542 223445677899999999 999999999998643 4689
Q ss_pred EEEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceec
Q 005940 427 LVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLY 506 (668)
Q Consensus 427 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~ 506 (668)
+||||++ ++|..++.. ..++|..+..++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||++...
T Consensus 86 lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~---~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~ 157 (337)
T cd07852 86 LVFEYME-TDLHAVIRA----NILEDVHKRYIMYQLLKALKYIHS---GNVIHRDLKPSNILLNSDCRVKLADFGLARSL 157 (337)
T ss_pred EEecccc-cCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEEeeccchhcc
Confidence 9999997 599888852 268899999999999999999998 99999999999999999999999999999866
Q ss_pred cCCCC----CcccccccCCcccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 005940 507 DHGGM----PHTTNVVGTFGYIAPELTQT-GKASTSSDVFAYGILLLEVATGRRPIGSG 560 (668)
Q Consensus 507 ~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~S~Gvvl~elltG~~p~~~~ 560 (668)
..... .......|+..|+|||.+.+ ...+.++||||||+++|||++|+.||...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~ 216 (337)
T cd07852 158 SELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGT 216 (337)
T ss_pred ccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCC
Confidence 44322 12234568899999998754 45789999999999999999999999643
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=293.59 Aligned_cols=196 Identities=28% Similarity=0.435 Sum_probs=167.0
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCC--chhHHHHHHHHHHHhcccccCceeEeeeeccc------Cc
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNS--LQGMREFAAEIESLGRLRHKNLVNLHGWCKQK------ND 424 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~------~~ 424 (668)
++|...+.||+|++|.||+|++..+++.||||++.+.. ......+.+|++++++++|+||+++++++... ..
T Consensus 15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 94 (342)
T cd07879 15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQD 94 (342)
T ss_pred cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCce
Confidence 78999999999999999999998889999999986532 22345688999999999999999999998644 34
Q ss_pred eEEEEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCce
Q 005940 425 LLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLAR 504 (668)
Q Consensus 425 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~ 504 (668)
.++|+||+.. +|..++. ..+++..+..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||+++
T Consensus 95 ~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~---~~i~H~dlkp~NIll~~~~~~kL~dfg~~~ 165 (342)
T cd07879 95 FYLVMPYMQT-DLQKIMG-----HPLSEDKVQYLVYQMLCGLKYIHS---AGIIHRDLKPGNLAVNEDCELKILDFGLAR 165 (342)
T ss_pred EEEEeccccc-CHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCCCCc
Confidence 6999999964 7766652 348899999999999999999998 899999999999999999999999999987
Q ss_pred eccCCCCCcccccccCCcccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCc
Q 005940 505 LYDHGGMPHTTNVVGTFGYIAPELTQT-GKASTSSDVFAYGILLLEVATGRRPIGSGD 561 (668)
Q Consensus 505 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~S~Gvvl~elltG~~p~~~~~ 561 (668)
..... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||...+
T Consensus 166 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~ 219 (342)
T cd07879 166 HADAE----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD 219 (342)
T ss_pred CCCCC----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 65332 223467889999998866 468899999999999999999999997643
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=290.29 Aligned_cols=203 Identities=31% Similarity=0.461 Sum_probs=173.4
Q ss_pred hHHHHhcCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecC--CchhHHHHHHHHHHHhcccccCceeEeeeecc-cC
Q 005940 347 DLYAATKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRN--SLQGMREFAAEIESLGRLRHKNLVNLHGWCKQ-KN 423 (668)
Q Consensus 347 el~~at~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~-~~ 423 (668)
++...+++|+..+.||+|+||.||++....++..||||++.+. .....+.+..|++++++++||||+++.+++.. ..
T Consensus 4 ~~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 83 (328)
T cd07856 4 TVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLE 83 (328)
T ss_pred ceeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCC
Confidence 4556788999999999999999999999889999999998643 22345678899999999999999999998865 56
Q ss_pred ceEEEEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCc
Q 005940 424 DLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLA 503 (668)
Q Consensus 424 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla 503 (668)
..++|+||+ +++|.+++. ...+++..+..++.|+++||.|||+ .+++||||+|+||++++++.+||+|||++
T Consensus 84 ~~~lv~e~~-~~~L~~~~~----~~~~~~~~~~~~~~ql~~aL~~LH~---~~iiH~dl~p~Nili~~~~~~~l~dfg~~ 155 (328)
T cd07856 84 DIYFVTELL-GTDLHRLLT----SRPLEKQFIQYFLYQILRGLKYVHS---AGVVHRDLKPSNILINENCDLKICDFGLA 155 (328)
T ss_pred cEEEEeehh-ccCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEeECCCCCEEeCccccc
Confidence 789999998 568988884 2347888899999999999999999 99999999999999999999999999998
Q ss_pred eeccCCCCCcccccccCCcccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCc
Q 005940 504 RLYDHGGMPHTTNVVGTFGYIAPELTQT-GKASTSSDVFAYGILLLEVATGRRPIGSGD 561 (668)
Q Consensus 504 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~S~Gvvl~elltG~~p~~~~~ 561 (668)
...... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||...+
T Consensus 156 ~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~ 210 (328)
T cd07856 156 RIQDPQ----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKD 210 (328)
T ss_pred cccCCC----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 754432 123457889999998765 568999999999999999999999996543
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=292.73 Aligned_cols=201 Identities=31% Similarity=0.438 Sum_probs=174.7
Q ss_pred CcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCC--chhHHHHHHHHHHHhcccccCceeEeeeecccC-----ceE
Q 005940 354 GFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNS--LQGMREFAAEIESLGRLRHKNLVNLHGWCKQKN-----DLL 426 (668)
Q Consensus 354 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~-----~~~ 426 (668)
+|.+.+.||+|++|.||+|+...+++.||||++.... ....+.+..|++++++++|+||+++++++.... ..|
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 4778899999999999999998889999999987644 344567899999999999999999999997765 789
Q ss_pred EEEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceec
Q 005940 427 LVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLY 506 (668)
Q Consensus 427 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~ 506 (668)
+||||++ ++|.+++.. +..+++..++.++.||+.||.|||+ .+|+||||||+||+++.++.++|+|||++...
T Consensus 81 lv~e~~~-~~l~~~l~~---~~~l~~~~~~~i~~~l~~~l~~LH~---~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~ 153 (330)
T cd07834 81 IVTELME-TDLHKVIKS---PQPLTDDHIQYFLYQILRGLKYLHS---ANVIHRDLKPSNILVNSNCDLKICDFGLARGV 153 (330)
T ss_pred EEecchh-hhHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence 9999997 589888853 3379999999999999999999999 99999999999999999999999999999876
Q ss_pred cCCCC--CcccccccCCcccCcccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCc
Q 005940 507 DHGGM--PHTTNVVGTFGYIAPELTQTG-KASTSSDVFAYGILLLEVATGRRPIGSGD 561 (668)
Q Consensus 507 ~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~sDV~S~Gvvl~elltG~~p~~~~~ 561 (668)
..... .......++..|+|||.+.+. .++.++||||||+++|+|++|+.||...+
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~ 211 (330)
T cd07834 154 DPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRD 211 (330)
T ss_pred cccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCC
Confidence 65431 122334678899999999877 78999999999999999999999996543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=317.34 Aligned_cols=250 Identities=30% Similarity=0.447 Sum_probs=184.8
Q ss_pred hcCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCC-chhHHHHHHHHHHHhcccccCceeEeeeecc---------
Q 005940 352 TKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNS-LQGMREFAAEIESLGRLRHKNLVNLHGWCKQ--------- 421 (668)
Q Consensus 352 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~--------- 421 (668)
.++|.+.+.||+||||.|||++.+-+|+.||||++.... ........+|++.+++|+|||||+++..+.+
T Consensus 478 ~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~e 557 (1351)
T KOG1035|consen 478 LNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLE 557 (1351)
T ss_pred hhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccccc
Confidence 357899999999999999999999999999999997653 3445678899999999999999999753200
Q ss_pred --------------------------------------------------------------------------------
Q 005940 422 -------------------------------------------------------------------------------- 421 (668)
Q Consensus 422 -------------------------------------------------------------------------------- 421 (668)
T Consensus 558 i~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e 637 (1351)
T KOG1035|consen 558 IVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSE 637 (1351)
T ss_pred ccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccC
Confidence
Q ss_pred ----------------------c--------CceEEEEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhh
Q 005940 422 ----------------------K--------NDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHE 471 (668)
Q Consensus 422 ----------------------~--------~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~ 471 (668)
+ -.+|+-||||+..+|.+++....-.. .-...++++++|++||+|+|+
T Consensus 638 ~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~--~~d~~wrLFreIlEGLaYIH~ 715 (1351)
T KOG1035|consen 638 GSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS--QRDEAWRLFREILEGLAYIHD 715 (1351)
T ss_pred CccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch--hhHHHHHHHHHHHHHHHHHHh
Confidence 0 12578899999988888885322111 356778999999999999999
Q ss_pred ccCCceEecCCCCCCEEECCCCCEEEEeecCceecc----------------C-CCCCcccccccCCcccCcccccCC--
Q 005940 472 EWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYD----------------H-GGMPHTTNVVGTFGYIAPELTQTG-- 532 (668)
Q Consensus 472 ~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~----------------~-~~~~~~~~~~gt~~y~aPE~~~~~-- 532 (668)
++||||||||.||+||++.++||+|||+|.... . ......+..+||.-|+|||++.+.
T Consensus 716 ---~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~ 792 (1351)
T KOG1035|consen 716 ---QGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSS 792 (1351)
T ss_pred ---CceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccc
Confidence 999999999999999999999999999998721 0 011134567899999999998764
Q ss_pred -CCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHH--HhcCccccccCcccCCcccHHHHHHHHHHHhhc-CCCC
Q 005940 533 -KASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVREC--HQLGRILDVADPLLNSSYVVKEMELVLKLGLMC-SHKT 608 (668)
Q Consensus 533 -~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~--~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C-~~~p 608 (668)
+|+.|+|+||+|||++||+. ||+.. ++.+... .+.+.+..- ..+..+++..=.++..++ .++|
T Consensus 793 ~~Yn~KiDmYSLGIVlFEM~y---PF~Ts----MERa~iL~~LR~g~iP~~------~~f~~~~~~~e~slI~~Ll~hdP 859 (1351)
T KOG1035|consen 793 NKYNSKIDMYSLGIVLFEMLY---PFGTS----MERASILTNLRKGSIPEP------ADFFDPEHPEEASLIRWLLSHDP 859 (1351)
T ss_pred ccccchhhhHHHHHHHHHHhc---cCCch----HHHHHHHHhcccCCCCCC------cccccccchHHHHHHHHHhcCCC
Confidence 49999999999999999997 67542 1111111 122222211 112222222222333444 4569
Q ss_pred CCCCCHHHHHH
Q 005940 609 QFRPTMRQVMR 619 (668)
Q Consensus 609 ~~RPs~~evl~ 619 (668)
.+|||+.|+++
T Consensus 860 ~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 860 SKRPTATELLN 870 (1351)
T ss_pred ccCCCHHHHhh
Confidence 99999999986
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-32 Score=286.89 Aligned_cols=251 Identities=30% Similarity=0.398 Sum_probs=196.5
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecC---CchhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEE
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRN---SLQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVY 429 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 429 (668)
+.|...+.||+|++|.||+|+...++..+|+|.+... .....+++.+|++++++++|+|++++++++......++||
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 3466778899999999999999888999999998643 2234567889999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCC
Q 005940 430 EYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHG 509 (668)
Q Consensus 430 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~ 509 (668)
||+. |+|.+++.. ....+++.++..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++......
T Consensus 95 e~~~-~~l~~~~~~--~~~~l~~~~~~~~~~~l~~~l~~LH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 168 (308)
T cd06634 95 EYCL-GSASDLLEV--HKKPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 168 (308)
T ss_pred EccC-CCHHHHHHH--cCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHhEEECCCCcEEECCcccceeecCc
Confidence 9996 688777742 23458999999999999999999998 99999999999999999999999999998765432
Q ss_pred CCCcccccccCCcccCccccc---CCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCcccC
Q 005940 510 GMPHTTNVVGTFGYIAPELTQ---TGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLN 586 (668)
Q Consensus 510 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 586 (668)
....++..|+|||.+. .+..+.++|||||||++|||++|+.||...+.. +....... ... +...
T Consensus 169 -----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--~~~~~~~~-~~~-----~~~~ 235 (308)
T cd06634 169 -----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM--SALYHIAQ-NES-----PALQ 235 (308)
T ss_pred -----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHH--HHHHHHhh-cCC-----CCcC
Confidence 2346788999999874 356788999999999999999999998654321 11111111 111 1111
Q ss_pred CcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhccCc
Q 005940 587 SSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSGEK 625 (668)
Q Consensus 587 ~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~~~ 625 (668)
.. .....+..+...|+.. |++||++.+++++.-...
T Consensus 236 ~~---~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~ 272 (308)
T cd06634 236 SG---HWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR 272 (308)
T ss_pred cc---cccHHHHHHHHHHhhCCcccCCCHHHHhhCccccc
Confidence 11 1123345666789887 999999999998755444
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=301.27 Aligned_cols=252 Identities=26% Similarity=0.352 Sum_probs=204.7
Q ss_pred CcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCchhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEEecC
Q 005940 354 GFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEYIP 433 (668)
Q Consensus 354 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~ 433 (668)
-|.++..||.|+||.||++..+.++-..|.|++...+.+..++|+-|++||..+.||+||+|++.|..++.+++..|||.
T Consensus 33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~ 112 (1187)
T KOG0579|consen 33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCG 112 (1187)
T ss_pred HHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecC
Confidence 46677889999999999999988888889999998888899999999999999999999999999999999999999999
Q ss_pred CCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCCCCc
Q 005940 434 NGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPH 513 (668)
Q Consensus 434 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 513 (668)
||-.+.++- .-+..|++.++..+++|++.||.|||+ +.|||||||+.|||++-+|.++|+|||.+-.... ....
T Consensus 113 GGAVDaiml--EL~r~LtE~QIqvvc~q~ldALn~LHs---~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~-t~qk 186 (1187)
T KOG0579|consen 113 GGAVDAIML--ELGRVLTEDQIQVVCYQVLDALNWLHS---QNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKS-TRQK 186 (1187)
T ss_pred CchHhHHHH--HhccccchHHHHHHHHHHHHHHHHHhh---cchhhhhccccceEEEecCcEeeecccccccchh-HHhh
Confidence 999999884 345789999999999999999999999 9999999999999999999999999998754332 1223
Q ss_pred ccccccCCcccCccccc-----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCcccCCc
Q 005940 514 TTNVVGTFGYIAPELTQ-----TGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSS 588 (668)
Q Consensus 514 ~~~~~gt~~y~aPE~~~-----~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 588 (668)
...+.||+.|||||+.. ...|..++||||||+.|.||..+.+|-.. ...+..+..... .. .|.+..
T Consensus 187 RDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhe--lnpMRVllKiaK-Se-----PPTLlq- 257 (1187)
T KOG0579|consen 187 RDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHE--LNPMRVLLKIAK-SE-----PPTLLQ- 257 (1187)
T ss_pred hccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccc--cchHHHHHHHhh-cC-----CCcccC-
Confidence 45678999999999764 46789999999999999999999998643 222222222111 11 122211
Q ss_pred ccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHh
Q 005940 589 YVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYL 621 (668)
Q Consensus 589 ~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L 621 (668)
+......+..+...|+.. |..||++.|+++|-
T Consensus 258 -PS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hp 290 (1187)
T KOG0579|consen 258 -PSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHP 290 (1187)
T ss_pred -cchhhhHHHHHHHHHHhcCCccCCCHHHHhhCc
Confidence 112223344555678776 99999999999873
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-32 Score=285.68 Aligned_cols=244 Identities=28% Similarity=0.401 Sum_probs=191.9
Q ss_pred cccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCc---hhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEEe
Q 005940 355 FKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSL---QGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEY 431 (668)
Q Consensus 355 f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~ 431 (668)
|...+.||+|++|.||+|+...++..|++|++..... ...+.+.+|++++++++|+|++++++++.+....++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 5556789999999999999988899999999875332 3446788999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCCC
Q 005940 432 IPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGM 511 (668)
Q Consensus 432 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~~ 511 (668)
+. |+|.+++.. ....+++.++..++.|++.||.|||+ .+++||||+|+||+++.++.+||+|||++.....
T Consensus 103 ~~-~~l~~~l~~--~~~~l~~~~~~~~~~qi~~al~~LH~---~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~--- 173 (313)
T cd06633 103 CL-GSASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP--- 173 (313)
T ss_pred CC-CCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCChhhEEECCCCCEEEeecCCCcccCC---
Confidence 96 577777742 33568999999999999999999998 9999999999999999999999999999864322
Q ss_pred CcccccccCCcccCccccc---CCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCcccCCc
Q 005940 512 PHTTNVVGTFGYIAPELTQ---TGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSS 588 (668)
Q Consensus 512 ~~~~~~~gt~~y~aPE~~~---~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 588 (668)
.....|+..|+|||++. .+.++.++|||||||++|||++|..|+...+.. .......... ...... ..
T Consensus 174 --~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~--~~~~~~~~~~-~~~~~~----~~ 244 (313)
T cd06633 174 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM--SALYHIAQND-SPTLQS----NE 244 (313)
T ss_pred --CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHhcC-CCCCCc----cc
Confidence 22346888999999874 456788999999999999999999998654321 1111111111 111111 11
Q ss_pred ccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 589 YVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 589 ~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
+. ..+..+...|++. |++||++.+++++
T Consensus 245 ~~----~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 245 WT----DSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred cC----HHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11 2345566688887 9999999999975
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=287.36 Aligned_cols=263 Identities=26% Similarity=0.286 Sum_probs=192.8
Q ss_pred hcCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCch--hHHHHHHHHHHHhcccccCceeEeeeeccc-------
Q 005940 352 TKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQ--GMREFAAEIESLGRLRHKNLVNLHGWCKQK------- 422 (668)
Q Consensus 352 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~------- 422 (668)
.++|+..++||+|++|.||+|++..+++.+|||++...... ....+.+|++++++++|+||+++++++...
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 46899999999999999999999888999999998654322 234567899999999999999999987443
Q ss_pred -CceEEEEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeec
Q 005940 423 -NDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFG 501 (668)
Q Consensus 423 -~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfG 501 (668)
..+++|+||+.. +|...+.. ....+++.++..++.|+++||.|||+ .+++||||||+||++++++.+||+|||
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~--~~~~~~~~~~~~i~~~l~~al~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg 160 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLEN--PSVKLTESQIKCYMLQLLEGINYLHE---NHILHRDIKAANILIDNQGILKIADFG 160 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECcCc
Confidence 346999999964 67776642 34569999999999999999999999 999999999999999999999999999
Q ss_pred CceeccCCCCC----------cccccccCCcccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCchh-HHHHHH
Q 005940 502 LARLYDHGGMP----------HTTNVVGTFGYIAPELTQT-GKASTSSDVFAYGILLLEVATGRRPIGSGDLL-LVEWVR 569 (668)
Q Consensus 502 la~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~-l~~~~~ 569 (668)
+++........ ..+...++..|+|||.+.+ ..++.++|||||||++|||++|+.||...... ......
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~ 240 (311)
T cd07866 161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIF 240 (311)
T ss_pred cchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 99865432211 1123456888999998765 35789999999999999999999999754221 111111
Q ss_pred HHHhc---------CccccccC----cccCCcc---cHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 570 ECHQL---------GRILDVAD----PLLNSSY---VVKEMELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 570 ~~~~~---------~~~~~~~d----~~l~~~~---~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
..... ..+....+ ....... .......+..+...|+.. |++||++.|++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~ 308 (311)
T cd07866 241 KLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEH 308 (311)
T ss_pred HHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence 11000 00000000 0000000 001113456677788887 9999999999864
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=285.99 Aligned_cols=201 Identities=30% Similarity=0.442 Sum_probs=182.0
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCc---hhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEE
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSL---QGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVY 429 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 429 (668)
+.|+.-++||+||||.||-+....+|+.+|.|++.++.. ++....++|-.+|.+++.+.||.+--.++.++.++||+
T Consensus 185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVL 264 (591)
T KOG0986|consen 185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVL 264 (591)
T ss_pred cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEE
Confidence 567888999999999999999999999999999976544 33456778999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCC
Q 005940 430 EYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHG 509 (668)
Q Consensus 430 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~ 509 (668)
..|.||+|.-+|... ....+++...+-++.+|+.||.+||. ..||+|||||+|||||+.|+++|+|+|+|..+..+
T Consensus 265 tlMNGGDLkfHiyn~-g~~gF~e~ra~FYAAEi~cGLehlH~---~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g 340 (591)
T KOG0986|consen 265 TLMNGGDLKFHIYNH-GNPGFDEQRARFYAAEIICGLEHLHR---RRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEG 340 (591)
T ss_pred EeecCCceeEEeecc-CCCCCchHHHHHHHHHHHhhHHHHHh---cceeeccCChhheeeccCCCeEeeccceEEecCCC
Confidence 999999999999743 34679999999999999999999999 99999999999999999999999999999988776
Q ss_pred CCCcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 005940 510 GMPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGS 559 (668)
Q Consensus 510 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~ 559 (668)
... ...+||.+|||||++.++.|+...|.||+||++|||+.|+.||..
T Consensus 341 ~~~--~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~ 388 (591)
T KOG0986|consen 341 KPI--RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQ 388 (591)
T ss_pred Ccc--ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhh
Confidence 543 234899999999999999999999999999999999999999964
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-32 Score=282.14 Aligned_cols=250 Identities=23% Similarity=0.323 Sum_probs=194.6
Q ss_pred CcccceeeeecCcEEEEEEEeC---CCCcEEEEEEEecCCc----hhHHHHHHHHHHHhcc-cccCceeEeeeecccCce
Q 005940 354 GFKESEVIGIGGFGSVYKGVLP---TTGGEVAVKKITRNSL----QGMREFAAEIESLGRL-RHKNLVNLHGWCKQKNDL 425 (668)
Q Consensus 354 ~f~~~~~lG~G~~g~Vy~~~~~---~~~~~vavK~~~~~~~----~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~ 425 (668)
+|+..+.||+|+||.||++... .+|..||+|++..... ...+.+..|+++++++ +|+||+++++.+......
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 4778899999999999999874 3688999999875422 2346778899999999 599999999999998899
Q ss_pred EEEEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCcee
Q 005940 426 LLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARL 505 (668)
Q Consensus 426 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~ 505 (668)
++||||+++++|.+++.. ...+++..+..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++..
T Consensus 81 ~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 154 (290)
T cd05613 81 HLILDYINGGELFTHLSQ---RERFKEQEVQIYSGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKE 154 (290)
T ss_pred EEEEecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeEECCCCCEEEeeCcccee
Confidence 999999999999999953 3458899999999999999999998 9999999999999999999999999999987
Q ss_pred ccCCCCCcccccccCCcccCcccccCC--CCCcchhHHHHHHHHHHHHhCCCCCCCCc--hhHHHHHHHHHhcCcccccc
Q 005940 506 YDHGGMPHTTNVVGTFGYIAPELTQTG--KASTSSDVFAYGILLLEVATGRRPIGSGD--LLLVEWVRECHQLGRILDVA 581 (668)
Q Consensus 506 ~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDV~S~Gvvl~elltG~~p~~~~~--~~l~~~~~~~~~~~~~~~~~ 581 (668)
.............|+..|+|||.+..+ .++.++||||||+++|||++|+.||.... ....++........
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~------ 228 (290)
T cd05613 155 FHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE------ 228 (290)
T ss_pred cccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccC------
Confidence 654333333345688999999998753 46789999999999999999999996321 12222222221111
Q ss_pred CcccCCcccHHHHHHHHHHHhhcCCC-CCCCC-----CHHHHHHH
Q 005940 582 DPLLNSSYVVKEMELVLKLGLMCSHK-TQFRP-----TMRQVMRY 620 (668)
Q Consensus 582 d~~l~~~~~~~~~~~l~~l~~~C~~~-p~~RP-----s~~evl~~ 620 (668)
+.....++ ..+..+...|+.. |++|| +.++++.+
T Consensus 229 -~~~~~~~~----~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 229 -PPYPQEMS----ALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred -CCCCccCC----HHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 11111112 2345566688887 99997 77777664
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=307.53 Aligned_cols=201 Identities=21% Similarity=0.362 Sum_probs=160.1
Q ss_pred hcCcccceeeeecCcEEEEEEEeCCCCcE-EEEEEE--------------e---cCCchhHHHHHHHHHHHhcccccCce
Q 005940 352 TKGFKESEVIGIGGFGSVYKGVLPTTGGE-VAVKKI--------------T---RNSLQGMREFAAEIESLGRLRHKNLV 413 (668)
Q Consensus 352 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~-vavK~~--------------~---~~~~~~~~~f~~Ei~~l~~l~H~nIv 413 (668)
.++|++.++||+|+||+||++.++..... .++|.+ . .........+.+|++++++++|+||+
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv 226 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL 226 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence 46899999999999999999876432221 222211 0 01112345688999999999999999
Q ss_pred eEeeeecccCceEEEEEecCCCChhhhhcCCCC--CCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECC
Q 005940 414 NLHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKD--GSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDA 491 (668)
Q Consensus 414 ~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~ 491 (668)
++++++...+..|+|+|++. ++|.+++..... .......+...++.||+.||.|||+ ++|+||||||+|||++.
T Consensus 227 ~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~---~gIiHrDLKP~NILl~~ 302 (501)
T PHA03210 227 KIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHD---KKLIHRDIKLENIFLNC 302 (501)
T ss_pred cEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECC
Confidence 99999999999999999985 567776642211 1223456677899999999999998 99999999999999999
Q ss_pred CCCEEEEeecCceeccCCCCCcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCC
Q 005940 492 EMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRP 556 (668)
Q Consensus 492 ~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p 556 (668)
++.+||+|||+++.+............||..|+|||++.+..++.++|||||||++|||++|..+
T Consensus 303 ~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~ 367 (501)
T PHA03210 303 DGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFC 367 (501)
T ss_pred CCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCC
Confidence 99999999999987765433333446799999999999988999999999999999999998754
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-32 Score=285.22 Aligned_cols=196 Identities=24% Similarity=0.262 Sum_probs=161.5
Q ss_pred eeeeecCcEEEEEEEeCCCCcEEEEEEEecC--CchhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEEecCCCC
Q 005940 359 EVIGIGGFGSVYKGVLPTTGGEVAVKKITRN--SLQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEYIPNGS 436 (668)
Q Consensus 359 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gs 436 (668)
+.+|.|+++.||++ ..+++.||||++... .....+.+.+|++++++++|+||+++++.+...+..+++|||+++|+
T Consensus 8 ~~~~~~~~v~~~~~--~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~ 85 (314)
T cd08216 8 KCFEDLMIVHLAKH--KPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGS 85 (314)
T ss_pred HhhcCCceEEEEEe--cCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCC
Confidence 34444555555554 447999999999765 33456789999999999999999999999999999999999999999
Q ss_pred hhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCCC-----
Q 005940 437 LDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGM----- 511 (668)
Q Consensus 437 L~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~~----- 511 (668)
|.+++... ....+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||.+........
T Consensus 86 l~~~l~~~-~~~~~~~~~~~~~~~~l~~~L~~LH~---~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~ 161 (314)
T cd08216 86 CEDLLKTH-FPEGLPELAIAFILKDVLNALDYIHS---KGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVV 161 (314)
T ss_pred HHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCcceEEEecCCceEEecCccceeecccccccccc
Confidence 99999643 23458899999999999999999998 9999999999999999999999999998875532211
Q ss_pred -CcccccccCCcccCcccccC--CCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 005940 512 -PHTTNVVGTFGYIAPELTQT--GKASTSSDVFAYGILLLEVATGRRPIGSG 560 (668)
Q Consensus 512 -~~~~~~~gt~~y~aPE~~~~--~~~~~~sDV~S~Gvvl~elltG~~p~~~~ 560 (668)
.......++..|+|||++.. ..++.++|||||||++|||++|+.||...
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~ 213 (314)
T cd08216 162 HDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDM 213 (314)
T ss_pred ccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Confidence 11123356778999999865 35789999999999999999999999754
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-32 Score=281.53 Aligned_cols=242 Identities=24% Similarity=0.311 Sum_probs=184.6
Q ss_pred eeeecCcEEEEEEEeCCCCcEEEEEEEecCCch---hHHHHHHHHHH---HhcccccCceeEeeeecccCceEEEEEecC
Q 005940 360 VIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQ---GMREFAAEIES---LGRLRHKNLVNLHGWCKQKNDLLLVYEYIP 433 (668)
Q Consensus 360 ~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~f~~Ei~~---l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~ 433 (668)
.||+|+||.||++....+++.||+|.+.+.... ....+..|..+ ++...||||+++++.+...+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 489999999999999888999999998764322 12234445443 444579999999999999999999999999
Q ss_pred CCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCCCCc
Q 005940 434 NGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPH 513 (668)
Q Consensus 434 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 513 (668)
+|+|.+++.. ...+++..+..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++.......
T Consensus 81 g~~L~~~l~~---~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~--- 151 (278)
T cd05606 81 GGDLHYHLSQ---HGVFSEAEMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--- 151 (278)
T ss_pred CCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC---
Confidence 9999998852 3469999999999999999999998 999999999999999999999999999987654322
Q ss_pred ccccccCCcccCcccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCcccCCcccHH
Q 005940 514 TTNVVGTFGYIAPELTQTG-KASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSYVVK 592 (668)
Q Consensus 514 ~~~~~gt~~y~aPE~~~~~-~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 592 (668)
.....|+..|+|||.+.++ .++.++||||+||++|||++|+.||................. .++.+.....
T Consensus 152 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~------~~~~~~~~~s-- 223 (278)
T cd05606 152 PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT------MAVELPDSFS-- 223 (278)
T ss_pred CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhc------cCCCCCCcCC--
Confidence 1234689999999998754 588999999999999999999999975422111111111111 1122222222
Q ss_pred HHHHHHHHHhhcCCC-CCCCC-----CHHHHHHH
Q 005940 593 EMELVLKLGLMCSHK-TQFRP-----TMRQVMRY 620 (668)
Q Consensus 593 ~~~~l~~l~~~C~~~-p~~RP-----s~~evl~~ 620 (668)
..+..+...|+.. |++|| ++++++++
T Consensus 224 --~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~ 255 (278)
T cd05606 224 --PELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH 255 (278)
T ss_pred --HHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence 2334444567776 99999 99999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-32 Score=288.55 Aligned_cols=207 Identities=28% Similarity=0.424 Sum_probs=175.4
Q ss_pred ccchhhHHHHhcCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCC--chhHHHHHHHHHHHhcccccCceeEeeee
Q 005940 342 RFRYKDLYAATKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNS--LQGMREFAAEIESLGRLRHKNLVNLHGWC 419 (668)
Q Consensus 342 ~f~~~el~~at~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~ 419 (668)
+....++...+++|...+.||+|+||.||+|....+++.||+|++.+.. ....+.+.+|+.++++++|+||+++++++
T Consensus 6 ~~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~ 85 (345)
T cd07877 6 QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVF 85 (345)
T ss_pred hhHHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeee
Confidence 3445667778899999999999999999999988889999999987542 23346788899999999999999999987
Q ss_pred ccc------CceEEEEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCC
Q 005940 420 KQK------NDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEM 493 (668)
Q Consensus 420 ~~~------~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~ 493 (668)
... ...+++++++ +++|.+++.. ..+++..+..++.|+++||+|||+ .+|+||||||+||+++.++
T Consensus 86 ~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~ 157 (345)
T cd07877 86 TPARSLEEFNDVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDC 157 (345)
T ss_pred eecccccccccEEEEehhc-ccCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChHHEEEcCCC
Confidence 532 3467888877 7899888742 348999999999999999999998 9999999999999999999
Q ss_pred CEEEEeecCceeccCCCCCcccccccCCcccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 005940 494 NARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPELTQT-GKASTSSDVFAYGILLLEVATGRRPIGSG 560 (668)
Q Consensus 494 ~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~S~Gvvl~elltG~~p~~~~ 560 (668)
.+||+|||+++..... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||...
T Consensus 158 ~~kl~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~ 221 (345)
T cd07877 158 ELKILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 221 (345)
T ss_pred CEEEeccccccccccc----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 9999999998865432 233467889999998765 46788999999999999999999999644
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-32 Score=281.71 Aligned_cols=253 Identities=23% Similarity=0.295 Sum_probs=195.6
Q ss_pred CcccceeeeecCcEEEEEEEeC---CCCcEEEEEEEecCC----chhHHHHHHHHHHHhcc-cccCceeEeeeecccCce
Q 005940 354 GFKESEVIGIGGFGSVYKGVLP---TTGGEVAVKKITRNS----LQGMREFAAEIESLGRL-RHKNLVNLHGWCKQKNDL 425 (668)
Q Consensus 354 ~f~~~~~lG~G~~g~Vy~~~~~---~~~~~vavK~~~~~~----~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~ 425 (668)
+|+..+.||+|++|.||+++.. .++..||||.+.+.. ....+.+..|++++.++ +|+||+++++.+......
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 4677899999999999999853 356789999987532 22345688999999999 599999999999988999
Q ss_pred EEEEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCcee
Q 005940 426 LLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARL 505 (668)
Q Consensus 426 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~ 505 (668)
++||||+++|+|.+++.. ...+++..+..++.|+++||.|||+ .+++||||||+||+++.++.++|+|||+++.
T Consensus 81 ~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~ql~~~l~~lH~---~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~ 154 (288)
T cd05583 81 HLILDYVNGGELFTHLYQ---REHFTESEVRVYIAEIVLALDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKE 154 (288)
T ss_pred EEEEecCCCCcHHHHHhh---cCCcCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEEECccccc
Confidence 999999999999999853 3458999999999999999999998 9999999999999999999999999999987
Q ss_pred ccCCCCCcccccccCCcccCcccccCCC--CCcchhHHHHHHHHHHHHhCCCCCCCCch--hHHHHHHHHHhcCcccccc
Q 005940 506 YDHGGMPHTTNVVGTFGYIAPELTQTGK--ASTSSDVFAYGILLLEVATGRRPIGSGDL--LLVEWVRECHQLGRILDVA 581 (668)
Q Consensus 506 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDV~S~Gvvl~elltG~~p~~~~~~--~l~~~~~~~~~~~~~~~~~ 581 (668)
.............|+..|+|||.+.+.. .+.++||||||+++|||++|..||...+. ...+........
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~------- 227 (288)
T cd05583 155 FLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKS------- 227 (288)
T ss_pred cccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHcc-------
Confidence 6544322233346889999999987655 78899999999999999999999953321 111111111111
Q ss_pred CcccCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhcc
Q 005940 582 DPLLNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSG 623 (668)
Q Consensus 582 d~~l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~ 623 (668)
.+.....++. .+..+...|+.. |++||+++++.+.|+-
T Consensus 228 ~~~~~~~~~~----~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 228 KPPFPKTMSA----EARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred CCCCCcccCH----HHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 1111122222 234455578776 9999998888776654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-32 Score=288.61 Aligned_cols=260 Identities=22% Similarity=0.255 Sum_probs=193.3
Q ss_pred cCccc-ceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCchh--------------HHHHHHHHHHHhcccccCceeEee
Q 005940 353 KGFKE-SEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQG--------------MREFAAEIESLGRLRHKNLVNLHG 417 (668)
Q Consensus 353 ~~f~~-~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~--------------~~~f~~Ei~~l~~l~H~nIv~l~g 417 (668)
++|.. .+.||+|+||.||+|.+..+++.||||++....... ...+.+|++++++++|+||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 45543 567999999999999998889999999986543221 125778999999999999999999
Q ss_pred eecccCceEEEEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEE
Q 005940 418 WCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARL 497 (668)
Q Consensus 418 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl 497 (668)
++..++..++||||++ |+|.+++.. ...+++.....++.|++.||.|||+ .+++||||||+||+++.++.+||
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~---~~~~~~~~~~~~~~ql~~aL~~LH~---~~i~H~dl~~~nill~~~~~~kl 160 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDR---KIRLTESQVKCILLQILNGLNVLHK---WYFMHRDLSPANIFINSKGICKI 160 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeecccccHHHeEECCCCCEEE
Confidence 9999999999999996 689988852 3458999999999999999999998 99999999999999999999999
Q ss_pred EeecCceeccCCC-------------CCcccccccCCcccCcccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCch-
Q 005940 498 GDFGLARLYDHGG-------------MPHTTNVVGTFGYIAPELTQTG-KASTSSDVFAYGILLLEVATGRRPIGSGDL- 562 (668)
Q Consensus 498 ~DfGla~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDV~S~Gvvl~elltG~~p~~~~~~- 562 (668)
+|||++....... ........++..|+|||++.+. .++.++|||||||++|||++|+.||...+.
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~ 240 (335)
T PTZ00024 161 ADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEI 240 (335)
T ss_pred CCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 9999998665111 0111223467889999988764 468999999999999999999999975432
Q ss_pred hHHHHHHHHHhcCccc---cc------------cCcccCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 563 LLVEWVRECHQLGRIL---DV------------ADPLLNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 563 ~l~~~~~~~~~~~~~~---~~------------~d~~l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
.....+.+........ .. ..+.... ........+..+...|+.. |++||+++|++.+
T Consensus 241 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~ 313 (335)
T PTZ00024 241 DQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKT-IFPNASDDAIDLLQSLLKLNPLERISAKEALKH 313 (335)
T ss_pred HHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHH-hCcCCChHHHHHHHHHcCCCchhccCHHHHhcC
Confidence 2222222211111000 00 0000000 0001123455666788886 9999999999974
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-32 Score=280.73 Aligned_cols=199 Identities=33% Similarity=0.427 Sum_probs=172.4
Q ss_pred cccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCC--chhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEEec
Q 005940 355 FKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNS--LQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEYI 432 (668)
Q Consensus 355 f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~ 432 (668)
|+..+.||+|++|.||+|+...+++.+|+|++.... ....+.+..|+.++++++|+|++++++++...+..++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 456788999999999999998889999999997653 333467889999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCCCC
Q 005940 433 PNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMP 512 (668)
Q Consensus 433 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~~~ 512 (668)
+ ++|.+++... ...+++..++.++.|++.||.|||+ .+|+||||+|+||++++++.+||+|||+++.......
T Consensus 81 ~-~~l~~~i~~~--~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~- 153 (282)
T cd07829 81 D-MDLKKYLDKR--PGPLSPNLIKSIMYQLLRGLAYCHS---HRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR- 153 (282)
T ss_pred C-cCHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChheEEEcCCCCEEEecCCcccccCCCcc-
Confidence 7 5899999632 2469999999999999999999999 8999999999999999999999999999987654322
Q ss_pred cccccccCCcccCcccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 005940 513 HTTNVVGTFGYIAPELTQTG-KASTSSDVFAYGILLLEVATGRRPIGSG 560 (668)
Q Consensus 513 ~~~~~~gt~~y~aPE~~~~~-~~~~~sDV~S~Gvvl~elltG~~p~~~~ 560 (668)
......++..|+|||.+.+. .++.++|||||||++|||++|+.||...
T Consensus 154 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~ 202 (282)
T cd07829 154 TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGD 202 (282)
T ss_pred ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCc
Confidence 22233557789999998766 7899999999999999999999999654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=283.81 Aligned_cols=246 Identities=22% Similarity=0.328 Sum_probs=200.1
Q ss_pred CcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCch--hHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEEe
Q 005940 354 GFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQ--GMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEY 431 (668)
Q Consensus 354 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~ 431 (668)
-|...+-||+|.|..|-++++.-+|+.||||++.+.... ....+.+|++.|+.++|||||+|+........+|||.|+
T Consensus 19 LYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLEL 98 (864)
T KOG4717|consen 19 LYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILEL 98 (864)
T ss_pred eehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEe
Confidence 466778899999999999999889999999999876543 335678999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCC-CCEEEEeecCceeccCCC
Q 005940 432 IPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAE-MNARLGDFGLARLYDHGG 510 (668)
Q Consensus 432 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~-~~~kl~DfGla~~~~~~~ 510 (668)
-.+|+|.+|+.+.. ..+++....+++.||+.|+.|+|+ ..+|||||||+||.+-+. |-+||.|||++-.+..+.
T Consensus 99 GD~GDl~DyImKHe--~Gl~E~La~kYF~QI~~AI~YCHq---LHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~ 173 (864)
T KOG4717|consen 99 GDGGDLFDYIMKHE--EGLNEDLAKKYFAQIVHAISYCHQ---LHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGK 173 (864)
T ss_pred cCCchHHHHHHhhh--ccccHHHHHHHHHHHHHHHHHHhh---hhhhcccCCcceeEEeeecCceEeeeccccccCCCcc
Confidence 99999999996543 458999999999999999999999 999999999999987655 789999999998887765
Q ss_pred CCcccccccCCcccCcccccCCCCC-cchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCcccC--C
Q 005940 511 MPHTTNVVGTFGYIAPELTQTGKAS-TSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLN--S 587 (668)
Q Consensus 511 ~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~--~ 587 (668)
. .+..+|...|-|||++.+..|. ++.||||+|||||.|+||+.||+..... +.+..++|-.+. .
T Consensus 174 k--L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDS-----------ETLTmImDCKYtvPs 240 (864)
T KOG4717|consen 174 K--LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDS-----------ETLTMIMDCKYTVPS 240 (864)
T ss_pred h--hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccch-----------hhhhhhhcccccCch
Confidence 3 4556999999999999988874 7899999999999999999999764211 112222333221 1
Q ss_pred cccHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 005940 588 SYVVKEMELVLKLGLMCSHKTQFRPTMRQVMRY 620 (668)
Q Consensus 588 ~~~~~~~~~l~~l~~~C~~~p~~RPs~~evl~~ 620 (668)
-...+ +--.|..|+..+|++|-+.+||...
T Consensus 241 hvS~e---CrdLI~sMLvRdPkkRAslEeI~s~ 270 (864)
T KOG4717|consen 241 HVSKE---CRDLIQSMLVRDPKKRASLEEIVST 270 (864)
T ss_pred hhhHH---HHHHHHHHHhcCchhhccHHHHhcc
Confidence 11112 2223344666679999999999864
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-33 Score=267.09 Aligned_cols=248 Identities=26% Similarity=0.369 Sum_probs=196.2
Q ss_pred cccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCC-chhHHHHHHHHHHHhccc-ccCceeEeeeecccCceEEEEEec
Q 005940 355 FKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNS-LQGMREFAAEIESLGRLR-HKNLVNLHGWCKQKNDLLLVYEYI 432 (668)
Q Consensus 355 f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~lV~E~~ 432 (668)
.+....||.|..|.|++++++.+|...|||.+.+.. .+..++++..+.++.+-+ +|.||+.+|+|......++.||.|
T Consensus 94 l~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelM 173 (391)
T KOG0983|consen 94 LENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELM 173 (391)
T ss_pred hhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHH
Confidence 344677999999999999999999999999997754 345667777787777665 899999999999999999999998
Q ss_pred CCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCCCC
Q 005940 433 PNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMP 512 (668)
Q Consensus 433 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~~~ 512 (668)
...++.+|.. -.+++++.-+-++...++.||.||.+ +++|+|||+||+|||+|+.|++||||||++..+-+..
T Consensus 174 -s~C~ekLlkr--ik~piPE~ilGk~tva~v~AL~YLKe--KH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk-- 246 (391)
T KOG0983|consen 174 -STCAEKLLKR--IKGPIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK-- 246 (391)
T ss_pred -HHHHHHHHHH--hcCCchHHhhhhhHHHHHHHHHHHHH--hcceeecccCccceEEccCCCEEeecccccceeeccc--
Confidence 4567777753 34568888888999999999999998 6899999999999999999999999999998765543
Q ss_pred cccccccCCcccCcccccC---CCCCcchhHHHHHHHHHHHHhCCCCCCCCc--hhHHHHHHHHHhcCccccccCcccCC
Q 005940 513 HTTNVVGTFGYIAPELTQT---GKASTSSDVFAYGILLLEVATGRRPIGSGD--LLLVEWVRECHQLGRILDVADPLLNS 587 (668)
Q Consensus 513 ~~~~~~gt~~y~aPE~~~~---~~~~~~sDV~S~Gvvl~elltG~~p~~~~~--~~l~~~~~~~~~~~~~~~~~d~~l~~ 587 (668)
..+...|-+.|||||.+.- .+|..++||||||+.++||.||+.||...+ .....-+. +...|.+..
T Consensus 247 AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvl---------n~ePP~L~~ 317 (391)
T KOG0983|consen 247 AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVL---------NEEPPLLPG 317 (391)
T ss_pred ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHH---------hcCCCCCCc
Confidence 2345689999999998853 468899999999999999999999998743 22222111 111244432
Q ss_pred cccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 588 SYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 588 ~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
... -...+..+...|+.. +.+||...+++++
T Consensus 318 ~~g--FSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 318 HMG--FSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred ccC--cCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 210 112355566689887 9999999999986
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-32 Score=290.31 Aligned_cols=200 Identities=29% Similarity=0.423 Sum_probs=168.9
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCchhHHHHHHHHHHHhcccccCceeEeeeeccc----------
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNLHGWCKQK---------- 422 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~---------- 422 (668)
.+|...+.||.|+||.||+|....++..||+|++........+.+.+|++++++++||||+++++.+...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS 84 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence 5788999999999999999999889999999999776666677889999999999999999999876543
Q ss_pred ----CceEEEEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECC-CCCEEE
Q 005940 423 ----NDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDA-EMNARL 497 (668)
Q Consensus 423 ----~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~-~~~~kl 497 (668)
...++||||++ ++|.+++. ...+++..+..++.||+.||.|||+ .+++||||||+||+++. +..+||
T Consensus 85 ~~~~~~~~lv~e~~~-~~L~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~---~givH~dikp~Nili~~~~~~~kl 156 (342)
T cd07854 85 LTELNSVYIVQEYME-TDLANVLE----QGPLSEEHARLFMYQLLRGLKYIHS---ANVLHRDLKPANVFINTEDLVLKI 156 (342)
T ss_pred ccccceEEEEeeccc-ccHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEcCCCceEEE
Confidence 35789999997 58988874 2358999999999999999999998 99999999999999974 567899
Q ss_pred EeecCceeccCCCCC--cccccccCCcccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 005940 498 GDFGLARLYDHGGMP--HTTNVVGTFGYIAPELTQT-GKASTSSDVFAYGILLLEVATGRRPIGSG 560 (668)
Q Consensus 498 ~DfGla~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~S~Gvvl~elltG~~p~~~~ 560 (668)
+|||+++........ ......++..|+|||.+.. ..++.++|||||||++|||++|+.||...
T Consensus 157 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~ 222 (342)
T cd07854 157 GDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGA 222 (342)
T ss_pred CCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 999999865432111 1123357889999997654 45788999999999999999999999654
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-32 Score=277.24 Aligned_cols=250 Identities=22% Similarity=0.356 Sum_probs=193.5
Q ss_pred CcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCC-----chhHHHHHHHHHHHhcccccCceeEeeeecccCceEEE
Q 005940 354 GFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNS-----LQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLV 428 (668)
Q Consensus 354 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV 428 (668)
+|...++||+|+||.||++.+...+..+++|.+.... .....++..|+.++++++||||+++++++.+....++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 4777899999999999999987666667666654321 22334567899999999999999999999999999999
Q ss_pred EEecCCCChhhhhcCC-CCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceecc
Q 005940 429 YEYIPNGSLDTLLFKP-KDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYD 507 (668)
Q Consensus 429 ~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~ 507 (668)
|||+++++|.+++... .....+++.+++.++.|++.||.|||+ .+++|+||||+||+++. +.+||+|||++....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQ---RRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHH---cCccccCCChhheEeec-CCEeecccCceeecC
Confidence 9999999999988532 234579999999999999999999998 99999999999999975 569999999998764
Q ss_pred CCCCCcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCcccCC
Q 005940 508 HGGMPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNS 587 (668)
Q Consensus 508 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 587 (668)
.... ......|+..|+|||.+....++.++|+||||+++|+|++|..||..... ......... . ..+.+..
T Consensus 157 ~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~--~~~~~~~~~-~-----~~~~~~~ 227 (260)
T cd08222 157 GSCD-LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNF--LSVVLRIVE-G-----PTPSLPE 227 (260)
T ss_pred CCcc-cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccH--HHHHHHHHc-C-----CCCCCcc
Confidence 3321 22234678899999998888889999999999999999999999965332 222222111 1 1111211
Q ss_pred cccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 588 SYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 588 ~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
.+ ...+..+...|+.. |++||++.|++++
T Consensus 228 ~~----~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 228 TY----SRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred hh----cHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 11 23445566678876 9999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-31 Score=285.18 Aligned_cols=198 Identities=27% Similarity=0.415 Sum_probs=170.1
Q ss_pred HhcCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCC--chhHHHHHHHHHHHhcccccCceeEeeeecccC-----
Q 005940 351 ATKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNS--LQGMREFAAEIESLGRLRHKNLVNLHGWCKQKN----- 423 (668)
Q Consensus 351 at~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~----- 423 (668)
..++|+..+.||+|++|.||++....++..||||++.... ....+.+.+|++++++++|+||+++++.+....
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF 92 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence 3568999999999999999999998889999999986432 233456889999999999999999999886543
Q ss_pred -ceEEEEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecC
Q 005940 424 -DLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGL 502 (668)
Q Consensus 424 -~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGl 502 (668)
..++||||+ +++|.+++. ...+++..++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+
T Consensus 93 ~~~~lv~e~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~al~~LH~---~gi~H~dlkp~Nill~~~~~~kl~dfg~ 164 (343)
T cd07880 93 HDFYLVMPFM-GTDLGKLMK----HEKLSEDRIQFLVYQMLKGLKYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGL 164 (343)
T ss_pred ceEEEEEecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeeccc
Confidence 458999999 779988884 2458999999999999999999998 9999999999999999999999999999
Q ss_pred ceeccCCCCCcccccccCCcccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 005940 503 ARLYDHGGMPHTTNVVGTFGYIAPELTQT-GKASTSSDVFAYGILLLEVATGRRPIGSG 560 (668)
Q Consensus 503 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~S~Gvvl~elltG~~p~~~~ 560 (668)
+...... .....++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||...
T Consensus 165 ~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~ 219 (343)
T cd07880 165 ARQTDSE----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGH 219 (343)
T ss_pred ccccccC----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 9865432 223467889999998865 45789999999999999999999999754
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.5e-33 Score=271.77 Aligned_cols=261 Identities=26% Similarity=0.386 Sum_probs=200.9
Q ss_pred cchhhHHHHhcCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCchhHHHHHHHHHHHhccc-ccCceeEeeeecc
Q 005940 343 FRYKDLYAATKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLR-HKNLVNLHGWCKQ 421 (668)
Q Consensus 343 f~~~el~~at~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~ 421 (668)
-++.|++..| .+.||+|+|+.|--++...++.++|||++.+..........+|++++.+.+ |+||++|++||++
T Consensus 73 g~F~d~YkLt-----~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEd 147 (463)
T KOG0607|consen 73 GKFEDMYKLT-----SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFED 147 (463)
T ss_pred chHHHHHHhH-----HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcc
Confidence 3577888777 478999999999999988999999999999887777788899999999996 9999999999999
Q ss_pred cCceEEEEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCC---EEEE
Q 005940 422 KNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMN---ARLG 498 (668)
Q Consensus 422 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~---~kl~ 498 (668)
+...|||||-|.+|+|..++.+ ++.+++.+..++.++|+.||.|||. ++|.||||||+|||-.+... +|||
T Consensus 148 d~~FYLVfEKm~GGplLshI~~---~~~F~E~EAs~vvkdia~aLdFlH~---kgIAHRDlKPENiLC~~pn~vsPvKiC 221 (463)
T KOG0607|consen 148 DTRFYLVFEKMRGGPLLSHIQK---RKHFNEREASRVVKDIASALDFLHT---KGIAHRDLKPENILCESPNKVSPVKIC 221 (463)
T ss_pred cceEEEEEecccCchHHHHHHH---hhhccHHHHHHHHHHHHHHHHHHhh---cCcccccCCccceeecCCCCcCceeee
Confidence 9999999999999999999963 4569999999999999999999999 99999999999999976544 8999
Q ss_pred eecCceeccC--C----CCCcccccccCCcccCccccc-----CCCCCcchhHHHHHHHHHHHHhCCCCCCCC-------
Q 005940 499 DFGLARLYDH--G----GMPHTTNVVGTFGYIAPELTQ-----TGKASTSSDVFAYGILLLEVATGRRPIGSG------- 560 (668)
Q Consensus 499 DfGla~~~~~--~----~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDV~S~Gvvl~elltG~~p~~~~------- 560 (668)
||.+...+.. + ..+.....+|+..|||||+.. ...|..+.|.||+|||||-|++|..||.+.
T Consensus 222 DfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGW 301 (463)
T KOG0607|consen 222 DFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGW 301 (463)
T ss_pred ccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCc
Confidence 9998764421 1 122334568999999999753 246789999999999999999999999643
Q ss_pred c-----hhHHHHHHHHHhcCccccccCcccCCcccHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 005940 561 D-----LLLVEWVRECHQLGRILDVADPLLNSSYVVKEMELVLKLGLMCSHKTQFRPTMRQVMR 619 (668)
Q Consensus 561 ~-----~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~p~~RPs~~evl~ 619 (668)
+ ..-.+-..+..++++. +..|... .....+.+.++.. ....++.+|-++.++++
T Consensus 302 drGe~Cr~CQ~~LFesIQEGkY-eFPdkdW--ahIS~eakdlisn--Llvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 302 DRGEVCRVCQNKLFESIQEGKY-EFPDKDW--AHISSEAKDLISN--LLVRDAKQRLSAAQVLN 360 (463)
T ss_pred cCCCccHHHHHHHHHHHhccCC-cCChhhh--HHhhHHHHHHHHH--HHhccHHhhhhhhhccC
Confidence 0 1111122233333332 1222221 1123334433332 23345888999888887
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-31 Score=271.82 Aligned_cols=239 Identities=28% Similarity=0.352 Sum_probs=192.6
Q ss_pred eeecCcEEEEEEEeCCCCcEEEEEEEecCCc---hhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEEecCCCCh
Q 005940 361 IGIGGFGSVYKGVLPTTGGEVAVKKITRNSL---QGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEYIPNGSL 437 (668)
Q Consensus 361 lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL 437 (668)
||+|++|.||++....+++.+++|++.+... .....+..|++++++++|+||+++++.+..+...++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 6899999999999988899999999876533 2456789999999999999999999999999999999999999999
Q ss_pred hhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCCCCccccc
Q 005940 438 DTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNV 517 (668)
Q Consensus 438 ~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~ 517 (668)
.+++.. ...+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++....... ......
T Consensus 81 ~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lh~---~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~ 153 (250)
T cd05123 81 FSHLSK---EGRFSEERARFYAAEIVLALEYLHS---LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRTNTF 153 (250)
T ss_pred HHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcceEEEcCCCcEEEeecCcceecccCC-CcccCC
Confidence 999953 2358999999999999999999998 999999999999999999999999999998765432 123345
Q ss_pred ccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCcccCCcccHHHHHHH
Q 005940 518 VGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSYVVKEMELV 597 (668)
Q Consensus 518 ~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l 597 (668)
.++..|++||...+...+.++|+||||+++|||++|+.||...+.. ........ .. ..+.... ...+
T Consensus 154 ~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~--~~~~~~~~-~~------~~~~~~~----~~~l 220 (250)
T cd05123 154 CGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRK--EIYEKILK-DP------LRFPEFL----SPEA 220 (250)
T ss_pred cCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH--HHHHHHhc-CC------CCCCCCC----CHHH
Confidence 6788999999998888899999999999999999999999765431 11111111 11 1111111 1334
Q ss_pred HHHHhhcCCC-CCCCCCH---HHHHH
Q 005940 598 LKLGLMCSHK-TQFRPTM---RQVMR 619 (668)
Q Consensus 598 ~~l~~~C~~~-p~~RPs~---~evl~ 619 (668)
..+...|+.. |++||++ +++++
T Consensus 221 ~~~i~~~l~~~p~~R~~~~~~~~l~~ 246 (250)
T cd05123 221 RDLISGLLQKDPTKRLGSGGAEEIKA 246 (250)
T ss_pred HHHHHHHhcCCHhhCCCcccHHHHHh
Confidence 5566678876 9999999 56554
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.98 E-value=4e-32 Score=289.37 Aligned_cols=249 Identities=26% Similarity=0.386 Sum_probs=200.4
Q ss_pred hcCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCc--hhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEE
Q 005940 352 TKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSL--QGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVY 429 (668)
Q Consensus 352 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 429 (668)
...|.+...||+|.|++|.+|++..++..||||.+.+... ...+.+.+|+++|..|+|||||+++.+...+..+|+||
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~ 134 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVM 134 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEE
Confidence 4678889999999999999999999999999999987644 33456889999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCC
Q 005940 430 EYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHG 509 (668)
Q Consensus 430 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~ 509 (668)
||+.+|.+.++|.+ ...+.......++.|+.+|++|||+ +.|+|||||++||||+.+.++||+|||++..++.+
T Consensus 135 eya~~ge~~~yl~~---~gr~~e~~ar~~F~q~vsaveYcH~---k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~ 208 (596)
T KOG0586|consen 135 EYASGGELFDYLVK---HGRMKEKEARAKFRQIVSAVEYCHS---KNIVHRDLKAENILLDENMNIKIADFGFSTFFDYG 208 (596)
T ss_pred EeccCchhHHHHHh---cccchhhhhhhhhHHHHHHHHHHhh---cceeccccchhhcccccccceeeeccccceeeccc
Confidence 99999999999963 2345568888999999999999999 99999999999999999999999999999988855
Q ss_pred CCCcccccccCCcccCcccccCCCC-CcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCcccCCc
Q 005940 510 GMPHTTNVVGTFGYIAPELTQTGKA-STSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSS 588 (668)
Q Consensus 510 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 588 (668)
.. ....+|++.|.|||++.+.++ .++.|+||+|+++|-|++|..||++...... +...+.. .-++...
T Consensus 209 ~~--lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~L-------r~rvl~g--k~rIp~~ 277 (596)
T KOG0586|consen 209 LM--LQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKEL-------RPRVLRG--KYRIPFY 277 (596)
T ss_pred cc--ccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccc-------cchheee--eecccce
Confidence 43 345699999999999988766 6899999999999999999999986431100 0000000 0111111
Q ss_pred ccHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 005940 589 YVVKEMELVLKLGLMCSHKTQFRPTMRQVMRY 620 (668)
Q Consensus 589 ~~~~~~~~l~~l~~~C~~~p~~RPs~~evl~~ 620 (668)
...++-..+.+ +...+|.+|+++++++++
T Consensus 278 ms~dce~lLrk---~lvl~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 278 MSCDCEDLLRK---FLVLNPSKRGPCDQIMKD 306 (596)
T ss_pred eechhHHHHHH---hhccCccccCCHHHhhhh
Confidence 22223332322 335569999999999975
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.2e-31 Score=283.17 Aligned_cols=200 Identities=29% Similarity=0.379 Sum_probs=166.6
Q ss_pred CcccceeeeecCcEEEEEEEeCCC--CcEEEEEEEecCC--chhHHHHHHHHHHHhccc-ccCceeEeeeecc----cCc
Q 005940 354 GFKESEVIGIGGFGSVYKGVLPTT--GGEVAVKKITRNS--LQGMREFAAEIESLGRLR-HKNLVNLHGWCKQ----KND 424 (668)
Q Consensus 354 ~f~~~~~lG~G~~g~Vy~~~~~~~--~~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~----~~~ 424 (668)
+|+..+.||+|+||.||++....+ +..||+|++.... ....+.+.+|++++++++ |+||+++++.+.. ...
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 477889999999999999999777 8899999986532 223467788999999994 9999999997542 245
Q ss_pred eEEEEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCce
Q 005940 425 LLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLAR 504 (668)
Q Consensus 425 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~ 504 (668)
.++++||+. ++|.+++. ....+++..+..++.||+.||.|||+ .+++||||||+||+++.++.+||+|||+++
T Consensus 81 ~~~~~e~~~-~~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~---~givH~dlkp~Nili~~~~~~kl~Dfg~a~ 153 (332)
T cd07857 81 LYLYEELME-ADLHQIIR---SGQPLTDAHFQSFIYQILCGLKYIHS---ANVLHRDLKPGNLLVNADCELKICDFGLAR 153 (332)
T ss_pred EEEEEeccc-CCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHeEEcCCCCEEeCcCCCce
Confidence 788899885 68988884 24568999999999999999999998 999999999999999999999999999998
Q ss_pred eccCCCCC---cccccccCCcccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 005940 505 LYDHGGMP---HTTNVVGTFGYIAPELTQT-GKASTSSDVFAYGILLLEVATGRRPIGSG 560 (668)
Q Consensus 505 ~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~S~Gvvl~elltG~~p~~~~ 560 (668)
........ ......|+..|+|||.+.+ ..++.++||||+||++|||++|+.||...
T Consensus 154 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~ 213 (332)
T cd07857 154 GFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGK 213 (332)
T ss_pred ecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCC
Confidence 66533221 1233468999999998765 46889999999999999999999999754
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.5e-32 Score=287.71 Aligned_cols=198 Identities=27% Similarity=0.424 Sum_probs=170.5
Q ss_pred HhcCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecC--CchhHHHHHHHHHHHhcccccCceeEeeeecccCc----
Q 005940 351 ATKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRN--SLQGMREFAAEIESLGRLRHKNLVNLHGWCKQKND---- 424 (668)
Q Consensus 351 at~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~---- 424 (668)
..++|...+.||+|++|.||+|.+..++..||||++... .....+.+..|+.++++++|+||+++++++.....
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 357899999999999999999999888999999998653 22344667789999999999999999998765544
Q ss_pred --eEEEEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecC
Q 005940 425 --LLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGL 502 (668)
Q Consensus 425 --~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGl 502 (668)
.++|+||+ +++|.+++.. ..+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||+
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~ql~~aL~~LH~---~gi~H~dlkp~Nill~~~~~~kL~dfg~ 164 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKC----QKLSDDHIQFLVYQILRGLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGL 164 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEccccc
Confidence 89999998 6799998852 458999999999999999999999 9999999999999999999999999999
Q ss_pred ceeccCCCCCcccccccCCcccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 005940 503 ARLYDHGGMPHTTNVVGTFGYIAPELTQT-GKASTSSDVFAYGILLLEVATGRRPIGSG 560 (668)
Q Consensus 503 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~S~Gvvl~elltG~~p~~~~ 560 (668)
+...... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||...
T Consensus 165 ~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~ 219 (343)
T cd07851 165 ARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGS 219 (343)
T ss_pred ccccccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence 9865432 223467889999998765 36789999999999999999999999654
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.8e-32 Score=306.13 Aligned_cols=255 Identities=29% Similarity=0.419 Sum_probs=202.4
Q ss_pred CcccceeeeecCcEEEEEEEeCC-------CCcEEEEEEEecCCc-hhHHHHHHHHHHHhcc-cccCceeEeeeecccCc
Q 005940 354 GFKESEVIGIGGFGSVYKGVLPT-------TGGEVAVKKITRNSL-QGMREFAAEIESLGRL-RHKNLVNLHGWCKQKND 424 (668)
Q Consensus 354 ~f~~~~~lG~G~~g~Vy~~~~~~-------~~~~vavK~~~~~~~-~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~ 424 (668)
+....+.||+|.||.|++|.... ....||||.+..... ...+.+..|+++|+.+ +|+||+.++|+|..++.
T Consensus 297 ~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~ 376 (609)
T KOG0200|consen 297 NLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDGP 376 (609)
T ss_pred hccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCCc
Confidence 33455699999999999998531 135799999876533 4567899999999998 69999999999999999
Q ss_pred eEEEEEecCCCChhhhhcCCC-------C----C--CCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECC
Q 005940 425 LLLVYEYIPNGSLDTLLFKPK-------D----G--SVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDA 491 (668)
Q Consensus 425 ~~lV~E~~~~gsL~~~l~~~~-------~----~--~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~ 491 (668)
.++|.||+..|+|.++|+..+ . . ..++....+.++.|||.|++||++ .+++||||-++|||+++
T Consensus 377 ~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~---~~~vHRDLAaRNVLi~~ 453 (609)
T KOG0200|consen 377 LYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLAS---VPCVHRDLAARNVLITK 453 (609)
T ss_pred eEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhh---CCccchhhhhhhEEecC
Confidence 999999999999999997544 0 0 248999999999999999999999 99999999999999999
Q ss_pred CCCEEEEeecCceeccCCCCCcccccc--cCCcccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCC--chhHHH
Q 005940 492 EMNARLGDFGLARLYDHGGMPHTTNVV--GTFGYIAPELTQTGKASTSSDVFAYGILLLEVAT-GRRPIGSG--DLLLVE 566 (668)
Q Consensus 492 ~~~~kl~DfGla~~~~~~~~~~~~~~~--gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~--~~~l~~ 566 (668)
+..+||+|||+|+...+.......... -...|||||.+....++.|+|||||||+||||+| |..|+..- ...+.+
T Consensus 454 ~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l~~ 533 (609)
T KOG0200|consen 454 NKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEELLE 533 (609)
T ss_pred CCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHHHHH
Confidence 999999999999976554332222222 2456999999999999999999999999999999 88898652 222222
Q ss_pred HHHHHHhcCccccccCcccCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhccC
Q 005940 567 WVRECHQLGRILDVADPLLNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSGE 624 (668)
Q Consensus 567 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~~ 624 (668)
..+.+..++. |.. ....+..+++.||+. |++||++.|+.+.|+..
T Consensus 534 ----~l~~G~r~~~--P~~-------c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~ 579 (609)
T KOG0200|consen 534 ----FLKEGNRMEQ--PEH-------CSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH 579 (609)
T ss_pred ----HHhcCCCCCC--CCC-------CCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence 3333332221 111 123455888899998 99999999999999883
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-32 Score=306.27 Aligned_cols=262 Identities=27% Similarity=0.318 Sum_probs=208.5
Q ss_pred chhhHHHHhcCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCC---chhHHHHHHHHHHHhcccccCceeEeeeec
Q 005940 344 RYKDLYAATKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNS---LQGMREFAAEIESLGRLRHKNLVNLHGWCK 420 (668)
Q Consensus 344 ~~~el~~at~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~ 420 (668)
...++....++|.+.++||+|+||.|..++++.+++.||+|++++-. .....-|..|-.+|..-..+=|++++-.|.
T Consensus 66 ~v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQ 145 (1317)
T KOG0612|consen 66 KVKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQ 145 (1317)
T ss_pred HHHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhc
Confidence 44556666688999999999999999999999999999999997732 233456889999999889999999999999
Q ss_pred ccCceEEEEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEee
Q 005940 421 QKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDF 500 (668)
Q Consensus 421 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~Df 500 (668)
++..+|+|||||+||+|-.++.+. . .+++....-++..|+.||.-||+ .|+|||||||.|||||..|++||+||
T Consensus 146 D~~~LYlVMdY~pGGDlltLlSk~--~-~~pE~~ArFY~aEiVlAldslH~---mgyVHRDiKPDNvLld~~GHikLADF 219 (1317)
T KOG0612|consen 146 DERYLYLVMDYMPGGDLLTLLSKF--D-RLPEDWARFYTAEIVLALDSLHS---MGYVHRDIKPDNVLLDKSGHIKLADF 219 (1317)
T ss_pred CccceEEEEecccCchHHHHHhhc--C-CChHHHHHHHHHHHHHHHHHHHh---ccceeccCCcceeEecccCcEeeccc
Confidence 999999999999999999999532 2 69999999999999999999999 99999999999999999999999999
Q ss_pred cCceeccCCCCCcccccccCCcccCcccccC-----CCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcC
Q 005940 501 GLARLYDHGGMPHTTNVVGTFGYIAPELTQT-----GKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLG 575 (668)
Q Consensus 501 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~ 575 (668)
|.|-.++....-.....+|||.|++||+++. +.|.+..|.||+||++|||++|..||..+ .+++-....+...
T Consensus 220 GsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYad--slveTY~KIm~hk 297 (1317)
T KOG0612|consen 220 GSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYAD--SLVETYGKIMNHK 297 (1317)
T ss_pred hhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHH--HHHHHHHHHhchh
Confidence 9998888666556667799999999999853 57899999999999999999999999642 2333223323222
Q ss_pred ccccccCcccCCcccHHHHHHHHHHHhhcCCCCCCCCC---HHHHHHH
Q 005940 576 RILDVADPLLNSSYVVKEMELVLKLGLMCSHKTQFRPT---MRQVMRY 620 (668)
Q Consensus 576 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~p~~RPs---~~evl~~ 620 (668)
......+... -.++...++ .....+|+.|.. ++++..|
T Consensus 298 ~~l~FP~~~~----VSeeakdLI---~~ll~~~e~RLgrngiedik~H 338 (1317)
T KOG0612|consen 298 ESLSFPDETD----VSEEAKDLI---EALLCDREVRLGRNGIEDIKNH 338 (1317)
T ss_pred hhcCCCcccc----cCHHHHHHH---HHHhcChhhhcccccHHHHHhC
Confidence 2233221111 223333333 234455666666 8888876
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-33 Score=314.80 Aligned_cols=253 Identities=32% Similarity=0.468 Sum_probs=201.0
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecC--CchhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEE
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRN--SLQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYE 430 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 430 (668)
-+++....||.|.||.||-|...++|+-.|+|.+.-. .....+...+|+.++..|+|||+|+++|.-.+.+..+|.||
T Consensus 1235 ~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFME 1314 (1509)
T KOG4645|consen 1235 FRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFME 1314 (1509)
T ss_pred eeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHH
Confidence 4567788999999999999999999999999987533 23445678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCC
Q 005940 431 YIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGG 510 (668)
Q Consensus 431 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~ 510 (668)
||++|+|.+++.. +...++.....+..|++.|++|||+ .+||||||||.||+|+.+|.+|++|||.|..+....
T Consensus 1315 yC~~GsLa~ll~~---gri~dE~vt~vyt~qll~gla~LH~---~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~ 1388 (1509)
T KOG4645|consen 1315 YCEGGSLASLLEH---GRIEDEMVTRVYTKQLLEGLAYLHE---HGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNA 1388 (1509)
T ss_pred HhccCcHHHHHHh---cchhhhhHHHHHHHHHHHHHHHHHh---cCceecCCCccceeeecCCcEEeecccceeEecCch
Confidence 9999999999953 3457777778889999999999999 999999999999999999999999999999876543
Q ss_pred C---CcccccccCCcccCcccccCCC---CCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHh-cCccccccCc
Q 005940 511 M---PHTTNVVGTFGYIAPELTQTGK---ASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQ-LGRILDVADP 583 (668)
Q Consensus 511 ~---~~~~~~~gt~~y~aPE~~~~~~---~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~-~~~~~~~~d~ 583 (668)
. .......||+.|||||++.+.+ ...++||||+|||++||+||++||...|. +|....+- .+.. |
T Consensus 1389 ~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dn---e~aIMy~V~~gh~-----P 1460 (1509)
T KOG4645|consen 1389 QTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDN---EWAIMYHVAAGHK-----P 1460 (1509)
T ss_pred hcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccc---hhHHHhHHhccCC-----C
Confidence 1 1223458999999999987643 46789999999999999999999975443 35443332 2222 2
Q ss_pred ccCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhcc
Q 005940 584 LLNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSG 623 (668)
Q Consensus 584 ~l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~ 623 (668)
.+.... ..+-. .+...|+.. |++|-++.|++++=-.
T Consensus 1461 q~P~~l-s~~g~---dFle~Cl~~dP~~Rw~~~qlle~~f~ 1497 (1509)
T KOG4645|consen 1461 QIPERL-SSEGR---DFLEHCLEQDPKMRWTASQLLEHAFG 1497 (1509)
T ss_pred CCchhh-hHhHH---HHHHHHHhcCchhhhHHHHHHHhhcc
Confidence 222221 12222 333468765 9999988888876443
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-33 Score=269.59 Aligned_cols=262 Identities=29% Similarity=0.351 Sum_probs=198.0
Q ss_pred CcccchhhHHHHhcCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCc-hhHHHHHHHHHHHhcc-cccCceeEee
Q 005940 340 PHRFRYKDLYAATKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSL-QGMREFAAEIESLGRL-RHKNLVNLHG 417 (668)
Q Consensus 340 ~~~f~~~el~~at~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~f~~Ei~~l~~l-~H~nIv~l~g 417 (668)
.+.|+.++|. ....||.|+||+|+|-.++..|+..|||+++.... ...++++.|.+...+- ++||||+++|
T Consensus 58 ~~~F~~~~Lq-------dlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyG 130 (361)
T KOG1006|consen 58 LHTFTSDNLQ-------DLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYG 130 (361)
T ss_pred ccccccchHH-------HHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhh
Confidence 3456655554 46789999999999999999999999999987654 5567888898887665 6999999999
Q ss_pred eecccCceEEEEEecCCCChhhhhcC--CCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCE
Q 005940 418 WCKQKNDLLLVYEYIPNGSLDTLLFK--PKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNA 495 (668)
Q Consensus 418 ~~~~~~~~~lV~E~~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~ 495 (668)
.+-.++..++.||.| ..||+.+-.. ...+..+++.-.-.|..-.+.||.||.+ +..|+|||+||+||||+..|.+
T Consensus 131 a~F~EGdcWiCMELM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~--~lkiIHRDvKPSNILldr~G~v 207 (361)
T KOG1006|consen 131 ALFSEGDCWICMELM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKE--ELKIIHRDVKPSNILLDRHGDV 207 (361)
T ss_pred hhhcCCceeeeHHHH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHH--HhhhhhccCChhheEEecCCCE
Confidence 999999999999999 4577665421 1234568888888999999999999998 4899999999999999999999
Q ss_pred EEEeecCceeccCCCCCcccccccCCcccCcccccCC--CCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHh
Q 005940 496 RLGDFGLARLYDHGGMPHTTNVVGTFGYIAPELTQTG--KASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQ 573 (668)
Q Consensus 496 kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~ 573 (668)
||||||++..+..+- ..+.-+|-..|||||.+... .|..+|||||+|+.|+|+.||+.|+...+.. .+.+.+...
T Consensus 208 KLCDFGIcGqLv~Si--AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~sv-feql~~Vv~ 284 (361)
T KOG1006|consen 208 KLCDFGICGQLVDSI--AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSV-FEQLCQVVI 284 (361)
T ss_pred eeecccchHhHHHHH--HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHH-HHHHHHHHc
Confidence 999999998765432 23344788999999988642 4789999999999999999999999875542 222333222
Q ss_pred cCccccccCcccCCccc-HHHHHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 574 LGRILDVADPLLNSSYV-VKEMELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 574 ~~~~~~~~d~~l~~~~~-~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
... |.+..... ..--..+....-.|+.. -+.||...++.++
T Consensus 285 gdp------p~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 285 GDP------PILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred CCC------CeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 211 22211111 01112233444467666 7899999998764
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=299.67 Aligned_cols=146 Identities=32% Similarity=0.451 Sum_probs=132.7
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCC---chhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEE
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNS---LQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVY 429 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 429 (668)
++|.+.++||+|+||.||+|.+..+++.||||++.... ....+.+..|+.++..++|+||+++++.+......|+||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 57889999999999999999998889999999997543 233467889999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCce
Q 005940 430 EYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLAR 504 (668)
Q Consensus 430 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~ 504 (668)
||+++++|.+++.. ...+++..++.++.||+.||.|||. .+|+||||||+||||+.++.+||+|||+++
T Consensus 84 Ey~~g~~L~~li~~---~~~l~~~~~~~i~~qil~aL~yLH~---~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 84 EYLIGGDVKSLLHI---YGYFDEEMAVKYISEVALALDYLHR---HGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred eCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 99999999999953 2358899999999999999999998 899999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.5e-32 Score=265.43 Aligned_cols=202 Identities=27% Similarity=0.362 Sum_probs=179.0
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCc---hhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEE
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSL---QGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVY 429 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 429 (668)
++|...++||+|.||+|-+++-+.+++.+|+|++++.-. .....-+.|-++|+..+||.+..|--.++..+.+|+||
T Consensus 168 ~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVM 247 (516)
T KOG0690|consen 168 EDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVM 247 (516)
T ss_pred chhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEE
Confidence 578889999999999999999999999999999987643 33344567999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCC
Q 005940 430 EYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHG 509 (668)
Q Consensus 430 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~ 509 (668)
||..+|.|.-+|.+ ...+++....-+-..|+.||.|||+ ++|++||||.+|.|||.+|++||.|||+++.--.
T Consensus 248 eyanGGeLf~HLsr---er~FsE~RtRFYGaEIvsAL~YLHs---~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~- 320 (516)
T KOG0690|consen 248 EYANGGELFFHLSR---ERVFSEDRTRFYGAEIVSALGYLHS---RNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIK- 320 (516)
T ss_pred EEccCceEeeehhh---hhcccchhhhhhhHHHHHHhhhhhh---CCeeeeechhhhheeccCCceEeeecccchhccc-
Confidence 99999999999853 4568888888899999999999999 9999999999999999999999999999984221
Q ss_pred CCCcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCc
Q 005940 510 GMPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGD 561 (668)
Q Consensus 510 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~ 561 (668)
.......++||+.|+|||++....|..+.|.|.+||++|||+||+.||...+
T Consensus 321 ~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~d 372 (516)
T KOG0690|consen 321 YGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKD 372 (516)
T ss_pred ccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccc
Confidence 1234556899999999999999999999999999999999999999997654
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=292.57 Aligned_cols=260 Identities=20% Similarity=0.230 Sum_probs=169.6
Q ss_pred HhcCcccceeeeecCcEEEEEEEeCCC----CcEEEEEEEecCCchhHHHHHHHHHHHhcccccCceeEeee------ec
Q 005940 351 ATKGFKESEVIGIGGFGSVYKGVLPTT----GGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNLHGW------CK 420 (668)
Q Consensus 351 at~~f~~~~~lG~G~~g~Vy~~~~~~~----~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~------~~ 420 (668)
..++|...++||+|+||.||+|++..+ +..||||++...... +.+..| .+.+..+.++..++.. +.
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 457899999999999999999999887 889999998653321 111111 1122222222222111 34
Q ss_pred ccCceEEEEEecCCCChhhhhcCCCC-----------------CCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCC
Q 005940 421 QKNDLLLVYEYIPNGSLDTLLFKPKD-----------------GSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVK 483 (668)
Q Consensus 421 ~~~~~~lV~E~~~~gsL~~~l~~~~~-----------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLk 483 (668)
.....++||||+++++|.+++..... +.......+..++.||+.||.|||+ ++|+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~---~gIiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHS---TGIVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHH---CCEEeCcCC
Confidence 56789999999999999999853210 0111234466899999999999998 999999999
Q ss_pred CCCEEECC-CCCEEEEeecCceeccCCCCCcccccccCCcccCcccccCC----------------------CCCcchhH
Q 005940 484 PSNALIDA-EMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPELTQTG----------------------KASTSSDV 540 (668)
Q Consensus 484 p~NIll~~-~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~sDV 540 (668)
|+|||+++ ++.+||+|||+++....+.........+++.|+|||.+... .++.++||
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DV 362 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI 362 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCccc
Confidence 99999986 57899999999987654433334456789999999965322 23456799
Q ss_pred HHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCc----cccccCccc----CCccc--HHHHHHHHHHHhhcCCC-CC
Q 005940 541 FAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGR----ILDVADPLL----NSSYV--VKEMELVLKLGLMCSHK-TQ 609 (668)
Q Consensus 541 ~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~----~~~~~d~~l----~~~~~--~~~~~~l~~l~~~C~~~-p~ 609 (668)
|||||++|||+++..+.+.. +..+.......+. ......+.. ...+. ..+-.....+...|++. |+
T Consensus 363 wSlGviL~el~~~~~~~~~~---~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~ 439 (566)
T PLN03225 363 YSAGLIFLQMAFPNLRSDSN---LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGR 439 (566)
T ss_pred HHHHHHHHHHHhCcCCCchH---HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcc
Confidence 99999999999987765432 2221111111110 000001110 00000 00011223456677776 99
Q ss_pred CCCCHHHHHHH
Q 005940 610 FRPTMRQVMRY 620 (668)
Q Consensus 610 ~RPs~~evl~~ 620 (668)
+||+++|+++|
T Consensus 440 kR~ta~e~L~H 450 (566)
T PLN03225 440 QRISAKAALAH 450 (566)
T ss_pred cCCCHHHHhCC
Confidence 99999999986
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.2e-31 Score=264.68 Aligned_cols=180 Identities=21% Similarity=0.242 Sum_probs=155.9
Q ss_pred cCcEEEEEEEeCCCCcEEEEEEEecCCchhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEEecCCCChhhhhcC
Q 005940 364 GGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEYIPNGSLDTLLFK 443 (668)
Q Consensus 364 G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~ 443 (668)
|.+|.||++.++.+++.+|+|++.... .+..|...+....||||+++++++.+....++||||+++|+|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 789999999999999999999997653 233455555566799999999999999999999999999999999853
Q ss_pred CCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCCCCcccccccCCcc
Q 005940 444 PKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGY 523 (668)
Q Consensus 444 ~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y 523 (668)
...+++..+..++.|++.||.|||+ .+++||||||+||+++.++.++++|||.+....... ....++..|
T Consensus 79 ---~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~----~~~~~~~~y 148 (237)
T cd05576 79 ---FLNIPEECVKRWAAEMVVALDALHR---EGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC----DGEAVENMY 148 (237)
T ss_pred ---hcCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEEcCCCCEEEecccchhcccccc----ccCCcCccc
Confidence 2358999999999999999999998 999999999999999999999999999886554321 223456789
Q ss_pred cCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 005940 524 IAPELTQTGKASTSSDVFAYGILLLEVATGRRPIG 558 (668)
Q Consensus 524 ~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~ 558 (668)
+|||....+.++.++||||+|+++|||++|+.|+.
T Consensus 149 ~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~ 183 (237)
T cd05576 149 CAPEVGGISEETEACDWWSLGAILFELLTGKTLVE 183 (237)
T ss_pred cCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhh
Confidence 99999988888999999999999999999998875
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-30 Score=258.73 Aligned_cols=237 Identities=33% Similarity=0.448 Sum_probs=191.5
Q ss_pred CcEEEEEEEeCCCCcEEEEEEEecCCchh-HHHHHHHHHHHhcccccCceeEeeeecccCceEEEEEecCCCChhhhhcC
Q 005940 365 GFGSVYKGVLPTTGGEVAVKKITRNSLQG-MREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEYIPNGSLDTLLFK 443 (668)
Q Consensus 365 ~~g~Vy~~~~~~~~~~vavK~~~~~~~~~-~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~ 443 (668)
+||.||+|+...+++.+++|++....... .+.+.+|++.+++++|+|++++++++......++++||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999998888999999998765544 68899999999999999999999999998999999999999999999853
Q ss_pred CCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCCCCcccccccCCcc
Q 005940 444 PKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGY 523 (668)
Q Consensus 444 ~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y 523 (668)
. ..+++..++.++.+++.++.|||+ .+++|+||+|+||+++.++.++|+|||.+....... ......++..|
T Consensus 81 ~---~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~ 152 (244)
T smart00220 81 R---GRLSEDEARFYARQILSALEYLHS---NGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPEY 152 (244)
T ss_pred c---cCCCHHHHHHHHHHHHHHHHHHHH---cCeecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcCC
Confidence 2 228999999999999999999999 899999999999999999999999999998766542 23345678899
Q ss_pred cCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC-chhHHHHHHHHHhcCccccccCcccCCcccHHHHHHHHHHHh
Q 005940 524 IAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSG-DLLLVEWVRECHQLGRILDVADPLLNSSYVVKEMELVLKLGL 602 (668)
Q Consensus 524 ~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~-~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~ 602 (668)
++||.......+.++||||||++++||++|..||... +.. ..... ........ ... .. .....+..+..
T Consensus 153 ~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~--~~~~~-~~~~~~~~-~~~---~~---~~~~~~~~~i~ 222 (244)
T smart00220 153 MAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLL--ELFKK-IGKPKPPF-PPP---EW---KISPEAKDLIR 222 (244)
T ss_pred CCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHH--HHHHH-HhccCCCC-ccc---cc---cCCHHHHHHHH
Confidence 9999998888899999999999999999999999652 211 11111 11111100 000 00 01234566777
Q ss_pred hcCCC-CCCCCCHHHHHH
Q 005940 603 MCSHK-TQFRPTMRQVMR 619 (668)
Q Consensus 603 ~C~~~-p~~RPs~~evl~ 619 (668)
.|+.. |++||++.++++
T Consensus 223 ~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 223 KLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHccCCchhccCHHHHhh
Confidence 89886 999999999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-30 Score=284.98 Aligned_cols=204 Identities=20% Similarity=0.326 Sum_probs=156.2
Q ss_pred hcCcccceeeeecCcEEEEEEEeC----------------CCCcEEEEEEEecCCchhHHHH--------------HHHH
Q 005940 352 TKGFKESEVIGIGGFGSVYKGVLP----------------TTGGEVAVKKITRNSLQGMREF--------------AAEI 401 (668)
Q Consensus 352 t~~f~~~~~lG~G~~g~Vy~~~~~----------------~~~~~vavK~~~~~~~~~~~~f--------------~~Ei 401 (668)
.++|.+.++||+|+||.||+|.+. ..++.||||++........++| ..|+
T Consensus 144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~ 223 (507)
T PLN03224 144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA 223 (507)
T ss_pred ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence 568999999999999999999752 2346799999875543333333 3467
Q ss_pred HHHhcccccCc-----eeEeeeecc--------cCceEEEEEecCCCChhhhhcCCCC---------------------C
Q 005940 402 ESLGRLRHKNL-----VNLHGWCKQ--------KNDLLLVYEYIPNGSLDTLLFKPKD---------------------G 447 (668)
Q Consensus 402 ~~l~~l~H~nI-----v~l~g~~~~--------~~~~~lV~E~~~~gsL~~~l~~~~~---------------------~ 447 (668)
.++.+++|.++ ++++++|.. ++..+|||||+++++|.++++.... .
T Consensus 224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~ 303 (507)
T PLN03224 224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ 303 (507)
T ss_pred HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence 77777776654 677888753 3568999999999999999863211 1
Q ss_pred CCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCCCCcccccccCCcccCcc
Q 005940 448 SVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPE 527 (668)
Q Consensus 448 ~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE 527 (668)
..++|..+..++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||+++....+.........+++.|+|||
T Consensus 304 ~~~~~~~~~~i~~ql~~aL~~lH~---~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE 380 (507)
T PLN03224 304 DKRDINVIKGVMRQVLTGLRKLHR---IGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPE 380 (507)
T ss_pred ccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChh
Confidence 235678899999999999999998 89999999999999999999999999999765443222222234578999999
Q ss_pred cccCCCC----------------------CcchhHHHHHHHHHHHHhCCC-CCC
Q 005940 528 LTQTGKA----------------------STSSDVFAYGILLLEVATGRR-PIG 558 (668)
Q Consensus 528 ~~~~~~~----------------------~~~sDV~S~Gvvl~elltG~~-p~~ 558 (668)
.+..... ..+.||||+||++|||++|.. |+.
T Consensus 381 ~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~ 434 (507)
T PLN03224 381 ELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVA 434 (507)
T ss_pred hhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCcc
Confidence 8754321 134799999999999999875 664
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.3e-31 Score=238.11 Aligned_cols=198 Identities=31% Similarity=0.413 Sum_probs=168.6
Q ss_pred CcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCc--hhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEEe
Q 005940 354 GFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSL--QGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEY 431 (668)
Q Consensus 354 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~ 431 (668)
+|...++||+|.||+||+|+..++++.||+|+++.+.. .......+|+-+++.|+|+|||++++....+..+-+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 46667899999999999999999999999999876543 2335678999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCCC
Q 005940 432 IPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGM 511 (668)
Q Consensus 432 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~~ 511 (668)
| ..+|..+.. .-+..++.+....++.|+++||.|+|+ +++.||||||.|.+++.+++.|++|||+++.+.-..
T Consensus 83 c-dqdlkkyfd--slng~~d~~~~rsfmlqllrgl~fchs---hnvlhrdlkpqnllin~ngelkladfglarafgipv- 155 (292)
T KOG0662|consen 83 C-DQDLKKYFD--SLNGDLDPEIVRSFMLQLLRGLGFCHS---HNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPV- 155 (292)
T ss_pred h-hHHHHHHHH--hcCCcCCHHHHHHHHHHHHhhhhhhhh---hhhhhccCCcceEEeccCCcEEecccchhhhcCCce-
Confidence 9 457777764 334568888999999999999999999 999999999999999999999999999999766432
Q ss_pred CcccccccCCcccCcccccCCC-CCcchhHHHHHHHHHHHHhCCCCCC
Q 005940 512 PHTTNVVGTFGYIAPELTQTGK-ASTSSDVFAYGILLLEVATGRRPIG 558 (668)
Q Consensus 512 ~~~~~~~gt~~y~aPE~~~~~~-~~~~sDV~S~Gvvl~elltG~~p~~ 558 (668)
......+-|..|.+|.++.+.+ |++..|+||.||++.|+....+|.-
T Consensus 156 rcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplf 203 (292)
T KOG0662|consen 156 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLF 203 (292)
T ss_pred EeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCC
Confidence 1223346789999999988764 7899999999999999998555543
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=259.99 Aligned_cols=261 Identities=23% Similarity=0.310 Sum_probs=195.2
Q ss_pred HhcCccc-ceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCchhHHHHHHHHHHHhcc-cccCceeEeeeecc----cCc
Q 005940 351 ATKGFKE-SEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRL-RHKNLVNLHGWCKQ----KND 424 (668)
Q Consensus 351 at~~f~~-~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~----~~~ 424 (668)
.|++|++ .++||-|-.|.|-.+.++.+++.+|+|++... ....+|++..-+. .|||||++++.+.+ ...
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc 133 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKC 133 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence 4556665 46799999999999999999999999998543 3445788876666 49999999998854 456
Q ss_pred eEEEEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECC---CCCEEEEeec
Q 005940 425 LLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDA---EMNARLGDFG 501 (668)
Q Consensus 425 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~---~~~~kl~DfG 501 (668)
+++|||.|+||.|...+.. +....+++.+.-.|++||+.|+.|||+ .+|.||||||+|+|.+. |-.+||+|||
T Consensus 134 LLiVmE~meGGeLfsriq~-~g~~afTErea~eI~~qI~~Av~~lH~---~nIAHRDlKpENLLyt~t~~na~lKLtDfG 209 (400)
T KOG0604|consen 134 LLIVMECMEGGELFSRIQD-RGDQAFTEREASEIMKQIGLAVRYLHS---MNIAHRDLKPENLLYTTTSPNAPLKLTDFG 209 (400)
T ss_pred eEeeeecccchHHHHHHHH-cccccchHHHHHHHHHHHHHHHHHHHh---cchhhccCChhheeeecCCCCcceEecccc
Confidence 7899999999999999964 345679999999999999999999999 99999999999999975 4569999999
Q ss_pred CceeccCCCCCcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCc-hhHHHHHHHHHhcCccccc
Q 005940 502 LARLYDHGGMPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGD-LLLVEWVRECHQLGRILDV 580 (668)
Q Consensus 502 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~-~~l~~~~~~~~~~~~~~~~ 580 (668)
.|+.-.... .....+-|+.|.|||++...+|....|+||+||++|-|+||..||-... ..+..=.+.....+.. +.
T Consensus 210 FAK~t~~~~--~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy-~F 286 (400)
T KOG0604|consen 210 FAKETQEPG--DLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQY-EF 286 (400)
T ss_pred cccccCCCc--cccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCc-cC
Confidence 998755322 2344578999999999999999999999999999999999999995431 1111112222222221 11
Q ss_pred cCcccCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHH--hccCcCCC
Q 005940 581 ADPLLNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRY--LSGEKQLR 628 (668)
Q Consensus 581 ~d~~l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~--L~~~~~~~ 628 (668)
.++.. ..-.++.+.++ ..++.- |.+|.++.|++.+ +.....+|
T Consensus 287 P~pEW--s~VSe~aKdlI---R~LLkt~PteRlTI~~~m~hpwi~~~~~vp 332 (400)
T KOG0604|consen 287 PEPEW--SCVSEAAKDLI---RKLLKTEPTERLTIEEVMDHPWINQYEAVP 332 (400)
T ss_pred CChhH--hHHHHHHHHHH---HHHhcCCchhheeHHHhhcCchhcccccCC
Confidence 12211 22233333333 334444 9999999999976 34444444
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-31 Score=275.11 Aligned_cols=197 Identities=30% Similarity=0.483 Sum_probs=174.6
Q ss_pred ceeeeecCcEEEEEEEeCCCCcEEEEEEEecCC--chhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEEecCCC
Q 005940 358 SEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNS--LQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEYIPNG 435 (668)
Q Consensus 358 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~g 435 (668)
.++||+|-||+||-|+++.+|+.||||++.+-. .+....+.+|+.||++++||.||.+.-.|+..+..++|||-+.+.
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD 648 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD 648 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence 578999999999999999999999999997642 344578899999999999999999999999999999999999666
Q ss_pred ChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCC---CCEEEEeecCceeccCCCCC
Q 005940 436 SLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAE---MNARLGDFGLARLYDHGGMP 512 (668)
Q Consensus 436 sL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~---~~~kl~DfGla~~~~~~~~~ 512 (668)
=|+.+|. .....|++..-.-++.||+.||.|||. ++|+|+||||+||||.+. .++||||||.||.+.....
T Consensus 649 MLEMILS--sEkgRL~er~TkFlvtQIL~ALr~LH~---knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksF- 722 (888)
T KOG4236|consen 649 MLEMILS--SEKGRLPERITKFLVTQILVALRYLHF---KNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSF- 722 (888)
T ss_pred HHHHHHH--hhcccchHHHHHHHHHHHHHHHHHhhh---cceeeccCCchheeeccCCCCCceeeccccceeecchhhh-
Confidence 6666664 345668888888899999999999998 999999999999999654 5799999999999876544
Q ss_pred cccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCc
Q 005940 513 HTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGD 561 (668)
Q Consensus 513 ~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~ 561 (668)
+..++||+.|+|||+++++.|...-|+||.|||+|--++|..||..++
T Consensus 723 -RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdE 770 (888)
T KOG4236|consen 723 -RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDE 770 (888)
T ss_pred -hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCcc
Confidence 345699999999999999999999999999999999999999997654
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=255.81 Aligned_cols=203 Identities=29% Similarity=0.396 Sum_probs=168.8
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCc----EEEEEEEecCCc--hhHHHHHHHHHHHhcccccCceeEeeeecc-cCce
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGG----EVAVKKITRNSL--QGMREFAAEIESLGRLRHKNLVNLHGWCKQ-KNDL 425 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~----~vavK~~~~~~~--~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~-~~~~ 425 (668)
..|+....||+|.||.||+++-++++. ++|||++..... .......+|+.+++.++|+|++.|...+.. +...
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v 103 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV 103 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence 367888999999999999997654433 799999865422 223456789999999999999999998876 7789
Q ss_pred EEEEEecCCCChhhhhcCC--CCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCC----CCEEEEe
Q 005940 426 LLVYEYIPNGSLDTLLFKP--KDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAE----MNARLGD 499 (668)
Q Consensus 426 ~lV~E~~~~gsL~~~l~~~--~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~----~~~kl~D 499 (668)
+|++||.+. +|.++++.. ...+.++-.....|+.||+.|+.|||+ .=|+||||||.|||+..+ |.+||+|
T Consensus 104 ~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~---NWvlHRDLKPaNIlvmgdgperG~VKIaD 179 (438)
T KOG0666|consen 104 WLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHS---NWVLHRDLKPANILVMGDGPERGRVKIAD 179 (438)
T ss_pred EEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhh---hheeeccCCcceEEEeccCCccCeeEeec
Confidence 999999976 677777432 234578999999999999999999999 779999999999999888 8999999
Q ss_pred ecCceeccCCCCC--cccccccCCcccCcccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCC
Q 005940 500 FGLARLYDHGGMP--HTTNVVGTFGYIAPELTQTG-KASTSSDVFAYGILLLEVATGRRPIGS 559 (668)
Q Consensus 500 fGla~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~sDV~S~Gvvl~elltG~~p~~~ 559 (668)
+|++|.+...-.+ ....++-|..|.|||.+.+. .||.+.|||+.|||+.||++-+.-|..
T Consensus 180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g 242 (438)
T KOG0666|consen 180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKG 242 (438)
T ss_pred ccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccc
Confidence 9999998765433 23456789999999998875 579999999999999999998877754
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-30 Score=260.14 Aligned_cols=263 Identities=24% Similarity=0.325 Sum_probs=203.4
Q ss_pred hhHHHHhcCcccceeeeecCcEEEEEEEeCCCC-----cEEEEEEEecC-CchhHHHHHHHHHHHhcccccCceeEeeee
Q 005940 346 KDLYAATKGFKESEVIGIGGFGSVYKGVLPTTG-----GEVAVKKITRN-SLQGMREFAAEIESLGRLRHKNLVNLHGWC 419 (668)
Q Consensus 346 ~el~~at~~f~~~~~lG~G~~g~Vy~~~~~~~~-----~~vavK~~~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~ 419 (668)
.++.....+++...++-+|.||.||+|.+.+.+ +.|-+|.+... +.-....+++|-..+..+.|||+.++.+.+
T Consensus 277 ~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ 356 (563)
T KOG1024|consen 277 QELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVS 356 (563)
T ss_pred HhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEE
Confidence 344444456777888999999999999876433 34666665433 223456788999999999999999999999
Q ss_pred ccc-CceEEEEEecCCCChhhhhc-----CCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCC
Q 005940 420 KQK-NDLLLVYEYIPNGSLDTLLF-----KPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEM 493 (668)
Q Consensus 420 ~~~-~~~~lV~E~~~~gsL~~~l~-----~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~ 493 (668)
.+. ...+.+|.++.-|+|..+|. +....+.++-.+...++.|++.|+.|||+ .+|+|.||-.+|++||+..
T Consensus 357 ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~---~~ViHkDiAaRNCvIdd~L 433 (563)
T KOG1024|consen 357 IEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHN---HGVIHKDIAARNCVIDDQL 433 (563)
T ss_pred eeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHh---cCcccchhhhhcceehhhe
Confidence 654 56899999999999999997 44455678889999999999999999999 9999999999999999999
Q ss_pred CEEEEeecCceeccCCCCCc-ccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHH
Q 005940 494 NARLGDFGLARLYDHGGMPH-TTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVAT-GRRPIGSGDLLLVEWVREC 571 (668)
Q Consensus 494 ~~kl~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~l~~~~~~~ 571 (668)
++||+|=.++|.+-...... ......+..||+||.+.+..++.++|||||||+||||+| |+.|+-.-|...++ ..
T Consensus 434 qVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~---~y 510 (563)
T KOG1024|consen 434 QVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEME---HY 510 (563)
T ss_pred eEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHH---HH
Confidence 99999999998665443322 122245678999999999999999999999999999999 99998654433222 22
Q ss_pred HhcCccccccCcccCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhcc
Q 005940 572 HQLGRILDVADPLLNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSG 623 (668)
Q Consensus 572 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~ 623 (668)
.+++. ++.. +..+..++..++..||.- |++||+.+|+..-|..
T Consensus 511 lkdGy-------RlaQ--P~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLse 554 (563)
T KOG1024|consen 511 LKDGY-------RLAQ--PFNCPDELFTVMACCWALLPEERPSFSQLVICLSE 554 (563)
T ss_pred Hhccc-------eecC--CCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHH
Confidence 22221 1111 112234567888899998 9999999999988753
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=278.02 Aligned_cols=240 Identities=25% Similarity=0.294 Sum_probs=190.9
Q ss_pred hcCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCchhHHHHHHHHHHHhcc-cccCceeEeeeecccCceEEEEE
Q 005940 352 TKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRL-RHKNLVNLHGWCKQKNDLLLVYE 430 (668)
Q Consensus 352 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~E 430 (668)
+..|.....+|.|+|+.|-++.+..+++..+||++.+.. .+-.+|+.++.+. .||||+++.+.+.+..+.|+|||
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e 396 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME 396 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence 466777888999999999999999999999999997762 2234577666665 69999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEE-CCCCCEEEEeecCceeccCC
Q 005940 431 YIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALI-DAEMNARLGDFGLARLYDHG 509 (668)
Q Consensus 431 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll-~~~~~~kl~DfGla~~~~~~ 509 (668)
++.++-|.+.+... +... .++..|+.+|+.|+.|||+ ++|+||||||+|||+ ++.++++|+|||.++.....
T Consensus 397 ~l~g~ell~ri~~~---~~~~-~e~~~w~~~lv~Av~~LH~---~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~ 469 (612)
T KOG0603|consen 397 LLDGGELLRRIRSK---PEFC-SEASQWAAELVSAVDYLHE---QGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS 469 (612)
T ss_pred hccccHHHHHHHhc---chhH-HHHHHHHHHHHHHHHHHHh---cCeeecCCChhheeecCCCCcEEEEEechhhhCchh
Confidence 99998777766422 2233 7777899999999999999 999999999999999 58899999999999977654
Q ss_pred CCCcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCcccCCcc
Q 005940 510 GMPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSY 589 (668)
Q Consensus 510 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 589 (668)
....+-|..|.|||++....+++++|+||||++||||++|+.||...... ..+....+.++.. ..
T Consensus 470 ----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~--~ei~~~i~~~~~s---------~~ 534 (612)
T KOG0603|consen 470 ----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG--IEIHTRIQMPKFS---------EC 534 (612)
T ss_pred ----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch--HHHHHhhcCCccc---------cc
Confidence 22336688999999999999999999999999999999999999755333 1122222222221 22
Q ss_pred cHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 590 VVKEMELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 590 ~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
-.++.+. |..+|++. |.+||+|.|+..+
T Consensus 535 vS~~AKd---Ll~~LL~~dP~~Rl~~~~i~~h 563 (612)
T KOG0603|consen 535 VSDEAKD---LLQQLLQVDPALRLGADEIGAH 563 (612)
T ss_pred cCHHHHH---HHHHhccCChhhCcChhhhccC
Confidence 2334443 34478887 9999999999875
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=262.60 Aligned_cols=203 Identities=28% Similarity=0.403 Sum_probs=174.4
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCch---hHHHHHHHHHHHhcc-cccCceeEeeeecccCceEEE
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQ---GMREFAAEIESLGRL-RHKNLVNLHGWCKQKNDLLLV 428 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV 428 (668)
.+|+...+||+|+||.|.++..+.+.+.+|||+++++-.- ..+--..|-++|+.. +-|.+++++.+++.-+.+|+|
T Consensus 349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFV 428 (683)
T KOG0696|consen 349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFV 428 (683)
T ss_pred cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeE
Confidence 4788899999999999999999989999999999876331 222234566777665 578999999999999999999
Q ss_pred EEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccC
Q 005940 429 YEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDH 508 (668)
Q Consensus 429 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~ 508 (668)
|||+.+|+|--++++ -..+.+....-++.+||.||-|||+ ++|++||||..||+||.++++||+|||+++.---
T Consensus 429 MEyvnGGDLMyhiQQ---~GkFKEp~AvFYAaEiaigLFFLh~---kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~ 502 (683)
T KOG0696|consen 429 MEYVNGGDLMYHIQQ---VGKFKEPVAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIF 502 (683)
T ss_pred EEEecCchhhhHHHH---hcccCCchhhhhhHHHHHHhhhhhc---CCeeeeeccccceEeccCCceEeeeccccccccc
Confidence 999999999888853 3457788899999999999999999 9999999999999999999999999999984322
Q ss_pred CCCCcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCch
Q 005940 509 GGMPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDL 562 (668)
Q Consensus 509 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~ 562 (668)
+. ..+...+||+.|+|||++..+.|....|.|||||+||||+.|+.||++.+.
T Consensus 503 ~~-~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE 555 (683)
T KOG0696|consen 503 DG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE 555 (683)
T ss_pred CC-cceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCH
Confidence 11 234567999999999999999999999999999999999999999987653
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-30 Score=241.71 Aligned_cols=203 Identities=29% Similarity=0.373 Sum_probs=171.2
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecC-CchhHHHHHHHHHHHhcc-cccCceeEeeeecccCceEEEEE
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRN-SLQGMREFAAEIESLGRL-RHKNLVNLHGWCKQKNDLLLVYE 430 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~E 430 (668)
+.......||+|++|.|-+-++..+|...|+|++... ..+..++.+.|+.+..+. .+|.+|.++|....++..++.||
T Consensus 46 d~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME 125 (282)
T KOG0984|consen 46 DDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICME 125 (282)
T ss_pred hhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHH
Confidence 3444567899999999999999999999999998654 335567788888887765 69999999999999999999999
Q ss_pred ecCCCChhhhhcC-CCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCC
Q 005940 431 YIPNGSLDTLLFK-PKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHG 509 (668)
Q Consensus 431 ~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~ 509 (668)
.| ..||+.+-.+ -+.+..+++..+-+|+..+.+||.|||+ +..++|||+||+|||++.+|++|+||||++..+.++
T Consensus 126 ~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~--kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dS 202 (282)
T KOG0984|consen 126 LM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHS--KLSVIHRDVKPSNILINYDGQVKICDFGISGYLVDS 202 (282)
T ss_pred Hh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHH--HhhhhhccCCcceEEEccCCcEEEcccccceeehhh
Confidence 99 4588776532 1346679999999999999999999999 589999999999999999999999999999887654
Q ss_pred CCCcccccccCCcccCcccccC----CCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 005940 510 GMPHTTNVVGTFGYIAPELTQT----GKASTSSDVFAYGILLLEVATGRRPIGSG 560 (668)
Q Consensus 510 ~~~~~~~~~gt~~y~aPE~~~~----~~~~~~sDV~S~Gvvl~elltG~~p~~~~ 560 (668)
-. .+...|-..|||||.+.. ..|+-|+||||+|+.+.||.+++.|++..
T Consensus 203 iA--kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w 255 (282)
T KOG0984|consen 203 IA--KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESW 255 (282)
T ss_pred hH--HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccccc
Confidence 32 223468889999998753 36889999999999999999999999754
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3e-29 Score=275.50 Aligned_cols=257 Identities=29% Similarity=0.378 Sum_probs=208.2
Q ss_pred HHHHhcCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCchhHHHHHHHHHHHhcc-cccCceeEeeeec-----c
Q 005940 348 LYAATKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRL-RHKNLVNLHGWCK-----Q 421 (668)
Q Consensus 348 l~~at~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~-----~ 421 (668)
+...+.-|.+.+.||.|.+|.||+++...+++..|+|+....... -++...|.++++.+ .|||++.++|++. .
T Consensus 14 lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~-deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~ 92 (953)
T KOG0587|consen 14 LPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDE-EEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGN 92 (953)
T ss_pred CCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccc-cHHHHHHHHHHHhccCCCCcceEEEEEEEecCCC
Confidence 334467788999999999999999999999999999998765433 36777899999988 5999999999985 3
Q ss_pred cCceEEEEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeec
Q 005940 422 KNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFG 501 (668)
Q Consensus 422 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfG 501 (668)
.+.++||||||.+||..++++.-. +..+.|..+..|++.++.||++||. ..++|||||-.||||+.++.+||+|||
T Consensus 93 ~DqLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~---nkviHRDikG~NiLLT~e~~VKLvDFG 168 (953)
T KOG0587|consen 93 GDQLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHN---NKVIHRDIKGQNVLLTENAEVKLVDFG 168 (953)
T ss_pred CCeEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhh---cceeeecccCceEEEeccCcEEEeeee
Confidence 467999999999999999997555 7789999999999999999999998 999999999999999999999999999
Q ss_pred CceeccCCCCCcccccccCCcccCcccccCC-----CCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCc
Q 005940 502 LARLYDHGGMPHTTNVVGTFGYIAPELTQTG-----KASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGR 576 (668)
Q Consensus 502 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~ 576 (668)
++..++.... .+....||+.|||||++... .|+..+|+||+|++..||.-|..|+-+. ..+ +. .-.
T Consensus 169 vSaQldsT~g-rRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~Dm--HPm---ra---LF~ 239 (953)
T KOG0587|consen 169 VSAQLDSTVG-RRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDM--HPM---RA---LFL 239 (953)
T ss_pred eeeeeecccc-cccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCc--chh---hh---hcc
Confidence 9988775443 34456899999999988542 4567899999999999999999998532 111 11 112
Q ss_pred cccccCcccCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 577 ILDVADPLLNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 577 ~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
+.....|.+ .-....-+.+...+..|+.. -++||++.+++++
T Consensus 240 IpRNPPPkL--krp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 240 IPRNPPPKL--KRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred CCCCCCccc--cchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 222222333 23455566777888889887 7899999998875
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-30 Score=263.09 Aligned_cols=254 Identities=26% Similarity=0.386 Sum_probs=194.6
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecC--Cchh-----HHHHHHHHHHHhcccccCceeEeeeec-ccCc
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRN--SLQG-----MREFAAEIESLGRLRHKNLVNLHGWCK-QKND 424 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~-----~~~f~~Ei~~l~~l~H~nIv~l~g~~~-~~~~ 424 (668)
++|-..++||+|||+.||++.+....+.||||+-... ..+. .+...+|.+|.+.|.||.||++++++. +...
T Consensus 463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtds 542 (775)
T KOG1151|consen 463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDS 542 (775)
T ss_pred HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecccc
Confidence 4577788999999999999999888899999986432 2111 234568999999999999999999996 5567
Q ss_pred eEEEEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECC---CCCEEEEeec
Q 005940 425 LLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDA---EMNARLGDFG 501 (668)
Q Consensus 425 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~---~~~~kl~DfG 501 (668)
+|-|.|||++.+|+-+|. ..+.+++.....|+.||+.||.||.+ .+.+|||-||||.||||-. -|.+||.|||
T Consensus 543 FCTVLEYceGNDLDFYLK---QhklmSEKEARSIiMQiVnAL~YLNE-ikpPIIHYDLKPgNILLv~GtacGeIKITDFG 618 (775)
T KOG1151|consen 543 FCTVLEYCEGNDLDFYLK---QHKLMSEKEARSIIMQIVNALKYLNE-IKPPIIHYDLKPGNILLVNGTACGEIKITDFG 618 (775)
T ss_pred ceeeeeecCCCchhHHHH---hhhhhhHHHHHHHHHHHHHHHHHHhc-cCCCeeeeccCCccEEEecCcccceeEeeecc
Confidence 899999999999999995 45679999999999999999999996 5789999999999999954 4789999999
Q ss_pred CceeccCCCC------CcccccccCCcccCcccccCC----CCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHH
Q 005940 502 LARLYDHGGM------PHTTNVVGTFGYIAPELTQTG----KASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVREC 571 (668)
Q Consensus 502 la~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~----~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~ 571 (668)
+++.++.... ..+....||.+|++||++.-+ +.+.|.||||.|||+|+.+.|++||+..... ...
T Consensus 619 LSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQ-----QdI 693 (775)
T KOG1151|consen 619 LSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQ-----QDI 693 (775)
T ss_pred hhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhH-----HHH
Confidence 9998875533 234556899999999987543 5688999999999999999999999865211 111
Q ss_pred HhcCccccccCcccC-CcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHH
Q 005940 572 HQLGRILDVADPLLN-SSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVM 618 (668)
Q Consensus 572 ~~~~~~~~~~d~~l~-~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl 618 (668)
.+...++.+..-.+. ......+...++ .+|+.. -++|-...|+.
T Consensus 694 LqeNTIlkAtEVqFP~KPvVsseAkaFI---RRCLaYRKeDR~DV~qLA 739 (775)
T KOG1151|consen 694 LQENTILKATEVQFPPKPVVSSEAKAFI---RRCLAYRKEDRIDVQQLA 739 (775)
T ss_pred HhhhchhcceeccCCCCCccCHHHHHHH---HHHHHhhhhhhhhHHHHc
Confidence 222233332222221 122233444444 489888 67787766654
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-30 Score=246.81 Aligned_cols=201 Identities=31% Similarity=0.474 Sum_probs=167.0
Q ss_pred CcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCc--hhHHHHHHHHHHHhcccccCceeEeeeeccc--------C
Q 005940 354 GFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSL--QGMREFAAEIESLGRLRHKNLVNLHGWCKQK--------N 423 (668)
Q Consensus 354 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~--------~ 423 (668)
.|....+||+|.||.||+++.+.+|+.||+|++--..+ .--....+|+++|..|+|+|++.++..|... .
T Consensus 18 ~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~ 97 (376)
T KOG0669|consen 18 KYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRA 97 (376)
T ss_pred HHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccc
Confidence 45556789999999999999999999999987643222 1224567899999999999999999999532 3
Q ss_pred ceEEEEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCc
Q 005940 424 DLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLA 503 (668)
Q Consensus 424 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla 503 (668)
.+|+||++|+. +|.-+|. .....++..++.++++++..||.|+|. ..|+|||+||.|+||+.++.+||+|||++
T Consensus 98 t~ylVf~~ceh-DLaGlLs--n~~vr~sls~Ikk~Mk~Lm~GL~~iHr---~kilHRDmKaaNvLIt~dgilklADFGla 171 (376)
T KOG0669|consen 98 TFYLVFDFCEH-DLAGLLS--NRKVRFSLSEIKKVMKGLMNGLYYIHR---NKILHRDMKAANVLITKDGILKLADFGLA 171 (376)
T ss_pred eeeeeHHHhhh-hHHHHhc--CccccccHHHHHHHHHHHHHHHHHHHH---hhHHhhcccHhhEEEcCCceEEeeccccc
Confidence 48999999965 7777774 233568999999999999999999999 99999999999999999999999999999
Q ss_pred eeccCCC---CCcccccccCCcccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 005940 504 RLYDHGG---MPHTTNVVGTFGYIAPELTQT-GKASTSSDVFAYGILLLEVATGRRPIGSG 560 (668)
Q Consensus 504 ~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~S~Gvvl~elltG~~p~~~~ 560 (668)
+.+.... .+..+..+-|..|.+||.+.+ ..++++.|||..||++.||.++..-++..
T Consensus 172 r~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgn 232 (376)
T KOG0669|consen 172 RAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGN 232 (376)
T ss_pred cceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCC
Confidence 8665332 223455677999999998765 56899999999999999999999887654
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.8e-30 Score=278.82 Aligned_cols=245 Identities=28% Similarity=0.412 Sum_probs=183.0
Q ss_pred cccceeeeecCcEE-EEEEEeCCCCcEEEEEEEecCCchhHHHHHHHHHHHhcc-cccCceeEeeeecccCceEEEEEec
Q 005940 355 FKESEVIGIGGFGS-VYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRL-RHKNLVNLHGWCKQKNDLLLVYEYI 432 (668)
Q Consensus 355 f~~~~~lG~G~~g~-Vy~~~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~E~~ 432 (668)
|...+++|.|+.|+ ||+|.. .+++||||++-... ..-..+|+..|+.- .|||||++++.-.+....|+..|.|
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~y--e~R~VAVKrll~e~---~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC 585 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVY--EGREVAVKRLLEEF---FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC 585 (903)
T ss_pred eccHHHcccCCCCcEEEEEee--CCceehHHHHhhHh---HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh
Confidence 56677899999986 899999 68899999985432 23456899999888 5999999999999999999999999
Q ss_pred CCCChhhhhcCC-CCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECC---C--CCEEEEeecCceec
Q 005940 433 PNGSLDTLLFKP-KDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDA---E--MNARLGDFGLARLY 506 (668)
Q Consensus 433 ~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~---~--~~~kl~DfGla~~~ 506 (668)
..+|++++... .+.....-...+.+..|++.||++||+ .+|+||||||.||||+. + ..++|+|||+++.+
T Consensus 586 -~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHs---l~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl 661 (903)
T KOG1027|consen 586 -ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHS---LKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKL 661 (903)
T ss_pred -hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHh---cccccccCCCceEEEEccCCCcceeEEeccccccccc
Confidence 56999999653 111111114457788999999999999 99999999999999976 2 56999999999988
Q ss_pred cCCCC--CcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhC-CCCCCCCchhHHHHHHHHHhcCccccccCc
Q 005940 507 DHGGM--PHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATG-RRPIGSGDLLLVEWVRECHQLGRILDVADP 583 (668)
Q Consensus 507 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG-~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~ 583 (668)
..+.. .......||.+|+|||++....-+.+.||||+||++|+.++| ..||+..- .++..+..-.-.
T Consensus 662 ~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~----------~R~~NIl~~~~~ 731 (903)
T KOG1027|consen 662 AGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSL----------ERQANILTGNYT 731 (903)
T ss_pred CCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchH----------HhhhhhhcCccc
Confidence 76543 234456899999999999998889999999999999999995 89997531 111111111101
Q ss_pred ccCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 584 LLNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 584 ~l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
...-....++ +...|+..+.+. |..||++.+|+.|
T Consensus 732 L~~L~~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~H 767 (903)
T KOG1027|consen 732 LVHLEPLPDC--EAKDLISRMLNPDPQLRPSATDVLNH 767 (903)
T ss_pred eeeeccCchH--HHHHHHHHhcCCCcccCCCHHHHhCC
Confidence 0000111111 223333355555 9999999999976
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5e-29 Score=263.45 Aligned_cols=201 Identities=27% Similarity=0.441 Sum_probs=174.5
Q ss_pred CcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCc---hhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEE
Q 005940 354 GFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSL---QGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYE 430 (668)
Q Consensus 354 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 430 (668)
-|..++-||-|+||.|+++...++...+|.|.+++.+. ......++|-.||.....+=||+|+-.|.+++.+|+|||
T Consensus 630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMd 709 (1034)
T KOG0608|consen 630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 709 (1034)
T ss_pred ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEe
Confidence 37778899999999999999888888999999987654 234567889999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceec----
Q 005940 431 YIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLY---- 506 (668)
Q Consensus 431 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~---- 506 (668)
|++||++-.+|.+ -..+++....-++.++.+|+.+.|. .|+|||||||.|||||.+|++||.|||||.-+
T Consensus 710 YIPGGDmMSLLIr---mgIFeE~LARFYIAEltcAiesVHk---mGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTH 783 (1034)
T KOG0608|consen 710 YIPGGDMMSLLIR---MGIFEEDLARFYIAELTCAIESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 783 (1034)
T ss_pred ccCCccHHHHHHH---hccCHHHHHHHHHHHHHHHHHHHHh---ccceecccCccceEEccCCceeeeeccccccceecc
Confidence 9999999999963 3568888888999999999999998 99999999999999999999999999998633
Q ss_pred -----cCCCCC--------------------------------cccccccCCcccCcccccCCCCCcchhHHHHHHHHHH
Q 005940 507 -----DHGGMP--------------------------------HTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLE 549 (668)
Q Consensus 507 -----~~~~~~--------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~e 549 (668)
..+... .....+||..|+|||++....++..+|.||.||||||
T Consensus 784 dskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~e 863 (1034)
T KOG0608|consen 784 DSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYE 863 (1034)
T ss_pred ccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHH
Confidence 111100 0012479999999999999999999999999999999
Q ss_pred HHhCCCCCCCC
Q 005940 550 VATGRRPIGSG 560 (668)
Q Consensus 550 lltG~~p~~~~ 560 (668)
|+-|+.||-..
T Consensus 864 m~~g~~pf~~~ 874 (1034)
T KOG0608|consen 864 MLVGQPPFLAD 874 (1034)
T ss_pred HhhCCCCccCC
Confidence 99999999543
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.9e-29 Score=251.77 Aligned_cols=199 Identities=24% Similarity=0.331 Sum_probs=171.1
Q ss_pred hcCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCchhHHHHHHHHHHHhcccc--c----CceeEeeeecccCce
Q 005940 352 TKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRH--K----NLVNLHGWCKQKNDL 425 (668)
Q Consensus 352 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H--~----nIv~l~g~~~~~~~~ 425 (668)
+++|.+...+|+|.||.|-.+.+..++..||||+++... ...+..+-|++++.++.+ | -+|++.+|++..++.
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~-kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghi 166 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD-KYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHI 166 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH-HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCce
Confidence 688999999999999999999998889999999986543 233456679999999942 2 488899999999999
Q ss_pred EEEEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECC--------------
Q 005940 426 LLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDA-------------- 491 (668)
Q Consensus 426 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~-------------- 491 (668)
|+|+|.+ |-|+.++|.. ..-.+++..++..|+.|++++++|||+ .+++|-||||+|||+.+
T Consensus 167 Civfell-G~S~~dFlk~-N~y~~fpi~~ir~m~~QL~~sv~fLh~---~kl~HTDLKPENILfvss~~~~~~~~k~~~~ 241 (415)
T KOG0671|consen 167 CIVFELL-GLSTFDFLKE-NNYIPFPIDHIRHMGYQLLESVAFLHD---LKLTHTDLKPENILFVSSEYFKTYNPKKKVC 241 (415)
T ss_pred EEEEecc-ChhHHHHhcc-CCccccchHHHHHHHHHHHHHHHHHHh---cceeecCCChheEEEeccceEEEeccCCccc
Confidence 9999988 6689999953 334578999999999999999999999 99999999999999831
Q ss_pred ------CCCEEEEeecCceeccCCCCCcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 005940 492 ------EMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSG 560 (668)
Q Consensus 492 ------~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~ 560 (668)
+..+|+.|||-|..-.... ...+.|.-|.|||++.+-.++.++||||+||||.|+.+|..-|...
T Consensus 242 ~~r~~ks~~I~vIDFGsAtf~~e~h----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtH 312 (415)
T KOG0671|consen 242 FIRPLKSTAIKVIDFGSATFDHEHH----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTH 312 (415)
T ss_pred eeccCCCcceEEEecCCcceeccCc----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccC
Confidence 3458999999998755432 4457899999999999999999999999999999999999988754
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.9e-27 Score=231.49 Aligned_cols=211 Identities=36% Similarity=0.557 Sum_probs=182.2
Q ss_pred eeecCcEEEEEEEeCCCCcEEEEEEEecCCch-hHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEEecCCCChhh
Q 005940 361 IGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQ-GMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEYIPNGSLDT 439 (668)
Q Consensus 361 lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~ 439 (668)
||+|.+|.||++....+++.+++|++...... ..+.+.+|++.+++++|++++++++++......++++|++++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 68999999999999777899999999776543 34678999999999999999999999999899999999999999999
Q ss_pred hhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECC-CCCEEEEeecCceeccCCCCCcccccc
Q 005940 440 LLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDA-EMNARLGDFGLARLYDHGGMPHTTNVV 518 (668)
Q Consensus 440 ~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~-~~~~kl~DfGla~~~~~~~~~~~~~~~ 518 (668)
++... ...+++..++.++.+++++|.+||+ .+++|+||+|.||+++. ++.++|+|||.+........ ......
T Consensus 81 ~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~---~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~ 154 (215)
T cd00180 81 LLKEN--EGKLSEDEILRILLQILEGLEYLHS---NGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTIV 154 (215)
T ss_pred HHHhc--cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhccc
Confidence 98532 1468999999999999999999999 89999999999999999 89999999999987655321 123345
Q ss_pred cCCcccCcccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCcccCCcccHHHHHHH
Q 005940 519 GTFGYIAPELTQTG-KASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSYVVKEMELV 597 (668)
Q Consensus 519 gt~~y~aPE~~~~~-~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l 597 (668)
+...|++||..... ..+.++|+|++|+++++| ..+
T Consensus 155 ~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l--------------------------------------------~~~ 190 (215)
T cd00180 155 GTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL--------------------------------------------PEL 190 (215)
T ss_pred CCCCccChhHhcccCCCCchhhhHHHHHHHHHH--------------------------------------------HHH
Confidence 78899999998877 788999999999999999 344
Q ss_pred HHHHhhcCCC-CCCCCCHHHHHHHh
Q 005940 598 LKLGLMCSHK-TQFRPTMRQVMRYL 621 (668)
Q Consensus 598 ~~l~~~C~~~-p~~RPs~~evl~~L 621 (668)
..+...|+.. |++||+++++++++
T Consensus 191 ~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 191 KDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred HHHHHHHhhCCcccCcCHHHHhhCC
Confidence 5666677776 99999999999764
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.4e-30 Score=245.29 Aligned_cols=260 Identities=25% Similarity=0.342 Sum_probs=196.4
Q ss_pred ccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCC--chhHHHHHHHHHHHhcccccCceeEeeeeccc-----CceEEE
Q 005940 356 KESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNS--LQGMREFAAEIESLGRLRHKNLVNLHGWCKQK-----NDLLLV 428 (668)
Q Consensus 356 ~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~-----~~~~lV 428 (668)
+..+.||.|+||.||.++++.+|+.||+|++.... ....+.+..|+++|.-++|.|++..++...-. .++|++
T Consensus 56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~ 135 (449)
T KOG0664|consen 56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVL 135 (449)
T ss_pred CCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHH
Confidence 44678999999999999999999999999986532 23457788999999999999999998876543 357889
Q ss_pred EEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccC
Q 005940 429 YEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDH 508 (668)
Q Consensus 429 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~ 508 (668)
.|.| ..+|.+++-. -..|+-..+.-+++||++||.|||+ .+|.||||||.|.|+++|..+||||||+|+..+.
T Consensus 136 TELm-QSDLHKIIVS---PQ~Ls~DHvKVFlYQILRGLKYLHs---A~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~ 208 (449)
T KOG0664|consen 136 TELM-QSDLHKIIVS---PQALTPDHVKVFVYQILRGLKYLHT---ANILHRDIKPGNLLVNSNCILKICDFGLARTWDQ 208 (449)
T ss_pred HHHH-Hhhhhheecc---CCCCCcchhhhhHHHHHhhhHHHhh---cchhhccCCCccEEeccCceEEecccccccccch
Confidence 9988 4578777743 3458888999999999999999999 9999999999999999999999999999998887
Q ss_pred CCCCcccccccCCcccCcccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCc-hhHHHHHHHHHhcCcccc-------
Q 005940 509 GGMPHTTNVVGTFGYIAPELTQTG-KASTSSDVFAYGILLLEVATGRRPIGSGD-LLLVEWVRECHQLGRILD------- 579 (668)
Q Consensus 509 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDV~S~Gvvl~elltG~~p~~~~~-~~l~~~~~~~~~~~~~~~------- 579 (668)
......+..+-|..|.|||++.+. .|+.+.||||.||++.|++..+..|.... ....+.+.++........
T Consensus 209 d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEG 288 (449)
T KOG0664|consen 209 RDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEG 288 (449)
T ss_pred hhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhh
Confidence 766666667889999999998875 58999999999999999999887776431 111222222221111000
Q ss_pred ----cc-----CcccC-----CcccHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhc
Q 005940 580 ----VA-----DPLLN-----SSYVVKEMELVLKLGLMCSHKTQFRPTMRQVMRYLS 622 (668)
Q Consensus 580 ----~~-----d~~l~-----~~~~~~~~~~l~~l~~~C~~~p~~RPs~~evl~~L~ 622 (668)
++ .|.+. ...+..+.+.+..+.++...+|++|-+..+.+.++-
T Consensus 289 Ak~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~ 345 (449)
T KOG0664|consen 289 AKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRY 345 (449)
T ss_pred hHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccc
Confidence 00 01110 111233344555555555556999999999888764
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.8e-27 Score=235.51 Aligned_cols=200 Identities=33% Similarity=0.483 Sum_probs=175.2
Q ss_pred cccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCch-hHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEEecC
Q 005940 355 FKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQ-GMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEYIP 433 (668)
Q Consensus 355 f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~ 433 (668)
|...+.||+|++|.||++....+++.+++|.+...... ..+.+.+|++.+++++|+|++++++++......++++|+++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 45678999999999999999877899999999876655 67789999999999999999999999999899999999999
Q ss_pred CCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCCCCc
Q 005940 434 NGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPH 513 (668)
Q Consensus 434 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 513 (668)
+++|.+++.... ..+++..+..++.+++.+|.|||+ .+++|+||+|+||+++.++.++|+|||.+..........
T Consensus 81 ~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~ 155 (225)
T smart00221 81 GGDLFDYLRKKG--GKLSEEEARFYLRQILEALEYLHS---LGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAAL 155 (225)
T ss_pred CCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccccc
Confidence 999999995322 128899999999999999999999 899999999999999999999999999998776543112
Q ss_pred ccccccCCcccCcccc-cCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 005940 514 TTNVVGTFGYIAPELT-QTGKASTSSDVFAYGILLLEVATGRRPIGS 559 (668)
Q Consensus 514 ~~~~~gt~~y~aPE~~-~~~~~~~~sDV~S~Gvvl~elltG~~p~~~ 559 (668)
.....++..|++||.+ ....++.++|||+||++++||++|+.||..
T Consensus 156 ~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 156 LKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred ccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 2334678889999998 666778899999999999999999999954
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.6e-29 Score=260.27 Aligned_cols=201 Identities=27% Similarity=0.378 Sum_probs=177.3
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCC---chhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEE
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNS---LQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVY 429 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 429 (668)
.+++...-||-||||.|=++........+|+|++++.. ....+....|-++|..++.|.||+++-.|.+....|+.|
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm 499 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM 499 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence 34556677999999999999886555558999887643 234456778999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCC
Q 005940 430 EYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHG 509 (668)
Q Consensus 430 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~ 509 (668)
|-|-+|.|...|. ++..++.....-++..+++|+.|||+ ++||+|||||+|.+|+.+|-+||.|||.|+.+..+
T Consensus 500 EaClGGElWTiLr---dRg~Fdd~tarF~~acv~EAfeYLH~---k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g 573 (732)
T KOG0614|consen 500 EACLGGELWTILR---DRGSFDDYTARFYVACVLEAFEYLHR---KGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG 573 (732)
T ss_pred HhhcCchhhhhhh---hcCCcccchhhhhHHHHHHHHHHHHh---cCceeccCChhheeeccCCceEEeehhhHHHhccC
Confidence 9999999999995 34568888888899999999999999 99999999999999999999999999999988765
Q ss_pred CCCcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCc
Q 005940 510 GMPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGD 561 (668)
Q Consensus 510 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~ 561 (668)
. .+-.++||+.|.|||++.+.....+.|.||+|+++|||++|..||...+
T Consensus 574 ~--KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~d 623 (732)
T KOG0614|consen 574 R--KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVD 623 (732)
T ss_pred C--ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCc
Confidence 4 3445799999999999999999999999999999999999999998654
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=7e-28 Score=238.11 Aligned_cols=199 Identities=29% Similarity=0.383 Sum_probs=174.8
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecC---CchhHHHHHHHHHHHhcc-cccCceeEeeeecccCceEEE
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRN---SLQGMREFAAEIESLGRL-RHKNLVNLHGWCKQKNDLLLV 428 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV 428 (668)
++|...++||+|+|.+|.++.++.+.+.+|+|++++. ..+..+-...|-.+..+. +||.+|-++.+++.+..+++|
T Consensus 250 ~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffv 329 (593)
T KOG0695|consen 250 QDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFV 329 (593)
T ss_pred ccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEE
Confidence 6789999999999999999999999999999998763 223344455676676665 699999999999999999999
Q ss_pred EEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccC
Q 005940 429 YEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDH 508 (668)
Q Consensus 429 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~ 508 (668)
.||+++|+|--++. ....|+++...-+..+|.-||.|||+ +||++||||..|||||..+++||.|+|+++.--.
T Consensus 330 ieyv~ggdlmfhmq---rqrklpeeharfys~ei~lal~flh~---rgiiyrdlkldnvlldaeghikltdygmcke~l~ 403 (593)
T KOG0695|consen 330 IEYVNGGDLMFHMQ---RQRKLPEEHARFYSAEICLALNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLG 403 (593)
T ss_pred EEEecCcceeeehh---hhhcCcHHHhhhhhHHHHHHHHHHhh---cCeeeeeccccceEEccCCceeecccchhhcCCC
Confidence 99999999977764 45669999999999999999999999 9999999999999999999999999999985332
Q ss_pred CCCCcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 005940 509 GGMPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIG 558 (668)
Q Consensus 509 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~ 558 (668)
. ...+..++||+.|.|||++++..|....|.|++||+++||+.|+.||+
T Consensus 404 ~-gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfd 452 (593)
T KOG0695|consen 404 P-GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFD 452 (593)
T ss_pred C-CcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcc
Confidence 2 233556899999999999999999999999999999999999999996
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.1e-28 Score=252.80 Aligned_cols=197 Identities=26% Similarity=0.394 Sum_probs=171.6
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCch--------hHHHHHHHHHHHhccc---ccCceeEeeeecc
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQ--------GMREFAAEIESLGRLR---HKNLVNLHGWCKQ 421 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--------~~~~f~~Ei~~l~~l~---H~nIv~l~g~~~~ 421 (668)
..|...+.+|+|+||.|+.|+++.+..+|+||.+.+...- ..-..-.|+.||..|+ |+||++++++|++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 3578899999999999999999998899999998765321 1113457999999997 9999999999999
Q ss_pred cCceEEEEEec-CCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEee
Q 005940 422 KNDLLLVYEYI-PNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDF 500 (668)
Q Consensus 422 ~~~~~lV~E~~-~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~Df 500 (668)
.+.+||++|-. ++-+|.+++.. +..+++....-|++||+.|+++||+ ++|+|||||-+||.++.+|-+||.||
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE~---kp~m~E~eAk~IFkQV~agi~hlh~---~~ivhrdikdenvivd~~g~~klidf 714 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIEF---KPRMDEPEAKLIFKQVVAGIKHLHD---QGIVHRDIKDENVIVDSNGFVKLIDF 714 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhhc---cCccchHHHHHHHHHHHhccccccc---cCceecccccccEEEecCCeEEEeec
Confidence 99999999965 56688888853 3559999999999999999999999 99999999999999999999999999
Q ss_pred cCceeccCCCCCcccccccCCcccCcccccCCCC-CcchhHHHHHHHHHHHHhCCCCCC
Q 005940 501 GLARLYDHGGMPHTTNVVGTFGYIAPELTQTGKA-STSSDVFAYGILLLEVATGRRPIG 558 (668)
Q Consensus 501 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDV~S~Gvvl~elltG~~p~~ 558 (668)
|.|.+...+.. ..++||.+|.|||++.+.+| ...-|||++|++||-++....||-
T Consensus 715 gsaa~~ksgpf---d~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 715 GSAAYTKSGPF---DVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred cchhhhcCCCc---ceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 99987766543 45689999999999998877 577899999999999999988874
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.8e-26 Score=238.88 Aligned_cols=155 Identities=26% Similarity=0.362 Sum_probs=126.7
Q ss_pred cchhhcccccCCcccchhhHHHHhcCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCchhHHHHHHHHHHHhccc
Q 005940 329 SETLEDWEKDCPHRFRYKDLYAATKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLR 408 (668)
Q Consensus 329 ~~~~~~~~~~~~~~f~~~el~~at~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~ 408 (668)
.+..+++.+...+..+..|.+. ..+|.+.++||.|.|++||++.+..+.+.||+|+.+... .-.+..+.||++|++++
T Consensus 55 qE~~~dY~kGGYHpV~IGD~F~-~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq-hYtEaAlDEIklL~~v~ 132 (590)
T KOG1290|consen 55 QEDPEDYRKGGYHPVRIGDVFN-GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ-HYTEAALDEIKLLQQVR 132 (590)
T ss_pred ccChhhhhcCCCceeecccccc-CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh-HHHHHHHHHHHHHHHHH
Confidence 3444556666666677777664 357999999999999999999999999999999985432 23456779999999985
Q ss_pred --------ccCceeEeeeecc----cCceEEEEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCc
Q 005940 409 --------HKNLVNLHGWCKQ----KNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQV 476 (668)
Q Consensus 409 --------H~nIv~l~g~~~~----~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ 476 (668)
...||+|+++|.. +.+.|+|+|++ |-+|..++.+. .-+-++...+.+|++||+.||.|||.+ .+
T Consensus 133 ~~Dp~~~~~~~VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s-~YrGlpl~~VK~I~~qvL~GLdYLH~e--cg 208 (590)
T KOG1290|consen 133 EGDPNDPGKKCVVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYS-NYRGLPLSCVKEICRQVLTGLDYLHRE--CG 208 (590)
T ss_pred hcCCCCCCCceeeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHh-CCCCCcHHHHHHHHHHHHHHHHHHHHh--cC
Confidence 2479999999964 45899999999 67888888643 345689999999999999999999994 79
Q ss_pred eEecCCCCCCEEE
Q 005940 477 VIHRDVKPSNALI 489 (668)
Q Consensus 477 ivHrDLkp~NIll 489 (668)
|||-||||+||||
T Consensus 209 IIHTDlKPENvLl 221 (590)
T KOG1290|consen 209 IIHTDLKPENVLL 221 (590)
T ss_pred ccccCCCcceeee
Confidence 9999999999999
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.6e-26 Score=215.05 Aligned_cols=195 Identities=26% Similarity=0.396 Sum_probs=166.1
Q ss_pred hcCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCchhHHHHHHHHHHHhccc-ccCceeEeeeeccc--CceEEE
Q 005940 352 TKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLR-HKNLVNLHGWCKQK--NDLLLV 428 (668)
Q Consensus 352 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~--~~~~lV 428 (668)
.++|++.+++|+|-|+.||.|....+++.++||++... ..+.+.+|+.+|..|+ ||||++|++...+. ..+.||
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi 113 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI 113 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence 46789999999999999999998888999999999654 3467789999999998 99999999998765 457899
Q ss_pred EEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCC-CCEEEEeecCceecc
Q 005940 429 YEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAE-MNARLGDFGLARLYD 507 (668)
Q Consensus 429 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~-~~~kl~DfGla~~~~ 507 (668)
+||+.+.+...+- ..|+...+...+.+++.||.|+|+ .||.|||+||.|+++|.. -.++|.|+|+|..+.
T Consensus 114 FE~v~n~Dfk~ly------~tl~d~dIryY~~elLkALdyCHS---~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYH 184 (338)
T KOG0668|consen 114 FEYVNNTDFKQLY------PTLTDYDIRYYIYELLKALDYCHS---MGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 184 (338)
T ss_pred hhhhccccHHHHh------hhhchhhHHHHHHHHHHHHhHHHh---cCcccccCCcceeeechhhceeeeeecchHhhcC
Confidence 9999998776654 247888899999999999999999 999999999999999976 469999999999877
Q ss_pred CCCCCcccccccCCcccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 005940 508 HGGMPHTTNVVGTFGYIAPELTQT-GKASTSSDVFAYGILLLEVATGRRPIGSG 560 (668)
Q Consensus 508 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~S~Gvvl~elltG~~p~~~~ 560 (668)
.+..- ...+.+..|.-||.+-. +.+...-|+|||||++..|+..+.||-.+
T Consensus 185 p~~eY--nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG 236 (338)
T KOG0668|consen 185 PGKEY--NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHG 236 (338)
T ss_pred CCcee--eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCC
Confidence 65422 22355677899998754 56788999999999999999999999544
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.4e-26 Score=227.35 Aligned_cols=207 Identities=26% Similarity=0.360 Sum_probs=170.7
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecC--CchhHHHHHHHHHHHhcccccCceeEeeeeccc------Cc
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRN--SLQGMREFAAEIESLGRLRHKNLVNLHGWCKQK------ND 424 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~------~~ 424 (668)
.+|.....+|.|.- .|..+.+.-.++.||+|++... .....+....|...+..++|+||++++.++.-. .+
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 45666677888888 7778877778999999998654 223446677899999999999999999998533 46
Q ss_pred eEEEEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCce
Q 005940 425 LLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLAR 504 (668)
Q Consensus 425 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~ 504 (668)
.|+|||+| ..+|...+. -.++-..+..|..|+++|++|||+ .+|+||||||+||++..+..+||.|||+|+
T Consensus 96 ~y~v~e~m-~~nl~~vi~-----~elDH~tis~i~yq~~~~ik~lhs---~~IihRdLkPsnivv~~~~~lKi~dfg~ar 166 (369)
T KOG0665|consen 96 VYLVMELM-DANLCQVIL-----MELDHETISYILYQMLCGIKHLHS---AGIIHRDLKPSNIVVNSDCTLKILDFGLAR 166 (369)
T ss_pred HHHHHHhh-hhHHHHHHH-----HhcchHHHHHHHHHHHHHHHHHHh---cceeecccCcccceecchhheeeccchhhc
Confidence 89999999 568888875 236667888999999999999999 999999999999999999999999999999
Q ss_pred eccCCCCCcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHH
Q 005940 505 LYDHGGMPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECH 572 (668)
Q Consensus 505 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~ 572 (668)
..+.. -..+..+.|..|.|||++.+..+.+..||||.||++.||++|.--|.+ +..+..|.+...
T Consensus 167 ~e~~~--~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g-~d~idQ~~ki~~ 231 (369)
T KOG0665|consen 167 TEDTD--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPG-KDHIDQWNKIIE 231 (369)
T ss_pred ccCcc--cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecC-chHHHHHHHHHH
Confidence 76544 234567889999999999888899999999999999999999988864 344555554433
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=9e-27 Score=248.77 Aligned_cols=253 Identities=26% Similarity=0.359 Sum_probs=202.3
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCchhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEEec
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEYI 432 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~ 432 (668)
.+|....++|.|.||.|||++++.+++..|+|+++........-..+|+-+++..+|+||+.++|-+.....+++.||||
T Consensus 15 ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEyc 94 (829)
T KOG0576|consen 15 DDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYC 94 (829)
T ss_pred cchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEec
Confidence 46778899999999999999999999999999998776666677789999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCCCC
Q 005940 433 PNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMP 512 (668)
Q Consensus 433 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~~~ 512 (668)
.+|+|++.-+ ...++++.++..+++...+||+|||+ ++=+|||||-.||++++.+.+|++|||.+-.+... ..
T Consensus 95 gggslQdiy~---~TgplselqiayvcRetl~gl~ylhs---~gk~hRdiKGanilltd~gDvklaDfgvsaqitat-i~ 167 (829)
T KOG0576|consen 95 GGGSLQDIYH---VTGPLSELQIAYVCRETLQGLKYLHS---QGKIHRDIKGANILLTDEGDVKLADFGVSAQITAT-IA 167 (829)
T ss_pred CCCcccceee---ecccchhHHHHHHHhhhhccchhhhc---CCcccccccccceeecccCceeecccCchhhhhhh-hh
Confidence 9999999875 35679999999999999999999999 99999999999999999999999999998765532 23
Q ss_pred cccccccCCcccCcccc---cCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCcccCCcc
Q 005940 513 HTTNVVGTFGYIAPELT---QTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSY 589 (668)
Q Consensus 513 ~~~~~~gt~~y~aPE~~---~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 589 (668)
++..+.||+.|||||+. +.+.|..++|||+.|+...|+---+.|... ...+. +..+..... .-.|.++.
T Consensus 168 KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfd--lhpmr-~l~LmTkS~---~qpp~lkD-- 239 (829)
T KOG0576|consen 168 KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFD--LHPMR-ALFLMTKSG---FQPPTLKD-- 239 (829)
T ss_pred hhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccc--cchHH-HHHHhhccC---CCCCcccC--
Confidence 45567899999999975 456789999999999999999887777532 11111 111111111 11122221
Q ss_pred cHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 590 VVKEMELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 590 ~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
....-+.+..+++.|+.. |++||+.+.++++
T Consensus 240 k~kws~~fh~fvK~altknpKkRptaeklL~h 271 (829)
T KOG0576|consen 240 KTKWSEFFHNFVKGALTKNPKKRPTAEKLLQH 271 (829)
T ss_pred CccchHHHHHHHHHHhcCCCccCCChhhheec
Confidence 112234556667778776 9999999887764
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.3e-26 Score=236.33 Aligned_cols=211 Identities=26% Similarity=0.294 Sum_probs=180.3
Q ss_pred CcccchhhHHHHhcCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCchhHHHHHHHHHHHhccc------ccCce
Q 005940 340 PHRFRYKDLYAATKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLR------HKNLV 413 (668)
Q Consensus 340 ~~~f~~~el~~at~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~------H~nIv 413 (668)
.-+..+.|+. -..|.+....|+|-|++|.+|.+...|..||||+++....- .+.=+.|+++|++|. -.|++
T Consensus 421 YYrv~igE~L--D~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M-~KtGl~EleiLkKL~~AD~Edk~Hcl 497 (752)
T KOG0670|consen 421 YYRVRIGELL--DSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVM-HKTGLKELEILKKLNDADPEDKFHCL 497 (752)
T ss_pred eEEEehhhhh--cceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHH-hhhhhHHHHHHHHhhccCchhhhHHH
Confidence 3445555554 46788888999999999999999888999999999876432 233457999999996 35899
Q ss_pred eEeeeecccCceEEEEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCC-
Q 005940 414 NLHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAE- 492 (668)
Q Consensus 414 ~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~- 492 (668)
+++-.|.+.+++|||+|-+ ..+|.++|.+...+..|....+..+++|+.-||..|.. .+|+|.||||.|||+++.
T Consensus 498 rl~r~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~---c~vlHaDIKPDNiLVNE~k 573 (752)
T KOG0670|consen 498 RLFRHFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKK---CGVLHADIKPDNILVNESK 573 (752)
T ss_pred HHHHHhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHh---cCeeecccCccceEeccCc
Confidence 9999999999999999987 56999999877777779999999999999999999998 999999999999999987
Q ss_pred CCEEEEeecCceeccCCCCCcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 005940 493 MNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSG 560 (668)
Q Consensus 493 ~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~ 560 (668)
..+||||||.|........ +.+.-+..|.|||++.+-.|....|+||.||.||||.||+..|.+.
T Consensus 574 ~iLKLCDfGSA~~~~enei---tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~ 638 (752)
T KOG0670|consen 574 NILKLCDFGSASFASENEI---TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGR 638 (752)
T ss_pred ceeeeccCccccccccccc---cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCC
Confidence 4589999999987765443 3345567899999999999999999999999999999999998754
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.4e-25 Score=216.87 Aligned_cols=251 Identities=20% Similarity=0.300 Sum_probs=185.2
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCchhHHHHHHHHHHHhcc-cccCceeEeee-ecccCceEEEEE
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRL-RHKNLVNLHGW-CKQKNDLLLVYE 430 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~-~~~~~~~~lV~E 430 (668)
+.|.+.+.||+|.||.+-++.++.++..+++|.+.+... ..++|.+|..---.| .|.||+.-++. |+..+.+++++|
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~t-t~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE 102 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQT-TQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQE 102 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchh-hHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeec
Confidence 568889999999999999999999999999999876543 457888888766666 48999987764 566677889999
Q ss_pred ecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEEC-CC-CCEEEEeecCceeccC
Q 005940 431 YIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALID-AE-MNARLGDFGLARLYDH 508 (668)
Q Consensus 431 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~-~~-~~~kl~DfGla~~~~~ 508 (668)
|+|.|+|.+-+.. ..+-+....+++.|+++|+.|+|+ .++||||||.+|||+- .+ .++||||||+.+....
T Consensus 103 ~aP~gdL~snv~~----~GigE~~~K~v~~ql~SAi~fMHs---knlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~ 175 (378)
T KOG1345|consen 103 FAPRGDLRSNVEA----AGIGEANTKKVFAQLLSAIEFMHS---KNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGT 175 (378)
T ss_pred cCccchhhhhcCc----ccccHHHHHHHHHHHHHHHHHhhc---cchhhcccccceEEEecCCccEEEeeecccccccCc
Confidence 9999999888742 347788888999999999999999 9999999999999993 33 4799999999875432
Q ss_pred CCCCcccccccCCcccCcccccCC-----CCCcchhHHHHHHHHHHHHhCCCCCCCC-chhHHHHHHHHHhcCccccccC
Q 005940 509 GGMPHTTNVVGTFGYIAPELTQTG-----KASTSSDVFAYGILLLEVATGRRPIGSG-DLLLVEWVRECHQLGRILDVAD 582 (668)
Q Consensus 509 ~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~sDV~S~Gvvl~elltG~~p~~~~-~~~l~~~~~~~~~~~~~~~~~d 582 (668)
.. ....-+..|.+||..... ...+.+|||+||++++.++||..|++.. -.....|-+..+..++....
T Consensus 176 tV----~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~-- 249 (378)
T KOG1345|consen 176 TV----KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPAL-- 249 (378)
T ss_pred ee----hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccC--
Confidence 11 112335679999976432 3467899999999999999999999854 12233445555555554433
Q ss_pred cccCCcccHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 005940 583 PLLNSSYVVKEMELVLKLGLMCSHKTQFRPTMRQVMRY 620 (668)
Q Consensus 583 ~~l~~~~~~~~~~~l~~l~~~C~~~p~~RPs~~evl~~ 620 (668)
|..-..+.+..+..+.+ ...+.+++|-...++.++
T Consensus 250 P~~F~~fs~~a~r~Fkk---~lt~~~~drcki~~~kk~ 284 (378)
T KOG1345|consen 250 PKKFNPFSEKALRLFKK---SLTPRFKDRCKIWTAKKM 284 (378)
T ss_pred chhhcccCHHHHHHHHH---hcCCcccccchhHHHHHH
Confidence 22223444444444433 334457778555555444
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.2e-25 Score=263.25 Aligned_cols=196 Identities=18% Similarity=0.213 Sum_probs=138.1
Q ss_pred hcccc-cCceeEeeeec-------ccCceEEEEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCc
Q 005940 405 GRLRH-KNLVNLHGWCK-------QKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQV 476 (668)
Q Consensus 405 ~~l~H-~nIv~l~g~~~-------~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ 476 (668)
+.++| +||++++++|. +...+++++|++ .++|.++|.. ....+++.+++.++.||++||.|||+ ++
T Consensus 27 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~---~g 100 (793)
T PLN00181 27 KSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDN--PDRSVDAFECFHVFRQIVEIVNAAHS---QG 100 (793)
T ss_pred chhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhc--ccccccHHHHHHHHHHHHHHHHHHHh---CC
Confidence 34556 68888999882 234567888987 6699999953 34569999999999999999999998 99
Q ss_pred eEecCCCCCCEEECCC-------------------CCEEEEeecCceeccCCCC---------------CcccccccCCc
Q 005940 477 VIHRDVKPSNALIDAE-------------------MNARLGDFGLARLYDHGGM---------------PHTTNVVGTFG 522 (668)
Q Consensus 477 ivHrDLkp~NIll~~~-------------------~~~kl~DfGla~~~~~~~~---------------~~~~~~~gt~~ 522 (668)
|+||||||+||||+.. +.+|++|||+++....... .......||+.
T Consensus 101 IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 180 (793)
T PLN00181 101 IVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSW 180 (793)
T ss_pred eeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcc
Confidence 9999999999999654 4456666666653211000 00112357889
Q ss_pred ccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCcccCCcccHHHHHHHHHHHh
Q 005940 523 YIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSYVVKEMELVLKLGL 602 (668)
Q Consensus 523 y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~ 602 (668)
|||||++.+..++.++|||||||+||||++|..|+............. ...+... .+......++.
T Consensus 181 Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~~~~~~~~~---------~~~~~~~-----~~~~~~~~~~~ 246 (793)
T PLN00181 181 YTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSRTMSSLRHR---------VLPPQIL-----LNWPKEASFCL 246 (793)
T ss_pred eEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHHHHHHHHHh---------hcChhhh-----hcCHHHHHHHH
Confidence 999999999999999999999999999999988875322111111110 0111110 11122335556
Q ss_pred hcCCC-CCCCCCHHHHHHH
Q 005940 603 MCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 603 ~C~~~-p~~RPs~~evl~~ 620 (668)
.|++. |.+||+|.||+++
T Consensus 247 ~~L~~~P~~Rps~~eil~h 265 (793)
T PLN00181 247 WLLHPEPSCRPSMSELLQS 265 (793)
T ss_pred HhCCCChhhCcChHHHhhc
Confidence 78887 9999999999875
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.9e-23 Score=199.63 Aligned_cols=166 Identities=19% Similarity=0.145 Sum_probs=123.0
Q ss_pred CChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCCCCcc
Q 005940 435 GSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHT 514 (668)
Q Consensus 435 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 514 (668)
|+|.+++.. .+..++|.+++.++.||+.||.|||+ .+ ||+||+++.++.+|+ ||+++......
T Consensus 1 GsL~~~l~~--~~~~l~~~~~~~i~~qi~~~L~~lH~---~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~---- 63 (176)
T smart00750 1 VSLADILEV--RGRPLNEEEIWAVCLQCLRALRELHR---QA------KSGNILLTWDGLLKL--DGSVAFKTPEQ---- 63 (176)
T ss_pred CcHHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHh---cC------CcccEeEcCccceee--ccceEeecccc----
Confidence 789999953 24569999999999999999999998 44 999999999999999 99998765422
Q ss_pred cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCcccCCcccHHHH
Q 005940 515 TNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSYVVKEM 594 (668)
Q Consensus 515 ~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 594 (668)
..||+.|||||++.+..++.++|||||||++|||++|+.||..... ............... ++... .......
T Consensus 64 --~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~-~~~~~~~~~~~~~~~---~~~~~-~~~~~~~ 136 (176)
T smart00750 64 --SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERE-LSAILEILLNGMPAD---DPRDR-SNLESVS 136 (176)
T ss_pred --CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccch-hcHHHHHHHHHhccC---Ccccc-ccHHHHH
Confidence 2688999999999999999999999999999999999999964321 111111111111000 01100 0011111
Q ss_pred --HHHHHHHhhcCCC-CCCCCCHHHHHHHhccC
Q 005940 595 --ELVLKLGLMCSHK-TQFRPTMRQVMRYLSGE 624 (668)
Q Consensus 595 --~~l~~l~~~C~~~-p~~RPs~~evl~~L~~~ 624 (668)
..+..++..|+.. |++||++.|+++++...
T Consensus 137 ~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 137 AARSFADFMRVCASRLPQRREAANHYLAHCRAL 169 (176)
T ss_pred hhhhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence 2477788899988 99999999999988643
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.5e-23 Score=218.28 Aligned_cols=168 Identities=22% Similarity=0.231 Sum_probs=131.8
Q ss_pred HHHHhcCcccceeeeecCcEEEEEEEeCC-CCcEEEEEEEecC-----CchhHHHHHHHHHHHhcccccCceeEeeeecc
Q 005940 348 LYAATKGFKESEVIGIGGFGSVYKGVLPT-TGGEVAVKKITRN-----SLQGMREFAAEIESLGRLRHKNLVNLHGWCKQ 421 (668)
Q Consensus 348 l~~at~~f~~~~~lG~G~~g~Vy~~~~~~-~~~~vavK~~~~~-----~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~ 421 (668)
......+|...++||+|+||+||+|.+.. ++..+|||++... .....+.|.+|++++++++|+|+++.+..+
T Consensus 13 ~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~-- 90 (365)
T PRK09188 13 IPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT-- 90 (365)
T ss_pred cccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc--
Confidence 33445789999999999999999998865 5777899987533 122346689999999999999998533322
Q ss_pred cCceEEEEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCC-CCCCEEECCCCCEEEEee
Q 005940 422 KNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDV-KPSNALIDAEMNARLGDF 500 (668)
Q Consensus 422 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDL-kp~NIll~~~~~~kl~Df 500 (668)
+..++||||+++++|.... .. . ...++.|+++||.|||+ ++|+|||| ||+|||++.++++||+||
T Consensus 91 -~~~~LVmE~~~G~~L~~~~--~~--~------~~~~~~~i~~aL~~lH~---~gIiHrDL~KP~NILv~~~~~ikLiDF 156 (365)
T PRK09188 91 -GKDGLVRGWTEGVPLHLAR--PH--G------DPAWFRSAHRALRDLHR---AGITHNDLAKPQNWLMGPDGEAAVIDF 156 (365)
T ss_pred -CCcEEEEEccCCCCHHHhC--cc--c------hHHHHHHHHHHHHHHHH---CCCeeCCCCCcceEEEcCCCCEEEEEC
Confidence 4579999999999996321 11 1 14678899999999999 99999999 999999999999999999
Q ss_pred cCceeccCCCCC-------cccccccCCcccCcccccC
Q 005940 501 GLARLYDHGGMP-------HTTNVVGTFGYIAPELTQT 531 (668)
Q Consensus 501 Gla~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~ 531 (668)
|+|+.+...... ..+...++..|+|||++..
T Consensus 157 GlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 157 QLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred ccceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 999977543211 1245678889999998864
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.3e-23 Score=212.51 Aligned_cols=198 Identities=30% Similarity=0.454 Sum_probs=166.9
Q ss_pred HhcCcccceeeeecCcEEEEEEEeCC---CCcEEEEEEEecCCchhHHHHHHHHHHHhccc-ccCceeEeeeecccCceE
Q 005940 351 ATKGFKESEVIGIGGFGSVYKGVLPT---TGGEVAVKKITRNSLQGMREFAAEIESLGRLR-HKNLVNLHGWCKQKNDLL 426 (668)
Q Consensus 351 at~~f~~~~~lG~G~~g~Vy~~~~~~---~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~ 426 (668)
..+.|...++||+|.|++||++++.. .++.||+|.+...+ ......+|+++|..+. +.||+++.+++..++...
T Consensus 34 ~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ 111 (418)
T KOG1167|consen 34 ISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVA 111 (418)
T ss_pred hhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhhhccCCeeE
Confidence 34678899999999999999999876 67899999987653 3456889999999996 999999999999999999
Q ss_pred EEEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCC-CCEEEEeecCcee
Q 005940 427 LVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAE-MNARLGDFGLARL 505 (668)
Q Consensus 427 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~-~~~kl~DfGla~~ 505 (668)
+|+||++.....+++.. ++...+..++..+..||.++|. .||+||||||+|+|.+.. +.-.|.|||+|..
T Consensus 112 ivlp~~~H~~f~~l~~~------l~~~~i~~Yl~~ll~Al~~~h~---~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~ 182 (418)
T KOG1167|consen 112 IVLPYFEHDRFRDLYRS------LSLAEIRWYLRNLLKALAHLHK---NGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQR 182 (418)
T ss_pred EEecccCccCHHHHHhc------CCHHHHHHHHHHHHHHhhhhhc---cCccccCCCccccccccccCCceEEechhHHH
Confidence 99999999999888842 6788999999999999999999 999999999999999765 5689999999972
Q ss_pred ccCCC--------------C-----------------------------CcccccccCCcccCcccccC-CCCCcchhHH
Q 005940 506 YDHGG--------------M-----------------------------PHTTNVVGTFGYIAPELTQT-GKASTSSDVF 541 (668)
Q Consensus 506 ~~~~~--------------~-----------------------------~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~ 541 (668)
.+... . .......||+||.|||++.. +.-+++.|||
T Consensus 183 ~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiw 262 (418)
T KOG1167|consen 183 YDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIW 262 (418)
T ss_pred HHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCcccee
Confidence 21000 0 00112469999999998765 5668999999
Q ss_pred HHHHHHHHHHhCCCCCCC
Q 005940 542 AYGILLLEVATGRRPIGS 559 (668)
Q Consensus 542 S~Gvvl~elltG~~p~~~ 559 (668)
|.|||++-+++++.||-.
T Consensus 263 s~GVI~Lslls~~~PFf~ 280 (418)
T KOG1167|consen 263 SAGVILLSLLSRRYPFFK 280 (418)
T ss_pred eccceeehhhcccccccc
Confidence 999999999999999954
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.4e-21 Score=194.10 Aligned_cols=280 Identities=20% Similarity=0.235 Sum_probs=211.8
Q ss_pred CcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCchhHHHHHHHHHHHhccc-ccCceeEeeeecccCceEEEEEec
Q 005940 354 GFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLR-HKNLVNLHGWCKQKNDLLLVYEYI 432 (668)
Q Consensus 354 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~lV~E~~ 432 (668)
.|.+.++||+|.||..+.|+...++++||||.-..++. ..++..|.+..+.|. .++|.+++-+..++.+-.||+|.+
T Consensus 29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~--APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL 106 (449)
T KOG1165|consen 29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSE--APQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL 106 (449)
T ss_pred cceeccccccCcceeeecccccccCceEEEEeccccCC--cchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh
Confidence 68889999999999999999888999999998766543 356778999988885 799999999988888899999998
Q ss_pred CCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCC-----CCEEEEeecCceecc
Q 005940 433 PNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAE-----MNARLGDFGLARLYD 507 (668)
Q Consensus 433 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~-----~~~kl~DfGla~~~~ 507 (668)
+-||+++.. -.+..++......++.|++.-++|+|+ +.+|+|||||+|+||... ..+.|.|||+|+.+.
T Consensus 107 -GPSLEDLFD--~CgR~FSvKTV~miA~Qmi~rie~vH~---k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Yr 180 (449)
T KOG1165|consen 107 -GPSLEDLFD--LCGRRFSVKTVAMIAKQMITRIEYVHE---KDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYR 180 (449)
T ss_pred -CcCHHHHHH--HhcCcccHHhHHHHHHHHHHHHHHHHh---cceeecccCccceeecCCCCCCCceEEEEeccchhhhc
Confidence 889999884 345679999999999999999999999 999999999999999543 348999999999886
Q ss_pred CCCCCc------ccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCcccccc
Q 005940 508 HGGMPH------TTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVA 581 (668)
Q Consensus 508 ~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~ 581 (668)
+..... .....||.+||+-....+.+-+.+.|+=|+|.++...+-|..||.+-...-.+...+...+.+-.--+
T Consensus 181 Dp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T~i 260 (449)
T KOG1165|consen 181 DPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRSTPI 260 (449)
T ss_pred CccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccCCH
Confidence 654432 34467999999998888888899999999999999999999999865333222222222222111111
Q ss_pred CcccCCcccHHHHHHHHHHHhhcCCC--CCC---CCCHHHHHHHhccCcCCCCCCCcCccccccccCcC
Q 005940 582 DPLLNSSYVVKEMELVLKLGLMCSHK--TQF---RPTMRQVMRYLSGEKQLRFNNDWGSIDYRQGFDEF 645 (668)
Q Consensus 582 d~~l~~~~~~~~~~~l~~l~~~C~~~--p~~---RPs~~evl~~L~~~~~~~~~~~~~~~~~~~~~~~~ 645 (668)
+ .|+. -.++|+...+..+..+... |+- |--+.+|+..+..-.. ...+|..+....+|...
T Consensus 261 ~-~Lc~-g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~g~t~D--g~yDW~~ln~g~gw~~~ 325 (449)
T KOG1165|consen 261 E-VLCE-GFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRLGETDD--GEYDWMGLNNGKGWPSG 325 (449)
T ss_pred H-HHHh-cCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhcCCccc--ccccccccCCCCCCccc
Confidence 1 1222 2467777888887777554 542 5556666655543321 34667766666665543
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.3e-21 Score=205.12 Aligned_cols=257 Identities=21% Similarity=0.221 Sum_probs=189.7
Q ss_pred CcccceeeeecCcEEEEEEEeCCCC-cEEEEEEEecCCchhHHHHHHHHHHHhcccc----cCceeEeeee-cccCceEE
Q 005940 354 GFKESEVIGIGGFGSVYKGVLPTTG-GEVAVKKITRNSLQGMREFAAEIESLGRLRH----KNLVNLHGWC-KQKNDLLL 427 (668)
Q Consensus 354 ~f~~~~~lG~G~~g~Vy~~~~~~~~-~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H----~nIv~l~g~~-~~~~~~~l 427 (668)
+|.+.++||+|+||.||++....++ ..+|+|............+..|+.++..+.. +++..+++.. ..+...++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 7899999999999999999986553 5788888766533333367788999888863 6899999988 47778899
Q ss_pred EEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCC-----CCEEEEeecC
Q 005940 428 VYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAE-----MNARLGDFGL 502 (668)
Q Consensus 428 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~-----~~~kl~DfGl 502 (668)
||+.+ +.+|.++..... ...++....++|+.|++.+|.+||+ .+++||||||.|+++... ..+.|.|||+
T Consensus 99 VM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~---~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl 173 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHS---KGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGL 173 (322)
T ss_pred EEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHh---cCcccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence 99988 889999885333 5779999999999999999999999 999999999999999765 4599999999
Q ss_pred ce--ecc-CCC---CCc---ccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchh-HHHHHHHHH
Q 005940 503 AR--LYD-HGG---MPH---TTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLL-LVEWVRECH 572 (668)
Q Consensus 503 a~--~~~-~~~---~~~---~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~-l~~~~~~~~ 572 (668)
++ .+. ... ... .....||.+|+++....+...+++.|+||++.++.|++.|..|+...+.. ...-+.+..
T Consensus 174 ar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~ 253 (322)
T KOG1164|consen 174 ARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDP 253 (322)
T ss_pred CccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHh
Confidence 98 321 111 111 23456999999999999999999999999999999999999999654321 111111111
Q ss_pred hcCccccccCcccCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhccC
Q 005940 573 QLGRILDVADPLLNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSGE 624 (668)
Q Consensus 573 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~~ 624 (668)
...... . .....+.+...+ ...+... ..++|....+...|+..
T Consensus 254 ~~~~~~----~--~~~~~~~~~~~~---~~~~~~~~~~~~Pdy~~~~~~l~~~ 297 (322)
T KOG1164|consen 254 RKLLTD----R--FGDLKPEEFAKI---LEYIDSLDYEDKPDYEKLAELLKDV 297 (322)
T ss_pred hhhccc----c--ccCCChHHHHHH---HHHhhccCCcCCCCHHHHHHHHHHH
Confidence 111111 0 112223333333 3334434 67899999998887544
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.86 E-value=6.1e-20 Score=191.36 Aligned_cols=201 Identities=37% Similarity=0.550 Sum_probs=170.8
Q ss_pred cccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCch---hHHHHHHHHHHHhccccc-CceeEeeeecccCceEEEEE
Q 005940 355 FKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQ---GMREFAAEIESLGRLRHK-NLVNLHGWCKQKNDLLLVYE 430 (668)
Q Consensus 355 f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~f~~Ei~~l~~l~H~-nIv~l~g~~~~~~~~~lV~E 430 (668)
|...+.||.|+||.||++.+. ..+++|.+...... ....+.+|+.+++.+.|+ +++++.+.+......+++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 78 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME 78 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence 566789999999999999985 78999998765433 367899999999999988 79999999977777899999
Q ss_pred ecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCC-CEEEEeecCceeccCC
Q 005940 431 YIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEM-NARLGDFGLARLYDHG 509 (668)
Q Consensus 431 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~-~~kl~DfGla~~~~~~ 509 (668)
++.++++.+++........++......++.|++.++.|+|+ .+++|||+||+||+++... .++++|||.++.....
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~---~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~ 155 (384)
T COG0515 79 YVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHS---KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDP 155 (384)
T ss_pred cCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeeecCCCCeEEEeccCcceecCCC
Confidence 99999999777432111368899999999999999999999 8999999999999999998 6999999999866544
Q ss_pred CCC-----cccccccCCcccCcccccC---CCCCcchhHHHHHHHHHHHHhCCCCCCCCc
Q 005940 510 GMP-----HTTNVVGTFGYIAPELTQT---GKASTSSDVFAYGILLLEVATGRRPIGSGD 561 (668)
Q Consensus 510 ~~~-----~~~~~~gt~~y~aPE~~~~---~~~~~~sDV~S~Gvvl~elltG~~p~~~~~ 561 (668)
... ......|+..|+|||.+.. .......|+|++|++++++++|..|+....
T Consensus 156 ~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~ 215 (384)
T COG0515 156 GSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEK 215 (384)
T ss_pred CccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 322 2355689999999999887 578899999999999999999999976543
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.9e-22 Score=194.86 Aligned_cols=246 Identities=21% Similarity=0.341 Sum_probs=182.2
Q ss_pred cceeeeecCcEEEEEEEeCCCCcEEEEEEEecC--CchhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEEecCC
Q 005940 357 ESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRN--SLQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEYIPN 434 (668)
Q Consensus 357 ~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~ 434 (668)
...+|.+...|..|+|+++ |..+++|++... .....++|..|.-.|+-+.||||+.++|.|.....+.++..||+-
T Consensus 194 l~tkl~e~hsgelwrgrwq--gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~ 271 (448)
T KOG0195|consen 194 LITKLAESHSGELWRGRWQ--GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPF 271 (448)
T ss_pred hhhhhccCCCccccccccc--CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccc
Confidence 3457888999999999994 566788877433 334457899999999999999999999999999999999999999
Q ss_pred CChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCCCCcc
Q 005940 435 GSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHT 514 (668)
Q Consensus 435 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 514 (668)
|+|..+|+. ..+-..+-.+..+++.++|+|++|||+ .++-|.---|.+..|++|++.+++|.- +-+++.- +.
T Consensus 272 gslynvlhe-~t~vvvd~sqav~faldiargmaflhs-lep~ipr~~lns~hvmidedltarism-ad~kfsf-----qe 343 (448)
T KOG0195|consen 272 GSLYNVLHE-QTSVVVDHSQAVRFALDIARGMAFLHS-LEPMIPRFYLNSKHVMIDEDLTARISM-ADTKFSF-----QE 343 (448)
T ss_pred hHHHHHHhc-CccEEEecchHHHHHHHHHhhHHHHhh-cchhhhhhhcccceEEecchhhhheec-ccceeee-----ec
Confidence 999999973 455678889999999999999999998 344555556899999999999988752 1111110 01
Q ss_pred cccccCCcccCcccccCCCC---CcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCcccCCcccH
Q 005940 515 TNVVGTFGYIAPELTQTGKA---STSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSYVV 591 (668)
Q Consensus 515 ~~~~gt~~y~aPE~~~~~~~---~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 591 (668)
....-.+.||+||.++..+. -.++|+|||.+++||+.|...||..-. .++-. +++.-..++...++
T Consensus 344 ~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadls--pmecg---------mkialeglrv~ipp 412 (448)
T KOG0195|consen 344 VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLS--PMECG---------MKIALEGLRVHIPP 412 (448)
T ss_pred cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCC--chhhh---------hhhhhccccccCCC
Confidence 11133678999999987654 468999999999999999999996421 11110 01111112222222
Q ss_pred HHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhcc
Q 005940 592 KEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSG 623 (668)
Q Consensus 592 ~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~ 623 (668)
.-...+.+++..|... |.+||.+.+|+-+|++
T Consensus 413 gis~hm~klm~icmnedpgkrpkfdmivpilek 445 (448)
T KOG0195|consen 413 GISRHMNKLMNICMNEDPGKRPKFDMIVPILEK 445 (448)
T ss_pred CccHHHHHHHHHHhcCCCCcCCCcceehhhHHH
Confidence 2233455666678887 9999999999988875
|
|
| >cd07308 lectin_leg-like legume-like lectins: ERGIC-53, ERGL, VIP36, VIPL, EMP46, and EMP47 | Back alignment and domain information |
|---|
Probab=99.85 E-value=6e-20 Score=182.79 Aligned_cols=195 Identities=24% Similarity=0.266 Sum_probs=134.7
Q ss_pred CCeEEeCceeeCCCCcEEccCCCCceEEEEEeeCceecccCCCCCCCCeeeeEEEEEEEEeCCCCCCCCCceEEEEcCCC
Q 005940 40 TNLSLQGAEIIKPSGALKLTNRSRYVIGHAFYVKPIQMFDTSASPSPNASSFSTTFVFEISTPRSGRGGHGLAFLLAPST 119 (668)
Q Consensus 40 ~~l~~~g~a~~~~~~~~~lt~~~~~~~G~~~y~~p~~l~~~~~~~~~~~~sF~t~F~f~i~~~~~~~~g~GlaF~l~p~~ 119 (668)
.+..+.|+|.+. ++.|+||++..++.|+++|+.|+++. +|+|+|+|.|.+.. ..+||||||+++|+.
T Consensus 20 ~~w~~~G~a~~~-~~~i~LT~~~~~~~G~~~~~~pi~~~-----------~F~~~f~F~i~~~~-~~~gdG~af~~~~~~ 86 (218)
T cd07308 20 GNWTVGGSTVIT-KNYIRLTPDVPSQSGSLWSRVPIPAK-----------DFEIEVEFSIHGGS-GLGGDGFAFWYTEEP 86 (218)
T ss_pred CCeEEcCCeEEe-CCEEEeCCCCCCCEeEEEeCCCccCC-----------CEEEEEEEEEeCCC-CCCCCEEEEEEECCC
Confidence 689999999997 88999999999999999999999973 59999999998763 568999999999865
Q ss_pred CCCCCCCCCcccccccCCCCCCCccEEEEEeecccCCCCCCCCCCCeeeeecCC-cccccccCCccccCCCCCccccccC
Q 005940 120 KLPGAQPEHYLGILNSTNNGEPSNHILIVEFDTVNGFNDKAENQGNHVGIGINT-MFSNRSEPASYYINGTDHKEEMTLE 198 (668)
Q Consensus 120 ~~~~~~~~~~lGl~~~~~~~~~~~~~~aVEfDt~~n~~d~~~~~~~Hvgid~~s-~~s~~~~~~~~~~~~~~~~~~~~l~ 198 (668)
. ..|..+|..+ ..+-+||||||++|. + -...+|.+-+|. ..+.....-.......++ .+...
T Consensus 87 ~----~~g~~~G~~~-------~~~Glai~fdt~~n~-~---~~~p~i~~~~Ndg~~~~~~~~d~~~~~~~~c--~~~~~ 149 (218)
T cd07308 87 G----SDGPLFGGPD-------KFKGLAIFFDTYDND-G---KGFPSISVFLNDGTKSYDYETDGEKLELASC--SLKFR 149 (218)
T ss_pred C----CCCcccccCC-------CCCEEEEEEEcCCCC-C---CCCCeEEEEEeCCCceecccCCCccccccce--eEecc
Confidence 3 2445555522 345689999999873 2 223455554332 111110000000001111 12222
Q ss_pred -CCCcEEEEEEEeCCcceEEEEEEeCCCCCCCCcceeeeeccccccccceeeeeecccCCcccceeeeccccc
Q 005940 199 -SGEPIQAWIEYDGEQKVLNVTISPAEIGKPMRPLISFGVNLTGYIKETMYVGFSASTGEKSSSHYILGWSFS 270 (668)
Q Consensus 199 -~g~~~~~~I~Y~~~~~~l~V~~~~~~~~~p~~~~ls~~~dLs~~l~~~~~vGFsastG~~~~~~~i~~w~F~ 270 (668)
++++++++|.|+ .+.|.|.+.... +..-..+..++.- .+++.+|+||||+||...+.|.|++|.+.
T Consensus 150 ~~~~~~~~~I~y~--~~~l~v~i~~~~---~~~~~~c~~~~~~-~l~~~~y~G~sA~tg~~~d~~dIls~~~~ 216 (218)
T cd07308 150 NSNAPTTLRISYL--NNTLKVDITYSE---GNNWKECFTVEDV-ILPSQGYFGFSAQTGDLSDNHDILSVHTY 216 (218)
T ss_pred cCCCCeEEEEEEE--CCEEEEEEeCCC---CCCccEEEEcCCc-ccCCCCEEEEEeccCCCcCcEEEEEEEee
Confidence 278999999999 678999887532 1122244444432 46789999999999999999999999763
|
The legume-like (leg-like) lectins are eukaryotic intracellular sugar transport proteins with a carbohydrate recognition domain similar to that of the legume lectins. This domain binds high-mannose-type oligosaccharides for transport from the endoplasmic reticulum to the Golgi complex. These leg-like lectins include ERGIC-53, ERGL, VIP36, VIPL, EMP46, EMP47, and the UIP5 (ULP1-interacting protein 5) precursor protein. Leg-like lectins have different intracellular distributions and dynamics in the endoplasmic reticulum-Golgi system of the secretory pathway and interact with N-glycans of glycoproteins in a calcium-dependent manner, suggesting a role in glycoprotein sorting and trafficking. L-type lectins have a dome-shaped beta-barrel carbohydrate recognition domain with a curved seven-stranded beta-sheet referred to as the "front face" and a flat six-stranded beta-sheet referred to as the "ba |
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.82 E-value=5.5e-20 Score=179.07 Aligned_cols=141 Identities=18% Similarity=0.181 Sum_probs=109.5
Q ss_pred ceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCch--h-------HHH-----------------HHHHHHHHhcccccC
Q 005940 358 SEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQ--G-------MRE-----------------FAAEIESLGRLRHKN 411 (668)
Q Consensus 358 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~-------~~~-----------------f~~Ei~~l~~l~H~n 411 (668)
...||+|++|.||+|.+. +|+.||||+++..... . ... ...|++.+.++.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 467999999999999996 7999999999754221 0 112 235999999998877
Q ss_pred ceeEeeeecccCceEEEEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHh-hhccCCceEecCCCCCCEEEC
Q 005940 412 LVNLHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYL-HEEWEQVVIHRDVKPSNALID 490 (668)
Q Consensus 412 Iv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yL-H~~~~~~ivHrDLkp~NIll~ 490 (668)
+.....+.. ...++||||+++++|..... ....+++.....++.|++.+|.|| |+ .+|+||||||+||+++
T Consensus 81 v~~p~~~~~--~~~~iVmE~i~g~~l~~~~~---~~~~~~~~~~~~i~~qi~~~L~~l~H~---~giiHrDlkP~NIli~ 152 (190)
T cd05147 81 IPCPEPILL--KSHVLVMEFIGDDGWAAPRL---KDAPLSESKARELYLQVIQIMRILYQD---CRLVHADLSEYNLLYH 152 (190)
T ss_pred CCCCcEEEe--cCCEEEEEEeCCCCCcchhh---hcCCCCHHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEE
Confidence 644333222 22489999999887765532 124588999999999999999999 67 8999999999999998
Q ss_pred CCCCEEEEeecCceeccC
Q 005940 491 AEMNARLGDFGLARLYDH 508 (668)
Q Consensus 491 ~~~~~kl~DfGla~~~~~ 508 (668)
++.++|+|||+|...++
T Consensus 153 -~~~v~LiDFG~a~~~~~ 169 (190)
T cd05147 153 -DGKLYIIDVSQSVEHDH 169 (190)
T ss_pred -CCcEEEEEccccccCCC
Confidence 47899999999976543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.6e-19 Score=172.38 Aligned_cols=200 Identities=25% Similarity=0.335 Sum_probs=168.7
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCchhHHHHHHHHHHHhcccc-cCceeEeeeecccCceEEEEEe
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRH-KNLVNLHGWCKQKNDLLLVYEY 431 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H-~nIv~l~g~~~~~~~~~lV~E~ 431 (668)
.+|...++||.|+||.+|.|....+|++||||.-+.... ..++.-|.++.+.|++ ..|..+..+..++..-.+|||.
T Consensus 15 gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~--hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdL 92 (341)
T KOG1163|consen 15 GKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK--HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDL 92 (341)
T ss_pred cceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC--CcchhHHHHHHHHhccCCCCchhhhhccccccceeeeec
Confidence 579999999999999999999999999999998765432 2456788999999975 6788888888888899999999
Q ss_pred cCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCC---CCEEEEeecCceeccC
Q 005940 432 IPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAE---MNARLGDFGLARLYDH 508 (668)
Q Consensus 432 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~---~~~kl~DfGla~~~~~ 508 (668)
+ +.||+++..- -...++..+.+-++-|++.-++|+|. ++.+||||||+|+|..-+ ..+.++|||+|+.+.+
T Consensus 93 L-GPsLEdLfnf--C~R~ftmkTvLMLaDQml~RiEyvH~---r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d 166 (341)
T KOG1163|consen 93 L-GPSLEDLFNF--CSRRFTMKTVLMLADQMLSRIEYVHL---RNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRD 166 (341)
T ss_pred c-CccHHHHHHH--HhhhhhHHhHHHHHHHHHHHHHHHHh---hccccccCCccceeeccccccceEEEEeccchhhhcc
Confidence 8 8899998853 23458889999999999999999998 999999999999998543 4689999999997654
Q ss_pred CCC------CcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 005940 509 GGM------PHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSG 560 (668)
Q Consensus 509 ~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~ 560 (668)
... .......||.+|.+-....+..-+.+.|+-|+|.+|....-|..||++-
T Consensus 167 ~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQgl 224 (341)
T KOG1163|consen 167 IRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGL 224 (341)
T ss_pred ccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCccccc
Confidence 322 2234568999999987777677789999999999999999999999864
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=6.2e-20 Score=181.22 Aligned_cols=170 Identities=15% Similarity=0.149 Sum_probs=132.1
Q ss_pred hcCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCchhH---H------HHHHHHHHHhcccccCceeEeeeeccc
Q 005940 352 TKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGM---R------EFAAEIESLGRLRHKNLVNLHGWCKQK 422 (668)
Q Consensus 352 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~---~------~f~~Ei~~l~~l~H~nIv~l~g~~~~~ 422 (668)
.++|+..+++|.|+||.||+... ++..+|||.+........ . .+.+|++.+.++.|++|..+.+++...
T Consensus 30 ~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 30 SYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 47899999999999999999655 467899999975432221 1 268999999999999999999885532
Q ss_pred --------CceEEEEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCC
Q 005940 423 --------NDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMN 494 (668)
Q Consensus 423 --------~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~ 494 (668)
+..+|||||++|.+|.++.. ++. ....+++.+|..||+ .+++|||+||+||+++.++
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~-------~~~----~~~~~i~~~l~~lH~---~gi~H~Dikp~Nili~~~g- 172 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMPE-------ISE----DVKAKIKASIESLHQ---HGMVSGDPHKGNFIVSKNG- 172 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhhh-------ccH----HHHHHHHHHHHHHHH---cCCccCCCChHHEEEeCCC-
Confidence 35789999999999988742 222 245699999999998 9999999999999999988
Q ss_pred EEEEeecCceeccCCCCCcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHH
Q 005940 495 ARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVA 551 (668)
Q Consensus 495 ~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ell 551 (668)
++|+|||............ .+.....+..++|+|+||+.+..+.
T Consensus 173 i~liDfg~~~~~~e~~a~d-------------~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 173 LRIIDLSGKRCTAQRKAKD-------------RIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EEEEECCCcccccchhhHH-------------HHHHHhHhcccccccceeEeehHHH
Confidence 9999999887553221111 1233344567999999999987654
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.80 E-value=3.7e-20 Score=208.64 Aligned_cols=198 Identities=24% Similarity=0.335 Sum_probs=160.1
Q ss_pred ccceeeeecCcEEEEEEEeCCCCcEEEEEEEe----c-CCchh-HHHHHHHHHHHhcccccCceeEeeeecccCceEEEE
Q 005940 356 KESEVIGIGGFGSVYKGVLPTTGGEVAVKKIT----R-NSLQG-MREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVY 429 (668)
Q Consensus 356 ~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~----~-~~~~~-~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 429 (668)
...+++|.|++|.|+...........+.|.+. . ..... ...+..|+-+-..|+|+|++..+..+.+....+-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 34678999999988877765555555555443 1 11111 122667888888899999999888888777777779
Q ss_pred EecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCC
Q 005940 430 EYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHG 509 (668)
Q Consensus 430 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~ 509 (668)
|||+. +|..++.. ...+....+..+++|+..|+.|||+ .+|.|||+|++|++++.++.+||+|||.+..+..+
T Consensus 401 E~~~~-Dlf~~~~~---~~~~~~~e~~c~fKqL~~Gv~y~h~---~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~ 473 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMS---NGKLTPLEADCFFKQLLRGVKYLHS---MGLAHRDLKLENLLVTENGILKIIDFGAASVFRYP 473 (601)
T ss_pred hcccH-HHHHHHhc---ccccchhhhhHHHHHHHHHHHHHHh---cCceeccCccccEEEecCCceEEeecCcceeeccC
Confidence 99999 99998853 2468888999999999999999999 99999999999999999999999999999877654
Q ss_pred CC---CcccccccCCcccCcccccCCCCC-cchhHHHHHHHHHHHHhCCCCCCCC
Q 005940 510 GM---PHTTNVVGTFGYIAPELTQTGKAS-TSSDVFAYGILLLEVATGRRPIGSG 560 (668)
Q Consensus 510 ~~---~~~~~~~gt~~y~aPE~~~~~~~~-~~sDV~S~Gvvl~elltG~~p~~~~ 560 (668)
.. ......+|...|+|||.+...+|. ...||||.|+++..|++|+.||...
T Consensus 474 ~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a 528 (601)
T KOG0590|consen 474 WEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVA 528 (601)
T ss_pred cchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccc
Confidence 33 334567899999999999888875 5799999999999999999998643
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.79 E-value=9.6e-19 Score=170.70 Aligned_cols=142 Identities=21% Similarity=0.207 Sum_probs=111.8
Q ss_pred ceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCchh--------------------------HHHHHHHHHHHhcccccC
Q 005940 358 SEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQG--------------------------MREFAAEIESLGRLRHKN 411 (668)
Q Consensus 358 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~--------------------------~~~f~~Ei~~l~~l~H~n 411 (668)
...||+|++|.||+|.+. +|+.||||+++...... ...+..|.+.+.++.|++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 468999999999999986 79999999987653210 112357899999999998
Q ss_pred ceeEeeeecccCceEEEEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECC
Q 005940 412 LVNLHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDA 491 (668)
Q Consensus 412 Iv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~ 491 (668)
+.....+... ..+|||||++++++..... ....++.....+++.|++.+|.+||+ +.+|+||||||+||+++
T Consensus 81 i~~p~~~~~~--~~~lVmE~~~g~~~~~~~l---~~~~~~~~~~~~i~~~l~~~l~~lH~--~~givHrDlkP~NIll~- 152 (190)
T cd05145 81 VPVPEPILLK--KNVLVMEFIGDDGSPAPRL---KDVPLEEEEAEELYEQVVEQMRRLYQ--EAGLVHGDLSEYNILYH- 152 (190)
T ss_pred CCCceEEEec--CCEEEEEEecCCCchhhhh---hhccCCHHHHHHHHHHHHHHHHHHHH--hCCEecCCCChhhEEEE-
Confidence 7554444332 2489999999886544321 12347788899999999999999997 37999999999999999
Q ss_pred CCCEEEEeecCceeccC
Q 005940 492 EMNARLGDFGLARLYDH 508 (668)
Q Consensus 492 ~~~~kl~DfGla~~~~~ 508 (668)
++.++|+|||++....+
T Consensus 153 ~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 153 DGKPYIIDVSQAVELDH 169 (190)
T ss_pred CCCEEEEEcccceecCC
Confidence 88999999999987654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=2.5e-19 Score=193.17 Aligned_cols=215 Identities=23% Similarity=0.355 Sum_probs=160.6
Q ss_pred HhcccccCceeEeeeecccCceEEEEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCC
Q 005940 404 LGRLRHKNLVNLHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVK 483 (668)
Q Consensus 404 l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLk 483 (668)
|+.+.|.|+.+++|.|.++...+.|.+||..|+|.+.+.. ....++|.....++++|+.||.|||. .+.-.|+.|+
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~--~~~~~d~~F~~s~~rdi~~Gl~ylh~--s~i~~hg~l~ 76 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN--EDIKLDYFFILSFIRDISKGLAYLHN--SPIGYHGALK 76 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc--cccCccHHHHHHHHHHHHHHHHHHhc--Ccceeeeeec
Confidence 4578899999999999999999999999999999999964 45679999999999999999999998 2333999999
Q ss_pred CCCEEECCCCCEEEEeecCceeccCC-CCCcccccccCCcccCcccccCC-------CCCcchhHHHHHHHHHHHHhCCC
Q 005940 484 PSNALIDAEMNARLGDFGLARLYDHG-GMPHTTNVVGTFGYIAPELTQTG-------KASTSSDVFAYGILLLEVATGRR 555 (668)
Q Consensus 484 p~NIll~~~~~~kl~DfGla~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~sDV~S~Gvvl~elltG~~ 555 (668)
++|+++|..+.+||.|||+....... .........-..-|.|||.+... ..+.+.||||||++++|+++.+.
T Consensus 77 s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~ 156 (484)
T KOG1023|consen 77 SSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSG 156 (484)
T ss_pred cccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccC
Confidence 99999999999999999998876421 11111122234579999988753 14778999999999999999999
Q ss_pred CCCCC--chhHHHHHHHHHhcCccccccCcccCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhccCcC
Q 005940 556 PIGSG--DLLLVEWVRECHQLGRILDVADPLLNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSGEKQ 626 (668)
Q Consensus 556 p~~~~--~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~~~~ 626 (668)
||... .....+.+..... .-...+.|.+.... +....++.++..||.. |++||++++|-..++....
T Consensus 157 ~~~~~~~~~~~~eii~~~~~--~~~~~~rP~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~ 226 (484)
T KOG1023|consen 157 PFDLRNLVEDPDEIILRVKK--GGSNPFRPSIELLN--ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINK 226 (484)
T ss_pred ccccccccCChHHHHHHHHh--cCCCCcCcchhhhh--hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcc
Confidence 99753 1111122222111 11112222221111 2223677888899998 9999999999998876653
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=7.1e-20 Score=205.78 Aligned_cols=249 Identities=20% Similarity=0.196 Sum_probs=175.7
Q ss_pred CcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCC-chhHHHHHHHHHHHh--cccccCceeEeeeecccCceEEEEE
Q 005940 354 GFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNS-LQGMREFAAEIESLG--RLRHKNLVNLHGWCKQKNDLLLVYE 430 (668)
Q Consensus 354 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~f~~Ei~~l~--~l~H~nIv~l~g~~~~~~~~~lV~E 430 (668)
++...+.||++.|=+|.+|++. ++.|+||++-+.. .-..+.|.++++-++ .++|||.+++.-+-......|||-+
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~--eG~vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRq 101 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDR--EGLVVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQ 101 (1431)
T ss_pred ceeeecccCchhhhhhhhccCC--CceEEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHH
Confidence 5666889999999999999984 4569999986654 344556665554444 4589999999888777778899999
Q ss_pred ecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCcee--ccC
Q 005940 431 YIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARL--YDH 508 (668)
Q Consensus 431 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~--~~~ 508 (668)
|+.+ +|.+.|. .+..|...+..-|+.|++.||..+|. .+|+|||||.+||||+.-.-+.|+||.--+. +.+
T Consensus 102 yvkh-nLyDRlS---TRPFL~~iEKkWiaFQLL~al~qcH~---~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPe 174 (1431)
T KOG1240|consen 102 YVKH-NLYDRLS---TRPFLVLIEKKWIAFQLLKALSQCHK---LGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPE 174 (1431)
T ss_pred HHhh-hhhhhhc---cchHHHHHHHHHHHHHHHHHHHHHHH---cCccccccccceEEEeeechhhhhcccccCCccCCC
Confidence 9854 7877773 56678888999999999999999999 9999999999999999998999999976542 233
Q ss_pred CCCCcccccc----cCCcccCcccccCC-----------CCCcchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHH-H
Q 005940 509 GGMPHTTNVV----GTFGYIAPELTQTG-----------KASTSSDVFAYGILLLEVAT-GRRPIGSGDLLLVEWVRE-C 571 (668)
Q Consensus 509 ~~~~~~~~~~----gt~~y~aPE~~~~~-----------~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~l~~~~~~-~ 571 (668)
+.....+.+. .-..|+|||.+... ..+++.||||+||++.||++ |+.||+-.+ +..+... .
T Consensus 175 DNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQ--L~aYr~~~~ 252 (1431)
T KOG1240|consen 175 DNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQ--LLAYRSGNA 252 (1431)
T ss_pred CCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHH--HHhHhccCc
Confidence 3322222222 22369999976431 25789999999999999998 788885321 1111000 0
Q ss_pred HhcCc-cccccCcccCCcccHHHHHHHHHHHhhcCC-CCCCCCCHHHHHHHhccCc
Q 005940 572 HQLGR-ILDVADPLLNSSYVVKEMELVLKLGLMCSH-KTQFRPTMRQVMRYLSGEK 625 (668)
Q Consensus 572 ~~~~~-~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~~L~~~~ 625 (668)
...+. +.++-|+. +-.+.+.+.+ +|++|-++++.++.-++..
T Consensus 253 ~~~e~~Le~Ied~~------------~Rnlil~Mi~rdPs~RlSAedyL~~yrG~~ 296 (1431)
T KOG1240|consen 253 DDPEQLLEKIEDVS------------LRNLILSMIQRDPSKRLSAEDYLQKYRGLV 296 (1431)
T ss_pred cCHHHHHHhCcCcc------------HHHHHHHHHccCchhccCHHHHHHhhhccc
Confidence 00000 01111211 2233344455 4999999999999866654
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=4.2e-18 Score=164.76 Aligned_cols=185 Identities=16% Similarity=0.066 Sum_probs=140.6
Q ss_pred cccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCchh----HHHHHHHHHHHhccc-ccCceeEeeeecccCceEEEE
Q 005940 355 FKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQG----MREFAAEIESLGRLR-HKNLVNLHGWCKQKNDLLLVY 429 (668)
Q Consensus 355 f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~----~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~lV~ 429 (668)
+.+...|++|+||+||.+.. .+.+++.+.+....... ...|..|+++|++|. |+++++++++ +..+++|
T Consensus 4 ~~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvm 77 (218)
T PRK12274 4 PAVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDR 77 (218)
T ss_pred cccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEE
Confidence 34578899999999997765 57788877776554321 125789999999995 5889999987 3469999
Q ss_pred EecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCC-CCCCEEECCCCCEEEEeecCceeccC
Q 005940 430 EYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDV-KPSNALIDAEMNARLGDFGLARLYDH 508 (668)
Q Consensus 430 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDL-kp~NIll~~~~~~kl~DfGla~~~~~ 508 (668)
||+.+.+|.+.+. . ....++.|++.+|.++|+ .+|+|||| ||+|||++.++.++|+|||+|.....
T Consensus 78 eyI~G~~L~~~~~--~--------~~~~~~~qi~~~L~~lH~---~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~ 144 (218)
T PRK12274 78 SYLAGAAMYQRPP--R--------GDLAYFRAARRLLQQLHR---CGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNP 144 (218)
T ss_pred eeecCccHHhhhh--h--------hhHHHHHHHHHHHHHHHH---CcCccCCCCCcceEEEcCCCCEEEEECCCceecCC
Confidence 9999999875541 1 113577899999999999 99999999 79999999999999999999986554
Q ss_pred CCCC----c--------ccccccCCcccCcccccC--CCCCcchhHHHHHHHHHHHHhCCCCCC
Q 005940 509 GGMP----H--------TTNVVGTFGYIAPELTQT--GKASTSSDVFAYGILLLEVATGRRPIG 558 (668)
Q Consensus 509 ~~~~----~--------~~~~~gt~~y~aPE~~~~--~~~~~~sDV~S~Gvvl~elltG~~p~~ 558 (668)
.... . ......++.|++|+...- .+.-...+.++-|+-+|.++|++.+.-
T Consensus 145 ~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~ 208 (218)
T PRK12274 145 RARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHW 208 (218)
T ss_pred cchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcc
Confidence 3210 0 011235778888875332 223367788999999999999998763
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.76 E-value=5.7e-18 Score=166.62 Aligned_cols=136 Identities=16% Similarity=0.236 Sum_probs=108.3
Q ss_pred ccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCchhHHHHHHHHHHHhcc-----cccCceeEeeeecccC---c-eE
Q 005940 356 KESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRL-----RHKNLVNLHGWCKQKN---D-LL 426 (668)
Q Consensus 356 ~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l-----~H~nIv~l~g~~~~~~---~-~~ 426 (668)
...+.||+|++|.||. ++.++.. +||++........+++.+|+++++++ .||||++++|++++.. . ..
T Consensus 5 ~~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~ 81 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD 81 (210)
T ss_pred CCcceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence 4467899999999996 6666655 69998765555567899999999999 5799999999998763 3 33
Q ss_pred EEEEe--cCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHH-HHhhhccCCceEecCCCCCCEEECC----CCCEEEEe
Q 005940 427 LVYEY--IPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGL-LYLHEEWEQVVIHRDVKPSNALIDA----EMNARLGD 499 (668)
Q Consensus 427 lV~E~--~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL-~yLH~~~~~~ivHrDLkp~NIll~~----~~~~kl~D 499 (668)
+|+|| +++|+|.+++.+ ..+++. ..++.|++.++ .|||+ .+|+||||||+||+++. +.+++|+|
T Consensus 82 ~I~e~~G~~~~tL~~~l~~----~~~~e~--~~~~~~~L~~l~~yLh~---~~IvhrDlKp~NILl~~~~~~~~~~~LiD 152 (210)
T PRK10345 82 VIADFDGKPSITLTEFAEQ----CRYEED--VAQLRQLLKKLKRYLLD---NRIVTMELKPQNILCQRISESEVIPVVCD 152 (210)
T ss_pred EEecCCCCcchhHHHHHHc----ccccHh--HHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEeccCCCCCcEEEEE
Confidence 78999 668999999953 125555 35677888777 89999 99999999999999974 34799999
Q ss_pred ecCc
Q 005940 500 FGLA 503 (668)
Q Consensus 500 fGla 503 (668)
++.+
T Consensus 153 g~G~ 156 (210)
T PRK10345 153 NIGE 156 (210)
T ss_pred CCCC
Confidence 5544
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.75 E-value=9.2e-18 Score=170.70 Aligned_cols=199 Identities=23% Similarity=0.312 Sum_probs=135.6
Q ss_pred CcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCc---hhHHHHHHHHHHHhccc----------ccCceeEeeeec
Q 005940 354 GFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSL---QGMREFAAEIESLGRLR----------HKNLVNLHGWCK 420 (668)
Q Consensus 354 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~f~~Ei~~l~~l~----------H~nIv~l~g~~~ 420 (668)
.....+.||.|+++.||.+++.++++++|||++..... ...+++++|.-.+..+. |-.++..++...
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 34557899999999999999999999999999854332 34567777765555532 223333333221
Q ss_pred ---------cc---C-----ceEEEEEecCCCChhhhhc---C-CCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEe
Q 005940 421 ---------QK---N-----DLLLVYEYIPNGSLDTLLF---K-PKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIH 479 (668)
Q Consensus 421 ---------~~---~-----~~~lV~E~~~~gsL~~~l~---~-~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH 479 (668)
.. . ..+++|+-+ .++|.+++. . ......+....++.+..|+++.+++||+ .|++|
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~---~GlVH 168 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHS---YGLVH 168 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH---TTEEE
T ss_pred EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhh---cceEe
Confidence 11 1 246788877 568877753 1 1122346677888899999999999999 99999
Q ss_pred cCCCCCCEEECCCCCEEEEeecCceeccCCCCCcccccccCCcccCcccccC--------CCCCcchhHHHHHHHHHHHH
Q 005940 480 RDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPELTQT--------GKASTSSDVFAYGILLLEVA 551 (668)
Q Consensus 480 rDLkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~sDV~S~Gvvl~ell 551 (668)
+||||+|++++.+|.++|+||+.......... . ...+..|.+||.... -.++.+.|.|++|+++|.|.
T Consensus 169 gdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~---~-~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lW 244 (288)
T PF14531_consen 169 GDIKPENFLLDQDGGVFLGDFSSLVRAGTRYR---C-SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLW 244 (288)
T ss_dssp ST-SGGGEEE-TTS-EEE--GGGEEETTEEEE---G-GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHH
T ss_pred cccceeeEEEcCCCCEEEcChHHHeecCceee---c-cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHH
Confidence 99999999999999999999987765443111 1 234578999996643 24688999999999999999
Q ss_pred hCCCCCCCC
Q 005940 552 TGRRPIGSG 560 (668)
Q Consensus 552 tG~~p~~~~ 560 (668)
||+.||+..
T Consensus 245 C~~lPf~~~ 253 (288)
T PF14531_consen 245 CGRLPFGLS 253 (288)
T ss_dssp HSS-STCCC
T ss_pred HccCCCCCC
Confidence 999999754
|
|
| >cd06901 lectin_VIP36_VIPL VIP36 and VIPL type 1 transmembrane proteins, lectin domain | Back alignment and domain information |
|---|
Probab=99.72 E-value=7.6e-16 Score=154.32 Aligned_cols=201 Identities=18% Similarity=0.197 Sum_probs=127.8
Q ss_pred CCeEEeCceeeCCCCcEEccCCCCceEEEEEeeCceecccCCCCCCCCeeeeEEEEEEEEeCCCCCCCCCceEEEEcCCC
Q 005940 40 TNLSLQGAEIIKPSGALKLTNRSRYVIGHAFYVKPIQMFDTSASPSPNASSFSTTFVFEISTPRSGRGGHGLAFLLAPST 119 (668)
Q Consensus 40 ~~l~~~g~a~~~~~~~~~lt~~~~~~~G~~~y~~p~~l~~~~~~~~~~~~sF~t~F~f~i~~~~~~~~g~GlaF~l~p~~ 119 (668)
.+..+.|+|.+. ++.|+||++..++.|+++|+.|+++- +|+|+|+|+|.+.....+||||||+++...
T Consensus 20 ~~w~~~G~a~v~-~~~IrLTp~~~~~~G~~w~~~p~~~~-----------~F~~~f~F~I~~~~~~~~GdGlAfw~t~~~ 87 (248)
T cd06901 20 PLWDFLGSTMVT-SQYIRLTPDHQSKQGSIWNRVPCYLR-----------DWEMHVHFKVHGSGKNLFGDGFAIWYTKER 87 (248)
T ss_pred CCEEEcceEEEc-CCeEEECCCCCCCEEEEeccCCccCC-----------CEEEEEEEEEeCCCCCCCCCEEEEEEEcCC
Confidence 689999999997 67999999998899999999999973 599999999998766678999999999865
Q ss_pred CCCCCCCCCcccccccCCCCCCCccEEEEEeecccCCCCCCCCCCCee-eeecCCcccccccCCccccCCCCCccccccC
Q 005940 120 KLPGAQPEHYLGILNSTNNGEPSNHILIVEFDTVNGFNDKAENQGNHV-GIGINTMFSNRSEPASYYINGTDHKEEMTLE 198 (668)
Q Consensus 120 ~~~~~~~~~~lGl~~~~~~~~~~~~~~aVEfDt~~n~~d~~~~~~~Hv-gid~~s~~s~~~~~~~~~~~~~~~~~~~~l~ 198 (668)
. ..|..+|-.+. -.=+||-|||+.|.........+-| ++--++...-....-+......++.... -+
T Consensus 88 ~----~~G~~fG~~~~-------f~Gl~I~~Dt~~n~~~~~~~~~P~i~~~~NDGt~~yd~~~Dg~~~~~~~C~~~~-rn 155 (248)
T cd06901 88 M----QPGPVFGSKDN-------FHGLAIFFDTYSNQNGEHEHVHPYISAMVNNGSLSYDHDRDGTHTELAGCSAPF-RN 155 (248)
T ss_pred C----ccCcccccCCC-------CceEEEEEECCCCCCCcccCCCceEEEEEcCCCeeecccCCCchhhcCceeeec-cC
Confidence 2 33444554222 1136999999988211000111122 2222221111110000000011121121 14
Q ss_pred CCCcEEEEEEEeCCcceEEEEEEeCCCCCCCCcceeeeecccc-ccccceeeeeecccCCcccceeeecccccc
Q 005940 199 SGEPIQAWIEYDGEQKVLNVTISPAEIGKPMRPLISFGVNLTG-YIKETMYVGFSASTGEKSSSHYILGWSFSL 271 (668)
Q Consensus 199 ~g~~~~~~I~Y~~~~~~l~V~~~~~~~~~p~~~~ls~~~dLs~-~l~~~~~vGFsastG~~~~~~~i~~w~F~~ 271 (668)
.+.+.+++|.|... .+.|.+...+. ... ..+ ++... .||...|+||||+||...+.|.|++-.+..
T Consensus 156 ~~~~t~~rI~Y~~~--~l~v~vd~~~~--~~w-~~C--f~~~~v~LP~~~yfGiSA~Tg~~sd~hdIlsv~~~~ 222 (248)
T cd06901 156 KDHDTFVAIRYSKG--RLTVMTDIDGK--NEW-KEC--FDVTGVRLPTGYYFGASAATGDLSDNHDIISMKLYE 222 (248)
T ss_pred CCCCeEEEEEEECC--eEEEEEecCCC--Cce-eee--EEeCCeecCCCCEEEEEecCCCCCCcEEEEEEEEec
Confidence 56778999999964 57777664321 111 112 23332 367789999999999999999999876653
|
The vesicular integral protein of 36 kDa (VIP36) is a type 1 transmembrane protein of the mammalian early secretory pathway that acts as a cargo receptor transporting high mannose type glycoproteins between the Golgi and the endoplasmic reticulum (ER). Lectins of the early secretory pathway are involved in the selective transport of newly synthesized glycoproteins from the ER to the ER-Golgi intermediate compartment (ERGIC). The most prominent cycling lectin is the mannose-binding type1 membrane protein ERGIC-53, which functions as a cargo receptor to facilitate export of glycoproteins from the ER. L-type lectins have a dome-shaped beta-barrel carbohydrate recognition domain with a curved seven-stranded beta-sheet referred to as the "front face" and a flat six-stranded beta-sheet referred to as the "back face". This domain homodimerizes so that adjacent back sheets form a contiguous 12-stranded she |
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.72 E-value=7e-17 Score=162.67 Aligned_cols=145 Identities=22% Similarity=0.249 Sum_probs=113.5
Q ss_pred cCcccceeeeecCcEEEEEEE-eCCCCcEEEEEEEecCCch------------------------hHHHHHHHHHHHhcc
Q 005940 353 KGFKESEVIGIGGFGSVYKGV-LPTTGGEVAVKKITRNSLQ------------------------GMREFAAEIESLGRL 407 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~-~~~~~~~vavK~~~~~~~~------------------------~~~~f~~Ei~~l~~l 407 (668)
..|.+.+.||+|++|.||+|+ +..+|+.||||++...... ....+..|++.+.++
T Consensus 28 ~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L 107 (237)
T smart00090 28 ILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRL 107 (237)
T ss_pred chHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence 347888999999999999998 5568999999998754210 012356899999999
Q ss_pred ccc--CceeEeeeecccCceEEEEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCc-eEecCCCC
Q 005940 408 RHK--NLVNLHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQV-VIHRDVKP 484 (668)
Q Consensus 408 ~H~--nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~-ivHrDLkp 484 (668)
.+. .+.+++++ ...++||||+++++|...... ...+...+...++.|++.+|.+||+ .+ ++||||||
T Consensus 108 ~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~---~g~iiH~Dikp 177 (237)
T smart00090 108 YEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLK---DVEPEEEEEFELYDDILEEMRKLYK---EGELVHGDLSE 177 (237)
T ss_pred HhcCCCCCeeeEe----cCceEEEEEecCCcccccccc---cCCcchHHHHHHHHHHHHHHHHHHh---cCCEEeCCCCh
Confidence 763 34455543 235899999999888765421 2335566678999999999999999 88 99999999
Q ss_pred CCEEECCCCCEEEEeecCceeccC
Q 005940 485 SNALIDAEMNARLGDFGLARLYDH 508 (668)
Q Consensus 485 ~NIll~~~~~~kl~DfGla~~~~~ 508 (668)
+||+++ +++++|+|||.+....+
T Consensus 178 ~NIli~-~~~i~LiDFg~a~~~~~ 200 (237)
T smart00090 178 YNILVH-DGKVVIIDVSQSVELDH 200 (237)
T ss_pred hhEEEE-CCCEEEEEChhhhccCC
Confidence 999999 88999999999875443
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.71 E-value=9.2e-18 Score=170.55 Aligned_cols=196 Identities=21% Similarity=0.269 Sum_probs=135.0
Q ss_pred cccCceeEeeeecc---------------------------cCceEEEEEecCCCChhhhhcCCCCCCCccHHHHHHHHH
Q 005940 408 RHKNLVNLHGWCKQ---------------------------KNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVK 460 (668)
Q Consensus 408 ~H~nIv~l~g~~~~---------------------------~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~ 460 (668)
+|||||++.++|.+ ...+|+||.-.+ .+|.+++.. ...+.....-|+.
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~----~~~s~r~~~~~la 348 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWT----RHRSYRTGRVILA 348 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhc----CCCchHHHHHHHH
Confidence 59999999987632 235789998774 589999852 3356667777999
Q ss_pred HHHHHHHHhhhccCCceEecCCCCCCEEEC--CC--CCEEEEeecCceeccCCC-----CCcccccccCCcccCcccccC
Q 005940 461 GIASGLLYLHEEWEQVVIHRDVKPSNALID--AE--MNARLGDFGLARLYDHGG-----MPHTTNVVGTFGYIAPELTQT 531 (668)
Q Consensus 461 qia~gL~yLH~~~~~~ivHrDLkp~NIll~--~~--~~~kl~DfGla~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~ 531 (668)
|+++|+.|||. ++|.|||||+.||||. +| ..+.|+|||++..-+... .......-|...-||||+...
T Consensus 349 QlLEav~hL~~---hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta 425 (598)
T KOG4158|consen 349 QLLEAVTHLHK---HGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATA 425 (598)
T ss_pred HHHHHHHHHHH---ccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhc
Confidence 99999999999 9999999999999993 33 357899999886543321 112233457788999998754
Q ss_pred CC------CCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCcccCCcccHHHHHHHHHHHhhcC
Q 005940 532 GK------ASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSYVVKEMELVLKLGLMCS 605 (668)
Q Consensus 532 ~~------~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~ 605 (668)
.. ...|+|.|+.|-+.||++....||-....-..+- +. ++ +..-|.+....++.. -++....+
T Consensus 426 ~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~-r~-Yq-----e~qLPalp~~vpp~~----rqlV~~lL 494 (598)
T KOG4158|consen 426 VPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDT-RT-YQ-----ESQLPALPSRVPPVA----RQLVFDLL 494 (598)
T ss_pred CCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheech-hh-hh-----hhhCCCCcccCChHH----HHHHHHHh
Confidence 22 2468999999999999999999996532111111 00 12 112233333333332 23444456
Q ss_pred CC-CCCCCCHHHHHHHhc
Q 005940 606 HK-TQFRPTMRQVMRYLS 622 (668)
Q Consensus 606 ~~-p~~RPs~~evl~~L~ 622 (668)
+. |++||+.+-..+.|.
T Consensus 495 ~r~pskRvsp~iAANvl~ 512 (598)
T KOG4158|consen 495 KRDPSKRVSPNIAANVLN 512 (598)
T ss_pred cCCccccCCccHHHhHHH
Confidence 66 999999887776664
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.70 E-value=9.9e-17 Score=159.01 Aligned_cols=134 Identities=22% Similarity=0.307 Sum_probs=114.0
Q ss_pred eeeeecCcEEEEEEEeCCCCcEEEEEEEecCCch--------hHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEE
Q 005940 359 EVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQ--------GMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYE 430 (668)
Q Consensus 359 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--------~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 430 (668)
+.||+|++|.||+|.+ .+..+++|+....... ....+..|++++.+++|+++.....++......++|||
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e 79 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVME 79 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEE
Confidence 5799999999999988 5778999986543221 12457889999999999999888877777788899999
Q ss_pred ecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCcee
Q 005940 431 YIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARL 505 (668)
Q Consensus 431 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~ 505 (668)
|+++++|.+++... .+ .+..++.+++.+|.+||+ .+++|||++|.||+++ ++.++|+|||++..
T Consensus 80 ~~~G~~L~~~~~~~------~~-~~~~i~~~i~~~l~~lH~---~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 80 YIEGEPLKDLINSN------GM-EELELSREIGRLVGKLHS---AGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred EeCCcCHHHHHHhc------cH-HHHHHHHHHHHHHHHHHh---CCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 99999999998521 12 888999999999999999 9999999999999999 78899999998864
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.7e-16 Score=179.31 Aligned_cols=141 Identities=21% Similarity=0.258 Sum_probs=115.1
Q ss_pred HHHhcCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCC--c------hhHHHHHHHHHHHhcccccCceeEeeeec
Q 005940 349 YAATKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNS--L------QGMREFAAEIESLGRLRHKNLVNLHGWCK 420 (668)
Q Consensus 349 ~~at~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~------~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~ 420 (668)
......|...++||+|+||.||+|.+. +..+++|+..... . ...+.+..|++++.+++|++++....++.
T Consensus 329 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~--~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~ 406 (535)
T PRK09605 329 EEVKRRKIPDHLIGKGAEADIKKGEYL--GRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDV 406 (535)
T ss_pred cccccccCccceeccCCcEEEEEEeec--CccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEE
Confidence 334455677899999999999999884 3445555432211 1 12356889999999999999998888887
Q ss_pred ccCceEEEEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEee
Q 005940 421 QKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDF 500 (668)
Q Consensus 421 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~Df 500 (668)
.....++||||+++++|.+++. ....++.|++++|.|||+ .+++||||||+||++ +++.++|+||
T Consensus 407 ~~~~~~lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~---~giiHrDlkp~NILl-~~~~~~liDF 471 (535)
T PRK09605 407 DPEEKTIVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHK---AGIVHGDLTTSNFIV-RDDRLYLIDF 471 (535)
T ss_pred eCCCCEEEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHh---CCCccCCCChHHEEE-ECCcEEEEeC
Confidence 7778899999999999998883 456799999999999999 999999999999999 6789999999
Q ss_pred cCceec
Q 005940 501 GLARLY 506 (668)
Q Consensus 501 Gla~~~ 506 (668)
|+++..
T Consensus 472 Gla~~~ 477 (535)
T PRK09605 472 GLGKYS 477 (535)
T ss_pred cccccC
Confidence 999753
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.69 E-value=2.3e-16 Score=154.99 Aligned_cols=145 Identities=22% Similarity=0.235 Sum_probs=113.6
Q ss_pred hHHHHhcCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCch----------------------hHHHHHHHHHHH
Q 005940 347 DLYAATKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQ----------------------GMREFAAEIESL 404 (668)
Q Consensus 347 el~~at~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----------------------~~~~f~~Ei~~l 404 (668)
++......|...+.||+|++|.||++... +|+.||||++...... ....+..|..++
T Consensus 9 ~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 87 (198)
T cd05144 9 TLVKRGVVESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAAL 87 (198)
T ss_pred HHHHcCchhhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHH
Confidence 34444445778899999999999999885 7899999987643210 012356788999
Q ss_pred hccccc--CceeEeeeecccCceEEEEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCC
Q 005940 405 GRLRHK--NLVNLHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDV 482 (668)
Q Consensus 405 ~~l~H~--nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDL 482 (668)
.++.|+ .+...++. ...++||||+++++|..+... .....++.+++.++.++|+ .+++||||
T Consensus 88 ~~l~~~~i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~---------~~~~~~~~~i~~~l~~lh~---~gi~H~Dl 151 (198)
T cd05144 88 KALYEEGFPVPKPIDW----NRHAVVMEYIDGVELYRVRVL---------EDPEEVLDEILEEIVKAYK---HGIIHGDL 151 (198)
T ss_pred HHHHHcCCCCCceeec----CCceEEEEEeCCcchhhcccc---------ccHHHHHHHHHHHHHHHHH---CCCCcCCC
Confidence 999887 45555543 345899999999999776521 3456788999999999999 99999999
Q ss_pred CCCCEEECCCCCEEEEeecCceeccC
Q 005940 483 KPSNALIDAEMNARLGDFGLARLYDH 508 (668)
Q Consensus 483 kp~NIll~~~~~~kl~DfGla~~~~~ 508 (668)
||+||++++++.++|+|||++.....
T Consensus 152 ~p~Nill~~~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 152 SEFNILVDDDEKIYIIDWPQMVSTDH 177 (198)
T ss_pred CcccEEEcCCCcEEEEECCccccCCC
Confidence 99999999999999999999976554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.69 E-value=9.7e-18 Score=177.49 Aligned_cols=124 Identities=29% Similarity=0.474 Sum_probs=112.1
Q ss_pred CceEEEEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecC
Q 005940 423 NDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGL 502 (668)
Q Consensus 423 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGl 502 (668)
..+|+.|++|...+|.++|.........+|...+.++.|++.|+.| ++.+|+|+||.||+...+.++||+|||+
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIgDFgl 402 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIGDFGL 402 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhhhhhh
Confidence 3578999999999999999876777789999999999999999999 6899999999999999999999999999
Q ss_pred ceeccCCC-----CCcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHh
Q 005940 503 ARLYDHGG-----MPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVAT 552 (668)
Q Consensus 503 a~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt 552 (668)
........ ....+...||..||+||.+.++.|+.|+||||||++|+|++.
T Consensus 403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI 457 (516)
T ss_pred eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence 98776554 234556789999999999999999999999999999999988
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.68 E-value=2e-16 Score=155.33 Aligned_cols=130 Identities=22% Similarity=0.294 Sum_probs=107.2
Q ss_pred eeeecCcEEEEEEEeCCCCcEEEEEEEecCCc--------hhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEEe
Q 005940 360 VIGIGGFGSVYKGVLPTTGGEVAVKKITRNSL--------QGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEY 431 (668)
Q Consensus 360 ~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--------~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~ 431 (668)
.||+|++|.||+|.+ ++..+++|+...... ....++.+|++++.+++|+++.....++......++||||
T Consensus 1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 78 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEY 78 (199)
T ss_pred CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEE
Confidence 489999999999996 578899998654321 1235677899999999988766655555566678999999
Q ss_pred cCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCcee
Q 005940 432 IPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARL 505 (668)
Q Consensus 432 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~ 505 (668)
+++++|.+++.... . .++.+++.+|.+||+ .+++|||++|.||+++ ++.+++.|||+++.
T Consensus 79 ~~g~~l~~~~~~~~----~------~~~~~i~~~l~~lH~---~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 79 IEGKPLKDVIEEGN----D------ELLREIGRLVGKLHK---AGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred ECCccHHHHHhhcH----H------HHHHHHHHHHHHHHH---CCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 99999999874211 1 789999999999999 9999999999999999 88999999999865
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.67 E-value=1.7e-16 Score=182.42 Aligned_cols=196 Identities=24% Similarity=0.229 Sum_probs=155.5
Q ss_pred HHhcCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCchhHHHHHHHHHHHhccc---ccCceeEeeeecccCceE
Q 005940 350 AATKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLR---HKNLVNLHGWCKQKNDLL 426 (668)
Q Consensus 350 ~at~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~---H~nIv~l~g~~~~~~~~~ 426 (668)
.....|.+.+.||+|+||+||+|+..+ |+.||+|+-+..... +|.--.+++.||+ -+-|..+.....-.+..+
T Consensus 695 ~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~W---EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~ 770 (974)
T KOG1166|consen 695 VGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPW---EFYICLQVMERLKPQMLPSIMHISSAHVFQNASV 770 (974)
T ss_pred ecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCce---eeeehHHHHHhhchhhhcchHHHHHHHccCCcce
Confidence 344678999999999999999999965 999999987665443 2222334444555 123333333344566789
Q ss_pred EEEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEEC-------CCCCEEEEe
Q 005940 427 LVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALID-------AEMNARLGD 499 (668)
Q Consensus 427 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~-------~~~~~kl~D 499 (668)
||+||.+.|+|.+++. ..+.++|.....++.|+++-+..||. .+||||||||.|.||. ++..++|+|
T Consensus 771 lv~ey~~~Gtlld~~N---~~~~m~e~lv~~~~~qml~ive~lH~---~~IIHgDiKPDNfll~~~~~~~~~~~~l~lID 844 (974)
T KOG1166|consen 771 LVSEYSPYGTLLDLIN---TNKVMDEYLVMFFSCQMLRIVEHLHA---MGIIHGDIKPDNFLLRREICADSDSKGLYLID 844 (974)
T ss_pred eeeeccccccHHHhhc---cCCCCCchhhhHHHHHHHHHHHHHHh---cceecccCCcceeEeecccCCCCcccceEEEe
Confidence 9999999999999996 56779999999999999999999999 9999999999999993 245699999
Q ss_pred ecCceeccCC-CCCcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCC
Q 005940 500 FGLARLYDHG-GMPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRR 555 (668)
Q Consensus 500 fGla~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~ 555 (668)
||.+..+.-- ........++|-.+-.+|+..+..++...|.|.+.-+++-|+-|+.
T Consensus 845 fG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 845 FGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred cccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 9998754311 1123445688999999999999999999999999999999999885
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.66 E-value=1.6e-17 Score=179.09 Aligned_cols=187 Identities=28% Similarity=0.379 Sum_probs=155.3
Q ss_pred eeeecCcEEEEEEEe---CCCCcEEEEEEEecCCchh--HHHHHHHHHHHhccc-ccCceeEeeeecccCceEEEEEecC
Q 005940 360 VIGIGGFGSVYKGVL---PTTGGEVAVKKITRNSLQG--MREFAAEIESLGRLR-HKNLVNLHGWCKQKNDLLLVYEYIP 433 (668)
Q Consensus 360 ~lG~G~~g~Vy~~~~---~~~~~~vavK~~~~~~~~~--~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~lV~E~~~ 433 (668)
.+|+|.||.|+++.- .+.+..+|+|++.+..... ......|..++...+ ||.+|++.-.++.+...+++.+|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 378999999987542 2456678888876543321 114557888888887 9999999999999999999999999
Q ss_pred CCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCCCCc
Q 005940 434 NGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPH 513 (668)
Q Consensus 434 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 513 (668)
+|.|...+.+ ...+.+.........++-++.++|+ .+|+|||+|++||+++.+|.+++.|||+.+..-..+..
T Consensus 81 gg~lft~l~~---~~~f~~~~~~~~~aelaLald~lh~---l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~- 153 (612)
T KOG0603|consen 81 GGDLFTRLSK---EVMFDELDVAFYLAELALALDHLHK---LGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA- 153 (612)
T ss_pred cchhhhcccc---CCchHHHHHHHHHHHHHHHHhhcch---hHHHHhcccccceeecccCccccCCchhhhHhHhhhhc-
Confidence 9999888853 3346666677778889999999998 99999999999999999999999999999865443322
Q ss_pred ccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 005940 514 TTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGS 559 (668)
Q Consensus 514 ~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~ 559 (668)
+||..|||||++. ......|.||||++++||++|-.||..
T Consensus 154 ----cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~ 193 (612)
T KOG0603|consen 154 ----CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG 193 (612)
T ss_pred ----ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence 8999999999987 577899999999999999999999976
|
|
| >cd06902 lectin_ERGIC-53_ERGL ERGIC-53 and ERGL type 1 transmembrane proteins, N-terminal lectin domain | Back alignment and domain information |
|---|
Probab=99.65 E-value=1.5e-14 Score=143.18 Aligned_cols=198 Identities=17% Similarity=0.196 Sum_probs=131.2
Q ss_pred CCeEEeCceeeCCCCcEEccCCCCceEEEEEeeCceecccCCCCCCCCeeeeEEEEEEEEeCCCCCCCCCceEEEEcCCC
Q 005940 40 TNLSLQGAEIIKPSGALKLTNRSRYVIGHAFYVKPIQMFDTSASPSPNASSFSTTFVFEISTPRSGRGGHGLAFLLAPST 119 (668)
Q Consensus 40 ~~l~~~g~a~~~~~~~~~lt~~~~~~~G~~~y~~p~~l~~~~~~~~~~~~sF~t~F~f~i~~~~~~~~g~GlaF~l~p~~ 119 (668)
++-.+.|+|.+. ++.|+||++..++.|.++.+.|++. + +|+.+|+|+|.... ..+||||||+++...
T Consensus 22 ~~W~~~G~t~~~-~~~IrLTp~~~~~~G~iw~~~~~~~-~----------~w~ie~~Fri~g~~-~~~gdG~a~W~t~~~ 88 (225)
T cd06902 22 PFWSHGGDAIAS-LEQVRLTPSLRSKKGSVWTKNPFSF-E----------NWEVEVTFRVTGRG-RIGADGLAIWYTKER 88 (225)
T ss_pred CceEecccEEec-CCEEEECCCCCCCEEEEeeCCCcCC-C----------CEEEEEEEEEecCC-CCCCCEEEEEEECCC
Confidence 578999999996 7899999998999999999999983 3 59999999999763 457899999999754
Q ss_pred CCCCCCCCCcccccccCCCCCCCccEEEEEeecccCCCCCCCCCCCeeeeec-CCcccccccCCccccCCCCCcccccc-
Q 005940 120 KLPGAQPEHYLGILNSTNNGEPSNHILIVEFDTVNGFNDKAENQGNHVGIGI-NTMFSNRSEPASYYINGTDHKEEMTL- 197 (668)
Q Consensus 120 ~~~~~~~~~~lGl~~~~~~~~~~~~~~aVEfDt~~n~~d~~~~~~~Hvgid~-~s~~s~~~~~~~~~~~~~~~~~~~~l- 197 (668)
. ..|..+|..+. -.=+||.|||+.|... .+...|-+-+ ++........-.......++. ...
T Consensus 89 ~----~~G~~~G~~~~-------f~Gl~I~~Dt~~n~~~---~~~p~i~~~~NDGt~~yd~~~D~~~~~~~~C~--~~~r 152 (225)
T cd06902 89 G----EEGPVFGSSDK-------WNGVGIFFDSFDNDGK---KNNPAILVVGNDGTKSYDHQNDGLTQALGSCL--RDFR 152 (225)
T ss_pred C----CCCCccCCCCc-------ccEEEEEEECCCCCCC---CCCcEEEEEECCCCeeccccCCCcccccceEE--Eecc
Confidence 2 24555555332 1236999999987222 2223553333 222211111100000001111 122
Q ss_pred CCCCcEEEEEEEeCCcceEEEEEEeCCCCCCCCcceeeeecccc-ccccceeeeeecccCCcccceeeeccccc
Q 005940 198 ESGEPIQAWIEYDGEQKVLNVTISPAEIGKPMRPLISFGVNLTG-YIKETMYVGFSASTGEKSSSHYILGWSFS 270 (668)
Q Consensus 198 ~~g~~~~~~I~Y~~~~~~l~V~~~~~~~~~p~~~~ls~~~dLs~-~l~~~~~vGFsastG~~~~~~~i~~w~F~ 270 (668)
+.+.+.+++|.|.. .+|.|.+.... .+........+++.. .||+..|+||||+||...+.|.|++|.+.
T Consensus 153 n~~~p~~~rI~Y~~--~~l~V~~d~~~--~~~~~~~~~Cf~~~~v~LP~~~yfGiSA~Tg~l~d~hDIls~~~~ 222 (225)
T cd06902 153 NKPYPVRAKITYYQ--NVLTVSINNGF--TPNKDDYELCTRVENMVLPPNGYFGVSAATGGLADDHDVLSFLTF 222 (225)
T ss_pred CCCCCeEEEEEEEC--CeEEEEEeCCc--CCCCCcccEEEecCCeeCCCCCEEEEEecCCCCCCcEeEEEEEEe
Confidence 34678999999998 46888886422 222222223344433 47788999999999999999999999875
|
ERGIC-53 and ERGL, N-terminal carbohydrate recognition domain. ERGIC-53 and ERGL are eukaryotic mannose-binding type 1 transmembrane proteins of the early secretory pathway that transport newly synthesized glycoproteins from the endoplasmic reticulum (ER) to the ER-Golgi intermediate compartment (ERGIC). ERGIC-53 and ERGL have an N-terminal lectin-like carbohydrate recognition domain (represented by this alignment model) as well as a C-terminal transmembrane domain. ERGIC-53 functions as a 'cargo receptor' to facilitate the export of glycoproteins with different characteristics from the ER, while the ERGIC-53-like protein (ERGL) which may act as a regulator of ERGIC-53. In mammals, ERGIC-53 forms a complex with MCFD2 (multi-coagulation factor deficiency 2) which then recruits blood coagulation factors V and VIII. Mutations in either MCFD2 or ERGIC-53 cause a mild form of inherite |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.61 E-value=7.7e-15 Score=136.15 Aligned_cols=135 Identities=20% Similarity=0.163 Sum_probs=115.3
Q ss_pred cceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCchhHHHHHHHHHHHhcccc--cCceeEeeeecccCceEEEEEecCC
Q 005940 357 ESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRH--KNLVNLHGWCKQKNDLLLVYEYIPN 434 (668)
Q Consensus 357 ~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H--~nIv~l~g~~~~~~~~~lV~E~~~~ 434 (668)
+.+.||+|.++.||++... +..+++|....... ...+..|+..+..++| .++++++++....+..++++||+++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~--~~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g 77 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTK--DEDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEG 77 (155)
T ss_pred cceecccccccceEEEEec--CCeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCC
Confidence 4578999999999999984 47899999865543 4678899999999987 5999999999888889999999988
Q ss_pred CChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCcee
Q 005940 435 GSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARL 505 (668)
Q Consensus 435 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~ 505 (668)
+.+..+ +......++.+++++|++||.....+++|+|++|+||++++.+.+++.|||.++.
T Consensus 78 ~~~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 78 ETLDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred eecccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 777543 5567778899999999999984445799999999999999989999999998864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.57 E-value=2e-14 Score=139.60 Aligned_cols=139 Identities=24% Similarity=0.234 Sum_probs=99.3
Q ss_pred ceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCch--hHHH----------------------HHHHHHHHhcccccC--
Q 005940 358 SEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQ--GMRE----------------------FAAEIESLGRLRHKN-- 411 (668)
Q Consensus 358 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~----------------------f~~Ei~~l~~l~H~n-- 411 (668)
.+.||+|+||.||+|.+. +++.||||++...... .... ...|.+.+.++.+..
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 467999999999999986 7899999998754221 1111 134556666664432
Q ss_pred ceeEeeeecccCceEEEEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECC
Q 005940 412 LVNLHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDA 491 (668)
Q Consensus 412 Iv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~ 491 (668)
+.+.++. ...++||||++++.+........ ... .+...++.+++.++.++|. +++|+||||||+||+++
T Consensus 81 ~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~---~~~-~~~~~~~~~~~~~l~~lh~--~~~ivH~Dl~p~Nili~- 149 (187)
T cd05119 81 VPKPIDL----NRHVLVMEFIGGDGIPAPRLKDV---RLL-EDPEELYDQILELMRKLYR--EAGLVHGDLSEYNILVD- 149 (187)
T ss_pred CCceEec----CCCEEEEEEeCCCCccChhhhhh---hhc-ccHHHHHHHHHHHHHHHhh--ccCcCcCCCChhhEEEE-
Confidence 4444443 24689999999955432211000 011 6678899999999999997 37999999999999999
Q ss_pred CCCEEEEeecCceeccC
Q 005940 492 EMNARLGDFGLARLYDH 508 (668)
Q Consensus 492 ~~~~kl~DfGla~~~~~ 508 (668)
++.++|+|||.+.....
T Consensus 150 ~~~~~liDfg~a~~~~~ 166 (187)
T cd05119 150 DGKVYIIDVPQAVEIDH 166 (187)
T ss_pred CCcEEEEECcccccccC
Confidence 89999999999975544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.56 E-value=4e-14 Score=142.92 Aligned_cols=135 Identities=23% Similarity=0.232 Sum_probs=106.1
Q ss_pred ceeee-ecCcEEEEEEEeCCCCcEEEEEEEecCCc-------------hhHHHHHHHHHHHhcccccCc--eeEeeeecc
Q 005940 358 SEVIG-IGGFGSVYKGVLPTTGGEVAVKKITRNSL-------------QGMREFAAEIESLGRLRHKNL--VNLHGWCKQ 421 (668)
Q Consensus 358 ~~~lG-~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-------------~~~~~f~~Ei~~l~~l~H~nI--v~l~g~~~~ 421 (668)
...|| .||.|+||++.. .+..++||++.+... .....+.+|++++.+|+|++| +..++++..
T Consensus 36 ~~~lg~~~g~gtv~~v~~--~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~ 113 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQT--PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVV 113 (239)
T ss_pred CceeecCCCCccEEEEEe--CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeee
Confidence 45788 899999999988 478899998864221 123467889999999998875 677776543
Q ss_pred cC----ceEEEEEecCC-CChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEE
Q 005940 422 KN----DLLLVYEYIPN-GSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNAR 496 (668)
Q Consensus 422 ~~----~~~lV~E~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~k 496 (668)
+. ..++|+|++++ .+|.+++.. ..++.. .+.+++.+|.+||+ .+|+||||||.|||++.++.++
T Consensus 114 ~~~~~~~~~lV~e~l~G~~~L~~~l~~----~~l~~~----~~~~i~~~l~~lH~---~GI~HrDlkp~NILv~~~~~v~ 182 (239)
T PRK01723 114 RHGLFYRADILIERIEGARDLVALLQE----APLSEE----QWQAIGQLIARFHD---AGVYHADLNAHNILLDPDGKFW 182 (239)
T ss_pred ecCcceeeeEEEEecCCCCCHHHHHhc----CCCCHH----HHHHHHHHHHHHHH---CCCCCCCCCchhEEEcCCCCEE
Confidence 32 23599999997 699888842 224433 36789999999999 9999999999999999999999
Q ss_pred EEeecCcee
Q 005940 497 LGDFGLARL 505 (668)
Q Consensus 497 l~DfGla~~ 505 (668)
|+|||.+..
T Consensus 183 LIDfg~~~~ 191 (239)
T PRK01723 183 LIDFDRGEL 191 (239)
T ss_pred EEECCCccc
Confidence 999998875
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.51 E-value=2.8e-14 Score=161.32 Aligned_cols=165 Identities=30% Similarity=0.385 Sum_probs=121.0
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCchhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEEec
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEYI 432 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~ 432 (668)
.+|+.++.|..|+||.||..+++.+.+.+|+| +.++..-- ++ ++.....|.+|
T Consensus 83 ~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~lil----Rn---ilt~a~npfvv------------------- 135 (1205)
T KOG0606|consen 83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNLIL----RN---ILTFAGNPFVV------------------- 135 (1205)
T ss_pred cccceeEeeccCCCCceeeeeccccccchhhc-ccccchhh----hc---cccccCCccee-------------------
Confidence 57888999999999999999998888899984 43322100 00 12222223222
Q ss_pred CCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCC--
Q 005940 433 PNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGG-- 510 (668)
Q Consensus 433 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~-- 510 (668)
|+=...+. .-+.++.. ++.+++|||+ .+|+|||+||.|.+|+.-|.+|+.|||+.+......
T Consensus 136 --gDc~tllk---~~g~lPvd--------mvla~Eylh~---ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~at 199 (1205)
T KOG0606|consen 136 --GDCATLLK---NIGPLPVD--------MVLAVEYLHS---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLAT 199 (1205)
T ss_pred --chhhhhcc---cCCCCcch--------hhHHhHhhcc---CCeecCCCCCCcceeeecccccccchhhhhhhhhhccc
Confidence 22222232 11223322 2789999999 999999999999999999999999999987432111
Q ss_pred ------C------CcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 005940 511 ------M------PHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSG 560 (668)
Q Consensus 511 ------~------~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~ 560 (668)
. .....++||+.|.|||++..+.|....|.|++|+|+||.+-|..||.++
T Consensus 200 nl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGd 261 (1205)
T KOG0606|consen 200 NLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGD 261 (1205)
T ss_pred hhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCC
Confidence 0 1124468999999999999999999999999999999999999999765
|
|
| >cd06903 lectin_EMP46_EMP47 EMP46 and EMP47 type 1 transmembrane proteins, N-terminal lectin domain | Back alignment and domain information |
|---|
Probab=99.49 E-value=1.9e-12 Score=127.12 Aligned_cols=190 Identities=19% Similarity=0.241 Sum_probs=124.0
Q ss_pred CCeEEeCceeeCCCCcEEccCCCCceEEEEEeeCceecccCCCCCCCCeeeeEEEEEEEEeCCCCCCCCCceEEEEcCCC
Q 005940 40 TNLSLQGAEIIKPSGALKLTNRSRYVIGHAFYVKPIQMFDTSASPSPNASSFSTTFVFEISTPRSGRGGHGLAFLLAPST 119 (668)
Q Consensus 40 ~~l~~~g~a~~~~~~~~~lt~~~~~~~G~~~y~~p~~l~~~~~~~~~~~~sF~t~F~f~i~~~~~~~~g~GlaF~l~p~~ 119 (668)
.+-.+.|+|.+. ++.|+||++ .++.|.+|-+.|+++-+ +|+.+|+|+|+.+. ..+||||||+++...
T Consensus 21 ~~W~~~G~t~v~-~~~IrLTp~-~s~~G~iWs~~pl~~~~----------~w~ie~~Fri~G~~-~~~gdGla~W~t~~~ 87 (215)
T cd06903 21 PNWQTSGNPKLE-SGRIILTPP-GNQRGSLWLKKPLSLKD----------EWTIEWTFRSTGPE-GRSGGGLNFWLVKDG 87 (215)
T ss_pred CCeEEcCcEEee-CCeEEECCC-CCceEeEeeCCcCCCCC----------CEEEEEEEEecccC-CcCCCEEEEEEECCC
Confidence 578999999997 789999999 99999999999999763 59999999998764 378999999999754
Q ss_pred CCCCCCCCCcccccccCCCCCCCccEEEEEeecccCCCCCCCCCCCeeeeecCCcccccccCCccccCCCCCccccccCC
Q 005940 120 KLPGAQPEHYLGILNSTNNGEPSNHILIVEFDTVNGFNDKAENQGNHVGIGINTMFSNRSEPASYYINGTDHKEEMTLES 199 (668)
Q Consensus 120 ~~~~~~~~~~lGl~~~~~~~~~~~~~~aVEfDt~~n~~d~~~~~~~Hvgid~~s~~s~~~~~~~~~~~~~~~~~~~~l~~ 199 (668)
....+ ...+|-.+. -.=+||.|||+.| ++ | ...++--++-.......- .-....++... ..+.
T Consensus 88 ~~~~g--~~~fG~~~~-------f~Gl~I~~Dt~~n--~~--p--~i~~~~NDGt~~yd~~~d-~~~~~g~C~~~-~rn~ 150 (215)
T cd06903 88 NADVG--TSSIYGPSK-------FDGLQLLIDNNGG--SG--G--SLRGFLNDGSKDYKNEDV-DSLAFGSCLFA-YQDS 150 (215)
T ss_pred cccCC--ccccCCCCC-------CcEEEEEEECCCC--CC--c--eEEEEECCCCeeccccCC-cccccceeeEe-ccCC
Confidence 21111 023333221 1125999999976 21 2 122332233221111110 00000112111 1356
Q ss_pred CCcEEEEEEEeCCcceEEEEEEeCCCCCCCCcceeeeeccccccc-cceeeeeecccCCcccceeeecccc
Q 005940 200 GEPIQAWIEYDGEQKVLNVTISPAEIGKPMRPLISFGVNLTGYIK-ETMYVGFSASTGEKSSSHYILGWSF 269 (668)
Q Consensus 200 g~~~~~~I~Y~~~~~~l~V~~~~~~~~~p~~~~ls~~~dLs~~l~-~~~~vGFsastG~~~~~~~i~~w~F 269 (668)
+.+.+++|.|......|+|.+... ++..++- -.|| ...|+||||+||...+.|.|++-..
T Consensus 151 ~~p~~iri~Y~~~~~~l~v~vd~~---------~Cf~~~~-v~lP~~~y~fGiSAaTg~~~d~hdIl~~~~ 211 (215)
T cd06903 151 GVPSTIRLSYDALNSLFKVQVDNR---------LCFQTDK-VQLPQGGYRFGITAANADNPESFEILKLKV 211 (215)
T ss_pred CCCEEEEEEEECCCCEEEEEECCC---------EEEecCC-eecCCCCCEEEEEEcCCCCCCcEEEEEEEE
Confidence 779999999998778899988521 3333321 1256 5678999999999999999987543
|
EMP46 and EMP47, N-terminal carbohydrate recognition domain. EMP46 and EMP47 are fungal type-I transmembrane proteins that cycle between the endoplasmic reticulum and the golgi apparatus and are thought to function as cargo receptors that transport newly synthesized glycoproteins. EMP47 is a receptor for EMP46 responsible for the selective transport of EMP46 by forming hetero-oligomerization between the two proteins. EMP46 and EMP47 have an N-terminal lectin-like carbohydrate recognition domain (represented by this alignment model) as well as a C-terminal transmembrane domain. EMP46 and EMP47 are 45% sequence-identical to one another and have sequence homology to a class of intracellular lectins defined by ERGIC-53 and VIP36. L-type lectins have a dome-shaped beta-barrel carbohydrate recognition domain with a curved seven-stranded beta-sheet referred to as the "front face" and a flat s |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.43 E-value=2.2e-13 Score=136.12 Aligned_cols=203 Identities=23% Similarity=0.305 Sum_probs=140.4
Q ss_pred HHHHhcccccCceeEeeeeccc-----CceEEEEEecCCCChhhhhcCCC-CCCCccHHHHHHHHHHHHHHHHHhhhccC
Q 005940 401 IESLGRLRHKNLVNLHGWCKQK-----NDLLLVYEYIPNGSLDTLLFKPK-DGSVLDWEQRFNIVKGIASGLLYLHEEWE 474 (668)
Q Consensus 401 i~~l~~l~H~nIv~l~g~~~~~-----~~~~lV~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~gL~yLH~~~~ 474 (668)
..-|-++-|.|||+++.|+.+. .+..++.|||..|+|..+|++.+ .+..+......+++-||..||.|||+ |.
T Consensus 118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs-~~ 196 (458)
T KOG1266|consen 118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHS-CD 196 (458)
T ss_pred HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhc-cC
Confidence 3445567799999999988543 45789999999999999996533 34567888888999999999999998 68
Q ss_pred CceEecCCCCCCEEECCCCCEEEEeecCceeccC----CCCCcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHH
Q 005940 475 QVVIHRDVKPSNALIDAEMNARLGDFGLARLYDH----GGMPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEV 550 (668)
Q Consensus 475 ~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~----~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~el 550 (668)
++|+|+++....|++..++-+|++---- ..... ..........+-++|.+||+-.....+-++|||+||+..+||
T Consensus 197 PpiihgnlTc~tifiq~ngLIkig~~ap-~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlem 275 (458)
T KOG1266|consen 197 PPIIHGNLTCDTIFIQHNGLIKIGSVAP-DSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEM 275 (458)
T ss_pred CccccCCcchhheeecCCceEEecccCc-cccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHH
Confidence 9999999999999999999888863211 11110 001112223567899999988777888899999999999999
Q ss_pred HhCCCCCCCCc-hhHHHHHHHHHhcCccccccCcccCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHh
Q 005940 551 ATGRRPIGSGD-LLLVEWVRECHQLGRILDVADPLLNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYL 621 (668)
Q Consensus 551 ltG~~p~~~~~-~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L 621 (668)
.-+..--...+ ....+ +... .-+...-+++-+ .....|.+. |..||+|++++.|.
T Consensus 276 ailEiq~tnseS~~~~e---e~ia-~~i~~len~lqr------------~~i~kcl~~eP~~rp~ar~llfHp 332 (458)
T KOG1266|consen 276 AILEIQSTNSESKVEVE---ENIA-NVIIGLENGLQR------------GSITKCLEGEPNGRPDARLLLFHP 332 (458)
T ss_pred HHheeccCCCcceeehh---hhhh-hheeeccCcccc------------CcCcccccCCCCCCcchhhhhcCc
Confidence 88775422211 11111 0000 011111122211 122368887 99999999988764
|
|
| >PF03388 Lectin_leg-like: Legume-like lectin family; InterPro: IPR005052 Lectins are structurally diverse proteins that bind to specific carbohydrates | Back alignment and domain information |
|---|
Probab=99.42 E-value=7.5e-12 Score=125.03 Aligned_cols=198 Identities=24% Similarity=0.307 Sum_probs=119.9
Q ss_pred CCeEEeCceeeCCCCcEEccCCCCceEEEEEeeCceecccCCCCCCCCeeeeEEEEEEEEeCCCCCCCCCceEEEEcCCC
Q 005940 40 TNLSLQGAEIIKPSGALKLTNRSRYVIGHAFYVKPIQMFDTSASPSPNASSFSTTFVFEISTPRSGRGGHGLAFLLAPST 119 (668)
Q Consensus 40 ~~l~~~g~a~~~~~~~~~lt~~~~~~~G~~~y~~p~~l~~~~~~~~~~~~sF~t~F~f~i~~~~~~~~g~GlaF~l~p~~ 119 (668)
.+-.+.|+|.+. ++.|+||++.+++.|.++.+.|++. + +|+.+|+|.|........||||||+++...
T Consensus 22 ~~W~~~G~t~i~-~~~IrLTp~~~~~~G~iws~~~~~~-~----------~w~i~~~Fri~g~~~~~~g~G~a~W~t~~~ 89 (229)
T PF03388_consen 22 PNWDIGGSTVIT-DNFIRLTPDRQSQSGSIWSRKPIPF-D----------NWEIEFTFRISGQEKGLGGDGMAFWYTKDP 89 (229)
T ss_dssp TTEEEEET-EEE-SSEEEEE-SSTTEEEEEEESS-BEE-S----------EEEEEEEEEEESS-SSS-S-EEEEEEESSS
T ss_pred CCEEECCeEEec-CCEEEECCCcccCEEEEEEcCCCCc-c----------CEEEEEEEEEeccccCcCCCeEEEEEEcCc
Confidence 368999999997 8899999999999999999999997 3 599999999998855678999999999755
Q ss_pred CCCCCCCCCcccccccCCCCCCCccEEEEEeecccCCCCCCCCCCCeeeeecCCcccccccCCccccCCCCC-c--cccc
Q 005940 120 KLPGAQPEHYLGILNSTNNGEPSNHILIVEFDTVNGFNDKAENQGNHVGIGINTMFSNRSEPASYYINGTDH-K--EEMT 196 (668)
Q Consensus 120 ~~~~~~~~~~lGl~~~~~~~~~~~~~~aVEfDt~~n~~d~~~~~~~Hvgid~~s~~s~~~~~~~~~~~~~~~-~--~~~~ 196 (668)
. ..|..+|..+. -.=+||=||||.|...+..-....|.+-+|. -+.......++... . ....
T Consensus 90 ~----~~G~~fG~~~~-------f~Gl~i~idt~~N~~~~~~~~~p~i~~~~ND----Gt~~~~~~~dg~~~~~~~C~~~ 154 (229)
T PF03388_consen 90 G----SDGPVFGGPDK-------FDGLGIFIDTYDNDEGGHKRGFPYISAMLND----GTKSYDHDNDGKDQSLGSCSAD 154 (229)
T ss_dssp S----SSCSBTTB-SS--------EEEEEEEEES-TTCTTCTSTSSEEEEEEEE----SSS---GGGTTTTT-SEEEE--
T ss_pred c----ccccccCCCcc-------cceEEEEEEcccCCCcccccccceEEEEecC----CCccccccccCcccccccceec
Confidence 3 24555665322 1236999999988221000112344333322 22222111121110 1 1122
Q ss_pred c-CCCCcEEEEEEEeCCcceEEEEEEeCCCCCCCCcceeeeeccccccccceeeeeecccCCcccceeeecc
Q 005940 197 L-ESGEPIQAWIEYDGEQKVLNVTISPAEIGKPMRPLISFGVNLTGYIKETMYVGFSASTGEKSSSHYILGW 267 (668)
Q Consensus 197 l-~~g~~~~~~I~Y~~~~~~l~V~~~~~~~~~p~~~~ls~~~dLs~~l~~~~~vGFsastG~~~~~~~i~~w 267 (668)
. +.+.+.+++|.|... .+.|.+...-......-..+..++ .-.||+..|+||||+||...+.|.|++-
T Consensus 155 ~rn~~~p~~~ri~Y~~~--~l~v~id~~~~~~~~~~~~Cf~~~-~v~LP~~~yfGvSA~Tg~~~d~hdi~s~ 223 (229)
T PF03388_consen 155 YRNSDVPTRIRISYSKN--TLTVSIDSNYLKNQDDWELCFTTD-GVDLPEGYYFGVSAATGELSDNHDILSV 223 (229)
T ss_dssp -BTESSEEEEEEEEETT--EEEEEEETSCCSECCTTEEEEEES-TEEGGSSBEEEEEEEESSSGGEEEEEEE
T ss_pred cCcCCCCEEEEEEEECC--eEEEEEecccccCCcCCcEEEEcC-CeecCCCCEEEEEecCCCCCCcEEEEEE
Confidence 2 246678999999875 566666522100011112333332 1237888999999999999999999875
|
This family includes the VIP36 and ERGIC-53 lectins. These two proteins were the first members of the family of animal lectins similar to the leguminous plant lectins []. The alignment for this family is towards the N terminus, where the similarity of VIP36 and ERGIC-53 is greatest. Although they have been identified as a family of animal lectins, this alignment also includes yeast sequences[]. ERGIC-53 is a 53kDa protein, localised to the intermediate region between the endoplasmic reticulum and the Golgi apparatus (ER-Golgi-Intermediate Compartment, ERGIC). It was identified as a calcium-dependent, mannose-specific lectin []. Its dysfunction has been associated with combined factors V and VIII deficiency, suggesting an important and substrate-specific role for ERGIC-53 in the glycoprotein-secreting pathway [,]. The L-type lectin-like domain has an overall globular shape composed of a beta-sandwich of two major twisted antiparallel beta-sheets. The beta-sandwich comprises a major concave beta-sheet and a minor convex beta-sheet, in a variation of the jelly roll fold [, , , ]. ; GO: 0016020 membrane; PDB: 3A4U_A 3LCP_B 2A6Z_A 2A71_C 2A70_B 2A6Y_A 2A6X_A 2A6W_B 2A6V_B 2E6V_B .... |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.40 E-value=2.9e-14 Score=161.03 Aligned_cols=204 Identities=29% Similarity=0.377 Sum_probs=163.7
Q ss_pred cCcccceeeeecCcEEEEEEEeCC-CCcEEEEEEEecCC--chhHHHHHHHHHHHhccc-ccCceeEeeeecccCceEEE
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPT-TGGEVAVKKITRNS--LQGMREFAAEIESLGRLR-HKNLVNLHGWCKQKNDLLLV 428 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~-~~~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~lV 428 (668)
..|...+.||+|.++.|-...... ....+|+|.+.... .........|..+-..+. |+|++.+++...+....+++
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~ 99 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS 99 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence 456777889999999998877633 34457777765543 223334445777777786 99999999999999999999
Q ss_pred EEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhh-hccCCceEecCCCCCCEEECCCC-CEEEEeecCceec
Q 005940 429 YEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLH-EEWEQVVIHRDVKPSNALIDAEM-NARLGDFGLARLY 506 (668)
Q Consensus 429 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH-~~~~~~ivHrDLkp~NIll~~~~-~~kl~DfGla~~~ 506 (668)
.||..++++.+.+.. ......+....-..+.|+..++.|+| . .++.|||+||+|.+++..+ ..++.|||+|..+
T Consensus 100 ~~~s~g~~~f~~i~~-~~~~~~~~~~~~~~~~ql~s~l~~~H~~---~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~ 175 (601)
T KOG0590|consen 100 LSYSDGGSLFSKISH-PDSTGTSSSSASRYLPQLNSGLSYLHPE---NGVTHRDIKPSNSLLDESGSALKIADFGLATAY 175 (601)
T ss_pred cCccccccccccccc-CCccCCCCcchhhhhhhhccCccccCcc---cccccCCCCCccchhccCCCcccCCCchhhccc
Confidence 999999999888831 12224556667778999999999999 6 9999999999999999999 9999999999877
Q ss_pred cC--CCCCccccccc-CCcccCcccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 005940 507 DH--GGMPHTTNVVG-TFGYIAPELTQTG-KASTSSDVFAYGILLLEVATGRRPIGSG 560 (668)
Q Consensus 507 ~~--~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~~sDV~S~Gvvl~elltG~~p~~~~ 560 (668)
.. +........+| ++.|+|||...+. ...+..|+||.|+++.-+++|..|++..
T Consensus 176 ~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~ 233 (601)
T KOG0590|consen 176 RNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFP 233 (601)
T ss_pred cccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccc
Confidence 66 33333445678 9999999998774 4578899999999999999999998643
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.40 E-value=1.6e-12 Score=142.56 Aligned_cols=142 Identities=19% Similarity=0.237 Sum_probs=101.0
Q ss_pred ceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCchhH----------------------------------------HHH
Q 005940 358 SEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGM----------------------------------------REF 397 (668)
Q Consensus 358 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~----------------------------------------~~f 397 (668)
.+.||.|++|.||+|+++ +|+.||||+......+.. -+|
T Consensus 122 ~~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf 200 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDL 200 (437)
T ss_pred CcceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCH
Confidence 467999999999999985 689999999865421110 024
Q ss_pred HHHHHHHhccc----ccCceeEeeee-cccCceEEEEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHH-HHHHhhh
Q 005940 398 AAEIESLGRLR----HKNLVNLHGWC-KQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIAS-GLLYLHE 471 (668)
Q Consensus 398 ~~Ei~~l~~l~----H~nIv~l~g~~-~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~-gL~yLH~ 471 (668)
..|.+.+.+++ |.+-+.+-..+ ......+|||||+++++|.++......+ . .+.+++.+++. .+..+|.
T Consensus 201 ~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~--~---~~~~ia~~~~~~~l~ql~~ 275 (437)
T TIGR01982 201 RREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAG--L---DRKALAENLARSFLNQVLR 275 (437)
T ss_pred HHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcC--C---CHHHHHHHHHHHHHHHHHh
Confidence 55666666553 33333332222 2334579999999999998876421111 1 34566777766 4678887
Q ss_pred ccCCceEecCCCCCCEEECCCCCEEEEeecCceeccC
Q 005940 472 EWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDH 508 (668)
Q Consensus 472 ~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~ 508 (668)
.+++|+|+||.||+++.++++++.|||++..+..
T Consensus 276 ---~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 276 ---DGFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred ---CCceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 9999999999999999999999999999986653
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.27 E-value=3.2e-11 Score=131.86 Aligned_cols=170 Identities=21% Similarity=0.260 Sum_probs=131.7
Q ss_pred EEEeCCCCcEEEEEEEecCCchhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEEecCCCChhhhhcCCCCCCCc
Q 005940 371 KGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVL 450 (668)
Q Consensus 371 ~~~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l 450 (668)
.|..+.++.+|.|+..............+-++.|+.||||||+++++....++..|||+|-+. .|..++.. +
T Consensus 30 ~~t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~------l 101 (690)
T KOG1243|consen 30 DGTRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE------L 101 (690)
T ss_pred ccceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH------h
Confidence 466677899999999987766444556778899999999999999999999999999999874 56767742 2
Q ss_pred cHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCCCCcccccccCCcccCccccc
Q 005940 451 DWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPELTQ 530 (668)
Q Consensus 451 ~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~ 530 (668)
......-.+.||+.||.|||+ +.+++|+||.-..|++++.|+.||++|.++...+.... ......--..|..|+.+.
T Consensus 102 ~~~~v~~Gl~qIl~AL~FL~~--d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~ 178 (690)
T KOG1243|consen 102 GKEEVCLGLFQILAALSFLND--DCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEID 178 (690)
T ss_pred HHHHHHHHHHHHHHHHHHHhc--cCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcC
Confidence 344555678999999999997 48999999999999999999999999998875443221 111112233566776543
Q ss_pred CCCCCcchhHHHHHHHHHHHHhC
Q 005940 531 TGKASTSSDVFAYGILLLEVATG 553 (668)
Q Consensus 531 ~~~~~~~sDV~S~Gvvl~elltG 553 (668)
... -..|.|-|||+++|++.|
T Consensus 179 ~s~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 179 PSE--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred ccc--cchhhhhHHHHHHHHhCc
Confidence 222 456999999999999999
|
|
| >KOG3839 consensus Lectin VIP36, involved in the transport of glycoproteins carrying high mannose-type glycans [Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=99.27 E-value=2e-10 Score=114.74 Aligned_cols=193 Identities=22% Similarity=0.264 Sum_probs=132.6
Q ss_pred CCCeEEeCceeeCCCCcEEccCCCCceEEEEEeeCceecccCCCCCCCCeeeeEEEEEEEEeCCCCCCCCCceEEEEcCC
Q 005940 39 ATNLSLQGAEIIKPSGALKLTNRSRYVIGHAFYVKPIQMFDTSASPSPNASSFSTTFVFEISTPRSGRGGHGLAFLLAPS 118 (668)
Q Consensus 39 ~~~l~~~g~a~~~~~~~~~lt~~~~~~~G~~~y~~p~~l~~~~~~~~~~~~sF~t~F~f~i~~~~~~~~g~GlaF~l~p~ 118 (668)
..+-.+.|.+.+. ..-|+||.+.+++.|.++-.+||...+ |...+.|.+..+.....|||||++.+-.
T Consensus 71 ~~~W~~~Gstvv~-~~~irLT~d~qsk~GAv~n~~Pv~s~~-----------wev~v~fkv~~~s~~lfgdG~Aiw~t~E 138 (351)
T KOG3839|consen 71 QPNWNLSGSTVVT-SNYIRLTPDEQSKSGAVWNRQPVFSRD-----------WEVLVHFKVHGQSKNLFGDGMAIWYTKE 138 (351)
T ss_pred ccCccccccEEEE-eeeeeccccccccccccccCCCccccc-----------eeEEEEEEEecCCCcccccceEEEeecc
Confidence 4677899999997 667999999999999999999998655 9999999999998899999999999977
Q ss_pred CCCCCCCCCCcccccccCCCCCCCccEEEEEeecccCCCCCCCCCCCeeeeecCCcccccccCCccccCCC-------CC
Q 005940 119 TKLPGAQPEHYLGILNSTNNGEPSNHILIVEFDTVNGFNDKAENQGNHVGIGINTMFSNRSEPASYYINGT-------DH 191 (668)
Q Consensus 119 ~~~~~~~~~~~lGl~~~~~~~~~~~~~~aVEfDt~~n~~d~~~~~~~Hvgid~~s~~s~~~~~~~~~~~~~-------~~ 191 (668)
+.. +|..+|-+.. -+.+||-.|||-|-.. | ..||=--+..|++. -+++|+-+.+ ++
T Consensus 139 r~q----~GPvFG~~dk-------F~GL~vfidtY~n~~g---~-~~~v~P~isvmv~~--gs~sYD~~~Dg~~tel~gc 201 (351)
T KOG3839|consen 139 RAQ----PGPVFGSKDK-------FTGLAVFIDTYGNHNG---P-HEHVFPYISVMVNI--GSLSYDHSKDGTHTELAGC 201 (351)
T ss_pred ccc----CCCCCCCccc-------ceeEEEEEeccCCcCC---C-cccceeeEEEEecc--CCcccccCCCCCccccccc
Confidence 643 4556666332 2347999999977211 1 23441111111111 1223332222 21
Q ss_pred ccccccCCCC-cEEEEEEEeCCcceEEEEEEeCCCCCCCCcceeeeeccccc-cccceeeeeecccCCcccceeeecccc
Q 005940 192 KEEMTLESGE-PIQAWIEYDGEQKVLNVTISPAEIGKPMRPLISFGVNLTGY-IKETMYVGFSASTGEKSSSHYILGWSF 269 (668)
Q Consensus 192 ~~~~~l~~g~-~~~~~I~Y~~~~~~l~V~~~~~~~~~p~~~~ls~~~dLs~~-l~~~~~vGFsastG~~~~~~~i~~w~F 269 (668)
...+ ++.. ....-|.|+. ++|++.....+ | ......+++..+ ||.--|+|+||+||..++.|.|.+-.+
T Consensus 202 ~a~~--rn~~~dt~~~iry~~--~~l~~~~dl~~---~--~~~~~c~~~n~v~lp~g~~fg~SasTGdlSd~HdivS~kl 272 (351)
T KOG3839|consen 202 TANF--RNLPHDTLVVIRYEK--KTLSISIDLEG---P--NEWIDCFSLNNVELPLGYFFGVSASTGDLSDSHDIVSLKL 272 (351)
T ss_pred eeee--ccCCCcceeEEEecC--CceEEEEecCC---C--ceeeeeeeecceecccceEEeeeeccCccchhhHHHHhhh
Confidence 1111 2221 2456689987 77777776544 1 124556788776 778899999999999999999988754
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.26 E-value=8e-12 Score=138.67 Aligned_cols=145 Identities=16% Similarity=0.206 Sum_probs=95.6
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCchh------------------------------H----H---
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQG------------------------------M----R--- 395 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~------------------------------~----~--- 395 (668)
..|+. +.||+|++|+||+|+++++|+.||||+.++...+. . +
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 35665 78999999999999998779999999997542110 0 1
Q ss_pred ---HHHHHHHHHhccc----ccCceeEeeeec-ccCceEEEEEecCCCChhhhhcCCCCC---CCccHHHHHHHHHHHHH
Q 005940 396 ---EFAAEIESLGRLR----HKNLVNLHGWCK-QKNDLLLVYEYIPNGSLDTLLFKPKDG---SVLDWEQRFNIVKGIAS 464 (668)
Q Consensus 396 ---~f~~Ei~~l~~l~----H~nIv~l~g~~~-~~~~~~lV~E~~~~gsL~~~l~~~~~~---~~l~~~~~~~i~~qia~ 464 (668)
+|..|+..+.+++ +.+.+.+-..+. .....+|||||++|+.+.++-.....+ ..+.......++.|+
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi-- 276 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV-- 276 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH--
Confidence 2444555555543 333333322222 234578999999999998753111111 123323333333333
Q ss_pred HHHHhhhccCCceEecCCCCCCEEECCCC----CEEEEeecCceeccC
Q 005940 465 GLLYLHEEWEQVVIHRDVKPSNALIDAEM----NARLGDFGLARLYDH 508 (668)
Q Consensus 465 gL~yLH~~~~~~ivHrDLkp~NIll~~~~----~~kl~DfGla~~~~~ 508 (668)
.. .+++|+|+||.||+++.++ ++++.|||++..++.
T Consensus 277 -----f~---~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 277 -----FR---DGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred -----Hh---CCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 23 8999999999999999988 999999999987754
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.26 E-value=2.7e-11 Score=115.41 Aligned_cols=130 Identities=20% Similarity=0.110 Sum_probs=96.4
Q ss_pred ceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCchhHHHHHHHHHHHhcccccCce-eEeeeecccCceEEEEEecCCCC
Q 005940 358 SEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLV-NLHGWCKQKNDLLLVYEYIPNGS 436 (668)
Q Consensus 358 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv-~l~g~~~~~~~~~lV~E~~~~gs 436 (668)
.+.|+.|..+.||+++. .++.+++|....... ....+..|+++++.+.+.+++ +++.+.. ...++||||+++.+
T Consensus 3 ~~~l~~G~~~~vy~~~~--~~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~ 77 (170)
T cd05151 3 ISPLKGGMTNKNYRVEV--ANKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSE 77 (170)
T ss_pred eeecCCcccCceEEEEE--CCeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCc
Confidence 46789999999999987 477899998765432 123467899999998765554 4554433 34589999999988
Q ss_pred hhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhcc--CCceEecCCCCCCEEECCCCCEEEEeecCce
Q 005940 437 LDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEW--EQVVIHRDVKPSNALIDAEMNARLGDFGLAR 504 (668)
Q Consensus 437 L~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~--~~~ivHrDLkp~NIll~~~~~~kl~DfGla~ 504 (668)
+.... .....++.+++++|+.||... ..+++|+|++|.||+++ ++.+++.||+.+.
T Consensus 78 l~~~~-----------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 78 LLTED-----------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred ccccc-----------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 75431 112345688999999999821 12369999999999999 6689999999875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.21 E-value=7.9e-12 Score=135.45 Aligned_cols=199 Identities=26% Similarity=0.317 Sum_probs=158.1
Q ss_pred Ccccceeeee--cCcEEEEEEEe--CCCCcEEEEEEEecC--CchhHHHHHHHHHHHhccc-ccCceeEeeeecccCceE
Q 005940 354 GFKESEVIGI--GGFGSVYKGVL--PTTGGEVAVKKITRN--SLQGMREFAAEIESLGRLR-HKNLVNLHGWCKQKNDLL 426 (668)
Q Consensus 354 ~f~~~~~lG~--G~~g~Vy~~~~--~~~~~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~ 426 (668)
.|.....+|. |.+|.||.+.. ..++..+|+|+-... .......=.+|+...++++ |+|.++....+...+..+
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf 194 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF 194 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence 4666788999 99999999988 788889999983322 1122222235666666664 999999888888999999
Q ss_pred EEEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHH----HHHHhhhccCCceEecCCCCCCEEECCC-CCEEEEeec
Q 005940 427 LVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIAS----GLLYLHEEWEQVVIHRDVKPSNALIDAE-MNARLGDFG 501 (668)
Q Consensus 427 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~----gL~yLH~~~~~~ivHrDLkp~NIll~~~-~~~kl~DfG 501 (668)
+-.|++. .+|..+.+ .....++....+....+..+ ||..+|+ ..++|-|+||.||++..+ ...+++|||
T Consensus 195 iqtE~~~-~sl~~~~~--~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs---~~~~~~~~kp~~i~~~~~~~s~~~~df~ 268 (524)
T KOG0601|consen 195 IQTELCG-ESLQSYCH--TPCNFLPDNLLWNSLRDWLSRDVTALSHLHS---NNIVHDDLKPANIFTTSDWTSCKLTDFG 268 (524)
T ss_pred eeecccc-chhHHhhh--cccccCCchhhhhHHhhhhhcccccccccCC---CcccccccchhheecccccceeecCCcc
Confidence 9999884 78887774 23445777888888888888 9999999 999999999999999999 889999999
Q ss_pred CceeccCCCCCc----ccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 005940 502 LARLYDHGGMPH----TTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGS 559 (668)
Q Consensus 502 la~~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~ 559 (668)
+...+..+.... .....|...|++||..+ +.++..+|+|++|.+++|..++......
T Consensus 269 ~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~ 329 (524)
T KOG0601|consen 269 LVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSV 329 (524)
T ss_pred eeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccC
Confidence 999877654321 22336778899999875 5789999999999999999998876643
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.16 E-value=4.8e-10 Score=108.62 Aligned_cols=138 Identities=18% Similarity=0.134 Sum_probs=100.7
Q ss_pred eeeeecCcEEEEEEEeCC------CCcEEEEEEEecCCc----------------------hhHHHH----HHHHHHHhc
Q 005940 359 EVIGIGGFGSVYKGVLPT------TGGEVAVKKITRNSL----------------------QGMREF----AAEIESLGR 406 (668)
Q Consensus 359 ~~lG~G~~g~Vy~~~~~~------~~~~vavK~~~~~~~----------------------~~~~~f----~~Ei~~l~~ 406 (668)
..||.|--+.||.|...+ .+..+|||+.+.... ...+.+ .+|++.|.+
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 568999999999998643 247999998742110 011223 389999999
Q ss_pred ccc--cCceeEeeeecccCceEEEEEecCCCChhh-hhcCCCCCCCccHHHHHHHHHHHHHHHHHh-hhccCCceEecCC
Q 005940 407 LRH--KNLVNLHGWCKQKNDLLLVYEYIPNGSLDT-LLFKPKDGSVLDWEQRFNIVKGIASGLLYL-HEEWEQVVIHRDV 482 (668)
Q Consensus 407 l~H--~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~-~l~~~~~~~~l~~~~~~~i~~qia~gL~yL-H~~~~~~ivHrDL 482 (668)
+.. -++.+++++ ..-+|||||+.++.+.. .+. ...++..+...+..+++.+|..| |. .+++||||
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lk----d~~~~~~~~~~i~~~i~~~l~~l~H~---~glVHGDL 151 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLK----DAKLNDEEMKNAYYQVLSMMKQLYKE---CNLVHADL 151 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhh----ccccCHHHHHHHHHHHHHHHHHHHHh---CCeecCCC
Confidence 863 466677764 45689999997654422 221 12244556677889999999999 77 89999999
Q ss_pred CCCCEEECCCCCEEEEeecCceeccC
Q 005940 483 KPSNALIDAEMNARLGDFGLARLYDH 508 (668)
Q Consensus 483 kp~NIll~~~~~~kl~DfGla~~~~~ 508 (668)
++.||+++ ++.++|+|||.+...++
T Consensus 152 s~~NIL~~-~~~v~iIDF~qav~~~h 176 (197)
T cd05146 152 SEYNMLWH-DGKVWFIDVSQSVEPTH 176 (197)
T ss_pred CHHHEEEE-CCcEEEEECCCceeCCC
Confidence 99999997 46799999999987665
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.09 E-value=1e-09 Score=109.25 Aligned_cols=143 Identities=20% Similarity=0.242 Sum_probs=112.0
Q ss_pred ceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCc-hhHHHHHHHHHHHhcccc--cCceeEeeeecccC---ceEEEEEe
Q 005940 358 SEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSL-QGMREFAAEIESLGRLRH--KNLVNLHGWCKQKN---DLLLVYEY 431 (668)
Q Consensus 358 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~f~~Ei~~l~~l~H--~nIv~l~g~~~~~~---~~~lV~E~ 431 (668)
.+.|+.|..+.||+++.. +|+.+++|+...... ....++..|+++++.+++ .++.+++.++.... ..++||||
T Consensus 3 ~~~l~~G~~n~~~~v~~~-~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~ 81 (223)
T cd05154 3 VRQLSGGQSNLTYLLTAG-GGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMER 81 (223)
T ss_pred ceecCCCccceEEEEEec-CCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEE
Confidence 467899999999999884 357899998765432 234578899999999976 44677888876643 56899999
Q ss_pred cCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhc---------------------------------------
Q 005940 432 IPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEE--------------------------------------- 472 (668)
Q Consensus 432 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~--------------------------------------- 472 (668)
+++.++.+.+.. ..++..++..++.+++++|..||+.
T Consensus 82 i~G~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (223)
T cd05154 82 VDGRVLRDRLLR----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAM 157 (223)
T ss_pred eCCEecCCCCCC----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHH
Confidence 999988776531 3467788888999999999999852
Q ss_pred --------------cCCceEecCCCCCCEEECC--CCCEEEEeecCcee
Q 005940 473 --------------WEQVVIHRDVKPSNALIDA--EMNARLGDFGLARL 505 (668)
Q Consensus 473 --------------~~~~ivHrDLkp~NIll~~--~~~~kl~DfGla~~ 505 (668)
....++|+|++|.||+++. +..+.|.||+.+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 158 ERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 1256899999999999998 56689999998763
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.02 E-value=3e-09 Score=99.77 Aligned_cols=131 Identities=21% Similarity=0.266 Sum_probs=103.1
Q ss_pred eeeeecCcEEEEEEEeCCCCcEEEEEEEecCCc------h--hHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEE
Q 005940 359 EVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSL------Q--GMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYE 430 (668)
Q Consensus 359 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------~--~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 430 (668)
..+++|+-+.+|.+.+ -|.++++|.-.++.. + ..+.-..|++++.+++--.|....-+..+.....++||
T Consensus 2 ~~i~~GAEa~i~~~~~--~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me 79 (204)
T COG3642 2 DLIKQGAEAIIYLTDF--LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVME 79 (204)
T ss_pred chhhCCcceeEEeeec--cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEE
Confidence 3578999999999977 355677775433221 1 12356789999999987666666666667788899999
Q ss_pred ecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCcee
Q 005940 431 YIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARL 505 (668)
Q Consensus 431 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~ 505 (668)
|+++..|.+.+... +..++..+-.-+.-||. .+|+|+||.++||++.... +.+.|||++..
T Consensus 80 ~I~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~---~givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 80 YIEGELLKDALEEA----------RPDLLREVGRLVGKLHK---AGIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred EeCChhHHHHHHhc----------chHHHHHHHHHHHHHHh---cCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 99999999888532 36678888899999998 9999999999999997765 99999999874
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.00 E-value=4.1e-09 Score=112.06 Aligned_cols=169 Identities=21% Similarity=0.327 Sum_probs=132.9
Q ss_pred cEEEEEEEeCCCCcEEEEEEEecCCchhHHHHHHHHHHHhcccccCceeEeeeec----ccCceEEEEEecCC-CChhhh
Q 005940 366 FGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNLHGWCK----QKNDLLLVYEYIPN-GSLDTL 440 (668)
Q Consensus 366 ~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~----~~~~~~lV~E~~~~-gsL~~~ 440 (668)
-.+.||+....+|..|++|++.....+....-..-+++++++.|.|+|++...+. ....+++||+|.|+ ++|.++
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence 4679999999999999999995444443334445688999999999999999876 33468999999986 677766
Q ss_pred hcCCC------------CCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccC
Q 005940 441 LFKPK------------DGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDH 508 (668)
Q Consensus 441 l~~~~------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~ 508 (668)
-+... .+...++..+|.++.|+..||.++|+ .|...+-|.+++|+++.+.+++|..+|.......
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHs---sGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHS---SGLACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHh---cCceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 54321 23457889999999999999999999 9999999999999999999999999998776654
Q ss_pred CCCCcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCC
Q 005940 509 GGMPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRR 555 (668)
Q Consensus 509 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~ 555 (668)
+.. |-+ .--.+-|.=.||.+++.|.||..
T Consensus 446 d~~---------------~~l---e~~Qq~D~~~lG~ll~aLAt~~~ 474 (655)
T KOG3741|consen 446 DPT---------------EPL---ESQQQNDLRDLGLLLLALATGTE 474 (655)
T ss_pred CCC---------------cch---hHHhhhhHHHHHHHHHHHhhccc
Confidence 431 111 11245688899999999999953
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.98 E-value=6.5e-09 Score=97.04 Aligned_cols=143 Identities=20% Similarity=0.246 Sum_probs=106.9
Q ss_pred cceeeeecCcEEEEEEEeCCCCcEEEEEEEecCC--------chhHHHHHHHHHHHhcccccCceeEeeeecccCceEEE
Q 005940 357 ESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNS--------LQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLV 428 (668)
Q Consensus 357 ~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--------~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV 428 (668)
....|-+|+-+.|+++.+ .|+..+||.-..+. .-..+...+|++.+.+++--.|.-..-++.+...-.|+
T Consensus 11 ~l~likQGAEArv~~~~~--~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ 88 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF--SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIY 88 (229)
T ss_pred cceeeeccceeeEeeecc--CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEE
Confidence 567899999999999998 57888888532221 11345678999999999865665555566666677899
Q ss_pred EEecCC-CChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCC---EEEEeecCce
Q 005940 429 YEYIPN-GSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMN---ARLGDFGLAR 504 (668)
Q Consensus 429 ~E~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~---~kl~DfGla~ 504 (668)
|||+++ .++.+++....... -.......++.+|-+.+.-||. ..|+||||..+||+|..++. +.+.|||++.
T Consensus 89 ME~~~g~~~vk~~i~~~~~~~-~~d~~~~~~~~~iG~~igklH~---ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~ 164 (229)
T KOG3087|consen 89 MEFIDGASTVKDFILSTMEDE-SEDEGLAELARRIGELIGKLHD---NDIIHGDLTTSNILLRSDGNQITPILIDFGLSS 164 (229)
T ss_pred EEeccchhHHHHHHHHHccCc-ccchhHHHHHHHHHHHHHHhhh---CCeecccccccceEEecCCCcCceEEEeecchh
Confidence 999976 47777775322221 2223336889999999999999 99999999999999976643 5899999986
Q ss_pred e
Q 005940 505 L 505 (668)
Q Consensus 505 ~ 505 (668)
.
T Consensus 165 ~ 165 (229)
T KOG3087|consen 165 V 165 (229)
T ss_pred c
Confidence 4
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.97 E-value=4.8e-10 Score=121.71 Aligned_cols=195 Identities=23% Similarity=0.242 Sum_probs=146.5
Q ss_pred hcCcccceeeeecCcEEEEEEEeC-CCCcEEEEEEEecCCchhHHHH--HHHHHHHhcc-cccCceeEeeeecccCceEE
Q 005940 352 TKGFKESEVIGIGGFGSVYKGVLP-TTGGEVAVKKITRNSLQGMREF--AAEIESLGRL-RHKNLVNLHGWCKQKNDLLL 427 (668)
Q Consensus 352 t~~f~~~~~lG~G~~g~Vy~~~~~-~~~~~vavK~~~~~~~~~~~~f--~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~l 427 (668)
+.+|..+..||.|.|+.|++.... .++..|++|.+.+.......+. ..|+.+...+ .|.+++....-+......|+
T Consensus 264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~i 343 (524)
T KOG0601|consen 264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYI 343 (524)
T ss_pred cCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccC
Confidence 457888999999999999998765 6778899998876544333222 3455555555 48888887666666666778
Q ss_pred EEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCC-CCEEEEeecCceec
Q 005940 428 VYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAE-MNARLGDFGLARLY 506 (668)
Q Consensus 428 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~-~~~kl~DfGla~~~ 506 (668)
=-|||+++++...+ .....+....++++..|++.++.++|+ ..++|+|+||+||++..+ +..+++|||++..+
T Consensus 344 p~e~~~~~s~~l~~---~~~~~~d~~~~~~~~~q~~~~l~~i~s---~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~ 417 (524)
T KOG0601|consen 344 PLEFCEGGSSSLRS---VTSQMLDEDPRLRLTAQILTALNVIHS---KLFVHLDVKPSNILISNDGFFSKLGDFGCWTRL 417 (524)
T ss_pred chhhhcCcchhhhh---HHHHhcCcchhhhhHHHHHhccccccc---hhhhcccccccceeeccchhhhhcccccccccc
Confidence 89999999887665 223457788899999999999999998 999999999999999886 88999999998642
Q ss_pred cCCCCCcccccccCCccc--CcccccCCCCCcchhHHHHHHHHHHHHhCCCC
Q 005940 507 DHGGMPHTTNVVGTFGYI--APELTQTGKASTSSDVFAYGILLLEVATGRRP 556 (668)
Q Consensus 507 ~~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p 556 (668)
.-. .......-+++ +|+......+-.+.|++|||.-+.|.+++..-
T Consensus 418 ~~~----~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~l 465 (524)
T KOG0601|consen 418 AFS----SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPL 465 (524)
T ss_pred cee----cccccccccccccchhhccccccccccccccccccccccccCccc
Confidence 211 11112233444 45555556678899999999999999998754
|
|
| >KOG3838 consensus Mannose lectin ERGIC-53, involved in glycoprotein traffic [Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=98.82 E-value=2.1e-07 Score=94.71 Aligned_cols=189 Identities=23% Similarity=0.343 Sum_probs=123.1
Q ss_pred eEEeCceeeCCCCcEEccCCCCceEEEEEeeCceecccCCCCCCCCeeeeEEEEEEEEeCCCCCCCCCceEEEEcCCCCC
Q 005940 42 LSLQGAEIIKPSGALKLTNRSRYVIGHAFYVKPIQMFDTSASPSPNASSFSTTFVFEISTPRSGRGGHGLAFLLAPSTKL 121 (668)
Q Consensus 42 l~~~g~a~~~~~~~~~lt~~~~~~~G~~~y~~p~~l~~~~~~~~~~~~sF~t~F~f~i~~~~~~~~g~GlaF~l~p~~~~ 121 (668)
-...|||... ...|+|+++-.++.|-+|-+.-+++-. |..+-+|.|+.. ...++||||++-+....
T Consensus 56 W~~~GdAIas-~eqvRlaPSmrsrkGavWtka~~~fe~-----------weVev~~rVtGr-GRiGAdGlaiWYt~~~G- 121 (497)
T KOG3838|consen 56 WSHHGDAIAS-SEQVRLAPSMRSRKGAVWTKASVPFEN-----------WEVEVQFRVTGR-GRIGADGLAIWYTRGRG- 121 (497)
T ss_pred eeecCccccc-ccceeeccccccccCceeecccCCccc-----------ceEEEEEEeccc-ccccCCceEEEEecCCC-
Confidence 4668888874 678999999999999999998777644 899999999987 46789999999986542
Q ss_pred CCCCCCCcccccccCCCCCCCccEEEEEeecccCCCCCCCCCCCeeeeecCCcccccccCCccccCCCCCccc-----cc
Q 005940 122 PGAQPEHYLGILNSTNNGEPSNHILIVEFDTVNGFNDKAENQGNHVGIGINTMFSNRSEPASYYINGTDHKEE-----MT 196 (668)
Q Consensus 122 ~~~~~~~~lGl~~~~~~~~~~~~~~aVEfDt~~n~~d~~~~~~~Hvgid~~s~~s~~~~~~~~~~~~~~~~~~-----~~ 196 (668)
--|..+|-...= | =+++-||.+.| |+- -|..-|.+-.|. -+.+ |.-.+++.... .+
T Consensus 122 ---~~GpVfGg~d~W-n------GigiffDSfdn--D~q-knnP~Is~~lnd----Gt~~--ydh~~DGasQ~LssCqrD 182 (497)
T KOG3838|consen 122 ---HVGPVFGGLDSW-N------GIGIFFDSFDN--DGQ-KNNPAISVLLND----GTIP--YDHPGDGASQGLSSCQRD 182 (497)
T ss_pred ---cccccccccccc-c------ceEEEeecccc--cCC-cCCccEEEEecC----Cccc--ccCCCccHHHHHHHhhHH
Confidence 233444442221 1 25899999988 311 233455554433 1111 11111121111 12
Q ss_pred cCC-CCcEEEEEEEeCCcceEEEEEEeCCCCCCCCcceeeeecccc-ccccceeeeeecccCCcccceeeeccc
Q 005940 197 LES-GEPIQAWIEYDGEQKVLNVTISPAEIGKPMRPLISFGVNLTG-YIKETMYVGFSASTGEKSSSHYILGWS 268 (668)
Q Consensus 197 l~~-g~~~~~~I~Y~~~~~~l~V~~~~~~~~~p~~~~ls~~~dLs~-~l~~~~~vGFsastG~~~~~~~i~~w~ 268 (668)
.+| --+.+|+|+|-. .+|.|.+...-. |..+ .-..++... .||..-|+|.||+||....-|.|++..
T Consensus 183 FRNkPyPvRarItY~~--nvLtv~innGmt--p~d~-yE~C~rve~~~lp~nGyFGvSAATGgLADDHDVl~Fl 251 (497)
T KOG3838|consen 183 FRNKPYPVRARITYYG--NVLTVMINNGMT--PSDD-YEFCVRVENLLLPPNGYFGVSAATGGLADDHDVLSFL 251 (497)
T ss_pred hccCCCCceEEEEEec--cEEEEEEcCCCC--CCCC-cceeEeccceeccCCCeeeeeecccccccccceeeeE
Confidence 222 336899999975 789998875432 3322 222333333 467899999999999999999999863
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.82 E-value=5.6e-08 Score=99.44 Aligned_cols=141 Identities=15% Similarity=0.105 Sum_probs=101.4
Q ss_pred eeeeecCcEEEEEEEeCCCCcEEEEEEEecCCch-hHH----------HHHHHHHHHhcccccCc--eeEeeeecc----
Q 005940 359 EVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQ-GMR----------EFAAEIESLGRLRHKNL--VNLHGWCKQ---- 421 (668)
Q Consensus 359 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~----------~f~~Ei~~l~~l~H~nI--v~l~g~~~~---- 421 (668)
+.+-.-....|++..+ .|+.+.||+....... ..+ .+.+|.+.+.+|...+| ++++++...
T Consensus 28 e~v~~~~~rrvvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~ 105 (268)
T PRK15123 28 EVFRELEGRRTLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNP 105 (268)
T ss_pred cEEecCCCceEEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCC
Confidence 4444444445777777 5778999987543321 111 37789999998864333 344555532
Q ss_pred -cCceEEEEEecCCC-ChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECC-------C
Q 005940 422 -KNDLLLVYEYIPNG-SLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDA-------E 492 (668)
Q Consensus 422 -~~~~~lV~E~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~-------~ 492 (668)
....+||+|++++. +|.+++.... ....+...+..++.+++..+.-||. .+|+|+|++++|||++. +
T Consensus 106 ~~~~s~LVte~l~~~~sL~~~~~~~~-~~~~~~~~~~~ll~~la~~i~~LH~---~Gi~HgDL~~~NiLl~~~~~~~~~~ 181 (268)
T PRK15123 106 ATRTSFIITEDLAPTISLEDYCADWA-TNPPDPRLKRMLIKRVATMVRDMHA---AGINHRDCYICHFLLHLPFPGREED 181 (268)
T ss_pred ccceeEEEEeeCCCCccHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHH---CcCccCCCChhhEEEeccccCCCCC
Confidence 23578999999886 8998874211 2334566778999999999999999 99999999999999975 4
Q ss_pred CCEEEEeecCcee
Q 005940 493 MNARLGDFGLARL 505 (668)
Q Consensus 493 ~~~kl~DfGla~~ 505 (668)
..+.++||+.++.
T Consensus 182 ~~~~LIDl~r~~~ 194 (268)
T PRK15123 182 LKLSVIDLHRAQI 194 (268)
T ss_pred ceEEEEECCcccc
Confidence 6799999998753
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.74 E-value=1e-07 Score=92.05 Aligned_cols=127 Identities=26% Similarity=0.291 Sum_probs=84.8
Q ss_pred EEEEEEeCCCCcEEEEEEEecCCc--------------------------hhHHHHHHHHHHHhccccc--CceeEeeee
Q 005940 368 SVYKGVLPTTGGEVAVKKITRNSL--------------------------QGMREFAAEIESLGRLRHK--NLVNLHGWC 419 (668)
Q Consensus 368 ~Vy~~~~~~~~~~vavK~~~~~~~--------------------------~~~~~f~~Ei~~l~~l~H~--nIv~l~g~~ 419 (668)
.||.|... ++..+|||+.+.... .......+|.+.|.++... ++.+++++.
T Consensus 1 ~Vy~~~~~-~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 1 DVYHAIDP-DGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEEEC-TTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred CEEEEECC-CCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 48999874 578999998743210 0112466899999999755 567777553
Q ss_pred cccCceEEEEEecC--CCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHh-hhccCCceEecCCCCCCEEECCCCCEE
Q 005940 420 KQKNDLLLVYEYIP--NGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYL-HEEWEQVVIHRDVKPSNALIDAEMNAR 496 (668)
Q Consensus 420 ~~~~~~~lV~E~~~--~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yL-H~~~~~~ivHrDLkp~NIll~~~~~~k 496 (668)
.-+|||||++ +..+..+... .++......++.+++..+..+ |. .+|+|+||.+.||+++++ .+.
T Consensus 80 ----~~~ivME~I~~~G~~~~~l~~~-----~~~~~~~~~~~~~il~~~~~~~~~---~givHGDLs~~NIlv~~~-~~~ 146 (188)
T PF01163_consen 80 ----RNVIVMEYIGEDGVPLPRLKDV-----DLSPEEPKELLEEILEEIIKMLHK---AGIVHGDLSEYNILVDDG-KVY 146 (188)
T ss_dssp ----TTEEEEE--EETTEEGGCHHHC-----GGGGSTHHHHHHHHHHHHHHHHHC---TTEEESS-STTSEEEETT-CEE
T ss_pred ----CCEEEEEecCCCccchhhHHhc-----cccchhHHHHHHHHHHHHHHHHHh---cCceecCCChhhEEeecc-eEE
Confidence 3479999998 6555544421 122456677888888866664 66 999999999999999988 999
Q ss_pred EEeecCceeccC
Q 005940 497 LGDFGLARLYDH 508 (668)
Q Consensus 497 l~DfGla~~~~~ 508 (668)
|.|||.+....+
T Consensus 147 iIDf~qav~~~~ 158 (188)
T PF01163_consen 147 IIDFGQAVDSSH 158 (188)
T ss_dssp E--GTTEEETTS
T ss_pred EEecCcceecCC
Confidence 999999876553
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >cd06900 lectin_VcfQ VcfQ bacterial pilus biogenesis protein, lectin domain | Back alignment and domain information |
|---|
Probab=98.63 E-value=4e-06 Score=81.42 Aligned_cols=203 Identities=18% Similarity=0.209 Sum_probs=116.3
Q ss_pred CCcEEccCCCCceEEEEEeeCceecccCCCCCCCCeeeeEEEEEEEEeCCCCCCCCCceEEEEcCCC-CCCCCCCCCccc
Q 005940 53 SGALKLTNRSRYVIGHAFYVKPIQMFDTSASPSPNASSFSTTFVFEISTPRSGRGGHGLAFLLAPST-KLPGAQPEHYLG 131 (668)
Q Consensus 53 ~~~~~lt~~~~~~~G~~~y~~p~~l~~~~~~~~~~~~sF~t~F~f~i~~~~~~~~g~GlaF~l~p~~-~~~~~~~~~~lG 131 (668)
+|.|+||+...+++|-+.|.+++|.-+ . -...+|.+-.=.. ...++||+||||+-.. ..-.+..|+.||
T Consensus 31 ~g~LRLT~~~~nqata~~~~~~FPs~~-----n----~v~veFd~yayg~-~g~GADGia~vLsDasv~p~~G~fGGsLG 100 (255)
T cd06900 31 NNRLRLTDASGNQATAVTLQRLFPSAG-----N----YVEVEFDYYAYGS-GGNGADGVALVLSDASVTPQAGAFGGSLG 100 (255)
T ss_pred cCeEEeccCccCcceeEEEeeeeccCC-----C----eEEEEEEEEEecC-CCCCCceEEEEEeCCCcCCcCCCcCcccc
Confidence 689999999999999999999998533 1 2677777766554 5678999999998422 222356688999
Q ss_pred ccccCC-CCCCCccEEEEEeecccCCCCCCCCCCCeeeeecCCcc---ccc-ccCCccccCCCCC-ccccccCC----CC
Q 005940 132 ILNSTN-NGEPSNHILIVEFDTVNGFNDKAENQGNHVGIGINTMF---SNR-SEPASYYINGTDH-KEEMTLES----GE 201 (668)
Q Consensus 132 l~~~~~-~~~~~~~~~aVEfDt~~n~~d~~~~~~~Hvgid~~s~~---s~~-~~~~~~~~~~~~~-~~~~~l~~----g~ 201 (668)
+..+.. ......-.++|-||-|-||....+....-.|--.+++. |-. .+...|. .++.. .+..+..+ +.
T Consensus 101 Ya~~~~~~~GfaGGwLGiGlDEyGNFsn~~eg~~~~~g~r~~sV~vRGsg~g~~gY~yl-~gt~~~~~~id~~~~~~~~~ 179 (255)
T cd06900 101 YAQRNDGVPGFAGGWLGIGLDEYGNFSNPNEGRNGFSGRRPQSVTVRGSGSGYTGYKYI-TGTGVLPPGIDNNSTSTPAP 179 (255)
T ss_pred cccccCCCCccccceEEEEEeccccccCCCCCccCCcccccceEEEECCCCCCcCceEe-cccCCCCcccccCCCCCCCC
Confidence 987652 22234568899999998853311011111122222221 111 1122221 11111 11111111 22
Q ss_pred cEEEEEEEeCC---cceEEEEEEeCCCCCCCCcceeeee---ccc--cccccceeeeeecccCCcccceeeeccc
Q 005940 202 PIQAWIEYDGE---QKVLNVTISPAEIGKPMRPLISFGV---NLT--GYIKETMYVGFSASTGEKSSSHYILGWS 268 (668)
Q Consensus 202 ~~~~~I~Y~~~---~~~l~V~~~~~~~~~p~~~~ls~~~---dLs--~~l~~~~~vGFsastG~~~~~~~i~~w~ 268 (668)
.++-+|.-|+. ...|+|.-+-..... ..+++ .++ +.+ .-+|+.++++|++|||...-.|.|..-.
T Consensus 180 ~hrY~i~Ids~~~~~~~vsV~R~~~~gg~-~~~~I-~~~d~~~~~~q~avP~~f~lS~TgSTGgstN~HEIdnf~ 252 (255)
T cd06900 180 GHRYRITIDSTNGDNAWLSVERDIGNGGA-YFVVI-LTFDALAEQNQDAIPENFYLSFTGSTGGSTNTHEIDNFQ 252 (255)
T ss_pred ceEEEEEEecCCCCceEEEEEEEccCCce-eEEee-cceeeccccCCCCCCccEEEEEEecCCCcccceeecceE
Confidence 35556666654 234555554221111 12222 222 333 4678999999999999999999886543
|
This family includes bacterial proteins homologous to the VcfQ (also known as MshQ) bacterial pilus biogenesis protein. VcfQ is encoded by the vcfQ gene of the type IV pilus gene cluster of Vibrio cholerae and is essential for type IV pilus assembly. VcfQ has a Laminin G-like domain as well as an L-type lectin domain. |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.52 E-value=2.6e-08 Score=113.87 Aligned_cols=202 Identities=24% Similarity=0.283 Sum_probs=136.2
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCc---hhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEE
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSL---QGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVY 429 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 429 (668)
..+.+.+-+-+|.++.++.+.-...+...++|....... ...+....+-.++-..++|-++...--+.-....+|++
T Consensus 804 d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~ 883 (1205)
T KOG0606|consen 804 DGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVG 883 (1205)
T ss_pred ccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhh
Confidence 445556667778888887766544454444443322111 01111112222222223454444433334456789999
Q ss_pred EecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceecc--
Q 005940 430 EYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYD-- 507 (668)
Q Consensus 430 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~-- 507 (668)
+|..+++|...|+... ..+.......+..+..++.|||. ..+.|+|++|.|++...++..++.|||......
T Consensus 884 ~~~~~~~~~Skl~~~~---~~saepaRs~i~~~vqs~e~L~s---~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~ 957 (1205)
T KOG0606|consen 884 HYLNGGDLPSKLHNSG---CLSAEPARSPILERVQSLESLHS---SLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLI 957 (1205)
T ss_pred HHhccCCchhhhhcCC---CcccccccchhHHHHhhhhcccc---chhhcccccccchhhcccCCcccCccccccccccc
Confidence 9999999999986422 34444455566678899999998 679999999999999999999999998432110
Q ss_pred -----C--------------CC---------CCcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 005940 508 -----H--------------GG---------MPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGS 559 (668)
Q Consensus 508 -----~--------------~~---------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~ 559 (668)
. .. ........||+.|.+||...+......+|.|++|++++|.++|..||..
T Consensus 958 ~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na 1037 (1205)
T KOG0606|consen 958 PPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNA 1037 (1205)
T ss_pred cCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCC
Confidence 0 00 0012235789999999999999999999999999999999999999975
Q ss_pred C
Q 005940 560 G 560 (668)
Q Consensus 560 ~ 560 (668)
.
T Consensus 1038 ~ 1038 (1205)
T KOG0606|consen 1038 E 1038 (1205)
T ss_pred c
Confidence 4
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.47 E-value=2.3e-06 Score=83.40 Aligned_cols=138 Identities=18% Similarity=0.132 Sum_probs=103.6
Q ss_pred eeecCcEEEEEEEeCCCCcEEEEEEEecCC------chhHHHHHHHHHHHhcccc--cCceeEeeeec-c----cCceEE
Q 005940 361 IGIGGFGSVYKGVLPTTGGEVAVKKITRNS------LQGMREFAAEIESLGRLRH--KNLVNLHGWCK-Q----KNDLLL 427 (668)
Q Consensus 361 lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~------~~~~~~f~~Ei~~l~~l~H--~nIv~l~g~~~-~----~~~~~l 427 (668)
-|+||-+.|++-.+ .|..+-+|+-...- .-+...|.+|+..|.+|.. -.+.++. ++. . ....+|
T Consensus 26 ~~rgG~SgV~r~~~--~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~L 102 (216)
T PRK09902 26 YRRNGMSGVQCVER--NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALL 102 (216)
T ss_pred cCCCCcceEEEEEe--CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEE
Confidence 46789999999877 45578899865211 2356789999999999963 3344454 332 1 123689
Q ss_pred EEEecCC-CChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCC--EEEEeecCce
Q 005940 428 VYEYIPN-GSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMN--ARLGDFGLAR 504 (668)
Q Consensus 428 V~E~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~--~kl~DfGla~ 504 (668)
|+|-+++ .+|.+++.. ..-...+..++..++.+|+..+.-||+ .++.|+|+-+.||+++.++. +++.||.-++
T Consensus 103 VTe~L~g~~~L~~~l~~-~~~~~~~~~~k~~il~~va~~ia~LH~---~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 103 VTEDMAGFISIADWYAQ-HAVSPYSDEVRQAMLKAVALAFKKMHS---VNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred EEEeCCCCccHHHHHhc-CCcCCcchHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence 9997754 689888843 223356778889999999999999999 99999999999999986666 9999998665
Q ss_pred e
Q 005940 505 L 505 (668)
Q Consensus 505 ~ 505 (668)
.
T Consensus 179 ~ 179 (216)
T PRK09902 179 R 179 (216)
T ss_pred h
Confidence 3
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.47 E-value=1.3e-06 Score=87.15 Aligned_cols=138 Identities=25% Similarity=0.270 Sum_probs=97.6
Q ss_pred cccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCc----------------------hhHHHHHHHHHHHhccccc--
Q 005940 355 FKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSL----------------------QGMREFAAEIESLGRLRHK-- 410 (668)
Q Consensus 355 f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----------------------~~~~~f~~Ei~~l~~l~H~-- 410 (668)
..+.++||.|--+.||.|..+ .|.++|||.-+.... -......+|.++|.+|.-.
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 455789999999999999996 689999996532211 0123456899999999754
Q ss_pred CceeEeeeecccCceEEEEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEEC
Q 005940 411 NLVNLHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALID 490 (668)
Q Consensus 411 nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~ 490 (668)
.+.+.++|-. -.+||||+++--|...- ++-...-.++..|++-+.-+-. .||+|+|+.+-||+++
T Consensus 172 ~VP~P~~~nR----HaVvMe~ieG~eL~~~r--------~~~en~~~il~~il~~~~~~~~---~GiVHGDlSefNIlV~ 236 (304)
T COG0478 172 KVPKPIAWNR----HAVVMEYIEGVELYRLR--------LDVENPDEILDKILEEVRKAYR---RGIVHGDLSEFNILVT 236 (304)
T ss_pred CCCCcccccc----ceeeeehcccceeeccc--------CcccCHHHHHHHHHHHHHHHHH---cCccccCCchheEEEe
Confidence 7777777654 46999999886654332 1222233334444444443334 8999999999999999
Q ss_pred CCCCEEEEeecCceeccC
Q 005940 491 AEMNARLGDFGLARLYDH 508 (668)
Q Consensus 491 ~~~~~kl~DfGla~~~~~ 508 (668)
+++.+.+.||-.+...++
T Consensus 237 ~dg~~~vIDwPQ~v~~~h 254 (304)
T COG0478 237 EDGDIVVIDWPQAVPISH 254 (304)
T ss_pred cCCCEEEEeCcccccCCC
Confidence 999999999987765443
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.47 E-value=3.9e-06 Score=87.62 Aligned_cols=192 Identities=16% Similarity=0.252 Sum_probs=127.7
Q ss_pred cceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCchhHHHHHHHHHHHhcc-cccCceeEeeee------cccCc-eEEE
Q 005940 357 ESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRL-RHKNLVNLHGWC------KQKND-LLLV 428 (668)
Q Consensus 357 ~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~------~~~~~-~~lV 428 (668)
..+.||+|+-+.+|-.-- -...+.|++.........+ .+..|.+. .||-+-.=+.|= -+++. .-+.
T Consensus 15 ~gr~LgqGgea~ly~l~e---~~d~VAKIYh~Pppa~~aq---k~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGfl 88 (637)
T COG4248 15 PGRPLGQGGEADLYTLGE---VRDQVAKIYHAPPPAAQAQ---KVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFL 88 (637)
T ss_pred CCccccCCccceeeecch---hhchhheeecCCCchHHHH---HHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEe
Confidence 467899999999996422 2234568876655433222 22333333 355433322321 12222 5677
Q ss_pred EEecCCCC-hhhhhc---CCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCce
Q 005940 429 YEYIPNGS-LDTLLF---KPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLAR 504 (668)
Q Consensus 429 ~E~~~~gs-L~~~l~---~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~ 504 (668)
|..+++.- ...++. +.+.-....|.-.++.++.+|.+.+-||+ .|.+-+|+.++|+|+.++..+.|.|=..-.
T Consensus 89 mP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~---~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfq 165 (637)
T COG4248 89 MPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHE---HGHVVGDVNQNSFLVSDDSKVVLVDSDSFQ 165 (637)
T ss_pred cccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHh---cCCcccccCccceeeecCceEEEEccccee
Confidence 77776542 222221 11223457899999999999999999998 999999999999999999999999854333
Q ss_pred eccCCCCCcccccccCCcccCccccc-----CCCCCcchhHHHHHHHHHHHHhC-CCCCCC
Q 005940 505 LYDHGGMPHTTNVVGTFGYIAPELTQ-----TGKASTSSDVFAYGILLLEVATG-RRPIGS 559 (668)
Q Consensus 505 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDV~S~Gvvl~elltG-~~p~~~ 559 (668)
...++ ......+|...|.+||.-. +-..+...|-|.+|+++++++.| +.||.+
T Consensus 166 i~~ng--~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysG 224 (637)
T COG4248 166 INANG--TLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSG 224 (637)
T ss_pred eccCC--ceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCc
Confidence 32222 2233457889999999654 23457789999999999999886 999964
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.43 E-value=1.4e-06 Score=86.07 Aligned_cols=106 Identities=26% Similarity=0.334 Sum_probs=83.8
Q ss_pred HHHHHHHHHHhcccc--cCceeEeeeecccC----ceEEEEEecCC-CChhhhhcCCCCCCCccHHHHHHHHHHHHHHHH
Q 005940 395 REFAAEIESLGRLRH--KNLVNLHGWCKQKN----DLLLVYEYIPN-GSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLL 467 (668)
Q Consensus 395 ~~f~~Ei~~l~~l~H--~nIv~l~g~~~~~~----~~~lV~E~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~ 467 (668)
....+|.+.+.+|+. -...+.+++..... ..+||+|++++ .+|.+++.... .++......++.+++..++
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~---~~~~~~~~~ll~~l~~~i~ 132 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE---QLDPSQRRELLRALARLIA 132 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc---ccchhhHHHHHHHHHHHHH
Confidence 457788888888863 34555666665432 45899999987 48999985311 2566778899999999999
Q ss_pred HhhhccCCceEecCCCCCCEEECCCC---CEEEEeecCceec
Q 005940 468 YLHEEWEQVVIHRDVKPSNALIDAEM---NARLGDFGLARLY 506 (668)
Q Consensus 468 yLH~~~~~~ivHrDLkp~NIll~~~~---~~kl~DfGla~~~ 506 (668)
-||. .+|+|+|++++|||++.+. .+.++||+-++..
T Consensus 133 ~lH~---~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 133 KLHD---AGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHH---CcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 9999 9999999999999999887 8999999987753
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.37 E-value=1.3e-06 Score=96.75 Aligned_cols=142 Identities=21% Similarity=0.289 Sum_probs=92.8
Q ss_pred eeeeecCcEEEEEEEeCCCCcEEEEEEEecCCchh------------------------------HH----------HHH
Q 005940 359 EVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQG------------------------------MR----------EFA 398 (668)
Q Consensus 359 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~------------------------------~~----------~f~ 398 (668)
+-|+.++-|.||+|+++ +|+.||||+.+.+-.+. .+ +|.
T Consensus 131 ~PiAsASIaQVH~A~L~-sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVLK-SGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEec-CCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 67999999999999996 49999999876542211 01 134
Q ss_pred HHHHHHhccc-----ccCceeEeeeecccCceEEEEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhcc
Q 005940 399 AEIESLGRLR-----HKNLVNLHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEW 473 (668)
Q Consensus 399 ~Ei~~l~~l~-----H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ 473 (668)
.|..-+.+++ .+++.-..=+.+-.+...|+|||++|..+.+....... ..+ +..++..++++. +-+-.
T Consensus 210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~--g~d---~k~ia~~~~~~f--~~q~~ 282 (517)
T COG0661 210 REAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSA--GID---RKELAELLVRAF--LRQLL 282 (517)
T ss_pred HHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhc--CCC---HHHHHHHHHHHH--HHHHH
Confidence 4555555543 23333222233345667999999999999888532222 223 223333333321 11111
Q ss_pred CCceEecCCCCCCEEECCCCCEEEEeecCceeccC
Q 005940 474 EQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDH 508 (668)
Q Consensus 474 ~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~ 508 (668)
..++.|.|.+|.||+++.+++..+.|||+...++.
T Consensus 283 ~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 283 RDGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred hcCccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 27899999999999999999999999999887654
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.37 E-value=1.6e-07 Score=103.65 Aligned_cols=153 Identities=20% Similarity=0.321 Sum_probs=98.7
Q ss_pred HHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCCC-C-------cccccccCCcccCcccccC
Q 005940 460 KGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGM-P-------HTTNVVGTFGYIAPELTQT 531 (668)
Q Consensus 460 ~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~~-~-------~~~~~~gt~~y~aPE~~~~ 531 (668)
.+++.||.|+|. ..++||++|.|++|.++.++.+||+.|+.+.....+.. + ...-......|.|||++..
T Consensus 106 ~~v~dgl~flh~--sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~ 183 (700)
T KOG2137|consen 106 GNVADGLAFLHR--SAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG 183 (700)
T ss_pred hcccchhhhhcc--CcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence 345599999998 58999999999999999999999999998865543211 0 0111134567999999988
Q ss_pred CCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCcccCCcccHHHHHHHHHHHhhcCCCCCCC
Q 005940 532 GKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSYVVKEMELVLKLGLMCSHKTQFR 611 (668)
Q Consensus 532 ~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~p~~R 611 (668)
...+.++|+||+||++|-+..|.++.-.........-.+....+ ..-.........+..+.+.+ +...++..|
T Consensus 184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~----~~~~~~s~~~p~el~~~l~k---~l~~~~~~r 256 (700)
T KOG2137|consen 184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLN----AGAFGYSNNLPSELRESLKK---LLNGDSAVR 256 (700)
T ss_pred ccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccc----cccccccccCcHHHHHHHHH---HhcCCcccC
Confidence 88899999999999999999766665333222222111111111 10111112233333444433 233347789
Q ss_pred CCHHHHHHHh
Q 005940 612 PTMRQVMRYL 621 (668)
Q Consensus 612 Ps~~evl~~L 621 (668)
|++.++....
T Consensus 257 p~~~~l~~~~ 266 (700)
T KOG2137|consen 257 PTLDLLLSIP 266 (700)
T ss_pred cchhhhhccc
Confidence 9888877654
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.23 E-value=1.4e-05 Score=79.98 Aligned_cols=133 Identities=17% Similarity=0.163 Sum_probs=85.9
Q ss_pred ceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCchhHHHHHHHHHHHhcccccC--ceeEeeeecccCceEEEEEecCCC
Q 005940 358 SEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKN--LVNLHGWCKQKNDLLLVYEYIPNG 435 (668)
Q Consensus 358 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~n--Iv~l~g~~~~~~~~~lV~E~~~~g 435 (668)
-..||+|..+.||+. .+..+++|...... ......+|.++++.+..-. +.+.++++...+...+|||+++|.
T Consensus 6 ~~~i~~G~t~~~y~~----~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~ 79 (226)
T TIGR02172 6 WTQTGEGGNGESYTH----KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGK 79 (226)
T ss_pred heeecCCCCcceeEe----cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCc
Confidence 467999999999984 24467888876533 2345678999999987544 467788887777788999999886
Q ss_pred C-hhhhhcCCCCCCCccHHHHHHHHHHHHHHH---------------------------------------HHhhh-ccC
Q 005940 436 S-LDTLLFKPKDGSVLDWEQRFNIVKGIASGL---------------------------------------LYLHE-EWE 474 (668)
Q Consensus 436 s-L~~~l~~~~~~~~l~~~~~~~i~~qia~gL---------------------------------------~yLH~-~~~ 474 (668)
. +.+.+.. +......++.++++.+ .+|.. ...
T Consensus 80 ~~~~~~~~~-------~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~ 152 (226)
T TIGR02172 80 RSFSRIISD-------NPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDT 152 (226)
T ss_pred cchhhhhcC-------CHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCC
Confidence 3 2222110 0001111111111111 12211 113
Q ss_pred CceEecCCCCCCEEECCCCCEEEEeecCce
Q 005940 475 QVVIHRDVKPSNALIDAEMNARLGDFGLAR 504 (668)
Q Consensus 475 ~~ivHrDLkp~NIll~~~~~~kl~DfGla~ 504 (668)
..++|+|+.|.||++++++ +.+.||+.+.
T Consensus 153 ~~~~HgD~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 153 STCLHGDFQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred CceEecCCCCCcEEEcCCC-cEEEechhcC
Confidence 4579999999999999888 9999999875
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.17 E-value=2.1e-05 Score=77.00 Aligned_cols=137 Identities=18% Similarity=0.225 Sum_probs=92.8
Q ss_pred hcCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCchhHHH---------HHHHHHHHhcccc---cCceeEeeee
Q 005940 352 TKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMRE---------FAAEIESLGRLRH---KNLVNLHGWC 419 (668)
Q Consensus 352 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~---------f~~Ei~~l~~l~H---~nIv~l~g~~ 419 (668)
.++|...+++-......|.+-.. +++.+++|..+.......+. ..+++..+.+++. ..+..++..+
T Consensus 30 ~~~~~~~kv~k~~~r~~ValIei--~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ 107 (229)
T PF06176_consen 30 DNNYKIIKVFKNTKRNYVALIEI--DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA 107 (229)
T ss_pred hCCceEEEeecCCCccEEEEEEE--CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence 46788888888877777877766 67899999876544322222 2344444444432 2222222222
Q ss_pred -----cccCceEEEEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCC
Q 005940 420 -----KQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMN 494 (668)
Q Consensus 420 -----~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~ 494 (668)
.-....+++|||++|..|.++.. ++. .+...+++++.-||+ .|++|+|.+|+|++++.+ .
T Consensus 108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~-------i~e----~~~~ki~~~ikqlH~---~G~~HGD~hpgNFlv~~~-~ 172 (229)
T PF06176_consen 108 EKKIFRYTSSYVLLMEYIEGVELNDIED-------IDE----DLAEKIVEAIKQLHK---HGFYHGDPHPGNFLVSNN-G 172 (229)
T ss_pred eeeeccceeEEEEEEEEecCeecccchh-------cCH----HHHHHHHHHHHHHHH---cCCccCCCCcCcEEEECC-c
Confidence 22244678999999988876542 221 255677888999999 999999999999999855 5
Q ss_pred EEEEeecCcee
Q 005940 495 ARLGDFGLARL 505 (668)
Q Consensus 495 ~kl~DfGla~~ 505 (668)
+++.||+..+.
T Consensus 173 i~iID~~~k~~ 183 (229)
T PF06176_consen 173 IRIIDTQGKRM 183 (229)
T ss_pred EEEEECccccc
Confidence 99999987653
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.17 E-value=3.1e-05 Score=76.66 Aligned_cols=158 Identities=20% Similarity=0.169 Sum_probs=103.0
Q ss_pred CcccchhhHHHHhcCcccceeee---ecCcEEEEEEEeCCCCcEEEEEEEecCCchh-------------------H---
Q 005940 340 PHRFRYKDLYAATKGFKESEVIG---IGGFGSVYKGVLPTTGGEVAVKKITRNSLQG-------------------M--- 394 (668)
Q Consensus 340 ~~~f~~~el~~at~~f~~~~~lG---~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~-------------------~--- 394 (668)
....+++.+....++..+....| .|--+.||+|.- .++..+|||++....... .
T Consensus 32 ~D~~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~l 110 (268)
T COG1718 32 FDKRTLETLRRLLSRGVITELVGCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKL 110 (268)
T ss_pred hhhHHHHHHHHHhcCCceeeeEeeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHH
Confidence 34456666666666666655555 666778999876 458899999985432111 0
Q ss_pred --HHHHHHHHHHhccc--ccCceeEeeeecccCceEEEEEecCCCCh-hhhhcCCCCCCCccHHHHHHHHHHHHHHHHHh
Q 005940 395 --REFAAEIESLGRLR--HKNLVNLHGWCKQKNDLLLVYEYIPNGSL-DTLLFKPKDGSVLDWEQRFNIVKGIASGLLYL 469 (668)
Q Consensus 395 --~~f~~Ei~~l~~l~--H~nIv~l~g~~~~~~~~~lV~E~~~~gsL-~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yL 469 (668)
.-..+|++-|.++. +-.+.+.+++.. -.|||||+....+ .-.|. ...+.......+..++++.+.-|
T Consensus 111 v~~W~~kEf~NL~R~~eAGVrvP~Pi~~~~----nVLvMEfIg~~g~pAP~Lk----Dv~~e~~e~~~~~~~~v~~~~~l 182 (268)
T COG1718 111 VFAWARKEFRNLKRAYEAGVRVPEPIAFRN----NVLVMEFIGDDGLPAPRLK----DVPLELEEAEGLYEDVVEYMRRL 182 (268)
T ss_pred HHHHHHHHHHHHHHHHHcCCCCCCceeecC----CeEEEEeccCCCCCCCCcc----cCCcCchhHHHHHHHHHHHHHHH
Confidence 01345677777764 444455555443 4699999965411 11111 11223335666777888887777
Q ss_pred hhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCC
Q 005940 470 HEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHG 509 (668)
Q Consensus 470 H~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~ 509 (668)
-. ..++||+||..-|||+. ++.+.|+|+|.|...+++
T Consensus 183 ~~--~a~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~hp 219 (268)
T COG1718 183 YK--EAGLVHGDLSEYNILVH-DGEPYIIDVSQAVTIDHP 219 (268)
T ss_pred HH--hcCcccccchhhheEEE-CCeEEEEECccccccCCC
Confidence 65 38999999999999999 889999999999876653
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.14 E-value=2.5e-05 Score=77.94 Aligned_cols=144 Identities=21% Similarity=0.198 Sum_probs=86.2
Q ss_pred ceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCchhHHHHHHHHHHHhcccccC--ceeEeeeec---ccCceEEEEEec
Q 005940 358 SEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKN--LVNLHGWCK---QKNDLLLVYEYI 432 (668)
Q Consensus 358 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~n--Iv~l~g~~~---~~~~~~lV~E~~ 432 (668)
.+.|+.|..+.||+.... ++.+++|..... .....+..|..+++.+.... +.+++.++. .....+++|+++
T Consensus 2 i~~l~~G~~n~~~~v~~~--~~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i 77 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTD--DGRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYI 77 (239)
T ss_dssp EEEEEESSSSEEEEEEET--TSEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEE
T ss_pred CccCCCCCeeeEEEEEEC--CcEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEe
Confidence 467999999999999984 369999997554 45567788999998886443 456666442 223468999999
Q ss_pred CCCChhh----------------hh---cCC-CCCCCccHHH---------HHHH------------HHHHHH-HHHHhh
Q 005940 433 PNGSLDT----------------LL---FKP-KDGSVLDWEQ---------RFNI------------VKGIAS-GLLYLH 470 (668)
Q Consensus 433 ~~gsL~~----------------~l---~~~-~~~~~l~~~~---------~~~i------------~~qia~-gL~yLH 470 (668)
++..+.. .+ +.. .....+.+.. .... ...+.+ .+..++
T Consensus 78 ~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (239)
T PF01636_consen 78 PGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELE 157 (239)
T ss_dssp SSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHH
Confidence 9988877 11 111 0111111100 0000 112222 333333
Q ss_pred h----ccCCceEecCCCCCCEEEC-CCCCEEEEeecCcee
Q 005940 471 E----EWEQVVIHRDVKPSNALID-AEMNARLGDFGLARL 505 (668)
Q Consensus 471 ~----~~~~~ivHrDLkp~NIll~-~~~~~kl~DfGla~~ 505 (668)
+ .....++|+|+.|.||+++ +++.+.|.||+.+..
T Consensus 158 ~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 158 ALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp HHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred hhhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence 2 1347799999999999999 556667999987753
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.00 E-value=7e-05 Score=75.91 Aligned_cols=140 Identities=17% Similarity=0.155 Sum_probs=85.8
Q ss_pred eeeecCc-EEEEEEEeCCCCcEEEEEEEecCCchhHHHHHHHHHHHhccc-ccCceeEeeeecccCceEEEEEecCCCCh
Q 005940 360 VIGIGGF-GSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLR-HKNLVNLHGWCKQKNDLLLVYEYIPNGSL 437 (668)
Q Consensus 360 ~lG~G~~-g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~lV~E~~~~gsL 437 (668)
.|-.|.. ..||+.... +..+.||+..... ..++..|+++++.+. +--+.+++++....+..++|||+++|.+|
T Consensus 5 ~~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l 79 (244)
T cd05150 5 RVTEGQSGATVYRLDGK--NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPA 79 (244)
T ss_pred ecCCCCCcCeEEEEcCC--CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccH
Confidence 3445555 689998763 4678888875543 345678999988884 44566778887766678999999999887
Q ss_pred hhhh-------------------cCCC-CCCCcc--HHHHHHHHHH--------------------HHHHHHHhhh----
Q 005940 438 DTLL-------------------FKPK-DGSVLD--WEQRFNIVKG--------------------IASGLLYLHE---- 471 (668)
Q Consensus 438 ~~~l-------------------~~~~-~~~~l~--~~~~~~i~~q--------------------ia~gL~yLH~---- 471 (668)
.... +... ....+. ...++..... +...+..|-.
T Consensus 80 ~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 159 (244)
T cd05150 80 AALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPA 159 (244)
T ss_pred hHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCC
Confidence 6442 1100 000111 0000000000 1111112211
Q ss_pred ccCCceEecCCCCCCEEECCCCCEEEEeecCce
Q 005940 472 EWEQVVIHRDVKPSNALIDAEMNARLGDFGLAR 504 (668)
Q Consensus 472 ~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~ 504 (668)
.....++|+|+.|.||+++++....|.||+.+.
T Consensus 160 ~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 160 EEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred cCceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 113569999999999999998778899999764
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.97 E-value=1.2e-06 Score=95.77 Aligned_cols=186 Identities=18% Similarity=0.128 Sum_probs=135.0
Q ss_pred CcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCchhHHHHHHHHHHHhcccccC-ceeEeeeecccCceEEEEEec
Q 005940 354 GFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKN-LVNLHGWCKQKNDLLLVYEYI 432 (668)
Q Consensus 354 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~n-Iv~l~g~~~~~~~~~lV~E~~ 432 (668)
-+...+..++++++++||.+-..+ +....+.+... ....-++++|.+++||| .+..++-++.+....++++++
T Consensus 243 ws~~fh~fvK~altknpKkRptae-klL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~ 316 (829)
T KOG0576|consen 243 WSEFFHNFVKGALTKNPKKRPTAE-KLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRIC 316 (829)
T ss_pred chHHHHHHHHHHhcCCCccCCChh-hheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhh
Confidence 334456678999999999876433 23335555433 34456889999999999 666677777777888999999
Q ss_pred CCC-ChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCCC
Q 005940 433 PNG-SLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGM 511 (668)
Q Consensus 433 ~~g-sL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~~ 511 (668)
..+ +-..-. ......+...+...+++.-+++|+|||+ ..-+|+| ||+..+ ...|.+||+.+..+....
T Consensus 317 s~~rs~~~~~--~~se~~~~~~~~~~~~r~et~~l~~l~~---~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~- 385 (829)
T KOG0576|consen 317 STGRSSALEM--TVSEIALEQYQFAYPLRKETRPLAELHS---SYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM- 385 (829)
T ss_pred cCCccccccC--ChhhHhhhhhhhhhhhhhhccccccccc---ccccCcc----cccccc-cccccccccCCcccCccc-
Confidence 877 221111 1112234555666777888899999998 4457888 777765 678999999988776654
Q ss_pred CcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCC
Q 005940 512 PHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPI 557 (668)
Q Consensus 512 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~ 557 (668)
......+++.++|||+...+.+..+.|+|+.|+-..++.-|..|-
T Consensus 386 -~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr 430 (829)
T KOG0576|consen 386 -KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR 430 (829)
T ss_pred -ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence 234457899999999999999999999999998777777777654
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.93 E-value=4.4e-05 Score=84.50 Aligned_cols=141 Identities=21% Similarity=0.279 Sum_probs=91.0
Q ss_pred ceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCchh-------------------------------------HHHHHHH
Q 005940 358 SEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQG-------------------------------------MREFAAE 400 (668)
Q Consensus 358 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~-------------------------------------~~~f~~E 400 (668)
.+.||.-+.|.||+|+++. |+.||||+-+..-.+. .-+|.+|
T Consensus 166 ~~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~E 244 (538)
T KOG1235|consen 166 EEPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKE 244 (538)
T ss_pred cchhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHH
Confidence 3678999999999999975 9999999865432110 0125555
Q ss_pred HHHHhcc----cccC------ceeEeeeecccCceEEEEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhh
Q 005940 401 IESLGRL----RHKN------LVNLHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLH 470 (668)
Q Consensus 401 i~~l~~l----~H~n------Iv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH 470 (668)
.+-..+. +|-+ |.+++- .-.....|+||||+|..+.+...-.+ ..++-.. ++..+.++ |++
T Consensus 245 A~Nae~~~~~f~~~~~~~~V~VP~Vy~--~~st~RVLtME~~~G~~i~Dl~~i~~--~gi~~~~---i~~~l~~~--~~~ 315 (538)
T KOG1235|consen 245 AKNAERFRENFKDFSLLTYVLVPKVYW--DLSTKRVLTMEYVDGIKINDLDAIDK--RGISPHD---ILNKLVEA--YLE 315 (538)
T ss_pred HHhHHHHHHHHHhcccccceeCCeehh--hcCcceEEEEEecCCccCCCHHHHHH--cCCCHHH---HHHHHHHH--HHH
Confidence 5444443 3555 333322 22346799999999988877653222 2233333 33333332 222
Q ss_pred hccCCceEecCCCCCCEEECC----CCCEEEEeecCceeccC
Q 005940 471 EEWEQVVIHRDVKPSNALIDA----EMNARLGDFGLARLYDH 508 (668)
Q Consensus 471 ~~~~~~ivHrDLkp~NIll~~----~~~~kl~DfGla~~~~~ 508 (668)
.-...|.+|+|=+|.||+++. ++++.+-|||+...+.+
T Consensus 316 qIf~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 316 QIFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred HHHhcCCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 222368999999999999984 67899999999886654
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.91 E-value=5e-05 Score=73.62 Aligned_cols=105 Identities=25% Similarity=0.196 Sum_probs=82.9
Q ss_pred HHHHHHhcccc-cCceeEeeeecccCceEEEEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCce
Q 005940 399 AEIESLGRLRH-KNLVNLHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVV 477 (668)
Q Consensus 399 ~Ei~~l~~l~H-~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~i 477 (668)
.|.-+++.+.+ +++++++|.|- .++|.||...+++...-..-..-...+|..|.+|+.++++.+.+|++.....+
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~ 83 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGFF 83 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCcE
Confidence 57788888876 69999999993 36789999877664221000011236899999999999999999998665569
Q ss_pred EecCCCCCCEEECCCCCEEEEeecCceecc
Q 005940 478 IHRDVKPSNALIDAEMNARLGDFGLARLYD 507 (668)
Q Consensus 478 vHrDLkp~NIll~~~~~~kl~DfGla~~~~ 507 (668)
...|++++|+-+++++++|+.|...+...+
T Consensus 84 ~lcDv~~~nfgv~~~~~lk~iDld~v~~~~ 113 (188)
T PF12260_consen 84 YLCDVSPDNFGVNDDGRLKLIDLDDVFVED 113 (188)
T ss_pred EEeecchHHeEEeCCCcEEEEechhcchhH
Confidence 999999999999999999999998776543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.83 E-value=0.00025 Score=84.63 Aligned_cols=80 Identities=16% Similarity=0.269 Sum_probs=58.9
Q ss_pred ceeeeecCcEEEEEEEeCCCC--cEEEEEEEecCC-chhHHHHHHHHHHHhccc-ccCc--eeEeeeeccc---CceEEE
Q 005940 358 SEVIGIGGFGSVYKGVLPTTG--GEVAVKKITRNS-LQGMREFAAEIESLGRLR-HKNL--VNLHGWCKQK---NDLLLV 428 (668)
Q Consensus 358 ~~~lG~G~~g~Vy~~~~~~~~--~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~-H~nI--v~l~g~~~~~---~~~~lV 428 (668)
.+.++.|....+|+......+ ..+++|+..... ......+..|+++++.+. |.++ .+++.+|.+. +..|+|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 577899999999998774322 367788764432 223457889999999996 6655 7888888764 468999
Q ss_pred EEecCCCCh
Q 005940 429 YEYIPNGSL 437 (668)
Q Consensus 429 ~E~~~~gsL 437 (668)
|||+++..+
T Consensus 123 ME~v~G~~~ 131 (822)
T PLN02876 123 MEYLEGRIF 131 (822)
T ss_pred EEecCCccc
Confidence 999988654
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.77 E-value=0.00042 Score=67.17 Aligned_cols=133 Identities=26% Similarity=0.378 Sum_probs=94.5
Q ss_pred CcccchhhHHHHhcCcccceeeeecCc-EEEEEEEeCCCCcEEEEEEEec---CCc------------------hhHHHH
Q 005940 340 PHRFRYKDLYAATKGFKESEVIGIGGF-GSVYKGVLPTTGGEVAVKKITR---NSL------------------QGMREF 397 (668)
Q Consensus 340 ~~~f~~~el~~at~~f~~~~~lG~G~~-g~Vy~~~~~~~~~~vavK~~~~---~~~------------------~~~~~f 397 (668)
..+|.. .+.+++..+.||.|.- |.|||+.. .|..+|+|.+.. ... .....|
T Consensus 29 L~~F~~-----h~~~I~flefLg~g~~~~~V~kv~I--~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF 101 (207)
T PF13095_consen 29 LEPFTH-----HGDDIEFLEFLGHGSHDGYVFKVEI--DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPF 101 (207)
T ss_pred cCCcCC-----CCCcEeeeeecCCCCceeEEEEEEE--CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChH
Confidence 345655 2378888999999999 99999999 688999999421 000 112358
Q ss_pred HHHHHHHhccc---ccCc--eeEeeeeccc------------------CceEEEEEecCCCChhhhhcCCCCCCCccHHH
Q 005940 398 AAEIESLGRLR---HKNL--VNLHGWCKQK------------------NDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQ 454 (668)
Q Consensus 398 ~~Ei~~l~~l~---H~nI--v~l~g~~~~~------------------~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~ 454 (668)
..|.+...+|+ +.++ |+.+||..-. ....+|.||++... .+.
T Consensus 102 ~~ECRAfgRLke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------~~~--- 166 (207)
T PF13095_consen 102 NCECRAFGRLKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------PLQ--- 166 (207)
T ss_pred HHHHHhhHHHHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------------ccc---
Confidence 89999999986 4466 9999997311 11357777775422 122
Q ss_pred HHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCc
Q 005940 455 RFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLA 503 (668)
Q Consensus 455 ~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla 503 (668)
.+-+.+|.+-|..+|. .+|+-+|+++.|.. .-||+|||.+
T Consensus 167 -~~~~~~~~~dl~~~~k---~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 167 -IRDIPQMLRDLKILHK---LGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred -hhHHHHHHHHHHHHHH---CCeeeccCcccccc-----CCEEEecccC
Confidence 2234567777788998 99999999999975 4689999854
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.69 E-value=0.00057 Score=71.45 Aligned_cols=78 Identities=14% Similarity=0.044 Sum_probs=57.5
Q ss_pred ccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCchhHHHHHHHHHHHhcccc---cCceeEeeeecc---cCceEEEE
Q 005940 356 KESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRH---KNLVNLHGWCKQ---KNDLLLVY 429 (668)
Q Consensus 356 ~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H---~nIv~l~g~~~~---~~~~~lV~ 429 (668)
...+.||.|..+.||+.... +..+.+|...... ....|..|.+.|+.|.- -.+.+++++|.. .+..+|||
T Consensus 17 ~~~~~i~~G~~~~vy~~~~~--~~~~~~k~~~~~~--~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVm 92 (297)
T PRK10593 17 SRVECISEQPYAALWALYDS--QGNPMPLMARSFS--TPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLL 92 (297)
T ss_pred heeeecCCccceeEEEEEcC--CCCEEEEEecccc--cchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEE
Confidence 34678999999999998763 3356777743311 23578899999998853 468888988854 36689999
Q ss_pred EecCCCCh
Q 005940 430 EYIPNGSL 437 (668)
Q Consensus 430 E~~~~gsL 437 (668)
|+++++++
T Consensus 93 E~i~G~~~ 100 (297)
T PRK10593 93 ERLRGVSV 100 (297)
T ss_pred eccCCEec
Confidence 99998765
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.66 E-value=0.00033 Score=65.85 Aligned_cols=129 Identities=22% Similarity=0.263 Sum_probs=89.6
Q ss_pred ccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCchhHHHHHHHHHHHhcccccCcee-EeeeecccCceEEEEEecCC
Q 005940 356 KESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVN-LHGWCKQKNDLLLVYEYIPN 434 (668)
Q Consensus 356 ~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~-l~g~~~~~~~~~lV~E~~~~ 434 (668)
+..+.|++|.+|.||+|.+ .|.++|+|+-+.++. ...+..|+++|..+.-.++-+ ++.|-. -++.|||..|
T Consensus 25 ~v~~~L~KG~~s~Vyl~~~--~~~~~a~Kvrr~ds~--r~~l~kEakiLeil~g~~~~p~vy~yg~----~~i~me~i~G 96 (201)
T COG2112 25 RVEKELAKGTTSVVYLGEW--RGGEVALKVRRRDSP--RRNLEKEAKILEILAGEGVTPEVYFYGE----DFIRMEYIDG 96 (201)
T ss_pred hhhhhhhcccccEEEEeec--cCceEEEEEecCCcc--hhhHHHHHHHHHHhhhcCCCceEEEech----hhhhhhhhcC
Confidence 3467899999999999999 577999998876653 467889999999988666544 444332 2455999988
Q ss_pred CChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCC-CCCEEECCCCCEEEEeecCcee
Q 005940 435 GSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVK-PSNALIDAEMNARLGDFGLARL 505 (668)
Q Consensus 435 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLk-p~NIll~~~~~~kl~DfGla~~ 505 (668)
-.|.+.-... + .+-+..+++.---|.. .||-|+.|. |...+|..+..+.|+||.-|..
T Consensus 97 ~~L~~~~~~~------~----rk~l~~vlE~a~~LD~---~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 97 RPLGKLEIGG------D----RKHLLRVLEKAYKLDR---LGIEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred cchhhhhhcc------c----HHHHHHHHHHHHHHHH---hccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 7887665311 1 1223345555333444 788888886 5555555555999999998874
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.55 E-value=0.00066 Score=68.39 Aligned_cols=75 Identities=16% Similarity=0.171 Sum_probs=48.1
Q ss_pred ceeeeecCcE-EEEEEEeCCCCcEEEEEEEecCCchhHHHHHHHHHHHhccccc---CceeEeeeeccc---CceEEEEE
Q 005940 358 SEVIGIGGFG-SVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHK---NLVNLHGWCKQK---NDLLLVYE 430 (668)
Q Consensus 358 ~~~lG~G~~g-~Vy~~~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~---nIv~l~g~~~~~---~~~~lV~E 430 (668)
.+.|+.|+.. .||+. +..+++|..... .....+..|.+++..|... .+.++++.+... ...+++||
T Consensus 2 ~~~~~~gG~~n~vy~~-----~~~~VlR~~~~~--~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~ 74 (235)
T cd05155 2 IEPVDSGGTDNATFRL-----GDDMSVRLPSAA--GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYR 74 (235)
T ss_pred ceeccCCCcccceEEc-----CCceEEEcCCcc--chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEE
Confidence 3567777776 48975 235777765432 2345788899999888532 345555554432 23588999
Q ss_pred ecCCCChhh
Q 005940 431 YIPNGSLDT 439 (668)
Q Consensus 431 ~~~~gsL~~ 439 (668)
+++|.++.+
T Consensus 75 ~i~G~~l~~ 83 (235)
T cd05155 75 WLEGETATA 83 (235)
T ss_pred eecCCCCCc
Confidence 999977743
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.43 E-value=0.0019 Score=69.72 Aligned_cols=77 Identities=18% Similarity=0.138 Sum_probs=53.9
Q ss_pred ceeeeecCcEEEEEEEeCCCCcEEEEEEEecC------C-chhHHHHHHHHHHHhccc---ccCceeEeeeecccCceEE
Q 005940 358 SEVIGIGGFGSVYKGVLPTTGGEVAVKKITRN------S-LQGMREFAAEIESLGRLR---HKNLVNLHGWCKQKNDLLL 427 (668)
Q Consensus 358 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~------~-~~~~~~f~~Ei~~l~~l~---H~nIv~l~g~~~~~~~~~l 427 (668)
.+.||.|....||++...+.++.++||.-... . .-..+.+..|.+.|..+. -.++++++.+. ....++
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D--~~~~~l 108 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYD--EELAVT 108 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCCCEE
Confidence 46799999999999998543358999985321 1 123456677888888763 24567777764 355789
Q ss_pred EEEecCCCC
Q 005940 428 VYEYIPNGS 436 (668)
Q Consensus 428 V~E~~~~gs 436 (668)
||||+++..
T Consensus 109 VME~L~~~~ 117 (401)
T PRK09550 109 VMEDLSDHK 117 (401)
T ss_pred EEecCCCcc
Confidence 999998643
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.42 E-value=0.00082 Score=68.66 Aligned_cols=138 Identities=14% Similarity=0.026 Sum_probs=79.0
Q ss_pred eeecCcEEEEEEEeCCCCcEEEEEEEecCCchhHHHHHHHHHHHhcccccCc-eeEeeeecccCceEEEEEecCCCChhh
Q 005940 361 IGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNL-VNLHGWCKQKNDLLLVYEYIPNGSLDT 439 (668)
Q Consensus 361 lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nI-v~l~g~~~~~~~~~lV~E~~~~gsL~~ 439 (668)
+..|-...+|+... +++.+++|..........-...+|.++++.+....+ .+++..+. -++||||++|..+..
T Consensus 4 ~~~G~tn~~y~~~~--~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~ 77 (256)
T TIGR02721 4 LSGGLTNRSWRIEH--PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITL 77 (256)
T ss_pred CCCcCcCCeEEEEe--CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCccccc
Confidence 45577788998874 567888887654322211235678899988864433 34444432 368999999877643
Q ss_pred h-----------------hcCCC-CCCCccHHHH-HHHHHHH---------HHHHHHhhh-----ccCCceEecCCCCCC
Q 005940 440 L-----------------LFKPK-DGSVLDWEQR-FNIVKGI---------ASGLLYLHE-----EWEQVVIHRDVKPSN 486 (668)
Q Consensus 440 ~-----------------l~~~~-~~~~l~~~~~-~~i~~qi---------a~gL~yLH~-----~~~~~ivHrDLkp~N 486 (668)
. ||... ....++...+ .....++ ...+..+-. .....++|+|+.|.|
T Consensus 78 ~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~N 157 (256)
T TIGR02721 78 DQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYN 157 (256)
T ss_pred ccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCc
Confidence 1 11111 1111221111 1111111 111111111 113468999999999
Q ss_pred EEECCCCCEEEEeecCcee
Q 005940 487 ALIDAEMNARLGDFGLARL 505 (668)
Q Consensus 487 Ill~~~~~~kl~DfGla~~ 505 (668)
|++++++ ++|.||..+..
T Consensus 158 il~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 158 LVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred EEEeCCC-CEEEeccccCc
Confidence 9999876 78999998753
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.42 E-value=0.0016 Score=65.41 Aligned_cols=142 Identities=16% Similarity=0.160 Sum_probs=81.9
Q ss_pred ceeeeecCcEEEEEEEeCC-CCcEEEEEEEecCCchhHHHHHHHHHHHhcccccC-ceeEeeeecccCceEEEEEecCCC
Q 005940 358 SEVIGIGGFGSVYKGVLPT-TGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKN-LVNLHGWCKQKNDLLLVYEYIPNG 435 (668)
Q Consensus 358 ~~~lG~G~~g~Vy~~~~~~-~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~n-Iv~l~g~~~~~~~~~lV~E~~~~g 435 (668)
.+.|..|-...+|+..... .++.+++|+....... .-+...|+.++..+.... .+++++.+. -.++|||+++.
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~-~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~ 77 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL-IIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGR 77 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc-eecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCC
Confidence 4567778888999997642 2567889976543221 123347888888885433 344444433 13799999987
Q ss_pred Chhhh-----------------hcCCCCC--------CCc-cHHHHHHHHH----------------------HHHHHHH
Q 005940 436 SLDTL-----------------LFKPKDG--------SVL-DWEQRFNIVK----------------------GIASGLL 467 (668)
Q Consensus 436 sL~~~-----------------l~~~~~~--------~~l-~~~~~~~i~~----------------------qia~gL~ 467 (668)
++... ++..... ... .|..+..+.. .+...+.
T Consensus 78 ~l~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 157 (235)
T cd05157 78 TLEPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRDEIS 157 (235)
T ss_pred cCCHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHHHHH
Confidence 76321 1111100 011 1222212211 1111111
Q ss_pred Hh----hh-ccCCceEecCCCCCCEEECC-CCCEEEEeecCce
Q 005940 468 YL----HE-EWEQVVIHRDVKPSNALIDA-EMNARLGDFGLAR 504 (668)
Q Consensus 468 yL----H~-~~~~~ivHrDLkp~NIll~~-~~~~kl~DfGla~ 504 (668)
.| .. .....++|+|+.+.||++++ +..+.+.||..|.
T Consensus 158 ~l~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~ 200 (235)
T cd05157 158 WLKELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAG 200 (235)
T ss_pred HHHHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence 11 11 12357999999999999998 5789999998775
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.39 E-value=0.002 Score=62.88 Aligned_cols=132 Identities=22% Similarity=0.313 Sum_probs=91.5
Q ss_pred cceeeeecCcEEEEEEEeCCCCcEEEEEEEecCC----------------chhHHHHHHHHHHHhccc------ccCcee
Q 005940 357 ESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNS----------------LQGMREFAAEIESLGRLR------HKNLVN 414 (668)
Q Consensus 357 ~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~----------------~~~~~~f~~Ei~~l~~l~------H~nIv~ 414 (668)
....||+|+.=.||.- + .+....||+..... ....++...|+.-...+. +.+|.+
T Consensus 5 ~~~~i~~G~~R~cy~H--P-~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r 81 (199)
T PF10707_consen 5 ESDLIAQGGERDCYQH--P-DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPR 81 (199)
T ss_pred CCcccccCCCceEEEC--C-CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCccccccc
Confidence 3567999999999964 3 34567888886654 123456777777766665 889999
Q ss_pred EeeeecccCceEEEEEecCC------CChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEE
Q 005940 415 LHGWCKQKNDLLLVYEYIPN------GSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNAL 488 (668)
Q Consensus 415 l~g~~~~~~~~~lV~E~~~~------gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIl 488 (668)
++|+.+.....-+|+|.+.+ -+|.+++.. ..++. ...+. +-+-..||-+ ..|+.+||+|.||+
T Consensus 82 ~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~----~~~~~-~~~~~---L~~f~~~l~~---~~Iv~~dl~~~NIv 150 (199)
T PF10707_consen 82 FYGFVETNLGLGLVVELIRDADGNISPTLEDYLKE----GGLTE-ELRQA---LDEFKRYLLD---HHIVIRDLNPHNIV 150 (199)
T ss_pred EeEEEecCCceEEEEEEEECCCCCcCccHHHHHHc----CCccH-HHHHH---HHHHHHHHHH---cCCeecCCCcccEE
Confidence 99999999999999998753 356777732 22444 33333 3344456665 78999999999999
Q ss_pred ECCCC----CEEEEe-ecC
Q 005940 489 IDAEM----NARLGD-FGL 502 (668)
Q Consensus 489 l~~~~----~~kl~D-fGl 502 (668)
+..+. .+.|+| ||.
T Consensus 151 ~~~~~~~~~~lvlIDG~G~ 169 (199)
T PF10707_consen 151 VQRRDSGEFRLVLIDGLGE 169 (199)
T ss_pred EEecCCCceEEEEEeCCCC
Confidence 95432 466666 443
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.34 E-value=0.0013 Score=68.71 Aligned_cols=142 Identities=18% Similarity=0.139 Sum_probs=86.4
Q ss_pred ceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCchhHHHHHHHHHHHhcccccC--ceeEeeee------cccCceEEEE
Q 005940 358 SEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKN--LVNLHGWC------KQKNDLLLVY 429 (668)
Q Consensus 358 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~n--Iv~l~g~~------~~~~~~~lV~ 429 (668)
.+.|..|....+|+... ++..+++|+.... ...+...|++++..|.+.. +.+++... ...+..++|+
T Consensus 19 i~~i~~G~~n~~y~v~~--~~~~~vLr~~~~~---~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~ 93 (296)
T cd05153 19 FEGISAGIENTNYFVTT--DSGRYVLTLFEKV---SAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALV 93 (296)
T ss_pred eecccCccccceEEEEe--CCCcEEEEEcCCC---ChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEE
Confidence 55677777789999865 3457899987642 2345667888888885433 44444421 2234568999
Q ss_pred EecCCCChhh----h----------hcCC----CC----CCCccHHHHHH----------HHHHHHHHHHHhhh----cc
Q 005940 430 EYIPNGSLDT----L----------LFKP----KD----GSVLDWEQRFN----------IVKGIASGLLYLHE----EW 473 (668)
Q Consensus 430 E~~~~gsL~~----~----------l~~~----~~----~~~l~~~~~~~----------i~~qia~gL~yLH~----~~ 473 (668)
++++|..+.. . ++.. .. .....|..... ....+..++.++.+ ..
T Consensus 94 ~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~ 173 (296)
T cd05153 94 EFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDL 173 (296)
T ss_pred EeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcC
Confidence 9999877643 0 1100 00 01123322210 11123334444442 23
Q ss_pred CCceEecCCCCCCEEECCCCCEEEEeecCce
Q 005940 474 EQVVIHRDVKPSNALIDAEMNARLGDFGLAR 504 (668)
Q Consensus 474 ~~~ivHrDLkp~NIll~~~~~~kl~DfGla~ 504 (668)
..+++|+|+.|.||+++++..+.|.||+.+.
T Consensus 174 ~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 174 PRGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred CCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 4679999999999999998777899999765
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.20 E-value=0.0022 Score=75.56 Aligned_cols=202 Identities=18% Similarity=0.161 Sum_probs=128.2
Q ss_pred HHHHHHHHHhcccccCceeEeeeecccCce----EEEEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhh
Q 005940 396 EFAAEIESLGRLRHKNLVNLHGWCKQKNDL----LLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHE 471 (668)
Q Consensus 396 ~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~----~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~ 471 (668)
....|+..+.++.|+|++.++.|..++... .+..|++..-++...+. .-...+....+.+..++.+||.|+|+
T Consensus 228 ~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q---~v~~i~~~~~r~~~~~~~~GL~~~h~ 304 (1351)
T KOG1035|consen 228 TTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQ---SVGSIPLETLRILHQKLLEGLAYLHS 304 (1351)
T ss_pred HHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHh---hccccCHHHHHHHHHHHhhhHHHHHH
Confidence 344677788888999999999987654332 34457777777777774 23457888888999999999999998
Q ss_pred ccCCceEecCCCCC---CEEECCCCCEEEE--eecCceeccCCCCCcccccccCCcccCcccccCCCCC--cchhHHHHH
Q 005940 472 EWEQVVIHRDVKPS---NALIDAEMNARLG--DFGLARLYDHGGMPHTTNVVGTFGYIAPELTQTGKAS--TSSDVFAYG 544 (668)
Q Consensus 472 ~~~~~ivHrDLkp~---NIll~~~~~~kl~--DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~--~~sDV~S~G 544 (668)
....|.-|..+ +.-.+..+...++ ||+..+......... ...-+..+.+||......+. ...|+|++|
T Consensus 305 ---~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~--~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lg 379 (1351)
T KOG1035|consen 305 ---LSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSF--SDLLAEIRNADEDLKENTAKKSRLTDLWCLG 379 (1351)
T ss_pred ---hccceeEEecccccccccCccceeecchhhhcccccCCCcccch--hhcCccccccccccccccchhhhhhHHHHHH
Confidence 44444444333 3334555666666 887776554432211 12334567788877655444 457999999
Q ss_pred HHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCcccCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhcc
Q 005940 545 ILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSG 623 (668)
Q Consensus 545 vvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~ 623 (668)
..+..+..|..+-.... .+. +.+...... ........|..+ +++|++..+++.+.-.
T Consensus 380 ll~~~~~~~~~i~~~~~--------------~~~----~~l~~~~~~----~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~ 437 (1351)
T KOG1035|consen 380 LLLLQLSQGEDISEKSA--------------VPV----SLLDVLSTS----ELLDALPKCLDEDSEERLSALELLTHPFL 437 (1351)
T ss_pred HHHhhhhhcCccccccc--------------chh----hhhccccch----hhhhhhhhhcchhhhhccchhhhhhchhc
Confidence 99999999876532110 000 111111111 122233367776 8999999999987654
Q ss_pred CcCC
Q 005940 624 EKQL 627 (668)
Q Consensus 624 ~~~~ 627 (668)
..+.
T Consensus 438 ~~~~ 441 (1351)
T KOG1035|consen 438 RFPT 441 (1351)
T ss_pred cccc
Confidence 4333
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.09 E-value=0.004 Score=65.18 Aligned_cols=142 Identities=25% Similarity=0.249 Sum_probs=84.0
Q ss_pred ceeeeecCcEEEEEEEeCC------CCcEEEEEEEecCCchhHHHHHHHHHHHhcccccCc-eeEeeeecccCceEEEEE
Q 005940 358 SEVIGIGGFGSVYKGVLPT------TGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNL-VNLHGWCKQKNDLLLVYE 430 (668)
Q Consensus 358 ~~~lG~G~~g~Vy~~~~~~------~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nI-v~l~g~~~~~~~~~lV~E 430 (668)
.+.+..|-...+|+..... .++.+++|+..... ....+...|.+++..+....+ .++++.+.. .+|+|
T Consensus 3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e 77 (302)
T cd05156 3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEE 77 (302)
T ss_pred EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhh
Confidence 3456666667899987643 25789999876543 222345678888888864333 345555532 35899
Q ss_pred ecCCCChhhh-----------------hcCCCCCC------C--ccHHHHHH--------------------------HH
Q 005940 431 YIPNGSLDTL-----------------LFKPKDGS------V--LDWEQRFN--------------------------IV 459 (668)
Q Consensus 431 ~~~~gsL~~~-----------------l~~~~~~~------~--l~~~~~~~--------------------------i~ 459 (668)
|++|..+... +|...... . .-|..+.+ +.
T Consensus 78 ~i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (302)
T cd05156 78 FIPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFL 157 (302)
T ss_pred eeCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHH
Confidence 9998776431 11111110 0 11111111 11
Q ss_pred HHHHHHHHHhhh------ccCCceEecCCCCCCEEECCC----CCEEEEeecCce
Q 005940 460 KGIASGLLYLHE------EWEQVVIHRDVKPSNALIDAE----MNARLGDFGLAR 504 (668)
Q Consensus 460 ~qia~gL~yLH~------~~~~~ivHrDLkp~NIll~~~----~~~kl~DfGla~ 504 (668)
..+..-+..|-. .....++|+|+.+.||+++++ +.+++.||..|.
T Consensus 158 ~~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~ 212 (302)
T cd05156 158 EDEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS 212 (302)
T ss_pred HHHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence 122222334431 235689999999999999985 789999999875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.95 E-value=0.0091 Score=63.04 Aligned_cols=142 Identities=15% Similarity=0.139 Sum_probs=77.5
Q ss_pred ceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCchhHHHHHHHHHHHhcccccC--ceeEeee------ecccCceEEEE
Q 005940 358 SEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKN--LVNLHGW------CKQKNDLLLVY 429 (668)
Q Consensus 358 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~n--Iv~l~g~------~~~~~~~~lV~ 429 (668)
.+.|+.|....+|+.... ++.+++|++..... +....|++++..|.... +.+++.. ....+..++++
T Consensus 27 ~~~l~~G~~n~~y~v~t~--~g~~vLK~~~~~~~---~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~ 101 (319)
T PRK05231 27 LKGIAEGIENSNFFLTTT--QGEYVLTLFERLTA---EDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIV 101 (319)
T ss_pred cchhccccccceEEEEeC--CCcEEEEEeccCCh---HHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEE
Confidence 355667777889998763 44789998763222 33334555565553222 3333321 12345678999
Q ss_pred EecCCCChhh-----------h---hcCCCC--------CCCccH-HHHHHH------------HHH-HHHHHHHhhh--
Q 005940 430 EYIPNGSLDT-----------L---LFKPKD--------GSVLDW-EQRFNI------------VKG-IASGLLYLHE-- 471 (668)
Q Consensus 430 E~~~~gsL~~-----------~---l~~~~~--------~~~l~~-~~~~~i------------~~q-ia~gL~yLH~-- 471 (668)
||++|..+.. . ++.... ...+.| .....- +.+ +...+..+..
T Consensus 102 ~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 181 (319)
T PRK05231 102 TFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAA 181 (319)
T ss_pred EecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhccc
Confidence 9999875421 1 111000 011222 221111 111 1112222221
Q ss_pred --ccCCceEecCCCCCCEEECCCCCEEEEeecCce
Q 005940 472 --EWEQVVIHRDVKPSNALIDAEMNARLGDFGLAR 504 (668)
Q Consensus 472 --~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~ 504 (668)
....+++|+|++|.||+++.+...-|.||+.+.
T Consensus 182 ~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 182 WPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred cccCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 134689999999999999876556899999875
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=96.70 E-value=0.017 Score=60.69 Aligned_cols=143 Identities=17% Similarity=0.138 Sum_probs=83.4
Q ss_pred ceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCchhHHHHHHHHHHHhcccccC--ceeEeeee------cccCceEEEE
Q 005940 358 SEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKN--LVNLHGWC------KQKNDLLLVY 429 (668)
Q Consensus 358 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~n--Iv~l~g~~------~~~~~~~lV~ 429 (668)
.+.++.|-...+|+... +++.+++|+..... ..++...|++++..|.... +.+++... ...+..++++
T Consensus 27 i~~~~~G~~n~~y~v~t--~~~~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~ 102 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTT--DVGRYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLV 102 (307)
T ss_pred ccccCCccccceEEEEe--CCCcEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEE
Confidence 45567777788998865 34468888875432 1234456777777774322 34444422 2235678999
Q ss_pred EecCCCChhhh--------------hcCCCCC---------CCccHHHHHH------------HHHHHHHHHHHhhh---
Q 005940 430 EYIPNGSLDTL--------------LFKPKDG---------SVLDWEQRFN------------IVKGIASGLLYLHE--- 471 (668)
Q Consensus 430 E~~~~gsL~~~--------------l~~~~~~---------~~l~~~~~~~------------i~~qia~gL~yLH~--- 471 (668)
||++|..+... ++....+ ..-.|..... ....+...+.++..
T Consensus 103 e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~ 182 (307)
T TIGR00938 103 EFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWP 182 (307)
T ss_pred EeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhh
Confidence 99988654211 1110000 0112221111 11123334555532
Q ss_pred -ccCCceEecCCCCCCEEECCCCCEEEEeecCce
Q 005940 472 -EWEQVVIHRDVKPSNALIDAEMNARLGDFGLAR 504 (668)
Q Consensus 472 -~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~ 504 (668)
....+++|+|+++.||+++++....|.||+.+.
T Consensus 183 ~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 183 RDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred hcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 235789999999999999988777899999764
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=96.64 E-value=0.00074 Score=80.96 Aligned_cols=160 Identities=14% Similarity=0.092 Sum_probs=115.5
Q ss_pred HHHHHHHHhcccccCceeEeeeec--ccCceEEEEEecCCCChhhhhcCCCC-CCCccHHHHHHHHHHHHHHHHHhhhc-
Q 005940 397 FAAEIESLGRLRHKNLVNLHGWCK--QKNDLLLVYEYIPNGSLDTLLFKPKD-GSVLDWEQRFNIVKGIASGLLYLHEE- 472 (668)
Q Consensus 397 f~~Ei~~l~~l~H~nIv~l~g~~~--~~~~~~lV~E~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~qia~gL~yLH~~- 472 (668)
...|...++...|+++.....-.. +..+.+.+++|+..|.+.+.+.+... ...+...-+.....+...+..-+|+.
T Consensus 1276 ll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~t 1355 (2724)
T KOG1826|consen 1276 LLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLT 1355 (2724)
T ss_pred hhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcc
Confidence 345555566678988887655443 33467889999999999999865432 23344444444444435555555542
Q ss_pred -cCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCCCCcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHH
Q 005940 473 -WEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVA 551 (668)
Q Consensus 473 -~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ell 551 (668)
...-.+|++||+-|.+|..+.++|++++|+.+...+ .........+++.|+.|++...-+++.++|+|..|+-+|+..
T Consensus 1356 nlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp-~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs 1434 (2724)
T KOG1826|consen 1356 NLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNP-VLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRS 1434 (2724)
T ss_pred cCCccchhhhhhhhccceecCCcccccccccccccCc-hHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHh
Confidence 234579999999999999999999999999984332 222334456788899999988888888999999999999998
Q ss_pred hCCCCC
Q 005940 552 TGRRPI 557 (668)
Q Consensus 552 tG~~p~ 557 (668)
-|..+|
T Consensus 1435 ~~n~~f 1440 (2724)
T KOG1826|consen 1435 DGNAYF 1440 (2724)
T ss_pred cccHHH
Confidence 888776
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.61 E-value=0.019 Score=61.39 Aligned_cols=142 Identities=20% Similarity=0.200 Sum_probs=83.6
Q ss_pred eeeeecCcEEEEEEEeCC----CCcEEEEEEEecCCchhHHHHHHHHHHHhcccccCce-eEeeeecccCceEEEEEecC
Q 005940 359 EVIGIGGFGSVYKGVLPT----TGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLV-NLHGWCKQKNDLLLVYEYIP 433 (668)
Q Consensus 359 ~~lG~G~~g~Vy~~~~~~----~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv-~l~g~~~~~~~~~lV~E~~~ 433 (668)
..|-.|-...+|+..... .+..|++|+......... +-.+|..++..+...++. ++++.+.. + .|+||++
T Consensus 42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~i-dR~~E~~~~~~l~~~gl~P~~~~~~~~-g---~v~efi~ 116 (344)
T PLN02236 42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFF-DRDDEIRTFECMSRHGQGPRLLGRFPN-G---RVEEFIH 116 (344)
T ss_pred EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeee-chHHHHHHHHHHHHcCCCCceEEEECC-c---eEEEeeC
Confidence 445556677899987532 236789998766543222 236789999888654444 45565533 2 5899998
Q ss_pred CCChhhh-----------------hcCCC-C--CCCccHHHHHHHHHHH-----------------HHHHHHh----hh-
Q 005940 434 NGSLDTL-----------------LFKPK-D--GSVLDWEQRFNIVKGI-----------------ASGLLYL----HE- 471 (668)
Q Consensus 434 ~gsL~~~-----------------l~~~~-~--~~~l~~~~~~~i~~qi-----------------a~gL~yL----H~- 471 (668)
+.+|..- +|... . .....|.++.++..++ ...+..| ..
T Consensus 117 g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~ 196 (344)
T PLN02236 117 ARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGD 196 (344)
T ss_pred CCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhccc
Confidence 8776421 11111 1 1122234333333221 1112222 11
Q ss_pred ccCCceEecCCCCCCEEECC-CCCEEEEeecCcee
Q 005940 472 EWEQVVIHRDVKPSNALIDA-EMNARLGDFGLARL 505 (668)
Q Consensus 472 ~~~~~ivHrDLkp~NIll~~-~~~~kl~DfGla~~ 505 (668)
.....++|+|+++.||++++ +..+++.||..+..
T Consensus 197 ~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 197 DQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred CCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 22357899999999999986 46799999988753
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.44 E-value=0.0031 Score=64.79 Aligned_cols=138 Identities=14% Similarity=0.083 Sum_probs=92.8
Q ss_pred CcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCc------------------h----hHHHHHHHHHHHhcccc--
Q 005940 354 GFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSL------------------Q----GMREFAAEIESLGRLRH-- 409 (668)
Q Consensus 354 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------------------~----~~~~f~~Ei~~l~~l~H-- 409 (668)
-++..++||-|--+.+|.+... .|.+.++|.-+.... . ..-...+|+..|+.|..
T Consensus 93 v~svGnqIGVGKESDIY~v~d~-~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~g 171 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVADE-EGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERG 171 (465)
T ss_pred hhhhccccccccccceEEEecC-CCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcC
Confidence 4678999999999999999984 588888885321110 0 01124567788887753
Q ss_pred cCceeEeeeecccCceEEEEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEE
Q 005940 410 KNLVNLHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALI 489 (668)
Q Consensus 410 ~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll 489 (668)
--+.+.++++. -++|||++.+-.|...-+- .+..++ ...+..-+.-|-. .|+||+|..--||++
T Consensus 172 fpVPkpiD~~R----H~Vvmelv~g~Pl~~v~~v------~d~~~l---y~~lm~~Iv~la~---~GlIHgDFNEFNimv 235 (465)
T KOG2268|consen 172 FPVPKPIDHNR----HCVVMELVDGYPLRQVRHV------EDPPTL---YDDLMGLIVRLAN---HGLIHGDFNEFNIMV 235 (465)
T ss_pred CCCCCcccccc----eeeHHHhhcccceeeeeec------CChHHH---HHHHHHHHHHHHH---cCceecccchheeEE
Confidence 34555566543 4789999988777655421 222222 2233333334444 899999999999999
Q ss_pred CCCCCEEEEeecCceeccC
Q 005940 490 DAEMNARLGDFGLARLYDH 508 (668)
Q Consensus 490 ~~~~~~kl~DfGla~~~~~ 508 (668)
+++..++++||-.+....+
T Consensus 236 ~dd~~i~vIDFPQmvS~sh 254 (465)
T KOG2268|consen 236 KDDDKIVVIDFPQMVSTSH 254 (465)
T ss_pred ecCCCEEEeechHhhccCC
Confidence 9999999999987665444
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.38 E-value=0.03 Score=58.03 Aligned_cols=75 Identities=25% Similarity=0.398 Sum_probs=49.6
Q ss_pred ccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCchhHHHHHHHHHHHhccc---ccCceeEeeeecccCceEEEEEec
Q 005940 356 KESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLR---HKNLVNLHGWCKQKNDLLLVYEYI 432 (668)
Q Consensus 356 ~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~---H~nIv~l~g~~~~~~~~~lV~E~~ 432 (668)
...+.|+.|....+|+.. .+++.+.||.-.. .....|..|.+-|+.|. --.+.+++++....+..+||+||+
T Consensus 20 ~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~---~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l 94 (288)
T PF03881_consen 20 TSIEPVSGGDINEAYRLD--TDGGSYFVKVNSE---SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFL 94 (288)
T ss_dssp -EEEEE--SSSSEEEEEE--TTS-EEEEEEEEG---GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE--
T ss_pred eeeEecCCCChhheEEEE--CCCccEEEEecCh---hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEee
Confidence 346778999999999987 4678899998762 23356788888888884 456788999888777789999999
Q ss_pred CCC
Q 005940 433 PNG 435 (668)
Q Consensus 433 ~~g 435 (668)
+.+
T Consensus 95 ~~~ 97 (288)
T PF03881_consen 95 EMG 97 (288)
T ss_dssp ---
T ss_pred cCC
Confidence 876
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.27 E-value=0.051 Score=56.86 Aligned_cols=129 Identities=20% Similarity=0.262 Sum_probs=82.0
Q ss_pred EEEEEEeCCCCcEEEEEEEec--CCchhHHHHHHHHHHHhcccc--cCceeEeeeecccC--ceEEEEEecCCCChhhhh
Q 005940 368 SVYKGVLPTTGGEVAVKKITR--NSLQGMREFAAEIESLGRLRH--KNLVNLHGWCKQKN--DLLLVYEYIPNGSLDTLL 441 (668)
Q Consensus 368 ~Vy~~~~~~~~~~vavK~~~~--~~~~~~~~f~~Ei~~l~~l~H--~nIv~l~g~~~~~~--~~~lV~E~~~~gsL~~~l 441 (668)
.+|+... ++++++++ ... ..........+|.++++.+.- --....++.|.++. ..+.||+|+++..+.+.+
T Consensus 40 ~t~~~~~--~~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~~~ 116 (321)
T COG3173 40 DTFRLGD--TGQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWSAL 116 (321)
T ss_pred ceEEEec--CCceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccCcC
Confidence 3555444 36778887 331 223344556678888887742 34455677786665 779999999986554433
Q ss_pred cCCCCCCCccHHHHHHHH-HHHHHHHHHhhh-------------------------------------------------
Q 005940 442 FKPKDGSVLDWEQRFNIV-KGIASGLLYLHE------------------------------------------------- 471 (668)
Q Consensus 442 ~~~~~~~~l~~~~~~~i~-~qia~gL~yLH~------------------------------------------------- 471 (668)
.... . . .+++ ..+++.|+-||+
T Consensus 117 ~~~~----~--~--~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~ 188 (321)
T COG3173 117 PPES----L--G--RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLE 188 (321)
T ss_pred Cccc----c--h--HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHH
Confidence 2110 0 1 1222 355566666662
Q ss_pred ------ccCCceEecCCCCCCEEECCCCCEEEEeecCceecc
Q 005940 472 ------EWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYD 507 (668)
Q Consensus 472 ------~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~ 507 (668)
.....++|+|+++.|++++.+.-+=+.||+++..-+
T Consensus 189 ~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGD 230 (321)
T COG3173 189 ANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGD 230 (321)
T ss_pred hcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccCC
Confidence 013569999999999999998889999999987544
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.25 E-value=0.053 Score=56.02 Aligned_cols=31 Identities=32% Similarity=0.583 Sum_probs=25.6
Q ss_pred CceEecCCCCCCEEECCCCC-EEEEeecCcee
Q 005940 475 QVVIHRDVKPSNALIDAEMN-ARLGDFGLARL 505 (668)
Q Consensus 475 ~~ivHrDLkp~NIll~~~~~-~kl~DfGla~~ 505 (668)
..++|+|+++.||++++++. .-|.||+.+..
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 45899999999999997555 46999998753
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=95.76 E-value=0.16 Score=54.99 Aligned_cols=80 Identities=16% Similarity=0.131 Sum_probs=52.8
Q ss_pred ceeeeecCcEEEEEEEeCCCCcEEEEEEEecC----Cc---hhHHHHHHHHHHHhccc---ccCceeEeeeecccCceEE
Q 005940 358 SEVIGIGGFGSVYKGVLPTTGGEVAVKKITRN----SL---QGMREFAAEIESLGRLR---HKNLVNLHGWCKQKNDLLL 427 (668)
Q Consensus 358 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~---~~~~~f~~Ei~~l~~l~---H~nIv~l~g~~~~~~~~~l 427 (668)
.+.||.|....||+... .++.++||+-... .. -....-..|.+.|+.+. ..++.+++.+|. +..++
T Consensus 37 ~~eiggGn~N~VyrV~~--~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vl 112 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVS--SSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALI 112 (418)
T ss_pred EEEcCCCceeeEEEEEc--CCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEE
Confidence 57889999999999887 3457999975411 11 12233334566666553 357888999887 44678
Q ss_pred EEEecCC--CChhhhh
Q 005940 428 VYEYIPN--GSLDTLL 441 (668)
Q Consensus 428 V~E~~~~--gsL~~~l 441 (668)
+||++++ ..+.+-+
T Consensus 113 vME~L~~~~~ilr~~L 128 (418)
T PLN02756 113 GMRYLEPPHIILRKGL 128 (418)
T ss_pred EEeecCCcceehhhhh
Confidence 9999976 3454443
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=95.64 E-value=0.082 Score=56.17 Aligned_cols=142 Identities=18% Similarity=0.205 Sum_probs=81.7
Q ss_pred eeeeecCcEEEEEEEeCCC---CcEEEEEEEecCCchhHHHHHHHHHHHhcccccCce-eEeeeecccCceEEEEEecCC
Q 005940 359 EVIGIGGFGSVYKGVLPTT---GGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLV-NLHGWCKQKNDLLLVYEYIPN 434 (668)
Q Consensus 359 ~~lG~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv-~l~g~~~~~~~~~lV~E~~~~ 434 (668)
+.|..|-...+|+...... +..|++|+....... .-+-.+|..+++.+...++- ++++++. .+ +|.+|+++
T Consensus 20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~-~IdR~~E~~il~~l~~~gl~P~~l~~~~-~G---~i~~fi~g 94 (330)
T PLN02421 20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDY-VIDRERELQAIKYLSAAGFGAKLLGVFG-NG---MIQSFINA 94 (330)
T ss_pred EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCe-EechHHHHHHHHHHHhcCCCCceeEEeC-Cc---EeehhhcC
Confidence 4455566678898876432 237889987654332 22335788899888765553 4566553 22 58999977
Q ss_pred CChhhh-----------------hcCCC-C--CCCccHHHHHHHHHHH----------------------HHHHHHhhh-
Q 005940 435 GSLDTL-----------------LFKPK-D--GSVLDWEQRFNIVKGI----------------------ASGLLYLHE- 471 (668)
Q Consensus 435 gsL~~~-----------------l~~~~-~--~~~l~~~~~~~i~~qi----------------------a~gL~yLH~- 471 (668)
..|..- +|... . ...-.|..+.++..++ ..-+..+..
T Consensus 95 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~ 174 (330)
T PLN02421 95 RTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEI 174 (330)
T ss_pred CCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHH
Confidence 665321 11111 1 1112344333333222 111211111
Q ss_pred ----ccCCceEecCCCCCCEEECC-CCCEEEEeecCcee
Q 005940 472 ----EWEQVVIHRDVKPSNALIDA-EMNARLGDFGLARL 505 (668)
Q Consensus 472 ----~~~~~ivHrDLkp~NIll~~-~~~~kl~DfGla~~ 505 (668)
......+|+|+.+.||++++ ++.+++.||..|..
T Consensus 175 ~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 175 TDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred hccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 11245899999999999975 47899999998753
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.58 E-value=0.14 Score=54.06 Aligned_cols=140 Identities=21% Similarity=0.299 Sum_probs=82.2
Q ss_pred eeeecCcEEEEEEEeCCCCcEEEEEEEecCCchhHHHHHHHHHHHhcccccC------ceeEeeee--cccC--ceEEEE
Q 005940 360 VIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKN------LVNLHGWC--KQKN--DLLLVY 429 (668)
Q Consensus 360 ~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~n------Iv~l~g~~--~~~~--~~~lV~ 429 (668)
.|.+ .-..+|+.... ++.+++|+.... ....+...|+..+..|.-.. +..+-|-. .-.+ ..+-++
T Consensus 33 ~l~s-~eN~~f~~~~~--~g~~iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf 107 (331)
T COG2334 33 GLNS-EENSNFRVQTE--DGRYILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALF 107 (331)
T ss_pred cccc-ccCceEEEEec--CCCeEEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEE
Confidence 3444 45678888773 344588888765 33456667788887774222 22222211 1123 678899
Q ss_pred EecCCCChhh-h--------------hcC---------CCCCCCccHHH-------------HHHHHHHHHHHHHHhhhc
Q 005940 430 EYIPNGSLDT-L--------------LFK---------PKDGSVLDWEQ-------------RFNIVKGIASGLLYLHEE 472 (668)
Q Consensus 430 E~~~~gsL~~-~--------------l~~---------~~~~~~l~~~~-------------~~~i~~qia~gL~yLH~~ 472 (668)
+|++|..+.. . |+. +.......|.. ......++...+..+.+.
T Consensus 108 ~~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~ 187 (331)
T COG2334 108 EYLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLAR 187 (331)
T ss_pred EecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhh
Confidence 9999988873 1 010 01111234430 111233344444444432
Q ss_pred ----cCCc---eEecCCCCCCEEECCCCC-EEEEeecCce
Q 005940 473 ----WEQV---VIHRDVKPSNALIDAEMN-ARLGDFGLAR 504 (668)
Q Consensus 473 ----~~~~---ivHrDLkp~NIll~~~~~-~kl~DfGla~ 504 (668)
+... +||+|+.|.||+++.+.. .-+.||+-++
T Consensus 188 ~~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 188 LPAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred chhhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 2233 999999999999999986 8899999775
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=95.47 E-value=0.056 Score=53.32 Aligned_cols=123 Identities=20% Similarity=0.230 Sum_probs=62.0
Q ss_pred CcEEEEEEEecCCchhHHHHHHHHHHHhcccccCc-eeEeeeecccCceEEEEEecCCCChhhh-h--------------
Q 005940 378 GGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNL-VNLHGWCKQKNDLLLVYEYIPNGSLDTL-L-------------- 441 (668)
Q Consensus 378 ~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nI-v~l~g~~~~~~~~~lV~E~~~~gsL~~~-l-------------- 441 (668)
++.|+||+..... ...-.-..|..+++.+...++ .++++.+.+. .|+||+++..|..- +
T Consensus 2 ~~~~~~Ri~g~~t-~~~idr~~E~~~~~~l~~~g~~p~~~~~~~~g----~v~e~i~g~~l~~~~~~~~~~~~~iA~~l~ 76 (211)
T PF01633_consen 2 PEKYLVRIPGEGT-ENFIDRENENEALKLLSEAGLGPKIIYFFENG----RVEEFIEGRTLSPEDFRNPEILKRIAKLLA 76 (211)
T ss_dssp TSEEEEEEEESCG-CSHHHHHHHHHHHHHHHHTTSSS-EEEEETTE----EEEE--SSEE--CGGGGSHHHHHHHHHHHH
T ss_pred CCEEEEEeCCCCc-ccccCHHHHHHHHHHHHHcCCCCeEEEEcCCC----cEEEEecccccChhhccChHHHHHHHHHHH
Confidence 4678888887663 333455688999998875554 4556655432 57799976665321 0
Q ss_pred --cC--C--CCCCCccHHHHHHH----------------------HHHHHHHHHHhhh-----ccCCceEecCCCCCCEE
Q 005940 442 --FK--P--KDGSVLDWEQRFNI----------------------VKGIASGLLYLHE-----EWEQVVIHRDVKPSNAL 488 (668)
Q Consensus 442 --~~--~--~~~~~l~~~~~~~i----------------------~~qia~gL~yLH~-----~~~~~ivHrDLkp~NIl 488 (668)
|. . .....--|..+..+ ..++..-+..+.+ .....++|+|+.+.||+
T Consensus 77 ~lH~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~v~cHnDl~~~Nil 156 (211)
T PF01633_consen 77 KLHSIPISPNSKKPDLWDRIDKYMNKKSEFLFKRKKKKKSIDKEDLEDLQEELEELEKLLEKSNSPLVFCHNDLNPGNIL 156 (211)
T ss_dssp HHHTHHHTTSSSS-HHHHHHHHHHHHHHTCCCCHHTTTCHHHHHHHHHHHHHHHHHHHHHHTSCGGEEEE-S--SGGGEE
T ss_pred HHhhcccccccCcchHHHHhhhhccchhhhhhhhhhhccccccCCHHHHHHHHhhhhhhhhccCCCceEeeccCccccEE
Confidence 10 0 01111112222222 0111111222111 11257899999999999
Q ss_pred E-CCCCCEEEEeecCcee
Q 005940 489 I-DAEMNARLGDFGLARL 505 (668)
Q Consensus 489 l-~~~~~~kl~DfGla~~ 505 (668)
+ +.++.++++||..|..
T Consensus 157 ~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 157 INNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp ETSSSSCEEE--GTT-EE
T ss_pred eccCCCeEEEecHHHHhh
Confidence 9 8889999999998864
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=95.20 E-value=0.11 Score=55.24 Aligned_cols=73 Identities=14% Similarity=0.098 Sum_probs=45.5
Q ss_pred eeeecCcEEEEEEEeCCCCcEEEEEEEec-------CCchhHHHHHHHHHHHhccc--ccC-ceeEeeeecccCceEEEE
Q 005940 360 VIGIGGFGSVYKGVLPTTGGEVAVKKITR-------NSLQGMREFAAEIESLGRLR--HKN-LVNLHGWCKQKNDLLLVY 429 (668)
Q Consensus 360 ~lG~G~~g~Vy~~~~~~~~~~vavK~~~~-------~~~~~~~~f~~Ei~~l~~l~--H~n-Iv~l~g~~~~~~~~~lV~ 429 (668)
.||.|....||++..+..++.|+||.-.. ...-..++..-|.+.|+... .|. +.+++.+ ++....+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence 47899999999999854336899997421 11222344456667776653 343 4444433 344566899
Q ss_pred EecCC
Q 005940 430 EYIPN 434 (668)
Q Consensus 430 E~~~~ 434 (668)
|+++.
T Consensus 80 EdL~~ 84 (370)
T TIGR01767 80 EDLSH 84 (370)
T ss_pred hhCcc
Confidence 99864
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=95.18 E-value=0.17 Score=53.00 Aligned_cols=30 Identities=20% Similarity=0.205 Sum_probs=25.9
Q ss_pred CCceEecCCCCCCEEECCCCCEEEEeecCce
Q 005940 474 EQVVIHRDVKPSNALIDAEMNARLGDFGLAR 504 (668)
Q Consensus 474 ~~~ivHrDLkp~NIll~~~~~~kl~DfGla~ 504 (668)
..+++|+|+++.||+++. +.+.|.||+.+.
T Consensus 186 ~~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 186 IRGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred cCceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 368999999999999987 678999999654
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 668 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 5e-53 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 1e-51 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 2e-38 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 1e-37 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-33 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-33 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 3e-33 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 1e-31 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 6e-26 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 1e-25 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 4e-23 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 1e-22 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 6e-22 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 6e-22 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 2e-21 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 2e-21 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 3e-21 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 3e-21 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 6e-21 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 6e-21 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 6e-21 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 6e-21 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 7e-21 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 8e-21 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-20 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 1e-20 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 1e-20 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-20 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-20 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 5e-20 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 5e-20 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 6e-20 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 6e-20 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 6e-20 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 6e-20 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 6e-20 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 6e-20 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 6e-20 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 6e-20 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 6e-20 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 8e-20 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-19 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-19 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 1e-19 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 1e-19 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-19 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-19 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-19 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 2e-19 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 3e-19 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 3e-19 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 3e-19 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-19 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 3e-19 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 3e-19 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 3e-19 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 4e-19 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 5e-19 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 7e-19 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 7e-19 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 7e-19 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 7e-19 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 8e-19 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 8e-19 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 9e-19 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 9e-19 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-18 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 1e-18 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 1e-18 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 1e-18 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 1e-18 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 1e-18 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-18 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-18 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 2e-18 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-18 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 3e-18 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 5e-18 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-18 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 5e-18 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 5e-18 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-18 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 7e-18 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 7e-18 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 8e-18 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 8e-18 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 9e-18 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 9e-18 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 9e-18 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 9e-18 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 9e-18 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 9e-18 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 9e-18 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 1e-17 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 1e-17 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-17 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 1e-17 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-17 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-17 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 1e-17 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 1e-17 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-17 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-17 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-17 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 2e-17 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-17 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-17 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-17 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-17 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-17 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-17 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 3e-17 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-17 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 3e-17 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 3e-17 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 3e-17 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 3e-17 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 3e-17 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 3e-17 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 3e-17 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 3e-17 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 3e-17 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 3e-17 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 3e-17 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 3e-17 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 3e-17 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 4e-17 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 4e-17 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 4e-17 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 4e-17 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 4e-17 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 4e-17 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 4e-17 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-17 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 4e-17 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-17 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 4e-17 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 4e-17 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 4e-17 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-17 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 4e-17 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 4e-17 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-17 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 4e-17 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-17 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 4e-17 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 4e-17 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-17 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 4e-17 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 4e-17 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 5e-17 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 5e-17 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 5e-17 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 5e-17 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 5e-17 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 5e-17 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 5e-17 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 5e-17 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 6e-17 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 6e-17 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 6e-17 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 6e-17 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 7e-17 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-17 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 7e-17 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 8e-17 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 8e-17 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 8e-17 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 8e-17 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 9e-17 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 9e-17 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 9e-17 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 9e-17 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 1e-16 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-16 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 1e-16 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 1e-16 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 1e-16 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 1e-16 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-16 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 1e-16 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 1e-16 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 1e-16 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 1e-16 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-16 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-16 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 1e-16 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 1e-16 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-16 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 1e-16 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-16 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-16 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 1e-16 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-16 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-16 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 2e-16 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-16 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-16 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-16 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-16 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 2e-16 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-16 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 2e-16 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 2e-16 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-16 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 2e-16 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 2e-16 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 2e-16 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-16 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 2e-16 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 2e-16 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-16 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 2e-16 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-16 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-16 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-16 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 2e-16 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 2e-16 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-16 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-16 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-16 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 2e-16 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-16 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-16 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-16 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-16 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-16 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-16 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-16 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 2e-16 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 3e-16 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-16 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 3e-16 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-16 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 3e-16 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 3e-16 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-16 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-16 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 3e-16 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 3e-16 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 3e-16 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 3e-16 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 3e-16 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 3e-16 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 3e-16 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 3e-16 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 3e-16 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 3e-16 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 3e-16 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-16 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 3e-16 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 4e-16 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 4e-16 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-16 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 4e-16 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 4e-16 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-16 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 5e-16 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 5e-16 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 5e-16 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-16 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 5e-16 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 5e-16 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 5e-16 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 6e-16 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 6e-16 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 6e-16 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 6e-16 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 6e-16 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 6e-16 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 7e-16 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 7e-16 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 8e-16 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 8e-16 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 8e-16 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 8e-16 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 8e-16 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 9e-16 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 9e-16 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 9e-16 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 1e-15 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 1e-15 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 1e-15 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-15 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 1e-15 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 1e-15 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 1e-15 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 1e-15 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 1e-15 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 1e-15 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-15 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 1e-15 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-15 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-15 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 1e-15 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-15 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-15 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-15 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 2e-15 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 2e-15 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-15 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 2e-15 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-15 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-15 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-15 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-15 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 2e-15 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 2e-15 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 2e-15 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 3e-15 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 3e-15 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 3e-15 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 3e-15 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 3e-15 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 3e-15 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 3e-15 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-15 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 3e-15 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 3e-15 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-15 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 3e-15 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 3e-15 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 3e-15 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 3e-15 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 3e-15 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 3e-15 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 4e-15 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-15 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 4e-15 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 4e-15 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-15 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 5e-15 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 5e-15 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 5e-15 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 6e-15 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-15 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 6e-15 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 6e-15 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 6e-15 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 7e-15 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 7e-15 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 7e-15 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 8e-15 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 9e-15 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 9e-15 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 9e-15 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-15 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 9e-15 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 9e-15 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 9e-15 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 9e-15 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 1e-14 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 1e-14 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 1e-14 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 1e-14 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 1e-14 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 1e-14 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 1e-14 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 1e-14 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-14 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-14 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 1e-14 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 1e-14 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 1e-14 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 1e-14 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 1e-14 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 1e-14 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 1e-14 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-14 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 1e-14 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-14 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 1e-14 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 1e-14 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-14 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 1e-14 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-14 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 2e-14 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-14 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-14 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-14 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-14 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-14 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-14 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-14 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-14 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-14 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 2e-14 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-14 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-14 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-14 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 2e-14 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-14 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-14 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-14 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-14 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-14 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-14 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 2e-14 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-14 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 2e-14 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 2e-14 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-14 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 2e-14 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 3e-14 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 3e-14 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-14 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 3e-14 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 3e-14 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-14 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 3e-14 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-14 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 3e-14 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 3e-14 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-14 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-14 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-14 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-14 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 3e-14 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 3e-14 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 3e-14 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 3e-14 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 3e-14 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 3e-14 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 3e-14 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-14 | ||
| 2fmd_A | 240 | Structural Basis Of Carbohydrate Recognition By Bow | 3e-14 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 3e-14 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 4e-14 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 4e-14 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 4e-14 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 4e-14 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 4e-14 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 4e-14 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 4e-14 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 5e-14 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 5e-14 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 5e-14 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 5e-14 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 5e-14 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 5e-14 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 6e-14 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 6e-14 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 6e-14 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 6e-14 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 6e-14 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 6e-14 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 6e-14 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-14 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 7e-14 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 7e-14 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 9e-14 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 9e-14 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 1e-13 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 1e-13 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 1e-13 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 1e-13 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 1e-13 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 1e-13 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 2e-13 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 2e-13 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-13 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-13 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 2e-13 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 2e-13 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 2e-13 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 2e-13 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-13 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 2e-13 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-13 | ||
| 1gz9_A | 239 | High-Resolution Crystal Structure Of Erythrina Cris | 2e-13 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 2e-13 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 2e-13 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 2e-13 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 3e-13 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-13 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 3e-13 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 3e-13 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 3e-13 | ||
| 1avb_A | 226 | Arcelin-1 From Phaseolus Vulgaris L Length = 226 | 3e-13 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 3e-13 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 3e-13 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 3e-13 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 3e-13 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 3e-13 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 3e-13 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 3e-13 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 3e-13 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-13 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 3e-13 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-13 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 3e-13 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 3e-13 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 3e-13 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 3e-13 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 4e-13 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 4e-13 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 4e-13 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 4e-13 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 4e-13 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 4e-13 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 4e-13 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 4e-13 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 4e-13 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 4e-13 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 4e-13 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 4e-13 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 4e-13 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 4e-13 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-13 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-13 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 4e-13 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 4e-13 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 4e-13 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 4e-13 | ||
| 1fat_A | 252 | Phytohemagglutinin-L Length = 252 | 4e-13 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 4e-13 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 4e-13 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-13 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 5e-13 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 5e-13 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 5e-13 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-13 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 5e-13 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 5e-13 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 5e-13 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 5e-13 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 5e-13 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 5e-13 | ||
| 1hql_A | 257 | The Xenograft Antigen In Complex With The B4 Isolec | 5e-13 | ||
| 1gnz_A | 257 | Lectin I-B4 From Griffonia Simplicifolia (Gs I-B4)m | 5e-13 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 5e-13 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 5e-13 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 5e-13 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 5e-13 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 6e-13 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 6e-13 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 6e-13 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 6e-13 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 6e-13 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 6e-13 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 6e-13 | ||
| 1g8w_A | 233 | Improved Structure Of Phytohemagglutinin-L From The | 6e-13 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 6e-13 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 6e-13 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 6e-13 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 6e-13 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 6e-13 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 6e-13 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 6e-13 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 6e-13 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 7e-13 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 7e-13 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 7e-13 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 7e-13 | ||
| 3ujo_A | 281 | Galactose-Specific Seed Lectin From Dolichos Lablab | 7e-13 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 7e-13 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 7e-13 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 7e-13 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 7e-13 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 7e-13 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 7e-13 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 7e-13 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 7e-13 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 7e-13 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 7e-13 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 7e-13 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 7e-13 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 7e-13 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 7e-13 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 7e-13 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 7e-13 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 7e-13 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 7e-13 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 7e-13 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 7e-13 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 7e-13 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 7e-13 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 8e-13 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 8e-13 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 8e-13 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 8e-13 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 9e-13 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 9e-13 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 9e-13 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 9e-13 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 9e-13 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 1e-12 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 1e-12 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 1e-12 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 1e-12 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 1e-12 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 1e-12 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 1e-12 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 1e-12 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 1e-12 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 1e-12 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 1e-12 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 1e-12 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 1e-12 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-12 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 1e-12 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-12 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 2e-12 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-12 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 2e-12 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-12 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 2e-12 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-12 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-12 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-12 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-12 | ||
| 3n35_A | 242 | Erythrina Corallodendron Lectin Mutant (Y106g) With | 2e-12 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 2e-12 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-12 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-12 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-12 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-12 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 2e-12 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 2e-12 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-12 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-12 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-12 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-12 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-12 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 2e-12 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 3e-12 | ||
| 1sfy_A | 239 | Crystal Structure Of Recombinant Erythrina Corallod | 3e-12 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 3e-12 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 3e-12 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 3e-12 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 3e-12 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 3e-12 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 3e-12 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 3e-12 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-12 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 3e-12 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-12 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 3e-12 | ||
| 1ax0_A | 239 | Erythrina Corallodendron Lectin In Complex With N-A | 3e-12 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 3e-12 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 3e-12 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 3e-12 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 4e-12 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 4e-12 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-12 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 4e-12 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 4e-12 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 4e-12 | ||
| 1fyu_A | 255 | Crystal Structure Of Erythrina Corallodendron Lecti | 4e-12 | ||
| 1lte_A | 239 | Structure Of A Legume Lectin With An Ordered N-Link | 4e-12 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 4e-12 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 4e-12 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 5e-12 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 5e-12 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 5e-12 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 5e-12 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 5e-12 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 5e-12 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 5e-12 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 5e-12 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 5e-12 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 5e-12 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 5e-12 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 5e-12 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 5e-12 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 6e-12 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 6e-12 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 6e-12 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 6e-12 | ||
| 2sba_A | 253 | Soybean Agglutinin Complexed With 2,6-Pentasacchari | 6e-12 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 6e-12 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 6e-12 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 6e-12 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 6e-12 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 7e-12 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 7e-12 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 7e-12 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 7e-12 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 7e-12 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 7e-12 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 8e-12 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 8e-12 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 8e-12 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 8e-12 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 8e-12 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 8e-12 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 8e-12 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 9e-12 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 9e-12 | ||
| 1fny_A | 237 | Legume Lectin Of The Bark Of Robinia Pseudoacacia. | 9e-12 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 9e-12 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 9e-12 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 1e-11 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 1e-11 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 1e-11 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 1e-11 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 1e-11 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 1e-11 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-11 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 1e-11 | ||
| 2bqp_A | 234 | The Structure Of The Pea Lectin-D-Glucopyranose Com | 1e-11 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 1e-11 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 1e-11 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 2e-11 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 2e-11 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 2e-11 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 2e-11 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-11 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-11 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 2e-11 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 2e-11 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 2e-11 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-11 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 2e-11 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 2e-11 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 2e-11 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 2e-11 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-11 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-11 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-11 | ||
| 2e7q_A | 237 | Crystal Structure Of Basic Winged Bean Lectin In Co | 2e-11 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-11 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-11 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-11 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 2e-11 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 2e-11 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-11 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 2e-11 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 3e-11 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 3e-11 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-11 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 3e-11 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 3e-11 | ||
| 1wbl_A | 241 | Winged Bean Lectin Complexed With Methyl-Alpha-D-Ga | 3e-11 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 3e-11 | ||
| 1wbf_A | 242 | Winged Bean Lectin, Saccharide Free Form Length = 2 | 3e-11 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 3e-11 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 3e-11 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 3e-11 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 3e-11 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 3e-11 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 3e-11 | ||
| 3usu_A | 256 | Crystal Structure Of Butea Monosperma Seed Lectin L | 3e-11 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 3e-11 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 3e-11 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 3e-11 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 4e-11 | ||
| 3usu_B | 242 | Crystal Structure Of Butea Monosperma Seed Lectin L | 4e-11 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 4e-11 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 4e-11 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-11 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 5e-11 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 5e-11 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 5e-11 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 5e-11 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 5e-11 | ||
| 1qnw_A | 242 | Lectin Ii From Ulex Europaeus Length = 242 | 5e-11 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 5e-11 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 6e-11 | ||
| 3ipv_A | 251 | Crystal Structure Of Spatholobus Parviflorus Seed L | 6e-11 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-11 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 6e-11 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 6e-11 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 6e-11 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 7e-11 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 7e-11 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 7e-11 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 8e-11 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 8e-11 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 8e-11 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 8e-11 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 8e-11 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 9e-11 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 9e-11 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 9e-11 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 9e-11 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 9e-11 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 1e-10 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 1e-10 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 1e-10 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 1e-10 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 1e-10 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 1e-10 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 1e-10 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 1e-10 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 1e-10 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 1e-10 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 1e-10 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 1e-10 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 1e-10 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 1e-10 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 2e-10 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 2e-10 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 2e-10 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 2e-10 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 2e-10 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 2e-10 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 2e-10 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 2e-10 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 2e-10 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-10 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-10 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 2e-10 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 2e-10 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-10 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-10 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-10 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 2e-10 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-10 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 2e-10 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 2e-10 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 2e-10 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 2e-10 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 2e-10 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-10 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 2e-10 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 2e-10 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-10 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-10 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-10 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 3e-10 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 3e-10 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-10 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 3e-10 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 3e-10 | ||
| 3ipv_B | 239 | Crystal Structure Of Spatholobus Parviflorus Seed L | 3e-10 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 3e-10 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-10 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-10 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 3e-10 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-10 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 4e-10 | ||
| 1ioa_A | 240 | Arcelin-5, A Lectin-Like Defense Protein From Phase | 4e-10 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 4e-10 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 4e-10 | ||
| 1lul_A | 253 | Db58, A Legume Lectin From Dolichos Biflorus Length | 4e-10 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 4e-10 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 4e-10 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 5e-10 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 5e-10 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-10 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 5e-10 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 5e-10 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 5e-10 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 5e-10 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 5e-10 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 6e-10 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 6e-10 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 6e-10 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 6e-10 | ||
| 3zvx_A | 261 | Structure Of The Lectin From Platypodium Elegans In | 6e-10 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 6e-10 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 6e-10 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-10 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 6e-10 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 7e-10 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 7e-10 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 7e-10 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 7e-10 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 7e-10 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 7e-10 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 7e-10 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 7e-10 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 7e-10 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 8e-10 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 8e-10 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 8e-10 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 8e-10 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 8e-10 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 8e-10 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 8e-10 | ||
| 1dbn_A | 239 | Maackia Amurensis Leukoagglutinin (Lectin) With Sia | 8e-10 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 8e-10 | ||
| 1bjq_A | 253 | The Dolichos Biflorus Seed Lectin In Complex With A | 8e-10 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 8e-10 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 8e-10 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 9e-10 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-09 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-09 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 1e-09 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-09 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 1e-09 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 1e-09 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 1e-09 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 1e-09 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 1e-09 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 2e-09 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-09 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 2e-09 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 2e-09 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-09 | ||
| 2eig_A | 234 | Lotus Tetragonolobus Seed Lectin (Isoform) Length = | 2e-09 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-09 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-09 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 2e-09 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 2e-09 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 2e-09 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 2e-09 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 2e-09 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 2e-09 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 2e-09 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-09 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-09 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-09 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 2e-09 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 2e-09 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 2e-09 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 2e-09 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 2e-09 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-09 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 3e-09 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 3e-09 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 3e-09 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 3e-09 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 3e-09 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 3e-09 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 4e-09 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 4e-09 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 4e-09 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 4e-09 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 4e-09 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 4e-09 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 4e-09 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 5e-09 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 5e-09 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 5e-09 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 5e-09 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 6e-09 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 6e-09 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 7e-09 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 7e-09 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 7e-09 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 8e-09 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-08 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 1e-08 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 1e-08 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 1e-08 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 1e-08 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-08 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-08 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 1e-08 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-08 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 2e-08 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 2e-08 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 2e-08 | ||
| 1fay_A | 238 | Winged Bean Acidic Lectin Complexed With Methyl-Alp | 2e-08 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-08 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 2e-08 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 2e-08 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-08 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 2e-08 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 3e-08 | ||
| 1dhk_B | 223 | Structure Of Porcine Pancreatic Alpha-Amylase Lengt | 3e-08 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 3e-08 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 3e-08 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-08 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-08 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-08 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-08 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 4e-08 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 4e-08 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 4e-08 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 4e-08 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 4e-08 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-08 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 4e-08 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 4e-08 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 5e-08 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 5e-08 | ||
| 1viw_B | 205 | Tenebrio Molitor Alpha-Amylase-Inhibitor Complex Le | 5e-08 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 6e-08 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 7e-08 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 8e-08 | ||
| 1n47_A | 233 | Isolectin B4 From Vicia Villosa In Complex With The | 9e-08 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 9e-08 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 9e-08 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 2e-07 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 2e-07 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 2e-07 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 2e-07 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 2e-07 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 2e-07 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 3e-07 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 3e-07 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-07 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 3e-07 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 3e-07 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-07 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 3e-07 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 4e-07 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 4e-07 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 4e-07 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 4e-07 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 4e-07 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 5e-07 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 5e-07 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 5e-07 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 5e-07 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 9e-07 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 1e-06 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2FMD|A Chain A, Structural Basis Of Carbohydrate Recognition By Bowringia Milbraedii Seed Agglutinin Length = 240 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|1GZ9|A Chain A, High-Resolution Crystal Structure Of Erythrina Cristagalli Lectin In Complex With 2'-Alpha-L-Fucosyllactose Length = 239 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|1AVB|A Chain A, Arcelin-1 From Phaseolus Vulgaris L Length = 226 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|1FAT|A Chain A, Phytohemagglutinin-L Length = 252 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1HQL|A Chain A, The Xenograft Antigen In Complex With The B4 Isolectin Of Griffonia Simplicifolia Lectin-1 Length = 257 | Back alignment and structure |
|
| >pdb|1GNZ|A Chain A, Lectin I-B4 From Griffonia Simplicifolia (Gs I-B4)metal Free Form Length = 257 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1G8W|A Chain A, Improved Structure Of Phytohemagglutinin-L From The Kidney Bean Length = 233 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3UJO|A Chain A, Galactose-Specific Seed Lectin From Dolichos Lablab In Complex With Adenine And Galactose Length = 281 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3N35|A Chain A, Erythrina Corallodendron Lectin Mutant (Y106g) With N- Acetylgalactosamine Length = 242 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|1SFY|A Chain A, Crystal Structure Of Recombinant Erythrina Corallodandron Lectin Length = 239 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|1AX0|A Chain A, Erythrina Corallodendron Lectin In Complex With N-Actylgalactosamine Length = 239 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|1FYU|A Chain A, Crystal Structure Of Erythrina Corallodendron Lectin In Hexagonal Crystal Form Length = 255 | Back alignment and structure |
|
| >pdb|1LTE|A Chain A, Structure Of A Legume Lectin With An Ordered N-Linked Carbohydrate In Complex With Lactose Length = 239 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2SBA|A Chain A, Soybean Agglutinin Complexed With 2,6-Pentasaccharide Length = 253 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|1FNY|A Chain A, Legume Lectin Of The Bark Of Robinia Pseudoacacia. Length = 237 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2BQP|A Chain A, The Structure Of The Pea Lectin-D-Glucopyranose Complex Length = 234 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2E7Q|A Chain A, Crystal Structure Of Basic Winged Bean Lectin In Complex With B Blood Group Trisaccharide Length = 237 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1WBL|A Chain A, Winged Bean Lectin Complexed With Methyl-Alpha-D-Galactose Length = 241 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|1WBF|A Chain A, Winged Bean Lectin, Saccharide Free Form Length = 242 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3USU|A Chain A, Crystal Structure Of Butea Monosperma Seed Lectin Length = 256 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3USU|B Chain B, Crystal Structure Of Butea Monosperma Seed Lectin Length = 242 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|1QNW|A Chain A, Lectin Ii From Ulex Europaeus Length = 242 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3IPV|A Chain A, Crystal Structure Of Spatholobus Parviflorus Seed Lectin Length = 251 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3IPV|B Chain B, Crystal Structure Of Spatholobus Parviflorus Seed Lectin Length = 239 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|1IOA|A Chain A, Arcelin-5, A Lectin-Like Defense Protein From Phaseolus Vulgaris Length = 240 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1LUL|A Chain A, Db58, A Legume Lectin From Dolichos Biflorus Length = 253 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3ZVX|A Chain A, Structure Of The Lectin From Platypodium Elegans In Complex With A Trimannoside Length = 261 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|1DBN|A Chain A, Maackia Amurensis Leukoagglutinin (Lectin) With Sialyllactose Length = 239 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|1BJQ|A Chain A, The Dolichos Biflorus Seed Lectin In Complex With Adenine Length = 253 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2EIG|A Chain A, Lotus Tetragonolobus Seed Lectin (Isoform) Length = 234 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|1FAY|A Chain A, Winged Bean Acidic Lectin Complexed With Methyl-Alpha-D-Galactose (Monoclinic Form) Length = 238 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|1DHK|B Chain B, Structure Of Porcine Pancreatic Alpha-Amylase Length = 223 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|1VIW|B Chain B, Tenebrio Molitor Alpha-Amylase-Inhibitor Complex Length = 205 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|1N47|A Chain A, Isolectin B4 From Vicia Villosa In Complex With The Tn Antigen Length = 233 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 380 bits (977), Expect = e-128
Identities = 115/294 (39%), Positives = 170/294 (57%), Gaps = 10/294 (3%)
Query: 340 PHRFRYKDLYAATKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGM-REFA 398
RF ++L A+ F ++G GGFG VYKG L G VAVK++ QG +F
Sbjct: 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLAD-GTLVAVKRLKEERTQGGELQFQ 75
Query: 399 AEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEYIPNGSLDTLLF-KPKDGSVLDWEQRFN 457
E+E + H+NL+ L G+C + LLVY Y+ NGS+ + L +P+ LDW +R
Sbjct: 76 TEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQR 135
Query: 458 IVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNV 517
I G A GL YLH+ + +IHRDVK +N L+D E A +GDFGLA+L D+ TT V
Sbjct: 136 IALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAV 195
Query: 518 VGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPI------GSGDLLLVEWVREC 571
GT G+IAPE TGK+S +DVF YG++LLE+ TG+R D++L++WV+
Sbjct: 196 RGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGL 255
Query: 572 HQLGRILDVADPLLNSSYVVKEMELVLKLGLMC-SHKTQFRPTMRQVMRYLSGE 624
+ ++ + D L +Y +E+E ++++ L+C RP M +V+R L G+
Sbjct: 256 LKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD 309
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 353 bits (909), Expect = e-118
Identities = 106/294 (36%), Positives = 155/294 (52%), Gaps = 11/294 (3%)
Query: 341 HRFRYKDLYAATKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAE 400
+R DL AT F +IG G FG VYKGVL G +VA+K+ T S QG+ EF E
Sbjct: 27 YRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRD-GAKVALKRRTPESSQGIEEFETE 85
Query: 401 IESLGRLRHKNLVNLHGWCKQKNDLLLVYEYIPNGSLDTLLF-KPKDGSVLDWEQRFNIV 459
IE+L RH +LV+L G+C ++N+++L+Y+Y+ NG+L L+ + WEQR I
Sbjct: 86 IETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEIC 145
Query: 460 KGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPH-TTNVV 518
G A GL YLH +IHRDVK N L+D ++ DFG+++ H +T V
Sbjct: 146 IGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVK 202
Query: 519 GTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPI----GSGDLLLVEWVRECHQL 574
GT GYI PE G+ + SDV+++G++L EV R I + L EW E H
Sbjct: 203 GTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNN 262
Query: 575 GRILDVADPLLNSSYVVKEMELVLKLGLMC-SHKTQFRPTMRQVMRYLSGEKQL 627
G++ + DP L + + + C + ++ RP+M V+ L +L
Sbjct: 263 GQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRL 316
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 349 bits (898), Expect = e-116
Identities = 97/299 (32%), Positives = 147/299 (49%), Gaps = 22/299 (7%)
Query: 340 PHRFRYKDLYAATKGFKESE------VIGIGGFGSVYKGVLPTTGGEVAVKK----ITRN 389
H F + +L T F E +G GGFG VYKG + VAVKK +
Sbjct: 12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN--NTTVAVKKLAAMVDIT 69
Query: 390 SLQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSV 449
+ + ++F EI+ + + +H+NLV L G+ +DL LVY Y+PNGSL L
Sbjct: 70 TEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPP 129
Query: 450 LDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHG 509
L W R I +G A+G+ +LHE IHRD+K +N L+D A++ DFGLAR +
Sbjct: 130 LSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDFGLARASEKF 186
Query: 510 GMPH-TTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSG--DLLLVE 566
T+ +VGT Y+APE G+ + SD++++G++LLE+ TG + LL++
Sbjct: 187 AQTVMTSRIVGTTAYMAPEAL-RGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLD 245
Query: 567 WVRECHQ-LGRILDVADPLLNSSYVVKEMELVLKLGLMC-SHKTQFRPTMRQVMRYLSG 623
E I D D +N +E + + C K RP +++V + L
Sbjct: 246 IKEEIEDEEKTIEDYIDKKMN-DADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQE 303
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 239 bits (612), Expect = 8e-74
Identities = 77/308 (25%), Positives = 128/308 (41%), Gaps = 35/308 (11%)
Query: 343 FRYKDLYAATKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIE 402
++LY + + EV G FG V+K L VAVK Q + E+
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDKQSW-QNEYEVY 70
Query: 403 SLGRLRHKNLVNLHGWCKQKND----LLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNI 458
SL ++H+N++ G K+ L L+ + GSL L V+ W + +I
Sbjct: 71 SLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN----VVSWNELCHI 126
Query: 459 VKGIASGLLYLHEE-------WEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGM 511
+ +A GL YLHE+ + + HRD+K N L+ + A + DFGLA ++ G
Sbjct: 127 AETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKS 186
Query: 512 PH-TTNVVGTFGYIAPELTQTG-----KASTSSDVFAYGILLLEVATGRRPIGS----GD 561
T VGT Y+APE+ + A D++A G++L E+A+
Sbjct: 187 AGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYM 246
Query: 562 LLLVEWVRECHQLGRILDV-----ADPLLNSSYVVKE-MELVLKLGLMC-SHKTQFRPTM 614
L E + + L + +V P+L + M ++ + C H + R +
Sbjct: 247 LPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSA 306
Query: 615 RQVMRYLS 622
V ++
Sbjct: 307 GCVGERIT 314
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 207 bits (528), Expect = 1e-61
Identities = 70/235 (29%), Positives = 118/235 (50%), Gaps = 19/235 (8%)
Query: 324 RKWSNSETLEDWEKDCPHRFRYKDLYAATKGFKESEVIGIGGFGSVYKGVLPTTGGEVAV 383
+ + +D + + DL E IG G FG+V++ G +VAV
Sbjct: 21 LYFQGAMDGDDMDIP------WCDL-------NIKEKIGAGSFGTVHRAEW--HGSDVAV 65
Query: 384 KKITRNSLQG--MREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEYIPNGSLDTLL 441
K + + EF E+ + RLRH N+V G Q +L +V EY+ GSL LL
Sbjct: 66 KILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLL 125
Query: 442 FKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFG 501
K LD +R ++ +A G+ YLH ++HR++K N L+D + ++ DFG
Sbjct: 126 HKSGAREQLDERRRLSMAYDVAKGMNYLH-NRNPPIVHRNLKSPNLLVDKKYTVKVCDFG 184
Query: 502 LARLYDHGGMPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRP 556
L+RL + + + GT ++APE+ + ++ SDV+++G++L E+AT ++P
Sbjct: 185 LSRLKASTFL-SSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQP 238
|
| >2fmd_A Lectin, agglutinin, BMA; legume lectin, beta sandwich, protein-carbohydrate complex, sugar binding protein; HET: MAN; 1.90A {Bowringia mildbraedii} Length = 240 | Back alignment and structure |
|---|
Score = 200 bits (508), Expect = 7e-60
Identities = 74/261 (28%), Positives = 114/261 (43%), Gaps = 27/261 (10%)
Query: 25 SQSSSFIFQGFNGGATNLSLQGAEIIKPSGALKLT------NRSRYVIGHAFYVKPIQMF 78
+ S F F F G +L QG + + AL+LT N +G A Y PI+++
Sbjct: 1 ANSVCFTFTDFESGQQDLIFQGDASVGSNKALQLTKVDSKGNPQGGSVGRALYTAPIRLW 60
Query: 79 DTSASPSPNASSFSTTFVFEISTPRSGRGGHGLAFLLAPSTKLPGAQPEHYLGILNSTNN 138
S +SF TTF F IS S F+ +P TK+P LG+ S+NN
Sbjct: 61 Q----SSSLVASFETTFTFSISQGSSTPADALTFFIASPDTKIPSGSGGRLLGLFGSSNN 116
Query: 139 GEPSNHILIVEFDTVNGFNDKAENQGNHVGIGINTMFSNRSEPASYYINGTDHKEEMTLE 198
N ++ VEFDT + + H+GI +N++ S + +
Sbjct: 117 AGSDNGVVSVEFDTYPNTDI-GDPNYRHIGIDVNSIRSKAASKWDWQ------------- 162
Query: 199 SGEPIQAWIEYDGEQKVLNVTISPAEIGKPMRPLISFGVNLTGYIKETMYVGFSASTGEK 258
+G+ A I Y+ K L+V S ++SF V L + + VGFSA+TG+
Sbjct: 163 NGKTATAHISYNSASKRLSVVSSY---PNSSPVVVSFDVELNNVBPBWVRVGFSATTGQY 219
Query: 259 SSSHYILGWSFSLNGVAPALN 279
+ ++ IL WSF + + N
Sbjct: 220 TQTNNILAWSFRSSLMGYQAN 240
|
| >1hql_A Lectin; xenograft antigen, sugar BI protein; HET: GLA MBG NAG; 2.20A {Griffonia simplicifolia} SCOP: b.29.1.1 PDB: 1gnz_A* Length = 257 | Back alignment and structure |
|---|
Score = 199 bits (506), Expect = 2e-59
Identities = 77/274 (28%), Positives = 126/274 (45%), Gaps = 29/274 (10%)
Query: 24 QSQSSSFIFQGFNG-GATNLSLQGAEIIKPSGALKLTNRSRYV------IGHAFYVKPIQ 76
+S S SF F F ++ QG +G L+L ++Y G A Y P+Q
Sbjct: 1 ESDSVSFTFPNFWSDVEDSIIFQGDANT-TAGTLQLCKTNQYGTPLQWSAGRALYSDPVQ 59
Query: 77 MFDTSASPSPNASSFSTTFVFEISTPRSGRGGHGLAFLLAPSTKLPGAQPEHYLGILNST 136
++D + + + +SF T F F + +G GLAF LAP YLG+ N +
Sbjct: 60 LWD---NKTESVASFYTEFTFFLKITGNG-PADGLAFFLAPP-DSDVKDAGEYLGLFNKS 114
Query: 137 NNGEPS-NHILIVEFDTVNGFNDKAENQGNHVGIGINTMFSNRSEPASYYINGTDHKEEM 195
+PS N ++ VEFDT N + H+GI +N++ S ++ +
Sbjct: 115 TATQPSKNQVVAVEFDTWTNPNFPEPS-YRHIGINVNSIVSVATKRWE----------DS 163
Query: 196 TLESGEPIQAWIEYDGEQKVLNVTISPAEIGKPMRPLISFGVNLTGYIKETMYVGFSAST 255
+ SG+ A I YDG ++L V +S ++S V++ + E++ VG SAST
Sbjct: 164 DIFSGKIATARISYDGSAEILTVVLSYP---DGSDYILSHSVDMRQNLPESVRVGISAST 220
Query: 256 GE-KSSSHYILGWSFSLNGVAPALNVSELPKPPK 288
G + + YIL W FS N + ++ + P+ +
Sbjct: 221 GNNQFLTVYILSWRFSSNLQSTSVKAAMEPEITR 254
|
| >1sbf_A Soybean agglutinin; lectin; HET: NAG GAL; 2.43A {Glycine max} SCOP: b.29.1.1 PDB: 1sbd_A* 1sbe_A* 1g9f_A* 2sba_A* Length = 253 | Back alignment and structure |
|---|
Score = 198 bits (504), Expect = 4e-59
Identities = 71/271 (26%), Positives = 115/271 (42%), Gaps = 33/271 (12%)
Query: 25 SQSSSFIFQGFNGGATNLSLQGAEIIKPSGALKLTNRSR------YVIGHAFYVKPIQMF 78
+++ SF + F N+ LQG I+ SG L+L +G A Y PI ++
Sbjct: 1 AETVSFSWNKFVPKQPNMILQGDAIVTSSGKLQLNKVDENGTPKPSSLGRALYSTPIHIW 60
Query: 79 DTSASPSPNASSFSTTFVFEISTPRSGRGGHGLAFLLAPSTKLPGAQPEHYLGILNSTNN 138
D + + +SF+ +F F P + R GLAF LAP P + G L N
Sbjct: 61 D---KETGSVASFAASFNFTFYAPDTKRLADGLAFFLAPIDTKPQT----HAGYLGLFNE 113
Query: 139 GEPSNHILIVEFDTVNGFNDKAENQGNHVGIGINTMFSNRSEPASYYINGTDHKEEMTLE 198
E + ++ VEFDT D H+GI +N++ S ++ L
Sbjct: 114 NESGDQVVAVEFDTFRNSWD---PPNPHIGINVNSIRSIKTTS-------------WDLA 157
Query: 199 SGEPIQAWIEYDGEQKVLNVTISPAEIGKPMRPLISFGVNLTGYIKETMYVGFSASTGE- 257
+ + + I YD +L ++ + ++S V+L + E + +GFSA+TG
Sbjct: 158 NNKVAKVLITYDASTSLLVASLVYP--SQRTSNILSDVVDLKTSLPEWVRIGFSAATGLD 215
Query: 258 -KSSSHYILGWSFSLNGVAPALNVSELPKPP 287
SH +L WSF+ N + N+ L
Sbjct: 216 IPGESHDVLSWSFASNLPHASSNIDPLDLTS 246
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 200 bits (510), Expect = 4e-59
Identities = 67/203 (33%), Positives = 98/203 (48%), Gaps = 11/203 (5%)
Query: 355 FKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVN 414
+ EV+G G FG V K +VA+K+I S + F E+ L R+ H N+V
Sbjct: 10 IEVEEVVGRGAFGVVCKAKW--RAKDVAIKQI--ESESERKAFIVELRQLSRVNHPNIVK 65
Query: 415 LHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWE 474
L+G C + LV EY GSL +L + + + G+ YLH
Sbjct: 66 LYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQP 123
Query: 475 QVVIHRDVKPSNALIDAEMN-ARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPELTQTGK 533
+ +IHRD+KP N L+ A ++ DFG A H TN G+ ++APE+ +
Sbjct: 124 KALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT----HMTNNKGSAAWMAPEVFEGSN 179
Query: 534 ASTSSDVFAYGILLLEVATGRRP 556
S DVF++GI+L EV T R+P
Sbjct: 180 YSEKCDVFSWGIILWEVITRRKP 202
|
| >3zyr_A Lectin; sugar binding protein, N-glycan; HET: NAG BMA MAN GOL; 1.65A {Platypodium elegans} PDB: 3zvx_A* 1ukg_A* 1q8o_A* 1q8q_A* 1q8s_A* 1q8v_A* 1q8p_A* 2auy_A* 2gme_A 2gmm_A* 2gmp_A* 2gn3_A* 2gn7_A* 2gnb_A* 2gnd_A* 2gnm_A* 2gnt_A 2phf_A* 2phr_A* 2pht_A* ... Length = 261 | Back alignment and structure |
|---|
Score = 198 bits (504), Expect = 5e-59
Identities = 63/272 (23%), Positives = 112/272 (41%), Gaps = 27/272 (9%)
Query: 19 LNIVAQSQSSSFIFQGFNGGATNLSLQGAEIIKPSGALKLTNRSR------YVIGHAFYV 72
LN + S SF F F+ NL QG + L+LT +G +
Sbjct: 3 LNRANSTDSLSFSFINFDRDERNLIFQGDAHTSRNNILQLTRTDSNGAPVRSTVGRILHS 62
Query: 73 KPIQMFDTSASPSPNASSFSTTFVFEISTPRSGRGGHGLAFLLAPSTKLPGAQPEHYLGI 132
+++++ + ++ T F F +S+P S F+ P T +P LG+
Sbjct: 63 AQVRLWE---KSTNRVANLQTQFSFFLSSPLSNPADGIAFFIAPPDTTIPSGSAGGLLGL 119
Query: 133 LNSTNN-GEPSNHILIVEFDTV-NGFNDKAENQGNHVGIGINTMFSNRSEPASYYINGTD 190
N E +N +L VEFDT ++ + H+GI +N++ S++
Sbjct: 120 FNPRTALNESANQVLAVEFDTFFAQNSNTWDPNYQHIGIDVNSIRSSKVVR--------- 170
Query: 191 HKEEMTLESGEPIQAWIEYDGEQKVLNVTISPAEIGKPMRPLISFGVNLTGYIKETMYVG 250
G+ + + Y+ + ++V + R +S V+LT + E + VG
Sbjct: 171 ----WERREGKTLNVLVTYNPSTRTIDVVATYP---DGQRYQLSHVVDLTTILPEWVRVG 223
Query: 251 FSASTGEKSSSHYILGWSFSLNGVAPALNVSE 282
FSA++GE+ +H + WSF+ + A E
Sbjct: 224 FSAASGEQFQTHNLESWSFTSTLLYTAQKEDE 255
|
| >3ipv_A Lectin alpha chain; galactose binding, SEED lectin, hemagglutinin, legume lectin fungal, sugar binding protein; 2.04A {Spatholobus parviflorus} PDB: 3ipv_B 3usu_B* 3usu_A* Length = 251 | Back alignment and structure |
|---|
Score = 198 bits (503), Expect = 6e-59
Identities = 72/268 (26%), Positives = 119/268 (44%), Gaps = 30/268 (11%)
Query: 25 SQSSSFIFQGFNGGATNLSLQGAEIIKPSGALKLTNRSR------YVIGHAFYVKPIQMF 78
++ +SF+F F NL LQG ++ +G L+LTN + +G A Y PI ++
Sbjct: 1 AEETSFVFSKFKPLEPNLILQGDALVTVAGVLQLTNVDKNGVPEPSSLGRATYSAPINIW 60
Query: 79 DTSASPSPNASSFSTTFVFEISTPRSGRGGHGLAFLLAPSTKLPGAQPEHYLGILNSTNN 138
D S + +SF+T+F F I P GLAF LAP P + +LG+ +S +
Sbjct: 61 D---SATGLVASFATSFRFTIYAPNIATIADGLAFFLAPVASAPDS-GGGFLGLFDSAVS 116
Query: 139 GEPSNHILIVEFDTVNGFNDKAENQGNHVGIGINTMFSNRSEPASYYINGTDHKEEMTLE 198
G + + VEFDT H+G +N++ S ++ +L
Sbjct: 117 G-STYQTVAVEFDTYENTVFTDPP-YTHIGFDVNSISSIKTVK-------------WSLA 161
Query: 199 SGEPIQAWIEYDGEQKVLNVTISPAEIGKPMRPLISFGVNLTGYIKETMYVGFSASTGE- 257
+GE + I Y+ K+L ++ +++ V+L+ + E + VGFSA+TG
Sbjct: 162 NGEAAKVLITYNSAVKLLVASLVYP--SSKTSFILADIVDLSSVLPEWVRVGFSAATGAS 219
Query: 258 --KSSSHYILGWSFSLNGVAPALNVSEL 283
K +H + WSF+ S
Sbjct: 220 GGKIETHDVFSWSFASKLAGXXTKDSSF 247
|
| >2bqp_A Protein (PEA lectin); D-glucopyranose complex, sugar binding protein; HET: GLC; 1.90A {Pisum sativum} SCOP: b.29.1.1 Length = 234 | Back alignment and structure |
|---|
Score = 196 bits (500), Expect = 9e-59
Identities = 66/249 (26%), Positives = 110/249 (44%), Gaps = 22/249 (8%)
Query: 25 SQSSSFIFQGFNGGATNLSLQGAEIIKPSGALKLTNRSRYVIGHAFYVKPIQMFDTSASP 84
++++SF+ F+ NL QG L LT + +G A Y PI ++D
Sbjct: 1 TETTSFLITKFSPDQQNLIFQGDGYTTK-EKLTLTKAVKNTVGRALYSSPIHIWD---RE 56
Query: 85 SPNASSFSTTFVFEISTPRSGRGGHGLAFLLAPSTKLPGAQPEHYLGILNSTNNGEPSNH 144
+ N ++F T+F F I+ P S G F +AP YLG+ NS +
Sbjct: 57 TGNVANFVTSFTFVINAPNSYNVADGFTFFIAPV-DTKPQTGGGYLGVFNSAEYD-KTTQ 114
Query: 145 ILIVEFDTVNGFNDKAENQGNHVGIGINTMFSNRSEPASYYINGTDHKEEMTLESGEPIQ 204
+ VEFDT N+ H+GI +N++ S ++ L++GE
Sbjct: 115 TVAVEFDTFYNAAWDPSNRDRHIGIDVNSIKSVNTKSWK-------------LQNGEEAN 161
Query: 205 AWIEYDGEQKVLNVTISPA---EIGKPMRPLISFGVNLTGYIKETMYVGFSASTGEKSSS 261
I ++ VL V+++ + +S V+L + E + +GFSA+TG + ++
Sbjct: 162 VVIAFNAATNVLTVSLTYPNNSLEEEVTSYTLSDVVSLKDVVPEWVRIGFSATTGAEYAA 221
Query: 262 HYILGWSFS 270
H +L WSF
Sbjct: 222 HEVLSWSFH 230
|
| >2eig_A Lectin; L-fucosyl, N-acetyl-D-glucosamine, SUG binding protein; HET: NAG; 2.00A {Lotus tetragonolobus} Length = 234 | Back alignment and structure |
|---|
Score = 196 bits (499), Expect = 1e-58
Identities = 68/252 (26%), Positives = 106/252 (42%), Gaps = 27/252 (10%)
Query: 29 SFIFQGFNGGATNLSLQGAEIIKPSGALKLTNRSR--YVIGHAFYVKPIQMFDTSASPSP 86
SF + F +L QG I G L + HA Y P+ ++D S +
Sbjct: 2 SFNYTRFKD-DGSLIFQGDAKIWTDGRLAMPTDPLVNRTTSHALYATPVPIWD---SATG 57
Query: 87 NASSFSTTFVFEISTPRSGRGGHGLAFLLAP-STKLPGAQPEHYLGILNSTNNGEPSNHI 145
N +SF T+F F +S + G+ F LAP T++P G L T++ N
Sbjct: 58 NVASFITSFSFIVSNVQRYPPTDGVVFFLAPWGTEIPPNS---QGGYLGITDSSNSQNQF 114
Query: 146 LIVEFDTVNGFNDKAENQGNHVGIGINTMFSNRSEPASYYINGTDHKEEMTLESGEPIQA 205
+ VEFD+ D + +H+GI +N++ S ++ SG +A
Sbjct: 115 VAVEFDSHPNVWDPKSLRSSHIGIDVNSIMSLKAVN-------------WNRVSGSLEKA 161
Query: 206 WIEYDGEQKVLNVTISPAEIGKPMRPLISFGVNLTGYIKETMYVGFSAST-GEKSSSHYI 264
I YD + K+L V ++ IS ++L + E + VGFSA+T + H I
Sbjct: 162 TIIYDSDTKILTVVMTHQN---GQITTISQEIDLKTVLPEKVSVGFSATTWNPERERHDI 218
Query: 265 LGWSFSLNGVAP 276
WSF+ P
Sbjct: 219 YSWSFTSTLKEP 230
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 196 bits (501), Expect = 1e-57
Identities = 66/319 (20%), Positives = 108/319 (33%), Gaps = 46/319 (14%)
Query: 343 FRYKDLYAATKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIE 402
+ K E+IG G +G+VYKG L VAVK + + Q I
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANRQNFINEK-NIY 59
Query: 403 SLGRLRHKNLVNLHGWCKQKND-----LLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFN 457
+ + H N+ ++ LLV EY PNGSL L DW
Sbjct: 60 RVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT----SDWVSSCR 115
Query: 458 IVKGIASGLLYLHEEWEQ------VVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGM 511
+ + GL YLH E + + HRD+ N L+ + + DFGL+ +
Sbjct: 116 LAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRL 175
Query: 512 PH-------TTNVVGTFGYIAPE-------LTQTGKASTSSDVFAYGILLLEVATGRRPI 557
+ VGT Y+APE L A D++A G++ E+ +
Sbjct: 176 VRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDL 235
Query: 558 GSGD------LLLVEWVRECHQLGRILDVAD-----PLLNSSYVVKEMELVLKLGLM--C 604
G+ + V + + P ++ + + + C
Sbjct: 236 FPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDC 295
Query: 605 -SHKTQFRPTMRQVMRYLS 622
+ R T + ++
Sbjct: 296 WDQDAEARLTAQXAEERMA 314
|
| >1fny_A BARK lectin, BARK agglutinin I,polypeptide A; legume lectin, jelly roll, sugar binding protein; 1.81A {Robinia pseudoacacia} SCOP: b.29.1.1 PDB: 1fnz_A* Length = 237 | Back alignment and structure |
|---|
Score = 192 bits (489), Expect = 4e-57
Identities = 74/259 (28%), Positives = 112/259 (43%), Gaps = 30/259 (11%)
Query: 25 SQSSSFIFQGFNGGATNLSLQGAEIIKPSGALKLTNR-----SRYVIGHAFYVKPIQMFD 79
+ S SF F F L QG ++ +G L+LTN S +G A Y P Q++D
Sbjct: 1 TGSLSFSFPKFAPNQPYLINQGDALVTSTGVLQLTNVVNGVPSSKSLGRALYAAPFQIWD 60
Query: 80 TSASPSPNASSFSTTFVFEISTPRSGRGGHGLAFLLAPSTKLPGAQPEHYLGILNSTNNG 139
S + N +SF T+F F I P GLAF LAP LGI
Sbjct: 61 ---STTGNVASFVTSFTFIIQAPNPATTADGLAFFLAPV-DTQPLDLGGMLGIFKD-GYF 115
Query: 140 EPSNHILIVEFDTVNGFNDKAENQGNHVGIGINTMFSNRSEPASYYINGTDHKEEMTLES 199
SN I+ VEFDT + + + +G H+GI +N++ S ++ P ++ +
Sbjct: 116 NKSNQIVAVEFDTFSNGDW--DPKGRHLGINVNSIESIKTVPWNWT-------------N 160
Query: 200 GEPIQAWIEYDGEQKVLNVTISPAEIGKPMRPLISFGVNLTGYIKETMYVGFSASTGEK- 258
GE +I Y+ K L ++ +I V++ + E + GFSA+TG
Sbjct: 161 GEVANVFISYEASTKSLTASLVYP--SLETSFIIDAIVDVKIVLPEWVRFGFSATTGIDK 218
Query: 259 --SSSHYILGWSFSLNGVA 275
++ +L WSF N
Sbjct: 219 GYVQTNDVLSWSFESNLPG 237
|
| >1wbf_A Protein (agglutinin); lectin (agglutinin), legume lectin, protein crystallography, group specificity, saccharide free form; HET: NAG; 2.30A {Psophocarpus tetragonolobus} SCOP: b.29.1.1 PDB: 2d3s_A* 2dtw_A* 1wbl_A* 2dty_A* 2du0_A* 2du1_A* 2e51_A* 2e53_A* 2zmk_A* 2zml_A* 2zmn_A* 2e7t_A* 2e7q_A* Length = 242 | Back alignment and structure |
|---|
Score = 192 bits (489), Expect = 4e-57
Identities = 78/264 (29%), Positives = 113/264 (42%), Gaps = 39/264 (14%)
Query: 26 QSSSFIFQGFNGGATNLSLQGAEIIKPSGALKLTNRSRYV-----IGHAFYVKPIQMFDT 80
++ SF F F+ L LQ I + L+LT V G A Y KP+Q++D
Sbjct: 2 KTISFNFNQFHQNEEQLKLQRDARISSNSVLELTKVVNGVPTWNSTGRALYAKPVQVWD- 60
Query: 81 SASPSPNASSFSTTFVFEISTPRSG-RGGHGLAFLLAPSTKLPGAQPEHYLGILNSTNNG 139
S + N +SF T F F I P GL F +AP + Y GI N +
Sbjct: 61 --STTGNVASFETRFSFSIRQPFPRPHPADGLVFFIAPP-NTQTGEGGGYFGIYNPLS-- 115
Query: 140 EPSNHILIVEFDTVNGFNDKAENQGNHVGIGINTMFSNRSEPASYYINGTDHKEEMTLES 199
+ VEFDT D Q H+GI +N++ S ++ P TL++
Sbjct: 116 --PYPFVAVEFDTFRNTWD---PQIPHIGIDVNSVISTKTVP-------------FTLDN 157
Query: 200 GEPIQAWIEYDGEQKVLNVTISPAEIGKPMRPLISFGVNLTGYIKETMYVGFSASTGEKS 259
G I+YD K+L+V + I+ V+L + E++ VGFSA+TG+ S
Sbjct: 158 GGIANVVIKYDASTKILHVVLVFPS--LGTIYTIADIVDLKQVLPESVNVGFSAATGDPS 215
Query: 260 -------SSHYILGWSFSLNGVAP 276
+H IL WSFS +
Sbjct: 216 GKQRNATETHDILSWSFSASLPGT 239
|
| >1fat_A Phytohemagglutinin-L; glycoprotein, plant defense protein, lectin; HET: NAG; 2.80A {Phaseolus vulgaris} SCOP: b.29.1.1 PDB: 1g8w_A* Length = 252 | Back alignment and structure |
|---|
Score = 193 bits (490), Expect = 5e-57
Identities = 78/272 (28%), Positives = 124/272 (45%), Gaps = 39/272 (14%)
Query: 25 SQSSSFIFQGFNGGATNLSLQGAEIIKPSGALKLTNRSR------YVIGHAFYVKPIQMF 78
S F FQ FN TNL LQ + SG L+LTN + +G AFY PIQ++
Sbjct: 1 SNDIYFNFQRFNE--TNLILQRDASVSSSGQLRLTNLNGNGEPRVGSLGRAFYSAPIQIW 58
Query: 79 DTSASPSPNASSFSTTFVFEISTPRSGRGGHGLAFLLAPSTKLPGAQPEHYLGILNSTNN 138
D + + +SF+T+F F I P + GLAF L P G+QP+ G L +
Sbjct: 59 D---NTTGTVASFATSFTFNIQVPNNAGPADGLAFALVPV----GSQPKDKGGFLGLFDG 111
Query: 139 GEPSNHILIVEFDTVNGFNDKAENQGNHVGIGINTMFSNRSEPASYYINGTDHKEEMTLE 198
+ H + VEFDT+ + + H+GI +N++ S ++ +
Sbjct: 112 SNSNFHTVAVEFDTLYNKDW--DPTERHIGIDVNSIRSIKTTRWDFV------------- 156
Query: 199 SGEPIQAWIEYDGEQKVLNVTISPAEIGKPMRPLISFGVNLTGYIKETMYVGFSASTGEK 258
+GE + I YD +L ++ + ++S V+L + E + VGFSA+TG
Sbjct: 157 NGENAEVLITYDSSTNLLVASLVYP--SQKTSFIVSDTVDLKSVLPEWVSVGFSATTGIN 214
Query: 259 S---SSHYILGWSFSLN----GVAPALNVSEL 283
++ +L WSF+ + LN++ L
Sbjct: 215 KGNVETNDVLSWSFASKLSDETTSEGLNLANL 246
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 193 bits (493), Expect = 7e-57
Identities = 66/285 (23%), Positives = 120/285 (42%), Gaps = 39/285 (13%)
Query: 355 FKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQG-------MREFAAEIESLGRL 407
+ + IG GGFG V+KG L VA+K + +G +EF E+ + L
Sbjct: 21 IEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNL 80
Query: 408 RHKNLVNLHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLL 467
H N+V L+G +V E++P G L L + W + ++ IA G+
Sbjct: 81 NHPNIVKLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAH--PIKWSVKLRLMLDIALGIE 136
Query: 468 YLHEEWEQVVIHRDVKPSNALID-----AEMNARLGDFGLARLYDHGGMPHTTNVVGTFG 522
Y+ ++HRD++ N + A + A++ DFGL++ H + ++G F
Sbjct: 137 YMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHS----VSGLLGNFQ 191
Query: 523 YIAPEL--TQTGKASTSSDVFAYGILLLEVATGRRP---IGSGDLLLVEWVRECHQLGRI 577
++APE + + +D +++ ++L + TG P G + + +RE I
Sbjct: 192 WMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTI 251
Query: 578 LDVADPLLNSSYVVKEMELVLKLGLMC-SHKTQFRPTMRQVMRYL 621
+ P L + +C S + RP +++ L
Sbjct: 252 PEDCPPRLR------------NVIELCWSGDPKKRPHFSYIVKEL 284
|
| >1n47_A Isolectin B4; cancer antigen, vicia villosa lectin, glycoprotein TN-bindin protein, carbohydrate recognition, sugar binding protein; HET: NAG FUC TNR; 2.70A {Vicia villosa} SCOP: b.29.1.1 Length = 233 | Back alignment and structure |
|---|
Score = 191 bits (486), Expect = 1e-56
Identities = 72/257 (28%), Positives = 112/257 (43%), Gaps = 33/257 (12%)
Query: 25 SQSSSFIFQGFNGGATNLSLQGAEIIKPSGALKLTNRSRYV-----IGHAFYVKPIQMFD 79
++S+SF F FN NL LQ ++ +G L+LT + +G A Y PI + D
Sbjct: 1 TESTSFSFTNFNPNQNNLILQEDALVNSAGTLELTAVAAGAPVPDSLGRALYAAPIHIHD 60
Query: 80 TSASPSPNASSFSTTFVFEISTPRSGRGGHGLAFLLAPSTKLPGAQPEHYLGILNSTNNG 139
+ +SF+T+F F ++ P + GLAF LAP P A +LG+ +
Sbjct: 61 NT-----TLASFTTSFSFVMAAPAAAAVADGLAFFLAPPDTQPQA-RGGFLGLFADRAHD 114
Query: 140 EPSNHILIVEFDTVNGFNDKAENQGNHVGIGINTMFSNRSEPASYYINGTDHKEEMTLES 199
S + VEFDT + D H+GI N + S ++ P +
Sbjct: 115 -ASYQTVAVEFDTYSNAWD---PNYTHIGIDTNGIESKKTTP-------------FDMVY 157
Query: 200 GEPIQAWIEYDGEQKVLNVTISPAEIGKPMRPLISFGVNLTGYIKETMYVGFSASTGEKS 259
GE I Y K L ++ +S V+L + E + VGFSA+TG +
Sbjct: 158 GEKANIVITYQASTKALAASLVFP--VSQTSYAVSARVDLRDILPEYVRVGFSATTGLNA 215
Query: 260 ---SSHYILGWSFSLNG 273
+H I+ WSF+++
Sbjct: 216 GVVETHDIVSWSFAVSL 232
|
| >1gzc_A Erythrina crista-galli lectin; carbohydrate, sugar binding protein, saccharide, protein-carbohydrate interactions, lactose, glycoprotein; HET: LAT; 1.58A {Erythrina crista-galli} SCOP: b.29.1.1 PDB: 1gz9_A* 1fyu_A* 1ax0_A* 1ax1_A* 1ax2_A* 1axy_A* 1axz_A* 1lte_A* 1sfy_A* 1v00_A* 1uzz_A 1uzy_A* 3n35_A* 3n36_A* 3n3h_A* Length = 239 | Back alignment and structure |
|---|
Score = 191 bits (486), Expect = 1e-56
Identities = 74/259 (28%), Positives = 119/259 (45%), Gaps = 34/259 (13%)
Query: 26 QSSSFIFQGFNGGATNLSLQGAEIIKPSGALKLTNRSR------YVIGHAFYVKPIQMFD 79
++ SF F F G NL+LQGA +I SG L+LT ++ G Y KP+ M+D
Sbjct: 2 ETISFSFSEFEPGNDNLTLQGAALITQSGVLQLTKINQNGMPAWDSTGRTLYTKPVHMWD 61
Query: 80 TSASPSPNASSFSTTFVFEISTPRSGRGG-HGLAFLLAPSTKLPGAQPEHYLGILNSTNN 138
S + +SF T F F I P + GL F + P+ P YLG+ N++
Sbjct: 62 ---STTGTVASFETRFSFSIEQPYTRPLPADGLVFFMGPTKSKPAQ-GYGYLGVFNNSKQ 117
Query: 139 GEPSNHILIVEFDTV-NGFNDKAENQGNHVGIGINTMFSNRSEPASYYINGTDHKEEMTL 197
S L VEFDT N ++ Q H+GI +N++ S +++P L
Sbjct: 118 D-NSYQTLAVEFDTFSNPWDP---PQVPHIGIDVNSIRSIKTQP-------------FQL 160
Query: 198 ESGEPIQAWIEYDGEQKVLNVTISPAEIGKPMRPLISFGVNLTGYIKETMYVGFSASTG- 256
++G+ I+YD K+L+V + I+ V++ + + + VG S +TG
Sbjct: 161 DNGQVANVVIKYDAPSKILHVVLVYP--SSGAIYTIAEIVDVKQVLPDWVDVGLSGATGA 218
Query: 257 --EKSSSHYILGWSFSLNG 273
+ + +H + WSF +
Sbjct: 219 QRDAAETHDVYSWSFQASL 237
|
| >1qnw_A Chitin binding lectin, UEA-II; carbohydrate binding; HET: NAG; 2.35A {Ulex europaeus} SCOP: b.29.1.1 PDB: 1dzq_A* 1qoo_A* 1qos_A* 1qot_A* Length = 242 | Back alignment and structure |
|---|
Score = 191 bits (485), Expect = 2e-56
Identities = 74/259 (28%), Positives = 117/259 (45%), Gaps = 27/259 (10%)
Query: 25 SQSSSFIFQGFNGGATNLSLQGAEIIKPSGALKLTNRSRYV---IGHAFYVKPIQMFDTS 81
S SF F F N+ QG + +G L++T S+ IG A Y PIQ++D
Sbjct: 3 SDDLSFNFDKFVPNQKNIIFQGDASVSTTGVLQVTKVSKPTTTSIGRALYAAPIQIWD-- 60
Query: 82 ASPSPNASSFSTTFVFEISTPRSGRGGHGLAFLLAPS-TKLPGAQPEHYLGILNSTNNGE 140
S + +SF+T+F F + +S G GLAF LAP+ +++P G+ +S ++ +
Sbjct: 61 -SITGKVASFATSFSFVVKADKSD-GVDGLAFFLAPANSQIPSGSSAGMFGLFSS-SDSK 117
Query: 141 PSNHILIVEFDTV-NGFNDKAENQGNHVGIGINTMFSNRSEPASYYINGTDHKEEMTLES 199
SN I+ VEFDT + + H+GI +N++ S ++ +
Sbjct: 118 SSNQIIAVEFDTYFGKAYNPWDPDFKHIGIDVNSIKSIKTVK-------------WDWRN 164
Query: 200 GEPIQAWIEYDGEQKVLNVTISPAEIGKPMRPLISFGVNLTGYIKETMYVGFSASTGE-- 257
GE I Y K L V +S +I+ V+L + E + VGFS G
Sbjct: 165 GEVADVVITYRAPTKSLTVCLSY--PSDGTSNIITASVDLKAILPEWVSVGFSGGVGNAA 222
Query: 258 KSSSHYILGWSFSLNGVAP 276
+ +H +L W F+ N A
Sbjct: 223 EFETHDVLSWYFTSNLEAN 241
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 193 bits (492), Expect = 2e-56
Identities = 63/211 (29%), Positives = 92/211 (43%), Gaps = 18/211 (8%)
Query: 359 EVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNLHGW 418
EV+G G FG K TG + +K++ R + R F E++ + L H N++ G
Sbjct: 16 EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGV 75
Query: 419 CKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVI 478
+ L + EYI G+L ++ S W QR + K IASG+ YLH +I
Sbjct: 76 LYKDKRLNFITEYIKGGTLRGIIKSM--DSQYPWSQRVSFAKDIASGMAYLH---SMNII 130
Query: 479 HRDVKPSNALIDAEMNARLGDFGLARLYDHGGM-------------PHTTNVVGTFGYIA 525
HRD+ N L+ N + DFGLARL VVG ++A
Sbjct: 131 HRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMA 190
Query: 526 PELTQTGKASTSSDVFAYGILLLEVATGRRP 556
PE+ DVF++GI+L E+
Sbjct: 191 PEMINGRSYDEKVDVFSFGIVLCEIIGRVNA 221
|
| >1v6i_A Agglutinin, PNA, galactose-binding lectin; open quaternary association, orthorhombic, carbohydrate specificity, protein crystallography; HET: GAL GLC; 2.15A {Arachis hypogaea} SCOP: b.29.1.1 PDB: 1bzw_A* 1v6j_A* 1v6k_A* 1v6l_A* 1v6m_A 1v6n_A 1v6o_A 2dva_A* 1cq9_A 1ciw_A* 1qf3_A* 1rir_A* 1rit_A* 2dh1_A 1cr7_A* 2dv9_A* 2dvb_A* 2dvd_A* 2dvf_A 2dvg_A* ... Length = 232 | Back alignment and structure |
|---|
Score = 189 bits (480), Expect = 6e-56
Identities = 61/248 (24%), Positives = 112/248 (45%), Gaps = 24/248 (9%)
Query: 25 SQSSSFIFQGFNGGATNLSLQGAEIIKPSGALKLTNRSRY-VIGHAFYVKPIQMFDTSAS 83
+++ SF F F+ G ++ QG + +G ++LTN ++ +G Y P++++ S
Sbjct: 1 AETVSFNFNSFSEGNPAINFQGDVTVLSNGNIQLTNLNKVNSVGRVLYAMPVRIWS---S 57
Query: 84 PSPNASSFSTTFVFEISTPRSGRGGHGLAFLLAPSTKLPGAQPEHYLGILNSTNNGEPSN 143
+ N +SF T+F FE+ + G+ F +AP G ++ + +
Sbjct: 58 ATGNVASFLTSFSFEMKDIKDYDPADGIIFFIAPEDTQIP--AGSIGGGTLGVSDTKGAG 115
Query: 144 HILIVEFDTVNGFNDKAENQGNHVGIGINTMFSNRSEPASYYINGTDHKEEMTLESGEPI 203
H + VEFDT + ++ + +HVGI +N++ S ++ P + SG +
Sbjct: 116 HFVGVEFDTYSN-SEYNDPPTDHVGIDVNSVDSVKTVPWN-------------SVSGAVV 161
Query: 204 QAWIEYDGEQKVLNVTISPAEIGKPMRPLISFGVNLTGYIKETMYVGFSASTGEKSSS-H 262
+ + YD K L+V ++ I+ V+L + E + GFSAS H
Sbjct: 162 KVTVIYDSSTKTLSVAVTND---NGDITTIAQVVDLKAKLPERVKFGFSASGSLGGRQIH 218
Query: 263 YILGWSFS 270
I WSF+
Sbjct: 219 LIRSWSFT 226
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 189 bits (481), Expect = 2e-55
Identities = 69/210 (32%), Positives = 105/210 (50%), Gaps = 21/210 (10%)
Query: 359 EVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQ----GMREFAAEIESLGRLRHKNLVN 414
E+IGIGGFG VY+ G EVAVK + + + E + L+H N++
Sbjct: 13 EIIGIGGFGKVYRAFW--IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIA 70
Query: 415 LHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWE 474
L G C ++ +L LV E+ G L+ +L + + + N IA G+ YLH+E
Sbjct: 71 LRGVCLKEPNLCLVMEFARGGPLNRVLSGKR----IPPDILVNWAVQIARGMNYLHDEAI 126
Query: 475 QVVIHRDVKPSNALIDAEMNAR--------LGDFGLARLYDHGGMPHTTNVVGTFGYIAP 526
+IHRD+K SN LI ++ + DFGLAR + + G + ++AP
Sbjct: 127 VPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTK---MSAAGAYAWMAP 183
Query: 527 ELTQTGKASTSSDVFAYGILLLEVATGRRP 556
E+ + S SDV++YG+LL E+ TG P
Sbjct: 184 EVIRASMFSKGSDVWSYGVLLWELLTGEVP 213
|
| >1avb_A Arcelin-1; lectin-like glycoprotein, plant defense, insecticidal activi lectin; HET: NAG; 1.90A {Phaseolus vulgaris} SCOP: b.29.1.1 Length = 226 | Back alignment and structure |
|---|
Score = 185 bits (470), Expect = 1e-54
Identities = 79/254 (31%), Positives = 113/254 (44%), Gaps = 36/254 (14%)
Query: 25 SQSSSFIFQGFNGGATNLSLQGAEIIKPSGALKLTNRS---RYVIGHAFYVKPIQMFDTS 81
S +SF + FN TNL LQG + G L LTN +G AFY PIQ+ D
Sbjct: 1 SNDASFNVETFNK--TNLILQGDATVSSEGHLLLTNVKGNEEDSMGRAFYSAPIQIND-- 56
Query: 82 ASPSPNASSFSTTFVFEISTPRSGRGGHGLAFLLAPSTKLPGAQPEHYLGILNSTNNGEP 141
N +SFST F F I+ +GLAF L P P YLG+ N+TN
Sbjct: 57 -RTIDNLASFSTNFTFRINAKNIENSAYGLAFALVPVGSRPKL-KGRYLGLFNTTNYD-R 113
Query: 142 SNHILIVEFDTVNGFNDKAENQGNHVGIGINTMFSNRSEPASYYINGTDHKEEMTLESGE 201
H + V FDT N + I +N++ +E ++ N +GE
Sbjct: 114 DAHTVAVVFDT----------VSNRIEIDVNSIRPIATESCNFGHN-----------NGE 152
Query: 202 PIQAWIEYDGEQKVLNVTISPAEIGKPMRPLISFGVNLTGYIKETMYVGFSASTG---EK 258
+ I YD + L V++ + +S V L +++ + VGFSA++G E
Sbjct: 153 KAEVRITYDSPKNDLRVSLLYP--SSEEKCHVSATVPLEKEVEDWVSVGFSATSGSKKET 210
Query: 259 SSSHYILGWSFSLN 272
+ +H +L WSFS N
Sbjct: 211 TETHNVLSWSFSSN 224
|
| >1fx5_A UEA-I, UE-I, anti-H(O) lectin I; legume lectin, HOMO-dimer, fucose specific lectin, SUG binding protein; HET: NAG FUC BMA MAN; 2.20A {Ulex europaeus} SCOP: b.29.1.1 PDB: 1jxn_A* Length = 242 | Back alignment and structure |
|---|
Score = 185 bits (470), Expect = 3e-54
Identities = 64/252 (25%), Positives = 105/252 (41%), Gaps = 24/252 (9%)
Query: 25 SQSSSFIFQGFNGGATNLSLQGAEIIKPSGALKLT----NRSRYVIGHAFYVKPIQMFDT 80
S SF F+ F+ +LS QG + +G L+L N G A Y+ PI +++
Sbjct: 1 SDDLSFKFKNFSQNGKDLSFQGNASVIETGVLQLNKVGNNLPDETGGIARYIAPIHIWN- 59
Query: 81 SASPSPNASSFSTTFVFEISTPRSGR-GGHGLAFLLAPSTKLPGAQPEHYLGILNSTNNG 139
+ +SF T+F F + T + + GL F LAP P + Y G+ N T
Sbjct: 60 --CNTGELASFITSFSFFMETSANPKAATDGLTFFLAPP-DSPLRRAGGYFGLFNDTKCD 116
Query: 140 EPSNHILIVEFDTVNGFNDKAENQGNHVGIGINTMFSNRSEPASYYINGTDHKEEMTLES 199
S + VEFDT+ + + H+GI +N + S +E +
Sbjct: 117 -SSYQTVAVEFDTIGSPVNFWDPGFPHIGIDVNCVKSINAERWNKRYG-----------L 164
Query: 200 GEPIQAWIEYDGEQKVLNVTISPAEIGKPMRPLISFGVNLTGYIKETMYVGFSASTGE-K 258
I Y+ K L +++ ++ V+L + E + VGFS ST +
Sbjct: 165 NNVANVEIIYEASSKTLTASLTYP--SDQTSISVTSIVDLKEILPEWVSVGFSGSTYIGR 222
Query: 259 SSSHYILGWSFS 270
++H +L W F+
Sbjct: 223 QATHEVLNWYFT 234
|
| >1dbn_A MAL, protein (leukoagglutinin); plant lectin, carbohydrate binding, sialyllactose, sugar BIN protein; HET: NAG SIA GAL BGC; 2.75A {Maackia amurensis} SCOP: b.29.1.1 Length = 239 | Back alignment and structure |
|---|
Score = 184 bits (468), Expect = 5e-54
Identities = 69/255 (27%), Positives = 112/255 (43%), Gaps = 28/255 (10%)
Query: 25 SQSSSFIFQGFNGGATNLSLQGAEIIKPSGALKLTNRSR-----YVIGHAFYVKPIQMFD 79
S SF F +L QG + +G L+LT Y +G A Y P++++
Sbjct: 1 SDELSFTINNFVPNEADLLFQGEASVSSTGVLQLTKVENGQPQKYSVGRALYAAPVRIWG 60
Query: 80 TSASPSPNASSFSTTFVFEISTPRSGRGGHGLAFLLAP-STKLPGAQPEHYLGILNSTNN 138
+ + + +SFST+F F + P GLAF LAP +++P YLG+ N++N
Sbjct: 61 ---NTTGSVASFSTSFTFVVKAPNPDITSDGLAFYLAPPDSQIPSGSVSKYLGLFNNSN- 116
Query: 139 GEPSNHILIVEFDTV-NGFNDKAENQGNHVGIGINTMFSNRSEPASYYINGTDHKEEMTL 197
+ SN I+ VEFDT D + H+GI +N + S ++ + G L
Sbjct: 117 SDSSNQIVAVEFDTYFAHSYDPWDPNYRHIGIDVNGIESIKTVQWDWINGGVAFATITYL 176
Query: 198 ESGEPIQAWIEYDGEQKVLNVTISPAEIGKPMRPLISFGVNLTGYIKETMYVGFSASTGE 257
+ + A + Y ++ V+L + E + VGFSA+TG
Sbjct: 177 APNKTLIASLVYP---------------SNQTTFSVAASVDLKEILPEWVRVGFSAATGY 221
Query: 258 KS--SSHYILGWSFS 270
+ +H +L WSF+
Sbjct: 222 PTEVETHDVLSWSFT 236
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 185 bits (471), Expect = 6e-54
Identities = 44/205 (21%), Positives = 84/205 (40%), Gaps = 17/205 (8%)
Query: 359 EVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQG--MREFAAEIESLGRLRHKNLVNLH 416
+ G ++KG G ++ VK + R+F E L H N++ +
Sbjct: 16 TKLNENHSGELWKGRW--QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVL 73
Query: 417 GWCKQ--KNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWE 474
G C+ L+ ++P GSL +L + V+D Q +A G+ +LH E
Sbjct: 74 GACQSPPAPHPTLITHWMPYGSLYNVLHEGT-NFVVDQSQAVKFALDMARGMAFLHT-LE 131
Query: 475 QVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPELTQ---T 531
++ + + +ID +M AR+ + + + + ++APE Q
Sbjct: 132 PLIPRHALNSRSVMIDEDMTARISMADVKFSF------QSPGRMYAPAWVAPEALQKKPE 185
Query: 532 GKASTSSDVFAYGILLLEVATGRRP 556
S+D++++ +LL E+ T P
Sbjct: 186 DTNRRSADMWSFAVLLWELVTREVP 210
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 184 bits (469), Expect = 4e-53
Identities = 72/310 (23%), Positives = 121/310 (39%), Gaps = 49/310 (15%)
Query: 328 NSETLEDWEKDCPHRFRYKDLYAATKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKIT 387
S L++W+ ++ L + E+IG G FG VY G GEVA++ I
Sbjct: 21 TSIFLQEWDIP------FEQL-------EIGELIGKGRFGQVYHGRW---HGEVAIRLID 64
Query: 388 RNSLQG--MREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEYIPNGSLDTLLFKPK 445
++ F E+ + + RH+N+V G C L ++ +L +++ K
Sbjct: 65 IERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAK 124
Query: 446 DGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARL 505
VLD + I + I G+ YLH + ++H+D+K N D + DFGL +
Sbjct: 125 I--VLDVNKTRQIAQEIVKGMGYLH---AKGILHKDLKSKNVFYD-NGKVVITDFGLFSI 178
Query: 506 YDHGGMPH----TTNVVGTFGYIAPELTQTGKA---------STSSDVFAYGILLLEVAT 552
G ++APE+ + S SDVFA G + E+
Sbjct: 179 SGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHA 238
Query: 553 GRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSYVVKEMELVLKLGLMC-SHKTQFR 611
P + + W P L+ + KE+ +L C + + + R
Sbjct: 239 REWPFKTQPAEAIIWQMGTGMK--------PNLSQIGMGKEISDILL---FCWAFEQEER 287
Query: 612 PTMRQVMRYL 621
PT ++M L
Sbjct: 288 PTFTKLMDML 297
|
| >1f9k_A Acidic lectin; legume lectin, glycosylated protein, H-antigenic specificity agglutinin, sugar binding protein; HET: NAG MAN AMG; 3.00A {Psophocarpus tetragonolobus} SCOP: b.29.1.1 PDB: 1fay_A* Length = 238 | Back alignment and structure |
|---|
Score = 181 bits (459), Expect = 6e-53
Identities = 72/263 (27%), Positives = 114/263 (43%), Gaps = 38/263 (14%)
Query: 26 QSSSFIFQGFNGGATNLSLQGAEIIKPSGALKLTNRSR------YVIGHAFYVKPIQMFD 79
++ SF F F + L+LQ IK +G L+LT ++ G A Y +PI+++D
Sbjct: 1 ETQSFNFDHFEENSKELNLQRQASIKSNGVLELTKLTKNGVPVWKSTGRALYAEPIKIWD 60
Query: 80 TSASPSPNASSFSTTFVFEISTPRS-GRGGHGLAFLLAPSTKLPGAQPEHYLGILNSTNN 138
S + N +SF T F F I+ P + GL F + P P + LG+
Sbjct: 61 ---STTGNVASFETRFSFNITQPYAYPEPADGLTFFMVPPN-SPQGEDGGNLGVFKPPEG 116
Query: 139 GEPSNHILIVEFDTVNGFNDKAENQGNHVGIGINTMFSNRSEPASYYINGTDHKEEMTLE 198
++ VEFDT D Q H+GI +N++ S+++ LE
Sbjct: 117 ----DNAFAVEFDTFQNTWD---PQVPHIGIDVNSIVSSKTLH-------------FQLE 156
Query: 199 SGEPIQAWIEYDGEQKVLNVTISPAEIGKPMRPLISFGVNLTGYI--KETMYVGFSASTG 256
+G I+YD K+LNV ++ +S V+L E + VG SA+TG
Sbjct: 157 NGGVANVVIKYDSPTKILNVVLAF--HSVGTVYTLSNIVDLKQEFPNSEWVNVGLSATTG 214
Query: 257 EK---SSSHYILGWSFSLNGVAP 276
+ +H I+ WSF+ +
Sbjct: 215 YQKNAVETHEIISWSFTSSLQET 237
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 179 bits (456), Expect = 1e-51
Identities = 64/239 (26%), Positives = 110/239 (46%), Gaps = 28/239 (11%)
Query: 324 RKWSNSETLEDWEKDCPHRFRYKDLYAATKGFKESEVIGIGGFGSVYKGVLPTTGGEVAV 383
+ + +DWE + + IG G FG+VYKG G+VAV
Sbjct: 8 HHHGSRDAADDWEIP------DGQI-------TVGQRIGSGSFGTVYKGKW---HGDVAV 51
Query: 384 KKITRNSLQG--MREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEYIPNGSLDTLL 441
K + + ++ F E+ L + RH N++ G+ L +V ++ SL L
Sbjct: 52 KMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAPQ-LAIVTQWCEGSSLYHHL 110
Query: 442 FKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFG 501
+ + + ++ +I + A G+ YLH + +IHRD+K +N + + ++GDFG
Sbjct: 111 HASE--TKFEMKKLIDIARQTARGMDYLHA---KSIIHRDLKSNNIFLHEDNTVKIGDFG 165
Query: 502 LARLYDHGGMPHT-TNVVGTFGYIAPEL---TQTGKASTSSDVFAYGILLLEVATGRRP 556
LA H + G+ ++APE+ + S SDV+A+GI+L E+ TG+ P
Sbjct: 166 LATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLP 224
|
| >1ioa_A Arcelin-5A, ARC5A; lectin-like proteins, plant defense proteins, lectin; HET: NAG FUC; 2.70A {Phaseolus vulgaris} SCOP: b.29.1.1 Length = 240 | Back alignment and structure |
|---|
Score = 176 bits (448), Expect = 3e-51
Identities = 72/265 (27%), Positives = 108/265 (40%), Gaps = 40/265 (15%)
Query: 25 SQSSSFIFQGFNGGATNLSLQGAEIIKPSGALKLTNRSR------YVIGHAFYVKPIQMF 78
+ +SF F F+ L LQG I G L+LT +G AFY PIQ+
Sbjct: 1 ATETSFNFPNFHTDD-KLILQGNATISSKGQLQLTGVGSNELPRVDSLGRAFYSDPIQIK 59
Query: 79 DTSASPSPNASSFSTTFVFEISTPRSGRGGHGLAFLLAPSTKLPGAQPEHYLGILNSTNN 138
S N +SF+T F F I +GLAF L P P + + +LGI N+ NN
Sbjct: 60 -----DSNNVASFNTNFTFIIRAKNQSISAYGLAFALVPV-NSPPQKKQEFLGIFNT-NN 112
Query: 139 GEPSNHILIVEFDTVNGFNDKAENQGNHVGIGINTMFSNRSEPASYYINGTDHKEEMTLE 198
EP+ + V F+T N + N + +E ++
Sbjct: 113 PEPNARTVAVVFNTFK----------NRIDFDKNFIKPYVNENCDFH-----------KY 151
Query: 199 SGEPIQAWIEYDGEQKVLNVTISPAEIGKPMRPLISFGVNLTGYIKETMYVGFSASTG-- 256
+GE I YD L V + ++ +S V+L + E + VGFS ++G
Sbjct: 152 NGEKTDVQITYDSSNNDLRVFLHFT--VSQVKCSVSATVHLEKEVDEWVSVGFSPTSGLT 209
Query: 257 -EKSSSHYILGWSFSLNGVAPALNV 280
+ + +H +L WSFS N+
Sbjct: 210 EDTTETHDVLSWSFSSKFRNKLSNI 234
|
| >1g7y_A Stem/LEAF lectin DB58; jelly roll fold, sugar binding protein; HET: NAG FUC FUL; 2.50A {Vigna unguiculata subsp} SCOP: b.29.1.1 PDB: 1lul_A 1lu1_A* 1bjq_A* 1lu2_A* Length = 253 | Back alignment and structure |
|---|
Score = 176 bits (448), Expect = 4e-51
Identities = 67/270 (24%), Positives = 118/270 (43%), Gaps = 38/270 (14%)
Query: 25 SQSSSFIFQGFNGGATNLSLQGAEIIKPSGALKLTNRSR------YVIGHAFYVKPIQMF 78
+ SF F+ FN ++ LQG + S L+LT +G AFY PIQ++
Sbjct: 1 ADIQSFSFKNFNS--SSFILQGDATV-SSSKLRLTKVKGNGLPTLSSLGRAFYSSPIQIY 57
Query: 79 DTSASPSPNASSFSTTFVFEISTPRSGRGGHGLAFLLAPSTKLPGAQPEHYLGILNSTNN 138
D + +S++T+F I P G+AF L P P + +LG+ +S
Sbjct: 58 D---KSTGAVASWATSFTANIFAPNKSSSADGIAFALVPVGSEPKS-NSGFLGVFDSDVY 113
Query: 139 GEPSNHILIVEFDTVNGFNDKAENQGNHVGIGINTMFSNRSEPASYYINGTDHKEEMTLE 198
S + VEFDT + + + H+GI +N++ S R+ L
Sbjct: 114 D-NSAQTVAVEFDTFSNTDW--DPTSRHIGIDVNSIKSIRTASW-------------GLA 157
Query: 199 SGEPIQAWIEYDGEQKVLNVTISPAEIGKPMRPLISFGVNLTGYIKETMYVGFSASTGEK 258
+G+ + I Y+ +L ++ + ++S V++T + E + +GFSA+TG
Sbjct: 158 NGQNAEILITYNAATSLLVASLVHP--SRRTSYIVSERVDITNELPEYVSIGFSATTGLS 215
Query: 259 ---SSSHYILGWSFSLN----GVAPALNVS 281
+ +H +L WSF+ L+++
Sbjct: 216 EGYTETHDVLSWSFASKLPDDSTTEPLDIA 245
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 177 bits (450), Expect = 1e-50
Identities = 71/295 (24%), Positives = 108/295 (36%), Gaps = 41/295 (13%)
Query: 359 EVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIE--SLGRLRHKNLVNLH 416
E +G G +G V++G G VAVK S + + + E E + LRH+N++
Sbjct: 14 ECVGKGRYGEVWRGSW--QGENVAVKIF---SSRDEKSWFRETELYNTVMLRHENILGFI 68
Query: 417 GWCKQKND----LLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEE 472
L L+ Y GSL L LD IV IASGL +LH E
Sbjct: 69 ASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT----LDTVSCLRIVLSIASGLAHLHIE 124
Query: 473 WEQ-----VVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMP---HTTNVVGTFGYI 524
+ HRD+K N L+ + D GLA ++ VGT Y+
Sbjct: 125 IFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYM 184
Query: 525 APEL------TQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRIL 578
APE+ + D++A+G++L EVA G + +
Sbjct: 185 APEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFE 244
Query: 579 DVAD--------PLLNSSYVVKEMELVLKLGLM--C-SHKTQFRPTMRQVMRYLS 622
D+ P + + + L LM C R T ++ + L+
Sbjct: 245 DMRKVVCVDQQRPNIPNRWFSDPTLTSLA-KLMKECWYQNPSARLTALRIKKTLT 298
|
| >1dhk_B Bean lectin-like inhibitor, porcine pancreatic alpha-amylase; CO (hydrolase-inhibitor), complex (hydrolase-inhibitor) comple; HET: NAG; 1.85A {Phaseolus vulgaris} SCOP: b.29.1.1 PDB: 1viw_B* Length = 223 | Back alignment and structure |
|---|
Score = 171 bits (434), Expect = 2e-49
Identities = 70/264 (26%), Positives = 101/264 (38%), Gaps = 51/264 (19%)
Query: 25 SQSSSFIFQGFNGGATNLSLQGAEIIKPSGALKLTNRSRYVIGHAFYVKPIQMFDTSASP 84
+ +SFI FN TNL LQG + +G L+L+ S + AFY PIQ+ D S
Sbjct: 1 ATETSFIIDAFNK--TNLILQGDATVSSNGNLQLSYNSYDSMSRAFYSAPIQIRD---ST 55
Query: 85 SPNASSFSTTFVFEISTPRSGRGGHGLAFLLAPSTKLPGAQPEHYLGILNSTNNGEPSNH 144
+ N +SF T F I T R GL F+L P E
Sbjct: 56 TGNVASFDTNFTMNIRTHRQANSAVGLDFVLVP-------------------VQPESKGD 96
Query: 145 ILIVEFDTVNGFNDKAENQGNHVGIGINTMFSNRSEPASYYINGTDHKEEMTLESGEPIQ 204
+ VEFDT + + I +N S P + G+ +
Sbjct: 97 TVTVEFDTFL----------SRISIDVNNNDIK-SVPWDVHDY-----------DGQNAE 134
Query: 205 AWIEYDGEQKVLNVTISPAEIGKPMRPLISFGVNLTGYIKETMYVGFSASTG---EKSSS 261
I Y+ KV +V++S +S V L + + + VGFSA++G +
Sbjct: 135 VRITYNSSTKVFSVSLSN--PSTGKSNNVSTTVELEKEVYDWVSVGFSATSGAYQWSYET 192
Query: 262 HYILGWSFSLNGVAPALNVSELPK 285
H +L WSFS + SE
Sbjct: 193 HDVLSWSFSSKFINLKDQKSERSN 216
|
| >1gsl_A Griffonia simplicifolia lectin 4; glycoprotein, manganese; HET: FUC GAL MAG NAG BMA; 2.00A {Griffonia simplicifolia} SCOP: b.29.1.1 PDB: 1lec_A* 1led_A* Length = 243 | Back alignment and structure |
|---|
Score = 170 bits (432), Expect = 6e-49
Identities = 67/255 (26%), Positives = 101/255 (39%), Gaps = 33/255 (12%)
Query: 27 SSSFIFQGF----NGGATNLSLQGAEIIKPSGALKLT------NRSRYVIGHAFYVKPIQ 76
+ +F + F T ++ G P GAL+LT N R G A Y +P+
Sbjct: 3 TVNFTYPDFWSYSLKNGTEITFLGDATRIP-GALQLTKTDANGNPVRSSAGQASYSEPVF 61
Query: 77 MFDTSASPSPNASSFSTTFVFEISTPRSGRGGHGLAFLLAPSTKLPGAQPEHYLGILNST 136
++D + A+SF T+F F + GLAF LAP +LG+
Sbjct: 62 LWD----STGKAASFYTSFTFLLKNY-GAPTADGLAFFLAPV-DSSVKDYGGFLGLFRHE 115
Query: 137 NNGEPS-NHILIVEFDTVNGFNDKAENQGNHVGIGINTMFSNRSEPASYYINGTDHKEEM 195
+PS N ++ VEFDT D + H+GI +N++ S +
Sbjct: 116 TAADPSKNQVVAVEFDTWI-NKDWNDPPYPHIGIDVNSIVSVATTRWEND---------- 164
Query: 196 TLESGEPIQAWIEYDGEQKVLNVTISPAEIGKPMRPLISFGVNLTGYIKETMYVGFSAST 255
A I YD K+L V +S ++S V+L + + + +GFSA
Sbjct: 165 DAYGSSIATAHITYDARSKILTVLLSYEH---GRDYILSHVVDLAKVLPQKVRIGFSAGV 221
Query: 256 GEKSSSHYILGWSFS 270
G YIL W F
Sbjct: 222 G-YDEVTYILSWHFF 235
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 173 bits (441), Expect = 6e-49
Identities = 69/294 (23%), Positives = 112/294 (38%), Gaps = 39/294 (13%)
Query: 359 EVIGIGGFGSVYKGVLPTTGGEVAVKKI-TRNSLQGMREFAAEIESLGRLRHKNLVNLHG 417
+ IG G +G V+ G G +VAVK T RE EI +RH+N++
Sbjct: 43 KQIGKGRYGEVWMGKW--RGEKVAVKVFFTTEEASWFRE--TEIYQTVLMRHENILGFIA 98
Query: 418 WCKQKND----LLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEE- 472
+ L L+ +Y NGSL L LD + + SGL +LH E
Sbjct: 99 ADIKGTGSWTQLYLITDYHENGSLYDYLKSTT----LDAKSMLKLAYSSVSGLCHLHTEI 154
Query: 473 ----WEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPH---TTNVVGTFGYIA 525
+ + HRD+K N L+ + D GLA + VGT Y+
Sbjct: 155 FSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMP 214
Query: 526 PEL------TQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILD 579
PE+ ++ +D++++G++L EVA G + + + D
Sbjct: 215 PEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYED 274
Query: 580 VAD--------PLLNSSYVVKEMELVLKLGLM--C-SHKTQFRPTMRQVMRYLS 622
+ + P + + E + LM C +H R T +V + L+
Sbjct: 275 MREIVCIKKLRPSFPNRWSSDECLRQMG-KLMTECWAHNPASRLTALRVKKTLA 327
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 173 bits (439), Expect = 1e-48
Identities = 77/294 (26%), Positives = 120/294 (40%), Gaps = 39/294 (13%)
Query: 359 EVIGIGGFGSVYKGVLPTTGGEVAVKKI-TRNSLQGMREFAAEIESLGRLRHKNLVNLHG 417
E IG G FG V++G G EVAVK +R RE AEI LRH+N++
Sbjct: 48 ESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFRE--AEIYQTVMLRHENILGFIA 103
Query: 418 WCKQKND----LLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEW 473
+ N L LV +Y +GSL L + + E + ASGL +LH E
Sbjct: 104 ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT----VTVEGMIKLALSTASGLAHLHMEI 159
Query: 474 EQ-----VVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHT---TNVVGTFGYIA 525
+ HRD+K N L+ + D GLA +D + VGT Y+A
Sbjct: 160 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMA 219
Query: 526 PEL------TQTGKASTSSDVFAYGILLLEVATGRRPIGSGD---LLLVEWVRECHQLGR 576
PE+ + ++ +D++A G++ E+A G + L + V +
Sbjct: 220 PEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEE 279
Query: 577 ILD-VAD----PLLNSSYVVKEMELVLKLGLM--C-SHKTQFRPTMRQVMRYLS 622
+ V + P + + + E V+ +M C R T ++ + LS
Sbjct: 280 MRKVVCEQKLRPNIPNRWQSCEALRVMA-KIMRECWYANGAARLTALRIKKTLS 332
|
| >2ltn_A PEA lectin, alpha chain; 1.70A {Pisum sativum} SCOP: b.29.1.1 PDB: 1bqp_A* 1hkd_A 1ofs_A* 1rin_A* 1lof_C* 1len_A 1lem_A 1les_A* 2lal_A 1loe_A 1loa_A* 1loc_A* 1lod_A* 1lob_A 1lof_A* 1log_A* 1lgc_A* 1lgb_A* 2b7y_A* Length = 181 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 8e-47
Identities = 51/197 (25%), Positives = 84/197 (42%), Gaps = 19/197 (9%)
Query: 25 SQSSSFIFQGFNGGATNLSLQGAEIIKPSGALKLTNRSRYVIGHAFYVKPIQMFDTSASP 84
++++SF+ F+ NL QG L LT + +G A Y PI ++D
Sbjct: 1 TETTSFLITKFSPDQQNLIFQGDGYT-TKEKLTLTKAVKNTVGRALYSSPIHIWD---RE 56
Query: 85 SPNASSFSTTFVFEISTPRSGRGGHGLAFLLAPSTKLPGAQPEHYLGILNSTNNGEPSNH 144
+ N ++F T+F F I+ P S G F +AP YLG+ NS +
Sbjct: 57 TGNVANFVTSFTFVINAPNSYNVADGFTFFIAPV-DTKPQTGGGYLGVFNSAEYD-KTTQ 114
Query: 145 ILIVEFDTVNGFNDKAENQGNHVGIGINTMFSNRSEPASYYINGTDHKEEMTLESGEPIQ 204
+ VEFDT N+ H+GI +N++ S ++ L++GE
Sbjct: 115 TVAVEFDTFYNAAWDPSNRDRHIGIDVNSIKSVNTKS-------------WKLQNGEEAN 161
Query: 205 AWIEYDGEQKVLNVTIS 221
I ++ VL V+++
Sbjct: 162 VVIAFNAATNVLTVSLT 178
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 1e-41
Identities = 68/235 (28%), Positives = 106/235 (45%), Gaps = 16/235 (6%)
Query: 327 SNSETLEDWEKDCPHRFRYKDLYAATKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKI 386
S T E + + Y + V+G G +G VY G + +A+K+I
Sbjct: 1 SMRSTEEGDCESDLLEYDY-EYDENGDR----VVLGKGTYGIVYAGRDLSNQVRIAIKEI 55
Query: 387 TRNSLQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKD 446
+ + EI L+HKN+V G + + + E +P GSL LL + K
Sbjct: 56 PERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALL-RSKW 114
Query: 447 GSVLDWEQRF-NIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEM-NARLGDFGLA- 503
G + D EQ K I GL YLH + ++HRD+K N LI+ ++ DFG +
Sbjct: 115 GPLKDNEQTIGFYTKQILEGLKYLH---DNQIVHRDIKGDNVLINTYSGVLKISDFGTSK 171
Query: 504 RLYDHGGMPHTTNVVGTFGYIAPELTQTGK--ASTSSDVFAYGILLLEVATGRRP 556
RL T GT Y+APE+ G ++D+++ G ++E+ATG+ P
Sbjct: 172 RLAGINPCTET--FTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPP 224
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 1e-41
Identities = 50/207 (24%), Positives = 95/207 (45%), Gaps = 13/207 (6%)
Query: 355 FKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGM----REFA-AEIESLGRLRH 409
+ + IG G FG G + +K+I ++ M RE + E+ L ++H
Sbjct: 26 YVRLQKIGEGSFGKAILVKSTEDGRQYVIKEI---NISRMSSKEREESRREVAVLANMKH 82
Query: 410 KNLVNLHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYL 469
N+V ++ L +V +Y G L + + G + +Q + I L ++
Sbjct: 83 PNIVQYRESFEENGSLYIVMDYCEGGDLFKRI-NAQKGVLFQEDQILDWFVQICLALKHV 141
Query: 470 HEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPELT 529
H+ + ++HRD+K N + + +LGDFG+AR+ + +GT Y++PE+
Sbjct: 142 HD---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARA-CIGTPYYLSPEIC 197
Query: 530 QTGKASTSSDVFAYGILLLEVATGRRP 556
+ + SD++A G +L E+ T +
Sbjct: 198 ENKPYNNKSDIWALGCVLYELCTLKHA 224
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 2e-41
Identities = 66/209 (31%), Positives = 102/209 (48%), Gaps = 15/209 (7%)
Query: 355 FKESEVIGIGGFGSVYKGVLPTTGGEVAVKKI--TRNSLQGMREFAAEIESLGRLRHKNL 412
K IG G F +VYKG+ T EVA ++ + + + F E E L L+H N+
Sbjct: 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNI 87
Query: 413 VNLHG----WCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLY 468
V + K K ++LV E + +G+L T L + K V+ + + + I GL +
Sbjct: 88 VRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQF 144
Query: 469 LHEEWEQVVIHRDVKPSNALIDAEM-NARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPE 527
LH +IHRD+K N I + ++GD GLA L V+GT ++APE
Sbjct: 145 LHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA---SFAKAVIGTPEFMAPE 200
Query: 528 LTQTGKASTSSDVFAYGILLLEVATGRRP 556
+ + S DV+A+G+ +LE+AT P
Sbjct: 201 MYEEK-YDESVDVYAFGMCMLEMATSEYP 228
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 3e-40
Identities = 68/281 (24%), Positives = 122/281 (43%), Gaps = 42/281 (14%)
Query: 355 FKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVN 414
FKE E+IG GGFG V+K G +K++ N+ + RE +++L +L H N+V+
Sbjct: 13 FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAERE----VKALAKLDHVNIVH 68
Query: 415 LHG----------------WCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNI 458
+G + L + E+ G+L+ + + + G LD +
Sbjct: 69 YNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWI-EKRRGEKLDKVLALEL 127
Query: 459 VKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVV 518
+ I G+ Y+H + +I+RD+KPSN + ++GDFGL + G +
Sbjct: 128 FEQITKGVDYIHS---KKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRS--K 182
Query: 519 GTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRIL 578
GT Y++PE + D++A G++L E+
Sbjct: 183 GTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKF-------------FT 229
Query: 579 DVADPLLNSSYVVKEMELVLKLGLMCSHKTQFRPTMRQVMR 619
D+ D +++ + KE L+ K + S K + RP +++R
Sbjct: 230 DLRDGIISDIFDKKEKTLLQK---LLSKKPEDRPNTSEILR 267
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 9e-40
Identities = 59/202 (29%), Positives = 87/202 (43%), Gaps = 11/202 (5%)
Query: 359 EVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAA----EIESLGRLRHKNLVN 414
++G GG G VY+ VA+K + +L F E + GRL+ ++V
Sbjct: 40 RLVGRGGMGDVYEAEDTVRERIVALK-LMSETLSSDPVFRTRMQREARTAGRLQEPHVVP 98
Query: 415 LHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWE 474
+H + + L + I L +L + L + IV+ I S L H
Sbjct: 99 IHDFGEIDGQLYVDMRLINGVDLAAML---RRQGPLAPPRAVAIVRQIGSALDAAHA--- 152
Query: 475 QVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPELTQTGKA 534
HRDVKP N L+ A+ A L DFG+A + N VGT Y+APE A
Sbjct: 153 AGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSESHA 212
Query: 535 STSSDVFAYGILLLEVATGRRP 556
+ +D++A +L E TG P
Sbjct: 213 TYRADIYALTCVLYECLTGSPP 234
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 146 bits (372), Expect = 9e-40
Identities = 61/242 (25%), Positives = 106/242 (43%), Gaps = 25/242 (10%)
Query: 359 EVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQ--GMRE-FAAEIESLGRLRHKNLVNL 415
+G GGF ++ T A K + ++ L RE + EI L H+++V
Sbjct: 21 RFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF 80
Query: 416 HGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQ 475
HG+ + + + +V E SL L + ++ + E R+ ++ I G YLH
Sbjct: 81 HGFFEDNDFVFVVLELCRRRSLLELH--KRRKALTEPEARY-YLRQIVLGCQYLHR---N 134
Query: 476 VVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPELTQTGKAS 535
VIHRD+K N ++ ++ ++GDFGLA ++ G + GT YIAPE+ S
Sbjct: 135 RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPEVLSKKGHS 193
Query: 536 TSSDVFAYGILLLEVATGRRP------------IGSGDLLLVEWV-RECHQL-GRILDVA 581
DV++ G ++ + G+ P I + + + + L ++L
Sbjct: 194 FEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQT- 252
Query: 582 DP 583
DP
Sbjct: 253 DP 254
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 2e-39
Identities = 56/237 (23%), Positives = 99/237 (41%), Gaps = 19/237 (8%)
Query: 325 KWSNSETLEDWEKDCPHRFRYKDLYAATKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVK 384
+ ++E + EK P + Y++ +G G FG V++ TG + AVK
Sbjct: 33 ETEDNEGVLLTEKLKPVDYEYRE---EVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVK 89
Query: 385 KITRNSLQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEYIPNGSLDTLLFKP 444
K+ L+ R E+ + L +V L+G ++ + + E + GSL L+
Sbjct: 90 KV---RLEVFRV--EELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLI--- 141
Query: 445 KDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAE-MNARLGDFG-- 501
K L ++ + GL YLH + ++H DVK N L+ ++ A L DFG
Sbjct: 142 KQMGCLPEDRALYYLGQALEGLEYLH---TRRILHGDVKADNVLLSSDGSRAALCDFGHA 198
Query: 502 --LARLYDHGGMPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRP 556
L + + GT ++APE+ D+++ ++L + G P
Sbjct: 199 LCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHP 255
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 2e-39
Identities = 61/242 (25%), Positives = 106/242 (43%), Gaps = 25/242 (10%)
Query: 359 EVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQ--GMRE-FAAEIESLGRLRHKNLVNL 415
+G GGF ++ T A K + ++ L RE + EI L H+++V
Sbjct: 47 RFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF 106
Query: 416 HGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQ 475
HG+ + + + +V E SL L + ++ + E R+ ++ I G YLH
Sbjct: 107 HGFFEDNDFVFVVLELCRRRSLLELH--KRRKALTEPEARY-YLRQIVLGCQYLHR---N 160
Query: 476 VVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPELTQTGKAS 535
VIHRD+K N ++ ++ ++GDFGLA ++ G + GT YIAPE+ S
Sbjct: 161 RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPEVLSKKGHS 219
Query: 536 TSSDVFAYGILLLEVATGRRP------------IGSGDLLLVEWV-RECHQL-GRILDVA 581
DV++ G ++ + G+ P I + + + + L ++L
Sbjct: 220 FEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQT- 278
Query: 582 DP 583
DP
Sbjct: 279 DP 280
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 2e-39
Identities = 60/207 (28%), Positives = 98/207 (47%), Gaps = 10/207 (4%)
Query: 355 FKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAA---EIESLGRLRHKN 411
F+ + IG G F VY+ G VA+KK+ L + A EI+ L +L H N
Sbjct: 34 FRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 93
Query: 412 LVNLHGWCKQKNDLLLVYEYIPNGSLDTLLFKPK-DGSVLDWEQRFNIVKGIASGLLYLH 470
++ + + N+L +V E G L ++ K ++ + + S L ++H
Sbjct: 94 VIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH 153
Query: 471 EEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHG-GMPHTTNVVGTFGYIAPELT 529
+ V+HRD+KP+N I A +LGD GL R + H+ +VGT Y++PE
Sbjct: 154 S---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMSPERI 208
Query: 530 QTGKASTSSDVFAYGILLLEVATGRRP 556
+ SD+++ G LL E+A + P
Sbjct: 209 HENGYNFKSDIWSLGCLLYEMAALQSP 235
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 3e-39
Identities = 52/202 (25%), Positives = 94/202 (46%), Gaps = 11/202 (5%)
Query: 359 EVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAA----EIESLGRLRHKNLVN 414
+ +G GG +VY +VA+K + E E+ + +L H+N+V+
Sbjct: 17 DKLGGGGMSTVYLAEDTILNIKVAIK-AIFIPPREKEETLKRFEREVHNSSQLSHQNIVS 75
Query: 415 LHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWE 474
+ ++ + LV EYI +L + + L + N I G+ + H+
Sbjct: 76 MIDVDEEDDCYYLVMEYIEGPTLSEYI---ESHGPLSVDTAINFTNQILDGIKHAHD--- 129
Query: 475 QVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPELTQTGKA 534
++HRD+KP N LID+ ++ DFG+A+ + T +V+GT Y +PE +
Sbjct: 130 MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEAT 189
Query: 535 STSSDVFAYGILLLEVATGRRP 556
+D+++ GI+L E+ G P
Sbjct: 190 DECTDIYSIGIVLYEMLVGEPP 211
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 4e-39
Identities = 60/206 (29%), Positives = 90/206 (43%), Gaps = 14/206 (6%)
Query: 355 FKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFA---AEIESLGRL-RHK 410
F+ +G G +G V+K G AVK+ +G ++ A AE+ S ++ +H
Sbjct: 59 FQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMS-PFRGPKDRARKLAEVGSHEKVGQHP 117
Query: 411 NLVNLHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLH 470
V L ++ L L E SL G+ L Q + ++ L +LH
Sbjct: 118 CCVRLEQAWEEGGILYLQTELC-GPSLQQHC--EAWGASLPEAQVWGYLRDTLLALAHLH 174
Query: 471 EEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPELTQ 530
Q ++H DVKP+N + +LGDFGL G G Y+APEL Q
Sbjct: 175 S---QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEV--QEGDPRYMAPELLQ 229
Query: 531 TGKASTSSDVFAYGILLLEVATGRRP 556
G T++DVF+ G+ +LEVA
Sbjct: 230 -GSYGTAADVFSLGLTILEVACNMEL 254
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 2e-38
Identities = 63/205 (30%), Positives = 93/205 (45%), Gaps = 16/205 (7%)
Query: 359 EVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMR-EFAAEIESLGRLRHKNLVNLHG 417
E IG G FG V+ G L VAVK ++ +F E L + H N+V L G
Sbjct: 120 EQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 179
Query: 418 WCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVV 477
C QK + +V E + G T L +G+ L + +V A+G+ YL +
Sbjct: 180 VCTQKQPIYIVMELVQGGDFLTFLR--TEGARLRVKTLLQMVGDAAAGMEYLE---SKCC 234
Query: 478 IHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYI-----APELTQTG 532
IHRD+ N L+ + ++ DFG++R G G + APE G
Sbjct: 235 IHRDLAARNCLVTEKNVLKISDFGMSREEADG----VYAASGGLRQVPVKWTAPEALNYG 290
Query: 533 KASTSSDVFAYGILLLEVAT-GRRP 556
+ S+ SDV+++GILL E + G P
Sbjct: 291 RYSSESDVWSFGILLWETFSLGASP 315
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 2e-38
Identities = 67/240 (27%), Positives = 112/240 (46%), Gaps = 24/240 (10%)
Query: 361 IGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQ--GMRE-FAAEIESLGRLRHKNLVNLHG 417
+G G F VY+ TG EVA+K I + ++ GM + E++ +L+H +++ L+
Sbjct: 19 LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78
Query: 418 WCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVV 477
+ + N + LV E NG ++ L K + + E R + I +G+LYLH +
Sbjct: 79 YFEDSNYVYLVLEMCHNGEMNRYL-KNRVKPFSENEARH-FMHQIITGMLYLHS---HGI 133
Query: 478 IHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPELTQTGKASTS 537
+HRD+ SN L+ MN ++ DFGLA H T + GT YI+PE+
Sbjct: 134 LHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT-LCGTPNYISPEIATRSAHGLE 192
Query: 538 SDVFAYGILLLEVATGRRP------------IGSGDLLLVEWV-RECHQL-GRILDVADP 583
SDV++ G + + GR P + D + ++ E L ++L +P
Sbjct: 193 SDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLSIEAKDLIHQLLRR-NP 251
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 2e-38
Identities = 62/290 (21%), Positives = 108/290 (37%), Gaps = 40/290 (13%)
Query: 355 FKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAA-EIESLGRLRHKNLV 413
F+ + +G GGFG V++ A+K+I + + RE E+++L +L H +V
Sbjct: 7 FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 66
Query: 414 NLHGWCKQKND------------LLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKG 461
+KN L + + +L + + +I
Sbjct: 67 RYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQ 126
Query: 462 IASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNV---- 517
IA + +LH + ++HRD+KPSN + ++GDFGL D T
Sbjct: 127 IAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPA 183
Query: 518 -------VGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRE 570
VGT Y++PE S D+F+ G++L E+ P + +
Sbjct: 184 YARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERV------ 234
Query: 571 CHQLGRILDVADPLLNSSYVVKEMELVLKLGLMCSHKTQFRPTMRQVMRY 620
L + ++ P L + E +V M S RP ++
Sbjct: 235 -RTLTDVRNLKFPPLFTQKYPCEYVMVQD---MLSPSPMERPEAINIIEN 280
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 6e-38
Identities = 58/212 (27%), Positives = 97/212 (45%), Gaps = 14/212 (6%)
Query: 355 FKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGM----REFA-AEIESLGRLRH 409
++ IG G +G K + G + K++ M ++ +E+ L L+H
Sbjct: 8 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKEL---DYGSMTEAEKQMLVSEVNLLRELKH 64
Query: 410 KNLVNLHGW--CKQKNDLLLVYEYIPNGSLDTLLFK-PKDGSVLDWEQRFNIVKGIASGL 466
N+V + + L +V EY G L +++ K K+ LD E ++ + L
Sbjct: 65 PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 124
Query: 467 LYLHE--EWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYI 524
H + V+HRD+KP+N +D + N +LGDFGLAR+ +H VGT Y+
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH-DTSFAKTFVGTPYYM 183
Query: 525 APELTQTGKASTSSDVFAYGILLLEVATGRRP 556
+PE + SD+++ G LL E+ P
Sbjct: 184 SPEQMNRMSYNEKSDIWSLGCLLYELCALMPP 215
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 8e-38
Identities = 57/199 (28%), Positives = 95/199 (47%), Gaps = 6/199 (3%)
Query: 359 EVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNLHGW 418
+G G +G VY+GV VAVK + ++++ + EF E + ++H NLV L G
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 284
Query: 419 CKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVI 478
C ++ ++ E++ G+L L + + + + I+S + YL ++ I
Sbjct: 285 CTREPPFYIITEFMTYGNLLDYL-RECNRQEVSAVVLLYMATQISSAMEYLE---KKNFI 340
Query: 479 HRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPELTQTGKASTSS 538
HR++ N L+ ++ DFGL+RL + APE K S S
Sbjct: 341 HRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 400
Query: 539 DVFAYGILLLEVAT-GRRP 556
DV+A+G+LL E+AT G P
Sbjct: 401 DVWAFGVLLWEIATYGMSP 419
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 2e-37
Identities = 54/217 (24%), Positives = 96/217 (44%), Gaps = 20/217 (9%)
Query: 355 FKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMRE-FAAEIESLGRLRHKNLV 413
+ S+++G G +V++G TG A+K S + E E L +L HKN+V
Sbjct: 11 WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIV 70
Query: 414 NLHG--WCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHE 471
L +L+ E+ P GSL T+L +P + L + +++ + G+ +L
Sbjct: 71 KLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR- 129
Query: 472 EWEQVVIHRDVKPSNALI----DAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPE 527
E ++HR++KP N + D + +L DFG AR + + + GT Y+ P+
Sbjct: 130 --ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVS--LYGTEEYLHPD 185
Query: 528 LTQTGKASTSS--------DVFAYGILLLEVATGRRP 556
+ + D+++ G+ ATG P
Sbjct: 186 MYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 1e-36
Identities = 60/201 (29%), Positives = 98/201 (48%), Gaps = 10/201 (4%)
Query: 359 EVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNLHGW 418
+G G +G VY+GV VAVK + ++++ + EF E + ++H NLV L G
Sbjct: 19 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 419 CKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVI 478
C ++ ++ E++ G+L L + + + + I+S + YL ++ I
Sbjct: 78 CTREPPFYIITEFMTYGNLLDYL-RECNRQEVSAVVLLYMATQISSAMEYLE---KKNFI 133
Query: 479 HRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGY--IAPELTQTGKAST 536
HRD+ N L+ ++ DFGL+RL +T + F APE K S
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRLMTGD--TYTAHAGAKFPIKWTAPESLAYNKFSI 191
Query: 537 SSDVFAYGILLLEVAT-GRRP 556
SDV+A+G+LL E+AT G P
Sbjct: 192 KSDVWAFGVLLWEIATYGMSP 212
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 1e-36
Identities = 57/207 (27%), Positives = 95/207 (45%), Gaps = 14/207 (6%)
Query: 357 ESEVIGIGGFGSVYKGVLPTTGGE--VAVK--KITRNSLQGMREFAAEIESLGRLRHKNL 412
E + +G G FG+V KG VAVK K N E AE + +L + +
Sbjct: 21 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 80
Query: 413 VNLHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEE 472
V + G C + +LV E G L+ L + + + +V ++ G+ YL E
Sbjct: 81 VRMIGIC-EAESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYL--E 134
Query: 473 WEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTF--GYIAPELTQ 530
E +HRD+ N L+ + A++ DFGL++ + G + + APE
Sbjct: 135 -ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN 193
Query: 531 TGKASTSSDVFAYGILLLEVAT-GRRP 556
K S+ SDV+++G+L+ E + G++P
Sbjct: 194 YYKFSSKSDVWSFGVLMWEAFSYGQKP 220
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 2e-36
Identities = 55/202 (27%), Positives = 96/202 (47%), Gaps = 12/202 (5%)
Query: 361 IGIGGFGSVYKGVLPTTGGE--VAVKKITRNSLQGMR-EFAAEIESLGRLRHKNLVNLHG 417
+G G FGSV +GV + VA+K + + + + E E + + +L + +V L G
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77
Query: 418 WCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVV 477
C Q L+LV E G L L ++ + ++ ++ G+ YL E +
Sbjct: 78 VC-QAEALMLVMEMAGGGPLHKFLVGKREE--IPVSNVAELLHQVSMGMKYLEE---KNF 131
Query: 478 IHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTF--GYIAPELTQTGKAS 535
+HRD+ N L+ A++ DFGL++ +T G + + APE K S
Sbjct: 132 VHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFS 191
Query: 536 TSSDVFAYGILLLEVAT-GRRP 556
+ SDV++YG+ + E + G++P
Sbjct: 192 SRSDVWSYGVTMWEALSYGQKP 213
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 2e-36
Identities = 66/209 (31%), Positives = 106/209 (50%), Gaps = 20/209 (9%)
Query: 359 EVIGIGGFGSVYKGVLPTTGGE---VAVKKITRNSLQGMR-EFAAEIESLGRLRHKNLVN 414
++IG G G V G L G VA+K + + R +F +E +G+ H N++
Sbjct: 55 KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIR 114
Query: 415 LHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWE 474
L G + ++V EY+ NGSLDT L + DG Q +++G+ +G+ YL +
Sbjct: 115 LEGVVTRGRLAMIVTEYMENGSLDTFL-RTHDGQ-FTIMQLVGMLRGVGAGMRYLS---D 169
Query: 475 QVVIHRDVKPSNALIDAEMNARLGDFGLAR-LYDHGGMPHTTNVVGTFGYI-----APEL 528
+HRD+ N L+D+ + ++ DFGL+R L D +TT G I APE
Sbjct: 170 LGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTG----GKIPIRWTAPEA 225
Query: 529 TQTGKASTSSDVFAYGILLLEVAT-GRRP 556
S++SDV+++G+++ EV G RP
Sbjct: 226 IAFRTFSSASDVWSFGVVMWEVLAYGERP 254
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 2e-36
Identities = 73/285 (25%), Positives = 118/285 (41%), Gaps = 31/285 (10%)
Query: 359 EVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMRE-FAAEIESLGRLRHKNLVNLH- 416
E +G GGFG V + + TG +VA+K+ + RE + EI+ + +L H N+V+
Sbjct: 20 ERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSARE 79
Query: 417 -----GWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHE 471
+ LL EY G L L + ++ L ++ I+S L YLH
Sbjct: 80 VPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH- 138
Query: 472 EWEQVVIHRDVKPSNALIDAE---MNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPEL 528
E +IHRD+KP N ++ + ++ D G A+ D G + VGT Y+APEL
Sbjct: 139 --ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTE--FVGTLQYLAPEL 194
Query: 529 TQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLV--------------EWVRECHQL 574
+ K + + D +++G L E TG RP + + +
Sbjct: 195 LEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAV 254
Query: 575 GRILDVADPLLNSSYVVKEMELVLKLGLMCSHKTQFRPTMRQVMR 619
+ P S + ++E L+ LM + R T Q
Sbjct: 255 KFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQ--RGTDPQNPN 297
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 2e-36
Identities = 68/292 (23%), Positives = 120/292 (41%), Gaps = 43/292 (14%)
Query: 355 FKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVN 414
F+E V+G G FG V K A+KKI + + +E+ L L H+ +V
Sbjct: 8 FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEK-LSTILSEVMLLASLNHQYVVR 66
Query: 415 LHG-WCKQKND------------LLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKG 461
+ W +++N L + EY NG+L L+ + ++ + + +
Sbjct: 67 YYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLI--HSENLNQQRDEYWRLFRQ 124
Query: 462 IASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTN----- 516
I L Y+H Q +IHRD+KP N ID N ++GDFGLA+ +
Sbjct: 125 ILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLP 181
Query: 517 --------VVGTFGYIAPE-LTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEW 567
+GT Y+A E L TG + D+++ GI+ E+ G + +++
Sbjct: 182 GSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFST-GMERVNILKK 240
Query: 568 VRECHQLGRILDVADPLLNSSYVVKEMELVLKLGLMCSHKTQFRPTMRQVMR 619
+R + P + + + E +++ + H RP R ++
Sbjct: 241 LR------SVSIEFPPDFDDNKMKVEKKIIRL---LIDHDPNKRPGARTLLN 283
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 3e-36
Identities = 55/208 (26%), Positives = 93/208 (44%), Gaps = 17/208 (8%)
Query: 359 EVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAA----EIESLGRLRHKNLVN 414
E++G GG V+ +VAVK + R L F E ++ L H +V
Sbjct: 18 EILGFGGMSEVHLARDLRDHRDVAVK-VLRADLARDPSFYLRFRREAQNAAALNHPAIVA 76
Query: 415 LHGWCKQKNDLL----LVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLH 470
++ + + +V EY+ +L ++ + ++ ++ L + H
Sbjct: 77 VYDTGEAETPAGPLPYIVMEYVDGVTLRDIV---HTEGPMTPKRAIEVIADACQALNFSH 133
Query: 471 EEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGG--MPHTTNVVGTFGYIAPEL 528
+ +IHRDVKP+N +I A ++ DFG+AR G + T V+GT Y++PE
Sbjct: 134 Q---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQ 190
Query: 529 TQTGKASTSSDVFAYGILLLEVATGRRP 556
+ SDV++ G +L EV TG P
Sbjct: 191 ARGDSVDARSDVYSLGCVLYEVLTGEPP 218
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 5e-36
Identities = 54/217 (24%), Positives = 96/217 (44%), Gaps = 20/217 (9%)
Query: 355 FKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMRE-FAAEIESLGRLRHKNLV 413
+ S+++G G +V++G TG A+K S + E E L +L HKN+V
Sbjct: 11 WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIV 70
Query: 414 NLHGW--CKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHE 471
L +L+ E+ P GSL T+L +P + L + +++ + G+ +L
Sbjct: 71 KLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR- 129
Query: 472 EWEQVVIHRDVKPSNALI----DAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPE 527
E ++HR++KP N + D + +L DFG AR + + + GT Y+ P+
Sbjct: 130 --ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVS--LYGTEEYLHPD 185
Query: 528 LTQTGKASTSS--------DVFAYGILLLEVATGRRP 556
+ + D+++ G+ ATG P
Sbjct: 186 MYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 6e-36
Identities = 50/218 (22%), Positives = 82/218 (37%), Gaps = 19/218 (8%)
Query: 355 FKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVN 414
+ + +G GGF V G A+K+I + Q E E + H N++
Sbjct: 31 YLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILR 90
Query: 415 LHGWCKQKND----LLLVYEYIPNGSL-DTLLFKPKDGSVLDWEQRFNIVKGIASGLLYL 469
L +C ++ L+ + G+L + + G+ L +Q ++ GI GL +
Sbjct: 91 LVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAI 150
Query: 470 HEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHG--------GMPHTTNVVGTF 521
H + HRD+KP+N L+ E L D G + T
Sbjct: 151 H---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTI 207
Query: 522 GYIAPELTQT---GKASTSSDVFAYGILLLEVATGRRP 556
Y APEL +DV++ G +L + G P
Sbjct: 208 SYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGP 245
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 7e-36
Identities = 62/199 (31%), Positives = 99/199 (49%), Gaps = 8/199 (4%)
Query: 359 EVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNLHGW 418
+G G FG V+ G T VA+K + ++ F E + + +LRH+ LV L+
Sbjct: 190 VKLGQGCFGEVWMGTWNGTT-RVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAV 247
Query: 419 CKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVI 478
++ + +V EY+ GSL L K + G L Q ++ IASG+ Y+ +
Sbjct: 248 VSEEP-IYIVTEYMSKGSLLDFL-KGETGKYLRLPQLVDMAAQIASGMAYVER---MNYV 302
Query: 479 HRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPELTQTGKASTSS 538
HRD++ +N L+ + ++ DFGLARL + + APE G+ + S
Sbjct: 303 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 362
Query: 539 DVFAYGILLLEVAT-GRRP 556
DV+++GILL E+ T GR P
Sbjct: 363 DVWSFGILLTELTTKGRVP 381
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 1e-35
Identities = 66/202 (32%), Positives = 96/202 (47%), Gaps = 18/202 (8%)
Query: 359 EVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNLHGW 418
+ IG G FG V G +VAVK I ++ + F AE + +LRH NLV L G
Sbjct: 27 QTIGKGEFGDVMLGDYRGN--KVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGV 82
Query: 419 C-KQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVV 477
++K L +V EY+ GSL L + + SVL + + + YL
Sbjct: 83 IVEEKGGLYIVTEYMAKGSLVDYL-RSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNF 138
Query: 478 IHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGY--IAPELTQTGKAS 535
+HRD+ N L+ + A++ DFGL + +T G APE + K S
Sbjct: 139 VHRDLAARNVLVSEDNVAKVSDFGLTKEA------SSTQDTGKLPVKWTAPEALREKKFS 192
Query: 536 TSSDVFAYGILLLEVAT-GRRP 556
T SDV+++GILL E+ + GR P
Sbjct: 193 TKSDVWSFGILLWEIYSFGRVP 214
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 1e-35
Identities = 69/209 (33%), Positives = 108/209 (51%), Gaps = 20/209 (9%)
Query: 359 EVIGIGGFGSVYKGVLPTTGGE---VAVKKITRNSLQGMR-EFAAEIESLGRLRHKNLVN 414
+V+G G FG V G L + VA+K + + R +F E +G+ H N++
Sbjct: 51 KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 415 LHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWE 474
L G + +++V EY+ NGSLD+ L + D Q +++GIASG+ YL +
Sbjct: 111 LEGVVTKSKPVMIVTEYMENGSLDSFL-RKHDAQ-FTVIQLVGMLRGIASGMKYLS---D 165
Query: 475 QVVIHRDVKPSNALIDAEMNARLGDFGLAR-LYDHGGMPHTTNVVGTFGYI-----APEL 528
+HRD+ N LI++ + ++ DFGL R L D +TT G I +PE
Sbjct: 166 MGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTT----RGGKIPIRWTSPEA 221
Query: 529 TQTGKASTSSDVFAYGILLLEVAT-GRRP 556
K +++SDV++YGI+L EV + G RP
Sbjct: 222 IAYRKFTSASDVWSYGIVLWEVMSYGERP 250
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 1e-35
Identities = 54/213 (25%), Positives = 98/213 (46%), Gaps = 29/213 (13%)
Query: 359 EVIGIGGFGSVYKGVLPTTGGE----VAVKKITRNSLQGMR-EFAAEIESLGRLRHKNLV 413
+V+G G FG+VYKG+ G + VA+K++ + E E + + + ++
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 414 NLHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEW 473
L G C + L+ + +P G L + + KD + + N IA G+ YL +
Sbjct: 81 RLLGICLTST-VQLITQLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAKGMNYLED-- 135
Query: 474 EQVVIHRDVKPSNALIDAEMNARLGDFGLARL---------YDHGGMPHTTNVVGTFGYI 524
+ ++HRD+ N L+ + ++ DFGLA+L + G +P ++
Sbjct: 136 -RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP--------IKWM 186
Query: 525 APELTQTGKASTSSDVFAYGILLLEVAT-GRRP 556
A E + SDV++YG+ + E+ T G +P
Sbjct: 187 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 1e-35
Identities = 63/202 (31%), Positives = 94/202 (46%), Gaps = 13/202 (6%)
Query: 359 EVIGIGGFGSVYKGVLPTTGGE----VAVKKITRNSLQGMREFAAEIESLGRLRHKNLVN 414
+ +G G FGSV VAVKK+ ++ + +R+F EIE L L+H N+V
Sbjct: 16 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75
Query: 415 LHGWCKQKND--LLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEE 472
G C L L+ EY+P GSL L K +D + I G+ YL
Sbjct: 76 YKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYLG-- 131
Query: 473 WEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTF--GYIAPELTQ 530
+ IHRD+ N L++ E ++GDFGL ++ G + APE
Sbjct: 132 -TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLT 190
Query: 531 TGKASTSSDVFAYGILLLEVAT 552
K S +SDV+++G++L E+ T
Sbjct: 191 ESKFSVASDVWSFGVVLYELFT 212
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 2e-35
Identities = 51/220 (23%), Positives = 92/220 (41%), Gaps = 25/220 (11%)
Query: 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSL--QGMREFAAEIESLGRLRHK 410
+ + + IG GG V++ L A+K + Q + + EI L +L+
Sbjct: 9 RIYSILKQIGSGGSSKVFQV-LNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQH 67
Query: 411 NL--VNLHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLY 468
+ + L+ + + +V E N L++ L K +D +R + K + +
Sbjct: 68 SDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWL---KKKKSIDPWERKSYWKNMLEAVHT 123
Query: 469 LHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLAR-LYDHGGMPHTTNVVGTFGYIAPE 527
+H + ++H D+KP+N LI + +L DFG+A + + VGT Y+ PE
Sbjct: 124 IH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPE 179
Query: 528 L-----------TQTGKASTSSDVFAYGILLLEVATGRRP 556
K S SDV++ G +L + G+ P
Sbjct: 180 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 219
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 140 bits (353), Expect = 2e-35
Identities = 62/199 (31%), Positives = 99/199 (49%), Gaps = 8/199 (4%)
Query: 359 EVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNLHGW 418
+G G FG V+ G T VA+K + ++ F E + + +LRH+ LV L+
Sbjct: 273 VKLGQGCFGEVWMGTWNGTT-RVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAV 330
Query: 419 CKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVI 478
++ + +V EY+ GSL L K + G L Q ++ IASG+ Y+ +
Sbjct: 331 VSEEP-IYIVTEYMSKGSLLDFL-KGETGKYLRLPQLVDMAAQIASGMAYVER---MNYV 385
Query: 479 HRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPELTQTGKASTSS 538
HRD++ +N L+ + ++ DFGLARL + + APE G+ + S
Sbjct: 386 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 445
Query: 539 DVFAYGILLLEVAT-GRRP 556
DV+++GILL E+ T GR P
Sbjct: 446 DVWSFGILLTELTTKGRVP 464
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 2e-35
Identities = 58/207 (28%), Positives = 90/207 (43%), Gaps = 15/207 (7%)
Query: 359 EVIGIGGFGSVYKGVLPTTGGE---VAVKKI---TRNSLQGMREFAAEIESLGRLRHKNL 412
E +G G FG V +G G+ VAVK + + + M +F E+ ++ L H+NL
Sbjct: 24 EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 83
Query: 413 VNLHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEE 472
+ L+G + +V E P GSL L K + +A G+ YL
Sbjct: 84 IRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQG--HFLLGTLSRYAVQVAEGMGYLE-- 138
Query: 473 WEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGY--IAPELTQ 530
+ IHRD+ N L+ ++GDFGL R + + APE +
Sbjct: 139 -SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLK 197
Query: 531 TGKASTSSDVFAYGILLLEVAT-GRRP 556
T S +SD + +G+ L E+ T G+ P
Sbjct: 198 TRTFSHASDTWMFGVTLWEMFTYGQEP 224
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 2e-35
Identities = 67/202 (33%), Positives = 97/202 (48%), Gaps = 18/202 (8%)
Query: 359 EVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNLHGW 418
+ IG G FG V G G +VAVK I ++ + F AE + +LRH NLV L G
Sbjct: 199 QTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGV 254
Query: 419 C-KQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVV 477
++K L +V EY+ GSL L + + SVL + + + YL
Sbjct: 255 IVEEKGGLYIVTEYMAKGSLVDYL-RSRGRSVLGGDCLLKFSLDVCEAMEYLEG---NNF 310
Query: 478 IHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGY--IAPELTQTGKAS 535
+HRD+ N L+ + A++ DFGL + +T G APE + K S
Sbjct: 311 VHRDLAARNVLVSEDNVAKVSDFGLTKEA------SSTQDTGKLPVKWTAPEALREKKFS 364
Query: 536 TSSDVFAYGILLLEVAT-GRRP 556
T SDV+++GILL E+ + GR P
Sbjct: 365 TKSDVWSFGILLWEIYSFGRVP 386
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 2e-35
Identities = 52/220 (23%), Positives = 93/220 (42%), Gaps = 25/220 (11%)
Query: 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSL--QGMREFAAEIESLGRLRHK 410
+ + + IG GG V++ VL A+K + Q + + EI L +L+
Sbjct: 28 RIYSILKQIGSGGSSKVFQ-VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQH 86
Query: 411 NL--VNLHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLY 468
+ + L+ + + +V E N L++ L K +D +R + K + +
Sbjct: 87 SDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWL---KKKKSIDPWERKSYWKNMLEAVHT 142
Query: 469 LHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLAR-LYDHGGMPHTTNVVGTFGYIAPE 527
+H + ++H D+KP+N LI + +L DFG+A + + VGT Y+ PE
Sbjct: 143 IH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPE 198
Query: 528 L-----------TQTGKASTSSDVFAYGILLLEVATGRRP 556
K S SDV++ G +L + G+ P
Sbjct: 199 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 238
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 3e-35
Identities = 72/210 (34%), Positives = 116/210 (55%), Gaps = 21/210 (10%)
Query: 359 EVIGIGGFGSVYKGVLPTTGGE----VAVKKITRNSLQGMR-EFAAEIESLGRLRHKNLV 413
+VIG G FG VYKG+L T+ G+ VA+K + + R +F E +G+ H N++
Sbjct: 50 KVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNII 109
Query: 414 NLHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEW 473
L G + ++++ EY+ NG+LD L + KDG Q +++GIA+G+ YL
Sbjct: 110 RLEGVISKYKPMMIITEYMENGALDKFL-REKDGE-FSVLQLVGMLRGIAAGMKYLA--- 164
Query: 474 EQVVIHRDVKPSNALIDAEMNARLGDFGLAR-LYDHGGMPHTTNVVGTFGYI-----APE 527
+HRD+ N L+++ + ++ DFGL+R L D +TT+ G I APE
Sbjct: 165 NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSG----GKIPIRWTAPE 220
Query: 528 LTQTGKASTSSDVFAYGILLLEVAT-GRRP 556
K +++SDV+++GI++ EV T G RP
Sbjct: 221 AISYRKFTSASDVWSFGIVMWEVMTYGERP 250
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 3e-35
Identities = 61/212 (28%), Positives = 93/212 (43%), Gaps = 24/212 (11%)
Query: 359 EVIGIGGFGSVYKGVLPTTGGE----VAVKKITRNSLQGMREFAAEIESLGRLRHKNLVN 414
+G G FGSV G VAVK++ + R+F EI+ L L +V
Sbjct: 29 SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 88
Query: 415 LHGWCKQKND--LLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEE 472
G L LV EY+P+G L L + + LD + I G+ YL
Sbjct: 89 YRGVSYGPGRQSLRLVMEYLPSGCLRDFL--QRHRARLDASRLLLYSSQICKGMEYLG-- 144
Query: 473 WEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTN--VVGTFGYI-----A 525
+ +HRD+ N L+++E + ++ DFGLA+L +P + VV G A
Sbjct: 145 -SRRCVHRDLAARNILVESEAHVKIADFGLAKL-----LPLDKDYYVVREPGQSPIFWYA 198
Query: 526 PELTQTGKASTSSDVFAYGILLLEVAT-GRRP 556
PE S SDV+++G++L E+ T +
Sbjct: 199 PESLSDNIFSRQSDVWSFGVVLYELFTYCDKS 230
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 4e-35
Identities = 51/220 (23%), Positives = 91/220 (41%), Gaps = 25/220 (11%)
Query: 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSL--QGMREFAAEIESLGRLRHK 410
+ + + IG GG V++ VL A+K + Q + + EI L +L+
Sbjct: 56 RIYSILKQIGSGGSSKVFQ-VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQH 114
Query: 411 NL--VNLHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLY 468
+ + L+ + + +V E N L++ L K +D +R + K + +
Sbjct: 115 SDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWL---KKKKSIDPWERKSYWKNMLEAVHT 170
Query: 469 LHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLY-DHGGMPHTTNVVGTFGYIAPE 527
+H + ++H D+KP+N LI + +L DFG+A + VG Y+ PE
Sbjct: 171 IH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPE 226
Query: 528 L-----------TQTGKASTSSDVFAYGILLLEVATGRRP 556
K S SDV++ G +L + G+ P
Sbjct: 227 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 266
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 5e-35
Identities = 63/202 (31%), Positives = 95/202 (47%), Gaps = 13/202 (6%)
Query: 359 EVIGIGGFGSVYKGVLPTTGGE----VAVKKITRNSLQGMREFAAEIESLGRLRHKNLVN 414
+ +G G FGSV VAVKK+ ++ + +R+F EIE L L+H N+V
Sbjct: 47 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 106
Query: 415 LHGWCKQKND--LLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEE 472
G C L L+ EY+P GSL L K +D + I G+ YL
Sbjct: 107 YKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYLG-- 162
Query: 473 WEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTF--GYIAPELTQ 530
+ IHRD+ N L++ E ++GDFGL ++ + G + APE
Sbjct: 163 -TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLT 221
Query: 531 TGKASTSSDVFAYGILLLEVAT 552
K S +SDV+++G++L E+ T
Sbjct: 222 ESKFSVASDVWSFGVVLYELFT 243
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 7e-35
Identities = 53/233 (22%), Positives = 92/233 (39%), Gaps = 32/233 (13%)
Query: 355 FKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAA--EIESLGRL-RHKN 411
F E E IG G FGSV+K V G A+K+ + + E A E+ + L +H +
Sbjct: 13 FHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSH 72
Query: 412 LVNLHGWCKQKNDLLLVYEYIPNGSLDTLLFK-PKDGSVLDWEQRFNIVKGIASGLLYLH 470
+V + + +L+ EY GSL + + + S + +++ + GL Y+H
Sbjct: 73 VVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH 132
Query: 471 EEWEQVVIHRDVKPSNALID-------------------AEMNARLGDFGLARLYDHGGM 511
++H D+KPSN I ++ ++GD G
Sbjct: 133 ---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVT---RISS 186
Query: 512 PHTTNVVGTFGYIAPELTQTGKA-STSSDVFAYGILLLEVATGRRPIGSGDLL 563
P G ++A E+ Q +D+FA + ++ A +GD
Sbjct: 187 PQV--EEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQW 237
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 1e-34
Identities = 61/201 (30%), Positives = 99/201 (49%), Gaps = 12/201 (5%)
Query: 359 EVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNLHGW 418
+ +G G FG V+ +VAVK + + + F AE + L+H LV LH
Sbjct: 194 KKLGAGQFGEVWMATYNKHT-KVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVKLHAV 251
Query: 419 CKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVI 478
K + ++ E++ GSL L K +GS + + IA G+ ++ + + I
Sbjct: 252 V-TKEPIYIITEFMAKGSLLDFL-KSDEGSKQPLPKLIDFSAQIAEGMAFIEQ---RNYI 306
Query: 479 HRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGY--IAPELTQTGKAST 536
HRD++ +N L+ A + ++ DFGLAR+ + +T F APE G +
Sbjct: 307 HRDLRAANILVSASLVCKIADFGLARVIEDN--EYTAREGAKFPIKWTAPEAINFGSFTI 364
Query: 537 SSDVFAYGILLLEVAT-GRRP 556
SDV+++GILL+E+ T GR P
Sbjct: 365 KSDVWSFGILLMEIVTYGRIP 385
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 2e-34
Identities = 66/201 (32%), Positives = 103/201 (51%), Gaps = 12/201 (5%)
Query: 359 EVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNLHGW 418
E +G G FG V+ G +VAVK + + S+ F AE + +L+H+ LV L+
Sbjct: 19 ERLGAGQFGEVWMGYYNGHT-KVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLVRLYAV 76
Query: 419 CKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVI 478
Q + ++ EY+ NGSL L K G L + ++ IA G+ ++ E + I
Sbjct: 77 VTQ-EPIYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYI 131
Query: 479 HRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGY--IAPELTQTGKAST 536
HRD++ +N L+ ++ ++ DFGLARL + +T F APE G +
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARLIEDNE--YTAREGAKFPIKWTAPEAINYGTFTI 189
Query: 537 SSDVFAYGILLLEVAT-GRRP 556
SDV+++GILL E+ T GR P
Sbjct: 190 KSDVWSFGILLTEIVTHGRIP 210
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 3e-34
Identities = 76/294 (25%), Positives = 125/294 (42%), Gaps = 36/294 (12%)
Query: 355 FKESEVIGIGGFGS-VYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRL-RHKNL 412
F +V+G G G+ VY+G+ +VAVK+I E++ L H N+
Sbjct: 26 FCPKDVLGHGAEGTIVYRGMF--DNRDVAVKRILPECFSFADR---EVQLLRESDEHPNV 80
Query: 413 VNLHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEE 472
+ K + + E +L + + KD + L E +++ SGL +LH
Sbjct: 81 IRYFCTEKDRQFQYIAIELCA-ATLQEYVEQ-KDFAHLGLEPI-TLLQQTTSGLAHLHS- 136
Query: 473 WEQVVIHRDVKPSNALI-----DAEMNARLGDFGLARLYDHG--GMPHTTNVVGTFGYIA 525
++HRD+KP N LI ++ A + DFGL + G + V GT G+IA
Sbjct: 137 --LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIA 194
Query: 526 PEL---TQTGKASTSSDVFAYGILLLEVAT-GRRPIGSGDLLLVEWVRECHQLGRILDVA 581
PE+ + + D+F+ G + V + G P G + LD
Sbjct: 195 PEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACS----LDCL 250
Query: 582 DPLLNSSYVVKEMELVLKLGLMCSHKTQFRPTMRQVMR---YLSGEKQLRFNND 632
P + + + EL+ K M + Q RP+ + V++ + S EKQL+F D
Sbjct: 251 HPEKHEDVIAR--ELIEK---MIAMDPQKRPSAKHVLKHPFFWSLEKQLQFFQD 299
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 3e-34
Identities = 58/212 (27%), Positives = 96/212 (45%), Gaps = 15/212 (7%)
Query: 355 FKESEVIGIGGFGSVYKGVLPTTGGE----VAVKKI-TRNSLQGMREFAAEIESLGRLRH 409
K +G G FG V G VAVK + + + + EIE L L H
Sbjct: 23 LKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYH 82
Query: 410 KNLVNLHGWCKQKND--LLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLL 467
+N+V G C + + L+ E++P+GSL L PK+ + ++ +Q+ I G+
Sbjct: 83 ENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL--PKNKNKINLKQQLKYAVQICKGMD 140
Query: 468 YLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTF--GYIA 525
YL + +HRD+ N L+++E ++GDFGL + + +T + A
Sbjct: 141 YLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYA 197
Query: 526 PELTQTGKASTSSDVFAYGILLLEVAT-GRRP 556
PE K +SDV+++G+ L E+ T
Sbjct: 198 PECLMQSKFYIASDVWSFGVTLHELLTYCDSD 229
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 4e-34
Identities = 59/202 (29%), Positives = 97/202 (48%), Gaps = 14/202 (6%)
Query: 359 EVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNLHGW 418
+ IG G FG V+ G +VA+K I R +F E E + +L H LV L+G
Sbjct: 14 QEIGSGQFGLVHLGYWLNKD-KVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGV 71
Query: 419 CKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVI 478
C ++ + LV E++ +G L L + E + + G+ YL E VI
Sbjct: 72 CLEQAPICLVTEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLE---EACVI 126
Query: 479 HRDVKPSNALIDAEMNARLGDFGLAR-LYDHGGMPHTTNVVGTFGY--IAPELTQTGKAS 535
HRD+ N L+ ++ DFG+ R + D +T++ F +PE+ + S
Sbjct: 127 HRDLAARNCLVGENQVIKVSDFGMTRFVLDD---QYTSSTGTKFPVKWASPEVFSFSRYS 183
Query: 536 TSSDVFAYGILLLEVAT-GRRP 556
+ SDV+++G+L+ EV + G+ P
Sbjct: 184 SKSDVWSFGVLMWEVFSEGKIP 205
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 4e-34
Identities = 58/241 (24%), Positives = 100/241 (41%), Gaps = 27/241 (11%)
Query: 360 VIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQ--GMRE-FAAEIESLGRLRHKNLVNLH 416
+G G FG+VY + +A+K + + L+ G+ E+E LRH N++ L+
Sbjct: 16 PLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 75
Query: 417 GWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQV 476
G+ + L+ EY P G++ L K + + +A+ L Y H +
Sbjct: 76 GYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTAT-YITELANALSYCHS---KR 129
Query: 477 VIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPELTQTGKAST 536
VIHRD+KP N L+ + ++ DFG + GT Y+ PE+ +
Sbjct: 130 VIHRDIKPENLLLGSAGELKIADFGWSVHAP-SSRRTDL--CGTLDYLPPEMIEGRMHDE 186
Query: 537 SSDVFAYGILLLEVATGRRP------------IGSGDLLLVEWV-RECHQL-GRILDVAD 582
D+++ G+L E G+ P I + ++V L R+L +
Sbjct: 187 KVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKH-N 245
Query: 583 P 583
P
Sbjct: 246 P 246
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 5e-34
Identities = 54/213 (25%), Positives = 98/213 (46%), Gaps = 29/213 (13%)
Query: 359 EVIGIGGFGSVYKGVLPTTGGE----VAVKKITRNSLQGMR-EFAAEIESLGRLRHKNLV 413
+V+G G FG+VYKG+ G + VA+K++ + E E + + + ++
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 414 NLHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEW 473
L G C + L+ + +P G L + + KD + + N IA G+ YL +
Sbjct: 81 RLLGICLTST-VQLITQLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAKGMNYLED-- 135
Query: 474 EQVVIHRDVKPSNALIDAEMNARLGDFGLARL---------YDHGGMPHTTNVVGTFGYI 524
+ ++HRD+ N L+ + ++ DFGLA+L + G +P ++
Sbjct: 136 -RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP--------IKWM 186
Query: 525 APELTQTGKASTSSDVFAYGILLLEVAT-GRRP 556
A E + SDV++YG+ + E+ T G +P
Sbjct: 187 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 5e-34
Identities = 53/203 (26%), Positives = 96/203 (47%), Gaps = 12/203 (5%)
Query: 360 VIGIGGFGSVYKGVLPTTGGE--VAVKKITRNSLQGMR-EFAAEIESLGRLRHKNLVNLH 416
+G G FGSV +GV + VA+K + + + + E E + + +L + +V L
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 402
Query: 417 GWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQV 476
G C+ + L+LV E G L L ++ + ++ ++ G+ YL E +
Sbjct: 403 GVCQAEA-LMLVMEMAGGGPLHKFLVGKREE--IPVSNVAELLHQVSMGMKYLEE---KN 456
Query: 477 VIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGY--IAPELTQTGKA 534
+HR++ N L+ A++ DFGL++ +T G + APE K
Sbjct: 457 FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKF 516
Query: 535 STSSDVFAYGILLLEVAT-GRRP 556
S+ SDV++YG+ + E + G++P
Sbjct: 517 SSRSDVWSYGVTMWEALSYGQKP 539
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 1e-33
Identities = 63/202 (31%), Positives = 99/202 (49%), Gaps = 14/202 (6%)
Query: 359 EVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNLHGW 418
+ +G G FG V G +VAVK I + EF E +++ +L H LV +G
Sbjct: 14 KELGSGQFGVVKLGKWKGQY-DVAVKMI-KEGSMSEDEFFQEAQTMMKLSHPKLVKFYGV 71
Query: 419 CKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVI 478
C ++ + +V EYI NG L L G L+ Q + + G+ +L I
Sbjct: 72 CSKEYPIYIVTEYISNGCLLNYL--RSHGKGLEPSQLLEMCYDVCEGMAFLE---SHQFI 126
Query: 479 HRDVKPSNALIDAEMNARLGDFGLAR-LYDHGGMPHTTNVVGTFGY--IAPELTQTGKAS 535
HRD+ N L+D ++ ++ DFG+ R + D + ++V F APE+ K S
Sbjct: 127 HRDLAARNCLVDRDLCVKVSDFGMTRYVLDD---QYVSSVGTKFPVKWSAPEVFHYFKYS 183
Query: 536 TSSDVFAYGILLLEVAT-GRRP 556
+ SDV+A+GIL+ EV + G+ P
Sbjct: 184 SKSDVWAFGILMWEVFSLGKMP 205
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 1e-33
Identities = 55/214 (25%), Positives = 94/214 (43%), Gaps = 33/214 (15%)
Query: 359 EVIGIGGFGSVYKGVLPTTGGE---VAVKKITRNSLQGMR-EFAAEIESLGRLRHKNLVN 414
++G G FG VY+GV GE VAVK ++ + +F +E + L H ++V
Sbjct: 18 RILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVK 77
Query: 415 LHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWE 474
L G +++ ++ E P G L L + K+ L I + YL
Sbjct: 78 LIGIIEEEP-TWIIMELYPYGELGHYLERNKNS--LKVLTLVLYSLQICKAMAYLES--- 131
Query: 475 QVVIHRDVKPSNALIDAEMNARLGDFGLAR-LYD-------HGGMPHTTNVVGTFGYI-- 524
+HRD+ N L+ + +LGDFGL+R + D +P I
Sbjct: 132 INCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLP-----------IKW 180
Query: 525 -APELTQTGKASTSSDVFAYGILLLEVAT-GRRP 556
+PE + +T+SDV+ + + + E+ + G++P
Sbjct: 181 MSPESINFRRFTTASDVWMFAVCMWEILSFGKQP 214
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 1e-33
Identities = 54/214 (25%), Positives = 94/214 (43%), Gaps = 33/214 (15%)
Query: 359 EVIGIGGFGSVYKGVLPTTGGE---VAVKKITRNSLQGMR-EFAAEIESLGRLRHKNLVN 414
IG G FG V++G+ + VA+K + +R +F E ++ + H ++V
Sbjct: 21 RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 80
Query: 415 LHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWE 474
L G +N + ++ E G L + L K LD +++ L YL
Sbjct: 81 LIGVI-TENPVWIIMELCTLGELRSFLQVRKYS--LDLASLILYAYQLSTALAYLES--- 134
Query: 475 QVVIHRDVKPSNALIDAEMNARLGDFGLAR-LYD-------HGGMPHTTNVVGTFGYI-- 524
+ +HRD+ N L+ + +LGDFGL+R + D G +P I
Sbjct: 135 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLP-----------IKW 183
Query: 525 -APELTQTGKASTSSDVFAYGILLLEVAT-GRRP 556
APE + +++SDV+ +G+ + E+ G +P
Sbjct: 184 MAPESINFRRFTSASDVWMFGVCMWEILMHGVKP 217
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 2e-33
Identities = 61/213 (28%), Positives = 99/213 (46%), Gaps = 29/213 (13%)
Query: 359 EVIGIGGFGSVYKGVLPTTGG----EVAVKKI-TRNSLQGMREFAAEIESLGRLRHKNLV 413
+V+G G FG+V+KGV G V +K I ++ Q + + ++G L H ++V
Sbjct: 19 KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 78
Query: 414 NLHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEW 473
L G C + L LV +Y+P GSL + + + L + N IA G+ YL E
Sbjct: 79 RLLGLCPGSS-LQLVTQYLPLGSLLDHVRQHRGA--LGPQLLLNWGVQIAKGMYYLEE-- 133
Query: 474 EQVVIHRDVKPSNALIDAEMNARLGDFGLARL---------YDHGGMPHTTNVVGTFGYI 524
++HR++ N L+ + ++ DFG+A L Y P ++
Sbjct: 134 -HGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTP--------IKWM 184
Query: 525 APELTQTGKASTSSDVFAYGILLLEVAT-GRRP 556
A E GK + SDV++YG+ + E+ T G P
Sbjct: 185 ALESIHFGKYTHQSDVWSYGVTVWELMTFGAEP 217
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 4e-33
Identities = 56/202 (27%), Positives = 99/202 (49%), Gaps = 14/202 (6%)
Query: 359 EVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNLHGW 418
+ +G G FG V G +VA+K I + EF E + + L H+ LV L+G
Sbjct: 30 KELGTGQFGVVKYGKWRGQY-DVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGV 87
Query: 419 CKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVI 478
C ++ + ++ EY+ NG L L + +Q + K + + YL + +
Sbjct: 88 CTKQRPIFIITEYMANGCLLNYL--REMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFL 142
Query: 479 HRDVKPSNALIDAEMNARLGDFGLAR-LYDHGGMPHTTNVVGTFGY--IAPELTQTGKAS 535
HRD+ N L++ + ++ DFGL+R + D +T++V F PE+ K S
Sbjct: 143 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE---YTSSVGSKFPVRWSPPEVLMYSKFS 199
Query: 536 TSSDVFAYGILLLEVAT-GRRP 556
+ SD++A+G+L+ E+ + G+ P
Sbjct: 200 SKSDIWAFGVLMWEIYSLGKMP 221
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 4e-33
Identities = 61/209 (29%), Positives = 103/209 (49%), Gaps = 11/209 (5%)
Query: 355 FKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNS-LQGMREFAAEIESLGRLRHKNLV 413
F++ +G G G V+K +G +A K I + E++ L +V
Sbjct: 35 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 94
Query: 414 NLHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEW 473
+G ++ + E++ GSLD +L K + + + + GL YL E+
Sbjct: 95 GFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPEQILGKVSIAVIKGLTYLREKH 151
Query: 474 EQVVIHRDVKPSNALIDAEMNARLGDFGLA-RLYDHGGMPHTTNVVGTFGYIAPELTQTG 532
+ ++HRDVKPSN L+++ +L DFG++ +L D M ++ VGT Y++PE Q
Sbjct: 152 K--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID--SMANS--FVGTRSYMSPERLQGT 205
Query: 533 KASTSSDVFAYGILLLEVATGRRPIGSGD 561
S SD+++ G+ L+E+A GR PI D
Sbjct: 206 HYSVQSDIWSMGLSLVEMAVGRYPIPPPD 234
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 5e-33
Identities = 43/205 (20%), Positives = 76/205 (37%), Gaps = 22/205 (10%)
Query: 359 EVIGIGGFGSVYKGV-LPTTGGEVAVKKITRNSLQGMRE-FAAEIESLGRLRHKNLVNL- 415
I GG G +Y + G V +K + + + AE + L + H ++V +
Sbjct: 86 GCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIF 145
Query: 416 ----HGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHE 471
H +V EY+ SL + L + + I L YLH
Sbjct: 146 NFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK-----LPVAEAIAYLLEILPALSYLHS 200
Query: 472 EWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPELTQT 531
+++ D+KP N ++ E +L D G + G + GT G+ APE+
Sbjct: 201 ---IGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSFGY-----LYGTPGFQAPEIV-R 250
Query: 532 GKASTSSDVFAYGILLLEVATGRRP 556
+ ++D++ G L +
Sbjct: 251 TGPTVATDIYTVGRTLAALTLDLPT 275
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 7e-33
Identities = 52/221 (23%), Positives = 95/221 (42%), Gaps = 39/221 (17%)
Query: 359 EVIGIGGFGSVYKGVLPTTGG-------EVAVKKITRNSLQGMREFAAEIESLGRLRHKN 411
E +G G F ++KGV G EV +K + + F + +L HK+
Sbjct: 14 ESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKH 73
Query: 412 LVNLHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHE 471
LV +G C ++ +LV E++ GSLDT L K+ + ++ + + K +A+ + +L
Sbjct: 74 LVLNYGVCVCGDENILVQEFVKFGSLDTYL--KKNKNCINILWKLEVAKQLAAAMHFLE- 130
Query: 472 EWEQVVIHRDVKPSNALIDAEMNAR--------LGDFGLAR-LYDHGG--MPHTTNVVGT 520
E +IH +V N L+ E + + L D G++ +
Sbjct: 131 --ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQER-------- 180
Query: 521 FGYI---APELTQTGKA-STSSDVFAYGILLLEVAT-GRRP 556
I PE + K + ++D +++G L E+ + G +P
Sbjct: 181 ---IPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKP 218
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 7e-33
Identities = 68/221 (30%), Positives = 102/221 (46%), Gaps = 33/221 (14%)
Query: 359 EVIGIGGFGSVYKGVLPTTGGE--VAVKKITRN-SLQGMREFAAEIESLGRL-RHKNLVN 414
+VIG G FG V K + G A+K++ S R+FA E+E L +L H N++N
Sbjct: 31 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 90
Query: 415 LHGWCKQKNDLLLVYEYIPNGSLDTLL-------------FKPKDGSVLDWEQRFNIVKG 461
L G C+ + L L EY P+G+L L S L +Q +
Sbjct: 91 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 150
Query: 462 IASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTF 521
+A G+ YL ++ IHRD+ N L+ A++ DFGL+R + V T
Sbjct: 151 VARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSRGQE-------VYVKKTM 200
Query: 522 GYI-----APELTQTGKASTSSDVFAYGILLLEVAT-GRRP 556
G + A E +T+SDV++YG+LL E+ + G P
Sbjct: 201 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 241
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 1e-32
Identities = 60/241 (24%), Positives = 100/241 (41%), Gaps = 27/241 (11%)
Query: 360 VIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQ--GMRE-FAAEIESLGRLRHKNLVNLH 416
+G G FG+VY +A+K + ++ L+ G+ EIE LRH N++ ++
Sbjct: 21 PLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMY 80
Query: 417 GWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQV 476
+ + + L+ E+ P G L L K G + ++ +A L Y HE +
Sbjct: 81 NYFHDRKRIYLMLEFAPRGELYKEL--QKHGRFDEQRSAT-FMEELADALHYCHE---RK 134
Query: 477 VIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPELTQTGKAST 536
VIHRD+KP N L+ + ++ DFG + T GT Y+ PE+ +
Sbjct: 135 VIHRDIKPENLLMGYKGELKIADFGWSVHAP-SLRRRTM--CGTLDYLPPEMIEGKTHDE 191
Query: 537 SSDVFAYGILLLEVATGRRP------------IGSGDLLLVEWV-RECHQL-GRILDVAD 582
D++ G+L E G P I + DL ++ L ++L
Sbjct: 192 KVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSDGSKDLISKLLRY-H 250
Query: 583 P 583
P
Sbjct: 251 P 251
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 2e-32
Identities = 64/211 (30%), Positives = 92/211 (43%), Gaps = 23/211 (10%)
Query: 359 EVIGIGGFGSVYKGVL----PTTGGEVAVKKITRN-SLQGMREFAAEIESLGRLRHKNLV 413
+G G FG V TG VAVK + + Q + EI+ L L H++++
Sbjct: 37 RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHII 96
Query: 414 NLHGWCKQKND--LLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHE 471
G C+ L LV EY+P GSL L + + Q + I G+ YLH
Sbjct: 97 KYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS----IGLAQLLLFAQQICEGMAYLH- 151
Query: 472 EWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYI-----AP 526
Q IHRD+ N L+D + ++GDFGLA+ G H V G AP
Sbjct: 152 --AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG---HEYYRVREDGDSPVFWYAP 206
Query: 527 ELTQTGKASTSSDVFAYGILLLEVAT-GRRP 556
E + K +SDV+++G+ L E+ T
Sbjct: 207 ECLKEYKFYYASDVWSFGVTLYELLTHCDSS 237
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 3e-32
Identities = 63/223 (28%), Positives = 104/223 (46%), Gaps = 33/223 (14%)
Query: 359 EVIGIGGFGSVYKGVLPTTGGE-----VAVKKITRNSLQGMREFAAEIESLGRLRHKNLV 413
+G G FG V+ VAVK + +L ++F E E L L+H+++V
Sbjct: 21 RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIV 80
Query: 414 NLHGWCKQKNDLLLVYEYIPNGSLDTLL-------------FKPKDGSVLDWEQRFNIVK 460
+G C + L++V+EY+ +G L+ L + L Q +I
Sbjct: 81 KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 140
Query: 461 GIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLAR-LYDHGGMPHTTNVVG 519
IASG++YL Q +HRD+ N L+ A + ++GDFG++R +Y VG
Sbjct: 141 QIASGMVYLA---SQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTD-----YYRVG 192
Query: 520 TFGYI-----APELTQTGKASTSSDVFAYGILLLEVAT-GRRP 556
+ PE K +T SDV+++G++L E+ T G++P
Sbjct: 193 GHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 235
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 4e-32
Identities = 61/224 (27%), Positives = 94/224 (41%), Gaps = 34/224 (15%)
Query: 359 EVIGIGGFGSVYKGVLPTTGGE-----VAVKKITRN-SLQGMREFAAEIESLGRLRHKNL 412
E +G FG VYKG L VA+K + EF E RL+H N+
Sbjct: 15 EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNV 74
Query: 413 VNLHGWCKQKNDLLLVYEYIPNGSLDTLL-------------FKPKDGSVLDWEQRFNIV 459
V L G + L +++ Y +G L L S L+ ++V
Sbjct: 75 VCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLV 134
Query: 460 KGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLAR-LYDHGGMPHTTNVV 518
IA+G+ YL V+H+D+ N L+ ++N ++ D GL R +Y +
Sbjct: 135 AQIAAGMEYLS---SHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAAD-----YYKL 186
Query: 519 GTFGYI-----APELTQTGKASTSSDVFAYGILLLEVAT-GRRP 556
+ APE GK S SD+++YG++L EV + G +P
Sbjct: 187 LGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 230
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 4e-32
Identities = 71/266 (26%), Positives = 113/266 (42%), Gaps = 35/266 (13%)
Query: 336 EKDCPHRFRYKDLYAATKGFKESEVIGIGGFGSVYKGV--LPTTGGEVAVKKITRN--SL 391
K R R +DL+ E +G G +G VYK + A+K+I S+
Sbjct: 9 VKLSSERERVEDLFE-----YEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISM 63
Query: 392 QGMREFAAEIESLGRLRHKNLVNLHGWCKQKND--LLLVYEYIPNGSLDTLLFKPKDGSV 449
RE I L L+H N+++L D + L+++Y + L ++ +
Sbjct: 64 SACRE----IALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKA 118
Query: 450 LDWEQRFN--IVKGIA----SGLLYLHEEWEQVVIHRDVKPSNALIDAEMNAR----LGD 499
+ +VK + G+ YLH W V+HRD+KP+N L+ E R + D
Sbjct: 119 NKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIAD 175
Query: 500 FGLARLYD--HGGMPHTTNVVGTFGYIAPELTQTGKA-STSSDVFAYGILLLEVATGRRP 556
G ARL++ + VV TF Y APEL + + + D++A G + E+ T P
Sbjct: 176 MGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEP 234
Query: 557 I--GSGDLLLVEWVRECHQLGRILDV 580
I + + QL RI +V
Sbjct: 235 IFHCRQEDIKTSNPYHHDQLDRIFNV 260
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 128 bits (322), Expect = 4e-32
Identities = 34/260 (13%), Positives = 70/260 (26%), Gaps = 43/260 (16%)
Query: 355 FKESEVIGIGGFGSVYKGVLPTTGGEVAVK------KITRNSLQGMREFAAEIESLGRLR 408
V+G + + TG V + N+++ M+E + L ++
Sbjct: 80 LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIK 139
Query: 409 HKNLVNLHGWCKQKNDLL-----------------------LVYEYIPNGSL----DTLL 441
++ +H DL+ +L + LL
Sbjct: 140 NQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLL 199
Query: 442 FKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFG 501
L R + + L LH ++H ++P + ++D L F
Sbjct: 200 SHSSTHKSLVHHARLQLTLQVIRLLASLHH---YGLVHTYLRPVDIVLDQRGGVFLTGFE 256
Query: 502 LARLYDHGGMPHTTNVVGTFGYIAPELT-----QTGKASTSSDVFAYGILLLEVATGRRP 556
+ A + + + D + G+ + + P
Sbjct: 257 HLVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP 316
Query: 557 -IGSGDLLLVEWV-RECHQL 574
L EW+ R C +
Sbjct: 317 NTDDAALGGSEWIFRSCKNI 336
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 4e-32
Identities = 61/207 (29%), Positives = 96/207 (46%), Gaps = 14/207 (6%)
Query: 359 EVIGIGGFGSVYKGVLPTTGGE---VAVKKITRN-SLQGMREFAAEIESLGRLRHKNLVN 414
EVIG G FG VY G L G+ AVK + R + + +F E + H N+++
Sbjct: 31 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90
Query: 415 LHGWC-KQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEW 473
L G C + + L+V Y+ +G L + + +A G+ YL
Sbjct: 91 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN--PTVKDLIGFGLQVAKGMKYLAS-- 146
Query: 474 EQVVIHRDVKPSNALIDAEMNARLGDFGLAR-LYDHGGMPHTTNVVGTF--GYIAPELTQ 530
+ +HRD+ N ++D + ++ DFGLAR +YD ++A E Q
Sbjct: 147 -KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQ 205
Query: 531 TGKASTSSDVFAYGILLLEVAT-GRRP 556
T K +T SDV+++G+LL E+ T G P
Sbjct: 206 TQKFTTKSDVWSFGVLLWELMTRGAPP 232
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 5e-32
Identities = 66/285 (23%), Positives = 115/285 (40%), Gaps = 43/285 (15%)
Query: 359 EVIGIGGFGSVYKGVLPTTGGE-----VAVKKITRN-SLQGMREFAAEIESLGRLRHKNL 412
+G G FG VY+G + + VAVK + S Q +F E + + H+N+
Sbjct: 36 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 95
Query: 413 VNLHGWCKQKNDLLLVYEYIPNGSLDTLL----FKPKDGSVLDWEQRFNIVKGIASGLLY 468
V G Q ++ E + G L + L +P S L ++ + IA G Y
Sbjct: 96 VRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 155
Query: 469 LHEEWEQVVIHRDVKPSNALIDAE---MNARLGDFGLAR-LYDHGGMPHTTNVVGTFGYI 524
L E IHRD+ N L+ A++GDFG+AR +Y G +
Sbjct: 156 LE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAS-----YYRKGGCAML 207
Query: 525 -----APELTQTGKASTSSDVFAYGILLLEVAT-GRRPI-GSGDLLLVEWVRECHQLGRI 577
PE G ++ +D +++G+LL E+ + G P + ++E+V ++
Sbjct: 208 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPP 267
Query: 578 LDVADPLLNSSYVVKEMELVLKLGLMC-SHKTQFRPTMRQVMRYL 621
+ P+ Y ++ C H+ + RP ++ +
Sbjct: 268 KNCPGPV----Y---------RIMTQCWQHQPEDRPNFAIILERI 299
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 6e-32
Identities = 52/211 (24%), Positives = 92/211 (43%), Gaps = 27/211 (12%)
Query: 359 EVIGIGGFGSVYKGVLPTTGGE---VAVKKITRN-SLQGMREFAAEIESLGRLRHKNLVN 414
IG G FG V++G+ + VA+K S +F E ++ + H ++V
Sbjct: 396 RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 455
Query: 415 LHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWE 474
L G + + ++ E G L + L K LD +++ L YL
Sbjct: 456 LIGVITENP-VWIIMELCTLGELRSFLQVRKFS--LDLASLILYAYQLSTALAYLES--- 509
Query: 475 QVVIHRDVKPSNALIDAEMNARLGDFGLAR-LYD-------HGGMPHTTNVVGTFGYIAP 526
+ +HRD+ N L+ + +LGDFGL+R + D G +P ++AP
Sbjct: 510 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLP--------IKWMAP 561
Query: 527 ELTQTGKASTSSDVFAYGILLLEVAT-GRRP 556
E + +++SDV+ +G+ + E+ G +P
Sbjct: 562 ESINFRRFTSASDVWMFGVCMWEILMHGVKP 592
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 6e-32
Identities = 63/203 (31%), Positives = 98/203 (48%), Gaps = 9/203 (4%)
Query: 355 FKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQG-MREFAAEIESLGRLRHKNLV 413
F + E IG G FG V+KG+ T VA+K I + + + EI L + +
Sbjct: 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 414 NLHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEW 473
+G + L ++ EY+ GS LL +P LD Q I++ I GL YLH
Sbjct: 84 KYYGSYLKDTKLWIIMEYLGGGSALDLL-EPG---PLDETQIATILREILKGLDYLH--- 136
Query: 474 EQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPELTQTGK 533
+ IHRD+K +N L+ +L DFG+A + T VGT ++APE+ +
Sbjct: 137 SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT-FVGTPFWMAPEVIKQSA 195
Query: 534 ASTSSDVFAYGILLLEVATGRRP 556
+ +D+++ GI +E+A G P
Sbjct: 196 YDSKADIWSLGITAIELARGEPP 218
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 9e-32
Identities = 60/207 (28%), Positives = 95/207 (45%), Gaps = 14/207 (6%)
Query: 359 EVIGIGGFGSVYKGVLPTTGGE---VAVKKITRN-SLQGMREFAAEIESLGRLRHKNLVN 414
EVIG G FG VY G L G+ AVK + R + + +F E + H N+++
Sbjct: 95 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 154
Query: 415 LHGWCKQKND-LLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEW 473
L G C + L+V Y+ +G L + + +A G+ +L
Sbjct: 155 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN--PTVKDLIGFGLQVAKGMKFLAS-- 210
Query: 474 EQVVIHRDVKPSNALIDAEMNARLGDFGLAR-LYDHGGMPHTTNVVGTF--GYIAPELTQ 530
+ +HRD+ N ++D + ++ DFGLAR +YD ++A E Q
Sbjct: 211 -KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQ 269
Query: 531 TGKASTSSDVFAYGILLLEVAT-GRRP 556
T K +T SDV+++G+LL E+ T G P
Sbjct: 270 TQKFTTKSDVWSFGVLLWELMTRGAPP 296
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 9e-32
Identities = 60/222 (27%), Positives = 100/222 (45%), Gaps = 32/222 (14%)
Query: 359 EVIGIGGFGSVYKGVLPTTGGE-----VAVKKITRNSLQGMREFAAEIESLGRLRHKNLV 413
+G G FG V+ E VAVK + S ++F E E L L+H+++V
Sbjct: 47 WELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIV 106
Query: 414 NLHGWCKQKNDLLLVYEYIPNGSLDTLL------------FKPKDGSVLDWEQRFNIVKG 461
G C + LL+V+EY+ +G L+ L + L Q +
Sbjct: 107 RFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQ 166
Query: 462 IASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLAR-LYDHGGMPHTTNVVGT 520
+A+G++YL +HRD+ N L+ + ++GDFG++R +Y VG
Sbjct: 167 VAAGMVYLA---GLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTD-----YYRVGG 218
Query: 521 FGYI-----APELTQTGKASTSSDVFAYGILLLEVAT-GRRP 556
+ PE K +T SDV+++G++L E+ T G++P
Sbjct: 219 RTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 260
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 1e-31
Identities = 54/218 (24%), Positives = 94/218 (43%), Gaps = 28/218 (12%)
Query: 359 EVIGIGGFGSVYKGVLPTTGGE-----VAVKKITRN-SLQGMREFAAEIESLGRLRHKNL 412
+G G FG VY+GV + VA+K + S++ EF E + ++
Sbjct: 31 RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 90
Query: 413 VNLHGWCKQKNDLLLVYEYIPNGSLDTLL-------FKPKDGSVLDWEQRFNIVKGIASG 465
V L G Q L++ E + G L + L + + + IA G
Sbjct: 91 VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADG 150
Query: 466 LLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLAR-LYDHGGMPHTTNVVGTFGYI 524
+ YL+ +HRD+ N ++ + ++GDFG+ R +Y+ G G +
Sbjct: 151 MAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD-----YYRKGGKGLL 202
Query: 525 -----APELTQTGKASTSSDVFAYGILLLEVAT-GRRP 556
+PE + G +T SDV+++G++L E+AT +P
Sbjct: 203 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP 240
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 2e-31
Identities = 68/233 (29%), Positives = 104/233 (44%), Gaps = 25/233 (10%)
Query: 355 FKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNS------LQGMREFAAEIESLGRLR 408
+++ E IG G +G+V+K T VA+K++ + +RE I L L+
Sbjct: 4 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALRE----ICLLKELK 59
Query: 409 HKNLVNLHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLY 468
HKN+V LH L LV+E+ L LD E + + + GL +
Sbjct: 60 HKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGD--LDPEIVKSFLFQLLKGLGF 116
Query: 469 LHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPE- 527
H V+HRD+KP N LI+ +L +FGLAR + ++ VV T Y P+
Sbjct: 117 CHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV-TLWYRPPDV 172
Query: 528 LTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDV 580
L STS D+++ G + E+A RP+ G+ QL RI +
Sbjct: 173 LFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGN-------DVDDQLKRIFRL 218
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 2e-31
Identities = 57/210 (27%), Positives = 92/210 (43%), Gaps = 14/210 (6%)
Query: 356 KESEVIGIGGFGSVYKGVLPTTGGE---VAVKKITRN-SLQGMREFAAEIESLGRLRHKN 411
VIG G FG VY G A+K ++R +Q + F E + L H N
Sbjct: 24 HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPN 83
Query: 412 LVNLHGWC-KQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLH 470
++ L G + ++ Y+ +G L + P+ + + +A G+ YL
Sbjct: 84 VLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRN--PTVKDLISFGLQVARGMEYLA 141
Query: 471 EEWEQVVIHRDVKPSNALIDAEMNARLGDFGLAR-LYDHGGMPHTTNVVGTF--GYIAPE 527
E Q +HRD+ N ++D ++ DFGLAR + D + + A E
Sbjct: 142 E---QKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALE 198
Query: 528 LTQTGKASTSSDVFAYGILLLEVAT-GRRP 556
QT + +T SDV+++G+LL E+ T G P
Sbjct: 199 SLQTYRFTTKSDVWSFGVLLWELLTRGAPP 228
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 125 bits (314), Expect = 2e-31
Identities = 34/298 (11%), Positives = 69/298 (23%), Gaps = 50/298 (16%)
Query: 359 EVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMRE---FAAEIESLGRLRHKNLVNL 415
E + +G V+ + A+K T + E + RL ++
Sbjct: 68 EPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEA 127
Query: 416 HGWCK--------------------------QKNDLLLVYEYIPNGSLDTLL----FKPK 445
+ + LL+ + L+ L F
Sbjct: 128 RDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPA-ASVDLELLFSTLDFVYV 186
Query: 446 DGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARL 505
+ + L + ++H P N I + LGD
Sbjct: 187 FRGDEGILALHILTAQLIRLAANLQSKG---LVHGHFTPDNLFIMPDGRLMLGDVSALWK 243
Query: 506 YDHGGMPHTTNVVGTFGYIAPELTQTGKA--STSSDVFAYGILLLEVATGRRPIGSGDLL 563
Y E A + + + + G+ + V P G
Sbjct: 244 VGT----RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVT-- 297
Query: 564 LVEWVRECHQLGRILDVADPLLNSSYVVKEMELVLKL--GLMCSHKTQFRPTMRQVMR 619
++ + + L + V L + + + R + M
Sbjct: 298 --PGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRR-RLLPLEAME 352
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 2e-31
Identities = 62/211 (29%), Positives = 95/211 (45%), Gaps = 15/211 (7%)
Query: 355 FKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNS-LQGMREFAAEIESLGRL-RHKNL 412
K+ IG G +GSV K V +G +AVK+I + ++ +++ + R +
Sbjct: 24 LKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYI 83
Query: 413 VNLHGWCKQKNDLLLVYEYIPNGSLDTLL--FKPKDGSVLDWEQRFNIVKGIASGLLYLH 470
V +G ++ D + E + + S D V+ E I L +L
Sbjct: 84 VQFYGALFREGDCWICMELM-STSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLK 142
Query: 471 EEWEQVVIHRDVKPSNALIDAEMNARLGDFGL-ARLYDHGGMPHTTNVVGTFGYIAPELT 529
E + +IHRD+KPSN L+D N +L DFG+ +L D T G Y+APE
Sbjct: 143 ENLK--IIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAK---TRDAGCRPYMAPERI 197
Query: 530 QTGKA----STSSDVFAYGILLLEVATGRRP 556
+ SDV++ GI L E+ATGR P
Sbjct: 198 DPSASRQGYDVRSDVWSLGITLYELATGRFP 228
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 3e-31
Identities = 68/285 (23%), Positives = 116/285 (40%), Gaps = 43/285 (15%)
Query: 359 EVIGIGGFGSVYKGVLPTTGGE-----VAVKKITRN-SLQGMREFAAEIESLGRLRHKNL 412
+G G FG VY+G + + VAVK + S Q +F E + + H+N+
Sbjct: 77 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 136
Query: 413 VNLHGWCKQKNDLLLVYEYIPNGSLDTLL----FKPKDGSVLDWEQRFNIVKGIASGLLY 468
V G Q ++ E + G L + L +P S L ++ + IA G Y
Sbjct: 137 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 196
Query: 469 LHEEWEQVVIHRDVKPSNALIDAE---MNARLGDFGLAR-LYDHGGMPHTTNVVGTFGYI 524
L E IHRD+ N L+ A++GDFG+AR +Y G G +
Sbjct: 197 LE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAG-----YYRKGGCAML 248
Query: 525 -----APELTQTGKASTSSDVFAYGILLLEVAT-GRRPI-GSGDLLLVEWVRECHQLGRI 577
PE G ++ +D +++G+LL E+ + G P + ++E+V ++
Sbjct: 249 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPP 308
Query: 578 LDVADPLLNSSYVVKEMELVLKLGLMC-SHKTQFRPTMRQVMRYL 621
+ P+ Y + M C H+ + RP ++ +
Sbjct: 309 KNCPGPV----YRI--M-------TQCWQHQPEDRPNFAIILERI 340
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 3e-31
Identities = 73/222 (32%), Positives = 107/222 (48%), Gaps = 18/222 (8%)
Query: 359 EVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAA--EIESLGRLRHKNLVNLH 416
++G G +G V K TG VA+KK + M + A EI+ L +LRH+NLVNL
Sbjct: 31 GLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLL 90
Query: 417 GWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQV 476
CK+K LV+E++ + ++ L +G LD++ + I +G+ + H
Sbjct: 91 EVCKKKKRWYLVFEFVDH-TILDDLELFPNG--LDYQVVQKYLFQIINGIGFCHSHN--- 144
Query: 477 VIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPE-LTQTGKAS 535
+IHRD+KP N L+ +L DFG AR G + V T Y APE L K
Sbjct: 145 IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVA-TRWYRAPELLVGDVKYG 203
Query: 536 TSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRI 577
+ DV+A G L+ E+ G P+ GD + QL I
Sbjct: 204 KAVDVWAIGCLVTEMFMG-EPLFPGD-------SDIDQLYHI 237
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 4e-31
Identities = 66/224 (29%), Positives = 93/224 (41%), Gaps = 22/224 (9%)
Query: 359 EVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAA--EIESLGRLRHKNLVNLH 416
IG G +G V+K TG VA+KK + + + A EI L +L+H NLVNL
Sbjct: 9 GKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLL 68
Query: 417 GWCKQKNDLLLVYEYIPNGSLDTLLFKPKD--GSVLDWEQRFNIVKGIASGLLYLHEEWE 474
++K L LV+EY D + D + +I + + H+
Sbjct: 69 EVFRRKRRLHLVFEY-----CDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHN- 122
Query: 475 QVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPE-LTQTGK 533
IHRDVKP N LI +L DFG ARL + V T Y +PE L +
Sbjct: 123 --CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVA-TRWYRSPELLVGDTQ 179
Query: 534 ASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRI 577
DV+A G + E+ + P+ G + QL I
Sbjct: 180 YGPPVDVWAIGCVFAELLS-GVPLWPGK-------SDVDQLYLI 215
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 4e-31
Identities = 56/224 (25%), Positives = 97/224 (43%), Gaps = 40/224 (17%)
Query: 359 EVIGIGGFGSVYKGVLPTTGGE---VAVK--KITRNSLQGMREFAAEIESLGRLRHKNLV 413
+++G G FGSV +G L G VAVK K+ +S + + EF +E + H N++
Sbjct: 40 KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVI 99
Query: 414 NLHGWCKQKN-----DLLLVYEYIPNGSLDTLLFK---PKDGSVLDWEQRFNIVKGIASG 465
L G C + + +++ ++ G L T L + + + IA G
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALG 159
Query: 466 LLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLAR-LYD--------HGGMPHTTN 516
+ YL + +HRD+ N ++ +M + DFGL++ +Y MP
Sbjct: 160 MEYLSN---RNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMP---- 212
Query: 517 VVGTFGYI---APELTQTGKASTSSDVFAYGILLLEVAT-GRRP 556
+ A E ++ SDV+A+G+ + E+AT G P
Sbjct: 213 -------VKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTP 249
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 6e-31
Identities = 70/274 (25%), Positives = 117/274 (42%), Gaps = 25/274 (9%)
Query: 355 FKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNS-LQGMREFAAEIE-SLGRLRHKNL 412
+ +G G +G V K +G +AVK+I Q + +++ S+ +
Sbjct: 9 LEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFT 68
Query: 413 VNLHGWCKQKNDLLLVYEYIPNGSLDTLLFK-PKDGSVLDWEQRFNIVKGIASGLLYLHE 471
V +G ++ D+ + E + + SLD + G + + I I L +LH
Sbjct: 69 VTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS 127
Query: 472 EWEQVVIHRDVKPSNALIDAEMNARLGDFGL-ARLYDHGGMPHTTNVVGTFGYIAPE--- 527
+ VIHRDVKPSN LI+A ++ DFG+ L D + + G Y+APE
Sbjct: 128 KLS--VIHRDVKPSNVLINALGQVKMCDFGISGYLVD--DVAKDID-AGCKPYMAPERIN 182
Query: 528 -LTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLN 586
S SD+++ GI ++E+A R P S W QL ++++ P L
Sbjct: 183 PELNQKGYSVKSDIWSLGITMIELAILRFPYDS-------WGTPFQQLKQVVEEPSPQLP 235
Query: 587 SSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMR 619
+ E C K ++ RPT ++M+
Sbjct: 236 ADKFSAEFVDFTSQ---CLKKNSKERPTYPELMQ 266
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 1e-30
Identities = 43/221 (19%), Positives = 86/221 (38%), Gaps = 31/221 (14%)
Query: 360 VIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAA-----------------EIE 402
+ G F + A+KK ++ L+ R+F E++
Sbjct: 38 TLNQGKFNKIILCE--KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQ 95
Query: 403 SLGRLRHKNLVNLHGWCKQKNDLLLVYEYIPNGSLDTLL-----FKPKDGSVLDWEQRFN 457
+ ++++ + G +++ ++YEY+ N S+ + +
Sbjct: 96 IITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKC 155
Query: 458 IVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNV 517
I+K + + Y+H E + + HRDVKPSN L+D +L DFG + +
Sbjct: 156 IIKSVLNSFSYIHNE--KNICHRDVKPSNILMDKNGRVKLSDFGESEYMV-DKKIKGS-- 210
Query: 518 VGTFGYIAPEL--TQTGKASTSSDVFAYGILLLEVATGRRP 556
GT+ ++ PE ++ D+++ GI L + P
Sbjct: 211 RGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVP 251
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 1e-30
Identities = 56/207 (27%), Positives = 94/207 (45%), Gaps = 11/207 (5%)
Query: 355 FKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVN 414
++ +G G FG VYK TG A K I S + + ++ EIE L H +V
Sbjct: 21 WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 80
Query: 415 LHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWE 474
L G L ++ E+ P G++D ++ + L Q + + + L +LH
Sbjct: 81 LLGAYYHDGKLWIMIEFCPGGAVDAIMLELD--RGLTEPQIQVVCRQMLEALNFLH---S 135
Query: 475 QVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPELTQTGKA 534
+ +IHRD+K N L+ E + RL DFG++ + +GT ++APE+
Sbjct: 136 KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS-FIGTPYWMAPEVVMCETM 194
Query: 535 STSS-----DVFAYGILLLEVATGRRP 556
+ D+++ GI L+E+A P
Sbjct: 195 KDTPYDYKADIWSLGITLIEMAQIEPP 221
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 1e-30
Identities = 47/220 (21%), Positives = 79/220 (35%), Gaps = 23/220 (10%)
Query: 359 EVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLR-HKNLVNLHG 417
V+ GGF VY+ +G E A+K++ N + R E+ + +L H N+V
Sbjct: 34 RVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCS 93
Query: 418 WC-------KQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLH 470
L+ + G L L K + L + I + ++H
Sbjct: 94 AASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH 153
Query: 471 EEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTT-----------NVVG 519
+ + +IHRD+K N L+ + +L DFG A H +
Sbjct: 154 RQ-KPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNT 212
Query: 520 TFGYIAPELTQTGK---ASTSSDVFAYGILLLEVATGRRP 556
T Y PE+ D++A G +L + + P
Sbjct: 213 TPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHP 252
|
| >1qmo_E Mannose binding lectin, FRIL; crosslink, hematopoietic progenitor, sugar complex; HET: MAN; 3.5A {Dolichos lab lab} SCOP: b.29.1.1 Length = 133 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 1e-30
Identities = 39/162 (24%), Positives = 66/162 (40%), Gaps = 29/162 (17%)
Query: 143 NHILIVEFDTVNGFNDKAENQGNHVGIGINTMFSNRSEPASYYINGTDHKEEMTLESGEP 202
++++ VEFDT + N H+GI +N++ S + + +G+
Sbjct: 1 SNVVAVEFDTYLNPDYGDPN-YIHIGIDVNSIRSKVTAKWDWQ-------------NGKI 46
Query: 203 IQAWIEYDGEQKVLNVTISPAEIGKPMRPLISFGVNLTGYIKETMYVGFSASTGEKSSSH 262
A I Y+ K L+VT A +S+ + L + E + VG SASTG+ +
Sbjct: 47 ATAHISYNSVSKRLSVTSYYA---GSKPATLSYDIELHTVLPEWVRVGLSASTGQDKERN 103
Query: 263 YILGWSFSLNGVAPALNVSELPKPPKEKEPSSYNPKILALIV 304
+ WSF+ S L +KE N I ++
Sbjct: 104 TVHSWSFT----------SSLWTNVAKKENE--NKYITRGVL 133
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 2e-30
Identities = 52/225 (23%), Positives = 89/225 (39%), Gaps = 41/225 (18%)
Query: 359 EVIGIGGFGSVYKGVLPTTGGE---VAVK--KITRNSLQGMREFAAEIESLGRLRHKNLV 413
++G G FGSV + L G VAVK K + + EF E + H ++
Sbjct: 29 RMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVA 88
Query: 414 NLHGWCKQK------NDLLLVYEYIPNGSLDTLLFK---PKDGSVLDWEQRFNIVKGIAS 464
L G + +++ ++ +G L L ++ L + + IA
Sbjct: 89 KLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIAC 148
Query: 465 GLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLAR-LYD--------HGGMPHTT 515
G+ YL + IHRD+ N ++ +M + DFGL+R +Y +P
Sbjct: 149 GMEYLSS---RNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLP--- 202
Query: 516 NVVGTFGYI---APELTQTGKASTSSDVFAYGILLLEVAT-GRRP 556
+ A E + SDV+A+G+ + E+ T G+ P
Sbjct: 203 --------VKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTP 239
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 2e-30
Identities = 68/232 (29%), Positives = 104/232 (44%), Gaps = 25/232 (10%)
Query: 355 FKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQG-----MREFAAEIESLGRLRH 409
+ + + +G G + +VYKG T VA+K+I +G +RE + L L+H
Sbjct: 4 YIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIRE----VSLLKDLKH 59
Query: 410 KNLVNLHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYL 469
N+V LH + L LV+EY+ L L G++++ + + GL Y
Sbjct: 60 ANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDC--GNIINMHNVKLFLFQLLRGLAYC 116
Query: 470 HEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPE-L 528
H + V+HRD+KP N LI+ +L DFGLAR + VV T Y P+ L
Sbjct: 117 HRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV-TLWYRPPDIL 172
Query: 529 TQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDV 580
+ ST D++ G + E+AT RP+ G QL I +
Sbjct: 173 LGSTDYSTQIDMWGVGCIFYEMAT-GRPLFPGS-------TVEEQLHFIFRI 216
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 3e-30
Identities = 55/251 (21%), Positives = 100/251 (39%), Gaps = 35/251 (13%)
Query: 359 EVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAA----EIESLGRLRHKNLVN 414
+++G G +G V + + T AVK + + L+ + A EI+ L RLRHKN++
Sbjct: 11 DLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQ 70
Query: 415 LHG--WCKQKNDLLLVYEYIPNGSLDTLLF-KPKDGSVLDWEQRFNIVKGIASGLLYLHE 471
L + ++K + +V EY G + + + + + GL YLH
Sbjct: 71 LVDVLYNEEKQKMYMVMEYCVCGMQE--MLDSVPEKRFPVCQAH-GYFCQLIDGLEYLHS 127
Query: 472 EWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDH---GGMPHTTNVVGTFGYIAPEL 528
Q ++H+D+KP N L+ ++ G+A T+ G+ + PE+
Sbjct: 128 ---QGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTS--QGSPAFQPPEI 182
Query: 529 TQTGK--ASTSSDVFAYGILLLEVATGRRP------------IGSGDLLLVEWV-RECHQ 573
+ D+++ G+ L + TG P IG G +
Sbjct: 183 ANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPGDCGPPLSD 242
Query: 574 L-GRILDVADP 583
L +L+ +P
Sbjct: 243 LLKGMLEY-EP 252
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 3e-30
Identities = 54/203 (26%), Positives = 94/203 (46%), Gaps = 10/203 (4%)
Query: 355 FKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVN 414
+ E IG G G+VY + TG EVA++++ EI + ++ N+VN
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 415 LHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWE 474
++L +V EY+ GSL ++ + +D Q + + L +LH
Sbjct: 82 YLDSYLVGDELWVVMEYLAGGSLTDVV----TETCMDEGQIAAVCRECLQALEFLH---S 134
Query: 475 QVVIHRDVKPSNALIDAEMNARLGDFGL-ARLYDHGGMPHTTNVVGTFGYIAPELTQTGK 533
VIHRD+K N L+ + + +L DFG A++ + +VGT ++APE+
Sbjct: 135 NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE--QSKRSTMVGTPYWMAPEVVTRKA 192
Query: 534 ASTSSDVFAYGILLLEVATGRRP 556
D+++ GI+ +E+ G P
Sbjct: 193 YGPKVDIWSLGIMAIEMIEGEPP 215
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 3e-30
Identities = 77/238 (32%), Positives = 122/238 (51%), Gaps = 32/238 (13%)
Query: 355 FKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQG-----MREFAAEIESLGRLRH 409
FK+ E +G G + +VYKG+ TTG VA+K++ +S +G +RE I + L+H
Sbjct: 7 FKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIRE----ISLMKELKH 62
Query: 410 KNLVNLHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRF--NIVKGIA---- 463
+N+V L+ +N L LV+E++ N L + +V + + N+VK
Sbjct: 63 ENIVRLYDVIHTENKLTLVFEFMDN-DLKKYM---DSRTVGNTPRGLELNLVKYFQWQLL 118
Query: 464 SGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGY 523
GL + HE ++HRD+KP N LI+ +LGDFGLAR + ++ VV T Y
Sbjct: 119 QGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVV-TLWY 174
Query: 524 IAPE-LTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDV 580
AP+ L + STS D+++ G +L E+ T +P+ G + QL I D+
Sbjct: 175 RAPDVLMGSRTYSTSIDIWSCGCILAEMIT-GKPLFPGT-------NDEEQLKLIFDI 224
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 6e-30
Identities = 63/214 (29%), Positives = 98/214 (45%), Gaps = 18/214 (8%)
Query: 355 FKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRL-RHKNLV 413
F+ E++G G +G VYKG TG A+K + E EI L + H+N+
Sbjct: 26 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIA 84
Query: 414 NLHG------WCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLL 467
+G + L LV E+ GS+ L+ K G+ L E I + I GL
Sbjct: 85 TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLI-KNTKGNTLKEEWIAYICREILRGLS 143
Query: 468 YLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPE 527
+LH + VIHRD+K N L+ +L DFG++ D T +GT ++APE
Sbjct: 144 HLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT-FIGTPYWMAPE 199
Query: 528 LTQTGKASTSS-----DVFAYGILLLEVATGRRP 556
+ + ++ D+++ GI +E+A G P
Sbjct: 200 VIACDENPDATYDFKSDLWSLGITAIEMAEGAPP 233
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 7e-30
Identities = 53/203 (26%), Positives = 95/203 (46%), Gaps = 10/203 (4%)
Query: 355 FKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVN 414
IG G G V +G +VAVK + Q E+ + +H N+V
Sbjct: 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVE 106
Query: 415 LHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWE 474
++ +L ++ E++ G+L ++ L+ EQ + + + L YLH
Sbjct: 107 MYKSYLVGEELWVLMEFLQGGALTDIV----SQVRLNEEQIATVCEAVLQALAYLH---A 159
Query: 475 QVVIHRDVKPSNALIDAEMNARLGDFGL-ARLYDHGGMPHTTNVVGTFGYIAPELTQTGK 533
Q VIHRD+K + L+ + +L DFG A++ +P ++VGT ++APE+
Sbjct: 160 QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKD--VPKRKSLVGTPYWMAPEVISRSL 217
Query: 534 ASTSSDVFAYGILLLEVATGRRP 556
+T D+++ GI+++E+ G P
Sbjct: 218 YATEVDIWSLGIMVIEMVDGEPP 240
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 7e-30
Identities = 49/222 (22%), Positives = 94/222 (42%), Gaps = 15/222 (6%)
Query: 333 EDWEKDCPHRFRYKDLYAATKGFKE----SEVIGIGGFGSVYKGVLPTTGGEVAVKKITR 388
+ + +D ++ + + + E +G G FG V++ V TG K I
Sbjct: 27 DKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINT 86
Query: 389 NSLQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEYIPNGSL-DTLLFKPKDG 447
EI + +L H L+NLH + K +++L+ E++ G L D + +
Sbjct: 87 PYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIA---AED 143
Query: 448 SVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARL--GDFGLARL 505
+ + N ++ GL ++H E ++H D+KP N + + + + + DFGLA
Sbjct: 144 YKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATK 200
Query: 506 YDHGGMPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILL 547
+ + T + APE+ +D++A G+L
Sbjct: 201 LNPDEI--VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLG 240
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 8e-30
Identities = 61/213 (28%), Positives = 103/213 (48%), Gaps = 14/213 (6%)
Query: 355 FKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQ-GMREFAAEIESLGRLRHKNLV 413
++ EVIG G V +VA+K+I Q M E EI+++ + H N+V
Sbjct: 17 YELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIV 76
Query: 414 NLHGWCKQKNDLLLVYEYIPNGSLDTLL-----FKPKDGSVLDWEQRFNIVKGIASGLLY 468
+ + K++L LV + + GS+ ++ VLD I++ + GL Y
Sbjct: 77 SYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEY 136
Query: 469 LHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGL-ARLYDHGGMPHTTN---VVGTFGYI 524
LH + IHRDVK N L+ + + ++ DFG+ A L G + VGT ++
Sbjct: 137 LH---KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWM 193
Query: 525 APELTQTGKA-STSSDVFAYGILLLEVATGRRP 556
APE+ + + +D++++GI +E+ATG P
Sbjct: 194 APEVMEQVRGYDFKADIWSFGITAIELATGAAP 226
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 9e-30
Identities = 55/210 (26%), Positives = 88/210 (41%), Gaps = 16/210 (7%)
Query: 355 FKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNS-LQGMREFAAEIESLGRL-RHKNL 412
+ +G G G V+K TG +AVK++ R+ + + +++ + + +
Sbjct: 27 LENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYI 86
Query: 413 VNLHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEE 472
V G D+ + E + + K + + + I L YL E+
Sbjct: 87 VQCFGTFITNTDVFIAMELM-GTCAE--KLKKRMQGPIPERILGKMTVAIVKALYYLKEK 143
Query: 473 WEQVVIHRDVKPSNALIDAEMNARLGDFGL-ARLYDHGGMPHTTNVVGTFGYIAPELTQT 531
VIHRDVKPSN L+D +L DFG+ RL D G Y+APE
Sbjct: 144 --HGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAK---DRSAGCAAYMAPERIDP 198
Query: 532 GKA-----STSSDVFAYGILLLEVATGRRP 556
+DV++ GI L+E+ATG+ P
Sbjct: 199 PDPTKPDYDIRADVWSLGISLVELATGQFP 228
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 1e-29
Identities = 48/214 (22%), Positives = 80/214 (37%), Gaps = 16/214 (7%)
Query: 355 FKESEVIGIG--GFGSVYKGVLPTTGGEVAVKKI--TRNSLQGMREFAAEIESLGRLRHK 410
++ VIG G +V TG V V++I S + + E+ H
Sbjct: 27 YELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHP 86
Query: 411 NLVNLHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLH 470
N+V N+L +V ++ GS L+ ++ I++G+ L Y+H
Sbjct: 87 NIVPYRATFIADNELWVVTSFMAYGSAKDLI-CTHFMDGMNELAIAYILQGVLKALDYIH 145
Query: 471 EEWEQVVIHRDVKPSNALIDAEMNARLGDFG-LARLYDHGGMPHT-----TNVVGTFGYI 524
+HR VK S+ LI + L + HG V ++
Sbjct: 146 H---MGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWL 202
Query: 525 APELTQTGKA--STSSDVFAYGILLLEVATGRRP 556
+PE+ Q SD+++ GI E+A G P
Sbjct: 203 SPEVLQQNLQGYDAKSDIYSVGITACELANGHVP 236
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 2e-29
Identities = 62/208 (29%), Positives = 91/208 (43%), Gaps = 17/208 (8%)
Query: 355 FKESEVIGIGGFGSVYKGVLPTTGGEVAVKKI---TRNSLQGMREFAAEIESLGRLRHKN 411
F + IG G FG+VY VA+KK+ + S + ++ E+ L +LRH N
Sbjct: 56 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 412 LVNLHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHE 471
+ G +++ LV EY + D L K L + + G GL YLH
Sbjct: 116 TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKK---PLQEVEIAAVTHGALQGLAYLH- 171
Query: 472 EWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPELTQT 531
+IHRDVK N L+ +LGDFG A M + VGT ++APE+
Sbjct: 172 --SHNMIHRDVKAGNILLSEPGLVKLGDFGSA-----SIMAPANSFVGTPYWMAPEVILA 224
Query: 532 GKAST---SSDVFAYGILLLEVATGRRP 556
DV++ GI +E+A + P
Sbjct: 225 MDEGQYDGKVDVWSLGITCIELAERKPP 252
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 2e-29
Identities = 62/202 (30%), Positives = 102/202 (50%), Gaps = 8/202 (3%)
Query: 355 FKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVN 414
F E +G G +GSVYK + TG VA+K++ ++E EI + + ++V
Sbjct: 31 FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQV--PVESDLQEIIKEISIMQQCDSPHVVK 88
Query: 415 LHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWE 474
+G + DL +V EY GS+ ++ L ++ I++ GL YLH
Sbjct: 89 YYGSYFKNTDLWIVMEYCGAGSVSDII--RLRNKTLTEDEIATILQSTLKGLEYLH---F 143
Query: 475 QVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPELTQTGKA 534
IHRD+K N L++ E +A+L DFG+A T V+GT ++APE+ Q
Sbjct: 144 MRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNT-VIGTPFWMAPEVIQEIGY 202
Query: 535 STSSDVFAYGILLLEVATGRRP 556
+ +D+++ GI +E+A G+ P
Sbjct: 203 NCVADIWSLGITAIEMAEGKPP 224
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 3e-29
Identities = 68/228 (29%), Positives = 104/228 (45%), Gaps = 21/228 (9%)
Query: 359 EVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMRE---FAA--EIESLGRLRHKNLV 413
+ +G G F +VYK T VA+KKI ++ A EI+ L L H N++
Sbjct: 16 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 75
Query: 414 NLHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEW 473
L K+++ LV++++ L+ ++ VL + GL YLH+ W
Sbjct: 76 GLLDAFGHKSNISLVFDFMET-DLEVIIKDN--SLVLTPSHIKAYMLMTLQGLEYLHQHW 132
Query: 474 EQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPE-LTQTG 532
++HRD+KP+N L+D +L DFGLA+ + +T VV T Y APE L
Sbjct: 133 ---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVV-TRWYRAPELLFGAR 188
Query: 533 KASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDV 580
D++A G +L E+ R P GD + QL RI +
Sbjct: 189 MYGVGVDMWAVGCILAELLL-RVPFLPGD-------SDLDQLTRIFET 228
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 6e-29
Identities = 59/227 (25%), Positives = 87/227 (38%), Gaps = 37/227 (16%)
Query: 359 EVIGIGGFGSVYKGVLPTTGGE-----VAVKKITRN-SLQGMREFAAEIESLGRL-RHKN 411
+ +G G FG V + VAVK + + L +E++ L L H N
Sbjct: 29 KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 88
Query: 412 LVNLHGWCKQKNDLLLVYEYIPNGSLDTLL---------------FKPKDGSVLDWEQRF 456
+VNL G C L++ EY G L L D LD E
Sbjct: 89 IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 148
Query: 457 NIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLAR-LYDHGGMPHTT 515
+ +A G+ +L + IHRD+ N L+ ++ DFGLAR + +
Sbjct: 149 SFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKG 205
Query: 516 NVVGTFGYI-----APELTQTGKASTSSDVFAYGILLLEVAT-GRRP 556
N + APE + SDV++YGI L E+ + G P
Sbjct: 206 N-----ARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP 247
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 6e-29
Identities = 51/194 (26%), Positives = 89/194 (45%), Gaps = 11/194 (5%)
Query: 359 EVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMRE-FAAEIESLGRLRHKNLVNLHG 417
+G G FG V+ ++G E +K I ++ Q E AEIE L L H N++ +
Sbjct: 28 RKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFE 87
Query: 418 WCKQKNDLLLVYEYIPNGSL-DTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQV 476
+ +++ +V E G L + ++ G L ++K + + L Y H Q
Sbjct: 88 VFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH---SQH 144
Query: 477 VIHRDVKPSNALI---DAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPELTQTGK 533
V+H+D+KP N L ++ DFGLA L+ GT Y+APE+ +
Sbjct: 145 VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTN--AAGTALYMAPEVFK-RD 201
Query: 534 ASTSSDVFAYGILL 547
+ D+++ G+++
Sbjct: 202 VTFKCDIWSAGVVM 215
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 6e-29
Identities = 59/201 (29%), Positives = 91/201 (45%), Gaps = 26/201 (12%)
Query: 359 EVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNLHGW 418
IG G +G V V T A KKI + ++ + F EIE + L H N++ L+
Sbjct: 15 NTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYET 74
Query: 419 CKQKNDLLLVYEYIPNGSL-DTLL----FKPKDGSVLDWEQRFNIVKGIASGLLYLHEEW 473
+ D+ LV E G L + ++ F+ D + I+K + S + Y H
Sbjct: 75 FEDNTDIYLVMELCTGGELFERVVHKRVFRESDAA--------RIMKDVLSAVAYCH--- 123
Query: 474 EQVVIHRDVKPSNALI---DAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPELTQ 530
+ V HRD+KP N L + +L DFGLA + G M T VGT Y++P++ +
Sbjct: 124 KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRT--KVGTPYYVSPQVLE 181
Query: 531 TGKASTSSDVFAYG----ILL 547
G D ++ G +LL
Sbjct: 182 -GLYGPECDEWSAGVMMYVLL 201
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 7e-29
Identities = 69/242 (28%), Positives = 112/242 (46%), Gaps = 30/242 (12%)
Query: 361 IGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQ--GMREFAAEIESLGRLRHKNLVNLHGW 418
IG G F V TG EVA+K I + L +++ E+ + L H N+V L
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 419 CKQKNDLLLVYEYIPNGSL-DTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVV 477
+ + L L+ EY G + D L+ G + + E R + + I S + Y H+ + +
Sbjct: 83 IETEKTLYLIMEYASGGEVFDYLV---AHGRMKEKEAR-SKFRQIVSAVQYCHQ---KRI 135
Query: 478 IHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPELTQTGK--AS 535
+HRD+K N L+DA+MN ++ DFG + + GG G Y APEL Q GK
Sbjct: 136 VHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAF--CGAPPYAAPELFQ-GKKYDG 192
Query: 536 TSSDVFAYGILLLEVATGRRP------------IGSGDLLLVEWV-REC-HQLGRILDVA 581
DV++ G++L + +G P + G + ++ +C + L R L +
Sbjct: 193 PEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLKRFLVL- 251
Query: 582 DP 583
+P
Sbjct: 252 NP 253
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 7e-29
Identities = 60/201 (29%), Positives = 97/201 (48%), Gaps = 26/201 (12%)
Query: 359 EVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNLHGW 418
EV+G G F V+ TG A+K I ++ EI L +++H+N+V L
Sbjct: 15 EVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDI 74
Query: 419 CKQKNDLLLVYEYIPNGSL-DTLL----FKPKDGSVLDWEQRFNIVKGIASGLLYLHEEW 473
+ LV + + G L D +L + KD S +++ + S + YLH
Sbjct: 75 YESTTHYYLVMQLVSGGELFDRILERGVYTEKDAS--------LVIQQVLSAVKYLH--- 123
Query: 474 EQVVIHRDVKPSNAL-IDAEMNARL--GDFGLARLYDHGGMPHTTNVVGTFGYIAPELTQ 530
E ++HRD+KP N L + E N+++ DFGL+++ +G M + GT GY+APE+
Sbjct: 124 ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIM---STACGTPGYVAPEVLA 180
Query: 531 TGKASTSSDVFAYG----ILL 547
S + D ++ G ILL
Sbjct: 181 QKPYSKAVDCWSIGVITYILL 201
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 1e-28
Identities = 60/245 (24%), Positives = 99/245 (40%), Gaps = 31/245 (12%)
Query: 359 EVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAA------EIESLGRLRHK-- 410
++G GGFGSVY G+ + VA+K + ++ + E E+ L ++
Sbjct: 49 PLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS 108
Query: 411 NLVNLHGWCKQKNDLLLVYEYI-PNGSL-DTLLFKPKDGSVLDWEQRFNIVKGIASGLLY 468
++ L W ++ + +L+ E P L D + + L E + + + +
Sbjct: 109 GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA----LQEELARSFFWQVLEAVRH 164
Query: 469 LHEEWEQVVIHRDVKPSNALIDAE-MNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPE 527
H V+HRD+K N LID +L DFG L + GT Y PE
Sbjct: 165 CH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVYTDF--DGTRVYSPPE 218
Query: 528 LTQTGK-ASTSSDVFAYGILLLEVATGRRP------IGSGDLLLVEWV-RECHQL-GRIL 578
+ + S+ V++ GILL ++ G P I G + + V EC L L
Sbjct: 219 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCL 278
Query: 579 DVADP 583
+ P
Sbjct: 279 AL-RP 282
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 1e-28
Identities = 58/212 (27%), Positives = 92/212 (43%), Gaps = 22/212 (10%)
Query: 355 FKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFA---AEIESLGRLRHKN 411
FK +++G G F +V T E A+K + + + + E + + RL H
Sbjct: 32 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 91
Query: 412 LVNLHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKG------IASG 465
V L+ + L Y NG L + K F+ I S
Sbjct: 92 FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK---------IGSFDETCTRFYTAEIVSA 142
Query: 466 LLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTN-VVGTFGYI 524
L YLH + +IHRD+KP N L++ +M+ ++ DFG A++ N VGT Y+
Sbjct: 143 LEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYV 199
Query: 525 APELTQTGKASTSSDVFAYGILLLEVATGRRP 556
+PEL A SSD++A G ++ ++ G P
Sbjct: 200 SPELLTEKSACKSSDLWALGCIIYQLVAGLPP 231
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 1e-28
Identities = 69/233 (29%), Positives = 114/233 (48%), Gaps = 27/233 (11%)
Query: 355 FKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNS------LQGMREFAAEIESLGRLR 408
+++ E +G G +G VYK + G VA+K+I ++ +RE I L L
Sbjct: 23 YQKLEKVGEGTYGVVYKA-KDSQGRIVALKRIRLDAEDEGIPSTAIRE----ISLLKELH 77
Query: 409 HKNLVNLHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLY 468
H N+V+L + L LV+E++ L +L + K G L Q + + G+ +
Sbjct: 78 HPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTG--LQDSQIKIYLYQLLRGVAH 134
Query: 469 LHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPE- 527
H+ ++HRD+KP N LI+++ +L DFGLAR + +T VV T Y AP+
Sbjct: 135 CHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV-TLWYRAPDV 190
Query: 528 LTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDV 580
L + K STS D+++ G + E+ T +P+ G + QL +I +
Sbjct: 191 LMGSKKYSTSVDIWSIGCIFAEMIT-GKPLFPGV-------TDDDQLPKIFSI 235
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 1e-28
Identities = 56/227 (24%), Positives = 95/227 (41%), Gaps = 37/227 (16%)
Query: 359 EVIGIGGFGSVYKGVLPTTGGE-------VAVKKITRN-SLQGMREFAAEIESLGRL-RH 409
+ +G G FG V + VAVK + + + + + + +E+E + + +H
Sbjct: 41 KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 410 KNLVNLHGWCKQKNDLLLVYEYIPNGSLDTLL-------------FKPKDGSVLDWEQRF 456
KN++NL G C Q L ++ EY G+L L + ++
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 457 NIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLAR-LYDHGGMPHTT 515
+ +A G+ YL Q IHRD+ N L+ ++ DFGLAR + +
Sbjct: 161 SCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYY---- 213
Query: 516 NVVGTFGYI-----APELTQTGKASTSSDVFAYGILLLEVAT-GRRP 556
T G + APE + SDV+++G+L+ E+ T G P
Sbjct: 214 -KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 259
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 114 bits (289), Expect = 2e-28
Identities = 72/232 (31%), Positives = 109/232 (46%), Gaps = 25/232 (10%)
Query: 355 FKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMRE---FAA--EIESLGRLRH 409
+ E IG G +G VYK G A+KKI L+ E EI L L+H
Sbjct: 4 YHGLEKIGEGTYGVVYKA-QNNYGETFALKKI---RLEKEDEGIPSTTIREISILKELKH 59
Query: 410 KNLVNLHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYL 469
N+V L+ K L+LV+E++ L LL + G L+ + + + +G+ Y
Sbjct: 60 SNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGG--LESVTAKSFLLQLLNGIAYC 116
Query: 470 HEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPE-L 528
H+ V+HRD+KP N LI+ E ++ DFGLAR + +T +V T Y AP+ L
Sbjct: 117 HDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV-TLWYRAPDVL 172
Query: 529 TQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDV 580
+ K ST+ D+++ G + E+ P+ G E QL RI +
Sbjct: 173 MGSKKYSTTIDIWSVGCIFAEMVN-GTPLFPGV-------SEADQLMRIFRI 216
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-28
Identities = 62/247 (25%), Positives = 96/247 (38%), Gaps = 33/247 (13%)
Query: 359 EVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAA------EIESLGRLR---- 408
++G GGFG+V+ G T +VA+K I RN + G + E+ L ++
Sbjct: 37 PLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGG 96
Query: 409 HKNLVNLHGWCKQKNDLLLVYEYIPNGS--LDTLLFKPKDGSVLDWEQRFNIVKGIASGL 466
H ++ L W + + +LV E D + K L + + +
Sbjct: 97 HPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGP----LGEGPSRCFFGQVVAAI 152
Query: 467 LYLHEEWEQVVIHRDVKPSNALIDAEMNA-RLGDFGLARLYDHGGMPHTTNVVGTFGYIA 525
+ H + V+HRD+K N LID +L DFG L H GT Y
Sbjct: 153 QHCHS---RGVVHRDIKDENILIDLRRGCAKLIDFGSGALL-HDEPYTDF--DGTRVYSP 206
Query: 526 PELTQTGK-ASTSSDVFAYGILLLEVATGRRP------IGSGDLLLVEWV-RECHQL-GR 576
PE + + + V++ GILL ++ G P I +L V +C L R
Sbjct: 207 PEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEILEAELHFPAHVSPDCCALIRR 266
Query: 577 ILDVADP 583
L P
Sbjct: 267 CLAP-KP 272
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 2e-28
Identities = 68/268 (25%), Positives = 113/268 (42%), Gaps = 52/268 (19%)
Query: 329 SETLEDWEKDCPHRFRYKDLYAATKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITR 388
D + Y + +VIG G FG V++ L + EVA+KK+
Sbjct: 26 KVLASDGKTGEQREIAYTNC----------KVIGNGSFGVVFQAKLVESD-EVAIKKV-- 72
Query: 389 NSLQGMREFAAEIESLGRLRHKNLVNLH------GWCKQKNDLLLVYEYIPNGSLDTL-- 440
LQ R E++ + ++H N+V+L G K + L LV EY+P +T+
Sbjct: 73 --LQDKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVP----ETVYR 126
Query: 441 --LFKPKDGSVLDWEQRFNIVKG----IASGLLYLHEEWEQVVIHRDVKPSNALIDAEMN 494
K + +K + L Y+H + HRD+KP N L+D
Sbjct: 127 ASRHYAKLKQTMPMLL----IKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSG 179
Query: 495 A-RLGDFGLARLYDHGGMPHTTNVVGTFGYIAPELTQTGKA-STSSDVFAYGILLLEVAT 552
+L DFG A++ G P+ + + + Y APEL +T+ D+++ G ++ E+
Sbjct: 180 VLKLIDFGSAKILIAGE-PNVSYIC-SRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQ 237
Query: 553 GRRPIGSGDLLLVEWVRECHQLGRILDV 580
G +P+ G+ QL I+ V
Sbjct: 238 G-QPLFPGE-------SGIDQLVEIIKV 257
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 2e-28
Identities = 50/228 (21%), Positives = 99/228 (43%), Gaps = 15/228 (6%)
Query: 327 SNSETLEDWEKDCPHRFRYKDLYAATKGFKE----SEVIGIGGFGSVYKGVLPTTGGEVA 382
+ S +++ D ++ + + + E +G G FG V++ TG A
Sbjct: 127 TVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFA 186
Query: 383 VKKITRNSLQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEYIPNGSL-DTLL 441
K + EI+++ LRH LVNLH + N+++++YE++ G L + +
Sbjct: 187 AKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVA 246
Query: 442 FKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARL--GD 499
+ + + ++ ++ + GL ++H E +H D+KP N + + + L D
Sbjct: 247 ---DEHNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLID 300
Query: 500 FGLARLYDHGGMPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILL 547
FGL D GT + APE+ + +D+++ G+L
Sbjct: 301 FGLTAHLDPKQ--SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLS 346
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 2e-28
Identities = 64/247 (25%), Positives = 101/247 (40%), Gaps = 35/247 (14%)
Query: 361 IGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMRE-FAAEIESLGRLRHKNLVNLHGWC 419
+G G +G V V T VAVK + E EI L H+N+V +G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 420 KQKNDLLLVYEYIPNGSL-DTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVI 478
++ N L EY G L D + D + + + + + +G++YLH +
Sbjct: 75 REGNIQYLFLEYCSGGELFDRIE---PDIGMPEPDAQR-FFHQLMAGVVYLHG---IGIT 127
Query: 479 HRDVKPSNALIDAEMNARLGDFGLARLYDHGGMP---HTTNVVGTFGYIAPELTQTGK-- 533
HRD+KP N L+D N ++ DFGLA ++ + + GT Y+APEL + +
Sbjct: 128 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM--CGTLPYVAPELLK-RREF 184
Query: 534 ASTSSDVFAYGILLLEVATGRRP-------------IGSGDLLLVEWVR---ECHQL-GR 576
+ DV++ GI+L + G P L W + L +
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHK 244
Query: 577 ILDVADP 583
IL +P
Sbjct: 245 ILVE-NP 250
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-28
Identities = 57/245 (23%), Positives = 92/245 (37%), Gaps = 31/245 (12%)
Query: 359 EVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAA--------EIESLGRLRHK 410
+G G FG V+ V EV VK I + + EI L R+ H
Sbjct: 30 SPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHA 89
Query: 411 NLVNLHGWCKQKNDLLLVYEYIPNGS--LDTLLFKPKDGSVLDWEQRFNIVKGIASGLLY 468
N++ + + + LV E +G + P+ LD I + + S + Y
Sbjct: 90 NIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPR----LDEPLASYIFRQLVSAVGY 145
Query: 469 LHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPEL 528
L + +IHRD+K N +I + +L DFG A + G + +T GT Y APE+
Sbjct: 146 LRL---KDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTF--CGTIEYCAPEV 200
Query: 529 TQTGK--ASTSSDVFAYGILLLEVATGRRP------IGSGDLLLVEWV-RECHQL-GRIL 578
G ++++ G+ L + P + V +E L +L
Sbjct: 201 LM-GNPYRGPELEMWSLGVTLYTLVFEENPFCELEETVEAAIHPPYLVSKELMSLVSGLL 259
Query: 579 DVADP 583
P
Sbjct: 260 QP-VP 263
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 2e-28
Identities = 55/239 (23%), Positives = 94/239 (39%), Gaps = 42/239 (17%)
Query: 337 KDCPHRFRYKDLYAA-----TKGFKE----SEVIGIGGFGSVYKGVLPTTGGEVAVKKIT 387
F + DL K ++ S+ +G G G V T +VA++ I+
Sbjct: 110 LSRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIIS 169
Query: 388 RNSLQGMREFAA--------EIESLGRLRHKNLVNLHGWCKQKNDLLLVYEYIPNGSL-D 438
+ A EIE L +L H ++ + + D +V E + G L D
Sbjct: 170 KRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFD 228
Query: 439 TLL----FKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALI---DA 491
++ K + + YLH E +IHRD+KP N L+ +
Sbjct: 229 KVVGNKRLKEATCK--------LYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEE 277
Query: 492 EMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPE-LTQTGKASTSS--DVFAYGILL 547
+ ++ DFG +++ + T + GT Y+APE L G A + D ++ G++L
Sbjct: 278 DCLIKITDFGHSKILGETSLMRT--LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 334
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 4e-28
Identities = 56/227 (24%), Positives = 95/227 (41%), Gaps = 37/227 (16%)
Query: 359 EVIGIGGFGSVYKGVLPTTGGE-------VAVKKITRN-SLQGMREFAAEIESLGRL-RH 409
+ +G G FG V + VAVK + + + + + + +E+E + + +H
Sbjct: 87 KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 146
Query: 410 KNLVNLHGWCKQKNDLLLVYEYIPNGSLDTLL-------------FKPKDGSVLDWEQRF 456
KN++NL G C Q L ++ EY G+L L + ++
Sbjct: 147 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 206
Query: 457 NIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLAR-LYDHGGMPHTT 515
+ +A G+ YL Q IHRD+ N L+ ++ DFGLAR + +
Sbjct: 207 SCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID-----Y 258
Query: 516 NVVGTFGYI-----APELTQTGKASTSSDVFAYGILLLEVAT-GRRP 556
T G + APE + SDV+++G+L+ E+ T G P
Sbjct: 259 YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 305
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 4e-28
Identities = 76/246 (30%), Positives = 119/246 (48%), Gaps = 31/246 (12%)
Query: 359 EVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAA---EIESLGRLRHKNLVNL 415
+ +G+G FG V G TG +VAVK + R ++ + EI++L RH +++ L
Sbjct: 17 DTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL 76
Query: 416 HGWCKQKNDLLLVYEYIPNGSL-DTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWE 474
+ D +V EY+ G L D + K G V + E R + + I S + Y H
Sbjct: 77 YQVISTPTDFFMVMEYVSGGELFDYIC---KHGRVEEMEAR-RLFQQILSAVDYCHR--- 129
Query: 475 QVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPELTQTGK- 533
+V+HRD+KP N L+DA MNA++ DFGL+ + G T+ G+ Y APE+ G+
Sbjct: 130 HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS--CGSPNYAAPEVIS-GRL 186
Query: 534 -ASTSSDVFAYGILLLEVATGRRP------------IGSGDLLLVEWV-RECHQL-GRIL 578
A D+++ G++L + G P I G + E++ R L +L
Sbjct: 187 YAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRSVATLLMHML 246
Query: 579 DVADPL 584
V DPL
Sbjct: 247 QV-DPL 251
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 5e-28
Identities = 63/243 (25%), Positives = 106/243 (43%), Gaps = 42/243 (17%)
Query: 355 FKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMRE---FAA--EIESLGRLRH 409
++ +G G +G VYK + T VA+K+I L+ E A E+ L L+H
Sbjct: 36 YRRITKLGEGTYGEVYKAIDTVTNETVAIKRI---RLEHEEEGVPGTAIREVSLLKELQH 92
Query: 410 KNLVNLHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFN--IVKG----IA 463
+N++ L + L L++EY + L K +D + ++K +
Sbjct: 93 RNIIELKSVIHHNHRLHLIFEY-----AENDLKK-----YMDKNPDVSMRVIKSFLYQLI 142
Query: 464 SGLLYLHEEWEQVVIHRDVKPSNALIDAEMNAR-----LGDFGLARLYDHGGMPHTTNVV 518
+G+ + H +HRD+KP N L+ + +GDFGLAR + T ++
Sbjct: 143 NGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEII 199
Query: 519 GTFGYIAPE-LTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRI 577
T Y PE L + STS D+++ + E+ + P+ GD E QL +I
Sbjct: 200 -TLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLM-KTPLFPGD-------SEIDQLFKI 250
Query: 578 LDV 580
+V
Sbjct: 251 FEV 253
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 5e-28
Identities = 64/232 (27%), Positives = 97/232 (41%), Gaps = 42/232 (18%)
Query: 359 EVIGIGGFGSVYKGVLPTTGGE-----VAVKKITRN-SLQGMREFAAEIESLGRLRHKNL 412
+ +G G FG V K G VAVK + N S +R+ +E L ++ H ++
Sbjct: 29 KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHV 88
Query: 413 VNLHGWCKQKNDLLLVYEYIPNGSLDTLL---------------------FKPKDGSVLD 451
+ L+G C Q LLL+ EY GSL L D L
Sbjct: 89 IKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALT 148
Query: 452 WEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLAR-LYDHGG 510
+ I+ G+ YL E ++HRD+ N L+ ++ DFGL+R +Y+
Sbjct: 149 MGDLISFAWQISQGMQYLA---EMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEED- 204
Query: 511 MPHTTNVVGTFGYI-----APELTQTGKASTSSDVFAYGILLLEVAT-GRRP 556
+ V + G I A E +T SDV+++G+LL E+ T G P
Sbjct: 205 ----SYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP 252
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 6e-28
Identities = 50/242 (20%), Positives = 87/242 (35%), Gaps = 27/242 (11%)
Query: 390 SLQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSV 449
S M + +I + KN V K L + + +L + +
Sbjct: 101 SPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLED 160
Query: 450 LDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHG 509
+ +I IA + +LH + ++HRD+KPSN + ++GDFGL D
Sbjct: 161 REHGVCLHIFIQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQD 217
Query: 510 GMPHT-----------TNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIG 558
T T VGT Y++PE S D+F+ G++L E+
Sbjct: 218 EEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLY---SFS 274
Query: 559 SGDLLLVEWVRECHQLGRILDVADPLLNSSYVVKEMELVLKLGLMCSHKTQFRPTMRQVM 618
+ + + + ++ PLL + +E +V M S RP ++
Sbjct: 275 TQMERV-------RIITDVRNLKFPLLFTQKYPQEHMMVQD---MLSPSPTERPEATDII 324
Query: 619 RY 620
Sbjct: 325 EN 326
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 6e-28
Identities = 70/240 (29%), Positives = 110/240 (45%), Gaps = 30/240 (12%)
Query: 355 FKESEVIGIGGFGSVYKGVLPTTGGEVAVKKI-TRNSLQGMREFAA----EIESLGRLR- 408
++ IG+G +G+VYK P +G VA+K + N G E+ L RL
Sbjct: 11 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEA 70
Query: 409 --HKNLVNLH-----GWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKG 461
H N+V L ++ + LV+E++ L T L L E ++++
Sbjct: 71 FEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYL-DKAPPPGLPAETIKDLMRQ 128
Query: 462 IASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHT-TNVVGT 520
GL +LH ++HRD+KP N L+ + +L DFGLAR+Y T VV T
Sbjct: 129 FLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIY---SYQMALTPVVVT 182
Query: 521 FGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDV 580
Y APE+ +T D+++ G + E+ R+P+ G+ E QLG+I D+
Sbjct: 183 LWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPLFCGN-------SEADQLGKIFDL 234
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 6e-28
Identities = 59/238 (24%), Positives = 95/238 (39%), Gaps = 54/238 (22%)
Query: 359 EVIGIGGFGSVYKGVLPTTGGE-----VAVKKITRN-SLQGMREFAAEIESLGRLRHKNL 412
IG G FG V++ P VAVK + S +F E + + N+
Sbjct: 53 RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNI 112
Query: 413 VNLHGWCKQKNDLLLVYEYIPNGSLDTLL---------------------FKPKDGSVLD 451
V L G C + L++EY+ G L+ L L
Sbjct: 113 VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLS 172
Query: 452 WEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLAR-LYD--- 507
++ I + +A+G+ YL E+ +HRD+ N L+ M ++ DFGL+R +Y
Sbjct: 173 CAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADY 229
Query: 508 -----HGGMPHTTNVVGTFGYI---APELTQTGKASTSSDVFAYGILLLEVAT-GRRP 556
+ +P I PE + +T SDV+AYG++L E+ + G +P
Sbjct: 230 YKADGNDAIP-----------IRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 276
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 7e-28
Identities = 58/200 (29%), Positives = 96/200 (48%), Gaps = 15/200 (7%)
Query: 355 FKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVN 414
++E++G G FG V+K TG ++A K I ++ E EI + +L H NL+
Sbjct: 91 VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQ 150
Query: 415 LHGWCKQKNDLLLVYEYIPNGSL-DTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEW 473
L+ + KND++LV EY+ G L D ++ + L +K I G+ ++H
Sbjct: 151 LYDAFESKNDIVLVMEYVDGGELFDRII---DESYNLTELDTILFMKQICEGIRHMH--- 204
Query: 474 EQVVIHRDVKPSNALIDAEMNARL--GDFGLARLYDHGGMPHTTNVVGTFGYIAPELTQT 531
+ ++H D+KP N L ++ DFGLAR Y GT ++APE+
Sbjct: 205 QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK--LKVNFGTPEFLAPEVVNY 262
Query: 532 GKASTSSDVFAYG----ILL 547
S +D+++ G +LL
Sbjct: 263 DFVSFPTDMWSVGVIAYMLL 282
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 1e-27
Identities = 60/223 (26%), Positives = 91/223 (40%), Gaps = 33/223 (14%)
Query: 359 EVIGIGGFGSVYKGVLPTTGGE-----VAVKKITRN-SLQGMREFAAEIESLGRL-RHKN 411
+ +G G FG V + G E VAVK + +E++ + L +H+N
Sbjct: 52 KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111
Query: 412 LVNLHGWCKQKNDLLLVYEYIPNGSLDTLL-----------FKPKDGSVLDWEQRFNIVK 460
+VNL G C +L++ EY G L L S +
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSS 171
Query: 461 GIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLAR-LYDHGGMPHTTNVVG 519
+A G+ +L + IHRDV N L+ A++GDFGLAR + + +V
Sbjct: 172 QVAQGMAFLA---SKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNY-----IVK 223
Query: 520 TFGYI-----APELTQTGKASTSSDVFAYGILLLEVAT-GRRP 556
+ APE + SDV++YGILL E+ + G P
Sbjct: 224 GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNP 266
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 1e-27
Identities = 70/237 (29%), Positives = 110/237 (46%), Gaps = 28/237 (11%)
Query: 355 FKESEVIGIGGFGSVYKGVLPTTGGEVAVKKI-TRNSLQGMREFAA-EIESLGRLRHKNL 412
+++ IG G FG V+K TG +VA+KK+ N +G A EI+ L L+H+N+
Sbjct: 19 YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENV 78
Query: 413 VNLHG--------WCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIAS 464
VNL + + K + LV+++ + L LL + +++ + +
Sbjct: 79 VNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNV--LVKFTLSEIKRVMQMLLN 135
Query: 465 GLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYD---HGGMPHTTNVVGTF 521
GL Y+H ++HRD+K +N LI + +L DFGLAR + + TN V T
Sbjct: 136 GLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTL 192
Query: 522 GYIAPE-LTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRI 577
Y PE L D++ G ++ E+ T R PI G+ E HQL I
Sbjct: 193 WYRPPELLLGERDYGPPIDLWGAGCIMAEMWT-RSPIMQGN-------TEQHQLALI 241
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 1e-27
Identities = 55/196 (28%), Positives = 87/196 (44%), Gaps = 32/196 (16%)
Query: 351 ATKGFKE----SEVIGIGGFGSVYKGVLPTTGGEVAVKKI--------TRNSLQGMRE-F 397
+T GF E E++G G V + + T E AVK I + +Q +RE
Sbjct: 11 STHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREAT 70
Query: 398 AAEIESLGRL-RHKNLVNLHGWCKQKNDLLLVYEYIPNGSL-DTLL----FKPKDGSVLD 451
E++ L ++ H N++ L + LV++ + G L D L K+
Sbjct: 71 LKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETR--- 127
Query: 452 WEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGM 511
I++ + + LH+ ++HRD+KP N L+D +MN +L DFG + D G
Sbjct: 128 -----KIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK 179
Query: 512 PHTTNVVGTFGYIAPE 527
V GT Y+APE
Sbjct: 180 --LREVCGTPSYLAPE 193
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 1e-27
Identities = 57/227 (25%), Positives = 95/227 (41%), Gaps = 37/227 (16%)
Query: 359 EVIGIGGFGSVYKGVLPTTGGE-------VAVKKITRN-SLQGMREFAAEIESLGRL-RH 409
+ +G G FG V + VAVK + + + + + + +E+E + + +H
Sbjct: 75 KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 134
Query: 410 KNLVNLHGWCKQKNDLLLVYEYIPNGSLDTLL-------------FKPKDGSVLDWEQRF 456
KN++NL G C Q L ++ EY G+L L L +
Sbjct: 135 KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 194
Query: 457 NIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLAR-LYDHGGMPHTT 515
+ +A G+ YL + IHRD+ N L+ + ++ DFGLAR ++
Sbjct: 195 SCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID-----Y 246
Query: 516 NVVGTFGYI-----APELTQTGKASTSSDVFAYGILLLEVAT-GRRP 556
T G + APE + SDV+++G+LL E+ T G P
Sbjct: 247 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 293
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 2e-27
Identities = 40/252 (15%), Positives = 78/252 (30%), Gaps = 28/252 (11%)
Query: 327 SNSETLEDWEKDCPHRFRYKDLYAATKGFKESEVIGIGGFGSVYKGV-----LPTTGGEV 381
S+ +W+ P + +K ++G G F VY+ +
Sbjct: 39 SSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKF 98
Query: 382 AVKKITRNSLQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEYIPNGSLDTLL 441
+K + +E L + + +N +LV E G+L +
Sbjct: 99 VLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAI 158
Query: 442 --FKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALI---------- 489
+K V+ + + + +H + +IH D+KP N ++
Sbjct: 159 NLYKNTPEKVMPQGLVISFAMRMLYMIEQVH---DCEIIHGDIKPDNFILGNGFLEQDDE 215
Query: 490 -DAEMNARLGDFGLA---RLYDHGGMPHTTNVVGTFGYIAPELTQTGKAST-SSDVFAYG 544
D L D G + +L+ G + T G+ E+ + K D F
Sbjct: 216 DDLSAGLALIDLGQSIDMKLFPKGTIFTA--KCETSGFQCVEM-LSNKPWNYQIDYFGVA 272
Query: 545 ILLLEVATGRRP 556
+ + G
Sbjct: 273 ATVYCMLFGTYM 284
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 2e-27
Identities = 71/312 (22%), Positives = 125/312 (40%), Gaps = 51/312 (16%)
Query: 355 FKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRL-RHKNLV 413
+++G G G+V G VAVK++ + EI+ L H N++
Sbjct: 17 VVSEKILGYGSSGTVVFQGS-FQGRPVAVKRMLIDFCDIALM---EIKLLTESDDHPNVI 72
Query: 414 NLHGWCKQKNDLLLVYEYIPNGSLDTLL----FKPKDGSVLDWEQRFNIVKGIASGLLYL 469
+ L + E N +L L+ ++ + ++++ IASG+ +L
Sbjct: 73 RYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHL 131
Query: 470 HEEWEQVVIHRDVKPSNALIDAE-------------MNARLGDFGLARLYDHGGMPHTTN 516
H +IHRD+KP N L+ + + DFGL + D G TN
Sbjct: 132 HS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTN 188
Query: 517 ---VVGTFGYIAPEL-------TQTGKASTSSDVFAYGILLLEVAT-GRRPIGSGDLLLV 565
GT G+ APEL + + S D+F+ G + + + G+ P G
Sbjct: 189 LNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGD------ 242
Query: 566 EWVRECHQLGRILDVAD-PLLNSSYVVKE-MELVLKLGLMCSHKTQFRPTMRQVMR---Y 620
++ RE + + I + + L+ ++ E +L+ + M H RPT +V+R +
Sbjct: 243 KYSRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQ---MIDHDPLKRPTAMKVLRHPLF 299
Query: 621 LSGEKQLRFNND 632
K+L F
Sbjct: 300 WPKSKKLEFLLK 311
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-27
Identities = 56/226 (24%), Positives = 91/226 (40%), Gaps = 36/226 (15%)
Query: 359 EVIGIGGFGSVYKGVLPTTGGE-----VAVKKITRN-SLQGMREFAAEIESLGRL-RHKN 411
+ +G G FG V + VAVK + + R +E++ L + H N
Sbjct: 33 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92
Query: 412 LVNLHGWCKQKND-LLLVYEYIPNGSLDTLL-------------FKPKDGSVLDWEQRFN 457
+VNL G C + L+++ E+ G+L T L + L E
Sbjct: 93 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152
Query: 458 IVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLAR-LYDHGGMPHTTN 516
+A G+ +L + IHRD+ N L+ + ++ DFGLAR +Y
Sbjct: 153 YSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY----- 204
Query: 517 VVGTFGYI-----APELTQTGKASTSSDVFAYGILLLEVAT-GRRP 556
V + APE + SDV+++G+LL E+ + G P
Sbjct: 205 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 250
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 2e-27
Identities = 56/200 (28%), Positives = 88/200 (44%), Gaps = 26/200 (13%)
Query: 358 SEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRL-RHKNLVNLH 416
E IG+G + + + T E AVK I ++ EIE L R +H N++ L
Sbjct: 27 KEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTE----EIEILLRYGQHPNIITLK 82
Query: 417 GWCKQKNDLLLVYEYIPNGSL-DTLL----FKPKDGSVLDWEQRFNIVKGIASGLLYLHE 471
+ +V E + G L D +L F ++ S ++ I + YLH
Sbjct: 83 DVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREAS--------AVLFTITKTVEYLH- 133
Query: 472 EWEQVVIHRDVKPSNAL-IDAEMNA---RLGDFGLARLYDHGGMPHTTNVVGTFGYIAPE 527
Q V+HRD+KPSN L +D N R+ DFG A+ T T ++APE
Sbjct: 134 --AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMT-PCYTANFVAPE 190
Query: 528 LTQTGKASTSSDVFAYGILL 547
+ + + D+++ G+LL
Sbjct: 191 VLERQGYDAACDIWSLGVLL 210
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-27
Identities = 64/247 (25%), Positives = 101/247 (40%), Gaps = 35/247 (14%)
Query: 361 IGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMRE-FAAEIESLGRLRHKNLVNLHGWC 419
+G G +G V V T VAVK + E EI L H+N+V +G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 420 KQKNDLLLVYEYIPNGSL-DTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVI 478
++ N L EY G L D + D + + + + + +G++YLH +
Sbjct: 75 REGNIQYLFLEYCSGGELFDRIE---PDIGMPEPDAQR-FFHQLMAGVVYLHG---IGIT 127
Query: 479 HRDVKPSNALIDAEMNARLGDFGLARLYDHGGMP---HTTNVVGTFGYIAPELTQTGK-- 533
HRD+KP N L+D N ++ DFGLA ++ + + GT Y+APEL + +
Sbjct: 128 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM--CGTLPYVAPELLK-RREF 184
Query: 534 ASTSSDVFAYGILLLEVATGRRP-------------IGSGDLLLVEWVR---ECHQL-GR 576
+ DV++ GI+L + G P L W + L +
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHK 244
Query: 577 ILDVADP 583
IL +P
Sbjct: 245 ILVE-NP 250
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-27
Identities = 72/239 (30%), Positives = 113/239 (47%), Gaps = 30/239 (12%)
Query: 355 FKESEVIGIGGFGSVYKGV-LPTTGGEVAVKKI-TRNSLQGM-----REFAAEIESLGRL 407
++ IG G +G V+K L G VA+K++ + +GM RE A + L
Sbjct: 13 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAV-LRHLETF 71
Query: 408 RHKNLVNLH-----GWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGI 462
H N+V L ++ L LV+E++ L T L K + + E +++ +
Sbjct: 72 EHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPG-VPTETIKDMMFQL 129
Query: 463 ASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHT-TNVVGTF 521
GL +LH V+HRD+KP N L+ + +L DFGLAR+Y T+VV T
Sbjct: 130 LRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTSVVVTL 183
Query: 522 GYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDV 580
Y APE+ +T D+++ G + E+ R+P+ G + QLG+ILDV
Sbjct: 184 WYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKPLFRGS-------SDVDQLGKILDV 234
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-27
Identities = 60/232 (25%), Positives = 93/232 (40%), Gaps = 42/232 (18%)
Query: 359 EVIGIGGFGSVYKGVLPTTGGE-----VAVKKITRN-SLQGMREFAAEIESLGRL-RHKN 411
+V+G G FG V VAVK + +E++ + +L H+N
Sbjct: 51 KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHEN 110
Query: 412 LVNLHGWCKQKNDLLLVYEYIPNGSLDTLL--------------------FKPKDGSVLD 451
+VNL G C + L++EY G L L + +D +VL
Sbjct: 111 IVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLT 170
Query: 452 WEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLAR-LYDHGG 510
+E +A G+ +L + +HRD+ N L+ ++ DFGLAR +
Sbjct: 171 FEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDS- 226
Query: 511 MPHTTNVVGTFGYI-----APELTQTGKASTSSDVFAYGILLLEVAT-GRRP 556
VV + APE G + SDV++YGILL E+ + G P
Sbjct: 227 ----NYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP 274
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 3e-27
Identities = 57/210 (27%), Positives = 99/210 (47%), Gaps = 28/210 (13%)
Query: 359 EVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMRE--FAAEIESLGRLRHKNLVNLH 416
+ +G G +G V T E A+K I + S+ E+ L L H N++ L+
Sbjct: 43 KKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLY 102
Query: 417 GWCKQKNDLLLVYEYIPNGSL-DTLLFKPKDGSVLDWEQRFN------IVKGIASGLLYL 469
+ + K + LV E G L D ++ + +FN I+K + SG+ YL
Sbjct: 103 DFFEDKRNYYLVMECYKGGELFDEIIHR----------MKFNEVDAAVIIKQVLSGVTYL 152
Query: 470 HEEWEQVVIHRDVKPSNALI---DAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAP 526
H + ++HRD+KP N L+ + + ++ DFGL+ ++++ +GT YIAP
Sbjct: 153 H---KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKE--RLGTAYYIAP 207
Query: 527 ELTQTGKASTSSDVFAYGILLLEVATGRRP 556
E+ + K DV++ G++L + G P
Sbjct: 208 EVLR-KKYDEKCDVWSIGVILFILLAGYPP 236
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 3e-27
Identities = 73/246 (29%), Positives = 121/246 (49%), Gaps = 31/246 (12%)
Query: 359 EVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAA---EIESLGRLRHKNLVNL 415
+ +G+G FG V G TG +VAVK + R ++ + EI++L RH +++ L
Sbjct: 22 DTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKL 81
Query: 416 HGWCKQKNDLLLVYEYIPNGSL-DTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWE 474
+ +D+ +V EY+ G L D + K+G + + E R + + I SG+ Y H
Sbjct: 82 YQVISTPSDIFMVMEYVSGGELFDYIC---KNGRLDEKESR-RLFQQILSGVDYCHR--- 134
Query: 475 QVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPELTQTGK- 533
+V+HRD+KP N L+DA MNA++ DFGL+ + G T+ G+ Y APE+ G+
Sbjct: 135 HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS--CGSPNYAAPEVIS-GRL 191
Query: 534 -ASTSSDVFAYGILLLEVATGRRP------------IGSGDLLLVEWV-RECHQL-GRIL 578
A D+++ G++L + G P I G +++ L +L
Sbjct: 192 YAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQYLNPSVISLLKHML 251
Query: 579 DVADPL 584
V DP+
Sbjct: 252 QV-DPM 256
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 3e-27
Identities = 72/244 (29%), Positives = 111/244 (45%), Gaps = 45/244 (18%)
Query: 355 FKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVN 414
+ +++VIG G FG VY+ L +G VA+KK+ LQ R E++ + +L H N+V
Sbjct: 56 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIVR 111
Query: 415 LH------GWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFN------IVKG- 461
L G K + L LV +Y+P +++ V R VK
Sbjct: 112 LRYFFYSSGEKKDEVYLNLVLDYVP-----ETVYR-----VARHYSRAKQTLPVIYVKLY 161
Query: 462 ---IASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNA-RLGDFGLARLYDHGGMPHTTNV 517
+ L Y+H + HRD+KP N L+D + +L DFG A+ G P+ + +
Sbjct: 162 MYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE-PNVSYI 217
Query: 518 VGTFGYIAPELTQTGKA-STSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGR 576
+ Y APEL ++S DV++ G +L E+ G +PI GD QL
Sbjct: 218 C-SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPIFPGD-------SGVDQLVE 268
Query: 577 ILDV 580
I+ V
Sbjct: 269 IIKV 272
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 4e-27
Identities = 60/211 (28%), Positives = 101/211 (47%), Gaps = 29/211 (13%)
Query: 359 EVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQG---MREFAAEIESLGRLRHKNLVNL 415
V+G G FG V TG E AVK I++ ++ E++ L +L H N++ L
Sbjct: 32 RVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKL 91
Query: 416 HGWCKQKNDLLLVYEYIPNGSL-DTLLFKPKDGSVLDWEQRFN------IVKGIASGLLY 468
+ + + K LV E G L D ++ + +RF+ I++ + SG+ Y
Sbjct: 92 YEFFEDKGYFYLVGEVYTGGELFDEIISR----------KRFSEVDAARIIRQVLSGITY 141
Query: 469 LHEEWEQVVIHRDVKPSNALI---DAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIA 525
+H + ++HRD+KP N L+ + N R+ DFGL+ ++ +GT YIA
Sbjct: 142 MH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKD--KIGTAYYIA 196
Query: 526 PELTQTGKASTSSDVFAYGILLLEVATGRRP 556
PE+ G DV++ G++L + +G P
Sbjct: 197 PEVLH-GTYDEKCDVWSTGVILYILLSGCPP 226
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 4e-27
Identities = 53/204 (25%), Positives = 93/204 (45%), Gaps = 28/204 (13%)
Query: 359 EVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAA------EIESLGRLRHKNL 412
E +G G F V K +TG E A K I + + R + E+ L ++ H N+
Sbjct: 18 EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNV 77
Query: 413 VNLHGWCKQKNDLLLVYEYIPNGSL-DTLLFKP----KDGSVLDWEQRFNIVKGIASGLL 467
+ LH + + D++L+ E + G L D L K ++ + + +K I G+
Sbjct: 78 ITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEAT--------SFIKQILDGVN 129
Query: 468 YLHEEWEQVVIHRDVKPSNALI----DAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGY 523
YLH + + H D+KP N ++ + +L DFGLA + G N+ GT +
Sbjct: 130 YLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE--FKNIFGTPEF 184
Query: 524 IAPELTQTGKASTSSDVFAYGILL 547
+APE+ +D+++ G++
Sbjct: 185 VAPEIVNYEPLGLEADMWSIGVIT 208
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 4e-27
Identities = 49/183 (26%), Positives = 80/183 (43%), Gaps = 27/183 (14%)
Query: 359 EVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAA--------EIESLGRLR-H 409
+VIG G V + V TG E AVK + + + E E L ++ H
Sbjct: 100 DVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGH 159
Query: 410 KNLVNLHGWCKQKNDLLLVYEYIPNGSL-DTLL----FKPKDGSVLDWEQRFNIVKGIAS 464
+++ L + + + LV++ + G L D L K+ +I++ +
Sbjct: 160 PHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETR--------SIMRSLLE 211
Query: 465 GLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYI 524
+ +LH ++HRD+KP N L+D M RL DFG + + G + GT GY+
Sbjct: 212 AVSFLHA---NNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRE--LCGTPGYL 266
Query: 525 APE 527
APE
Sbjct: 267 APE 269
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 5e-27
Identities = 52/209 (24%), Positives = 87/209 (41%), Gaps = 33/209 (15%)
Query: 358 SEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAA--------EIESLGRLRH 409
S+ +G G G V T +VA+K I++ A EIE L +L H
Sbjct: 15 SKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNH 74
Query: 410 KNLVNLHGWCKQKNDLLLVYEYIPNGSL-DTLL----FKPKDGSVLDWEQRFNIVKGIAS 464
++ + + D +V E + G L D ++ K +
Sbjct: 75 PCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATCK--------LYFYQMLL 125
Query: 465 GLLYLHEEWEQVVIHRDVKPSNALI---DAEMNARLGDFGLARLYDHGGMPHTTNVVGTF 521
+ YLH E +IHRD+KP N L+ + + ++ DFG +++ + T + GT
Sbjct: 126 AVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRT--LCGTP 180
Query: 522 GYIAPE-LTQTGKASTSS--DVFAYGILL 547
Y+APE L G A + D ++ G++L
Sbjct: 181 TYLAPEVLVSVGTAGYNRAVDCWSLGVIL 209
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 5e-27
Identities = 55/199 (27%), Positives = 85/199 (42%), Gaps = 24/199 (12%)
Query: 358 SEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLR-HKNLVNLH 416
+ +G G F K V + AVK I++ ++ EI +L H N+V LH
Sbjct: 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQK---EITALKLCEGHPNIVKLH 72
Query: 417 GWCKQKNDLLLVYEYIPNGSL-DTLL----FKPKDGSVLDWEQRFNIVKGIASGLLYLHE 471
+ LV E + G L + + F + S I++ + S + ++H
Sbjct: 73 EVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEAS--------YIMRKLVSAVSHMH- 123
Query: 472 EWEQVVIHRDVKPSNAL-IDAEMNA--RLGDFGLARLYDHGGMPHTTNVVGTFGYIAPEL 528
+ V+HRD+KP N L D N ++ DFG ARL P T T Y APEL
Sbjct: 124 --DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKT-PCFTLHYAAPEL 180
Query: 529 TQTGKASTSSDVFAYGILL 547
S D+++ G++L
Sbjct: 181 LNQNGYDESCDLWSLGVIL 199
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 6e-27
Identities = 58/203 (28%), Positives = 93/203 (45%), Gaps = 28/203 (13%)
Query: 359 EVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQG--MREFAAEIESLGRLRHKNLVNLH 416
++G G FG V K T E AVK I + S + E+E L +L H N++ L
Sbjct: 28 CMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLF 87
Query: 417 GWCKQKNDLLLVYEYIPNGSL-DTLL----FKPKDGSVLDWEQRFNIVKGIASGLLYLHE 471
+ + +V E G L D ++ F D + I+K + SG+ Y+H
Sbjct: 88 EILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAA--------RIIKQVFSGITYMH- 138
Query: 472 EWEQVVIHRDVKPSNALI---DAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPEL 528
+ ++HRD+KP N L+ + + + ++ DFGL+ + +GT YIAPE+
Sbjct: 139 --KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKD--RIGTAYYIAPEV 194
Query: 529 TQTGKASTSSDVFAYG----ILL 547
+ G DV++ G ILL
Sbjct: 195 LR-GTYDEKCDVWSAGVILYILL 216
|
| >1nls_A Concanavalin A; lectin, agglutinin; 0.94A {Canavalia ensiformis} SCOP: b.29.1.1 PDB: 1bxh_A* 1apn_A 1ces_A 1cjp_A* 1c57_A 1cvn_A* 1con_A 1dq1_A 1dq2_A 1dq4_A 1dq5_A 1dq6_A 1enq_A 1enr_A 1ens_A 1gic_A* 1dq0_A 1hqw_A 1gkb_A* 1i3h_A ... Length = 237 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 7e-27
Identities = 33/131 (25%), Positives = 59/131 (45%), Gaps = 17/131 (12%)
Query: 142 SNHILIVEFDTVNGFNDKAENQGNHVGIGINTMFSNRSEPASYYINGTDHKEEMTLESGE 201
++ I+ VE DT + + H+GI I ++ S ++ + +++G+
Sbjct: 1 ADTIVAVELDTYPNTDIGDPS-YPHIGIDIKSVRSKKTAKWN-------------MQNGK 46
Query: 202 PIQAWIEYDGEQKVLNVTISPAEIGKPMRPLISFGVNLTGYIKETMYVGFSASTGEKSSS 261
A I Y+ K L+ +S +S+ V+L + E + VG SASTG +
Sbjct: 47 VGTAHIIYNSVDKRLSAVVSYP---NADSATVSYDVDLDNVLPEWVRVGLSASTGLYKET 103
Query: 262 HYILGWSFSLN 272
+ IL WSF+
Sbjct: 104 NTILSWSFTSK 114
|
| >1nls_A Concanavalin A; lectin, agglutinin; 0.94A {Canavalia ensiformis} SCOP: b.29.1.1 PDB: 1bxh_A* 1apn_A 1ces_A 1cjp_A* 1c57_A 1cvn_A* 1con_A 1dq1_A 1dq2_A 1dq4_A 1dq5_A 1dq6_A 1enq_A 1enr_A 1ens_A 1gic_A* 1dq0_A 1hqw_A 1gkb_A* 1i3h_A ... Length = 237 | Back alignment and structure |
|---|
Score = 80.3 bits (197), Expect = 4e-17
Identities = 34/132 (25%), Positives = 58/132 (43%), Gaps = 12/132 (9%)
Query: 13 FFFFIRLNIVAQSQSSSFIFQGFNGGATNLSLQGAEIIKPSGALKLTNRSR------YVI 66
F ++ N ++ + F+F F+ +L LQG G L+LT S +
Sbjct: 111 FTSKLKSNSTHETNALHFMFNQFSKDQKDLILQGDATTGTDGNLELTRVSSNGSPQGSSV 170
Query: 67 GHAFYVKPIQMFDTSASPSPNASSFSTTFVFEISTPRSGRGGHGLAFLLAP-STKLPGAQ 125
G A + P+ ++++SA +SF TF F I +P S G+AF ++ + +P
Sbjct: 171 GRALFYAPVHIWESSA----VVASFEATFTFLIKSPDSH-PADGIAFFISNIDSSIPSGS 225
Query: 126 PEHYLGILNSTN 137
LG+ N
Sbjct: 226 TGRLLGLFPDAN 237
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 8e-27
Identities = 57/217 (26%), Positives = 95/217 (43%), Gaps = 37/217 (17%)
Query: 352 TKGFKE----SEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQG--MREFAAEIESLG 405
+ F + E +G G F V + V TTG E A K I L ++ E
Sbjct: 1 STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICR 60
Query: 406 RLRHKNLVNLHGWCKQKNDLLLVYEYIPNGSL-DTLL----FKPKDGSVLDWEQRFNIVK 460
+L+H N+V LH ++++ LV++ + G L + ++ + D S + ++
Sbjct: 61 KLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADAS--------HCIQ 112
Query: 461 GIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNA---RLGDFGLARLYDHGGMPHTTNV 517
I + Y H ++HR++KP N L+ ++ +L DFGLA +
Sbjct: 113 QILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA--WHGF 167
Query: 518 VGTFGYIAPE-LTQT--GKASTSSDVFAYG----ILL 547
GT GY++PE L + K D++A G ILL
Sbjct: 168 AGTPGYLSPEVLKKDPYSKP---VDIWACGVILYILL 201
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 1e-26
Identities = 55/211 (26%), Positives = 86/211 (40%), Gaps = 21/211 (9%)
Query: 359 EVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAA-----EIESLGRLRHKNLV 413
EVIG G F V + + TG + AVK + + E L+H ++V
Sbjct: 30 EVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIV 89
Query: 414 NLHGWCKQKNDLLLVYEYIPNGSL-DTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEE 472
L L +V+E++ L ++ + G V + ++ I L Y H
Sbjct: 90 ELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCH-- 147
Query: 473 WEQVVIHRDVKPSNALI---DAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPELT 529
+ +IHRDVKP L+ + +LG FG+A G+ VGT ++APE+
Sbjct: 148 -DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGG-RVGTPHFMAPEVV 205
Query: 530 QTGKASTSSDVFAYG----ILLLEVATGRRP 556
+ DV+ G ILL +G P
Sbjct: 206 KREPYGKPVDVWGCGVILFILL----SGCLP 232
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 1e-26
Identities = 53/204 (25%), Positives = 92/204 (45%), Gaps = 28/204 (13%)
Query: 359 EVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAA------EIESLGRLRHKNL 412
E +G G F V K +TG E A K I + + R E+ L ++ H N+
Sbjct: 18 EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNI 77
Query: 413 VNLHGWCKQKNDLLLVYEYIPNGSL-DTLLFKP----KDGSVLDWEQRFNIVKGIASGLL 467
+ LH + + D++L+ E + G L D L K ++ + + +K I G+
Sbjct: 78 ITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEAT--------SFIKQILDGVN 129
Query: 468 YLHEEWEQVVIHRDVKPSNALI----DAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGY 523
YLH + + H D+KP N ++ + +L DFGLA + G N+ GT +
Sbjct: 130 YLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE--FKNIFGTPEF 184
Query: 524 IAPELTQTGKASTSSDVFAYGILL 547
+APE+ +D+++ G++
Sbjct: 185 VAPEIVNYEPLGLEADMWSIGVIT 208
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 1e-26
Identities = 35/249 (14%), Positives = 71/249 (28%), Gaps = 52/249 (20%)
Query: 352 TKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVK------KITRNSLQGMREFAAEIESLG 405
+ V+G + + TG V + N+++ M+E + L
Sbjct: 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLR 131
Query: 406 RLRHKNLVNLHGWCKQKNDLL-----------------------LVYEYIPNGSL----D 438
++++ +H DL+ +L +
Sbjct: 132 GIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGE 191
Query: 439 TLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLG 498
LL L R + + L LH ++H ++P + ++D L
Sbjct: 192 VLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---YGLVHTYLRPVDIVLDQRGGVFLT 248
Query: 499 DFGLARLYDHGGMPHTTNVVGTFGYIAPELTQT-----------GKASTSSDVFAYGILL 547
F G + + G+ PEL + S D +A G+++
Sbjct: 249 GFEHLV---RDGARVVS--SVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVI 303
Query: 548 LEVATGRRP 556
+ P
Sbjct: 304 YWIWCADLP 312
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 2e-26
Identities = 54/206 (26%), Positives = 84/206 (40%), Gaps = 32/206 (15%)
Query: 359 EVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMRE--FAAEIESLGRLRHKNLVNLH 416
E +G G F V + V G E A I L E L+H N+V LH
Sbjct: 17 EELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLH 76
Query: 417 GWCKQKNDLLLVYEYIPNGSL-DTLL----FKPKDGSVLDWEQRFNIVKGIASGLLYLHE 471
++ L+++ + G L + ++ + D S + ++ I +L+ H
Sbjct: 77 DSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADAS--------HCIQQILEAVLHCH- 127
Query: 472 EWEQVVIHRDVKPSNAL-IDAEMNARL--GDFGLARLYDHGGMPHTTNVVGTFGYIAPE- 527
+ V+HR++KP N L A + DFGLA + GT GY++PE
Sbjct: 128 --QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFG-FAGTPGYLSPEV 184
Query: 528 LTQT--GKASTSSDVFAYG----ILL 547
L + GK D++A G ILL
Sbjct: 185 LRKDPYGKP---VDLWACGVILYILL 207
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 3e-26
Identities = 57/284 (20%), Positives = 100/284 (35%), Gaps = 58/284 (20%)
Query: 322 IYRKWSNSETLEDWEKDCPHRFRYKDLYAATKGFKESEVIGIGGFGSVYKGVLPTTGGEV 381
++ +S E+ + Y IG G +G V + T
Sbjct: 1 MHHHHHHSSGRENLYFQGGSLLELQKKY------HLKGAIGQGSYGVVRVAIENQTRAIR 54
Query: 382 AVKKITRNSLQGMRE-----FAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEYIPNGS 436
A+K + +N ++ + E+ + +L H N+ L+ + + + LV E G
Sbjct: 55 AIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGH 114
Query: 437 L-------------------------------DTLLFKPKDGSVLDWEQRFN------IV 459
L + + G + I+
Sbjct: 115 LLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIM 174
Query: 460 KGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARL--GDFGLARLY---DHGGMPHT 514
+ I S L YLH Q + HRD+KP N L + + DFGL++ + ++G
Sbjct: 175 RQIFSALHYLHN---QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGM 231
Query: 515 TNVVGTFGYIAPE-LTQTGKA-STSSDVFAYGILLLEVATGRRP 556
T GT ++APE L T ++ D ++ G+LL + G P
Sbjct: 232 TTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVP 275
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 3e-26
Identities = 56/206 (27%), Positives = 90/206 (43%), Gaps = 33/206 (16%)
Query: 359 EVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQG--MREFAAEIESLGRLRHKNLVNLH 416
E +G G F V + V TTG E A K I L ++ E +L+H N+V LH
Sbjct: 35 EELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLH 94
Query: 417 GWCKQKNDLLLVYEYIPNGSL-DTLLFKP----KDGSVLDWEQRFNIVKGIASGLLYLHE 471
++++ LV++ + G L + ++ + D S + ++ I + Y H
Sbjct: 95 DSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADAS--------HCIQQILESIAYCH- 145
Query: 472 EWEQVVIHRDVKPSNALI---DAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPE- 527
++HR++KP N L+ +L DFGLA + GT GY++PE
Sbjct: 146 --SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA--WHGFAGTPGYLSPEV 201
Query: 528 LTQT--GKASTSSDVFAYG----ILL 547
L + K D++A G ILL
Sbjct: 202 LKKDPYSKP---VDIWACGVILYILL 224
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 3e-26
Identities = 56/221 (25%), Positives = 95/221 (42%), Gaps = 39/221 (17%)
Query: 359 EVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAA-------------EIESLG 405
+G G +G V E A+K I ++ R EI L
Sbjct: 42 RKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLK 101
Query: 406 RLRHKNLVNLHGWCKQKNDLLLVYEYIPNGSL-DTLLFKPKDGSVLDWEQRFN------I 458
L H N++ L + K LV E+ G L + ++ + +F+ I
Sbjct: 102 SLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINR----------HKFDECDAANI 151
Query: 459 VKGIASGLLYLHEEWEQVVIHRDVKPSNALI---DAEMNARLGDFGLARLYDHGGMPHTT 515
+K I SG+ YLH + ++HRD+KP N L+ ++ +N ++ DFGL+ +
Sbjct: 152 MKQILSGICYLH---KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRD- 207
Query: 516 NVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRP 556
+GT YIAPE+ + K + DV++ G+++ + G P
Sbjct: 208 -RLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPP 246
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 4e-26
Identities = 54/204 (26%), Positives = 89/204 (43%), Gaps = 28/204 (13%)
Query: 359 EVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAA------EIESLGRLRHKNL 412
E +G G F V K TG E A K I + L R + E+ L +RH N+
Sbjct: 11 EELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNI 70
Query: 413 VNLHGWCKQKNDLLLVYEYIPNGSL-DTLL----FKPKDGSVLDWEQRFNIVKGIASGLL 467
+ LH + K D++L+ E + G L D L + + +K I G+
Sbjct: 71 ITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEAT--------QFLKQILDGVH 122
Query: 468 YLHEEWEQVVIHRDVKPSNALI---DAEMNA-RLGDFGLARLYDHGGMPHTTNVVGTFGY 523
YLH + + H D+KP N ++ + +L DFG+A + G N+ GT +
Sbjct: 123 YLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE--FKNIFGTPEF 177
Query: 524 IAPELTQTGKASTSSDVFAYGILL 547
+APE+ +D+++ G++
Sbjct: 178 VAPEIVNYEPLGLEADMWSIGVIT 201
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 5e-26
Identities = 46/205 (22%), Positives = 89/205 (43%), Gaps = 20/205 (9%)
Query: 359 EVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNLHGW 418
E +G G FG V++ V ++ K + + EI L RH+N+++LH
Sbjct: 11 EDLGRGEFGIVHRCVETSSKKTYMAKFV-KVKGTDQVLVKKEISILNIARHRNILHLHES 69
Query: 419 CKQKNDLLLVYEYIPNGSL-DTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVV 477
+ +L++++E+I + + + L+ + + V + L +LH +
Sbjct: 70 FESMEELVMIFEFISGLDIFERIN---TSAFELNEREIVSYVHQVCEALQFLH---SHNI 123
Query: 478 IHRDVKPSNALIDAEMNARL--GDFGLARLYDHGGMPHTTNVVGTFGYIAPELTQTGKAS 535
H D++P N + ++ + +FG AR G + Y APE+ Q S
Sbjct: 124 GHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN--FRLLFTAPEYYAPEVHQHDVVS 181
Query: 536 TSSDVFAYG----ILLLEVATGRRP 556
T++D+++ G +LL +G P
Sbjct: 182 TATDMWSLGTLVYVLL----SGINP 202
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 7e-26
Identities = 58/210 (27%), Positives = 99/210 (47%), Gaps = 28/210 (13%)
Query: 359 EVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQG--MREFAAEIESLGRLRHKNLVNLH 416
++G G FG V K T E AVK I + S + E+E L +L H N++ L
Sbjct: 28 CMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLF 87
Query: 417 GWCKQKNDLLLVYEYIPNGSL-DTLLFKPKDGSVLDWEQRFN------IVKGIASGLLYL 469
+ + +V E G L D ++ + +RF+ I+K + SG+ Y+
Sbjct: 88 EILEDSSSFYIVGELYTGGELFDEIIKR----------KRFSEHDAARIIKQVFSGITYM 137
Query: 470 HEEWEQVVIHRDVKPSNALI---DAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAP 526
H + ++HRD+KP N L+ + + + ++ DFGL+ + +GT YIAP
Sbjct: 138 H---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKD--RIGTAYYIAP 192
Query: 527 ELTQTGKASTSSDVFAYGILLLEVATGRRP 556
E+ + G DV++ G++L + +G P
Sbjct: 193 EVLR-GTYDEKCDVWSAGVILYILLSGTPP 221
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 8e-26
Identities = 68/246 (27%), Positives = 112/246 (45%), Gaps = 32/246 (13%)
Query: 359 EVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAA---EIESLGRLRHKNLVNL 415
E +G G FG V T +VA+K I+R L+ EI L LRH +++ L
Sbjct: 15 ETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKL 74
Query: 416 HGWCKQKNDLLLVYEYIPNGSL-DTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWE 474
+ D+++V EY G L D ++ + + + E R + I + Y H
Sbjct: 75 YDVITTPTDIVMVIEYA-GGELFDYIV---EKKRMTEDEGR-RFFQQIICAIEYCHR--- 126
Query: 475 QVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPELTQTGK- 533
++HRD+KP N L+D +N ++ DFGL+ + G T+ G+ Y APE+ GK
Sbjct: 127 HKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTS--CGSPNYAAPEVIN-GKL 183
Query: 534 -ASTSSDVFAYGILLLEVATGRRP------------IGSGDLLLVEWV-RECHQL-GRIL 578
A DV++ GI+L + GR P + S ++ +++ L R++
Sbjct: 184 YAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDFLSPGAQSLIRRMI 243
Query: 579 DVADPL 584
DP+
Sbjct: 244 VA-DPM 248
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 1e-25
Identities = 56/201 (27%), Positives = 90/201 (44%), Gaps = 27/201 (13%)
Query: 359 EVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNLHGW 418
+G G VY+ T A+K + + + + EI L RL H N++ L
Sbjct: 59 SELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVR--TEIGVLLRLSHPNIIKLKEI 116
Query: 419 CKQKNDLLLVYEYIPNGSL-DTLL----FKPKDGSVLDWEQRFNIVKGIASGLLYLHEEW 473
+ ++ LV E + G L D ++ + +D + + VK I + YLH
Sbjct: 117 FETPTEISLVLELVTGGELFDRIVEKGYYSERDAA--------DAVKQILEAVAYLH--- 165
Query: 474 EQVVIHRDVKPSNAL-IDAEMNARL--GDFGLARLYDHGGMPHTTNVVGTFGYIAPELTQ 530
E ++HRD+KP N L +A L DFGL+++ +H + V GT GY APE+ +
Sbjct: 166 ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVL--MKTVCGTPGYCAPEILR 223
Query: 531 TGKASTSSDVFAYG----ILL 547
D+++ G ILL
Sbjct: 224 GCAYGPEVDMWSVGIITYILL 244
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 51/224 (22%), Positives = 97/224 (43%), Gaps = 36/224 (16%)
Query: 344 RYKDLYAATKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIES 403
R++D+Y + +V+G G V + T E AVK I + E+E
Sbjct: 9 RFEDVYQLQE-----DVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEM 63
Query: 404 LGRLR-HKNLVNLHGWCKQKNDLLLVYEYIPNGSL-DTLL----FKPKDGSVLDWEQRFN 457
L + + H+N++ L + ++++ LV+E + GS+ + F + S
Sbjct: 64 LYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEAS--------V 115
Query: 458 IVKGIASGLLYLHEEWEQVVIHRDVKPSNALI---DAEMNARLGDFGLARLYDHGGMPHT 514
+V+ +AS L +LH + + HRD+KP N L + ++ DF L G
Sbjct: 116 VVQDVASALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSP 172
Query: 515 TN------VVGTFGYIAPE-LTQTGKAST----SSDVFAYGILL 547
+ G+ Y+APE + + ++ D+++ G++L
Sbjct: 173 ISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVIL 216
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 52/204 (25%), Positives = 91/204 (44%), Gaps = 28/204 (13%)
Query: 359 EVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAA------EIESLGRLRHKNL 412
E +G G F V K +TG + A K I + + R + E+ L ++H N+
Sbjct: 17 EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 76
Query: 413 VNLHGWCKQKNDLLLVYEYIPNGSL-DTLL----FKPKDGSVLDWEQRFNIVKGIASGLL 467
+ LH + K D++L+ E + G L D L ++ + +K I +G+
Sbjct: 77 ITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEAT--------EFLKQILNGVY 128
Query: 468 YLHEEWEQVVIHRDVKPSNALI---DAEMNA-RLGDFGLARLYDHGGMPHTTNVVGTFGY 523
YLH + H D+KP N ++ + ++ DFGLA D G N+ GT +
Sbjct: 129 YLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE--FKNIFGTPEF 183
Query: 524 IAPELTQTGKASTSSDVFAYGILL 547
+APE+ +D+++ G++
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVIT 207
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 3e-25
Identities = 50/223 (22%), Positives = 91/223 (40%), Gaps = 39/223 (17%)
Query: 340 PHRFRYKDLYAATKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAA 399
P ++ D Y +K +V+G+G G V + TG + A+K + +
Sbjct: 21 PKKYAVTDDYQLSK-----QVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQ----- 70
Query: 400 EIESLGRL-RHKNLVNLHGWC----KQKNDLLLVYEYIPNGSL-------DTLLFKPKDG 447
E++ + ++V + K LL++ E + G L F ++
Sbjct: 71 EVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREA 130
Query: 448 SVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNAL-IDAEMNA--RLGDFGLAR 504
+ I++ I + + +LH + HRDVKP N L E +A +L DFG A+
Sbjct: 131 A--------EIMRDIGTAIQFLH---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK 179
Query: 505 LYDHGGMPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILL 547
+ T Y+APE+ K S D+++ G+++
Sbjct: 180 ETTQNAL---QTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 219
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 7e-25
Identities = 65/246 (26%), Positives = 101/246 (41%), Gaps = 37/246 (15%)
Query: 352 TKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKN 411
F+ + G G FG+V G +TG VA+KK+ ++ RE ++ L L H N
Sbjct: 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNREL-QIMQDLAVLHHPN 80
Query: 412 LVNLH-----GWCKQKND--LLLVYEYIPNGSLDTL----LFKPKDGSVLDWEQRFNIVK 460
+V L + + D L +V EY+P DTL + +K
Sbjct: 81 IVQLQSYFYTLGERDRRDIYLNVVMEYVP----DTLHRCCRNYYRRQVAPPPIL----IK 132
Query: 461 G----IASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNA-RLGDFGLARLYDHGGMPHTT 515
+ + LH V HRD+KP N L++ +L DFG A+ P+
Sbjct: 133 VFLFQLIRSIGCLHLPSVN-VCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSP-SEPNVA 190
Query: 516 NVVGTFGYIAPELTQTGKA-STSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQL 574
+ + Y APEL + +T+ D+++ G + E+ G PI GD QL
Sbjct: 191 YICSRY-YRAPELIFGNQHYTTAVDIWSVGCIFAEMMLG-EPIFRGD-------NSAGQL 241
Query: 575 GRILDV 580
I+ V
Sbjct: 242 HEIVRV 247
|
| >1qmo_A Mannose binding lectin, FRIL; crosslink, hematopoietic progenitor, sugar complex; HET: MAN; 3.5A {Dolichos lab lab} SCOP: b.29.1.1 Length = 113 | Back alignment and structure |
|---|
Score = 97.7 bits (243), Expect = 2e-24
Identities = 34/119 (28%), Positives = 52/119 (43%), Gaps = 12/119 (10%)
Query: 25 SQSSSFIFQGFNGGATNLSLQGAEIIKPSGALKLTNRSR------YVIGHAFYVKPIQMF 78
+QS SF F F+ +L QG + L++T G Y P++++
Sbjct: 1 AQSLSFSFTKFDPNQEDLIFQGHATS-TNNVLQVTKLDSAGNPVSSSAGRVLYSAPLRLW 59
Query: 79 DTSASPSPNASSFSTTFVFEISTPRSGRGGHGLAFLLAPSTKLPGAQPEHYLGILNSTN 137
+ S +SF T FEISTP + R GLAF +AP + +LG+ + N
Sbjct: 60 E----DSAVLTSFDTIINFEISTPYTSRIADGLAFFIAPPDSVISY-HGGFLGLFPNAN 113
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 63/271 (23%), Positives = 105/271 (38%), Gaps = 58/271 (21%)
Query: 361 IGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAA--------------------- 399
IG G +G V A+K +++ L F
Sbjct: 21 IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 400 -----EIESLGRLRHKNLVNLHG--WCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDW 452
EI L +L H N+V L ++ L +V+E + G + + P + +
Sbjct: 81 EQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPV---MEVPTLKPLSED 137
Query: 453 EQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLY-DHGGM 511
+ RF + + G+ YLH Q +IHRD+KPSN L+ + + ++ DFG++ + +
Sbjct: 138 QARF-YFQDLIKGIEYLHY---QKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDAL 193
Query: 512 PHTTNVVGTFGYIAPELTQTGKAS---TSSDVFAYGILLLEVATGRRP------------ 556
T VGT ++APE + + DV+A G+ L G+ P
Sbjct: 194 LSNT--VGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSK 251
Query: 557 IGSGDLLLVEWV---RECHQL-GRILDVADP 583
I S L + + L R+LD +P
Sbjct: 252 IKSQALEFPDQPDIAEDLKDLITRMLDK-NP 281
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 49/203 (24%), Positives = 92/203 (45%), Gaps = 24/203 (11%)
Query: 357 ESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQG--MREFAAEIESLGRLRH-KNLV 413
S+ +G G F V + + +TG E A K + + E EI L + ++
Sbjct: 33 TSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVI 92
Query: 414 NLHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRF------NIVKGIASGLL 467
NLH + ++++L+ EY G +F + + + ++K I G+
Sbjct: 93 NLHEVYENTSEIILILEYAAGGE----IF---SLCLPELAEMVSENDVIRLIKQILEGVY 145
Query: 468 YLHEEWEQVVIHRDVKPSNALI---DAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYI 524
YLH + ++H D+KP N L+ + ++ DFG++R H ++GT Y+
Sbjct: 146 YLH---QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELRE--IMGTPEYL 200
Query: 525 APELTQTGKASTSSDVFAYGILL 547
APE+ +T++D++ GI+
Sbjct: 201 APEILNYDPITTATDMWNIGIIA 223
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 5e-24
Identities = 57/209 (27%), Positives = 87/209 (41%), Gaps = 26/209 (12%)
Query: 360 VIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFA---AEIESLGRLRHKNLVNLH 416
IG G FG V T A+K + + E E++ + L H LVNL
Sbjct: 22 AIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLW 81
Query: 417 GWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRF--NIVK----GIASGLLYLH 470
+ + D+ +V + + G L L + F VK + L YL
Sbjct: 82 YSFQDEEDMFMVVDLLLGGDLRYHLQQ---------NVHFKEETVKLFICELVMALDYLQ 132
Query: 471 EEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPELTQ 530
Q +IHRD+KP N L+D + + DF +A + T + GT Y+APE+
Sbjct: 133 N---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITT--MAGTKPYMAPEMFS 187
Query: 531 TGKA---STSSDVFAYGILLLEVATGRRP 556
+ K S + D ++ G+ E+ GRRP
Sbjct: 188 SRKGAGYSFAVDWWSLGVTAYELLRGRRP 216
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 6e-24
Identities = 26/201 (12%), Positives = 55/201 (27%), Gaps = 39/201 (19%)
Query: 359 EVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSL---QGMREFAAEIESLGRLRHKNLVNL 415
G ++ + +VA+ + + ++E + L R+ + +
Sbjct: 37 IFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARV 96
Query: 416 HGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQ 475
+ L+V E+I GSL + + ++ +A+ H
Sbjct: 97 LDVVHTRAGGLVVAEWIRGGSLQEVA-----DTSPSPVGAIRAMQSLAAAADAAHRAG-- 149
Query: 476 VVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPELTQTGKAS 535
V PS + + G V+ + A+
Sbjct: 150 -VALSIDHPSRVRVSID--------GDV-------------VLAYPATMPD-------AN 180
Query: 536 TSSDVFAYGILLLEVATGRRP 556
D+ G L + R P
Sbjct: 181 PQDDIRGIGASLYALLVNRWP 201
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 8e-24
Identities = 58/201 (28%), Positives = 84/201 (41%), Gaps = 16/201 (7%)
Query: 361 IGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNLHGWCK 420
IG G FG T VAVK I R + EI + LRH N+V
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYIERGAAIDEN-VQREIINHRSLRHPNIVRFKEVIL 86
Query: 421 QKNDLLLVYEYIPNGSL-DTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIH 479
L ++ EY G L + + G + E RF + + SG+ Y H + H
Sbjct: 87 TPTHLAIIMEYASGGELYERIC---NAGRFSEDEARF-FFQQLLSGVSYCH---SMQICH 139
Query: 480 RDVKPSNALIDA--EMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPELTQTGK--AS 535
RD+K N L+D ++ DFG ++ P +T VGT YIAPE+ +
Sbjct: 140 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLL-RQEYDG 196
Query: 536 TSSDVFAYGILLLEVATGRRP 556
+DV++ G+ L + G P
Sbjct: 197 KIADVWSCGVTLYVMLVGAYP 217
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 58/227 (25%), Positives = 91/227 (40%), Gaps = 26/227 (11%)
Query: 359 EVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLR-HKNLVNLHG 417
+G G + V++ + T +V VK + ++ EI+ L LR N++ L
Sbjct: 42 RKLGRGKYSEVFEAINITNNEKVVVKILK---PVKKKKIKREIKILENLRGGPNIITLAD 98
Query: 418 --WCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQ 475
LV+E++ N L D + + + + I L Y H
Sbjct: 99 IVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDI----RFY--MYEILKALDYCHSMG-- 150
Query: 476 VVIHRDVKPSNALIDAE-MNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPELTQTGKA 534
++HRDVKP N +ID E RL D+GLA Y H G + V + + PEL +
Sbjct: 151 -IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY-HPGQEYNVRVA-SRYFKGPELLVDYQM 207
Query: 535 -STSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDV 580
S D+++ G +L + + P G QL RI V
Sbjct: 208 YDYSLDMWSLGCMLASMIFRKEPFFHGH-------DNYDQLVRIAKV 247
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 3e-23
Identities = 59/205 (28%), Positives = 90/205 (43%), Gaps = 13/205 (6%)
Query: 360 VIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMRE---FAAEIESLGRLRHKNLVNLH 416
VIG G FG V L A+K + + + E F E + L K + LH
Sbjct: 81 VIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLH 140
Query: 417 GWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQV 476
+ N+L LV +Y G L TLL K +D + RF + + + + +H+
Sbjct: 141 YAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEM-ARFYLAE-MVIAIDSVHQ---LH 195
Query: 477 VIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPELTQTGKAST 536
+HRD+KP N L+D + RL DFG G ++ VGT YI+PE+ Q +
Sbjct: 196 YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGK 255
Query: 537 SS-----DVFAYGILLLEVATGRRP 556
D ++ G+ + E+ G P
Sbjct: 256 GRYGPECDWWSLGVCMYEMLYGETP 280
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 4e-23
Identities = 60/206 (29%), Positives = 99/206 (48%), Gaps = 11/206 (5%)
Query: 355 FKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFA---AEIESLGRLRHKN 411
F++ V+G GGFG V + TG A KK+ + ++ + A E + L ++ +
Sbjct: 186 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 245
Query: 412 LVNLHGWCKQ-KNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLH 470
+V+L + + K+ L LV + G L ++ + F + I GL LH
Sbjct: 246 VVSLA-YAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAE-ICCGLEDLH 303
Query: 471 EEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPELTQ 530
+ +++RD+KP N L+D + R+ D GLA G VGT GY+APE+ +
Sbjct: 304 R---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKG--RVGTVGYMAPEVVK 358
Query: 531 TGKASTSSDVFAYGILLLEVATGRRP 556
+ + S D +A G LL E+ G+ P
Sbjct: 359 NERYTFSPDWWALGCLLYEMIAGQSP 384
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 5e-23
Identities = 55/246 (22%), Positives = 103/246 (41%), Gaps = 39/246 (15%)
Query: 344 RYKDLYAATKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITR---NSLQGMREFAAE 400
RY++L + IG G G V VA+KK++R N R + E
Sbjct: 63 RYQNL----------KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR-E 111
Query: 401 IESLGRLRHKNLVNLH------GWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQ 454
+ + + HKN+++L ++ D+ LV E +D L + +
Sbjct: 112 LVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMEL-----MDANLCQVIQMELDHERM 166
Query: 455 RFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHT 514
+ ++ + G+ +LH +IHRD+KPSN ++ ++ ++ DFGLAR
Sbjct: 167 SY-LLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS--FMM 220
Query: 515 TNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQL 574
T V T Y APE+ + D+++ G ++ E+ + + G + Q
Sbjct: 221 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRH-KILFPGRDYI-------DQW 272
Query: 575 GRILDV 580
++++
Sbjct: 273 NKVIEQ 278
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 103 bits (257), Expect = 5e-23
Identities = 58/209 (27%), Positives = 94/209 (44%), Gaps = 16/209 (7%)
Query: 355 FKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFA---AE---IESLGRLR 408
F +IG GGFG VY TG A+K + + ++ + E + +
Sbjct: 191 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 250
Query: 409 HKNLVNLHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLY 468
+V + + L + + + G L L + G + + RF + I GL +
Sbjct: 251 CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQ--HGVFSEADMRFYAAE-IILGLEH 307
Query: 469 LHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPEL 528
+H + V++RD+KP+N L+D + R+ D GLA + VGT GY+APE+
Sbjct: 308 MHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---PHASVGTHGYMAPEV 361
Query: 529 TQTGKASTSS-DVFAYGILLLEVATGRRP 556
Q G A SS D F+ G +L ++ G P
Sbjct: 362 LQKGVAYDSSADWFSLGCMLFKLLRGHSP 390
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 6e-23
Identities = 57/246 (23%), Positives = 105/246 (42%), Gaps = 39/246 (15%)
Query: 344 RYKDLYAATKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITR---NSLQGMREFAAE 400
RY++L + IG G G V VA+KK++R N R + E
Sbjct: 26 RYQNL----------KPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYR-E 74
Query: 401 IESLGRLRHKNLVNLH------GWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQ 454
+ + + HKN++ L ++ D+ +V E + +L ++ LD E+
Sbjct: 75 LVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQME-----LDHER 128
Query: 455 RFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHT 514
++ + G+ +LH +IHRD+KPSN ++ ++ ++ DFGLAR
Sbjct: 129 MSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS--FMM 183
Query: 515 TNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQL 574
T V T Y APE+ + D+++ G ++ E+ G + G + Q
Sbjct: 184 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG-GVLFPGTDHI-------DQW 235
Query: 575 GRILDV 580
++++
Sbjct: 236 NKVIEQ 241
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 6e-23
Identities = 74/310 (23%), Positives = 126/310 (40%), Gaps = 36/310 (11%)
Query: 257 EKSSSHYILGWSFSLNGVAPALNVSELPKPPKEKEPSSYNPKILALIVSLCLVTFLLLGT 316
+K+ + L+ + + + P + A++ L F
Sbjct: 105 QKAQALRAAYLEPQAQLFCSFLDAETVARARAGAGDGLFQPLLRAVLAHLGQAPFQEFLD 164
Query: 317 LVFFLIYRKWSNSE----TLEDWEKDCPHRFRYKDLYAATKGFKESEVIGIGGFGSVYKG 372
++FL + +W E + F + V+G GGFG V+
Sbjct: 165 SLYFLRFLQWKWLEAQPMGEDW--------------------FLDFRVLGRGGFGEVFAC 204
Query: 373 VLPTTGGEVAVKKITRNSLQGMREFA---AEIESLGRLRHKNLVNLHGWCKQ-KNDLLLV 428
+ TG A KK+ + L+ + + E + L ++ + +V+L + + K DL LV
Sbjct: 205 QMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLA-YAFETKTDLCLV 263
Query: 429 YEYIPNGSLDT-LLFKPKDGSVLDWEQ-RFNIVKGIASGLLYLHEEWEQVVIHRDVKPSN 486
+ G + + +D + F + I SGL +LH+ + +I+RD+KP N
Sbjct: 264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQ-IVSGLEHLHQ---RNIIYRDLKPEN 319
Query: 487 ALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGIL 546
L+D + N R+ D GLA G T GT G++APEL + S D FA G+
Sbjct: 320 VLLDDDGNVRISDLGLAVELKAGQTK-TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVT 378
Query: 547 LLEVATGRRP 556
L E+ R P
Sbjct: 379 LYEMIAARGP 388
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 8e-23
Identities = 52/205 (25%), Positives = 82/205 (40%), Gaps = 33/205 (16%)
Query: 358 SEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRL-RHKNLVNLH 416
S+V+G+G G V + T + A+K + E+E R + ++V +
Sbjct: 67 SQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR-----EVELHWRASQCPHIVRIV 121
Query: 417 GWC----KQKNDLLLVYEYIPNGSL-------DTLLFKPKDGSVLDWEQRFNIVKGIASG 465
+ LL+V E + G L F ++ S I+K I
Sbjct: 122 DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREAS--------EIMKSIGEA 173
Query: 466 LLYLHEEWEQVVIHRDVKPSNAL-IDAEMNA--RLGDFGLARLYDHGGMPHTTNVVGTFG 522
+ YLH + HRDVKP N L NA +L DFG A+ T T
Sbjct: 174 IQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT--PCYTPY 228
Query: 523 YIAPELTQTGKASTSSDVFAYGILL 547
Y+APE+ K S D+++ G+++
Sbjct: 229 YVAPEVLGPEKYDKSCDMWSLGVIM 253
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 1e-22
Identities = 62/239 (25%), Positives = 109/239 (45%), Gaps = 32/239 (13%)
Query: 352 TKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITR---NSLQGMREFAAEIESLGRLR 408
K + +G G +GSV + +G +VA+KK++R + + R + E+ L ++
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYR-ELLLLKHMQ 81
Query: 409 HKNLVNLH------GWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGI 462
H+N++ L + D LV + + T L K + + ++ +V +
Sbjct: 82 HENVIGLLDVFTPASSLRNFYDFYLVMPF-----MQTDLQKIMGLKFSEEKIQY-LVYQM 135
Query: 463 ASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFG 522
GL Y+H V+HRD+KP N ++ + ++ DFGLAR D T V T
Sbjct: 136 LKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLARHAD----AEMTGYVVTRW 188
Query: 523 YIAPE-LTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDV 580
Y APE + + + D+++ G ++ E+ TG + + G L QL +IL V
Sbjct: 189 YRAPEVILSWMHYNQTVDIWSVGCIMAEMLTG-KTLFKGKDYL-------DQLTQILKV 239
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 1e-22
Identities = 61/208 (29%), Positives = 89/208 (42%), Gaps = 17/208 (8%)
Query: 360 VIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMRE---FAAEIESLGRLRHKNLVNLH 416
VIG G F V + TG A+K + + + E F E + L + + LH
Sbjct: 68 VIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLH 127
Query: 417 GWCKQ-KNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQ 475
+ Q +N L LV EY G L TLL K + + RF + + I + +H
Sbjct: 128 -FAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEM-ARFYLAE-IVMAIDSVHR---L 181
Query: 476 VVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPE-LTQTGKA 534
+HRD+KP N L+D + RL DFG G + VGT Y++PE L G
Sbjct: 182 GYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGG 241
Query: 535 STSS------DVFAYGILLLEVATGRRP 556
+ D +A G+ E+ G+ P
Sbjct: 242 PGTGSYGPECDWWALGVFAYEMFYGQTP 269
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 3e-22
Identities = 55/210 (26%), Positives = 80/210 (38%), Gaps = 26/210 (12%)
Query: 360 VIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMRE---FAAEIESLGRLRHKNLVNLH 416
VIG G FG V +T A+K +++ + + F E + + +V L
Sbjct: 76 VIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 135
Query: 417 GWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKG------IASGLLYLH 470
+ L +V EY+P G L L+ + L +H
Sbjct: 136 YAFQDDRYLYMVMEYMPGGDLVNLMSN----------YDVPEKWARFYTAEVVLALDAIH 185
Query: 471 EEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPE-LT 529
IHRDVKP N L+D + +L DFG + GM VGT YI+PE L
Sbjct: 186 S---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLK 242
Query: 530 QTGKAST---SSDVFAYGILLLEVATGRRP 556
G D ++ G+ L E+ G P
Sbjct: 243 SQGGDGYYGRECDWWSVGVFLYEMLVGDTP 272
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 5e-22
Identities = 73/248 (29%), Positives = 109/248 (43%), Gaps = 39/248 (15%)
Query: 344 RYKDLYAATKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKIT--RNSLQGMREFAAEI 401
RY +L IG G +G V VA+KKI+ + R EI
Sbjct: 28 RYTNL----------SYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR-EI 76
Query: 402 ESLGRLRHKNLVNLH-----GWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRF 456
+ L R RH+N++ ++ +Q D+ +V + ++T L+K L +
Sbjct: 77 KILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDL-----METDLYKLLKTQHLSNDHIC 131
Query: 457 NIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYD--HGGMPHT 514
+ I GL Y+H V+HRD+KPSN L++ + ++ DFGLAR+ D H
Sbjct: 132 YFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFL 188
Query: 515 TNVVGTFGYIAPELTQTGKASTSS-DVFAYGILLLEVATGRRPIGSG-DLLLVEWVRECH 572
T V T Y APE+ K T S D+++ G +L E+ RPI G L
Sbjct: 189 TEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEM-LSNRPIFPGKHYL--------D 239
Query: 573 QLGRILDV 580
QL IL +
Sbjct: 240 QLNHILGI 247
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 5e-22
Identities = 67/247 (27%), Positives = 109/247 (44%), Gaps = 41/247 (16%)
Query: 344 RYKDLYAATKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITR---NSLQGMREFAAE 400
Y+DL + +G G +G+V V TG +VA+KK+ R + L R + E
Sbjct: 26 VYRDL----------QPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYR-E 74
Query: 401 IESLGRLRHKNLVNLH------GWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQ 454
+ L +RH+N++ L D LV + + T L K L ++
Sbjct: 75 LRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPF-----MGTDLGKLMKHEKLGEDR 129
Query: 455 RFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHT 514
+V + GL Y+H +IHRD+KP N ++ + ++ DFGLAR D
Sbjct: 130 IQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQAD----SEM 182
Query: 515 TNVVGTFGYIAPE-LTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQ 573
T V T Y APE + + + + D+++ G ++ E+ TG + + G L Q
Sbjct: 183 TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITG-KTLFKGSDHL-------DQ 234
Query: 574 LGRILDV 580
L I+ V
Sbjct: 235 LKEIMKV 241
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 6e-22
Identities = 57/239 (23%), Positives = 98/239 (41%), Gaps = 32/239 (13%)
Query: 327 SNSETLEDWEKDCPHRFRYKDLYAATKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKI 386
+ + L+ WE + + F + +G G FG V +G A+K +
Sbjct: 22 AKEDFLKKWETPSQNTAQLDQ-------FDRIKTLGTGSFGRVMLVKHKESGNHYAMKIL 74
Query: 387 TRNSLQGMREFA---AEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEYIPNGSLDTLLFK 443
+ + +++ E L + LV L K ++L +V EY+ G + + L +
Sbjct: 75 DKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR 134
Query: 444 PKDGSVLDWEQRFNIVKG------IASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARL 497
RF+ I YLH +I+RD+KP N LID + ++
Sbjct: 135 ---------IGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQV 182
Query: 498 GDFGLARLYDHGGMPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRP 556
DFG A+ T + GT +APE+ + + + D +A G+L+ E+A G P
Sbjct: 183 TDFGFAKRVKG----RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 7e-22
Identities = 69/256 (26%), Positives = 110/256 (42%), Gaps = 46/256 (17%)
Query: 344 RYKDLYAATKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKIT-RNSLQGMREFAAEIE 402
RY DL + +G GG G V+ V VA+KKI + EI+
Sbjct: 12 RYMDL----------KPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALR-EIK 60
Query: 403 SLGRLRHKNLVNLH--------------GWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGS 448
+ RL H N+V + G + N + +V EY ++T L +
Sbjct: 61 IIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEY-----METDLANVLEQG 115
Query: 449 VLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAE-MNARLGDFGLARLYD 507
L E + + GL Y+H V+HRD+KP+N I+ E + ++GDFGLAR+ D
Sbjct: 116 PLLEEHARLFMYQLLRGLKYIHS---ANVLHRDLKPANLFINTEDLVLKIGDFGLARIMD 172
Query: 508 --HGGMPHTTNVVGTFGYIAPELTQTGKASTSS-DVFAYGILLLEVATGRRPIGSGDLLL 564
+ H + + T Y +P L + T + D++A G + E+ TG + + +G L
Sbjct: 173 PHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTG-KTLFAGAHEL 231
Query: 565 VEWVRECHQLGRILDV 580
Q+ IL+
Sbjct: 232 -------EQMQLILES 240
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 9e-22
Identities = 65/247 (26%), Positives = 107/247 (43%), Gaps = 41/247 (16%)
Query: 344 RYKDLYAATKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITR---NSLQGMREFAAE 400
RY++L +G G +GSV TG VAVKK++R + + R + E
Sbjct: 30 RYQNL----------SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-E 78
Query: 401 IESLGRLRHKNLVNLH------GWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQ 454
+ L ++H+N++ L ++ ND+ LV + L L +
Sbjct: 79 LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHL-----MGADLNNIVKCQKLTDDH 133
Query: 455 RFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHT 514
++ I GL Y+H +IHRD+KPSN ++ + ++ DFGLAR
Sbjct: 134 VQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTA----DEM 186
Query: 515 TNVVGTFGYIAPE-LTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQ 573
T V T Y APE + + + D+++ G ++ E+ TG R + G + Q
Sbjct: 187 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG-RTLFPGTDHI-------DQ 238
Query: 574 LGRILDV 580
L IL +
Sbjct: 239 LKLILRL 245
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 1e-20
Identities = 67/246 (27%), Positives = 105/246 (42%), Gaps = 34/246 (13%)
Query: 352 TKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKIT--RNSLQGMREFAAEIESLGRLRH 409
+ F+ ++G G +G V TG VA+KKI L +R EI+ L +H
Sbjct: 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR-EIKILKHFKH 68
Query: 410 KNLVNLH-----GWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIAS 464
+N++ + + N++ ++ E + T L + +L + +
Sbjct: 69 ENIITIFNIQRPDSFENFNEVYIIQEL-----MQTDLHRVISTQMLSDDHIQYFIYQTLR 123
Query: 465 GLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYD---------HGGMPHTT 515
+ LH VIHRD+KPSN LI++ + ++ DFGLAR+ D G
Sbjct: 124 AVKVLHG---SNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMV 180
Query: 516 NVVGTFGYIAPELTQTGKA-STSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQL 574
V T Y APE+ T S + DV++ G +L E+ RRPI G HQL
Sbjct: 181 EFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAEL-FLRRPIFPGRDYR-------HQL 232
Query: 575 GRILDV 580
I +
Sbjct: 233 LLIFGI 238
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 91.4 bits (228), Expect = 3e-20
Identities = 56/211 (26%), Positives = 94/211 (44%), Gaps = 25/211 (11%)
Query: 355 FKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFA---AEIESLGRLRHKN 411
F+ +G G FG V+ G A+K + + + +++ E L + H
Sbjct: 8 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 67
Query: 412 LVNLHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKG------IASG 465
++ + G + + ++ +YI G L +LL K QRF +
Sbjct: 68 IIRMWGTFQDAQQIFMIMDYIEGGELFSLLRK---------SQRFPNPVAKFYAAEVCLA 118
Query: 466 LLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIA 525
L YLH + +I+RD+KP N L+D + ++ DFG A+ T + GT YIA
Sbjct: 119 LEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV----TYTLCGTPDYIA 171
Query: 526 PELTQTGKASTSSDVFAYGILLLEVATGRRP 556
PE+ T + S D +++GIL+ E+ G P
Sbjct: 172 PEVVSTKPYNKSIDWWSFGILIYEMLAGYTP 202
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 92.1 bits (229), Expect = 4e-20
Identities = 52/269 (19%), Positives = 98/269 (36%), Gaps = 57/269 (21%)
Query: 352 TKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKN 411
+K + + +G G FG V + +G A+KK+ ++ RE ++ + L H N
Sbjct: 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRE----LDIMKVLDHVN 61
Query: 412 LVNL-------HGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIV----- 459
++ L + + + + + N++
Sbjct: 62 IIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP 121
Query: 460 ----KGIAS----------------------GLLYLHEEWEQVVIHRDVKPSNALIDAEM 493
K + S + ++H + HRD+KP N L++++
Sbjct: 122 DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS---LGICHRDIKPQNLLVNSKD 178
Query: 494 NA-RLGDFGLARLYDHGGMPHTTNVVGTFGYIAPELTQTGKA-STSSDVFAYGILLLEVA 551
N +L DFG A+ P + F Y APEL + S D+++ G + E+
Sbjct: 179 NTLKLCDFGSAKKLIPSE-PSVAYICSRF-YRAPELMLGATEYTPSIDLWSIGCVFGELI 236
Query: 552 TGRRPIGSGDLLLVEWVRECHQLGRILDV 580
G +P+ SG+ QL RI+ +
Sbjct: 237 LG-KPLFSGE-------TSIDQLVRIIQI 257
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 5e-20
Identities = 58/256 (22%), Positives = 101/256 (39%), Gaps = 40/256 (15%)
Query: 345 YKDLYAATKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITR--NSLQGMREFAA--- 399
+L+A + I G +G+V GV + G VA+K++ + + + +
Sbjct: 14 IAELHAMQSPYTVQRFISSGSYGAVCAGV-DSEGIPVAIKRVFNTVSDGRTVNILSDSFL 72
Query: 400 ------EIESLGRLRHKNLVNLH-----GWCKQKNDLLLVYEYIPNGSLDTLL---FKPK 445
EI L H N++ L + L LV E + T L +
Sbjct: 73 CKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTEL-----MRTDLAQVIHDQ 127
Query: 446 DGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARL 505
+ ++ + I GL LH E V+HRD+ P N L+ + + DF LAR
Sbjct: 128 RIVISPQHIQY-FMYHILLGLHVLH---EAGVVHRDLHPGNILLADNNDITICDFNLARE 183
Query: 506 YDHGGMPHTTNVVGTFGYIAPE-LTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLL 564
+ T+ V Y APE + Q + D+++ G ++ E+ R+ + G
Sbjct: 184 DTAD--ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEM-FNRKALFRGSTFY 240
Query: 565 VEWVRECHQLGRILDV 580
+QL +I++V
Sbjct: 241 -------NQLNKIVEV 249
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 88.0 bits (218), Expect = 1e-18
Identities = 60/285 (21%), Positives = 105/285 (36%), Gaps = 68/285 (23%)
Query: 355 FKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITR---NSLQGMREFAAEIESLGRLRHKN 411
++ +IG G +G V + VA+KKI R + + R EI L RL H +
Sbjct: 55 YEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRIL-REIAILNRLNHDH 113
Query: 412 LVNLH-----GWCKQKNDLLLVYEYIPNGSLDTLLFKP-KDGSVLDWEQRFNIVKGIASG 465
+V + ++ ++L +V E D+ K + L ++ + G
Sbjct: 114 VVKVLDIVIPKDVEKFDELYVVLEI-----ADSDFKKLFRTPVYLTELHIKTLLYNLLVG 168
Query: 466 LLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDH----------------- 508
+ Y+H ++HRD+KP+N L++ + + ++ DFGLAR D+
Sbjct: 169 VKYVH---SAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDM 225
Query: 509 ---------GGMPHTTNVVGTFGYIAPELTQTGKA-STSSDVFAYGILLLE--------- 549
T V T Y APEL + + + DV++ G + E
Sbjct: 226 NLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENV 285
Query: 550 -VATGRRPI-------------GSGDLLLVEWVRECHQLGRILDV 580
R P+ +G+ QL I ++
Sbjct: 286 AYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNI 330
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 86.7 bits (215), Expect = 4e-18
Identities = 58/208 (27%), Positives = 90/208 (43%), Gaps = 25/208 (12%)
Query: 360 VIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFA---AEIESLGRLRHKNLVNLH 416
++G G FG V TG A+K + + + E A E L RH L L
Sbjct: 155 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 214
Query: 417 GWCKQ-KNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKG------IASGLLYL 469
+ Q + L V EY G L L + E+ F+ + I S L YL
Sbjct: 215 -YSFQTHDRLCFVMEYANGGELFFHLSR---------ERVFSEDRARFYGAEIVSALDYL 264
Query: 470 HEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVV-GTFGYIAPEL 528
H E + V++RD+K N ++D + + ++ DFGL + G T GT Y+APE+
Sbjct: 265 HSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG--ATMKTFCGTPEYLAPEV 320
Query: 529 TQTGKASTSSDVFAYGILLLEVATGRRP 556
+ + D + G+++ E+ GR P
Sbjct: 321 LEDNDYGRAVDWWGLGVVMYEMMCGRLP 348
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 4e-18
Identities = 67/280 (23%), Positives = 108/280 (38%), Gaps = 60/280 (21%)
Query: 352 TKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITR---NSLQGMREFAAEIESLGRLR 408
+ +IG G +G VY T VA+KK+ R + + R EI L RL+
Sbjct: 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRIL-REITILNRLK 83
Query: 409 HKNLVNLH-----GWCKQKNDLLLVYEYIPNGSLDTLLFKP-KDGSVLDWEQRFNIVKGI 462
++ L+ + ++L +V E D+ L K K L E I+ +
Sbjct: 84 SDYIIRLYDLIIPDDLLKFDELYIVLEI-----ADSDLKKLFKTPIFLTEEHIKTILYNL 138
Query: 463 ASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHT-------- 514
G ++H E +IHRD+KP+N L++ + + ++ DFGLAR + +
Sbjct: 139 LLGENFIH---ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENE 195
Query: 515 -------------TNVVGTFGYIAPELTQTGKA-STSSDVFAYGILLLE----------V 550
T+ V T Y APEL + + S D+++ G + E
Sbjct: 196 EPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHIND 255
Query: 551 ATGRRPI--GSGDLLLVEWVREC--------HQLGRILDV 580
T R P+ GS L QL I ++
Sbjct: 256 PTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNI 295
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 7e-18
Identities = 73/254 (28%), Positives = 117/254 (46%), Gaps = 46/254 (18%)
Query: 355 FKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITR---NSLQGMREFAAEIESLGRLR-HK 410
++ + +G G +G V+K + TG VAVKKI NS R F EI L L H+
Sbjct: 11 YELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFR-EIMILTELSGHE 69
Query: 411 NLVNLHGWCKQKN--DLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLY 468
N+VNL + N D+ LV++Y ++T L ++L+ + +V + + Y
Sbjct: 70 NIVNLLNVLRADNDRDVYLVFDY-----METDLHAVIRANILEPVHKQYVVYQLIKVIKY 124
Query: 469 LHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLY--------------------DH 508
LH ++HRD+KPSN L++AE + ++ DFGL+R +
Sbjct: 125 LHS---GGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFD 181
Query: 509 GGMPHTTNVVGTFGYIAPELTQTGKA-STSSDVFAYGILLLEVATGRRPIGSG-DLLLVE 566
P T+ V T Y APE+ + D+++ G +L E+ +PI G +
Sbjct: 182 DDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEI-LCGKPIFPGSSTM--- 237
Query: 567 WVRECHQLGRILDV 580
+QL RI+ V
Sbjct: 238 -----NQLERIIGV 246
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 1e-17
Identities = 58/212 (27%), Positives = 100/212 (47%), Gaps = 30/212 (14%)
Query: 360 VIGIGGFGSVY---KGVLPTTGGEVAVKKITRNSL-QGMREFA---AEIESLGRLRHKNL 412
V+G GG+G V+ K TG A+K + + + + ++ A AE L ++H +
Sbjct: 24 VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFI 83
Query: 413 VNLHGWCKQ-KNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKG------IASG 465
V+L + Q L L+ EY+ G L L + E F I+
Sbjct: 84 VDLI-YAFQTGGKLYLILEYLSGGELFMQLER---------EGIFMEDTACFYLAEISMA 133
Query: 466 LLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTN-VVGTFGYI 524
L +LH+ + +I+RD+KP N +++ + + +L DFGL + H G T+ GT Y+
Sbjct: 134 LGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDG--TVTHTFCGTIEYM 188
Query: 525 APELTQTGKASTSSDVFAYGILLLEVATGRRP 556
APE+ + + D ++ G L+ ++ TG P
Sbjct: 189 APEILMRSGHNRAVDWWSLGALMYDMLTGAPP 220
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 82.6 bits (205), Expect = 3e-17
Identities = 60/210 (28%), Positives = 99/210 (47%), Gaps = 28/210 (13%)
Query: 360 VIGIGGFGSVY---KGVLPTTGGEVAVKKITRNSLQGMREFAAEIES--LGRLRHKNLVN 414
V+G G FG V+ K A+K + + +L+ ++E L + H +V
Sbjct: 31 VLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVK 90
Query: 415 LHGWCKQ-KNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKG------IASGLL 467
LH + Q + L L+ +++ G L T L K E F +A L
Sbjct: 91 LH-YAFQTEGKLYLILDFLRGGDLFTRLSK---------EVMFTEEDVKFYLAELALALD 140
Query: 468 YLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLY-DHGGMPHTTNVVGTFGYIAP 526
+LH +I+RD+KP N L+D E + +L DFGL++ DH ++ GT Y+AP
Sbjct: 141 HLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGTVEYMAP 195
Query: 527 ELTQTGKASTSSDVFAYGILLLEVATGRRP 556
E+ + S+D +++G+L+ E+ TG P
Sbjct: 196 EVVNRRGHTQSADWWSFGVLMFEMLTGTLP 225
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 7e-17
Identities = 56/214 (26%), Positives = 97/214 (45%), Gaps = 30/214 (14%)
Query: 360 VIGIGGFGSVY---KGVLPTTGGEVAVKKITRNSLQGMREFAAEIES----LGRLRHKN- 411
V+G G +G V+ K TG A+K + + ++ + + L +R
Sbjct: 61 VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 120
Query: 412 LVNLHGWCKQ-KNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKG------IAS 464
LV LH + Q + L L+ +YI G L T L + +RF + I
Sbjct: 121 LVTLH-YAFQTETKLHLILDYINGGELFTHLSQ---------RERFTEHEVQIYVGEIVL 170
Query: 465 GLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYI 524
L +LH+ +I+RD+K N L+D+ + L DFGL++ + + GT Y+
Sbjct: 171 ALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYM 227
Query: 525 APELTQTGKA--STSSDVFAYGILLLEVATGRRP 556
AP++ + G + + D ++ G+L+ E+ TG P
Sbjct: 228 APDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP 261
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 9e-17
Identities = 58/208 (27%), Positives = 88/208 (42%), Gaps = 26/208 (12%)
Query: 360 VIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFA---AEIESLGRLRHKNLVNLH 416
++G G FG V TG A+K + + + E A E L RH L L
Sbjct: 12 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 71
Query: 417 GWCKQ-KNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKG------IASGLLYL 469
+ Q + L V EY G L F L E+ F + I S L YL
Sbjct: 72 -YAFQTHDRLCFVMEYANGGEL---FFH------LSRERVFTEERARFYGAEIVSALEYL 121
Query: 470 HEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVV-GTFGYIAPEL 528
H + V++RD+K N ++D + + ++ DFGL + G T GT Y+APE+
Sbjct: 122 HS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--ATMKTFCGTPEYLAPEV 176
Query: 529 TQTGKASTSSDVFAYGILLLEVATGRRP 556
+ + D + G+++ E+ GR P
Sbjct: 177 LEDNDYGRAVDWWGLGVVMYEMMCGRLP 204
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 2e-16
Identities = 42/160 (26%), Positives = 63/160 (39%), Gaps = 31/160 (19%)
Query: 359 EVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRL-RHKNLVNLHG 417
+V+G+G G V + T + A+K + R E+E R + ++V +
Sbjct: 24 QVLGLGINGKVLQIFNKRTQEKFALKMLQDCPK--ARR---EVELHWRASQCPHIVRIVD 78
Query: 418 WC----KQKNDLLLVYEYIPNGSL-DTLLFKPKDGSVLDWEQRF------NIVKGIASGL 466
+ LL+V E + G L + + Q F I+K I +
Sbjct: 79 VYENLYAGRKCLLIVMECLDGGELFSRIQDRGD--------QAFTEREASEIMKSIGEAI 130
Query: 467 LYLHEEWEQVVIHRDVKPSNAL-IDAEMNA--RLGDFGLA 503
YLH + HRDVKP N L NA +L DFG A
Sbjct: 131 QYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFA 167
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 79.3 bits (195), Expect = 2e-15
Identities = 58/208 (27%), Positives = 91/208 (43%), Gaps = 15/208 (7%)
Query: 355 FKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFA---AEIESLGR-LRHK 410
F V+G G FG V T AVK + ++ + + E L +
Sbjct: 343 FNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPP 402
Query: 411 NLVNLHGWCKQ-KNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQ-RFNIVKGIASGLLY 468
L LH C Q + L V EY+ G L ++ + F + IA GL +
Sbjct: 403 FLTQLH-SCFQTMDRLYFVMEYVNGGDL---MYHIQQVGRFKEPHAVFYAAE-IAIGLFF 457
Query: 469 LHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPEL 528
L + +I+RD+K N ++D+E + ++ DFG+ + G+ T GT YIAPE+
Sbjct: 458 LQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV-TTKTFCGTPDYIAPEI 513
Query: 529 TQTGKASTSSDVFAYGILLLEVATGRRP 556
S D +A+G+LL E+ G+ P
Sbjct: 514 IAYQPYGKSVDWWAFGVLLYEMLAGQAP 541
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 2e-15
Identities = 53/211 (25%), Positives = 92/211 (43%), Gaps = 31/211 (14%)
Query: 360 VIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFA---AEIESLGR-LRHKNLVNL 415
++G G FG V+ T A+K + ++ + + E L H L ++
Sbjct: 24 MLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHM 83
Query: 416 HGWCKQ-KNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKG------IASGLLY 468
Q K +L V EY+ G L + +F++ + I GL +
Sbjct: 84 F-CTFQTKENLFFVMEYLNGGDLMYHIQS---------CHKFDLSRATFYAAEIILGLQF 133
Query: 469 LHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPH---TTNVVGTFGYIA 525
LH + +++RD+K N L+D + + ++ DFG+ + M T GT YIA
Sbjct: 134 LHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKE----NMLGDAKTNTFCGTPDYIA 186
Query: 526 PELTQTGKASTSSDVFAYGILLLEVATGRRP 556
PE+ K + S D +++G+LL E+ G+ P
Sbjct: 187 PEILLGQKYNHSVDWWSFGVLLYEMLIGQSP 217
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 2e-15
Identities = 61/211 (28%), Positives = 93/211 (44%), Gaps = 31/211 (14%)
Query: 360 VIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFA---AEIESLGR-LRHKNLVNL 415
VIG G FG V AVK + + ++ +E +E L + ++H LV L
Sbjct: 45 VIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 104
Query: 416 HGWCKQ-KNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKG------IASGLLY 468
H + Q + L V +YI G L L + E+ F + IAS L Y
Sbjct: 105 H-FSFQTADKLYFVLDYINGGELFYHLQR---------ERCFLEPRARFYAAEIASALGY 154
Query: 469 LHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPH---TTNVVGTFGYIA 525
LH +++RD+KP N L+D++ + L DFGL + + H T+ GT Y+A
Sbjct: 155 LHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKE----NIEHNSTTSTFCGTPEYLA 207
Query: 526 PELTQTGKASTSSDVFAYGILLLEVATGRRP 556
PE+ + D + G +L E+ G P
Sbjct: 208 PEVLHKQPYDRTVDWWCLGAVLYEMLYGLPP 238
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 9e-15
Identities = 59/209 (28%), Positives = 89/209 (42%), Gaps = 27/209 (12%)
Query: 360 VIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFA---AEIESLGR-LRHKNLVNL 415
V+G G FG V T AVK + ++ + + E L + L L
Sbjct: 27 VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQL 86
Query: 416 HGWCKQ-KNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKG------IASGLLY 468
H C Q + L V EY+ G L + + RF IA GL +
Sbjct: 87 H-SCFQTMDRLYFVMEYVNGGDLMYHIQQ---------VGRFKEPHAVFYAAEIAIGLFF 136
Query: 469 LHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTN-VVGTFGYIAPE 527
L + +I+RD+K N ++D+E + ++ DFG+ + G TT GT YIAPE
Sbjct: 137 LQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG--VTTKTFCGTPDYIAPE 191
Query: 528 LTQTGKASTSSDVFAYGILLLEVATGRRP 556
+ S D +A+G+LL E+ G+ P
Sbjct: 192 IIAYQPYGKSVDWWAFGVLLYEMLAGQAP 220
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 1e-14
Identities = 58/208 (27%), Positives = 92/208 (44%), Gaps = 25/208 (12%)
Query: 360 VIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFA---AEIESLGR-LRHKNLVNL 415
VIG G + V L T A+K + + + + E + H LV L
Sbjct: 16 VIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 75
Query: 416 HGWCKQ-KNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKG------IASGLLY 468
H C Q ++ L V EY+ G L + + +++ I+ L Y
Sbjct: 76 H-SCFQTESRLFFVIEYVNGGDLMFHMQR---------QRKLPEEHARFYSAEISLALNY 125
Query: 469 LHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPEL 528
LHE + +I+RD+K N L+D+E + +L D+G+ + G T+ GT YIAPE+
Sbjct: 126 LHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT-TSTFCGTPNYIAPEI 181
Query: 529 TQTGKASTSSDVFAYGILLLEVATGRRP 556
+ S D +A G+L+ E+ GR P
Sbjct: 182 LRGEDYGFSVDWWALGVLMFEMMAGRSP 209
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 2e-14
Identities = 62/209 (29%), Positives = 93/209 (44%), Gaps = 27/209 (12%)
Query: 360 VIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFA---AEIESLGR-LRHKNLVNL 415
V+G G FG V + TG AVK + ++ + + E L H L L
Sbjct: 30 VLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 89
Query: 416 HGWCKQ-KNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKG------IASGLLY 468
C Q + L V E++ G L + K +RF+ + I S L++
Sbjct: 90 F-CCFQTPDRLFFVMEFVNGGDLMFHIQK---------SRRFDEARARFYAAEIISALMF 139
Query: 469 LHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTN-VVGTFGYIAPE 527
LH+ + +I+RD+K N L+D E + +L DFG+ + G TT GT YIAPE
Sbjct: 140 LHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNG--VTTATFCGTPDYIAPE 194
Query: 528 LTQTGKASTSSDVFAYGILLLEVATGRRP 556
+ Q + D +A G+LL E+ G P
Sbjct: 195 ILQEMLYGPAVDWWAMGVLLYEMLCGHAP 223
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 2e-14
Identities = 58/209 (27%), Positives = 93/209 (44%), Gaps = 27/209 (12%)
Query: 360 VIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFA---AEIESLGR-LRHKNLVNL 415
VIG G + V L T A++ + + + + E + H LV L
Sbjct: 59 VIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 118
Query: 416 HGWCKQ-KNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKG------IASGLLY 468
H C Q ++ L V EY+ G L + + +++ I+ L Y
Sbjct: 119 H-SCFQTESRLFFVIEYVNGGDLMFHMQR---------QRKLPEEHARFYSAEISLALNY 168
Query: 469 LHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVV-GTFGYIAPE 527
LHE + +I+RD+K N L+D+E + +L D+G+ + G TT+ GT YIAPE
Sbjct: 169 LHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG--DTTSTFCGTPNYIAPE 223
Query: 528 LTQTGKASTSSDVFAYGILLLEVATGRRP 556
+ + S D +A G+L+ E+ GR P
Sbjct: 224 ILRGEDYGFSVDWWALGVLMFEMMAGRSP 252
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 4e-13
Identities = 56/274 (20%), Positives = 106/274 (38%), Gaps = 45/274 (16%)
Query: 334 DWEKDCPHRFRYKDLYAATKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQG 393
D+ H + Y + + +G G F +V+ VA+K I R
Sbjct: 1 DYRPGGYHPAFKGEPYKDAR-YILVRKLGWGHFSTVWLAKDMVNNTHVAMK-IVRGDKVY 58
Query: 394 MREFAAEIESLGRLR-----------HKNLVNLHGWCKQKND----LLLVYEYIPNGSLD 438
EI+ L R+ +++ L K +++V+E + +L
Sbjct: 59 TEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLL 117
Query: 439 TLLFKPKDGSVLDWEQRFNI--VKGIA----SGLLYLHEEWEQVVIHRDVKPSNALIDAE 492
L+ K + + + VK I+ GL Y+H +IH D+KP N L++
Sbjct: 118 ALIKKYEH-------RGIPLIYVKQISKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIV 168
Query: 493 ------MNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGIL 546
+ ++ D G A YD H TN + T Y +PE+ +D+++ L
Sbjct: 169 DSPENLIQIKIADLGNACWYDE----HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACL 224
Query: 547 LLEVATGRRPIGSGDLLLVEWVRECHQLGRILDV 580
+ E+ TG + D + ++ + +I+++
Sbjct: 225 IFELITG-DFLFEPD-EGHSYTKDDDHIAQIIEL 256
|
| >1gv9_A P58/ergic-53; lectin, carbohydrate binding; 1.46A {Rattus norvegicus} SCOP: b.29.1.13 PDB: 1r1z_A 3a4u_A 3lcp_A Length = 260 | Back alignment and structure |
|---|
Score = 68.3 bits (166), Expect = 6e-13
Identities = 38/249 (15%), Positives = 70/249 (28%), Gaps = 32/249 (12%)
Query: 25 SQSSSFIFQGFNGGATNLSLQGAEIIKPSGALKLTNRSRYVIGHAFYVKPIQMFDTSASP 84
S + Q +G + G I + +++ + G +
Sbjct: 35 SFKGPHLVQS-DGTVPFWAHAGNAIPS-ADQIRIAPSLKSQRGSVWTKTKA--------- 83
Query: 85 SPNASSFSTTFVFEISTPRSGRGGHGLAFLLAPSTKLPGAQPEHYLGILNSTNNGEPSNH 144
++ F ++ G GLA + L G +
Sbjct: 84 --AFENWEVEVTFRVTGR-GRIGADGLAIWYTENQGLDG-----------PVFGSADMWN 129
Query: 145 ILIVEFDTVNGFNDKAENQGNHVGIGINTMFSNRSEPASYYINGTDHKEEMTLESGEPIQ 204
+ + FD+ F++ + + + N N + P++
Sbjct: 130 GVGIFFDS---FDNDGKKNNPAIVVVGNNGQINYDHQNDGATQALASCQRDFRNKPYPVR 186
Query: 205 AWIEYDGEQKVLNVTISPAEIGKPMRPLISFGVNLTGYIKETMYVGFSASTGEKSSSHYI 264
A I Y QK L V I+ V I + G SA+TG + H +
Sbjct: 187 AKITYY--QKTLTVMINNGFTPDKNDYEFCAKVE-NMVIPTQGHFGISAATGGLADDHDV 243
Query: 265 LG-WSFSLN 272
L +F L
Sbjct: 244 LSFLTFQLT 252
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 69.5 bits (169), Expect = 7e-13
Identities = 34/251 (13%), Positives = 65/251 (25%), Gaps = 68/251 (27%)
Query: 340 PHRFRYKDLYAATKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKI--------TRNSL 391
P F + T+ + E IG G FG V++ + VA+K I +
Sbjct: 10 PVPFSH---CLPTEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQ 64
Query: 392 QGMREFAAEIESLGRL---------RHKNLVNLHGWC----------------------- 419
+ E EI L R + + L+
Sbjct: 65 KTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGS 124
Query: 420 -------KQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEE 472
+ + L +V E+ G + + +I+ + + L
Sbjct: 125 ANDRPDFFKDDQLFIVLEFEFGGI----DLEQMRTKLSSLATAKSILHQLTASLAVAEAS 180
Query: 473 WEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPELTQTG 532
HRD+ N L+ +L + + + G + T
Sbjct: 181 LR--FEHRDLHWGNVLLKKTSLKKLHYTLNGKSST----------IPSCGLQVSIIDYTL 228
Query: 533 KASTSSDVFAY 543
+ +
Sbjct: 229 SRLERDGIVVF 239
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 65.3 bits (159), Expect = 2e-11
Identities = 28/97 (28%), Positives = 48/97 (49%), Gaps = 5/97 (5%)
Query: 462 IASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLAR-LYDHGGMPHTTNVVGT 520
+A G+ +L + IHRD+ N L+ + ++ DFGLAR +Y +
Sbjct: 202 VAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 258
Query: 521 FGYIAPELTQTGKASTSSDVFAYGILLLEVAT-GRRP 556
++APE + SDV+++G+LL E+ + G P
Sbjct: 259 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 295
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 54.2 bits (130), Expect = 7e-08
Identities = 28/111 (25%), Positives = 47/111 (42%), Gaps = 8/111 (7%)
Query: 359 EVIGIGGFGSVYKGVLPTTGGE-----VAVKKITRN-SLQGMREFAAEIESLGRL-RHKN 411
+ +G G FG V + VAVK + + R +E++ L + H N
Sbjct: 28 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 87
Query: 412 LVNLHGWC-KQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKG 461
+VNL G C K L+++ E+ G+L T L ++ V + +G
Sbjct: 88 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQG 138
|
| >2dur_A VIP36;, vesicular integral-membrane protein VIP36; beta sandwich, carbohydrate binding protein, cargo receptor, transport; HET: MAN; 1.65A {Canis lupus familiaris} PDB: 2dup_A 2duq_A* 2duo_A* 2e6v_A* Length = 253 | Back alignment and structure |
|---|
Score = 59.5 bits (143), Expect = 5e-10
Identities = 41/253 (16%), Positives = 77/253 (30%), Gaps = 40/253 (15%)
Query: 25 SQSSSFI--FQGFNGGAT-NLSLQGAEIIKPSGALKLTNRSRYVIGHAFYVKPIQMFDTS 81
+ S I +QG + QG+ I+ S ++LT R G + +P
Sbjct: 7 KREHSLIKPYQGVGSSSMPLWDFQGSTILT-SQYVRLTPDERSKEGSIWNHQPC------ 59
Query: 82 ASPSPNASSFSTTFVFEISTP-RSGRGGHGLAFLLAPSTKLPGAQPEHYLGILNSTNNGE 140
+ F++ + G G+A +PG +
Sbjct: 60 -----FLKDWEMHVHFKVHGTGKKNLHGDGIALWYTRDRLVPG-----------PVFGSK 103
Query: 141 PSNHILIVEFDTVNGFNDKAENQGNHVGIGIN---TMFSNRSEPASYYINGTDHKEEMTL 197
+ H L + DT ++ E ++ + +N + + + + G
Sbjct: 104 DNFHGLAIFLDTYPN-DETTERVFPYISVMVNNGSLSYDHSKDGRWTELAGCTADF---R 159
Query: 198 ESGEPIQAWIEYDGEQKVLNVTISPAEIGKPMRPLISFGVNLTGYIKETMYVGFSASTGE 257
+ Y + L V + + + GV L Y G SA TG+
Sbjct: 160 NRDHDTFLAVRYS--RGRLTVMTDLEDKNEWKNCIDITGVRL----PTGYYFGASAGTGD 213
Query: 258 KSSSHYILGWSFS 270
S +H I+
Sbjct: 214 LSDNHDIISMKLF 226
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 7e-10
Identities = 57/238 (23%), Positives = 94/238 (39%), Gaps = 42/238 (17%)
Query: 359 EVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHK------NL 412
+VIG G FG V K VA+ K+ RN + R+ A EI L LR + N+
Sbjct: 103 KVIGKGSFGQVVKAYDHKVHQHVAL-KMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNV 161
Query: 413 VNLHGWCKQKNDLLLV--------YEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIAS 464
+++ +N + + YE I F+ I
Sbjct: 162 IHMLENFTFRNHICMTFELLSMNLYELIKKNK-----FQG-----FSLPLVRKFAHSILQ 211
Query: 465 GLLYLHEEWEQVVIHRDVKPSNALIDAEMNA--RLGDFGLARLYDHGGMPHTTNVVGTFG 522
L LH + +IH D+KP N L+ + + ++ DFG + T + F
Sbjct: 212 CLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQ---RVYTYIQSRF- 264
Query: 523 YIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDV 580
Y APE+ + D+++ G +L E+ TG P+ G+ E QL ++++
Sbjct: 265 YRAPEVILGARYGMPIDMWSLGCILAELLTG-YPLLPGE-------DEGDQLACMIEL 314
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 9e-10
Identities = 59/232 (25%), Positives = 101/232 (43%), Gaps = 28/232 (12%)
Query: 359 EVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFA-AEIESLGRLRH------KN 411
+IG G FG V K VA+ KI +N + A E+ L +
Sbjct: 60 SLIGKGSFGQVVKAYDRVEQEWVAI-KIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYY 117
Query: 412 LVNLHGWCKQKNDLLLVYEYIPNGSLDTLLFK-PKDGSVLDWEQRFNIVKGIASGLLYLH 470
+V+L +N L LV+E + + +L LL G L+ ++F + + + LL+L
Sbjct: 118 IVHLKRHFMFRNHLCLVFEML-SYNLYDLLRNTNFRGVSLNLTRKF--AQQMCTALLFLA 174
Query: 471 EEWEQVVIHRDVKPSNALIDAEMNA--RLGDFGLARLYDHGGMPHTTNVVGTFGYIAPEL 528
E +IH D+KP N L+ + ++ DFG + + F Y +PE+
Sbjct: 175 TP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQ---RIYQYIQSRF-YRSPEV 229
Query: 529 TQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDV 580
+ D+++ G +L+E+ TG P+ SG E Q+ +I++V
Sbjct: 230 LLGMPYDLAIDMWSLGCILVEMHTG-EPLFSGA-------NEVDQMNKIVEV 273
|
| >2ltn_B PEA lectin, beta chain; 1.70A {Pisum sativum} SCOP: b.29.1.1 PDB: 1hkd_B 1rin_B* 1ofs_B* 1bqp_B* 1loe_B 1loa_B* 1loc_B* 1lod_B* 1lob_B 1lof_B* 1log_B* 1lof_D* 1les_B* 2b7y_B* 1lgc_B* 1lgb_B* 1len_B 1lem_B 2lal_B Length = 52 | Back alignment and structure |
|---|
Score = 52.1 bits (125), Expect = 3e-09
Identities = 15/38 (39%), Positives = 25/38 (65%)
Query: 233 ISFGVNLTGYIKETMYVGFSASTGEKSSSHYILGWSFS 270
+S V+L + E + +GFSA+TG + ++H +L WSF
Sbjct: 6 LSDVVSLKDVVPEWVRIGFSATTGAEYAAHEVLSWSFH 43
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 8e-09
Identities = 49/190 (25%), Positives = 73/190 (38%), Gaps = 38/190 (20%)
Query: 355 FKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVN 414
F+ + IG G FG + G T VA+K S +K L +
Sbjct: 11 FRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRF-------YKQLGS 63
Query: 415 LHGWCKQKNDLLLVYEYIPNGSLDTL---LFKPKDGSVLDW-EQRFNI--VKGIASGLL- 467
G + VY + P G + + L P + D ++ F++ V IA L+
Sbjct: 64 GDGIPQ-------VYYFGPCGKYNAMVLELLGPSLEDLFDLCDRTFSLKTVLMIAIQLIS 116
Query: 468 ---YLHEEWEQVVIHRDVKPSNALIDAEMNAR-----LGDFGLARLY-DHGGMPH----- 513
Y+H + +I+RDVKP N LI N + DF LA+ Y D H
Sbjct: 117 RMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYRE 173
Query: 514 TTNVVGTFGY 523
++ GT Y
Sbjct: 174 HKSLTGTARY 183
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 54.6 bits (131), Expect = 6e-08
Identities = 46/186 (24%), Positives = 76/186 (40%), Gaps = 32/186 (17%)
Query: 355 FKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLV- 413
F+ IG G FG +Y G T EVA+K + + E + L+ +
Sbjct: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLY--ESKIYRILQGGTGIP 66
Query: 414 NLHGWCKQKNDLLLVYEYIPNG-SLDTLL------FKPKDGSVLDWEQRFNIVKGIASGL 466
N+ + + + +LV + + G SL+ L K +VL + + + +
Sbjct: 67 NVRWFGVEGDYNVLVMDLL--GPSLEDLFNFCSRKLSLK--TVL------MLADQMINRV 116
Query: 467 LYLHEEWEQVVIHRDVKPSNALIDAEMNAR---LGDFGLARLY-DHGGMPH-----TTNV 517
++H + +HRD+KP N L+ A + DFGLA+ Y D H N+
Sbjct: 117 EFVHS---KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNL 173
Query: 518 VGTFGY 523
GT Y
Sbjct: 174 TGTARY 179
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 7e-08
Identities = 47/186 (25%), Positives = 73/186 (39%), Gaps = 32/186 (17%)
Query: 355 FKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLV- 413
++ IG G FG +Y G G EVA+K + E + ++ +
Sbjct: 11 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHI--ESKIYKMMQGGVGIP 68
Query: 414 NLHGWCKQKNDLLLVYEYIPNG-SLDTLL------FKPKDGSVLDWEQRFNIVKGIASGL 466
+ + + ++V E + G SL+ L F K +VL + + S +
Sbjct: 69 TIRWCGAEGDYNVMVMELL--GPSLEDLFNFCSRKFSLK--TVL------LLADQMISRI 118
Query: 467 LYLHEEWEQVVIHRDVKPSNALIDAEMNA---RLGDFGLARLY-DHGGMPH-----TTNV 517
Y+H + IHRDVKP N L+ + DFGLA+ Y D H N+
Sbjct: 119 EYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNL 175
Query: 518 VGTFGY 523
GT Y
Sbjct: 176 TGTARY 181
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 54.1 bits (130), Expect = 7e-08
Identities = 55/301 (18%), Positives = 102/301 (33%), Gaps = 76/301 (25%)
Query: 319 FFLIYRKWSNSETLEDWEKDCPHRFRYKDLYAATKGFKESEVIGIGGFGSVYKGVLPTTG 378
++ E D+ K H + DL+ + +G G F +V+
Sbjct: 5 EEILGSDDDEQEDPNDYCKGGYHLVKIGDLFNGR--YHVIRKLGWGHFSTVWLSWDIQGK 62
Query: 379 GEVAVKKITRNSLQGMREFAA-EIESLGRLRHKNLVNL-HGWCKQKNDLLLVYEYI-PNG 435
VA+K + +++ + E A EI L +R+ + + Q LL ++ NG
Sbjct: 63 KFVAMK-VVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQ---LLDDFKISGVNG 117
Query: 436 SLDTLLFKPKDGSVLDWEQRFN-----------IVKGIASGLLYLHEEWEQVVIHRDVKP 484
+ ++F+ +L W + N I++ + GL YLH + +IH D+KP
Sbjct: 118 THICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCR--IIHTDIKP 175
Query: 485 SNALIDAE-------------------------------------------------MNA 495
N L+ +
Sbjct: 176 ENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKV 235
Query: 496 RLGDFGLARLYDHGGMPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRR 555
++ D G A H T + T Y + E+ +T +D+++ + E+ATG
Sbjct: 236 KIADLGNACWVHK----HFTEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDY 291
Query: 556 P 556
Sbjct: 292 L 292
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 1e-07
Identities = 46/190 (24%), Positives = 72/190 (37%), Gaps = 38/190 (20%)
Query: 355 FKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVN 414
+K IG G FG +++G +VA+K R S +K L
Sbjct: 12 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRT-------YKLLAG 64
Query: 415 LHGWCKQKNDLLLVYEYIPNGSLDTL---LFKPKDGSVLDW-EQRFNI--VKGIASGLL- 467
G VY + G + L L P +LD ++F++ V A +L
Sbjct: 65 CTGIPN-------VYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLA 117
Query: 468 ---YLHEEWEQVVIHRDVKPSNALIDAEMNAR-----LGDFGLARLY-DHGGMPH----- 513
+HE + +++RD+KP N LI + + DFG+ + Y D H
Sbjct: 118 RVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYRE 174
Query: 514 TTNVVGTFGY 523
N+ GT Y
Sbjct: 175 KKNLSGTARY 184
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 1e-07
Identities = 35/174 (20%), Positives = 62/174 (35%), Gaps = 31/174 (17%)
Query: 355 FKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVN 414
+ + IG GGFG +Y + A + + F+ E++ R+ K+ +
Sbjct: 39 WVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFS-ELKFYQRVAKKDCIK 97
Query: 415 LHGWCKQKNDLLLVYEYIPN----GSLDTL----------LFKPKDGSVLDWEQRFNI-- 458
W ++K L Y IP G + + F
Sbjct: 98 K--WIERKQ---LDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKKST 152
Query: 459 VKGIASGLL----YLHEEWEQVVIHRDVKPSNALIDAEMNAR--LGDFGLARLY 506
V + +L Y+HE +H D+K +N L+ + + L D+GL+ Y
Sbjct: 153 VLQLGIRMLDVLEYIHE---NEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRY 203
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 52.1 bits (125), Expect = 3e-07
Identities = 38/183 (20%), Positives = 62/183 (33%), Gaps = 43/183 (23%)
Query: 361 IGIGGFGSVYKGVLPT-----TGGEVAVKKITRNSLQGMREF-----AAEIESLGRLRHK 410
IG GGFG +Y + + + VK ++ E AA+ E + +
Sbjct: 43 IGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRT 102
Query: 411 NLVNLHG-----WCKQKNDLLLVYEYI------PNGSLDTLL------FKPKDGSVLDWE 453
+ G + Y ++ L + F K +VL
Sbjct: 103 RKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGS--DLQKIYEANAKRFSRK--TVL--- 155
Query: 454 QRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNAR--LGDFGLARLY-DHGG 510
+ I L Y+HE +H D+K SN L++ + + L D+GLA Y G
Sbjct: 156 ---QLSLRILDILEYIHE---HEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGV 209
Query: 511 MPH 513
Sbjct: 210 HKA 212
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 49.4 bits (118), Expect = 2e-06
Identities = 28/169 (16%), Positives = 55/169 (32%), Gaps = 30/169 (17%)
Query: 361 IGIGGFGSVYKGVLPTTGG--------EVAVKKITRNSLQGMREF--------AAEIESL 404
G +Y+ +T + ++K ++ + E ++
Sbjct: 50 QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDG-RLFNEQNFFQRAAKPLQVNKW 108
Query: 405 GRLRHKNLV---NLHGWCKQKNDL-LLVYEYIPNG-SLDTLLFKPKDGSVLDWEQRFNIV 459
+L L+ G+ ++ LV + G SL + VL +
Sbjct: 109 KKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL--GRSLQSA-LDVSPKHVLSERSVLQVA 165
Query: 460 KGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNAR--LGDFGLARLY 506
+ L +LHE +H +V N +D E ++ L +G A Y
Sbjct: 166 CRLLDALEFLHE---NEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRY 211
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 49.9 bits (118), Expect = 2e-06
Identities = 81/584 (13%), Positives = 175/584 (29%), Gaps = 164/584 (28%)
Query: 113 FLLAP---STKLPGAQPEHYLGILNSTNNGEPSNHIL----IVEFDTVNGFNDKAENQGN 165
FL++P + P Y+ + N N + +
Sbjct: 93 FLMSPIKTEQRQPSMMTRMYIEQRDRLYND---NQVFAKYNVSRLQPYLKLRQALLELRP 149
Query: 166 HVGIGINTMF-------------SNRSEPAS----YYIN-GTDHKEEMTLESGEPIQAWI 207
+ I+ + S + + +++N + E LE + + I
Sbjct: 150 AKNVLIDGVLGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQI 209
Query: 208 EYDGEQKV---LNVTISPAEIGKPMRPLI----------------------SFGVN---- 238
+ + + N+ + I +R L+ +F ++
Sbjct: 210 DPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKIL 269
Query: 239 -LTGYIKETMYVGFSASTGEKSSSHYILGWSF--SLNGVAPALNVS--ELPKPPKEKEPS 293
T + + T ++ +A+T S H+ + + + + L+ +LP+ E
Sbjct: 270 LTTRFKQVTDFLS-AATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPR-----EVL 323
Query: 294 SYNPKILALIVSLCLVTFLLLGTLVFFLIYRKWSNSETLE---DWEKDCPHRFRYKDLYA 350
+ NP+ L++I L T + + +E + + +R + L
Sbjct: 324 TTNPRRLSIIAESIRD---GLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSV 380
Query: 351 ATKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSL--QGMREFAAEIESLG-RL 407
F S I S+ + + V V K+ + SL + +E I S+ L
Sbjct: 381 ----FPPSAHIPTILL-SLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLEL 435
Query: 408 RHK--NLVNLHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDG----------SVLDWEQR 455
+ K N LH ++ Y D L+ D ++ +R
Sbjct: 436 KVKLENEYALH------RSIVDHYNIPKTFDSDDLIPPYLDQYFYSHIGHHLKNIEHPER 489
Query: 456 FNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTT 515
+ + +++L + + I D NA + L + Y
Sbjct: 490 MTLFR-----MVFLDFRFLEQKIRHDSTAWNA--SGSILNTLQQL---KFYK-------- 531
Query: 516 NVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLG 575
YI +D R + + +++++ +
Sbjct: 532 ------PYI-----------CDND-----------PKYERLVNA----ILDFLPKI---- 555
Query: 576 RILDVADPLLNSSYVVKEMELVLKLGLMCSHKTQFRPTMRQVMR 619
+ L+ S K +L+ ++ LM + F +QV R
Sbjct: 556 -----EENLICS----KYTDLL-RIALMAEDEAIFEEAHKQVQR 589
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 1e-04
Identities = 53/261 (20%), Positives = 86/261 (32%), Gaps = 62/261 (23%)
Query: 359 EVIGIGGFGSVYKGV-LPTTGGEVAVKKITRNSLQGMREFAA-EIESLGRLRHK------ 410
+G G FG V + + +VA+ KI RN + RE A EI L +++ K
Sbjct: 25 GNLGEGTFGKVVECLDHARGKSQVAL-KIIRN-VGKYREAARLEINVLKKIKEKDKENKF 82
Query: 411 NLVNLHGWCKQKNDLLLV--------YEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGI 462
V + W + + +E++ + F+P + + +
Sbjct: 83 LCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENN-----FQPYPLPHV---RHM--AYQL 132
Query: 463 ASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNA-------------------RLGDFGLA 503
L +LHE + H D+KP N L R+ DFG A
Sbjct: 133 CHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSA 189
Query: 504 RLYDHGGMPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLL 563
HTT V Y PE+ + DV++ G +L E G +
Sbjct: 190 TFDHE---HHTTIVATRH-YRPPEVILELGWAQPCDVWSIGCILFEYYRG-FTLFQTH-- 242
Query: 564 LVEWVRECHQLGRILDVADPL 584
L + + P+
Sbjct: 243 -----ENREHLVMMEKILGPI 258
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 1e-04
Identities = 33/148 (22%), Positives = 52/148 (35%), Gaps = 35/148 (23%)
Query: 359 EVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAA-EIESLGRLRH-----KNL 412
+G G FG V AV K+ RN + A E + L ++++ N+
Sbjct: 41 RKMGDGTFGRVLLCQHIDNKKYYAV-KVVRNI-KKYTRSAKIEADILKKIQNDDINNNNI 98
Query: 413 VNLHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFN-----------IVKG 461
V HG + + L++E L S+ + R N
Sbjct: 99 VKYHGKFMYYDHMCLIFE---------PL----GPSLYEIITRNNYNGFHIEDIKLYCIE 145
Query: 462 IASGLLYLHEEWEQVVIHRDVKPSNALI 489
I L YL + + H D+KP N L+
Sbjct: 146 ILKALNYLRKM---SLTHTDLKPENILL 170
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 668 | |||
| 3ujo_A | 281 | Legume lectin; carbohydrate-binding, galactose, ad | 100.0 | |
| 3zyr_A | 261 | Lectin; sugar binding protein, N-glycan; HET: NAG | 100.0 | |
| 3ipv_A | 251 | Lectin alpha chain; galactose binding, SEED lectin | 100.0 | |
| 1dbn_A | 239 | MAL, protein (leukoagglutinin); plant lectin, carb | 100.0 | |
| 1fny_A | 237 | BARK lectin, BARK agglutinin I,polypeptide A; legu | 100.0 | |
| 1qnw_A | 242 | Chitin binding lectin, UEA-II; carbohydrate bindin | 100.0 | |
| 1gzc_A | 239 | Erythrina crista-galli lectin; carbohydrate, sugar | 100.0 | |
| 1fx5_A | 242 | UEA-I, UE-I, anti-H(O) lectin I; legume lectin, HO | 100.0 | |
| 1v6i_A | 232 | Agglutinin, PNA, galactose-binding lectin; open qu | 100.0 | |
| 1hql_A | 257 | Lectin; xenograft antigen, sugar BI protein; HET: | 100.0 | |
| 1sbf_A | 253 | Soybean agglutinin; lectin; HET: NAG GAL; 2.43A {G | 100.0 | |
| 2eig_A | 234 | Lectin; L-fucosyl, N-acetyl-D-glucosamine, SUG bin | 100.0 | |
| 1n47_A | 233 | Isolectin B4; cancer antigen, vicia villosa lectin | 100.0 | |
| 2bqp_A | 234 | Protein (PEA lectin); D-glucopyranose complex, sug | 100.0 | |
| 2fmd_A | 240 | Lectin, agglutinin, BMA; legume lectin, beta sandw | 100.0 | |
| 1wbf_A | 242 | Protein (agglutinin); lectin (agglutinin), legume | 100.0 | |
| 1f9k_A | 238 | Acidic lectin; legume lectin, glycosylated protein | 100.0 | |
| 1fat_A | 252 | Phytohemagglutinin-L; glycoprotein, plant defense | 100.0 | |
| 1g7y_A | 253 | Stem/LEAF lectin DB58; jelly roll fold, sugar bind | 100.0 | |
| 1avb_A | 226 | Arcelin-1; lectin-like glycoprotein, plant defense | 100.0 | |
| 1gsl_A | 243 | Griffonia simplicifolia lectin 4; glycoprotein, ma | 100.0 | |
| 1ioa_A | 240 | Arcelin-5A, ARC5A; lectin-like proteins, plant def | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 1dhk_B | 223 | Bean lectin-like inhibitor, porcine pancreatic alp | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 2ltn_A | 181 | PEA lectin, alpha chain; 1.70A {Pisum sativum} SCO | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2dur_A | 253 | VIP36;, vesicular integral-membrane protein VIP36; | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 1qmo_E | 133 | Mannose binding lectin, FRIL; crosslink, hematopoi | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 1gv9_A | 260 | P58/ergic-53; lectin, carbohydrate binding; 1.46A | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 1nls_A | 237 | Concanavalin A; lectin, agglutinin; 0.94A {Canaval | 99.97 | |
| 1qmo_A | 113 | Mannose binding lectin, FRIL; crosslink, hematopoi | 99.95 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.95 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.92 | |
| 2a6y_A | 256 | EMP47P (FORM1); beta sandwich, carbohydrate bindin | 99.91 | |
| 1nls_A | 237 | Concanavalin A; lectin, agglutinin; 0.94A {Canaval | 99.9 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.88 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.78 | |
| 2a6z_A | 222 | EMP47P (FORM2); beta sandwich, carbohydrate bindin | 99.73 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.62 | |
| 2a6v_A | 226 | EMP46P; beta sandwich, carbohydrate binding protei | 99.47 | |
| 2ltn_B | 52 | PEA lectin, beta chain; 1.70A {Pisum sativum} SCOP | 99.36 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.27 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.1 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.97 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.87 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.54 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.41 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.35 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.35 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.21 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.15 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.98 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.85 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.67 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.66 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.39 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.2 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.01 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.84 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.84 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.83 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.69 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.64 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.51 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 95.93 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.51 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 95.21 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 94.65 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 92.13 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 82.66 |
| >3ujo_A Legume lectin; carbohydrate-binding, galactose, adenine binding protein; HET: ADE GAL; 2.00A {Dolichos lablab} PDB: 3ujq_A* 3uk9_A* 3ul2_A* 1fat_A* 1g8w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-61 Score=483.99 Aligned_cols=234 Identities=32% Similarity=0.540 Sum_probs=202.5
Q ss_pred HHHHHHhhccCCceeEEeCCCCCCCCCeEEeCceeeCCCCcEEccCCCCc------eEEEEEeeCceecccCCCCCCCCe
Q 005940 15 FFIRLNIVAQSQSSSFIFQGFNGGATNLSLQGAEIIKPSGALKLTNRSRY------VIGHAFYVKPIQMFDTSASPSPNA 88 (668)
Q Consensus 15 ~~~~~~~~~~~~~~~f~~~~f~~~~~~l~~~g~a~~~~~~~~~lt~~~~~------~~G~~~y~~p~~l~~~~~~~~~~~ 88 (668)
|++++..+.++..++|+|++|.. .||+|+|+|.+. +|.|+||+.... ++|||+|++||+||| +.++++
T Consensus 14 fl~l~~~~~sa~~~sF~f~~F~~--~nL~l~GdA~i~-~g~L~LT~~~~~~~p~~~s~Gra~Y~~Pi~l~d---~~tg~v 87 (281)
T 3ujo_A 14 FLILLTKAASANLISFTFKKFNE--TNLILQRDATVS-SGKLRITKAAENGVPTAGSLGRAFYSTPIQIWD---NTTGTV 87 (281)
T ss_dssp ----------CEEEEEEESSCCS--TTEEECSSCCCB-TTBEECSCCCSSCCCCSSCEEEEEESSCEECBC---SSSCCB
T ss_pred HHHHHcccCcCCcceEEcCCCCc--cCEEEecceEEe-CCEEEeCCCCCCCcccCCceEEEEECCCEEccc---CCCCCc
Confidence 33445555666889999999985 899999999997 999999998765 899999999999999 889999
Q ss_pred eeeEEEEEEEEeCCCCCCCCCceEEEEcCCCCCCCCCCCCcccccccCCCCCCCccEEEEEeecccCCCCCCCCCCCeee
Q 005940 89 SSFSTTFVFEISTPRSGRGGHGLAFLLAPSTKLPGAQPEHYLGILNSTNNGEPSNHILIVEFDTVNGFNDKAENQGNHVG 168 (668)
Q Consensus 89 ~sF~t~F~f~i~~~~~~~~g~GlaF~l~p~~~~~~~~~~~~lGl~~~~~~~~~~~~~~aVEfDt~~n~~d~~~~~~~Hvg 168 (668)
+||+|+|+|.|.+++...+||||||||+|....|+ +.||||||+|.+++ ++++|+|||||||++| ..|||++||||
T Consensus 88 aSFsTsFsF~I~~~~~~~~gdGlAF~laP~~~~p~-~~gg~LGL~n~~~~-~~~n~~vAVEFDT~~N--~e~Dp~~nHVG 163 (281)
T 3ujo_A 88 ASWATSFTFNLQAPNAASPADGLAFALVPVGSQPK-DKGGFLGLFDSKNY-ASSNQTVAVEFDTFYN--GGWDPTERHIG 163 (281)
T ss_dssp EEEEEEEEEECCCSSTTSCCEEEEEEEEETTCCCC-CCGGGTTTCSCSSC-CTTSCCEEEEECCSCC--CSSCCSSSEEE
T ss_pred eeEEEEEEEEEecCCCCCCCCceEEEEecCCCCCC-CCcceeeeccccCC-CccCcEEEEEEecccc--ccCCCCCCeEE
Confidence 99999999999988777899999999999876554 67999999998776 7789999999999998 12349999999
Q ss_pred eecCCcccccccCCccccCCCCCccccccCCCCcEEEEEEEeCCcceEEEEEEeCCCCCCCCcceeeeecccccccccee
Q 005940 169 IGINTMFSNRSEPASYYINGTDHKEEMTLESGEPIQAWIEYDGEQKVLNVTISPAEIGKPMRPLISFGVNLTGYIKETMY 248 (668)
Q Consensus 169 id~~s~~s~~~~~~~~~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~V~~~~~~~~~p~~~~ls~~~dLs~~l~~~~~ 248 (668)
|||||+.|.+++++ .+.+|+.++|||+||+.+++|+|++++.+. |.+|+|++.+||+++|+|+||
T Consensus 164 IDvNSi~S~~t~~~-------------~l~~G~~~~vwI~Yd~~tk~L~V~l~~~~~--~~~~~lS~~vDL~~~L~e~v~ 228 (281)
T 3ujo_A 164 IDVNSIKSIKTTSW-------------DFANGENAEVLITYDSSTNLLVASLVHPSQ--KTSFIVSERVDLTSVLPEWVS 228 (281)
T ss_dssp EEESSSCCSCEEEC-------------CCCSSCCEEEEEEECTTTCEEEEEEECTTT--CCCEEEEEECCSTTTSCSEEE
T ss_pred EEcCCCCccccccc-------------cccCCCEEEEEEEEeCCCCEEEEEEecCCC--CCCceEEEEechHHhccCcEE
Confidence 99999999988764 356899999999999999999999998764 558899999999999999999
Q ss_pred eeeecccCC---cccceeeecccccccC
Q 005940 249 VGFSASTGE---KSSSHYILGWSFSLNG 273 (668)
Q Consensus 249 vGFsastG~---~~~~~~i~~w~F~~~~ 273 (668)
|||||+||. ..|.|+|++|+|++..
T Consensus 229 VGFSAsTG~~~~~~e~H~IlsWSFss~l 256 (281)
T 3ujo_A 229 VGFSATTGLSKGYVETNEVLSWSFASKL 256 (281)
T ss_dssp EEEEEEECSSTTSCCCCEEEEEEEEEEE
T ss_pred EEEEeecCCCCcccceeEEEEEEEEEEc
Confidence 999999996 5899999999999753
|
| >3zyr_A Lectin; sugar binding protein, N-glycan; HET: NAG BMA MAN GOL; 1.65A {Platypodium elegans} SCOP: b.29.1.1 PDB: 3zvx_A* 1ukg_A* 1q8o_A* 1q8q_A* 1q8s_A* 1q8v_A* 1q8p_A* 2auy_A* 2gme_A 2gmm_A* 2gmp_A* 2gn3_A* 2gn7_A* 2gnb_A* 2gnd_A* 2gnm_A* 2gnt_A 2phf_A* 2phr_A* 2pht_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-60 Score=475.56 Aligned_cols=233 Identities=27% Similarity=0.467 Sum_probs=205.3
Q ss_pred HHhhccCCceeEEeCCCCCCCCCeEEeCceeeCCCCcEEccCCCC------ceEEEEEeeCceecccCCCCCCCCeeeeE
Q 005940 19 LNIVAQSQSSSFIFQGFNGGATNLSLQGAEIIKPSGALKLTNRSR------YVIGHAFYVKPIQMFDTSASPSPNASSFS 92 (668)
Q Consensus 19 ~~~~~~~~~~~f~~~~f~~~~~~l~~~g~a~~~~~~~~~lt~~~~------~~~G~~~y~~p~~l~~~~~~~~~~~~sF~ 92 (668)
+..+.++..++|+|++|.+++.||+|+|+|.+.++|.|+||+... +++|||+|++||+||| +.+++++||+
T Consensus 3 ~~~~~sa~~~sF~f~~F~~~~~~l~l~GdA~i~~~g~L~LT~~~~~~~~~~~s~Gra~Y~~Pv~l~d---~~tg~vaSFs 79 (261)
T 3zyr_A 3 LNRANSTDSLSFSFINFDRDERNLIFQGDAHTSRNNILQLTRTDSNGAPVRSTVGRILHSAQVRLWE---KSTNRVANLQ 79 (261)
T ss_dssp -----CCEEEEEEESSCCSCCTTEEEEETCEECTTSCEECSCBCTTSCBCSSEEEEEEESSCEECBC---TTTCCBEEEE
T ss_pred ccccCcCcccEEEcCCCCCCCCCeEEeccEEecCCCeEEeCCCCCCCccccCCEEEEEECCCEEeec---CCCCCceeEE
Confidence 334556678999999999766899999999997789999998765 7999999999999999 8899999999
Q ss_pred EEEEEEEeCCCCCCCCCceEEEEcCCCC-CCCCCCCCcccccccCCCCC-CCccEEEEEeecc---cCCCCCCCCCCCee
Q 005940 93 TTFVFEISTPRSGRGGHGLAFLLAPSTK-LPGAQPEHYLGILNSTNNGE-PSNHILIVEFDTV---NGFNDKAENQGNHV 167 (668)
Q Consensus 93 t~F~f~i~~~~~~~~g~GlaF~l~p~~~-~~~~~~~~~lGl~~~~~~~~-~~~~~~aVEfDt~---~n~~d~~~~~~~Hv 167 (668)
|+|+|.|.++ ...+||||||||+|... +|.+++||||||+|.+++++ ..||+|||||||+ +| ..|||++|||
T Consensus 80 T~F~F~I~~~-~~~~gdGlAF~lap~~~~~p~~~~g~~LGL~n~~~~g~~~~n~~vAVEFDT~~~~~n--~~~Dp~~nHV 156 (261)
T 3zyr_A 80 TQFSFFLSSP-LSNPADGIAFFIAPPDTTIPSGSAGGLLGLFNPRTALNESANQVLAVEFDTFFAQNS--NTWDPNYQHI 156 (261)
T ss_dssp EEEEEEEECS-SSSCCCEEEEEEECTTCCCCTTCCGGGTTTCCTTTTTCGGGCCCEEEEEECCCCTTT--CTTSCSSCEE
T ss_pred EEEEEEEecC-CCCCCccEEEEEccCCCCCCCCCCCceeeeecccccCCCccCcEEEEEEeccccccC--cCCCCCCCeE
Confidence 9999999987 67789999999999864 58889999999999887754 4689999999999 77 2245999999
Q ss_pred eeecCCcccccccCCccccCCCCCccccccCCCCcEEEEEEEeCCcceEEEEEEeCCCCCCCCcceeeeeccccccccce
Q 005940 168 GIGINTMFSNRSEPASYYINGTDHKEEMTLESGEPIQAWIEYDGEQKVLNVTISPAEIGKPMRPLISFGVNLTGYIKETM 247 (668)
Q Consensus 168 gid~~s~~s~~~~~~~~~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~V~~~~~~~~~p~~~~ls~~~dLs~~l~~~~ 247 (668)
||||||+.|.+++++ .+.+|+.++|||+||+..++|+|+|++.+. ..|+|++.+||+++|+|+|
T Consensus 157 GIdvNsi~S~~s~~~-------------~l~~G~~~~v~I~Yd~~~~~L~V~l~~~~~---~~~~ls~~vdL~~~l~e~v 220 (261)
T 3zyr_A 157 GIDVNSIRSSKVVRW-------------ERREGKTLNVLVTYNPSTRTIDVVATYPDG---QRYQLSHVVDLTTILPEWV 220 (261)
T ss_dssp EEEESSSSCSEEEEC-------------CCCTTCCEEEEEEEETTTTEEEEEEECTTC---CEEEEEEECCGGGTSCSEE
T ss_pred EEEcCCCCccccccc-------------cccCCceEEEEEEEcCCCCEEEEEEEcCCC---CCeEEEEEechHHhCcCcE
Confidence 999999999988764 456899999999999999999999998652 3889999999999999999
Q ss_pred eeeeecccCCcccceeeecccccccC
Q 005940 248 YVGFSASTGEKSSSHYILGWSFSLNG 273 (668)
Q Consensus 248 ~vGFsastG~~~~~~~i~~w~F~~~~ 273 (668)
||||||+||...|.|+|++|+|++..
T Consensus 221 ~VGFSAsTG~~~e~h~IlsWsF~s~l 246 (261)
T 3zyr_A 221 RVGFSAASGEQFQTHNLESWSFTSTL 246 (261)
T ss_dssp EEEEEEEESSSCCEEEEEEEEEEEEE
T ss_pred EEEEEecCCCccceEEEEEEEEEEEc
Confidence 99999999999999999999999753
|
| >3ipv_A Lectin alpha chain; galactose binding, SEED lectin, hemagglutinin, legume lectin fungal, sugar binding protein; 2.04A {Spatholobus parviflorus} PDB: 3ipv_B 3usu_B* 3usu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-60 Score=473.47 Aligned_cols=225 Identities=32% Similarity=0.529 Sum_probs=203.9
Q ss_pred CceeEEeCCCCCCCCCeEEeCceeeCCCCcEEccCCCCc------eEEEEEeeCceecccCCCCCCCCeeeeEEEEEEEE
Q 005940 26 QSSSFIFQGFNGGATNLSLQGAEIIKPSGALKLTNRSRY------VIGHAFYVKPIQMFDTSASPSPNASSFSTTFVFEI 99 (668)
Q Consensus 26 ~~~~f~~~~f~~~~~~l~~~g~a~~~~~~~~~lt~~~~~------~~G~~~y~~p~~l~~~~~~~~~~~~sF~t~F~f~i 99 (668)
..++|+|++|.++..||+|+|+|.+.++|.|+||+...+ ++|||+|++||+||+ +.+++++||+|+|+|.|
T Consensus 2 ~~~sF~f~~F~~~~~nl~l~GdA~v~~~g~L~LT~~~~~~~~~~~s~Gra~Y~~Pi~l~d---~~tg~vaSFsT~F~F~I 78 (251)
T 3ipv_A 2 EETSFVFSKFKPLEPNLILQGDALVTVAGVLQLTNVDKNGVPEPSSLGRATYSAPINIWD---SATGLVASFATSFRFTI 78 (251)
T ss_dssp EEEEEEESSCCSSCTTEEEEETCEECTTSCEESSCBCTTSCBCSSCEEEEEESSCEECBC---TTTCCBCEEEEEEEEEC
T ss_pred cceEEEeCCCCCCCCCeEEeccEEecCCCeEEcCCCCCCCcccCCcEEEEEECCCEEeec---CCCCceeeEEEEEEEEE
Confidence 468999999997668999999999977999999997765 899999999999999 88999999999999999
Q ss_pred eCCCCCCCCCceEEEEcCCCCCCCCCCCCcccccccCCCCCCCccEEEEEeecccC--CCCCCCCCCCeeeeecCCcccc
Q 005940 100 STPRSGRGGHGLAFLLAPSTKLPGAQPEHYLGILNSTNNGEPSNHILIVEFDTVNG--FNDKAENQGNHVGIGINTMFSN 177 (668)
Q Consensus 100 ~~~~~~~~g~GlaF~l~p~~~~~~~~~~~~lGl~~~~~~~~~~~~~~aVEfDt~~n--~~d~~~~~~~Hvgid~~s~~s~ 177 (668)
.+++...+||||||||+|....|+ ..||||||+|.+++ +..||+|||||||++| ++| |++|||||||||+.|.
T Consensus 79 ~~~~~~~~gdGlAF~lap~~~~~~-~~gg~LGL~n~~~~-~~~n~~vAVEFDT~~n~~~~D---p~~nHVGIdvNsi~S~ 153 (251)
T 3ipv_A 79 YAPNIATIADGLAFFLAPVASAPD-SGGGFLGLFDSAVS-GSTYQTVAVEFDTYENTVFTD---PPYTHIGFDVNSISSI 153 (251)
T ss_dssp CCSSTTSCCEEEEEEEEETTCCCC-CCGGGTTTCSSSSC-CTTSCCEEEEEECSCCGGGTC---CSSCEEEEEESSSSCS
T ss_pred eCCCCCCCCCceEEEEecCCCCCC-CCCceeeeccccCC-CccCcEEEEEEecccccccCC---CCCCeEEEEcCCCccc
Confidence 988778899999999999876555 57999999998776 7789999999999998 335 9999999999999999
Q ss_pred cccCCccccCCCCCccccccCCCCcEEEEEEEeCCcceEEEEEEeCCCCCCCCcceeeeeccccccccceeeeeecccCC
Q 005940 178 RSEPASYYINGTDHKEEMTLESGEPIQAWIEYDGEQKVLNVTISPAEIGKPMRPLISFGVNLTGYIKETMYVGFSASTGE 257 (668)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~V~~~~~~~~~p~~~~ls~~~dLs~~l~~~~~vGFsastG~ 257 (668)
+++++ .+.+|+.++|||+||+..++|+|+|++.+. |..|+|++.+||+++|+|+|||||||+||.
T Consensus 154 ~t~~~-------------~l~~G~~~~v~I~Yd~~tk~L~V~l~~~~~--~~~~~ls~~vdL~~~l~e~v~VGFSAsTG~ 218 (251)
T 3ipv_A 154 KTVKW-------------SLANGEAAKVLITYNSAVKLLVASLVYPSS--KTSFILADIVDLSSVLPEWVRVGFSAATGA 218 (251)
T ss_dssp EEEEC-------------CCCTTCEEEEEEEEETTTTEEEEEEECTTT--CCEEEEEEECCHHHHSCSEEEEEEEEEECS
T ss_pred cccee-------------EecCCCEEEEEEEEeCCCCEEEEEEecCCC--CccceEEEEechHHhCCCcEEEEEEEecCC
Confidence 88763 467899999999999999999999998664 567899999999999999999999999999
Q ss_pred c---ccceeeecccccccC
Q 005940 258 K---SSSHYILGWSFSLNG 273 (668)
Q Consensus 258 ~---~~~~~i~~w~F~~~~ 273 (668)
. .|.|+|++|+|++..
T Consensus 219 ~~~~~e~h~IlsWsF~s~l 237 (251)
T 3ipv_A 219 SGGKIETHDVFSWSFASKL 237 (251)
T ss_dssp STTCCCCCEEEEEEEEEEE
T ss_pred CccccceeEEEEEEEEEEC
Confidence 8 999999999999753
|
| >1dbn_A MAL, protein (leukoagglutinin); plant lectin, carbohydrate binding, sialyllactose, sugar BIN protein; HET: NAG SIA GAL BGC; 2.75A {Maackia amurensis} SCOP: b.29.1.1 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-59 Score=463.57 Aligned_cols=227 Identities=30% Similarity=0.511 Sum_probs=204.6
Q ss_pred CceeEEeCCCCCCCCCeEEeCceeeCCCCcEEccCCC-----CceEEEEEeeCceecccCCCCCCCCeeeeEEEEEEEEe
Q 005940 26 QSSSFIFQGFNGGATNLSLQGAEIIKPSGALKLTNRS-----RYVIGHAFYVKPIQMFDTSASPSPNASSFSTTFVFEIS 100 (668)
Q Consensus 26 ~~~~f~~~~f~~~~~~l~~~g~a~~~~~~~~~lt~~~-----~~~~G~~~y~~p~~l~~~~~~~~~~~~sF~t~F~f~i~ 100 (668)
.+++|+|++|.++..||+|+|+|.+.++|.|+||++. .++.|||+|++||+||+ +.+++++||+|+|+|.|.
T Consensus 2 ~~~~F~f~~F~~~~~~l~l~G~A~v~~~g~l~LT~~~~~~~~~~~~Gra~y~~Pi~l~~---~~tg~vaSFsT~F~F~I~ 78 (239)
T 1dbn_A 2 DELSFTINNFVPNEADLLFQGEASVSSTGVLQLTKVENGQPQKYSVGRALYAAPVRIWG---NTTGSVASFSTSFTFVVK 78 (239)
T ss_dssp CEEEEEESSCCTTCTTEEEEETCEECTTSCEESSCEETTEECSSCEEEEEESSCEECBC---TTTCCBCEEEEEEEEECC
T ss_pred cceEEEcCCCCCCCCCeEEcccEEecCCCcEEeCCCCCCCcccCceEEEEeCCCEeccc---CCCCCccceEEEEEEEEe
Confidence 4689999999976689999999999878999999876 68999999999999999 889999999999999999
Q ss_pred CCCCCCCCCceEEEEcCCCC-CCCCCCCCcccccccCCCCCCCccEEEEEeecccCC--CCCCCCCCCeeeeecCCcccc
Q 005940 101 TPRSGRGGHGLAFLLAPSTK-LPGAQPEHYLGILNSTNNGEPSNHILIVEFDTVNGF--NDKAENQGNHVGIGINTMFSN 177 (668)
Q Consensus 101 ~~~~~~~g~GlaF~l~p~~~-~~~~~~~~~lGl~~~~~~~~~~~~~~aVEfDt~~n~--~d~~~~~~~Hvgid~~s~~s~ 177 (668)
+++...+||||||||+|... +|.++.|+||||+|.++ ++..+|+|||||||++|. .+ +||++||||||+||+.|.
T Consensus 79 ~~~~~~~gdGlAF~l~p~~~~~p~~~~g~~LGl~n~~~-~~~~~~~vAVEFDT~~n~~~~~-~Dp~~nHVGIdvNs~~S~ 156 (239)
T 1dbn_A 79 APNPDITSDGLAFYLAPPDSQIPSGSVSKYLGLFNNSN-SDSSNQIVAVEFDTYFAHSYDP-WDPNYRHIGIDVNGIESI 156 (239)
T ss_dssp CSSTTSCCEEEEEEEECTTCCCCSSSCGGGTTSCSSSC-CCTTSCCEEEEEECCCCTTTCT-TSCSSCEEEEEESSSSCS
T ss_pred CCCCCCCCCCEEEEEecCCCCCCcCCCCCcccccccCC-CCccccEEEEEEeccccCcccc-cCCCCCcEEEecCCcccc
Confidence 88777889999999999875 68889999999999764 477899999999999981 12 569999999999999998
Q ss_pred cccCCccccCCCCCccccccCCCCcEEEEEEEeCCcceEEEEEEeCCCCCCCCcceeeeeccccccccceeeeeecccCC
Q 005940 178 RSEPASYYINGTDHKEEMTLESGEPIQAWIEYDGEQKVLNVTISPAEIGKPMRPLISFGVNLTGYIKETMYVGFSASTGE 257 (668)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~V~~~~~~~~~p~~~~ls~~~dLs~~l~~~~~vGFsastG~ 257 (668)
+++++ +|.+|+.++|||+||+.+++|+|+|++.+. |..|+|++.+||+++|+|+|||||||+||.
T Consensus 157 ~~~~~-------------~l~~g~~~~v~I~Yd~~~~~L~V~l~~~~~--~~~~~ls~~vdL~~~l~e~v~VGFSAsTG~ 221 (239)
T 1dbn_A 157 KTVQW-------------DWINGGVAFATITYLAPNKTLIASLVYPSN--QTTFSVAASVDLKEILPEWVRVGFSAATGY 221 (239)
T ss_dssp EEEEC-------------CCCTTCCEEEEEEEEGGGTEEEEEEEETTT--TEEEEEEEECCHHHHSCSEEEEEEEEEECS
T ss_pred ceEcc-------------cccCCCEEEEEEEEeCCCcEEEEEEccCCC--CCcceEEEEechHHhCCccEEEEEEeccCC
Confidence 88763 477999999999999999999999998754 567899999999999999999999999999
Q ss_pred c--ccceeeeccccccc
Q 005940 258 K--SSSHYILGWSFSLN 272 (668)
Q Consensus 258 ~--~~~~~i~~w~F~~~ 272 (668)
. .|.|+|++|+|+++
T Consensus 222 ~~~~~~h~IlsWsF~s~ 238 (239)
T 1dbn_A 222 PTEVETHDVLSWSFTST 238 (239)
T ss_dssp GGGCCCCEEEEEEEEEE
T ss_pred CccceeeEEEEEEeEec
Confidence 9 99999999999863
|
| >1fny_A BARK lectin, BARK agglutinin I,polypeptide A; legume lectin, jelly roll, sugar binding protein; 1.81A {Robinia pseudoacacia} SCOP: b.29.1.1 PDB: 1fnz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-59 Score=462.20 Aligned_cols=224 Identities=33% Similarity=0.519 Sum_probs=200.5
Q ss_pred ceeEEeCCCCCCCCCeEEeCceeeCCCCcEEccCCC-----CceEEEEEeeCceecccCCCCCCCCeeeeEEEEEEEEeC
Q 005940 27 SSSFIFQGFNGGATNLSLQGAEIIKPSGALKLTNRS-----RYVIGHAFYVKPIQMFDTSASPSPNASSFSTTFVFEIST 101 (668)
Q Consensus 27 ~~~f~~~~f~~~~~~l~~~g~a~~~~~~~~~lt~~~-----~~~~G~~~y~~p~~l~~~~~~~~~~~~sF~t~F~f~i~~ 101 (668)
+++|+|++|.++..||+|+|+|.+.++|.|+||++. .++.|||+|++||+||+ +.+++++||+|+|+|.|.+
T Consensus 3 ~~~F~f~~F~~~~~~l~l~G~A~v~~~g~l~LT~~~~~~~~~~~~Gra~y~~Pi~l~d---~~tg~vaSFsT~F~F~I~~ 79 (237)
T 1fny_A 3 SLSFSFPKFAPNQPYLINQGDALVTSTGVLQLTNVVNGVPSSKSLGRALYAAPFQIWD---STTGNVASFVTSFTFIIQA 79 (237)
T ss_dssp EEEEEESSCCTTCTTEEEEETCEECTTSCEECSCEETTEECSSCEEEEEESSCEECBC---TTTCCBCEEEEEEEEECCC
T ss_pred ceEEEcCCCCCCCCCeEEcccEEeccCCeEEecCCcCCCcccCceEEEEeCCCEeccc---CCCCCccceEEEEEEEEeC
Confidence 578999999976689999999999878999999876 68999999999999999 8899999999999999998
Q ss_pred CCCCCCCCceEEEEcCCCCCCCCCCCCcccccccCCCCCCCccEEEEEeecccCCCCCCCCCCCeeeeecCCcccccccC
Q 005940 102 PRSGRGGHGLAFLLAPSTKLPGAQPEHYLGILNSTNNGEPSNHILIVEFDTVNGFNDKAENQGNHVGIGINTMFSNRSEP 181 (668)
Q Consensus 102 ~~~~~~g~GlaF~l~p~~~~~~~~~~~~lGl~~~~~~~~~~~~~~aVEfDt~~n~~d~~~~~~~Hvgid~~s~~s~~~~~ 181 (668)
++...+||||||||+|....| ++.|+||||+|.++ ++..+|+|||||||++|. .|||++|||||||||+.|.++++
T Consensus 80 ~~~~~~gdGlAF~l~p~~~~~-~~~g~~LGl~n~~~-~~~~~~~vAVEFDT~~n~--~~Dp~~nHVGIdvNsi~S~~~~~ 155 (237)
T 1fny_A 80 PNPATTADGLAFFLAPVDTQP-LDLGGMLGIFKDGY-FNKSNQIVAVEFDTFSNG--DWDPKGRHLGINVNSIESIKTVP 155 (237)
T ss_dssp SSTTSCCEEEEEEEEETTCCC-CCCGGGTTTCC----CCTTSCCEEEEEECSCCT--TTCCSSSEEEEEESSSSCSEEEE
T ss_pred CCCCCCCCCEEEEeccCCCCC-CCCCCcccccccCC-CCccccEEEEEeecccCc--ccCCCCCceEEecCCcccccccc
Confidence 877788999999999987555 48899999999764 477999999999999983 14599999999999999998876
Q ss_pred CccccCCCCCccccccCCCCcEEEEEEEeCCcceEEEEEEeCCCCCCCCcceeeeeccccccccceeeeeecccCCc---
Q 005940 182 ASYYINGTDHKEEMTLESGEPIQAWIEYDGEQKVLNVTISPAEIGKPMRPLISFGVNLTGYIKETMYVGFSASTGEK--- 258 (668)
Q Consensus 182 ~~~~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~V~~~~~~~~~p~~~~ls~~~dLs~~l~~~~~vGFsastG~~--- 258 (668)
+ +|.+|+.++|||+||+.+++|+|+|++.+. |..|+|++.+||+.+|+|+|||||||+||..
T Consensus 156 ~-------------~l~~G~~~~v~I~Yd~~~~~L~V~l~~~~~--~~~~~ls~~vdL~~~l~e~v~VGFSAsTG~~~~~ 220 (237)
T 1fny_A 156 W-------------NWTNGEVANVFISYEASTKSLTASLVYPSL--ETSFIIDAIVDVKIVLPEWVRFGFSATTGIDKGY 220 (237)
T ss_dssp C-------------CCCTTCCEEEEEEEEGGGTEEEEEEEETTT--TEEEEEEEECCHHHHSCSEEEEEEEEEECSSTTC
T ss_pred c-------------cccCCCEEEEEEEEeCCCcEEEEEEecCCC--CCcceEEEEechHHhCCCcEEEEEEEeeCCCCcc
Confidence 3 477899999999999999999999998754 6678999999999999999999999999998
Q ss_pred ccceeeeccccccc
Q 005940 259 SSSHYILGWSFSLN 272 (668)
Q Consensus 259 ~~~~~i~~w~F~~~ 272 (668)
.|.|+|++|+|++.
T Consensus 221 ~~~h~IlsWsF~s~ 234 (237)
T 1fny_A 221 VQTNDVLSWSFESN 234 (237)
T ss_dssp CCCCEEEEEEEEEE
T ss_pred cceeEEEEEEEEEe
Confidence 99999999999875
|
| >1qnw_A Chitin binding lectin, UEA-II; carbohydrate binding; HET: NAG; 2.35A {Ulex europaeus} SCOP: b.29.1.1 PDB: 1dzq_A* 1qoo_A* 1qos_A* 1qot_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-58 Score=457.11 Aligned_cols=226 Identities=32% Similarity=0.515 Sum_probs=204.9
Q ss_pred CCceeEEeCCCCCCCCCeEEeCceeeCCCCcEEccCCC---CceEEEEEeeCceecccCCCCCCCCeeeeEEEEEEEEeC
Q 005940 25 SQSSSFIFQGFNGGATNLSLQGAEIIKPSGALKLTNRS---RYVIGHAFYVKPIQMFDTSASPSPNASSFSTTFVFEIST 101 (668)
Q Consensus 25 ~~~~~f~~~~f~~~~~~l~~~g~a~~~~~~~~~lt~~~---~~~~G~~~y~~p~~l~~~~~~~~~~~~sF~t~F~f~i~~ 101 (668)
+..++|+|++|.++..||+|+|+|.+.++|.|+||++. .++.|||+|++||+||+ +.+++++||+|+|+|.|.+
T Consensus 3 ~~~~~F~f~~F~~~~~~l~l~G~A~i~~~g~l~LT~~~~~~~~~~Gra~y~~Pv~l~~---~~tg~vasFsT~F~F~I~~ 79 (242)
T 1qnw_A 3 SDDLSFNFDKFVPNQKNIIFQGDASVSTTGVLQVTKVSKPTTTSIGRALYAAPIQIWD---SITGKVASFATSFSFVVKA 79 (242)
T ss_dssp CCSEEEEESSCCTTCTTEEEEETCEECTTSCEESSCCC--CCCEEEEEEESSCEECBC---TTTCCBCEEEEEEEEECCB
T ss_pred ccceEEEcCCCCCCCCCeEEccceEEccCCcEEecCCCCcccCCeEEEEeCCCEeeec---CCCCCcccEEEEEEEEEec
Confidence 45789999999976689999999999878999999887 78999999999999999 7899999999999999998
Q ss_pred CCCCCCCCceEEEEcCCC-CCCCCCCCCcccccccCCCCCCCccEEEEEeecc----cCCCCCCCCCCCeeeeecCCccc
Q 005940 102 PRSGRGGHGLAFLLAPST-KLPGAQPEHYLGILNSTNNGEPSNHILIVEFDTV----NGFNDKAENQGNHVGIGINTMFS 176 (668)
Q Consensus 102 ~~~~~~g~GlaF~l~p~~-~~~~~~~~~~lGl~~~~~~~~~~~~~~aVEfDt~----~n~~d~~~~~~~Hvgid~~s~~s 176 (668)
+ ...+||||||||+|.. .+|.++.|+||||+|.++ ++..+|+|||||||+ +|. +||++||||||+||+.|
T Consensus 80 ~-~~~~gdGlAF~l~p~~~~~p~~~~g~~LGl~n~~~-~~~~~~~vAVEFDT~~~~~~N~---~Dp~~nHVGIdvNs~~S 154 (242)
T 1qnw_A 80 D-KSDGVDGLAFFLAPANSQIPSGSSAGMFGLFSSSD-SKSSNQIIAVEFDTYFGKAYNP---WDPDFKHIGIDVNSIKS 154 (242)
T ss_dssp S-SSCCCCEEEEEEEETTCCCCTTCCGGGTTTCSSSS-CCTTSCCEEEEEECCCCTTTCT---TSCSSCEEEEEESSSSC
T ss_pred C-CCCCCCCEEEEEecCCCCCCcCCCCCcccccccCC-CCccccEEEEEeecccccccCC---CCCCCCcEEEecCCccc
Confidence 7 6778999999999987 478889999999999765 477899999999999 874 45999999999999999
Q ss_pred ccccCCccccCCCCCccccccCCCCcEEEEEEEeCCcceEEEEEEeCCCCCCCCcceeeeeccccccccceeeeeecccC
Q 005940 177 NRSEPASYYINGTDHKEEMTLESGEPIQAWIEYDGEQKVLNVTISPAEIGKPMRPLISFGVNLTGYIKETMYVGFSASTG 256 (668)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~V~~~~~~~~~p~~~~ls~~~dLs~~l~~~~~vGFsastG 256 (668)
.+++++ +|.+|+.++|||+||+..++|+|+|++.+. |..|+|++.+||+.+|+|+|||||||+||
T Consensus 155 ~~~~~~-------------~l~~G~~~~v~I~Yd~~~~~L~V~l~~~~~--~~~~~ls~~vdL~~~l~e~v~VGFSAsTG 219 (242)
T 1qnw_A 155 IKTVKW-------------DWRNGEVADVVITYRAPTKSLTVCLSYPSD--GTSNIITASVDLKAILPEWVSVGFSGGVG 219 (242)
T ss_dssp SEEEEC-------------CCCTTCCEEEEEEEEGGGTEEEEEEECTTT--CCEEEEEEECCHHHHSCSEEEEEEEEEES
T ss_pred cceecc-------------cccCCCEEEEEEEEeCCCcEEEEEEecCCC--CcceeEEEeechHHhcCCceEEEEEeccC
Confidence 988763 477899999999999999999999998654 66799999999999999999999999999
Q ss_pred Cc--ccceeeecccccccC
Q 005940 257 EK--SSSHYILGWSFSLNG 273 (668)
Q Consensus 257 ~~--~~~~~i~~w~F~~~~ 273 (668)
.. .|.|+|++|+|++..
T Consensus 220 ~~~~~~~h~IlsWsF~s~l 238 (242)
T 1qnw_A 220 NAAEFETHDVLSWYFTSNL 238 (242)
T ss_dssp CGGGCBCCEEEEEEEEEEC
T ss_pred CCccceEEEEEEEEeEeec
Confidence 99 999999999998764
|
| >1gzc_A Erythrina crista-galli lectin; carbohydrate, sugar binding protein, saccharide, protein-carbohydrate interactions, lactose, glycoprotein; HET: LAT; 1.58A {Erythrina crista-galli} SCOP: b.29.1.1 PDB: 1gz9_A* 1fyu_A* 1ax0_A* 1ax1_A* 1ax2_A* 1axy_A* 1axz_A* 1lte_A* 1sfy_A* 1v00_A* 1uzz_A 1uzy_A* 3n35_A* 3n36_A* 3n3h_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-58 Score=457.26 Aligned_cols=224 Identities=33% Similarity=0.569 Sum_probs=200.7
Q ss_pred CceeEEeCCCCCCCCCeEEeCceeeCCCCcEEccCCC------CceEEEEEeeCceecccCCCCCCCCeeeeEEEEEEEE
Q 005940 26 QSSSFIFQGFNGGATNLSLQGAEIIKPSGALKLTNRS------RYVIGHAFYVKPIQMFDTSASPSPNASSFSTTFVFEI 99 (668)
Q Consensus 26 ~~~~f~~~~f~~~~~~l~~~g~a~~~~~~~~~lt~~~------~~~~G~~~y~~p~~l~~~~~~~~~~~~sF~t~F~f~i 99 (668)
.+++|+|++|.++..||+|+|+|.+.++|.|+||++. .++.|||+|++||+||+ +.+++++||+|+|+|.|
T Consensus 2 ~~~~F~f~~F~~~~~~l~l~G~A~v~~~g~l~LT~~~~~~~~~~~~~Gra~y~~Pi~l~~---~~tg~vaSFsT~F~F~I 78 (239)
T 1gzc_A 2 ETISFSFSEFEPGNDNLTLQGAALITQSGVLQLTKINQNGMPAWDSTGRTLYTKPVHMWD---STTGTVASFETRFSFSI 78 (239)
T ss_dssp EEEEEEESSCCTTCTTEEEEETCEECTTSCEESSCBCTTSCBCSSCEEEEEESSCEECBC---TTTCCBCEEEEEEEEEC
T ss_pred eeEEEEeCCCCCCCCCeEEcccEEEcCCCcEEeCCCCcCCcccCCceEEEEeCCCEeccc---CCCCCccceEEEEEEEE
Confidence 3578999999976689999999999878999999876 57999999999999999 78999999999999999
Q ss_pred eCCC-CCCCCCceEEEEcCCCCCCCCCCCCcccccccCCCCCCCccEEEEEeecccC-CCCCCCCCCCeeeeecCCcccc
Q 005940 100 STPR-SGRGGHGLAFLLAPSTKLPGAQPEHYLGILNSTNNGEPSNHILIVEFDTVNG-FNDKAENQGNHVGIGINTMFSN 177 (668)
Q Consensus 100 ~~~~-~~~~g~GlaF~l~p~~~~~~~~~~~~lGl~~~~~~~~~~~~~~aVEfDt~~n-~~d~~~~~~~Hvgid~~s~~s~ 177 (668)
.+++ ...+||||||||+|....| ++.|+||||+|.++ ++..+|+|||||||++| +.| |++||||||+||+.|.
T Consensus 79 ~~~~~~~~~gdGlAF~l~p~~~~~-~~~g~~LGl~n~~~-~~~~~~~vAVEFDT~~n~~dD---p~~nHVGIdvns~~S~ 153 (239)
T 1gzc_A 79 EQPYTRPLPADGLVFFMGPTKSKP-AQGYGYLGVFNNSK-QDNSYQTLAVEFDTFSNPWDP---PQVPHIGIDVNSIRSI 153 (239)
T ss_dssp CCCCSSSCCCEEEEEEEECSSCCC-CCCGGGTTTCSSSS-CCGGGCCEEEEEECSCCTTSC---SSSSEEEEEESSSSCS
T ss_pred eCCCCCCCCCCcEEEEEecCCCCC-CCCCCcccccccCC-CCccccEEEEEEecccccCCC---CCCCeEEEecCCcccc
Confidence 9876 6778999999999987555 48899999999764 57789999999999998 333 9999999999999998
Q ss_pred cccCCccccCCCCCccccccCCCCcEEEEEEEeCCcceEEEEEEeCCCCCCCCcceeeeeccccccccceeeeeecccCC
Q 005940 178 RSEPASYYINGTDHKEEMTLESGEPIQAWIEYDGEQKVLNVTISPAEIGKPMRPLISFGVNLTGYIKETMYVGFSASTGE 257 (668)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~V~~~~~~~~~p~~~~ls~~~dLs~~l~~~~~vGFsastG~ 257 (668)
+++++ +|.+|+.++|||+||+.+++|+|+|++.+. |..|+|++.+||+.+|+|+|||||||+||.
T Consensus 154 ~~~~~-------------~l~~G~~~~v~I~Yd~~~~~L~V~l~~~~~--~~~~~ls~~vdL~~~l~e~v~VGFSAsTG~ 218 (239)
T 1gzc_A 154 KTQPF-------------QLDNGQVANVVIKYDAPSKILHVVLVYPSS--GAIYTIAEIVDVKQVLPDWVDVGLSGATGA 218 (239)
T ss_dssp EEEEC-------------CCCTTCEEEEEEEEETTTTEEEEEEECTTT--CCEEEEEEECCHHHHSCSEEEEEEEEEECS
T ss_pred ccccc-------------cccCCCEEEEEEEEeCCCcEEEEEEecCCC--CccceEEEEechHHhCCCceEEEEEeccCC
Confidence 88653 477999999999999999999999998654 567899999999999999999999999997
Q ss_pred ---cccceeeeccccccc
Q 005940 258 ---KSSSHYILGWSFSLN 272 (668)
Q Consensus 258 ---~~~~~~i~~w~F~~~ 272 (668)
..|.|+|++|+|++.
T Consensus 219 ~~~~~~~h~IlsWsF~s~ 236 (239)
T 1gzc_A 219 QRDAAETHDVYSWSFQAS 236 (239)
T ss_dssp STTCCCCCEEEEEEEEEE
T ss_pred CccccceEEEEEEEeEEe
Confidence 499999999999875
|
| >1fx5_A UEA-I, UE-I, anti-H(O) lectin I; legume lectin, HOMO-dimer, fucose specific lectin, SUG binding protein; HET: NAG FUC BMA MAN; 2.20A {Ulex europaeus} SCOP: b.29.1.1 PDB: 1jxn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-58 Score=456.22 Aligned_cols=227 Identities=28% Similarity=0.424 Sum_probs=202.0
Q ss_pred CceeEEeCCCCCCCCCeEEeCceeeCCCCcEEccCCC---CceEEE-EEeeCceecccCCCCCCCCeeeeEEEEEEEEeC
Q 005940 26 QSSSFIFQGFNGGATNLSLQGAEIIKPSGALKLTNRS---RYVIGH-AFYVKPIQMFDTSASPSPNASSFSTTFVFEIST 101 (668)
Q Consensus 26 ~~~~f~~~~f~~~~~~l~~~g~a~~~~~~~~~lt~~~---~~~~G~-~~y~~p~~l~~~~~~~~~~~~sF~t~F~f~i~~ 101 (668)
.+++|+|++|.++..+|+|+|+|.+.++|.|+||++. .++.|| |+|++||+||+ +.+++++||+|+|+|.|.+
T Consensus 2 ~~~~F~f~~F~~~~~~l~l~G~A~v~~~g~l~LT~~~~~~~~~~Gr~a~y~~Pv~l~~---~~tg~vaSFsT~F~F~I~~ 78 (242)
T 1fx5_A 2 DDLSFKFKNFSQNGKDLSFQGNASVIETGVLQLNKVGNNLPDETGGIARYIAPIHIWN---CNTGELASFITSFSFFMET 78 (242)
T ss_dssp CEEEEEESSCCTTCSSEEEEETCEECTTSCEESCCCSSSSCSEEEEEEEESSCEECEE---TTTTEECEEEEEEEEEEEE
T ss_pred cceEEEcCCCCCCCCCeEEcccEEeccCCcEEecCCCCcccCCccCEEEeCCCEEeec---CCCCCccceEEEEEEEEec
Confidence 4689999999976689999999999878999999886 689999 99999999999 7889999999999999998
Q ss_pred C-CCCCCCCceEEEEcCCCCCCCCCCCCcccccccCCCCCCCccEEEEEeecccCCCCCCCCCCCeeeeecCCccccccc
Q 005940 102 P-RSGRGGHGLAFLLAPSTKLPGAQPEHYLGILNSTNNGEPSNHILIVEFDTVNGFNDKAENQGNHVGIGINTMFSNRSE 180 (668)
Q Consensus 102 ~-~~~~~g~GlaF~l~p~~~~~~~~~~~~lGl~~~~~~~~~~~~~~aVEfDt~~n~~d~~~~~~~Hvgid~~s~~s~~~~ 180 (668)
+ +...+||||||||+|....|+ +.|+||||+|.++ ++..+|+|||||||++|..-+|||++||||||+||+.|.+++
T Consensus 79 ~~~~~~~gdGlAF~l~p~~~~~~-~~g~~LGl~n~~~-~~~~n~~vAVEFDT~~N~~~~~Dp~~nHVGIdvNs~~S~~~~ 156 (242)
T 1fx5_A 79 SANPKAATDGLTFFLAPPDSPLR-RAGGYFGLFNDTK-CDSSYQTVAVEFDTIGSPVNFWDPGFPHIGIDVNCVKSINAE 156 (242)
T ss_dssp SSCGGGCCCEEEEEEECTTCCCC-BCGGGTTTBSSSC-CCGGGCCEEEEEECCCTTTSTTSCSSCEEEEEESSSSCSEEE
T ss_pred CCCCCCCCCcEEEEEecCCCCCC-CCCCcccccccCC-CCccCcEEEEEeccccCcccccCCCCCeEEEecCCcccccee
Confidence 7 566789999999999875554 7899999999765 477899999999999992101349999999999999999887
Q ss_pred CCccccCCCCCccccccCCC--CcEEEEEEEeCCcceEEEEEEeCCCCCCCCcceeeeeccccccccceeeeeeccc--C
Q 005940 181 PASYYINGTDHKEEMTLESG--EPIQAWIEYDGEQKVLNVTISPAEIGKPMRPLISFGVNLTGYIKETMYVGFSAST--G 256 (668)
Q Consensus 181 ~~~~~~~~~~~~~~~~l~~g--~~~~~~I~Y~~~~~~l~V~~~~~~~~~p~~~~ls~~~dLs~~l~~~~~vGFsast--G 256 (668)
++ +|.+| +.++|||+||+..++|+|+|++.+. |..|+|++.+||+.+|+|+|||||||+| |
T Consensus 157 ~~-------------~l~~G~~~~~~v~I~Yd~~~~~L~V~l~~~~~--~~~~~ls~~vdL~~~l~e~v~VGFSAsT~~G 221 (242)
T 1fx5_A 157 RW-------------NKRYGLNNVANVEIIYEASSKTLTASLTYPSD--QTSISVTSIVDLKEILPEWVSVGFSGSTYIG 221 (242)
T ss_dssp EC-------------CCCCSGGGCEEEEEEEETTTTEEEEEEEETTT--TEEEEEEEECCGGGTSCSEEEEEEEEEEETT
T ss_pred cc-------------cccCCCceeEEEEEEEeCCCCEEEEEEecCCC--CccceeeEEechHHhCCccEEEEEEecccCC
Confidence 63 46789 9999999999999999999998754 5678999999999999999999999999 9
Q ss_pred CcccceeeecccccccC
Q 005940 257 EKSSSHYILGWSFSLNG 273 (668)
Q Consensus 257 ~~~~~~~i~~w~F~~~~ 273 (668)
.. |.|+|++|+|++..
T Consensus 222 ~~-~~h~IlsWsF~s~l 237 (242)
T 1fx5_A 222 RQ-ATHEVLNWYFTSTF 237 (242)
T ss_dssp SC-EEEEEEEEEEEEES
T ss_pred Cc-ceeEEEEEEeEeec
Confidence 98 99999999999864
|
| >1v6i_A Agglutinin, PNA, galactose-binding lectin; open quaternary association, orthorhombic, carbohydrate specificity, protein crystallography; HET: GAL GLC; 2.15A {Arachis hypogaea} SCOP: b.29.1.1 PDB: 1bzw_A* 1v6j_A* 1v6k_A* 1v6l_A* 1v6m_A 1v6n_A 1v6o_A 2dva_A* 1cq9_A 1ciw_A* 1qf3_A* 1rir_A* 1rit_A* 2dh1_A 1cr7_A* 2dv9_A* 2dvb_A* 2dvd_A* 2dvf_A 2dvg_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-58 Score=453.82 Aligned_cols=220 Identities=29% Similarity=0.533 Sum_probs=200.9
Q ss_pred CceeEEeCCCCCCCCCeEEeCceeeCCCCcEEccCC-CCceEEEEEeeCceecccCCCCCCCCeeeeEEEEEEEEeCCCC
Q 005940 26 QSSSFIFQGFNGGATNLSLQGAEIIKPSGALKLTNR-SRYVIGHAFYVKPIQMFDTSASPSPNASSFSTTFVFEISTPRS 104 (668)
Q Consensus 26 ~~~~f~~~~f~~~~~~l~~~g~a~~~~~~~~~lt~~-~~~~~G~~~y~~p~~l~~~~~~~~~~~~sF~t~F~f~i~~~~~ 104 (668)
.+++|+|++|.++..||+|+|+|.+.++|.|+||++ ..++.|||+|++||+||+ +.+++++||+|+|+|.|.+++.
T Consensus 2 ~~~~F~f~~F~~~~~~l~l~G~A~v~~~g~l~LT~~~~~~~~Gra~y~~Pi~l~~---~~tg~vaSFsT~F~F~I~~~~~ 78 (232)
T 1v6i_A 2 ETVSFNFNSFSEGNPAINFQGDVTVLSNGNIQLTNLNKVNSVGRVLYAMPVRIWS---SATGNVASFLTSFSFEMKDIKD 78 (232)
T ss_dssp EEEEEEESSCCTTCTTEEEEESCEECTTSCEECSCTTSTTCEEEEEESSCEECBC---TTTCCBCEEEEEEEEEEECCSS
T ss_pred cceEEEcCCCCCCCCCeEEcccEEEccCCcEEeCCCCCCCceEEEEeCCCEEeec---CCCCCccceEEEEEEEEecCCC
Confidence 357999999997668999999999987899999998 889999999999999999 8899999999999999998877
Q ss_pred CCCCCceEEEEcCCC-CCCCCC-CCCcccccccCCCCCCCccEEEEEeecccC--CCCCCCCCCCeeeeecCCccccccc
Q 005940 105 GRGGHGLAFLLAPST-KLPGAQ-PEHYLGILNSTNNGEPSNHILIVEFDTVNG--FNDKAENQGNHVGIGINTMFSNRSE 180 (668)
Q Consensus 105 ~~~g~GlaF~l~p~~-~~~~~~-~~~~lGl~~~~~~~~~~~~~~aVEfDt~~n--~~d~~~~~~~Hvgid~~s~~s~~~~ 180 (668)
..+||||||||+|.. .+|.++ +|+||||+|. ++.+|+|||||||++| ++| |++||||||+||+.|.+++
T Consensus 79 ~~~gdGlAF~l~p~~~~~p~~~~~g~~LGl~n~----~~~~~~vAVEFDT~~n~~~~D---p~~nHVGIdvns~~S~~~~ 151 (232)
T 1v6i_A 79 YDPADGIIFFIAPEDTQIPAGSIGGGTLGVSDT----KGAGHFVGVEFDTYSNSEYND---PPTDHVGIDVNSVDSVKTV 151 (232)
T ss_dssp SBCCCEEEEEEEETTCCCCTTCCCGGGTTTSCT----TSEEEEEEEEEECSCCGGGTC---CSSCEEEEEEEESSCSEEE
T ss_pred CCCCCCEEEEEecCCCCCCCCcCCCcccccccC----CCcccEEEEEeecccccccCC---CCCCeEEEEcCCccccccc
Confidence 788999999999987 568888 9999999986 5689999999999999 356 9999999999999998887
Q ss_pred CCccccCCCCCccccccCCCCcEEEEEEEeCCcceEEEEEEeCCCCCCCCcceeeeeccccccccceeeeeecccCC--c
Q 005940 181 PASYYINGTDHKEEMTLESGEPIQAWIEYDGEQKVLNVTISPAEIGKPMRPLISFGVNLTGYIKETMYVGFSASTGE--K 258 (668)
Q Consensus 181 ~~~~~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~V~~~~~~~~~p~~~~ls~~~dLs~~l~~~~~vGFsastG~--~ 258 (668)
++ +|.+|+.++|||+||+.+++|+|+|++ + +|..|+|++.+||+++|+|+|||||| +||. .
T Consensus 152 ~~-------------~l~~G~~~~v~I~Yd~~~~~L~V~l~~-~--~~~~~~ls~~vdL~~~l~e~v~VGFS-sTG~~~~ 214 (232)
T 1v6i_A 152 PW-------------NSVSGAVVKVTVIYDSSTKTLSVAVTN-D--NGDITTIAQVVDLKAKLPERVKFGFS-ASGSLGG 214 (232)
T ss_dssp EC-------------CCCTTCEEEEEEEEETTTTEEEEEEEC-T--TSCEEEEEEECCHHHHSCSEEEEEEE-EECCSSB
T ss_pred cc-------------cccCCCEEEEEEEEeCCCcEEEEEEec-C--CCCcceEEEEechHHhCCccEEEEEE-ecCCCcc
Confidence 63 477999999999999999999999998 4 47789999999999999999999999 9998 6
Q ss_pred ccceeeeccccccc
Q 005940 259 SSSHYILGWSFSLN 272 (668)
Q Consensus 259 ~~~~~i~~w~F~~~ 272 (668)
.|.|+|++|+|++.
T Consensus 215 ~~~h~IlsWsF~s~ 228 (232)
T 1v6i_A 215 RQIHLIRSWSFTST 228 (232)
T ss_dssp CCEEEEEEEEEEEE
T ss_pred ccEEEEEEEEEEee
Confidence 99999999999875
|
| >1hql_A Lectin; xenograft antigen, sugar BI protein; HET: GLA MBG NAG; 2.20A {Griffonia simplicifolia} SCOP: b.29.1.1 PDB: 1gnz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-58 Score=459.05 Aligned_cols=239 Identities=30% Similarity=0.506 Sum_probs=201.0
Q ss_pred CceeEEeCCCC-CCCCCeEEeCceeeCCCCcEEccCCC------CceEEEEEeeCceecccCCCCCCCCeeeeEEEEEEE
Q 005940 26 QSSSFIFQGFN-GGATNLSLQGAEIIKPSGALKLTNRS------RYVIGHAFYVKPIQMFDTSASPSPNASSFSTTFVFE 98 (668)
Q Consensus 26 ~~~~f~~~~f~-~~~~~l~~~g~a~~~~~~~~~lt~~~------~~~~G~~~y~~p~~l~~~~~~~~~~~~sF~t~F~f~ 98 (668)
.+++|+|++|. ++..||+|+|+|.+. +|.|+||++. .++.|||+|++||+||+ +.+++++||+|+|+|.
T Consensus 3 ~~~~F~f~~F~~~~~~~l~l~GdA~v~-~g~l~LT~~~~~~~~~~~~~Gra~y~~Pv~l~d---~~tg~vasFsT~F~F~ 78 (257)
T 1hql_A 3 DSVSFTFPNFWSDVEDSIIFQGDANTT-AGTLQLCKTNQYGTPLQWSAGRALYSDPVQLWD---NKTESVASFYTEFTFF 78 (257)
T ss_dssp -CCEEEESCSCSCGGGTEEEEETCEEE-TTEEECSCBCTTSCBCSSCEEEEEESSCEECCC---STTCCCCEEEEEEEEE
T ss_pred cceEEEcCCCCCCCCCCEEEccceEec-CCcEEecCCccCCcccCCCeEEEEECCCEeccc---CCCCCeeceEEEEEEE
Confidence 46799999998 445799999999998 8999999875 57999999999999999 8899999999999999
Q ss_pred EeCCCCCCCCCceEEEEcCCCCCCCCCCCCcccccccCC-CCCCCccEEEEEeecccC--CCCCCCCCCCeeeeecCCcc
Q 005940 99 ISTPRSGRGGHGLAFLLAPSTKLPGAQPEHYLGILNSTN-NGEPSNHILIVEFDTVNG--FNDKAENQGNHVGIGINTMF 175 (668)
Q Consensus 99 i~~~~~~~~g~GlaF~l~p~~~~~~~~~~~~lGl~~~~~-~~~~~~~~~aVEfDt~~n--~~d~~~~~~~Hvgid~~s~~ 175 (668)
|.++ ...+||||||||+|....| ++.|+||||+|.++ +++..+|+|||||||++| +.| |++||||||+||+.
T Consensus 79 I~~~-~~~~gdGlAF~l~p~~~~~-~~~g~~LGl~n~~~~~~~~~n~~vAVEFDT~~N~~~~D---p~~nHVGIdvNs~~ 153 (257)
T 1hql_A 79 LKIT-GNGPADGLAFFLAPPDSDV-KDAGEYLGLFNKSTATQPSKNQVVAVEFDTWTNPNFPE---PSYRHIGINVNSIV 153 (257)
T ss_dssp EEEC-SSCCCCEEEEEEECTTCCC-CCCGGGTTTSCTTTTTCGGGCCCEEEEEECSCCSSSCC---CSSCEEEEEESSSS
T ss_pred EecC-CCCCCCcEEEEEecCCCCC-CCCCccccccccccccCCccCceEEEEecccccccccC---CCCCceeeeeCCcc
Confidence 9987 6778999999999987544 48899999999875 377889999999999998 335 99999999999999
Q ss_pred cccccCCccccCCCCCcccc-ccCCCCcEEEEEEEeCCcceEEEEEEeCCCCCCCCcceeeeeccccccccceeeeeecc
Q 005940 176 SNRSEPASYYINGTDHKEEM-TLESGEPIQAWIEYDGEQKVLNVTISPAEIGKPMRPLISFGVNLTGYIKETMYVGFSAS 254 (668)
Q Consensus 176 s~~~~~~~~~~~~~~~~~~~-~l~~g~~~~~~I~Y~~~~~~l~V~~~~~~~~~p~~~~ls~~~dLs~~l~~~~~vGFsas 254 (668)
|.++.++. + +|.+|+.++|||+||+.+++|+|+|++.+. ..|+|++.+||+.+|+++|||||||+
T Consensus 154 S~~s~~~~-----------~~~l~~g~~~~v~I~Yd~~~~~L~V~l~~~~~---~~~~ls~~vdL~~~l~e~~~vGFSAs 219 (257)
T 1hql_A 154 SVATKRWE-----------DSDIFSGKIATARISYDGSAEILTVVLSYPDG---SDYILSHSVDMRQNLPESVRVGISAS 219 (257)
T ss_dssp CSEEEECC-----------HHHHTSCSCEEEEEEEETTTTEEEEEEEETTT---EEEEEEEECCGGGTSCSEEEEEEEEE
T ss_pred ccceeccC-----------cccccCCceEEEEEEEeCCCCEEEEEEecCCC---CceeeEEeechHHhcCCceEEEEEec
Confidence 99887752 2 356799999999999999999999998754 46899999999999999999999999
Q ss_pred cC-CcccceeeecccccccCCCCCCCCCCCCCCC
Q 005940 255 TG-EKSSSHYILGWSFSLNGVAPALNVSELPKPP 287 (668)
Q Consensus 255 tG-~~~~~~~i~~w~F~~~~~~p~l~~s~~P~~~ 287 (668)
|| ...+.|+|++|+|++.+..+..+.+.+|..|
T Consensus 220 TG~~~~~~H~IlsWsF~s~~~~~~~~~~~~p~~~ 253 (257)
T 1hql_A 220 TGNNQFLTVYILSWRFSSNLQSTSVKAAMEPEIT 253 (257)
T ss_dssp CCSCCCEEEEEEEEEEEEEC--------------
T ss_pred cCCCccceeEEEEEEeEecCCCCCcccccCCCCC
Confidence 99 9999999999999998877777777776655
|
| >1sbf_A Soybean agglutinin; lectin; HET: NAG GAL; 2.43A {Glycine max} SCOP: b.29.1.1 PDB: 1sbd_A* 1sbe_A* 1g9f_A* 2sba_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-57 Score=455.68 Aligned_cols=223 Identities=31% Similarity=0.524 Sum_probs=201.4
Q ss_pred CceeEEeCCCCCCCCCeEEeCceeeCCCCcEEccCCC------CceEEEEEeeCceecccCCCCCCCCeeeeEEEEEEEE
Q 005940 26 QSSSFIFQGFNGGATNLSLQGAEIIKPSGALKLTNRS------RYVIGHAFYVKPIQMFDTSASPSPNASSFSTTFVFEI 99 (668)
Q Consensus 26 ~~~~f~~~~f~~~~~~l~~~g~a~~~~~~~~~lt~~~------~~~~G~~~y~~p~~l~~~~~~~~~~~~sF~t~F~f~i 99 (668)
.+++|+|++|.++..+|+|+|+|.+.++|.|+||++. .++.|||+|++||+||+ +.+++++||+|+|+|.|
T Consensus 2 ~~~~F~f~~F~~~~~~l~l~GdA~v~~~g~l~LT~~~~~~~~~~~~~Gra~y~~Pv~l~d---~~tg~vaSFsT~F~F~I 78 (253)
T 1sbf_A 2 ETVSFSWNKFVPKQPNMILQGDAIVTSSGKLQLNKVDENGTPKPSSLGRALYSTPIHIWD---KETGSVASFAASFNFTF 78 (253)
T ss_dssp EEEEEEESSCCTTCTTEEEEETCEECTTSCEECSCBCTTSCBCTTCEEEEEESSCEECBC---TTTCCBCEEEEEEEEEE
T ss_pred cceEEEcCCCCCCCCCeEEcccEEEcCCCeEEeCCCccCCcccCCCeEEEEECCCEeccc---CCCCcccceEEEEEEEE
Confidence 3679999999976689999999999878999999876 57999999999999999 88999999999999999
Q ss_pred eCCCCCCCCCceEEEEcCCCCCCCCCCCCcccccccCCCCCCCccEEEEEeecccCCCCCCCCCCCeeeeecCCcccccc
Q 005940 100 STPRSGRGGHGLAFLLAPSTKLPGAQPEHYLGILNSTNNGEPSNHILIVEFDTVNGFNDKAENQGNHVGIGINTMFSNRS 179 (668)
Q Consensus 100 ~~~~~~~~g~GlaF~l~p~~~~~~~~~~~~lGl~~~~~~~~~~~~~~aVEfDt~~n~~d~~~~~~~Hvgid~~s~~s~~~ 179 (668)
.+++...+||||||||+|....| ++.|+||||+|.+ +..+|+|||||||++|. |||++||||||+||+.|.++
T Consensus 79 ~~~~~~~~gdGlAF~l~p~~~~~-~~~g~~LGL~n~~---~~~n~~vAVEFDT~~N~---~Dp~~nHVGIdvNs~~S~~t 151 (253)
T 1sbf_A 79 YAPDTKRLADGLAFFLAPIDTKP-QTHAGYLGLFNEN---ESGDQVVAVEFDTFRNS---WDPPNPHIGINVNSIRSIKT 151 (253)
T ss_dssp ECSSTTSCCEEEEEEEEETTCCC-CCCGGGTTTCCTT---SCCCSCEEEEEECSCCT---TCCSSSEEEEEESSSSCSEE
T ss_pred eCCCCCCCCCcEEEEEecCCCCC-CCCCCccccccCC---CcccceEEEEeccccCC---CCCCCCcEEEEcCCccccce
Confidence 98877788999999999987555 4889999999875 56899999999999985 45999999999999999888
Q ss_pred cCCccccCCCCCccccccCCCCcEEEEEEEeCCcceEEEEEEeCCCCCCCCcceeeeeccccccccceeeeeecccCCc-
Q 005940 180 EPASYYINGTDHKEEMTLESGEPIQAWIEYDGEQKVLNVTISPAEIGKPMRPLISFGVNLTGYIKETMYVGFSASTGEK- 258 (668)
Q Consensus 180 ~~~~~~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~V~~~~~~~~~p~~~~ls~~~dLs~~l~~~~~vGFsastG~~- 258 (668)
.++ +|.+|+.++|||+||+.+++|+|+|++.+. |..|+|++.+||+.+|+|+|||||||+||..
T Consensus 152 ~~~-------------~l~~G~~~~v~I~Yd~~~~~L~V~l~~~~~--~~~~~ls~~vdL~~~l~e~~~VGFSAsTG~~~ 216 (253)
T 1sbf_A 152 TSW-------------DLANNKVAKVLITYDASTSLLVASLVYPSQ--RTSNILSDVVDLKTSLPEWVRIGFSAATGLDI 216 (253)
T ss_dssp EEC-------------CCCTTCCEEEEEEEETTTTEEEEEEEETTT--TEEEEEEEECCHHHHSCSEEEEEEEEEECSSS
T ss_pred ecc-------------cccCCCeeEEEEEEeCCCcEEEEEEecCCC--CCcceEEEEechHHhCCCceEEEEEeccCCCc
Confidence 763 477899999999999999999999998754 5678999999999999999999999999999
Q ss_pred -ccceeeecccccccC
Q 005940 259 -SSSHYILGWSFSLNG 273 (668)
Q Consensus 259 -~~~~~i~~w~F~~~~ 273 (668)
.+.|+|++|+|++..
T Consensus 217 ~~~~H~IlsWsF~s~l 232 (253)
T 1sbf_A 217 PGESHDVLSWSFASNL 232 (253)
T ss_dssp CCCEEEEEEEEEEEEE
T ss_pred cceeeEEEEEEeEeec
Confidence 999999999999863
|
| >2eig_A Lectin; L-fucosyl, N-acetyl-D-glucosamine, SUG binding protein; HET: NAG; 2.00A {Lotus tetragonolobus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-57 Score=450.60 Aligned_cols=219 Identities=31% Similarity=0.499 Sum_probs=199.2
Q ss_pred eeEEeCCCCCCCCCeEEeCceeeCCCCcEEccCC--CCceEEEEEeeCceecccCCCCCCCCeeeeEEEEEEEEeCCCCC
Q 005940 28 SSFIFQGFNGGATNLSLQGAEIIKPSGALKLTNR--SRYVIGHAFYVKPIQMFDTSASPSPNASSFSTTFVFEISTPRSG 105 (668)
Q Consensus 28 ~~f~~~~f~~~~~~l~~~g~a~~~~~~~~~lt~~--~~~~~G~~~y~~p~~l~~~~~~~~~~~~sF~t~F~f~i~~~~~~ 105 (668)
++|+|++|. +..||+|+|+|.+.++|.|+||++ ..++.|||+|++||+||+ +.+++++||+|+|+|.|.+++..
T Consensus 1 ~sF~f~~F~-~~~~l~l~G~A~v~~~g~l~LT~~~~~~~~~Gra~y~~Pv~l~~---~~tg~vaSFsT~F~F~I~~~~~~ 76 (234)
T 2eig_A 1 VSFNYTRFK-DDGSLIFQGDAKIWTDGRLAMPTDPLVNRTTSHALYATPVPIWD---SATGNVASFITSFSFIVSNVQRY 76 (234)
T ss_dssp CEEEESSCC-SSSSEEEEETCEEEGGGEEESSSCGGGSSEEEEEEESSCEECBC---TTTCCBCEEEEEEEEEEEECTTS
T ss_pred CeEEcCCCC-CCCCeEEcccEEEcCCCCeeeCCCCCccCceEEEEeCCCEEeec---CCCCCccceEEEEEEEEeCCCCC
Confidence 479999998 347999999999977899999998 778999999999999999 88999999999999999988777
Q ss_pred CCCCceEEEEcCCC-CCCCCCCCCcccccccCCCCCCCccEEEEEeecccCCCCCCCCCC---CeeeeecCCcccccccC
Q 005940 106 RGGHGLAFLLAPST-KLPGAQPEHYLGILNSTNNGEPSNHILIVEFDTVNGFNDKAENQG---NHVGIGINTMFSNRSEP 181 (668)
Q Consensus 106 ~~g~GlaF~l~p~~-~~~~~~~~~~lGl~~~~~~~~~~~~~~aVEfDt~~n~~d~~~~~~---~Hvgid~~s~~s~~~~~ 181 (668)
.+||||||||+|.. .+|.++.|+||||+|.+ ++.+|+|||||||++|. |||++ ||||||+||+.|.++++
T Consensus 77 ~~gdGlAF~l~p~~~~~p~~~~g~~LGl~n~~---~~~~~~vAVEFDT~~N~---~Dp~~~~~nHVGIdvNsi~S~~~~~ 150 (234)
T 2eig_A 77 PPTDGVVFFLAPWGTEIPPNSQGGYLGITDSS---NSQNQFVAVEFDSHPNV---WDPKSLRSSHIGIDVNSIMSLKAVN 150 (234)
T ss_dssp CCCCEEEEEEEETTCCCCTTCCGGGTTTCCTT---CSCCCCEEEEEECSCCT---TSCTTTCSSEEEEEESSSSCSEEEE
T ss_pred CCCCcEEEEEecCCCCCCcCCCCCccccccCC---CccccEEEEEeccccCc---cCCCCCCCCceEEecCCccccceec
Confidence 88999999999987 47888999999999875 56899999999999985 44888 99999999999988876
Q ss_pred CccccCCCCCccccccCCCCcEEEEEEEeCCcceEEEEEEeCCCCCCCCcceeeeeccccccccceeeeeeccc--CCcc
Q 005940 182 ASYYINGTDHKEEMTLESGEPIQAWIEYDGEQKVLNVTISPAEIGKPMRPLISFGVNLTGYIKETMYVGFSAST--GEKS 259 (668)
Q Consensus 182 ~~~~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~V~~~~~~~~~p~~~~ls~~~dLs~~l~~~~~vGFsast--G~~~ 259 (668)
+ +|.+|+.++|||+||+.+++|+|+|++ + +|..|+|++.+||+.+|+|+|||||||+| |..
T Consensus 151 ~-------------~l~~g~~~~v~I~Yd~~~~~L~V~l~~-~--~~~~~~ls~~vdL~~~l~e~v~VGFSAsT~~G~~- 213 (234)
T 2eig_A 151 W-------------NRVSGSLEKATIIYDSDTKILTVVMTH-Q--NGQITTISQEIDLKTVLPEKVSVGFSATTWNPER- 213 (234)
T ss_dssp C-------------CCCTTCCEEEEEEEETTTTEEEEEEEE-T--TSCEEEEEEECCHHHHSCSEEEEEEEEEECSSCC-
T ss_pred c-------------cccCCCEEEEEEEEeCCCcEEEEEEec-C--CCCcceEeEeechHHhcCCceEEEEEeeecCCCc-
Confidence 3 477899999999999999999999998 4 46789999999999999999999999999 988
Q ss_pred cceeeecccccccC
Q 005940 260 SSHYILGWSFSLNG 273 (668)
Q Consensus 260 ~~~~i~~w~F~~~~ 273 (668)
|.|+|++|+|++..
T Consensus 214 ~~h~IlsWsF~s~l 227 (234)
T 2eig_A 214 ERHDIYSWSFTSTL 227 (234)
T ss_dssp EEEEEEEEEEEEEC
T ss_pred ceeEEEEEEEEecC
Confidence 99999999999864
|
| >1n47_A Isolectin B4; cancer antigen, vicia villosa lectin, glycoprotein TN-bindin protein, carbohydrate recognition, sugar binding protein; HET: NAG FUC TNR; 2.70A {Vicia villosa} SCOP: b.29.1.1 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-57 Score=448.51 Aligned_cols=222 Identities=32% Similarity=0.527 Sum_probs=199.1
Q ss_pred CceeEEeCCCCCCCCCeEEeCceeeCCCCcEEccCCC-----CceEEEEEeeCceecccCCCCCCCCeeeeEEEEEEEEe
Q 005940 26 QSSSFIFQGFNGGATNLSLQGAEIIKPSGALKLTNRS-----RYVIGHAFYVKPIQMFDTSASPSPNASSFSTTFVFEIS 100 (668)
Q Consensus 26 ~~~~f~~~~f~~~~~~l~~~g~a~~~~~~~~~lt~~~-----~~~~G~~~y~~p~~l~~~~~~~~~~~~sF~t~F~f~i~ 100 (668)
.+++|+|++|.++..||+++|+|.+.++|.|+||++. .++.|||+|++||++|+ +.+ ++||+|+|+|.|.
T Consensus 2 ~~~~F~f~~F~~~~~~l~l~G~A~v~~~g~l~LT~~~~~~~~~~~~Gra~y~~Pi~l~d---~~~--~~sFsT~F~F~I~ 76 (233)
T 1n47_A 2 ESTSFSFTNFNPNQNNLILQEDALVNSAGTLELTAVAAGAPVPDSLGRALYAAPIHIHD---NTT--LASFTTSFSFVMA 76 (233)
T ss_dssp EEEEEEESSCCTTCTTEEEEETCEECTTSCEESSCBSSSSBCTTCEEEEEESSCEECBC---SSC--BCEEEEEEEEECC
T ss_pred cceEEEcCCCCCCCCCeEEccceEEccCCcEEeccCcCCCccCCCeEEEEECCCEeccC---CCC--cCCEEEEEEEEEe
Confidence 4679999999976689999999999878999999876 47999999999999999 554 9999999999999
Q ss_pred CCCCCCCCCceEEEEcCCCCCCCCCCCCcccccccCCCCCCCccEEEEEeecccCCCCCCCCCCCeeeeecCCccccccc
Q 005940 101 TPRSGRGGHGLAFLLAPSTKLPGAQPEHYLGILNSTNNGEPSNHILIVEFDTVNGFNDKAENQGNHVGIGINTMFSNRSE 180 (668)
Q Consensus 101 ~~~~~~~g~GlaF~l~p~~~~~~~~~~~~lGl~~~~~~~~~~~~~~aVEfDt~~n~~d~~~~~~~Hvgid~~s~~s~~~~ 180 (668)
+++...+||||||||+|....|+ +.|+||||+|.++ ++..+|+|||||||++|. +||++||||||+||+.|.++.
T Consensus 77 ~~~~~~~gdGlAF~l~p~~~~p~-~~g~~LGl~n~~~-~~~~n~~vAVEFDT~~N~---~Dp~~nHvGIdvns~~S~~~~ 151 (233)
T 1n47_A 77 APAAAAVADGLAFFLAPPDTQPQ-ARGGFLGLFADRA-HDASYQTVAVEFDTYSNA---WDPNYTHIGIDTNGIESKKTT 151 (233)
T ss_dssp CSSTTSCCEEEEEEEECTTCCCC-CCGGGTTTCSSSS-CCGGGCCEEEEEECSCCT---TSCSSCEEEEEESSSSCSEEE
T ss_pred CCCCCCCCCcEEEEEecCCCCCC-CCCCcccccccCC-CCccCceEEEEeccccCC---CCCCCCcEEEccCCccccccc
Confidence 88777889999999999876665 8899999999774 577899999999999985 459999999999999998876
Q ss_pred CCccccCCCCCccccccCCCCcEEEEEEEeCCcceEEEEEEeCCCCCCCCcceeeeeccccccccceeeeeecccCCc--
Q 005940 181 PASYYINGTDHKEEMTLESGEPIQAWIEYDGEQKVLNVTISPAEIGKPMRPLISFGVNLTGYIKETMYVGFSASTGEK-- 258 (668)
Q Consensus 181 ~~~~~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~V~~~~~~~~~p~~~~ls~~~dLs~~l~~~~~vGFsastG~~-- 258 (668)
++ ++.+|+.++|||+||+..++|+|+|++.+. +..|+|++.+||+.+|+|+|||||||+||..
T Consensus 152 ~~-------------~l~~g~~~~v~I~Yd~~~~~L~V~l~~~~~--~~~~~ls~~vdL~~~l~~~~~vGFSAsTG~~~~ 216 (233)
T 1n47_A 152 PF-------------DMVYGEKANIVITYQASTKALAASLVFPVS--QTSYAVSARVDLRDILPEYVRVGFSATTGLNAG 216 (233)
T ss_dssp EC-------------CCCTTSCEEEEEEEETTTTEEEEEEEETTT--TEEEEEEEECCGGGTSCSEEEEEEEEEECSSTT
T ss_pred cc-------------cccCCCEEEEEEEEeCCCCEEEEEEecCCC--CCcceEEEEechHHhCCCceEEEEEeccCCCcc
Confidence 53 467899999999999999999999998754 3578999999999999999999999999998
Q ss_pred -ccceeeeccccccc
Q 005940 259 -SSSHYILGWSFSLN 272 (668)
Q Consensus 259 -~~~~~i~~w~F~~~ 272 (668)
.|.|+|++|+|+++
T Consensus 217 ~~~~h~IlsWsF~s~ 231 (233)
T 1n47_A 217 VVETHDIVSWSFAVS 231 (233)
T ss_dssp CCCCCEEEEEEEEEE
T ss_pred ccceeEEEEEEEEee
Confidence 99999999999864
|
| >2bqp_A Protein (PEA lectin); D-glucopyranose complex, sugar binding protein; HET: GLC; 1.90A {Pisum sativum} SCOP: b.29.1.1 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-57 Score=449.28 Aligned_cols=226 Identities=29% Similarity=0.508 Sum_probs=202.7
Q ss_pred CceeEEeCCCCCCCCCeEEeCceeeCCCCcEEccCCCCceEEEEEeeCceecccCCCCCCCCeeeeEEEEEEEEeCCCCC
Q 005940 26 QSSSFIFQGFNGGATNLSLQGAEIIKPSGALKLTNRSRYVIGHAFYVKPIQMFDTSASPSPNASSFSTTFVFEISTPRSG 105 (668)
Q Consensus 26 ~~~~f~~~~f~~~~~~l~~~g~a~~~~~~~~~lt~~~~~~~G~~~y~~p~~l~~~~~~~~~~~~sF~t~F~f~i~~~~~~ 105 (668)
.+++|+|++|.++..+|+++|+|. .++|.|+||++..++.|||+|++||+||+ +.+++++||+|+|+|.|.+++..
T Consensus 2 ~~~~F~f~~F~~~~~~l~l~G~A~-~~~g~l~LT~~~~~~~G~a~y~~Pv~l~~---~~~~~~~sFst~F~F~I~~~~~~ 77 (234)
T 2bqp_A 2 ETTSFLITKFSPDQQNLIFQGDGY-TTKEKLTLTKAVKNTVGRALYSSPIHIWD---RETGNVANFVTSFTFVINAPNSY 77 (234)
T ss_dssp EEEEEEESSBCTTCTTEEEEETCE-EETBEEEEECSCTTCEEEEEESSCEECBC---TTTCCBCEEEEEEEEEEECSSTT
T ss_pred cceEEEcCCCCCCCCCEEEeecee-cCCCEEEeCCCCCCCEEEEEECCCEEccc---CCCCceeeEEEEEEEEEeCCCCC
Confidence 467999999997668999999999 46899999999999999999999999999 88999999999999999988777
Q ss_pred CCCCceEEEEcCCCCCCCCCCCCcccccccCCCCCCCccEEEEEeecccCCCCCCCCC--CCeeeeecCCcccccccCCc
Q 005940 106 RGGHGLAFLLAPSTKLPGAQPEHYLGILNSTNNGEPSNHILIVEFDTVNGFNDKAENQ--GNHVGIGINTMFSNRSEPAS 183 (668)
Q Consensus 106 ~~g~GlaF~l~p~~~~~~~~~~~~lGl~~~~~~~~~~~~~~aVEfDt~~n~~d~~~~~--~~Hvgid~~s~~s~~~~~~~ 183 (668)
.+||||||+|+|....|+ +.|+||||+|.++ ++..+|+|||||||++|. + +||+ +||||||+|++.|..+.++
T Consensus 78 ~~gdGlAF~l~p~~~~p~-~~g~~LGl~n~~~-~~~~~~~vAVEFDT~~N~-~-~Dp~~~~nHVgIdvns~~S~~s~~~- 152 (234)
T 2bqp_A 78 NVADGFTFFIAPVDTKPQ-TGGGYLGVFNSAE-YDKTTQTVAVEFDTFYNA-A-WDPSNRDRHIGIDVNSIKSVNTKSW- 152 (234)
T ss_dssp SCCCEEEEEEEETTCCCC-CCGGGTTTCSCSS-CCGGGCCEEEEEECSCCT-T-TSCTTCCCEEEEEESSSSCSEEEEC-
T ss_pred CCCCcEEEEEecCCCCCC-CCCCccccccccC-CCCCCcEEEEEEecccCc-c-cCCCCCCCceeEeeCCccccceEee-
Confidence 889999999999876666 8899999999874 577899999999999983 1 4599 9999999999999887653
Q ss_pred cccCCCCCccccccCCCCcEEEEEEEeCCcceEEEEEEeCCCC---CCCCcceeeeeccccccccceeeeeecccCCccc
Q 005940 184 YYINGTDHKEEMTLESGEPIQAWIEYDGEQKVLNVTISPAEIG---KPMRPLISFGVNLTGYIKETMYVGFSASTGEKSS 260 (668)
Q Consensus 184 ~~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~V~~~~~~~~---~p~~~~ls~~~dLs~~l~~~~~vGFsastG~~~~ 260 (668)
++.+|+.++|||+||+..++|+|+|++.+.. ||..|+|+..+||+.+||++|||||||+||...+
T Consensus 153 ------------~l~~g~~~~v~I~Yd~~~~~L~V~l~~~~~~~~~~p~~~~ls~~vdL~~~l~~~~yvGFSAsTG~~~~ 220 (234)
T 2bqp_A 153 ------------KLQNGEEANVVIAFNAATNVLTVSLTYPNNSLEEEVTSYTLSDVVSLKDVVPEWVRIGFSATTGAEYA 220 (234)
T ss_dssp ------------CCCTTCEEEEEEEEETTTTEEEEEEEECC------CEEEEEEEECCGGGTSCSEEEEEEEEECSSSCC
T ss_pred ------------EEcCCCEEEEEEEEeCCCCEEEEEEecCCCCcccCCCcceEEEEechHHhCCCceEEEEEeccCCCcc
Confidence 4678999999999999999999999988765 6788999999999999999999999999999999
Q ss_pred ceeeeccccccc
Q 005940 261 SHYILGWSFSLN 272 (668)
Q Consensus 261 ~~~i~~w~F~~~ 272 (668)
.|+|++|+|+++
T Consensus 221 ~H~IlsWsF~s~ 232 (234)
T 2bqp_A 221 AHEVLSWSFHSE 232 (234)
T ss_dssp EEEEEEEEEEEE
T ss_pred cEEEEEEEEEee
Confidence 999999999864
|
| >2fmd_A Lectin, agglutinin, BMA; legume lectin, beta sandwich, protein-carbohydrate complex, sugar binding protein; HET: MAN; 1.90A {Bowringia mildbraedii} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-57 Score=447.91 Aligned_cols=224 Identities=32% Similarity=0.500 Sum_probs=200.2
Q ss_pred CceeEEeCCCCCCCCCeEEeCceeeCCCCcEEccCCCC------ceEEEEEeeCceecccCCCCCCCCeeeeEEEEEEEE
Q 005940 26 QSSSFIFQGFNGGATNLSLQGAEIIKPSGALKLTNRSR------YVIGHAFYVKPIQMFDTSASPSPNASSFSTTFVFEI 99 (668)
Q Consensus 26 ~~~~f~~~~f~~~~~~l~~~g~a~~~~~~~~~lt~~~~------~~~G~~~y~~p~~l~~~~~~~~~~~~sF~t~F~f~i 99 (668)
.+++|+|++|.++..+|+++|+|.+.++|.|+||++.. ++.|||+|++||+||+ + +++++||+|+|+|.|
T Consensus 2 ~~~~F~f~~F~~~~~~l~l~G~A~v~~~g~l~LT~~~~~~~~~~~~~G~a~y~~Pv~l~~---~-~g~~~sFst~F~F~I 77 (240)
T 2fmd_A 2 NSVCFTFTDFESGQQDLIFQGDASVGSNKALQLTKVDSKGNPQGGSVGRALYTAPIRLWQ---S-SSLVASFETTFTFSI 77 (240)
T ss_dssp CEEEEEESSCCTTCTTEEEEETCEECTTSCEECSCBCTTSCBCSSCEEEEEESSCEECCC---T-TCSEEEEEEEEEEEC
T ss_pred cceEEEcCCCCCCCCCeEEccceEEcCCCCEEeCCCCcCCcccCCCeEEEEECCCEEeeC---C-CCCcCcEEEEEEEEE
Confidence 46899999999766899999999998789999998875 7999999999999999 7 899999999999999
Q ss_pred eCCCCCCCCCceEEEEcCCCCCCCC-CCCCcccccccCCCCCCCccEEEEEeecccC--CCCCCCCCCCeeeeecCCccc
Q 005940 100 STPRSGRGGHGLAFLLAPSTKLPGA-QPEHYLGILNSTNNGEPSNHILIVEFDTVNG--FNDKAENQGNHVGIGINTMFS 176 (668)
Q Consensus 100 ~~~~~~~~g~GlaF~l~p~~~~~~~-~~~~~lGl~~~~~~~~~~~~~~aVEfDt~~n--~~d~~~~~~~Hvgid~~s~~s 176 (668)
.++ ...+||||||||+|....|.+ +.|+||||+|.+++++..+|+|||||||++| ++| |++||||||+|++.|
T Consensus 78 ~~~-~~~~gdGlAF~l~p~~~~p~~g~~g~~LGl~n~~~~~~~~n~~vAVEfDT~~N~~~~D---p~~nHvgIdvns~~S 153 (240)
T 2fmd_A 78 SQG-SSTPADALTFFIASPDTKIPSGSGGRLLGLFGSSNNAGSDNGVVSVEFDTYPNTDIGD---PNYRHIGIDVNSIRS 153 (240)
T ss_dssp CBS-SSSCCCEEEEEEECTTCCCCTTCCGGGTTTCSCCC----CCCEEEEEEECSCCGGGTC---CSSCEEEEEESSSSC
T ss_pred ecC-CCCCCCcEEEEEecCCCCCCccCCCCcccccccCcCCCCcCcEEEEEeccccccccCC---CCCCceeeccccccc
Confidence 987 677899999999998766765 8899999999887788899999999999998 355 999999999999999
Q ss_pred ccccCCccccCCCCCccccccCCCCcEEEEEEEeCCcceEEEEEEeCCCCCCCCcceeeeeccccccccceeeeeecccC
Q 005940 177 NRSEPASYYINGTDHKEEMTLESGEPIQAWIEYDGEQKVLNVTISPAEIGKPMRPLISFGVNLTGYIKETMYVGFSASTG 256 (668)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~V~~~~~~~~~p~~~~ls~~~dLs~~l~~~~~vGFsastG 256 (668)
..+.++ ++.+|+.++|||+||+..++|+|+|++.+. ..|+|++.+||+.+||++|||||||+||
T Consensus 154 ~~s~~~-------------~l~~g~~~~v~I~Yd~~~~~L~V~l~~~~~---~~~~ls~~vdL~~~l~~~~yvGFSAsTG 217 (240)
T 2fmd_A 154 KAASKW-------------DWQNGKTATAHISYNSASKRLSVVSSYPNS---SPVVVSFDVELNNVBPBWVRVGFSATTG 217 (240)
T ss_dssp SEEEEC-------------CCCSSCEEEEEEEEETTTTEEEEEEECTTS---CCEEEEEECCGGGTSCSEEEEEEEEECC
T ss_pred cceeEE-------------EeeCCCEEEEEEEEeCCCCEEEEEEecCCC---CceEEEEEechHHhCCCceEEEEEeccC
Confidence 887753 467899999999999999999999998754 4789999999999999999999999999
Q ss_pred CcccceeeecccccccC
Q 005940 257 EKSSSHYILGWSFSLNG 273 (668)
Q Consensus 257 ~~~~~~~i~~w~F~~~~ 273 (668)
...+.|+|++|+|++..
T Consensus 218 ~~~~~H~IlsWsF~s~~ 234 (240)
T 2fmd_A 218 QYTQTNNILAWSFRSSL 234 (240)
T ss_dssp SSCBCCEEEEEEEEEEE
T ss_pred CccccEEEEEEEeEecC
Confidence 99999999999998753
|
| >1wbf_A Protein (agglutinin); lectin (agglutinin), legume lectin, protein crystallography, group specificity, saccharide free form; HET: NAG; 2.30A {Psophocarpus tetragonolobus} SCOP: b.29.1.1 PDB: 2d3s_A* 2dtw_A* 1wbl_A* 2dty_A* 2du0_A* 2du1_A* 2e51_A* 2e53_A* 2zmk_A* 2zml_A* 2zmn_A* 2e7t_A* 2e7q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-57 Score=448.92 Aligned_cols=222 Identities=34% Similarity=0.534 Sum_probs=199.5
Q ss_pred CceeEEeCCCCCCCCCeEEeCceeeCCCCcEEccCCC-----CceEEEEEeeCceecccCCCCCCCCeeeeEEEEEEEEe
Q 005940 26 QSSSFIFQGFNGGATNLSLQGAEIIKPSGALKLTNRS-----RYVIGHAFYVKPIQMFDTSASPSPNASSFSTTFVFEIS 100 (668)
Q Consensus 26 ~~~~f~~~~f~~~~~~l~~~g~a~~~~~~~~~lt~~~-----~~~~G~~~y~~p~~l~~~~~~~~~~~~sF~t~F~f~i~ 100 (668)
.+++|+|++|.++..||+|+|+|.+.++|.|+||+.. .++.|||+|++||+||+ +.+++++||+|+|+|.|.
T Consensus 2 ~~~~F~f~~F~~~~~~l~l~G~A~v~~~g~l~LT~~~~~~~~~~~~Gra~y~~Pv~l~d---~~tg~vaSFsT~F~F~I~ 78 (242)
T 1wbf_A 2 KTISFNFNQFHQNEEQLKLQRDARISSNSVLELTKVVNGVPTWNSTGRALYAKPVQVWD---STTGNVASFETRFSFSIR 78 (242)
T ss_dssp CEEEEEESSCCTTCTTEEEEETCEECTTSCEESSCEETTEECSSCEEEEEESSCEECBC---TTTCCBCEEEEEEEEECC
T ss_pred cceEEEcCCCCCCCCCeEEccceEEccCCcEEecCcccCCcccCCeEEEEECCCEeccc---CCCCCeeeEEEEEEEEEe
Confidence 4679999999976689999999999878999999876 68999999999999999 889999999999999999
Q ss_pred CC-CCCCCCCceEEEEcCCCCCCCCCCCCcccccccCCCCCCCccEEEEEeecccCCCCCCCCCCCeeeeecCCcccccc
Q 005940 101 TP-RSGRGGHGLAFLLAPSTKLPGAQPEHYLGILNSTNNGEPSNHILIVEFDTVNGFNDKAENQGNHVGIGINTMFSNRS 179 (668)
Q Consensus 101 ~~-~~~~~g~GlaF~l~p~~~~~~~~~~~~lGl~~~~~~~~~~~~~~aVEfDt~~n~~d~~~~~~~Hvgid~~s~~s~~~ 179 (668)
++ +...+||||||||+|....| ++.|+||||+|.+ +.+|+|||||||++|. +||++||||||+||+.|.++
T Consensus 79 ~~~~~~~~gdGlAF~l~p~~~~~-~~~g~~LGl~n~~----~~~~~vAVEFDT~~N~---~Dp~~nHVGIdvNs~~S~~~ 150 (242)
T 1wbf_A 79 QPFPRPHPADGLVFFIAPPNTQT-GEGGGYFGIYNPL----SPYPFVAVEFDTFRNT---WDPQIPHIGIDVNSVISTKT 150 (242)
T ss_dssp CSCCSSCCCEEEEEEEECSSCCC-CCCGGGTTTCCTT----SCCCCEEEEEECSCCT---TCCSSSEEEEEESSSSCSEE
T ss_pred CCCCCCCCCCcEEEEEecCCCCC-CCCCCccccccCC----CcCcEEEEEeccccCC---CCCCCCeEEEECCCccccce
Confidence 87 56778999999999987544 4789999999864 5789999999999985 44999999999999999887
Q ss_pred cCCccccCCCCCccccccCCCCcEEEEEEEeCCcceEEEEEEeCCCCCCCCcceeeeeccccccccceeeeeeccc----
Q 005940 180 EPASYYINGTDHKEEMTLESGEPIQAWIEYDGEQKVLNVTISPAEIGKPMRPLISFGVNLTGYIKETMYVGFSAST---- 255 (668)
Q Consensus 180 ~~~~~~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~V~~~~~~~~~p~~~~ls~~~dLs~~l~~~~~vGFsast---- 255 (668)
.++ +|.+|+.++|||+||+.+++|+|+|++.+. |..|+|+..+||+.+|+|+|||||||+|
T Consensus 151 ~~~-------------~l~~G~~~~v~I~Yd~~~~~L~V~l~~~~~--~~~~~ls~~vdL~~~l~e~v~VGFSAsTg~~~ 215 (242)
T 1wbf_A 151 VPF-------------TLDNGGIANVVIKYDASTKILHVVLVFPSL--GTIYTIADIVDLKQVLPESVNVGFSAATGDPS 215 (242)
T ss_dssp EEC-------------CCCTTSCEEEEEEEETTTTEEEEEEEETTT--TEEEEEEEECCHHHHSCSEEEEEEEEEECCGG
T ss_pred eee-------------EecCCCEEEEEEEEeCCCCEEEEEEccCCC--CCcceEEEEechHHhcCCceEEEEEEeecCcC
Confidence 653 477999999999999999999999998754 5678999999999999999999999999
Q ss_pred CCc---ccceeeecccccccC
Q 005940 256 GEK---SSSHYILGWSFSLNG 273 (668)
Q Consensus 256 G~~---~~~~~i~~w~F~~~~ 273 (668)
|.. .|.|+|++|+|++..
T Consensus 216 G~~~~~~~~h~IlsWsF~s~l 236 (242)
T 1wbf_A 216 GKQRNATETHDILSWSFSASL 236 (242)
T ss_dssp GCCTTCCCCCEEEEEEEEEEC
T ss_pred CccccccceEEEEEEEeEecC
Confidence 888 899999999999864
|
| >1f9k_A Acidic lectin; legume lectin, glycosylated protein, H-antigenic specificity agglutinin, sugar binding protein; HET: NAG MAN AMG; 3.00A {Psophocarpus tetragonolobus} SCOP: b.29.1.1 PDB: 1fay_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-57 Score=447.49 Aligned_cols=221 Identities=32% Similarity=0.508 Sum_probs=199.2
Q ss_pred ceeEEeCCCCCCCCCeEEeCceeeCCCCcEEccCCC------CceEEEEEeeCceecccCCCCCCCCeeeeEEEEEEEEe
Q 005940 27 SSSFIFQGFNGGATNLSLQGAEIIKPSGALKLTNRS------RYVIGHAFYVKPIQMFDTSASPSPNASSFSTTFVFEIS 100 (668)
Q Consensus 27 ~~~f~~~~f~~~~~~l~~~g~a~~~~~~~~~lt~~~------~~~~G~~~y~~p~~l~~~~~~~~~~~~sF~t~F~f~i~ 100 (668)
+++|+|++|.++..+|+|+|+|.+.++|.|+||++. .++.|||+|++||+||+ +.+++++||+|+|+|.|.
T Consensus 2 ~~~F~f~~F~~~~~~l~l~G~A~v~~~g~l~LT~~~~~~~~~~~~~Gra~y~~Pv~l~d---~~~g~vasFsT~F~F~I~ 78 (238)
T 1f9k_A 2 TQSFNFDHFEENSKELNLQRQASIKSNGVLELTKLTKNGVPVWKSTGRALYAEPIKIWD---STTGNVASFETRFSFNIT 78 (238)
T ss_dssp EEEEEESSCCSSCTTEEEEETCEECTTSCEECSCSEETTEECCSCEEEEEESSCEECBC---TTTCCBCEEEEEEEEEEE
T ss_pred CeEEEcCCCCCCCCCeEEccceEECcCCcEEecCccccCccccCCEEEEEECCCEEeec---CCCCCeeeEEEEEEEEEe
Confidence 578999999966689999999999878999999876 57999999999999999 789999999999999999
Q ss_pred CC-CCCCCCCceEEEEcCCCCCCCCCCCCcccccccCCCCCCCccEEEEEeecccCCCCCCCCCCCeeeeecCCcccccc
Q 005940 101 TP-RSGRGGHGLAFLLAPSTKLPGAQPEHYLGILNSTNNGEPSNHILIVEFDTVNGFNDKAENQGNHVGIGINTMFSNRS 179 (668)
Q Consensus 101 ~~-~~~~~g~GlaF~l~p~~~~~~~~~~~~lGl~~~~~~~~~~~~~~aVEfDt~~n~~d~~~~~~~Hvgid~~s~~s~~~ 179 (668)
++ +...+||||||||+|....| ++.|+||||+|.+ +. +|+|||||||++|.+ ||++||||||+|++.|.++
T Consensus 79 ~~~~~~~~gdGlAF~l~p~~~~~-~~~g~~LGl~n~~---~~-~~~vAVEFDT~~N~~---Dp~~nHVgIdvns~~S~~s 150 (238)
T 1f9k_A 79 QPYAYPEPADGLTFFMVPPNSPQ-GEDGGNLGVFKPP---EG-DNAFAVEFDTFQNTW---DPQVPHIGIDVNSIVSSKT 150 (238)
T ss_dssp CCCSSSCCCEEEEEEEECTTCCC-CCSGGGTTTCCSS---CC-SCCEEEEEECSCCTT---CCSSSEEEEEESSSSCSEE
T ss_pred cCCCCCCCCCcEEEEEccCCCCC-CCCCCcccccccC---CC-CcEEEEEEecccCCC---CCCCCeEEEecCCccccce
Confidence 87 66778999999999987555 4789999999876 45 999999999999854 4999999999999999887
Q ss_pred cCCccccCCCCCccccccCCCCcEEEEEEEeCCcceEEEEEEeCCCCCCCCcceeeeecccccccc--ceeeeeecccCC
Q 005940 180 EPASYYINGTDHKEEMTLESGEPIQAWIEYDGEQKVLNVTISPAEIGKPMRPLISFGVNLTGYIKE--TMYVGFSASTGE 257 (668)
Q Consensus 180 ~~~~~~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~V~~~~~~~~~p~~~~ls~~~dLs~~l~~--~~~vGFsastG~ 257 (668)
.++ +|.+|+.++|||+||+..++|+|+|++.+. |..|+|+..+||+.+|++ +|||||||+||.
T Consensus 151 ~~~-------------~l~~g~~~~v~I~Yd~~~~~L~V~l~~~~~--~~~~~ls~~vdL~~~l~~~~~~~vGFSAsTG~ 215 (238)
T 1f9k_A 151 LHF-------------QLENGGVANVVIKYDSPTKILNVVLAFHSV--GTVYTLSNIVDLKQEFPNSEWVNVGLSATTGY 215 (238)
T ss_dssp EEC-------------CCCTTCCEEEEEEEETTTTEEEEEEEETTT--TEEEEEEEECCHHHHSTTCSEEEEEEEEEECS
T ss_pred Eee-------------cccCCCEEEEEEEEeCCCCEEEEEEecCCC--CCceeEEEEechHHhCCCCceEEEEEEeCcCC
Confidence 653 477999999999999999999999998754 567899999999999999 999999999999
Q ss_pred c---ccceeeecccccccC
Q 005940 258 K---SSSHYILGWSFSLNG 273 (668)
Q Consensus 258 ~---~~~~~i~~w~F~~~~ 273 (668)
. .|.|+|++|+|++..
T Consensus 216 ~~~~~~~h~IlsWsF~s~~ 234 (238)
T 1f9k_A 216 QKNAVETHEIISWSFTSSL 234 (238)
T ss_dssp STTCCCEEEEEEEEEEEEC
T ss_pred CCcccceEEEEEeEeEeec
Confidence 9 999999999998764
|
| >1fat_A Phytohemagglutinin-L; glycoprotein, plant defense protein, lectin; HET: NAG; 2.80A {Phaseolus vulgaris} SCOP: b.29.1.1 PDB: 1g8w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-57 Score=450.04 Aligned_cols=222 Identities=32% Similarity=0.524 Sum_probs=200.0
Q ss_pred CceeEEeCCCCCCCCCeEEeCceeeCCCCcEEccCCC------CceEEEEEeeCceecccCCCCCCCCeeeeEEEEEEEE
Q 005940 26 QSSSFIFQGFNGGATNLSLQGAEIIKPSGALKLTNRS------RYVIGHAFYVKPIQMFDTSASPSPNASSFSTTFVFEI 99 (668)
Q Consensus 26 ~~~~f~~~~f~~~~~~l~~~g~a~~~~~~~~~lt~~~------~~~~G~~~y~~p~~l~~~~~~~~~~~~sF~t~F~f~i 99 (668)
.+++|+|++|.. .||+++|+|.+.++|.|+||++. .++.|||+|++||+||+ +.+++++||+|+|+|.|
T Consensus 2 ~~~~F~f~~F~~--~~l~l~G~A~v~~~g~l~LT~~~~~~~~~~~~~Gra~y~~Pv~l~d---~~tg~vaSFsT~F~F~I 76 (252)
T 1fat_A 2 NDIYFNFQRFNE--TNLILQRDASVSSSGQLRLTNLNGNGEPRVGSLGRAFYSAPIQIWD---NTTGTVASFATSFTFNI 76 (252)
T ss_dssp CCEEEEESSCCG--GGEEEEETCEECTTSCEECSCCC-CCCCCTTCEEEEEEEEEEECEE---TTTTEEEEEEEEEEEEC
T ss_pred cceEEEcCCCCc--CCEEEeccEEECCCCEEEeCCCCCCCccccCCEEEEEECCCEeccc---CCCCcccceEEEEEEEE
Confidence 468999999985 79999999999878999999876 57999999999999999 78999999999999999
Q ss_pred eCCCCCCCCCceEEEEcCCCCCCCCCCCCcccccccCCCCCCCccEEEEEeecccCCCCCCCCCCCeeeeecCCcccccc
Q 005940 100 STPRSGRGGHGLAFLLAPSTKLPGAQPEHYLGILNSTNNGEPSNHILIVEFDTVNGFNDKAENQGNHVGIGINTMFSNRS 179 (668)
Q Consensus 100 ~~~~~~~~g~GlaF~l~p~~~~~~~~~~~~lGl~~~~~~~~~~~~~~aVEfDt~~n~~d~~~~~~~Hvgid~~s~~s~~~ 179 (668)
.+++...+||||||||+|....| ++.|+||||+|.+ ++.+|+|||||||++|. .|||++||||||+||+.|.++
T Consensus 77 ~~~~~~~~gdGlAF~l~p~~~~~-~~~g~~LGl~n~~---~~~~~~vAVEFDT~~N~--~~Dp~~nHVGIdvNs~~S~~~ 150 (252)
T 1fat_A 77 QVPNNAGPADGLAFALVPVGSQP-KDKGGFLGLFDGS---NSNFHTVAVEFDTLYNK--DWDPTERHIGIDVNSIRSIKT 150 (252)
T ss_dssp CCCSSCBCCEEEEEEEEETTCCC-CCSGGGTTTCCSS---CCCCCCEEEEEECSCCT--TTCCSSCEEEEEESSSSCSEE
T ss_pred eCCCCCCCCCcEEEEEccCCCCC-CCCCccccccccC---CccCcEEEEEeecccCC--CCCCCCCeEEEecCCccccce
Confidence 98876778999999999987655 4789999999975 56899999999999983 245999999999999999888
Q ss_pred cCCccccCCCCCccccccCCCCcEEEEEEEeCCcceEEEEEEeCCCCCCCCcceeeeeccccccccceeeeeecccCCc-
Q 005940 180 EPASYYINGTDHKEEMTLESGEPIQAWIEYDGEQKVLNVTISPAEIGKPMRPLISFGVNLTGYIKETMYVGFSASTGEK- 258 (668)
Q Consensus 180 ~~~~~~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~V~~~~~~~~~p~~~~ls~~~dLs~~l~~~~~vGFsastG~~- 258 (668)
.++ ++.+|+.++|||+||+..++|+|+|++.+. |..|+|++.+||+.+||++|||||||+||..
T Consensus 151 ~~~-------------~l~~G~~~~v~I~Yd~~~~~L~V~l~~~~~--~~~~~ls~~vdL~~~l~e~~~VGFSAsTG~~~ 215 (252)
T 1fat_A 151 TRW-------------DFVNGENAEVLITYDSSTNLLVASLVYPSQ--KTSFIVSDTVDLKSVLPEWVSVGFSATTGINK 215 (252)
T ss_dssp EEC-------------CCCTTCEEEEEEEEETTTTEEEEEEEETTT--TEEEEEEEECCHHHHSCSEEEEEEEEEECSST
T ss_pred ecc-------------cccCCCEEEEEEEEeCCCCEEEEEEecCCC--CCcceEEEEechHHhCCCceEEEEEeccCCCC
Confidence 763 467899999999999999999999998754 5678999999999999999999999999999
Q ss_pred --ccceeeecccccccC
Q 005940 259 --SSSHYILGWSFSLNG 273 (668)
Q Consensus 259 --~~~~~i~~w~F~~~~ 273 (668)
.+.|+|++|+|++..
T Consensus 216 ~~~~~H~IlsWsF~s~l 232 (252)
T 1fat_A 216 GNVETNDVLSWSFASKL 232 (252)
T ss_dssp TBCCCCEEEEEEEEEEE
T ss_pred cccceEEEEEEEEEeeC
Confidence 999999999999863
|
| >1g7y_A Stem/LEAF lectin DB58; jelly roll fold, sugar binding protein; HET: NAG FUC FUL; 2.50A {Vigna unguiculata subsp} SCOP: b.29.1.1 PDB: 1lul_A 1lu1_A* 1bjq_A* 1lu2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-56 Score=449.38 Aligned_cols=223 Identities=30% Similarity=0.511 Sum_probs=200.5
Q ss_pred CceeEEeCCCCCCCCCeEEeCceeeCCCCcEEccCCC------CceEEEEEeeCceecccCCCCCCCCeeeeEEEEEEEE
Q 005940 26 QSSSFIFQGFNGGATNLSLQGAEIIKPSGALKLTNRS------RYVIGHAFYVKPIQMFDTSASPSPNASSFSTTFVFEI 99 (668)
Q Consensus 26 ~~~~f~~~~f~~~~~~l~~~g~a~~~~~~~~~lt~~~------~~~~G~~~y~~p~~l~~~~~~~~~~~~sF~t~F~f~i 99 (668)
.+++|+|++|.. .+|+++|+|.+. +|.|+||++. .++.|||+|++||+||+ +.+++++||+|+|+|.|
T Consensus 2 ~~~~F~f~~F~~--~~l~l~GdA~v~-~g~l~LT~~~~~~~~~~~~~Gra~y~~Pv~l~d---~~tg~vaSFsT~F~F~I 75 (253)
T 1g7y_A 2 DIQSFSFKNFNS--SSFILQGDATVS-SSKLRLTKVKGNGLPTLSSLGRAFYSSPIQIYD---KSTGAVASWATSFTANI 75 (253)
T ss_dssp EEEEEEESSCCS--SCEEEEETCEEE-TTEEECSCBCTTSCBCSSCEEEEEESSCEECBC---TTTCCBCEEEEEEEEEC
T ss_pred cceEEEcCCCCc--CCEEEecceEEe-CCEEEeCCCCCCCccccCCeEEEEECCCEEeec---CCCCCccceEEEEEEEE
Confidence 467999999985 799999999998 8999999876 57999999999999999 88999999999999999
Q ss_pred eCCCCCCCCCceEEEEcCCCCCCCCCCCCcccccccCCCCCCCccEEEEEeecccCCCCCCCCCCCeeeeecCCcccccc
Q 005940 100 STPRSGRGGHGLAFLLAPSTKLPGAQPEHYLGILNSTNNGEPSNHILIVEFDTVNGFNDKAENQGNHVGIGINTMFSNRS 179 (668)
Q Consensus 100 ~~~~~~~~g~GlaF~l~p~~~~~~~~~~~~lGl~~~~~~~~~~~~~~aVEfDt~~n~~d~~~~~~~Hvgid~~s~~s~~~ 179 (668)
.+++...+||||||||+|....| ++.|+||||+|.++ ++..+|+|||||||++|. .|||++||||||+||+.|.++
T Consensus 76 ~~~~~~~~gdGlAF~l~p~~~~~-~~~g~~LGl~n~~~-~~~~n~~vAVEFDT~~N~--~~Dp~~nHVGIdvns~~S~~t 151 (253)
T 1g7y_A 76 FAPNKSSSADGIAFALVPVGSEP-KSNSGFLGVFDSDV-YDNSAQTVAVEFDTFSNT--DWDPTSRHIGIDVNSIKSIRT 151 (253)
T ss_dssp CCSSGGGCCCEEEEEEEETTCCC-CCCGGGTTTCSCSS-CCGGGCCEEEEEECSCCT--TTCCSSCEEEEEESSSSCSEE
T ss_pred ecCCCCCCCCcEEEEEecCCCCC-CCCCCcccccccCC-CCccCceEEEEecceecc--CcCCCCCcEeeccCCccccce
Confidence 98866778999999999987555 48899999999775 467899999999999983 145999999999999999888
Q ss_pred cCCccccCCCCCccccccCCCCcEEEEEEEeCCcceEEEEEEeCCCCCCCCcceeeeeccccccccceeeeeecccCCc-
Q 005940 180 EPASYYINGTDHKEEMTLESGEPIQAWIEYDGEQKVLNVTISPAEIGKPMRPLISFGVNLTGYIKETMYVGFSASTGEK- 258 (668)
Q Consensus 180 ~~~~~~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~V~~~~~~~~~p~~~~ls~~~dLs~~l~~~~~vGFsastG~~- 258 (668)
.++ ++.+|+.++|||+||+..++|+|+|++.+. |..|+|+..+||+.+||++|||||||+||..
T Consensus 152 ~~~-------------~l~~g~~~~v~I~Yd~~~~~L~V~l~~~~~--~~~~~ls~~vdL~~~l~e~~~VGFSAsTG~~~ 216 (253)
T 1g7y_A 152 ASW-------------GLANGQNAEILITYNAATSLLVASLVHPSR--RTSYIVSERVDITNELPEYVSIGFSATTGLSE 216 (253)
T ss_dssp EEC-------------CCCTTSEEEEEEEEETTTTEEEEEEEETTT--TEEEEEEEECCHHHHSCSEEEEEEEEECCSSS
T ss_pred ecc-------------ccCCCCeEEEEEEEeCCCCEEEEEEecCCC--CCcceEEEEechHHhCCCceEEEEEeCcCCCC
Confidence 763 477899999999999999999999998754 5678999999999999999999999999999
Q ss_pred --ccceeeecccccccC
Q 005940 259 --SSSHYILGWSFSLNG 273 (668)
Q Consensus 259 --~~~~~i~~w~F~~~~ 273 (668)
.+.|+|++|+|++..
T Consensus 217 ~~~~~H~IlsWsF~s~l 233 (253)
T 1g7y_A 217 GYTETHDVLSWSFASKL 233 (253)
T ss_dssp SCCCCCEEEEEEEEEEE
T ss_pred cccceeEEEEEEEEeeC
Confidence 999999999999863
|
| >1avb_A Arcelin-1; lectin-like glycoprotein, plant defense, insecticidal activi lectin; HET: NAG; 1.90A {Phaseolus vulgaris} SCOP: b.29.1.1 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-56 Score=441.01 Aligned_cols=217 Identities=36% Similarity=0.545 Sum_probs=196.6
Q ss_pred CceeEEeCCCCCCCCCeEEeCceeeCCCCcEEccCC---CCceEEEEEeeCceecccCCCCCCCCeeeeEEEEEEEEeCC
Q 005940 26 QSSSFIFQGFNGGATNLSLQGAEIIKPSGALKLTNR---SRYVIGHAFYVKPIQMFDTSASPSPNASSFSTTFVFEISTP 102 (668)
Q Consensus 26 ~~~~f~~~~f~~~~~~l~~~g~a~~~~~~~~~lt~~---~~~~~G~~~y~~p~~l~~~~~~~~~~~~sF~t~F~f~i~~~ 102 (668)
..++|+|++|.. .||+|+|+|.+.++|.|+||++ ..++.|||+|++||++|+ +.+++++||+|+|+|.|.++
T Consensus 2 ~~~~F~f~~F~~--~~l~l~G~A~v~~~g~l~LT~~~~~~~~~~Gra~y~~Pv~l~~---~~~g~vaSFsT~F~F~I~~~ 76 (226)
T 1avb_A 2 NDASFNVETFNK--TNLILQGDATVSSEGHLLLTNVKGNEEDSMGRAFYSAPIQIND---RTIDNLASFSTNFTFRINAK 76 (226)
T ss_dssp EEEEEEESSCCG--GGEEEEETCEECTTSCEECSCSSSCCTTCEEEEEESSCEECEE---GGGTEEEEEEEEEEEEEEES
T ss_pred cceEEEcCCCCc--cCEEEeccEEECCCCEEEeCCCCCCccCCeEEEEeCCCEEeec---CCCCCcccEEEEEEEEEeCC
Confidence 357899999985 7999999999977899999988 778999999999999999 78899999999999999988
Q ss_pred CCCCCCCceEEEEcCCCCCCCCCCCCcccccccCCCCCCCccEEEEEeecccCCCCCCCCCCCeeeeecCCcccccccCC
Q 005940 103 RSGRGGHGLAFLLAPSTKLPGAQPEHYLGILNSTNNGEPSNHILIVEFDTVNGFNDKAENQGNHVGIGINTMFSNRSEPA 182 (668)
Q Consensus 103 ~~~~~g~GlaF~l~p~~~~~~~~~~~~lGl~~~~~~~~~~~~~~aVEfDt~~n~~d~~~~~~~Hvgid~~s~~s~~~~~~ 182 (668)
+...+||||||||+|....|+ +.|+||||+|.+ +++..+|+|||||||+ +||||||+||+.|.+++++
T Consensus 77 ~~~~~gdGlAF~l~p~~~~p~-~~g~~LGl~n~~-~~~~~~~~vAVEFDT~----------~nHVGIdvNs~~S~~t~~~ 144 (226)
T 1avb_A 77 NIENSAYGLAFALVPVGSRPK-LKGRYLGLFNTT-NYDRDAHTVAVVFDTV----------SNRIEIDVNSIRPIATESC 144 (226)
T ss_dssp STTSCCEEEEEEEEETTCCCC-CCGGGTTTCSCS-SCCGGGCCEEEEEETT----------TTEEEEEESSSSCSEEEEC
T ss_pred CCCCCCCcEEEEEecCCCCCC-CCCCcccccccC-CCCCcccEEEEEecCc----------CCccceeecCcccCccccC
Confidence 777889999999999876666 889999999976 4577899999999998 3699999999999998774
Q ss_pred ccccCCCCCccccccCCCCcEEEEEEEeCCcceEEEEEEeCCCCCCCCcceeeeeccccccccceeeeeecccCCc---c
Q 005940 183 SYYINGTDHKEEMTLESGEPIQAWIEYDGEQKVLNVTISPAEIGKPMRPLISFGVNLTGYIKETMYVGFSASTGEK---S 259 (668)
Q Consensus 183 ~~~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~V~~~~~~~~~p~~~~ls~~~dLs~~l~~~~~vGFsastG~~---~ 259 (668)
+..|.+|+.++|||+||+..++|+|+|++.+. +++|+|++.+||+++|+|+|||||||+||.. .
T Consensus 145 -----------~~~l~~g~~~~v~I~Yd~~~~~L~V~l~~~~~--~~~~~ls~~vdL~~~l~e~~~VGFSAsTG~~~~~~ 211 (226)
T 1avb_A 145 -----------NFGHNNGEKAEVRITYDSPKNDLRVSLLYPSS--EEKCHVSATVPLEKEVEDWVSVGFSATSGSKKETT 211 (226)
T ss_dssp -----------CSGGGTTCEEEEEEEEEGGGTEEEEEEEETTT--TEEEEEEEECCHHHHSCSEEEEEEEEEECSSGGGC
T ss_pred -----------CccccCCCeEEEEEEEeCCCcEEEEEEeecCC--CccceEEEEechHHhCCCceEEEEEeccCCCCccc
Confidence 25677999999999999999999999998754 3478999999999999999999999999999 9
Q ss_pred cceeeeccccccc
Q 005940 260 SSHYILGWSFSLN 272 (668)
Q Consensus 260 ~~~~i~~w~F~~~ 272 (668)
|.|+|++|+|+++
T Consensus 212 ~~h~IlsWsF~s~ 224 (226)
T 1avb_A 212 ETHNVLSWSFSSN 224 (226)
T ss_dssp EEEEEEEEEEEEE
T ss_pred ceeEEEEEEEEee
Confidence 9999999999864
|
| >1gsl_A Griffonia simplicifolia lectin 4; glycoprotein, manganese; HET: FUC GAL MAG NAG BMA; 2.00A {Griffonia simplicifolia} SCOP: b.29.1.1 PDB: 1lec_A* 1led_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-56 Score=440.78 Aligned_cols=221 Identities=29% Similarity=0.468 Sum_probs=196.6
Q ss_pred CceeEEeCCC----CCCCCCeEEeCceeeCCCCcEEccCCC------CceEEEEEeeCceecccCCCCCCCCeeeeEEEE
Q 005940 26 QSSSFIFQGF----NGGATNLSLQGAEIIKPSGALKLTNRS------RYVIGHAFYVKPIQMFDTSASPSPNASSFSTTF 95 (668)
Q Consensus 26 ~~~~f~~~~f----~~~~~~l~~~g~a~~~~~~~~~lt~~~------~~~~G~~~y~~p~~l~~~~~~~~~~~~sF~t~F 95 (668)
.+++|+|++| .++..+|+|+|+|.+. +|.|+||++. .++.|||+|++||+||+ .+++++||+|+|
T Consensus 2 ~~~~F~f~~F~~~~~~~~~~l~l~GdA~i~-~g~l~LT~~~~~~~~~~~~~Gra~y~~Pv~l~~----~tg~vasFsT~F 76 (243)
T 1gsl_A 2 NTVNFTYPDFWSYSLKNGTEITFLGDATRI-PGALQLTKTDANGNPVRSSAGQASYSEPVFLWD----STGKAASFYTSF 76 (243)
T ss_dssp CCCEEEESCCCCTTCCTTSSEEEEETCEEE-TTEEECSCBCTTSCBCSSEEEEEEESSCEECBC----TTSCBCEEEEEE
T ss_pred cceEEEcCCCccccCCCCCCEEEccceEec-CCcEEecCCccCCcccCCCeEEEEECCCEEccC----CCCCcCceEEEE
Confidence 4679999999 6545799999999998 8999999876 57999999999999998 367899999999
Q ss_pred EEEEeCCCCCCCCCceEEEEcCCCCCCCCCCCCcccccccCCC-CCCCccEEEEEeecccC--CCCCCCCCCCeeeeecC
Q 005940 96 VFEISTPRSGRGGHGLAFLLAPSTKLPGAQPEHYLGILNSTNN-GEPSNHILIVEFDTVNG--FNDKAENQGNHVGIGIN 172 (668)
Q Consensus 96 ~f~i~~~~~~~~g~GlaF~l~p~~~~~~~~~~~~lGl~~~~~~-~~~~~~~~aVEfDt~~n--~~d~~~~~~~Hvgid~~ 172 (668)
+|.|.++ ...+||||||||+|....| ++.|+||||+|.+++ ++..+|+|||||||++| ++| |++||||||+|
T Consensus 77 ~F~I~~~-~~~~gdGlAF~l~p~~~~~-~~~g~~LGl~n~~~~~~~~~n~~vAVEFDT~~N~~~~D---p~~nHvGIdvn 151 (243)
T 1gsl_A 77 TFLLKNY-GAPTADGLAFFLAPVDSSV-KDYGGFLGLFRHETAADPSKNQVVAVEFDTWINKDWND---PPYPHIGIDVN 151 (243)
T ss_dssp EEEEEES-SSSCBCEEEEEEEETTCCC-CCCGGGTTTSCTTTTTCGGGCCCEEEEEECSCCGGGTC---CSSCEEEEEES
T ss_pred EEEEecC-CCCCCCCEEEEEecCCCCC-CCCCCcccccccccccCCccCcEEEEEeccccccccCC---CCCCceeeccC
Confidence 9999987 6778999999999987554 488999999998764 77889999999999998 336 99999999999
Q ss_pred CcccccccCCccccCCCCCccccccCC---CCcEEEEEEEeCCcceEEEEEEeCCCCCCCCcceeeeeccccccccceee
Q 005940 173 TMFSNRSEPASYYINGTDHKEEMTLES---GEPIQAWIEYDGEQKVLNVTISPAEIGKPMRPLISFGVNLTGYIKETMYV 249 (668)
Q Consensus 173 s~~s~~~~~~~~~~~~~~~~~~~~l~~---g~~~~~~I~Y~~~~~~l~V~~~~~~~~~p~~~~ls~~~dLs~~l~~~~~v 249 (668)
|+.|.++.++ ++.+ |+.++|||+||+..++|+|+|++.+. ..|+|++.+||+.+||++|||
T Consensus 152 s~~S~~~~~~-------------~l~~~~~g~~~~v~I~Yd~~~~~L~V~l~~~~~---~~~~ls~~vdL~~~l~~~~~v 215 (243)
T 1gsl_A 152 SIVSVATTRW-------------ENDDAYGSSIATAHITYDARSKILTVLLSYEHG---RDYILSHVVDLAKVLPQKVRI 215 (243)
T ss_dssp SSSCSEEEEC-------------CHHHHTSCCEEEEEEEEETTTTEEEEEEEETTS---CEEEEEEECCHHHHSCSEEEE
T ss_pred Cccccceeee-------------EEeccCCCcEEEEEEEEeCCCCEEEEEEecCCC---CceeEEEEechHHhCCCceEE
Confidence 9999888764 3556 99999999999999999999998764 468999999999999999999
Q ss_pred eeecccCCcccceeeecccccccC
Q 005940 250 GFSASTGEKSSSHYILGWSFSLNG 273 (668)
Q Consensus 250 GFsastG~~~~~~~i~~w~F~~~~ 273 (668)
||||+|| ..+.|+|++|+|++..
T Consensus 216 GFSAsTG-~~~~h~IlsWsF~s~l 238 (243)
T 1gsl_A 216 GFSAGVG-YDEVTYILSWHFFSTL 238 (243)
T ss_dssp EEEEEEC-BSEEEEEEEEEEEEEC
T ss_pred EEEeccC-CcceeEEEEEEEEeec
Confidence 9999999 9999999999999864
|
| >1ioa_A Arcelin-5A, ARC5A; lectin-like proteins, plant defense proteins, lectin; HET: NAG FUC; 2.70A {Phaseolus vulgaris} SCOP: b.29.1.1 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-55 Score=436.79 Aligned_cols=216 Identities=33% Similarity=0.505 Sum_probs=194.3
Q ss_pred CceeEEeCCCCCCCCC-eEEeCceeeCCCCcEEccCCCC------ceEEEEEeeCceecccCCCCCCCCeeeeEEEEEEE
Q 005940 26 QSSSFIFQGFNGGATN-LSLQGAEIIKPSGALKLTNRSR------YVIGHAFYVKPIQMFDTSASPSPNASSFSTTFVFE 98 (668)
Q Consensus 26 ~~~~f~~~~f~~~~~~-l~~~g~a~~~~~~~~~lt~~~~------~~~G~~~y~~p~~l~~~~~~~~~~~~sF~t~F~f~ 98 (668)
.+++|+|++|.. .| |+|+|+|.+.++|.|+||++.. ++.|||+|++||+||+ +. +++||+|+|+|.
T Consensus 2 ~~~~F~f~~F~~--~~~l~l~G~A~v~~~g~l~LT~~~~~~~~~~~s~Gra~y~~Pi~l~d---~~--~vaSFsT~F~F~ 74 (240)
T 1ioa_A 2 TETSFNFPNFHT--DDKLILQGNATISSKGQLQLTGVGSNELPRVDSLGRAFYSDPIQIKD---SN--NVASFNTNFTFI 74 (240)
T ss_dssp CCCEEEESSCCT--TSSEEEEETCEECTTSCEETTCBCTTSSBCSSCBEEEEESSCEECBC---SS--CBEEEEEEEEEE
T ss_pred cceEEEcCCCCC--CCcEEEccceEECCCCeEEeCCCCCCCccccCceEEEEECCCEEccC---CC--ccccEEEEEEEE
Confidence 457899999986 78 9999999997789999998775 7999999999999999 44 799999999999
Q ss_pred EeCCCCCCCCCceEEEEcCCCCCCCCCCCCcccccccCCCCCCCccEEEEEeecccCCCCCCCCCCCeeeeecCCccccc
Q 005940 99 ISTPRSGRGGHGLAFLLAPSTKLPGAQPEHYLGILNSTNNGEPSNHILIVEFDTVNGFNDKAENQGNHVGIGINTMFSNR 178 (668)
Q Consensus 99 i~~~~~~~~g~GlaF~l~p~~~~~~~~~~~~lGl~~~~~~~~~~~~~~aVEfDt~~n~~d~~~~~~~Hvgid~~s~~s~~ 178 (668)
|.+++...+||||||||+|....|+ +.|+||||+|.+ +++..+|+|||||||+ +||||||+||+.|.+
T Consensus 75 I~~~~~~~~gdGlAF~l~p~~~~p~-~~g~~LGL~n~~-~~~~~~~~vAVEFDT~----------~nHVGIdvNs~~S~~ 142 (240)
T 1ioa_A 75 IRAKNQSISAYGLAFALVPVNSPPQ-KKQEFLGIFNTN-NPEPNARTVAVVFNTF----------KNRIDFDKNFIKPYV 142 (240)
T ss_dssp CCBSCTTSCCEEEEEEEEETTCCCC-CCGGGTTTCCCS-SCCGGGCCEEEEEETT----------TTEEEEEESSSSCSE
T ss_pred EeCCCCCCCCCcEEEEEecCCCCCC-CCCCcccccccC-CCCCcCcEEEEEecCc----------CCceeeeeCCccccc
Confidence 9988777889999999999876666 889999999976 4577899999999998 369999999999998
Q ss_pred ccCCccccCCCCCccccccCCCCcEEEEEEEeCCcceEEEEEEeCCCCCCCCcceeeeeccccccccceeeeeecccCCc
Q 005940 179 SEPASYYINGTDHKEEMTLESGEPIQAWIEYDGEQKVLNVTISPAEIGKPMRPLISFGVNLTGYIKETMYVGFSASTGEK 258 (668)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~V~~~~~~~~~p~~~~ls~~~dLs~~l~~~~~vGFsastG~~ 258 (668)
++++ +..|.+|+.++|||+||+..++|+|+|++.+. +.+|+|+..+||+++|+|+|||||||+||..
T Consensus 143 t~~~-----------~~~l~~g~~~~v~I~Yd~~~~~L~V~l~~~~~--~~~~~ls~~vdL~~~l~e~v~VGFSAsTG~~ 209 (240)
T 1ioa_A 143 NENC-----------DFHKYNGEKTDVQITYDSSNNDLRVFLHFTVS--QVKCSVSATVHLEKEVDEWVSVGFSPTSGLT 209 (240)
T ss_dssp EEEC-----------CHHHHCSSCEEEEEEEETTTTEEEEEEEETTT--CCEEEEEEECCGGGTSCSEEEEEEEEEECSS
T ss_pred cccC-----------CccccCCCEEEEEEEEeCCCcEEEEEEecCCC--CccceeEEEechHHhCCCceEEEEEeccCCC
Confidence 8774 25677999999999999999999999998754 4478999999999999999999999999999
Q ss_pred ---ccceeeecccccccC
Q 005940 259 ---SSSHYILGWSFSLNG 273 (668)
Q Consensus 259 ---~~~~~i~~w~F~~~~ 273 (668)
.|.|+|++|+|++.+
T Consensus 210 ~~~~~~H~IlsWsF~s~~ 227 (240)
T 1ioa_A 210 EDTTETHDVLSWSFSSKF 227 (240)
T ss_dssp TTTCBCCEEEEEEEEEEE
T ss_pred CcccceeEEEEEEEEeeC
Confidence 999999999999864
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-51 Score=434.22 Aligned_cols=261 Identities=26% Similarity=0.384 Sum_probs=206.4
Q ss_pred cCcccceeeeecCcEEEEEEEeC-----CCCcEEEEEEEecCCchhHHHHHHHHHHHhcccccCceeEeeeecccCceEE
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLP-----TTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLL 427 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l 427 (668)
++|...++||+|+||+||+|++. .++..||||++.....+..++|.+|+++|++|+|||||+++|+|.+.+.++|
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 120 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 35667889999999999999874 3577899999988777778899999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhcCCCC------------CCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCE
Q 005940 428 VYEYIPNGSLDTLLFKPKD------------GSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNA 495 (668)
Q Consensus 428 V~E~~~~gsL~~~l~~~~~------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~ 495 (668)
|||||++|+|.++|+.... ...++|.++++|+.|||+||+|||+ ++|+||||||+||||++++.+
T Consensus 121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDLKp~NILl~~~~~~ 197 (329)
T 4aoj_A 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAG---LHFVHRDLATRNCLVGQGLVV 197 (329)
T ss_dssp EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTTEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecccccHhhEEECCCCcE
Confidence 9999999999999975321 2469999999999999999999999 999999999999999999999
Q ss_pred EEEeecCceeccCCCC-CcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHHHh
Q 005940 496 RLGDFGLARLYDHGGM-PHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVAT-GRRPIGSGDLLLVEWVRECHQ 573 (668)
Q Consensus 496 kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~l~~~~~~~~~ 573 (668)
||+|||+++....... .......||+.|||||++.+..++.++|||||||++|||+| |+.||...... +.+.....
T Consensus 198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~--~~~~~i~~ 275 (329)
T 4aoj_A 198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNT--EAIDCITQ 275 (329)
T ss_dssp EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHH--HHHHHHHH
T ss_pred EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHH--HHHHHHHc
Confidence 9999999997654332 23345689999999999999999999999999999999999 99999764321 11122222
Q ss_pred cCccccccCcccCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhccCcCCC
Q 005940 574 LGRILDVADPLLNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSGEKQLR 628 (668)
Q Consensus 574 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~~~~~~ 628 (668)
+... .....++ ..+..++..|++. |++||+|+||+++|+...+.|
T Consensus 276 -g~~~-----~~p~~~~----~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~p 321 (329)
T 4aoj_A 276 -GREL-----ERPRACP----PEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAP 321 (329)
T ss_dssp -TCCC-----CCCTTCC----HHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHSC
T ss_pred -CCCC-----CCccccc----HHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhCC
Confidence 2211 1112222 3455677799998 999999999999998876554
|
| >1dhk_B Bean lectin-like inhibitor, porcine pancreatic alpha-amylase; CO (hydrolase-inhibitor), complex (hydrolase-inhibitor) comple; HET: NAG; 1.85A {Phaseolus vulgaris} SCOP: b.29.1.1 PDB: 1viw_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-51 Score=403.32 Aligned_cols=200 Identities=34% Similarity=0.502 Sum_probs=175.4
Q ss_pred CceeEEeCCCCCCCCCeEEeCceeeCCCCcEEccCCCCceEEEEEeeCceecccCCCCCCCCeeeeEEEEEEEEeCCCCC
Q 005940 26 QSSSFIFQGFNGGATNLSLQGAEIIKPSGALKLTNRSRYVIGHAFYVKPIQMFDTSASPSPNASSFSTTFVFEISTPRSG 105 (668)
Q Consensus 26 ~~~~f~~~~f~~~~~~l~~~g~a~~~~~~~~~lt~~~~~~~G~~~y~~p~~l~~~~~~~~~~~~sF~t~F~f~i~~~~~~ 105 (668)
..++|+|++|.. .||+++|+|.+.++|.|+||++..++.|||+|++||++|+ +.+++++||+|+|+|.|.+++..
T Consensus 2 ~~~~F~f~~F~~--~~l~l~G~A~v~~~g~l~LT~~~~~~~Gra~y~~Pi~l~~---~~~g~vaSFsT~F~F~I~~~~~~ 76 (223)
T 1dhk_B 2 TETSFIIDAFNK--TNLILQGDATVSSNGNLQLSYNSYDSMSRAFYSAPIQIRD---STTGNVASFDTNFTMNIRTHRQA 76 (223)
T ss_dssp CCCEEEESSCCG--GGEEEESSEEECTTSCEEESSSCSSEEEEEEESSCEESEE---TTTTEECEEEEEEEEEEECCC--
T ss_pred cceEEEcCCCCc--CCEEEeccEEECCCCEEEcCCCCCCCEEEEEECCCEEeec---CCCCCccceEEEEEEEEeCCCCC
Confidence 457899999985 7999999999977899999999889999999999999999 78899999999999999988777
Q ss_pred CCCCceEEEEcCCCCCCCCCCCCcccccccCCCCCCCccEEEEEeecccCCCCCCCCCCCeeeeecCCcccccccCCccc
Q 005940 106 RGGHGLAFLLAPSTKLPGAQPEHYLGILNSTNNGEPSNHILIVEFDTVNGFNDKAENQGNHVGIGINTMFSNRSEPASYY 185 (668)
Q Consensus 106 ~~g~GlaF~l~p~~~~~~~~~~~~lGl~~~~~~~~~~~~~~aVEfDt~~n~~d~~~~~~~Hvgid~~s~~s~~~~~~~~~ 185 (668)
.+||||||||+|....|+ +++|||||||+ +||||||+||+ |.+++++
T Consensus 77 ~~gdGlAF~l~p~~~~p~-------------------~~~vAVEFDT~----------~nHVGIdvNsi-S~~~~~~--- 123 (223)
T 1dhk_B 77 NSAVGLDFVLVPVQPESK-------------------GDTVTVEFDTF----------LSRISIDVNNN-DIKSVPW--- 123 (223)
T ss_dssp -CCSEEEEEEEEC-------------------------CCEEEEEETT----------TTEEEEEETTE-EEEEEEC---
T ss_pred CCCCceEEEEecCCCCCC-------------------ccEEEEEecCC----------CCcccccCCcc-ccccccC---
Confidence 889999999999764321 34899999998 36999999999 9888764
Q ss_pred cCCCCCccccccCCCCcEEEEEEEeCCcceEEEEEEeCCCCCCCCcceeeeeccccccccceeeeeecccCCc---ccce
Q 005940 186 INGTDHKEEMTLESGEPIQAWIEYDGEQKVLNVTISPAEIGKPMRPLISFGVNLTGYIKETMYVGFSASTGEK---SSSH 262 (668)
Q Consensus 186 ~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~V~~~~~~~~~p~~~~ls~~~dLs~~l~~~~~vGFsastG~~---~~~~ 262 (668)
+..|.+|+.++|||+||+..++|+|++++.+. +++|+|+..+||+++|||+|||||||+||.. .+.|
T Consensus 124 --------~~~l~~g~~~~v~I~Yd~~~~~L~V~l~~~~~--~~~~~ls~~vdLs~~l~e~~~VGFSAsTG~~~~~~~~H 193 (223)
T 1dhk_B 124 --------DVHDYDGQNAEVRITYNSSTKVFSVSLSNPST--GKSNNVSTTVELEKEVYDWVSVGFSATSGAYQWSYETH 193 (223)
T ss_dssp --------CGGGTTTSCEEEEEEEETTTTEEEEEEECTTT--CCEEEEEEECCCCSGGGSEEEEEEEEEECSGGGSCCEE
T ss_pred --------CccccCCCEEEEEEEEeCCCCEEEEEEecCCC--CccceEEEEechHHhCCCceEEEEEeccCCCccccceE
Confidence 35677999999999999999999999998754 3479999999999999999999999999999 9999
Q ss_pred eeecccccccC
Q 005940 263 YILGWSFSLNG 273 (668)
Q Consensus 263 ~i~~w~F~~~~ 273 (668)
+|++|+|++.+
T Consensus 194 ~IlsWsF~s~~ 204 (223)
T 1dhk_B 194 DVLSWSFSSKF 204 (223)
T ss_dssp EEEEEEEEEEC
T ss_pred EEEEEEEEecc
Confidence 99999999864
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-51 Score=429.47 Aligned_cols=258 Identities=26% Similarity=0.418 Sum_probs=209.9
Q ss_pred cCcccceeeeecCcEEEEEEEeC-----CCCcEEEEEEEecCCchhHHHHHHHHHHHhcccccCceeEeeeecccCceEE
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLP-----TTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLL 427 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l 427 (668)
++|...++||+|+||+||+|++. .++..||||++.....+..++|.+|+++|++|+|||||+++|+|.+++..+|
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 92 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 92 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 45777899999999999999874 3467899999988777778899999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhcCC----------CCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEE
Q 005940 428 VYEYIPNGSLDTLLFKP----------KDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARL 497 (668)
Q Consensus 428 V~E~~~~gsL~~~l~~~----------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl 497 (668)
|||||++|+|.++|+.. .....++|.++++|+.|||+||.|||+ ++|+||||||+||||++++.+||
T Consensus 93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDlKp~NILl~~~~~~Ki 169 (299)
T 4asz_A 93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLAS---QHFVHRDLATRNCLVGENLLVKI 169 (299)
T ss_dssp EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCccCHhhEEECCCCcEEE
Confidence 99999999999999642 123569999999999999999999999 99999999999999999999999
Q ss_pred EeecCceeccCCCCC-cccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHHHhcC
Q 005940 498 GDFGLARLYDHGGMP-HTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVAT-GRRPIGSGDLLLVEWVRECHQLG 575 (668)
Q Consensus 498 ~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~l~~~~~~~~~~~ 575 (668)
+|||+|+........ ......||+.|||||++.++.++.++|||||||++|||+| |+.||...... +.... ...+
T Consensus 170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~--~~~~~-i~~~ 246 (299)
T 4asz_A 170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN--EVIEC-ITQG 246 (299)
T ss_dssp CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH--HHHHH-HHHT
T ss_pred CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH--HHHHH-HHcC
Confidence 999999876543322 2233578999999999999999999999999999999999 99999764322 11222 2222
Q ss_pred ccccccCcccCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhccCc
Q 005940 576 RILDVADPLLNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSGEK 625 (668)
Q Consensus 576 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~~~ 625 (668)
.... ....++ ..+..++..|++. |++||+|+||++.|+...
T Consensus 247 ~~~~-----~p~~~~----~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~ 288 (299)
T 4asz_A 247 RVLQ-----RPRTCP----QEVYELMLGCWQREPHMRKNIKGIHTLLQNLA 288 (299)
T ss_dssp CCCC-----CCTTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCC-----CCccch----HHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 2211 111222 3456677799998 999999999999998653
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-51 Score=425.17 Aligned_cols=256 Identities=27% Similarity=0.401 Sum_probs=207.0
Q ss_pred CcccceeeeecCcEEEEEEEeC-----CCCcEEEEEEEecCCc-hhHHHHHHHHHHHhcccccCceeEeeeecccCceEE
Q 005940 354 GFKESEVIGIGGFGSVYKGVLP-----TTGGEVAVKKITRNSL-QGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLL 427 (668)
Q Consensus 354 ~f~~~~~lG~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l 427 (668)
.++..++||+|+||+||+|++. .+++.||||++..... ...++|.+|+.++++++|||||+++|+|.+.+.++|
T Consensus 27 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~l 106 (308)
T 4gt4_A 27 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSM 106 (308)
T ss_dssp GEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred HCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEE
Confidence 3556789999999999999973 3567899999975433 345789999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhcCCCC-------------CCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCC
Q 005940 428 VYEYIPNGSLDTLLFKPKD-------------GSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMN 494 (668)
Q Consensus 428 V~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~ 494 (668)
|||||++|+|.++|..... ...++|.++++|+.|||+||+|||+ ++|+||||||+||||+++++
T Consensus 107 V~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDLK~~NILl~~~~~ 183 (308)
T 4gt4_A 107 IFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSS---HHVVHKDLATRNVLVYDKLN 183 (308)
T ss_dssp EEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGC
T ss_pred EEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCCCCCCccccceEECCCCC
Confidence 9999999999999964321 2459999999999999999999999 99999999999999999999
Q ss_pred EEEEeecCceeccCCCC-CcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHHH
Q 005940 495 ARLGDFGLARLYDHGGM-PHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVAT-GRRPIGSGDLLLVEWVRECH 572 (668)
Q Consensus 495 ~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~l~~~~~~~~ 572 (668)
+||+|||+++....... .......||++|||||++.++.++.++|||||||++|||+| |+.||...... +.+ +..
T Consensus 184 ~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~--~~~-~~i 260 (308)
T 4gt4_A 184 VKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ--DVV-EMI 260 (308)
T ss_dssp EEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHH--HHH-HHH
T ss_pred EEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHH--HHH-HHH
Confidence 99999999987654322 22345689999999999999999999999999999999998 89999765321 111 222
Q ss_pred hcCccccccCcccCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhccC
Q 005940 573 QLGRILDVADPLLNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSGE 624 (668)
Q Consensus 573 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~~ 624 (668)
..+..... ...++ ..+..++..||+. |++||+|+||+++|+..
T Consensus 261 ~~~~~~~~-----p~~~~----~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 261 RNRQVLPC-----PDDCP----AWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp HTTCCCCC-----CTTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred HcCCCCCC-----cccch----HHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 22222211 11222 3456777899998 99999999999999864
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-50 Score=420.81 Aligned_cols=256 Identities=27% Similarity=0.415 Sum_probs=198.3
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecC--CchhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEE
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRN--SLQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYE 430 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 430 (668)
+++...++||+|+||+||+|++. ..||||+++.. ..+..++|.+|++++++++|||||+++|+|.+ +.++||||
T Consensus 36 ~~l~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmE 111 (307)
T 3omv_A 36 SEVMLSTRIGSGSFGTVYKGKWH---GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQ 111 (307)
T ss_dssp TSCCEEEECCCCSSSEEEEEESS---SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEEC---CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEE
Confidence 45677899999999999999984 36999998643 34556789999999999999999999999865 56899999
Q ss_pred ecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCC
Q 005940 431 YIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGG 510 (668)
Q Consensus 431 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~ 510 (668)
||++|+|.++|+. ....++|.++++|+.|||+||+|||+ ++|+||||||+||||++++++||+|||+|+......
T Consensus 112 y~~gGsL~~~l~~--~~~~l~~~~~~~i~~qia~gL~yLH~---~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~ 186 (307)
T 3omv_A 112 WCEGSSLYKHLHV--QETKFQMFQLIDIARQTAQGMDYLHA---KNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWS 186 (307)
T ss_dssp CCSSCBHHHHHHT--SCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCCSSSEEEETTEEEEECCCSSCBC-----
T ss_pred cCCCCCHHHHHhh--cCCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCccCHHHEEECCCCcEEEeeccCceecccCC
Confidence 9999999999963 33569999999999999999999999 999999999999999999999999999998765432
Q ss_pred C-CcccccccCCcccCcccccC---CCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCcccC
Q 005940 511 M-PHTTNVVGTFGYIAPELTQT---GKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLN 586 (668)
Q Consensus 511 ~-~~~~~~~gt~~y~aPE~~~~---~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 586 (668)
. ......+||+.|||||++.. +.++.++|||||||++|||+||+.||...+.. ..+......+...... +.+.
T Consensus 187 ~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~--~~~~~~~~~~~~~p~~-~~~~ 263 (307)
T 3omv_A 187 GSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNR--DQIIFMVGRGYASPDL-SKLY 263 (307)
T ss_dssp -------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH--HHHHHHHHTTCCCCCS-TTSC
T ss_pred cceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChH--HHHHHHHhcCCCCCCc-cccc
Confidence 2 23445689999999999864 46899999999999999999999999754321 1111112211111000 1111
Q ss_pred CcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhccC
Q 005940 587 SSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSGE 624 (668)
Q Consensus 587 ~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~~ 624 (668)
..++ ..+..++..|++. |++||+|.||++.|+..
T Consensus 264 ~~~~----~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l 298 (307)
T 3omv_A 264 KNCP----KAMKRLVADCVKKVKEERPLFPQILSSIELL 298 (307)
T ss_dssp TTSC----HHHHHHHHHHTCSSSTTSCCHHHHHHHHHHH
T ss_pred ccch----HHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 1222 3455677799998 99999999999998754
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-50 Score=423.22 Aligned_cols=251 Identities=22% Similarity=0.381 Sum_probs=201.8
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCC--chhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEE
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNS--LQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYE 430 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 430 (668)
++|...++||+|+||+||+|++..+|+.||||++.+.. ....+.|.+|++++++|+|||||++++++.+++.+|||||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 57999999999999999999999999999999997653 3446789999999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCC
Q 005940 431 YIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGG 510 (668)
Q Consensus 431 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~ 510 (668)
||++|+|.++|.. ..+..+++.+++.++.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+|+......
T Consensus 104 y~~gg~L~~~i~~-~~~~~~~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~ 179 (350)
T 4b9d_A 104 YCEGGDLFKRINA-QKGVLFQEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV 179 (350)
T ss_dssp CCTTCBHHHHHHH-TTTCCCCHHHHHHHHHHHHHHHHHHHH---TTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHH
T ss_pred CCCCCcHHHHHHH-cCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHHHEEECCCCCEEEcccccceeecCCc
Confidence 9999999999963 234568999999999999999999999 999999999999999999999999999998765321
Q ss_pred CCcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCcccCCccc
Q 005940 511 MPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSYV 590 (668)
Q Consensus 511 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 590 (668)
......+||+.|||||++.+..++.++|||||||++|||+||+.||...+.. +....... +.. +.+...+.
T Consensus 180 -~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~--~~~~~i~~-~~~-----~~~~~~~s 250 (350)
T 4b9d_A 180 -ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMK--NLVLKIIS-GSF-----PPVSLHYS 250 (350)
T ss_dssp -HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHH-TCC-----CCCCTTSC
T ss_pred -ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH--HHHHHHHc-CCC-----CCCCccCC
Confidence 1233468999999999999999999999999999999999999999765322 22222222 111 11222222
Q ss_pred HHHHHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 591 VKEMELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 591 ~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
+ .+..+...|+.. |++||+++|++++
T Consensus 251 -~---~~~~li~~~L~~dP~~R~s~~e~l~h 277 (350)
T 4b9d_A 251 -Y---DLRSLVSQLFKRNPRDRPSVNSILEK 277 (350)
T ss_dssp -H---HHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred -H---HHHHHHHHHccCChhHCcCHHHHhcC
Confidence 2 234555678887 9999999999975
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-49 Score=417.85 Aligned_cols=248 Identities=23% Similarity=0.307 Sum_probs=206.9
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCchhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEEec
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEYI 432 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~ 432 (668)
+.|+..++||+|+||+||+|+++.+|+.||||++........+.+.+|+++|++++|||||++++++.+++.+|||||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 46888999999999999999999999999999998766566677899999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCCCC
Q 005940 433 PNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMP 512 (668)
Q Consensus 433 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~~~ 512 (668)
++|+|.+++.+ ..+++.++..++.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+|+.+.....
T Consensus 154 ~gg~L~~~l~~----~~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~- 225 (346)
T 4fih_A 154 EGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP- 225 (346)
T ss_dssp TTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC-
T ss_pred CCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEECCCCCEEEecCcCceecCCCCC-
Confidence 99999999963 349999999999999999999999 9999999999999999999999999999998765432
Q ss_pred cccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCcccC--Cccc
Q 005940 513 HTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLN--SSYV 590 (668)
Q Consensus 513 ~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~--~~~~ 590 (668)
.....+||+.|||||++.+..|+.++|||||||++|||++|+.||...+.. +....... .. .+.+. ..+.
T Consensus 226 ~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~--~~~~~i~~-~~-----~~~~~~~~~~s 297 (346)
T 4fih_A 226 RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL--KAMKMIRD-NL-----PPRLKNLHKVS 297 (346)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--HHHHHHHH-SS-----CCCCSCGGGSC
T ss_pred cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH--HHHHHHHc-CC-----CCCCCccccCC
Confidence 344568999999999999999999999999999999999999999764322 11111111 11 11111 1122
Q ss_pred HHHHHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 591 VKEMELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 591 ~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
++ +..+...|+.. |++||+++|++++
T Consensus 298 -~~---~~dli~~~L~~dP~~R~ta~e~l~H 324 (346)
T 4fih_A 298 -PS---LKGFLDRLLVRDPAQRATAAELLKH 324 (346)
T ss_dssp -HH---HHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred -HH---HHHHHHHHcCCChhHCcCHHHHhcC
Confidence 22 34455578876 9999999999975
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-48 Score=401.06 Aligned_cols=245 Identities=29% Similarity=0.411 Sum_probs=195.6
Q ss_pred ccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCC--chhHHHHHHHHHHHhcccccCceeEeeeecc----cCceEEEE
Q 005940 356 KESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNS--LQGMREFAAEIESLGRLRHKNLVNLHGWCKQ----KNDLLLVY 429 (668)
Q Consensus 356 ~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~----~~~~~lV~ 429 (668)
...++||+|+||+||+|.+..++..||||++.... ....+.|.+|++++++|+|||||+++++|.. +..+||||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 55678999999999999999999999999997543 3445789999999999999999999999864 35689999
Q ss_pred EecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCc--eEecCCCCCCEEECC-CCCEEEEeecCceec
Q 005940 430 EYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQV--VIHRDVKPSNALIDA-EMNARLGDFGLARLY 506 (668)
Q Consensus 430 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~--ivHrDLkp~NIll~~-~~~~kl~DfGla~~~ 506 (668)
|||++|+|.+++.+ ...+++..+..++.||+.||+|||+ ++ |+||||||+||||+. ++.+||+|||+|+..
T Consensus 109 Ey~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~ylH~---~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~ 182 (290)
T 3fpq_A 109 ELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 182 (290)
T ss_dssp ECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred eCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCCCEEecccChhheeEECCCCCEEEEeCcCCEeC
Confidence 99999999999963 3569999999999999999999998 66 999999999999985 799999999999864
Q ss_pred cCCCCCcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCcccC
Q 005940 507 DHGGMPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLN 586 (668)
Q Consensus 507 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 586 (668)
... .....+||+.|||||++.+ +++.++|||||||++|||+||+.||...... ...... ...+... +...
T Consensus 183 ~~~---~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~-~~~~~~-i~~~~~~----~~~~ 252 (290)
T 3fpq_A 183 RAS---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA-AQIYRR-VTSGVKP----ASFD 252 (290)
T ss_dssp CTT---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH-HHHHHH-HTTTCCC----GGGG
T ss_pred CCC---ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcH-HHHHHH-HHcCCCC----CCCC
Confidence 432 2345689999999998864 6999999999999999999999999654321 111111 1111111 1111
Q ss_pred CcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 587 SSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 587 ~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
.... .+ +..+...|+.. |++|||++|+++|
T Consensus 253 ~~~~-~~---~~~li~~~L~~dP~~R~s~~e~l~H 283 (290)
T 3fpq_A 253 KVAI-PE---VKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp GCCC-HH---HHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ccCC-HH---HHHHHHHHccCChhHCcCHHHHhcC
Confidence 1122 22 44566688887 9999999999975
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-48 Score=419.35 Aligned_cols=248 Identities=23% Similarity=0.307 Sum_probs=207.8
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCchhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEEec
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEYI 432 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~ 432 (668)
+.|+..++||+|+||.||+|+++.+|+.||||++........+.+.+|+++|++++|||||++++++.+++.+|||||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~ 230 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 230 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence 56999999999999999999999999999999998776666677899999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCCCC
Q 005940 433 PNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMP 512 (668)
Q Consensus 433 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~~~ 512 (668)
++|+|.+++.. ..+++.++..++.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+|+.+.....
T Consensus 231 ~gG~L~~~i~~----~~l~e~~~~~~~~qil~aL~ylH~---~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~- 302 (423)
T 4fie_A 231 EGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP- 302 (423)
T ss_dssp TTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC-
T ss_pred CCCcHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHH---CCeecccCCHHHEEEcCCCCEEEecCccceECCCCCc-
Confidence 99999999953 349999999999999999999999 9999999999999999999999999999998765432
Q ss_pred cccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCcccC--Cccc
Q 005940 513 HTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLN--SSYV 590 (668)
Q Consensus 513 ~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~--~~~~ 590 (668)
.....+||+.|||||++.+..|+.++|||||||++|||++|+.||...... +....... .. .+.+. ..+.
T Consensus 303 ~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~--~~~~~i~~-~~-----~~~~~~~~~~s 374 (423)
T 4fie_A 303 RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL--KAMKMIRD-NL-----PPRLKNLHKVS 374 (423)
T ss_dssp CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--HHHHHHHH-SC-----CCCCSCTTSSC
T ss_pred cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH--HHHHHHHc-CC-----CCCCcccccCC
Confidence 344568999999999999999999999999999999999999999764322 11111111 11 11111 1122
Q ss_pred HHHHHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 591 VKEMELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 591 ~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
.+ +..+...|+.. |++||+++|+++|
T Consensus 375 -~~---~~dli~~~L~~dP~~R~ta~ell~H 401 (423)
T 4fie_A 375 -PS---LKGFLDRLLVRDPAQRATAAELLKH 401 (423)
T ss_dssp -HH---HHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred -HH---HHHHHHHHcCCChhHCcCHHHHhcC
Confidence 22 34455578876 9999999999985
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-49 Score=412.56 Aligned_cols=261 Identities=28% Similarity=0.339 Sum_probs=199.0
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCchhHHHHHHHHHHHhcccccCceeEeeeecccC----ceEEE
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNLHGWCKQKN----DLLLV 428 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~----~~~lV 428 (668)
++|...++||+|+||+||+|++ +|+.||||++...... ...+..|+..+.+++|||||+++|+|.+.+ .+|||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~~~-~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV 79 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchh-hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEE
Confidence 3567789999999999999998 5889999999754322 223445677778899999999999997654 57999
Q ss_pred EEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhcc-----CCceEecCCCCCCEEECCCCCEEEEeecCc
Q 005940 429 YEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEW-----EQVVIHRDVKPSNALIDAEMNARLGDFGLA 503 (668)
Q Consensus 429 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~-----~~~ivHrDLkp~NIll~~~~~~kl~DfGla 503 (668)
||||++|+|.++|+. ..++|..+++++.|+++||+|||+.+ .++|+||||||+||||+.++++||+|||+|
T Consensus 80 ~Ey~~~gsL~~~l~~----~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla 155 (303)
T 3hmm_A 80 SDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155 (303)
T ss_dssp EECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred ecCCCCCcHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCC
Confidence 999999999999963 35999999999999999999999732 349999999999999999999999999999
Q ss_pred eeccCCCCC---cccccccCCcccCcccccCC------CCCcchhHHHHHHHHHHHHhCCCCCCCCc------------h
Q 005940 504 RLYDHGGMP---HTTNVVGTFGYIAPELTQTG------KASTSSDVFAYGILLLEVATGRRPIGSGD------------L 562 (668)
Q Consensus 504 ~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~------~~~~~sDV~S~Gvvl~elltG~~p~~~~~------------~ 562 (668)
+........ .....+||+.|||||++.+. .++.++|||||||++|||+||+.|+.... .
T Consensus 156 ~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~ 235 (303)
T 3hmm_A 156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 235 (303)
T ss_dssp EEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred ccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhccccc
Confidence 987654322 22345899999999998654 46789999999999999999987764221 0
Q ss_pred hHHHHHHHHHhcCccccccCcccCCcc-cHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhccC
Q 005940 563 LLVEWVRECHQLGRILDVADPLLNSSY-VVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSGE 624 (668)
Q Consensus 563 ~l~~~~~~~~~~~~~~~~~d~~l~~~~-~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~~ 624 (668)
...+........ ...+|.+.... ..+....+..++..|++. |++||||.||++.|+..
T Consensus 236 ~~~~~~~~~~~~----~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l 295 (303)
T 3hmm_A 236 PSVEEMRKVVCE----QKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 295 (303)
T ss_dssp CCHHHHHHHHTT----SCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHH
T ss_pred chHHHHHHHHhc----ccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 011112222111 11233333222 234566788899999998 99999999999999764
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-49 Score=411.67 Aligned_cols=250 Identities=22% Similarity=0.257 Sum_probs=200.9
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCchhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEEec
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEYI 432 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~ 432 (668)
+.|...++||+|+||.||+|+++.+|+.||||+++..... .+|++++++|+|||||++++++.+++.+|||||||
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~-----~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 132 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-----VEELVACAGLSSPRIVPLYGAVREGPWVNIFMELL 132 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC-----THHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHhH-----HHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEecc
Confidence 4677889999999999999999999999999999765322 46999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCC-CEEEEeecCceeccCCCC
Q 005940 433 PNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEM-NARLGDFGLARLYDHGGM 511 (668)
Q Consensus 433 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~-~~kl~DfGla~~~~~~~~ 511 (668)
++|+|.++|.+ ...+++.++..++.||+.||.|||+ ++|+||||||+||||+.++ .+||+|||+|+.+.....
T Consensus 133 ~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~ 206 (336)
T 4g3f_A 133 EGGSLGQLIKQ---MGCLPEDRALYYLGQALEGLEYLHT---RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGL 206 (336)
T ss_dssp TTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCCGGGEEECTTSCCEEECCCTTCEEC-----
T ss_pred CCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCc
Confidence 99999999963 3469999999999999999999998 9999999999999999987 699999999998765432
Q ss_pred Cc----ccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCc-hhHHHHHHHHHhcCccccccCcccC
Q 005940 512 PH----TTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGD-LLLVEWVRECHQLGRILDVADPLLN 586 (668)
Q Consensus 512 ~~----~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~-~~l~~~~~~~~~~~~~~~~~d~~l~ 586 (668)
.. ....+||+.|||||++.+..++.++|||||||++|||+||+.||.... ..+...+ ....... ..+.
T Consensus 207 ~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i---~~~~~~~----~~~~ 279 (336)
T 4g3f_A 207 GKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKI---ASEPPPI----REIP 279 (336)
T ss_dssp -------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHH---HHSCCGG----GGSC
T ss_pred ccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHH---HcCCCCc----hhcC
Confidence 21 233579999999999999999999999999999999999999997542 1121111 1111111 1111
Q ss_pred CcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhccC
Q 005940 587 SSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSGE 624 (668)
Q Consensus 587 ~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~~ 624 (668)
..+. ..+..+...|+.. |++|||+.|++++|...
T Consensus 280 ~~~s----~~~~~li~~~L~~dP~~R~sa~el~~~l~~~ 314 (336)
T 4g3f_A 280 PSCA----PLTAQAIQEGLRKEPVHRASAMELRRKVGKA 314 (336)
T ss_dssp TTSC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ccCC----HHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 2222 2344555678887 99999999999998654
|
| >2ltn_A PEA lectin, alpha chain; 1.70A {Pisum sativum} SCOP: b.29.1.1 PDB: 1bqp_A* 1hkd_A 1ofs_A* 1rin_A* 1lof_C* 1len_A 1lem_A 1les_A* 2lal_A 1loe_A 1loa_A* 1loc_A* 1lod_A* 1lob_A 1lof_A* 1log_A* 1lgc_A* 1lgb_A* 2b7y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-48 Score=365.44 Aligned_cols=177 Identities=29% Similarity=0.525 Sum_probs=159.1
Q ss_pred CceeEEeCCCCCCCCCeEEeCceeeCCCCcEEccCCCCceEEEEEeeCceecccCCCCCCCCeeeeEEEEEEEEeCCCCC
Q 005940 26 QSSSFIFQGFNGGATNLSLQGAEIIKPSGALKLTNRSRYVIGHAFYVKPIQMFDTSASPSPNASSFSTTFVFEISTPRSG 105 (668)
Q Consensus 26 ~~~~f~~~~f~~~~~~l~~~g~a~~~~~~~~~lt~~~~~~~G~~~y~~p~~l~~~~~~~~~~~~sF~t~F~f~i~~~~~~ 105 (668)
.+++|+|++|.++..+|+|+|+|. .++|.|+||+...+++|||+|++||+||+ +.+++++||+|+|+|.|.+++..
T Consensus 2 ~~~sF~f~~F~~~~~~l~l~G~A~-~~~g~l~LT~~~~~~~Gra~y~~Pv~l~d---~~tg~vaSFsT~F~F~I~~~~~~ 77 (181)
T 2ltn_A 2 ETTSFLITKFSPDQQNLIFQGDGY-TTKEKLTLTKAVKNTVGRALYSSPIHIWD---RETGNVANFVTSFTFVINAPNSY 77 (181)
T ss_dssp EEEEEEESSCCSSCTTEEEEETCE-ECSSSEEEECSCSSCEEEEEESSCEECBC---TTTCCBCEEEEEEEEEEECSSTT
T ss_pred cceEEEcCCCCCCCCCEEEecccc-CCCCCeEcCCCCCCCEEEEEECCCEEeec---CCCCCccceEEEEEEEEecCCCC
Confidence 467999999997668999999999 56899999999899999999999999999 88999999999999999988777
Q ss_pred CCCCceEEEEcCCCCCCCCCCCCcccccccCCCCCCCccEEEEEeecccCCCCCCCCC--CCeeeeecCCcccccccCCc
Q 005940 106 RGGHGLAFLLAPSTKLPGAQPEHYLGILNSTNNGEPSNHILIVEFDTVNGFNDKAENQ--GNHVGIGINTMFSNRSEPAS 183 (668)
Q Consensus 106 ~~g~GlaF~l~p~~~~~~~~~~~~lGl~~~~~~~~~~~~~~aVEfDt~~n~~d~~~~~--~~Hvgid~~s~~s~~~~~~~ 183 (668)
.+||||||||+|....|+ +.|+||||+|.++ ++..+|+|||||||++|. + |||+ +|||||||||+.|.+++++
T Consensus 78 ~~gdGlAF~l~p~~~~p~-~~g~~LGL~n~~~-~~~~n~~vAVEFDT~~n~-~-~Dp~~~~nHVGIdvNs~~S~~t~~~- 152 (181)
T 2ltn_A 78 NVADGFTFFIAPVDTKPQ-TGGGYLGVFNSAE-YDKTTQTVAVEFDTFYNA-A-WDPSNRDRHIGIDVNSIKSVNTKSW- 152 (181)
T ss_dssp SCCCEEEEEEEETTCCCC-CCGGGTTTCSCSS-CCTTSCCEEEEEECSCCT-T-TSCTTCCCEEEEEESSSSCSEEEEC-
T ss_pred CCCCceEEEEecCCCCCC-CCCccccccccCC-CCccccEEEEEecccccc-c-cCCCCCCCEEEEEcCCccccceecc-
Confidence 889999999999876666 8899999999774 578899999999999983 1 4599 9999999999999988763
Q ss_pred cccCCCCCccccccCCCCcEEEEEEEeCCcceEEEEEEeC
Q 005940 184 YYINGTDHKEEMTLESGEPIQAWIEYDGEQKVLNVTISPA 223 (668)
Q Consensus 184 ~~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~V~~~~~ 223 (668)
+|.+|+.++|||+||+.+++|+|+|++.
T Consensus 153 ------------~l~~G~~~~v~I~Yd~~~~~L~V~l~~~ 180 (181)
T 2ltn_A 153 ------------KLQNGEEANVVIAFNAATNVLTVSLTYP 180 (181)
T ss_dssp ------------CCCTTCCEEEEEEEETTTTEEEEEEEEC
T ss_pred ------------ccCCCCEEEEEEEEECCCCEEEEEEecC
Confidence 3679999999999999999999999874
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-48 Score=413.57 Aligned_cols=259 Identities=25% Similarity=0.338 Sum_probs=207.6
Q ss_pred hcCcccceeeeecCcEEEEEEEeCCCC-----cEEEEEEEecCCc-hhHHHHHHHHHHHhcccc-cCceeEeeeeccc-C
Q 005940 352 TKGFKESEVIGIGGFGSVYKGVLPTTG-----GEVAVKKITRNSL-QGMREFAAEIESLGRLRH-KNLVNLHGWCKQK-N 423 (668)
Q Consensus 352 t~~f~~~~~lG~G~~g~Vy~~~~~~~~-----~~vavK~~~~~~~-~~~~~f~~Ei~~l~~l~H-~nIv~l~g~~~~~-~ 423 (668)
.++|+..++||+|+||+||+|++...+ +.||||++..... ...++|.+|+++|.+++| ||||+++|+|.+. +
T Consensus 63 ~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~ 142 (353)
T 4ase_A 63 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 142 (353)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTS
T ss_pred HHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCC
Confidence 467888999999999999999975433 5799999976544 345789999999999965 8999999999764 5
Q ss_pred ceEEEEEecCCCChhhhhcCCC-------------CCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEEC
Q 005940 424 DLLLVYEYIPNGSLDTLLFKPK-------------DGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALID 490 (668)
Q Consensus 424 ~~~lV~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~ 490 (668)
.+++|||||++|+|.++|+... ....++|.+++.++.|||+||.|||+ ++|+||||||+||||+
T Consensus 143 ~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~---~~iiHRDLK~~NILl~ 219 (353)
T 4ase_A 143 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLS 219 (353)
T ss_dssp CCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEC
T ss_pred EEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhh---CCeecCccCccceeeC
Confidence 6899999999999999996422 13459999999999999999999999 9999999999999999
Q ss_pred CCCCEEEEeecCceeccCCCC-CcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHH
Q 005940 491 AEMNARLGDFGLARLYDHGGM-PHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVAT-GRRPIGSGDLLLVEWV 568 (668)
Q Consensus 491 ~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~l~~~~ 568 (668)
+++.+||+|||+|+....... ......+||+.|||||++.++.++.++|||||||++|||+| |+.||...... +.+
T Consensus 220 ~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~--~~~ 297 (353)
T 4ase_A 220 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID--EEF 297 (353)
T ss_dssp GGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS--HHH
T ss_pred CCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHH--HHH
Confidence 999999999999997654432 23445689999999999999999999999999999999998 99999754211 111
Q ss_pred HHHHhcCccccccCcccCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhccC
Q 005940 569 RECHQLGRILDVADPLLNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSGE 624 (668)
Q Consensus 569 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~~ 624 (668)
......+.... ....+. ..+..++..||+. |++|||+.||+++|+..
T Consensus 298 ~~~i~~g~~~~-----~p~~~~----~~~~~li~~c~~~dP~~RPt~~eil~~L~~l 345 (353)
T 4ase_A 298 CRRLKEGTRMR-----APDYTT----PEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 345 (353)
T ss_dssp HHHHHHTCCCC-----CCTTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHcCCCCC-----CCccCC----HHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence 22222222111 111222 2355667789998 99999999999998764
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-48 Score=404.33 Aligned_cols=248 Identities=25% Similarity=0.322 Sum_probs=205.1
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCC---chhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEE
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNS---LQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVY 429 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 429 (668)
++|+..++||+|+||+||+|+++.+++.||||++.+.. ....+.+.+|++++++|+|||||++++++.+++.+|+||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 46889999999999999999999999999999997642 234577899999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCC
Q 005940 430 EYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHG 509 (668)
Q Consensus 430 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~ 509 (668)
|||++|+|.+++.+ ...+++.++..++.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+|+.+...
T Consensus 112 Ey~~gG~L~~~i~~---~~~l~e~~~~~~~~qi~~al~ylH~---~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~ 185 (311)
T 4aw0_A 112 SYAKNGELLKYIRK---IGSFDETCTRFYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 185 (311)
T ss_dssp CCCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred ecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCC
Confidence 99999999999963 3469999999999999999999999 99999999999999999999999999999987643
Q ss_pred C-CCcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCcccCCc
Q 005940 510 G-MPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSS 588 (668)
Q Consensus 510 ~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 588 (668)
. .......+||+.|||||++.+..++.++||||+||++|||+||+.||...+... ...... ...+ .+...
T Consensus 186 ~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~--~~~~i~-~~~~------~~p~~ 256 (311)
T 4aw0_A 186 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGL--IFAKII-KLEY------DFPEK 256 (311)
T ss_dssp TTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHH-HTCC------CCCTT
T ss_pred CCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHH-cCCC------CCCcc
Confidence 3 233455789999999999999999999999999999999999999997653221 111111 1111 11222
Q ss_pred ccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHH
Q 005940 589 YVVKEMELVLKLGLMCSHK-TQFRPTMRQVMR 619 (668)
Q Consensus 589 ~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~ 619 (668)
+.. + +..+...|+.. |++||+++|++.
T Consensus 257 ~s~-~---~~dli~~lL~~dp~~R~t~~e~~~ 284 (311)
T 4aw0_A 257 FFP-K---ARDLVEKLLVLDATKRLGCEEMEG 284 (311)
T ss_dssp CCH-H---HHHHHHHHSCSSGGGSTTSGGGTC
T ss_pred cCH-H---HHHHHHHHccCCHhHCcChHHHcC
Confidence 232 2 33455577776 999999998754
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-47 Score=391.43 Aligned_cols=246 Identities=24% Similarity=0.384 Sum_probs=189.3
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCc---hhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEE
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSL---QGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVY 429 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 429 (668)
++|+..+.||+|+||+||+|++..+++.||||++.+... ...+.+.+|++++++++|||||++++++.+++..|+||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 579999999999999999999999999999999976432 33567899999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCC
Q 005940 430 EYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHG 509 (668)
Q Consensus 430 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~ 509 (668)
||+ +|+|.+++.+ ...+++.++..++.||+.||+|||+ ++|+||||||+||||++++++||+|||+|+.....
T Consensus 93 Ey~-~g~L~~~l~~---~~~l~e~~~~~~~~qi~~al~ylH~---~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~ 165 (275)
T 3hyh_A 93 EYA-GNELFDYIVQ---RDKMSEQEARRFFQQIISAVEYCHR---HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG 165 (275)
T ss_dssp ECC-CEEHHHHHHH---SCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCTTTEEECTTCCEEECCSSCC------
T ss_pred eCC-CCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCChHHeEECCCCCEEEeecCCCeecCCC
Confidence 999 6899999853 3469999999999999999999999 99999999999999999999999999999876543
Q ss_pred CCCcccccccCCcccCcccccCCCC-CcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCcccCCc
Q 005940 510 GMPHTTNVVGTFGYIAPELTQTGKA-STSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSS 588 (668)
Q Consensus 510 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 588 (668)
.. ....+||+.|||||++.+..+ +.++||||+||++|||+||+.||...+.. +...... .+.. .+...
T Consensus 166 ~~--~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~--~~~~~i~-~~~~------~~p~~ 234 (275)
T 3hyh_A 166 NF--LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIP--VLFKNIS-NGVY------TLPKF 234 (275)
T ss_dssp -----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHH-HTCC------CCCTT
T ss_pred Cc--cCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHH--HHHHHHH-cCCC------CCCCC
Confidence 32 334689999999999988776 58999999999999999999999765322 2222221 1211 11122
Q ss_pred ccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 589 YVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 589 ~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
.+ ++ +..+...|+.. |++|||++|++++
T Consensus 235 ~s-~~---~~~li~~~L~~dP~~R~s~~eil~h 263 (275)
T 3hyh_A 235 LS-PG---AAGLIKRMLIVNPLNRISIHEIMQD 263 (275)
T ss_dssp SC-HH---HHHHHHHHSCSSGGGSCCHHHHHHC
T ss_pred CC-HH---HHHHHHHHccCChhHCcCHHHHHcC
Confidence 22 22 33455578776 9999999999985
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-47 Score=395.20 Aligned_cols=251 Identities=22% Similarity=0.330 Sum_probs=188.4
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCc-hhHHHHHHHHHHHhcccccCceeEeeeecccC--------
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSL-QGMREFAAEIESLGRLRHKNLVNLHGWCKQKN-------- 423 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~-------- 423 (668)
++|+..+.||+|+||+||+|+++.+++.||||++..... ...+.+.+|++++++|+|||||++++++.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 358899999999999999999999999999999976543 34567999999999999999999999986544
Q ss_pred ----ceEEEEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEe
Q 005940 424 ----DLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGD 499 (668)
Q Consensus 424 ----~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~D 499 (668)
.+|+|||||++|+|.+++.........++..++.++.||+.||+|||+ ++|+||||||+||||+.++.+||+|
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~---~~IiHRDlKp~NILl~~~~~vKl~D 161 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGD 161 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHH---CcCccccCcHHHeEECCCCcEEEcc
Confidence 369999999999999999754333445677789999999999999999 9999999999999999999999999
Q ss_pred ecCceeccCCCCC-----------cccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHH
Q 005940 500 FGLARLYDHGGMP-----------HTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWV 568 (668)
Q Consensus 500 fGla~~~~~~~~~-----------~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~ 568 (668)
||+|+........ ..+..+||+.|||||++.+..++.++|||||||++|||++ ||..... .....
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~-~~~~~ 237 (299)
T 4g31_A 162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQME-RVRTL 237 (299)
T ss_dssp CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHH-HHHHH
T ss_pred CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccH-HHHHH
Confidence 9999977654321 1234579999999999999999999999999999999997 7754211 11111
Q ss_pred HHHHhcCccccccCcccCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 569 RECHQLGRILDVADPLLNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 569 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
... ..... |.. .......+..+...|++. |++||++.|++++
T Consensus 238 ~~~-~~~~~-----p~~----~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 280 (299)
T 4g31_A 238 TDV-RNLKF-----PPL----FTQKYPCEYVMVQDMLSPSPMERPEAINIIEN 280 (299)
T ss_dssp HHH-HTTCC-----CHH----HHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHH-hcCCC-----CCC----CcccCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 111 11111 111 111112234466678887 9999999999974
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-47 Score=396.74 Aligned_cols=248 Identities=25% Similarity=0.329 Sum_probs=193.8
Q ss_pred cCcccceeeeecCcEEEEEEEeC---CCCcEEEEEEEecCCc--hhHHHHHHHHHHHhcccccCceeEeeeecccCceEE
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLP---TTGGEVAVKKITRNSL--QGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLL 427 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~---~~~~~vavK~~~~~~~--~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l 427 (668)
++|+..+.||+|+||+||+|+.. .+++.||||++.+... .....+.+|++++++++|||||++++++.+++.+|+
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 46999999999999999999873 4578999999975432 233468899999999999999999999999999999
Q ss_pred EEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceecc
Q 005940 428 VYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYD 507 (668)
Q Consensus 428 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~ 507 (668)
|||||++|+|.+++.+ ...+++.++..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+|+...
T Consensus 104 vmEy~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~ 177 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSK---EVMFTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESI 177 (304)
T ss_dssp EECCCTTCEEHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECTTSCEEEESSEEEEC--
T ss_pred EEEcCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHeEEcCCCCEEecccccceecc
Confidence 9999999999999963 3469999999999999999999999 999999999999999999999999999998654
Q ss_pred CCCCCcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCcccCC
Q 005940 508 HGGMPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNS 587 (668)
Q Consensus 508 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 587 (668)
.... .....+||+.|||||++.+..++.++||||+||++|||+||+.||...+.. +....... ... .+..
T Consensus 178 ~~~~-~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~--~~~~~i~~-~~~------~~p~ 247 (304)
T 3ubd_A 178 DHEK-KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRK--ETMTMILK-AKL------GMPQ 247 (304)
T ss_dssp ---C-CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHH-CCC------CCCT
T ss_pred CCCc-cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHH--HHHHHHHc-CCC------CCCC
Confidence 4322 234468999999999999999999999999999999999999999765422 11122111 111 1112
Q ss_pred cccHHHHHHHHHHHhhcCCC-CCCCCC-----HHHHHHH
Q 005940 588 SYVVKEMELVLKLGLMCSHK-TQFRPT-----MRQVMRY 620 (668)
Q Consensus 588 ~~~~~~~~~l~~l~~~C~~~-p~~RPs-----~~evl~~ 620 (668)
..+ .+ +..+...|+.. |++||+ ++|+++|
T Consensus 248 ~~s-~~---~~~li~~~L~~dP~~R~ta~~~~~~eil~H 282 (304)
T 3ubd_A 248 FLS-PE---AQSLLRMLFKRNPANRLGAGPDGVEEIKRH 282 (304)
T ss_dssp TSC-HH---HHHHHHHHTCSSGGGSTTCSTTTHHHHHTS
T ss_pred cCC-HH---HHHHHHHHcccCHHHCCCCCcCCHHHHHcC
Confidence 222 22 34555678887 999998 5788764
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-45 Score=382.89 Aligned_cols=290 Identities=39% Similarity=0.697 Sum_probs=251.1
Q ss_pred cCCcccchhhHHHHhcCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCch-hHHHHHHHHHHHhcccccCceeEe
Q 005940 338 DCPHRFRYKDLYAATKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQ-GMREFAAEIESLGRLRHKNLVNLH 416 (668)
Q Consensus 338 ~~~~~f~~~el~~at~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~f~~Ei~~l~~l~H~nIv~l~ 416 (668)
.....|++.++...+++|...+.||+|+||.||+|.+. +++.||||++...... ....+.+|++++++++||||++++
T Consensus 15 ~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~ 93 (326)
T 3uim_A 15 GQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLR 93 (326)
T ss_dssp CCCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCS-SSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCC
T ss_pred CccceecHHHHHHHhhccccceeEecCCCcEEEEEEec-CCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceE
Confidence 33678999999999999999999999999999999874 5889999998765332 234688999999999999999999
Q ss_pred eeecccCceEEEEEecCCCChhhhhcCCC-CCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCE
Q 005940 417 GWCKQKNDLLLVYEYIPNGSLDTLLFKPK-DGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNA 495 (668)
Q Consensus 417 g~~~~~~~~~lV~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~ 495 (668)
++|...+..++||||+++|+|.+++.... ....++|..++.++.|++.||.|||+.+..+|+||||||+||+++.++.+
T Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~ 173 (326)
T 3uim_A 94 GFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEA 173 (326)
T ss_dssp EEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCE
T ss_pred EEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCE
Confidence 99999999999999999999999997533 33469999999999999999999999333399999999999999999999
Q ss_pred EEEeecCceeccCCCCCcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCC------CCchhHHHHHH
Q 005940 496 RLGDFGLARLYDHGGMPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIG------SGDLLLVEWVR 569 (668)
Q Consensus 496 kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~------~~~~~l~~~~~ 569 (668)
||+|||+++..............||+.|+|||++.+..++.++|||||||++|||++|+.||. ..+....+|+.
T Consensus 174 kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 253 (326)
T 3uim_A 174 VVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK 253 (326)
T ss_dssp EECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHT
T ss_pred EeccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHH
Confidence 999999999876555445555679999999999988889999999999999999999999995 23556777877
Q ss_pred HHHhcCccccccCcccCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhccCcCCC
Q 005940 570 ECHQLGRILDVADPLLNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSGEKQLR 628 (668)
Q Consensus 570 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~~~~~~ 628 (668)
............+..+...+..++...+..++..|++. |++||+++||+++|+......
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~~~ 313 (326)
T 3uim_A 254 GLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLAE 313 (326)
T ss_dssp TTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSCSS
T ss_pred HHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcchhh
Confidence 77777777788888888888888899999999999998 999999999999999876555
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-44 Score=384.32 Aligned_cols=202 Identities=26% Similarity=0.415 Sum_probs=174.9
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCC--chhHHHHHHHHHHHhcccccCceeEeeeecc------cCc
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNS--LQGMREFAAEIESLGRLRHKNLVNLHGWCKQ------KND 424 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~------~~~ 424 (668)
++|.+.++||+|+||+||+|++..+|+.||||++.+.. ....+.+.+|+++|++|+|||||++++++.. .+.
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 57999999999999999999999999999999997543 2345678899999999999999999998753 367
Q ss_pred eEEEEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCce
Q 005940 425 LLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLAR 504 (668)
Q Consensus 425 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~ 504 (668)
+|||||||+ |+|.+++.. ...+++.++..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+|+
T Consensus 134 ~~ivmE~~~-g~L~~~i~~---~~~l~~~~~~~~~~qil~al~ylH~---~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~ 206 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIHS---SQPLTLEHVRYFLYQLLRGLKYMHS---AQVIHRDLKPSNLLVNENCELKIGDFGMAR 206 (398)
T ss_dssp EEEEEECCS-EEHHHHHTS---SSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred EEEEEeCCC-CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CcCcCCCcCccccccCCCCCEEEeecceee
Confidence 899999995 789999953 4569999999999999999999999 999999999999999999999999999998
Q ss_pred eccCCC---CCcccccccCCcccCcccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCc
Q 005940 505 LYDHGG---MPHTTNVVGTFGYIAPELTQTG-KASTSSDVFAYGILLLEVATGRRPIGSGD 561 (668)
Q Consensus 505 ~~~~~~---~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDV~S~Gvvl~elltG~~p~~~~~ 561 (668)
.+.... .......+||+.|||||++.+. .++.++||||+||++|||++|+.||...+
T Consensus 207 ~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~ 267 (398)
T 4b99_A 207 GLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKN 267 (398)
T ss_dssp CC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSS
T ss_pred ecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCC
Confidence 764332 1223456899999999998765 56899999999999999999999997653
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=374.04 Aligned_cols=282 Identities=37% Similarity=0.626 Sum_probs=242.5
Q ss_pred cccchhhHHHHhcCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCchhHHHHHHHHHHHhcccccCceeEeeeec
Q 005940 341 HRFRYKDLYAATKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNLHGWCK 420 (668)
Q Consensus 341 ~~f~~~el~~at~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~ 420 (668)
.++.+.++..++++|+..+.||+|+||.||+|++. +++.||||++........+.+.+|++++++++||||++++++|.
T Consensus 27 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 105 (321)
T 2qkw_B 27 YRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCD 105 (321)
T ss_dssp ---CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECC
T ss_pred eeecHHHHHHHHhccCccceeecCCCeeEEEEEEC-CCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEc
Confidence 45566677778899999999999999999999974 68899999998777677788999999999999999999999999
Q ss_pred ccCceEEEEEecCCCChhhhhcCCC-CCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEe
Q 005940 421 QKNDLLLVYEYIPNGSLDTLLFKPK-DGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGD 499 (668)
Q Consensus 421 ~~~~~~lV~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~D 499 (668)
+.+..++||||+++|+|.+++.... ....++|.+++.++.|++.||.|||+ .+|+||||||+||+++.++.+||+|
T Consensus 106 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~D 182 (321)
T 2qkw_B 106 ERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHT---RAIIHRDVKSINILLDENFVPKITD 182 (321)
T ss_dssp CTTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCSTTEEECTTCCEEECC
T ss_pred CCCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcC---CCeecCCCCHHHEEECCCCCEEEee
Confidence 9999999999999999999996432 23469999999999999999999999 9999999999999999999999999
Q ss_pred ecCceeccCCC-CCcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC----chhHHHHHHHHHhc
Q 005940 500 FGLARLYDHGG-MPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSG----DLLLVEWVRECHQL 574 (668)
Q Consensus 500 fGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~----~~~l~~~~~~~~~~ 574 (668)
||+++...... ........||..|+|||++.++.++.++|||||||++|||++|+.||... ......|.......
T Consensus 183 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~ 262 (321)
T 2qkw_B 183 FGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNN 262 (321)
T ss_dssp CTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTT
T ss_pred cccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhcccc
Confidence 99998754322 22233456899999999998889999999999999999999999999643 23456677777777
Q ss_pred CccccccCcccCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhccCcC
Q 005940 575 GRILDVADPLLNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSGEKQ 626 (668)
Q Consensus 575 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~~~~ 626 (668)
+.+....++.+......+....+..++..|++. |++||+++||+++|+....
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~ 315 (321)
T 2qkw_B 263 GQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALR 315 (321)
T ss_dssp TCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhh
Confidence 777777888877777788888899999999998 9999999999999987643
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-43 Score=395.21 Aligned_cols=252 Identities=23% Similarity=0.343 Sum_probs=208.3
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCchhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEEec
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEYI 432 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~ 432 (668)
++|.+.+.||+|+||.||+|+++.+|+.||||++........+.+.+|+++|++|+|||||++++++.+.+.+|||||||
T Consensus 157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~ 236 (573)
T 3uto_A 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 236 (573)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeec
Confidence 57999999999999999999999999999999998877666778999999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCC--CCEEEEeecCceeccCCC
Q 005940 433 PNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAE--MNARLGDFGLARLYDHGG 510 (668)
Q Consensus 433 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~--~~~kl~DfGla~~~~~~~ 510 (668)
++|+|.++|.. ....+++.++..++.||+.||.|||+ ++|+||||||+||||+.+ +.+||+|||+|+.+....
T Consensus 237 ~gg~L~~~i~~--~~~~l~e~~~~~~~~qi~~al~ylH~---~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~ 311 (573)
T 3uto_A 237 SGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 311 (573)
T ss_dssp CCCBHHHHHTC--TTSCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS
T ss_pred CCCcHHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCChhhccccCCCCCCEEEeeccceeEccCCC
Confidence 99999999853 34569999999999999999999999 999999999999999864 889999999999876543
Q ss_pred CCcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCcccCCccc
Q 005940 511 MPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSYV 590 (668)
Q Consensus 511 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 590 (668)
.....+||+.|||||++.+..++.++||||+||++|||++|+.||...+.. +....... ... . +++.......
T Consensus 312 --~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~--~~~~~i~~-~~~-~-~~~~~~~~~s 384 (573)
T 3uto_A 312 --SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD--ETLRNVKS-CDW-N-MDDSAFSGIS 384 (573)
T ss_dssp --EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH--HHHHHHHT-TCC-C-CCSGGGTTSC
T ss_pred --ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH--HHHHHHHh-CCC-C-CCcccccCCC
Confidence 234468999999999999999999999999999999999999999765322 11111111 110 0 1111111122
Q ss_pred HHHHHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 591 VKEMELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 591 ~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
+ .+..+...|++. |++||++.|+++|
T Consensus 385 -~---~~~dli~~~L~~dp~~R~t~~e~l~H 411 (573)
T 3uto_A 385 -E---DGKDFIRKLLLADPNTRMTIHQALEH 411 (573)
T ss_dssp -H---HHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred -H---HHHHHHHHHccCChhHCcCHHHHhcC
Confidence 2 233455578776 9999999999986
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-43 Score=373.69 Aligned_cols=199 Identities=26% Similarity=0.402 Sum_probs=172.1
Q ss_pred HhcCcccceeeeecCcEEEEEEEeC---CCCcEEEEEEEecCCchhHHHHHHHHHHHhcc-cccCceeEeeeecccCceE
Q 005940 351 ATKGFKESEVIGIGGFGSVYKGVLP---TTGGEVAVKKITRNSLQGMREFAAEIESLGRL-RHKNLVNLHGWCKQKNDLL 426 (668)
Q Consensus 351 at~~f~~~~~lG~G~~g~Vy~~~~~---~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~ 426 (668)
..+.|++.++||+|+||+||+|+++ .+++.||||++.+... ..++.+|+++|+++ +||||+++++++.+.+..|
T Consensus 19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~--~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~ 96 (361)
T 4f9c_A 19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH--PIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVV 96 (361)
T ss_dssp GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC--HHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEE
T ss_pred ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC--HHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEE
Confidence 3578999999999999999999864 3567899999876542 35678999999998 6999999999999999999
Q ss_pred EEEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCC-CCEEEEeecCcee
Q 005940 427 LVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAE-MNARLGDFGLARL 505 (668)
Q Consensus 427 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~-~~~kl~DfGla~~ 505 (668)
+||||+++|+|.+++. .+++.++..++.||+.||.|||+ ++|+||||||+|||++.+ +.+||+|||+|+.
T Consensus 97 lvmE~~~g~~L~~~~~------~l~~~~~~~~~~qll~al~ylH~---~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~ 167 (361)
T 4f9c_A 97 IAMPYLEHESFLDILN------SLSFQEVREYMLNLFKALKRIHQ---FGIVHRDVKPSNFLYNRRLKKYALVDFGLAQG 167 (361)
T ss_dssp EEEECCCCCCHHHHHT------TCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEEeCCCcccHHHHHc------CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCcCCHHHeEEeCCCCeEEECcCCCCcc
Confidence 9999999999999983 38999999999999999999999 999999999999999887 7999999999986
Q ss_pred ccCCCCC---------------------------cccccccCCcccCcccccCC-CCCcchhHHHHHHHHHHHHhCCCCC
Q 005940 506 YDHGGMP---------------------------HTTNVVGTFGYIAPELTQTG-KASTSSDVFAYGILLLEVATGRRPI 557 (668)
Q Consensus 506 ~~~~~~~---------------------------~~~~~~gt~~y~aPE~~~~~-~~~~~sDV~S~Gvvl~elltG~~p~ 557 (668)
....... .....+||+.|||||++.+. .++.++||||+||++|||++|+.||
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf 247 (361)
T 4f9c_A 168 THDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPF 247 (361)
T ss_dssp CTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSS
T ss_pred cCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCC
Confidence 6543211 12235799999999998765 5899999999999999999999999
Q ss_pred CCC
Q 005940 558 GSG 560 (668)
Q Consensus 558 ~~~ 560 (668)
...
T Consensus 248 ~~~ 250 (361)
T 4f9c_A 248 YKA 250 (361)
T ss_dssp SCC
T ss_pred CCC
Confidence 654
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-42 Score=387.32 Aligned_cols=248 Identities=25% Similarity=0.317 Sum_probs=197.1
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCc---hh---HHHHHHHHHHHhcccccCceeEeeeecccCceE
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSL---QG---MREFAAEIESLGRLRHKNLVNLHGWCKQKNDLL 426 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~---~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~ 426 (668)
++|.+.++||+|+||.||+|+++.+|+.||||++.+... .. ......++.+++.++|||||++++++.+.+.+|
T Consensus 189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly 268 (689)
T 3v5w_A 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 268 (689)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence 579999999999999999999999999999999975421 11 222334567777889999999999999999999
Q ss_pred EEEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceec
Q 005940 427 LVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLY 506 (668)
Q Consensus 427 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~ 506 (668)
||||||++|+|.++|.+ ...+++..+..++.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+|+..
T Consensus 269 lVmEy~~GGdL~~~l~~---~~~l~E~~a~~y~~qIl~aL~yLH~---~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~ 342 (689)
T 3v5w_A 269 FILDLMNGGDLHYHLSQ---HGVFSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDF 342 (689)
T ss_dssp EEECCCCSCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCchHHeEEeCCCCEEecccceeeec
Confidence 99999999999999963 3469999999999999999999999 99999999999999999999999999999977
Q ss_pred cCCCCCcccccccCCcccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCch-hHHHHHHHHHhcCccccccCcc
Q 005940 507 DHGGMPHTTNVVGTFGYIAPELTQT-GKASTSSDVFAYGILLLEVATGRRPIGSGDL-LLVEWVRECHQLGRILDVADPL 584 (668)
Q Consensus 507 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~-~l~~~~~~~~~~~~~~~~~d~~ 584 (668)
.... ....+||+.|||||++.. ..|+.++||||+||++|||++|+.||..... ...+ +........ ..
T Consensus 343 ~~~~---~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~-i~~~i~~~~------~~ 412 (689)
T 3v5w_A 343 SKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE-IDRMTLTMA------VE 412 (689)
T ss_dssp SSCC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHH-HHHHHHHCC------CC
T ss_pred CCCC---CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHH-HHHhhcCCC------CC
Confidence 6533 334689999999999975 4789999999999999999999999964321 1111 111111111 11
Q ss_pred cCCcccHHHHHHHHHHHhhcCCC-CCCCCC-----HHHHHHH
Q 005940 585 LNSSYVVKEMELVLKLGLMCSHK-TQFRPT-----MRQVMRY 620 (668)
Q Consensus 585 l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs-----~~evl~~ 620 (668)
+...+.. + +..+...|+.. |++|++ ++||++|
T Consensus 413 ~p~~~S~-~---a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~H 450 (689)
T 3v5w_A 413 LPDSFSP-E---LRSLLEGLLQRDVNRRLGCLGRGAQEVKES 450 (689)
T ss_dssp CCTTSCH-H---HHHHHHHHTCSCGGGCTTCSSSTHHHHTTS
T ss_pred CCccCCH-H---HHHHHHHHccCCHhHCCCCCCCCHHHHhcC
Confidence 2222232 2 33444567776 999998 7888875
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=352.52 Aligned_cols=279 Identities=34% Similarity=0.572 Sum_probs=229.0
Q ss_pred CcccchhhHHHHhcCcccc------eeeeecCcEEEEEEEeCCCCcEEEEEEEecCC----chhHHHHHHHHHHHhcccc
Q 005940 340 PHRFRYKDLYAATKGFKES------EVIGIGGFGSVYKGVLPTTGGEVAVKKITRNS----LQGMREFAAEIESLGRLRH 409 (668)
Q Consensus 340 ~~~f~~~el~~at~~f~~~------~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~f~~Ei~~l~~l~H 409 (668)
...|++.++..++++|... ++||+|+||.||+|.+ ++..||||++.... ....+.+.+|++++++++|
T Consensus 12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 89 (307)
T 2nru_A 12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH 89 (307)
T ss_dssp CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC
T ss_pred CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC
Confidence 5789999999999999887 8999999999999997 57899999986532 3345789999999999999
Q ss_pred cCceeEeeeecccCceEEEEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEE
Q 005940 410 KNLVNLHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALI 489 (668)
Q Consensus 410 ~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll 489 (668)
|||+++++++.+.+..++||||+++++|.+++........+++..++.++.||+.||.|||+ .+|+||||||+||++
T Consensus 90 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dlkp~Nili 166 (307)
T 2nru_A 90 ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHE---NHHIHRDIKSANILL 166 (307)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEE
T ss_pred CCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecCCCCHHHEEE
Confidence 99999999999999999999999999999999754445679999999999999999999999 999999999999999
Q ss_pred CCCCCEEEEeecCceeccCCCCC-cccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCc--hhHHH
Q 005940 490 DAEMNARLGDFGLARLYDHGGMP-HTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGD--LLLVE 566 (668)
Q Consensus 490 ~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~--~~l~~ 566 (668)
+.++.+||+|||+++........ ......||..|+|||.+.+ .++.++||||||+++|||++|+.||.... ..+..
T Consensus 167 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~ 245 (307)
T 2nru_A 167 DEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLD 245 (307)
T ss_dssp CTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTH
T ss_pred cCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHH
Confidence 99999999999999876543222 2334578999999998764 58999999999999999999999997542 22223
Q ss_pred HHHHHHhc-CccccccCcccCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhccCc
Q 005940 567 WVRECHQL-GRILDVADPLLNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSGEK 625 (668)
Q Consensus 567 ~~~~~~~~-~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~~~ 625 (668)
+....... ..+.+.+++.+ ..........+..++..|++. |++||++++|+++|+...
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~ 305 (307)
T 2nru_A 246 IKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305 (307)
T ss_dssp HHHHHHTTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred HHHHhhhhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 33332222 22333344443 234555667788888899998 999999999999998643
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-42 Score=358.04 Aligned_cols=255 Identities=27% Similarity=0.398 Sum_probs=208.2
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCchhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEEec
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEYI 432 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~ 432 (668)
++|...++||+|+||.||+|.+..+++.||+|++........+.|.+|++++++++||||+++++++.+.+..++||||+
T Consensus 10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 89 (310)
T 3s95_A 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYI 89 (310)
T ss_dssp GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEec
Confidence 56888999999999999999999899999999998777777889999999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCCCC
Q 005940 433 PNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMP 512 (668)
Q Consensus 433 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~~~ 512 (668)
++|+|.+++.. ....+++.+++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++........
T Consensus 90 ~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 164 (310)
T 3s95_A 90 KGGTLRGIIKS--MDSQYPWSQRVSFAKDIASGMAYLHS---MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQ 164 (310)
T ss_dssp TTCBHHHHHHH--CCTTSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEECTTSCEEECCCTTCEECC-----
T ss_pred CCCcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCcCeEEECCCCCEEEeecccceeccccccc
Confidence 99999999963 24569999999999999999999999 99999999999999999999999999999876543321
Q ss_pred c-------------ccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhH---HHHHHHHHhcCc
Q 005940 513 H-------------TTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLL---VEWVRECHQLGR 576 (668)
Q Consensus 513 ~-------------~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l---~~~~~~~~~~~~ 576 (668)
. .....||+.|+|||++.+..++.++|||||||++|||++|..|+....... .........
T Consensus 165 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~--- 241 (310)
T 3s95_A 165 PEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLD--- 241 (310)
T ss_dssp ---------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHH---
T ss_pred ccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcccc---
Confidence 1 114579999999999999999999999999999999999999986431100 000000000
Q ss_pred cccccCcccCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhccCc
Q 005940 577 ILDVADPLLNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSGEK 625 (668)
Q Consensus 577 ~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~~~ 625 (668)
......++ ..+..+...|++. |++||+++|+++.|+...
T Consensus 242 ------~~~~~~~~----~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~ 281 (310)
T 3s95_A 242 ------RYCPPNCP----PSFFPITVRCCDLDPEKRPSFVKLEHWLETLR 281 (310)
T ss_dssp ------HTCCTTCC----TTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ------ccCCCCCC----HHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 00011111 2355677789887 999999999999998653
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=351.89 Aligned_cols=251 Identities=24% Similarity=0.359 Sum_probs=208.1
Q ss_pred hcCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCchhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEEe
Q 005940 352 TKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEY 431 (668)
Q Consensus 352 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~ 431 (668)
.++|...++||+|+||.||+|.+..+++.||||++........+.+.+|+.++++++||||+++++++...+..++||||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 98 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence 36799999999999999999999889999999999876666667889999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCCC
Q 005940 432 IPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGM 511 (668)
Q Consensus 432 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~~ 511 (668)
+++|+|.+++.. ..+++.++..++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||++........
T Consensus 99 ~~~~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 171 (297)
T 3fxz_A 99 LAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (297)
T ss_dssp CTTCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred CCCCCHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHh---CCceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc
Confidence 999999999953 248999999999999999999999 9999999999999999999999999999987664432
Q ss_pred CcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCcccCCcccH
Q 005940 512 PHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSYVV 591 (668)
Q Consensus 512 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 591 (668)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...+..... .......... ...+ ....
T Consensus 172 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~--~~~~~~~~~~-~~~~---~~~~- 243 (297)
T 3fxz_A 172 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL--YLIATNGTPE-LQNP---EKLS- 243 (297)
T ss_dssp -CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH--HHHHHHCSCC-CSCG---GGSC-
T ss_pred -ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH--HHHHhCCCCC-CCCc---cccC-
Confidence 234457999999999999999999999999999999999999999765432211 1111111110 0001 1111
Q ss_pred HHHHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 592 KEMELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 592 ~~~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
..+..+...|++. |++||+++|++++
T Consensus 244 ---~~~~~li~~~l~~dp~~Rps~~ell~h 270 (297)
T 3fxz_A 244 ---AIFRDFLNRCLEMDVEKRGSAKELLQH 270 (297)
T ss_dssp ---HHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ---HHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 2345666688887 9999999999975
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-41 Score=351.96 Aligned_cols=262 Identities=23% Similarity=0.315 Sum_probs=214.6
Q ss_pred CcccchhhHHHHhcC----------cccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCchhHHHHHHHHHHHhcccc
Q 005940 340 PHRFRYKDLYAATKG----------FKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRH 409 (668)
Q Consensus 340 ~~~f~~~el~~at~~----------f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H 409 (668)
+..|+++++..+++. |...++||+|+||.||+|++..+|+.||||++........+.+.+|+.++++++|
T Consensus 22 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h 101 (321)
T 2c30_A 22 SGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQH 101 (321)
T ss_dssp ---CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCC
T ss_pred CCcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCC
Confidence 346888888888764 6778899999999999999988899999999987776677889999999999999
Q ss_pred cCceeEeeeecccCceEEEEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEE
Q 005940 410 KNLVNLHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALI 489 (668)
Q Consensus 410 ~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll 489 (668)
|||+++++++...+..++||||+++++|.+++.. ..+++..+..++.|++.||.|||+ .+|+||||||+||++
T Consensus 102 ~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll 174 (321)
T 2c30_A 102 FNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ----VRLNEEQIATVCEAVLQALAYLHA---QGVIHRDIKSDSILL 174 (321)
T ss_dssp TTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEE
T ss_pred CCcceEEEEEEECCEEEEEEecCCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEE
Confidence 9999999999999999999999999999999852 359999999999999999999999 999999999999999
Q ss_pred CCCCCEEEEeecCceeccCCCCCcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHH
Q 005940 490 DAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVR 569 (668)
Q Consensus 490 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~ 569 (668)
+.++.+||+|||+++....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... +...
T Consensus 175 ~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~--~~~~ 251 (321)
T 2c30_A 175 TLDGRVKLSDFGFCAQISKDVP-KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPV--QAMK 251 (321)
T ss_dssp CTTCCEEECCCTTCEECCSSSC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--HHHH
T ss_pred CCCCcEEEeeeeeeeecccCcc-ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHH
Confidence 9999999999999987654322 234467999999999999989999999999999999999999999764322 1111
Q ss_pred HHHhcCccccccCcccCC-cccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 570 ECHQLGRILDVADPLLNS-SYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 570 ~~~~~~~~~~~~d~~l~~-~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
.... .. .+.+.. .... ..+..+...|+.. |++||+++|++++
T Consensus 252 ~~~~-~~-----~~~~~~~~~~~---~~l~~li~~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 252 RLRD-SP-----PPKLKNSHKVS---PVLRDFLERMLVRDPQERATAQELLDH 295 (321)
T ss_dssp HHHH-SS-----CCCCTTGGGSC---HHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHhc-CC-----CCCcCccccCC---HHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1111 11 111111 0111 2344556678887 9999999999985
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-41 Score=352.53 Aligned_cols=260 Identities=30% Similarity=0.440 Sum_probs=201.1
Q ss_pred HHHhcCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCC--chhHHHHHHHHHHHhcccccCceeEeeeecccCceE
Q 005940 349 YAATKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNS--LQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLL 426 (668)
Q Consensus 349 ~~at~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~ 426 (668)
.....+|++.++||+|+||.||+|++ ++..||||++.... ....+++.+|++++++++||||+++++++...+..+
T Consensus 33 ~i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 110 (309)
T 3p86_A 33 DIPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLS 110 (309)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCE
T ss_pred cCChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceE
Confidence 33456789999999999999999988 58899999997654 344578999999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCc--eEecCCCCCCEEECCCCCEEEEeecCce
Q 005940 427 LVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQV--VIHRDVKPSNALIDAEMNARLGDFGLAR 504 (668)
Q Consensus 427 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~--ivHrDLkp~NIll~~~~~~kl~DfGla~ 504 (668)
+||||+++|+|.+++........+++..++.++.||+.||+|||+ .+ |+||||||+||+++.++.+||+|||+++
T Consensus 111 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~ 187 (309)
T 3p86_A 111 IVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN---RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSR 187 (309)
T ss_dssp EEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHT---SSSCCCCTTCCGGGEEECTTCCEEECCCC---
T ss_pred EEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHc---CCCCEECCCCChhhEEEeCCCcEEECCCCCCc
Confidence 999999999999999753333459999999999999999999998 78 9999999999999999999999999998
Q ss_pred eccCCCCCcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCcc
Q 005940 505 LYDHGGMPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPL 584 (668)
Q Consensus 505 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 584 (668)
...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...+.... ........... .
T Consensus 188 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~--~~~~~~~~~~~-----~ 259 (309)
T 3p86_A 188 LKASTF-LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQV--VAAVGFKCKRL-----E 259 (309)
T ss_dssp ---------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHH--HHHHHHSCCCC-----C
T ss_pred cccccc-cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHhcCCCC-----C
Confidence 654332 223345799999999999999999999999999999999999999976532211 11111111111 1
Q ss_pred cCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhccCc
Q 005940 585 LNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSGEK 625 (668)
Q Consensus 585 l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~~~ 625 (668)
+...++ ..+..+...|+.. |++||+++||++.|+...
T Consensus 260 ~~~~~~----~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~ 297 (309)
T 3p86_A 260 IPRNLN----PQVAAIIEGCWTNEPWKRPSFATIMDLLRPLI 297 (309)
T ss_dssp CCTTSC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCccCC----HHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 111222 2355666789887 999999999999998664
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=345.64 Aligned_cols=262 Identities=24% Similarity=0.379 Sum_probs=206.0
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCC---chhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEE
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNS---LQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVY 429 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 429 (668)
++|...+.||+|+||.||+|.+..++..||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 90 (294)
T 4eqm_A 11 ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVM 90 (294)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEE
T ss_pred ccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEE
Confidence 57899999999999999999998899999999986532 344578899999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCC
Q 005940 430 EYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHG 509 (668)
Q Consensus 430 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~ 509 (668)
||+++++|.+++.. ...+++..++.++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||+++.....
T Consensus 91 e~~~g~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 164 (294)
T 4eqm_A 91 EYIEGPTLSEYIES---HGPLSVDTAINFTNQILDGIKHAHD---MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSET 164 (294)
T ss_dssp ECCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCSSSTTC---
T ss_pred eCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEEeCCCccccccc
Confidence 99999999999953 3469999999999999999999999 99999999999999999999999999999876654
Q ss_pred CCCcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCcccCCcc
Q 005940 510 GMPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSY 589 (668)
Q Consensus 510 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 589 (668)
.........||+.|+|||.+.+..++.++|||||||++|||++|+.||........ ....... ..... ........
T Consensus 165 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~--~~~~~~~-~~~~~-~~~~~~~~ 240 (294)
T 4eqm_A 165 SLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSI--AIKHIQD-SVPNV-TTDVRKDI 240 (294)
T ss_dssp ----------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHH--HHHHHSS-CCCCH-HHHSCTTS
T ss_pred cccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH--HHHHhhc-cCCCc-chhcccCC
Confidence 44444556799999999999998999999999999999999999999976542211 1111111 11110 01111112
Q ss_pred cHHHHHHHHHHHhhcCCC-CCCCC-CHHHHHHHhccCcCCC
Q 005940 590 VVKEMELVLKLGLMCSHK-TQFRP-TMRQVMRYLSGEKQLR 628 (668)
Q Consensus 590 ~~~~~~~l~~l~~~C~~~-p~~RP-s~~evl~~L~~~~~~~ 628 (668)
+ ..+..+...|+.. |++|| +++++.+.|+....-.
T Consensus 241 ~----~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~ 277 (294)
T 4eqm_A 241 P----QSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHEN 277 (294)
T ss_dssp C----HHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSS
T ss_pred C----HHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhc
Confidence 2 3455666688887 99998 9999999998765444
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=370.67 Aligned_cols=265 Identities=24% Similarity=0.284 Sum_probs=209.1
Q ss_pred ccchhhHHHHhcCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCc---hhHHHHHHHHHHHhcccccCceeEeee
Q 005940 342 RFRYKDLYAATKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSL---QGMREFAAEIESLGRLRHKNLVNLHGW 418 (668)
Q Consensus 342 ~f~~~el~~at~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~f~~Ei~~l~~l~H~nIv~l~g~ 418 (668)
.+.+.++...+++|+..++||+|+||+||+|+++.+++.||||++.+... ...+.+.+|+.++.+++||||++++++
T Consensus 63 ~~~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~ 142 (437)
T 4aw2_A 63 TSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYA 142 (437)
T ss_dssp HHHHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEE
T ss_pred cchhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence 34566677778899999999999999999999998899999999975322 122348899999999999999999999
Q ss_pred ecccCceEEEEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEE
Q 005940 419 CKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLG 498 (668)
Q Consensus 419 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~ 498 (668)
|.+.+..|+||||+++|+|.+++.. ....+++..+..++.||+.||.|||+ .+|+||||||+||||+.++.+||+
T Consensus 143 ~~~~~~~~lV~Ey~~gg~L~~~l~~--~~~~l~e~~~~~~~~qi~~aL~~LH~---~giiHrDLKp~NILl~~~g~vkL~ 217 (437)
T 4aw2_A 143 FQDDNNLYLVMDYYVGGDLLTLLSK--FEDRLPEEMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLA 217 (437)
T ss_dssp EECSSEEEEEECCCTTCBHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEEC
T ss_pred EeeCCEEEEEEecCCCCcHHHHHHH--ccCCCCHHHHHHHHHHHHHHHHHHHh---CCeEecccCHHHeeEcCCCCEEEc
Confidence 9999999999999999999999964 23569999999999999999999999 999999999999999999999999
Q ss_pred eecCceeccCCCCCcccccccCCcccCccccc-----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCchh-HHHHHHHHH
Q 005940 499 DFGLARLYDHGGMPHTTNVVGTFGYIAPELTQ-----TGKASTSSDVFAYGILLLEVATGRRPIGSGDLL-LVEWVRECH 572 (668)
Q Consensus 499 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~-l~~~~~~~~ 572 (668)
|||+++.............+||+.|+|||++. .+.++.++|||||||++|||++|+.||...+.. ....+....
T Consensus 218 DFGla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~ 297 (437)
T 4aw2_A 218 DFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHK 297 (437)
T ss_dssp CCTTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHH
T ss_pred chhhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhcc
Confidence 99999877655444444568999999999986 567899999999999999999999999765322 111111111
Q ss_pred hcCccccccCcccCCcccHHHHHHHHHHHhhcCCC-CCC--CCCHHHHHHH
Q 005940 573 QLGRILDVADPLLNSSYVVKEMELVLKLGLMCSHK-TQF--RPTMRQVMRY 620 (668)
Q Consensus 573 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~-p~~--RPs~~evl~~ 620 (668)
.... -|....... +++. .+...|+.. |++ ||+++|++++
T Consensus 298 ~~~~-----~p~~~~~~s-~~~~---dLi~~lL~~~~~r~~r~~~~eil~H 339 (437)
T 4aw2_A 298 ERFQ-----FPTQVTDVS-ENAK---DLIRRLICSREHRLGQNGIEDFKKH 339 (437)
T ss_dssp HHCC-----CCSSCCCSC-HHHH---HHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred cccc-----CCcccccCC-HHHH---HHHHHHhcccccccCCCCHHHHhCC
Confidence 1111 111111122 2233 333345544 655 9999999986
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-41 Score=359.64 Aligned_cols=257 Identities=26% Similarity=0.389 Sum_probs=207.5
Q ss_pred cCcccceeeeecCcEEEEEEEeC-------CCCcEEEEEEEecCCc-hhHHHHHHHHHHHhcc-cccCceeEeeeecccC
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLP-------TTGGEVAVKKITRNSL-QGMREFAAEIESLGRL-RHKNLVNLHGWCKQKN 423 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~-------~~~~~vavK~~~~~~~-~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~ 423 (668)
++|...+.||+|+||.||+|++. .++..||||++..... ...+++.+|+++++++ +||||++++++|...+
T Consensus 81 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~ 160 (370)
T 2psq_A 81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 160 (370)
T ss_dssp GGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSS
T ss_pred HHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCC
Confidence 57888999999999999999864 2345799999976533 4457899999999999 8999999999999999
Q ss_pred ceEEEEEecCCCChhhhhcCCCC-------------CCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEEC
Q 005940 424 DLLLVYEYIPNGSLDTLLFKPKD-------------GSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALID 490 (668)
Q Consensus 424 ~~~lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~ 490 (668)
..|+||||+++|+|.+++..... ...+++.+++.++.||+.||.|||+ .+|+||||||+|||++
T Consensus 161 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~ 237 (370)
T 2psq_A 161 PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLAARNVLVT 237 (370)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEC
T ss_pred CEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCeeccccchhhEEEC
Confidence 99999999999999999964321 2458999999999999999999999 9999999999999999
Q ss_pred CCCCEEEEeecCceeccCCCC-CcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCchh-HHHH
Q 005940 491 AEMNARLGDFGLARLYDHGGM-PHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVAT-GRRPIGSGDLL-LVEW 567 (668)
Q Consensus 491 ~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~-l~~~ 567 (668)
.++.+||+|||+++....... .......+|+.|+|||++.+..++.++|||||||++|||++ |+.||...... +..
T Consensus 238 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~~- 316 (370)
T 2psq_A 238 ENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK- 316 (370)
T ss_dssp TTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHH-
T ss_pred CCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH-
Confidence 999999999999997654332 22334567889999999999899999999999999999999 99999754322 211
Q ss_pred HHHHHhcCccccccCcccCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhccCc
Q 005940 568 VRECHQLGRILDVADPLLNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSGEK 625 (668)
Q Consensus 568 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~~~ 625 (668)
....+... .....+. ..+..++..|++. |++||+++|+++.|+...
T Consensus 317 ---~~~~~~~~-----~~~~~~~----~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il 363 (370)
T 2psq_A 317 ---LLKEGHRM-----DKPANCT----NELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 363 (370)
T ss_dssp ---HHHTTCCC-----CCCTTSC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---HHhcCCCC-----CCCCCCC----HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 11111111 1111222 3455667789987 999999999999998653
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=351.44 Aligned_cols=248 Identities=26% Similarity=0.395 Sum_probs=204.4
Q ss_pred hcCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecC--CchhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEE
Q 005940 352 TKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRN--SLQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVY 429 (668)
Q Consensus 352 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 429 (668)
..+|...+.||+|+||.||+|.+..+++.||||++.+. .....+.+.+|++++++++||||+++++++...+..++||
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM 93 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 35799999999999999999999889999999999764 3345577889999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCC
Q 005940 430 EYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHG 509 (668)
Q Consensus 430 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~ 509 (668)
||+++|+|.+++.. ...+++.++..++.||+.||.|||+ .+|+||||||+||+++.++++||+|||+++.....
T Consensus 94 e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 167 (328)
T 3fe3_A 94 EYASGGEVFDYLVA---HGRMKEKEARSKFRQIVSAVQYCHQ---KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG 167 (328)
T ss_dssp CCCTTCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS
T ss_pred ECCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCEeccCCCHHHEEEcCCCCEEEeeccCceecCCC
Confidence 99999999999953 2458999999999999999999999 99999999999999999999999999999876543
Q ss_pred CCCcccccccCCcccCcccccCCCCC-cchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCcccCCc
Q 005940 510 GMPHTTNVVGTFGYIAPELTQTGKAS-TSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSS 588 (668)
Q Consensus 510 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 588 (668)
. .....+||+.|+|||++.+..+. .++||||+||++|||++|+.||...+.. +....... +.. .+...
T Consensus 168 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--~~~~~i~~-~~~------~~p~~ 236 (328)
T 3fe3_A 168 G--KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLK--ELRERVLR-GKY------RIPFY 236 (328)
T ss_dssp C--GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHH-CCC------CCCTT
T ss_pred C--ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHH--HHHHHHHh-CCC------CCCCC
Confidence 2 23456899999999999887764 8999999999999999999999765422 22222222 111 11111
Q ss_pred ccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 589 YVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 589 ~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
.. . .+..+...|+.. |++||+++|++++
T Consensus 237 ~s-~---~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 237 MS-T---DCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp SC-H---HHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred CC-H---HHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 22 2 234455578776 9999999999986
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=349.89 Aligned_cols=259 Identities=27% Similarity=0.427 Sum_probs=206.2
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCc---EEEEEEEecC-CchhHHHHHHHHHHHhcccccCceeEeeeecccCceEEE
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGG---EVAVKKITRN-SLQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLV 428 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~---~vavK~~~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV 428 (668)
++|.+.+.||+|+||.||+|.+..++. .||||++... .....+.|.+|++++++++||||+++++++.+.+..++|
T Consensus 49 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 128 (325)
T 3kul_A 49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIV 128 (325)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEE
T ss_pred hHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEE
Confidence 568889999999999999999975444 5999999765 334557899999999999999999999999999999999
Q ss_pred EEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccC
Q 005940 429 YEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDH 508 (668)
Q Consensus 429 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~ 508 (668)
|||+++|+|.+++.. ....+++.+++.++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 129 ~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 203 (325)
T 3kul_A 129 TEYMENGSLDTFLRT--HDGQFTIMQLVGMLRGVGAGMRYLSD---LGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLED 203 (325)
T ss_dssp EECCTTCBHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCSSCEECC-
T ss_pred eeCCCCCcHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCcceEEECCCCCEEECCCCccccccc
Confidence 999999999999963 33569999999999999999999999 9999999999999999999999999999997754
Q ss_pred CCCC--cccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHHHhcCccccccCccc
Q 005940 509 GGMP--HTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVAT-GRRPIGSGDLLLVEWVRECHQLGRILDVADPLL 585 (668)
Q Consensus 509 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 585 (668)
.... ......+|..|+|||++.+..++.++|||||||++|||++ |+.||...... +.......... ...
T Consensus 204 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~--~~~~~~~~~~~------~~~ 275 (325)
T 3kul_A 204 DPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNR--DVISSVEEGYR------LPA 275 (325)
T ss_dssp ---CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHH--HHHHHHHTTCC------CCC
T ss_pred CccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHH--HHHHHHHcCCC------CCC
Confidence 4322 1223356778999999988889999999999999999999 99999754322 11111111111 111
Q ss_pred CCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhccCcCCC
Q 005940 586 NSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSGEKQLR 628 (668)
Q Consensus 586 ~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~~~~~~ 628 (668)
...+. ..+..++..|+.. |++||+++||++.|+.....+
T Consensus 276 ~~~~~----~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~ 315 (325)
T 3kul_A 276 PMGCP----HALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSP 315 (325)
T ss_dssp CTTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSC
T ss_pred CCCcC----HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCc
Confidence 11122 3455677789987 999999999999998765433
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-40 Score=344.22 Aligned_cols=268 Identities=24% Similarity=0.301 Sum_probs=212.4
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCC-chhHHHHHHHHHHHhcccccCceeEeeeecccC--ceEEEE
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNS-LQGMREFAAEIESLGRLRHKNLVNLHGWCKQKN--DLLLVY 429 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~--~~~lV~ 429 (668)
++|...++||+|+||.||+|.+..+++.||||++.... ....+.+.+|++++++++||||+++++++.... ..++||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (319)
T 4euu_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (319)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEE
Confidence 56889999999999999999999889999999997643 234577889999999999999999999987655 789999
Q ss_pred EecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEE----CCCCCEEEEeecCcee
Q 005940 430 EYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALI----DAEMNARLGDFGLARL 505 (668)
Q Consensus 430 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll----~~~~~~kl~DfGla~~ 505 (668)
||+++++|.+++........+++.+++.++.||+.||.|||+ .+|+||||||+||++ +.++.+||+|||+++.
T Consensus 89 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~ 165 (319)
T 4euu_A 89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE 165 (319)
T ss_dssp ECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEE
T ss_pred eCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEEeccCCCCceEEEccCCCcee
Confidence 999999999999754444559999999999999999999999 999999999999999 7888899999999987
Q ss_pred ccCCCCCcccccccCCcccCccccc--------CCCCCcchhHHHHHHHHHHHHhCCCCCCCCc--hhHHHHHHHHHhcC
Q 005940 506 YDHGGMPHTTNVVGTFGYIAPELTQ--------TGKASTSSDVFAYGILLLEVATGRRPIGSGD--LLLVEWVRECHQLG 575 (668)
Q Consensus 506 ~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~--~~l~~~~~~~~~~~ 575 (668)
...... .....||..|+|||++. ...++.++|||||||++|||++|+.||...+ ....+.........
T Consensus 166 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 243 (319)
T 4euu_A 166 LEDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGK 243 (319)
T ss_dssp CCTTCC--BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHC
T ss_pred cCCCCc--eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCC
Confidence 765432 23457999999999875 5678999999999999999999999996431 11122222222211
Q ss_pred c---ccccc-----------CcccCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhccCc
Q 005940 576 R---ILDVA-----------DPLLNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSGEK 625 (668)
Q Consensus 576 ~---~~~~~-----------d~~l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~~~ 625 (668)
. +.... +..............+..+...|+.. |++||+++|++++...+.
T Consensus 244 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~ 308 (319)
T 4euu_A 244 PSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL 308 (319)
T ss_dssp CTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHT
T ss_pred CcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHh
Confidence 0 00000 00111233445556677777888887 999999999999987654
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=348.71 Aligned_cols=252 Identities=26% Similarity=0.341 Sum_probs=204.7
Q ss_pred hcCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCch------hHHHHHHHHHHHhcccccCceeEeeeecccCce
Q 005940 352 TKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQ------GMREFAAEIESLGRLRHKNLVNLHGWCKQKNDL 425 (668)
Q Consensus 352 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~------~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~ 425 (668)
.+.|...+.||+|+||.||+|++..++..||+|++.+.... ..+.+.+|+.++++++||||+++++++.+....
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 35789999999999999999999989999999999765432 346889999999999999999999999999999
Q ss_pred EEEEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCC----CEEEEeec
Q 005940 426 LLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEM----NARLGDFG 501 (668)
Q Consensus 426 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~----~~kl~DfG 501 (668)
++||||+++|+|.+++.. ...+++..+..++.||+.||.|||+ .+|+||||||+||+++.++ .+||+|||
T Consensus 91 ~lv~e~~~gg~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDlkp~NIll~~~~~~~~~vkl~DFG 164 (361)
T 2yab_A 91 VLILELVSGGELFDFLAQ---KESLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFG 164 (361)
T ss_dssp EEEEECCCSCBHHHHHTT---CSCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCTTSSSCCEEECCCS
T ss_pred EEEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEeCCCCCccCEEEEecC
Confidence 999999999999999953 3569999999999999999999999 9999999999999998877 79999999
Q ss_pred CceeccCCCCCcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCcccccc
Q 005940 502 LARLYDHGGMPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVA 581 (668)
Q Consensus 502 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~ 581 (668)
+++....... .....||+.|+|||++....++.++|||||||++|||++|+.||...+.. +...... ..... .
T Consensus 165 ~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~--~~~~~i~-~~~~~--~ 237 (361)
T 2yab_A 165 LAHEIEDGVE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ--ETLANIT-AVSYD--F 237 (361)
T ss_dssp SCEECCTTCC--CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH--HHHHHHH-TTCCC--C
T ss_pred CceEcCCCCc--cccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHH-hcCCC--C
Confidence 9987765432 33457999999999999889999999999999999999999999764322 1111111 11110 0
Q ss_pred CcccCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 582 DPLLNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 582 d~~l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
++....... ..+..+...|+.. |++||++.|++++
T Consensus 238 ~~~~~~~~s----~~~~~li~~~L~~dP~~R~t~~e~l~h 273 (361)
T 2yab_A 238 DEEFFSQTS----ELAKDFIRKLLVKETRKRLTIQEALRH 273 (361)
T ss_dssp CHHHHTTSC----HHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CchhccCCC----HHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 111101111 2344556678876 9999999999975
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-40 Score=347.10 Aligned_cols=253 Identities=25% Similarity=0.328 Sum_probs=200.7
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCc-hhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEEe
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSL-QGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEY 431 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~ 431 (668)
++|+..+.||+|+||.||+|.+..+++.||||++..... ...+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 7 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 86 (323)
T 3tki_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 86 (323)
T ss_dssp TCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEc
Confidence 579999999999999999999988999999999975433 3346788999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCCC
Q 005940 432 IPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGM 511 (668)
Q Consensus 432 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~~ 511 (668)
+++|+|.+++.. ...+++.+++.++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++.......
T Consensus 87 ~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 160 (323)
T 3tki_A 87 CSGGELFDRIEP---DIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 160 (323)
T ss_dssp CTTEEGGGGSBT---TTBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred CCCCcHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccccchHHEEEeCCCCEEEEEeeccceeccCCc
Confidence 999999999953 3469999999999999999999999 9999999999999999999999999999987643221
Q ss_pred -CcccccccCCcccCcccccCCCC-CcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCcccCCcc
Q 005940 512 -PHTTNVVGTFGYIAPELTQTGKA-STSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSY 589 (668)
Q Consensus 512 -~~~~~~~gt~~y~aPE~~~~~~~-~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 589 (668)
.......||+.|+|||++.+..+ +.++|||||||++|||++|+.||.........+... ....... .+. ...
T Consensus 161 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~-~~~~~~~---~~~--~~~ 234 (323)
T 3tki_A 161 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW-KEKKTYL---NPW--KKI 234 (323)
T ss_dssp ECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHH-HTTCTTS---TTG--GGS
T ss_pred ccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHH-hcccccC---Ccc--ccC
Confidence 22334579999999999987765 789999999999999999999997543221111111 1111110 110 111
Q ss_pred cHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHh
Q 005940 590 VVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYL 621 (668)
Q Consensus 590 ~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L 621 (668)
+ ..+..+...|+.. |++||+++|++++-
T Consensus 235 ~----~~~~~li~~~L~~dP~~R~t~~eil~h~ 263 (323)
T 3tki_A 235 D----SAPLALLHKILVENPSARITIPDIKKDR 263 (323)
T ss_dssp C----HHHHHHHHHHSCSSTTTSCCHHHHTTCT
T ss_pred C----HHHHHHHHHHccCChhhCcCHHHHhhCh
Confidence 2 2234556678887 99999999999864
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=344.14 Aligned_cols=251 Identities=24% Similarity=0.346 Sum_probs=204.0
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCch------hHHHHHHHHHHHhcccccCceeEeeeecccCceE
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQ------GMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLL 426 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~------~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~ 426 (668)
+.|...+.||+|+||.||+|.+..++..||||++...... ..+.+.+|+.++++++||||+++++++......+
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 90 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 5688999999999999999999889999999999765332 3578999999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCC----CEEEEeecC
Q 005940 427 LVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEM----NARLGDFGL 502 (668)
Q Consensus 427 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~----~~kl~DfGl 502 (668)
+||||+++|+|.+++.. ...+++..++.++.||+.||.|||+ .+|+||||||+||+++.++ .+||+|||+
T Consensus 91 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~ 164 (326)
T 2y0a_A 91 LILELVAGGELFDFLAE---KESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL 164 (326)
T ss_dssp EEEECCCSCBHHHHHTT---SSCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEEcCCCCCHHHHHHh---cCCcCHHHHHHHHHHHHHHHHHHHH---CCeEcCCCCHHHEEEecCCCCCCCEEEEECCC
Confidence 99999999999999953 3569999999999999999999999 9999999999999999887 799999999
Q ss_pred ceeccCCCCCcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccC
Q 005940 503 ARLYDHGGMPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVAD 582 (668)
Q Consensus 503 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d 582 (668)
++....... .....||+.|+|||++....++.++|||||||++|||++|+.||...... +........ ... ..
T Consensus 165 a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--~~~~~~~~~-~~~--~~ 237 (326)
T 2y0a_A 165 AHKIDFGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ--ETLANVSAV-NYE--FE 237 (326)
T ss_dssp CEECCTTSC--CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH--HHHHHHHHT-CCC--CC
T ss_pred CeECCCCCc--cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHH--HHHHHHHhc-CCC--cC
Confidence 987754332 23457999999999999889999999999999999999999999754322 111111111 100 00
Q ss_pred cccCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 583 PLLNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 583 ~~l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
+....... ..+..+...|+.. |++||+++|++++
T Consensus 238 ~~~~~~~~----~~~~~li~~~L~~dP~~Rpt~~e~l~h 272 (326)
T 2y0a_A 238 DEYFSNTS----ALAKDFIRRLLVKDPKKRMTIQDSLQH 272 (326)
T ss_dssp HHHHTTSC----HHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred ccccccCC----HHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 00001111 2345566688887 9999999999985
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=338.49 Aligned_cols=256 Identities=28% Similarity=0.423 Sum_probs=209.0
Q ss_pred hcCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCchhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEEe
Q 005940 352 TKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEY 431 (668)
Q Consensus 352 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~ 431 (668)
.++|...+.||+|+||.||+|.+. ++..||||++..... ..+++.+|++++.+++||||+++++++.+.+..++||||
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEY 84 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred hhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEc
Confidence 467889999999999999999885 567899999976543 346789999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCCC
Q 005940 432 IPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGM 511 (668)
Q Consensus 432 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~~ 511 (668)
+++++|.+++.. .+..+++.+++.++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||+++.......
T Consensus 85 ~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 159 (268)
T 3sxs_A 85 ISNGCLLNYLRS--HGKGLEPSQLLEMCYDVCEGMAFLES---HQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY 159 (268)
T ss_dssp CTTCBHHHHHHH--HGGGCCHHHHHHHHHHHHHHHHHHHH---TTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCE
T ss_pred cCCCcHHHHHHH--cCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCcCcceEEECCCCCEEEccCccceecchhhh
Confidence 999999999953 23459999999999999999999999 9999999999999999999999999999987765543
Q ss_pred CcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHHHhcCccccccCcccCCccc
Q 005940 512 PHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVAT-GRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSYV 590 (668)
Q Consensus 512 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 590 (668)
.......+|..|+|||.+.+..++.++||||||+++|||++ |+.||...... +.......... ...+. ...
T Consensus 160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~~~~~~~~~~~---~~~~~---~~~ 231 (268)
T 3sxs_A 160 VSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNS--EVVLKVSQGHR---LYRPH---LAS 231 (268)
T ss_dssp EECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHH--HHHHHHHTTCC---CCCCT---TSC
T ss_pred hcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChH--HHHHHHHcCCC---CCCCC---cCh
Confidence 33444566778999999988889999999999999999999 99999765322 11122111111 11111 111
Q ss_pred HHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhccCcC
Q 005940 591 VKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSGEKQ 626 (668)
Q Consensus 591 ~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~~~~ 626 (668)
..+..+...|++. |++||+++|++++|+...+
T Consensus 232 ----~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (268)
T 3sxs_A 232 ----DTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE 264 (268)
T ss_dssp ----HHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred ----HHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhh
Confidence 2355666789887 9999999999999987653
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-41 Score=351.48 Aligned_cols=245 Identities=26% Similarity=0.342 Sum_probs=193.2
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCc--hhHHHHHHHHHHHhcc-cccCceeEeeeecccCceEEEE
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSL--QGMREFAAEIESLGRL-RHKNLVNLHGWCKQKNDLLLVY 429 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~ 429 (668)
++|+..++||+|+||+||+|.+..+++.||||++..... ....++..|+..+.++ +||||++++++|.+.+..++||
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~ 136 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT 136 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence 579999999999999999999988899999999865432 3344556666666665 8999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCC
Q 005940 430 EYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHG 509 (668)
Q Consensus 430 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~ 509 (668)
||+ +++|.+++.. .+..++|..++.++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 137 e~~-~~~L~~~~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~ 210 (311)
T 3p1a_A 137 ELC-GPSLQQHCEA--WGASLPEAQVWGYLRDTLLALAHLHS---QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA 210 (311)
T ss_dssp ECC-CCBHHHHHHH--HCSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECGGGCEEECCCTTCEECC--
T ss_pred ecc-CCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEECCCCCEEEccceeeeecccC
Confidence 999 7799888853 23569999999999999999999999 89999999999999999999999999999876543
Q ss_pred CCCcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCcccCCcc
Q 005940 510 GMPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSY 589 (668)
Q Consensus 510 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 589 (668)
. ......||+.|+|||++.+ .++.++|||||||++|||++|..|+...+ .| ........ .+.+....
T Consensus 211 ~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~----~~--~~~~~~~~----~~~~~~~~ 277 (311)
T 3p1a_A 211 G--AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGE----GW--QQLRQGYL----PPEFTAGL 277 (311)
T ss_dssp ------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHH----HH--HHHTTTCC----CHHHHTTS
T ss_pred C--CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc----HH--HHHhccCC----CcccccCC
Confidence 2 2334579999999998875 78999999999999999999987765321 11 11111111 11111111
Q ss_pred cHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 590 VVKEMELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 590 ~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
...+..+...|++. |++||+++|++++
T Consensus 278 ----~~~l~~li~~~L~~dP~~Rpt~~ell~h 305 (311)
T 3p1a_A 278 ----SSELRSVLVMMLEPDPKLRATAEALLAL 305 (311)
T ss_dssp ----CHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred ----CHHHHHHHHHHcCCChhhCcCHHHHHhC
Confidence 23456667789887 9999999999974
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=339.80 Aligned_cols=253 Identities=26% Similarity=0.411 Sum_probs=206.3
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCchhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEEec
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEYI 432 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~ 432 (668)
++|...+.||+|+||.||+|.+. +++.||+|++..... ..+++.+|++++++++||||+++++++.+.+..++||||+
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 87 (269)
T 4hcu_A 10 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM 87 (269)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhceeeheecCCCccEEEEEEec-CCCeEEEEEeccccc-CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeC
Confidence 57888999999999999999986 577899999976543 3467899999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCCCC
Q 005940 433 PNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMP 512 (668)
Q Consensus 433 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~~~ 512 (668)
++++|.+++.. ....+++..++.++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||+++........
T Consensus 88 ~~~~L~~~l~~--~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 162 (269)
T 4hcu_A 88 EHGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT 162 (269)
T ss_dssp TTCBHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHH
T ss_pred CCCcHHHHHHh--cCcccCHHHHHHHHHHHHHHHHHHHh---CCeecCCcchheEEEcCCCCEEeccccccccccccccc
Confidence 99999999963 34568999999999999999999999 99999999999999999999999999999866543322
Q ss_pred cccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHHHhcCccccccCcccCCcccH
Q 005940 513 HTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVAT-GRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSYVV 591 (668)
Q Consensus 513 ~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 591 (668)
......+|..|+|||.+....++.++||||+|+++|||++ |+.||...... +.......... +......+
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~--~~~~~~~~~~~------~~~~~~~~- 233 (269)
T 4hcu_A 163 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS--EVVEDISTGFR------LYKPRLAS- 233 (269)
T ss_dssp STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHHHHHHTTCC------CCCCTTSC-
T ss_pred cccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHH--HHHHHHhcCcc------CCCCCcCC-
Confidence 3334466788999999988899999999999999999999 99999765322 11122111111 11111111
Q ss_pred HHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhccC
Q 005940 592 KEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSGE 624 (668)
Q Consensus 592 ~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~~ 624 (668)
..+..+...|++. |++||+++|++++|+..
T Consensus 234 ---~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l 264 (269)
T 4hcu_A 234 ---THVYQIMNHCWRERPEDRPAFSRLLRQLAEI 264 (269)
T ss_dssp ---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---HHHHHHHHHHccCCcccCcCHHHHHHHHHHH
Confidence 2355666688887 99999999999999764
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-41 Score=360.26 Aligned_cols=256 Identities=29% Similarity=0.462 Sum_probs=195.2
Q ss_pred cCcccceeeeecCcEEEEEEEeC---CCCcEEEEEEEecCC-chhHHHHHHHHHHHhcccccCceeEeeeecccCceEEE
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLP---TTGGEVAVKKITRNS-LQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLV 428 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~---~~~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV 428 (668)
++|...+.||+|+||.||+|++. .++..||||++.... ....++|.+|++++++++||||++++++|.+.+..++|
T Consensus 45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 124 (373)
T 2qol_A 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIV 124 (373)
T ss_dssp GGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEE
Confidence 57889999999999999999986 456789999997653 34557899999999999999999999999999999999
Q ss_pred EEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccC
Q 005940 429 YEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDH 508 (668)
Q Consensus 429 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~ 508 (668)
|||+++|+|.+++.. .+..+++.+++.++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 125 ~e~~~~~sL~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 199 (373)
T 2qol_A 125 TEYMENGSLDSFLRK--HDAQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLGRVLED 199 (373)
T ss_dssp EECCTTCBHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EeCCCCCcHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCcceEEEcCCCCEEECcCcccccccc
Confidence 999999999999963 34569999999999999999999999 9999999999999999999999999999987654
Q ss_pred CCCCc--ccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHHHhcCccccccCccc
Q 005940 509 GGMPH--TTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVAT-GRRPIGSGDLLLVEWVRECHQLGRILDVADPLL 585 (668)
Q Consensus 509 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 585 (668)
..... .....++..|+|||++....++.++|||||||++|||++ |+.||....... .... ...+... + .
T Consensus 200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~--~~~~-i~~~~~~----~-~ 271 (373)
T 2qol_A 200 DPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD--VIKA-VDEGYRL----P-P 271 (373)
T ss_dssp --------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHH--HHHH-HHTTEEC----C-C
T ss_pred CCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHH-HHcCCCC----C-C
Confidence 32211 122245778999999998899999999999999999998 999997543221 1111 1111100 0 0
Q ss_pred CCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhccCc
Q 005940 586 NSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSGEK 625 (668)
Q Consensus 586 ~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~~~ 625 (668)
...+ ...+..++..|++. |++||+++||++.|+...
T Consensus 272 ~~~~----~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~ 308 (373)
T 2qol_A 272 PMDC----PAALYQLMLDCWQKDRNNRPKFEQIVSILDKLI 308 (373)
T ss_dssp CTTC----BHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred Cccc----cHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHH
Confidence 1111 23456777789988 999999999999997653
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-40 Score=344.17 Aligned_cols=253 Identities=19% Similarity=0.258 Sum_probs=206.0
Q ss_pred hcCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCchhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEEe
Q 005940 352 TKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEY 431 (668)
Q Consensus 352 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~ 431 (668)
.++|...+.||+|+||.||+|++..++..||+|.+.... .....+.+|++++++++||||+++++++.+.+..++||||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 82 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence 367899999999999999999999899999999987543 3446788999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECC--CCCEEEEeecCceeccCC
Q 005940 432 IPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDA--EMNARLGDFGLARLYDHG 509 (668)
Q Consensus 432 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~--~~~~kl~DfGla~~~~~~ 509 (668)
+++|+|.+++.. ....+++.+++.++.||+.||.|||+ .+|+||||||+|||++. ++.+||+|||+++.....
T Consensus 83 ~~g~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~---~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~ 157 (321)
T 1tki_A 83 ISGLDIFERINT--SAFELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp CCCCBHHHHHTS--SSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred CCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHH---CCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC
Confidence 999999999953 33569999999999999999999999 99999999999999987 789999999999887654
Q ss_pred CCCcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCcccCCcc
Q 005940 510 GMPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSY 589 (668)
Q Consensus 510 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 589 (668)
. ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... +........ ... .++......
T Consensus 158 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--~~~~~i~~~-~~~--~~~~~~~~~ 230 (321)
T 1tki_A 158 D--NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ--QIIENIMNA-EYT--FDEEAFKEI 230 (321)
T ss_dssp C--EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH--HHHHHHHHT-CCC--CCHHHHTTS
T ss_pred C--ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHH--HHHHHHHcC-CCC--CChhhhccC
Confidence 3 234457899999999998888899999999999999999999999765322 112222211 110 000000111
Q ss_pred cHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHh
Q 005940 590 VVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYL 621 (668)
Q Consensus 590 ~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L 621 (668)
. ..+..+...|+.. |++||++.|++++-
T Consensus 231 s----~~~~~li~~~L~~dp~~Rpt~~e~l~hp 259 (321)
T 1tki_A 231 S----IEAMDFVDRLLVKERKSRMTASEALQHP 259 (321)
T ss_dssp C----HHHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred C----HHHHHHHHHHcCCChhHCcCHHHHhcCh
Confidence 1 2345666688887 99999999999863
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=343.41 Aligned_cols=258 Identities=28% Similarity=0.397 Sum_probs=202.4
Q ss_pred cCcccceeeeecCcEEEEEEE----eCCCCcEEEEEEEecCCchhHHHHHHHHHHHhcccccCceeEeeeecc--cCceE
Q 005940 353 KGFKESEVIGIGGFGSVYKGV----LPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNLHGWCKQ--KNDLL 426 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~----~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~--~~~~~ 426 (668)
++|+..++||+|+||.||+|+ ...+++.||||++........+.+.+|++++++++||||++++++|.. ....+
T Consensus 10 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 89 (295)
T 3ugc_A 10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK 89 (295)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCE
T ss_pred HHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceE
Confidence 578889999999999999998 456788999999988777777889999999999999999999999854 35689
Q ss_pred EEEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceec
Q 005940 427 LVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLY 506 (668)
Q Consensus 427 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~ 506 (668)
+||||+++|+|.+++... ...+++.+++.++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||+++..
T Consensus 90 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~ 164 (295)
T 3ugc_A 90 LIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTKVL 164 (295)
T ss_dssp EEEECCTTCBHHHHHHHC--GGGCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCCSCC--
T ss_pred EEEEeCCCCCHHHHHHhc--ccccCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHhhEEEcCCCeEEEccCcccccc
Confidence 999999999999999632 3458999999999999999999999 99999999999999999999999999999876
Q ss_pred cCCCC--CcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHH-------------HHHHHH
Q 005940 507 DHGGM--PHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLV-------------EWVREC 571 (668)
Q Consensus 507 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~-------------~~~~~~ 571 (668)
..... .......++..|+|||.+.+..++.++||||||+++|||++|..|+........ ....+.
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (295)
T 3ugc_A 165 PQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIEL 244 (295)
T ss_dssp -----------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHH
T ss_pred cCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHH
Confidence 54322 122234567789999999988999999999999999999999999864321111 111111
Q ss_pred HhcCccccccCcccCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhccC
Q 005940 572 HQLGRILDVADPLLNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSGE 624 (668)
Q Consensus 572 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~~ 624 (668)
....... .....+. ..+..++..|++. |++||+++||++.|+..
T Consensus 245 ~~~~~~~-----~~~~~~~----~~l~~li~~~l~~dp~~Rps~~el~~~L~~l 289 (295)
T 3ugc_A 245 LKNNGRL-----PRPDGCP----DEIYMIMTECWNNNVNQRPSFRDLALRVDQI 289 (295)
T ss_dssp HHTTCCC-----CCCTTCC----HHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred HhccCcC-----CCCcCcC----HHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 1111111 1111122 3455677789987 99999999999999764
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=349.12 Aligned_cols=259 Identities=27% Similarity=0.391 Sum_probs=203.5
Q ss_pred HhcCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCchhHHHHHHHHHHHhcccccCceeEeeeecccC----ceE
Q 005940 351 ATKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNLHGWCKQKN----DLL 426 (668)
Q Consensus 351 at~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~----~~~ 426 (668)
..++|+..++||+|+||.||+|++. ++.||||++..... ....+..|+.++++++||||+++++++.... .++
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 98 (322)
T 3soc_A 22 QSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDK-QSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLW 98 (322)
T ss_dssp TTEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred chhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCch-HHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEE
Confidence 3467899999999999999999984 78999999976543 3345667999999999999999999998754 369
Q ss_pred EEEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCC----------ceEecCCCCCCEEECCCCCEE
Q 005940 427 LVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQ----------VVIHRDVKPSNALIDAEMNAR 496 (668)
Q Consensus 427 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~----------~ivHrDLkp~NIll~~~~~~k 496 (668)
+||||+++|+|.+++.. ..++|..++.++.|++.||.|||+ . +|+||||||+|||++.++.+|
T Consensus 99 lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~qi~~al~~LH~---~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~k 171 (322)
T 3soc_A 99 LITAFHEKGSLSDFLKA----NVVSWNELCHIAETMARGLAYLHE---DIPGLKDGHKPAISHRDIKSKNVLLKNNLTAC 171 (322)
T ss_dssp EEEECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHTC---CEEEETTEEECEEECSCCSGGGEEECTTCCEE
T ss_pred EEEecCCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHh---hccccccccCCCEEeCCCChHhEEECCCCeEE
Confidence 99999999999999953 349999999999999999999998 6 999999999999999999999
Q ss_pred EEeecCceeccCCCCC-cccccccCCcccCcccccC-----CCCCcchhHHHHHHHHHHHHhCCCCCCCCch--------
Q 005940 497 LGDFGLARLYDHGGMP-HTTNVVGTFGYIAPELTQT-----GKASTSSDVFAYGILLLEVATGRRPIGSGDL-------- 562 (668)
Q Consensus 497 l~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-----~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~-------- 562 (668)
|+|||+++........ ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.....
T Consensus 172 L~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~ 251 (322)
T 3soc_A 172 IADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEE 251 (322)
T ss_dssp ECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHH
T ss_pred EccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhh
Confidence 9999999877654322 2334579999999999876 3456789999999999999999999964311
Q ss_pred ------hHHHHHHHHHhcCccccccCcccCCcc-cHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhccC
Q 005940 563 ------LLVEWVRECHQLGRILDVADPLLNSSY-VVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSGE 624 (668)
Q Consensus 563 ------~l~~~~~~~~~~~~~~~~~d~~l~~~~-~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~~ 624 (668)
...++...... .. ..+.+.... .......+..++..|+.. |++||+++||++.|+..
T Consensus 252 ~~~~~~~~~~~~~~~~~-~~----~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l 316 (322)
T 3soc_A 252 EIGQHPSLEDMQEVVVH-KK----KRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQM 316 (322)
T ss_dssp HHCSSCCHHHHHHHHTT-SC----CCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred hhccCCchhhhhhhhhc-cc----CCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 11122111111 11 112221111 123445577888899998 99999999999999764
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=350.16 Aligned_cols=253 Identities=23% Similarity=0.311 Sum_probs=207.7
Q ss_pred hcCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCchhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEEe
Q 005940 352 TKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEY 431 (668)
Q Consensus 352 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~ 431 (668)
.++|...+.||+|+||.||+|.+..+++.||+|++..........+.+|++++++++||||+++++++.+....++||||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 36799999999999999999999989999999999877666667899999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECC--CCCEEEEeecCceeccCC
Q 005940 432 IPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDA--EMNARLGDFGLARLYDHG 509 (668)
Q Consensus 432 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~--~~~~kl~DfGla~~~~~~ 509 (668)
+++|+|.+++.. ....+++..++.++.||+.||.|||+ .+|+||||||+|||++. ++.+||+|||+++.....
T Consensus 130 ~~gg~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~ 204 (387)
T 1kob_A 130 LSGGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 204 (387)
T ss_dssp CCCCBHHHHTTC--TTCCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred CCCCcHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccchHHeEEecCCCCceEEEecccceecCCC
Confidence 999999999953 34569999999999999999999999 99999999999999974 477999999999987654
Q ss_pred CCCcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCcccCCcc
Q 005940 510 GMPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSY 589 (668)
Q Consensus 510 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 589 (668)
.. .....||+.|+|||++.+..++.++|||||||++|||++|+.||...+.. +......... . ..++......
T Consensus 205 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~--~~~~~i~~~~-~--~~~~~~~~~~ 277 (387)
T 1kob_A 205 EI--VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL--ETLQNVKRCD-W--EFDEDAFSSV 277 (387)
T ss_dssp SC--EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH--HHHHHHHHCC-C--CCCSSTTTTS
T ss_pred cc--eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHH--HHHHHHHhCC-C--CCCccccccC
Confidence 32 23447999999999999889999999999999999999999999765321 1111111111 1 0111111122
Q ss_pred cHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 590 VVKEMELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 590 ~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
+ ..+..+...|+.. |++||+++|++++
T Consensus 278 s----~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 278 S----PEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp C----HHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred C----HHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 2 2345666688887 9999999999986
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=348.20 Aligned_cols=251 Identities=21% Similarity=0.315 Sum_probs=197.9
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCc-hhHHHHHHHHHHHhcccccCceeEeeeecccC--------
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSL-QGMREFAAEIESLGRLRHKNLVNLHGWCKQKN-------- 423 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~-------- 423 (668)
++|+..+.||+|+||.||+|++..+++.||||++..... ...+.+.+|++++++++||||++++++|.+..
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 85 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEM 85 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHH
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhh
Confidence 568899999999999999999988999999999975443 35578999999999999999999999985433
Q ss_pred -------------------------------------------------ceEEEEEecCCCChhhhhcCCCCCCCccHHH
Q 005940 424 -------------------------------------------------DLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQ 454 (668)
Q Consensus 424 -------------------------------------------------~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~ 454 (668)
..++||||+++|+|.+++.........++..
T Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~ 165 (332)
T 3qd2_B 86 DEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGV 165 (332)
T ss_dssp HC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHH
T ss_pred hhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHH
Confidence 2799999999999999997655545567788
Q ss_pred HHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCCC-----------CcccccccCCcc
Q 005940 455 RFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGM-----------PHTTNVVGTFGY 523 (668)
Q Consensus 455 ~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~~-----------~~~~~~~gt~~y 523 (668)
++.++.||+.||.|||+ .+|+||||||+||+++.++.+||+|||+++....... .......||+.|
T Consensus 166 ~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 242 (332)
T 3qd2_B 166 CLHIFIQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY 242 (332)
T ss_dssp HHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGG
T ss_pred HHHHHHHHHHHHHHHHh---CCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCc
Confidence 99999999999999999 9999999999999999999999999999998765421 122335799999
Q ss_pred cCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCcccCCcccHHHHHHHHHHHhh
Q 005940 524 IAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSYVVKEMELVLKLGLM 603 (668)
Q Consensus 524 ~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~ 603 (668)
+|||++.+..++.++|||||||++|||++|..|+.. ....... ...... +. ........+..+...
T Consensus 243 ~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~----~~~~~~~-~~~~~~-----~~----~~~~~~~~~~~li~~ 308 (332)
T 3qd2_B 243 MSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME----RVRIITD-VRNLKF-----PL----LFTQKYPQEHMMVQD 308 (332)
T ss_dssp SCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH----HHHHHHH-HHTTCC-----CH----HHHHHCHHHHHHHHH
T ss_pred cChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH----HHHHHHH-hhccCC-----Cc----ccccCChhHHHHHHH
Confidence 999999998999999999999999999998876521 1111111 111111 11 111112234556677
Q ss_pred cCCC-CCCCCCHHHHHHH
Q 005940 604 CSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 604 C~~~-p~~RPs~~evl~~ 620 (668)
|+.. |++||+++|++++
T Consensus 309 ~l~~~p~~Rps~~~~l~~ 326 (332)
T 3qd2_B 309 MLSPSPTERPEATDIIEN 326 (332)
T ss_dssp HHCSSGGGSCCHHHHHHS
T ss_pred HccCCCCcCCCHHHHhhc
Confidence 8887 9999999999985
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=361.17 Aligned_cols=265 Identities=25% Similarity=0.281 Sum_probs=208.8
Q ss_pred ccchhhHHHHhcCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCc---hhHHHHHHHHHHHhcccccCceeEeee
Q 005940 342 RFRYKDLYAATKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSL---QGMREFAAEIESLGRLRHKNLVNLHGW 418 (668)
Q Consensus 342 ~f~~~el~~at~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~f~~Ei~~l~~l~H~nIv~l~g~ 418 (668)
.+++++.....++|+..++||+|+||.||+++++.+++.||||++.+... ...+.+.+|..++.+++||||++++++
T Consensus 50 ~~~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~ 129 (412)
T 2vd5_A 50 VVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFA 129 (412)
T ss_dssp HHHHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEE
T ss_pred hhhhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEE
Confidence 35566666677899999999999999999999998999999999976322 233458899999999999999999999
Q ss_pred ecccCceEEEEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEE
Q 005940 419 CKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLG 498 (668)
Q Consensus 419 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~ 498 (668)
+.+.+.+|+||||+++|+|.+++.+ .+..+++..+..++.||+.||.|||+ .+|+||||||+||||+.++++||+
T Consensus 130 ~~~~~~~~lVmE~~~gg~L~~~l~~--~~~~l~~~~~~~~~~qi~~aL~~LH~---~giiHrDLKp~NILld~~g~vkL~ 204 (412)
T 2vd5_A 130 FQDENYLYLVMEYYVGGDLLTLLSK--FGERIPAEMARFYLAEIVMAIDSVHR---LGYVHRDIKPDNILLDRCGHIRLA 204 (412)
T ss_dssp EECSSEEEEEECCCCSCBHHHHHHH--HSSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEEC
T ss_pred EeeCCEEEEEEcCCCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccCHHHeeecCCCCEEEe
Confidence 9999999999999999999999963 23469999999999999999999999 999999999999999999999999
Q ss_pred eecCceeccCCCCCcccccccCCcccCccccc-------CCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhH-HHHHHH
Q 005940 499 DFGLARLYDHGGMPHTTNVVGTFGYIAPELTQ-------TGKASTSSDVFAYGILLLEVATGRRPIGSGDLLL-VEWVRE 570 (668)
Q Consensus 499 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l-~~~~~~ 570 (668)
|||+++.............+||+.|+|||++. .+.++.++|||||||++|||++|+.||...+... ...+..
T Consensus 205 DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~ 284 (412)
T 2vd5_A 205 DFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVH 284 (412)
T ss_dssp CCTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHT
T ss_pred echhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHh
Confidence 99999887654433344568999999999987 4578999999999999999999999997653221 111111
Q ss_pred HHhcCccccccCcccCCcccHHHHHHHHHHHhhcCCCCCCC---CCHHHHHHH
Q 005940 571 CHQLGRILDVADPLLNSSYVVKEMELVLKLGLMCSHKTQFR---PTMRQVMRY 620 (668)
Q Consensus 571 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~p~~R---Ps~~evl~~ 620 (668)
...... .+.....+. .+ +..+...|+.+|++| |+++||++|
T Consensus 285 ~~~~~~-----~p~~~~~~s-~~---~~dli~~lL~~p~~Rlgr~~~~ei~~H 328 (412)
T 2vd5_A 285 YKEHLS-----LPLVDEGVP-EE---ARDFIQRLLCPPETRLGRGGAGDFRTH 328 (412)
T ss_dssp HHHHCC-----CC----CCC-HH---HHHHHHTTSSCGGGCTTTTTHHHHHTS
T ss_pred cccCcC-----CCccccCCC-HH---HHHHHHHHcCChhhcCCCCCHHHHhcC
Confidence 101001 111111222 22 334445676677666 799999876
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-40 Score=351.61 Aligned_cols=266 Identities=24% Similarity=0.328 Sum_probs=208.8
Q ss_pred hhhHHHHhcCcccceeeeecCcEEEEEEE-----eCCCCcEEEEEEEecCCc-hhHHHHHHHHHHHhcc-cccCceeEee
Q 005940 345 YKDLYAATKGFKESEVIGIGGFGSVYKGV-----LPTTGGEVAVKKITRNSL-QGMREFAAEIESLGRL-RHKNLVNLHG 417 (668)
Q Consensus 345 ~~el~~at~~f~~~~~lG~G~~g~Vy~~~-----~~~~~~~vavK~~~~~~~-~~~~~f~~Ei~~l~~l-~H~nIv~l~g 417 (668)
..+.....++|...+.||+|+||.||+|. ...+++.||||++..... ...+.+.+|++++.++ +||||+++++
T Consensus 14 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~ 93 (359)
T 3vhe_A 14 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG 93 (359)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeee
Confidence 34444456789999999999999999998 445668999999976543 3456799999999999 7999999999
Q ss_pred eecccCc-eEEEEEecCCCChhhhhcCCCC--------------------------------------------------
Q 005940 418 WCKQKND-LLLVYEYIPNGSLDTLLFKPKD-------------------------------------------------- 446 (668)
Q Consensus 418 ~~~~~~~-~~lV~E~~~~gsL~~~l~~~~~-------------------------------------------------- 446 (668)
+|.+.+. .++||||+++|+|.+++.....
T Consensus 94 ~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (359)
T 3vhe_A 94 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSL 173 (359)
T ss_dssp EECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC--------------------------------------------
T ss_pred eeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccccc
Confidence 9987654 8999999999999999975322
Q ss_pred -------------CCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCCC-C
Q 005940 447 -------------GSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGM-P 512 (668)
Q Consensus 447 -------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~~-~ 512 (668)
...+++..++.++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++....... .
T Consensus 174 ~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 250 (359)
T 3vhe_A 174 SDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV 250 (359)
T ss_dssp ----------CTTTTCBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCE
T ss_pred chhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEEcCCCcEEEEeccceeeecccccch
Confidence 1228999999999999999999999 9999999999999999999999999999986644322 2
Q ss_pred cccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHHHhcCccccccCcccCCcccH
Q 005940 513 HTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVAT-GRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSYVV 591 (668)
Q Consensus 513 ~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 591 (668)
......||..|+|||++.+..++.++|||||||++|||++ |+.||....... ............. ......
T Consensus 251 ~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--~~~~~~~~~~~~~-----~~~~~~- 322 (359)
T 3vhe_A 251 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE--EFCRRLKEGTRMR-----APDYTT- 322 (359)
T ss_dssp EC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH--HHHHHHHHTCCCC-----CCTTCC-
T ss_pred hccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhH--HHHHHHHcCCCCC-----CCCCCC-
Confidence 2344578899999999988899999999999999999998 999997543211 1111122111111 111122
Q ss_pred HHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhccC
Q 005940 592 KEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSGE 624 (668)
Q Consensus 592 ~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~~ 624 (668)
..+..++..|++. |++||+++||+++|+..
T Consensus 323 ---~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 353 (359)
T 3vhe_A 323 ---PEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 353 (359)
T ss_dssp ---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---HHHHHHHHHHccCChhhCCCHHHHHHHHHHH
Confidence 2345666789887 99999999999999864
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=359.25 Aligned_cols=256 Identities=28% Similarity=0.404 Sum_probs=206.4
Q ss_pred hcCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCc-hhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEE
Q 005940 352 TKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSL-QGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYE 430 (668)
Q Consensus 352 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 430 (668)
.++|...+.||+|+||.||+|++..++..||||++..... ...++|.+|++++++++||||++++++|...+..++|||
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 192 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME 192 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEE
Confidence 3578889999999999999999988899999999876532 344578899999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCC
Q 005940 431 YIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGG 510 (668)
Q Consensus 431 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~ 510 (668)
|+++|+|.+++.. .+..+++.+++.++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 193 ~~~~g~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~ 267 (377)
T 3cbl_A 193 LVQGGDFLTFLRT--EGARLRVKTLLQMVGDAAAGMEYLES---KCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGV 267 (377)
T ss_dssp CCTTCBHHHHHHH--HGGGCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSE
T ss_pred cCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHH---CCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCc
Confidence 9999999999963 23468999999999999999999999 999999999999999999999999999998654332
Q ss_pred CCcc-cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHHHhcCccccccCcccCCc
Q 005940 511 MPHT-TNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVAT-GRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSS 588 (668)
Q Consensus 511 ~~~~-~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 588 (668)
.... ....++..|+|||.+..+.++.++|||||||++|||++ |+.||....... +.+....+.... ....
T Consensus 268 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~---~~~~~~~~~~~~-----~~~~ 339 (377)
T 3cbl_A 268 YAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQ---TREFVEKGGRLP-----CPEL 339 (377)
T ss_dssp EECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHH---HHHHHHTTCCCC-----CCTT
T ss_pred eeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHHcCCCCC-----CCCC
Confidence 1111 11235678999999988889999999999999999998 999997653221 112222221111 1111
Q ss_pred ccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhccC
Q 005940 589 YVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSGE 624 (668)
Q Consensus 589 ~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~~ 624 (668)
++ ..+..++..|++. |++||++++|++.|+..
T Consensus 340 ~~----~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 372 (377)
T 3cbl_A 340 CP----DAVFRLMEQCWAYEPGQRPSFSTIYQELQSI 372 (377)
T ss_dssp CC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CC----HHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence 22 2355667789987 99999999999999754
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=336.80 Aligned_cols=249 Identities=23% Similarity=0.341 Sum_probs=196.1
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCch--------------------------hHHHHHHHHHHHhc
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQ--------------------------GMREFAAEIESLGR 406 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--------------------------~~~~f~~Ei~~l~~ 406 (668)
++|...+.||+|+||.||+|++..+++.||||++...... ..+.+.+|++++++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 92 (298)
T 2zv2_A 13 NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKK 92 (298)
T ss_dssp TTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHT
T ss_pred cceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHh
Confidence 6789999999999999999999889999999999764321 23568899999999
Q ss_pred ccccCceeEeeeecc--cCceEEEEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCC
Q 005940 407 LRHKNLVNLHGWCKQ--KNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKP 484 (668)
Q Consensus 407 l~H~nIv~l~g~~~~--~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp 484 (668)
++||||+++++++.+ ....++||||+++++|.+++. ...+++.+++.++.||+.||.|||+ .+|+||||||
T Consensus 93 l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp 165 (298)
T 2zv2_A 93 LDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT----LKPLSEDQARFYFQDLIKGIEYLHY---QKIIHRDIKP 165 (298)
T ss_dssp CCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC----SSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCG
T ss_pred CCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCH
Confidence 999999999999976 567899999999999988763 3469999999999999999999999 9999999999
Q ss_pred CCEEECCCCCEEEEeecCceeccCCCCCcccccccCCcccCcccccCCC---CCcchhHHHHHHHHHHHHhCCCCCCCCc
Q 005940 485 SNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPELTQTGK---ASTSSDVFAYGILLLEVATGRRPIGSGD 561 (668)
Q Consensus 485 ~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~sDV~S~Gvvl~elltG~~p~~~~~ 561 (668)
+||+++.++.+||+|||+++....... ......||+.|+|||++.+.. .+.++|||||||++|||++|+.||....
T Consensus 166 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 244 (298)
T 2zv2_A 166 SNLLVGEDGHIKIADFGVSNEFKGSDA-LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDER 244 (298)
T ss_dssp GGEEECTTSCEEECCCTTCEECSSSSC-EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred HHEEECCCCCEEEecCCCccccccccc-cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCcc
Confidence 999999999999999999987654332 233457999999999987655 3788999999999999999999997653
Q ss_pred hhHHHHHHHHHhcCccccccCcccCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 562 LLLVEWVRECHQLGRILDVADPLLNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 562 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
.. .+...... .... . +. ..... ..+..+...|++. |++||+++|++++
T Consensus 245 ~~--~~~~~~~~-~~~~-~--~~-~~~~~----~~l~~li~~~l~~dp~~R~s~~e~l~h 293 (298)
T 2zv2_A 245 IM--CLHSKIKS-QALE-F--PD-QPDIA----EDLKDLITRMLDKNPESRIVVPEIKLH 293 (298)
T ss_dssp HH--HHHHHHHH-CCCC-C--CS-SSCCC----HHHHHHHHHHTCSCTTTSCCHHHHTTC
T ss_pred HH--HHHHHHhc-ccCC-C--CC-ccccC----HHHHHHHHHHhhcChhhCCCHHHHhcC
Confidence 22 22222211 1111 0 10 11122 2345566688887 9999999999864
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-40 Score=346.52 Aligned_cols=248 Identities=24% Similarity=0.278 Sum_probs=203.5
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCC---chhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEE
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNS---LQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVY 429 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 429 (668)
++|+..+.||+|+||.||+|+.+.+++.||||++.+.. ....+.+.+|++++++++||||+++++++...+..++||
T Consensus 5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~ 84 (337)
T 1o6l_A 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence 57889999999999999999999899999999997642 234567889999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCC
Q 005940 430 EYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHG 509 (668)
Q Consensus 430 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~ 509 (668)
||+++|+|..++.. ...+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 85 E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 158 (337)
T 1o6l_A 85 EYANGGELFFHLSR---ERVFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp ECCTTCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred eCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCcCCHHHEEECCCCCEEEeeccchhhcccC
Confidence 99999999999953 3458999999999999999999999 99999999999999999999999999999864332
Q ss_pred CCCcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCcccCCcc
Q 005940 510 GMPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSY 589 (668)
Q Consensus 510 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 589 (668)
. ......+||+.|+|||++.+..++.++|||||||++|||++|+.||...+... ....... .. ..+....
T Consensus 159 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~--~~~~i~~-~~------~~~p~~~ 228 (337)
T 1o6l_A 159 G-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER--LFELILM-EE------IRFPRTL 228 (337)
T ss_dssp T-CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHH-CC------CCCCTTS
T ss_pred C-CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHH--HHHHHHc-CC------CCCCCCC
Confidence 2 22345689999999999999999999999999999999999999997654221 1111111 11 1111222
Q ss_pred cHHHHHHHHHHHhhcCCC-CCCCC-----CHHHHHHH
Q 005940 590 VVKEMELVLKLGLMCSHK-TQFRP-----TMRQVMRY 620 (668)
Q Consensus 590 ~~~~~~~l~~l~~~C~~~-p~~RP-----s~~evl~~ 620 (668)
. . .+..+...|++. |++|| +++||+++
T Consensus 229 s-~---~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 229 S-P---EAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp C-H---HHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred C-H---HHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 2 2 234455578776 99999 99999876
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=359.12 Aligned_cols=260 Identities=24% Similarity=0.304 Sum_probs=205.7
Q ss_pred hhhHHHHhcCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCc---hhHHHHHHHHHHHhcccccCceeEeeeecc
Q 005940 345 YKDLYAATKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSL---QGMREFAAEIESLGRLRHKNLVNLHGWCKQ 421 (668)
Q Consensus 345 ~~el~~at~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~ 421 (668)
+.++....++|...++||+|+||.||+|+++.+++.||+|++.+... ...+.+.+|+.+++.++||||++++++|.+
T Consensus 61 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 140 (410)
T 3v8s_A 61 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 140 (410)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred HHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE
Confidence 34455567889999999999999999999998999999999975321 223457899999999999999999999999
Q ss_pred cCceEEEEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeec
Q 005940 422 KNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFG 501 (668)
Q Consensus 422 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfG 501 (668)
....|+||||+++|+|.+++.. ..+++..+..++.||+.||.|||+ .+|+||||||+||||+.++.+||+|||
T Consensus 141 ~~~~~lV~E~~~gg~L~~~l~~----~~~~e~~~~~~~~qi~~aL~~LH~---~givHrDLKp~NILl~~~g~ikL~DFG 213 (410)
T 3v8s_A 141 DRYLYMVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFG 213 (410)
T ss_dssp SSEEEEEECCCTTEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCT
T ss_pred CCEEEEEEeCCCCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeeECCCCCEEEeccc
Confidence 9999999999999999999953 348999999999999999999999 999999999999999999999999999
Q ss_pred CceeccCCCCCcccccccCCcccCcccccCCC----CCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCcc
Q 005940 502 LARLYDHGGMPHTTNVVGTFGYIAPELTQTGK----ASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRI 577 (668)
Q Consensus 502 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~ 577 (668)
+++.............+||+.|+|||++.... ++.++|||||||++|||++|+.||...+.. +...........
T Consensus 214 ~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~--~~~~~i~~~~~~ 291 (410)
T 3v8s_A 214 TCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV--GTYSKIMNHKNS 291 (410)
T ss_dssp TCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHH--HHHHHHHTHHHH
T ss_pred eeEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChh--hHHHHHHhcccc
Confidence 99877654433344568999999999987655 789999999999999999999999765322 111111111000
Q ss_pred ccccCcccCCcccHHHHHHHHHHHhhcCCC-CCC--CCCHHHHHHH
Q 005940 578 LDVADPLLNSSYVVKEMELVLKLGLMCSHK-TQF--RPTMRQVMRY 620 (668)
Q Consensus 578 ~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~-p~~--RPs~~evl~~ 620 (668)
... |. ..... .+ +..+...|+.. |.+ ||+++||++|
T Consensus 292 ~~~--p~-~~~~s-~~---~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 292 LTF--PD-DNDIS-KE---AKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp CCC--CT-TCCCC-HH---HHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred ccC--CC-ccccc-HH---HHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 011 11 01122 22 33444466666 777 9999999987
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=338.07 Aligned_cols=258 Identities=27% Similarity=0.381 Sum_probs=198.8
Q ss_pred hcCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCchhHHHHHHHHHHHhc--ccccCceeEeeeecc----cCce
Q 005940 352 TKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGR--LRHKNLVNLHGWCKQ----KNDL 425 (668)
Q Consensus 352 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~--l~H~nIv~l~g~~~~----~~~~ 425 (668)
.++|...+.||+|+||.||+|++ +++.||||++... ..+.+..|.+++.. ++||||+++++++.. ....
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~ 81 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQL 81 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCcee
Confidence 36789999999999999999998 6889999999654 33455666666665 799999999998654 3458
Q ss_pred EEEEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhcc-----CCceEecCCCCCCEEECCCCCEEEEee
Q 005940 426 LLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEW-----EQVVIHRDVKPSNALIDAEMNARLGDF 500 (668)
Q Consensus 426 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~-----~~~ivHrDLkp~NIll~~~~~~kl~Df 500 (668)
++||||+++|+|.+++. ...+++..+++++.||+.||.|||... +++|+||||||+|||++.++.+||+||
T Consensus 82 ~lv~e~~~~g~L~~~l~----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df 157 (301)
T 3q4u_A 82 WLITHYHEMGSLYDYLQ----LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADL 157 (301)
T ss_dssp EEEECCCTTCBHHHHHT----TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCC
T ss_pred EEehhhccCCCHHHHHh----hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeC
Confidence 99999999999999994 245999999999999999999999211 299999999999999999999999999
Q ss_pred cCceeccCCCCCc---ccccccCCcccCcccccCC------CCCcchhHHHHHHHHHHHHhC----------CCCCCCC-
Q 005940 501 GLARLYDHGGMPH---TTNVVGTFGYIAPELTQTG------KASTSSDVFAYGILLLEVATG----------RRPIGSG- 560 (668)
Q Consensus 501 Gla~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~------~~~~~sDV~S~Gvvl~elltG----------~~p~~~~- 560 (668)
|+++......... .....||+.|+|||++.+. .++.++|||||||++|||++| +.||...
T Consensus 158 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~ 237 (301)
T 3q4u_A 158 GLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVV 237 (301)
T ss_dssp TTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred CCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccC
Confidence 9998765543221 2234799999999998876 455799999999999999999 8888542
Q ss_pred --chhHHHHHHHHHhcCccccccCcccCC-cccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhcc
Q 005940 561 --DLLLVEWVRECHQLGRILDVADPLLNS-SYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSG 623 (668)
Q Consensus 561 --~~~l~~~~~~~~~~~~~~~~~d~~l~~-~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~ 623 (668)
+...... ........ ..+.+.. .........+..+...|+.. |++||+++||++.|+.
T Consensus 238 ~~~~~~~~~-~~~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~ 299 (301)
T 3q4u_A 238 PNDPSFEDM-RKVVCVDQ----QRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTK 299 (301)
T ss_dssp CSSCCHHHH-HHHHTTSC----CCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHH
T ss_pred CCCcchhhh-hHHHhccC----CCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhc
Confidence 1112221 11111111 1112211 12334556777888899998 9999999999999975
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=347.09 Aligned_cols=252 Identities=23% Similarity=0.340 Sum_probs=203.8
Q ss_pred hcCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCC--chhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEE
Q 005940 352 TKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNS--LQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVY 429 (668)
Q Consensus 352 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 429 (668)
.++|...+.||+|+||.||+|.+..++..||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~ 107 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 107 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 467999999999999999999999899999999997653 344567899999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCC---CEEEEeecCceec
Q 005940 430 EYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEM---NARLGDFGLARLY 506 (668)
Q Consensus 430 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~---~~kl~DfGla~~~ 506 (668)
||+++|+|.+++.. ...+++..+..++.||+.||.|||+ .+|+||||||+|||++.++ .+||+|||+++..
T Consensus 108 e~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~ 181 (362)
T 2bdw_A 108 DLVTGGELFEDIVA---REFYSEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 181 (362)
T ss_dssp CCCCSCBHHHHHTT---CSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCC
T ss_pred ecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCchHHEEEecCCCCCCEEEeecCcceEe
Confidence 99999999999853 3468999999999999999999999 9999999999999998654 5999999999876
Q ss_pred cCCCCCcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCcccC
Q 005940 507 DHGGMPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLN 586 (668)
Q Consensus 507 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 586 (668)
.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+.. +.... ...+... ...+..
T Consensus 182 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~--~~~~~-i~~~~~~-~~~~~~- 254 (362)
T 2bdw_A 182 NDSE--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH--RLYAQ-IKAGAYD-YPSPEW- 254 (362)
T ss_dssp TTCC--SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHH-HHHTCCC-CCTTGG-
T ss_pred cCCc--ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH--HHHHH-HHhCCCC-CCcccc-
Confidence 6432 223457999999999999889999999999999999999999999765422 11111 1111111 001111
Q ss_pred CcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 587 SSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 587 ~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
.... ..+..+...|+.. |++||++.|++++
T Consensus 255 ~~~~----~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 255 DTVT----PEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp GGSC----HHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred cCCC----HHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 1112 2344555678876 9999999999976
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=372.34 Aligned_cols=256 Identities=26% Similarity=0.382 Sum_probs=210.2
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCchhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEEec
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEYI 432 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~ 432 (668)
.+|...++||+|+||.||+|++..++..||||++..... ..++|.+|++++++++||||++++++|......++||||+
T Consensus 220 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~ 298 (495)
T 1opk_A 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 298 (495)
T ss_dssp GGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred HHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc-chHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEcc
Confidence 567889999999999999999988889999999976543 4578999999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCCCC
Q 005940 433 PNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMP 512 (668)
Q Consensus 433 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~~~ 512 (668)
++|+|.+++... ....+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++........
T Consensus 299 ~~g~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 374 (495)
T 1opk_A 299 TYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYT 374 (495)
T ss_dssp TTCBHHHHHHHS-CTTTSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCEE
T ss_pred CCCCHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChhhEEECCCCcEEEeecccceeccCCcee
Confidence 999999999642 34568999999999999999999999 99999999999999999999999999999976544332
Q ss_pred cccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHHHhcCccccccCcccCCcccH
Q 005940 513 HTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVAT-GRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSYVV 591 (668)
Q Consensus 513 ~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 591 (668)
......++..|+|||++..+.++.++|||||||++|||++ |+.||...+.... .+........ .....+.
T Consensus 375 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~---~~~~~~~~~~-----~~~~~~~- 445 (495)
T 1opk_A 375 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV---YELLEKDYRM-----ERPEGCP- 445 (495)
T ss_dssp CCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH---HHHHHTTCCC-----CCCTTCC-
T ss_pred ecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHH---HHHHHcCCCC-----CCCCCCC-
Confidence 2333456789999999988899999999999999999999 9999976532211 1111111111 1111122
Q ss_pred HHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhccCc
Q 005940 592 KEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSGEK 625 (668)
Q Consensus 592 ~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~~~ 625 (668)
..+..++..|++. |++||++++|++.|+...
T Consensus 446 ---~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~ 477 (495)
T 1opk_A 446 ---EKVYELMRACWQWNPSDRPSFAEIHQAFETMF 477 (495)
T ss_dssp ---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred ---HHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence 3455667789998 999999999999998764
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=333.64 Aligned_cols=251 Identities=24% Similarity=0.469 Sum_probs=202.1
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCch-------hHHHHHHHHHHHhcccccCceeEeeeecccCce
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQ-------GMREFAAEIESLGRLRHKNLVNLHGWCKQKNDL 425 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-------~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~ 425 (668)
++|...+.||+|+||.||+|++..+++.||||++...... ..+.+.+|++++++++||||+++++++.+..
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-- 96 (287)
T 4f0f_A 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP-- 96 (287)
T ss_dssp TTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--
T ss_pred ccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--
Confidence 6788999999999999999999889999999998654322 1267899999999999999999999997654
Q ss_pred EEEEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCc--eEecCCCCCCEEECCCCC-----EEEE
Q 005940 426 LLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQV--VIHRDVKPSNALIDAEMN-----ARLG 498 (668)
Q Consensus 426 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~--ivHrDLkp~NIll~~~~~-----~kl~ 498 (668)
++||||+++|+|.+++.. ....+++..++.++.|++.||.|||+ .+ |+||||||+||+++.++. +||+
T Consensus 97 ~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~l~~~l~~lH~---~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~ 171 (287)
T 4f0f_A 97 RMVMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLDIALGIEYMQN---QNPPIVHRDLRSPNIFLQSLDENAPVCAKVA 171 (287)
T ss_dssp EEEEECCTTCBHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHT---SSSCCBCSCCSGGGEEESCCCTTCSCCEEEC
T ss_pred eEEEEecCCCCHHHHHhc--ccCCccHHHHHHHHHHHHHHHHHHHh---CCCCeecCCCCcceEEEeccCCCCceeEEeC
Confidence 799999999999998853 34579999999999999999999998 78 999999999999988776 9999
Q ss_pred eecCceeccCCCCCcccccccCCcccCccccc--CCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCc
Q 005940 499 DFGLARLYDHGGMPHTTNVVGTFGYIAPELTQ--TGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGR 576 (668)
Q Consensus 499 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~ 576 (668)
|||+++.... ......||..|+|||++. ...++.++|||||||++|||++|+.||.........+.........
T Consensus 172 Dfg~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 247 (287)
T 4f0f_A 172 DFGLSQQSVH----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGL 247 (287)
T ss_dssp CCTTCBCCSS----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCC
T ss_pred CCCccccccc----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCC
Confidence 9999975433 234457899999999983 4567899999999999999999999997654333333332222221
Q ss_pred cccccCcccCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhcc
Q 005940 577 ILDVADPLLNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSG 623 (668)
Q Consensus 577 ~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~ 623 (668)
.+.+...++ ..+..+...|+.. |++||+++||++.|+.
T Consensus 248 -----~~~~~~~~~----~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 286 (287)
T 4f0f_A 248 -----RPTIPEDCP----PRLRNVIELCWSGDPKKRPHFSYIVKELSE 286 (287)
T ss_dssp -----CCCCCTTSC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred -----CCCCCcccC----HHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence 111222222 3455666788887 9999999999999875
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=336.76 Aligned_cols=261 Identities=26% Similarity=0.286 Sum_probs=198.4
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCc--hhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEE
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSL--QGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYE 430 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 430 (668)
++|+..++||+|+||+||+|.+..+++.||||++..... ...+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 478899999999999999999998999999999975433 345778899999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCC
Q 005940 431 YIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGG 510 (668)
Q Consensus 431 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~ 510 (668)
|+++ +|.+.+.. ....+++..+..++.||+.||.|||+ .+|+||||||+||+++.++.+||+|||+++......
T Consensus 82 ~~~~-~l~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lH~---~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 155 (292)
T 3o0g_A 82 FCDQ-DLKKYFDS--CNGDLDPEIVKSFLFQLLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp CCSE-EHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCC
T ss_pred cCCC-CHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeecccceecCCcc
Confidence 9976 55555532 23569999999999999999999999 999999999999999999999999999998765432
Q ss_pred CCcccccccCCcccCcccccCCC-CCcchhHHHHHHHHHHHHhCCCCCCCCch--hHHHHHHHHHhcCcc------cccc
Q 005940 511 MPHTTNVVGTFGYIAPELTQTGK-ASTSSDVFAYGILLLEVATGRRPIGSGDL--LLVEWVRECHQLGRI------LDVA 581 (668)
Q Consensus 511 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDV~S~Gvvl~elltG~~p~~~~~~--~l~~~~~~~~~~~~~------~~~~ 581 (668)
.......||..|+|||++.+.. ++.++|||||||++|||++|..|+..... .....+......... ....
T Consensus 156 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 234 (292)
T 3o0g_A 156 -RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLP 234 (292)
T ss_dssp -SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGST
T ss_pred -ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccc
Confidence 2233457899999999987765 79999999999999999999988644321 111112111111000 0000
Q ss_pred Cc----cc-----CCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 582 DP----LL-----NSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 582 d~----~l-----~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
+. .. ...........+..+...|++. |++||+++|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 283 (292)
T 3o0g_A 235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp TCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 00 00 0000011112344566678887 9999999999975
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-40 Score=349.82 Aligned_cols=254 Identities=25% Similarity=0.329 Sum_probs=203.1
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCC-----chhHHHHHHHHHHHhcccccCceeEeeeecccCceEE
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNS-----LQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLL 427 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l 427 (668)
+.|...+.||+|+||.||+|.+..+++.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++
T Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 103 (351)
T 3c0i_A 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYM 103 (351)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 46888999999999999999999899999999986432 1235789999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhcCC-CCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCC---EEEEeecCc
Q 005940 428 VYEYIPNGSLDTLLFKP-KDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMN---ARLGDFGLA 503 (668)
Q Consensus 428 V~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~---~kl~DfGla 503 (668)
||||+++|+|.+.+... ..+..+++..+..++.||+.||.|||+ .+|+||||||+|||++.++. +||+|||++
T Consensus 104 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a 180 (351)
T 3c0i_A 104 VFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD---NNIIHRDVKPHCVLLASKENSAPVKLGGFGVA 180 (351)
T ss_dssp EEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECSSSTTCCEEECCCTTC
T ss_pred EEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCChHHeEEecCCCCCcEEEecCcce
Confidence 99999999998877532 223468999999999999999999999 99999999999999987655 999999999
Q ss_pred eeccCCCCCcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCc
Q 005940 504 RLYDHGGMPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADP 583 (668)
Q Consensus 504 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~ 583 (668)
+....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+...+ ...... .++
T Consensus 181 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~i----~~~~~~--~~~ 253 (351)
T 3c0i_A 181 IQLGESGL-VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFEGI----IKGKYK--MNP 253 (351)
T ss_dssp EECCTTSC-BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHHHHHHHH----HHTCCC--CCH
T ss_pred eEecCCCe-eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHHHHHHHH----HcCCCC--CCc
Confidence 87765332 23345799999999999988999999999999999999999999976533222211 111110 011
Q ss_pred ccCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 584 LLNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 584 ~l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
....... ..+..+...|+.. |++||++.|++++
T Consensus 254 ~~~~~~s----~~~~~li~~~L~~dP~~R~s~~e~l~h 287 (351)
T 3c0i_A 254 RQWSHIS----ESAKDLVRRMLMLDPAERITVYEALNH 287 (351)
T ss_dssp HHHTTSC----HHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccccCC----HHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0001111 2345566678887 9999999999975
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=348.88 Aligned_cols=249 Identities=25% Similarity=0.359 Sum_probs=198.1
Q ss_pred ccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCchhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEEecCCC
Q 005940 356 KESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEYIPNG 435 (668)
Q Consensus 356 ~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~g 435 (668)
...+.||+|+||.||+|.+..++..||+|++........+++.+|++++++++||||+++++++...+..++||||++++
T Consensus 92 ~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~ 171 (373)
T 2x4f_A 92 SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGG 171 (373)
T ss_dssp EEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTC
T ss_pred ecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCC
Confidence 33678999999999999998899999999998877677788999999999999999999999999999999999999999
Q ss_pred ChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEE--CCCCCEEEEeecCceeccCCCCCc
Q 005940 436 SLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALI--DAEMNARLGDFGLARLYDHGGMPH 513 (668)
Q Consensus 436 sL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll--~~~~~~kl~DfGla~~~~~~~~~~ 513 (668)
+|.+++.. ....+++..++.++.||+.||.|||+ .+|+||||||+|||+ +.++.+||+|||+++.......
T Consensus 172 ~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~-- 244 (373)
T 2x4f_A 172 ELFDRIID--ESYNLTELDTILFMKQICEGIRHMHQ---MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK-- 244 (373)
T ss_dssp EEHHHHHH--TGGGCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB--
T ss_pred cHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc--
Confidence 99998853 23468999999999999999999999 999999999999999 6678899999999997764332
Q ss_pred ccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCcccCCcccHHH
Q 005940 514 TTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSYVVKE 593 (668)
Q Consensus 514 ~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 593 (668)
.....||+.|+|||++....++.++|||||||++|||++|+.||...+.. +.......... ....+.. ..+.
T Consensus 245 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~--~~~~~i~~~~~--~~~~~~~-~~~~--- 316 (373)
T 2x4f_A 245 LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDA--ETLNNILACRW--DLEDEEF-QDIS--- 316 (373)
T ss_dssp CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHH--HHHHHHHHTCC--CSCSGGG-TTSC---
T ss_pred cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhccC--CCChhhh-ccCC---
Confidence 23347999999999999889999999999999999999999999765322 11222222111 0001111 1122
Q ss_pred HHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 594 MELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 594 ~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
..+..+...|+.. |++||+++|++++
T Consensus 317 -~~~~~li~~~L~~dp~~Rps~~e~l~h 343 (373)
T 2x4f_A 317 -EEAKEFISKLLIKEKSWRISASEALKH 343 (373)
T ss_dssp -HHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred -HHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 2345566688887 9999999999984
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-40 Score=338.76 Aligned_cols=254 Identities=24% Similarity=0.362 Sum_probs=203.5
Q ss_pred hcCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCchhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEEe
Q 005940 352 TKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEY 431 (668)
Q Consensus 352 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~ 431 (668)
.++|...+.||+|+||.||+|.+. ++..||||++...... .+++.+|++++++++||||+++++++.+.+..++||||
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 100 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMS-EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY 100 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBC-HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECC
T ss_pred HHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCC-HHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEec
Confidence 467888999999999999999985 5778999999765433 46789999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCCC
Q 005940 432 IPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGM 511 (668)
Q Consensus 432 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~~ 511 (668)
+++++|.+++.. ....+++.+++.++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||+++.......
T Consensus 101 ~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 175 (283)
T 3gen_A 101 MANGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY 175 (283)
T ss_dssp CTTCBHHHHHHC--GGGCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHH
T ss_pred cCCCcHHHHHHH--hccCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCccceEEEcCCCCEEEcccccccccccccc
Confidence 999999999963 23459999999999999999999999 9999999999999999999999999999987654332
Q ss_pred CcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHHHhcCccccccCcccCCccc
Q 005940 512 PHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVAT-GRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSYV 590 (668)
Q Consensus 512 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 590 (668)
.......+|..|+|||.+....++.++||||||+++|||++ |+.||...+... ......... .........
T Consensus 176 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~--~~~~~~~~~------~~~~~~~~~ 247 (283)
T 3gen_A 176 TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE--TAEHIAQGL------RLYRPHLAS 247 (283)
T ss_dssp HSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH--HHHHHHTTC------CCCCCTTCC
T ss_pred ccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhH--HHHHHhccc------CCCCCCcCC
Confidence 22333456788999999988889999999999999999998 999997654321 111111111 111111111
Q ss_pred HHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhccC
Q 005940 591 VKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSGE 624 (668)
Q Consensus 591 ~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~~ 624 (668)
..+..+...|++. |++||+++|++++|+..
T Consensus 248 ----~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~ 278 (283)
T 3gen_A 248 ----EKVYTIMYSCWHEKADERPTFKILLSNILDV 278 (283)
T ss_dssp ----HHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----HHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence 3455667789887 99999999999999754
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-40 Score=347.49 Aligned_cols=260 Identities=26% Similarity=0.398 Sum_probs=208.5
Q ss_pred HhcCcccceeeeecCcEEEEEEEeC-----CCCcEEEEEEEecCCc-hhHHHHHHHHHHHhcccccCceeEeeeecccCc
Q 005940 351 ATKGFKESEVIGIGGFGSVYKGVLP-----TTGGEVAVKKITRNSL-QGMREFAAEIESLGRLRHKNLVNLHGWCKQKND 424 (668)
Q Consensus 351 at~~f~~~~~lG~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~ 424 (668)
..++|...+.||+|+||.||+|++. .+++.||||++..... ...+.+.+|++++++++||||++++++|.+.+.
T Consensus 45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 124 (343)
T 1luf_A 45 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP 124 (343)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred cHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCc
Confidence 3468899999999999999999986 3447899999976543 445789999999999999999999999999999
Q ss_pred eEEEEEecCCCChhhhhcCCCC---------------------CCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCC
Q 005940 425 LLLVYEYIPNGSLDTLLFKPKD---------------------GSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVK 483 (668)
Q Consensus 425 ~~lV~E~~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLk 483 (668)
.++||||+++|+|.+++..... ...+++.+++.++.||++||.|||+ .+|+|||||
T Consensus 125 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlk 201 (343)
T 1luf_A 125 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLA 201 (343)
T ss_dssp CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCS
T ss_pred eEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCC
Confidence 9999999999999999964321 2569999999999999999999999 999999999
Q ss_pred CCCEEECCCCCEEEEeecCceeccCCCC-CcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCc
Q 005940 484 PSNALIDAEMNARLGDFGLARLYDHGGM-PHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVAT-GRRPIGSGD 561 (668)
Q Consensus 484 p~NIll~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~ 561 (668)
|+||+++.++.+||+|||+++....... .......+|..|+|||++.+..++.++|||||||++|||++ |+.||....
T Consensus 202 p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 281 (343)
T 1luf_A 202 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA 281 (343)
T ss_dssp GGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred cceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCC
Confidence 9999999999999999999986543221 12234567899999999988899999999999999999999 999997653
Q ss_pred hhHHHHHHHHHhcCccccccCcccCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhccCc
Q 005940 562 LLLVEWVRECHQLGRILDVADPLLNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSGEK 625 (668)
Q Consensus 562 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~~~ 625 (668)
.. +... ....+.... ....+. ..+..+...|+.. |++||++.+|+++|+...
T Consensus 282 ~~--~~~~-~~~~~~~~~-----~~~~~~----~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~ 334 (343)
T 1luf_A 282 HE--EVIY-YVRDGNILA-----CPENCP----LELYNLMRLCWSKLPADRPSFCSIHRILQRMC 334 (343)
T ss_dssp HH--HHHH-HHHTTCCCC-----CCTTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred hH--HHHH-HHhCCCcCC-----CCCCCC----HHHHHHHHHHcccCcccCCCHHHHHHHHHHHH
Confidence 22 1111 222222211 111222 2355666789887 999999999999998765
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-39 Score=353.30 Aligned_cols=253 Identities=23% Similarity=0.309 Sum_probs=203.1
Q ss_pred hcCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCc--hhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEE
Q 005940 352 TKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSL--QGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVY 429 (668)
Q Consensus 352 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 429 (668)
.++|...+.||+|+||.||+|.+..+++.+|+|++..... ...+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~ 89 (444)
T 3soa_A 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIF 89 (444)
T ss_dssp HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEE
T ss_pred cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEE
Confidence 4678999999999999999999999999999999976543 34567899999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEEC---CCCCEEEEeecCceec
Q 005940 430 EYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALID---AEMNARLGDFGLARLY 506 (668)
Q Consensus 430 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~---~~~~~kl~DfGla~~~ 506 (668)
||+++|+|.+.+.. ...+++..+..++.||+.||.|||+ .+|+||||||+|||++ .++.+||+|||+++..
T Consensus 90 E~~~gg~L~~~i~~---~~~~~e~~~~~i~~qil~aL~~lH~---~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~ 163 (444)
T 3soa_A 90 DLVTGGELFEDIVA---REYYSEADASHCIQQILEAVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEV 163 (444)
T ss_dssp CCCBCCBHHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCC
T ss_pred EeCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEeccCCCCcEEEccCceeEEe
Confidence 99999999999863 3459999999999999999999999 9999999999999998 4578999999999876
Q ss_pred cCCCCCcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCcccC
Q 005940 507 DHGGMPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLN 586 (668)
Q Consensus 507 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 586 (668)
..... ......||+.|+|||++.+..++.++||||+||++|||++|+.||...+... .... ...+.. ....+..
T Consensus 164 ~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~--~~~~-i~~~~~-~~~~~~~- 237 (444)
T 3soa_A 164 EGEQQ-AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHR--LYQQ-IKAGAY-DFPSPEW- 237 (444)
T ss_dssp CTTCC-BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHH-HHHTCC-CCCTTTT-
T ss_pred cCCCc-eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHH--HHHH-HHhCCC-CCCcccc-
Confidence 54332 2334689999999999998899999999999999999999999997653221 1111 111111 1111111
Q ss_pred CcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 587 SSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 587 ~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
.... + .+..+...|++. |++||++.|++++
T Consensus 238 ~~~s-~---~~~~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 238 DTVT-P---EAKDLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp TTSC-H---HHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred ccCC-H---HHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 1122 2 244555678877 9999999999986
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=350.53 Aligned_cols=257 Identities=24% Similarity=0.374 Sum_probs=198.5
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcE----EEEEEEecCC-chhHHHHHHHHHHHhcccccCceeEeeeecccCceEE
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGE----VAVKKITRNS-LQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLL 427 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~----vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l 427 (668)
++|+..++||+|+||.||+|++..+++. ||+|.+.... ....++|.+|++++++++||||++++++|... ..++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~ 93 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 93 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS-SEEE
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-CeEE
Confidence 5688899999999999999998766664 5777775432 34567899999999999999999999999875 4789
Q ss_pred EEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceecc
Q 005940 428 VYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYD 507 (668)
Q Consensus 428 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~ 507 (668)
|+||+++|+|.+++.. ....+++..++.++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 94 v~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~ 168 (327)
T 3poz_A 94 ITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp EEECCTTCBHHHHHHH--STTSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCTTHHHHHT
T ss_pred EEEecCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCChheEEECCCCCEEEccCcceeEcc
Confidence 9999999999999964 24569999999999999999999999 999999999999999999999999999998765
Q ss_pred CCCCC-cccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHHHhcCccccccCccc
Q 005940 508 HGGMP-HTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVAT-GRRPIGSGDLLLVEWVRECHQLGRILDVADPLL 585 (668)
Q Consensus 508 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 585 (668)
..... ......+|..|+|||++.+..++.++|||||||++|||++ |+.||......... ......... ..
T Consensus 169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~---~~~~~~~~~-----~~ 240 (327)
T 3poz_A 169 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS---SILEKGERL-----PQ 240 (327)
T ss_dssp TTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH---HHHHTTCCC-----CC
T ss_pred CCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHH---HHHHcCCCC-----CC
Confidence 44322 2233456889999999999999999999999999999999 99999765332211 111111111 01
Q ss_pred CCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhccCcCC
Q 005940 586 NSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSGEKQL 627 (668)
Q Consensus 586 ~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~~~~~ 627 (668)
..... ..+..++..|++. |++||+++||+++|+.....
T Consensus 241 ~~~~~----~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~ 279 (327)
T 3poz_A 241 PPICT----IDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp CTTBC----HHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTS
T ss_pred CccCC----HHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhh
Confidence 11112 3456677789998 99999999999999876543
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=344.00 Aligned_cols=251 Identities=23% Similarity=0.282 Sum_probs=188.0
Q ss_pred hcCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCchhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEEe
Q 005940 352 TKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEY 431 (668)
Q Consensus 352 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~ 431 (668)
.++|...+.||+|+||.||+|++..+++.||||++.... ..+.+.+|++++++++||||+++++++...+..++||||
T Consensus 52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 129 (349)
T 2w4o_A 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLEL 129 (349)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEe
Confidence 467999999999999999999998889999999997653 345688999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECC---CCCEEEEeecCceeccC
Q 005940 432 IPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDA---EMNARLGDFGLARLYDH 508 (668)
Q Consensus 432 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~---~~~~kl~DfGla~~~~~ 508 (668)
+++|+|.+++.. ...+++.+++.++.||+.||.|||+ .+|+||||||+||+++. ++.+||+|||+++....
T Consensus 130 ~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~ 203 (349)
T 2w4o_A 130 VTGGELFDRIVE---KGYYSERDAADAVKQILEAVAYLHE---NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH 203 (349)
T ss_dssp CCSCBHHHHHTT---CSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEESSSSTTCCEEECCCC-------
T ss_pred CCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCcccEEEecCCCCCCEEEccCccccccCc
Confidence 999999999953 3458999999999999999999999 99999999999999975 88999999999987654
Q ss_pred CCCCcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCcccCCc
Q 005940 509 GGMPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSS 588 (668)
Q Consensus 509 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 588 (668)
.. ......||+.|+|||++.+..++.++|||||||++|||++|+.||........ .......... ....+.. ..
T Consensus 204 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~--~~~~i~~~~~-~~~~~~~-~~ 277 (349)
T 2w4o_A 204 QV--LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQF--MFRRILNCEY-YFISPWW-DE 277 (349)
T ss_dssp -----------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHH--HHHHHHTTCC-CCCTTTT-TT
T ss_pred cc--ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHH--HHHHHHhCCC-ccCCchh-hh
Confidence 32 22345789999999999988999999999999999999999999975432211 1111111111 1111111 11
Q ss_pred ccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 589 YVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 589 ~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
.. ..+..+...|+.. |++||++.|++++
T Consensus 278 ~~----~~~~~li~~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 278 VS----LNAKDLVRKLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp SC----HHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred CC----HHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 22 2345566688887 9999999999985
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=343.18 Aligned_cols=263 Identities=23% Similarity=0.271 Sum_probs=203.7
Q ss_pred hhHHHHhcCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecC-----CchhHHHHHHHHHHHhcccccCceeEeeeec
Q 005940 346 KDLYAATKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRN-----SLQGMREFAAEIESLGRLRHKNLVNLHGWCK 420 (668)
Q Consensus 346 ~el~~at~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~ 420 (668)
.++....++|...+.||+|+||.||+|.+..++..||+|++... .....+.+.+|++++++++||||+++++++.
T Consensus 19 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 98 (345)
T 3hko_A 19 GSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYE 98 (345)
T ss_dssp BCHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred chhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhc
Confidence 44556678899999999999999999999989999999998654 2345678999999999999999999999999
Q ss_pred ccCceEEEEEecCCCChhhhhcCCC-------------------------------------CCCCccHHHHHHHHHHHH
Q 005940 421 QKNDLLLVYEYIPNGSLDTLLFKPK-------------------------------------DGSVLDWEQRFNIVKGIA 463 (668)
Q Consensus 421 ~~~~~~lV~E~~~~gsL~~~l~~~~-------------------------------------~~~~l~~~~~~~i~~qia 463 (668)
+.+..++||||+++|+|.+++.... ....+++..++.++.||+
T Consensus 99 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~ 178 (345)
T 3hko_A 99 DEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIF 178 (345)
T ss_dssp CSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHH
T ss_pred cCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHH
Confidence 9999999999999999999984210 022357788899999999
Q ss_pred HHHHHhhhccCCceEecCCCCCCEEECCCC--CEEEEeecCceeccCCCC---CcccccccCCcccCcccccC--CCCCc
Q 005940 464 SGLLYLHEEWEQVVIHRDVKPSNALIDAEM--NARLGDFGLARLYDHGGM---PHTTNVVGTFGYIAPELTQT--GKAST 536 (668)
Q Consensus 464 ~gL~yLH~~~~~~ivHrDLkp~NIll~~~~--~~kl~DfGla~~~~~~~~---~~~~~~~gt~~y~aPE~~~~--~~~~~ 536 (668)
.||.|||+ .+|+||||||+||+++.++ .+||+|||+++....... .......||+.|+|||++.. ..++.
T Consensus 179 ~~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 255 (345)
T 3hko_A 179 SALHYLHN---QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGP 255 (345)
T ss_dssp HHHHHHHH---TTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCT
T ss_pred HHHHHHHH---CCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCc
Confidence 99999999 8999999999999998776 899999999987643221 12344579999999999865 67889
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCcccCCcccHHHHHHHHHHHhhcCCC-CCCCCCHH
Q 005940 537 SSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSYVVKEMELVLKLGLMCSHK-TQFRPTMR 615 (668)
Q Consensus 537 ~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~ 615 (668)
++|||||||++|||++|+.||...... +............ ..+.. .... ..+..+...|+.. |++||++.
T Consensus 256 ~~DiwslG~il~el~~g~~pf~~~~~~--~~~~~~~~~~~~~--~~~~~-~~~~----~~~~~li~~~l~~~p~~Rps~~ 326 (345)
T 3hko_A 256 KCDAWSAGVLLHLLLMGAVPFPGVNDA--DTISQVLNKKLCF--ENPNY-NVLS----PLARDLLSNLLNRNVDERFDAM 326 (345)
T ss_dssp HHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHCCCCT--TSGGG-GGSC----HHHHHHHHHHSCSCTTTSCCHH
T ss_pred HHHHHHHHHHHHHHHHCCCCCCCCChH--HHHHHHHhccccc--CCccc-ccCC----HHHHHHHHHHcCCChhHCCCHH
Confidence 999999999999999999999765322 2222222221111 11111 1112 2344566688887 99999999
Q ss_pred HHHHH
Q 005940 616 QVMRY 620 (668)
Q Consensus 616 evl~~ 620 (668)
|++++
T Consensus 327 ~~l~h 331 (345)
T 3hko_A 327 RALQH 331 (345)
T ss_dssp HHHHS
T ss_pred HHhcC
Confidence 99985
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-39 Score=334.48 Aligned_cols=257 Identities=21% Similarity=0.236 Sum_probs=206.2
Q ss_pred hcCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCchhHHHHHHHHHHHhcc-cccCceeEeeeecccCceEEEEE
Q 005940 352 TKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRL-RHKNLVNLHGWCKQKNDLLLVYE 430 (668)
Q Consensus 352 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~E 430 (668)
.++|...+.||+|+||.||+|.+..+++.||||++..... .+.+.+|+++++++ +|+|++++++++.+....++|||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e 86 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 86 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc--cHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence 3579999999999999999999988999999999875432 34578899999999 79999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCC-----EEEEeecCcee
Q 005940 431 YIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMN-----ARLGDFGLARL 505 (668)
Q Consensus 431 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~-----~kl~DfGla~~ 505 (668)
|+ +++|.+++.. .+..+++..++.++.||+.||.|||+ .+|+||||||+||+++.++. +||+|||+++.
T Consensus 87 ~~-~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~ 160 (298)
T 1csn_A 87 LL-GPSLEDLLDL--CGRKFSVKTVAMAAKQMLARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 160 (298)
T ss_dssp CC-CCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred ec-CCCHHHHHHH--hccCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEeccCCCCCCCeEEEEECccccc
Confidence 99 9999999963 23469999999999999999999998 99999999999999987776 99999999997
Q ss_pred ccCCCCC------cccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCch----hHHHHHHHHHhcC
Q 005940 506 YDHGGMP------HTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDL----LLVEWVRECHQLG 575 (668)
Q Consensus 506 ~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~----~l~~~~~~~~~~~ 575 (668)
....... ......||..|+|||++.+..++.++|||||||++|||++|+.||..... .....+.......
T Consensus 161 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 240 (298)
T 1csn_A 161 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST 240 (298)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS
T ss_pred cccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCc
Confidence 7654321 23445799999999999998999999999999999999999999976321 1111111111111
Q ss_pred ccccccCcccCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhccCc
Q 005940 576 RILDVADPLLNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSGEK 625 (668)
Q Consensus 576 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~~~ 625 (668)
... .+...++ ..+..+...|+.. |++||++++|++.|+...
T Consensus 241 ~~~-----~~~~~~~----~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~ 282 (298)
T 1csn_A 241 PLR-----ELCAGFP----EEFYKYMHYARNLAFDATPDYDYLQGLFSKVL 282 (298)
T ss_dssp CHH-----HHTTTSC----HHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred cHH-----HHHhhCc----HHHHHHHHHHhcCCcccCCCHHHHHHHHHHHH
Confidence 111 1111122 3455666788877 999999999999998653
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=343.99 Aligned_cols=258 Identities=27% Similarity=0.414 Sum_probs=201.7
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcE----EEEEEEecCC-chhHHHHHHHHHHHhcccccCceeEeeeecccCceEE
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGE----VAVKKITRNS-LQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLL 427 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~----vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l 427 (668)
++|...++||+|+||.||+|.+..++.. ||+|.+.... ....+.+.+|+.++++++||||++++++|. .+..++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~ 91 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL 91 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence 5788899999999999999998777765 7777775432 233456788999999999999999999986 567899
Q ss_pred EEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceecc
Q 005940 428 VYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYD 507 (668)
Q Consensus 428 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~ 507 (668)
||||+++|+|.+++.. .+..+++..++.++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 92 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 166 (325)
T 3kex_A 92 VTQYLPLGSLLDHVRQ--HRGALGPQLLLNWGVQIAKGMYYLEE---HGMVHRNLAARNVLLKSPSQVQVADFGVADLLP 166 (325)
T ss_dssp EEECCTTCBSHHHHHS--SGGGSCTTHHHHHHHHHHHHHHHHHH---TTCCCSCCSSTTEEESSSSCEEECSCSGGGGSC
T ss_pred EEEeCCCCCHHHHHHH--ccccCCHHHHHHHHHHHHHHHHHHHh---CCCCCCccchheEEECCCCeEEECCCCcccccC
Confidence 9999999999999963 24569999999999999999999999 999999999999999999999999999999775
Q ss_pred CCCCC-cccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHHHhcCccccccCccc
Q 005940 508 HGGMP-HTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVAT-GRRPIGSGDLLLVEWVRECHQLGRILDVADPLL 585 (668)
Q Consensus 508 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 585 (668)
..... ......++..|+|||++.++.++.++|||||||++|||++ |+.||......... ........... +.
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~---~~~~~~~~~~~--~~- 240 (325)
T 3kex_A 167 PDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVP---DLLEKGERLAQ--PQ- 240 (325)
T ss_dssp CCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHH---HHHHTTCBCCC--CT-
T ss_pred cccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHH---HHHHcCCCCCC--CC-
Confidence 44322 2344567889999999998899999999999999999999 99999764322111 11111111111 11
Q ss_pred CCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhccCcCCC
Q 005940 586 NSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSGEKQLR 628 (668)
Q Consensus 586 ~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~~~~~~ 628 (668)
.+. ..+..++..|+.. |++||+++|++++|+....-|
T Consensus 241 --~~~----~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~~ 278 (325)
T 3kex_A 241 --ICT----IDVYMVMVKCWMIDENIRPTFKELANEFTRMARDP 278 (325)
T ss_dssp --TBC----TTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTSH
T ss_pred --cCc----HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence 011 1234566788887 999999999999998765433
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-40 Score=345.37 Aligned_cols=258 Identities=20% Similarity=0.195 Sum_probs=205.7
Q ss_pred hcCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCchhHHHHHHHHHHHhcc-cccCceeEeeeecccCceEEEEE
Q 005940 352 TKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRL-RHKNLVNLHGWCKQKNDLLLVYE 430 (668)
Q Consensus 352 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~E 430 (668)
.++|...+.||+|+||.||+|++..+++.||||++..... .+.+..|+++++++ +||||+++++++...+..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e 85 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE 85 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence 3679999999999999999999988999999999876533 24688999999999 89999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCC-----EEEEeecCcee
Q 005940 431 YIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMN-----ARLGDFGLARL 505 (668)
Q Consensus 431 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~-----~kl~DfGla~~ 505 (668)
|+ +++|.+++... ...+++..++.++.||+.||.|||+ .+|+||||||+|||++.++. +||+|||+++.
T Consensus 86 ~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~---~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~ 159 (330)
T 2izr_A 86 LL-GPSLEDLFDLC--DRTFSLKTVLMIAIQLISRMEYVHS---KNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE 159 (330)
T ss_dssp CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEE
T ss_pred eC-CCCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeeeccCCCCCCceEEEEEccccee
Confidence 99 99999999642 4569999999999999999999999 99999999999999999887 99999999997
Q ss_pred ccCCCCC------cccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCc-hhHHHHHHHHHhcCccc
Q 005940 506 YDHGGMP------HTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGD-LLLVEWVRECHQLGRIL 578 (668)
Q Consensus 506 ~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~-~~l~~~~~~~~~~~~~~ 578 (668)
....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.... ....+........ ...
T Consensus 160 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~-~~~ 238 (330)
T 2izr_A 160 YIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDT-KRA 238 (330)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHH-HHH
T ss_pred eecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhh-hcc
Confidence 6543321 1245689999999999999999999999999999999999999997542 1222211111110 000
Q ss_pred cccCcccCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhccC
Q 005940 579 DVADPLLNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSGE 624 (668)
Q Consensus 579 ~~~d~~l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~~ 624 (668)
. ....+...+ + .+..+...|+.. |.+||++++|.+.|+..
T Consensus 239 ~-~~~~~~~~~-p----~~~~li~~~l~~~p~~RP~~~~l~~~l~~~ 279 (330)
T 2izr_A 239 T-PIEVLCENF-P----EMATYLRYVRRLDFFEKPDYDYLRKLFTDL 279 (330)
T ss_dssp S-CHHHHTTTC-H----HHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred C-CHHHHhccC-h----HHHHHHHHHHhCCCCCCCCHHHHHHHHHHH
Confidence 0 000111111 1 455666688887 99999999999998744
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-40 Score=352.78 Aligned_cols=261 Identities=25% Similarity=0.363 Sum_probs=205.7
Q ss_pred cCcccceeeeecCcEEEEEEEe-----CCCCcEEEEEEEecC-CchhHHHHHHHHHHHhcccccCceeEeeeecccCceE
Q 005940 353 KGFKESEVIGIGGFGSVYKGVL-----PTTGGEVAVKKITRN-SLQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLL 426 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~-----~~~~~~vavK~~~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~ 426 (668)
++|...++||+|+||.||+|++ ..++..||||++... ..+...++..|+.++++++||||+++++++......+
T Consensus 71 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 150 (367)
T 3l9p_A 71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRF 150 (367)
T ss_dssp GGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred hHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCE
Confidence 5688899999999999999995 345678999999654 3345567899999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhcCCC----CCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCC---CEEEEe
Q 005940 427 LVYEYIPNGSLDTLLFKPK----DGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEM---NARLGD 499 (668)
Q Consensus 427 lV~E~~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~---~~kl~D 499 (668)
+||||+++|+|.+++.... ....+++.+++.++.||+.||.|||+ .+|+||||||+|||++.++ .+||+|
T Consensus 151 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~~~~kL~D 227 (367)
T 3l9p_A 151 ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKIGD 227 (367)
T ss_dssp EEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEECC
T ss_pred EEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChhhEEEecCCCCceEEECC
Confidence 9999999999999996422 22458999999999999999999999 9999999999999999554 599999
Q ss_pred ecCceeccCCC-CCcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHHHhcCcc
Q 005940 500 FGLARLYDHGG-MPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVAT-GRRPIGSGDLLLVEWVRECHQLGRI 577 (668)
Q Consensus 500 fGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~l~~~~~~~~~~~~~ 577 (668)
||+++...... ........||+.|+|||++.++.++.++|||||||++|||++ |+.||...+... ..........
T Consensus 228 FG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~--~~~~i~~~~~- 304 (367)
T 3l9p_A 228 FGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE--VLEFVTSGGR- 304 (367)
T ss_dssp CHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH--HHHHHHTTCC-
T ss_pred CccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHcCCC-
Confidence 99998553221 122334567899999999988899999999999999999998 999997654221 1122111111
Q ss_pred ccccCcccCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhccCcCCC
Q 005940 578 LDVADPLLNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSGEKQLR 628 (668)
Q Consensus 578 ~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~~~~~~ 628 (668)
. .....+. ..+..++..|++. |++||++.||+++|+....-+
T Consensus 305 ~-----~~~~~~~----~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~ 347 (367)
T 3l9p_A 305 M-----DPPKNCP----GPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP 347 (367)
T ss_dssp C-----CCCTTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred C-----CCCccCC----HHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhCh
Confidence 1 1111122 2355677789987 999999999999998665433
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=331.68 Aligned_cols=248 Identities=33% Similarity=0.531 Sum_probs=191.6
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCc----hhHHHHHHHHHHHhcccccCceeEeeeecccCceEEE
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSL----QGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLV 428 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV 428 (668)
++|+..++||+|+||.||+|.+ .+..||||++..... ...+.+.+|++++++++||||+++++++...+..++|
T Consensus 7 ~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (271)
T 3dtc_A 7 AELTLEEIIGIGGFGKVYRAFW--IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV 84 (271)
T ss_dssp TSEEEEEEEEEETTEEEEEEEE--TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred hheeeeeeeccCCCeEEEEEEE--cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence 5788999999999999999998 488999999865432 3356789999999999999999999999999999999
Q ss_pred EEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCc---eEecCCCCCCEEECC--------CCCEEE
Q 005940 429 YEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQV---VIHRDVKPSNALIDA--------EMNARL 497 (668)
Q Consensus 429 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~---ivHrDLkp~NIll~~--------~~~~kl 497 (668)
|||+++++|.+++. +..+++..++.++.|++.||.|||+ .+ |+||||||+||+++. ++.+||
T Consensus 85 ~e~~~~~~L~~~~~----~~~~~~~~~~~i~~~l~~~l~~lH~---~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl 157 (271)
T 3dtc_A 85 MEFARGGPLNRVLS----GKRIPPDILVNWAVQIARGMNYLHD---EAIVPIIHRDLKSSNILILQKVENGDLSNKILKI 157 (271)
T ss_dssp EECCTTEEHHHHHT----SSCCCHHHHHHHHHHHHHHHHHHHH---SSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEE
T ss_pred EEcCCCCCHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHh---CCCCceeecCCchHHEEEecccccccccCcceEE
Confidence 99999999999994 3468999999999999999999999 66 999999999999986 678999
Q ss_pred EeecCceeccCCCCCcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCcc
Q 005940 498 GDFGLARLYDHGGMPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRI 577 (668)
Q Consensus 498 ~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~ 577 (668)
+|||+++...... .....||..|+|||.+.+..++.++||||||+++|||++|+.||...+.....+ ..... ..
T Consensus 158 ~Dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~--~~~~~-~~ 231 (271)
T 3dtc_A 158 TDFGLAREWHRTT---KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAY--GVAMN-KL 231 (271)
T ss_dssp CCCCC----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHH--HHHTS-CC
T ss_pred ccCCccccccccc---ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH--hhhcC-CC
Confidence 9999998665432 223478999999999988889999999999999999999999997654332221 11111 11
Q ss_pred ccccCcccCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhcc
Q 005940 578 LDVADPLLNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSG 623 (668)
Q Consensus 578 ~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~ 623 (668)
. ......+. ..+..+...|+.. |++||+++|++++|+.
T Consensus 232 ~----~~~~~~~~----~~~~~li~~~l~~~p~~Rps~~e~l~~L~~ 270 (271)
T 3dtc_A 232 A----LPIPSTCP----EPFAKLMEDCWNPDPHSRPSFTNILDQLTT 270 (271)
T ss_dssp C----CCCCTTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred C----CCCCcccC----HHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence 1 11111222 3455667789887 9999999999999975
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-39 Score=347.70 Aligned_cols=260 Identities=27% Similarity=0.388 Sum_probs=209.2
Q ss_pred cCcccceeeeecCcEEEEEEEeCC-------CCcEEEEEEEecCCc-hhHHHHHHHHHHHhcc-cccCceeEeeeecccC
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPT-------TGGEVAVKKITRNSL-QGMREFAAEIESLGRL-RHKNLVNLHGWCKQKN 423 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~-------~~~~vavK~~~~~~~-~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~ 423 (668)
++|...++||+|+||.||+|++.. .+..||||++..... ...+++.+|+++++++ +||||++++++|...+
T Consensus 69 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~ 148 (382)
T 3tt0_A 69 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 148 (382)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred hheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccCC
Confidence 578889999999999999999643 235799999976533 4457899999999999 8999999999999999
Q ss_pred ceEEEEEecCCCChhhhhcCCCC-------------CCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEEC
Q 005940 424 DLLLVYEYIPNGSLDTLLFKPKD-------------GSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALID 490 (668)
Q Consensus 424 ~~~lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~ 490 (668)
..++||||+++|+|.+++..... ...+++.+++.++.||+.||.|||+ .+|+||||||+|||++
T Consensus 149 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~ 225 (382)
T 3tt0_A 149 PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVT 225 (382)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEC
T ss_pred ceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCcceEEEc
Confidence 99999999999999999964321 2459999999999999999999999 9999999999999999
Q ss_pred CCCCEEEEeecCceeccCCCC-CcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHH
Q 005940 491 AEMNARLGDFGLARLYDHGGM-PHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVAT-GRRPIGSGDLLLVEWV 568 (668)
Q Consensus 491 ~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~l~~~~ 568 (668)
.++.+||+|||+++....... .......+|..|+|||++.+..++.++|||||||++|||++ |+.||...+.. +..
T Consensus 226 ~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~--~~~ 303 (382)
T 3tt0_A 226 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE--ELF 303 (382)
T ss_dssp TTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--HHH
T ss_pred CCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH--HHH
Confidence 999999999999987654332 22334467889999999999999999999999999999999 99999765322 111
Q ss_pred HHHHhcCccccccCcccCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhccCcCC
Q 005940 569 RECHQLGRILDVADPLLNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSGEKQL 627 (668)
Q Consensus 569 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~~~~~ 627 (668)
......... .....+. ..+..+...|++. |++||+++||+++|+.....
T Consensus 304 -~~~~~~~~~-----~~~~~~~----~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 353 (382)
T 3tt0_A 304 -KLLKEGHRM-----DKPSNCT----NELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 353 (382)
T ss_dssp -HHHHTTCCC-----CCCSSCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -HHHHcCCCC-----CCCccCC----HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 222222111 1111222 2355667789987 99999999999999876533
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=336.39 Aligned_cols=250 Identities=23% Similarity=0.340 Sum_probs=202.4
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCC-------cEEEEEEEecCCchhHHHHHHHHHHHhcccccCceeEeeeecccCce
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTG-------GEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDL 425 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~-------~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~ 425 (668)
++|...+.||+|+||.||+|.+..++ ..||+|++........+.+.+|++++++++||||+++++++...+..
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (289)
T 4fvq_A 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDEN 87 (289)
T ss_dssp GGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCC
T ss_pred hHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCC
Confidence 57888999999999999999987665 47999999877767778899999999999999999999999999999
Q ss_pred EEEEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCC--------EEE
Q 005940 426 LLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMN--------ARL 497 (668)
Q Consensus 426 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~--------~kl 497 (668)
++||||+++|+|.+++.. ....+++..++.++.||+.||.|||+ .+|+||||||+||+++.++. +||
T Consensus 88 ~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl 162 (289)
T 4fvq_A 88 ILVQEFVKFGSLDTYLKK--NKNCINILWKLEVAKQLAAAMHFLEE---NTLIHGNVCAKNILLIREEDRKTGNPPFIKL 162 (289)
T ss_dssp EEEEECCTTCBHHHHHHH--TGGGCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEEECCBGGGTBCCEEEE
T ss_pred EEEEECCCCCCHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHhh---CCeECCCcCcceEEEecCCcccccccceeee
Confidence 999999999999999963 23458999999999999999999999 99999999999999998887 999
Q ss_pred EeecCceeccCCCCCcccccccCCcccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCC-CCCCchhHHHHHHHHHhcC
Q 005940 498 GDFGLARLYDHGGMPHTTNVVGTFGYIAPELTQT-GKASTSSDVFAYGILLLEVATGRRP-IGSGDLLLVEWVRECHQLG 575 (668)
Q Consensus 498 ~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~S~Gvvl~elltG~~p-~~~~~~~l~~~~~~~~~~~ 575 (668)
+|||++..... .....||..|+|||++.+ ..++.++|||||||++|||++|..| +...+..... .......
T Consensus 163 ~Dfg~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~--~~~~~~~ 235 (289)
T 4fvq_A 163 SDPGISITVLP-----KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKL--QFYEDRH 235 (289)
T ss_dssp CCCCSCTTTSC-----HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH--HHHHTTC
T ss_pred ccCcccccccC-----ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHH--HHhhccC
Confidence 99999865432 233468899999999887 6789999999999999999996554 4433322111 1111111
Q ss_pred ccccccCcccCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhccCcC
Q 005940 576 RILDVADPLLNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSGEKQ 626 (668)
Q Consensus 576 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~~~~ 626 (668)
.... .. . ..+..+...|++. |++||+++|++++|+....
T Consensus 236 ~~~~----~~----~----~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~ 275 (289)
T 4fvq_A 236 QLPA----PK----A----AELANLINNCMDYEPDHRPSFRAIIRDLNSLFT 275 (289)
T ss_dssp CCCC----CS----S----CTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred CCCC----CC----C----HHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 1111 11 1 1244666789887 9999999999999987753
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-39 Score=337.34 Aligned_cols=260 Identities=26% Similarity=0.276 Sum_probs=197.3
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCc--hhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEE
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSL--QGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYE 430 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 430 (668)
++|+..++||+|+||.||+|.+. +++.||||++..... ...+.+.+|++++++++||||+++++++..+...++|||
T Consensus 21 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 99 (311)
T 3niz_A 21 EKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE 99 (311)
T ss_dssp CEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEE
T ss_pred hhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEc
Confidence 67899999999999999999995 589999999965432 234678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCC
Q 005940 431 YIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGG 510 (668)
Q Consensus 431 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~ 510 (668)
|++ ++|.+++.. ....+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 100 ~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 173 (311)
T 3niz_A 100 FME-KDLKKVLDE--NKTGLQDSQIKIYLYQLLRGVAHCHQ---HRILHRDLKPQNLLINSDGALKLADFGLARAFGIPV 173 (311)
T ss_dssp CCS-EEHHHHHHT--CTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCC
T ss_pred CCC-CCHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCchHhEEECCCCCEEEccCcCceecCCCc
Confidence 997 478888753 34569999999999999999999999 999999999999999999999999999998765432
Q ss_pred CCcccccccCCcccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCC-chhHHHHHHHHHhcCcccc---------
Q 005940 511 MPHTTNVVGTFGYIAPELTQT-GKASTSSDVFAYGILLLEVATGRRPIGSG-DLLLVEWVRECHQLGRILD--------- 579 (668)
Q Consensus 511 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~S~Gvvl~elltG~~p~~~~-~~~l~~~~~~~~~~~~~~~--------- 579 (668)
. ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||... +......+...........
T Consensus 174 ~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 252 (311)
T 3niz_A 174 R-SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPL 252 (311)
T ss_dssp C----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHH
T ss_pred c-cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccch
Confidence 2 2334578999999999876 56899999999999999999999999754 2222222222221111000
Q ss_pred -------ccCcccCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 580 -------VADPLLNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 580 -------~~d~~l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
..+..............+..+...|+.. |++||+++|++++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 301 (311)
T 3niz_A 253 WKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH 301 (311)
T ss_dssp HHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred hhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 0000000000000112345566678887 9999999999974
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-40 Score=339.90 Aligned_cols=256 Identities=26% Similarity=0.387 Sum_probs=211.8
Q ss_pred HhcCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCchhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEE
Q 005940 351 ATKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYE 430 (668)
Q Consensus 351 at~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 430 (668)
..++|...+.||+|+||.||+|.+..++..||+|++.... ...+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 89 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 89 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEE
Confidence 4567899999999999999999998889999999997644 345789999999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCC
Q 005940 431 YIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGG 510 (668)
Q Consensus 431 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~ 510 (668)
|+++++|.+++.. .....+++..++.++.||+.||.|||+ .+|+||||||+||+++.++.+||+|||++.......
T Consensus 90 ~~~~~~L~~~~~~-~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 165 (288)
T 3kfa_A 90 FMTYGNLLDYLRE-CNRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 165 (288)
T ss_dssp CCTTEEHHHHHHH-CCTTTSCHHHHHHHHHHHHHHHHHHHH---HTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSS
T ss_pred cCCCCcHHHHHHh-cccCCccHhHHHHHHHHHHHHHHHHHH---CCccCCCCCcceEEEcCCCCEEEccCccceeccCCc
Confidence 9999999999964 234569999999999999999999999 899999999999999999999999999998776554
Q ss_pred CCcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCchh-HHHHHHHHHhcCccccccCcccCCc
Q 005940 511 MPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVAT-GRRPIGSGDLL-LVEWVRECHQLGRILDVADPLLNSS 588 (668)
Q Consensus 511 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~-l~~~~~~~~~~~~~~~~~d~~l~~~ 588 (668)
........+|..|+|||.+.+..++.++||||||+++|||++ |+.||...+.. ..+.+ .... .......
T Consensus 166 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~----~~~~-----~~~~~~~ 236 (288)
T 3kfa_A 166 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL----EKDY-----RMERPEG 236 (288)
T ss_dssp SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHH----HTTC-----CCCCCTT
T ss_pred cccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH----hccC-----CCCCCCC
Confidence 444445567889999999988899999999999999999999 99999765322 22111 1111 0111111
Q ss_pred ccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhccC
Q 005940 589 YVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSGE 624 (668)
Q Consensus 589 ~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~~ 624 (668)
++ ..+..+...|+.. |++||+++|+++.|+..
T Consensus 237 ~~----~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~ 269 (288)
T 3kfa_A 237 CP----EKVYELMRACWQWNPSDRPSFAEIHQAFETM 269 (288)
T ss_dssp CC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CC----HHHHHHHHHHhCCChhhCcCHHHHHHHHHHH
Confidence 22 3455666688887 99999999999998764
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-39 Score=329.14 Aligned_cols=251 Identities=25% Similarity=0.296 Sum_probs=204.2
Q ss_pred hcCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCchhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEEe
Q 005940 352 TKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEY 431 (668)
Q Consensus 352 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~ 431 (668)
.++|...+.||+|+||.||+|.+..++..+|+|++........+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMEL 87 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEec
Confidence 35688999999999999999999988999999999877666678899999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEE---CCCCCEEEEeecCceeccC
Q 005940 432 IPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALI---DAEMNARLGDFGLARLYDH 508 (668)
Q Consensus 432 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll---~~~~~~kl~DfGla~~~~~ 508 (668)
+++++|.+++.. ...+++..++.++.|++.||.|||+ .+|+||||||+||++ +.++.+||+|||++.....
T Consensus 88 ~~~~~L~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~ 161 (277)
T 3f3z_A 88 CTGGELFERVVH---KRVFRESDAARIMKDVLSAVAYCHK---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP 161 (277)
T ss_dssp CCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCT
T ss_pred cCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCCHHHEEEecCCCCCcEEEEecccceeccC
Confidence 999999998853 3458999999999999999999999 999999999999999 7889999999999987664
Q ss_pred CCCCcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCcccCCc
Q 005940 509 GGMPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSS 588 (668)
Q Consensus 509 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 588 (668)
... .....||+.|+|||++.+ .++.++||||||+++|||++|+.||....... ....... ..... .......
T Consensus 162 ~~~--~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~--~~~~~~~-~~~~~--~~~~~~~ 233 (277)
T 3f3z_A 162 GKM--MRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSE--VMLKIRE-GTFTF--PEKDWLN 233 (277)
T ss_dssp TSC--BCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHH-CCCCC--CHHHHTT
T ss_pred ccc--hhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCHHH--HHHHHHh-CCCCC--Cchhhhc
Confidence 432 234579999999998865 58999999999999999999999997654221 1111111 11100 0000001
Q ss_pred ccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 589 YVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 589 ~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
.+ ..+..+...|++. |++||++.|++++
T Consensus 234 ~~----~~~~~li~~~l~~dp~~R~s~~~~l~h 262 (277)
T 3f3z_A 234 VS----PQAESLIRRLLTKSPKQRITSLQALEH 262 (277)
T ss_dssp SC----HHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred CC----HHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11 2345566688887 9999999999874
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=347.93 Aligned_cols=249 Identities=25% Similarity=0.326 Sum_probs=198.3
Q ss_pred hcCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCC---chhHHHHHHHHHHHhcc-cccCceeEeeeecccCceEE
Q 005940 352 TKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNS---LQGMREFAAEIESLGRL-RHKNLVNLHGWCKQKNDLLL 427 (668)
Q Consensus 352 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~l 427 (668)
.++|+..++||+|+||.||+|+++.+++.||||++.+.. ....+.+..|.+++.++ +||||+++++++.+.+..|+
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 101 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF 101 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence 368999999999999999999999899999999997642 23456688999999988 69999999999999999999
Q ss_pred EEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceecc
Q 005940 428 VYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYD 507 (668)
Q Consensus 428 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~ 507 (668)
||||+++|+|.+++.. ...+++..+..++.||+.||.|||+ .+|+||||||+||||+.++.+||+|||+++...
T Consensus 102 v~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~ 175 (353)
T 3txo_A 102 VMEFVNGGDLMFHIQK---SRRFDEARARFYAAEIISALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGI 175 (353)
T ss_dssp EEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred EEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCCcccCCCHHHEEECCCCCEEEccccceeecc
Confidence 9999999999999963 3459999999999999999999999 999999999999999999999999999998543
Q ss_pred CCCCCcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCcccCC
Q 005940 508 HGGMPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNS 587 (668)
Q Consensus 508 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 587 (668)
... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||...+.. +....... ... ....
T Consensus 176 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~--~~~~~i~~-~~~------~~p~ 245 (353)
T 3txo_A 176 CNG-VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENED--DLFEAILN-DEV------VYPT 245 (353)
T ss_dssp C----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHH-CCC------CCCT
T ss_pred cCC-ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHH--HHHHHHHc-CCC------CCCC
Confidence 322 2234468999999999998888999999999999999999999999765422 11122211 111 1111
Q ss_pred cccHHHHHHHHHHHhhcCCC-CCCCCCH------HHHHHH
Q 005940 588 SYVVKEMELVLKLGLMCSHK-TQFRPTM------RQVMRY 620 (668)
Q Consensus 588 ~~~~~~~~~l~~l~~~C~~~-p~~RPs~------~evl~~ 620 (668)
... + .+..+...|+.. |++||++ +||+++
T Consensus 246 ~~~-~---~~~~li~~lL~~dP~~R~~~~~~~~~~~il~h 281 (353)
T 3txo_A 246 WLH-E---DATGILKSFMTKNPTMRLGSLTQGGEHAILRH 281 (353)
T ss_dssp TSC-H---HHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTS
T ss_pred CCC-H---HHHHHHHHHhhhCHHHccCCcccCCHHHHhhC
Confidence 122 2 234455577776 9999998 788764
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=350.25 Aligned_cols=251 Identities=25% Similarity=0.317 Sum_probs=200.4
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCc---hhHHHHHHHHHHHhcc-cccCceeEeeeecccCceEEE
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSL---QGMREFAAEIESLGRL-RHKNLVNLHGWCKQKNDLLLV 428 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV 428 (668)
++|...++||+|+||.||+|+++.+++.||||++.+... ...+.+..|..++.++ +||||+++++++.+.+..++|
T Consensus 52 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV 131 (396)
T 4dc2_A 52 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 131 (396)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred hHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEE
Confidence 578999999999999999999999999999999976532 2335678899999887 899999999999999999999
Q ss_pred EEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccC
Q 005940 429 YEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDH 508 (668)
Q Consensus 429 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~ 508 (668)
|||+++|+|..++.. ...+++..+..++.||+.||.|||+ .+|+||||||+||||+.++.+||+|||+++....
T Consensus 132 ~E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~---~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~ 205 (396)
T 4dc2_A 132 IEYVNGGDLMFHMQR---QRKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 205 (396)
T ss_dssp EECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EEcCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCEEeccCCHHHEEECCCCCEEEeecceeeeccc
Confidence 999999999999963 3459999999999999999999999 9999999999999999999999999999986332
Q ss_pred CCCCcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCc------hhHHHHHHHHHhcCccccccC
Q 005940 509 GGMPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGD------LLLVEWVRECHQLGRILDVAD 582 (668)
Q Consensus 509 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~------~~l~~~~~~~~~~~~~~~~~d 582 (668)
.. ......+||+.|+|||++.+..++.++|||||||++|||++|+.||.... ....++..+......+
T Consensus 206 ~~-~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~----- 279 (396)
T 4dc2_A 206 PG-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI----- 279 (396)
T ss_dssp TT-CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCC-----
T ss_pred CC-CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcccc-----
Confidence 22 23445689999999999999999999999999999999999999995321 1111222222222211
Q ss_pred cccCCcccHHHHHHHHHHHhhcCCC-CCCCCCH------HHHHHH
Q 005940 583 PLLNSSYVVKEMELVLKLGLMCSHK-TQFRPTM------RQVMRY 620 (668)
Q Consensus 583 ~~l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~------~evl~~ 620 (668)
.+...... .+..+...|++. |++||++ +||+++
T Consensus 280 -~~p~~~s~----~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~H 319 (396)
T 4dc2_A 280 -RIPRSLSV----KAASVLKSFLNKDPKERLGCHPQTGFADIQGH 319 (396)
T ss_dssp -CCCTTSCH----HHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHS
T ss_pred -CCCCcCCH----HHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcC
Confidence 11122222 234555577776 9999984 777765
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=349.01 Aligned_cols=264 Identities=18% Similarity=0.203 Sum_probs=202.8
Q ss_pred HhcCcccceeeeecCcEEEEEEEeCCC-----CcEEEEEEEecCCchhH-----------HHHHHHHHHHhcccccCcee
Q 005940 351 ATKGFKESEVIGIGGFGSVYKGVLPTT-----GGEVAVKKITRNSLQGM-----------REFAAEIESLGRLRHKNLVN 414 (668)
Q Consensus 351 at~~f~~~~~lG~G~~g~Vy~~~~~~~-----~~~vavK~~~~~~~~~~-----------~~f~~Ei~~l~~l~H~nIv~ 414 (668)
..++|...++||+|+||.||+|.+..+ ++.||||++........ ..+..|+..+.+++|+||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 346899999999999999999998654 47899999976653211 23445667778889999999
Q ss_pred Eeeeeccc----CceEEEEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEEC
Q 005940 415 LHGWCKQK----NDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALID 490 (668)
Q Consensus 415 l~g~~~~~----~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~ 490 (668)
+++++... ...++||||+ +++|.+++.. ....+++.+++.++.||+.||.|||+ .+|+||||||+|||++
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~--~~~~l~~~~~~~i~~qi~~~l~~lH~---~~iiHrDlkp~Nill~ 186 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEA--NAKRFSRKTVLQLSLRILDILEYIHE---HEYVHGDIKASNLLLN 186 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHH--TTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEE
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHH---CCeEEecCCHHHEEEe
Confidence 99998764 4589999999 9999999963 34569999999999999999999999 9999999999999999
Q ss_pred --CCCCEEEEeecCceeccCCCCC------cccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC--
Q 005940 491 --AEMNARLGDFGLARLYDHGGMP------HTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSG-- 560 (668)
Q Consensus 491 --~~~~~kl~DfGla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~-- 560 (668)
.++.+||+|||+++.+...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 187 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~ 266 (364)
T 3op5_A 187 YKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLK 266 (364)
T ss_dssp SSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTT
T ss_pred cCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcccccc
Confidence 8899999999999876533211 113346999999999999989999999999999999999999999742
Q ss_pred chhHHHHHHHHHhcCccccccCcccCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhccC
Q 005940 561 DLLLVEWVRECHQLGRILDVADPLLNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSGE 624 (668)
Q Consensus 561 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~~ 624 (668)
+.....+...... ..+....++.+.....++ .+..++..|+.. |++||++++|++.|+..
T Consensus 267 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~---~~~~li~~cl~~~p~~RP~~~~l~~~l~~~ 327 (364)
T 3op5_A 267 DPKYVRDSKIRYR-ENIASLMDKCFPAANAPG---EIAKYMETVKLLDYTEKPLYENLRDILLQG 327 (364)
T ss_dssp CHHHHHHHHHHHH-HCHHHHHHHHSCTTCCCH---HHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred CHHHHHHHHHHhh-hhHHHHHHHhcccccCHH---HHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Confidence 3333333332222 123333333322122222 345566688887 99999999999998754
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-40 Score=361.85 Aligned_cols=256 Identities=27% Similarity=0.450 Sum_probs=206.2
Q ss_pred HhcCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCchhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEE
Q 005940 351 ATKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYE 430 (668)
Q Consensus 351 at~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 430 (668)
..++|...++||+|+||.||+|.+. .+..||||++.... ...++|.+|++++++++||||+++++++. .+..++|||
T Consensus 186 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e 262 (454)
T 1qcf_A 186 PRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITE 262 (454)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEC
T ss_pred chHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEe
Confidence 3467888999999999999999995 47789999997654 34678999999999999999999999987 567899999
Q ss_pred ecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCC
Q 005940 431 YIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGG 510 (668)
Q Consensus 431 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~ 510 (668)
|+++|+|.+++... ....+++..++.++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 263 ~~~~g~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~ 338 (454)
T 1qcf_A 263 FMAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE 338 (454)
T ss_dssp CCTTCBHHHHHHSH-HHHTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHH
T ss_pred ecCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCc
Confidence 99999999999632 22358899999999999999999999 999999999999999999999999999998765432
Q ss_pred CCcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHHHhcCccccccCcccCCcc
Q 005940 511 MPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVAT-GRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSY 589 (668)
Q Consensus 511 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 589 (668)
........++..|+|||++..+.++.++|||||||++|||++ |+.||...... +.........+.. .+ ..+
T Consensus 339 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~--~~~~~i~~~~~~~---~~---~~~ 410 (454)
T 1qcf_A 339 YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP--EVIRALERGYRMP---RP---ENC 410 (454)
T ss_dssp HHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--HHHHHHHHTCCCC---CC---TTS
T ss_pred eeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHcCCCCC---CC---CCC
Confidence 222233456788999999988899999999999999999999 99999764322 1111221211111 11 112
Q ss_pred cHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhccCc
Q 005940 590 VVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSGEK 625 (668)
Q Consensus 590 ~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~~~ 625 (668)
. ..+..++..|+.. |++||++++|++.|+...
T Consensus 411 ~----~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~ 443 (454)
T 1qcf_A 411 P----EELYNIMMRCWKNRPEERPTFEYIQSVLDDFY 443 (454)
T ss_dssp C----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred C----HHHHHHHHHHccCChhHCcCHHHHHHHHHHHH
Confidence 2 3455677789987 999999999999998764
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=334.66 Aligned_cols=252 Identities=26% Similarity=0.347 Sum_probs=205.3
Q ss_pred hcCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCch------hHHHHHHHHHHHhcccccCceeEeeeecccCce
Q 005940 352 TKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQ------GMREFAAEIESLGRLRHKNLVNLHGWCKQKNDL 425 (668)
Q Consensus 352 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~------~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~ 425 (668)
.++|...+.||+|+||.||+|.+..+++.||||++...... ..+++.+|+.++++++||||+++++++.+....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 35688999999999999999999888999999999765322 357899999999999999999999999999999
Q ss_pred EEEEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCC----CEEEEeec
Q 005940 426 LLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEM----NARLGDFG 501 (668)
Q Consensus 426 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~----~~kl~DfG 501 (668)
++||||+++++|.+++.. ...+++..++.++.|++.||.|||+ .+|+||||||+||+++.++ .+||+|||
T Consensus 91 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~---~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg 164 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQ---KESLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFG 164 (321)
T ss_dssp EEEECCCCSCBHHHHHHT---CSCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCTTSSSCCEEECCCT
T ss_pred EEEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCChHHEEEecCCCCcCCEEEccCc
Confidence 999999999999999963 3469999999999999999999999 9999999999999999888 79999999
Q ss_pred CceeccCCCCCcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCcccccc
Q 005940 502 LARLYDHGGMPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVA 581 (668)
Q Consensus 502 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~ 581 (668)
+++....... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...... +....... ... ..
T Consensus 165 ~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~i~~-~~~--~~ 237 (321)
T 2a2a_A 165 LAHEIEDGVE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ--ETLANITS-VSY--DF 237 (321)
T ss_dssp TCEECCTTCC--CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH--HHHHHHHT-TCC--CC
T ss_pred cceecCcccc--ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHH--HHHHHHHh-ccc--cc
Confidence 9987765332 23457899999999999889999999999999999999999999764322 11111111 110 01
Q ss_pred CcccCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 582 DPLLNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 582 d~~l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
++......+ ..+..+...|+.. |++||+++|++++
T Consensus 238 ~~~~~~~~~----~~~~~li~~~l~~dp~~Rps~~e~l~h 273 (321)
T 2a2a_A 238 DEEFFSHTS----ELAKDFIRKLLVKETRKRLTIQEALRH 273 (321)
T ss_dssp CHHHHTTCC----HHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred ChhhhcccC----HHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 111111111 2355666788887 9999999999985
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=336.66 Aligned_cols=260 Identities=23% Similarity=0.344 Sum_probs=202.6
Q ss_pred hhHHHHhcCcccc-eeeeecCcEEEEEEEeCCCCcEEEEEEEecCC--chhHHHHHHHHHHHhccc-ccCceeEeeeecc
Q 005940 346 KDLYAATKGFKES-EVIGIGGFGSVYKGVLPTTGGEVAVKKITRNS--LQGMREFAAEIESLGRLR-HKNLVNLHGWCKQ 421 (668)
Q Consensus 346 ~el~~at~~f~~~-~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~ 421 (668)
.....-.+.|... +.||+|+||.||+|.+..+++.||||++.... .....++.+|+.++.+++ ||||+++++++.+
T Consensus 21 ~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~ 100 (327)
T 3lm5_A 21 QSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYEN 100 (327)
T ss_dssp BCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred HHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEe
Confidence 3344445667776 88999999999999999899999999987543 334678899999999995 6999999999999
Q ss_pred cCceEEEEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECC---CCCEEEE
Q 005940 422 KNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDA---EMNARLG 498 (668)
Q Consensus 422 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~---~~~~kl~ 498 (668)
.+..++||||+++|+|.+++.. .....+++.+++.++.||+.||.|||+ .+|+||||||+||+++. ++.+||+
T Consensus 101 ~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~i~~ql~~~L~~LH~---~givH~Dikp~NIl~~~~~~~~~~kL~ 176 (327)
T 3lm5_A 101 TSEIILILEYAAGGEIFSLCLP-ELAEMVSENDVIRLIKQILEGVYYLHQ---NNIVHLDLKPQNILLSSIYPLGDIKIV 176 (327)
T ss_dssp SSEEEEEEECCTTEEGGGGGSS-CC-CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESCBTTBCCEEEC
T ss_pred CCeEEEEEEecCCCcHHHHHHH-hcccCCCHHHHHHHHHHHHHHHHHHHH---CCeecCcCChHHEEEecCCCCCcEEEe
Confidence 9999999999999999999853 234679999999999999999999999 99999999999999998 7899999
Q ss_pred eecCceeccCCCCCcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccc
Q 005940 499 DFGLARLYDHGGMPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRIL 578 (668)
Q Consensus 499 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~ 578 (668)
|||+++....... .....||+.|+|||++....++.++|||||||++|||++|+.||...+..... ...... ..
T Consensus 177 Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~--~~i~~~-~~- 250 (327)
T 3lm5_A 177 DFGMSRKIGHACE--LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETY--LNISQV-NV- 250 (327)
T ss_dssp CGGGCEEC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH--HHHHHT-CC-
T ss_pred eCccccccCCccc--cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHH--HHHHhc-cc-
Confidence 9999987654322 23457999999999999999999999999999999999999999765432111 111111 10
Q ss_pred cccCcccCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 579 DVADPLLNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 579 ~~~d~~l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
.. ......... ..+..+...|+.. |++||+++|++++
T Consensus 251 ~~-~~~~~~~~~----~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 251 DY-SEETFSSVS----QLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp CC-CTTTTTTSC----HHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred cc-CchhhcccC----HHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 00 011111112 2345566688887 9999999999875
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=338.96 Aligned_cols=258 Identities=26% Similarity=0.359 Sum_probs=207.0
Q ss_pred hcCcccceeeeecCcEEEEEEEeC-----CCCcEEEEEEEecCC-chhHHHHHHHHHHHhcccccCceeEeeeecccCce
Q 005940 352 TKGFKESEVIGIGGFGSVYKGVLP-----TTGGEVAVKKITRNS-LQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDL 425 (668)
Q Consensus 352 t~~f~~~~~lG~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~ 425 (668)
.++|...+.||+|+||.||+|++. .++..||||++.... ....+.+.+|++++++++||||+++++++.+.+..
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 101 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL 101 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCce
Confidence 467888999999999999999873 345789999997643 34567899999999999999999999999999999
Q ss_pred EEEEEecCCCChhhhhcCCCC---------------------CCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCC
Q 005940 426 LLVYEYIPNGSLDTLLFKPKD---------------------GSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKP 484 (668)
Q Consensus 426 ~lV~E~~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp 484 (668)
++||||+++|+|.+++..... ...+++.+++.++.||+.||.|||+ .+|+||||||
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dikp 178 (314)
T 2ivs_A 102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE---MKLVHRDLAA 178 (314)
T ss_dssp EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHH---TTEECCCCSG
T ss_pred EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHH---CCCcccccch
Confidence 999999999999999964322 2348999999999999999999999 9999999999
Q ss_pred CCEEECCCCCEEEEeecCceeccCCCCC-cccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCch
Q 005940 485 SNALIDAEMNARLGDFGLARLYDHGGMP-HTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVAT-GRRPIGSGDL 562 (668)
Q Consensus 485 ~NIll~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~ 562 (668)
+||+++.++.+||+|||+++........ ......++..|+|||.+.+..++.++|||||||++|||++ |+.||.....
T Consensus 179 ~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 258 (314)
T 2ivs_A 179 RNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPP 258 (314)
T ss_dssp GGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred heEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 9999999999999999999876543321 2233467888999999988889999999999999999999 9999976532
Q ss_pred hHHHHHHHHHhcCccccccCcccCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhccC
Q 005940 563 LLVEWVRECHQLGRILDVADPLLNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSGE 624 (668)
Q Consensus 563 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~~ 624 (668)
... ......... +.....+. ..+..+...|+.. |++||++.||+++|+..
T Consensus 259 ~~~---~~~~~~~~~-----~~~~~~~~----~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~ 309 (314)
T 2ivs_A 259 ERL---FNLLKTGHR-----MERPDNCS----EEMYRLMLQCWKQEPDKRPVFADISKDLEKM 309 (314)
T ss_dssp GGH---HHHHHTTCC-----CCCCTTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHH---HHHhhcCCc-----CCCCccCC----HHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 211 111121111 11111222 2355666788887 99999999999999764
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=327.73 Aligned_cols=252 Identities=23% Similarity=0.343 Sum_probs=204.0
Q ss_pred hcCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCC--chhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEE
Q 005940 352 TKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNS--LQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVY 429 (668)
Q Consensus 352 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 429 (668)
.++|+..+.||+|+||.||+|.+..++..||+|++.... ....+.+.+|++++++++||||+++++++...+..++||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 468999999999999999999998899999999997643 344577889999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCC---EEEEeecCceec
Q 005940 430 EYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMN---ARLGDFGLARLY 506 (668)
Q Consensus 430 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~---~kl~DfGla~~~ 506 (668)
||+++++|.+.+.. ...+++..+..++.|++.||.|||+ .+|+||||||+||+++.++. +||+|||++...
T Consensus 85 e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~ 158 (284)
T 3kk8_A 85 DLVTGGELFEDIVA---REFYSEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 158 (284)
T ss_dssp CCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred ecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEc
Confidence 99999999888853 3458999999999999999999999 99999999999999987665 999999999876
Q ss_pred cCCCCCcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCcccC
Q 005940 507 DHGGMPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLN 586 (668)
Q Consensus 507 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 586 (668)
.... ......||+.|+|||++.+..++.++||||||+++|||++|+.||...+.... ...... .... ...+..
T Consensus 159 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~--~~~~~~-~~~~-~~~~~~- 231 (284)
T 3kk8_A 159 NDSE--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRL--YAQIKA-GAYD-YPSPEW- 231 (284)
T ss_dssp CSSC--BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHH-TCCC-CCTTTT-
T ss_pred ccCc--cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHH--HHHHHh-cccc-CCchhh-
Confidence 5433 22345789999999999998999999999999999999999999976543211 111111 1111 111111
Q ss_pred CcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 587 SSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 587 ~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
.... ..+..+...|+.. |++||+++|++++
T Consensus 232 ~~~~----~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (284)
T 3kk8_A 232 DTVT----PEAKSLIDSMLTVNPKKRITADQALKV 262 (284)
T ss_dssp TTSC----HHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred cccC----HHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 1122 2344566678887 9999999999975
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-39 Score=347.97 Aligned_cols=205 Identities=22% Similarity=0.284 Sum_probs=179.3
Q ss_pred hcCcccceeeeec--CcEEEEEEEeCCCCcEEEEEEEecCC--chhHHHHHHHHHHHhcccccCceeEeeeecccCceEE
Q 005940 352 TKGFKESEVIGIG--GFGSVYKGVLPTTGGEVAVKKITRNS--LQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLL 427 (668)
Q Consensus 352 t~~f~~~~~lG~G--~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l 427 (668)
.++|++.++||+| +||.||+|++..+++.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 103 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV 103 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence 3679999999999 99999999999899999999997653 3445678899999999999999999999999999999
Q ss_pred EEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceecc
Q 005940 428 VYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYD 507 (668)
Q Consensus 428 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~ 507 (668)
||||+++|+|.+++... ....+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||.+....
T Consensus 104 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~ 179 (389)
T 3gni_B 104 VTSFMAYGSAKDLICTH-FMDGMNELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLSMI 179 (389)
T ss_dssp EEECCTTCBHHHHHHHT-CTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCGGGCEECE
T ss_pred EEEccCCCCHHHHHhhh-cccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEcccccceeec
Confidence 99999999999999643 23559999999999999999999999 999999999999999999999999999987543
Q ss_pred CCCC------CcccccccCCcccCcccccC--CCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 005940 508 HGGM------PHTTNVVGTFGYIAPELTQT--GKASTSSDVFAYGILLLEVATGRRPIGSG 560 (668)
Q Consensus 508 ~~~~------~~~~~~~gt~~y~aPE~~~~--~~~~~~sDV~S~Gvvl~elltG~~p~~~~ 560 (668)
.... .......||..|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 240 (389)
T 3gni_B 180 SHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDM 240 (389)
T ss_dssp ETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred cccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCC
Confidence 2211 11223478999999999987 57899999999999999999999999754
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-39 Score=337.08 Aligned_cols=245 Identities=23% Similarity=0.319 Sum_probs=202.4
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCc---hhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEE
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSL---QGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVY 429 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 429 (668)
++|+..+.||+|+||.||+++...+++.||+|++.+... ...+.+.+|+.+++.++||||+++++++.+....++||
T Consensus 6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~ 85 (318)
T 1fot_A 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 85 (318)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence 578899999999999999999988999999999976422 34567889999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCC
Q 005940 430 EYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHG 509 (668)
Q Consensus 430 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~ 509 (668)
||+++|+|.+++.. ...+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 86 e~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~ 159 (318)
T 1fot_A 86 DYIEGGELFSLLRK---SQRFPNPVAKFYAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV 159 (318)
T ss_dssp CCCCSCBHHHHHHH---TSSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred eCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChheEEEcCCCCEEEeecCcceecCCc
Confidence 99999999999963 3458999999999999999999998 99999999999999999999999999999876532
Q ss_pred CCCcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCcccCCcc
Q 005940 510 GMPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSY 589 (668)
Q Consensus 510 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 589 (668)
....+||+.|+|||++.+..++.++|||||||++|||++|+.||...+.. +........ . ..+...+
T Consensus 160 ----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--~~~~~i~~~-~------~~~p~~~ 226 (318)
T 1fot_A 160 ----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM--KTYEKILNA-E------LRFPPFF 226 (318)
T ss_dssp ----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH--HHHHHHHHC-C------CCCCTTS
T ss_pred ----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH--HHHHHHHhC-C------CCCCCCC
Confidence 23458999999999999989999999999999999999999999765322 112222221 1 1111222
Q ss_pred cHHHHHHHHHHHhhcCCC-CCCCC-----CHHHHHHH
Q 005940 590 VVKEMELVLKLGLMCSHK-TQFRP-----TMRQVMRY 620 (668)
Q Consensus 590 ~~~~~~~l~~l~~~C~~~-p~~RP-----s~~evl~~ 620 (668)
. + .+..+...|+.. |++|| +++||+++
T Consensus 227 ~-~---~~~~li~~lL~~dp~~R~~~~~~~~~~i~~h 259 (318)
T 1fot_A 227 N-E---DVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 259 (318)
T ss_dssp C-H---HHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred C-H---HHHHHHHHHhccCHHHcCCCcCCCHHHHhcC
Confidence 2 2 234455577776 99999 89999965
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=340.17 Aligned_cols=254 Identities=24% Similarity=0.340 Sum_probs=194.3
Q ss_pred hcCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCc---hhHHHHHHHHHHHhcccccCceeEeeeecccCc----
Q 005940 352 TKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSL---QGMREFAAEIESLGRLRHKNLVNLHGWCKQKND---- 424 (668)
Q Consensus 352 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~---- 424 (668)
.++|...++||+|+||.||+|.+..+++.||||++..... ...+.+.+|++++++++||||+++++++.....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 3679999999999999999999988999999999976532 345678999999999999999999999876554
Q ss_pred eEEEEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCce
Q 005940 425 LLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLAR 504 (668)
Q Consensus 425 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~ 504 (668)
.++||||+++++|.+++.. ...+++.+++.++.||+.||.|||+ .+|+||||||+||+++.++.+||+|||+++
T Consensus 91 ~~lv~e~~~g~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~ 164 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHT---EGPMTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIAR 164 (311)
T ss_dssp EEEEEECCCEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEETTSCEEECCCSCC-
T ss_pred cEEEEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCCCcCCCCHHHEEEcCCCCEEEeeccCcc
Confidence 4999999999999999963 3468999999999999999999999 999999999999999999999999999998
Q ss_pred eccCCCC--CcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccC
Q 005940 505 LYDHGGM--PHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVAD 582 (668)
Q Consensus 505 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d 582 (668)
....... .......||+.|+|||++.+..++.++|||||||++|||++|+.||........ ............
T Consensus 165 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~--~~~~~~~~~~~~--- 239 (311)
T 3ork_A 165 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV--AYQHVREDPIPP--- 239 (311)
T ss_dssp -----------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHHHHCCCCCH---
T ss_pred cccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH--HHHHhcCCCCCc---
Confidence 7654322 223345789999999999998999999999999999999999999976543322 222222211110
Q ss_pred cccCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 583 PLLNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 583 ~~l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
......+. ..+..+...|+.. |++||+..+++++
T Consensus 240 ~~~~~~~~----~~l~~li~~~l~~dP~~R~~~~~~l~~ 274 (311)
T 3ork_A 240 SARHEGLS----ADLDAVVLKALAKNPENRYQTAAEMRA 274 (311)
T ss_dssp HHHSTTCC----HHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred ccccCCCC----HHHHHHHHHHHhcCHhhChhhHHHHHH
Confidence 00011111 2345666688887 9999977776643
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-39 Score=335.52 Aligned_cols=253 Identities=30% Similarity=0.443 Sum_probs=197.1
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCchhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEEec
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEYI 432 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~ 432 (668)
++|+..+.||+|+||.||+|++ .++.||||++... ...+.|.+|++++++++||||+++++++.+ ..++||||+
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~ 81 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKW--RAKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYA 81 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECC
T ss_pred hHeeeeeEeecCCCceEEEEEE--CCeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcC
Confidence 5688899999999999999998 4788999998654 345789999999999999999999999874 489999999
Q ss_pred CCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCC-EEEEeecCceeccCCCC
Q 005940 433 PNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMN-ARLGDFGLARLYDHGGM 511 (668)
Q Consensus 433 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~-~kl~DfGla~~~~~~~~ 511 (668)
++|+|.+++........+++..++.++.|+++||.|||+....+|+||||||+||+++.++. +||+|||+++.....
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~-- 159 (307)
T 2eva_A 82 EGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH-- 159 (307)
T ss_dssp TTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC---------
T ss_pred CCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc--
Confidence 99999999975443345789999999999999999999854468999999999999998887 799999999765432
Q ss_pred CcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCcccCCcccH
Q 005940 512 PHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSYVV 591 (668)
Q Consensus 512 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 591 (668)
.....||..|+|||++.+..++.++|||||||++|||++|+.||...........+....... +.....+.
T Consensus 160 --~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~------~~~~~~~~- 230 (307)
T 2eva_A 160 --MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTR------PPLIKNLP- 230 (307)
T ss_dssp -------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCC------CCCBTTCC-
T ss_pred --cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCC------CCcccccC-
Confidence 223468999999999998899999999999999999999999997543322222222222111 11111222
Q ss_pred HHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhccCc
Q 005940 592 KEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSGEK 625 (668)
Q Consensus 592 ~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~~~ 625 (668)
..+..+...|+.. |++||+++|+++.|+...
T Consensus 231 ---~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 262 (307)
T 2eva_A 231 ---KPIESLMTRCWSKDPSQRPSMEEIVKIMTHLM 262 (307)
T ss_dssp ---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHG
T ss_pred ---HHHHHHHHHHhcCChhhCcCHHHHHHHHHHHH
Confidence 2345666789887 999999999999998653
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=345.86 Aligned_cols=212 Identities=25% Similarity=0.306 Sum_probs=186.5
Q ss_pred CcccchhhHHHHhcCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCchhHHHHHHHHHHHhccc-----ccCcee
Q 005940 340 PHRFRYKDLYAATKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLR-----HKNLVN 414 (668)
Q Consensus 340 ~~~f~~~el~~at~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~-----H~nIv~ 414 (668)
...+++.+.....++|.+.++||+|+||.||+|++..+++.||||++... ....+.+..|++++++++ ||||++
T Consensus 22 ~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~ 100 (360)
T 3llt_A 22 IVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVK 100 (360)
T ss_dssp GGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCC
T ss_pred ceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeec
Confidence 45667777777788999999999999999999999889999999999753 344567788999999986 999999
Q ss_pred EeeeecccCceEEEEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECC---
Q 005940 415 LHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDA--- 491 (668)
Q Consensus 415 l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~--- 491 (668)
+++++...+..++||||+ +++|.+++... ....+++..++.++.||+.||.|||+ .+|+||||||+|||++.
T Consensus 101 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~ 175 (360)
T 3llt_A 101 YHGKFMYYDHMCLIFEPL-GPSLYEIITRN-NYNGFHIEDIKLYCIEILKALNYLRK---MSLTHTDLKPENILLDDPYF 175 (360)
T ss_dssp EEEEEEETTEEEEEECCC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCTTC
T ss_pred ccceeeECCeeEEEEcCC-CCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCcccEEEccccc
Confidence 999999999999999999 99999999642 23458999999999999999999999 99999999999999976
Q ss_pred ----------------------CCCEEEEeecCceeccCCCCCcccccccCCcccCcccccCCCCCcchhHHHHHHHHHH
Q 005940 492 ----------------------EMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLE 549 (668)
Q Consensus 492 ----------------------~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~e 549 (668)
++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++||
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~e 251 (360)
T 3llt_A 176 EKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAE 251 (360)
T ss_dssp CEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHH
T ss_pred cccccchhcccccccccccccCCCCEEEEeccCceecCCC----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHH
Confidence 788999999999875432 234578999999999999999999999999999999
Q ss_pred HHhCCCCCCCCc
Q 005940 550 VATGRRPIGSGD 561 (668)
Q Consensus 550 lltG~~p~~~~~ 561 (668)
|++|+.||...+
T Consensus 252 ll~g~~pf~~~~ 263 (360)
T 3llt_A 252 LYTGSLLFRTHE 263 (360)
T ss_dssp HHHSSCSCCCSS
T ss_pred HHHCCCCCCCCc
Confidence 999999997653
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=335.72 Aligned_cols=254 Identities=22% Similarity=0.348 Sum_probs=191.9
Q ss_pred hcCcccceeeeecCcEEEEEEEeCCC---CcEEEEEEEecCC-chhHHHHHHHHHHHhcccccCceeEeeeecccCceEE
Q 005940 352 TKGFKESEVIGIGGFGSVYKGVLPTT---GGEVAVKKITRNS-LQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLL 427 (668)
Q Consensus 352 t~~f~~~~~lG~G~~g~Vy~~~~~~~---~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l 427 (668)
.++|...+.||+|+||.||+|.+..+ +..||+|++.... ....+.+.+|+.++++++||||+++++++. .+..++
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~l 92 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 92 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEE
Confidence 35788899999999999999998543 4469999987543 344578999999999999999999999985 467899
Q ss_pred EEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceecc
Q 005940 428 VYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYD 507 (668)
Q Consensus 428 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~ 507 (668)
||||+++++|.+++.. ....+++..++.++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||+++...
T Consensus 93 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 167 (281)
T 1mp8_A 93 IMELCTLGELRSFLQV--RKYSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME 167 (281)
T ss_dssp EEECCTTEEHHHHHHH--TTTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECC--------
T ss_pred EEecCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecccccHHHEEECCCCCEEECccccccccC
Confidence 9999999999999963 23469999999999999999999999 999999999999999999999999999998776
Q ss_pred CCCCCcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCch-hHHHHHHHHHhcCccccccCccc
Q 005940 508 HGGMPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVAT-GRRPIGSGDL-LLVEWVRECHQLGRILDVADPLL 585 (668)
Q Consensus 508 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~-~l~~~~~~~~~~~~~~~~~d~~l 585 (668)
...........+++.|+|||.+....++.++|||||||++|||++ |+.||..... .....+ .. .... .+
T Consensus 168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i---~~-~~~~-----~~ 238 (281)
T 1mp8_A 168 DSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI---EN-GERL-----PM 238 (281)
T ss_dssp -----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH---HT-TCCC-----CC
T ss_pred cccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHH---Hc-CCCC-----CC
Confidence 544333344467789999999988889999999999999999997 9999975432 222211 11 1111 11
Q ss_pred CCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhccC
Q 005940 586 NSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSGE 624 (668)
Q Consensus 586 ~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~~ 624 (668)
...++ ..+..+...|+.. |++||++.|+++.|+..
T Consensus 239 ~~~~~----~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 274 (281)
T 1mp8_A 239 PPNCP----PTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 274 (281)
T ss_dssp CTTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCC----HHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 11222 2345666788887 99999999999999754
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-39 Score=346.48 Aligned_cols=249 Identities=24% Similarity=0.306 Sum_probs=201.9
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCC---chhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEE
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNS---LQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVY 429 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 429 (668)
++|...+.||+|+||.||++.+..+++.||+|++.+.. ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 94 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV 94 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 57889999999999999999999999999999997542 234567889999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCC
Q 005940 430 EYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHG 509 (668)
Q Consensus 430 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~ 509 (668)
||+++|+|..++.. ...+++..+..++.||+.||.|||+ .+|+||||||+||||+.++.+||+|||+++.....
T Consensus 95 e~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 168 (384)
T 4fr4_A 95 DLLLGGDLRYHLQQ---NVHFKEETVKLFICELVMALDYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE 168 (384)
T ss_dssp CCCTTEEHHHHHHT---TCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred ecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCcHHHeEECCCCCEEEeccceeeeccCC
Confidence 99999999999963 3469999999999999999999999 99999999999999999999999999999876543
Q ss_pred CCCcccccccCCcccCcccccC---CCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCcccC
Q 005940 510 GMPHTTNVVGTFGYIAPELTQT---GKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLN 586 (668)
Q Consensus 510 ~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 586 (668)
. .....+||+.|+|||++.. ..++.++|||||||++|||++|+.||................... ....
T Consensus 169 ~--~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~------~~~p 240 (384)
T 4fr4_A 169 T--QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTV------VTYP 240 (384)
T ss_dssp C--CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCC------CCCC
T ss_pred C--ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcc------cCCC
Confidence 2 2345689999999999864 358999999999999999999999997432211111111111111 1111
Q ss_pred CcccHHHHHHHHHHHhhcCCC-CCCCCC-HHHHHH
Q 005940 587 SSYVVKEMELVLKLGLMCSHK-TQFRPT-MRQVMR 619 (668)
Q Consensus 587 ~~~~~~~~~~l~~l~~~C~~~-p~~RPs-~~evl~ 619 (668)
..+. ..+..+...|+.. |++||+ +++|++
T Consensus 241 ~~~s----~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 241 SAWS----QEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp TTSC----HHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred CcCC----HHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 1222 2344556678887 999998 788775
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-40 Score=347.62 Aligned_cols=259 Identities=27% Similarity=0.327 Sum_probs=207.4
Q ss_pred cCcccceeeeecCcEEEEEEE----eCCCCcEEEEEEEecCCchhHHHHHHHHHHHhcccccCceeEeeeec--ccCceE
Q 005940 353 KGFKESEVIGIGGFGSVYKGV----LPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNLHGWCK--QKNDLL 426 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~----~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~--~~~~~~ 426 (668)
++|+..+.||+|+||.||+|+ ...++..||||++........+.+.+|++++++++||||+++++++. +....+
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 102 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR 102 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence 578899999999999999999 45678899999998877777788999999999999999999999886 456689
Q ss_pred EEEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceec
Q 005940 427 LVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLY 506 (668)
Q Consensus 427 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~ 506 (668)
+||||+++++|.+++.. ....+++.+++.++.||+.||.|||+ .+|+||||||+||+++.++.+||+|||+++..
T Consensus 103 lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 177 (327)
T 3lxl_A 103 LVMEYLPSGCLRDFLQR--HRARLDASRLLLYSSQICKGMEYLGS---RRCVHRDLAARNILVESEAHVKIADFGLAKLL 177 (327)
T ss_dssp EEEECCTTCBHHHHHHH--HGGGCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCGGGCEEC
T ss_pred EEEeecCCCCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCChhhEEECCCCCEEEcccccceec
Confidence 99999999999999953 23458999999999999999999999 99999999999999999999999999999977
Q ss_pred cCCCCC--cccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHH------------HHHHHHH
Q 005940 507 DHGGMP--HTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLV------------EWVRECH 572 (668)
Q Consensus 507 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~------------~~~~~~~ 572 (668)
...... ......+|..|+|||++.+..++.++|||||||++|||++|+.||........ .......
T Consensus 178 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (327)
T 3lxl_A 178 PLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELL 257 (327)
T ss_dssp CTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHH
T ss_pred ccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHh
Confidence 544321 12334678889999999888899999999999999999999999864321111 1111111
Q ss_pred hcCccccccCcccCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhccCc
Q 005940 573 QLGRILDVADPLLNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSGEK 625 (668)
Q Consensus 573 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~~~ 625 (668)
..... ......+ ...+..+...|+.. |++||+++|++++|+...
T Consensus 258 ~~~~~-----~~~~~~~----~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~ 302 (327)
T 3lxl_A 258 EEGQR-----LPAPPAC----PAEVHELMKLCWAPSPQDRPSFSALGPQLDMLW 302 (327)
T ss_dssp HTTCC-----CCCCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC-
T ss_pred hcccC-----CCCCCcc----cHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 11110 1111111 23455667789887 999999999999998764
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=356.88 Aligned_cols=248 Identities=31% Similarity=0.409 Sum_probs=200.3
Q ss_pred hcCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCchhHHHHHHHHHHHhcccccCceeEeeeecccC-ceEEEEE
Q 005940 352 TKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNLHGWCKQKN-DLLLVYE 430 (668)
Q Consensus 352 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~-~~~lV~E 430 (668)
.++|...++||+|+||.||+|.+ .++.||||++.... ..+.|.+|++++++++||||++++++|.+.. ..++|||
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~--~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e 267 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 267 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEE
T ss_pred hHHeEEEeeecCcCCeeEEEEEe--cCCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEE
Confidence 35688899999999999999998 47899999997654 4578999999999999999999999986654 7999999
Q ss_pred ecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCC
Q 005940 431 YIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGG 510 (668)
Q Consensus 431 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~ 510 (668)
|+++|+|.+++... ....+++..++.++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 268 ~~~~g~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 343 (450)
T 1k9a_A 268 YMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ 343 (450)
T ss_dssp CCTTCBHHHHHHHH-CTTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTSCEEECCCTTCEECC---
T ss_pred ecCCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHhhEEECCCCCEEEeeCCCcccccccc
Confidence 99999999999642 23457999999999999999999999 999999999999999999999999999998654321
Q ss_pred CCcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCch-hHHHHHHHHHhcCccccccCcccCCc
Q 005940 511 MPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVAT-GRRPIGSGDL-LLVEWVRECHQLGRILDVADPLLNSS 588 (668)
Q Consensus 511 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~-~l~~~~~~~~~~~~~~~~~d~~l~~~ 588 (668)
....++..|+|||++....++.++|||||||++|||++ |+.||..... .... . ...+... .....
T Consensus 344 ----~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~---~-i~~~~~~-----~~p~~ 410 (450)
T 1k9a_A 344 ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVP---R-VEKGYKM-----DAPDG 410 (450)
T ss_dssp -------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHH---H-HHTTCCC-----CCCTT
T ss_pred ----cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH---H-HHcCCCC-----CCCCc
Confidence 12357889999999999999999999999999999998 9999975432 2221 1 1111111 11112
Q ss_pred ccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhccC
Q 005940 589 YVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSGE 624 (668)
Q Consensus 589 ~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~~ 624 (668)
++ ..+..++..|++. |++||++++|++.|+..
T Consensus 411 ~~----~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i 443 (450)
T 1k9a_A 411 CP----PAVYDVMKNCWHLDAATRPTFLQLREQLEHI 443 (450)
T ss_dssp CC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CC----HHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 22 3455667789987 99999999999998754
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=342.60 Aligned_cols=266 Identities=23% Similarity=0.364 Sum_probs=194.0
Q ss_pred hHHHHhcCcccceeeeecCcEEEEEEEeCCCCc---EEEEEEEecC--CchhHHHHHHHHHHHhcccccCceeEeeeecc
Q 005940 347 DLYAATKGFKESEVIGIGGFGSVYKGVLPTTGG---EVAVKKITRN--SLQGMREFAAEIESLGRLRHKNLVNLHGWCKQ 421 (668)
Q Consensus 347 el~~at~~f~~~~~lG~G~~g~Vy~~~~~~~~~---~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~ 421 (668)
++....++|...+.||+|+||.||+|.+..+++ .||||++... .....+++.+|++++++++||||+++++++..
T Consensus 17 ~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 96 (323)
T 3qup_A 17 DVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLR 96 (323)
T ss_dssp TTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEEC
T ss_pred hcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeec
Confidence 333445789999999999999999999876654 8999998764 33456789999999999999999999999977
Q ss_pred cCce------EEEEEecCCCChhhhhcCCC---CCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCC
Q 005940 422 KNDL------LLVYEYIPNGSLDTLLFKPK---DGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAE 492 (668)
Q Consensus 422 ~~~~------~lV~E~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~ 492 (668)
.... ++||||+++|+|.+++.... ....+++.+++.++.||+.||.|||+ .+|+||||||+||+++.+
T Consensus 97 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~---~~ivH~Dikp~NIli~~~ 173 (323)
T 3qup_A 97 SRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSS---RNFIHRDLAARNCMLAED 173 (323)
T ss_dssp C-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTT
T ss_pred cccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHc---CCcccCCCCcceEEEcCC
Confidence 6554 99999999999999985321 22358999999999999999999999 999999999999999999
Q ss_pred CCEEEEeecCceeccCCCC-CcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCchh-HHHHHH
Q 005940 493 MNARLGDFGLARLYDHGGM-PHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVAT-GRRPIGSGDLL-LVEWVR 569 (668)
Q Consensus 493 ~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~-l~~~~~ 569 (668)
+.+||+|||+++....... .......++..|+|||.+.+..++.++|||||||++|||++ |+.||...+.. ...
T Consensus 174 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~--- 250 (323)
T 3qup_A 174 MTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYN--- 250 (323)
T ss_dssp SCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHH---
T ss_pred CCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHH---
Confidence 9999999999987654332 12233456788999999998899999999999999999999 99999764322 211
Q ss_pred HHHhcCccccccCcccCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhccCcCCC
Q 005940 570 ECHQLGRILDVADPLLNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSGEKQLR 628 (668)
Q Consensus 570 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~~~~~~ 628 (668)
.... .... ....... ..+..+...|+.. |++||++.++++.|+....-+
T Consensus 251 ~~~~-~~~~-----~~~~~~~----~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~ 300 (323)
T 3qup_A 251 YLIG-GNRL-----KQPPECM----EEVYDLMYQCWSADPKQRPSFTCLRMELENILGHL 300 (323)
T ss_dssp HHHT-TCCC-----CCCTTCC----HHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred HHhc-CCCC-----CCCCccC----HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 1111 1111 1111122 3456677789987 999999999999999876555
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=330.65 Aligned_cols=253 Identities=26% Similarity=0.402 Sum_probs=205.4
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCchhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEEec
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEYI 432 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~ 432 (668)
++|...+.||+|+||.||+|.+. +++.||+|++..... ..+++.+|++++++++||||+++++++.+.+..++||||+
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (267)
T 3t9t_A 8 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFM 85 (267)
T ss_dssp GGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCC
T ss_pred hheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCC
Confidence 57888999999999999999985 578899999976543 3467899999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCCCC
Q 005940 433 PNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMP 512 (668)
Q Consensus 433 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~~~ 512 (668)
++++|.+++.. ....+++..++.++.|++.||.|||+ .+++||||||+||+++.++.+||+|||+++........
T Consensus 86 ~~~~L~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~ 160 (267)
T 3t9t_A 86 EHGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT 160 (267)
T ss_dssp TTCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHH
T ss_pred CCCcHHHHHhh--CcccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCchheEEECCCCCEEEccccccccccccccc
Confidence 99999999963 23568999999999999999999999 99999999999999999999999999999866443222
Q ss_pred cccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHHHhcCccccccCcccCCcccH
Q 005940 513 HTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVAT-GRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSYVV 591 (668)
Q Consensus 513 ~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 591 (668)
......++..|+|||++....++.++||||||+++|||++ |+.||...... +.......... +.......
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~~~~~i~~~~~------~~~~~~~~- 231 (267)
T 3t9t_A 161 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS--EVVEDISTGFR------LYKPRLAS- 231 (267)
T ss_dssp STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHHHHHHTTCC------CCCCTTSC-
T ss_pred ccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHH--HHHHHHhcCCc------CCCCccCc-
Confidence 2233467788999999988889999999999999999999 89999765322 11122111111 11111111
Q ss_pred HHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhccC
Q 005940 592 KEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSGE 624 (668)
Q Consensus 592 ~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~~ 624 (668)
..+..+...|+.. |++||+++|++++|+..
T Consensus 232 ---~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l 262 (267)
T 3t9t_A 232 ---THVYQIMNHCWRERPEDRPAFSRLLRQLAEI 262 (267)
T ss_dssp ---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---HHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 2345666789887 99999999999999764
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-39 Score=331.53 Aligned_cols=260 Identities=27% Similarity=0.318 Sum_probs=195.7
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCc--hhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEE
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSL--QGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYE 430 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 430 (668)
++|...+.||+|+||.||+|.+ .+++.||||++..... ...+.+.+|++++++++||||+++++++...+..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE 80 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEE
Confidence 4788999999999999999998 5789999999965433 234678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCC
Q 005940 431 YIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGG 510 (668)
Q Consensus 431 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~ 510 (668)
|+++ +|.+++.. ....+++..+..++.||+.||.|||+ .+|+||||||+||+++.++.+||+|||+++......
T Consensus 81 ~~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 154 (288)
T 1ob3_A 81 HLDQ-DLKKLLDV--CEGGLESVTAKSFLLQLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV 154 (288)
T ss_dssp CCSE-EHHHHHHT--STTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred ecCC-CHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEEeECccccccCccc
Confidence 9975 89998863 23568999999999999999999999 999999999999999999999999999998765322
Q ss_pred CCcccccccCCcccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCchh-HHHHHHHHHhcCc------cc--cc
Q 005940 511 MPHTTNVVGTFGYIAPELTQT-GKASTSSDVFAYGILLLEVATGRRPIGSGDLL-LVEWVRECHQLGR------IL--DV 580 (668)
Q Consensus 511 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~-l~~~~~~~~~~~~------~~--~~ 580 (668)
.......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... ....+........ .. ..
T Consensus 155 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (288)
T 1ob3_A 155 -RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPK 233 (288)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred -cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccc
Confidence 12234578999999999875 45899999999999999999999999765321 1111111111100 00 00
Q ss_pred cCcccC-------CcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 581 ADPLLN-------SSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 581 ~d~~l~-------~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
.++... ..........+..+...|+.. |++||+++|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 281 (288)
T 1ob3_A 234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (288)
T ss_dssp CCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 011100 000000112344566678886 9999999999974
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-39 Score=340.96 Aligned_cols=251 Identities=25% Similarity=0.309 Sum_probs=201.4
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCC---chhHHHHHHHHHHHhcc-cccCceeEeeeecccCceEEE
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNS---LQGMREFAAEIESLGRL-RHKNLVNLHGWCKQKNDLLLV 428 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV 428 (668)
++|...+.||+|+||.||+|+++.+++.||||++.+.. ....+.+..|..++.++ +||||+++++++...+..|+|
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 56888999999999999999999899999999997653 23456788999999988 899999999999999999999
Q ss_pred EEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccC
Q 005940 429 YEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDH 508 (668)
Q Consensus 429 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~ 508 (668)
|||+++|+|.+++.. ...+++..++.++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 89 ~e~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~ 162 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQR---QRKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 162 (345)
T ss_dssp ECCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCC
T ss_pred EeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEECCCCCEEEEeccccccccC
Confidence 999999999999953 2459999999999999999999999 9999999999999999999999999999986433
Q ss_pred CCCCcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCch------hHHHHHHHHHhcCccccccC
Q 005940 509 GGMPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDL------LLVEWVRECHQLGRILDVAD 582 (668)
Q Consensus 509 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~------~l~~~~~~~~~~~~~~~~~d 582 (668)
.. ......+||+.|+|||++.+..++.++|||||||++|||++|+.||..... ...+...+.......
T Consensus 163 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~----- 236 (345)
T 3a8x_A 163 PG-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI----- 236 (345)
T ss_dssp TT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCC-----
T ss_pred CC-CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCC-----
Confidence 22 223456899999999999998999999999999999999999999964210 111122222222211
Q ss_pred cccCCcccHHHHHHHHHHHhhcCCC-CCCCCCH------HHHHHH
Q 005940 583 PLLNSSYVVKEMELVLKLGLMCSHK-TQFRPTM------RQVMRY 620 (668)
Q Consensus 583 ~~l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~------~evl~~ 620 (668)
.+...... .+..+...|+.. |++||++ +|++++
T Consensus 237 -~~p~~~s~----~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~h 276 (345)
T 3a8x_A 237 -RIPRSLSV----KAASVLKSFLNKDPKERLGCHPQTGFADIQGH 276 (345)
T ss_dssp -CCCTTSCH----HHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTS
T ss_pred -CCCCCCCH----HHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcC
Confidence 11122222 234455577776 9999995 788765
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=325.23 Aligned_cols=250 Identities=22% Similarity=0.342 Sum_probs=200.9
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCC--chhHHHHHHHHHHHhcccccCceeEeeeeccc--CceEEE
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNS--LQGMREFAAEIESLGRLRHKNLVNLHGWCKQK--NDLLLV 428 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~--~~~~lV 428 (668)
++|...+.||+|+||.||+|++ .+..||||++.... ....++|.+|++++++++||||+++++++... +..++|
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~--~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (271)
T 3kmu_A 10 KQLNFLTKLNENHSGELWKGRW--QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI 87 (271)
T ss_dssp GGCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred HHhHHHHHhcCCCcceEEEEEE--CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence 5688899999999999999998 48899999997653 34557899999999999999999999999876 788999
Q ss_pred EEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCc--eEecCCCCCCEEECCCCCEEEEeecCceec
Q 005940 429 YEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQV--VIHRDVKPSNALIDAEMNARLGDFGLARLY 506 (668)
Q Consensus 429 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~--ivHrDLkp~NIll~~~~~~kl~DfGla~~~ 506 (668)
|||+++|+|.+++.. .....+++.+++.++.||+.||.|||+ .+ |+||||||+||+++.++.++|+|||++...
T Consensus 88 ~e~~~~~~L~~~l~~-~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~ 163 (271)
T 3kmu_A 88 THWMPYGSLYNVLHE-GTNFVVDQSQAVKFALDMARGMAFLHT---LEPLIPRHALNSRSVMIDEDMTARISMADVKFSF 163 (271)
T ss_dssp EECCTTCBHHHHHHS-CSSCCCCHHHHHHHHHHHHHHHHHHTT---SSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTT
T ss_pred ecccCCCcHHHHHhh-cccCCCCHHHHHHHHHHHHHHHHHHhc---CCCceecCCCccceEEEcCCcceeEEeccceeee
Confidence 999999999999974 233469999999999999999999998 78 999999999999999999999999987653
Q ss_pred cCCCCCcccccccCCcccCcccccCCCCCc---chhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCc
Q 005940 507 DHGGMPHTTNVVGTFGYIAPELTQTGKAST---SSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADP 583 (668)
Q Consensus 507 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~ 583 (668)
.. ....||+.|+|||.+.+...+. ++|||||||++|||++|+.||....... .......... .+
T Consensus 164 ~~------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~--~~~~~~~~~~-----~~ 230 (271)
T 3kmu_A 164 QS------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNME--IGMKVALEGL-----RP 230 (271)
T ss_dssp SC------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHH--HHHHHHHSCC-----CC
T ss_pred cc------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHH--HHHHHHhcCC-----CC
Confidence 32 2346899999999988765444 8999999999999999999997643221 1122222111 11
Q ss_pred ccCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhccCc
Q 005940 584 LLNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSGEK 625 (668)
Q Consensus 584 ~l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~~~ 625 (668)
.+....+ ..+..+...|++. |++||+++|+++.|+...
T Consensus 231 ~~~~~~~----~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~ 269 (271)
T 3kmu_A 231 TIPPGIS----PHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ 269 (271)
T ss_dssp CCCTTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred CCCCCCC----HHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 2222222 2355666688887 999999999999997643
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=344.84 Aligned_cols=261 Identities=25% Similarity=0.342 Sum_probs=205.2
Q ss_pred HhcCcccceeeeecCcEEEEEEEe-----CCCCcEEEEEEEecCC-chhHHHHHHHHHHHhcc-cccCceeEeeeecccC
Q 005940 351 ATKGFKESEVIGIGGFGSVYKGVL-----PTTGGEVAVKKITRNS-LQGMREFAAEIESLGRL-RHKNLVNLHGWCKQKN 423 (668)
Q Consensus 351 at~~f~~~~~lG~G~~g~Vy~~~~-----~~~~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~ 423 (668)
..++|...+.||+|+||.||+|++ ..++..||||++.... ....+.+.+|++++.++ +||||+++++++...+
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 122 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 122 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence 346889999999999999999997 2355689999997543 23457899999999999 8999999999999999
Q ss_pred ceEEEEEecCCCChhhhhcCCCC--------------------CCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCC
Q 005940 424 DLLLVYEYIPNGSLDTLLFKPKD--------------------GSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVK 483 (668)
Q Consensus 424 ~~~lV~E~~~~gsL~~~l~~~~~--------------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLk 483 (668)
..++||||+++|+|.+++..... ...+++..++.++.||+.||.|||+ .+|+|||||
T Consensus 123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dik 199 (344)
T 1rjb_A 123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLA 199 (344)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH---TTEEETTCS
T ss_pred ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCC
Confidence 99999999999999999964322 1348999999999999999999999 999999999
Q ss_pred CCCEEECCCCCEEEEeecCceeccCCCCC-cccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCc
Q 005940 484 PSNALIDAEMNARLGDFGLARLYDHGGMP-HTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVAT-GRRPIGSGD 561 (668)
Q Consensus 484 p~NIll~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~ 561 (668)
|+||+++.++.+||+|||+++........ ......+|+.|+|||.+.++.++.++|||||||++|||+| |+.||....
T Consensus 200 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 279 (344)
T 1rjb_A 200 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 279 (344)
T ss_dssp GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred hhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCC
Confidence 99999999999999999999876543322 2334567889999999988899999999999999999998 999997543
Q ss_pred hhHHHHHHHHHhcCccccccCcccCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhccCc
Q 005940 562 LLLVEWVRECHQLGRILDVADPLLNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSGEK 625 (668)
Q Consensus 562 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~~~ 625 (668)
... ........... +......+ ..+..+...|+.. |++||++.||+++|+...
T Consensus 280 ~~~--~~~~~~~~~~~-----~~~~~~~~----~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~ 333 (344)
T 1rjb_A 280 VDA--NFYKLIQNGFK-----MDQPFYAT----EEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQL 333 (344)
T ss_dssp CSH--HHHHHHHTTCC-----CCCCTTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred cHH--HHHHHHhcCCC-----CCCCCCCC----HHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence 211 11111221111 11111111 3355666788887 999999999999998764
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=342.66 Aligned_cols=246 Identities=24% Similarity=0.360 Sum_probs=199.2
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCc---hhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEE
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSL---QGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVY 429 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 429 (668)
.+|...+.||+|+||.||+|.+..+++.||||++.+... ...+.+.+|++++++++||||+++++++...+..++||
T Consensus 9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 88 (336)
T 3h4j_B 9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVI 88 (336)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 578999999999999999999988999999999975422 22357889999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCC
Q 005940 430 EYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHG 509 (668)
Q Consensus 430 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~ 509 (668)
||+ +|+|.+++.. ...+++.+++.++.||+.||.|||+ .+|+||||||+||+++.++.+||+|||++......
T Consensus 89 E~~-~g~l~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~ 161 (336)
T 3h4j_B 89 EYA-GGELFDYIVE---KKRMTEDEGRRFFQQIICAIEYCHR---HKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG 161 (336)
T ss_dssp CCC-CEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHH---HTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS
T ss_pred ECC-CCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCchhhEEEcCCCCEEEEEeccceeccCC
Confidence 999 7889888853 3459999999999999999999999 89999999999999999999999999999876544
Q ss_pred CCCcccccccCCcccCcccccCCCC-CcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCcccCCc
Q 005940 510 GMPHTTNVVGTFGYIAPELTQTGKA-STSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSS 588 (668)
Q Consensus 510 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 588 (668)
.. ....+||+.|+|||++.+..+ +.++|||||||++|||++|+.||...... . ....+... .......
T Consensus 162 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~------~--~~~~i~~~-~~~~p~~ 230 (336)
T 3h4j_B 162 NF--LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIP------N--LFKKVNSC-VYVMPDF 230 (336)
T ss_dssp BT--TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSST------T--CBCCCCSS-CCCCCTT
T ss_pred cc--cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHH------H--HHHHHHcC-CCCCccc
Confidence 32 234579999999999987765 78999999999999999999999653211 0 00011100 0111111
Q ss_pred ccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 589 YVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 589 ~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
.+ . .+..+...|+.. |.+||+++|++++
T Consensus 231 ~s-~---~~~~li~~~L~~dP~~Rpt~~eil~h 259 (336)
T 3h4j_B 231 LS-P---GAQSLIRRMIVADPMQRITIQEIRRD 259 (336)
T ss_dssp SC-H---HHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred CC-H---HHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 22 2 344556688887 9999999999976
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=333.63 Aligned_cols=261 Identities=27% Similarity=0.282 Sum_probs=198.3
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCc--hhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEE
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSL--QGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYE 430 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 430 (668)
++|...++||+|+||.||+|.+..+++.||||++..... ...+.+.+|++++++++||||+++++++...+..++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 578899999999999999999988899999999865433 335678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCC
Q 005940 431 YIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGG 510 (668)
Q Consensus 431 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~ 510 (668)
|+++++|.+++.. ...+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||+++......
T Consensus 83 ~~~~~~l~~~~~~---~~~~~~~~~~~i~~~l~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 156 (311)
T 4agu_A 83 YCDHTVLHELDRY---QRGVPEHLVKSITWQTLQAVNFCHK---HNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPS 156 (311)
T ss_dssp CCSEEHHHHHHHT---SSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred eCCCchHHHHHhh---hcCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc
Confidence 9999999998853 3458999999999999999999999 999999999999999999999999999998765432
Q ss_pred CCcccccccCCcccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCchhH-HHHHHHHH-----------hcCcc
Q 005940 511 MPHTTNVVGTFGYIAPELTQT-GKASTSSDVFAYGILLLEVATGRRPIGSGDLLL-VEWVRECH-----------QLGRI 577 (668)
Q Consensus 511 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l-~~~~~~~~-----------~~~~~ 577 (668)
. ......||..|+|||++.+ ..++.++|||||||++|||++|+.||....... ...+.... .....
T Consensus 157 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (311)
T 4agu_A 157 D-YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQY 235 (311)
T ss_dssp ----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGG
T ss_pred c-ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccc
Confidence 2 2234578999999998875 567999999999999999999999997653221 11111111 00000
Q ss_pred c---cccCcccCCccc---HHHHHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 578 L---DVADPLLNSSYV---VKEMELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 578 ~---~~~d~~l~~~~~---~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
. ...++....... ......+..+...|++. |++||+++|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 236 FSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp GTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred cccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 0 001110000000 01112355677788887 9999999999976
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=335.16 Aligned_cols=205 Identities=31% Similarity=0.447 Sum_probs=164.8
Q ss_pred hcCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCc-hhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEE
Q 005940 352 TKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSL-QGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYE 430 (668)
Q Consensus 352 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 430 (668)
.++|+..+.||+|+||.||+|.+..+++.||||++..... ...+.+.+|++++++++||||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 4678999999999999999999988899999999976543 334678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCC---CCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceecc
Q 005940 431 YIPNGSLDTLLFKP---KDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYD 507 (668)
Q Consensus 431 ~~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~ 507 (668)
|++ |+|.+++... .....+++..+..++.||+.||.|||+ .+|+||||||+||+++.++.+||+|||+++...
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHE---NKILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 998 6999888532 122458999999999999999999999 999999999999999999999999999998765
Q ss_pred CCCCCcccccccCCcccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCc
Q 005940 508 HGGMPHTTNVVGTFGYIAPELTQT-GKASTSSDVFAYGILLLEVATGRRPIGSGD 561 (668)
Q Consensus 508 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~S~Gvvl~elltG~~p~~~~~ 561 (668)
.... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...+
T Consensus 160 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 213 (317)
T 2pmi_A 160 IPVN-TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTN 213 (317)
T ss_dssp SCCC-CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred CCcc-cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 4321 2234578999999999876 468999999999999999999999997653
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=333.79 Aligned_cols=259 Identities=24% Similarity=0.278 Sum_probs=198.9
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCc---hhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEE
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSL---QGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVY 429 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 429 (668)
++|...+.||+|+||.||+|.+..+++.||||++..... ...+.+.+|+.++++++||||+++++++...+..++||
T Consensus 34 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 113 (309)
T 2h34_A 34 GPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDM 113 (309)
T ss_dssp CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEEE
Confidence 679999999999999999999988899999999975432 33477899999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCC
Q 005940 430 EYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHG 509 (668)
Q Consensus 430 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~ 509 (668)
||+++++|.+++.. ...+++.+++.++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||++......
T Consensus 114 e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 187 (309)
T 2h34_A 114 RLINGVDLAAMLRR---QGPLAPPRAVAIVRQIGSALDAAHA---AGATHRDVKPENILVSADDFAYLVDFGIASATTDE 187 (309)
T ss_dssp ECCCCEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSCCC-------
T ss_pred EecCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CcCCcCCCChHHEEEcCCCCEEEecCccCcccccc
Confidence 99999999999963 2458999999999999999999999 99999999999999999999999999999876654
Q ss_pred CCCcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCc-cccccCcccCCc
Q 005940 510 GMPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGR-ILDVADPLLNSS 588 (668)
Q Consensus 510 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~-~~~~~d~~l~~~ 588 (668)
.........|+..|+|||.+.+..++.++||||||+++|||++|+.||...+... ......... ......+ .
T Consensus 188 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~~~~~~~~~~~~~~~~----~ 260 (309)
T 2h34_A 188 KLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSV---MGAHINQAIPRPSTVRP----G 260 (309)
T ss_dssp ---------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHH---HHHHHHSCCCCGGGTST----T
T ss_pred ccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHH---HHHHhccCCCCccccCC----C
Confidence 4333445578999999999998899999999999999999999999997654321 122222111 1111111 1
Q ss_pred ccHHHHHHHHHHHhhcCCC-CCCCC-CHHHHHHHhccCcCCC
Q 005940 589 YVVKEMELVLKLGLMCSHK-TQFRP-TMRQVMRYLSGEKQLR 628 (668)
Q Consensus 589 ~~~~~~~~l~~l~~~C~~~-p~~RP-s~~evl~~L~~~~~~~ 628 (668)
++ ..+..+...|+.. |++|| +++++++.|+......
T Consensus 261 ~~----~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~ 298 (309)
T 2h34_A 261 IP----VAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATA 298 (309)
T ss_dssp CC----THHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC--
T ss_pred CC----HHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhh
Confidence 11 2345566688887 99999 9999999998775443
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=333.30 Aligned_cols=263 Identities=27% Similarity=0.316 Sum_probs=197.9
Q ss_pred HhcCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCc-----hhHHHHHHHHHHHhccc---ccCceeEeeeeccc
Q 005940 351 ATKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSL-----QGMREFAAEIESLGRLR---HKNLVNLHGWCKQK 422 (668)
Q Consensus 351 at~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-----~~~~~f~~Ei~~l~~l~---H~nIv~l~g~~~~~ 422 (668)
.+++|+..++||+|+||+||+|++..+++.||||++..... .....+.+|++++++++ ||||++++++|...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 35789999999999999999999988999999999864321 12345667887777775 99999999999765
Q ss_pred C-----ceEEEEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEE
Q 005940 423 N-----DLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARL 497 (668)
Q Consensus 423 ~-----~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl 497 (668)
. ..++||||+. ++|.+++... ....+++.+++.++.||+.||+|||+ .+|+||||||+||+++.++.+||
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~-~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~Nil~~~~~~~kl 161 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKA-PPPGLPAETIKDLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGTVKL 161 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTC-CTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCTTTEEECTTSCEEE
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCEEE
Confidence 4 4799999996 6999999643 23459999999999999999999999 99999999999999999999999
Q ss_pred EeecCceeccCCCCCcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCch-hHHHHHHHHHhcCc
Q 005940 498 GDFGLARLYDHGGMPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDL-LLVEWVRECHQLGR 576 (668)
Q Consensus 498 ~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~-~l~~~~~~~~~~~~ 576 (668)
+|||+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..... .....+.+......
T Consensus 162 ~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~ 239 (308)
T 3g33_A 162 ADFGLARIYSYQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPP 239 (308)
T ss_dssp CSCSCTTTSTTCC--CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred eeCccccccCCCc--ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 9999998665432 23446789999999999999999999999999999999999999976532 22222222211110
Q ss_pred cccc----------cCcccCC---cccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 577 ILDV----------ADPLLNS---SYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 577 ~~~~----------~d~~l~~---~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
.... ..+.... ....+....+..+...|++. |++||++.|++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 297 (308)
T 3g33_A 240 EDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH 297 (308)
T ss_dssp TTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence 0000 0000000 00001113445566678887 9999999999975
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=337.55 Aligned_cols=260 Identities=25% Similarity=0.386 Sum_probs=206.7
Q ss_pred hcCcccceeeeecCcEEEEEEEeC-------CCCcEEEEEEEecCC-chhHHHHHHHHHHHhcc-cccCceeEeeeeccc
Q 005940 352 TKGFKESEVIGIGGFGSVYKGVLP-------TTGGEVAVKKITRNS-LQGMREFAAEIESLGRL-RHKNLVNLHGWCKQK 422 (668)
Q Consensus 352 t~~f~~~~~lG~G~~g~Vy~~~~~-------~~~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~ 422 (668)
.++|...+.||+|+||.||+|.+. .++..||||++.... ....+.+.+|+++++++ +||||++++++|...
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 113 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 113 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence 367889999999999999999974 356789999997653 34567899999999999 899999999999999
Q ss_pred CceEEEEEecCCCChhhhhcCCCC-------------CCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEE
Q 005940 423 NDLLLVYEYIPNGSLDTLLFKPKD-------------GSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALI 489 (668)
Q Consensus 423 ~~~~lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll 489 (668)
+..++||||+++|+|.+++..... ...+++..++.++.||+.||.|||+ .+|+||||||+||++
T Consensus 114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll 190 (334)
T 2pvf_A 114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLAARNVLV 190 (334)
T ss_dssp SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEE
T ss_pred CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCccceEEE
Confidence 999999999999999999964321 2348999999999999999999999 999999999999999
Q ss_pred CCCCCEEEEeecCceeccCCCCC-cccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCchhHHHH
Q 005940 490 DAEMNARLGDFGLARLYDHGGMP-HTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVAT-GRRPIGSGDLLLVEW 567 (668)
Q Consensus 490 ~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~l~~~ 567 (668)
+.++.+||+|||+++........ ......+|..|+|||++.+..++.++|||||||++|||++ |+.||...... +.
T Consensus 191 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--~~ 268 (334)
T 2pvf_A 191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE--EL 268 (334)
T ss_dssp CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--HH
T ss_pred cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHH--HH
Confidence 99999999999999876543321 2233457889999999988889999999999999999999 99999765322 11
Q ss_pred HHHHHhcCccccccCcccCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhccCcC
Q 005940 568 VRECHQLGRILDVADPLLNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSGEKQ 626 (668)
Q Consensus 568 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~~~~ 626 (668)
...... .... .....+. ..+..+...|+.. |++||+++||++.|+....
T Consensus 269 ~~~~~~-~~~~-----~~~~~~~----~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~ 318 (334)
T 2pvf_A 269 FKLLKE-GHRM-----DKPANCT----NELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 318 (334)
T ss_dssp HHHHHH-TCCC-----CCCTTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHhc-CCCC-----CCCccCC----HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 121111 1111 1111222 2355666789887 9999999999999987643
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=333.11 Aligned_cols=259 Identities=25% Similarity=0.349 Sum_probs=207.0
Q ss_pred hcCcccceeeeecCcEEEEEEEe-----CCCCcEEEEEEEecCCc-hhHHHHHHHHHHHhcc-cccCceeEeeeecccCc
Q 005940 352 TKGFKESEVIGIGGFGSVYKGVL-----PTTGGEVAVKKITRNSL-QGMREFAAEIESLGRL-RHKNLVNLHGWCKQKND 424 (668)
Q Consensus 352 t~~f~~~~~lG~G~~g~Vy~~~~-----~~~~~~vavK~~~~~~~-~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~ 424 (668)
.++|...+.||+|+||.||+|++ ..++..||||++..... ...+.+.+|+++++++ +||||+++++++...+.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 101 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCC
Confidence 35788999999999999999985 34677899999976543 3457899999999999 89999999999999999
Q ss_pred eEEEEEecCCCChhhhhcCCCC---------------CCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEE
Q 005940 425 LLLVYEYIPNGSLDTLLFKPKD---------------GSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALI 489 (668)
Q Consensus 425 ~~lV~E~~~~gsL~~~l~~~~~---------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll 489 (668)
.++||||+++|+|.+++..... ...+++.+++.++.||+.||.|||+ .+|+||||||+||++
T Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~ 178 (313)
T 1t46_A 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILL 178 (313)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEE
T ss_pred cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCccceEEE
Confidence 9999999999999999964321 2258999999999999999999999 999999999999999
Q ss_pred CCCCCEEEEeecCceeccCCCCC-cccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCchhHHHH
Q 005940 490 DAEMNARLGDFGLARLYDHGGMP-HTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVAT-GRRPIGSGDLLLVEW 567 (668)
Q Consensus 490 ~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~l~~~ 567 (668)
+.++.+||+|||+++........ ......+|..|+|||.+.+..++.++|||||||++|||++ |+.||........
T Consensus 179 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~-- 256 (313)
T 1t46_A 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK-- 256 (313)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH--
T ss_pred cCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhH--
Confidence 99999999999999876654322 2233457889999999988899999999999999999999 9999975432111
Q ss_pred HHHHHhcCccccccCcccCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhccC
Q 005940 568 VRECHQLGRILDVADPLLNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSGE 624 (668)
Q Consensus 568 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~~ 624 (668)
......... .+....... ..+..+...|+.. |++||+++|++++|+..
T Consensus 257 ~~~~~~~~~-----~~~~~~~~~----~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 305 (313)
T 1t46_A 257 FYKMIKEGF-----RMLSPEHAP----AEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305 (313)
T ss_dssp HHHHHHHTC-----CCCCCTTSC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHhccCC-----CCCCcccCC----HHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence 111111111 011111112 2355666788887 99999999999999864
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=343.98 Aligned_cols=251 Identities=24% Similarity=0.335 Sum_probs=202.2
Q ss_pred HHhcCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCC---chhHHHHHHHHHHHhcc-cccCceeEeeeecccCce
Q 005940 350 AATKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNS---LQGMREFAAEIESLGRL-RHKNLVNLHGWCKQKNDL 425 (668)
Q Consensus 350 ~at~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~ 425 (668)
...++|...+.||+|+||.||+|+++.+++.||||++.+.. ....+.+..|.+++.++ +||||+++++++.+.+..
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~ 93 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL 93 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence 34578999999999999999999999899999999997642 23446678899999887 899999999999999999
Q ss_pred EEEEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCcee
Q 005940 426 LLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARL 505 (668)
Q Consensus 426 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~ 505 (668)
|+||||+++|+|.+++.. ...+++.++..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++.
T Consensus 94 ~lv~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~ 167 (345)
T 1xjd_A 94 FFVMEYLNGGDLMYHIQS---CHKFDLSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKE 167 (345)
T ss_dssp EEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCChhhEEECCCCCEEEeEChhhhh
Confidence 999999999999999963 2458999999999999999999999 9999999999999999999999999999986
Q ss_pred ccCCCCCcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCccc
Q 005940 506 YDHGGMPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLL 585 (668)
Q Consensus 506 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 585 (668)
..... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||...+... ....... .. +.+
T Consensus 168 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~--~~~~i~~-~~------~~~ 237 (345)
T 1xjd_A 168 NMLGD-AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE--LFHSIRM-DN------PFY 237 (345)
T ss_dssp CCCTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHH-CC------CCC
T ss_pred cccCC-CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHH--HHHHHHh-CC------CCC
Confidence 44322 22345689999999999999899999999999999999999999997654321 1111111 11 111
Q ss_pred CCcccHHHHHHHHHHHhhcCCC-CCCCCCHH-HHHHH
Q 005940 586 NSSYVVKEMELVLKLGLMCSHK-TQFRPTMR-QVMRY 620 (668)
Q Consensus 586 ~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~-evl~~ 620 (668)
..... . .+..+...|+.. |++||++. ||+++
T Consensus 238 p~~~s-~---~~~~li~~lL~~dp~~R~~~~~~i~~h 270 (345)
T 1xjd_A 238 PRWLE-K---EAKDLLVKLFVREPEKRLGVRGDIRQH 270 (345)
T ss_dssp CTTSC-H---HHHHHHHHHSCSSGGGSBTTBSCGGGS
T ss_pred CcccC-H---HHHHHHHHHhcCCHhHcCCChHHHHcC
Confidence 11222 2 234455577776 99999997 77643
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=330.52 Aligned_cols=253 Identities=25% Similarity=0.349 Sum_probs=200.4
Q ss_pred CcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCchhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEEecC
Q 005940 354 GFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEYIP 433 (668)
Q Consensus 354 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~ 433 (668)
+|....+||+|+||.||+|.+..++..||||++........+.+.+|+.++++++||||+++++++...+..++||||++
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 102 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVP 102 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCC
Confidence 45556799999999999999988899999999987766667889999999999999999999999999999999999999
Q ss_pred CCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECC-CCCEEEEeecCceeccCCCCC
Q 005940 434 NGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDA-EMNARLGDFGLARLYDHGGMP 512 (668)
Q Consensus 434 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~-~~~~kl~DfGla~~~~~~~~~ 512 (668)
+++|.+++........+++..+..++.||+.||.|||+ .+|+||||||+||+++. ++.+||+|||+++...... .
T Consensus 103 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~-~ 178 (295)
T 2clq_A 103 GGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHD---NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN-P 178 (295)
T ss_dssp EEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC----
T ss_pred CCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHh---CCEEccCCChhhEEEECCCCCEEEeecccccccCCCC-C
Confidence 99999999754444567899999999999999999999 99999999999999987 8999999999998765432 1
Q ss_pred cccccccCCcccCcccccCCC--CCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCcccCCccc
Q 005940 513 HTTNVVGTFGYIAPELTQTGK--ASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSYV 590 (668)
Q Consensus 513 ~~~~~~gt~~y~aPE~~~~~~--~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 590 (668)
......|+..|+|||++..+. ++.++||||||+++|||++|+.||................ . ..+.+...+.
T Consensus 179 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~-~-----~~~~~~~~~~ 252 (295)
T 2clq_A 179 CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMF-K-----VHPEIPESMS 252 (295)
T ss_dssp --CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHH-C-----CCCCCCTTSC
T ss_pred cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccc-c-----ccccccccCC
Confidence 223457899999999987643 7899999999999999999999996432222111111111 1 1122222222
Q ss_pred HHHHHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 591 VKEMELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 591 ~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
..+..+...|++. |++||+++|++++
T Consensus 253 ----~~~~~li~~~l~~dp~~Rps~~~ll~~ 279 (295)
T 2clq_A 253 ----AEAKAFILKCFEPDPDKRACANDLLVD 279 (295)
T ss_dssp ----HHHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred ----HHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 2344566689887 9999999999974
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=332.68 Aligned_cols=260 Identities=26% Similarity=0.383 Sum_probs=197.8
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecC---CchhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEE
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRN---SLQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVY 429 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 429 (668)
.+|...+.||+|+||.||+|....++..||||++... .....+++.+|++++++++||||+++++++...+..++||
T Consensus 32 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 111 (310)
T 2wqm_A 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 111 (310)
T ss_dssp GGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEE
Confidence 5788999999999999999999888999999999753 2345578899999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCC-CCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccC
Q 005940 430 EYIPNGSLDTLLFKP-KDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDH 508 (668)
Q Consensus 430 E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~ 508 (668)
||+++++|.+++... .....+++..++.++.||+.||.|||+ .+++||||||+||+++.++.+||+|||+++....
T Consensus 112 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~ 188 (310)
T 2wqm_A 112 ELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 188 (310)
T ss_dssp ECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCC--------
T ss_pred ecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCcHHHEEEcCCCCEEEEeccceeeecC
Confidence 999999999998531 124568999999999999999999999 9999999999999999999999999999986654
Q ss_pred CCCCcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCcccCCc
Q 005940 509 GGMPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSS 588 (668)
Q Consensus 509 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 588 (668)
... ......|+..|+|||++.+..++.++||||||+++|||++|+.||................ ...... ....
T Consensus 189 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~----~~~~ 262 (310)
T 2wqm_A 189 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQ-CDYPPL----PSDH 262 (310)
T ss_dssp -----------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHT-TCSCCC----CTTT
T ss_pred CCc-cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhc-ccCCCC----cccc
Confidence 321 2233578999999999998899999999999999999999999997543333333332222 111111 1111
Q ss_pred ccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhccCc
Q 005940 589 YVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSGEK 625 (668)
Q Consensus 589 ~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~~~ 625 (668)
+. ..+..+...|+.. |++||++++|++.|+...
T Consensus 263 ~~----~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~ 296 (310)
T 2wqm_A 263 YS----EELRQLVNMCINPDPEKRPDVTYVYDVAKRMH 296 (310)
T ss_dssp SC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred cC----HHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 22 2345666689887 999999999999998764
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=358.25 Aligned_cols=255 Identities=27% Similarity=0.434 Sum_probs=199.5
Q ss_pred hcCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCchhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEEe
Q 005940 352 TKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEY 431 (668)
Q Consensus 352 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~ 431 (668)
.++|...++||+|+||.||+|.+.. +..||||++..... ..++|.+|++++++++||||+++++++.+ +..++||||
T Consensus 183 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~ 259 (452)
T 1fmk_A 183 RESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 259 (452)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred hhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehh
Confidence 3567889999999999999999954 56799999976543 35789999999999999999999999976 678999999
Q ss_pred cCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCCC
Q 005940 432 IPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGM 511 (668)
Q Consensus 432 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~~ 511 (668)
+++|+|.+++.. ..+..+++.+++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 260 ~~~gsL~~~l~~-~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 335 (452)
T 1fmk_A 260 MSKGSLLDFLKG-ETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 335 (452)
T ss_dssp CTTCBHHHHHSH-HHHTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCTTC-------
T ss_pred hcCCCHHHHHHh-cCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChhhEEECCCCCEEECCCccceecCCCce
Confidence 999999999953 123458999999999999999999999 9999999999999999999999999999987654433
Q ss_pred CcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHHHhcCccccccCcccCCccc
Q 005940 512 PHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVAT-GRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSYV 590 (668)
Q Consensus 512 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 590 (668)
.......++..|+|||++..+.++.++|||||||++|||++ |+.||...... +..... ..+... .....++
T Consensus 336 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~--~~~~~i-~~~~~~-----~~~~~~~ 407 (452)
T 1fmk_A 336 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR--EVLDQV-ERGYRM-----PCPPECP 407 (452)
T ss_dssp -------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--HHHHHH-HTTCCC-----CCCTTSC
T ss_pred ecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHH--HHHHHH-HcCCCC-----CCCCCCC
Confidence 33334467889999999988899999999999999999999 99999764322 111111 111111 1111122
Q ss_pred HHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhccCc
Q 005940 591 VKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSGEK 625 (668)
Q Consensus 591 ~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~~~ 625 (668)
..+..++..|++. |++||++++|++.|+...
T Consensus 408 ----~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~ 439 (452)
T 1fmk_A 408 ----ESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 439 (452)
T ss_dssp ----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred ----HHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence 3455677789997 999999999999998764
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-39 Score=340.22 Aligned_cols=262 Identities=17% Similarity=0.172 Sum_probs=197.6
Q ss_pred cCcccceeeeecCcEEEEEEEeCC---CCcEEEEEEEecCCchh-----------HHHHHHHHHHHhcccccCceeEeee
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPT---TGGEVAVKKITRNSLQG-----------MREFAAEIESLGRLRHKNLVNLHGW 418 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~---~~~~vavK~~~~~~~~~-----------~~~f~~Ei~~l~~l~H~nIv~l~g~ 418 (668)
++|...+.||+|+||.||+|.+.. ++..+|||++....... .+.+..|+..++.++||||++++++
T Consensus 37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~ 116 (345)
T 2v62_A 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS 116 (345)
T ss_dssp CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence 578899999999999999999976 67899999997654321 1346788899999999999999999
Q ss_pred ecc----cCceEEEEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCC-
Q 005940 419 CKQ----KNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEM- 493 (668)
Q Consensus 419 ~~~----~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~- 493 (668)
+.. ....++||||+ +++|.+++... ..+++.+++.++.||+.||.|||+ .+|+||||||+|||++.++
T Consensus 117 ~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~ 189 (345)
T 2v62_A 117 GLTEFKGRSYRFMVMERL-GIDLQKISGQN---GTFKKSTVLQLGIRMLDVLEYIHE---NEYVHGDIKAANLLLGYKNP 189 (345)
T ss_dssp EEEESSSCEEEEEEEECE-EEEHHHHCBGG---GBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEESSST
T ss_pred cccccCCCcEEEEEEecc-CCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCcCHHHEEEccCCC
Confidence 977 67899999999 99999999632 379999999999999999999999 9999999999999999887
Q ss_pred -CEEEEeecCceeccCCCC------CcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC--chhH
Q 005940 494 -NARLGDFGLARLYDHGGM------PHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSG--DLLL 564 (668)
Q Consensus 494 -~~kl~DfGla~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~--~~~l 564 (668)
.+||+|||+++.+..... .......||..|+|||++.+..++.++|||||||++|||++|+.||... +...
T Consensus 190 ~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~ 269 (345)
T 2v62_A 190 DQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVA 269 (345)
T ss_dssp TSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHH
T ss_pred CcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHH
Confidence 999999999987643211 1124457999999999999888999999999999999999999999542 2222
Q ss_pred HHHHHHHHhcCccccccCcccCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhccCc
Q 005940 565 VEWVRECHQLGRILDVADPLLNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSGEK 625 (668)
Q Consensus 565 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~~~ 625 (668)
........... +.............+ ..+..+...|+.. |++||++++|++.|+...
T Consensus 270 ~~~~~~~~~~~-~~~~~~~~~~~~~~~---~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 327 (345)
T 2v62_A 270 VQTAKTNLLDE-LPQSVLKWAPSGSSC---CEIAQFLVCAHSLAYDEKPNYQALKKILNPHG 327 (345)
T ss_dssp HHHHHHHHHHT-TTHHHHHHSCTTSCC---HHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTC
T ss_pred HHHHHHhhccc-ccHHHHhhccccccH---HHHHHHHHHHhhcCcccCCCHHHHHHHHhccC
Confidence 22222222111 111110111000111 2455666688887 999999999999998865
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=340.36 Aligned_cols=245 Identities=23% Similarity=0.293 Sum_probs=203.4
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCc---hhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEE
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSL---QGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVY 429 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 429 (668)
++|...+.||+|+||.||++++..+++.||||++.+... ...+.+.+|++++++++||||+++++++.+....|+||
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 120 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 578899999999999999999988999999999976432 34567889999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCC
Q 005940 430 EYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHG 509 (668)
Q Consensus 430 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~ 509 (668)
||+++|+|.+++.. ...+++..++.++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 121 e~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~ 194 (350)
T 1rdq_E 121 EYVAGGEMFSHLRR---IGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp ECCTTCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred cCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCccceEEECCCCCEEEcccccceeccCC
Confidence 99999999999963 2458999999999999999999999 99999999999999999999999999999876542
Q ss_pred CCCcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCcccCCcc
Q 005940 510 GMPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSY 589 (668)
Q Consensus 510 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 589 (668)
....+||+.|+|||++.+..++.++|||||||++|||++|+.||...+.. +....... +.. .+...+
T Consensus 195 ----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~--~~~~~i~~-~~~------~~p~~~ 261 (350)
T 1rdq_E 195 ----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI--QIYEKIVS-GKV------RFPSHF 261 (350)
T ss_dssp ----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHH-CCC------CCCTTC
T ss_pred ----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHH--HHHHHHHc-CCC------CCCCCC
Confidence 23457999999999999989999999999999999999999999765322 11222221 111 111222
Q ss_pred cHHHHHHHHHHHhhcCCC-CCCCCC-----HHHHHHH
Q 005940 590 VVKEMELVLKLGLMCSHK-TQFRPT-----MRQVMRY 620 (668)
Q Consensus 590 ~~~~~~~l~~l~~~C~~~-p~~RPs-----~~evl~~ 620 (668)
. ..+..+...|++. |++||+ ++||+++
T Consensus 262 ~----~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h 294 (350)
T 1rdq_E 262 S----SDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp C----HHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred C----HHHHHHHHHHhhcCHHhccCCccCCHHHHHhC
Confidence 2 2244555678876 999998 9999875
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=328.94 Aligned_cols=258 Identities=27% Similarity=0.442 Sum_probs=192.3
Q ss_pred hcCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCC--chhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEE
Q 005940 352 TKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNS--LQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVY 429 (668)
Q Consensus 352 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 429 (668)
.++|...++||+|+||.||+|++. ..||||++.... ....+.|.+|++++++++||||+++++++. ....++||
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~~~~~lv~ 98 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAIVT 98 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESS---SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEE
T ss_pred ccceeeeeEecCCCCeEEEEEEEc---CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeecc-CCccEEEE
Confidence 357899999999999999999873 369999986543 345678999999999999999999999764 55689999
Q ss_pred EecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCC
Q 005940 430 EYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHG 509 (668)
Q Consensus 430 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~ 509 (668)
||+++++|.+++.. ....+++..++.++.||+.||.|||+ .+|+||||||+||+++.++.+||+|||+++.....
T Consensus 99 e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~L~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 173 (289)
T 3og7_A 99 QWCEGSSLYHHLHA--SETKFEMKKLIDIARQTARGMDYLHA---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRW 173 (289)
T ss_dssp ECCCEEEHHHHHTT--C---CCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTTEEEECCCC--------
T ss_pred EecCCCcHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHh---CCcccccCccceEEECCCCCEEEccceeccccccc
Confidence 99999999999953 34569999999999999999999999 99999999999999999999999999999865432
Q ss_pred C-CCcccccccCCcccCccccc---CCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCccc
Q 005940 510 G-MPHTTNVVGTFGYIAPELTQ---TGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLL 585 (668)
Q Consensus 510 ~-~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 585 (668)
. ........||..|+|||.+. ...++.++|||||||++|||++|+.||...... +...+............ .+
T Consensus 174 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~-~~ 250 (289)
T 3og7_A 174 SGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR--DQIIEMVGRGSLSPDLS-KV 250 (289)
T ss_dssp ----------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCH--HHHHHHHHHTSCCCCTT-SS
T ss_pred cccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchH--HHHHHHhcccccCcchh-hc
Confidence 2 12233457899999999886 566888999999999999999999999754221 11122222222211111 11
Q ss_pred CCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhccCc
Q 005940 586 NSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSGEK 625 (668)
Q Consensus 586 ~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~~~ 625 (668)
...+. ..+..+...|+.. |++||+++|+++.|+...
T Consensus 251 ~~~~~----~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~ 287 (289)
T 3og7_A 251 RSNCP----KRMKRLMAECLKKKRDERPSFPRILAEIEELA 287 (289)
T ss_dssp CTTSC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred cccCC----HHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence 11222 3455666789887 999999999999998764
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=331.41 Aligned_cols=257 Identities=26% Similarity=0.385 Sum_probs=201.4
Q ss_pred cCcccceeeeecCcEEEEEEE----eCCCCcEEEEEEEecCC-chhHHHHHHHHHHHhcccccCceeEeeeeccc--Cce
Q 005940 353 KGFKESEVIGIGGFGSVYKGV----LPTTGGEVAVKKITRNS-LQGMREFAAEIESLGRLRHKNLVNLHGWCKQK--NDL 425 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~----~~~~~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~--~~~ 425 (668)
+.|+..+.||+|+||.||+|+ ...+++.||||++.... ....+.+.+|++++++++||||+++++++... ...
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 100 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 100 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence 457889999999999999999 45678899999997543 33457889999999999999999999999876 668
Q ss_pred EEEEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCcee
Q 005940 426 LLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARL 505 (668)
Q Consensus 426 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~ 505 (668)
++||||+++|+|.+++.. ....+++.+++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++.
T Consensus 101 ~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 175 (302)
T 4e5w_A 101 KLIMEFLPSGSLKEYLPK--NKNKINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLTKA 175 (302)
T ss_dssp EEEEECCTTCBHHHHHHH--HTTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEEeCCCCcHHHHHHh--ccccCCHHHHHHHHHHHHHHHHHhhc---CCcccCCCchheEEEcCCCCEEECccccccc
Confidence 999999999999999953 23459999999999999999999999 9999999999999999999999999999987
Q ss_pred ccCCCC--CcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCc------------hhHHHHHHHH
Q 005940 506 YDHGGM--PHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGD------------LLLVEWVREC 571 (668)
Q Consensus 506 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~------------~~l~~~~~~~ 571 (668)
...... .......||..|+|||++.+..++.++|||||||++|||++|+.|+.... ..........
T Consensus 176 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (302)
T 4e5w_A 176 IETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNT 255 (302)
T ss_dssp CCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHH
T ss_pred ccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHH
Confidence 765432 12234567888999999988889999999999999999999999864321 0111111111
Q ss_pred HhcCccccccCcccCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhcc
Q 005940 572 HQLGRILDVADPLLNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSG 623 (668)
Q Consensus 572 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~ 623 (668)
....... .....+. ..+..+...|+.. |++||+++|+++.|+.
T Consensus 256 ~~~~~~~-----~~~~~~~----~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 299 (302)
T 4e5w_A 256 LKEGKRL-----PCPPNCP----DEVYQLMRKCWEFQPSNRTSFQNLIEGFEA 299 (302)
T ss_dssp HHTTCCC-----CCCTTCC----HHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred HhccCCC-----CCCCCCC----HHHHHHHHHHcCCCCCCCCCHHHHHHHHHH
Confidence 1111111 1111112 3455677789887 9999999999999975
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=326.08 Aligned_cols=251 Identities=26% Similarity=0.357 Sum_probs=200.9
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCch------hHHHHHHHHHHHhcccccCceeEeeeecccCceE
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQ------GMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLL 426 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~------~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~ 426 (668)
++|...+.||+|+||.||+|.+..+++.||+|++...... ..+.+.+|++++++++||||+++++++.+....+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 4688899999999999999999888999999999764321 3578999999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCC----CEEEEeecC
Q 005940 427 LVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEM----NARLGDFGL 502 (668)
Q Consensus 427 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~----~~kl~DfGl 502 (668)
+||||+++++|.+++.. ...+++.+++.++.||+.||.|||+ .+++||||||+||+++.++ .+||+|||+
T Consensus 85 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~ 158 (283)
T 3bhy_A 85 LILELVSGGELFDFLAE---KESLTEDEATQFLKQILDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGI 158 (283)
T ss_dssp EEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEeecCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCChHHEEEecCCCCCCceEEEeccc
Confidence 99999999999999953 3468999999999999999999999 9999999999999998877 899999999
Q ss_pred ceeccCCCCCcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccC
Q 005940 503 ARLYDHGGMPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVAD 582 (668)
Q Consensus 503 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d 582 (668)
+........ .....|++.|+|||++....++.++||||||+++|||++|+.||...... +..... ...... .+
T Consensus 159 ~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~~-~~~~~~--~~ 231 (283)
T 3bhy_A 159 AHKIEAGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQ--ETLTNI-SAVNYD--FD 231 (283)
T ss_dssp CEECC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHH--HHHHHH-HTTCCC--CC
T ss_pred ceeccCCCc--ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchH--HHHHHh-HhcccC--Cc
Confidence 987654322 23456899999999999889999999999999999999999999765322 111111 111100 01
Q ss_pred cccCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 583 PLLNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 583 ~~l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
+...... ...+..+...|+.. |++||++.|++++
T Consensus 232 ~~~~~~~----~~~~~~li~~~l~~dp~~Rps~~~~l~h 266 (283)
T 3bhy_A 232 EEYFSNT----SELAKDFIRRLLVKDPKRRMTIAQSLEH 266 (283)
T ss_dssp HHHHTTC----CHHHHHHHHTTSCSSGGGSCCHHHHHHC
T ss_pred chhcccC----CHHHHHHHHHHccCCHhHCcCHHHHHhC
Confidence 1100111 13455667789887 9999999999984
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=341.42 Aligned_cols=251 Identities=22% Similarity=0.264 Sum_probs=192.2
Q ss_pred hcCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCchhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEEe
Q 005940 352 TKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEY 431 (668)
Q Consensus 352 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~ 431 (668)
.++|...+.||+|+||.||++.+..+++.||||++..... ..+.+.+|+.++++++||||+++++++...+..++||||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 97 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY 97 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence 3679999999999999999999998999999999976543 336788999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCC--EEEEeecCceeccCC
Q 005940 432 IPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMN--ARLGDFGLARLYDHG 509 (668)
Q Consensus 432 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~--~kl~DfGla~~~~~~ 509 (668)
+++|+|.+++.. ...+++..++.++.||+.||.|||+ .+|+||||||+||+++.++. +||+|||+++.....
T Consensus 98 ~~~~~L~~~l~~---~~~~~~~~~~~i~~ql~~~L~~LH~---~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~ 171 (361)
T 3uc3_A 98 ASGGELYERICN---AGRFSEDEARFFFQQLLSGVSYCHS---MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 171 (361)
T ss_dssp CCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH---TTCCSCCCCGGGEEECSSSSCCEEECCCCCC------
T ss_pred CCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCceEEEeecCcccccccc
Confidence 999999999853 3459999999999999999999999 99999999999999988766 999999999854332
Q ss_pred CCCcccccccCCcccCcccccCCCCCcc-hhHHHHHHHHHHHHhCCCCCCCCc--hhHHHHHHHHHhcCccccccCcccC
Q 005940 510 GMPHTTNVVGTFGYIAPELTQTGKASTS-SDVFAYGILLLEVATGRRPIGSGD--LLLVEWVRECHQLGRILDVADPLLN 586 (668)
Q Consensus 510 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~-sDV~S~Gvvl~elltG~~p~~~~~--~~l~~~~~~~~~~~~~~~~~d~~l~ 586 (668)
. ......||+.|+|||++.+..+..+ +|||||||++|||++|+.||.... ............. ... ..+.
T Consensus 172 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~-~~~-~~~~--- 244 (361)
T 3uc3_A 172 S--QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSV-KYS-IPDD--- 244 (361)
T ss_dssp -----------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTT-CCC-CCTT---
T ss_pred C--CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcC-CCC-CCCc---
Confidence 2 2234579999999999988777655 899999999999999999997532 1222222222211 110 0000
Q ss_pred CcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 587 SSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 587 ~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
.... ..+..+...|+.. |++||+++|++++
T Consensus 245 ~~~s----~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 245 IRIS----PECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp SCCC----HHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred CCCC----HHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 0112 2344566688887 9999999999987
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-39 Score=331.25 Aligned_cols=254 Identities=23% Similarity=0.347 Sum_probs=199.8
Q ss_pred hcCcccceeeeecCcEEEEEEEeCCC---CcEEEEEEEecCC-chhHHHHHHHHHHHhcccccCceeEeeeecccCceEE
Q 005940 352 TKGFKESEVIGIGGFGSVYKGVLPTT---GGEVAVKKITRNS-LQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLL 427 (668)
Q Consensus 352 t~~f~~~~~lG~G~~g~Vy~~~~~~~---~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l 427 (668)
.++|...+.||+|+||.||+|++... +..||+|++.... ....+.+.+|++++++++||||+++++++.+ +..++
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~ 89 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWI 89 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEE
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEE
Confidence 46788999999999999999986432 3469999987653 3456789999999999999999999999875 45789
Q ss_pred EEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceecc
Q 005940 428 VYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYD 507 (668)
Q Consensus 428 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~ 507 (668)
||||+++++|.+++.. ....+++..++.++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||+++...
T Consensus 90 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 164 (281)
T 3cc6_A 90 IMELYPYGELGHYLER--NKNSLKVLTLVLYSLQICKAMAYLES---INCVHRDIAVRNILVASPECVKLGDFGLSRYIE 164 (281)
T ss_dssp EEECCTTCBHHHHHHH--HTTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEEEETTEEEECCCCGGGCC-
T ss_pred EEecCCCCCHHHHHHh--ccccCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCccceEEECCCCcEEeCccCCCcccc
Confidence 9999999999999953 23568999999999999999999999 999999999999999999999999999998766
Q ss_pred CCCCCcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCch-hHHHHHHHHHhcCccccccCccc
Q 005940 508 HGGMPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVAT-GRRPIGSGDL-LLVEWVRECHQLGRILDVADPLL 585 (668)
Q Consensus 508 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~-~l~~~~~~~~~~~~~~~~~d~~l 585 (668)
...........++..|+|||++....++.++||||||+++|||++ |+.||..... .....+. .... .. .
T Consensus 165 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~---~~~~-~~-----~ 235 (281)
T 3cc6_A 165 DEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLE---KGDR-LP-----K 235 (281)
T ss_dssp --------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHH---HTCC-CC-----C
T ss_pred cccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHh---cCCC-CC-----C
Confidence 544333344567889999999988889999999999999999998 9999965422 2222111 1111 11 1
Q ss_pred CCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhccC
Q 005940 586 NSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSGE 624 (668)
Q Consensus 586 ~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~~ 624 (668)
...++ ..+..+...|+.. |++||++.|++++|+..
T Consensus 236 ~~~~~----~~l~~li~~~l~~~p~~Rps~~ell~~L~~~ 271 (281)
T 3cc6_A 236 PDLCP----PVLYTLMTRCWDYDPSDRPRFTELVCSLSDV 271 (281)
T ss_dssp CTTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCC----HHHHHHHHHHccCCchhCcCHHHHHHHHHHH
Confidence 11122 2355666788887 99999999999999764
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=340.34 Aligned_cols=249 Identities=24% Similarity=0.301 Sum_probs=202.1
Q ss_pred hcCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCC---chhHHHHHHHHHHHhcc-cccCceeEeeeecccCceEE
Q 005940 352 TKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNS---LQGMREFAAEIESLGRL-RHKNLVNLHGWCKQKNDLLL 427 (668)
Q Consensus 352 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~l 427 (668)
.++|...+.||+|+||.||+|++..+++.||||++.+.. ....+.+..|.+++..+ +||||+++++++...+..|+
T Consensus 19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 98 (353)
T 2i0e_A 19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 98 (353)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEE
Confidence 367999999999999999999998889999999997642 23456788999999988 79999999999999999999
Q ss_pred EEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceecc
Q 005940 428 VYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYD 507 (668)
Q Consensus 428 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~ 507 (668)
||||+++|+|.+++.. ...+++..++.++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 99 v~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 172 (353)
T 2i0e_A 99 VMEYVNGGDLMYHIQQ---VGRFKEPHAVFYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI 172 (353)
T ss_dssp EEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCEEeccCCHHHEEEcCCCcEEEEeCCcccccc
Confidence 9999999999999963 2459999999999999999999999 999999999999999999999999999998643
Q ss_pred CCCCCcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCcccCC
Q 005940 508 HGGMPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNS 587 (668)
Q Consensus 508 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 587 (668)
... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||...+.. +....... .. ..+..
T Consensus 173 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~--~~~~~i~~-~~------~~~p~ 242 (353)
T 2i0e_A 173 WDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED--ELFQSIME-HN------VAYPK 242 (353)
T ss_dssp CTT-CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHH-CC------CCCCT
T ss_pred cCC-cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHH--HHHHHHHh-CC------CCCCC
Confidence 222 2234568999999999999999999999999999999999999999765422 11122221 11 11111
Q ss_pred cccHHHHHHHHHHHhhcCCC-CCCCCC-----HHHHHHH
Q 005940 588 SYVVKEMELVLKLGLMCSHK-TQFRPT-----MRQVMRY 620 (668)
Q Consensus 588 ~~~~~~~~~l~~l~~~C~~~-p~~RPs-----~~evl~~ 620 (668)
... ..+..+...|+.. |++||+ ++||+++
T Consensus 243 ~~s----~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h 277 (353)
T 2i0e_A 243 SMS----KEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 277 (353)
T ss_dssp TSC----HHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred CCC----HHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 222 2234555577776 999995 6888876
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=328.38 Aligned_cols=247 Identities=25% Similarity=0.385 Sum_probs=199.6
Q ss_pred hcCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCc---hhHHHHHHHHHHHhcccccCceeEeeeecccCceEEE
Q 005940 352 TKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSL---QGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLV 428 (668)
Q Consensus 352 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV 428 (668)
.++|...+.||+|+||.||+|.+..++..||||++..... ...+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 87 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence 4678899999999999999999998899999999965432 2346788999999999999999999999999999999
Q ss_pred EEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccC
Q 005940 429 YEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDH 508 (668)
Q Consensus 429 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~ 508 (668)
|||+++|+|.+++.. ...+++..++.++.||+.||.|||+ .+|+||||||+||+++.++.+||+|||++.....
T Consensus 88 ~e~~~~~~l~~~l~~---~~~~~~~~~~~~~~qi~~~l~~LH~---~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~ 161 (279)
T 3fdn_A 88 LEYAPLGTVYRELQK---LSKFDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS 161 (279)
T ss_dssp ECCCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHT---TTCEECCCCGGGEEECTTSCEEECSCCEESCC--
T ss_pred EecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCEecccCChHhEEEcCCCCEEEEeccccccCCc
Confidence 999999999999853 2458999999999999999999998 9999999999999999999999999999865443
Q ss_pred CCCCcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCcccCCc
Q 005940 509 GGMPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSS 588 (668)
Q Consensus 509 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 588 (668)
. ......|+..|+|||.+.+..++.++||||||+++|||++|+.||...+.... ...... .. ......
T Consensus 162 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~~~~~~-~~------~~~~~~ 229 (279)
T 3fdn_A 162 S---RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET--YKRISR-VE------FTFPDF 229 (279)
T ss_dssp ---------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH--HHHHHH-TC------CCCCTT
T ss_pred c---cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHH--HHHHHh-CC------CCCCCc
Confidence 2 22345789999999999988899999999999999999999999976542211 111111 11 111111
Q ss_pred ccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 589 YVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 589 ~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
.. ..+..+...|++. |++||+++||+++
T Consensus 230 ~~----~~~~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 230 VT----EGARDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp SC----HHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred CC----HHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 12 2344566688887 9999999999985
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=328.81 Aligned_cols=252 Identities=26% Similarity=0.373 Sum_probs=196.9
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCc-hhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEEe
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSL-QGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEY 431 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~ 431 (668)
++|...++||+|+||.||++....++..+|+|++..... ...+.+.+|++++++++||||+++++++.+....++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 101 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET 101 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence 568889999999999999999988899999999976542 3457889999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCC-CCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEE---CCCCCEEEEeecCceecc
Q 005940 432 IPNGSLDTLLFKP-KDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALI---DAEMNARLGDFGLARLYD 507 (668)
Q Consensus 432 ~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll---~~~~~~kl~DfGla~~~~ 507 (668)
+++|+|.+++... ..+..+++..++.++.||+.||.|||+ .+|+||||||+||++ +.++.+||+|||+++...
T Consensus 102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 178 (285)
T 3is5_A 102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK 178 (285)
T ss_dssp CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHh---CCEEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence 9999999988532 123569999999999999999999999 999999999999999 456789999999998765
Q ss_pred CCCCCcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCcccCC
Q 005940 508 HGGMPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNS 587 (668)
Q Consensus 508 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 587 (668)
... ......||..|+|||++. +.++.++|||||||++|||++|+.||......... ........... ....
T Consensus 179 ~~~--~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~--~~~~~~~~~~~----~~~~ 249 (285)
T 3is5_A 179 SDE--HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQ--QKATYKEPNYA----VECR 249 (285)
T ss_dssp ----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH--HHHHHCCCCCC----C--C
T ss_pred Ccc--cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHH--hhhccCCcccc----cccC
Confidence 432 233457899999999885 57899999999999999999999999765422211 11111111000 0001
Q ss_pred cccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 588 SYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 588 ~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
... ..+..+...|+.. |++||+++||+++
T Consensus 250 ~~~----~~~~~li~~~L~~dP~~Rps~~e~l~h 279 (285)
T 3is5_A 250 PLT----PQAVDLLKQMLTKDPERRPSAAQVLHH 279 (285)
T ss_dssp CCC----HHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred cCC----HHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 112 2344566678887 9999999999974
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-39 Score=340.48 Aligned_cols=247 Identities=30% Similarity=0.409 Sum_probs=200.1
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCc---hhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEE
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSL---QGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVY 429 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 429 (668)
+.|...+.||+|+||.||+|+...+++.||||++..... ...+++.+|++++++++||||+++++++...+..++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 458889999999999999999988899999999975432 34467899999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCC
Q 005940 430 EYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHG 509 (668)
Q Consensus 430 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~ 509 (668)
||+. |+|.+++.. ....+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 134 e~~~-g~l~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~ 207 (348)
T 1u5q_A 134 EYCL-GSASDLLEV--HKKPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 207 (348)
T ss_dssp ECCS-EEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB
T ss_pred ecCC-CCHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEeeccCceecCCC
Confidence 9997 688887742 23569999999999999999999999 89999999999999999999999999999865432
Q ss_pred CCCcccccccCCcccCccccc---CCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCcccC
Q 005940 510 GMPHTTNVVGTFGYIAPELTQ---TGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLN 586 (668)
Q Consensus 510 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 586 (668)
....||+.|+|||++. .+.++.++|||||||++|||++|+.||...... +.......... +.+.
T Consensus 208 -----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~--~~~~~~~~~~~------~~~~ 274 (348)
T 1u5q_A 208 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM--SALYHIAQNES------PALQ 274 (348)
T ss_dssp -----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--HHHHHHHHSCC------CCCC
T ss_pred -----CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHhcCC------CCCC
Confidence 2357999999999884 567899999999999999999999999754322 22222222211 1111
Q ss_pred CcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHh
Q 005940 587 SSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYL 621 (668)
Q Consensus 587 ~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L 621 (668)
..... ..+..+...|++. |++||+++|++++.
T Consensus 275 ~~~~~---~~l~~li~~~l~~dP~~Rps~~~ll~h~ 307 (348)
T 1u5q_A 275 SGHWS---EYFRNFVDSCLQKIPQDRPTSEVLLKHR 307 (348)
T ss_dssp CTTSC---HHHHHHHHHHTCSSGGGSCCHHHHTTCH
T ss_pred CCCCC---HHHHHHHHHHcccChhhCcCHHHHhhCh
Confidence 11112 2344566689887 99999999999764
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-39 Score=329.38 Aligned_cols=254 Identities=29% Similarity=0.451 Sum_probs=204.0
Q ss_pred hcCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCchhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEEe
Q 005940 352 TKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEY 431 (668)
Q Consensus 352 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~ 431 (668)
.++|+..+.||+|+||.||+|.+. ++..||||++.... ...+.+.+|++++++++||||+++++++.. +..++||||
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~ 88 (279)
T 1qpc_A 12 RETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEY 88 (279)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred HHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEec
Confidence 367888999999999999999985 56789999997654 335789999999999999999999999874 568999999
Q ss_pred cCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCCC
Q 005940 432 IPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGM 511 (668)
Q Consensus 432 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~~ 511 (668)
+++++|.+++... .+..+++..++.++.|++.||.|||+ .+|+||||||+||++++++.+||+|||+++.......
T Consensus 89 ~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 164 (279)
T 1qpc_A 89 MENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY 164 (279)
T ss_dssp CTTCBHHHHTTSH-HHHTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE
T ss_pred CCCCCHHHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHhhEEEcCCCCEEECCCcccccccCccc
Confidence 9999999999531 12358999999999999999999999 9999999999999999999999999999988765443
Q ss_pred CcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHHHhcCccccccCcccCCccc
Q 005940 512 PHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVAT-GRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSYV 590 (668)
Q Consensus 512 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 590 (668)
.......++..|+|||.+..+.++.++||||||+++|||++ |+.||...... +.......... ......+.
T Consensus 165 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--~~~~~~~~~~~------~~~~~~~~ 236 (279)
T 1qpc_A 165 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP--EVIQNLERGYR------MVRPDNCP 236 (279)
T ss_dssp ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--HHHHHHHTTCC------CCCCTTCC
T ss_pred ccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHH--HHHHHHhcccC------CCCccccc
Confidence 33334467889999999988889999999999999999999 99999754322 11122111111 11111122
Q ss_pred HHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhccC
Q 005940 591 VKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSGE 624 (668)
Q Consensus 591 ~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~~ 624 (668)
..+..+...|+.. |++||+++++++.|+..
T Consensus 237 ----~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 267 (279)
T 1qpc_A 237 ----EELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267 (279)
T ss_dssp ----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----HHHHHHHHHHhccChhhCCCHHHHHHHHHHH
Confidence 3455666788887 99999999999999764
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-39 Score=331.33 Aligned_cols=261 Identities=23% Similarity=0.346 Sum_probs=206.5
Q ss_pred hcCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCC--chhHHHHHHHHHHHhcccccCceeEeeeec--ccCceEE
Q 005940 352 TKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNS--LQGMREFAAEIESLGRLRHKNLVNLHGWCK--QKNDLLL 427 (668)
Q Consensus 352 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~--~~~~~~l 427 (668)
.++|+..+.||+|+||.||++.+..+++.||+|++.... ....+.+.+|++++++++||||+++++++. .....++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 357889999999999999999998899999999997643 344577999999999999999999999874 4678999
Q ss_pred EEEecCCCChhhhhcCCC-CCCCccHHHHHHHHHHHHHHHHHhhhccCCc-----eEecCCCCCCEEECCCCCEEEEeec
Q 005940 428 VYEYIPNGSLDTLLFKPK-DGSVLDWEQRFNIVKGIASGLLYLHEEWEQV-----VIHRDVKPSNALIDAEMNARLGDFG 501 (668)
Q Consensus 428 V~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~-----ivHrDLkp~NIll~~~~~~kl~DfG 501 (668)
||||+++++|.+++.... ....+++..++.++.|++.||.|||+ .+ |+||||||+||+++.++.+||+|||
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg 161 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR---RSDGGHTVLHRDLKPANVFLDGKQNVKLGDFG 161 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---HC------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhc---ccCCCCeeEEeccchhhEEEcCCCCEEEecCc
Confidence 999999999999996421 23459999999999999999999999 67 9999999999999999999999999
Q ss_pred CceeccCCCCCcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCcccccc
Q 005940 502 LARLYDHGGMPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVA 581 (668)
Q Consensus 502 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~ 581 (668)
+++...... .......|+..|+|||.+.+..++.++||||||+++|||++|+.||...+... ... ....+...
T Consensus 162 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~-~i~~~~~~--- 234 (279)
T 2w5a_A 162 LARILNHDT-SFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE--LAG-KIREGKFR--- 234 (279)
T ss_dssp HHHHC---C-HHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHH-HHHHTCCC---
T ss_pred hheeecccc-ccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHH--HHH-HHhhcccc---
Confidence 998765432 12233578999999999998889999999999999999999999997654221 111 12222211
Q ss_pred CcccCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhccCcCCC
Q 005940 582 DPLLNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSGEKQLR 628 (668)
Q Consensus 582 d~~l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~~~~~~ 628 (668)
.+...+. ..+..+...|++. |++||+++||++++....+.+
T Consensus 235 --~~~~~~~----~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~~ 276 (279)
T 2w5a_A 235 --RIPYRYS----DELNEIITRMLNLKDYHRPSVEEILENPLILEHHH 276 (279)
T ss_dssp --CCCTTSC----HHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGGGS
T ss_pred --cCCcccC----HHHHHHHHHHcCCCcccCCCHHHHHhChhhhhhcc
Confidence 1111222 2355666688887 999999999999887665443
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=343.26 Aligned_cols=259 Identities=22% Similarity=0.266 Sum_probs=190.3
Q ss_pred HHHhcCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCchhHHHHHHHHHHHhccc-ccCceeEeeee--------
Q 005940 349 YAATKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLR-HKNLVNLHGWC-------- 419 (668)
Q Consensus 349 ~~at~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~-------- 419 (668)
.....+|+..++||+|+||.||+|.+..+++.||||++........+.+.+|+.++.++. ||||+++++++
T Consensus 24 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 103 (337)
T 3ll6_A 24 ELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESD 103 (337)
T ss_dssp EETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTST
T ss_pred eccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccc
Confidence 334467899999999999999999998899999999998777777788999999999996 99999999998
Q ss_pred cccCceEEEEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCc--eEecCCCCCCEEECCCCCEEE
Q 005940 420 KQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQV--VIHRDVKPSNALIDAEMNARL 497 (668)
Q Consensus 420 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~--ivHrDLkp~NIll~~~~~~kl 497 (668)
......++||||+. |+|.+++........+++..++.++.||+.||.|||+ .+ |+||||||+|||++.++.+||
T Consensus 104 ~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~~~ivH~Dikp~NIl~~~~~~~kl 179 (337)
T 3ll6_A 104 TGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHR---QKPPIIHRDLKVENLLLSNQGTIKL 179 (337)
T ss_dssp TSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHT---SSSCCBCCCCCGGGCEECTTSCEEB
T ss_pred cCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHh---CCCCEEEccCCcccEEECCCCCEEE
Confidence 33445899999995 7999988643345579999999999999999999998 77 999999999999999999999
Q ss_pred EeecCceeccCCCCC-----------cccccccCCcccCcccc---cCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchh
Q 005940 498 GDFGLARLYDHGGMP-----------HTTNVVGTFGYIAPELT---QTGKASTSSDVFAYGILLLEVATGRRPIGSGDLL 563 (668)
Q Consensus 498 ~DfGla~~~~~~~~~-----------~~~~~~gt~~y~aPE~~---~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~ 563 (668)
+|||+++........ ......||+.|+|||++ .+..++.++|||||||++|||++|+.||......
T Consensus 180 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~ 259 (337)
T 3ll6_A 180 CDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL 259 (337)
T ss_dssp CCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC------
T ss_pred ecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHH
Confidence 999999876543211 11234689999999998 5667899999999999999999999999653211
Q ss_pred HHHHHHHHHhcCccccccCcccCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhccCcC
Q 005940 564 LVEWVRECHQLGRILDVADPLLNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSGEKQ 626 (668)
Q Consensus 564 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~~~~ 626 (668)
..... ....... .... ..+..+...|++. |++||+++|++++|+....
T Consensus 260 --~~~~~-----~~~~~~~----~~~~----~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~ 308 (337)
T 3ll6_A 260 --RIVNG-----KYSIPPH----DTQY----TVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAA 308 (337)
T ss_dssp -------------CCCCTT----CCSS----GGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --HhhcC-----cccCCcc----cccc----hHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 10000 0000000 1111 1244566788887 9999999999999987643
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-39 Score=336.53 Aligned_cols=261 Identities=22% Similarity=0.255 Sum_probs=204.4
Q ss_pred hcCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCchhHHHHHHHHHHHhcccccCceeEeeeec----ccCceEE
Q 005940 352 TKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNLHGWCK----QKNDLLL 427 (668)
Q Consensus 352 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~----~~~~~~l 427 (668)
.++|...+.||+|+||.||++....+++.||||++........+.+.+|++++++++||||+++++++. .....++
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 107 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL 107 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence 467999999999999999999998899999999998777777788999999999999999999999986 3457899
Q ss_pred EEEecCCCChhhhhcCC-CCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceec
Q 005940 428 VYEYIPNGSLDTLLFKP-KDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLY 506 (668)
Q Consensus 428 V~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~ 506 (668)
||||+++|+|.+++... ..+..+++.+++.++.||+.||.|||+ .+|+||||||+||+++.++.+||+|||++...
T Consensus 108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~ 184 (317)
T 2buj_A 108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQA 184 (317)
T ss_dssp EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence 99999999999998532 134669999999999999999999999 89999999999999999999999999998765
Q ss_pred cCCCCC--------cccccccCCcccCcccccCCC---CCcchhHHHHHHHHHHHHhCCCCCCCC---chhHHHHHHHHH
Q 005940 507 DHGGMP--------HTTNVVGTFGYIAPELTQTGK---ASTSSDVFAYGILLLEVATGRRPIGSG---DLLLVEWVRECH 572 (668)
Q Consensus 507 ~~~~~~--------~~~~~~gt~~y~aPE~~~~~~---~~~~sDV~S~Gvvl~elltG~~p~~~~---~~~l~~~~~~~~ 572 (668)
...... ......||..|+|||++.... ++.++|||||||++|||++|+.||... ...... ..
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~----~~ 260 (317)
T 2buj_A 185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVAL----AV 260 (317)
T ss_dssp CEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHH----HH
T ss_pred ccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhH----Hh
Confidence 321110 012345799999999987543 689999999999999999999998521 111111 11
Q ss_pred hcCccccccCcccCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhccCcCCC
Q 005940 573 QLGRILDVADPLLNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSGEKQLR 628 (668)
Q Consensus 573 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~~~~~~ 628 (668)
.. .. .. + ....++ ..+..+...|+.. |++||+++||+++|+...+.+
T Consensus 261 ~~-~~-~~--~-~~~~~~----~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~ 308 (317)
T 2buj_A 261 QN-QL-SI--P-QSPRHS----SALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPA 308 (317)
T ss_dssp HC-C---C--C-CCTTSC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCC
T ss_pred hc-cC-CC--C-ccccCC----HHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCC
Confidence 11 00 00 0 011122 2355666788887 999999999999998876433
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=329.16 Aligned_cols=249 Identities=29% Similarity=0.440 Sum_probs=206.2
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCC-chhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEEe
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNS-LQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEY 431 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~ 431 (668)
+.|...+.||+|+||.||+|++..+++.||||++.... ....+.+.+|+.++++++||||+++++++.+....++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 101 (303)
T 3a7i_A 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 101 (303)
T ss_dssp GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEe
Confidence 46888999999999999999998889999999997654 34567899999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCCC
Q 005940 432 IPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGM 511 (668)
Q Consensus 432 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~~ 511 (668)
+++++|.+++.. ..+++..++.++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||++........
T Consensus 102 ~~~~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 174 (303)
T 3a7i_A 102 LGGGSALDLLEP----GPLDETQIATILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI 174 (303)
T ss_dssp CTTEEHHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBC
T ss_pred CCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCChheEEECCCCCEEEeecccceecCcccc
Confidence 999999999952 458999999999999999999999 9999999999999999999999999999987654332
Q ss_pred CcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCcccCCcccH
Q 005940 512 PHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSYVV 591 (668)
Q Consensus 512 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 591 (668)
......|+..|+|||++.+..++.++||||||+++|||++|+.||........ ...... .. .+.+...+.
T Consensus 175 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~~~~~~-~~-----~~~~~~~~~- 244 (303)
T 3a7i_A 175 -KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKV--LFLIPK-NN-----PPTLEGNYS- 244 (303)
T ss_dssp -CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH--HHHHHH-SC-----CCCCCSSCC-
T ss_pred -ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHH--HHHhhc-CC-----CCCCccccC-
Confidence 22345789999999999988999999999999999999999999976432211 111111 11 112222222
Q ss_pred HHHHHHHHHHhhcCCC-CCCCCCHHHHHHHh
Q 005940 592 KEMELVLKLGLMCSHK-TQFRPTMRQVMRYL 621 (668)
Q Consensus 592 ~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L 621 (668)
..+..+...|++. |++||+++|++++.
T Consensus 245 ---~~l~~li~~~l~~dp~~Rps~~~ll~~~ 272 (303)
T 3a7i_A 245 ---KPLKEFVEACLNKEPSFRPTAKELLKHK 272 (303)
T ss_dssp ---HHHHHHHHHHCCSSGGGSCCHHHHTTCH
T ss_pred ---HHHHHHHHHHcCCChhhCcCHHHHhhCh
Confidence 2355666688887 99999999999864
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=326.91 Aligned_cols=249 Identities=25% Similarity=0.386 Sum_probs=182.1
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCc---hhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEE
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSL---QGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVY 429 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 429 (668)
++|...+.||+|+||.||+|++..+++.||||++..... ...+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 90 (278)
T 3cok_A 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVL 90 (278)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEE
Confidence 578899999999999999999988899999999975432 23467899999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCC
Q 005940 430 EYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHG 509 (668)
Q Consensus 430 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~ 509 (668)
||+++++|.+++.. ....+++.+++.++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||++......
T Consensus 91 e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~ 165 (278)
T 3cok_A 91 EMCHNGEMNRYLKN--RVKPFSENEARHFMHQIITGMLYLHS---HGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMP 165 (278)
T ss_dssp ECCTTEEHHHHHHT--CSSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSSCCGGGEEECTTCCEEECCCTTCEECC--
T ss_pred ecCCCCcHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEEEeecceeeccCC
Confidence 99999999999963 33568999999999999999999999 99999999999999999999999999999876543
Q ss_pred CCCcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCcccCCcc
Q 005940 510 GMPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSY 589 (668)
Q Consensus 510 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 589 (668)
.. ......||+.|+|||.+.+..++.++||||||+++|||++|+.||........ ...... .+.......
T Consensus 166 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~------~~~~~~---~~~~~~~~~ 235 (278)
T 3cok_A 166 HE-KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT------LNKVVL---ADYEMPSFL 235 (278)
T ss_dssp ---------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----------CCS---SCCCCCTTS
T ss_pred CC-cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH------HHHHhh---cccCCcccc
Confidence 22 22335789999999999888899999999999999999999999975431100 000000 011111122
Q ss_pred cHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 590 VVKEMELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 590 ~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
. ..+..+...|++. |++||+++|++++
T Consensus 236 ~----~~~~~li~~~l~~dp~~Rps~~~~l~h 263 (278)
T 3cok_A 236 S----IEAKDLIHQLLRRNPADRLSLSSVLDH 263 (278)
T ss_dssp C----HHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred C----HHHHHHHHHHcccCHhhCCCHHHHhcC
Confidence 2 2344566688887 9999999999874
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-39 Score=340.36 Aligned_cols=258 Identities=27% Similarity=0.457 Sum_probs=198.8
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCC----cEEEEEEEecCCc-hhHHHHHHHHHHHhcccccCceeEeeeecccCceEE
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTG----GEVAVKKITRNSL-QGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLL 427 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~----~~vavK~~~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l 427 (668)
++|...+.||+|+||.||+|.+..++ ..||||++..... .....+.+|++++++++||||+++++++...+..++
T Consensus 44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 123 (333)
T 1mqb_A 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 123 (333)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence 46777899999999999999986443 3599999976533 345678999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceecc
Q 005940 428 VYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYD 507 (668)
Q Consensus 428 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~ 507 (668)
||||+++|+|.+++.. ....+++.+++.++.||+.||.|||+ .+|+||||||+||+++.++.+||+|||+++...
T Consensus 124 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~ 198 (333)
T 1mqb_A 124 ITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 198 (333)
T ss_dssp EEECCTTEEHHHHHHH--TTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred EEeCCCCCcHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChheEEECCCCcEEECCCCcchhhc
Confidence 9999999999999963 33569999999999999999999999 999999999999999999999999999998765
Q ss_pred CCCCC--cccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHHHhcCccccccCcc
Q 005940 508 HGGMP--HTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVAT-GRRPIGSGDLLLVEWVRECHQLGRILDVADPL 584 (668)
Q Consensus 508 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 584 (668)
..... ......+|..|+|||++....++.++|||||||++|||++ |+.||...... +.... ...+... .
T Consensus 199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~--~~~~~-~~~~~~~-----~ 270 (333)
T 1mqb_A 199 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH--EVMKA-INDGFRL-----P 270 (333)
T ss_dssp ------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHHHH-HHTTCCC-----C
T ss_pred cccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHH--HHHHH-HHCCCcC-----C
Confidence 43221 1222346788999999998899999999999999999999 99999754322 11111 1111111 1
Q ss_pred cCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhccCcCC
Q 005940 585 LNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSGEKQL 627 (668)
Q Consensus 585 l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~~~~~ 627 (668)
....+. ..+..++..|+.. |++||++.||++.|+.....
T Consensus 271 ~~~~~~----~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~ 310 (333)
T 1mqb_A 271 TPMDCP----SAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 310 (333)
T ss_dssp CCTTCB----HHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred CcccCC----HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 111122 3355667789887 99999999999999876533
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=346.17 Aligned_cols=268 Identities=24% Similarity=0.301 Sum_probs=210.2
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCc-hhHHHHHHHHHHHhcccccCceeEeeeecccC--ceEEEE
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSL-QGMREFAAEIESLGRLRHKNLVNLHGWCKQKN--DLLLVY 429 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~--~~~lV~ 429 (668)
++|...++||+|+||.||+|.+..+++.||||++..... ...+.+.+|++++++++||||+++++++.... ..++||
T Consensus 9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~ 88 (396)
T 4eut_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (396)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEE
Confidence 568899999999999999999998899999999976432 34577889999999999999999999997655 689999
Q ss_pred EecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEE----CCCCCEEEEeecCcee
Q 005940 430 EYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALI----DAEMNARLGDFGLARL 505 (668)
Q Consensus 430 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll----~~~~~~kl~DfGla~~ 505 (668)
||+++|+|.+++........+++..++.++.||+.||.|||+ .+|+||||||+|||+ +.++.+||+|||+++.
T Consensus 89 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~ 165 (396)
T 4eut_A 89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE 165 (396)
T ss_dssp CCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEE
T ss_pred ecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHH---CCEEECCcCHHHEEEeecCCCceeEEEecCCCceE
Confidence 999999999999754444459999999999999999999999 999999999999999 7788899999999987
Q ss_pred ccCCCCCcccccccCCcccCcccccC--------CCCCcchhHHHHHHHHHHHHhCCCCCCCCc--hhHHHHHHHHHhcC
Q 005940 506 YDHGGMPHTTNVVGTFGYIAPELTQT--------GKASTSSDVFAYGILLLEVATGRRPIGSGD--LLLVEWVRECHQLG 575 (668)
Q Consensus 506 ~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~sDV~S~Gvvl~elltG~~p~~~~~--~~l~~~~~~~~~~~ 575 (668)
..... ......||..|+|||++.. ..++.++|||||||++|||++|+.||...+ ....+.........
T Consensus 166 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~ 243 (396)
T 4eut_A 166 LEDDE--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGK 243 (396)
T ss_dssp CCCGG--GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSC
T ss_pred ccCCC--ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCC
Confidence 65432 2234579999999998764 467889999999999999999999996321 11122222222211
Q ss_pred c---ccccc-----------CcccCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhccCc
Q 005940 576 R---ILDVA-----------DPLLNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSGEK 625 (668)
Q Consensus 576 ~---~~~~~-----------d~~l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~~~ 625 (668)
. +.... +..............+..+...|+.. |++||+++|+++.++...
T Consensus 244 p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il 308 (396)
T 4eut_A 244 PSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL 308 (396)
T ss_dssp CTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHH
T ss_pred CcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHh
Confidence 1 00000 00111223355566777777888887 999999999999886543
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=339.67 Aligned_cols=269 Identities=23% Similarity=0.394 Sum_probs=212.8
Q ss_pred cchhhHHHHhcCcccceeeeecCcEEEEEEEeC-----CCCcEEEEEEEecCCc-hhHHHHHHHHHHHhcccccCceeEe
Q 005940 343 FRYKDLYAATKGFKESEVIGIGGFGSVYKGVLP-----TTGGEVAVKKITRNSL-QGMREFAAEIESLGRLRHKNLVNLH 416 (668)
Q Consensus 343 f~~~el~~at~~f~~~~~lG~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~ 416 (668)
+..++.....++|...+.||+|+||.||+|++. .++..||||++..... ....++.+|++++++++||||++++
T Consensus 15 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~ 94 (322)
T 1p4o_A 15 YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLL 94 (322)
T ss_dssp CCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEE
T ss_pred cChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeE
Confidence 444555566788999999999999999999875 3467899999976533 4456789999999999999999999
Q ss_pred eeecccCceEEEEEecCCCChhhhhcCCC-------CCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEE
Q 005940 417 GWCKQKNDLLLVYEYIPNGSLDTLLFKPK-------DGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALI 489 (668)
Q Consensus 417 g~~~~~~~~~lV~E~~~~gsL~~~l~~~~-------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll 489 (668)
+++.+.+..++||||+++|+|.+++.... ....+++..+++++.||+.||.|||+ .+|+||||||+||++
T Consensus 95 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~NIli 171 (322)
T 1p4o_A 95 GVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMV 171 (322)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCSGGGEEE
T ss_pred EEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCCccCCCccceEEE
Confidence 99999999999999999999999985321 12457899999999999999999999 999999999999999
Q ss_pred CCCCCEEEEeecCceeccCCCC-CcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCchhHHHH
Q 005940 490 DAEMNARLGDFGLARLYDHGGM-PHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVAT-GRRPIGSGDLLLVEW 567 (668)
Q Consensus 490 ~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~l~~~ 567 (668)
+.++.+||+|||+++....... .......+|..|+|||++.+..++.++|||||||++|||++ |+.||...+.. +.
T Consensus 172 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--~~ 249 (322)
T 1p4o_A 172 AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE--QV 249 (322)
T ss_dssp CTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH--HH
T ss_pred cCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHH--HH
Confidence 9999999999999986543322 12223456889999999988889999999999999999999 89999764322 11
Q ss_pred HHHHHhcCccccccCcccCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhccCcC
Q 005940 568 VRECHQLGRILDVADPLLNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSGEKQ 626 (668)
Q Consensus 568 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~~~~ 626 (668)
... ........ ...... ..+..+...|+.. |++||++.|++++|+....
T Consensus 250 ~~~-~~~~~~~~-----~~~~~~----~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 250 LRF-VMEGGLLD-----KPDNCP----DMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp HHH-HHTTCCCC-----CCTTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred HHH-HHcCCcCC-----CCCCCC----HHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 111 11121111 111122 2355666788887 9999999999999988754
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-38 Score=323.72 Aligned_cols=252 Identities=24% Similarity=0.332 Sum_probs=202.0
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCC-chhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEEe
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNS-LQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEY 431 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~ 431 (668)
++|+..+.||+|+||.||+|.+..+++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 86 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 86 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEe
Confidence 57889999999999999999998889999999997543 34457889999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCCC
Q 005940 432 IPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGM 511 (668)
Q Consensus 432 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~~ 511 (668)
+++++|.+++.. ...+++..++.++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++........
T Consensus 87 ~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~ 160 (276)
T 2yex_A 87 CSGGELFDRIEP---DIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 160 (276)
T ss_dssp CTTEEGGGGSBT---TTBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred cCCCcHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcc
Confidence 999999999953 3569999999999999999999999 9999999999999999999999999999986543221
Q ss_pred -CcccccccCCcccCcccccCCCC-CcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCcccCCcc
Q 005940 512 -PHTTNVVGTFGYIAPELTQTGKA-STSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSY 589 (668)
Q Consensus 512 -~~~~~~~gt~~y~aPE~~~~~~~-~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 589 (668)
.......|+..|+|||.+.+..+ +.++||||||+++|||++|+.||.........+.. ....... ..+ ....
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~--~~~~~~~--~~~--~~~~ 234 (276)
T 2yex_A 161 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD--WKEKKTY--LNP--WKKI 234 (276)
T ss_dssp ECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHH--HHTTCTT--STT--GGGS
T ss_pred hhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHH--hhhcccc--cCc--hhhc
Confidence 12234578999999999987665 78999999999999999999999754322111111 1111100 000 0111
Q ss_pred cHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 590 VVKEMELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 590 ~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
+ ..+..+...|+.. |++||+++|++++
T Consensus 235 ~----~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (276)
T 2yex_A 235 D----SAPLALLHKILVENPSARITIPDIKKD 262 (276)
T ss_dssp C----HHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred C----HHHHHHHHHHCCCCchhCCCHHHHhcC
Confidence 2 2344566688887 9999999999874
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=332.08 Aligned_cols=266 Identities=24% Similarity=0.326 Sum_probs=208.4
Q ss_pred hhHHHHhcCcccceeeeecCcEEEEEEEe-----CCCCcEEEEEEEecCCc-hhHHHHHHHHHHHhcc-cccCceeEeee
Q 005940 346 KDLYAATKGFKESEVIGIGGFGSVYKGVL-----PTTGGEVAVKKITRNSL-QGMREFAAEIESLGRL-RHKNLVNLHGW 418 (668)
Q Consensus 346 ~el~~at~~f~~~~~lG~G~~g~Vy~~~~-----~~~~~~vavK~~~~~~~-~~~~~f~~Ei~~l~~l-~H~nIv~l~g~ 418 (668)
.+.....++|...+.||+|+||.||+|.+ ..+++.||||++..... ...+.+.+|++++.++ +||||++++++
T Consensus 20 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 99 (316)
T 2xir_A 20 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA 99 (316)
T ss_dssp HHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEE
Confidence 33334457899999999999999999985 34568899999976543 3456789999999999 69999999999
Q ss_pred ecccC-ceEEEEEecCCCChhhhhcCCCC-------------CCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCC
Q 005940 419 CKQKN-DLLLVYEYIPNGSLDTLLFKPKD-------------GSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKP 484 (668)
Q Consensus 419 ~~~~~-~~~lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp 484 (668)
+...+ ..++||||+++|+|.+++..... ...+++..++.++.||+.||.|||+ .+|+||||||
T Consensus 100 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dikp 176 (316)
T 2xir_A 100 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAA 176 (316)
T ss_dssp ECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSG
T ss_pred EecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHh---CCcccccCcc
Confidence 87654 58999999999999999974332 2238999999999999999999999 9999999999
Q ss_pred CCEEECCCCCEEEEeecCceeccCCCC-CcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCch
Q 005940 485 SNALIDAEMNARLGDFGLARLYDHGGM-PHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVAT-GRRPIGSGDL 562 (668)
Q Consensus 485 ~NIll~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~ 562 (668)
+||+++.++.+||+|||+++....... .......+|..|+|||++.+..++.++|||||||++|||++ |+.||.....
T Consensus 177 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~ 256 (316)
T 2xir_A 177 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 256 (316)
T ss_dssp GGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCC
T ss_pred ceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccch
Confidence 999999999999999999987654332 22334567889999999988899999999999999999998 9999975432
Q ss_pred hHHHHHHHHHhcCccccccCcccCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhccCc
Q 005940 563 LLVEWVRECHQLGRILDVADPLLNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSGEK 625 (668)
Q Consensus 563 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~~~ 625 (668)
.. ........+... ....... ..+..+...|++. |++||++.||+++|+...
T Consensus 257 ~~--~~~~~~~~~~~~-----~~~~~~~----~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 309 (316)
T 2xir_A 257 DE--EFCRRLKEGTRM-----RAPDYTT----PEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 309 (316)
T ss_dssp SH--HHHHHHHHTCCC-----CCCTTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred hH--HHHHHhccCccC-----CCCCCCC----HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 11 111111111111 1111122 2345666689887 999999999999998653
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=334.72 Aligned_cols=248 Identities=23% Similarity=0.323 Sum_probs=191.6
Q ss_pred cCcccceeeeecCcEEEEEEEeC---CCCcEEEEEEEecCC----chhHHHHHHHHHHHhcccccCceeEeeeecccCce
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLP---TTGGEVAVKKITRNS----LQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDL 425 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~---~~~~~vavK~~~~~~----~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~ 425 (668)
++|...+.||+|+||.||+++.. .+++.||+|++.+.. ......+.+|++++++++||||+++++++...+..
T Consensus 17 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 96 (327)
T 3a62_A 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKL 96 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCE
T ss_pred HHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEE
Confidence 57889999999999999999974 578899999997643 23345678999999999999999999999999999
Q ss_pred EEEEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCcee
Q 005940 426 LLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARL 505 (668)
Q Consensus 426 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~ 505 (668)
++||||+++|+|.+++.. ...+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++.
T Consensus 97 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~ 170 (327)
T 3a62_A 97 YLILEYLSGGELFMQLER---EGIFMEDTACFYLAEISMALGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKE 170 (327)
T ss_dssp EEEEECCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCTTTEEECTTSCEEECCCSCC--
T ss_pred EEEEeCCCCCcHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHh---CCEEcccCCHHHeEECCCCcEEEEeCCcccc
Confidence 999999999999999953 3458999999999999999999999 9999999999999999999999999999986
Q ss_pred ccCCCCCcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCccc
Q 005940 506 YDHGGMPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLL 585 (668)
Q Consensus 506 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 585 (668)
..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...+.. +........ . ..+
T Consensus 171 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--~~~~~i~~~-~------~~~ 240 (327)
T 3a62_A 171 SIHDG-TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRK--KTIDKILKC-K------LNL 240 (327)
T ss_dssp ---------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHHT-C------CCC
T ss_pred cccCC-ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHH--HHHHHHHhC-C------CCC
Confidence 44322 1233457999999999999889999999999999999999999999765322 111222211 1 111
Q ss_pred CCcccHHHHHHHHHHHhhcCCC-CCCCC-----CHHHHHHH
Q 005940 586 NSSYVVKEMELVLKLGLMCSHK-TQFRP-----TMRQVMRY 620 (668)
Q Consensus 586 ~~~~~~~~~~~l~~l~~~C~~~-p~~RP-----s~~evl~~ 620 (668)
..... ..+..+...|+.. |++|| +++|++++
T Consensus 241 p~~~~----~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~h 277 (327)
T 3a62_A 241 PPYLT----QEARDLLKKLLKRNAASRLGAGPGDAGEVQAH 277 (327)
T ss_dssp CTTSC----HHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred CCCCC----HHHHHHHHHHHhcCHhhccCCCCCCHHHHHcC
Confidence 11122 2344555678887 99999 88899876
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=338.30 Aligned_cols=252 Identities=26% Similarity=0.317 Sum_probs=198.2
Q ss_pred hcCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCchhHHHHHHHHHHHhcc-cccCceeEeeeecccCceEEEEE
Q 005940 352 TKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRL-RHKNLVNLHGWCKQKNDLLLVYE 430 (668)
Q Consensus 352 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~E 430 (668)
.++|...+.||+|+||.||+|.++.+++.||||++.+.... ..+|++++.++ +||||+++++++.+....|+|||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~----~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E 96 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD----PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTE 96 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC----CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC----hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEe
Confidence 45789999999999999999999989999999999765432 34688888888 79999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCC----CCEEEEeecCceec
Q 005940 431 YIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAE----MNARLGDFGLARLY 506 (668)
Q Consensus 431 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~----~~~kl~DfGla~~~ 506 (668)
|+++|+|.+++.. ...+++..+..++.||+.||.|||+ .+|+||||||+|||+..+ +.+||+|||+++..
T Consensus 97 ~~~gg~L~~~i~~---~~~~~~~~~~~~~~qi~~al~~lH~---~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~ 170 (342)
T 2qr7_A 97 LMKGGELLDKILR---QKFFSEREASAVLFTITKTVEYLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQL 170 (342)
T ss_dssp CCCSCBHHHHHHT---CTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEEC
T ss_pred CCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccC
Confidence 9999999999963 3469999999999999999999999 999999999999998543 34999999999876
Q ss_pred cCCCCCcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCcccC
Q 005940 507 DHGGMPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLN 586 (668)
Q Consensus 507 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 586 (668)
..... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||..........+......+.... .....
T Consensus 171 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~--~~~~~ 247 (342)
T 2qr7_A 171 RAENG-LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSL--SGGYW 247 (342)
T ss_dssp BCTTC-CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCC--CSTTT
T ss_pred cCCCC-ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCccc--Ccccc
Confidence 54332 2334578999999999988788999999999999999999999997532111112222222222111 11111
Q ss_pred CcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 587 SSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 587 ~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
.... + .+..+...|+.. |++||++.|++++
T Consensus 248 ~~~s-~---~~~~li~~~L~~dP~~R~t~~~il~h 278 (342)
T 2qr7_A 248 NSVS-D---TAKDLVSKMLHVDPHQRLTAALVLRH 278 (342)
T ss_dssp TTSC-H---HHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred ccCC-H---HHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 1122 2 234555577776 9999999999975
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=340.60 Aligned_cols=256 Identities=15% Similarity=0.095 Sum_probs=199.4
Q ss_pred hhHHHHhcCcccceeeeecCcEEEEEEE-----eCCCCcEEEEEEEecCCchhHHHHHHHHHHHhccc---ccCceeEee
Q 005940 346 KDLYAATKGFKESEVIGIGGFGSVYKGV-----LPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLR---HKNLVNLHG 417 (668)
Q Consensus 346 ~el~~at~~f~~~~~lG~G~~g~Vy~~~-----~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~---H~nIv~l~g 417 (668)
.++....++|...++||+|+||.||+|+ ...+++.||||++.... ..++..|++++.+++ |+||+++++
T Consensus 58 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~~~ 134 (365)
T 3e7e_A 58 TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFYS 134 (365)
T ss_dssp CEEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCEEE
T ss_pred eeEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhhhe
Confidence 3444456789999999999999999994 55678899999997654 345667777777775 999999999
Q ss_pred eecccCceEEEEEecCCCChhhhhcCC--CCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECC----
Q 005940 418 WCKQKNDLLLVYEYIPNGSLDTLLFKP--KDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDA---- 491 (668)
Q Consensus 418 ~~~~~~~~~lV~E~~~~gsL~~~l~~~--~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~---- 491 (668)
++...+..++||||+++|+|.+++... .....+++..++.++.||+.||.|||+ .+|+||||||+||||+.
T Consensus 135 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~---~~ivHrDiKp~NIll~~~~~~ 211 (365)
T 3e7e_A 135 AHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHD---CEIIHGDIKPDNFILGNGFLE 211 (365)
T ss_dssp EEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECGGGTC
T ss_pred eeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhh---CCeecCCCCHHHEEecccccC
Confidence 999999999999999999999999531 134569999999999999999999998 99999999999999998
Q ss_pred -------CCCEEEEeecCceeccCC-CCCcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchh
Q 005940 492 -------EMNARLGDFGLARLYDHG-GMPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLL 563 (668)
Q Consensus 492 -------~~~~kl~DfGla~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~ 563 (668)
++.+||+|||+++..... ........+||..|+|||++.+..++.++|||||||++|||++|+.||...+..
T Consensus 212 ~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~ 291 (365)
T 3e7e_A 212 QDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGG 291 (365)
T ss_dssp C------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETT
T ss_pred ccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCC
Confidence 899999999999865422 222344568999999999999989999999999999999999999998532110
Q ss_pred HHHHHHHHHhcCccccccCcccCCcccHHHHHHHHHHHhhcCCC-CCCC-CCHHHHHHHhccC
Q 005940 564 LVEWVRECHQLGRILDVADPLLNSSYVVKEMELVLKLGLMCSHK-TQFR-PTMRQVMRYLSGE 624 (668)
Q Consensus 564 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~-p~~R-Ps~~evl~~L~~~ 624 (668)
.......+......++...+ ...|+.. |.+| |+++++.+.|+..
T Consensus 292 --------------~~~~~~~~~~~~~~~~~~~~---~~~~l~~~p~~r~~~~~~l~~~l~~~ 337 (365)
T 3e7e_A 292 --------------ECKPEGLFRRLPHLDMWNEF---FHVMLNIPDCHHLPSLDLLRQKLKKV 337 (365)
T ss_dssp --------------EEEECSCCTTCSSHHHHHHH---HHHHHCCCCTTCCCCHHHHHHHHHHH
T ss_pred --------------ceeechhccccCcHHHHHHH---HHHHcCCCCCCcchHHHHHHHHHHHH
Confidence 00111222222234444443 3455555 6665 8888888887754
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-39 Score=338.23 Aligned_cols=246 Identities=25% Similarity=0.287 Sum_probs=177.3
Q ss_pred ceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCchhHHHHHHHHHHHhccc-ccCceeEeeeecccCceEEEEEecCCCC
Q 005940 358 SEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLR-HKNLVNLHGWCKQKNDLLLVYEYIPNGS 436 (668)
Q Consensus 358 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~lV~E~~~~gs 436 (668)
.+.||+|+||.||+|.+..+++.||||++.+. ....+.+|+.++++++ ||||+++++++.+....++||||+++|+
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 92 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE 92 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence 47899999999999999989999999999754 3456778999999997 9999999999999999999999999999
Q ss_pred hhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCC---CEEEEeecCceeccCCCCCc
Q 005940 437 LDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEM---NARLGDFGLARLYDHGGMPH 513 (668)
Q Consensus 437 L~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~---~~kl~DfGla~~~~~~~~~~ 513 (668)
|.+++.. ...+++.+++.++.||+.||.|||+ .+|+||||||+||+++.++ .+||+|||+++....... .
T Consensus 93 L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~-~ 165 (325)
T 3kn6_A 93 LFERIKK---KKHFSETEASYIMRKLVSAVSHMHD---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ-P 165 (325)
T ss_dssp HHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC-----
T ss_pred HHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC-c
Confidence 9999963 3569999999999999999999999 9999999999999997765 799999999987654332 2
Q ss_pred ccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchh-----HHHHHHHHHhcCccccccCcccCCc
Q 005940 514 TTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLL-----LVEWVRECHQLGRILDVADPLLNSS 588 (668)
Q Consensus 514 ~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~-----l~~~~~~~~~~~~~~~~~d~~l~~~ 588 (668)
.....||..|+|||++.+..++.++|||||||++|||++|+.||...+.. ..+ .......+.. .....
T Consensus 166 ~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~-~~~~i~~~~~------~~~~~ 238 (325)
T 3kn6_A 166 LKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVE-IMKKIKKGDF------SFEGE 238 (325)
T ss_dssp ------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHH-HHHHHTTTCC------CCCSH
T ss_pred ccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHH-HHHHHHcCCC------CCCcc
Confidence 33457899999999999989999999999999999999999999754211 111 1111211111 11111
Q ss_pred ccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 589 YVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 589 ~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
........+..+...|++. |++||+++|++++
T Consensus 239 ~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 271 (325)
T 3kn6_A 239 AWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYN 271 (325)
T ss_dssp HHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred cccCCCHHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence 0001123345566678776 9999999999864
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=326.72 Aligned_cols=254 Identities=23% Similarity=0.327 Sum_probs=202.4
Q ss_pred cCcccce-eeeecCcEEEEEEEeC--CCCcEEEEEEEecCC-chhHHHHHHHHHHHhcccccCceeEeeeecccCceEEE
Q 005940 353 KGFKESE-VIGIGGFGSVYKGVLP--TTGGEVAVKKITRNS-LQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLV 428 (668)
Q Consensus 353 ~~f~~~~-~lG~G~~g~Vy~~~~~--~~~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV 428 (668)
++|...+ .||+|+||.||+|++. .++..||||++.... ....+++.+|++++++++||||+++++++ ..+..++|
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv 87 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV 87 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence 4555665 8999999999999863 357789999997653 34567899999999999999999999999 45679999
Q ss_pred EEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccC
Q 005940 429 YEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDH 508 (668)
Q Consensus 429 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~ 508 (668)
|||+++++|.+++.. ....+++..++.++.||+.||.|||+ .+|+||||||+||+++.++.+||+|||+++....
T Consensus 88 ~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~ 162 (287)
T 1u59_A 88 MEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGA 162 (287)
T ss_dssp EECCTTEEHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred EEeCCCCCHHHHHHh--CCccCCHHHHHHHHHHHHHHHHHHHH---CCEeeCCCchheEEEcCCCCEEECcccceeeecc
Confidence 999999999999953 34569999999999999999999999 9999999999999999999999999999987754
Q ss_pred CCCC--cccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHHHhcCccccccCccc
Q 005940 509 GGMP--HTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVAT-GRRPIGSGDLLLVEWVRECHQLGRILDVADPLL 585 (668)
Q Consensus 509 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 585 (668)
.... ......+|..|+|||++.+..++.++|||||||++|||++ |+.||....... .... ...... +..
T Consensus 163 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--~~~~-i~~~~~-----~~~ 234 (287)
T 1u59_A 163 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE--VMAF-IEQGKR-----MEC 234 (287)
T ss_dssp CSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH--HHHH-HHTTCC-----CCC
T ss_pred CcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH--HHHH-HhcCCc-----CCC
Confidence 3321 1223356889999999988889999999999999999998 999997653221 1111 111111 111
Q ss_pred CCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhccC
Q 005940 586 NSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSGE 624 (668)
Q Consensus 586 ~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~~ 624 (668)
...++ ..+..+...|+.. |++||+++|++++|+..
T Consensus 235 ~~~~~----~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 270 (287)
T 1u59_A 235 PPECP----PELYALMSDCWIYKWEDRPDFLTVEQRMRAC 270 (287)
T ss_dssp CTTCC----HHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCcC----HHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 11222 3455666789987 99999999999999765
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=336.22 Aligned_cols=262 Identities=25% Similarity=0.353 Sum_probs=207.3
Q ss_pred HHHhcCcccceeeeecCcEEEEEEEeCCCCc-----EEEEEEEecCCc-hhHHHHHHHHHHHhcc-cccCceeEeeeecc
Q 005940 349 YAATKGFKESEVIGIGGFGSVYKGVLPTTGG-----EVAVKKITRNSL-QGMREFAAEIESLGRL-RHKNLVNLHGWCKQ 421 (668)
Q Consensus 349 ~~at~~f~~~~~lG~G~~g~Vy~~~~~~~~~-----~vavK~~~~~~~-~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~ 421 (668)
....++|...+.||+|+||.||+|.+..++. .||+|++..... ...+.+.+|+++++++ +||||++++++|.+
T Consensus 42 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 121 (333)
T 2i1m_A 42 EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTH 121 (333)
T ss_dssp BCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEec
Confidence 3345789999999999999999999865554 799999976543 4457799999999999 89999999999999
Q ss_pred cCceEEEEEecCCCChhhhhcCCC-----------CCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEEC
Q 005940 422 KNDLLLVYEYIPNGSLDTLLFKPK-----------DGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALID 490 (668)
Q Consensus 422 ~~~~~lV~E~~~~gsL~~~l~~~~-----------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~ 490 (668)
.+..++||||+++|+|.+++.... ....+++..++.++.||+.||.|||+ .+|+||||||+||+++
T Consensus 122 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~NIl~~ 198 (333)
T 2i1m_A 122 GGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLAS---KNCIHRDVAARNVLLT 198 (333)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGCEEE
T ss_pred CCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhc---CCcccCCcccceEEEC
Confidence 999999999999999999985321 13458999999999999999999999 9999999999999999
Q ss_pred CCCCEEEEeecCceeccCCCCC-cccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHH
Q 005940 491 AEMNARLGDFGLARLYDHGGMP-HTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVAT-GRRPIGSGDLLLVEWV 568 (668)
Q Consensus 491 ~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~l~~~~ 568 (668)
.++.+||+|||+++........ ......+|..|+|||.+.+..++.++|||||||++|||++ |..||........ .
T Consensus 199 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~--~ 276 (333)
T 2i1m_A 199 NGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK--F 276 (333)
T ss_dssp GGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHH--H
T ss_pred CCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHH--H
Confidence 9999999999999866543221 2233467889999999988899999999999999999999 9999975432111 1
Q ss_pred HHHHhcCccccccCcccCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhccC
Q 005940 569 RECHQLGRILDVADPLLNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSGE 624 (668)
Q Consensus 569 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~~ 624 (668)
......... ....... + ..+..+...|++. |++||+++||+++|+..
T Consensus 277 ~~~~~~~~~-----~~~~~~~-~---~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~ 324 (333)
T 2i1m_A 277 YKLVKDGYQ-----MAQPAFA-P---KNIYSIMQACWALEPTHRPTFQQICSFLQEQ 324 (333)
T ss_dssp HHHHHHTCC-----CCCCTTC-C---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHhcCCC-----CCCCCCC-C---HHHHHHHHHHhccChhhCcCHHHHHHHHHHH
Confidence 111111111 1111111 1 2355666789887 99999999999999754
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=350.07 Aligned_cols=247 Identities=27% Similarity=0.445 Sum_probs=203.1
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCc---hhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEE
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSL---QGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVY 429 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 429 (668)
.+|...+.||+|+||.||+|++..+|+.||||++.+... ...+.+.+|++++++++||||+++++++...+..++||
T Consensus 16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 95 (476)
T 2y94_A 16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM 95 (476)
T ss_dssp TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 578899999999999999999988999999999976432 23467899999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCC
Q 005940 430 EYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHG 509 (668)
Q Consensus 430 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~ 509 (668)
||+++|+|.+++.. ...+++..++.++.||+.||.|||+ .+|+||||||+|||++.++++||+|||+++.....
T Consensus 96 E~~~gg~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~ 169 (476)
T 2y94_A 96 EYVSGGELFDYICK---NGRLDEKESRRLFQQILSGVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG 169 (476)
T ss_dssp ECCSSEEHHHHTTS---SSSCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCSGGGEEECTTCCEEECCCSSCEECCTT
T ss_pred eCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCCCcccccHHHEEEecCCCeEEEeccchhhcccc
Confidence 99999999999953 3569999999999999999999998 99999999999999999999999999999987654
Q ss_pred CCCcccccccCCcccCcccccCCCC-CcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCcccCCc
Q 005940 510 GMPHTTNVVGTFGYIAPELTQTGKA-STSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSS 588 (668)
Q Consensus 510 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 588 (668)
.. ....+||+.|+|||++.+..+ +.++|||||||++|||++|+.||...... ....... .+.. .....
T Consensus 170 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~--~~~~~i~-~~~~------~~p~~ 238 (476)
T 2y94_A 170 EF--LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVP--TLFKKIC-DGIF------YTPQY 238 (476)
T ss_dssp CC--BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSH--HHHHHHH-TTCC------CCCTT
T ss_pred cc--ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHH--HHHHHHh-cCCc------CCCcc
Confidence 32 234579999999999987765 68999999999999999999999765322 1111111 1111 11111
Q ss_pred ccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 589 YVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 589 ~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
.+ . .+..+...|+.. |++||+++||+++
T Consensus 239 ~s-~---~~~~Li~~~L~~dP~~Rpt~~eil~h 267 (476)
T 2y94_A 239 LN-P---SVISLLKHMLQVDPMKRATIKDIREH 267 (476)
T ss_dssp CC-H---HHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred CC-H---HHHHHHHHHcCCCchhCcCHHHHHhC
Confidence 22 2 244555678887 9999999999985
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-38 Score=347.30 Aligned_cols=199 Identities=26% Similarity=0.341 Sum_probs=169.1
Q ss_pred hcCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecC--CchhHHHHHHHHHHHhcccccCceeEeeeeccc------C
Q 005940 352 TKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRN--SLQGMREFAAEIESLGRLRHKNLVNLHGWCKQK------N 423 (668)
Q Consensus 352 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~------~ 423 (668)
.++|+..++||+|+||.||+|.+..+++.||||++.+. .....+.+.+|++++++++||||+++++++... .
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 46899999999999999999999989999999999764 334457788999999999999999999999654 3
Q ss_pred ceEEEEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCc
Q 005940 424 DLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLA 503 (668)
Q Consensus 424 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla 503 (668)
..|+||||++++ |.+.+. ..+++.++..++.||+.||.|||+ .+|+||||||+||||+.++.+||+|||++
T Consensus 141 ~~~lv~E~~~~~-l~~~~~-----~~l~~~~~~~~~~qil~aL~~lH~---~~iiHrDlkp~NIll~~~~~~kl~DFG~a 211 (464)
T 3ttj_A 141 DVYLVMELMDAN-LCQVIQ-----MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLA 211 (464)
T ss_dssp EEEEEEECCSEE-HHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCCC
T ss_pred eEEEEEeCCCCC-HHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChHhEEEeCCCCEEEEEEEee
Confidence 579999999764 666663 238999999999999999999999 99999999999999999999999999999
Q ss_pred eeccCCCCCcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCc
Q 005940 504 RLYDHGGMPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGD 561 (668)
Q Consensus 504 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~ 561 (668)
+...... .....+||+.|+|||++.+..++.++||||+||++|||++|+.||...+
T Consensus 212 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~ 267 (464)
T 3ttj_A 212 RTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRD 267 (464)
T ss_dssp -----CC--CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred eecCCCc--ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 8765432 2344689999999999999999999999999999999999999997653
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-39 Score=338.61 Aligned_cols=258 Identities=24% Similarity=0.368 Sum_probs=198.8
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcE----EEEEEEecC-CchhHHHHHHHHHHHhcccccCceeEeeeecccCceEE
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGE----VAVKKITRN-SLQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLL 427 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~----vavK~~~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l 427 (668)
++|+..++||+|+||.||+|.+..+++. ||+|.+... .....+++.+|+.++++++||||++++++|.... .++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~ 93 (327)
T 3lzb_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL 93 (327)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEE
T ss_pred hHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceE
Confidence 5789999999999999999998777765 467766543 3345678999999999999999999999998754 889
Q ss_pred EEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceecc
Q 005940 428 VYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYD 507 (668)
Q Consensus 428 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~ 507 (668)
|+||+++|+|.+++.. ....+++..++.++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 94 v~~~~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~ 168 (327)
T 3lzb_A 94 ITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp EECCCSSCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCTTC-----
T ss_pred EEEecCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHhh---CCCcCCCCCHHHEEEcCCCCEEEccCcceeEcc
Confidence 9999999999999963 23569999999999999999999999 999999999999999999999999999998765
Q ss_pred CCCCC-cccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHHHhcCccccccCccc
Q 005940 508 HGGMP-HTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVAT-GRRPIGSGDLLLVEWVRECHQLGRILDVADPLL 585 (668)
Q Consensus 508 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 585 (668)
..... ......+|..|+|||.+.+..++.++|||||||++|||++ |+.||......... ......... ..
T Consensus 169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~---~~~~~~~~~-----~~ 240 (327)
T 3lzb_A 169 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS---SILEKGERL-----PQ 240 (327)
T ss_dssp -----------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH---HHHHTTCCC-----CC
T ss_pred CccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHH---HHHHcCCCC-----CC
Confidence 43221 2233456788999999998899999999999999999999 99999765332211 111111111 11
Q ss_pred CCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhccCcCCC
Q 005940 586 NSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSGEKQLR 628 (668)
Q Consensus 586 ~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~~~~~~ 628 (668)
...+. ..+..+...|++. |++||+++|+++.|+.....|
T Consensus 241 ~~~~~----~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 280 (327)
T 3lzb_A 241 PPICT----IDVYMIMRKCWMIDADSRPKFRELIIEFSKMARDP 280 (327)
T ss_dssp CTTBC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTSH
T ss_pred CccCC----HHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhCc
Confidence 11122 2355666789887 999999999999999876554
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-38 Score=339.89 Aligned_cols=251 Identities=24% Similarity=0.301 Sum_probs=188.8
Q ss_pred cCcccc-eeeeecCcEEEEEEEeCCCCcEEEEEEEecCCchhHHHHHHHHHHHhc-ccccCceeEeeeecc----cCceE
Q 005940 353 KGFKES-EVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGR-LRHKNLVNLHGWCKQ----KNDLL 426 (668)
Q Consensus 353 ~~f~~~-~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~-l~H~nIv~l~g~~~~----~~~~~ 426 (668)
++|... ++||+|+||+||+|.+..+++.||||++... ..+.+|++++.+ .+||||+++++++.. ...+|
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~ 135 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 135 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence 456665 6899999999999999989999999999643 456788888755 489999999998865 56789
Q ss_pred EEEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECC---CCCEEEEeecCc
Q 005940 427 LVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDA---EMNARLGDFGLA 503 (668)
Q Consensus 427 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~---~~~~kl~DfGla 503 (668)
+||||+++|+|.+++.. .....+++..+..++.||+.||.|||+ .+|+||||||+|||++. ++.+||+|||++
T Consensus 136 lv~E~~~gg~L~~~l~~-~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a 211 (400)
T 1nxk_A 136 IVMECLDGGELFSRIQD-RGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFA 211 (400)
T ss_dssp EEEECCCSEEHHHHHHC-C---CCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSTTCCEEECCCTTC
T ss_pred EEEEeCCCCcHHHHHHH-hCCCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCcCcceEEEecCCCCccEEEEecccc
Confidence 99999999999999964 223569999999999999999999999 99999999999999998 788999999999
Q ss_pred eeccCCCCCcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhH-HHHHHHHHhcCccccccC
Q 005940 504 RLYDHGGMPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLL-VEWVRECHQLGRILDVAD 582 (668)
Q Consensus 504 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l-~~~~~~~~~~~~~~~~~d 582 (668)
+...... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||....... ..........+... ...
T Consensus 212 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~-~~~ 288 (400)
T 1nxk_A 212 KETTSHN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYE-FPN 288 (400)
T ss_dssp EECC-------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCC-CCT
T ss_pred cccCCCC--ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCccc-CCC
Confidence 8765332 2334578999999999998999999999999999999999999996542110 00011111111111 111
Q ss_pred cccCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 583 PLLNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 583 ~~l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
+.. ..+. ..+..+...|++. |++||+++||+++
T Consensus 289 ~~~-~~~s----~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 289 PEW-SEVS----EEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp TTT-TTSC----HHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ccc-ccCC----HHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 111 1112 2345666688887 9999999999987
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-38 Score=327.21 Aligned_cols=248 Identities=23% Similarity=0.356 Sum_probs=204.4
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCC---chhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEE
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNS---LQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVY 429 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 429 (668)
++|...+.||+|+||.||++.+..+++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 15 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 94 (294)
T 2rku_A 15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL 94 (294)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEE
Confidence 56888999999999999999998889999999997642 344567899999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCC
Q 005940 430 EYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHG 509 (668)
Q Consensus 430 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~ 509 (668)
||+++++|.+++.. ...+++.+++.++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||++......
T Consensus 95 e~~~~~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 168 (294)
T 2rku_A 95 ELCRRRSLLELHKR---RKALTEPEARYYLRQIVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD 168 (294)
T ss_dssp ECCTTCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred ecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEcCCCCEEEEeccCceecccC
Confidence 99999999998853 3468999999999999999999999 99999999999999999999999999999876543
Q ss_pred CCCcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCcccCCcc
Q 005940 510 GMPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSY 589 (668)
Q Consensus 510 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 589 (668)
.. ......||..|+|||++.+..++.++||||||+++|||++|+.||...... +....... .. ..+....
T Consensus 169 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~~~~~~~~-~~------~~~~~~~ 238 (294)
T 2rku_A 169 GE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK--ETYLRIKK-NE------YSIPKHI 238 (294)
T ss_dssp TC-CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH--HHHHHHHT-TC------CCCCTTS
T ss_pred cc-ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHhh-cc------CCCcccc
Confidence 22 233457899999999999888999999999999999999999999765322 11111111 11 1111122
Q ss_pred cHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 590 VVKEMELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 590 ~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
+ ..+..+...|++. |++||+++|++++
T Consensus 239 ~----~~~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 239 N----PVAASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp C----HHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred C----HHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 2 2344566688887 9999999999975
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-39 Score=352.17 Aligned_cols=249 Identities=24% Similarity=0.280 Sum_probs=193.3
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecC---CchhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEE
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRN---SLQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVY 429 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 429 (668)
++|...++||+|+||.||+|.+..+++.||||++... .......+.+|++++++++||||++++++|...+..++||
T Consensus 148 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 227 (446)
T 4ejn_A 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVM 227 (446)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEEE
T ss_pred HHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEE
Confidence 5688999999999999999999999999999999753 2334467789999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCC
Q 005940 430 EYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHG 509 (668)
Q Consensus 430 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~ 509 (668)
||+++|+|.+++.. ...+++..+..++.||+.||.|||+ +.+|+||||||+||||+.++.+||+|||+++.....
T Consensus 228 e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~--~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 302 (446)
T 4ejn_A 228 EYANGGELFFHLSR---ERVFSEDRARFYGAEIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD 302 (446)
T ss_dssp CCCSSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHH--HTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC-
T ss_pred eeCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHhh--cCCEEECCCCHHHEEECCCCCEEEccCCCceeccCC
Confidence 99999999999953 3468999999999999999999996 278999999999999999999999999999864332
Q ss_pred CCCcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCcccCCcc
Q 005940 510 GMPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSY 589 (668)
Q Consensus 510 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 589 (668)
. ......+||+.|+|||++.+..++.++|||||||++|||++|+.||...+.... ...... .. ..+....
T Consensus 303 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~--~~~i~~-~~------~~~p~~~ 372 (446)
T 4ejn_A 303 G-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL--FELILM-EE------IRFPRTL 372 (446)
T ss_dssp -----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHH-CC------CCCCTTS
T ss_pred C-cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHH--HHHHHh-CC------CCCCccC
Confidence 2 223446899999999999999999999999999999999999999976543211 111111 11 1111122
Q ss_pred cHHHHHHHHHHHhhcCCC-CCCCC-----CHHHHHHH
Q 005940 590 VVKEMELVLKLGLMCSHK-TQFRP-----TMRQVMRY 620 (668)
Q Consensus 590 ~~~~~~~l~~l~~~C~~~-p~~RP-----s~~evl~~ 620 (668)
+ ..+..+...|+.. |++|| +++|++++
T Consensus 373 ~----~~~~~li~~~L~~dP~~R~~~~~~t~~ell~h 405 (446)
T 4ejn_A 373 G----PEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQH 405 (446)
T ss_dssp C----HHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred C----HHHHHHHHHHcccCHHHhCCCCCCCHHHHHhC
Confidence 2 2344555678887 99999 99999975
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-39 Score=339.51 Aligned_cols=258 Identities=28% Similarity=0.386 Sum_probs=204.9
Q ss_pred cCcccceeeeecCcEEEEEEEe----CCCCcEEEEEEEecCCchhHHHHHHHHHHHhcccccCceeEeeeecccC--ceE
Q 005940 353 KGFKESEVIGIGGFGSVYKGVL----PTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNLHGWCKQKN--DLL 426 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~----~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~--~~~ 426 (668)
++|...+.||+|+||.||+|.+ ..+++.||||++........+.+.+|++++++++||||+++++++...+ ..+
T Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 120 (326)
T 2w1i_A 41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK 120 (326)
T ss_dssp GGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCE
T ss_pred HHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceE
Confidence 4688899999999999999984 5578899999998877777788999999999999999999999987654 789
Q ss_pred EEEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceec
Q 005940 427 LVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLY 506 (668)
Q Consensus 427 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~ 506 (668)
+||||+++++|.+++.. ....+++.+++.++.||+.||.|||+ .+|+||||||+||+++.++.+||+|||+++..
T Consensus 121 lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~ 195 (326)
T 2w1i_A 121 LIMEYLPYGSLRDYLQK--HKERIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTKVL 195 (326)
T ss_dssp EEECCCTTCBHHHHHHH--STTSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEECCCCCCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHh---CCEeccCCCcceEEEcCCCcEEEecCcchhhc
Confidence 99999999999999964 23469999999999999999999999 99999999999999999999999999999877
Q ss_pred cCCCCC--cccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHH-------------HHHHHH
Q 005940 507 DHGGMP--HTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLV-------------EWVREC 571 (668)
Q Consensus 507 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~-------------~~~~~~ 571 (668)
...... ......++..|+|||.+.+..++.++|||||||++|||++|+.|+........ ....+.
T Consensus 196 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (326)
T 2w1i_A 196 PQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIEL 275 (326)
T ss_dssp CSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHH
T ss_pred cccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHH
Confidence 654321 12234567789999999888899999999999999999999998854211111 111111
Q ss_pred HhcCccccccCcccCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhccC
Q 005940 572 HQLGRILDVADPLLNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSGE 624 (668)
Q Consensus 572 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~~ 624 (668)
...... ......+. ..+..++..|+.. |++||+++||++.|+..
T Consensus 276 ~~~~~~-----~~~~~~~~----~~l~~li~~cl~~dP~~Rps~~el~~~L~~l 320 (326)
T 2w1i_A 276 LKNNGR-----LPRPDGCP----DEIYMIMTECWNNNVNQRPSFRDLALRVDQI 320 (326)
T ss_dssp HHTTCC-----CCCCTTCC----HHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred hhcCCC-----CCCCCccc----HHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 111111 01111122 3455677789987 99999999999998754
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=336.32 Aligned_cols=260 Identities=26% Similarity=0.330 Sum_probs=193.0
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCchh-HHHHHHHHHHHhcccccCceeEeeeecccCceEEEEEe
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQG-MREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEY 431 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~-~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~ 431 (668)
++|...++||+|+||.||+|.+..+++.||||++....... ...+.+|++++++++||||+++++++...+..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 47889999999999999999998889999999996543221 22455799999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCCC
Q 005940 432 IPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGM 511 (668)
Q Consensus 432 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~~ 511 (668)
++ |+|.+++.. .+..+++..+..++.||+.||.|||+ .+|+||||||+||+++.++.+||+|||+++.......
T Consensus 82 ~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~ 155 (324)
T 3mtl_A 82 LD-KDLKQYLDD--CGNIINMHNVKLFLFQLLRGLAYCHR---QKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK 155 (324)
T ss_dssp CS-EEHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHH---TTEEESSCCGGGEEECTTCCEEECSSSEEECC-----
T ss_pred cc-cCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCcCHHHEEECCCCCEEEccCcccccccCCcc
Confidence 97 589888853 34569999999999999999999999 9999999999999999999999999999986543321
Q ss_pred CcccccccCCcccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCch-hHHHHHHHHHhcCccccccCccc----
Q 005940 512 PHTTNVVGTFGYIAPELTQT-GKASTSSDVFAYGILLLEVATGRRPIGSGDL-LLVEWVRECHQLGRILDVADPLL---- 585 (668)
Q Consensus 512 ~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~-~l~~~~~~~~~~~~~~~~~d~~l---- 585 (668)
......||..|+|||++.+ ..++.++|||||||++|||++|+.||..... .....+........ .......+
T Consensus 156 -~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~-~~~~~~~~~~~~ 233 (324)
T 3mtl_A 156 -TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPT-EETWPGILSNEE 233 (324)
T ss_dssp --------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC-TTTSTTGGGCHH
T ss_pred -ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC-hHhchhhhcchh
Confidence 2234578999999999876 5689999999999999999999999976532 22222222211110 00000000
Q ss_pred ---------CCcc----cHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 586 ---------NSSY----VVKEMELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 586 ---------~~~~----~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
.... ....-..+..+...|++. |++||+++|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 282 (324)
T 3mtl_A 234 FKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKH 282 (324)
T ss_dssp HHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 0000 000012345666688887 9999999999984
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-38 Score=328.27 Aligned_cols=250 Identities=24% Similarity=0.343 Sum_probs=200.0
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCchhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEEec
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEYI 432 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~ 432 (668)
++|...+.||+|+||.||++++..+++.||+|++........+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 88 (304)
T 2jam_A 9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLV 88 (304)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred ccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEcC
Confidence 57889999999999999999998889999999998765555567899999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEE---CCCCCEEEEeecCceeccCC
Q 005940 433 PNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALI---DAEMNARLGDFGLARLYDHG 509 (668)
Q Consensus 433 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll---~~~~~~kl~DfGla~~~~~~ 509 (668)
++++|.+++.. ...+++..++.++.|++.||.|||+ .+|+||||||+||++ +.++.+||+|||+++.....
T Consensus 89 ~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~ 162 (304)
T 2jam_A 89 SGGELFDRILE---RGVYTEKDASLVIQQVLSAVKYLHE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG 162 (304)
T ss_dssp CSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB
T ss_pred CCccHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC
Confidence 99999999853 2458999999999999999999999 999999999999999 78899999999999765432
Q ss_pred CCCcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCcccCCcc
Q 005940 510 GMPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSY 589 (668)
Q Consensus 510 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 589 (668)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...... +..... ..+... . ........
T Consensus 163 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~i-~~~~~~-~-~~~~~~~~ 234 (304)
T 2jam_A 163 ---IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETES--KLFEKI-KEGYYE-F-ESPFWDDI 234 (304)
T ss_dssp ---TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHH--HHHHHH-HHCCCC-C-CTTTTTTS
T ss_pred ---ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH--HHHHHH-HcCCCC-C-CccccccC
Confidence 223346899999999999889999999999999999999999999764322 111111 111110 0 11111112
Q ss_pred cHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 590 VVKEMELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 590 ~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
+ ..+..+...|+.. |++||+++|++++
T Consensus 235 ~----~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (304)
T 2jam_A 235 S----ESAKDFICHLLEKDPNERYTCEKALSH 262 (304)
T ss_dssp C----HHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred C----HHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 2 2344556678776 9999999999975
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=341.03 Aligned_cols=201 Identities=29% Similarity=0.411 Sum_probs=178.3
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCC-chhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEEe
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNS-LQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEY 431 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~ 431 (668)
++|...+.||+|+||.||+|.+..++..||+|++.... ....+.+.+|++++++++||||+++++++...+..++||||
T Consensus 33 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 112 (360)
T 3eqc_A 33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 112 (360)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEEC
Confidence 57899999999999999999998889999999997653 34457889999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCC-ceEecCCCCCCEEECCCCCEEEEeecCceeccCCC
Q 005940 432 IPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQ-VVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGG 510 (668)
Q Consensus 432 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~-~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~ 510 (668)
+++++|.+++.. ...+++..+..++.|++.||.|||+ . +|+||||||+||+++.++.+||+|||++......
T Consensus 113 ~~~~~L~~~l~~---~~~~~~~~~~~i~~~i~~~l~~lh~---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~- 185 (360)
T 3eqc_A 113 MDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLRE---KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 185 (360)
T ss_dssp CTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH---HHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH-
T ss_pred CCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---hCCEEcCCccHHHEEECCCCCEEEEECCCCcccccc-
Confidence 999999999963 2458999999999999999999998 5 8999999999999999999999999999755322
Q ss_pred CCcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCch
Q 005940 511 MPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDL 562 (668)
Q Consensus 511 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~ 562 (668)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...+.
T Consensus 186 --~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 235 (360)
T 3eqc_A 186 --MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDA 235 (360)
T ss_dssp --C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCH
T ss_pred --cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 12335789999999999998999999999999999999999999976543
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=341.24 Aligned_cols=201 Identities=30% Similarity=0.466 Sum_probs=165.7
Q ss_pred hcCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecC--CchhHHHHHHHHHHHhccc-ccCceeEeeeeccc--CceE
Q 005940 352 TKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRN--SLQGMREFAAEIESLGRLR-HKNLVNLHGWCKQK--NDLL 426 (668)
Q Consensus 352 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~--~~~~ 426 (668)
.++|...+.||+|+||.||+|.+..+++.||||++... .....+.+.+|+.++.++. ||||+++++++... ...|
T Consensus 8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~ 87 (388)
T 3oz6_A 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVY 87 (388)
T ss_dssp HTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEE
T ss_pred cCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEE
Confidence 46899999999999999999999999999999998653 3345567889999999997 99999999999644 3789
Q ss_pred EEEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceec
Q 005940 427 LVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLY 506 (668)
Q Consensus 427 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~ 506 (668)
+|||||+ ++|.+++.. ..+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++..
T Consensus 88 lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 159 (388)
T 3oz6_A 88 LVFDYME-TDLHAVIRA----NILEPVHKQYVVYQLIKVIKYLHS---GGLLHRDMKPSNILLNAECHVKVADFGLSRSF 159 (388)
T ss_dssp EEEECCS-EEHHHHHHH----TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEES
T ss_pred EEecccC-cCHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHeEEcCCCCEEecCCcccccc
Confidence 9999997 689998853 358999999999999999999999 99999999999999999999999999999876
Q ss_pred cCCC--------------------CCcccccccCCcccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 005940 507 DHGG--------------------MPHTTNVVGTFGYIAPELTQT-GKASTSSDVFAYGILLLEVATGRRPIGSG 560 (668)
Q Consensus 507 ~~~~--------------------~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~S~Gvvl~elltG~~p~~~~ 560 (668)
.... ....+..+||+.|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 234 (388)
T 3oz6_A 160 VNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGS 234 (388)
T ss_dssp SSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Confidence 4311 112234589999999999876 67899999999999999999999999765
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-38 Score=323.86 Aligned_cols=256 Identities=21% Similarity=0.287 Sum_probs=202.4
Q ss_pred hcCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCchhHHHHHHHHHHHhcccccCceeEeeee-cccCceEEEEE
Q 005940 352 TKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNLHGWC-KQKNDLLLVYE 430 (668)
Q Consensus 352 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~-~~~~~~~lV~E 430 (668)
.++|...+.||+|+||.||+|++..+++.||||++...... +++.+|++++++++|++++..++++ ......++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC--CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch--hHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence 46899999999999999999999889999999998765432 4688999999999988877766665 55667899999
Q ss_pred ecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEE---CCCCCEEEEeecCceecc
Q 005940 431 YIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALI---DAEMNARLGDFGLARLYD 507 (668)
Q Consensus 431 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll---~~~~~~kl~DfGla~~~~ 507 (668)
|+ +++|.+++.. ....+++.+++.++.||+.||.|||+ .+|+||||||+||++ +.++.+||+|||+++...
T Consensus 86 ~~-~~~L~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 159 (296)
T 3uzp_A 86 LL-GPSLEDLFNF--CSRKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp CC-CCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred ec-CCCHHHHHHh--hccCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccc
Confidence 99 9999999953 23469999999999999999999999 999999999999999 488899999999999776
Q ss_pred CCCCC------cccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCc----hhHHHHHHHHHhcCcc
Q 005940 508 HGGMP------HTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGD----LLLVEWVRECHQLGRI 577 (668)
Q Consensus 508 ~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~----~~l~~~~~~~~~~~~~ 577 (668)
..... ......||..|+|||.+.+..++.++|||||||++|||++|+.||.... ......+.........
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 239 (296)
T 3uzp_A 160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI 239 (296)
T ss_dssp CTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH
T ss_pred ccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCch
Confidence 54321 1244579999999999999899999999999999999999999997531 1122211111111100
Q ss_pred ccccCcccCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhccC
Q 005940 578 LDVADPLLNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSGE 624 (668)
Q Consensus 578 ~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~~ 624 (668)
+.+...++ ..+..+...|+.. |++||++++|++.|+..
T Consensus 240 -----~~~~~~~~----~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~ 278 (296)
T 3uzp_A 240 -----EVLCKGYP----SEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 278 (296)
T ss_dssp -----HHHTTTSC----HHHHHHHHHHHTSCTTCCCCHHHHHHHHHHH
T ss_pred -----HHHHhhCC----HHHHHHHHHHHhcCcCcCCCHHHHHHHHHHH
Confidence 01111122 2355666788887 99999999999999865
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=331.59 Aligned_cols=256 Identities=23% Similarity=0.293 Sum_probs=195.9
Q ss_pred cCcccc-eeeeecCcEEEEEEEeCCCCcEEEEEEEecCCchhHHHHHHHHHHHhcc-cccCceeEeeeecccCceEEEEE
Q 005940 353 KGFKES-EVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRL-RHKNLVNLHGWCKQKNDLLLVYE 430 (668)
Q Consensus 353 ~~f~~~-~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~E 430 (668)
+.|.+. +.||+|+||.||+|.+..+++.||||++........+.+.+|++++.++ +||||+++++++.+.+..++|||
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 91 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFE 91 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEE
Confidence 456664 7899999999999999888999999999877666678899999999985 79999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCC---EEEEeecCceecc
Q 005940 431 YIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMN---ARLGDFGLARLYD 507 (668)
Q Consensus 431 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~---~kl~DfGla~~~~ 507 (668)
|+++|+|.+++.. ...+++..++.++.||+.||+|||+ .+|+||||||+||+++.++. +||+|||+++...
T Consensus 92 ~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~ 165 (316)
T 2ac3_A 92 KMRGGSILSHIHK---RRHFNELEASVVVQDVASALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIK 165 (316)
T ss_dssp CCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC---
T ss_pred cCCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHh---CCceeCCCCHHHEEEccCCCcCceEEEEccCccccc
Confidence 9999999999963 2458999999999999999999999 99999999999999998776 9999999998654
Q ss_pred CCCC------CcccccccCCcccCcccccC-----CCCCcchhHHHHHHHHHHHHhCCCCCCCCchh------------H
Q 005940 508 HGGM------PHTTNVVGTFGYIAPELTQT-----GKASTSSDVFAYGILLLEVATGRRPIGSGDLL------------L 564 (668)
Q Consensus 508 ~~~~------~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~------------l 564 (668)
.... .......||..|+|||++.. ..++.++|||||||++|||++|+.||...... .
T Consensus 166 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 245 (316)
T 2ac3_A 166 LNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPAC 245 (316)
T ss_dssp ----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHH
T ss_pred cCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhH
Confidence 2211 11223469999999999864 45789999999999999999999999654211 0
Q ss_pred HHHHHHHHhcCccccccCcccCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 565 VEWVRECHQLGRILDVADPLLNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 565 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
.....+........ ...... .... ..+..+...|+.. |++||+++|++++
T Consensus 246 ~~~~~~~i~~~~~~-~~~~~~-~~~~----~~~~~li~~~L~~dP~~Rps~~e~l~h 296 (316)
T 2ac3_A 246 QNMLFESIQEGKYE-FPDKDW-AHIS----CAAKDLISKLLVRDAKQRLSAAQVLQH 296 (316)
T ss_dssp HHHHHHHHHHCCCC-CCHHHH-TTSC----HHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHHHHhccCcc-cCchhc-ccCC----HHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 11111111111110 000000 0111 2355666788887 9999999999985
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=336.84 Aligned_cols=243 Identities=22% Similarity=0.323 Sum_probs=200.8
Q ss_pred hcCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCc--------hhHHHHHHHHHHHhcccccCceeEeeeecccC
Q 005940 352 TKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSL--------QGMREFAAEIESLGRLRHKNLVNLHGWCKQKN 423 (668)
Q Consensus 352 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--------~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~ 423 (668)
.++|...+.||+|+||.||+|.+..+++.||||++..... ...+.+.+|++++++++||||+++++++.+.+
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 102 (335)
T 3dls_A 23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQG 102 (335)
T ss_dssp HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCC
Confidence 3679999999999999999999988999999999976532 13345778999999999999999999999999
Q ss_pred ceEEEEEecCCC-ChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecC
Q 005940 424 DLLLVYEYIPNG-SLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGL 502 (668)
Q Consensus 424 ~~~lV~E~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGl 502 (668)
..++||||+.+| +|.+++.. ...+++..++.++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+
T Consensus 103 ~~~lv~e~~~~g~~l~~~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~Dfg~ 176 (335)
T 3dls_A 103 FFQLVMEKHGSGLDLFAFIDR---HPRLDEPLASYIFRQLVSAVGYLRL---KDIIHRDIKDENIVIAEDFTIKLIDFGS 176 (335)
T ss_dssp EEEEEEECCTTSCBHHHHHHT---CCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTT
T ss_pred EEEEEEEeCCCCccHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEEeccCHHHEEEcCCCcEEEeeccc
Confidence 999999999777 99999963 3459999999999999999999999 9999999999999999999999999999
Q ss_pred ceeccCCCCCcccccccCCcccCcccccCCCC-CcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCcccccc
Q 005940 503 ARLYDHGGMPHTTNVVGTFGYIAPELTQTGKA-STSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVA 581 (668)
Q Consensus 503 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~ 581 (668)
++....... .....||+.|+|||++.+..+ +.++|||||||++|||++|+.||...... .....
T Consensus 177 a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-------------~~~~~ 241 (335)
T 3dls_A 177 AAYLERGKL--FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET-------------VEAAI 241 (335)
T ss_dssp CEECCTTCC--BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG-------------TTTCC
T ss_pred ceECCCCCc--eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH-------------Hhhcc
Confidence 987765432 234579999999999988776 88999999999999999999999642110 00000
Q ss_pred CcccCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHh
Q 005940 582 DPLLNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYL 621 (668)
Q Consensus 582 d~~l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L 621 (668)
.+ ...++ ..+..+...|+.. |++||+++|++++-
T Consensus 242 ~~--~~~~~----~~l~~li~~~L~~dP~~Rps~~ell~hp 276 (335)
T 3dls_A 242 HP--PYLVS----KELMSLVSGLLQPVPERRTTLEKLVTDP 276 (335)
T ss_dssp CC--SSCCC----HHHHHHHHHHTCSSGGGSCCHHHHHHCT
T ss_pred CC--CcccC----HHHHHHHHHHccCChhhCcCHHHHhcCc
Confidence 01 11122 2345566688887 99999999999973
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=327.27 Aligned_cols=249 Identities=27% Similarity=0.437 Sum_probs=202.1
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCchhHHHHHHHHHHHhcccccCceeEeeeecc-----------
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNLHGWCKQ----------- 421 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~----------- 421 (668)
.+|+..+.||+|+||.||+|.+..+++.||+|++.... +.+.+|++++++++||||+++++++..
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 86 (284)
T 2a19_B 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKN 86 (284)
T ss_dssp HHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-------
T ss_pred cccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccccc
Confidence 56889999999999999999998889999999997654 346689999999999999999998854
Q ss_pred -----cCceEEEEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEE
Q 005940 422 -----KNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNAR 496 (668)
Q Consensus 422 -----~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~k 496 (668)
....++||||+++++|.+++... ....+++..++.++.||+.||.|||+ .+|+||||||+||+++.++.+|
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~k 162 (284)
T 2a19_B 87 SSRSKTKCLFIQMEFCDKGTLEQWIEKR-RGEKLDKVLALELFEQITKGVDYIHS---KKLINRDLKPSNIFLVDTKQVK 162 (284)
T ss_dssp --CCEEEEEEEEECCCCSCBHHHHHHHG-GGSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEE
T ss_pred ccccCcceEEEEEeccCCCCHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCCHHHEEEcCCCCEE
Confidence 44589999999999999999632 23568999999999999999999999 9999999999999999999999
Q ss_pred EEeecCceeccCCCCCcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCc
Q 005940 497 LGDFGLARLYDHGGMPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGR 576 (668)
Q Consensus 497 l~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~ 576 (668)
|+|||++........ .....|++.|+|||.+.+..++.++||||||+++|||++|..|+... ..+... .....
T Consensus 163 l~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~----~~~~~~-~~~~~ 235 (284)
T 2a19_B 163 IGDFGLVTSLKNDGK--RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET----SKFFTD-LRDGI 235 (284)
T ss_dssp ECCCTTCEESSCCSC--CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH----HHHHHH-HHTTC
T ss_pred ECcchhheecccccc--ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH----HHHHHH-hhccc
Confidence 999999987765432 23457899999999999888999999999999999999999887421 111111 11111
Q ss_pred cccccCcccCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhccCcCCC
Q 005940 577 ILDVADPLLNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSGEKQLR 628 (668)
Q Consensus 577 ~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~~~~~~ 628 (668)
+...++. .+..+...|++. |++||++.|++++|.....-+
T Consensus 236 --------~~~~~~~----~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~ 276 (284)
T 2a19_B 236 --------ISDIFDK----KEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSP 276 (284)
T ss_dssp --------CCTTSCH----HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC--
T ss_pred --------ccccCCH----HHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCC
Confidence 1122222 234556688887 999999999999998765443
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=329.31 Aligned_cols=254 Identities=24% Similarity=0.325 Sum_probs=200.7
Q ss_pred hcCcccce-eeeecCcEEEEEEEe--CCCCcEEEEEEEecCC--chhHHHHHHHHHHHhcccccCceeEeeeecccCceE
Q 005940 352 TKGFKESE-VIGIGGFGSVYKGVL--PTTGGEVAVKKITRNS--LQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLL 426 (668)
Q Consensus 352 t~~f~~~~-~lG~G~~g~Vy~~~~--~~~~~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~ 426 (668)
.++|...+ .||+|+||.||+|.+ ..++..||||++.... ....+++.+|++++++++||||+++++++ ..+..+
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~ 93 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWM 93 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcE
Confidence 35677777 999999999999954 4567889999997643 23457899999999999999999999999 567789
Q ss_pred EEEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceec
Q 005940 427 LVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLY 506 (668)
Q Consensus 427 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~ 506 (668)
+||||+++++|.+++.. ...+++..++.++.||+.||.|||+ .+|+||||||+||+++.++.+||+|||+++..
T Consensus 94 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 167 (291)
T 1xbb_A 94 LVMEMAELGPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKAL 167 (291)
T ss_dssp EEEECCTTEEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEEeCCCCCHHHHHHh---CcCCCHHHHHHHHHHHHHHHHHHHh---CCeEcCCCCcceEEEeCCCcEEEccCCcceee
Confidence 99999999999999963 3458999999999999999999999 99999999999999999999999999999877
Q ss_pred cCCCCCc--ccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHHHhcCccccccCc
Q 005940 507 DHGGMPH--TTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVAT-GRRPIGSGDLLLVEWVRECHQLGRILDVADP 583 (668)
Q Consensus 507 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~ 583 (668)
....... .....++..|+|||.+.+..++.++||||||+++|||++ |+.||........ ......... +
T Consensus 168 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~---~~~~~~~~~-----~ 239 (291)
T 1xbb_A 168 RADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV---TAMLEKGER-----M 239 (291)
T ss_dssp CTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH---HHHHHTTCC-----C
T ss_pred ccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHH---HHHHHcCCC-----C
Confidence 5443221 222346788999999988889999999999999999999 9999976543211 111222211 1
Q ss_pred ccCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhccC
Q 005940 584 LLNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSGE 624 (668)
Q Consensus 584 ~l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~~ 624 (668)
.....++ ..+..+...|+.. |++||++.+|++.|+..
T Consensus 240 ~~~~~~~----~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~ 277 (291)
T 1xbb_A 240 GCPAGCP----REMYDLMNLCWTYDVENRPGFAAVELRLRNY 277 (291)
T ss_dssp CCCTTCC----HHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred CCCCCCC----HHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 1111222 3455667789887 99999999999999754
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-38 Score=325.07 Aligned_cols=257 Identities=21% Similarity=0.280 Sum_probs=199.2
Q ss_pred hcCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCchhHHHHHHHHHHHhcccccCceeEeeee-cccCceEEEEE
Q 005940 352 TKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNLHGWC-KQKNDLLLVYE 430 (668)
Q Consensus 352 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~-~~~~~~~lV~E 430 (668)
.++|...+.||+|+||.||+|++..+++.||||++...... +++..|++++++++|++++..++++ ......++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 4hgt_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp ---CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C--CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc--hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEE
Confidence 46899999999999999999999889999999987654322 3578899999999988877777666 56677899999
Q ss_pred ecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEE---CCCCCEEEEeecCceecc
Q 005940 431 YIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALI---DAEMNARLGDFGLARLYD 507 (668)
Q Consensus 431 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll---~~~~~~kl~DfGla~~~~ 507 (668)
|+ +++|.+++.. ....+++..++.++.||+.||.|||+ .+|+||||||+||++ +.++.+||+|||+++...
T Consensus 86 ~~-~~~L~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~ 159 (296)
T 4hgt_A 86 LL-GPSLEDLFNF--CSRKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp CC-CCBHHHHHHH--TTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred cc-CCCHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeeeeccCCCCeEEEecCccceecc
Confidence 99 9999999963 23459999999999999999999999 999999999999999 788999999999999776
Q ss_pred CCCC------CcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCc----hhHHHHHHHHHhcCcc
Q 005940 508 HGGM------PHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGD----LLLVEWVRECHQLGRI 577 (668)
Q Consensus 508 ~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~----~~l~~~~~~~~~~~~~ 577 (668)
.... .......||..|+|||.+.+..++.++|||||||++|||++|+.||.... ...............
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~- 238 (296)
T 4hgt_A 160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP- 238 (296)
T ss_dssp CTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC-
T ss_pred CcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccch-
Confidence 5432 12234579999999999999899999999999999999999999997531 111111111111100
Q ss_pred ccccCcccCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhccCc
Q 005940 578 LDVADPLLNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSGEK 625 (668)
Q Consensus 578 ~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~~~ 625 (668)
. +.+...++ ..+..+...|++. |++||++++|++.|+...
T Consensus 239 ~----~~~~~~~~----~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~ 279 (296)
T 4hgt_A 239 I----EVLCKGYP----SEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF 279 (296)
T ss_dssp H----HHHTTTSC----HHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHH
T ss_pred h----hhhhccCC----HHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHH
Confidence 0 01111112 2455666788887 999999999999997653
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-38 Score=333.88 Aligned_cols=248 Identities=23% Similarity=0.356 Sum_probs=204.4
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCC---chhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEE
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNS---LQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVY 429 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 429 (668)
++|...+.||+|+||.||++.+..+++.||+|++.... ....+.+.+|+.++++++|+||+++++++.+.+..++||
T Consensus 41 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 120 (335)
T 2owb_A 41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL 120 (335)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence 56888999999999999999999889999999997642 345577899999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCC
Q 005940 430 EYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHG 509 (668)
Q Consensus 430 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~ 509 (668)
||+++++|.+++.. ...+++.+++.++.||+.||.|||+ .+|+||||||+||+++.++.+||+|||+++.....
T Consensus 121 e~~~~~~L~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 194 (335)
T 2owb_A 121 ELCRRRSLLELHKR---RKALTEPEARYYLRQIVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD 194 (335)
T ss_dssp CCCTTCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred ecCCCCCHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHH---CCCEecCCCchhEEEcCCCCEEEeeccCceecccC
Confidence 99999999999853 3468999999999999999999999 99999999999999999999999999999876543
Q ss_pred CCCcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCcccCCcc
Q 005940 510 GMPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSY 589 (668)
Q Consensus 510 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 589 (668)
.. ......||..|+|||++.+..++.++|||||||++|||++|+.||...... +....... .. ..+....
T Consensus 195 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~~~~-~~------~~~~~~~ 264 (335)
T 2owb_A 195 GE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK--ETYLRIKK-NE------YSIPKHI 264 (335)
T ss_dssp TC-CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH--HHHHHHHH-TC------CCCCTTS
T ss_pred cc-cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHH--HHHHHHhc-CC------CCCCccC
Confidence 22 233457899999999999888999999999999999999999999765322 11111111 11 1111122
Q ss_pred cHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 590 VVKEMELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 590 ~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
+ ..+..+...|++. |++||+++|++++
T Consensus 265 ~----~~~~~li~~~l~~dp~~Rps~~ell~~ 292 (335)
T 2owb_A 265 N----PVAASLIQKMLQTDPTARPTINELLND 292 (335)
T ss_dssp C----HHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred C----HHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 2 2344566688887 9999999999975
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-38 Score=324.26 Aligned_cols=246 Identities=24% Similarity=0.327 Sum_probs=198.3
Q ss_pred hcCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCC--chhHHHHHHHHHHHhcc-cccCceeEeeeecccCceEEE
Q 005940 352 TKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNS--LQGMREFAAEIESLGRL-RHKNLVNLHGWCKQKNDLLLV 428 (668)
Q Consensus 352 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV 428 (668)
.++|...+.||+|+||.||+|.+..+++.||||++.... .....++.+|+..+.++ +||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv 89 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ 89 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 467899999999999999999998889999999997642 34456788999999999 899999999999999999999
Q ss_pred EEecCCCChhhhhcCCC-CCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECC----------------
Q 005940 429 YEYIPNGSLDTLLFKPK-DGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDA---------------- 491 (668)
Q Consensus 429 ~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~---------------- 491 (668)
|||+++++|.+++.... ....+++..++.++.||+.||.|||+ .+|+||||||+||+++.
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~ 166 (289)
T 1x8b_A 90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHS---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDW 166 (289)
T ss_dssp EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEC-----------------
T ss_pred EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHh---CCEeecCCCHHHEEEcCCCCCcccccccccccc
Confidence 99999999999996321 12568999999999999999999999 99999999999999984
Q ss_pred ---CCCEEEEeecCceeccCCCCCcccccccCCcccCcccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHH
Q 005940 492 ---EMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPELTQTG-KASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEW 567 (668)
Q Consensus 492 ---~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~ 567 (668)
...+||+|||++....... ...||..|+|||++.+. .++.++|||||||++|||++|..++...+.
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~----- 236 (289)
T 1x8b_A 167 ASNKVMFKIGDLGHVTRISSPQ-----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ----- 236 (289)
T ss_dssp ---CCCEEECCCTTCEETTCSC-----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH-----
T ss_pred cCCceEEEEcccccccccCCcc-----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH-----
Confidence 4479999999998765432 23589999999998765 566899999999999999999987754321
Q ss_pred HHHHHhcCccccccCcccCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 568 VRECHQLGRILDVADPLLNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 568 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
......... +.+...++ ..+..+...|++. |++||+++|++++
T Consensus 237 -~~~~~~~~~-----~~~~~~~~----~~~~~li~~~l~~dp~~Rps~~~ll~h 280 (289)
T 1x8b_A 237 -WHEIRQGRL-----PRIPQVLS----QEFTELLKVMIHPDPERRPSAMALVKH 280 (289)
T ss_dssp -HHHHHTTCC-----CCCSSCCC----HHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred -HHHHHcCCC-----CCCCcccC----HHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence 111121221 12222222 2345566688887 9999999999975
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=345.05 Aligned_cols=251 Identities=22% Similarity=0.326 Sum_probs=190.7
Q ss_pred HhcCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCc--------hhHHHHHHHHHHHhcccccCceeEeeeeccc
Q 005940 351 ATKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSL--------QGMREFAAEIESLGRLRHKNLVNLHGWCKQK 422 (668)
Q Consensus 351 at~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--------~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~ 422 (668)
..++|...+.||+|+||.||+|.+..+++.||||++.+... .....+.+|++++++++||||+++++++..
T Consensus 133 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~- 211 (419)
T 3i6u_A 133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA- 211 (419)
T ss_dssp HHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-
T ss_pred hhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-
Confidence 35789999999999999999999999999999999976421 122357899999999999999999999854
Q ss_pred CceEEEEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCC---CEEEEe
Q 005940 423 NDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEM---NARLGD 499 (668)
Q Consensus 423 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~---~~kl~D 499 (668)
+..++||||+++|+|.+++.. ...+++.++..++.||+.||.|||+ .+|+||||||+|||++.++ .+||+|
T Consensus 212 ~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivHrDlkp~NIll~~~~~~~~~kl~D 285 (419)
T 3i6u_A 212 EDYYIVLELMEGGELFDKVVG---NKRLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITD 285 (419)
T ss_dssp SEEEEEEECCTTCBGGGGTSS---SCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSSSCCEEECC
T ss_pred CceEEEEEcCCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEecCCCcceEEEee
Confidence 458999999999999999853 3569999999999999999999999 9999999999999997544 599999
Q ss_pred ecCceeccCCCCCcccccccCCcccCcccccC---CCCCcchhHHHHHHHHHHHHhCCCCCCCCc--hhHHHHHHHHHhc
Q 005940 500 FGLARLYDHGGMPHTTNVVGTFGYIAPELTQT---GKASTSSDVFAYGILLLEVATGRRPIGSGD--LLLVEWVRECHQL 574 (668)
Q Consensus 500 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDV~S~Gvvl~elltG~~p~~~~~--~~l~~~~~~~~~~ 574 (668)
||+++...... ......||+.|+|||++.. ..++.++|||||||++|||++|+.||.... ..+.+.+ ..
T Consensus 286 FG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i----~~ 359 (419)
T 3i6u_A 286 FGHSKILGETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQI----TS 359 (419)
T ss_dssp SSTTTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHH----HT
T ss_pred cccceecCCCc--cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHH----hc
Confidence 99998765432 2334579999999999853 567889999999999999999999997532 1222111 11
Q ss_pred CccccccCcccCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 575 GRILDVADPLLNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 575 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
+.... .+...... ...+..+...|++. |++||+++|++++
T Consensus 360 ~~~~~--~~~~~~~~----~~~~~~li~~~L~~dP~~Rps~~e~l~h 400 (419)
T 3i6u_A 360 GKYNF--IPEVWAEV----SEKALDLVKKLLVVDPKARFTTEEALRH 400 (419)
T ss_dssp TCCCC--CHHHHTTS----CHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCCCC--Cchhhccc----CHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 11110 00000111 13455666788887 9999999999985
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-38 Score=330.84 Aligned_cols=261 Identities=26% Similarity=0.361 Sum_probs=196.7
Q ss_pred HhcCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCchhHHHHHHHHHHHhc--ccccCceeEeeeeccc----Cc
Q 005940 351 ATKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGR--LRHKNLVNLHGWCKQK----ND 424 (668)
Q Consensus 351 at~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~--l~H~nIv~l~g~~~~~----~~ 424 (668)
..++|+..++||+|+||.||+|++ .++.||||++.... ...+..|.+++.. ++||||+++++++... ..
T Consensus 35 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 109 (337)
T 3mdy_A 35 IAKQIQMVKQIGKGRYGEVWMGKW--RGEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQ 109 (337)
T ss_dssp HHHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCE
T ss_pred cccceEEEeEeecCCCeEEEEEEE--CCceEEEEEEeccc---cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCc
Confidence 346899999999999999999998 48899999986543 2344455555555 4899999999999776 67
Q ss_pred eEEEEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhcc-----CCceEecCCCCCCEEECCCCCEEEEe
Q 005940 425 LLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEW-----EQVVIHRDVKPSNALIDAEMNARLGD 499 (668)
Q Consensus 425 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~-----~~~ivHrDLkp~NIll~~~~~~kl~D 499 (668)
.++||||+++|+|.+++.. ..+++..++.++.|++.||.|||+.. ..+|+||||||+||+++.++.+||+|
T Consensus 110 ~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~D 185 (337)
T 3mdy_A 110 LYLITDYHENGSLYDYLKS----TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIAD 185 (337)
T ss_dssp EEEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECC
T ss_pred eEEEEeccCCCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEe
Confidence 8999999999999999953 35999999999999999999999810 12999999999999999999999999
Q ss_pred ecCceeccCCCCCc---ccccccCCcccCcccccCCCCCcc------hhHHHHHHHHHHHHhC----------CCCCCCC
Q 005940 500 FGLARLYDHGGMPH---TTNVVGTFGYIAPELTQTGKASTS------SDVFAYGILLLEVATG----------RRPIGSG 560 (668)
Q Consensus 500 fGla~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~------sDV~S~Gvvl~elltG----------~~p~~~~ 560 (668)
||+++......... .....||+.|+|||++.+.....+ +|||||||++|||++| +.||...
T Consensus 186 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~ 265 (337)
T 3mdy_A 186 LGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDL 265 (337)
T ss_dssp CTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred CCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhh
Confidence 99998765433221 124579999999999987766554 9999999999999999 6666432
Q ss_pred ---chhHHHHHHHHHhcCccccccCcccCCcc-cHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhccCc
Q 005940 561 ---DLLLVEWVRECHQLGRILDVADPLLNSSY-VVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSGEK 625 (668)
Q Consensus 561 ---~~~l~~~~~~~~~~~~~~~~~d~~l~~~~-~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~~~ 625 (668)
+..... .......... .+.+.... .......+..++..|++. |++||++.||+++|+...
T Consensus 266 ~~~~~~~~~-~~~~~~~~~~----~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~ 330 (337)
T 3mdy_A 266 VPSDPSYED-MREIVCIKKL----RPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMS 330 (337)
T ss_dssp SCSSCCHHH-HHHHHTTSCC----CCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred cCCCCchhh-hHHHHhhhcc----CccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHH
Confidence 111111 1121211111 12222111 124456677888899998 999999999999998654
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-38 Score=326.04 Aligned_cols=253 Identities=26% Similarity=0.343 Sum_probs=199.6
Q ss_pred CcccceeeeecCcEEEEEEEeCCCCc---EEEEEEEecCCc-hhHHHHHHHHHHHhcccccCceeEeeeecccCce-EEE
Q 005940 354 GFKESEVIGIGGFGSVYKGVLPTTGG---EVAVKKITRNSL-QGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDL-LLV 428 (668)
Q Consensus 354 ~f~~~~~lG~G~~g~Vy~~~~~~~~~---~vavK~~~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~-~lV 428 (668)
.|...++||+|+||.||+|.+..++. .||+|++..... ...+.+.+|++++++++||||+++++++.+.+.. ++|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 45567899999999999999755444 799999976433 4567899999999999999999999999866655 999
Q ss_pred EEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccC
Q 005940 429 YEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDH 508 (668)
Q Consensus 429 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~ 508 (668)
|||+.+|+|.+++.. ....+++..++.++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||+++....
T Consensus 102 ~e~~~~~~L~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 176 (298)
T 3pls_A 102 LPYMCHGDLLQFIRS--PQRNPTVKDLISFGLQVARGMEYLAE---QKFVHRDLAARNCMLDESFTVKVADFGLARDILD 176 (298)
T ss_dssp ECCCTTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTT
T ss_pred EecccCCCHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCcEEeCcCCCcccccC
Confidence 999999999999964 34568999999999999999999999 9999999999999999999999999999986543
Q ss_pred CC---CCcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCC-CCCch-hHHHHHHHHHhcCccccccCc
Q 005940 509 GG---MPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPI-GSGDL-LLVEWVRECHQLGRILDVADP 583 (668)
Q Consensus 509 ~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~-~~~~~-~l~~~~~~~~~~~~~~~~~d~ 583 (668)
.. ........++..|+|||.+.+..++.++|||||||++|||++|..|+ ...+. .....+. .....
T Consensus 177 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~----~~~~~----- 247 (298)
T 3pls_A 177 REYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLA----QGRRL----- 247 (298)
T ss_dssp GGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHH----TTCCC-----
T ss_pred CcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhh----cCCCC-----
Confidence 21 12223456788999999999989999999999999999999966664 33222 2222111 11111
Q ss_pred ccCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhccC
Q 005940 584 LLNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSGE 624 (668)
Q Consensus 584 ~l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~~ 624 (668)
....... ..+..+...|+.. |++||+++++++.|+..
T Consensus 248 ~~~~~~~----~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~ 285 (298)
T 3pls_A 248 PQPEYCP----DSLYQVMQQCWEADPAVRPTFRVLVGEVEQI 285 (298)
T ss_dssp CCCTTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCccch----HHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 1111112 2355666789887 99999999999999865
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=336.62 Aligned_cols=251 Identities=21% Similarity=0.282 Sum_probs=193.7
Q ss_pred hcCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCC--chhHHHHHHHHHHHhcccc--cCceeEeeeecccCceEE
Q 005940 352 TKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNS--LQGMREFAAEIESLGRLRH--KNLVNLHGWCKQKNDLLL 427 (668)
Q Consensus 352 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H--~nIv~l~g~~~~~~~~~l 427 (668)
.+.|.+.+.||+|+||.||++.+. +++.||||++.... .+..+.+.+|++++.+++| +||+++++++......++
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l 86 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 86 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECT-TSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeC-CCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEE
Confidence 457899999999999999999984 68899999997543 3455789999999999986 999999999999999999
Q ss_pred EEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceecc
Q 005940 428 VYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYD 507 (668)
Q Consensus 428 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~ 507 (668)
||| +.+++|.+++.. ...+++.++..++.||+.||.|||+ .+|+||||||+|||++ ++.+||+|||+++...
T Consensus 87 v~e-~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~---~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~ 158 (343)
T 3dbq_A 87 VME-CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQ 158 (343)
T ss_dssp EEC-CCSEEHHHHHHH---SCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC-
T ss_pred EEe-CCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCcceEEEE-CCcEEEeecccccccC
Confidence 999 568899999963 3468999999999999999999999 9999999999999997 5789999999998765
Q ss_pred CCCCC-cccccccCCcccCcccccC-----------CCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcC
Q 005940 508 HGGMP-HTTNVVGTFGYIAPELTQT-----------GKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLG 575 (668)
Q Consensus 508 ~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~ 575 (668)
..... ......||+.|+|||++.. ..++.++|||||||++|||++|+.||.......... .......
T Consensus 159 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~-~~~~~~~ 237 (343)
T 3dbq_A 159 PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKL-HAIIDPN 237 (343)
T ss_dssp -----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHH-HHHHCTT
T ss_pred cccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHH-HHHhcCC
Confidence 43322 2334579999999999854 678999999999999999999999997543222221 1111111
Q ss_pred ccccccCcccCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHh
Q 005940 576 RILDVADPLLNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYL 621 (668)
Q Consensus 576 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L 621 (668)
... ..... .. ..+..+...|++. |++||++.|++++-
T Consensus 238 ~~~-----~~~~~-~~---~~l~~li~~~L~~dp~~Rpt~~e~l~hp 275 (343)
T 3dbq_A 238 HEI-----EFPDI-PE---KDLQDVLKCCLKRDPKQRISIPELLAHP 275 (343)
T ss_dssp SCC-----CCCCC-SC---HHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred ccc-----CCccc-CC---HHHHHHHHHHcCCChhHCCCHHHHHhCc
Confidence 100 11111 11 2345666789887 99999999999874
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-38 Score=334.51 Aligned_cols=265 Identities=25% Similarity=0.271 Sum_probs=196.3
Q ss_pred HHhcCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCch-----hHHHHHHHHHHHhcccccCceeEeeeecccCc
Q 005940 350 AATKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQ-----GMREFAAEIESLGRLRHKNLVNLHGWCKQKND 424 (668)
Q Consensus 350 ~at~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-----~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~ 424 (668)
...++|...+.||+|+||.||+|++..+++.||||++...... ..+.+.+|++++++++||||+++++++.+.+.
T Consensus 7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (346)
T 1ua2_A 7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN 86 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence 3457899999999999999999999888999999998653221 12468899999999999999999999999999
Q ss_pred eEEEEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCce
Q 005940 425 LLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLAR 504 (668)
Q Consensus 425 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~ 504 (668)
.++||||+++ +|.+++.. ....+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||+++
T Consensus 87 ~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (346)
T 1ua2_A 87 ISLVFDFMET-DLEVIIKD--NSLVLTPSHIKAYMLMTLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGLAK 160 (346)
T ss_dssp CEEEEECCSE-EHHHHHTT--CCSSCCSSHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCCGGGS
T ss_pred eEEEEEcCCC-CHHHHHHh--cCcCCCHHHHHHHHHHHHHHHHHHHH---CCEECCCCCHHHEEEcCCCCEEEEecccce
Confidence 9999999975 88888853 34568999999999999999999999 999999999999999999999999999998
Q ss_pred eccCCCCCcccccccCCcccCcccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCch-hHHHHHHHHHhcCccc----
Q 005940 505 LYDHGGMPHTTNVVGTFGYIAPELTQTG-KASTSSDVFAYGILLLEVATGRRPIGSGDL-LLVEWVRECHQLGRIL---- 578 (668)
Q Consensus 505 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDV~S~Gvvl~elltG~~p~~~~~~-~l~~~~~~~~~~~~~~---- 578 (668)
....... ......||+.|+|||++.+. .++.++|||||||++|||++|..||..... .....+.+........
T Consensus 161 ~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 239 (346)
T 1ua2_A 161 SFGSPNR-AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPD 239 (346)
T ss_dssp TTTSCCC-CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSS
T ss_pred eccCCcc-cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhh
Confidence 7654322 23345789999999998654 578999999999999999999999976532 1111122211111000
Q ss_pred --cccCcccC---Cccc-----HHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHh
Q 005940 579 --DVADPLLN---SSYV-----VKEMELVLKLGLMCSHK-TQFRPTMRQVMRYL 621 (668)
Q Consensus 579 --~~~d~~l~---~~~~-----~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L 621 (668)
...+.... .... ......+..+...|+.. |++||+++|++++-
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~ 293 (346)
T 1ua2_A 240 MCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMK 293 (346)
T ss_dssp TTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSG
T ss_pred hccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcCh
Confidence 00000000 0000 01113455666678776 99999999999874
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=333.15 Aligned_cols=254 Identities=24% Similarity=0.373 Sum_probs=202.7
Q ss_pred HHhcCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCc--------hhHHHHHHHHHHHhcc-cccCceeEeeeec
Q 005940 350 AATKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSL--------QGMREFAAEIESLGRL-RHKNLVNLHGWCK 420 (668)
Q Consensus 350 ~at~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--------~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~ 420 (668)
...++|...+.||+|+||.||+|++..+|+.||||++..... ...+.+..|+.+++++ +||||+++++++.
T Consensus 91 ~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 170 (365)
T 2y7j_A 91 EFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYE 170 (365)
T ss_dssp HHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEe
Confidence 344679999999999999999999988899999999976532 1245678999999999 7999999999999
Q ss_pred ccCceEEEEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEee
Q 005940 421 QKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDF 500 (668)
Q Consensus 421 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~Df 500 (668)
..+..++||||+++++|.+++.. ...+++..+..++.||+.||.|||+ .+|+||||||+||+++.++.+||+||
T Consensus 171 ~~~~~~lv~e~~~g~~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~~LH~---~gi~H~Dlkp~NIl~~~~~~ikl~Df 244 (365)
T 2y7j_A 171 SSSFMFLVFDLMRKGELFDYLTE---KVALSEKETRSIMRSLLEAVSFLHA---NNIVHRDLKPENILLDDNMQIRLSDF 244 (365)
T ss_dssp BSSEEEEEECCCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCC
T ss_pred eCCEEEEEEEeCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEEEec
Confidence 99999999999999999999953 3469999999999999999999999 99999999999999999999999999
Q ss_pred cCceeccCCCCCcccccccCCcccCcccccC------CCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhc
Q 005940 501 GLARLYDHGGMPHTTNVVGTFGYIAPELTQT------GKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQL 574 (668)
Q Consensus 501 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~ 574 (668)
|++........ .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ ......
T Consensus 245 G~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~--~~~i~~- 319 (365)
T 2y7j_A 245 GFSCHLEPGEK--LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILM--LRMIME- 319 (365)
T ss_dssp TTCEECCTTCC--BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHH-
T ss_pred CcccccCCCcc--cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHH--HHHHHh-
Confidence 99987765432 334679999999998853 3578999999999999999999999976432211 111111
Q ss_pred CccccccCcccCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 575 GRILDVADPLLNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 575 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
+... ...+.. ... ...+..+...|+.. |++||+++|++++
T Consensus 320 ~~~~-~~~~~~-~~~----~~~~~~li~~~L~~dP~~Rps~~ell~h 360 (365)
T 2y7j_A 320 GQYQ-FSSPEW-DDR----SSTVKDLISRLLQVDPEARLTAEQALQH 360 (365)
T ss_dssp TCCC-CCHHHH-SSS----CHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCCC-CCCccc-ccC----CHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 1110 000000 011 12355666688887 9999999999985
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-38 Score=354.23 Aligned_cols=253 Identities=26% Similarity=0.339 Sum_probs=204.7
Q ss_pred hcCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCC---chhHHHHHHHHHHHhcccccCceeEeeeecccCceEEE
Q 005940 352 TKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNS---LQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLV 428 (668)
Q Consensus 352 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV 428 (668)
.++|...++||+|+||.||+|.+..+++.||||++.+.. ......+.+|++++++++||||+++++++.+.+..|+|
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 262 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 262 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence 367999999999999999999999899999999997642 23346788999999999999999999999999999999
Q ss_pred EEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccC
Q 005940 429 YEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDH 508 (668)
Q Consensus 429 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~ 508 (668)
|||+++|+|.+++... ....+++..++.++.||+.||.|||+ .+|+||||||+||||+.++.+||+|||+++....
T Consensus 263 mEy~~gg~L~~~l~~~-~~~~l~e~~~~~i~~qIl~aL~yLH~---~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~ 338 (576)
T 2acx_A 263 LTLMNGGDLKFHIYHM-GQAGFPEARAVFYAAEICCGLEDLHR---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPE 338 (576)
T ss_dssp ECCCCSCBHHHHHHSS-SSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEcCCCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeccCCchheEEEeCCCCeEEEecccceeccc
Confidence 9999999999999643 23459999999999999999999999 9999999999999999999999999999987754
Q ss_pred CCCCcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchh-HHHHHHHHHhcCccccccCcccCC
Q 005940 509 GGMPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLL-LVEWVRECHQLGRILDVADPLLNS 587 (668)
Q Consensus 509 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~-l~~~~~~~~~~~~~~~~~d~~l~~ 587 (668)
... ....+||+.|+|||++.+..++.++|||||||++|||++|+.||...... ....+........ ..+..
T Consensus 339 ~~~--~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~------~~~p~ 410 (576)
T 2acx_A 339 GQT--IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVP------EEYSE 410 (576)
T ss_dssp TCC--EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCC------CCCCT
T ss_pred Ccc--ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhccc------ccCCc
Confidence 432 23458999999999999889999999999999999999999999754211 1111111111111 11112
Q ss_pred cccHHHHHHHHHHHhhcCCC-CCCCC-----CHHHHHHH
Q 005940 588 SYVVKEMELVLKLGLMCSHK-TQFRP-----TMRQVMRY 620 (668)
Q Consensus 588 ~~~~~~~~~l~~l~~~C~~~-p~~RP-----s~~evl~~ 620 (668)
.+. . .+..+...|+.. |++|| +++||++|
T Consensus 411 ~~s-~---~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H 445 (576)
T 2acx_A 411 RFS-P---QARSLCSQLLCKDPAERLGCRGGSAREVKEH 445 (576)
T ss_dssp TSC-H---HHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred cCC-H---HHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence 222 2 234455577776 99999 78999876
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=344.32 Aligned_cols=250 Identities=20% Similarity=0.280 Sum_probs=193.8
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCC--chhHHHHHHHHHHHhccc--ccCceeEeeeecccCceEEE
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNS--LQGMREFAAEIESLGRLR--HKNLVNLHGWCKQKNDLLLV 428 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~--H~nIv~l~g~~~~~~~~~lV 428 (668)
+.|.+.++||+|+||.||+|.+.. ++.||||++.... .+..+.+.+|++++++++ ||||+++++++...+..++|
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 134 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 134 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEE
Confidence 458999999999999999999864 8899999997543 345678999999999996 59999999999999999999
Q ss_pred EEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccC
Q 005940 429 YEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDH 508 (668)
Q Consensus 429 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~ 508 (668)
|| +.+++|.+++.. ...+++.++..++.||+.||.|||+ .+|+||||||+|||++ ++.+||+|||+++....
T Consensus 135 ~E-~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~---~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~ 206 (390)
T 2zmd_A 135 ME-CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 206 (390)
T ss_dssp EE-CCSEEHHHHHHH---CSSCCHHHHHHHHHHHHHHHHHHHT---TTCCCCCCCGGGEEES-SSCEEECCCSSSCCC--
T ss_pred Ee-cCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHEEEE-CCeEEEEecCccccccC
Confidence 99 668999999963 2468899999999999999999998 9999999999999995 57899999999987654
Q ss_pred CCCC-cccccccCCcccCcccccC-----------CCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCc
Q 005940 509 GGMP-HTTNVVGTFGYIAPELTQT-----------GKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGR 576 (668)
Q Consensus 509 ~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~ 576 (668)
.... .....+||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... ...........
T Consensus 207 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~-~~~~~~~~~~~ 285 (390)
T 2zmd_A 207 DTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI-SKLHAIIDPNH 285 (390)
T ss_dssp -------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH-HHHHHHHCTTS
T ss_pred CCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHH-HHHHHHhCccc
Confidence 3321 2334579999999999864 468899999999999999999999997542221 11122211111
Q ss_pred cccccCcccCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHh
Q 005940 577 ILDVADPLLNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYL 621 (668)
Q Consensus 577 ~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L 621 (668)
.. .... ... ..+..+...|+.. |++||++.||+++-
T Consensus 286 ~~-----~~~~-~~~---~~~~~li~~~L~~dP~~Rps~~ell~hp 322 (390)
T 2zmd_A 286 EI-----EFPD-IPE---KDLQDVLKCCLKRDPKQRISIPELLAHP 322 (390)
T ss_dssp CC-----CCCC-CSC---HHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred cC-----CCCc-cch---HHHHHHHHHHcccChhhCCCHHHHhhCc
Confidence 00 1111 111 2345666688887 99999999999863
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=322.02 Aligned_cols=248 Identities=28% Similarity=0.402 Sum_probs=197.8
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecC--CchhHHHHHHHHHHHhcccccCceeEeeeecc----cCceE
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRN--SLQGMREFAAEIESLGRLRHKNLVNLHGWCKQ----KNDLL 426 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~----~~~~~ 426 (668)
+.|...+.||+|+||.||+|.+..++..||+|++... .....+.+.+|+.++++++||||+++++++.. ....+
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 105 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence 3477788999999999999999989999999999754 33456789999999999999999999998864 35689
Q ss_pred EEEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCc--eEecCCCCCCEEEC-CCCCEEEEeecCc
Q 005940 427 LVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQV--VIHRDVKPSNALID-AEMNARLGDFGLA 503 (668)
Q Consensus 427 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~--ivHrDLkp~NIll~-~~~~~kl~DfGla 503 (668)
+||||+++++|.+++.. ...+++..++.++.||+.||.|||+ .+ |+||||||+||+++ .++.+||+|||++
T Consensus 106 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~ 179 (290)
T 1t4h_A 106 LVTELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLA 179 (290)
T ss_dssp EEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCSCCCGGGEEESSTTSCEEECCTTGG
T ss_pred EEEEecCCCCHHHHHHH---ccCCCHHHHHHHHHHHHHHHHHHHc---CCCCEEECCCCHHHEEEECCCCCEEEeeCCCc
Confidence 99999999999999953 2458999999999999999999998 77 99999999999998 7899999999999
Q ss_pred eeccCCCCCcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCc
Q 005940 504 RLYDHGGMPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADP 583 (668)
Q Consensus 504 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~ 583 (668)
...... ......||+.|+|||++. +.++.++|||||||++|||++|+.||...... ......... .....
T Consensus 180 ~~~~~~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-~~~~~~~~~-~~~~~---- 249 (290)
T 1t4h_A 180 TLKRAS---FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNA-AQIYRRVTS-GVKPA---- 249 (290)
T ss_dssp GGCCTT---SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH-HHHHHHHTT-TCCCG----
T ss_pred cccccc---ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcH-HHHHHHHhc-cCCcc----
Confidence 754432 233457899999999886 46899999999999999999999999754322 111222211 11111
Q ss_pred ccCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 584 LLNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 584 ~l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
....... ..+..+...|+.. |++||+++|++++
T Consensus 250 ~~~~~~~----~~l~~li~~~l~~dp~~Rps~~ell~h 283 (290)
T 1t4h_A 250 SFDKVAI----PEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp GGGGCCC----HHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ccCCCCC----HHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 1111111 2355666789887 9999999999975
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-38 Score=332.42 Aligned_cols=261 Identities=27% Similarity=0.375 Sum_probs=204.9
Q ss_pred HhcCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCchhHHHHHHHHHHHhc--ccccCceeEeeeecccC----c
Q 005940 351 ATKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGR--LRHKNLVNLHGWCKQKN----D 424 (668)
Q Consensus 351 at~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~--l~H~nIv~l~g~~~~~~----~ 424 (668)
..++|...+.||+|+||.||+|++ +++.||||++... ..+.+..|++++.. ++||||+++++++.... .
T Consensus 40 ~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~ 114 (342)
T 1b6c_B 40 IARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQ 114 (342)
T ss_dssp HHHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCC
T ss_pred ccccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccce
Confidence 446899999999999999999998 5889999999653 34567788888887 78999999999998765 7
Q ss_pred eEEEEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhcc-----CCceEecCCCCCCEEECCCCCEEEEe
Q 005940 425 LLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEW-----EQVVIHRDVKPSNALIDAEMNARLGD 499 (668)
Q Consensus 425 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~-----~~~ivHrDLkp~NIll~~~~~~kl~D 499 (668)
.++||||+++|+|.+++.. ..+++.+++.++.|++.||.|||... +.+|+||||||+||+++.++.+||+|
T Consensus 115 ~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 190 (342)
T 1b6c_B 115 LWLVSDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD 190 (342)
T ss_dssp EEEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECC
T ss_pred eEEEEeecCCCcHHHHHhc----cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEE
Confidence 8999999999999999953 35899999999999999999999211 28999999999999999999999999
Q ss_pred ecCceeccCCCCC---cccccccCCcccCcccccCC------CCCcchhHHHHHHHHHHHHhC----------CCCCCCC
Q 005940 500 FGLARLYDHGGMP---HTTNVVGTFGYIAPELTQTG------KASTSSDVFAYGILLLEVATG----------RRPIGSG 560 (668)
Q Consensus 500 fGla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~------~~~~~sDV~S~Gvvl~elltG----------~~p~~~~ 560 (668)
||+++........ ......||..|+|||++.+. .++.++|||||||++|||++| +.||...
T Consensus 191 fg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~ 270 (342)
T 1b6c_B 191 LGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDL 270 (342)
T ss_dssp CTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred CCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCcccc
Confidence 9999877654322 12345789999999998765 234789999999999999999 7788543
Q ss_pred ---chhHHHHHHHHHhcCccccccCcccCCcc-cHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhccCc
Q 005940 561 ---DLLLVEWVRECHQLGRILDVADPLLNSSY-VVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSGEK 625 (668)
Q Consensus 561 ---~~~l~~~~~~~~~~~~~~~~~d~~l~~~~-~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~~~ 625 (668)
+.....+...... .. ..+.+...+ ..+....+..++..|++. |++||+++||+++|+...
T Consensus 271 ~~~~~~~~~~~~~~~~-~~----~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~ 335 (342)
T 1b6c_B 271 VPSDPSVEEMRKVVCE-QK----LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 335 (342)
T ss_dssp SCSSCCHHHHHHHHTT-SC----CCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHH
T ss_pred CcCcccHHHHHHHHHH-HH----hCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHH
Confidence 1222222222211 11 122222221 234556778888899987 999999999999998653
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=335.62 Aligned_cols=261 Identities=30% Similarity=0.396 Sum_probs=198.7
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCc--hhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEE
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSL--QGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYE 430 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 430 (668)
++|...+.||+|+||.||+|.+..+++.||||++..... ...+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 104 (331)
T 4aaa_A 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFE 104 (331)
T ss_dssp GGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEe
Confidence 578889999999999999999988899999999865433 334668899999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCC
Q 005940 431 YIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGG 510 (668)
Q Consensus 431 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~ 510 (668)
|+++++|.+++.. ...+++..++.++.||+.||.|||+ .+|+||||||+||+++.++.+||+|||+++......
T Consensus 105 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 178 (331)
T 4aaa_A 105 FVDHTILDDLELF---PNGLDYQVVQKYLFQIINGIGFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG 178 (331)
T ss_dssp CCSEEHHHHHHHS---TTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred cCCcchHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHH---CCEEccCcChheEEEcCCCcEEEEeCCCceeecCCc
Confidence 9999999988753 3459999999999999999999999 999999999999999999999999999998665432
Q ss_pred CCcccccccCCcccCcccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCchhH-HHHHHHH-----------Hhc-Cc
Q 005940 511 MPHTTNVVGTFGYIAPELTQTG-KASTSSDVFAYGILLLEVATGRRPIGSGDLLL-VEWVREC-----------HQL-GR 576 (668)
Q Consensus 511 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l-~~~~~~~-----------~~~-~~ 576 (668)
. ......||..|+|||++.+. .++.++|||||||++|||++|+.||....... ...+... ... ..
T Consensus 179 ~-~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (331)
T 4aaa_A 179 E-VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPV 257 (331)
T ss_dssp ------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGG
T ss_pred c-ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccc
Confidence 2 22345789999999998765 78999999999999999999999997653221 1111110 000 00
Q ss_pred cccccCcccCCcccH-----HHHHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 577 ILDVADPLLNSSYVV-----KEMELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 577 ~~~~~d~~l~~~~~~-----~~~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
......+.+...... .....+..+...|++. |++||+++|++++
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 307 (331)
T 4aaa_A 258 FAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH 307 (331)
T ss_dssp GTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred cccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 111111111111111 1124466777789887 9999999999874
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-39 Score=337.91 Aligned_cols=254 Identities=29% Similarity=0.400 Sum_probs=200.0
Q ss_pred cccceeeeecCcEEEEEEEe----CCCCcEEEEEEEecCCc-hhHHHHHHHHHHHhcccccCceeEeeeeccc--CceEE
Q 005940 355 FKESEVIGIGGFGSVYKGVL----PTTGGEVAVKKITRNSL-QGMREFAAEIESLGRLRHKNLVNLHGWCKQK--NDLLL 427 (668)
Q Consensus 355 f~~~~~lG~G~~g~Vy~~~~----~~~~~~vavK~~~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~--~~~~l 427 (668)
|...++||+|+||.||++.+ ..+++.||||++..... ...+.+.+|++++++++||||+++++++.+. ...++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 48899999999999988864 34678899999986543 4467799999999999999999999999764 56899
Q ss_pred EEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceecc
Q 005940 428 VYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYD 507 (668)
Q Consensus 428 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~ 507 (668)
||||+++|+|.+++.. ..+++.+++.++.||+.||.|||+ .+|+||||||+||+++.++.+||+|||+++...
T Consensus 113 v~e~~~~~~L~~~l~~----~~~~~~~~~~i~~~l~~~l~~LH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 185 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPR----HSIGLAQLLLFAQQICEGMAYLHA---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 185 (318)
T ss_dssp EECCCTTCBHHHHGGG----SCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCGGGCEECC
T ss_pred EEecccCCcHHHHHhh----CCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCchheEEEcCCCCEEECCcccccccc
Confidence 9999999999999953 238999999999999999999999 999999999999999999999999999999876
Q ss_pred CCCCC--cccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHH------------HHHHHHh
Q 005940 508 HGGMP--HTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVE------------WVRECHQ 573 (668)
Q Consensus 508 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~------------~~~~~~~ 573 (668)
..... ......+|..|+|||++.+..++.++|||||||++|||++|+.||......... ...+...
T Consensus 186 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (318)
T 3lxp_A 186 EGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLE 265 (318)
T ss_dssp TTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHH
T ss_pred ccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHh
Confidence 54321 123346788899999998888999999999999999999999998643211110 1111111
Q ss_pred cCccccccCcccCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhccC
Q 005940 574 LGRILDVADPLLNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSGE 624 (668)
Q Consensus 574 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~~ 624 (668)
.... ......+. ..+..+...|++. |++||+++|+++.|+..
T Consensus 266 ~~~~-----~~~~~~~~----~~l~~li~~~l~~dP~~Rps~~ell~~L~~l 308 (318)
T 3lxp_A 266 RGER-----LPRPDKCP----AEVYHLMKNCWETEASFRPTFENLIPILKTV 308 (318)
T ss_dssp TTCC-----CCCCTTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cccC-----CCCCcccc----HHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 1111 11111122 3456677789887 99999999999999764
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=335.65 Aligned_cols=256 Identities=30% Similarity=0.430 Sum_probs=201.5
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEE--EEEEEecCC-chhHHHHHHHHHHHhcc-cccCceeEeeeecccCceEEE
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEV--AVKKITRNS-LQGMREFAAEIESLGRL-RHKNLVNLHGWCKQKNDLLLV 428 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~v--avK~~~~~~-~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV 428 (668)
++|...+.||+|+||.||+|++..++..+ |||++.... ....+.+.+|+++++++ +||||+++++++.+.+..++|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 57888999999999999999998777755 999987532 33456789999999999 899999999999999999999
Q ss_pred EEecCCCChhhhhcCCC-------------CCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCE
Q 005940 429 YEYIPNGSLDTLLFKPK-------------DGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNA 495 (668)
Q Consensus 429 ~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~ 495 (668)
|||+++|+|.+++.... ....+++.+++.++.||+.||.|||+ .+|+||||||+||+++.++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCccceEEEcCCCeE
Confidence 99999999999996432 23469999999999999999999999 999999999999999999999
Q ss_pred EEEeecCceeccCCCCCcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHHHhc
Q 005940 496 RLGDFGLARLYDHGGMPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVAT-GRRPIGSGDLLLVEWVRECHQL 574 (668)
Q Consensus 496 kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~l~~~~~~~~~~ 574 (668)
||+|||+++...... ......++..|+|||++....++.++|||||||++|||++ |+.||...... +.. .....
T Consensus 182 kL~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~--~~~-~~~~~ 256 (327)
T 1fvr_A 182 KIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA--ELY-EKLPQ 256 (327)
T ss_dssp EECCTTCEESSCEEC--CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHH-HHGGG
T ss_pred EEcccCcCccccccc--cccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHH--HHH-HHhhc
Confidence 999999997433211 1223456889999999988889999999999999999998 99999765422 111 11111
Q ss_pred CccccccCcccCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhccCc
Q 005940 575 GRILDVADPLLNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSGEK 625 (668)
Q Consensus 575 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~~~ 625 (668)
+. .......++ ..+..+...|+.. |++||+++|++++|+...
T Consensus 257 ~~-----~~~~~~~~~----~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 299 (327)
T 1fvr_A 257 GY-----RLEKPLNCD----DEVYDLMRQCWREKPYERPSFAQILVSLNRML 299 (327)
T ss_dssp TC-----CCCCCTTBC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CC-----CCCCCCCCC----HHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 11 111111222 2345666688887 999999999999997653
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-38 Score=327.16 Aligned_cols=255 Identities=27% Similarity=0.402 Sum_probs=197.5
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCC---cEEEEEEEecCC-chhHHHHHHHHHHHhcccccCceeEeeeec-ccCceEE
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTG---GEVAVKKITRNS-LQGMREFAAEIESLGRLRHKNLVNLHGWCK-QKNDLLL 427 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~---~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~-~~~~~~l 427 (668)
..|...++||+|+||.||+|++..++ ..+|+|.+.... ....+.+.+|++++++++||||++++++|. .++..++
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 104 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence 46888899999999999999975433 358999987643 345578999999999999999999999864 5567899
Q ss_pred EEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceecc
Q 005940 428 VYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYD 507 (668)
Q Consensus 428 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~ 507 (668)
||||+++|+|.+++.. ....+++..++.++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||+++...
T Consensus 105 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~ql~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~ 179 (298)
T 3f66_A 105 VLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKYLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMY 179 (298)
T ss_dssp EEECCTTCBHHHHHHC--TTCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECSCGGGCCCS
T ss_pred EEeCCCCCCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCchheEEECCCCCEEECccccccccc
Confidence 9999999999999963 34568999999999999999999999 999999999999999999999999999998665
Q ss_pred CCCC---CcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCch-hHHHHHHHHHhcCccccccC
Q 005940 508 HGGM---PHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVAT-GRRPIGSGDL-LLVEWVRECHQLGRILDVAD 582 (668)
Q Consensus 508 ~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~-~l~~~~~~~~~~~~~~~~~d 582 (668)
.... .......+|..|+|||.+.+..++.++||||||+++|||++ |..||..... ..... ......
T Consensus 180 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~---~~~~~~------ 250 (298)
T 3f66_A 180 DKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY---LLQGRR------ 250 (298)
T ss_dssp CGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHH---HHTTCC------
T ss_pred ccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHH---HhcCCC------
Confidence 4321 12334467889999999988899999999999999999999 5555544321 11111 111111
Q ss_pred cccCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhccCc
Q 005940 583 PLLNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSGEK 625 (668)
Q Consensus 583 ~~l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~~~ 625 (668)
.......+ ..+..+...|++. |++||+++|+++.|+...
T Consensus 251 ~~~~~~~~----~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~ 290 (298)
T 3f66_A 251 LLQPEYCP----DPLYEVMLKCWHPKAEMRPSFSELVSRISAIF 290 (298)
T ss_dssp CCCCTTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCccCC----HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 01111112 2355666789887 999999999999998653
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=333.80 Aligned_cols=258 Identities=24% Similarity=0.350 Sum_probs=191.7
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCchhHHHHHHHHHH--HhcccccCceeEeeeec-----ccCce
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIES--LGRLRHKNLVNLHGWCK-----QKNDL 425 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~--l~~l~H~nIv~l~g~~~-----~~~~~ 425 (668)
++|...+.||+|+||.||+|++ +++.||||++.... ...+..|.++ +..++|+||+++++.+. .....
T Consensus 13 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 87 (336)
T 3g2f_A 13 DNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY 87 (336)
T ss_dssp TSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred HHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence 6789999999999999999987 68899999997543 2334444444 55689999999998543 33467
Q ss_pred EEEEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCC---------ceEecCCCCCCEEECCCCCEE
Q 005940 426 LLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQ---------VVIHRDVKPSNALIDAEMNAR 496 (668)
Q Consensus 426 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~---------~ivHrDLkp~NIll~~~~~~k 496 (668)
++||||+++|+|.+++.. ...++..+++++.||+.||.|||+ . +|+||||||+|||++.++.+|
T Consensus 88 ~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~qi~~~L~~LH~---~~~~~~~~~~~ivH~Dikp~Nill~~~~~~k 160 (336)
T 3g2f_A 88 LLVMEYYPNGSLXKYLSL----HTSDWVSSCRLAHSVTRGLAYLHT---ELPRGDHYKPAISHRDLNSRNVLVKNDGTCV 160 (336)
T ss_dssp EEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHC---CBCCGGGCBCCEECSSCSGGGEEECTTSCEE
T ss_pred EEEEecCCCCcHHHHHhh----cccchhHHHHHHHHHHHHHHHHHh---hhccccccccceeecccccceEEEcCCCcEE
Confidence 899999999999999953 235899999999999999999998 6 999999999999999999999
Q ss_pred EEeecCceeccCCCC-------CcccccccCCcccCcccccC-------CCCCcchhHHHHHHHHHHHHhCCCCCCCCch
Q 005940 497 LGDFGLARLYDHGGM-------PHTTNVVGTFGYIAPELTQT-------GKASTSSDVFAYGILLLEVATGRRPIGSGDL 562 (668)
Q Consensus 497 l~DfGla~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~-------~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~ 562 (668)
|+|||+++....... .......||..|+|||++.+ ..++.++|||||||++|||++|+.|+.....
T Consensus 161 L~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~ 240 (336)
T 3g2f_A 161 ISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGES 240 (336)
T ss_dssp ECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSC
T ss_pred EeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccc
Confidence 999999987654321 11224479999999999876 3566899999999999999999877643210
Q ss_pred ----------------hHHHHHHHHHhcCccccccCcccCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhccCc
Q 005940 563 ----------------LLVEWVRECHQLGRILDVADPLLNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSGEK 625 (668)
Q Consensus 563 ----------------~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~~~ 625 (668)
...++ ............+.+.. .........+..+...|+.. |++||+++||++.|+...
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll 317 (336)
T 3g2f_A 241 VPEYQMAFQTEVGNHPTFEDM-QVLVSREKQRPKFPEAW--KENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELM 317 (336)
T ss_dssp CCCCCCTTHHHHCSSCCHHHH-HHHHTTSCCCCCCCTTC--CCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred hhHHHHhhhcccCCCchHHHH-HhhhcccccCCCCCccc--ccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHH
Confidence 01111 11111111111111111 01122344577777899998 999999999999998764
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-38 Score=347.67 Aligned_cols=194 Identities=27% Similarity=0.394 Sum_probs=156.5
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecC--CchhHHHHHHHHHHHhcccccCceeEeeeecc-----cCce
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRN--SLQGMREFAAEIESLGRLRHKNLVNLHGWCKQ-----KNDL 425 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~-----~~~~ 425 (668)
++|...++||+|+||.||+|.+..+++.||||++.+. .....+.+.+|++++++++||||+++++++.. ....
T Consensus 53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 132 (458)
T 3rp9_A 53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDEL 132 (458)
T ss_dssp TTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceE
Confidence 5789999999999999999999889999999999764 33455788999999999999999999999943 3578
Q ss_pred EEEEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCcee
Q 005940 426 LLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARL 505 (668)
Q Consensus 426 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~ 505 (668)
|+||||+ +++|.+++.. ...+++..+..++.||+.||.|||+ .+|+||||||+||||+.++.+||+|||+++.
T Consensus 133 ~lv~e~~-~~~L~~~~~~---~~~l~~~~~~~~~~qi~~aL~~LH~---~~iiHrDlKp~NILl~~~~~~kl~DFGla~~ 205 (458)
T 3rp9_A 133 YVVLEIA-DSDFKKLFRT---PVYLTELHIKTLLYNLLVGVKYVHS---AGILHRDLKPANCLVNQDCSVKVCDFGLART 205 (458)
T ss_dssp EEEECCC-SEEHHHHHHS---SCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred EEEEecc-ccchhhhccc---CCCCCHHHHHHHHHHHHHHHHHHHh---CCcCCCCCChhhEEECCCCCEeecccccchh
Confidence 9999998 5789999863 3469999999999999999999999 9999999999999999999999999999987
Q ss_pred ccCCCC--------------------------CcccccccCCcccCcccc-cCCCCCcchhHHHHHHHHHHHHhC
Q 005940 506 YDHGGM--------------------------PHTTNVVGTFGYIAPELT-QTGKASTSSDVFAYGILLLEVATG 553 (668)
Q Consensus 506 ~~~~~~--------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~sDV~S~Gvvl~elltG 553 (668)
...... ...+..+||+.|+|||++ ....++.++|||||||++|||++|
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 206 VDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp TTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred ccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 653221 122345789999999976 456799999999999999999993
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=331.64 Aligned_cols=263 Identities=23% Similarity=0.374 Sum_probs=197.1
Q ss_pred hhHHHHhcCcccceeeeecCcEEEEEEEeCC---CCcEEEEEEEecC--CchhHHHHHHHHHHHhcccccCceeEeeeec
Q 005940 346 KDLYAATKGFKESEVIGIGGFGSVYKGVLPT---TGGEVAVKKITRN--SLQGMREFAAEIESLGRLRHKNLVNLHGWCK 420 (668)
Q Consensus 346 ~el~~at~~f~~~~~lG~G~~g~Vy~~~~~~---~~~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~ 420 (668)
+++....++|...+.||+|+||.||+|.+.. ++..||||++... .....+.+.+|++++++++||||+++++++.
T Consensus 27 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 106 (313)
T 3brb_A 27 EDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCI 106 (313)
T ss_dssp TTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEE
T ss_pred HhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEe
Confidence 3444455789999999999999999998754 3458999998754 3345578999999999999999999999997
Q ss_pred ccC-----ceEEEEEecCCCChhhhhcCC---CCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCC
Q 005940 421 QKN-----DLLLVYEYIPNGSLDTLLFKP---KDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAE 492 (668)
Q Consensus 421 ~~~-----~~~lV~E~~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~ 492 (668)
+.. ..++||||+++|+|.+++... .....+++..++.++.||+.||.|||+ .+|+||||||+||+++.+
T Consensus 107 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dikp~NIli~~~ 183 (313)
T 3brb_A 107 EMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSN---RNFLHRDLAARNCMLRDD 183 (313)
T ss_dssp C-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHT---TTCCCCCCSGGGEEECTT
T ss_pred eccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCC
Confidence 654 359999999999999998422 234569999999999999999999998 999999999999999999
Q ss_pred CCEEEEeecCceeccCCCC-CcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCch-hHHHHHH
Q 005940 493 MNARLGDFGLARLYDHGGM-PHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVAT-GRRPIGSGDL-LLVEWVR 569 (668)
Q Consensus 493 ~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~-~l~~~~~ 569 (668)
+.+||+|||+++....... .......++..|+|||.+.+..++.++|||||||++|||++ |+.||..... ...+..
T Consensus 184 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~- 262 (313)
T 3brb_A 184 MTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYL- 262 (313)
T ss_dssp SCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHH-
T ss_pred CcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHH-
Confidence 9999999999987654322 12233467889999999998899999999999999999999 8899875432 222211
Q ss_pred HHHhcCccccccCcccCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhccC
Q 005940 570 ECHQLGRILDVADPLLNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSGE 624 (668)
Q Consensus 570 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~~ 624 (668)
.. ... +.....+. ..+..+...|+.. |++||++++++++|+..
T Consensus 263 --~~-~~~-----~~~~~~~~----~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l 306 (313)
T 3brb_A 263 --LH-GHR-----LKQPEDCL----DELYEIMYSCWRTDPLDRPTFSVLRLQLEKL 306 (313)
T ss_dssp --HT-TCC-----CCCBTTCC----HHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred --Hc-CCC-----CCCCcccc----HHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 11 111 11111122 3455666789887 99999999999999865
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-39 Score=362.74 Aligned_cols=256 Identities=27% Similarity=0.432 Sum_probs=204.9
Q ss_pred HhcCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCchhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEE
Q 005940 351 ATKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYE 430 (668)
Q Consensus 351 at~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 430 (668)
..++|...++||+|+||.||+|.+.. +..||||++..... ..++|.+|++++++++|+||++++++|.+ +..++|||
T Consensus 265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e 341 (535)
T 2h8h_A 265 PRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE 341 (535)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred chhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeee
Confidence 34578889999999999999999954 56799999976543 35789999999999999999999999976 67899999
Q ss_pred ecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCC
Q 005940 431 YIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGG 510 (668)
Q Consensus 431 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~ 510 (668)
|+++|+|.++|... .+..+++.+++.++.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+++......
T Consensus 342 ~~~~gsL~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 417 (535)
T 2h8h_A 342 YMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 417 (535)
T ss_dssp CCTTEEHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHH
T ss_pred hhcCCcHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCc
Confidence 99999999999531 23458999999999999999999999 999999999999999999999999999998665322
Q ss_pred CCcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHHHhcCccccccCcccCCcc
Q 005940 511 MPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVAT-GRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSY 589 (668)
Q Consensus 511 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 589 (668)
........++..|+|||++..+.++.++|||||||++|||++ |+.||...... +..... ..+.... ....+
T Consensus 418 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~--~~~~~i-~~~~~~~-----~~~~~ 489 (535)
T 2h8h_A 418 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR--EVLDQV-ERGYRMP-----CPPEC 489 (535)
T ss_dssp HHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHH--HHHHHH-HTTCCCC-----CCTTC
T ss_pred eecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHH-HcCCCCC-----CCCCC
Confidence 112223456788999999988899999999999999999999 99999764321 111111 1111111 11112
Q ss_pred cHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhccCc
Q 005940 590 VVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSGEK 625 (668)
Q Consensus 590 ~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~~~ 625 (668)
. ..+..++..|++. |++||++++|++.|+...
T Consensus 490 ~----~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~ 522 (535)
T 2h8h_A 490 P----ESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 522 (535)
T ss_dssp C----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred C----HHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 2 3455677789997 999999999999998764
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=335.52 Aligned_cols=261 Identities=21% Similarity=0.278 Sum_probs=191.2
Q ss_pred hcCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCc--hhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEE
Q 005940 352 TKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSL--QGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVY 429 (668)
Q Consensus 352 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 429 (668)
.++|...++||+|+||.||+|.+..+++.||||++..... ...+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 112 (329)
T 3gbz_A 33 IDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIF 112 (329)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEE
Confidence 3579999999999999999999988999999999975433 23456789999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEEC-----CCCCEEEEeecCce
Q 005940 430 EYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALID-----AEMNARLGDFGLAR 504 (668)
Q Consensus 430 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~-----~~~~~kl~DfGla~ 504 (668)
||++ |+|.+++.. ...+++..++.++.||+.||.|||+ .+|+||||||+|||++ .++.+||+|||+++
T Consensus 113 e~~~-~~L~~~~~~---~~~~~~~~~~~i~~ql~~~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~ 185 (329)
T 3gbz_A 113 EYAE-NDLKKYMDK---NPDVSMRVIKSFLYQLINGVNFCHS---RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR 185 (329)
T ss_dssp ECCS-EEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEC-----CCEEEECCTTHHH
T ss_pred ecCC-CCHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCEECCCCCHHHEEEecCCCCccceEEECcCCCcc
Confidence 9997 599999863 3459999999999999999999999 9999999999999994 45569999999998
Q ss_pred eccCCCCCcccccccCCcccCcccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCchhH-HHHHHHHHhcCcccc---
Q 005940 505 LYDHGGMPHTTNVVGTFGYIAPELTQTG-KASTSSDVFAYGILLLEVATGRRPIGSGDLLL-VEWVRECHQLGRILD--- 579 (668)
Q Consensus 505 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l-~~~~~~~~~~~~~~~--- 579 (668)
...... .......||..|+|||++.+. .++.++|||||||++|||++|+.||....... ...+.+.........
T Consensus 186 ~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (329)
T 3gbz_A 186 AFGIPI-RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPG 264 (329)
T ss_dssp HHC------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTT
T ss_pred ccCCcc-cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhh
Confidence 765432 223345789999999998774 48999999999999999999999997653221 111111111000000
Q ss_pred ---c-----cCcccCCcccHH-----HHHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 580 ---V-----ADPLLNSSYVVK-----EMELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 580 ---~-----~d~~l~~~~~~~-----~~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
. ..+......... .-..+..+...|+.. |++||+++|++++
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 319 (329)
T 3gbz_A 265 VTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEH 319 (329)
T ss_dssp GGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred hhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCC
Confidence 0 000000000000 113445666788887 9999999999974
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=339.78 Aligned_cols=258 Identities=17% Similarity=0.170 Sum_probs=199.7
Q ss_pred cCcccceeeeecCcEEEEEEEeCC--------CCcEEEEEEEecCCchhHHHHHHHHHHHhcccccCcee----------
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPT--------TGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVN---------- 414 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~--------~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~---------- 414 (668)
++|...+.||+|+||.||+|++.. .++.||||++... +.+.+|++++++++||||++
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 116 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPL 116 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTT
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCc
Confidence 679999999999999999999976 3789999999755 35788999999999999988
Q ss_pred -----Eeeeecc-cCceEEEEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEE
Q 005940 415 -----LHGWCKQ-KNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNAL 488 (668)
Q Consensus 415 -----l~g~~~~-~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIl 488 (668)
+++++.. ....++||||+ +++|.+++... ....+++.+++.++.||+.||.|||+ .+|+||||||+||+
T Consensus 117 ~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dikp~NIl 191 (352)
T 2jii_A 117 LAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVS-PKHVLSERSVLQVACRLLDALEFLHE---NEYVHGNVTAENIF 191 (352)
T ss_dssp CSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCCGGGEE
T ss_pred cCccchhhccccCCcEEEEEecCC-CcCHHHHHHhC-CcCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCHHHEE
Confidence 5666665 67889999999 99999999632 23569999999999999999999999 99999999999999
Q ss_pred ECCCC--CEEEEeecCceeccCCCC------CcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 005940 489 IDAEM--NARLGDFGLARLYDHGGM------PHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSG 560 (668)
Q Consensus 489 l~~~~--~~kl~DfGla~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~ 560 (668)
++.++ .+||+|||+++....... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 192 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 271 (352)
T 2jii_A 192 VDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNC 271 (352)
T ss_dssp EETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred EcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence 99998 899999999986653221 1123347999999999999889999999999999999999999999753
Q ss_pred c---hhHHHHHHHHHhcCccccccCcccCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhccCc
Q 005940 561 D---LLLVEWVRECHQLGRILDVADPLLNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSGEK 625 (668)
Q Consensus 561 ~---~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~~~ 625 (668)
. ..+......... ......+......... ..+..+...|+.. |++||++++|++.|+...
T Consensus 272 ~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~---~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 335 (352)
T 2jii_A 272 LPNTEDIMKQKQKFVD--KPGPFVGPCGHWIRPS---ETLQKYLKVVMALTYEEKPPYAMLRNNLEALL 335 (352)
T ss_dssp TTCHHHHHHHHHHHHH--SCCCEECTTSCEECCC---HHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHH
T ss_pred CcCHHHHHHHHHhccC--ChhhhhhhccccCCCc---HHHHHHHHHHHhCChhhCCCHHHHHHHHHHHH
Confidence 2 222222222111 1111212111111112 2345556678877 999999999999997653
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=360.82 Aligned_cols=253 Identities=23% Similarity=0.349 Sum_probs=198.0
Q ss_pred cCcccce-eeeecCcEEEEEEEeCC--CCcEEEEEEEecCC-chhHHHHHHHHHHHhcccccCceeEeeeecccCceEEE
Q 005940 353 KGFKESE-VIGIGGFGSVYKGVLPT--TGGEVAVKKITRNS-LQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLV 428 (668)
Q Consensus 353 ~~f~~~~-~lG~G~~g~Vy~~~~~~--~~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV 428 (668)
+++...+ +||+|+||.||+|.+.. ++..||||++.... ....++|.+|++++++++||||++++++|.. +..++|
T Consensus 335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv 413 (613)
T 2ozo_A 335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 413 (613)
T ss_dssp TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEE
T ss_pred cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEE
Confidence 3444444 79999999999998753 45679999997653 3456789999999999999999999999976 569999
Q ss_pred EEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccC
Q 005940 429 YEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDH 508 (668)
Q Consensus 429 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~ 508 (668)
|||+++|+|.+++.. ....+++.+++.++.||+.||.|||+ .+|+||||||+||||+.++.+||+|||+++....
T Consensus 414 ~E~~~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~~L~~LH~---~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~ 488 (613)
T 2ozo_A 414 MEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEE---KNFVHRNLAARNVLLVNRHYAKISDFGLSKALGA 488 (613)
T ss_dssp EECCTTCBHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC-
T ss_pred EEeCCCCcHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHH---CCEEcCcCCHHHEEEcCCCcEEEeeccCcccccC
Confidence 999999999999953 34569999999999999999999999 9999999999999999999999999999987654
Q ss_pred CCCCc--ccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCch-hHHHHHHHHHhcCccccccCcc
Q 005940 509 GGMPH--TTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVAT-GRRPIGSGDL-LLVEWVRECHQLGRILDVADPL 584 (668)
Q Consensus 509 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~-~l~~~~~~~~~~~~~~~~~d~~ 584 (668)
..... .....++..|+|||++..+.++.++|||||||++|||++ |+.||...+. .+.+ ....+....
T Consensus 489 ~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~----~i~~~~~~~----- 559 (613)
T 2ozo_A 489 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMA----FIEQGKRME----- 559 (613)
T ss_dssp -------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHH----HHHTTCCCC-----
T ss_pred CCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHH----HHHcCCCCC-----
Confidence 32211 122345689999999998899999999999999999998 9999976532 2222 122221111
Q ss_pred cCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhccC
Q 005940 585 LNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSGE 624 (668)
Q Consensus 585 l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~~ 624 (668)
....+. ..+..++..|++. |++||++++|++.|+..
T Consensus 560 ~p~~~~----~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~ 596 (613)
T 2ozo_A 560 CPPECP----PELYALMSDCWIYKWEDRPDFLTVEQRMRAC 596 (613)
T ss_dssp CCTTCC----HHHHHHHHHTTCSSTTTSCCHHHHHHHHHHH
T ss_pred CCCcCC----HHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 111122 3456677799998 99999999999998753
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-38 Score=323.90 Aligned_cols=246 Identities=24% Similarity=0.341 Sum_probs=202.2
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCc---hhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEE
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSL---QGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVY 429 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 429 (668)
++|...+.||+|+||.||+|.+..++..||||++..... ...+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 93 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML 93 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence 578899999999999999999988899999999965422 23467899999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCC
Q 005940 430 EYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHG 509 (668)
Q Consensus 430 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~ 509 (668)
||+++++|.+++.. ...+++..++.++.||+.||.|||+ .+|+||||||+||+++.++.+||+|||++......
T Consensus 94 e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~ 167 (284)
T 2vgo_A 94 EFAPRGELYKELQK---HGRFDEQRSATFMEELADALHYCHE---RKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL 167 (284)
T ss_dssp CCCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECTTCCEEECCCTTCEECSSS
T ss_pred EeCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEEcCCCCEEEecccccccCccc
Confidence 99999999999963 2358999999999999999999998 99999999999999999999999999999765432
Q ss_pred CCCcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCcccCCcc
Q 005940 510 GMPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSY 589 (668)
Q Consensus 510 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 589 (668)
. .....|+..|+|||++.+..++.++||||||+++|||++|+.||....... ....... . +..+....
T Consensus 168 ~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~~~~-~------~~~~~~~~ 235 (284)
T 2vgo_A 168 R---RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTE--THRRIVN-V------DLKFPPFL 235 (284)
T ss_dssp C---BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH--HHHHHHT-T------CCCCCTTS
T ss_pred c---cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhH--HHHHHhc-c------ccCCCCcC
Confidence 2 234578999999999998899999999999999999999999997653221 1111111 1 11111222
Q ss_pred cHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 590 VVKEMELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 590 ~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
+ ..+..+...|+.. |++||+++|++++
T Consensus 236 ~----~~~~~li~~~l~~~p~~Rps~~~ll~h 263 (284)
T 2vgo_A 236 S----DGSKDLISKLLRYHPPQRLPLKGVMEH 263 (284)
T ss_dssp C----HHHHHHHHHHSCSSGGGSCCHHHHHTC
T ss_pred C----HHHHHHHHHHhhcCHhhCCCHHHHhhC
Confidence 2 2344566678887 9999999999974
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=321.48 Aligned_cols=252 Identities=24% Similarity=0.369 Sum_probs=202.6
Q ss_pred hcCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCC---------chhHHHHHHHHHHHhccc-ccCceeEeeeecc
Q 005940 352 TKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNS---------LQGMREFAAEIESLGRLR-HKNLVNLHGWCKQ 421 (668)
Q Consensus 352 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---------~~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~ 421 (668)
.++|...+.||+|+||.||+|.+..+++.||||++.... ....+.+.+|++++++++ ||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 95 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence 368999999999999999999998899999999997643 123457889999999996 9999999999999
Q ss_pred cCceEEEEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeec
Q 005940 422 KNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFG 501 (668)
Q Consensus 422 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfG 501 (668)
.+..++||||+++++|.+++.. ...+++..++.++.||+.||.|||+ .+++||||||+||+++.++.+||+|||
T Consensus 96 ~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg 169 (298)
T 1phk_A 96 NTFFFLVFDLMKKGELFDYLTE---KVTLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFG 169 (298)
T ss_dssp SSEEEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCT
T ss_pred CCeEEEEEeccCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEEcCCCcEEEeccc
Confidence 9999999999999999999963 3468999999999999999999999 999999999999999999999999999
Q ss_pred CceeccCCCCCcccccccCCcccCccccc------CCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcC
Q 005940 502 LARLYDHGGMPHTTNVVGTFGYIAPELTQ------TGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLG 575 (668)
Q Consensus 502 la~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~ 575 (668)
++....... ......|+..|+|||++. ...++.++||||||+++|||++|+.||....... ....... .
T Consensus 170 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~--~~~~~~~-~ 244 (298)
T 1phk_A 170 FSCQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML--MLRMIMS-G 244 (298)
T ss_dssp TCEECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHH-T
T ss_pred chhhcCCCc--ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHH--HHHHHhc-C
Confidence 998766433 233457899999999874 4568899999999999999999999997653221 1122111 1
Q ss_pred ccccccCcccCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 576 RILDVADPLLNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 576 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
... ...+.. ..+. ..+..+...|+.. |++||++.|++++
T Consensus 245 ~~~-~~~~~~-~~~~----~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (298)
T 1phk_A 245 NYQ-FGSPEW-DDYS----DTVKDLVSRFLVVQPQKRYTAEEALAH 284 (298)
T ss_dssp CCC-CCTTTG-GGSC----HHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred Ccc-cCcccc-cccC----HHHHHHHHHHccCCcccCCCHHHHHhC
Confidence 111 001111 1111 2355666688887 9999999999873
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=346.75 Aligned_cols=250 Identities=26% Similarity=0.389 Sum_probs=197.1
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCC--chhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEE
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNS--LQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYE 430 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 430 (668)
+.|...++||+|+||.||+|++..++..||||++.+.. ......+.+|++++++++||||++++++|.+....++|||
T Consensus 37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 116 (494)
T 3lij_A 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVME 116 (494)
T ss_dssp HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence 56889999999999999999999899999999997653 2345778999999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCC---CCEEEEeecCceecc
Q 005940 431 YIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAE---MNARLGDFGLARLYD 507 (668)
Q Consensus 431 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~---~~~kl~DfGla~~~~ 507 (668)
|+++|+|.+++.. ...+++..+..++.||+.||.|||+ .+|+||||||+|||++.+ +.+||+|||+++...
T Consensus 117 ~~~~g~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~ 190 (494)
T 3lij_A 117 CYKGGELFDEIIH---RMKFNEVDAAVIIKQVLSGVTYLHK---HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFE 190 (494)
T ss_dssp CCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECB
T ss_pred cCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCChhhEEEeCCCCCCcEEEEECCCCeECC
Confidence 9999999988853 3458999999999999999999999 999999999999999764 459999999998776
Q ss_pred CCCCCcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCcccCC
Q 005940 508 HGGMPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNS 587 (668)
Q Consensus 508 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 587 (668)
... ......||+.|+|||++. +.++.++||||+||++|||++|+.||...... +....... +... ...+.. .
T Consensus 191 ~~~--~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--~~~~~i~~-~~~~-~~~~~~-~ 262 (494)
T 3lij_A 191 NQK--KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQ--EILRKVEK-GKYT-FDSPEW-K 262 (494)
T ss_dssp TTB--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHH-TCCC-CCSGGG-T
T ss_pred CCc--cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHh-CCCC-CCchhc-c
Confidence 543 233457999999999886 57999999999999999999999999765322 11222221 1111 111111 1
Q ss_pred cccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 588 SYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 588 ~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
... ..+..+...|++. |++||+++|++++
T Consensus 263 ~~s----~~~~~li~~~L~~dp~~R~s~~e~l~h 292 (494)
T 3lij_A 263 NVS----EGAKDLIKQMLQFDSQRRISAQQALEH 292 (494)
T ss_dssp TSC----HHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred cCC----HHHHHHHHHHCCCChhhCccHHHHhcC
Confidence 112 2344556678887 9999999999975
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-38 Score=350.30 Aligned_cols=253 Identities=26% Similarity=0.360 Sum_probs=204.3
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCc---hhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEE
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSL---QGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVY 429 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 429 (668)
++|...++||+|+||.||+|+++.+++.||||++.+... ...+.+..|++++++++||||+++++++......|+||
T Consensus 185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm 264 (543)
T 3c4z_A 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM 264 (543)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence 678899999999999999999988999999999976432 33467889999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCC-CCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccC
Q 005940 430 EYIPNGSLDTLLFKPK-DGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDH 508 (668)
Q Consensus 430 E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~ 508 (668)
||+++|+|.+++.... ....+++..++.++.||+.||.|||+ .+|+||||||+||||+.++.+||+|||+++....
T Consensus 265 E~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~---~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~ 341 (543)
T 3c4z_A 265 TIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKA 341 (543)
T ss_dssp CCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHH---cCCcccCCChHHEEEeCCCCEEEeecceeeeccC
Confidence 9999999999986432 24569999999999999999999999 9999999999999999999999999999997665
Q ss_pred CCCCcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCch--hHHHHHHHHHhcCccccccCcccC
Q 005940 509 GGMPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDL--LLVEWVRECHQLGRILDVADPLLN 586 (668)
Q Consensus 509 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~--~l~~~~~~~~~~~~~~~~~d~~l~ 586 (668)
... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||..... ...+....... .. ....
T Consensus 342 ~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~-~~------~~~p 413 (543)
T 3c4z_A 342 GQT-KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLE-QA------VTYP 413 (543)
T ss_dssp TCC-CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHH-CC------CCCC
T ss_pred CCc-ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhh-cc------cCCC
Confidence 432 23345899999999999998999999999999999999999999975421 12222222221 11 1111
Q ss_pred CcccHHHHHHHHHHHhhcCCC-CCCCCCH-----HHHHHH
Q 005940 587 SSYVVKEMELVLKLGLMCSHK-TQFRPTM-----RQVMRY 620 (668)
Q Consensus 587 ~~~~~~~~~~l~~l~~~C~~~-p~~RPs~-----~evl~~ 620 (668)
..+. . .+..+...|+.. |++||++ ++|+++
T Consensus 414 ~~~s-~---~~~~li~~lL~~dP~~R~~~~~~~a~ei~~H 449 (543)
T 3c4z_A 414 DKFS-P---ASKDFCEALLQKDPEKRLGFRDGSCDGLRTH 449 (543)
T ss_dssp TTSC-H---HHHHHHHHHSCSSGGGSCCCBTTBSHHHHTS
T ss_pred cccC-H---HHHHHHHHhccCCHhHCCCCcccCHHHHHcC
Confidence 1222 2 234455578776 9999975 677754
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=331.10 Aligned_cols=260 Identities=27% Similarity=0.406 Sum_probs=183.5
Q ss_pred hcCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCC-chhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEE
Q 005940 352 TKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNS-LQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYE 430 (668)
Q Consensus 352 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 430 (668)
.++|...+.||+|+||.||+|.+..+++.||||++.... ....+++.+|++++++++||||+++++++...+..++|||
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 93 (303)
T 2vwi_A 14 RDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMK 93 (303)
T ss_dssp CCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEE
T ss_pred hhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEeh
Confidence 468999999999999999999998889999999986543 2345678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhcC-----CCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCcee
Q 005940 431 YIPNGSLDTLLFK-----PKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARL 505 (668)
Q Consensus 431 ~~~~gsL~~~l~~-----~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~ 505 (668)
|+++++|.+++.. ......+++..++.++.||+.||.|||+ .+|+||||||+||+++.++.+||+|||++..
T Consensus 94 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~ 170 (303)
T 2vwi_A 94 LLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHK---NGQIHRDVKAGNILLGEDGSVQIADFGVSAF 170 (303)
T ss_dssp CCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTCCEEECCCHHHHH
T ss_pred hccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCCCCCCCChhhEEEcCCCCEEEEeccchhe
Confidence 9999999999852 1134569999999999999999999999 9999999999999999999999999999976
Q ss_pred ccCCCC----CcccccccCCcccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCc--c-
Q 005940 506 YDHGGM----PHTTNVVGTFGYIAPELTQT-GKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGR--I- 577 (668)
Q Consensus 506 ~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~--~- 577 (668)
...... .......||+.|+|||++.. ..++.++|||||||++|||++|+.||......... ........ .
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~--~~~~~~~~~~~~ 248 (303)
T 2vwi_A 171 LATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVL--MLTLQNDPPSLE 248 (303)
T ss_dssp CC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHH--HHHHTSSCCCTT
T ss_pred eccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHH--HHHhccCCCccc
Confidence 543221 11234578999999998865 56899999999999999999999999764322111 11111110 0
Q ss_pred ccccCcccCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 578 LDVADPLLNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 578 ~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
....++.....+. ..+..+...|++. |++||++.|++++
T Consensus 249 ~~~~~~~~~~~~~----~~~~~li~~~l~~dp~~Rps~~~ll~h 288 (303)
T 2vwi_A 249 TGVQDKEMLKKYG----KSFRKMISLCLQKDPEKRPTAAELLRH 288 (303)
T ss_dssp C-----CCCCCCC----HHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred cccccchhhhhhh----HHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 0011111112222 2345566688887 9999999999974
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=328.88 Aligned_cols=253 Identities=24% Similarity=0.353 Sum_probs=198.0
Q ss_pred hcCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCchhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEEe
Q 005940 352 TKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEY 431 (668)
Q Consensus 352 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~ 431 (668)
.+.|++.+.||+|+||.||+|.+..++..||+|++........+.+.+|++++++++||||+++++++...+..++||||
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 97 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEF 97 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEEC
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEe
Confidence 46799999999999999999999888999999999877666778899999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCCC
Q 005940 432 IPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGM 511 (668)
Q Consensus 432 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~~ 511 (668)
+++++|.+++.. ....+++..++.++.||+.||.|||+ .+++||||||+||+++.++.+||+|||++.......
T Consensus 98 ~~~~~l~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 171 (302)
T 2j7t_A 98 CPGGAVDAIMLE--LDRGLTEPQIQVVCRQMLEALNFLHS---KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL- 171 (302)
T ss_dssp CTTEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH-
T ss_pred CCCCcHHHHHHh--hccCCCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHHHEEECCCCCEEEEECCCCccccccc-
Confidence 999999999853 23458999999999999999999999 999999999999999999999999999876432110
Q ss_pred CcccccccCCcccCcccc-----cCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCcccC
Q 005940 512 PHTTNVVGTFGYIAPELT-----QTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLN 586 (668)
Q Consensus 512 ~~~~~~~gt~~y~aPE~~-----~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 586 (668)
.......||..|+|||++ ....++.++||||||+++|||++|+.||...+.. +.......... ..... .
T Consensus 172 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~~~~-~~~~~---~ 245 (302)
T 2j7t_A 172 QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM--RVLLKIAKSDP-PTLLT---P 245 (302)
T ss_dssp HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHH--HHHHHHHHSCC-CCCSS---G
T ss_pred cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHH--HHHHHHhccCC-cccCC---c
Confidence 112234689999999987 4567899999999999999999999999765422 11222222111 11100 1
Q ss_pred CcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 587 SSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 587 ~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
..++ ..+..+...|++. |++||++.|++++
T Consensus 246 ~~~~----~~l~~li~~~l~~dp~~Rps~~~ll~h 276 (302)
T 2j7t_A 246 SKWS----VEFRDFLKIALDKNPETRPSAAQLLEH 276 (302)
T ss_dssp GGSC----HHHHHHHHHHSCSCTTTSCCHHHHTTS
T ss_pred cccC----HHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 1111 2345666688887 9999999999874
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-38 Score=332.71 Aligned_cols=260 Identities=24% Similarity=0.363 Sum_probs=201.4
Q ss_pred hcCcccceeeeecCcEEEEEEEe-----CCCCcEEEEEEEecCC-chhHHHHHHHHHHHhcccccCceeEeeeecccCce
Q 005940 352 TKGFKESEVIGIGGFGSVYKGVL-----PTTGGEVAVKKITRNS-LQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDL 425 (668)
Q Consensus 352 t~~f~~~~~lG~G~~g~Vy~~~~-----~~~~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~ 425 (668)
.++|...+.||+|+||.||+|++ ..++..||||++.... .....++.+|+.++++++||||+++++++.+....
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 108 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence 36788999999999999999994 4567789999997543 34556889999999999999999999999999999
Q ss_pred EEEEEecCCCChhhhhcCCCC----CCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECC---CCCEEEE
Q 005940 426 LLVYEYIPNGSLDTLLFKPKD----GSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDA---EMNARLG 498 (668)
Q Consensus 426 ~lV~E~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~---~~~~kl~ 498 (668)
++||||+++++|.+++..... ...+++..++.++.||+.||.|||+ .+|+||||||+||+++. +..+||+
T Consensus 109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~---~~i~H~dlkp~NIli~~~~~~~~~kl~ 185 (327)
T 2yfx_A 109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKIG 185 (327)
T ss_dssp EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhh---CCeecCcCCHhHEEEecCCCcceEEEC
Confidence 999999999999999964321 2458999999999999999999999 99999999999999994 4569999
Q ss_pred eecCceeccCCCC-CcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHHHhcCc
Q 005940 499 DFGLARLYDHGGM-PHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVAT-GRRPIGSGDLLLVEWVRECHQLGR 576 (668)
Q Consensus 499 DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~l~~~~~~~~~~~~ 576 (668)
|||+++....... .......++..|+|||++.+..++.++|||||||++|||++ |+.||...... +....... ..
T Consensus 186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--~~~~~~~~-~~ 262 (327)
T 2yfx_A 186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ--EVLEFVTS-GG 262 (327)
T ss_dssp CCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--HHHHHHHT-TC
T ss_pred ccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHH--HHHHHHhc-CC
Confidence 9999986543322 22234467889999999988899999999999999999998 99999765322 11111111 11
Q ss_pred cccccCcccCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhccCcC
Q 005940 577 ILDVADPLLNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSGEKQ 626 (668)
Q Consensus 577 ~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~~~~ 626 (668)
.. .....++ ..+..+...|+.. |++||++.||+++|+....
T Consensus 263 ~~-----~~~~~~~----~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~ 304 (327)
T 2yfx_A 263 RM-----DPPKNCP----GPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 304 (327)
T ss_dssp CC-----CCCTTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CC-----CCCCCCC----HHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhc
Confidence 11 1111222 2355666789887 9999999999999986543
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=344.03 Aligned_cols=243 Identities=16% Similarity=0.158 Sum_probs=188.3
Q ss_pred hcCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecC---CchhHHHHHHHH---HHHhcccccCceeEe-------ee
Q 005940 352 TKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRN---SLQGMREFAAEI---ESLGRLRHKNLVNLH-------GW 418 (668)
Q Consensus 352 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~f~~Ei---~~l~~l~H~nIv~l~-------g~ 418 (668)
.++|...+.||+|+||.||+|++..+++.||||++... .....+.+.+|+ +++++++||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 46788899999999999999999888999999999743 334567889999 555566899999998 55
Q ss_pred ecccC-----------------ceEEEEEecCCCChhhhhcCC----CCCCCccHHHHHHHHHHHHHHHHHhhhccCCce
Q 005940 419 CKQKN-----------------DLLLVYEYIPNGSLDTLLFKP----KDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVV 477 (668)
Q Consensus 419 ~~~~~-----------------~~~lV~E~~~~gsL~~~l~~~----~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~i 477 (668)
+...+ ..|+||||+ +|+|.+++... .....+++..++.++.||+.||+|||+ .+|
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---YGL 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHH---TTE
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHh---CCe
Confidence 55443 278999999 68999999632 112346679999999999999999999 999
Q ss_pred EecCCCCCCEEECCCCCEEEEeecCceeccCCCCCcccccccCCcccCcccccCC-----------CCCcchhHHHHHHH
Q 005940 478 IHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPELTQTG-----------KASTSSDVFAYGIL 546 (668)
Q Consensus 478 vHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~sDV~S~Gvv 546 (668)
+||||||+|||++.++.+||+|||+++.... ......| +.|+|||++.+. .++.++|||||||+
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~i 302 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLV 302 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHH
Confidence 9999999999999999999999999986432 2334567 999999999877 89999999999999
Q ss_pred HHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCcccCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 547 LLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 547 l~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
+|||++|+.||..... ......... .. ..++ ..+..+...|+.. |++||++.|++++
T Consensus 303 l~elltg~~Pf~~~~~-----------~~~~~~~~~-~~-~~~~----~~~~~li~~~L~~dp~~Rpt~~e~l~h 360 (377)
T 3byv_A 303 IYWIWCADLPITKDAA-----------LGGSEWIFR-SC-KNIP----QPVRALLEGFLRYPKEDRLLPLQAMET 360 (377)
T ss_dssp HHHHHHSSCCC-----------------CCSGGGGS-SC-CCCC----HHHHHHHHHHTCSSGGGCCCHHHHHTS
T ss_pred HHHHHHCCCCCccccc-----------ccchhhhhh-hc-cCCC----HHHHHHHHHHcCCCchhCCCHHHHhhC
Confidence 9999999999964321 001111111 00 1222 2345566688887 9999999999974
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=340.62 Aligned_cols=254 Identities=27% Similarity=0.444 Sum_probs=191.1
Q ss_pred CcccceeeeecCcEEEEEEEeCCCC---cEEEEEEEecCC-chhHHHHHHHHHHHhcccccCceeEeeeecc-cCceEEE
Q 005940 354 GFKESEVIGIGGFGSVYKGVLPTTG---GEVAVKKITRNS-LQGMREFAAEIESLGRLRHKNLVNLHGWCKQ-KNDLLLV 428 (668)
Q Consensus 354 ~f~~~~~lG~G~~g~Vy~~~~~~~~---~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~-~~~~~lV 428 (668)
.|...++||+|+||.||+|++..++ ..||||.+.... ....++|.+|+.++++++||||++++++|.+ ++..++|
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv 169 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 169 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence 4667889999999999999975332 368999986543 3456789999999999999999999998754 5678999
Q ss_pred EEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccC
Q 005940 429 YEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDH 508 (668)
Q Consensus 429 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~ 508 (668)
|||+++|+|.+++.. ....+++..++.++.||++||.|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 170 ~e~~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~ 244 (373)
T 3c1x_A 170 LPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD 244 (373)
T ss_dssp EECCTTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EECCCCCCHHHHHhh--cccCCCHHHHHHHHHHHHHHHHHHHH---CCEecCccchheEEECCCCCEEEeeccccccccc
Confidence 999999999999963 34568999999999999999999999 9999999999999999999999999999986644
Q ss_pred CCCC---cccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCc-hhHHHHHHHHHhcCccccccCc
Q 005940 509 GGMP---HTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVAT-GRRPIGSGD-LLLVEWVRECHQLGRILDVADP 583 (668)
Q Consensus 509 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~-~~l~~~~~~~~~~~~~~~~~d~ 583 (668)
.... ......+|..|+|||++.+..++.++|||||||++|||++ |..||...+ ......+ .. +... ..+
T Consensus 245 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~---~~-~~~~--~~p 318 (373)
T 3c1x_A 245 KEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL---LQ-GRRL--LQP 318 (373)
T ss_dssp -------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHH---HT-TCCC--CCC
T ss_pred cccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHH---Hc-CCCC--CCC
Confidence 3211 2233467889999999998899999999999999999999 677775432 2222211 11 1111 011
Q ss_pred ccCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhccCc
Q 005940 584 LLNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSGEK 625 (668)
Q Consensus 584 ~l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~~~ 625 (668)
..++ ..+..++..|++. |++||+++|+++.|+...
T Consensus 319 ---~~~~----~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~ 354 (373)
T 3c1x_A 319 ---EYCP----DPLYEVMLKCWHPKAEMRPSFSELVSRISAIF 354 (373)
T ss_dssp ---TTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---CCCC----HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 1122 2355667789987 999999999999998654
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-38 Score=330.27 Aligned_cols=263 Identities=27% Similarity=0.374 Sum_probs=199.8
Q ss_pred cccchhhHHHHhcCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCchhHHHHHHHHHHHhcc-cccCceeEeeee
Q 005940 341 HRFRYKDLYAATKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRL-RHKNLVNLHGWC 419 (668)
Q Consensus 341 ~~f~~~el~~at~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~ 419 (668)
..+.+.++....++|...+.||+|+||.||+|++..+++.||||++.... ...+.+.+|+.+++++ +||||+++++++
T Consensus 12 ~~~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 90 (326)
T 2x7f_A 12 DEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAF 90 (326)
T ss_dssp ----CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEE
T ss_pred hhccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEE
Confidence 34555666667789999999999999999999998889999999997654 3346788999999999 799999999999
Q ss_pred cc------cCceEEEEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCC
Q 005940 420 KQ------KNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEM 493 (668)
Q Consensus 420 ~~------~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~ 493 (668)
.. .+..++||||+++|+|.+++... ....+++..++.++.||+.||.|||+ .+|+||||||+||+++.++
T Consensus 91 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~ 166 (326)
T 2x7f_A 91 IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENA 166 (326)
T ss_dssp EECC--CCCCEEEEEEECCTTEEHHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTC
T ss_pred eeccCccccceEEEEEEcCCCCcHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCcHHHEEEcCCC
Confidence 76 46789999999999999999642 23568999999999999999999999 9999999999999999999
Q ss_pred CEEEEeecCceeccCCCCCcccccccCCcccCccccc-----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHH
Q 005940 494 NARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPELTQ-----TGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWV 568 (668)
Q Consensus 494 ~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~ 568 (668)
.+||+|||++........ ......|+..|+|||++. ...++.++|||||||++|||++|+.||.........
T Consensus 167 ~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-- 243 (326)
T 2x7f_A 167 EVKLVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRAL-- 243 (326)
T ss_dssp CEEECCCTTTC--------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHH--
T ss_pred CEEEeeCcCceecCcCcc-ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHH--
Confidence 999999999987654321 223457899999999986 567899999999999999999999999765422111
Q ss_pred HHHHhcCccccccCcccCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 569 RECHQLGRILDVADPLLNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 569 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
....... . +.+...... ..+..+...|+.. |++||+++|++++
T Consensus 244 ~~~~~~~-~-----~~~~~~~~~---~~l~~li~~~l~~dp~~Rps~~~ll~h 287 (326)
T 2x7f_A 244 FLIPRNP-A-----PRLKSKKWS---KKFQSFIESCLVKNHSQRPATEQLMKH 287 (326)
T ss_dssp HHHHHSC-C-----CCCSCSCSC---HHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred HHhhcCc-c-----ccCCccccC---HHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 1111111 1 111111111 2345566688887 9999999999984
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-38 Score=332.68 Aligned_cols=260 Identities=25% Similarity=0.310 Sum_probs=198.9
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCc--hhHHHHHHHHHHHhcccccCceeEeeeecc--------c
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSL--QGMREFAAEIESLGRLRHKNLVNLHGWCKQ--------K 422 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~--------~ 422 (668)
++|...++||+|+||.||+|++..+++.||||++..... .....+.+|++++++++||||+++++++.. .
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 96 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 96 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence 579999999999999999999988999999999865433 234678899999999999999999999876 4
Q ss_pred CceEEEEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecC
Q 005940 423 NDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGL 502 (668)
Q Consensus 423 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGl 502 (668)
+..++||||+++ +|.+.+.. ....+++.+++.++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+
T Consensus 97 ~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 170 (351)
T 3mi9_A 97 GSIYLVFDFCEH-DLAGLLSN--VLVKFTLSEIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGL 170 (351)
T ss_dssp CEEEEEEECCSE-EHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred ceEEEEEeccCC-CHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCHHHEEEcCCCCEEEccchh
Confidence 468999999975 77777743 23459999999999999999999999 9999999999999999999999999999
Q ss_pred ceeccCCCC---CcccccccCCcccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCchh-HHHHHHHHHhcCcc
Q 005940 503 ARLYDHGGM---PHTTNVVGTFGYIAPELTQT-GKASTSSDVFAYGILLLEVATGRRPIGSGDLL-LVEWVRECHQLGRI 577 (668)
Q Consensus 503 a~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~-l~~~~~~~~~~~~~ 577 (668)
++....... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... ....+..... ..
T Consensus 171 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~--~~ 248 (351)
T 3mi9_A 171 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCG--SI 248 (351)
T ss_dssp CEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC--CC
T ss_pred cccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC--CC
Confidence 987653321 22344578999999998876 45799999999999999999999999765322 2222222111 11
Q ss_pred ccccCccc-------------C-CcccHHH------HHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 578 LDVADPLL-------------N-SSYVVKE------MELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 578 ~~~~d~~l-------------~-~~~~~~~------~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
.....+.. . .....+. -..+..+...|+.. |++||+++|++++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 312 (351)
T 3mi9_A 249 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312 (351)
T ss_dssp CTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence 11000000 0 0000111 12355677788887 9999999999985
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=338.96 Aligned_cols=253 Identities=24% Similarity=0.310 Sum_probs=200.9
Q ss_pred cCcccceeeeecCcEEEEEEEeC---CCCcEEEEEEEecCC----chhHHHHHHHHHHHhcc-cccCceeEeeeecccCc
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLP---TTGGEVAVKKITRNS----LQGMREFAAEIESLGRL-RHKNLVNLHGWCKQKND 424 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~---~~~~~vavK~~~~~~----~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~ 424 (668)
++|...++||+|+||.||+++.. .+++.||||++.+.. ....+.+..|+++++++ +||||+++++++...+.
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 133 (355)
T 1vzo_A 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 133 (355)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence 57899999999999999999984 478999999986532 22345677899999999 59999999999999999
Q ss_pred eEEEEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCce
Q 005940 425 LLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLAR 504 (668)
Q Consensus 425 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~ 504 (668)
.++||||+++|+|.+++.. ...+++..++.++.||+.||.|||+ .+|+||||||+||||+.++.+||+|||+++
T Consensus 134 ~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 207 (355)
T 1vzo_A 134 LHLILDYINGGELFTHLSQ---RERFTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSK 207 (355)
T ss_dssp EEEEECCCCSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred EEEEeecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCcEEEeeCCCCe
Confidence 9999999999999999963 2458999999999999999999999 999999999999999999999999999998
Q ss_pred eccCCCCCcccccccCCcccCcccccC--CCCCcchhHHHHHHHHHHHHhCCCCCCCCc--hhHHHHHHHHHhcCccccc
Q 005940 505 LYDHGGMPHTTNVVGTFGYIAPELTQT--GKASTSSDVFAYGILLLEVATGRRPIGSGD--LLLVEWVRECHQLGRILDV 580 (668)
Q Consensus 505 ~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDV~S~Gvvl~elltG~~p~~~~~--~~l~~~~~~~~~~~~~~~~ 580 (668)
..............||+.|+|||++.+ ..++.++|||||||++|||++|+.||.... .............
T Consensus 208 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~------ 281 (355)
T 1vzo_A 208 EFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKS------ 281 (355)
T ss_dssp ECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHC------
T ss_pred ecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhcc------
Confidence 765433333445689999999999875 347899999999999999999999996431 2222222222211
Q ss_pred cCcccCCcccHHHHHHHHHHHhhcCCC-CCCCC-----CHHHHHHHhc
Q 005940 581 ADPLLNSSYVVKEMELVLKLGLMCSHK-TQFRP-----TMRQVMRYLS 622 (668)
Q Consensus 581 ~d~~l~~~~~~~~~~~l~~l~~~C~~~-p~~RP-----s~~evl~~L~ 622 (668)
.+.....+. ..+..+...|+.. |++|| +++|++++.-
T Consensus 282 -~~~~~~~~~----~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~ 324 (355)
T 1vzo_A 282 -EPPYPQEMS----ALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLF 324 (355)
T ss_dssp -CCCCCTTSC----HHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGG
T ss_pred -CCCCCcccC----HHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcc
Confidence 111112222 2345566688887 99999 9999998753
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-37 Score=325.56 Aligned_cols=194 Identities=27% Similarity=0.377 Sum_probs=172.9
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCchhHHHHHHHHHHHhccc-ccCceeEeeeecc--cCceEEEE
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLR-HKNLVNLHGWCKQ--KNDLLLVY 429 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~--~~~~~lV~ 429 (668)
++|+..++||+|+||.||+|.+..+++.||||++.... .+.+.+|++++++++ ||||+++++++.. ....++||
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~ 112 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 112 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc---hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEE
Confidence 57899999999999999999998899999999997543 467889999999997 9999999999987 56789999
Q ss_pred EecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCC-CEEEEeecCceeccC
Q 005940 430 EYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEM-NARLGDFGLARLYDH 508 (668)
Q Consensus 430 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~-~~kl~DfGla~~~~~ 508 (668)
||+++++|.+++. .+++..+..++.||+.||.|||+ .+|+||||||+|||++.++ .+||+|||+++....
T Consensus 113 e~~~~~~l~~~~~------~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~ 183 (330)
T 3nsz_A 113 EHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 183 (330)
T ss_dssp ECCCCCCHHHHGG------GCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred eccCchhHHHHHH------hCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCC
Confidence 9999999999984 28899999999999999999999 9999999999999999776 899999999987654
Q ss_pred CCCCcccccccCCcccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 005940 509 GGMPHTTNVVGTFGYIAPELTQT-GKASTSSDVFAYGILLLEVATGRRPIGSG 560 (668)
Q Consensus 509 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~S~Gvvl~elltG~~p~~~~ 560 (668)
... .....|+..|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 184 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~ 234 (330)
T 3nsz_A 184 GQE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHG 234 (330)
T ss_dssp TCC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCC
T ss_pred CCc--cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence 432 234578999999999876 67899999999999999999999999544
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-38 Score=338.70 Aligned_cols=243 Identities=26% Similarity=0.303 Sum_probs=189.0
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCc---hhHHHHHHHHHH-HhcccccCceeEeeeecccCceEEE
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSL---QGMREFAAEIES-LGRLRHKNLVNLHGWCKQKNDLLLV 428 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~f~~Ei~~-l~~l~H~nIv~l~g~~~~~~~~~lV 428 (668)
++|+..+.||+|+||.||+|+++.+++.||||++.+... ...+.+..|..+ ++.++||||+++++++.+.+..|+|
T Consensus 38 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv 117 (373)
T 2r5t_A 38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFV 117 (373)
T ss_dssp GGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEE
Confidence 568899999999999999999998999999999976542 233456677776 5678999999999999999999999
Q ss_pred EEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccC
Q 005940 429 YEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDH 508 (668)
Q Consensus 429 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~ 508 (668)
|||+++|+|.+++.. ...+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 118 ~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~ 191 (373)
T 2r5t_A 118 LDYINGGELFYHLQR---ERCFLEPRARFYAAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIE 191 (373)
T ss_dssp EECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBC
T ss_pred EeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEECCCCCEEEeeCcccccccc
Confidence 999999999999963 3458899999999999999999999 9999999999999999999999999999986433
Q ss_pred CCCCcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCcccCCc
Q 005940 509 GGMPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSS 588 (668)
Q Consensus 509 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 588 (668)
.. ......+||+.|+|||++.+..++.++|||||||++|||++|+.||...+.. +........ .. .+...
T Consensus 192 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~--~~~~~i~~~-~~------~~~~~ 261 (373)
T 2r5t_A 192 HN-STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA--EMYDNILNK-PL------QLKPN 261 (373)
T ss_dssp CC-CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHH--HHHHHHHHS-CC------CCCSS
T ss_pred CC-CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH--HHHHHHHhc-cc------CCCCC
Confidence 22 2234568999999999999989999999999999999999999999765422 111121111 11 11112
Q ss_pred ccHHHHHHHHHHHhhcCCC-CCCCCCHH
Q 005940 589 YVVKEMELVLKLGLMCSHK-TQFRPTMR 615 (668)
Q Consensus 589 ~~~~~~~~l~~l~~~C~~~-p~~RPs~~ 615 (668)
.. . .+..+...|++. |++||++.
T Consensus 262 ~~-~---~~~~li~~lL~~dp~~R~~~~ 285 (373)
T 2r5t_A 262 IT-N---SARHLLEGLLQKDRTKRLGAK 285 (373)
T ss_dssp SC-H---HHHHHHHHHTCSSGGGSTTTT
T ss_pred CC-H---HHHHHHHHHcccCHHhCCCCC
Confidence 22 2 234555577776 99999974
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=345.63 Aligned_cols=251 Identities=25% Similarity=0.375 Sum_probs=199.4
Q ss_pred hcCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCc-------------hhHHHHHHHHHHHhcccccCceeEeee
Q 005940 352 TKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSL-------------QGMREFAAEIESLGRLRHKNLVNLHGW 418 (668)
Q Consensus 352 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-------------~~~~~f~~Ei~~l~~l~H~nIv~l~g~ 418 (668)
.++|.+.++||+|+||.||+|.+..++..||||++.+... ...+.+.+|++++++++||||++++++
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 114 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV 114 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 4679999999999999999999998999999999975432 235678999999999999999999999
Q ss_pred ecccCceEEEEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCC---CE
Q 005940 419 CKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEM---NA 495 (668)
Q Consensus 419 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~---~~ 495 (668)
+.+....++||||+++|+|.+++.. ...+++..++.++.||+.||.|||+ .+|+||||||+|||++.++ .+
T Consensus 115 ~~~~~~~~lv~e~~~gg~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~ 188 (504)
T 3q5i_A 115 FEDKKYFYLVTEFYEGGELFEQIIN---RHKFDECDAANIMKQILSGICYLHK---HNIVHRDIKPENILLENKNSLLNI 188 (504)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESSTTCCSSE
T ss_pred EEcCCEEEEEEecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCcHHHEEEecCCCCccE
Confidence 9999999999999999999998853 3459999999999999999999999 9999999999999998775 69
Q ss_pred EEEeecCceeccCCCCCcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcC
Q 005940 496 RLGDFGLARLYDHGGMPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLG 575 (668)
Q Consensus 496 kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~ 575 (668)
||+|||+++...... ......||+.|+|||++. +.++.++||||+||++|||++|+.||...... +....... +
T Consensus 189 kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--~~~~~i~~-~ 262 (504)
T 3q5i_A 189 KIVDFGLSSFFSKDY--KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQ--DIIKKVEK-G 262 (504)
T ss_dssp EECCCTTCEECCTTS--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHH-C
T ss_pred EEEECCCCEEcCCCC--ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHc-C
Confidence 999999998776543 233457999999999986 56999999999999999999999999765322 11222211 1
Q ss_pred ccccccCcccCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 576 RILDVADPLLNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 576 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
.... +........ ..+..+...|+.. |++||+++|++++
T Consensus 263 ~~~~--~~~~~~~~s----~~~~~li~~~L~~dp~~R~t~~e~l~h 302 (504)
T 3q5i_A 263 KYYF--DFNDWKNIS----DEAKELIKLMLTYDYNKRCTAEEALNS 302 (504)
T ss_dssp CCCC--CHHHHTTSC----HHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCCC--CccccCCCC----HHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 1110 000001111 2345566678887 9999999999975
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=324.93 Aligned_cols=251 Identities=27% Similarity=0.381 Sum_probs=199.9
Q ss_pred hcCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCchhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEEe
Q 005940 352 TKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEY 431 (668)
Q Consensus 352 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~ 431 (668)
.++|...+.||+|+||.||+|.+..+++.||||++.... ..+++.+|++++++++||||+++++++...+..++||||
T Consensus 28 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 105 (314)
T 3com_A 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEY 105 (314)
T ss_dssp --CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeec
Confidence 467999999999999999999998889999999997653 346788999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCCC
Q 005940 432 IPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGM 511 (668)
Q Consensus 432 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~~ 511 (668)
+++++|.+++.. ....+++..++.++.||+.||.|||+ .+++||||||+||+++.++.+||+|||++........
T Consensus 106 ~~~~~L~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~ 180 (314)
T 3com_A 106 CGAGSVSDIIRL--RNKTLTEDEIATILQSTLKGLEYLHF---MRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMA 180 (314)
T ss_dssp CTTEEHHHHHHH--HTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBS
T ss_pred CCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHh---CCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhcc
Confidence 999999999852 24568999999999999999999999 9999999999999999999999999999987654322
Q ss_pred CcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCcccCCcccH
Q 005940 512 PHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSYVV 591 (668)
Q Consensus 512 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 591 (668)
......|+..|+|||++.+..++.++||||||+++|||++|+.||......... ....... ......+ ..++
T Consensus 181 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~--~~~~~~~-~~~~~~~---~~~~- 252 (314)
T 3com_A 181 -KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAI--FMIPTNP-PPTFRKP---ELWS- 252 (314)
T ss_dssp -CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHH--HHHHHSC-CCCCSSG---GGSC-
T ss_pred -ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHH--HHHhcCC-CcccCCc---ccCC-
Confidence 233457899999999999889999999999999999999999999765432211 1111111 1110001 1111
Q ss_pred HHHHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 592 KEMELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 592 ~~~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
..+..+...|+.. |++||++.|++++
T Consensus 253 ---~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (314)
T 3com_A 253 ---DNFTDFVKQCLVKSPEQRATATQLLQH 279 (314)
T ss_dssp ---HHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred ---HHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 2345666688887 9999999999874
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=346.92 Aligned_cols=251 Identities=25% Similarity=0.399 Sum_probs=203.1
Q ss_pred hcCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCC---chhHHHHHHHHHHHhcccccCceeEeeeecccCceEEE
Q 005940 352 TKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNS---LQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLV 428 (668)
Q Consensus 352 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV 428 (668)
.++|...++||+|+||.||+|.+..+++.||||++.+.. ....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 104 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV 104 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 357889999999999999999999899999999997643 23467899999999999999999999999999999999
Q ss_pred EEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEE---CCCCCEEEEeecCcee
Q 005940 429 YEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALI---DAEMNARLGDFGLARL 505 (668)
Q Consensus 429 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll---~~~~~~kl~DfGla~~ 505 (668)
|||+.+|+|.+++.. ...+++..+..++.||+.||.|||+ .+|+||||||+|||+ +.++.+||+|||+++.
T Consensus 105 ~e~~~~~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 178 (484)
T 3nyv_A 105 GEVYTGGELFDEIIS---RKRFSEVDAARIIRQVLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTH 178 (484)
T ss_dssp ECCCCSCBHHHHHHT---CSCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHH
T ss_pred EecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEE
Confidence 999999999999863 3459999999999999999999999 999999999999999 5678999999999987
Q ss_pred ccCCCCCcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCccc
Q 005940 506 YDHGGMPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLL 585 (668)
Q Consensus 506 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 585 (668)
..... ......||+.|+|||++.+ .++.++||||+||++|||++|+.||...+.. +....... +.... ..+..
T Consensus 179 ~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--~~~~~i~~-~~~~~-~~~~~ 251 (484)
T 3nyv_A 179 FEASK--KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEY--DILKKVEK-GKYTF-ELPQW 251 (484)
T ss_dssp BCCCC--SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHH-CCCCC-CSGGG
T ss_pred ccccc--ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHH--HHHHHHHc-CCCCC-CCccc
Confidence 66543 2334579999999999865 6899999999999999999999999765322 11112111 21110 00111
Q ss_pred CCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 586 NSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 586 ~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
.... ..+..+...|+.. |++||+++|++++
T Consensus 252 -~~~s----~~~~~li~~~L~~dp~~R~s~~e~l~h 282 (484)
T 3nyv_A 252 -KKVS----ESAKDLIRKMLTYVPSMRISARDALDH 282 (484)
T ss_dssp -GGSC----HHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred -ccCC----HHHHHHHHHHCCCChhHCcCHHHHhhC
Confidence 1111 2344566688887 9999999999975
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=320.46 Aligned_cols=247 Identities=26% Similarity=0.435 Sum_probs=194.2
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCC---chhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEE
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNS---LQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVY 429 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 429 (668)
++|...+.||+|+||.||+|++..+++.||||++.... ....+.+.+|++++++++||||+++++++...+..++||
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 90 (276)
T 2h6d_A 11 GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVM 90 (276)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEE
Confidence 57889999999999999999998889999999997542 233567899999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCC
Q 005940 430 EYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHG 509 (668)
Q Consensus 430 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~ 509 (668)
||+++++|.+++.. ...+++..++.++.||+.||.|||+ .+|+||||||+||+++.++.+||+|||++......
T Consensus 91 e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~ 164 (276)
T 2h6d_A 91 EYVSGGELFDYICK---HGRVEEMEARRLFQQILSAVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG 164 (276)
T ss_dssp ECCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHH---HCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC-
T ss_pred eccCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCChhhEEECCCCCEEEeecccccccCCC
Confidence 99999999999953 2458999999999999999999999 89999999999999999999999999999876543
Q ss_pred CCCcccccccCCcccCcccccCCCC-CcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCcccCCc
Q 005940 510 GMPHTTNVVGTFGYIAPELTQTGKA-STSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSS 588 (668)
Q Consensus 510 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 588 (668)
.. .....|++.|+|||.+.+..+ +.++||||||+++|||++|+.||...... ..... ...... .+...
T Consensus 165 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~~~~~-~~~~~~------~~~~~ 233 (276)
T 2h6d_A 165 EF--LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVP--TLFKK-IRGGVF------YIPEY 233 (276)
T ss_dssp --------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHH-HHHCCC------CCCTT
T ss_pred cc--eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHH--HHHHH-hhcCcc------cCchh
Confidence 22 233478999999999987665 68999999999999999999999764322 11111 111111 11111
Q ss_pred ccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 589 YVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 589 ~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
.+ ..+..+...|++. |++||+++|++++
T Consensus 234 ~~----~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 234 LN----RSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp SC----HHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred cC----HHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 22 2344566688887 9999999999986
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=333.39 Aligned_cols=198 Identities=28% Similarity=0.438 Sum_probs=169.0
Q ss_pred hcCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCC--chhHHHHHHHHHHHhcccccCceeEeeeecccC------
Q 005940 352 TKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNS--LQGMREFAAEIESLGRLRHKNLVNLHGWCKQKN------ 423 (668)
Q Consensus 352 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~------ 423 (668)
.++|...+.||+|+||.||+|.+..+|+.||||++.... ....+.+.+|++++++++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 367899999999999999999998899999999986532 334567889999999999999999999997653
Q ss_pred ceEEEEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCc
Q 005940 424 DLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLA 503 (668)
Q Consensus 424 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla 503 (668)
..|+||||+ +++|.+++.. ..+++..+..++.||+.||.|||+ .+|+||||||+||+++.++.+||+|||++
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 175 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLA 175 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCcCHHHEEEcCCCCEEEEeeecc
Confidence 469999999 8899999963 358999999999999999999999 99999999999999999999999999999
Q ss_pred eeccCCCCCcccccccCCcccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCc
Q 005940 504 RLYDHGGMPHTTNVVGTFGYIAPELTQT-GKASTSSDVFAYGILLLEVATGRRPIGSGD 561 (668)
Q Consensus 504 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~S~Gvvl~elltG~~p~~~~~ 561 (668)
+..... .....+|..|+|||++.+ ..++.++||||+||++|||++|+.||...+
T Consensus 176 ~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 230 (367)
T 1cm8_A 176 RQADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSD 230 (367)
T ss_dssp EECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cccccc----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 876532 234578999999998876 678999999999999999999999997653
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-37 Score=324.43 Aligned_cols=199 Identities=24% Similarity=0.338 Sum_probs=174.8
Q ss_pred cCcccceeeeecCcEEEEEEEe-CCCCcEEEEEEEecCCchhHHHHHHHHHHHhcccccC------ceeEeeeecccCce
Q 005940 353 KGFKESEVIGIGGFGSVYKGVL-PTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKN------LVNLHGWCKQKNDL 425 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~n------Iv~l~g~~~~~~~~ 425 (668)
++|.+.+.||+|+||.||+|.+ ..+++.||||++... ....+.+.+|++++++++|+| ++++++++...+..
T Consensus 14 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~ 92 (339)
T 1z57_A 14 ARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHI 92 (339)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEE
T ss_pred CceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcE
Confidence 5799999999999999999998 457889999999654 344577889999999998765 99999999999999
Q ss_pred EEEEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECC--------------
Q 005940 426 LLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDA-------------- 491 (668)
Q Consensus 426 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~-------------- 491 (668)
++||||+ +++|.+++... ....+++..++.++.||+.||.|||+ .+|+||||||+||+++.
T Consensus 93 ~lv~e~~-~~~l~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~ 167 (339)
T 1z57_A 93 CIVFELL-GLSTYDFIKEN-GFLPFRLDHIRKMAYQICKSVNFLHS---NKLTHTDLKPENILFVQSDYTEAYNPKIKRD 167 (339)
T ss_dssp EEEEECC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESCCCEEEEEC----CE
T ss_pred EEEEcCC-CCCHHHHHHhc-CCCCCcHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHEEEeccccccccCCccccc
Confidence 9999999 89999998642 23468999999999999999999999 99999999999999987
Q ss_pred -----CCCEEEEeecCceeccCCCCCcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCc
Q 005940 492 -----EMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGD 561 (668)
Q Consensus 492 -----~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~ 561 (668)
++.+||+|||+++..... .....||..|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 168 ~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 238 (339)
T 1z57_A 168 ERTLINPDIKVVDFGSATYDDEH----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHD 238 (339)
T ss_dssp EEEESCCCEEECCCSSCEETTSC----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSC
T ss_pred cccccCCCceEeeCcccccCccc----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Confidence 678999999999875432 234578999999999998899999999999999999999999997654
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-37 Score=321.10 Aligned_cols=250 Identities=22% Similarity=0.314 Sum_probs=197.8
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCC----chhHHHHHHHHHHHhcccccCceeEeeee--cccCceE
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNS----LQGMREFAAEIESLGRLRHKNLVNLHGWC--KQKNDLL 426 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~--~~~~~~~ 426 (668)
++|...+.||+|+||.||++.+..++..||+|++.... ....+.+.+|++++++++||||+++++++ .+....+
T Consensus 5 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (305)
T 2wtk_C 5 GKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMY 84 (305)
T ss_dssp CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEE
T ss_pred cceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEE
Confidence 67999999999999999999998899999999997542 23457899999999999999999999998 4556889
Q ss_pred EEEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceec
Q 005940 427 LVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLY 506 (668)
Q Consensus 427 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~ 506 (668)
+||||++++ |.+++... ....+++..++.++.||+.||.|||+ .+|+||||||+||+++.++.+||+|||++...
T Consensus 85 lv~e~~~~~-l~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~---~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~ 159 (305)
T 2wtk_C 85 MVMEYCVCG-MQEMLDSV-PEKRFPVCQAHGYFCQLIDGLEYLHS---QGIVHKDIKPGNLLLTTGGTLKISALGVAEAL 159 (305)
T ss_dssp EEEECCSEE-HHHHHHHS-TTCSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEehhccCC-HHHHHHhC-cccccCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCcccEEEcCCCcEEeecccccccc
Confidence 999999877 76776532 34569999999999999999999999 99999999999999999999999999999876
Q ss_pred cCCCC-CcccccccCCcccCcccccCCC--CCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCc
Q 005940 507 DHGGM-PHTTNVVGTFGYIAPELTQTGK--ASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADP 583 (668)
Q Consensus 507 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~--~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~ 583 (668)
..... .......||..|+|||++.+.. .+.++||||||+++|||++|+.||...+.. +.... ......
T Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~-i~~~~~------ 230 (305)
T 2wtk_C 160 HPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIY--KLFEN-IGKGSY------ 230 (305)
T ss_dssp CTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHH-HHHCCC------
T ss_pred CccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHH--HHHHH-HhcCCC------
Confidence 54322 2233457899999999987644 378999999999999999999999765322 11122 111111
Q ss_pred ccCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 584 LLNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 584 ~l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
.+...+. ..+..+...|+.. |++||+++|++++
T Consensus 231 ~~~~~~~----~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 231 AIPGDCG----PPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp CCCSSSC----HHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred CCCCccC----HHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 1112222 2344566688887 9999999999986
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-38 Score=322.92 Aligned_cols=253 Identities=25% Similarity=0.300 Sum_probs=186.1
Q ss_pred hcCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCc--hhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEE
Q 005940 352 TKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSL--QGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVY 429 (668)
Q Consensus 352 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 429 (668)
.++|+..+.||+|+||.||+|.+..+++.||||++..... ...+.+.++...++.++||||+++++++.+.+..++||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~ 85 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM 85 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence 3678999999999999999999988999999999976532 22334455556688889999999999999999999999
Q ss_pred EecCCCChhhhhcC-CCCCCCccHHHHHHHHHHHHHHHHHhhhccCC-ceEecCCCCCCEEECCCCCEEEEeecCceecc
Q 005940 430 EYIPNGSLDTLLFK-PKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQ-VVIHRDVKPSNALIDAEMNARLGDFGLARLYD 507 (668)
Q Consensus 430 E~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~-~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~ 507 (668)
||++ |+|.+++.. ...+..+++..++.++.|++.||.|||+ . +|+||||||+||+++.++.+||+|||+++...
T Consensus 86 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 161 (290)
T 3fme_A 86 ELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS---KLSVIHRDVKPSNVLINALGQVKMCDFGISGYLV 161 (290)
T ss_dssp ECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---HSCCCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred ehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhh---cCCeecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 9997 588777642 1234579999999999999999999998 6 99999999999999999999999999998765
Q ss_pred CCCCCcccccccCCcccCcccc----cCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCc
Q 005940 508 HGGMPHTTNVVGTFGYIAPELT----QTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADP 583 (668)
Q Consensus 508 ~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~ 583 (668)
.... .....||+.|+|||++ ....++.++|||||||++|||++|+.||.......... ........ .....
T Consensus 162 ~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~-~~~~~~~~-~~~~~- 236 (290)
T 3fme_A 162 DDVA--KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQL-KQVVEEPS-PQLPA- 236 (290)
T ss_dssp ----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHH-HHHHHSCC-CCCCT-
T ss_pred cccc--ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHH-HHHhccCC-CCccc-
Confidence 4322 2234789999999996 55678999999999999999999999997543322222 22222111 11111
Q ss_pred ccCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 584 LLNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 584 ~l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
..+. ..+..+...|++. |++||+++|++++
T Consensus 237 ---~~~~----~~~~~li~~~l~~~p~~Rpt~~e~l~h 267 (290)
T 3fme_A 237 ---DKFS----AEFVDFTSQCLKKNSKERPTYPELMQH 267 (290)
T ss_dssp ---TTSC----HHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred ---ccCC----HHHHHHHHHHhhcChhhCcCHHHHHhC
Confidence 1122 2345666688887 9999999999873
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=327.33 Aligned_cols=250 Identities=23% Similarity=0.333 Sum_probs=195.1
Q ss_pred hcCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCc--------hhHHHHHHHHHHHhcccccCceeEeeeecccC
Q 005940 352 TKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSL--------QGMREFAAEIESLGRLRHKNLVNLHGWCKQKN 423 (668)
Q Consensus 352 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--------~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~ 423 (668)
.++|...+.||+|+||.||+|.+..+++.||||++..... .....+.+|++++++++||||+++++++..+.
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 88 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED 88 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence 3578999999999999999999988899999999865421 22345889999999999999999999987654
Q ss_pred ceEEEEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCC---EEEEee
Q 005940 424 DLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMN---ARLGDF 500 (668)
Q Consensus 424 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~---~kl~Df 500 (668)
.++||||+++++|.+++.. ...+++..++.++.||+.||.|||+ .+|+||||||+||+++.++. +||+||
T Consensus 89 -~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~~~~kl~Df 161 (322)
T 2ycf_A 89 -YYIVLELMEGGELFDKVVG---NKRLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDF 161 (322)
T ss_dssp -EEEEEECCTTEETHHHHST---TCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSSSCCEEECCC
T ss_pred -eEEEEecCCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEecCCCCCeEEEccC
Confidence 8999999999999999853 3569999999999999999999999 99999999999999987665 999999
Q ss_pred cCceeccCCCCCcccccccCCcccCccccc---CCCCCcchhHHHHHHHHHHHHhCCCCCCCCc--hhHHHHHHHHHhcC
Q 005940 501 GLARLYDHGGMPHTTNVVGTFGYIAPELTQ---TGKASTSSDVFAYGILLLEVATGRRPIGSGD--LLLVEWVRECHQLG 575 (668)
Q Consensus 501 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~--~~l~~~~~~~~~~~ 575 (668)
|+++...... ......||..|+|||++. ...++.++|||||||++|||++|+.||.... ..+.+.+. .+
T Consensus 162 g~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~----~~ 235 (322)
T 2ycf_A 162 GHSKILGETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQIT----SG 235 (322)
T ss_dssp TTCEECCCCH--HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHH----HT
T ss_pred ccceeccccc--ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHH----hC
Confidence 9998765422 223457899999999863 5678999999999999999999999996532 12222211 11
Q ss_pred ccccccCcccCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 576 RILDVADPLLNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 576 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
.... .+...... ...+..+...|+.. |++||++.|++++
T Consensus 236 ~~~~--~~~~~~~~----~~~~~~li~~~l~~dP~~Rps~~~~l~h 275 (322)
T 2ycf_A 236 KYNF--IPEVWAEV----SEKALDLVKKLLVVDPKARFTTEEALRH 275 (322)
T ss_dssp CCCC--CHHHHTTS----CHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred cccc--Cchhhhhc----CHHHHHHHHHHcccCHhhCCCHHHHhhC
Confidence 1100 01110111 13455666788887 9999999999975
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-38 Score=358.79 Aligned_cols=246 Identities=25% Similarity=0.356 Sum_probs=194.6
Q ss_pred eeeeecCcEEEEEEEe--CCCCcEEEEEEEecCCc--hhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEEecCC
Q 005940 359 EVIGIGGFGSVYKGVL--PTTGGEVAVKKITRNSL--QGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEYIPN 434 (668)
Q Consensus 359 ~~lG~G~~g~Vy~~~~--~~~~~~vavK~~~~~~~--~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~ 434 (668)
++||+|+||.||+|.+ ...+..||||++..... ...++|.+|++++++++||||++++++|.. +..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 5799999999999965 34567899999976433 346789999999999999999999999964 568999999999
Q ss_pred CChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCCC--C
Q 005940 435 GSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGM--P 512 (668)
Q Consensus 435 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~~--~ 512 (668)
|+|.+++.. ...+++.+++.++.||+.||.|||+ .+|+||||||+||||+.++.+||+|||+++....... .
T Consensus 454 g~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~yLH~---~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 527 (635)
T 4fl3_A 454 GPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 527 (635)
T ss_dssp EEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC------
T ss_pred CCHHHHHhh---CCCCCHHHHHHHHHHHHHHHHHHHH---CCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccc
Confidence 999999953 3469999999999999999999999 9999999999999999999999999999987654332 1
Q ss_pred cccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHHHhcCccccccCcccCCcccH
Q 005940 513 HTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVAT-GRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSYVV 591 (668)
Q Consensus 513 ~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 591 (668)
......+|..|+|||++....++.++|||||||++|||++ |+.||...+... +......+.... ....+.
T Consensus 528 ~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~---~~~~i~~~~~~~-----~p~~~~- 598 (635)
T 4fl3_A 528 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE---VTAMLEKGERMG-----CPAGCP- 598 (635)
T ss_dssp -------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH---HHHHHHTTCCCC-----CCTTCC-
T ss_pred cccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHHcCCCCC-----CCCCCC-
Confidence 2233456789999999998899999999999999999998 999997654321 122222222111 111222
Q ss_pred HHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhcc
Q 005940 592 KEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSG 623 (668)
Q Consensus 592 ~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~ 623 (668)
..+..++..|++. |++||++++|++.|+.
T Consensus 599 ---~~l~~li~~cl~~dP~~RPs~~~l~~~L~~ 628 (635)
T 4fl3_A 599 ---REMYDLMNLCWTYDVENRPGFAAVELRLRN 628 (635)
T ss_dssp ---HHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred ---HHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 3455667789998 9999999999999875
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=336.29 Aligned_cols=262 Identities=20% Similarity=0.274 Sum_probs=193.5
Q ss_pred HHHhcCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCchhHHHHHHHHHHHhcccccCceeEeeeecc-------
Q 005940 349 YAATKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNLHGWCKQ------- 421 (668)
Q Consensus 349 ~~at~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~------- 421 (668)
....++|...+.||+|+||.||+|.+..+++.||||++...... ..+|++++++++||||+++++++..
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~----~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 78 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY----KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK 78 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS----CCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch----HHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence 34567899999999999999999999889999999999765322 2369999999999999999999843
Q ss_pred -------------------------------cCceEEEEEecCCCChhhhhcCC-CCCCCccHHHHHHHHHHHHHHHHHh
Q 005940 422 -------------------------------KNDLLLVYEYIPNGSLDTLLFKP-KDGSVLDWEQRFNIVKGIASGLLYL 469 (668)
Q Consensus 422 -------------------------------~~~~~lV~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~gL~yL 469 (668)
....++||||++ |+|.+.+... ..+..+++..+..++.||++||.||
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L 157 (383)
T 3eb0_A 79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI 157 (383)
T ss_dssp -------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence 234889999998 5877776421 2345799999999999999999999
Q ss_pred hhccCCceEecCCCCCCEEEC-CCCCEEEEeecCceeccCCCCCcccccccCCcccCcccccCC-CCCcchhHHHHHHHH
Q 005940 470 HEEWEQVVIHRDVKPSNALID-AEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPELTQTG-KASTSSDVFAYGILL 547 (668)
Q Consensus 470 H~~~~~~ivHrDLkp~NIll~-~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDV~S~Gvvl 547 (668)
|+ .+|+||||||+||+++ .++.+||+|||+++....... .....||..|+|||++.+. .++.++||||+||++
T Consensus 158 H~---~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il 232 (383)
T 3eb0_A 158 HS---LGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP--SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVF 232 (383)
T ss_dssp HT---TTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC--CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHH
T ss_pred HH---CcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC--CcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHH
Confidence 98 9999999999999998 678999999999997654432 2345789999999988764 489999999999999
Q ss_pred HHHHhCCCCCCCCchh-HHHHHHHHHhc----------CccccccCcccCCc-----ccHHHHHHHHHHHhhcCCC-CCC
Q 005940 548 LEVATGRRPIGSGDLL-LVEWVRECHQL----------GRILDVADPLLNSS-----YVVKEMELVLKLGLMCSHK-TQF 610 (668)
Q Consensus 548 ~elltG~~p~~~~~~~-l~~~~~~~~~~----------~~~~~~~d~~l~~~-----~~~~~~~~l~~l~~~C~~~-p~~ 610 (668)
|||++|+.||...... ....+...... ....+..-+.+... +.......+..+...|+.. |++
T Consensus 233 ~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 312 (383)
T 3eb0_A 233 GELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDL 312 (383)
T ss_dssp HHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGG
T ss_pred HHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhh
Confidence 9999999999765321 11111111100 00000000111000 0111112355666688887 999
Q ss_pred CCCHHHHHHH
Q 005940 611 RPTMRQVMRY 620 (668)
Q Consensus 611 RPs~~evl~~ 620 (668)
||++.|++++
T Consensus 313 R~t~~e~l~h 322 (383)
T 3eb0_A 313 RINPYEAMAH 322 (383)
T ss_dssp SCCHHHHHTS
T ss_pred CCCHHHHhcC
Confidence 9999999975
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=345.93 Aligned_cols=259 Identities=20% Similarity=0.264 Sum_probs=202.2
Q ss_pred hcCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCchhHHHHHHHHHHHhcccc-cCceeEeeeecccCceEEEEE
Q 005940 352 TKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRH-KNLVNLHGWCKQKNDLLLVYE 430 (668)
Q Consensus 352 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H-~nIv~l~g~~~~~~~~~lV~E 430 (668)
.++|.+.++||+|+||.||+|++..+++.||||++...... +++..|+++++.|+| +++..+..++......++|||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme 83 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS--CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc--HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence 36799999999999999999999888999999998765432 357889999999986 566666667777788899999
Q ss_pred ecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEE---CCCCCEEEEeecCceecc
Q 005940 431 YIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALI---DAEMNARLGDFGLARLYD 507 (668)
Q Consensus 431 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll---~~~~~~kl~DfGla~~~~ 507 (668)
|+ +++|.+++.. ....+++..++.|+.||+.||.|||+ .+|+||||||+|||| +.++.+||+|||+++...
T Consensus 84 ~~-g~sL~~ll~~--~~~~l~~~~~~~i~~qi~~aL~yLH~---~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (483)
T 3sv0_A 84 LL-GPSLEDLFNF--CSRKLSLKTVLMLADQMINRVEFVHS---KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (483)
T ss_dssp CC-CCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred CC-CCCHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence 99 9999999963 23469999999999999999999999 999999999999999 688999999999999776
Q ss_pred CCCCC------cccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCch-hHHHHHHHHHhcCccccc
Q 005940 508 HGGMP------HTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDL-LLVEWVRECHQLGRILDV 580 (668)
Q Consensus 508 ~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~-~l~~~~~~~~~~~~~~~~ 580 (668)
..... ......||..|+|||++.+..++.++|||||||++|||++|+.||..... ...+....... ......
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~-~~~~~~ 236 (483)
T 3sv0_A 158 DTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISE-KKVATS 236 (483)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHH-HHHHSC
T ss_pred CCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhh-cccccc
Confidence 54321 12356799999999999999999999999999999999999999975421 11111111111 011000
Q ss_pred cCcccCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhccC
Q 005940 581 ADPLLNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSGE 624 (668)
Q Consensus 581 ~d~~l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~~ 624 (668)
.. .+...+. ..+..++..|+.. |++||++++|++.|+..
T Consensus 237 ~~-~l~~~~p----~~l~~li~~cl~~dP~~RPs~~el~~~L~~l 276 (483)
T 3sv0_A 237 IE-ALCRGYP----TEFASYFHYCRSLRFDDKPDYSYLKRLFRDL 276 (483)
T ss_dssp HH-HHHTTSC----HHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred HH-HHhcCCc----HHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 00 0111111 3456677789887 99999999999988754
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-37 Score=330.53 Aligned_cols=199 Identities=26% Similarity=0.338 Sum_probs=166.0
Q ss_pred hcCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCC--chhHHHHHHHHHHHhcccccCceeEeeeecccC------
Q 005940 352 TKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNS--LQGMREFAAEIESLGRLRHKNLVNLHGWCKQKN------ 423 (668)
Q Consensus 352 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~------ 423 (668)
.++|...+.||+|+||.||+|.+..+++.||||++.... ....+.+.+|+.++++++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 368999999999999999999998889999999997642 344567889999999999999999999997654
Q ss_pred ceEEEEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCc
Q 005940 424 DLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLA 503 (668)
Q Consensus 424 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla 503 (668)
..++||||++ ++|.+++. ..+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||++
T Consensus 104 ~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 174 (371)
T 2xrw_A 104 DVYIVMELMD-ANLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLA 174 (371)
T ss_dssp EEEEEEECCS-EEHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCCCC-
T ss_pred ceEEEEEcCC-CCHHHHHh-----hccCHHHHHHHHHHHHHHHHHHHH---CCeecccCCHHHEEEcCCCCEEEEEeecc
Confidence 6899999997 57888874 238899999999999999999999 99999999999999999999999999999
Q ss_pred eeccCCCCCcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCc
Q 005940 504 RLYDHGGMPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGD 561 (668)
Q Consensus 504 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~ 561 (668)
+...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 175 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 230 (371)
T 2xrw_A 175 RTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTD 230 (371)
T ss_dssp -----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ccccccc--ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 8665432 2234578999999999998899999999999999999999999997653
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-37 Score=337.66 Aligned_cols=199 Identities=28% Similarity=0.401 Sum_probs=169.4
Q ss_pred hcCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecC--CchhHHHHHHHHHHHhcccccCceeEeeeeccc-----Cc
Q 005940 352 TKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRN--SLQGMREFAAEIESLGRLRHKNLVNLHGWCKQK-----ND 424 (668)
Q Consensus 352 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~-----~~ 424 (668)
.++|...+.||+|+||.||+|.+..+++.||||++... .....+.+.+|++++++++|+||+++++++... ..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 36899999999999999999999999999999999764 334457889999999999999999999999765 57
Q ss_pred eEEEEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCce
Q 005940 425 LLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLAR 504 (668)
Q Consensus 425 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~ 504 (668)
.|+||||+. |+|.+++.. ...+++..++.++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++
T Consensus 105 ~~lv~e~~~-~~L~~~~~~---~~~l~~~~~~~i~~qil~aL~~LH~---~givHrDlkp~NILl~~~~~~kL~DFGla~ 177 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKT---PIFLTEEHIKTILYNLLLGENFIHE---SGIIHRDLKPANCLLNQDCSVKVCDFGLAR 177 (432)
T ss_dssp EEEEEECCS-EEHHHHHHS---SCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEecCC-cCHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCHHHeEECCCCCEEEccCCCcc
Confidence 899999986 699999963 3569999999999999999999999 999999999999999999999999999999
Q ss_pred eccCCCC---------------------CcccccccCCcccCcccc-cCCCCCcchhHHHHHHHHHHHHhCCCCC
Q 005940 505 LYDHGGM---------------------PHTTNVVGTFGYIAPELT-QTGKASTSSDVFAYGILLLEVATGRRPI 557 (668)
Q Consensus 505 ~~~~~~~---------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~sDV~S~Gvvl~elltG~~p~ 557 (668)
....... ...+..+||+.|+|||++ ....++.++||||+||++|||++|..|+
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~ 252 (432)
T 3n9x_A 178 TINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH 252 (432)
T ss_dssp EC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred cccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence 7654321 123456899999999986 5567999999999999999999865444
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=326.20 Aligned_cols=249 Identities=31% Similarity=0.401 Sum_probs=193.0
Q ss_pred hcCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCchhHHHHHHHHHHHhcccccCceeEeeeeccc-CceEEEEE
Q 005940 352 TKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNLHGWCKQK-NDLLLVYE 430 (668)
Q Consensus 352 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~-~~~~lV~E 430 (668)
.++|...+.||+|+||.||+|.+ .++.||||++.... ..+.+.+|++++++++||||+++++++.+. +..++|||
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e 95 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 95 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred hhhceEEeEEecCCCceEEEEEE--cCCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEe
Confidence 35788999999999999999998 48899999987543 457789999999999999999999997544 57899999
Q ss_pred ecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCC
Q 005940 431 YIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGG 510 (668)
Q Consensus 431 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~ 510 (668)
|+++++|.+++... ....+++..++.++.|++.||.|||+ .+++||||||+||+++.++.+||+|||+++......
T Consensus 96 ~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 171 (278)
T 1byg_A 96 YMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ 171 (278)
T ss_dssp CCTTEEHHHHHHHH-HHHHCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEECCCCC--------
T ss_pred cCCCCCHHHHHHhc-ccccCCHHHHHHHHHHHHHHHHHHHh---CCccccCCCcceEEEeCCCcEEEeeccccccccccc
Confidence 99999999999532 12347899999999999999999999 999999999999999999999999999998654322
Q ss_pred CCcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHHHhcCccccccCcccCCcc
Q 005940 511 MPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVAT-GRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSY 589 (668)
Q Consensus 511 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 589 (668)
....++..|+|||.+.+..++.++||||||+++|||++ |+.||....... ..... ..+. .+.....+
T Consensus 172 ----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~--~~~~~-~~~~-----~~~~~~~~ 239 (278)
T 1byg_A 172 ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--VVPRV-EKGY-----KMDAPDGC 239 (278)
T ss_dssp --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG--HHHHH-TTTC-----CCCCCTTC
T ss_pred ----cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHH-hcCC-----CCCCcccC
Confidence 22357889999999988889999999999999999998 999997543211 11111 1111 11111222
Q ss_pred cHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhccC
Q 005940 590 VVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSGE 624 (668)
Q Consensus 590 ~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~~ 624 (668)
. ..+..+...|++. |++||+++|+++.|+..
T Consensus 240 ~----~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i 271 (278)
T 1byg_A 240 P----PAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 271 (278)
T ss_dssp C----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred C----HHHHHHHHHHhcCChhhCCCHHHHHHHHHHH
Confidence 2 3355666789887 99999999999999765
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=340.67 Aligned_cols=255 Identities=13% Similarity=0.051 Sum_probs=179.8
Q ss_pred hcCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCc---hhHHHHHHHHHHHhcc--cccCceeEe-------eee
Q 005940 352 TKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSL---QGMREFAAEIESLGRL--RHKNLVNLH-------GWC 419 (668)
Q Consensus 352 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~f~~Ei~~l~~l--~H~nIv~l~-------g~~ 419 (668)
...|...+.||+|+||.||+|++..+++.||||++..... ...+.+.+|+++++.| +||||++++ +.+
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 3458899999999999999999988999999999987543 3445677886555555 599988855 333
Q ss_pred ccc-----------------CceEEEEEecCCCChhhhhcCCCCCCCccHHHH------HHHHHHHHHHHHHhhhccCCc
Q 005940 420 KQK-----------------NDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQR------FNIVKGIASGLLYLHEEWEQV 476 (668)
Q Consensus 420 ~~~-----------------~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~------~~i~~qia~gL~yLH~~~~~~ 476 (668)
... ...++||||++ |+|.+++... +..+++..+ +.++.||+.||+|||+ .+
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~--~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~---~~ 214 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTL--DFVYVFRGDEGILALHILTAQLIRLAANLQS---KG 214 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHH--HHSCCCCHHHHHHHHHHHHHHHHHHHHHHHH---TT
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHh--ccccchhhhhhhhhHHHHHHHHHHHHHHHHH---CC
Confidence 322 33799999998 8999999632 234566666 7888999999999999 99
Q ss_pred eEecCCCCCCEEECCCCCEEEEeecCceeccCCCCCcccccccCCcccCcccccC--CCCCcchhHHHHHHHHHHHHhCC
Q 005940 477 VIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPELTQT--GKASTSSDVFAYGILLLEVATGR 554 (668)
Q Consensus 477 ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDV~S~Gvvl~elltG~ 554 (668)
|+||||||+|||++.++.+||+|||+++..... .....+|+.|+|||++.+ ..++.++|||||||++|||++|+
T Consensus 215 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~ 290 (371)
T 3q60_A 215 LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLF 290 (371)
T ss_dssp EEETTCSGGGEEECTTSCEEECCGGGEEETTCE----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSS
T ss_pred CccCcCCHHHEEECCCCCEEEEecceeeecCCC----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCC
Confidence 999999999999999999999999999876431 224467799999999987 67899999999999999999999
Q ss_pred CCCCCCchhHHHHHHHHHhcCccccccCcccCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 555 RPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 555 ~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
.||......... ..............+...........+..+...|++. |++||++.|++++
T Consensus 291 ~Pf~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 353 (371)
T 3q60_A 291 LPFGLVTPGIKG----SWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMET 353 (371)
T ss_dssp CSTTBCCTTCTT----CCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTS
T ss_pred CCCCCcCccccc----chhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 999754211000 0000000000001110000001113345566688887 9999999999863
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=344.62 Aligned_cols=250 Identities=24% Similarity=0.369 Sum_probs=199.5
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCC--chhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEE
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNS--LQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYE 430 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 430 (668)
++|.+.++||+|+||.||+|.+..+++.||||++.+.. ....+.+.+|++++++++||||+++++++.+....++|||
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 101 (486)
T 3mwu_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGE 101 (486)
T ss_dssp HHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred cceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEE
Confidence 57899999999999999999998899999999996532 2345788999999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEEC---CCCCEEEEeecCceecc
Q 005940 431 YIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALID---AEMNARLGDFGLARLYD 507 (668)
Q Consensus 431 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~---~~~~~kl~DfGla~~~~ 507 (668)
|+++|+|.+.+.. ...+++..+..++.||+.||.|||+ .+|+||||||+|||++ .++.+||+|||+++...
T Consensus 102 ~~~~~~L~~~~~~---~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~ 175 (486)
T 3mwu_A 102 LYTGGELFDEIIK---RKRFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ 175 (486)
T ss_dssp CCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBC
T ss_pred cCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCchHHEEEecCCCCCCEEEEECCcCeECC
Confidence 9999999998853 2459999999999999999999999 9999999999999995 45679999999998765
Q ss_pred CCCCCcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCcccCC
Q 005940 508 HGGMPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNS 587 (668)
Q Consensus 508 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 587 (668)
... ......||+.|+|||++.+ .++.++||||+||++|||++|+.||...... +....... +..... .+.. .
T Consensus 176 ~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--~~~~~i~~-~~~~~~-~~~~-~ 247 (486)
T 3mwu_A 176 QNT--KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY--DILKRVET-GKYAFD-LPQW-R 247 (486)
T ss_dssp CC------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHH-TCCCSC-SGGG-G
T ss_pred CCC--ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHh-CCCCCC-Cccc-C
Confidence 432 2334579999999999875 6999999999999999999999999765322 11122111 111100 0111 1
Q ss_pred cccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 588 SYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 588 ~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
... ..+..+...|+.. |++||++.|++++
T Consensus 248 ~~s----~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 248 TIS----DDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp GSC----HHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred CCC----HHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 111 2344566678887 9999999999986
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=333.06 Aligned_cols=268 Identities=21% Similarity=0.226 Sum_probs=189.0
Q ss_pred hhHHHHhcCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCchhHHHHHHHHHHHhcccccCceeEeeeecccCc-
Q 005940 346 KDLYAATKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNLHGWCKQKND- 424 (668)
Q Consensus 346 ~el~~at~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~- 424 (668)
.+.....++|...+.||+|+||.||+|++..++..||||++..... ....+.+|++.+..++||||+++++++...+.
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~ 94 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR-FRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER 94 (360)
T ss_dssp HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTT-CCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcc-ccHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence 3445566899999999999999999999988899999999866432 23456788888999999999999999965433
Q ss_pred ------eEEEEEecCCCChhhhhc-CCCCCCCccHHHHHHHHHHHHHHHHHhh--hccCCceEecCCCCCCEEECC-CCC
Q 005940 425 ------LLLVYEYIPNGSLDTLLF-KPKDGSVLDWEQRFNIVKGIASGLLYLH--EEWEQVVIHRDVKPSNALIDA-EMN 494 (668)
Q Consensus 425 ------~~lV~E~~~~gsL~~~l~-~~~~~~~l~~~~~~~i~~qia~gL~yLH--~~~~~~ivHrDLkp~NIll~~-~~~ 494 (668)
.++||||++++ |.+.+. .......+++..+..++.|++.||.||| + .+|+||||||+|||++. ++.
T Consensus 95 ~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~ivH~Dlkp~NIll~~~~~~ 170 (360)
T 3e3p_A 95 DRRDIYLNVVMEYVPDT-LHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPS---VNVCHRDIKPHNVLVNEADGT 170 (360)
T ss_dssp CTTCEEEEEEEECCSCB-HHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTT---TCCBCSCCCGGGEEEETTTTE
T ss_pred cccceeEEEEeeccccc-HHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCC---CCeecCcCCHHHEEEeCCCCc
Confidence 78999999864 443332 1234566899999999999999999999 7 99999999999999997 899
Q ss_pred EEEEeecCceeccCCCCCcccccccCCcccCcccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCchh-HHHHHHHHH
Q 005940 495 ARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPELTQTG-KASTSSDVFAYGILLLEVATGRRPIGSGDLL-LVEWVRECH 572 (668)
Q Consensus 495 ~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~-l~~~~~~~~ 572 (668)
+||+|||+++....... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||...+.. ....+....
T Consensus 171 ~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~ 248 (360)
T 3e3p_A 171 LKLCDFGSAKKLSPSEP--NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVL 248 (360)
T ss_dssp EEECCCTTCBCCCTTSC--CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHH
T ss_pred EEEeeCCCceecCCCCC--cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHc
Confidence 99999999987664332 2345789999999988654 4899999999999999999999999765322 111111111
Q ss_pred hcC------------ccccccCcc-c-----CCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 573 QLG------------RILDVADPL-L-----NSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 573 ~~~------------~~~~~~d~~-l-----~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
... ......+.. . ...........+..+...|++. |++||++.|++++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 315 (360)
T 3e3p_A 249 GCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH 315 (360)
T ss_dssp CCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred CCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 000 000000000 0 0000111234566777789887 9999999999976
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=333.78 Aligned_cols=259 Identities=20% Similarity=0.215 Sum_probs=200.8
Q ss_pred hcCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCchhHHHHHHHHHHHhccc--------ccCceeEeeeec---
Q 005940 352 TKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLR--------HKNLVNLHGWCK--- 420 (668)
Q Consensus 352 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~--------H~nIv~l~g~~~--- 420 (668)
.++|.+.++||+|+||.||+|++..+++.||||++... ....+.+.+|++++++++ |+||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~ 114 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG 114 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence 36899999999999999999999888999999999754 344577889999999996 788999999987
Q ss_pred -ccCceEEEEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCC-ceEecCCCCCCEEECCCC-----
Q 005940 421 -QKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQ-VVIHRDVKPSNALIDAEM----- 493 (668)
Q Consensus 421 -~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~-~ivHrDLkp~NIll~~~~----- 493 (668)
.....++||||+ +++|.+.+.. .....+++..++.++.||+.||.|||+ . +|+||||||+||||+.++
T Consensus 115 ~~~~~~~lv~e~~-~~~l~~~~~~-~~~~~~~~~~~~~i~~qi~~aL~~lH~---~~givHrDikp~NIll~~~~~~~~~ 189 (397)
T 1wak_A 115 VNGTHICMVFEVL-GHHLLKWIIK-SNYQGLPLPCVKKIIQQVLQGLDYLHT---KCRIIHTDIKPENILLSVNEQYIRR 189 (397)
T ss_dssp TTEEEEEEEECCC-CCBHHHHHHH-TTTSCCCHHHHHHHHHHHHHHHHHHHH---TTCEECCCCSGGGEEECCCHHHHHH
T ss_pred CCCceEEEEEecc-CccHHHHHHh-cccCCCCHHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHeeEeccchhhhh
Confidence 566899999999 5566555542 233569999999999999999999999 7 999999999999999775
Q ss_pred --------------------------------------------CEEEEeecCceeccCCCCCcccccccCCcccCcccc
Q 005940 494 --------------------------------------------NARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPELT 529 (668)
Q Consensus 494 --------------------------------------------~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~ 529 (668)
.+||+|||+++..... .....||..|+|||++
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~~y~aPE~~ 265 (397)
T 1wak_A 190 LAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQYRSLEVL 265 (397)
T ss_dssp HHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCGGGCCHHHH
T ss_pred hhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCCCcccCChhh
Confidence 8999999999876543 2334789999999999
Q ss_pred cCCCCCcchhHHHHHHHHHHHHhCCCCCCCCch-------hHHHHHHHHHhc--------Cccc-cccCc----------
Q 005940 530 QTGKASTSSDVFAYGILLLEVATGRRPIGSGDL-------LLVEWVRECHQL--------GRIL-DVADP---------- 583 (668)
Q Consensus 530 ~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~-------~l~~~~~~~~~~--------~~~~-~~~d~---------- 583 (668)
.+..++.++|||||||++|||++|+.||..... .....+.+.... .... .....
T Consensus 266 ~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 345 (397)
T 1wak_A 266 IGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKL 345 (397)
T ss_dssp HTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCC
T ss_pred cCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccccccccc
Confidence 998999999999999999999999999975321 111111111100 0000 00000
Q ss_pred cc---------CCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 584 LL---------NSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 584 ~l---------~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
.. ...........+..+...|++. |++||+++|++++
T Consensus 346 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 392 (397)
T 1wak_A 346 KPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH 392 (397)
T ss_dssp CCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred CCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence 00 0122345566778888899987 9999999999975
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=332.51 Aligned_cols=269 Identities=23% Similarity=0.256 Sum_probs=196.4
Q ss_pred cchhhHHHHhcCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCc-----------hhHHHHHHHHHHHhcccccC
Q 005940 343 FRYKDLYAATKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSL-----------QGMREFAAEIESLGRLRHKN 411 (668)
Q Consensus 343 f~~~el~~at~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-----------~~~~~f~~Ei~~l~~l~H~n 411 (668)
....++....++|...+.||+|+||.||+|.+.. +..||||++..... ...+.+.+|++++++++|||
T Consensus 12 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ 90 (362)
T 3pg1_A 12 DLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPN 90 (362)
T ss_dssp HHHHHHHHTTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTT
T ss_pred HHHHHHHHhccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcC
Confidence 3456778888999999999999999999999854 89999999854322 12378899999999999999
Q ss_pred ceeEeeeec-----ccCceEEEEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCC
Q 005940 412 LVNLHGWCK-----QKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSN 486 (668)
Q Consensus 412 Iv~l~g~~~-----~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~N 486 (668)
|+++++++. .....++||||++ |+|.+++.. ....+++..++.++.||+.||.|||+ .+|+||||||+|
T Consensus 91 iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~N 164 (362)
T 3pg1_A 91 ILGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHD--QRIVISPQHIQYFMYHILLGLHVLHE---AGVVHRDLHPGN 164 (362)
T ss_dssp BCCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGG
T ss_pred ccceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHH---CcCEecCCChHH
Confidence 999999984 3346899999997 688888853 34569999999999999999999999 999999999999
Q ss_pred EEECCCCCEEEEeecCceeccCCCCCcccccccCCcccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCch-hH
Q 005940 487 ALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPELTQT-GKASTSSDVFAYGILLLEVATGRRPIGSGDL-LL 564 (668)
Q Consensus 487 Ill~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~-~l 564 (668)
|+++.++.+||+|||+++...... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... ..
T Consensus 165 Il~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~ 242 (362)
T 3pg1_A 165 ILLADNNDITICDFNLAREDTADA--NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQ 242 (362)
T ss_dssp EEECTTCCEEECCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred EEEcCCCCEEEEecCccccccccc--ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHH
Confidence 999999999999999998544332 2334578999999998876 6789999999999999999999999976532 11
Q ss_pred HHHHHHHHhcCccc---------------cccCcccCC---cccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 565 VEWVRECHQLGRIL---------------DVADPLLNS---SYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 565 ~~~~~~~~~~~~~~---------------~~~d~~l~~---~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
...+.+........ ......... .........+..+...|++. |++||+++|++++
T Consensus 243 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 317 (362)
T 3pg1_A 243 LNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH 317 (362)
T ss_dssp HHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence 11111111111000 000000000 00001123355667788887 9999999999985
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=323.03 Aligned_cols=252 Identities=26% Similarity=0.407 Sum_probs=192.0
Q ss_pred hcCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCchhHHHHHHHHHHHhcccccCceeEeeeecc----------
Q 005940 352 TKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNLHGWCKQ---------- 421 (668)
Q Consensus 352 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~---------- 421 (668)
.++|+..+.||+|+||.||+|++..+++.||||++... ....+.+.+|++++++++||||+++++++.+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA 83 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence 35788999999999999999999888999999999653 3445788999999999999999999998754
Q ss_pred ---cCceEEEEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEE
Q 005940 422 ---KNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLG 498 (668)
Q Consensus 422 ---~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~ 498 (668)
....++||||+++|+|.+++.. ....+++..++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dlkp~Nil~~~~~~~kl~ 158 (303)
T 1zy4_A 84 VKKKSTLFIQMEYCENGTLYDLIHS--ENLNQQRDEYWRLFRQILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIG 158 (303)
T ss_dssp --CEEEEEEEEECCCSCBHHHHHHH--SCGGGCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEEC
T ss_pred cccCCceEEEEecCCCCCHHHhhhc--cccccchHHHHHHHHHHHHHHHHHHh---CCeecccCCHHhEEEcCCCCEEEe
Confidence 4568999999999999999963 33568889999999999999999999 999999999999999999999999
Q ss_pred eecCceeccCCC-------------CCcccccccCCcccCcccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCchhH
Q 005940 499 DFGLARLYDHGG-------------MPHTTNVVGTFGYIAPELTQTG-KASTSSDVFAYGILLLEVATGRRPIGSGDLLL 564 (668)
Q Consensus 499 DfGla~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l 564 (668)
|||+++...... ........||..|+|||++.+. .++.++|||||||++|||++ ||.... ..
T Consensus 159 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~-~~ 234 (303)
T 1zy4_A 159 DFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGM-ER 234 (303)
T ss_dssp CCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHH-HH
T ss_pred eCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCch-hH
Confidence 999998664321 1122345789999999998754 68999999999999999998 554321 11
Q ss_pred HHHHHHHHhcCccccccCcccCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 565 VEWVRECHQLGRILDVADPLLNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 565 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
.+..... .... ..+...+.......+..+...|++. |++||+++|++++
T Consensus 235 ~~~~~~~-~~~~------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 284 (303)
T 1zy4_A 235 VNILKKL-RSVS------IEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS 284 (303)
T ss_dssp HHHHHHH-HSTT------CCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred HHHHHhc-cccc------cccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence 1111111 1111 1111112222223455667788887 9999999999984
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-38 Score=342.39 Aligned_cols=258 Identities=24% Similarity=0.303 Sum_probs=191.1
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCchhHHHHHHHHHHHhcccccCceeEeeeeccc------CceE
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNLHGWCKQK------NDLL 426 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~------~~~~ 426 (668)
.+|...++||+|+||.||+|++..+++.||||++..... .+.+|++++++++||||++++++|... ..++
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 358889999999999999999988899999999976432 234699999999999999999998432 2367
Q ss_pred EEEEecCCCChhhhhcC-CCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCC-CCEEEEeecCce
Q 005940 427 LVYEYIPNGSLDTLLFK-PKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAE-MNARLGDFGLAR 504 (668)
Q Consensus 427 lV~E~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~-~~~kl~DfGla~ 504 (668)
+||||+++ +|.+.+.. ......+++..++.++.||++||.|||+ .+|+||||||+||||+.+ +.+||+|||+++
T Consensus 130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~ 205 (420)
T 1j1b_A 130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK 205 (420)
T ss_dssp EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChhhEEEeCCCCeEEeccchhhh
Confidence 99999975 56555532 1234569999999999999999999998 999999999999999965 568999999999
Q ss_pred eccCCCCCcccccccCCcccCcccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCch--hHHHHHHHHH---------
Q 005940 505 LYDHGGMPHTTNVVGTFGYIAPELTQTG-KASTSSDVFAYGILLLEVATGRRPIGSGDL--LLVEWVRECH--------- 572 (668)
Q Consensus 505 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDV~S~Gvvl~elltG~~p~~~~~~--~l~~~~~~~~--------- 572 (668)
....... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||...+. .+.+.+....
T Consensus 206 ~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~ 283 (420)
T 1j1b_A 206 QLVRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE 283 (420)
T ss_dssp ECCTTCC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHH
T ss_pred hcccCCC--ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 7654332 2345789999999998764 789999999999999999999999976532 1222211100
Q ss_pred hcCccccccCcccCCc-----ccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 573 QLGRILDVADPLLNSS-----YVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 573 ~~~~~~~~~d~~l~~~-----~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
......+...+.+... +.......+..+...|+.. |++||++.|++++
T Consensus 284 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h 337 (420)
T 1j1b_A 284 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 337 (420)
T ss_dssp HCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence 0001111111111100 0001113455666678887 9999999999976
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=332.81 Aligned_cols=263 Identities=24% Similarity=0.284 Sum_probs=201.3
Q ss_pred hhHHHHhcCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCc-hhHHHHHHHHHHHhcccccCceeEeeeeccc--
Q 005940 346 KDLYAATKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSL-QGMREFAAEIESLGRLRHKNLVNLHGWCKQK-- 422 (668)
Q Consensus 346 ~el~~at~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~-- 422 (668)
.+.....++|...+.||+|+||.||+|.+..++..||||++..... ...+.+.+|++++++++||||+++++++...
T Consensus 20 g~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 99 (364)
T 3qyz_A 20 GQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTI 99 (364)
T ss_dssp -CBCCCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSST
T ss_pred cEeccccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCc
Confidence 3344445689999999999999999999988899999999975433 3447889999999999999999999998654
Q ss_pred ---CceEEEEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEe
Q 005940 423 ---NDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGD 499 (668)
Q Consensus 423 ---~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~D 499 (668)
...++||||+. |+|.+++.. ..+++.++..++.||+.||.|||+ .+|+||||||+||+++.++.+||+|
T Consensus 100 ~~~~~~~iv~e~~~-~~L~~~l~~----~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~D 171 (364)
T 3qyz_A 100 EQMKDVYIVQDLME-TDLYKLLKT----QHLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICD 171 (364)
T ss_dssp TTCCCEEEEEECCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECC
T ss_pred cccceEEEEEcccC-cCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCChHhEEECCCCCEEEEe
Confidence 46899999997 599998853 349999999999999999999999 9999999999999999999999999
Q ss_pred ecCceeccCCCCC--cccccccCCcccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCc-hhHHHHHHHHHhcC
Q 005940 500 FGLARLYDHGGMP--HTTNVVGTFGYIAPELTQT-GKASTSSDVFAYGILLLEVATGRRPIGSGD-LLLVEWVRECHQLG 575 (668)
Q Consensus 500 fGla~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~S~Gvvl~elltG~~p~~~~~-~~l~~~~~~~~~~~ 575 (668)
||+++........ ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...+ ......+.......
T Consensus 172 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~ 251 (364)
T 3qyz_A 172 FGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSP 251 (364)
T ss_dssp CTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSC
T ss_pred CcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCC
Confidence 9999876543211 1234589999999998654 458999999999999999999999997542 22222221111100
Q ss_pred ccc---------------cccCc------ccCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 576 RIL---------------DVADP------LLNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 576 ~~~---------------~~~d~------~l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
... ....+ .+....+ ..+..+...|+.. |++||+++|++++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~li~~~L~~dP~~R~t~~e~l~h 314 (364)
T 3qyz_A 252 SQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNAD----SKALDLLDKMLTFNPHKRIEVEQALAH 314 (364)
T ss_dssp CHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSC----HHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCC----HHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000 00000 0001111 2345666688887 9999999999986
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=338.55 Aligned_cols=199 Identities=24% Similarity=0.303 Sum_probs=174.4
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCchhHHHHHHHHHHHhcc------cccCceeEeeeecccCceE
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRL------RHKNLVNLHGWCKQKNDLL 426 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l------~H~nIv~l~g~~~~~~~~~ 426 (668)
.+|...++||+|+||.||+|.+..+++.||||++... ....+++..|+++++.+ +|+||+++++++...+..+
T Consensus 97 ~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~ 175 (429)
T 3kvw_A 97 YRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHIC 175 (429)
T ss_dssp TTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEE
T ss_pred CcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEE
Confidence 5688999999999999999999888999999999754 23446778888888887 4679999999999999999
Q ss_pred EEEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCC--EEEEeecCce
Q 005940 427 LVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMN--ARLGDFGLAR 504 (668)
Q Consensus 427 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~--~kl~DfGla~ 504 (668)
+||||+. ++|.+++... ....+++..++.++.||+.||.|||+ .+|+||||||+||||+.++. +||+|||+++
T Consensus 176 lv~e~~~-~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~ 250 (429)
T 3kvw_A 176 MTFELLS-MNLYELIKKN-KFQGFSLPLVRKFAHSILQCLDALHK---NRIIHCDLKPENILLKQQGRSGIKVIDFGSSC 250 (429)
T ss_dssp EEECCCC-CBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHH---HTEECSCCSGGGEEESSTTSCCEEECCCTTCE
T ss_pred EEEeccC-CCHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEEccCCCcceEEeecccce
Confidence 9999996 6899988642 23458999999999999999999999 89999999999999999987 9999999998
Q ss_pred eccCCCCCcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCc
Q 005940 505 LYDHGGMPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGD 561 (668)
Q Consensus 505 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~ 561 (668)
..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 251 ~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~ 303 (429)
T 3kvw_A 251 YEHQR----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGED 303 (429)
T ss_dssp ETTCC----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ecCCc----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCC
Confidence 65432 233578999999999999999999999999999999999999997653
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=322.80 Aligned_cols=259 Identities=26% Similarity=0.360 Sum_probs=194.5
Q ss_pred cCcccceeeeecCcEEEEEEEeCC-CCc--EEEEEEEecC---CchhHHHHHHHHHHHhcccccCceeEeeeecccCceE
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPT-TGG--EVAVKKITRN---SLQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLL 426 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~-~~~--~vavK~~~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~ 426 (668)
++|+..+.||+|+||.||+|++.. ++. .||||++... .....+.+.+|++++++++||||+++++++.... .+
T Consensus 18 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~ 96 (291)
T 1u46_A 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MK 96 (291)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CE
T ss_pred hHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ce
Confidence 578899999999999999998643 233 6999998754 2345678999999999999999999999998764 89
Q ss_pred EEEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceec
Q 005940 427 LVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLY 506 (668)
Q Consensus 427 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~ 506 (668)
+|+||+++++|.+++.. ....+++..++.++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||+++..
T Consensus 97 ~v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~ 171 (291)
T 1u46_A 97 MVTELAPLGSLLDRLRK--HQGHFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRAL 171 (291)
T ss_dssp EEEECCTTCBHHHHHHH--HGGGSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred eeEecccCCCHHHHHHh--ccCCcCHHHHHHHHHHHHHHHHHHHh---CCcccCCCchheEEEcCCCCEEEccccccccc
Confidence 99999999999999963 23468999999999999999999999 99999999999999999999999999999877
Q ss_pred cCCCCC--cccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHHHhcCccccccCc
Q 005940 507 DHGGMP--HTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVAT-GRRPIGSGDLLLVEWVRECHQLGRILDVADP 583 (668)
Q Consensus 507 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~ 583 (668)
...... ......+|..|+|||++.+..++.++||||||+++|||++ |+.||...+.. +............
T Consensus 172 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~~~~~~~~~~~~~----- 244 (291)
T 1u46_A 172 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS--QILHKIDKEGERL----- 244 (291)
T ss_dssp CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHHHHHHTSCCCC-----
T ss_pred cccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHH--HHHHHHHccCCCC-----
Confidence 544321 1223467888999999988888999999999999999999 99999765322 2222222211111
Q ss_pred ccCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhccCcCCC
Q 005940 584 LLNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSGEKQLR 628 (668)
Q Consensus 584 ~l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~~~~~~ 628 (668)
.....+. ..+..+...|+.. |++||++.++++.|+...+.+
T Consensus 245 ~~~~~~~----~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 286 (291)
T 1u46_A 245 PRPEDCP----QDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPTD 286 (291)
T ss_dssp CCCTTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC---
T ss_pred CCCcCcC----HHHHHHHHHHccCCcccCcCHHHHHHHHHHhCccc
Confidence 1111122 3355666788887 999999999999998765433
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-37 Score=325.04 Aligned_cols=202 Identities=28% Similarity=0.406 Sum_probs=173.4
Q ss_pred hcCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCC-chhHHHHHHHHHHHhcccccCceeEeeeeccc-----Cce
Q 005940 352 TKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNS-LQGMREFAAEIESLGRLRHKNLVNLHGWCKQK-----NDL 425 (668)
Q Consensus 352 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~-----~~~ 425 (668)
.++|...+.||+|+||.||+|.+..+++.||||++.... ......+.+|++++++++||||+++++++... ...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 468999999999999999999998889999999997543 33456788999999999999999999988654 678
Q ss_pred EEEEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCcee
Q 005940 426 LLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARL 505 (668)
Q Consensus 426 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~ 505 (668)
++||||+. ++|.+++.. ..+++..++.++.||+.||.|||+ .+|+||||||+||+++.++.+||+|||+++.
T Consensus 90 ~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~ 161 (353)
T 2b9h_A 90 YIIQELMQ-TDLHRVIST----QMLSDDHIQYFIYQTLRAVKVLHG---SNVIHRDLKPSNLLINSNCDLKVCDFGLARI 161 (353)
T ss_dssp EEEECCCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEeccC-ccHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEEcCCCcEEEEecccccc
Confidence 99999997 689999853 358999999999999999999999 9999999999999999999999999999987
Q ss_pred ccCCCCC---------cccccccCCcccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCc
Q 005940 506 YDHGGMP---------HTTNVVGTFGYIAPELTQT-GKASTSSDVFAYGILLLEVATGRRPIGSGD 561 (668)
Q Consensus 506 ~~~~~~~---------~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~S~Gvvl~elltG~~p~~~~~ 561 (668)
....... ......||..|+|||++.. ..++.++|||||||++|||++|+.||...+
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 227 (353)
T 2b9h_A 162 IDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRD 227 (353)
T ss_dssp CC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 6543211 1223478999999998754 678999999999999999999999997654
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=332.31 Aligned_cols=198 Identities=29% Similarity=0.444 Sum_probs=157.9
Q ss_pred hcCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecC--CchhHHHHHHHHHHHhcccccCceeEeeeeccc------C
Q 005940 352 TKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRN--SLQGMREFAAEIESLGRLRHKNLVNLHGWCKQK------N 423 (668)
Q Consensus 352 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~------~ 423 (668)
.++|...+.||+|+||.||+|.+..+++.||||++... .....+.+.+|++++++++||||+++++++... .
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 36899999999999999999999889999999999654 234457788999999999999999999998654 5
Q ss_pred ceEEEEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCc
Q 005940 424 DLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLA 503 (668)
Q Consensus 424 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla 503 (668)
..++|+|++ +++|.+++.. ..+++..+..++.||++||.|||+ .+|+||||||+||+++.++.+||+|||++
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kL~DFG~a 179 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLA 179 (367)
T ss_dssp CCEEEEECC-CEECC---------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECC----
T ss_pred eEEEEeccc-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHhhEEECCCCCEEEeecccc
Confidence 689999999 7899998852 459999999999999999999999 99999999999999999999999999999
Q ss_pred eeccCCCCCcccccccCCcccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCc
Q 005940 504 RLYDHGGMPHTTNVVGTFGYIAPELTQT-GKASTSSDVFAYGILLLEVATGRRPIGSGD 561 (668)
Q Consensus 504 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~S~Gvvl~elltG~~p~~~~~ 561 (668)
+..... .....||..|+|||++.+ ..++.++|||||||++|||++|+.||...+
T Consensus 180 ~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 234 (367)
T 2fst_X 180 RHTADE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 234 (367)
T ss_dssp ---------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cccccc----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 865432 234578999999999876 678999999999999999999999997653
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=327.52 Aligned_cols=208 Identities=23% Similarity=0.297 Sum_probs=177.0
Q ss_pred hhhHHHHhcCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCchhHHHHHHHHHHHhccc-cc-----CceeEeee
Q 005940 345 YKDLYAATKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLR-HK-----NLVNLHGW 418 (668)
Q Consensus 345 ~~el~~at~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~-H~-----nIv~l~g~ 418 (668)
........++|...++||+|+||.||+|.+..+++.||||++... ....+++..|+++++.++ |+ +|++++++
T Consensus 46 ~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~ 124 (382)
T 2vx3_A 46 VKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRH 124 (382)
T ss_dssp CCTTCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEE
T ss_pred eecCCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeee
Confidence 334444567899999999999999999999888999999999754 234567788999988885 44 49999999
Q ss_pred ecccCceEEEEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEEC--CCCCEE
Q 005940 419 CKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALID--AEMNAR 496 (668)
Q Consensus 419 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~--~~~~~k 496 (668)
+...+..++||||++ ++|.+++... ....+++..+..++.|++.||.|||+. +.+|+||||||+|||++ .++.+|
T Consensus 125 ~~~~~~~~lv~e~~~-~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~k 201 (382)
T 2vx3_A 125 FMFRNHLCLVFEMLS-YNLYDLLRNT-NFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIK 201 (382)
T ss_dssp EEETTEEEEEEECCC-CBHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEE
T ss_pred eccCCceEEEEecCC-CCHHHHHhhc-CcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEE
Confidence 999999999999996 5999998643 234589999999999999999999941 27999999999999995 478899
Q ss_pred EEeecCceeccCCCCCcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 005940 497 LGDFGLARLYDHGGMPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSG 560 (668)
Q Consensus 497 l~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~ 560 (668)
|+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 202 L~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~ 261 (382)
T 2vx3_A 202 IVDFGSSCQLGQR----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGA 261 (382)
T ss_dssp ECCCTTCEETTCC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred EEeccCceecccc----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 9999999876542 23457899999999999989999999999999999999999999765
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-37 Score=320.90 Aligned_cols=258 Identities=24% Similarity=0.330 Sum_probs=192.5
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCchhHHHHHHHHHHHhcccccCceeEeeeec------------
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNLHGWCK------------ 420 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~------------ 420 (668)
++|...+.||+|+||.||+|.+..+++.||||++........+++.+|++++++++||||+++++++.
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 90 (320)
T 2i6l_A 11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGS 90 (320)
T ss_dssp TTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----
T ss_pred CceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccccc
Confidence 57889999999999999999998889999999998877777788999999999999999999999873
Q ss_pred --ccCceEEEEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEEC-CCCCEEE
Q 005940 421 --QKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALID-AEMNARL 497 (668)
Q Consensus 421 --~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~-~~~~~kl 497 (668)
+....++||||++ |+|.+++.. ..+++..++.++.|++.||.|||+ .+|+||||||+||+++ +++.+||
T Consensus 91 ~~~~~~~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~kl 162 (320)
T 2i6l_A 91 LTELNSVYIVQEYME-TDLANVLEQ----GPLLEEHARLFMYQLLRGLKYIHS---ANVLHRDLKPANLFINTEDLVLKI 162 (320)
T ss_dssp CCSCSEEEEEEECCS-EEHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTTEEEE
T ss_pred ccccCceeEEeeccC-CCHHHHhhc----CCccHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCeEEE
Confidence 3467899999997 699999942 458999999999999999999999 9999999999999997 5679999
Q ss_pred EeecCceeccCCCC--CcccccccCCcccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhc
Q 005940 498 GDFGLARLYDHGGM--PHTTNVVGTFGYIAPELTQT-GKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQL 574 (668)
Q Consensus 498 ~DfGla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~ 574 (668)
+|||+++....... .......+|..|+|||.+.. ..++.++|||||||++|||++|+.||....... ........
T Consensus 163 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~--~~~~~~~~ 240 (320)
T 2i6l_A 163 GDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELE--QMQLILES 240 (320)
T ss_dssp CCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHH
T ss_pred ccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHh
Confidence 99999987653221 12233467999999998765 678999999999999999999999997653211 11111110
Q ss_pred Ccc---------cc---------ccCcccC-CcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 575 GRI---------LD---------VADPLLN-SSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 575 ~~~---------~~---------~~d~~l~-~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
... .. ...+... ..........+..+...|+.. |++||+++|++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (320)
T 2i6l_A 241 IPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH 306 (320)
T ss_dssp SCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred cCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCC
Confidence 000 00 0000000 000000123455677789887 9999999999975
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-37 Score=327.91 Aligned_cols=259 Identities=21% Similarity=0.305 Sum_probs=201.0
Q ss_pred hcCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCchh-----------------HHHHHHHHHHHhcccccCcee
Q 005940 352 TKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQG-----------------MREFAAEIESLGRLRHKNLVN 414 (668)
Q Consensus 352 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~-----------------~~~f~~Ei~~l~~l~H~nIv~ 414 (668)
.++|...+.||+|+||.||+|.+ +++.||||++....... .+.+.+|++++++++||||++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~ 107 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLT 107 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcce
Confidence 36899999999999999999999 79999999996542211 178999999999999999999
Q ss_pred EeeeecccCceEEEEEecCCCChhhh------hcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEE
Q 005940 415 LHGWCKQKNDLLLVYEYIPNGSLDTL------LFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNAL 488 (668)
Q Consensus 415 l~g~~~~~~~~~lV~E~~~~gsL~~~------l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIl 488 (668)
+++++.+.+..++||||+++|+|.++ +.. .....+++..++.++.||+.||.|||+ +.+|+||||||+||+
T Consensus 108 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~-~~~~~~~~~~~~~i~~qi~~~l~~lH~--~~~i~H~dl~p~Nil 184 (348)
T 2pml_X 108 CEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDK-NYTCFIPIQVIKCIIKSVLNSFSYIHN--EKNICHRDVKPSNIL 184 (348)
T ss_dssp CSEEEESSSEEEEEEECCTTCBSSEESSSEESSCS-SSCCCCCHHHHHHHHHHHHHHHHHHHH--TSCEECCCCCGGGEE
T ss_pred EEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhh-ccccCCCHHHHHHHHHHHHHHHHHHhc--cCCEeecCCChHhEE
Confidence 99999999999999999999999999 532 225679999999999999999999996 379999999999999
Q ss_pred ECCCCCEEEEeecCceeccCCCCCcccccccCCcccCcccccCC-CCCc-chhHHHHHHHHHHHHhCCCCCCCCchhHHH
Q 005940 489 IDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPELTQTG-KAST-SSDVFAYGILLLEVATGRRPIGSGDLLLVE 566 (668)
Q Consensus 489 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~sDV~S~Gvvl~elltG~~p~~~~~~~l~~ 566 (668)
++.++.+||+|||++...... ......|+..|+|||++.+. .++. ++|||||||++|||++|+.||...... .+
T Consensus 185 ~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-~~ 260 (348)
T 2pml_X 185 MDKNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL-VE 260 (348)
T ss_dssp ECTTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS-HH
T ss_pred EcCCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH-HH
Confidence 999999999999999876543 33445789999999999876 5655 999999999999999999999765321 11
Q ss_pred HHHHHHhcCccccccC------cccCC---cccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 567 WVRECHQLGRILDVAD------PLLNS---SYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 567 ~~~~~~~~~~~~~~~d------~~l~~---~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
.... ..........+ +.... .........+..+...|++. |++||+++|++++
T Consensus 261 ~~~~-i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~h 323 (348)
T 2pml_X 261 LFNN-IRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH 323 (348)
T ss_dssp HHHH-HTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred HHHH-HhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 1111 11111110000 00000 00011113445666688887 9999999999984
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=327.42 Aligned_cols=255 Identities=23% Similarity=0.309 Sum_probs=194.2
Q ss_pred hcCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCC--chhHHHHHHHHHHHhcccccCceeEeeeecccCce----
Q 005940 352 TKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNS--LQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDL---- 425 (668)
Q Consensus 352 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~---- 425 (668)
.++|...+.||+|+||.||+|.+..+++.||||++.... ....+.+.+|+.++++++||||+++++++...+..
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 367889999999999999999999899999999997643 23457888999999999999999999999876654
Q ss_pred --EEEEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCc
Q 005940 426 --LLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLA 503 (668)
Q Consensus 426 --~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla 503 (668)
++||||+. ++|.+++. ..+++..+..++.||+.||.|||+ .+|+||||||+||+++.++.+||+|||++
T Consensus 121 ~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kL~Dfg~a 191 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMG-----MEFSEEKIQYLVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLA 191 (371)
T ss_dssp CCEEEEECCC-EEHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECSTTCC
T ss_pred eEEEEEcccc-ccHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCcCHHHeEECCCCCEEEEecCcc
Confidence 99999997 68888873 238999999999999999999999 99999999999999999999999999999
Q ss_pred eeccCCCCCcccccccCCcccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCchh-HHHHHHHHHhcCccccc-
Q 005940 504 RLYDHGGMPHTTNVVGTFGYIAPELTQT-GKASTSSDVFAYGILLLEVATGRRPIGSGDLL-LVEWVRECHQLGRILDV- 580 (668)
Q Consensus 504 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~-l~~~~~~~~~~~~~~~~- 580 (668)
+..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||...+.. ....+....... ..+.
T Consensus 192 ~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~-~~~~~ 266 (371)
T 4exu_A 192 RHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVP-GTEFV 266 (371)
T ss_dssp ------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC-CHHHH
T ss_pred cccccC----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC-cHHHH
Confidence 865432 234578999999999877 67899999999999999999999999765321 111111111000 0000
Q ss_pred --------------cCcccCCcc---cHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 581 --------------ADPLLNSSY---VVKEMELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 581 --------------~d~~l~~~~---~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
........+ .......+..+...|+.. |++||+++|++++
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 267 QKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp TTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 000000000 000123455666788887 9999999999986
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-37 Score=354.34 Aligned_cols=249 Identities=25% Similarity=0.305 Sum_probs=203.1
Q ss_pred hcCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCC---chhHHHHHHHHHHHhcc-cccCceeEeeeecccCceEE
Q 005940 352 TKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNS---LQGMREFAAEIESLGRL-RHKNLVNLHGWCKQKNDLLL 427 (668)
Q Consensus 352 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~l 427 (668)
.++|...++||+|+||.||+|.+..+++.||||++.+.. ....+.+..|.+++..+ +||||+++++++.+.+.+|+
T Consensus 340 ~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~l 419 (674)
T 3pfq_A 340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 419 (674)
T ss_dssp CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEE
T ss_pred ccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEE
Confidence 467999999999999999999999999999999997542 23456788899999988 69999999999999999999
Q ss_pred EEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceecc
Q 005940 428 VYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYD 507 (668)
Q Consensus 428 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~ 507 (668)
||||+++|+|.+++.. ...+++..++.++.||+.||.|||+ .+|+||||||+||||+.++.+||+|||+++...
T Consensus 420 V~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~---~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~ 493 (674)
T 3pfq_A 420 VMEYVNGGDLMYHIQQ---VGRFKEPHAVFYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI 493 (674)
T ss_dssp EEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH---TSEECCCCCSTTEEECSSSCEEECCCTTCEECC
T ss_pred EEeCcCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEeccCChhhEEEcCCCcEEEeecceeeccc
Confidence 9999999999999963 2459999999999999999999999 999999999999999999999999999998644
Q ss_pred CCCCCcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCcccCC
Q 005940 508 HGGMPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNS 587 (668)
Q Consensus 508 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 587 (668)
... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||...+.. +....... .. ..+..
T Consensus 494 ~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~--~~~~~i~~-~~------~~~p~ 563 (674)
T 3pfq_A 494 WDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED--ELFQSIME-HN------VAYPK 563 (674)
T ss_dssp CTT-CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHS-SC------CCCCT
T ss_pred cCC-cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHH--HHHHHHHh-CC------CCCCc
Confidence 332 2344568999999999999999999999999999999999999999765432 11122111 11 11112
Q ss_pred cccHHHHHHHHHHHhhcCCC-CCCCCCH-----HHHHHH
Q 005940 588 SYVVKEMELVLKLGLMCSHK-TQFRPTM-----RQVMRY 620 (668)
Q Consensus 588 ~~~~~~~~~l~~l~~~C~~~-p~~RPs~-----~evl~~ 620 (668)
... . .+..+...|+.. |++||++ +||+++
T Consensus 564 ~~s-~---~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h 598 (674)
T 3pfq_A 564 SMS-K---EAVAICKGLMTKHPGKRLGCGPEGERDIKEH 598 (674)
T ss_dssp TSC-H---HHHHHHHHHSCSSSTTCTTCSTTHHHHHHSS
T ss_pred cCC-H---HHHHHHHHHccCCHHHCCCCCCCcHHHHhcC
Confidence 222 2 234455577776 9999997 888764
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=335.20 Aligned_cols=258 Identities=23% Similarity=0.309 Sum_probs=189.6
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCchhHHHHHHHHHHHhcccccCceeEeeeecccCc------eE
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNLHGWCKQKND------LL 426 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~------~~ 426 (668)
.+|...++||+|+||.||+|++..++ .+|+|++...... ..+|++++++++||||+++++++...+. .+
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~-~~aikk~~~~~~~----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 114 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVESD-EVAIKKVLQDKRF----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN 114 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTE-EEEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred ceEEEeEEEeeCCCeEEEEEEECCCC-eEEEEEEecCcch----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence 46888999999999999999996544 5999988654322 2369999999999999999999954433 78
Q ss_pred EEEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEEC-CCCCEEEEeecCcee
Q 005940 427 LVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALID-AEMNARLGDFGLARL 505 (668)
Q Consensus 427 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~-~~~~~kl~DfGla~~ 505 (668)
+||||++++.+............+++..+..++.||++||.|||+ .+|+||||||+|||++ .++.+||+|||+++.
T Consensus 115 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~ 191 (394)
T 4e7w_A 115 LVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKI 191 (394)
T ss_dssp EEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCCHHHEEEcCCCCcEEEeeCCCccc
Confidence 999999876554443222234569999999999999999999999 9999999999999999 789999999999987
Q ss_pred ccCCCCCcccccccCCcccCcccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCchh--HHHHHHHHHh---------
Q 005940 506 YDHGGMPHTTNVVGTFGYIAPELTQTG-KASTSSDVFAYGILLLEVATGRRPIGSGDLL--LVEWVRECHQ--------- 573 (668)
Q Consensus 506 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~--l~~~~~~~~~--------- 573 (668)
...... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||...+.. +.........
T Consensus 192 ~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~ 269 (394)
T 4e7w_A 192 LIAGEP--NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTM 269 (394)
T ss_dssp CCTTCC--CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHH
T ss_pred ccCCCC--CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence 654432 2345789999999988664 5899999999999999999999999765321 1111111000
Q ss_pred cCccccccCcccCC-----cccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 574 LGRILDVADPLLNS-----SYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 574 ~~~~~~~~d~~l~~-----~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
........-+.... .+.......+..+...|+.. |++||++.|++++
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (394)
T 4e7w_A 270 NPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322 (394)
T ss_dssp CGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred ChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence 00000000010000 00000113455666688887 9999999999986
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-37 Score=324.65 Aligned_cols=255 Identities=27% Similarity=0.355 Sum_probs=177.4
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCc-hhHHHHHHHHH-HHhcccccCceeEeeeecccCceEEEEE
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSL-QGMREFAAEIE-SLGRLRHKNLVNLHGWCKQKNDLLLVYE 430 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~f~~Ei~-~l~~l~H~nIv~l~g~~~~~~~~~lV~E 430 (668)
++|...+.||+|+||.||+|.+..+++.||||++..... ....++..|+. +++.++||||+++++++...+..++|||
T Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e 101 (327)
T 3aln_A 22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICME 101 (327)
T ss_dssp CSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred HHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEe
Confidence 578889999999999999999988899999999976533 33455666666 7777899999999999999999999999
Q ss_pred ecCCCChhhhhcC--CCCCCCccHHHHHHHHHHHHHHHHHhhhccCC-ceEecCCCCCCEEECCCCCEEEEeecCceecc
Q 005940 431 YIPNGSLDTLLFK--PKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQ-VVIHRDVKPSNALIDAEMNARLGDFGLARLYD 507 (668)
Q Consensus 431 ~~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~-~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~ 507 (668)
|+++ +|.+++.. ......+++..+..++.|++.||.|||+ . +|+||||||+||+++.++.+||+|||+++...
T Consensus 102 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~ 177 (327)
T 3aln_A 102 LMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKE---NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLV 177 (327)
T ss_dssp CCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHH---HHSCCCSCCCGGGEEEETTTEEEECCCSSSCC--
T ss_pred ecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhc---cCCEeECCCCHHHEEEcCCCCEEEccCCCceecc
Confidence 9975 78777642 1124568999999999999999999999 7 99999999999999999999999999998765
Q ss_pred CCCCCcccccccCCcccCcccc----cCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCc
Q 005940 508 HGGMPHTTNVVGTFGYIAPELT----QTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADP 583 (668)
Q Consensus 508 ~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~ 583 (668)
.... .....||..|+|||++ .+..++.++|||||||++|||++|+.||....... + ..........+
T Consensus 178 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~------~~~~~~~~~~~ 248 (327)
T 3aln_A 178 DSIA--KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVF-D------QLTQVVKGDPP 248 (327)
T ss_dssp ------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC--------------CCCCCSCCC
T ss_pred cccc--cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHH-H------HHHHHhcCCCC
Confidence 4322 2334789999999998 45678999999999999999999999997532110 0 00111111111
Q ss_pred ccCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 584 LLNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 584 ~l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
.+...........+..+...|+.. |++||+++||+++
T Consensus 249 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 286 (327)
T 3aln_A 249 QLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKH 286 (327)
T ss_dssp CCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred CCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhC
Confidence 111111011113455666789887 9999999999874
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-36 Score=320.90 Aligned_cols=200 Identities=23% Similarity=0.333 Sum_probs=173.1
Q ss_pred hcCcccceeeeecCcEEEEEEEeCCCC-cEEEEEEEecCCchhHHHHHHHHHHHhcccccC------ceeEeeeecccCc
Q 005940 352 TKGFKESEVIGIGGFGSVYKGVLPTTG-GEVAVKKITRNSLQGMREFAAEIESLGRLRHKN------LVNLHGWCKQKND 424 (668)
Q Consensus 352 t~~f~~~~~lG~G~~g~Vy~~~~~~~~-~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~n------Iv~l~g~~~~~~~ 424 (668)
.++|...+.||+|+||.||+|.+..++ ..||||++... ....+.+..|++++++++|++ ++.+++++...+.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 96 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH 96 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence 368999999999999999999987666 68999999754 344567889999999998876 9999999999999
Q ss_pred eEEEEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEE---------------
Q 005940 425 LLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALI--------------- 489 (668)
Q Consensus 425 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll--------------- 489 (668)
.++||||+ +++|.+++.. .....+++.+++.++.||+.||.|||+ .+|+||||||+|||+
T Consensus 97 ~~lv~e~~-~~~l~~~l~~-~~~~~~~~~~~~~i~~qi~~~L~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~ 171 (355)
T 2eu9_A 97 MCIAFELL-GKNTFEFLKE-NNFQPYPLPHVRHMAYQLCHALRFLHE---NQLTHTDLKPENILFVNSEFETLYNEHKSC 171 (355)
T ss_dssp EEEEEECC-CCBHHHHHHH-TTTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEESCCCEEEEECCC-CC
T ss_pred EEEEEecc-CCChHHHHHh-ccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEecccccccccccccc
Confidence 99999999 5666666643 233569999999999999999999998 999999999999999
Q ss_pred ----CCCCCEEEEeecCceeccCCCCCcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCc
Q 005940 490 ----DAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGD 561 (668)
Q Consensus 490 ----~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~ 561 (668)
+.++.+||+|||+++..... .....||..|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 172 ~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 243 (355)
T 2eu9_A 172 EEKSVKNTSIRVADFGSATFDHEH----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHE 243 (355)
T ss_dssp CEEEESCCCEEECCCTTCEETTSC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cccccCCCcEEEeecCcccccccc----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Confidence 56789999999999875432 234578999999999998899999999999999999999999997653
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=313.99 Aligned_cols=251 Identities=24% Similarity=0.368 Sum_probs=200.3
Q ss_pred hcCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCc--hhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEE
Q 005940 352 TKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSL--QGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVY 429 (668)
Q Consensus 352 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 429 (668)
.++|.+.+.||+|+||.||+|++..+++.||||++..... ...+.+.+|++++++++||||+++++++...+..++|+
T Consensus 21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 100 (287)
T 2wei_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (287)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEE
Confidence 3679999999999999999999988899999999975432 34678899999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCC---CCEEEEeecCceec
Q 005940 430 EYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAE---MNARLGDFGLARLY 506 (668)
Q Consensus 430 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~---~~~kl~DfGla~~~ 506 (668)
||+++++|.+++.. ...+++.+++.++.||+.||.|||+ .+++||||||+||+++.+ +.+||+|||++...
T Consensus 101 e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~ 174 (287)
T 2wei_A 101 ELYTGGELFDEIIK---RKRFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF 174 (287)
T ss_dssp CCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTB
T ss_pred EccCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCChhhEEEecCCCcccEEEeccCcceee
Confidence 99999999998853 2358999999999999999999999 999999999999999764 46999999999876
Q ss_pred cCCCCCcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCcccC
Q 005940 507 DHGGMPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLN 586 (668)
Q Consensus 507 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 586 (668)
..... .....|+..|+|||.+.+ .++.++||||||+++|||++|+.||...... +....... +..... .+..
T Consensus 175 ~~~~~--~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~~~~~~~~-~~~~~~-~~~~- 246 (287)
T 2wei_A 175 QQNTK--MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY--DILKRVET-GKYAFD-LPQW- 246 (287)
T ss_dssp CCCSS--CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHH-CCCCCC-SGGG-
T ss_pred cCCCc--cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHH--HHHHHHHc-CCCCCC-chhh-
Confidence 54322 223468899999998865 5899999999999999999999999765322 11222222 211100 0100
Q ss_pred CcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 587 SSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 587 ~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
..+. ..+..+...|+.. |++||++.|++++
T Consensus 247 ~~~~----~~~~~li~~~l~~dp~~Rps~~ell~h 277 (287)
T 2wei_A 247 RTIS----DDAKDLIRKMLTFHPSLRITATQCLEH 277 (287)
T ss_dssp TTSC----HHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred hhcC----HHHHHHHHHHcccChhhCcCHHHHhcC
Confidence 1112 2345566688887 9999999999984
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=320.18 Aligned_cols=260 Identities=26% Similarity=0.311 Sum_probs=198.1
Q ss_pred HHhcCcccceeeeecCcEEEEEEEeC-CCCcEEEEEEEecCCc--hhHHHHHHHHHHHhcc---cccCceeEeeeec---
Q 005940 350 AATKGFKESEVIGIGGFGSVYKGVLP-TTGGEVAVKKITRNSL--QGMREFAAEIESLGRL---RHKNLVNLHGWCK--- 420 (668)
Q Consensus 350 ~at~~f~~~~~lG~G~~g~Vy~~~~~-~~~~~vavK~~~~~~~--~~~~~f~~Ei~~l~~l---~H~nIv~l~g~~~--- 420 (668)
.+.++|...+.||+|+||.||+|.+. .+++.||||++..... .....+.+|+.+++++ +||||++++++|.
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~ 87 (326)
T 1blx_A 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 87 (326)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence 34578999999999999999999985 5688999999865332 2223566777777766 7999999999987
Q ss_pred --ccCceEEEEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEE
Q 005940 421 --QKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLG 498 (668)
Q Consensus 421 --~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~ 498 (668)
.....++||||++ |+|.+++... ....+++..++.++.||+.||.|||+ .+|+||||||+||+++.++.+||+
T Consensus 88 ~~~~~~~~lv~e~~~-~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~---~gi~H~dlkp~Nili~~~~~~kl~ 162 (326)
T 1blx_A 88 TDRETKLTLVFEHVD-QDLTTYLDKV-PEPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLA 162 (326)
T ss_dssp CSSEEEEEEEEECCS-CBHHHHHHHS-CTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEEC
T ss_pred cCCCceEEEEEecCC-CCHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCCHHHeEEcCCCCEEEe
Confidence 5667899999997 6999998642 23458999999999999999999999 999999999999999999999999
Q ss_pred eecCceeccCCCCCcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCch-hHHHHHHHHHhcCcc
Q 005940 499 DFGLARLYDHGGMPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDL-LLVEWVRECHQLGRI 577 (668)
Q Consensus 499 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~-~l~~~~~~~~~~~~~ 577 (668)
|||+++...... ......||..|+|||++.+..++.++|||||||++|||++|+.||..... .....+.........
T Consensus 163 Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 240 (326)
T 1blx_A 163 DFGLARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGE 240 (326)
T ss_dssp SCCSCCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCG
T ss_pred cCcccccccCCC--CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCc
Confidence 999998654321 23345789999999999988999999999999999999999999976532 222222221111000
Q ss_pred ccc----------cC-------cccCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 578 LDV----------AD-------PLLNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 578 ~~~----------~d-------~~l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
... .. ..+....+ ..+..+...|+.. |++||++.|++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~li~~~L~~dP~~Rpt~~e~l~h 297 (326)
T 1blx_A 241 EDWPRDVALPRQAFHSKSAQPIEKFVTDID----ELGKDLLLKCLTFNPAKRISAYSALSH 297 (326)
T ss_dssp GGSCTTCSSCGGGSCCCCCCCGGGTCCSCC----HHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred ccCccccccchhhhcccCcchhhhccccCC----HHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 000 00 00011112 3345666688887 9999999999964
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=324.05 Aligned_cols=256 Identities=25% Similarity=0.348 Sum_probs=196.2
Q ss_pred hcCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCC--chhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEE
Q 005940 352 TKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNS--LQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVY 429 (668)
Q Consensus 352 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 429 (668)
.++|...+.||+|+||.||+|.+. ..+|+|++.... ....+.+.+|+.++++++||||+++++++...+..++||
T Consensus 32 ~~~~~~~~~lg~G~~g~V~~~~~~---~~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~ 108 (319)
T 2y4i_B 32 FEQLEIGELIGKGRFGQVYHGRWH---GEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIIT 108 (319)
T ss_dssp CSCEECCCBCCCSSSSEEEEEEES---SSEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEEC
T ss_pred HHHeEEeeEeccCCceEEEEEEEc---CeEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEe
Confidence 467889999999999999999984 359999986532 233456788999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCC
Q 005940 430 EYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHG 509 (668)
Q Consensus 430 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~ 509 (668)
||+++++|.+++.. .+..+++..++.++.||+.||.|||+ .+|+||||||+||+++ ++.+||+|||+++.....
T Consensus 109 e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~ 182 (319)
T 2y4i_B 109 SLCKGRTLYSVVRD--AKIVLDVNKTRQIAQEIVKGMGYLHA---KGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVL 182 (319)
T ss_dssp BCCCSEEHHHHTTS--SCCCCCSHHHHHHHHHHHHHHHHHHH---TTCCCCCCCSTTEEEC---CCEECCCSCCC-----
T ss_pred ecccCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHh---CCccccCCChhhEEEe-CCCEEEeecCCccccccc
Confidence 99999999999953 34569999999999999999999999 9999999999999998 679999999998765321
Q ss_pred C----CCcccccccCCcccCcccccC---------CCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCc
Q 005940 510 G----MPHTTNVVGTFGYIAPELTQT---------GKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGR 576 (668)
Q Consensus 510 ~----~~~~~~~~gt~~y~aPE~~~~---------~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~ 576 (668)
. ........|+..|+|||++.. ..++.++|||||||++|||++|+.||......... +.... ..
T Consensus 183 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~--~~~~~-~~ 259 (319)
T 2y4i_B 183 QAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAII--WQMGT-GM 259 (319)
T ss_dssp -----CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHH--HHHHT-TC
T ss_pred cccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH--HHhcc-CC
Confidence 1 112233468999999998864 35789999999999999999999999765433222 22111 11
Q ss_pred cccccCcccCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhccCcCC
Q 005940 577 ILDVADPLLNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSGEKQL 627 (668)
Q Consensus 577 ~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~~~~~ 627 (668)
........ ++ ..+..+...|+.. |++||++++|++.|+.....
T Consensus 260 ~~~~~~~~----~~----~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~ 303 (319)
T 2y4i_B 260 KPNLSQIG----MG----KEISDILLFCWAFEQEERPTFTKLMDMLEKLPKR 303 (319)
T ss_dssp CCCCCCSS----CC----TTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC---
T ss_pred CCCCCcCC----CC----HHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHh
Confidence 11111111 11 1245666788887 99999999999999987543
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=322.87 Aligned_cols=196 Identities=27% Similarity=0.411 Sum_probs=169.2
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCC--chhHHHHHHHHHHHhcccccCceeEeeeecccCc------
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNS--LQGMREFAAEIESLGRLRHKNLVNLHGWCKQKND------ 424 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~------ 424 (668)
++|...+.||+|+||.||+|.+..+|+.||||++.... ....+.+.+|+.++++++||||+++++++.....
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 103 (353)
T 3coi_A 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD 103 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccccee
Confidence 57889999999999999999998899999999997643 2345678899999999999999999999977654
Q ss_pred eEEEEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCce
Q 005940 425 LLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLAR 504 (668)
Q Consensus 425 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~ 504 (668)
.++||||+. ++|.+++. ..+++.+++.++.||+.||.|||+ .+|+||||||+||+++.++.+||+|||+++
T Consensus 104 ~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~al~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~ 174 (353)
T 3coi_A 104 FYLVMPFMQ-TDLQKIMG-----LKFSEEKIQYLVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLAR 174 (353)
T ss_dssp CEEEEECCS-EEGGGTTT-----SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECTTCCEEECSTTCTT
T ss_pred EEEEecccc-CCHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEeECCCCcEEEeeccccc
Confidence 499999997 68888873 238999999999999999999999 999999999999999999999999999998
Q ss_pred eccCCCCCcccccccCCcccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCc
Q 005940 505 LYDHGGMPHTTNVVGTFGYIAPELTQT-GKASTSSDVFAYGILLLEVATGRRPIGSGD 561 (668)
Q Consensus 505 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~S~Gvvl~elltG~~p~~~~~ 561 (668)
..... .....+|..|+|||++.+ ..++.++|||||||++|||++|+.||...+
T Consensus 175 ~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 228 (353)
T 3coi_A 175 HADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD 228 (353)
T ss_dssp C------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSC
T ss_pred CCCCC----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 65432 234578999999998876 678999999999999999999999997653
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=321.65 Aligned_cols=252 Identities=23% Similarity=0.301 Sum_probs=169.7
Q ss_pred hcCcccce-eeeecCcEEEEEEEeCCCCcEEEEEEEecCCchhHHHHHHHHHHHhcccccCceeEeeeecc----cCceE
Q 005940 352 TKGFKESE-VIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNLHGWCKQ----KNDLL 426 (668)
Q Consensus 352 t~~f~~~~-~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~----~~~~~ 426 (668)
.++|.+.+ +||+|+||.||+|.+..+++.||||++.... ... .+....++.++||||+++++++.. ....+
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~---~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 102 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP-KAR---QEVDHHWQASGGPHIVCILDVYENMHHGKRCLL 102 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH-HHH---HHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH-HHH---HHHHHHHHhcCCCChHHHHHHHhhccCCCceEE
Confidence 45788854 6999999999999999899999999996542 111 222334566789999999999865 45589
Q ss_pred EEEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCC---CCEEEEeecCc
Q 005940 427 LVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAE---MNARLGDFGLA 503 (668)
Q Consensus 427 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~---~~~kl~DfGla 503 (668)
+||||+++|+|.+++... ....+++.+++.++.||+.||.|||+ .+|+||||||+||+++.+ +.+||+|||++
T Consensus 103 lv~e~~~gg~L~~~l~~~-~~~~l~~~~~~~i~~ql~~~l~~LH~---~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~ 178 (336)
T 3fhr_A 103 IIMECMEGGELFSRIQER-GDQAFTEREAAEIMRDIGTAIQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFA 178 (336)
T ss_dssp EEEECCTTEEHHHHHHTC--CCCCBHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EEEeccCCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEEecCCCceEEEeccccc
Confidence 999999999999999743 33579999999999999999999999 999999999999999864 55999999999
Q ss_pred eeccCCCCCcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHH-HHHHHHHhcCccccccC
Q 005940 504 RLYDHGGMPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLV-EWVRECHQLGRILDVAD 582 (668)
Q Consensus 504 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~-~~~~~~~~~~~~~~~~d 582 (668)
+...... .....||+.|+|||++....++.++|||||||++|||++|+.||........ ........... .....
T Consensus 179 ~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~ 254 (336)
T 3fhr_A 179 KETTQNA---LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQ-YGFPN 254 (336)
T ss_dssp EEC-------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC----------------------CCCT
T ss_pred eeccccc---cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccc-cccCc
Confidence 8765432 2345789999999999888899999999999999999999999965422111 00011111000 00001
Q ss_pred cccCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 583 PLLNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 583 ~~l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
+.. ..+. ..+..+...|+.. |++||+++|++++
T Consensus 255 ~~~-~~~~----~~~~~li~~~L~~dP~~Rpt~~ell~h 288 (336)
T 3fhr_A 255 PEW-SEVS----EDAKQLIRLLLKTDPTERLTITQFMNH 288 (336)
T ss_dssp TTS-TTCC----HHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred hhh-ccCC----HHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 110 1122 2345566678887 9999999999985
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-37 Score=351.50 Aligned_cols=255 Identities=22% Similarity=0.336 Sum_probs=200.2
Q ss_pred hcCcccceeeeecCcEEEEEEEeCCC---CcEEEEEEEecCC-chhHHHHHHHHHHHhcccccCceeEeeeecccCceEE
Q 005940 352 TKGFKESEVIGIGGFGSVYKGVLPTT---GGEVAVKKITRNS-LQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLL 427 (668)
Q Consensus 352 t~~f~~~~~lG~G~~g~Vy~~~~~~~---~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l 427 (668)
.++|...+.||+|+||.||+|.+..+ +..||||++.... ....+.|.+|+.++++++||||+++++++. .+..++
T Consensus 389 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~l 467 (656)
T 2j0j_A 389 RERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 467 (656)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEE
T ss_pred cccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceEE
Confidence 46788899999999999999998543 4579999987543 344578999999999999999999999985 456899
Q ss_pred EEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceecc
Q 005940 428 VYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYD 507 (668)
Q Consensus 428 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~ 507 (668)
||||+++|+|.+++.. .+..+++..++.++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 468 v~E~~~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDikp~NILl~~~~~vkL~DFG~a~~~~ 542 (656)
T 2j0j_A 468 IMELCTLGELRSFLQV--RKFSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME 542 (656)
T ss_dssp EEECCTTCBHHHHHHH--TTTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCCCCCSCC
T ss_pred EEEcCCCCcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccchHhEEEeCCCCEEEEecCCCeecC
Confidence 9999999999999963 23468999999999999999999999 999999999999999999999999999998776
Q ss_pred CCCCCcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHHHhcCccccccCcccC
Q 005940 508 HGGMPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVAT-GRRPIGSGDLLLVEWVRECHQLGRILDVADPLLN 586 (668)
Q Consensus 508 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 586 (668)
...........+|+.|+|||++....++.++|||||||++|||++ |..||...... +.......... . ...
T Consensus 543 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~--~~~~~i~~~~~-~-----~~~ 614 (656)
T 2j0j_A 543 DSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN--DVIGRIENGER-L-----PMP 614 (656)
T ss_dssp C----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHHHHHHHTCC-C-----CCC
T ss_pred CCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHH--HHHHHHHcCCC-C-----CCC
Confidence 544333334567889999999988899999999999999999997 99999765322 11122111111 1 111
Q ss_pred CcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhccC
Q 005940 587 SSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSGE 624 (668)
Q Consensus 587 ~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~~ 624 (668)
..++ ..+..++..|+.. |++||++.||++.|+..
T Consensus 615 ~~~~----~~l~~li~~~l~~dP~~RPs~~el~~~L~~i 649 (656)
T 2j0j_A 615 PNCP----PTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 649 (656)
T ss_dssp TTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cccc----HHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 1222 3455666789887 99999999999998754
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=318.58 Aligned_cols=260 Identities=20% Similarity=0.275 Sum_probs=196.1
Q ss_pred ccchhhHHHHhcCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCC--chhHHHHHHHHHHHhccc--ccCceeEee
Q 005940 342 RFRYKDLYAATKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNS--LQGMREFAAEIESLGRLR--HKNLVNLHG 417 (668)
Q Consensus 342 ~f~~~el~~at~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~--H~nIv~l~g 417 (668)
.+.+..+....++|...+.||+|+||.||++.+. +++.||||++.... ....+.+.+|++++.+++ |+||+++++
T Consensus 17 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~ 95 (313)
T 3cek_A 17 NLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 95 (313)
T ss_dssp ---CCEEEETTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEE
T ss_pred CCCeeeeeeccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEE
Confidence 3444455555678999999999999999999985 58899999997543 345678999999999997 499999999
Q ss_pred eecccCceEEEEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEE
Q 005940 418 WCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARL 497 (668)
Q Consensus 418 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl 497 (668)
++...+..++||| +.+++|.+++.. ...+++.+++.++.||+.||.|||+ .+|+||||||+||++++ +.+||
T Consensus 96 ~~~~~~~~~lv~e-~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~-~~~kL 167 (313)
T 3cek_A 96 YEITDQYIYMVME-CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIVD-GMLKL 167 (313)
T ss_dssp EEECSSEEEEEEC-CCSEEHHHHHHH---CSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEET-TEEEE
T ss_pred EeecCCEEEEEEe-cCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcccEEEEC-CeEEE
Confidence 9999999999999 668899999963 3468999999999999999999999 99999999999999964 88999
Q ss_pred EeecCceeccCCCCC-cccccccCCcccCcccccC-----------CCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHH
Q 005940 498 GDFGLARLYDHGGMP-HTTNVVGTFGYIAPELTQT-----------GKASTSSDVFAYGILLLEVATGRRPIGSGDLLLV 565 (668)
Q Consensus 498 ~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~ 565 (668)
+|||+++........ ......|+..|+|||++.. ..++.++|||||||++|||++|+.||........
T Consensus 168 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~ 247 (313)
T 3cek_A 168 IDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS 247 (313)
T ss_dssp CCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHH
T ss_pred eeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHH
Confidence 999999876543221 1234578999999999865 4688899999999999999999999975432222
Q ss_pred HHHHHHHhcCccccccCcccCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 566 EWVRECHQLGRILDVADPLLNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 566 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
. .......... ....... . ..+..+...|+.. |++||+++|++++
T Consensus 248 ~-~~~~~~~~~~-----~~~~~~~-~---~~l~~li~~~l~~dp~~Rps~~ell~h 293 (313)
T 3cek_A 248 K-LHAIIDPNHE-----IEFPDIP-E---KDLQDVLKCCLKRDPKQRISIPELLAH 293 (313)
T ss_dssp H-HHHHHCTTSC-----CCCCCCS-C---HHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred H-HHHHHhcccc-----cCCcccc-h---HHHHHHHHHHccCCcccCcCHHHHhcC
Confidence 1 1121111111 1111111 1 2345566688887 9999999999975
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-36 Score=329.14 Aligned_cols=200 Identities=27% Similarity=0.409 Sum_probs=154.2
Q ss_pred ccc-ceeeeecCcEEEEEEEeC--CCCcEEEEEEEecCCchhHHHHHHHHHHHhcccccCceeEeeee--cccCceEEEE
Q 005940 355 FKE-SEVIGIGGFGSVYKGVLP--TTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNLHGWC--KQKNDLLLVY 429 (668)
Q Consensus 355 f~~-~~~lG~G~~g~Vy~~~~~--~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~--~~~~~~~lV~ 429 (668)
|.. .++||+|+||.||+|++. .++..||||++..... ...+.+|++++++++||||+++++++ ......++||
T Consensus 22 y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~ 99 (405)
T 3rgf_A 22 FEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLF 99 (405)
T ss_dssp EECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC--CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEE
T ss_pred hhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC--CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEE
Confidence 444 468999999999999975 4678999999975432 35678999999999999999999999 4567899999
Q ss_pred EecCCCChhhhhcCC------CCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEE----CCCCCEEEEe
Q 005940 430 EYIPNGSLDTLLFKP------KDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALI----DAEMNARLGD 499 (668)
Q Consensus 430 E~~~~gsL~~~l~~~------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll----~~~~~~kl~D 499 (668)
||++ ++|.+++... .....+++..++.++.||+.||.|||+ .+|+||||||+|||| +.++.+||+|
T Consensus 100 e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kl~D 175 (405)
T 3rgf_A 100 DYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIAD 175 (405)
T ss_dssp ECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECCSSTTTTCEEECC
T ss_pred eCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCEeCCCcCHHHeEEecCCCCCCcEEEEE
Confidence 9996 5777776421 122359999999999999999999999 999999999999999 7788999999
Q ss_pred ecCceeccCCCC--CcccccccCCcccCcccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 005940 500 FGLARLYDHGGM--PHTTNVVGTFGYIAPELTQTG-KASTSSDVFAYGILLLEVATGRRPIGSG 560 (668)
Q Consensus 500 fGla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~sDV~S~Gvvl~elltG~~p~~~~ 560 (668)
||+++....... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||...
T Consensus 176 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 239 (405)
T 3rgf_A 176 MGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 239 (405)
T ss_dssp TTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCC
T ss_pred CCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCc
Confidence 999987654321 223446789999999998774 5899999999999999999999999644
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-36 Score=315.67 Aligned_cols=251 Identities=24% Similarity=0.296 Sum_probs=178.8
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCch-h-HHHHHHHHHHHhcccccCceeEeeeecccCceEEEEE
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQ-G-MREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYE 430 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~-~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 430 (668)
++|...+.||+|+||.||+|.+..+++.||||++...... . .+.+.++..+++.++||||+++++++...+..++|||
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e 104 (318)
T 2dyl_A 25 NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAME 104 (318)
T ss_dssp GGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEe
Confidence 5788899999999999999999888999999999765432 2 2344455567888899999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCC-ceEecCCCCCCEEECCCCCEEEEeecCceeccCC
Q 005940 431 YIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQ-VVIHRDVKPSNALIDAEMNARLGDFGLARLYDHG 509 (668)
Q Consensus 431 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~-~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~ 509 (668)
|+ ++.+..+... ....+++..++.++.||+.||.|||+ . +|+||||||+||+++.++.+||+|||++......
T Consensus 105 ~~-~~~~~~l~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (318)
T 2dyl_A 105 LM-GTCAEKLKKR--MQGPIPERILGKMTVAIVKALYYLKE---KHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDD 178 (318)
T ss_dssp CC-SEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHH---HHCCCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred cc-CCcHHHHHHH--hccCCCHHHHHHHHHHHHHHHHHHHh---hCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCC
Confidence 99 5555555532 23568999999999999999999998 5 9999999999999999999999999999766543
Q ss_pred CCCcccccccCCcccCccccc-----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCcc
Q 005940 510 GMPHTTNVVGTFGYIAPELTQ-----TGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPL 584 (668)
Q Consensus 510 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 584 (668)
.. .....||..|+|||++. ...++.++|||||||++|||++|+.||........ .......... .....
T Consensus 179 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~~~~~~~~-~~~~~-- 252 (318)
T 2dyl_A 179 KA--KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFE-VLTKVLQEEP-PLLPG-- 252 (318)
T ss_dssp ----------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHH-HHHHHHHSCC-CCCCS--
T ss_pred cc--ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHH-HHHHHhccCC-CCCCc--
Confidence 22 23457899999999984 45688999999999999999999999976432221 1222222111 11000
Q ss_pred cCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 585 LNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 585 l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
...++ ..+..+...|+.. |++||+++|++++
T Consensus 253 -~~~~~----~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (318)
T 2dyl_A 253 -HMGFS----GDFQSFVKDCLTKDHRKRPKYNKLLEH 284 (318)
T ss_dssp -SSCCC----HHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred -cCCCC----HHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 01112 2345566688887 9999999999874
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-36 Score=324.58 Aligned_cols=258 Identities=20% Similarity=0.262 Sum_probs=198.5
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCchhHHHHHHHHHHHhccc-----------ccCceeEeeeecc
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLR-----------HKNLVNLHGWCKQ 421 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~-----------H~nIv~l~g~~~~ 421 (668)
++|...+.||+|+||.||+|++..+++.||||++.... ...+.+.+|++++++++ |+||+++++++..
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~ 97 (373)
T 1q8y_A 19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 97 (373)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc-cchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhc
Confidence 57999999999999999999998899999999997543 34567889999999886 8999999999976
Q ss_pred cC----ceEEEEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCC-ceEecCCCCCCEEEC------
Q 005940 422 KN----DLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQ-VVIHRDVKPSNALID------ 490 (668)
Q Consensus 422 ~~----~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~-~ivHrDLkp~NIll~------ 490 (668)
.+ ..++||||+ +++|.+++... ....+++..++.++.||+.||.|||+ . +|+||||||+|||++
T Consensus 98 ~~~~~~~~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~---~~~ivH~Dikp~NIll~~~~~~~ 172 (373)
T 1q8y_A 98 KGPNGVHVVMVFEVL-GENLLALIKKY-EHRGIPLIYVKQISKQLLLGLDYMHR---RCGIIHTDIKPENVLMEIVDSPE 172 (373)
T ss_dssp EETTEEEEEEEECCC-CEEHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHHH---TTCEECSCCSGGGEEEEEEETTT
T ss_pred cCCCCceEEEEEecC-CCCHHHHHHHh-hccCCcHHHHHHHHHHHHHHHHHHHh---cCCEEecCCChHHeEEeccCCCc
Confidence 54 789999999 89999999642 23458999999999999999999999 7 999999999999994
Q ss_pred CCCCEEEEeecCceeccCCCCCcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchh----HHH
Q 005940 491 AEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLL----LVE 566 (668)
Q Consensus 491 ~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~----l~~ 566 (668)
..+.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...+.. ..+
T Consensus 173 ~~~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~ 248 (373)
T 1q8y_A 173 NLIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD 248 (373)
T ss_dssp TEEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHH
T ss_pred CcceEEEcccccccccCCC----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHH
Confidence 4457999999999876542 23347899999999999989999999999999999999999999754211 001
Q ss_pred HHHHHHh-cCcccc--------------------ccCc-c---------cCCcccHHHHHHHHHHHhhcCCC-CCCCCCH
Q 005940 567 WVRECHQ-LGRILD--------------------VADP-L---------LNSSYVVKEMELVLKLGLMCSHK-TQFRPTM 614 (668)
Q Consensus 567 ~~~~~~~-~~~~~~--------------------~~d~-~---------l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~ 614 (668)
....... .+.... .... . -...+.......+..+...|+.. |++||++
T Consensus 249 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~ 328 (373)
T 1q8y_A 249 HIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADA 328 (373)
T ss_dssp HHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCH
T ss_pred HHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCH
Confidence 1111100 000000 0000 0 00123344556777888899887 9999999
Q ss_pred HHHHHH
Q 005940 615 RQVMRY 620 (668)
Q Consensus 615 ~evl~~ 620 (668)
+|++++
T Consensus 329 ~ell~h 334 (373)
T 1q8y_A 329 GGLVNH 334 (373)
T ss_dssp HHHHTC
T ss_pred HHHhhC
Confidence 999985
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-37 Score=319.70 Aligned_cols=241 Identities=24% Similarity=0.354 Sum_probs=190.2
Q ss_pred hcCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCch------hHHHHHHHHHHHhcc----cccCceeEeeeecc
Q 005940 352 TKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQ------GMREFAAEIESLGRL----RHKNLVNLHGWCKQ 421 (668)
Q Consensus 352 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~------~~~~f~~Ei~~l~~l----~H~nIv~l~g~~~~ 421 (668)
.++|...+.||+|+||.||+|.+..+++.||||++...... ....+..|+.++.++ +|+||+++++++..
T Consensus 30 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~ 109 (312)
T 2iwi_A 30 EAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFET 109 (312)
T ss_dssp ---CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC--
T ss_pred hhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEec
Confidence 46799999999999999999999888999999999765331 223456799999998 89999999999999
Q ss_pred cCceEEEEEe-cCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEEC-CCCCEEEEe
Q 005940 422 KNDLLLVYEY-IPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALID-AEMNARLGD 499 (668)
Q Consensus 422 ~~~~~lV~E~-~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~-~~~~~kl~D 499 (668)
.+..++|+|+ +.+++|.+++.. ...+++..++.++.||+.||.|||+ .+|+||||||+||+++ .++.+||+|
T Consensus 110 ~~~~~~v~e~~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~kl~d 183 (312)
T 2iwi_A 110 QEGFMLVLERPLPAQDLFDYITE---KGPLGEGPSRCFFGQVVAAIQHCHS---RGVVHRDIKDENILIDLRRGCAKLID 183 (312)
T ss_dssp ---CEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHH---HTEECCCCSGGGEEEETTTTEEEECC
T ss_pred CCeEEEEEEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChhhEEEeCCCCeEEEEE
Confidence 9999999999 789999999963 3458999999999999999999999 8999999999999999 889999999
Q ss_pred ecCceeccCCCCCcccccccCCcccCcccccCCCC-CcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccc
Q 005940 500 FGLARLYDHGGMPHTTNVVGTFGYIAPELTQTGKA-STSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRIL 578 (668)
Q Consensus 500 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~ 578 (668)
||+++...... .....|+..|+|||++.+..+ +.++|||||||++|||++|+.||..... ... ..
T Consensus 184 fg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--------~~~-~~-- 249 (312)
T 2iwi_A 184 FGSGALLHDEP---YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE--------ILE-AE-- 249 (312)
T ss_dssp CSSCEECCSSC---BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH--------HHH-TC--
T ss_pred cchhhhcccCc---ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH--------Hhh-hc--
Confidence 99998776432 234578999999999876666 4589999999999999999999975321 111 11
Q ss_pred cccCcccCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 579 DVADPLLNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 579 ~~~d~~l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
..+..... ..+..+...|+.. |++||+++|++++
T Consensus 250 ----~~~~~~~~----~~~~~li~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 250 ----LHFPAHVS----PDCCALIRRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp ----CCCCTTSC----HHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred ----cCCcccCC----HHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11111222 2345566688887 9999999999985
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-36 Score=329.77 Aligned_cols=251 Identities=24% Similarity=0.287 Sum_probs=183.7
Q ss_pred CcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCchhHHHHHHHHHHHhcc-cccCceeEeeeecccCceEEEEEec
Q 005940 354 GFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRL-RHKNLVNLHGWCKQKNDLLLVYEYI 432 (668)
Q Consensus 354 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~E~~ 432 (668)
.|...++||+|+||+||.+.. .+|+.||||++.... .+.+.+|++++.++ +||||+++++++.+.+..++||||+
T Consensus 16 ~~~~~~~LG~G~~g~V~~~~~-~~g~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~ 91 (434)
T 2rio_A 16 LVVSEKILGYGSSGTVVFQGS-FQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC 91 (434)
T ss_dssp CEEEEEEEEECSTTCEEEEEE-SSSSEEEEEEEEGGG---HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC
T ss_pred eeeccCeEeeCCCeEEEEEEE-ECCeEEEEEEEcHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecC
Confidence 445578899999999976544 468999999986542 35678899999987 8999999999999999999999999
Q ss_pred CCCChhhhhcCCCCC----CCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCC-------------CCE
Q 005940 433 PNGSLDTLLFKPKDG----SVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAE-------------MNA 495 (668)
Q Consensus 433 ~~gsL~~~l~~~~~~----~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~-------------~~~ 495 (668)
. |+|.+++...... ...++..++.++.||+.||.|||+ .+|+||||||+|||++.+ +.+
T Consensus 92 ~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~ 167 (434)
T 2rio_A 92 N-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRI 167 (434)
T ss_dssp S-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred C-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEecCcccccccccCCCceEE
Confidence 5 6999999643221 112455678899999999999999 999999999999999754 489
Q ss_pred EEEeecCceeccCCCCC---cccccccCCcccCcccccC-------CCCCcchhHHHHHHHHHHHHh-CCCCCCCCchhH
Q 005940 496 RLGDFGLARLYDHGGMP---HTTNVVGTFGYIAPELTQT-------GKASTSSDVFAYGILLLEVAT-GRRPIGSGDLLL 564 (668)
Q Consensus 496 kl~DfGla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-------~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~l 564 (668)
||+|||+++........ ......||+.|+|||++.+ ..++.++|||||||++|||++ |+.||.......
T Consensus 168 kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~ 247 (434)
T 2rio_A 168 LISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE 247 (434)
T ss_dssp EECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH
T ss_pred EEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH
Confidence 99999999987654321 1234579999999999865 568999999999999999999 999997543222
Q ss_pred HHHHHHHHhcCccccccCcccCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 565 VEWVRECHQLGRILDVADPLLNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 565 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
..... ..... +.+...........+..+...|++. |++||++.||+++
T Consensus 248 ~~i~~----~~~~~----~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 296 (434)
T 2rio_A 248 SNIIR----GIFSL----DEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRH 296 (434)
T ss_dssp HHHHH----TCCCC----CCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHhc----CCCCc----ccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhC
Confidence 21111 11000 1111111223334566777789887 9999999999974
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-37 Score=322.47 Aligned_cols=241 Identities=23% Similarity=0.368 Sum_probs=197.3
Q ss_pred hcCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCch------hHHHHHHHHHHHhccc--ccCceeEeeeecccC
Q 005940 352 TKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQ------GMREFAAEIESLGRLR--HKNLVNLHGWCKQKN 423 (668)
Q Consensus 352 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~------~~~~f~~Ei~~l~~l~--H~nIv~l~g~~~~~~ 423 (668)
.++|...+.||+|+||.||+|++..+++.||||++...... ..+.+..|+.++++++ |+||+++++++...+
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~ 121 (320)
T 3a99_A 42 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 121 (320)
T ss_dssp TTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred cCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecCC
Confidence 46799999999999999999999889999999999764321 2245678999999996 599999999999999
Q ss_pred ceEEEEEecCC-CChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEEC-CCCCEEEEeec
Q 005940 424 DLLLVYEYIPN-GSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALID-AEMNARLGDFG 501 (668)
Q Consensus 424 ~~~lV~E~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~-~~~~~kl~DfG 501 (668)
..++|+|++.+ ++|.+++.. ...+++..++.++.||+.||.|||+ .+|+||||||+||+++ .++.+||+|||
T Consensus 122 ~~~lv~e~~~~~~~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~kL~Dfg 195 (320)
T 3a99_A 122 SFVLILERPEPVQDLFDFITE---RGALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFG 195 (320)
T ss_dssp EEEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCCT
T ss_pred cEEEEEEcCCCCccHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHH---CCcEeCCCCHHHEEEeCCCCCEEEeeCc
Confidence 99999999976 899999853 3468999999999999999999999 9999999999999999 77899999999
Q ss_pred CceeccCCCCCcccccccCCcccCcccccCCCC-CcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccc
Q 005940 502 LARLYDHGGMPHTTNVVGTFGYIAPELTQTGKA-STSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDV 580 (668)
Q Consensus 502 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~ 580 (668)
+++...... .....||..|+|||++....+ +.++|||||||++|||++|+.||...+. ... ...
T Consensus 196 ~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~--------~~~-~~~--- 260 (320)
T 3a99_A 196 SGALLKDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE--------IIR-GQV--- 260 (320)
T ss_dssp TCEECCSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH--------HHH-CCC---
T ss_pred ccccccccc---ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh--------hhc-ccc---
Confidence 998766432 234578999999999876665 6889999999999999999999975321 111 111
Q ss_pred cCcccCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 581 ADPLLNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 581 ~d~~l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
.....+. ..+..+...|+.. |++||+++||+++
T Consensus 261 ---~~~~~~~----~~~~~li~~~l~~dp~~Rps~~~ll~h 294 (320)
T 3a99_A 261 ---FFRQRVS----SECQHLIRWCLALRPSDRPTFEEIQNH 294 (320)
T ss_dssp ---CCSSCCC----HHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ---cccccCC----HHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1111222 2345666789887 9999999999874
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=343.51 Aligned_cols=259 Identities=27% Similarity=0.361 Sum_probs=198.5
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecC-CchhHHHHHHHHHHHhcccccCceeEeeeecc------cCce
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRN-SLQGMREFAAEIESLGRLRHKNLVNLHGWCKQ------KNDL 425 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~------~~~~ 425 (668)
.+|...++||+|+||.||+|.+..+++.||||++... .....+.+.+|++++++++||||+++++++.. .+..
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~ 93 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP 93 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence 6799999999999999999999888999999998764 33456779999999999999999999999865 6778
Q ss_pred EEEEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCC---EEEEeecC
Q 005940 426 LLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMN---ARLGDFGL 502 (668)
Q Consensus 426 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~---~kl~DfGl 502 (668)
++||||+++|+|.+++........+++..++.++.|++.||.|||+ .+|+||||||+||+++.++. +||+|||+
T Consensus 94 ~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs---~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~ 170 (676)
T 3qa8_A 94 LLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLGY 170 (676)
T ss_dssp CCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHH---TTBCCCCCCSTTEEEECCSSSCEEEECSCCC
T ss_pred EEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHeEeecCCCceeEEEccccc
Confidence 9999999999999999765555579999999999999999999999 99999999999999997765 99999999
Q ss_pred ceeccCCCCCcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccC
Q 005940 503 ARLYDHGGMPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVAD 582 (668)
Q Consensus 503 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d 582 (668)
++....... .....||..|+|||++.+..++.++|||||||++|||++|+.||..... ...|...............
T Consensus 171 a~~~~~~~~--~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~-~~~~~~~i~~~~~~~~~~~ 247 (676)
T 3qa8_A 171 AKELDQGEL--CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQ-PVQWHGKVREKSNEHIVVY 247 (676)
T ss_dssp CCBTTSCCC--CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCH-HHHSSTTCC------CCSC
T ss_pred ccccccccc--cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccc-hhhhhhhhhcccchhhhhh
Confidence 987765432 2345799999999999999999999999999999999999999975421 2222111111000000000
Q ss_pred c----------c--cCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHH
Q 005940 583 P----------L--LNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQV 617 (668)
Q Consensus 583 ~----------~--l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~ev 617 (668)
. . ............+..+...|+.. |++||+++|+
T Consensus 248 ~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~el 295 (676)
T 3qa8_A 248 DDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQN 295 (676)
T ss_dssp CCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTC
T ss_pred hhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHH
Confidence 0 0 01112222345566677788887 9999999663
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-35 Score=324.82 Aligned_cols=248 Identities=25% Similarity=0.360 Sum_probs=183.2
Q ss_pred hcCcccceeeeecCcEEEE-EEEeCCCCcEEEEEEEecCCchhHHHHHHHHHHHhcc-cccCceeEeeeecccCceEEEE
Q 005940 352 TKGFKESEVIGIGGFGSVY-KGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRL-RHKNLVNLHGWCKQKNDLLLVY 429 (668)
Q Consensus 352 t~~f~~~~~lG~G~~g~Vy-~~~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~ 429 (668)
..+|...++||+|+||+|| ++.. +++.||||++...... .+.+|+++++++ +||||+++++++.+....++||
T Consensus 23 ~~~y~~~~~LG~G~~G~V~~~~~~--~~~~vAvK~~~~~~~~---~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~ 97 (432)
T 3p23_A 23 KISFCPKDVLGHGAEGTIVYRGMF--DNRDVAVKRILPECFS---FADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAI 97 (432)
T ss_dssp TEEEEEEEEEEECGGGCEEEEEES--SSSEEEEEEECTTTEE---ECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cEEEecCCeeecCcCEEEEEEEEe--CCeEEEEEEECHHHHH---HHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEE
Confidence 3568889999999999854 4443 6899999999765432 345799999999 7999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECC-----CCCEEEEeecCce
Q 005940 430 EYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDA-----EMNARLGDFGLAR 504 (668)
Q Consensus 430 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~-----~~~~kl~DfGla~ 504 (668)
||++ |+|.+++... ...+.+..++.++.||+.||.|||+ .+|+||||||+|||++. ...+||+|||+++
T Consensus 98 E~~~-g~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~ 171 (432)
T 3p23_A 98 ELCA-ATLQEYVEQK--DFAHLGLEPITLLQQTTSGLAHLHS---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCK 171 (432)
T ss_dssp ECCS-EEHHHHHHSS--SCCCCSSCHHHHHHHHHHHHHHHHH---TTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEE
T ss_pred ECCC-CCHHHHHHhc--CCCccchhHHHHHHHHHHHHHHHHH---CcCEeCCCCHHHEEEecCCCCCceeEEEeccccee
Confidence 9996 6999999642 3345666778999999999999999 99999999999999953 3468899999998
Q ss_pred eccCCCC--CcccccccCCcccCccccc---CCCCCcchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHHHhcCccc
Q 005940 505 LYDHGGM--PHTTNVVGTFGYIAPELTQ---TGKASTSSDVFAYGILLLEVAT-GRRPIGSGDLLLVEWVRECHQLGRIL 578 (668)
Q Consensus 505 ~~~~~~~--~~~~~~~gt~~y~aPE~~~---~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~l~~~~~~~~~~~~~~ 578 (668)
....... .......||+.|+|||++. ...++.++|||||||++|||++ |..||.......... ... ....
T Consensus 172 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~---~~~-~~~~ 247 (432)
T 3p23_A 172 KLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANI---LLG-ACSL 247 (432)
T ss_dssp CC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHH---HTT-CCCC
T ss_pred eccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHH---Hhc-cCCc
Confidence 7654321 2234467999999999987 4567889999999999999999 999996543222111 111 1111
Q ss_pred cccCcccCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 579 DVADPLLNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 579 ~~~d~~l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
....+ . ...-..+..+...|++. |++||+++||+++
T Consensus 248 ~~~~~---~---~~~~~~~~~li~~~L~~dP~~Rps~~evl~h 284 (432)
T 3p23_A 248 DCLHP---E---KHEDVIARELIEKMIAMDPQKRPSAKHVLKH 284 (432)
T ss_dssp TTSCT---T---CHHHHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cccCc---c---ccccHHHHHHHHHHHhCCHhhCCCHHHHHhC
Confidence 11111 1 11122345566788887 9999999999964
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=335.76 Aligned_cols=236 Identities=21% Similarity=0.292 Sum_probs=188.7
Q ss_pred cCcccceeeeecCcEEEEEEEeCC-CCcEEEEEEEecCC-chhHHHHHHHHHHHhcccccCceeEeeeecccCc-----e
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPT-TGGEVAVKKITRNS-LQGMREFAAEIESLGRLRHKNLVNLHGWCKQKND-----L 425 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~-~~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~-----~ 425 (668)
++|.+.++||+|+||.||+|.+.. +++.||||++.... ....+.+.+|++++++++||||+++++++...+. .
T Consensus 80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~ 159 (681)
T 2pzi_A 80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVG 159 (681)
T ss_dssp TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCcee
Confidence 689999999999999999999865 68899999986543 3455678999999999999999999999987665 7
Q ss_pred EEEEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCcee
Q 005940 426 LLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARL 505 (668)
Q Consensus 426 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~ 505 (668)
|+||||+++++|.+++.. .++|.+++.++.||+.||.|||+ .+|+||||||+|||++.+ .+||+|||+++.
T Consensus 160 ~lv~E~~~g~~L~~~~~~-----~l~~~~~~~~~~qi~~aL~~lH~---~giiHrDlkp~NIll~~~-~~kl~DFG~a~~ 230 (681)
T 2pzi_A 160 YIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYLHS---IGLVYNDLKPENIMLTEE-QLKLIDLGAVSR 230 (681)
T ss_dssp EEEEECCCCEECC----C-----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECSS-CEEECCCTTCEE
T ss_pred EEEEEeCCCCcHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHH---CCCeecccChHHeEEeCC-cEEEEecccchh
Confidence 999999999999988742 59999999999999999999999 999999999999999986 899999999987
Q ss_pred ccCCCCCcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCccc
Q 005940 506 YDHGGMPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLL 585 (668)
Q Consensus 506 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 585 (668)
.... ....||+.|+|||++.++ .+.++|||||||++|||++|..|+..... ..+ .
T Consensus 231 ~~~~-----~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~------------~~~-------~ 285 (681)
T 2pzi_A 231 INSF-----GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYV------------DGL-------P 285 (681)
T ss_dssp TTCC-----SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEEC------------SSC-------C
T ss_pred cccC-----CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCccccc------------ccc-------c
Confidence 6543 345799999999998765 48999999999999999999988753110 000 0
Q ss_pred CCcccHHHHHHHHHHHhhcCCC-CCCCCC-HHHHHHHhc
Q 005940 586 NSSYVVKEMELVLKLGLMCSHK-TQFRPT-MRQVMRYLS 622 (668)
Q Consensus 586 ~~~~~~~~~~~l~~l~~~C~~~-p~~RPs-~~evl~~L~ 622 (668)
...........+..+...|++. |++||+ ++++.+.|.
T Consensus 286 ~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~ 324 (681)
T 2pzi_A 286 EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLT 324 (681)
T ss_dssp TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHH
Confidence 0001111123456677789887 999995 555555554
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-34 Score=298.51 Aligned_cols=231 Identities=22% Similarity=0.274 Sum_probs=176.1
Q ss_pred cCcccc-eeeeecCcEEEEEEEeCCCCcEEEEEEEecCCchhHHHHHHHHHHH-hcccccCceeEeeeecc----cCceE
Q 005940 353 KGFKES-EVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESL-GRLRHKNLVNLHGWCKQ----KNDLL 426 (668)
Q Consensus 353 ~~f~~~-~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l-~~l~H~nIv~l~g~~~~----~~~~~ 426 (668)
++|... +.||+|+||.||+|.+..+++.||||++... ..+.+|++++ +.++||||+++++++.. ....+
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 91 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 91 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEE
Confidence 467666 7799999999999999889999999999643 4567888888 55589999999999876 67789
Q ss_pred EEEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECC---CCCEEEEeecCc
Q 005940 427 LVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDA---EMNARLGDFGLA 503 (668)
Q Consensus 427 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~---~~~~kl~DfGla 503 (668)
+||||+++|+|.+++... ....+++..++.++.||+.||.|||+ .+|+||||||+||+++. ++.+||+|||++
T Consensus 92 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a 167 (299)
T 3m2w_A 92 IVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFA 167 (299)
T ss_dssp EEECCCCSCBHHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred EEEeecCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEecCCCCCcEEEeccccc
Confidence 999999999999999642 33569999999999999999999999 99999999999999998 788999999998
Q ss_pred eeccCCCCCcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCc
Q 005940 504 RLYDHGGMPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADP 583 (668)
Q Consensus 504 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~ 583 (668)
.... +..++.++|||||||++|||++|+.||........ .............
T Consensus 168 ~~~~-----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~-----~~~~~~~~~~~~~ 219 (299)
T 3m2w_A 168 KETT-----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI-----SPGMKTRIRMGQY 219 (299)
T ss_dssp EECT-----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC------------CCSCCSSCTTCC
T ss_pred cccc-----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhh-----hHHHHHHHhhccc
Confidence 6533 23567899999999999999999999965321100 0000000000000
Q ss_pred ccCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 584 LLNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 584 ~l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
.............+..+...|+.. |++||+++|++++
T Consensus 220 ~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~h 257 (299)
T 3m2w_A 220 EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 257 (299)
T ss_dssp SSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 000000000123455666788887 9999999999985
|
| >2dur_A VIP36;, vesicular integral-membrane protein VIP36; beta sandwich, carbohydrate binding protein, cargo receptor, transport; HET: MAN; 1.65A {Canis lupus familiaris} PDB: 2dup_A 2duq_A* 2duo_A* 2e6v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-34 Score=287.75 Aligned_cols=199 Identities=19% Similarity=0.199 Sum_probs=152.4
Q ss_pred CCeEEeCceeeCCCCcEEccCCCCceEEEEEeeCceecccCCCCCCCCeeeeEEEEEEEEeCCCC-CCCCCceEEEEcCC
Q 005940 40 TNLSLQGAEIIKPSGALKLTNRSRYVIGHAFYVKPIQMFDTSASPSPNASSFSTTFVFEISTPRS-GRGGHGLAFLLAPS 118 (668)
Q Consensus 40 ~~l~~~g~a~~~~~~~~~lt~~~~~~~G~~~y~~p~~l~~~~~~~~~~~~sF~t~F~f~i~~~~~-~~~g~GlaF~l~p~ 118 (668)
.++.++|+|.+. +|.|+||++..++.|||||+.|+++ +||+|+|+|.|.+++. ..+||||||+|+|.
T Consensus 25 ~~~~l~G~a~i~-~g~l~LT~~~~~~~G~~w~~~pi~~-----------~sF~t~F~F~I~~~~~~~~~gdGlAF~l~~~ 92 (253)
T 2dur_A 25 PLWDFQGSTILT-SQYVRLTPDERSKEGSIWNHQPCFL-----------KDWEMHVHFKVHGTGKKNLHGDGIALWYTRD 92 (253)
T ss_dssp CSEEEEETCEEC-SSCEEEECSSSSEEEEEEESSCBCC-----------SSEEEEEEEEEECCCCTTCCCCEEEEEEESC
T ss_pred CCEEEccceEEE-CCEEEECCCCCCCEEEEEeCCCCcc-----------CcEEEEEEEEEecCCCCCcCCCcEEEEEECC
Confidence 689999999995 8999999999999999999999986 2699999999998765 57899999999997
Q ss_pred CCCCCCCCCCcccccccCCCCCCCccEEEEEeecccCCCCCCCCCCCeeeeecCCcccccccCCccccCCCC-C--cccc
Q 005940 119 TKLPGAQPEHYLGILNSTNNGEPSNHILIVEFDTVNGFNDKAENQGNHVGIGINTMFSNRSEPASYYINGTD-H--KEEM 195 (668)
Q Consensus 119 ~~~~~~~~~~~lGl~~~~~~~~~~~~~~aVEfDt~~n~~d~~~~~~~Hvgid~~s~~s~~~~~~~~~~~~~~-~--~~~~ 195 (668)
.. ..|++||+.+ .++.|||||||++|.++ ++ |+++||+++.|..++.+....++.. . ....
T Consensus 93 ~~----~~G~~lG~~~-------~~~gvAVefDT~~n~~~---~~--~~~~~I~~~~n~gs~~~d~~~dg~~~~~~~c~~ 156 (253)
T 2dur_A 93 RL----VPGPVFGSKD-------NFHGLAIFLDTYPNDET---TE--RVFPYISVMVNNGSLSYDHSKDGRWTELAGCTA 156 (253)
T ss_dssp CS----CEETBTEECS-------SCEEEEEEEECSCCCTT---CC--SCSSEEEEEEEESCCCCCGGGTTGGGCCEEEEC
T ss_pred CC----CCCcccCcCC-------CCCEEEEEEECCCCCCC---CC--CCCcEEEEEecCCceeeeccCCCcccccccccH
Confidence 63 3578999732 35689999999988333 33 7788888887766653211111100 0 0112
Q ss_pred cc-CCCCcEEEEEEEeCCcceEEEEEEeCCCCCCCCcceeeeeccccccccceeeeeecccCCcccceeeeccccccc
Q 005940 196 TL-ESGEPIQAWIEYDGEQKVLNVTISPAEIGKPMRPLISFGVNLTGYIKETMYVGFSASTGEKSSSHYILGWSFSLN 272 (668)
Q Consensus 196 ~l-~~g~~~~~~I~Y~~~~~~l~V~~~~~~~~~p~~~~ls~~~dLs~~l~~~~~vGFsastG~~~~~~~i~~w~F~~~ 272 (668)
.+ +.|++++|||+||+. +|+|++++.+.. +.. ++..++ ..+||+.|||||||+||...+.|+|++|+|..-
T Consensus 157 ~~~n~g~~~~v~I~Y~~~--~L~V~l~~~~~~-~~~--~~~~~~-~v~Lp~~~yvGfSAaTG~~~~~h~Ilswsf~sl 228 (253)
T 2dur_A 157 DFRNRDHDTFLAVRYSRG--RLTVMTDLEDKN-EWK--NCIDIT-GVRLPTGYYFGASAGTGDLSDNHDIISMKLFQL 228 (253)
T ss_dssp CCBTCSSCEEEEEEEETT--EEEEEEECSSSS-CCE--EEEEEC-CEECCSSBEEEEEEEESSSCCEEEEEEEEEEEC
T ss_pred hhccCCCCeEEEEEEECC--EEEEEEeCCCCC-Cce--EEEEeC-CcccCCCcEEEEEeccCCCcceEEEEEEEEEec
Confidence 34 348999999999975 899999975432 333 334445 345899999999999999999999999999763
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-34 Score=313.99 Aligned_cols=244 Identities=16% Similarity=0.123 Sum_probs=181.4
Q ss_pred HhcCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCc---hhHHHHHHHHHHHhcccc-cCceeE---------e-
Q 005940 351 ATKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSL---QGMREFAAEIESLGRLRH-KNLVNL---------H- 416 (668)
Q Consensus 351 at~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~f~~Ei~~l~~l~H-~nIv~l---------~- 416 (668)
.++.|...++||+|+||.||+|++..+++.||||++..... ...+.|.+|+.+++.++| +|...+ .
T Consensus 76 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~ 155 (413)
T 3dzo_A 76 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 155 (413)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCE
T ss_pred CceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchh
Confidence 34567788999999999999999988999999999874332 235789999999999977 322111 1
Q ss_pred -----------eeecc-----cCceEEEEEecCCCChhhhhcC----CCCCCCccHHHHHHHHHHHHHHHHHhhhccCCc
Q 005940 417 -----------GWCKQ-----KNDLLLVYEYIPNGSLDTLLFK----PKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQV 476 (668)
Q Consensus 417 -----------g~~~~-----~~~~~lV~E~~~~gsL~~~l~~----~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ 476 (668)
.++.. ....+++|+++ +++|.+++.. ...+..+++..++.++.||++||.|||+ ++
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ 231 (413)
T 3dzo_A 156 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---YG 231 (413)
T ss_dssp EEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH---TT
T ss_pred hcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHh---CC
Confidence 11111 22456777765 6899988831 1234568999999999999999999999 99
Q ss_pred eEecCCCCCCEEECCCCCEEEEeecCceeccCCCCCcccccccCCcccCcccc----------cCCCCCcchhHHHHHHH
Q 005940 477 VIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPELT----------QTGKASTSSDVFAYGIL 546 (668)
Q Consensus 477 ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~sDV~S~Gvv 546 (668)
|+||||||+||||+.++.+||+|||+++..... ....+| +.|+|||++ ....++.++|||||||+
T Consensus 232 iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvi 306 (413)
T 3dzo_A 232 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLA 306 (413)
T ss_dssp EECSCCCGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHH
T ss_pred cccCCcccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHH
Confidence 999999999999999999999999999865432 334567 999999998 55668899999999999
Q ss_pred HHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCcccCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 547 LLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 547 l~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
+|||++|+.||...... ......+... ..++ ..+..+...|+.. |++||++.|++++
T Consensus 307 l~elltg~~Pf~~~~~~-----------~~~~~~~~~~--~~~~----~~~~~li~~~l~~dP~~Rpt~~~~l~~ 364 (413)
T 3dzo_A 307 IYWIWCADLPNTDDAAL-----------GGSEWIFRSC--KNIP----QPVRALLEGFLRYPKEDRLLPLQAMET 364 (413)
T ss_dssp HHHHHHSSCCCCTTGGG-----------SCSGGGGSSC--CCCC----HHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred HHHHHHCCCCCCCcchh-----------hhHHHHHhhc--ccCC----HHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 99999999999754211 0111111110 1122 3355666688887 9999998888653
|
| >1qmo_E Mannose binding lectin, FRIL; crosslink, hematopoietic progenitor, sugar complex; HET: MAN; 3.5A {Dolichos lab lab} SCOP: b.29.1.1 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-34 Score=258.03 Aligned_cols=112 Identities=30% Similarity=0.442 Sum_probs=102.1
Q ss_pred ccEEEEEeecccC--CCCCCCCCCCeeeeecCCcccccccCCccccCCCCCccccccCCCCcEEEEEEEeCCcceEEEEE
Q 005940 143 NHILIVEFDTVNG--FNDKAENQGNHVGIGINTMFSNRSEPASYYINGTDHKEEMTLESGEPIQAWIEYDGEQKVLNVTI 220 (668)
Q Consensus 143 ~~~~aVEfDt~~n--~~d~~~~~~~Hvgid~~s~~s~~~~~~~~~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~V~~ 220 (668)
||+|||||||++| ++| |++||||||+||+.|.+++++ ++.+|+.++|||+||+.+++|+|++
T Consensus 1 n~~vAVEFDT~~N~e~~D---p~~nHVGIdvNsi~S~~s~~~-------------~l~sG~~~~v~I~Yd~~~~~L~V~l 64 (133)
T 1qmo_E 1 SNVVAVEFDTYLNPDYGD---PNYIHIGIDVNSIRSKVTAKW-------------DWQNGKIATAHISYNSVSKRLSVTS 64 (133)
T ss_dssp CCCEEEEEECSCCGGGTC---CSSCEEEEEESSSSCSEEEEC-------------CCCTTSCEEEEEEEETTTTEEEEEE
T ss_pred CCEEEEEEeCCcCccccC---CCCCeeEEecccccccceeee-------------EEcCCCEEEEEEEEeCCCcEEEEEE
Confidence 5799999999999 356 999999999999999988763 4679999999999999999999999
Q ss_pred EeCCCCCCCCcceeeeeccccccccceeeeeecccCCcccceeeecccccccC
Q 005940 221 SPAEIGKPMRPLISFGVNLTGYIKETMYVGFSASTGEKSSSHYILGWSFSLNG 273 (668)
Q Consensus 221 ~~~~~~~p~~~~ls~~~dLs~~l~~~~~vGFsastG~~~~~~~i~~w~F~~~~ 273 (668)
++.+. + .|+|+..+||+++|+++|||||||+||...|.|+|++|+|++..
T Consensus 65 ~~~~~-~--~p~ls~~vdLs~~l~e~v~VGFSAsTG~~~~~h~IlsWsF~s~l 114 (133)
T 1qmo_E 65 YYAGS-K--PATLSYDIELHTVLPEWVRVGLSASTGQDKERNTVHSWSFTSSL 114 (133)
T ss_dssp ECSSS-C--CEEEEEECCGGGTSCSEEEEEEEEECSSSCCEEEEEEEEEEEEE
T ss_pred ccCCC-c--cceEEEeechHHhccccEEEEEEeccCCCcceeEEEEEEEEeeC
Confidence 98754 2 79999999999999999999999999999999999999999863
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-34 Score=294.57 Aligned_cols=230 Identities=12% Similarity=0.066 Sum_probs=179.2
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCc---hhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEE
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSL---QGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVY 429 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 429 (668)
++|.+.+.||+|+||.||+|.+..+++.||||++..... +..+.+.+|+.++.+++||||+++++++.+.+..|+||
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 110 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA 110 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence 578899999999999999999988899999999976532 34578999999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCC
Q 005940 430 EYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHG 509 (668)
Q Consensus 430 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~ 509 (668)
||+++++|.+++.. . ....++.+++.||+.||.|||+ .+|+||||||+|||++.++.+||++++
T Consensus 111 e~~~g~~L~~~l~~----~-~~~~~~~~i~~ql~~aL~~lH~---~givH~Dikp~NIll~~~g~~kl~~~~-------- 174 (286)
T 3uqc_A 111 EWIRGGSLQEVADT----S-PSPVGAIRAMQSLAAAADAAHR---AGVALSIDHPSRVRVSIDGDVVLAYPA-------- 174 (286)
T ss_dssp ECCCEEEHHHHHTT----C-CCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEEETTSCEEECSCC--------
T ss_pred EecCCCCHHHHHhc----C-CChHHHHHHHHHHHHHHHHHHH---CCCccCCCCcccEEEcCCCCEEEEecc--------
Confidence 99999999999942 1 3445688899999999999999 999999999999999999999997433
Q ss_pred CCCcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCcccC--C
Q 005940 510 GMPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLN--S 587 (668)
Q Consensus 510 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~--~ 587 (668)
|++ .++.++|||||||++|||++|+.||...+... ... ........... .
T Consensus 175 -------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~------~~~--~~~~~~~~~~~~~~ 226 (286)
T 3uqc_A 175 -------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRS------GLA--PAERDTAGQPIEPA 226 (286)
T ss_dssp -------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCC------CSE--ECCBCTTSCBCCHH
T ss_pred -------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcch------hhH--HHHHHhccCCCChh
Confidence 443 36899999999999999999999997542110 000 00000000000 0
Q ss_pred cccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhccCcCC
Q 005940 588 SYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSGEKQL 627 (668)
Q Consensus 588 ~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~~~~~ 627 (668)
.........+..+...|++. |++| ++.|+++.|+.....
T Consensus 227 ~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~ 266 (286)
T 3uqc_A 227 DIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAV 266 (286)
T ss_dssp HHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC-
T ss_pred hcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhcc
Confidence 00001113355666788887 9999 999999999876543
|
| >1gv9_A P58/ergic-53; lectin, carbohydrate binding; 1.46A {Rattus norvegicus} SCOP: b.29.1.13 PDB: 1r1z_A 3a4u_A 3lcp_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-33 Score=285.07 Aligned_cols=207 Identities=14% Similarity=0.134 Sum_probs=157.7
Q ss_pred ceeEEeCCCCCC---CCCeEEeCceeeCCCCcEEccCCCCceEEEEEeeCceecccCCCCCCCCeeeeEEEEEEEEeCCC
Q 005940 27 SSSFIFQGFNGG---ATNLSLQGAEIIKPSGALKLTNRSRYVIGHAFYVKPIQMFDTSASPSPNASSFSTTFVFEISTPR 103 (668)
Q Consensus 27 ~~~f~~~~f~~~---~~~l~~~g~a~~~~~~~~~lt~~~~~~~G~~~y~~p~~l~~~~~~~~~~~~sF~t~F~f~i~~~~ 103 (668)
..||.-+.+..+ -.++.++|+|.+. ++.|+||++..++.||+||+.|+++ +||+|+|+|+|.++.
T Consensus 33 ~~Sf~~P~~~~~~~~i~~w~~~G~a~i~-~~~IrLT~~~~~~~G~~w~~~p~~~-----------~sF~t~F~F~I~~~~ 100 (260)
T 1gv9_A 33 KYSFKGPHLVQSDGTVPFWAHAGNAIPS-ADQIRIAPSLKSQRGSVWTKTKAAF-----------ENWEVEVTFRVTGRG 100 (260)
T ss_dssp GGCEECSSCSCTTSCBTTEEEEETCEEC-SSCEEEECSSTTCEEEEEESSCBCC-----------SSEEEEEEEEEECSS
T ss_pred ceeEcCccccCCCCccCCeEEcccEEee-CCEEEeCCCCCCCEEEEEECCCccc-----------cCEEEEEEEEEecCC
Confidence 456766655432 3689999999994 8999999998999999999999964 479999999999874
Q ss_pred CCCCCCceEEEEcCCCCCCCCCCCCcccccccCCCCCCCccEEEEEeecccCCCCCCCC------CCCeeeeecCC-ccc
Q 005940 104 SGRGGHGLAFLLAPSTKLPGAQPEHYLGILNSTNNGEPSNHILIVEFDTVNGFNDKAEN------QGNHVGIGINT-MFS 176 (668)
Q Consensus 104 ~~~~g~GlaF~l~p~~~~~~~~~~~~lGl~~~~~~~~~~~~~~aVEfDt~~n~~d~~~~------~~~Hvgid~~s-~~s 176 (668)
..+||||||+|+|... ..|+++|+. ..++.|||||||+.|.++...| +++|+|||+|+ +.|
T Consensus 101 -~~~gdGlAF~l~~~~~----~~g~~~G~~-------~~~~gvaVefDT~~N~~~~~~p~I~~~indg~~~~d~~~d~~s 168 (260)
T 1gv9_A 101 -RIGADGLAIWYTENQG----LDGPVFGSA-------DMWNGVGIFFDSFDNDGKKNNPAIVVVGNNGQINYDHQNDGAT 168 (260)
T ss_dssp -SCCCCEEEEEEESSCC----CEEEETTEC-------SCCEEEEEEEECCCC-----CCEEEEEEEESCCCCCHHHHHHH
T ss_pred -CCCCCeEEEEEecCCC----CCCCccCCC-------CCCCEEEEEEECCCCCCCCCCCceEEEeCCCceEeecCCCccc
Confidence 4689999999999653 357888983 2456799999999883221113 46788888876 555
Q ss_pred ccccCCccccCCCCCcccccc-CCCCcEEEEEEEeCCcceEEEEEEeCCCCCCCCcceeeeeccccccccceeeeeeccc
Q 005940 177 NRSEPASYYINGTDHKEEMTL-ESGEPIQAWIEYDGEQKVLNVTISPAEIGKPMRPLISFGVNLTGYIKETMYVGFSAST 255 (668)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~l-~~g~~~~~~I~Y~~~~~~l~V~~~~~~~~~p~~~~ls~~~dLs~~l~~~~~vGFsast 255 (668)
....... ..+ ++|++++|||+|++. +|+|.+.+...+......++..+| ..+||+.+||||||+|
T Consensus 169 ~~~~~c~-----------~~~~n~g~~~~~~I~Y~~~--~L~V~l~~~~~~~~~~~~~~~~vd-~~~LP~~~~vGfSAaT 234 (260)
T 1gv9_A 169 QALASCQ-----------RDFRNKPYPVRAKITYYQK--TLTVMINNGFTPDKNDYEFCAKVE-NMVIPTQGHFGISAAT 234 (260)
T ss_dssp HCSEEEC-----------CCCBSCSSCEEEEEEEETT--EEEEEEECSSCCCTTCCEEEEEET-TCCCCSSBEEEEEEEC
T ss_pred ceeeccC-----------hhhccCCCcEEEEEEEECC--EEEEEEeeccCCCCCcceEEEEEc-ccccCCCcEEEEEEeC
Confidence 4333211 122 359999999999986 899999874221111236788888 6779999999999999
Q ss_pred CCcccceeeecccccc
Q 005940 256 GEKSSSHYILGWSFSL 271 (668)
Q Consensus 256 G~~~~~~~i~~w~F~~ 271 (668)
|...+.|.|++|+|..
T Consensus 235 G~~~e~hdIlsw~~~~ 250 (260)
T 1gv9_A 235 GGLADDHDVLSFLTFQ 250 (260)
T ss_dssp CSSCCEEEEEEEEEEE
T ss_pred CCCcceEEEEEEEEEE
Confidence 9999999999999975
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-34 Score=304.35 Aligned_cols=239 Identities=17% Similarity=0.179 Sum_probs=180.8
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCc--------hhHHHHHHHHHHHhccc---------ccCceeE
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSL--------QGMREFAAEIESLGRLR---------HKNLVNL 415 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--------~~~~~f~~Ei~~l~~l~---------H~nIv~l 415 (668)
++|...++||+|+||.||+|++ +++.||||++..... ...+.+.+|++++++++ ||||+++
T Consensus 20 ~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 20 EKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred ccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 5688899999999999999998 689999999976532 23477889999999886 6666666
Q ss_pred eee-----------------ecc-------------cCceEEEEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHH
Q 005940 416 HGW-----------------CKQ-------------KNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASG 465 (668)
Q Consensus 416 ~g~-----------------~~~-------------~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~g 465 (668)
.+. +.. .+..++||||+++|++.+.+.+ ..+++.+++.++.||+.|
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~----~~~~~~~~~~i~~qi~~a 173 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT----KLSSLATAKSILHQLTAS 173 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT----TCCCHHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh----cCCCHHHHHHHHHHHHHH
Confidence 554 332 6789999999999977666632 458999999999999999
Q ss_pred HHHhh-hccCCceEecCCCCCCEEECCCC--------------------CEEEEeecCceeccCCCCCcccccccCCccc
Q 005940 466 LLYLH-EEWEQVVIHRDVKPSNALIDAEM--------------------NARLGDFGLARLYDHGGMPHTTNVVGTFGYI 524 (668)
Q Consensus 466 L~yLH-~~~~~~ivHrDLkp~NIll~~~~--------------------~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~ 524 (668)
|.||| + .+|+||||||+||||+.++ .+||+|||+|+..... ...||+.|+
T Consensus 174 L~~lH~~---~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt~~y~ 244 (336)
T 2vuw_A 174 LAVAEAS---LRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVFCDVSM 244 (336)
T ss_dssp HHHHHHH---HCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------EEECCCCTT
T ss_pred HHHHHHh---CCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------cEEEeeccc
Confidence 99999 8 8999999999999999887 8999999999976542 347999999
Q ss_pred CcccccCCCCCcchhHHHHHHH-HHHHHhCCCCCCCCchhHHHHHHHH----HhcCccccccCcccCCcccHHHHHHHHH
Q 005940 525 APELTQTGKASTSSDVFAYGIL-LLEVATGRRPIGSGDLLLVEWVREC----HQLGRILDVADPLLNSSYVVKEMELVLK 599 (668)
Q Consensus 525 aPE~~~~~~~~~~sDV~S~Gvv-l~elltG~~p~~~~~~~l~~~~~~~----~~~~~~~~~~d~~l~~~~~~~~~~~l~~ 599 (668)
|||++.+.. +.++||||++++ .+++++|..||.. ..|.... ...... ...............+..
T Consensus 245 aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~-----~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~s~~~~d 314 (336)
T 2vuw_A 245 DEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSN-----VLWLHYLTDKMLKQMTF----KTKCNTPAMKQIKRKIQE 314 (336)
T ss_dssp CSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHH-----HHHHHHHHHHHHHTCCC----SSCCCSHHHHHHHHHHHH
T ss_pred ChhhhcCCC-ccceehhhhhCCCCcccccccCCCcc-----hhhhhHHHHhhhhhhcc----CcccchhhhhhcCHHHHH
Confidence 999998655 899999998777 7778889999842 1221111 111111 111111122233345666
Q ss_pred HHhhcCCCCCCCCCHHHHH-HH
Q 005940 600 LGLMCSHKTQFRPTMRQVM-RY 620 (668)
Q Consensus 600 l~~~C~~~p~~RPs~~evl-~~ 620 (668)
+...|+.. +|++|++ ++
T Consensus 315 li~~~L~~----dsa~e~l~~H 332 (336)
T 2vuw_A 315 FHRTMLNF----SSATDLLCQH 332 (336)
T ss_dssp HHHHGGGS----SSHHHHHHHC
T ss_pred HHHHHhcc----CCHHHHHhcC
Confidence 66778864 3999998 64
|
| >1nls_A Concanavalin A; lectin, agglutinin; 0.94A {Canavalia ensiformis} SCOP: b.29.1.1 PDB: 1bxh_A* 1apn_A 1ces_A 1cjp_A* 1c57_A 1cvn_A* 1con_A 1dq1_A 1dq2_A 1dq4_A 1dq5_A 1dq6_A 1enq_A 1enr_A 1ens_A 1gic_A* 1dq0_A 1hqw_A 1gkb_A* 1i3h_A ... | Back alignment and structure |
|---|
Probab=99.97 E-value=5.7e-31 Score=259.85 Aligned_cols=113 Identities=30% Similarity=0.438 Sum_probs=102.9
Q ss_pred CccEEEEEeecccC--CCCCCCCCCCeeeeecCCcccccccCCccccCCCCCccccccCCCCcEEEEEEEeCCcceEEEE
Q 005940 142 SNHILIVEFDTVNG--FNDKAENQGNHVGIGINTMFSNRSEPASYYINGTDHKEEMTLESGEPIQAWIEYDGEQKVLNVT 219 (668)
Q Consensus 142 ~~~~~aVEfDt~~n--~~d~~~~~~~Hvgid~~s~~s~~~~~~~~~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~V~ 219 (668)
+||+|||||||++| ++| |++|||||||||+.|.+++++ ++.+|+.++|||+||+..++|+|+
T Consensus 1 ~n~~vAVEFDT~~n~~~~D---p~~nHVGIdvNs~~S~~~~~~-------------~l~~g~~~~v~I~Yd~~~~~L~V~ 64 (237)
T 1nls_A 1 ADTIVAVELDTYPNTDIGD---PSYPHIGIDIKSVRSKKTAKW-------------NMQNGKVGTAHIIYNSVDKRLSAV 64 (237)
T ss_dssp CCCEEEEEEECSCCGGGTC---CSSCEEEEEESSSSCSEEEEC-------------CCCTTCEEEEEEEEETTTTEEEEE
T ss_pred CCCEEEEEEeCCCCcccCC---CCCCeeeEecCCccccccccc-------------cccCCCEEEEEEEEeCCCCEEEEE
Confidence 47899999999998 335 999999999999999988763 367999999999999999999999
Q ss_pred EEeCCCCCCCCcceeeeeccccccccceeeeeecccCCcccceeeecccccccC
Q 005940 220 ISPAEIGKPMRPLISFGVNLTGYIKETMYVGFSASTGEKSSSHYILGWSFSLNG 273 (668)
Q Consensus 220 ~~~~~~~~p~~~~ls~~~dLs~~l~~~~~vGFsastG~~~~~~~i~~w~F~~~~ 273 (668)
+++.+. ..|+|++.+||+++|+|+|||||||+||...|.|+|++|+|++.+
T Consensus 65 l~~~~~---~~~~ls~~vdLs~~l~e~~~VGFSAsTG~~~~~h~IlsWsF~s~~ 115 (237)
T 1nls_A 65 VSYPNA---DSATVSYDVDLDNVLPEWVRVGLSASTGLYKETNTILSWSFTSKL 115 (237)
T ss_dssp EECTTS---CCEEEEEECCGGGTSCSEEEEEEEEECSSSCCCCEEEEEEEEEEE
T ss_pred EecCCC---CcceEEEeeChHHhCccccEEEEEeccCCcceeeeeEEEEEEecc
Confidence 997653 578999999999999999999999999999999999999999865
|
| >1qmo_A Mannose binding lectin, FRIL; crosslink, hematopoietic progenitor, sugar complex; HET: MAN; 3.5A {Dolichos lab lab} SCOP: b.29.1.1 | Back alignment and structure |
|---|
Probab=99.95 E-value=3.8e-28 Score=211.37 Aligned_cols=105 Identities=31% Similarity=0.535 Sum_probs=94.9
Q ss_pred CceeEEeCCCCCCCCCeEEeCceeeCCCCcEEccCCCC------ceEEEEEeeCceecccCCCCCCCCeeeeEEEEEEEE
Q 005940 26 QSSSFIFQGFNGGATNLSLQGAEIIKPSGALKLTNRSR------YVIGHAFYVKPIQMFDTSASPSPNASSFSTTFVFEI 99 (668)
Q Consensus 26 ~~~~f~~~~f~~~~~~l~~~g~a~~~~~~~~~lt~~~~------~~~G~~~y~~p~~l~~~~~~~~~~~~sF~t~F~f~i 99 (668)
.+++|+|++|.++..||+|+|+|.+.+ |.|+||+... +++|||+|++||+||| + +++++||+|+|+|.|
T Consensus 2 ~~~~F~f~~F~~~~~nl~l~G~A~v~~-g~l~LT~~~~~g~~~~~s~Gra~Y~~Pv~l~d---~-tg~vaSFsT~F~F~I 76 (113)
T 1qmo_A 2 QSLSFSFTKFDPNQEDLIFQGHATSTN-NVLQVTKLDSAGNPVSSSAGRVLYSAPLRLWE---D-SAVLTSFDTIINFEI 76 (113)
T ss_dssp EEEEEEESSCCSSCTTEEEEETCEEET-TEEECSCBCTTSCBCSSCEEEEEESSCEECCC---T-TEEEEEEEEEEEEEE
T ss_pred cceEEEcCCCCCCCCCeEEecceEcCC-CceEeCCCCCCCcccCCcEEEEEeCCCEEeeC---C-CCCEEeeEEEEEEEE
Confidence 467999999997668999999999975 9999998765 7999999999999999 7 889999999999999
Q ss_pred eCCCCCCCCCceEEEEcCCCCCCCCCCCCcccccccC
Q 005940 100 STPRSGRGGHGLAFLLAPSTKLPGAQPEHYLGILNST 136 (668)
Q Consensus 100 ~~~~~~~~g~GlaF~l~p~~~~~~~~~~~~lGl~~~~ 136 (668)
.+++...+||||||||+|....|. +.||||||+|.+
T Consensus 77 ~~~~~~~~gdGlAF~lap~~~~p~-s~g~~LGL~n~~ 112 (113)
T 1qmo_A 77 STPYTSRIADGLAFFIAPPDSVIS-YHGGFLGLFPNA 112 (113)
T ss_dssp ECSSSSCCCCEEEEEEECTTCCCC-CCGGGTTTCSSC
T ss_pred ecCCCCCCCCeEEEEecCCCCCCC-CCccccccccCC
Confidence 988777889999999999876677 999999999864
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=5.6e-29 Score=281.23 Aligned_cols=186 Identities=22% Similarity=0.161 Sum_probs=131.8
Q ss_pred eeeecCcEEEEEEEeCCCCcEEEEEEEecCC----------chhHHHHHHHHHHHhcc-cccCceeEeeeecccCceEEE
Q 005940 360 VIGIGGFGSVYKGVLPTTGGEVAVKKITRNS----------LQGMREFAAEIESLGRL-RHKNLVNLHGWCKQKNDLLLV 428 (668)
Q Consensus 360 ~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~----------~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV 428 (668)
..+.|+.|.+..+.....|+.++||++.+.. ....++|.+|+++|+++ .|+||+++++++++++..|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 3456666666665555568899999997642 12346799999999999 699999999999999999999
Q ss_pred EEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccC
Q 005940 429 YEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDH 508 (668)
Q Consensus 429 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~ 508 (668)
|||++|++|.++|.. +..++.. +|+.||+.||+|||+ ++|+||||||+||||++++++||+|||+|+....
T Consensus 321 MEyv~G~~L~d~i~~---~~~l~~~---~I~~QIl~AL~ylH~---~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~ 391 (569)
T 4azs_A 321 MEKLPGRLLSDMLAA---GEEIDRE---KILGSLLRSLAALEK---QGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQ 391 (569)
T ss_dssp EECCCSEEHHHHHHT---TCCCCHH---HHHHHHHHHHHHHHH---TTCEESCCCGGGEEECTTSCEEECCCTTEESCC-
T ss_pred EecCCCCcHHHHHHh---CCCCCHH---HHHHHHHHHHHHHHH---CCceeccCchHhEEECCCCCEEEeecccCeeCCC
Confidence 999999999999963 3345543 588999999999999 9999999999999999999999999999997654
Q ss_pred CCCCcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCC
Q 005940 509 GGMPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRP 556 (668)
Q Consensus 509 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p 556 (668)
... .....+||+.|||||++.+ ++..++|+|++|++++++.++..+
T Consensus 392 ~~~-~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 392 DCS-WPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp --C-CSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred CCc-cccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence 432 2344689999999999864 577889999999998877665433
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=3.8e-26 Score=256.68 Aligned_cols=184 Identities=17% Similarity=0.171 Sum_probs=146.5
Q ss_pred ccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCc--------hhHHHHHHHHHHHhcccccCceeEeeeecccCceEE
Q 005940 356 KESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSL--------QGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLL 427 (668)
Q Consensus 356 ~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--------~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l 427 (668)
...++||+|+||.||+|.. .+..+++|+...... ...+.+.+|++++++++||||+++..++...+..++
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~--~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l 416 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY--LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRI 416 (540)
T ss_dssp ---------CCEEEEEEEC--SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEE
T ss_pred CCCCEEeeCCCEEEEEEEE--CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEE
Confidence 4467899999999999965 578899998754321 113458999999999999999966666667778899
Q ss_pred EEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceecc
Q 005940 428 VYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYD 507 (668)
Q Consensus 428 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~ 507 (668)
||||+++++|.+++.. ++.++.|+++||.|||+ ++|+||||||+|||++. ++||+|||+++...
T Consensus 417 VmE~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH~---~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~ 480 (540)
T 3en9_A 417 MMSYINGKLAKDVIED-----------NLDIAYKIGEIVGKLHK---NDVIHNDLTTSNFIFDK--DLYIIDFGLGKISN 480 (540)
T ss_dssp EEECCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHHH---TTEECTTCCTTSEEESS--SEEECCCTTCEECC
T ss_pred EEECCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHHH---CcCccCCCCHHHEEECC--eEEEEECccCEECC
Confidence 9999999999999953 56899999999999999 99999999999999999 99999999999876
Q ss_pred CCCCCc------ccccccCCcccCcccccC--CCCCcchhHHHHHHHHHHHHhCCCCC
Q 005940 508 HGGMPH------TTNVVGTFGYIAPELTQT--GKASTSSDVFAYGILLLEVATGRRPI 557 (668)
Q Consensus 508 ~~~~~~------~~~~~gt~~y~aPE~~~~--~~~~~~sDV~S~Gvvl~elltG~~p~ 557 (668)
...... .....||+.|||||++.. ..|+...|+|+..+-.++-+.++.+|
T Consensus 481 ~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 481 LDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp CHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred CccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 532211 134689999999999876 56788899999999999888877766
|
| >2a6y_A EMP47P (FORM1); beta sandwich, carbohydrate binding protein, cargo receptor, structural genomics, NPPSFA; 1.42A {Saccharomyces cerevisiae} SCOP: b.29.1.13 | Back alignment and structure |
|---|
Probab=99.91 E-value=3e-24 Score=215.74 Aligned_cols=185 Identities=15% Similarity=0.255 Sum_probs=142.3
Q ss_pred CCCeEEeCceeeCCCCcEEccCCCCceEEEEEeeCceecccCCCCCCCCeeeeEEEEEEEEeCCCCCCCCCceEEEEcCC
Q 005940 39 ATNLSLQGAEIIKPSGALKLTNRSRYVIGHAFYVKPIQMFDTSASPSPNASSFSTTFVFEISTPRSGRGGHGLAFLLAPS 118 (668)
Q Consensus 39 ~~~l~~~g~a~~~~~~~~~lt~~~~~~~G~~~y~~p~~l~~~~~~~~~~~~sF~t~F~f~i~~~~~~~~g~GlaF~l~p~ 118 (668)
-.+..+.|+|.+. ++.|+||++ .++.|++|.+.|+.+.+ +|+|+|+|.|..+. ..+||||||+++|.
T Consensus 30 i~~w~~~G~a~v~-~~~IrLTp~-~~s~G~iW~~~p~~~~~----------~f~~~f~FrI~g~~-~~~gdGlAfwlt~~ 96 (256)
T 2a6y_A 30 PNNWQTGEQASLE-EGRIVLTSN-QNSKGSLWLKQGFDLKD----------SFTMEWTFRSVGYS-GQTDGGISFWFVQD 96 (256)
T ss_dssp CTTEEEEETCEEE-TBEEECCCS-TTCEEEEEESSCEEESS----------CEEEEEEEEEESCC-SCCSCEEEEEEEEC
T ss_pred cCCeEEccceEEe-CCEEEECCC-CCceEEEeeCCCCcccC----------CEEEEEEEEEecCC-CCCCCeEEEEEeCC
Confidence 4689999999994 899999998 67899999999998544 79999999999874 34799999999997
Q ss_pred CCCCCCCCCCcccccccCCCCCCCccEEEEEeecccCCCCCCCCC------CCeeeeecCCcccccccCCccccCCCCCc
Q 005940 119 TKLPGAQPEHYLGILNSTNNGEPSNHILIVEFDTVNGFNDKAENQ------GNHVGIGINTMFSNRSEPASYYINGTDHK 192 (668)
Q Consensus 119 ~~~~~~~~~~~lGl~~~~~~~~~~~~~~aVEfDt~~n~~d~~~~~------~~Hvgid~~s~~s~~~~~~~~~~~~~~~~ 192 (668)
...| ..|+.+|..+ ...-+||||||+.|. . |. +.|+++|.+++.+.......
T Consensus 97 ~~~~--~~g~~~G~~~-------~f~GlaV~fDT~~n~-~---p~i~~~~Ndg~~~~d~~~~~~~~~~~c~--------- 154 (256)
T 2a6y_A 97 SNIP--RDKQLYNGPV-------NYDGLQLLVDNNGPL-G---PTLRGQLNDGQKPVDKTKIYDQSFASCL--------- 154 (256)
T ss_dssp SSSC--CCCTBTTBCT-------TCEEEEEEEESCSTT-C---SEEEEEEEESSSCCCGGGHHHHCSEEEE---------
T ss_pred CCcc--cCCcccCcCC-------CCCEEEEEEECCCCC-C---ceEEEEECCCceecccCCCcccceecce---------
Confidence 6422 5678888853 223589999999761 2 32 56778887764333322211
Q ss_pred ccccc-CCCCcEEEEEEEe-CCcceEEEEEEeCCCCCCCCcceeeeeccccc-cccce-eeeeecccC---Ccccceeee
Q 005940 193 EEMTL-ESGEPIQAWIEYD-GEQKVLNVTISPAEIGKPMRPLISFGVNLTGY-IKETM-YVGFSASTG---EKSSSHYIL 265 (668)
Q Consensus 193 ~~~~l-~~g~~~~~~I~Y~-~~~~~l~V~~~~~~~~~p~~~~ls~~~dLs~~-l~~~~-~vGFsastG---~~~~~~~i~ 265 (668)
... ++|.+.++||.|+ +..+.|+|.+.+ ...+++..+ ||+.. ||||||+|| ...+.|.|+
T Consensus 155 --~~~rn~~~~~~v~I~Y~~~~~~~L~V~i~~-----------~~c~~~~~v~LP~~~~~~GfSAaTG~~~~~~d~hdIl 221 (256)
T 2a6y_A 155 --MGYQDSSVPSTIRVTYDLEDDNLLKVQVDN-----------KVCFQTRKVRFPSGSYRIGVTAQNGAVNNNAESFEIF 221 (256)
T ss_dssp --CCCTTCSSCEEEEEEEEGGGTSEEEEEETT-----------EEEEEESCEECCSEEEEEEEEEECCSGGGCCCEEEEE
T ss_pred --eecccCCCcEEEEEEEecCCCcEEEEEEcC-----------EEEEEECcEEeCCCCeEEEEEEeCCCCCCCcceEEEE
Confidence 112 4789999999999 888899999964 123445555 88887 699999999 889999999
Q ss_pred cccccc
Q 005940 266 GWSFSL 271 (668)
Q Consensus 266 ~w~F~~ 271 (668)
+|+|..
T Consensus 222 s~~~~~ 227 (256)
T 2a6y_A 222 KMQFFN 227 (256)
T ss_dssp EEEEEE
T ss_pred EEEEEe
Confidence 999987
|
| >1nls_A Concanavalin A; lectin, agglutinin; 0.94A {Canavalia ensiformis} SCOP: b.29.1.1 PDB: 1bxh_A* 1apn_A 1ces_A 1cjp_A* 1c57_A 1cvn_A* 1con_A 1dq1_A 1dq2_A 1dq4_A 1dq5_A 1dq6_A 1enq_A 1enr_A 1ens_A 1gic_A* 1dq0_A 1hqw_A 1gkb_A* 1i3h_A ... | Back alignment and structure |
|---|
Probab=99.90 E-value=2.8e-24 Score=212.03 Aligned_cols=106 Identities=28% Similarity=0.574 Sum_probs=94.8
Q ss_pred CceeEEeCCCCCCCCCeEEeCceeeCCCCcEEccCCCC------ceEEEEEeeCceecccCCCCCCCCeeeeEEEEEEEE
Q 005940 26 QSSSFIFQGFNGGATNLSLQGAEIIKPSGALKLTNRSR------YVIGHAFYVKPIQMFDTSASPSPNASSFSTTFVFEI 99 (668)
Q Consensus 26 ~~~~f~~~~f~~~~~~l~~~g~a~~~~~~~~~lt~~~~------~~~G~~~y~~p~~l~~~~~~~~~~~~sF~t~F~f~i 99 (668)
..++|+|++|.+.+.||+|+|+|.+.++|.|+||+... +++|||+|++||+||+ + +++++||+|+|+|.|
T Consensus 124 ~~~~F~~~~F~~~~~nl~l~G~A~v~~~g~l~LT~~~~n~~~~~~~~Gra~Y~~Pv~lwd---~-~~~vaSFsT~F~F~I 199 (237)
T 1nls_A 124 NALHFMFNQFSKDQKDLILQGDATTGTDGNLELTRVSSNGSPQGSSVGRALFYAPVHIWE---S-SAVVASFEATFTFLI 199 (237)
T ss_dssp EEEEEEESCCCTTCTTEEEEETCEEEETTEEESSCBCTTSCBCSSCEEEEEESSCEECCC---T-TEEEEEEEEEEEEEC
T ss_pred ccchhhhccccccCCCeEEccceEecCCCceEecCCccCCccccCceEEEEeCCCEEeec---C-CCCEeeeEEEEEEEE
Confidence 56799999999866799999999997789999998763 6899999999999999 5 678999999999999
Q ss_pred eCCCCCCCCCceEEEEcCCC-CCCCCCCCCcccccccC
Q 005940 100 STPRSGRGGHGLAFLLAPST-KLPGAQPEHYLGILNST 136 (668)
Q Consensus 100 ~~~~~~~~g~GlaF~l~p~~-~~~~~~~~~~lGl~~~~ 136 (668)
.+++ ..+||||||||+|.. .+|.+++||||||+|.+
T Consensus 200 ~~~~-~~~g~GlAF~lap~~~~~p~~~~g~~LGL~n~~ 236 (237)
T 1nls_A 200 KSPD-SHPADGIAFFISNIDSSIPSGSTGRLLGLFPDA 236 (237)
T ss_dssp CCSS-SSCCCEEEEEEECTTCCCCTTCCGGGTTTCSSC
T ss_pred ecCC-CCCCccEEEEECCCCCCCCCCCCcCeeccccCC
Confidence 9873 568999999999977 58999999999999865
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=8e-23 Score=210.76 Aligned_cols=151 Identities=17% Similarity=0.119 Sum_probs=121.9
Q ss_pred hHHHHhcCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCc------------------hhHHHHHHHHHHHhccc
Q 005940 347 DLYAATKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSL------------------QGMREFAAEIESLGRLR 408 (668)
Q Consensus 347 el~~at~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------------------~~~~~f~~Ei~~l~~l~ 408 (668)
.+......|...+.||+|+||.||+|.+ .+++.||||++..... .....+.+|++++++++
T Consensus 84 ~~~~~~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~ 162 (282)
T 1zar_A 84 RLVRSGKVDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ 162 (282)
T ss_dssp HHHHTTSCSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHhCCeEEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc
Confidence 3444556677889999999999999999 7799999999964321 13457899999999999
Q ss_pred ccCceeEeeeecccCceEEEEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEE
Q 005940 409 HKNLVNLHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNAL 488 (668)
Q Consensus 409 H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIl 488 (668)
| +++.+++. .+..++||||+++++|.+ +.. .....++.|++.||.|||+ .+|+||||||+|||
T Consensus 163 --~-~~v~~~~~-~~~~~lvmE~~~g~~L~~-l~~---------~~~~~i~~qi~~~l~~lH~---~giiHrDlkp~NIL 225 (282)
T 1zar_A 163 --G-LAVPKVYA-WEGNAVLMELIDAKELYR-VRV---------ENPDEVLDMILEEVAKFYH---RGIVHGDLSQYNVL 225 (282)
T ss_dssp --T-SSSCCEEE-EETTEEEEECCCCEEGGG-CCC---------SCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEE
T ss_pred --C-CCcCeEEe-ccceEEEEEecCCCcHHH-cch---------hhHHHHHHHHHHHHHHHHH---CCCEeCCCCHHHEE
Confidence 4 56666543 356799999999999988 521 2345799999999999999 99999999999999
Q ss_pred ECCCCCEEEEeecCceeccCCCCCcccccccCCcccCccccc
Q 005940 489 IDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPELTQ 530 (668)
Q Consensus 489 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~ 530 (668)
++ ++.+||+|||+|+. +..++|||++.
T Consensus 226 l~-~~~vkl~DFG~a~~--------------~~~~~a~e~l~ 252 (282)
T 1zar_A 226 VS-EEGIWIIDFPQSVE--------------VGEEGWREILE 252 (282)
T ss_dssp EE-TTEEEECCCTTCEE--------------TTSTTHHHHHH
T ss_pred EE-CCcEEEEECCCCeE--------------CCCCCHHHHHH
Confidence 99 99999999999974 33478899864
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.78 E-value=7.5e-19 Score=178.61 Aligned_cols=138 Identities=19% Similarity=0.137 Sum_probs=109.5
Q ss_pred cccceeeeecCcEEEEEEEeCCCCcE--EEEEEEecCCch------------------------hHHHHHHHHHHHhccc
Q 005940 355 FKESEVIGIGGFGSVYKGVLPTTGGE--VAVKKITRNSLQ------------------------GMREFAAEIESLGRLR 408 (668)
Q Consensus 355 f~~~~~lG~G~~g~Vy~~~~~~~~~~--vavK~~~~~~~~------------------------~~~~f~~Ei~~l~~l~ 408 (668)
|...+.||+|+||.||+|.+..+|+. ||||++...... ....+..|++++.+++
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 66789999999999999998667888 999987543111 1136789999999999
Q ss_pred ccCc--eeEeeeecccCceEEEEEecCC-C----ChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhh-hccCCceEec
Q 005940 409 HKNL--VNLHGWCKQKNDLLLVYEYIPN-G----SLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLH-EEWEQVVIHR 480 (668)
Q Consensus 409 H~nI--v~l~g~~~~~~~~~lV~E~~~~-g----sL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH-~~~~~~ivHr 480 (668)
|+++ ..++++ ...+|||||+.+ | +|.++... .++..+..++.|++.||.||| + .+|+||
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~------~~~~~~~~i~~qi~~~l~~lH~~---~givHr 195 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE------LKELDVEGIFNDVVENVKRLYQE---AELVHA 195 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG------GGGSCHHHHHHHHHHHHHHHHHT---SCEECS
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc------cChHHHHHHHHHHHHHHHHHHHH---CCEEeC
Confidence 8864 444443 357899999942 4 66665421 346678899999999999999 7 999999
Q ss_pred CCCCCCEEECCCCCEEEEeecCceecc
Q 005940 481 DVKPSNALIDAEMNARLGDFGLARLYD 507 (668)
Q Consensus 481 DLkp~NIll~~~~~~kl~DfGla~~~~ 507 (668)
||||+|||++. .++|+|||+|....
T Consensus 196 Dlkp~NILl~~--~~~liDFG~a~~~~ 220 (258)
T 1zth_A 196 DLSEYNIMYID--KVYFIDMGQAVTLR 220 (258)
T ss_dssp SCSTTSEEESS--SEEECCCTTCEETT
T ss_pred CCCHHHEEEcC--cEEEEECcccccCC
Confidence 99999999998 99999999998654
|
| >2a6z_A EMP47P (FORM2); beta sandwich, carbohydrate binding protein, cargo receptor, structural genomics, NPPSFA; 1.00A {Saccharomyces cerevisiae} SCOP: b.29.1.13 PDB: 2a70_A 2a71_A | Back alignment and structure |
|---|
Probab=99.73 E-value=3.7e-17 Score=160.61 Aligned_cols=191 Identities=16% Similarity=0.210 Sum_probs=127.3
Q ss_pred CCCeEEeCceeeCCCCcEEccCCCCceEEEEEeeCceecccCCCCCCCCeeeeEEEEEEEEeCCCCCCCCCceEEEEcCC
Q 005940 39 ATNLSLQGAEIIKPSGALKLTNRSRYVIGHAFYVKPIQMFDTSASPSPNASSFSTTFVFEISTPRSGRGGHGLAFLLAPS 118 (668)
Q Consensus 39 ~~~l~~~g~a~~~~~~~~~lt~~~~~~~G~~~y~~p~~l~~~~~~~~~~~~sF~t~F~f~i~~~~~~~~g~GlaF~l~p~ 118 (668)
-.+..+.|+|.+. ++.|+||++ .++.|.+|.+.|+++.+ +|+++|+|+|+.+. ..+||||||++++.
T Consensus 23 ~~~W~~~G~a~i~-~~~IrLTp~-~~~~G~iWs~~p~~~~~----------~weie~~Fri~g~~-~~~gdGlA~W~t~~ 89 (222)
T 2a6z_A 23 PNNWQTGEQASLE-EGRIVLTSN-QNSKGSLWLKQGFDLKD----------SFTMEWTFRSVGYS-GQTDGGISFWFVQD 89 (222)
T ss_dssp CTTEEEEETCEEE-TTEEESCCS-TTCEEEEEESSCEECCS----------CEEEEEEEEEESCC-SCCSCEEEEEEEEC
T ss_pred cCCcEEcccEEEc-CCEEEECCC-CCCeEEEEeCCCCCCCC----------CEEEEEEEEEeCCC-CCCCCEEEEEEECC
Confidence 3689999999996 789999999 57789999999998755 69999999999764 45799999999986
Q ss_pred CCCCCCCCCCcccccccCCCCCCCccEEEEEeecccCCCCCCCCCCCeeeeecCCc-ccccccCCccccCCCCCcccccc
Q 005940 119 TKLPGAQPEHYLGILNSTNNGEPSNHILIVEFDTVNGFNDKAENQGNHVGIGINTM-FSNRSEPASYYINGTDHKEEMTL 197 (668)
Q Consensus 119 ~~~~~~~~~~~lGl~~~~~~~~~~~~~~aVEfDt~~n~~d~~~~~~~Hvgid~~s~-~s~~~~~~~~~~~~~~~~~~~~l 197 (668)
... ...|..+|..+. -.=+||+|||+.| + ..+|.+.+|.= .+..... +.-....++.... .
T Consensus 90 ~~~--~~~g~~~G~~~~-------f~GL~I~~Dt~~n--~-----~p~i~~~~ndG~~~yd~~~-~~~~~~~~C~~~~-r 151 (222)
T 2a6z_A 90 SNI--PRDKQLYNGPVN-------YDGLQLLVDNNGP--L-----GPTLRGQLNDGQKPVDKTK-IYDQSFASCLMGY-Q 151 (222)
T ss_dssp SSS--CCCCTBTTBCTT-------CEEEEEEEESCST--T-----SSEEEEEEEESSSCCCGGG-HHHHCSEEEECCC-T
T ss_pred Ccc--cCCCcccCCCCC-------CCEEEEEEECCCC--C-----CceEEEEECCCCeeeccCC-Cccccccccceec-c
Confidence 531 123445554221 1125999999976 1 23565544321 1100000 0000000111111 1
Q ss_pred CCCCcEEEEEEEe-CCcceEEEEEEeCCCCCCCCcceeeeeccccccccc-eeeeeecccC---Ccccceeeeccccc
Q 005940 198 ESGEPIQAWIEYD-GEQKVLNVTISPAEIGKPMRPLISFGVNLTGYIKET-MYVGFSASTG---EKSSSHYILGWSFS 270 (668)
Q Consensus 198 ~~g~~~~~~I~Y~-~~~~~l~V~~~~~~~~~p~~~~ls~~~dLs~~l~~~-~~vGFsastG---~~~~~~~i~~w~F~ 270 (668)
+.+.+.++||.|+ ...+.|+|.+.. -++..++ .-.||+. +|+||||+|| ...+.|.|++|++.
T Consensus 152 n~~~~~~~rI~Y~~~~~~~l~v~id~---------~~C~~~~-~v~LP~~~~y~G~SA~TG~l~~~~d~hdil~~~~~ 219 (222)
T 2a6z_A 152 DSSVPSTIRVTYDLEDDNLLKVQVDN---------KVCFQTR-KVRFPSGSYRIGVTAQNGAVNNNAESFEIFKMQFF 219 (222)
T ss_dssp TEEEEEEEEEEEEGGGTSEEEEEETT---------EEEEEES-CCCCCSSEEEEEEEEECCSGGGCCCEEEEEEEEEE
T ss_pred CCCCcEEEEEEEEcCCCcEEEEEEcC---------eEEEEeC-CeecCCCCcEEEEEEcCCCCCCCCccEEEEEEEEE
Confidence 4578899999999 667789998853 1333322 1125665 5799999999 88999999999864
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.62 E-value=8e-16 Score=163.28 Aligned_cols=139 Identities=14% Similarity=0.144 Sum_probs=101.1
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCc--------------hhHHHH--------HHHHHHHhccccc
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSL--------------QGMREF--------AAEIESLGRLRHK 410 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--------------~~~~~f--------~~Ei~~l~~l~H~ 410 (668)
.-|.+.++||+|++|.||+|... +|+.||||+++.... ...... ..|...|.++.+.
T Consensus 95 ~iY~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~ 173 (397)
T 4gyi_A 95 DVYSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEE 173 (397)
T ss_dssp SCSEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred CEEEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhc
Confidence 34899999999999999999985 689999998753210 001111 2455556666444
Q ss_pred Cce--eEeeeecccCceEEEEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEE
Q 005940 411 NLV--NLHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNAL 488 (668)
Q Consensus 411 nIv--~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIl 488 (668)
++. ..+++ ...+|||||+++++|.++... .....++.||+.+|.|||+ .+||||||||.|||
T Consensus 174 gv~vp~p~~~----~~~~LVME~i~G~~L~~l~~~---------~~~~~l~~qll~~l~~lH~---~gIVHrDLKp~NIL 237 (397)
T 4gyi_A 174 GFPVPEPIAQ----SRHTIVMSLVDALPMRQVSSV---------PDPASLYADLIALILRLAK---HGLIHGDFNEFNIL 237 (397)
T ss_dssp TCSCCCEEEE----ETTEEEEECCSCEEGGGCCCC---------SCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEE
T ss_pred CCCCCeeeec----cCceEEEEecCCccHhhhccc---------HHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHEE
Confidence 332 22222 224799999999888766521 2345688999999999998 99999999999999
Q ss_pred ECCCCC----------EEEEeecCceeccC
Q 005940 489 IDAEMN----------ARLGDFGLARLYDH 508 (668)
Q Consensus 489 l~~~~~----------~kl~DfGla~~~~~ 508 (668)
+++++. +.|+||+.+....+
T Consensus 238 l~~dgd~~d~~~~~~~~~iID~~Q~V~~~h 267 (397)
T 4gyi_A 238 IREEKDAEDPSSITLTPIIIXFPQMVSMDH 267 (397)
T ss_dssp EEEEECSSCTTSEEEEEEECCCTTCEETTS
T ss_pred EeCCCCcccccccccceEEEEeCCcccCCC
Confidence 988763 89999998876554
|
| >2a6v_A EMP46P; beta sandwich, carbohydrate binding protein, cargo receptor, structural genomics, NPPSFA; 1.52A {Saccharomyces cerevisiae} SCOP: b.29.1.13 PDB: 2a6w_A 2a6x_A | Back alignment and structure |
|---|
Probab=99.47 E-value=9e-13 Score=128.85 Aligned_cols=188 Identities=16% Similarity=0.152 Sum_probs=121.2
Q ss_pred CCeEEeCceeeCCCCcEEccCCCCceEEEEEeeCceecccCCCCCCCCeeeeEEEEEEEEeCCCCCCCCCceEEEEcCCC
Q 005940 40 TNLSLQGAEIIKPSGALKLTNRSRYVIGHAFYVKPIQMFDTSASPSPNASSFSTTFVFEISTPRSGRGGHGLAFLLAPST 119 (668)
Q Consensus 40 ~~l~~~g~a~~~~~~~~~lt~~~~~~~G~~~y~~p~~l~~~~~~~~~~~~sF~t~F~f~i~~~~~~~~g~GlaF~l~p~~ 119 (668)
++-.+.|+|.+. ++.|+||++ +++.|.+|.+.|+.+-+ +|+.+|+|+|+... ..+||||||+++..+
T Consensus 27 ~~W~~~G~t~v~-~~~IrLTp~-~s~~G~lWs~~p~~~~~----------~weiev~Fri~G~~-~~~gdGlA~Wyt~~~ 93 (226)
T 2a6v_A 27 SQWTLGDKVKLE-EGRFVLTPG-KNTKGSLWLKPEYSIKD----------AMTIEWTFRSFGFR-GSTKGGLAFWLKQGN 93 (226)
T ss_dssp TTEEEEETCEEE-TTEEESCCS-TTCEEEEEESSCBCCSS----------CEEEEEEEEEESCC-SCCSCEEEEEEECSC
T ss_pred CCcEEcCCeEEe-CCEEEECCC-CCceEEEeeCCCCCCCC----------CeEEEEEEEEecCC-CCCCCEEEEEEECCC
Confidence 578999999997 678999999 99999999999998623 49999999999874 337999999999755
Q ss_pred CCCCCCCCCcccccccCCCCCCCccEEEEEeecccCCCCCCCCCCCee-eeecCCcccccccCCccccCCCCCccccccC
Q 005940 120 KLPGAQPEHYLGILNSTNNGEPSNHILIVEFDTVNGFNDKAENQGNHV-GIGINTMFSNRSEPASYYINGTDHKEEMTLE 198 (668)
Q Consensus 120 ~~~~~~~~~~lGl~~~~~~~~~~~~~~aVEfDt~~n~~d~~~~~~~Hv-gid~~s~~s~~~~~~~~~~~~~~~~~~~~l~ 198 (668)
.. ..|..+|-... .-.=+||.|||+.| . ...| ++--++-.+..... .....++..+ ..+
T Consensus 94 ~~---~~g~vfGg~~d------~f~GlgI~~Dt~~n--~-----~p~i~~~~NDGt~~yd~~~---~~~~g~C~~~-~rn 153 (226)
T 2a6v_A 94 EG---DSTELFGGSSK------KFNGLMILLRLDDK--L-----GESVTAYLNDGTKDLDIES---SPYFASCLFQ-YQD 153 (226)
T ss_dssp CC---CCCTBTTTBCS------SCEEEEEEEEEETT--T-----EEEEEEEEEESSSCCCTTT---SCCSEEEECC-CSS
T ss_pred CC---CCcccccccCC------CccEEEEEEECCCC--C-----CceEEEEECCCCcccCCCC---CcccceEeEe-ccC
Confidence 31 22333321111 11125999999965 1 1122 22222211111110 0000111111 124
Q ss_pred CCCcEEEEEEEe-CCcceEEEEEEeCCCCCCCCcceeeeeccccccccce--eeeeecccCCcccceeeeccccc
Q 005940 199 SGEPIQAWIEYD-GEQKVLNVTISPAEIGKPMRPLISFGVNLTGYIKETM--YVGFSASTGEKSSSHYILGWSFS 270 (668)
Q Consensus 199 ~g~~~~~~I~Y~-~~~~~l~V~~~~~~~~~p~~~~ls~~~dLs~~l~~~~--~vGFsastG~~~~~~~i~~w~F~ 270 (668)
.+.+.+++|.|. ...+.|+|.+.. + .+..++= -.||..- |+||||+||...+.|.|++..+-
T Consensus 154 ~~~~t~~ri~Y~~~~~~~l~v~id~-------~--~Cf~~~~-v~LP~g~~~yfGiSAaTg~~~D~hdils~~~~ 218 (226)
T 2a6v_A 154 SMVPSTLRLTYNPLDNHLLKLQMDN-------R--VCFQTRK-VKFMGSSPFRIGTSAINDASKESFEILKMKLY 218 (226)
T ss_dssp CSSCEEEEEEEEGGGTSEEEEEETT-------E--EEEEESC-CCGGGTSCBEEEEEEECCTTCCEEEEEEEEEE
T ss_pred CCCCEEEEEEEEccCCCEEEEEEcC-------C--eeEEECC-eecCCCCccEEEEEEcCCCCcccEEEEEEEEE
Confidence 678899999998 456789998852 1 2333221 1356544 99999999999999999987543
|
| >2ltn_B PEA lectin, beta chain; 1.70A {Pisum sativum} SCOP: b.29.1.1 PDB: 1hkd_B 1rin_B* 1ofs_B* 1bqp_B* 1loe_B 1loa_B* 1loc_B* 1lod_B* 1lob_B 1lof_B* 1log_B* 1lof_D* 1les_B* 2b7y_B* 1lgc_B* 1lgb_B* 1len_B 1lem_B 2lal_B | Back alignment and structure |
|---|
Probab=99.36 E-value=1.1e-13 Score=101.53 Aligned_cols=44 Identities=34% Similarity=0.487 Sum_probs=41.5
Q ss_pred CcceeeeeccccccccceeeeeecccCCcccceeeecccccccC
Q 005940 230 RPLISFGVNLTGYIKETMYVGFSASTGEKSSSHYILGWSFSLNG 273 (668)
Q Consensus 230 ~~~ls~~~dLs~~l~~~~~vGFsastG~~~~~~~i~~w~F~~~~ 273 (668)
+|+|+..+||+++|+|+|||||||+||...+.|+|++|+|++.+
T Consensus 3 ~p~ls~~vdLs~~l~e~v~VGFSAsTG~~~~~h~IlsWsF~s~~ 46 (52)
T 2ltn_B 3 SYTLSDVVSLKDVVPEWVRIGFSATTGAEYAAHEVLSWSFHSEL 46 (52)
T ss_dssp EEEEEEECCHHHHSCSEEEEEEEEECCSSCCEEEEEEEEEEEEE
T ss_pred eeeEEEEEcHHHhcCceEEEEEEeccCCcceeEEEEEeEEEeec
Confidence 47899999999999999999999999999999999999998864
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.27 E-value=1.6e-11 Score=124.25 Aligned_cols=145 Identities=14% Similarity=0.027 Sum_probs=114.5
Q ss_pred HHhcCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCchhHHHHHHHHHHHhccc-ccCceeEeeeecccCceEEE
Q 005940 350 AATKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLR-HKNLVNLHGWCKQKNDLLLV 428 (668)
Q Consensus 350 ~at~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~lV 428 (668)
..-.+|.....++.|+.+.||++.. .++.+++|+...........+..|+++++.+. +.++.++++++...+..|+|
T Consensus 11 ~~l~~~~~~~~~~g~s~~~v~~~~~--~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv 88 (263)
T 3tm0_A 11 KLIEKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL 88 (263)
T ss_dssp HHHTTSEEEECCSCCSSSEEEEEEC--SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred HHhccceeEeeccCCCCCeEEEEEC--CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEE
Confidence 3445788888888888999999976 36899999987532222346888999999985 67888999999888899999
Q ss_pred EEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhc------------------------------------
Q 005940 429 YEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEE------------------------------------ 472 (668)
Q Consensus 429 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~------------------------------------ 472 (668)
|||++|.+|.+.+. +......++.+++++|..||+-
T Consensus 89 ~e~i~G~~l~~~~~--------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (263)
T 3tm0_A 89 MSEADGVLCSEEYE--------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEE 160 (263)
T ss_dssp EECCSSEEHHHHCC--------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGST
T ss_pred EEecCCeehhhccC--------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccc
Confidence 99999999987642 1223457889999999999981
Q ss_pred --------------------cCCceEecCCCCCCEEECCCCCEEEEeecCce
Q 005940 473 --------------------WEQVVIHRDVKPSNALIDAEMNARLGDFGLAR 504 (668)
Q Consensus 473 --------------------~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~ 504 (668)
....++|+|++|.||+++++..+.|.||+.+.
T Consensus 161 ~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 161 DTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp TCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred cccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 01559999999999999876556799999775
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.10 E-value=2.3e-10 Score=115.15 Aligned_cols=138 Identities=17% Similarity=0.098 Sum_probs=100.9
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCchhHHHHHHHHHHHhcccccC--ceeEeeeecccCceEEEEE
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKN--LVNLHGWCKQKNDLLLVYE 430 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~n--Iv~l~g~~~~~~~~~lV~E 430 (668)
.++....+.+.|..+.||++.. .+|..+++|+.... ....+..|+++++.+++.+ +.++++++...+..++|||
T Consensus 20 ~~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e 95 (264)
T 1nd4_A 20 FGYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLG 95 (264)
T ss_dssp TTCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEE
T ss_pred CCCceEecccCCCCceEEEEec-CCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEE
Confidence 3444433334555699999976 35678999997654 2245778999999987545 5568888888888999999
Q ss_pred ecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhcc-------------------------------------
Q 005940 431 YIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEW------------------------------------- 473 (668)
Q Consensus 431 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~------------------------------------- 473 (668)
|+++.+|. .. . . ....++.++++.|..||+..
T Consensus 96 ~i~G~~l~--~~--~----~---~~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (264)
T 1nd4_A 96 EVPGQDLL--SS--H----L---APAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQG 164 (264)
T ss_dssp CCSSEETT--TS--C----C---CHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTT
T ss_pred ecCCcccC--cC--c----C---CHhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccC
Confidence 99998884 21 1 1 12367788888888888621
Q ss_pred ------------------CCceEecCCCCCCEEECCCCCEEEEeecCcee
Q 005940 474 ------------------EQVVIHRDVKPSNALIDAEMNARLGDFGLARL 505 (668)
Q Consensus 474 ------------------~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~ 505 (668)
...++|+|++|.||+++++..+.|.||+.+..
T Consensus 165 ~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 165 LAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp CCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred ccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 12399999999999998776677999998753
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.97 E-value=2.2e-09 Score=113.93 Aligned_cols=142 Identities=15% Similarity=0.206 Sum_probs=108.4
Q ss_pred cceeeeecCcEEEEEEEeCCCCcEEEEEEEe--cCCc-hhHHHHHHHHHHHhccc--ccCceeEeeeeccc---CceEEE
Q 005940 357 ESEVIGIGGFGSVYKGVLPTTGGEVAVKKIT--RNSL-QGMREFAAEIESLGRLR--HKNLVNLHGWCKQK---NDLLLV 428 (668)
Q Consensus 357 ~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~--~~~~-~~~~~f~~Ei~~l~~l~--H~nIv~l~g~~~~~---~~~~lV 428 (668)
..+.|+.|.++.||+.... +..+++|+.. .... .....+..|+++++.|+ +..+.+++.++.+. +..++|
T Consensus 42 ~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~v 119 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYI 119 (359)
T ss_dssp EEEECCC-CCSCEEEEECS--SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEE
T ss_pred eEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEE
Confidence 4678999999999999873 5688899876 3221 23356788999999997 45688899998776 458999
Q ss_pred EEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhcc-----------------------------------
Q 005940 429 YEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEW----------------------------------- 473 (668)
Q Consensus 429 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~----------------------------------- 473 (668)
|||+++..+.+.. -..++..++..++.++++.|+.||+..
T Consensus 120 me~v~G~~l~~~~-----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (359)
T 3dxp_A 120 MEFVSGRVLWDQS-----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESI 194 (359)
T ss_dssp EECCCCBCCCCTT-----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCC
T ss_pred EEecCCeecCCCc-----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCC
Confidence 9999998885422 123678888999999999999999720
Q ss_pred --------------------CCceEecCCCCCCEEECCCCC--EEEEeecCcee
Q 005940 474 --------------------EQVVIHRDVKPSNALIDAEMN--ARLGDFGLARL 505 (668)
Q Consensus 474 --------------------~~~ivHrDLkp~NIll~~~~~--~kl~DfGla~~ 505 (668)
...++|||+++.||+++.++. +.|.||+.+..
T Consensus 195 ~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 195 PAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred hHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 257999999999999997754 68999998875
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.87 E-value=1.5e-09 Score=112.29 Aligned_cols=183 Identities=17% Similarity=0.177 Sum_probs=124.0
Q ss_pred ceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCchhHHHHHHHHHHHhccc-ccC--ceeEeeeecccC---ceEEEEEe
Q 005940 358 SEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLR-HKN--LVNLHGWCKQKN---DLLLVYEY 431 (668)
Q Consensus 358 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~-H~n--Iv~l~g~~~~~~---~~~lV~E~ 431 (668)
.+.++.|....||+.. ..+++|+.... .....+..|.++++.+. +.. +.+++..+...+ ..|+|||+
T Consensus 25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~ 97 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN-----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTK 97 (304)
T ss_dssp CCEEEECSSEEEEEST-----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEEC
T ss_pred eEecCCCCcceEEEEC-----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcc
Confidence 4668999999999862 46889986432 34567889999998884 322 445666554433 35899999
Q ss_pred cCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhc---------------------------------------
Q 005940 432 IPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEE--------------------------------------- 472 (668)
Q Consensus 432 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~--------------------------------------- 472 (668)
++|.+|..... ..++..++..++.++++.|+.||+-
T Consensus 98 i~G~~l~~~~~-----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (304)
T 3sg8_A 98 IKGVPLTPLLL-----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKK 172 (304)
T ss_dssp CCCEECCHHHH-----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHH
T ss_pred cCCeECCcccc-----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHH
Confidence 99988875432 1366777888888999988888861
Q ss_pred ----------------cCCceEecCCCCCCEEECC--CCCEEEEeecCceeccCCCCCcccccccCCcc---cCcccccC
Q 005940 473 ----------------WEQVVIHRDVKPSNALIDA--EMNARLGDFGLARLYDHGGMPHTTNVVGTFGY---IAPELTQT 531 (668)
Q Consensus 473 ----------------~~~~ivHrDLkp~NIll~~--~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y---~aPE~~~~ 531 (668)
....++|+|++|.||++++ ...+.|.||+.+...+... + ......+ ..|+....
T Consensus 173 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~--D---l~~~~~~~~~~~~~~~~~ 247 (304)
T 3sg8_A 173 VDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDN--D---FISLMEDDEEYGMEFVSK 247 (304)
T ss_dssp HHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTH--H---HHTTCCTTTSCCHHHHHH
T ss_pred HHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHH--H---HHHHHhhccccCHHHHHH
Confidence 0246899999999999998 4567899999987643210 0 0000111 12221110
Q ss_pred -----C---------CCCcchhHHHHHHHHHHHHhCCCCC
Q 005940 532 -----G---------KASTSSDVFAYGILLLEVATGRRPI 557 (668)
Q Consensus 532 -----~---------~~~~~sDV~S~Gvvl~elltG~~p~ 557 (668)
+ +.....+.|+++.++|++.+|..++
T Consensus 248 ~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 248 ILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 0 1122368999999999999998765
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.41 E-value=1.7e-06 Score=87.37 Aligned_cols=137 Identities=21% Similarity=0.194 Sum_probs=101.3
Q ss_pred eeeeecCcE-EEEEEEeCCCCcEEEEEEEecCCchhHHHHHHHHHHHhccc-ccCceeEeeeecccCceEEEEEecCCCC
Q 005940 359 EVIGIGGFG-SVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLR-HKNLVNLHGWCKQKNDLLLVYEYIPNGS 436 (668)
Q Consensus 359 ~~lG~G~~g-~Vy~~~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~lV~E~~~~gs 436 (668)
+.+..|..| .||+......+..+++|+-... ...++..|.+.|+.|. +--+.++++++.+.+..++|||++++.+
T Consensus 30 ~~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~ 106 (272)
T 4gkh_A 30 ARDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKT 106 (272)
T ss_dssp EEEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEE
T ss_pred EEccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcc
Confidence 445556555 6999887666778999986543 3456788999998885 3447788999988899999999999988
Q ss_pred hhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhc--------------------------------------------
Q 005940 437 LDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEE-------------------------------------------- 472 (668)
Q Consensus 437 L~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~-------------------------------------------- 472 (668)
+.+.... .......++.+++..|.-||..
T Consensus 107 ~~~~~~~-------~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 179 (272)
T 4gkh_A 107 AFQVLEE-------YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQV 179 (272)
T ss_dssp HHHHHHH-------CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHH
T ss_pred ccccccC-------CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHH
Confidence 8776531 1233455677777777777741
Q ss_pred -----------cCCceEecCCCCCCEEECCCCCEEEEeecCcee
Q 005940 473 -----------WEQVVIHRDVKPSNALIDAEMNARLGDFGLARL 505 (668)
Q Consensus 473 -----------~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~ 505 (668)
....++|+|+++.||+++++..+-|.||+.+..
T Consensus 180 ~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 180 WKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 012379999999999999877677999998753
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.35 E-value=3.8e-06 Score=86.77 Aligned_cols=137 Identities=21% Similarity=0.175 Sum_probs=98.2
Q ss_pred ceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCchhHHHHHHHHHHHhccccc---CceeEeeeec-ccCceEEEEEecC
Q 005940 358 SEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHK---NLVNLHGWCK-QKNDLLLVYEYIP 433 (668)
Q Consensus 358 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~---nIv~l~g~~~-~~~~~~lV~E~~~ 433 (668)
.+.++.|....||+. ++.+++|+-. .......+..|.++|+.|.+. .+.+++.++. ..+..++|||+++
T Consensus 24 v~~l~~G~~n~v~~v-----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~ 96 (306)
T 3tdw_A 24 VESLGEGFRNYAILV-----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQ 96 (306)
T ss_dssp EEEEEECSSEEEEEE-----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCC
T ss_pred eeecCCCcceeEEEE-----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccC
Confidence 567888999999987 4678888843 223456788999999999753 3566777774 4566889999999
Q ss_pred CCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhc-----------------------------------------
Q 005940 434 NGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEE----------------------------------------- 472 (668)
Q Consensus 434 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~----------------------------------------- 472 (668)
|.+|.+.... .++..++..++.++++.|+.||+-
T Consensus 97 G~~l~~~~~~-----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~ 171 (306)
T 3tdw_A 97 GQILGEDGMA-----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDY 171 (306)
T ss_dssp SEECHHHHHT-----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHH
T ss_pred CeECchhhhh-----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHH
Confidence 9888764321 134455556666666666666641
Q ss_pred ----------------cCCceEecCCCCCCEEECC---CCC-EEEEeecCceec
Q 005940 473 ----------------WEQVVIHRDVKPSNALIDA---EMN-ARLGDFGLARLY 506 (668)
Q Consensus 473 ----------------~~~~ivHrDLkp~NIll~~---~~~-~kl~DfGla~~~ 506 (668)
....++|+|+++.||+++. ++. +.|.||+.+..-
T Consensus 172 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g 225 (306)
T 3tdw_A 172 LTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS 225 (306)
T ss_dssp HHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred HHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence 1235799999999999987 455 489999988653
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.15 E-value=5.5e-06 Score=87.32 Aligned_cols=82 Identities=4% Similarity=-0.019 Sum_probs=57.4
Q ss_pred ceee-eecCcEEEEEEEeC--C----CCcEEEEEEEecCC---chhHHHHHHHHHHHhcccc---cCceeEeeeeccc--
Q 005940 358 SEVI-GIGGFGSVYKGVLP--T----TGGEVAVKKITRNS---LQGMREFAAEIESLGRLRH---KNLVNLHGWCKQK-- 422 (668)
Q Consensus 358 ~~~l-G~G~~g~Vy~~~~~--~----~~~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H---~nIv~l~g~~~~~-- 422 (668)
.+.| +.|....+|+.... . +++.+++|+..... ......+..|+++++.|.. -.+.+++.++.+.
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~ 104 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV 104 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence 4667 78888999998763 0 15678888765432 1112456789999988853 3577788888665
Q ss_pred -CceEEEEEecCCCChhh
Q 005940 423 -NDLLLVYEYIPNGSLDT 439 (668)
Q Consensus 423 -~~~~lV~E~~~~gsL~~ 439 (668)
+..++||||+++..+.+
T Consensus 105 ~g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 105 LGTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp TSSCEEEEECCCCBCCCB
T ss_pred cCCceEEEEecCCCChhh
Confidence 45789999999877754
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.98 E-value=3e-05 Score=82.99 Aligned_cols=76 Identities=13% Similarity=0.035 Sum_probs=50.2
Q ss_pred ceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCc-------hhHHHHHHHHHHHhcccc--c-CceeEeeeecccCceEE
Q 005940 358 SEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSL-------QGMREFAAEIESLGRLRH--K-NLVNLHGWCKQKNDLLL 427 (668)
Q Consensus 358 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-------~~~~~f~~Ei~~l~~l~H--~-nIv~l~g~~~~~~~~~l 427 (668)
.+.||.|..+.||++....+++.++||....... ...+.+..|.++++.+.. + .+.+++.+. ....++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d--~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEc--CCccEE
Confidence 5689999999999998755678899998653211 123456778888888742 3 344566543 345689
Q ss_pred EEEecCCC
Q 005940 428 VYEYIPNG 435 (668)
Q Consensus 428 V~E~~~~g 435 (668)
|||++++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999763
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.85 E-value=4.4e-05 Score=79.51 Aligned_cols=141 Identities=18% Similarity=0.219 Sum_probs=82.1
Q ss_pred ceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCchhHHHHHHHHHHHhccccc--CceeEeee------ecccCceEEEE
Q 005940 358 SEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHK--NLVNLHGW------CKQKNDLLLVY 429 (668)
Q Consensus 358 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~--nIv~l~g~------~~~~~~~~lV~ 429 (668)
.+.|+.|..+.||+.... ++.+++|+.... ..++..|.++++.|... .+.+++.. ....+..+++|
T Consensus 37 ~~~l~gG~~n~~~~v~~~--~~~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~ 110 (346)
T 2q83_A 37 IDVIQGNQMALVWKVHTD--SGAVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVY 110 (346)
T ss_dssp EEECC----CEEEEEEET--TEEEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEE
T ss_pred eeeccccccCcEEEEEeC--CCCEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEE
Confidence 345666678899998873 456999998752 13344566666666421 23444431 12356688999
Q ss_pred EecCCCChhh--------------hhcC---CC--C-C-----CCccHHHHH----------------------------
Q 005940 430 EYIPNGSLDT--------------LLFK---PK--D-G-----SVLDWEQRF---------------------------- 456 (668)
Q Consensus 430 E~~~~gsL~~--------------~l~~---~~--~-~-----~~l~~~~~~---------------------------- 456 (668)
||+++..+.. .++. .. . . ....|...+
T Consensus 111 ~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 190 (346)
T 2q83_A 111 DWIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQ 190 (346)
T ss_dssp ECCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHH
T ss_pred EeecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHH
Confidence 9999876530 1111 00 0 0 012232211
Q ss_pred ---HHHHHHHHHHHHhhh----------ccCCceEecCCCCCCEEECCCCCEEEEeecCce
Q 005940 457 ---NIVKGIASGLLYLHE----------EWEQVVIHRDVKPSNALIDAEMNARLGDFGLAR 504 (668)
Q Consensus 457 ---~i~~qia~gL~yLH~----------~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~ 504 (668)
.+..++..++.+|+. .....++|+|+++.||+++.++.+.|.||+.+.
T Consensus 191 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 191 EIDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 111223445666653 135789999999999999888899999999775
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.67 E-value=0.00026 Score=73.09 Aligned_cols=140 Identities=17% Similarity=0.118 Sum_probs=94.0
Q ss_pred ccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCchhHHHHHHHHHHHhccc---ccCceeEeeeecccCceEEEEEec
Q 005940 356 KESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLR---HKNLVNLHGWCKQKNDLLLVYEYI 432 (668)
Q Consensus 356 ~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~---H~nIv~l~g~~~~~~~~~lV~E~~ 432 (668)
...+.|+.|....+|+... +++.+++|+.... ....+..|.+.|+.|. ...+.++++++...+..++||||+
T Consensus 39 ~~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l 113 (312)
T 3jr1_A 39 KHKEKLYSGEMNEIWLIND--EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEAL 113 (312)
T ss_dssp CEEEEECCSSSSEEEEEES--SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECC
T ss_pred eeeEEeCCccceeeeEEEE--CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEec
Confidence 3457799999999999986 4678999987643 3567889999999885 256888999988888899999999
Q ss_pred CCCChhh-----------hhcCCCCCC-------------------CccHHHHH---HHHH----------------HHH
Q 005940 433 PNGSLDT-----------LLFKPKDGS-------------------VLDWEQRF---NIVK----------------GIA 463 (668)
Q Consensus 433 ~~gsL~~-----------~l~~~~~~~-------------------~l~~~~~~---~i~~----------------qia 463 (668)
++..+.. .|+...... .-+|...+ ++.. +++
T Consensus 114 ~G~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~ 193 (312)
T 3jr1_A 114 NKSKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIV 193 (312)
T ss_dssp CCCCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHH
T ss_pred cCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHH
Confidence 9886531 122211100 11354321 1111 111
Q ss_pred HHH-HHhhh-ccCCceEecCCCCCCEEECCCCCEEEEeec
Q 005940 464 SGL-LYLHE-EWEQVVIHRDVKPSNALIDAEMNARLGDFG 501 (668)
Q Consensus 464 ~gL-~yLH~-~~~~~ivHrDLkp~NIll~~~~~~kl~DfG 501 (668)
..+ ..|.. ...+.++|+|+.+.|++++.++ +.|.|+.
T Consensus 194 ~~l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 194 QIVADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 111 23321 2247899999999999999887 8888873
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.66 E-value=0.00027 Score=71.95 Aligned_cols=80 Identities=20% Similarity=0.225 Sum_probs=59.1
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCchhHHHHHHHHHHHhcccc---cCceeEeeeecccCceEEEE
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRH---KNLVNLHGWCKQKNDLLLVY 429 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H---~nIv~l~g~~~~~~~~~lV~ 429 (668)
......+.+|.|..+.||+.+.. +|+.+.+|+...........|..|.+.|+.|.- --+.+++++. ..++||
T Consensus 15 ~~v~~v~~~g~G~~~~vyrv~l~-DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~ 89 (288)
T 3f7w_A 15 REVAAVAERGHSHRWHLYRVELA-DGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAM 89 (288)
T ss_dssp CCEEEEEEEEEETTEEEEEEEET-TSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEE
T ss_pred CCeEEEEecCCCCCeEEEEEEEC-CCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEE
Confidence 34556788999999999999984 688999998765544444568889999988842 2355566653 347899
Q ss_pred EecCCCCh
Q 005940 430 EYIPNGSL 437 (668)
Q Consensus 430 E~~~~gsL 437 (668)
||++.+..
T Consensus 90 e~l~~~~~ 97 (288)
T 3f7w_A 90 EWVDERPP 97 (288)
T ss_dssp ECCCCCCC
T ss_pred EeecccCC
Confidence 99987654
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.39 E-value=0.0006 Score=73.45 Aligned_cols=78 Identities=12% Similarity=0.089 Sum_probs=49.2
Q ss_pred CCceEecCCCCCCEEECCCCCEEEEeecCceeccCCCCCcccccc--cCCcccCcccccCC---CCCcchhHHHHHHHHH
Q 005940 474 EQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVV--GTFGYIAPELTQTG---KASTSSDVFAYGILLL 548 (668)
Q Consensus 474 ~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~--gt~~y~aPE~~~~~---~~~~~sDV~S~Gvvl~ 548 (668)
...++|+|++|.||+++.+. +++.||+.+..-.... +..... -...|++|+..... ......++......+|
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~--Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGF--DIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTW 307 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHH--HHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHH--HHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHH
Confidence 48899999999999998876 9999999887543210 000000 01346666654321 1223456667788888
Q ss_pred HHHhCC
Q 005940 549 EVATGR 554 (668)
Q Consensus 549 elltG~ 554 (668)
+.++++
T Consensus 308 ~~y~~~ 313 (420)
T 2pyw_A 308 NLFNKR 313 (420)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 777653
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.20 E-value=0.0017 Score=66.89 Aligned_cols=157 Identities=14% Similarity=0.066 Sum_probs=87.0
Q ss_pred chhhHHHHhcCccc-----ceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCchhHHHHHHHHHHHhcccccC--ceeEe
Q 005940 344 RYKDLYAATKGFKE-----SEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKN--LVNLH 416 (668)
Q Consensus 344 ~~~el~~at~~f~~-----~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~n--Iv~l~ 416 (668)
+.+++...-..|.. .+.|+.|....+|+.... ++.+++|+..... ..+++..|++++..|.... +.+++
T Consensus 8 ~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~--~g~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP~~~ 83 (322)
T 2ppq_A 8 TEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTT--KDPLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPL 83 (322)
T ss_dssp CHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEES--SCCEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred CHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeC--CccEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCCccc
Confidence 33444444444433 345667888899999873 3478899886521 1234556788887775323 23333
Q ss_pred eee------cccCceEEEEEecCCCChhhh--------------hcC---C--CCC----CCccHHHHHHH---------
Q 005940 417 GWC------KQKNDLLLVYEYIPNGSLDTL--------------LFK---P--KDG----SVLDWEQRFNI--------- 458 (668)
Q Consensus 417 g~~------~~~~~~~lV~E~~~~gsL~~~--------------l~~---~--~~~----~~l~~~~~~~i--------- 458 (668)
... ...+..+++++|+++..+... ++. . ... ....|...+.-
T Consensus 84 ~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~ 163 (322)
T 2ppq_A 84 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE 163 (322)
T ss_dssp CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred CCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhh
Confidence 221 123557899999998654210 111 0 000 11234331110
Q ss_pred ---HHHHHHHHHHhhhc----cCCceEecCCCCCCEEECCCCCEEEEeecCce
Q 005940 459 ---VKGIASGLLYLHEE----WEQVVIHRDVKPSNALIDAEMNARLGDFGLAR 504 (668)
Q Consensus 459 ---~~qia~gL~yLH~~----~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~ 504 (668)
...+...+..++.. ...+++|+|+++.||+++++..+.|.||+.+.
T Consensus 164 ~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 164 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 11244455555532 23679999999999999887556899998775
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.01 E-value=0.0025 Score=65.05 Aligned_cols=140 Identities=12% Similarity=0.042 Sum_probs=78.3
Q ss_pred cceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCchhHHHHHHHHHHHhcccccCc-eeEeeeecccCceEEEEEec-CC
Q 005940 357 ESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNL-VNLHGWCKQKNDLLLVYEYI-PN 434 (668)
Q Consensus 357 ~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nI-v~l~g~~~~~~~~~lV~E~~-~~ 434 (668)
..+.|+.|....+|+. +.+++|+....... ......|+.+++.+....+ .++++.+.+ .-++++||+ ++
T Consensus 22 ~i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~~~~--~~~~v~e~i~~g 92 (301)
T 3dxq_A 22 GPLERLGGLTNLVFRA------GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHVDPA--TGVMVTRYIAGA 92 (301)
T ss_dssp SCEEEESCSSEEEEEE------TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEECTT--TCCEEEECCTTC
T ss_pred ceeEcCCcccccccee------eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEEECC--CCEEEEeecCCC
Confidence 3688999999999998 45888987653221 1123468888887753333 456665433 347899999 66
Q ss_pred CChhhh------------------hcCCCCC--CCcc-HHHHHHHHHH--------------HHHHHH----Hhh-hccC
Q 005940 435 GSLDTL------------------LFKPKDG--SVLD-WEQRFNIVKG--------------IASGLL----YLH-EEWE 474 (668)
Q Consensus 435 gsL~~~------------------l~~~~~~--~~l~-~~~~~~i~~q--------------ia~gL~----yLH-~~~~ 474 (668)
.+|... +|..... .... +.....+... +...+. .|. ....
T Consensus 93 ~~l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~ 172 (301)
T 3dxq_A 93 QTMSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLP 172 (301)
T ss_dssp EECCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCC
T ss_pred ccCCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCC
Confidence 555320 1111100 0001 1111111110 111111 111 1123
Q ss_pred CceEecCCCCCCEEECCCCCEEEEeecCceec
Q 005940 475 QVVIHRDVKPSNALIDAEMNARLGDFGLARLY 506 (668)
Q Consensus 475 ~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~ 506 (668)
..++|+|+.+.||+ ..++.+.+.||..+..-
T Consensus 173 ~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~g 203 (301)
T 3dxq_A 173 LAACHCDPLCENFL-DTGERMWIVDWEYSGMN 203 (301)
T ss_dssp CEEECSCCCGGGEE-ECSSCEEECCCTTCEEE
T ss_pred ceeeccCCCcCCEE-ECCCCEEEEecccccCC
Confidence 56899999999999 56677899999987643
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.84 E-value=0.0039 Score=65.99 Aligned_cols=143 Identities=20% Similarity=0.168 Sum_probs=86.6
Q ss_pred ceeeeecCcEEEEEEEeCC-------CCcEEEEEEEecCCchhHHHHHHHHHHHhcccc-cCceeEeeeecccCceEEEE
Q 005940 358 SEVIGIGGFGSVYKGVLPT-------TGGEVAVKKITRNSLQGMREFAAEIESLGRLRH-KNLVNLHGWCKQKNDLLLVY 429 (668)
Q Consensus 358 ~~~lG~G~~g~Vy~~~~~~-------~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H-~nIv~l~g~~~~~~~~~lV~ 429 (668)
.+.|..|-...+|+..... +++.+++|+.... ........+|.++++.|.- .--.++++.+.+. +||
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~g----~v~ 129 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPEG----RLE 129 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETTE----EEE
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCCc----cEE
Confidence 4567777778899988742 3468999986332 2334566789999988853 2235677777542 899
Q ss_pred EecCCCChhhh-----------------hcCCC--CCCCc--cHHHHHHHHHHHHH-------------------HHHHh
Q 005940 430 EYIPNGSLDTL-----------------LFKPK--DGSVL--DWEQRFNIVKGIAS-------------------GLLYL 469 (668)
Q Consensus 430 E~~~~gsL~~~-----------------l~~~~--~~~~l--~~~~~~~i~~qia~-------------------gL~yL 469 (668)
||+++.+|..- |+... -.+.. -|.++.++..++.. .+..|
T Consensus 130 e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L 209 (379)
T 3feg_A 130 QYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNL 209 (379)
T ss_dssp ECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHH
T ss_pred EEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHH
Confidence 99998665421 11110 01112 34555555544422 23333
Q ss_pred hh-----ccCCceEecCCCCCCEEECCC----CCEEEEeecCcee
Q 005940 470 HE-----EWEQVVIHRDVKPSNALIDAE----MNARLGDFGLARL 505 (668)
Q Consensus 470 H~-----~~~~~ivHrDLkp~NIll~~~----~~~kl~DfGla~~ 505 (668)
.+ .....++|+|+.+.||+++.+ +.+.+.||..+..
T Consensus 210 ~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 210 RKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 22 123579999999999999876 6899999998763
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.84 E-value=0.0053 Score=66.20 Aligned_cols=74 Identities=20% Similarity=0.160 Sum_probs=51.8
Q ss_pred ceeeeecCcEEEEEEEeCC-------CCcEEEEEEEecCCchhHHHHHHHHHHHhcccccCc-eeEeeeecccCceEEEE
Q 005940 358 SEVIGIGGFGSVYKGVLPT-------TGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNL-VNLHGWCKQKNDLLLVY 429 (668)
Q Consensus 358 ~~~lG~G~~g~Vy~~~~~~-------~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nI-v~l~g~~~~~~~~~lV~ 429 (668)
.+.|+.|-...+|+..... .+..+++|+..... ..+.+..|..+++.|...++ .++++.+.+ .+|+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~--~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~ 151 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 151 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC--cHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence 4678888889999998753 25789999884421 12455679999998864444 567776653 2899
Q ss_pred EecCCCCh
Q 005940 430 EYIPNGSL 437 (668)
Q Consensus 430 E~~~~gsL 437 (668)
||+++.+|
T Consensus 152 e~l~G~~l 159 (429)
T 1nw1_A 152 EYIPSRPL 159 (429)
T ss_dssp CCCCEEEC
T ss_pred EEeCCccc
Confidence 99986444
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.83 E-value=0.0044 Score=67.35 Aligned_cols=75 Identities=12% Similarity=-0.007 Sum_probs=49.3
Q ss_pred ceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCchhHHHHHHHHHHHhcccccCc-eeEeeeecccCceEEEEEecCCCC
Q 005940 358 SEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNL-VNLHGWCKQKNDLLLVYEYIPNGS 436 (668)
Q Consensus 358 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nI-v~l~g~~~~~~~~~lV~E~~~~gs 436 (668)
.+.|+.|-...+|+......+..+++|+........ -+...|..++..|...++ .++++.+.. .+||||+++.+
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~-idR~~E~~vl~~L~~~gl~P~ll~~~~~----G~v~e~I~G~~ 187 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEI-INREREKKISCILYNKNIAKKIYVFFTN----GRIEEFMDGYA 187 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSC-SCHHHHHHHHHHHTTSSSBCCEEEEETT----EEEEECCCSEE
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhh-cCHHHHHHHHHHHHhcCCCCCEEEEeCC----eEEEEeeCCcc
Confidence 567888888999999885434788899875432211 112478888988865444 567777742 25999998755
Q ss_pred h
Q 005940 437 L 437 (668)
Q Consensus 437 L 437 (668)
|
T Consensus 188 l 188 (458)
T 2qg7_A 188 L 188 (458)
T ss_dssp C
T ss_pred C
Confidence 5
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.69 E-value=0.0076 Score=62.36 Aligned_cols=143 Identities=17% Similarity=0.119 Sum_probs=73.4
Q ss_pred ceeeeecCcEE-EEEEEeCCCCcEEEEEEEecCCchhHHHHHHHHHHHhccccc--CceeEeeeecccCceEEEEEecCC
Q 005940 358 SEVIGIGGFGS-VYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHK--NLVNLHGWCKQKNDLLLVYEYIPN 434 (668)
Q Consensus 358 ~~~lG~G~~g~-Vy~~~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~--nIv~l~g~~~~~~~~~lV~E~~~~ 434 (668)
.+.|+.|+... +|+.... +++.+++|....... .++..|+++++.|... .+.+++.++.+.+ +++||++.+
T Consensus 23 ~~~l~gg~s~~~~~r~~~~-~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~ 96 (333)
T 3csv_A 23 RTPLAGDASSRRYQRLRSP-TGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGD 96 (333)
T ss_dssp ECC--------CCEEEECT-TCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCS
T ss_pred eeECCCCCCCceEEEEEcC-CCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCC
Confidence 34565555554 6677642 256777776543221 2334567777776532 3556777654443 789999977
Q ss_pred CChhhhhcC---------------------CCCC--CCccHHHHH-------H-------------HHHHHHHHHHHhh-
Q 005940 435 GSLDTLLFK---------------------PKDG--SVLDWEQRF-------N-------------IVKGIASGLLYLH- 470 (668)
Q Consensus 435 gsL~~~l~~---------------------~~~~--~~l~~~~~~-------~-------------i~~qia~gL~yLH- 470 (668)
..+.+.+.. .... ..++..... . ....+...+..|.
T Consensus 97 ~~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~ 176 (333)
T 3csv_A 97 ALFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILS 176 (333)
T ss_dssp CBHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHH
T ss_pred cchHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHH
Confidence 666443311 0000 011110000 0 0011111222221
Q ss_pred --hccCCceEecCCCCCCEEECCC----CCEEEEeecCceec
Q 005940 471 --EEWEQVVIHRDVKPSNALIDAE----MNARLGDFGLARLY 506 (668)
Q Consensus 471 --~~~~~~ivHrDLkp~NIll~~~----~~~kl~DfGla~~~ 506 (668)
......++|||+.+.||+++.+ ..+.|.||+.+..-
T Consensus 177 ~~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 177 AQLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp HHCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred hcccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 1124689999999999999875 67999999988643
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.64 E-value=0.01 Score=61.15 Aligned_cols=142 Identities=11% Similarity=0.112 Sum_probs=81.0
Q ss_pred eeeeecCcEEEEEEEeCCCCcEEEEEEEecCCchhHHHHHHHHHHHhcccccC--ceeEeee-----ecccCceEEEEEe
Q 005940 359 EVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKN--LVNLHGW-----CKQKNDLLLVYEY 431 (668)
Q Consensus 359 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~n--Iv~l~g~-----~~~~~~~~lV~E~ 431 (668)
..++ |....||+.... +|+.+++|+..... .....+..|..++..|.... +++++.. ....+..+++||+
T Consensus 32 ~~l~-g~~n~~y~v~~~-~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~ 108 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDE-DRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPS 108 (328)
T ss_dssp EEEC-CSSSEEEEECCT-TCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEEC
T ss_pred Eeec-CcccceEEEEcC-CCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEe
Confidence 4566 778899988663 45679999986432 12356667888888875322 3444443 1123456789999
Q ss_pred cCCCChhh-----h---------hcC---CC---CCCCccHHHH----HHH---------------HHHHHHHHHHhhhc
Q 005940 432 IPNGSLDT-----L---------LFK---PK---DGSVLDWEQR----FNI---------------VKGIASGLLYLHEE 472 (668)
Q Consensus 432 ~~~gsL~~-----~---------l~~---~~---~~~~l~~~~~----~~i---------------~~qia~gL~yLH~~ 472 (668)
+++..+.. . ++. .. .....++... ..+ ...+...+..+...
T Consensus 109 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 188 (328)
T 1zyl_A 109 VGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAH 188 (328)
T ss_dssp CCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHH
T ss_pred cCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHH
Confidence 98755421 0 110 00 0111222111 001 11111122222221
Q ss_pred ----cCCceEecCCCCCCEEECCCCCEEEEeecCcee
Q 005940 473 ----WEQVVIHRDVKPSNALIDAEMNARLGDFGLARL 505 (668)
Q Consensus 473 ----~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~ 505 (668)
....++|+|+++.||+++ + .+.|.||+.+..
T Consensus 189 ~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 189 WREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred hhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 246789999999999999 4 899999988754
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.51 E-value=0.0094 Score=62.69 Aligned_cols=75 Identities=12% Similarity=0.042 Sum_probs=45.7
Q ss_pred ceeeeecCcEEEEEEEeCC--------CCcEEEEEEEecCCchhHHHHHHHHHHHhcccccCc-eeEeeeecccCceEEE
Q 005940 358 SEVIGIGGFGSVYKGVLPT--------TGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNL-VNLHGWCKQKNDLLLV 428 (668)
Q Consensus 358 ~~~lG~G~~g~Vy~~~~~~--------~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nI-v~l~g~~~~~~~~~lV 428 (668)
.+.|+.|....+|+..... .++.+++|+...... ...+...|.++++.|...++ .++++... -++|
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~~~~E~~~l~~L~~~g~~P~~~~~~~----~~~v 112 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD-ELYNTISEFEVYKTMSKYKIAPQLLNTFN----GGRI 112 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG-GTSCHHHHHHHHHHHHHTTSSCCEEEEET----TEEE
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc-ceecHHHHHHHHHHHHhcCCCCceEEecC----CcEE
Confidence 4567778888999998742 126788887754322 11233578888888864443 46665542 3689
Q ss_pred EEecCCCCh
Q 005940 429 YEYIPNGSL 437 (668)
Q Consensus 429 ~E~~~~gsL 437 (668)
|||+++..+
T Consensus 113 ~e~i~G~~l 121 (369)
T 3c5i_A 113 EEWLYGDPL 121 (369)
T ss_dssp EECCCSEEC
T ss_pred EEEecCCcC
Confidence 999987544
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=95.93 E-value=0.03 Score=58.16 Aligned_cols=33 Identities=24% Similarity=0.340 Sum_probs=28.8
Q ss_pred CCceEecCCCCCCEEECCCCCEEEEeecCceec
Q 005940 474 EQVVIHRDVKPSNALIDAEMNARLGDFGLARLY 506 (668)
Q Consensus 474 ~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~ 506 (668)
...++|+|+.+.||++++++.+.|.||+.+...
T Consensus 205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~ 237 (339)
T 3i1a_A 205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPMLA 237 (339)
T ss_dssp GCEEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred CceeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence 367999999999999998888999999877643
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=95.21 E-value=0.12 Score=49.58 Aligned_cols=99 Identities=14% Similarity=0.104 Sum_probs=64.9
Q ss_pred CChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCCCCcc
Q 005940 435 GSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHT 514 (668)
Q Consensus 435 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 514 (668)
-||.++|. ..+.++++.++|-++.|.+.+|.-+-.. ..-..+=+.|..|+|..+|++.+.+ ..+.
T Consensus 33 vSL~eIL~--~~~~PlsEEqaWALc~Qc~~~L~~~~~~--~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~---------- 97 (229)
T 2yle_A 33 LSLEEILR--LYNQPINEEQAWAVCYQCCGSLRAAARR--RQPRHRVRSAAQIRVWRDGAVTLAP-AADD---------- 97 (229)
T ss_dssp EEHHHHHH--HHTSCCCHHHHHHHHHHHHHHHHHHHHT--TCCCCCCCSGGGEEEETTSCEEECC-C-------------
T ss_pred ccHHHHHH--HcCCCcCHHHHHHHHHHHHHHHHhhhhc--ccCCceecCCcceEEecCCceeccc-cccc----------
Confidence 47899995 3457899999999999999998776210 1111223456899999999988764 1110
Q ss_pred cccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHh
Q 005940 515 TNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVAT 552 (668)
Q Consensus 515 ~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt 552 (668)
.....+.|||... ...+.+.=|||+|+++|.-+-
T Consensus 98 ---~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALD 131 (229)
T 2yle_A 98 ---AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALD 131 (229)
T ss_dssp ------------CCSS-SSSCHHHHHHHHHHHHHHHHT
T ss_pred ---ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhh
Confidence 1123466888764 356789999999999998876
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=94.65 E-value=0.14 Score=54.85 Aligned_cols=142 Identities=16% Similarity=0.177 Sum_probs=86.1
Q ss_pred ceeeeecCcEEEEEEEeCCC-------CcEEEEEEEecCCchhHHHHHHHHHHHhcccccC-ceeEeeeecccCceEEEE
Q 005940 358 SEVIGIGGFGSVYKGVLPTT-------GGEVAVKKITRNSLQGMREFAAEIESLGRLRHKN-LVNLHGWCKQKNDLLLVY 429 (668)
Q Consensus 358 ~~~lG~G~~g~Vy~~~~~~~-------~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~n-Iv~l~g~~~~~~~~~lV~ 429 (668)
.+.+..|-...+|+...... +..+++|+....... .-+..+|.++++.|.-.+ ..++++.+. -++||
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~-~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~ 149 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGK-FYDSKVELDVFRYLSNINIAPNIIADFP----EGRIE 149 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-C-CCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcch-hcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEE
Confidence 45677788889999987421 578999886543221 122357888888885333 345665443 27899
Q ss_pred EecCCCChhhh-----------------hcC--------CC--CCCCccHHHHHHHHHHHH-------------------
Q 005940 430 EYIPNGSLDTL-----------------LFK--------PK--DGSVLDWEQRFNIVKGIA------------------- 463 (668)
Q Consensus 430 E~~~~gsL~~~-----------------l~~--------~~--~~~~l~~~~~~~i~~qia------------------- 463 (668)
||+++..|..- |+. .. .+.+.-|.++.++..++-
T Consensus 150 efI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~ 229 (424)
T 3mes_A 150 EFIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKIL 229 (424)
T ss_dssp ECCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHHH
T ss_pred EEeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHHH
Confidence 99998664210 110 00 112223555444443322
Q ss_pred HHHHHhhh---------------------ccCCceEecCCCCCCEEECCCCCEEEEeecCcee
Q 005940 464 SGLLYLHE---------------------EWEQVVIHRDVKPSNALIDAEMNARLGDFGLARL 505 (668)
Q Consensus 464 ~gL~yLH~---------------------~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~ 505 (668)
..+..|.+ .....++|+|+.+.||+ +.++.+.+.||..+..
T Consensus 230 ~e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~ 291 (424)
T 3mes_A 230 EEIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI 291 (424)
T ss_dssp HHHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred HHHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence 22333321 11356899999999999 7888999999998864
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=92.13 E-value=0.87 Score=48.16 Aligned_cols=30 Identities=27% Similarity=0.385 Sum_probs=25.2
Q ss_pred ceEecCCCCCCEEE------CCCCCEEEEeecCcee
Q 005940 476 VVIHRDVKPSNALI------DAEMNARLGDFGLARL 505 (668)
Q Consensus 476 ~ivHrDLkp~NIll------~~~~~~kl~DfGla~~ 505 (668)
.++|+|+.+.||++ +++..+++.||.+|..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 46899999999999 4567799999998764
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=82.66 E-value=4 Score=38.89 Aligned_cols=115 Identities=10% Similarity=0.138 Sum_probs=78.4
Q ss_pred cccCceeEeeeecccCceEEEEEecCC-CChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCC
Q 005940 408 RHKNLVNLHGWCKQKNDLLLVYEYIPN-GSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSN 486 (668)
Q Consensus 408 ~H~nIv~l~g~~~~~~~~~lV~E~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~N 486 (668)
.||+++.. .+-...+...+.|+.-+. -++.. + ..++...+++++.+|+....+++. -+|--|+|+|
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-i------k~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P~N 109 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-I------KSFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAPDE 109 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-G------GGSCHHHHHHHHHHGGGGGGGGGS-----SEECCCSGGG
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHH-H------HhcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEecce
Confidence 58888876 455555666666665432 22322 2 237788999999999988766664 4677899999
Q ss_pred EEECCCCCEEEEeecCceeccCCCCCcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 005940 487 ALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIG 558 (668)
Q Consensus 487 Ill~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~ 558 (668)
|+++.++.+++.-.|+-.. ++|. ..+...=.-.+=|++..+++++..|+
T Consensus 110 L~f~~~~~p~i~~RGik~~------------------l~P~-----~~~ee~fL~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 110 LFFTRDGLPIAKTRGLQNV------------------VDPL-----PVSEAEFLTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp EEECTTSCEEESCCEETTT------------------BSCC-----CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred EEEcCCCCEEEEEccCccC------------------CCCC-----CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 9999999999977665321 2222 22333334578889999999998874
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 668 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-64 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 6e-64 | |
| d1g9fa_ | 251 | b.29.1.1 (A:) Legume lectin {Soybean (Glycine max) | 5e-63 | |
| d1qnwa_ | 237 | b.29.1.1 (A:) Legume lectin {Furze (Ulex europaeus | 1e-62 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 3e-62 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 3e-61 | |
| d1gzca_ | 239 | b.29.1.1 (A:) Legume lectin {Cockspur coral tree ( | 1e-60 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 1e-60 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-60 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 6e-60 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-59 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 1e-58 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-58 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-58 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 3e-58 | |
| d1g8wa_ | 233 | b.29.1.1 (A:) Phytohemagglutinin-L, PHA-L, also ar | 5e-58 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-57 | |
| d1f9ka_ | 234 | b.29.1.1 (A:) Legume lectin {Winged bean (Psophoca | 3e-57 | |
| d1fx5a_ | 240 | b.29.1.1 (A:) Legume lectin {Furze (Ulex europaeus | 5e-57 | |
| d1n47a_ | 233 | b.29.1.1 (A:) Legume lectin {Hairy vetch (Vicia vi | 5e-57 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 7e-57 | |
| d1hqla_ | 236 | b.29.1.1 (A:) Legume lectin {Griffonia simplicifol | 1e-56 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 1e-56 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 1e-56 | |
| d1dbna_ | 239 | b.29.1.1 (A:) Legume lectin {Maackia amurensis, le | 1e-56 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-56 | |
| d1avba_ | 226 | b.29.1.1 (A:) Phytohemagglutinin-L, PHA-L, also ar | 2e-56 | |
| d1g7ya_ | 253 | b.29.1.1 (A:) Legume lectin {Horse gram (Dolichos | 2e-56 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 7e-56 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 7e-56 | |
| d1v6ia_ | 232 | b.29.1.1 (A:) Legume lectin {Peanut (Arachis hypog | 9e-56 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-55 | |
| d2d3sa1 | 237 | b.29.1.1 (A:1-237) Legume lectin {Winged bean (Pso | 1e-55 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 3e-55 | |
| g2ltn.1 | 229 | b.29.1.1 (A:,B:) Legume lectin {Garden pea (Pisum | 6e-55 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 6e-55 | |
| d1fnya_ | 237 | b.29.1.1 (A:) Legume lectin {Black locust (Robinia | 3e-54 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 4e-54 | |
| d1ukga_ | 241 | b.29.1.1 (A:) Legume lectin {Bloodwood tree (Ptero | 5e-54 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 8e-54 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 1e-53 | |
| g1qmo.1 | 230 | b.29.1.1 (A:,E:) Legume lectin {Field bean (Dolich | 1e-53 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-53 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 8e-53 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-52 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-52 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-52 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-52 | |
| d1leda_ | 243 | b.29.1.1 (A:) Legume lectin {West-central african | 2e-52 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-50 | |
| d1ioaa_ | 228 | b.29.1.1 (A:) Phytohemagglutinin-L, PHA-L, also ar | 1e-50 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-49 | |
| d1dhkb_ | 204 | b.29.1.1 (B:) Phytohemagglutinin-L, PHA-L, also ar | 6e-48 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 7e-48 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 4e-47 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 6e-47 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-46 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 5e-46 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 4e-45 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-44 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-44 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 8e-44 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-43 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-43 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 3e-43 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-42 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-42 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-41 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 3e-41 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 9e-40 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 9e-40 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 1e-39 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-39 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 3e-39 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-38 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 4e-37 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 5e-37 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-34 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 4e-34 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 5e-34 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-32 | |
| d1nlsa_ | 237 | b.29.1.1 (A:) Concanavalin A {Jack bean (Canavalia | 1e-30 | |
| d1nlsa_ | 237 | b.29.1.1 (A:) Concanavalin A {Jack bean (Canavalia | 5e-25 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 7e-28 | |
| d1gv9a_ | 228 | b.29.1.13 (A:) Carbohydrate-recognition domain of | 5e-24 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 4e-21 | |
| d2a6va1 | 218 | b.29.1.13 (A:9-226) Emp46p N-terminal domain {Bake | 1e-09 | |
| d2a6za1 | 221 | b.29.1.13 (A:7-227) Emp47p N-terminal domain {Bake | 3e-08 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 212 bits (540), Expect = 2e-64
Identities = 73/295 (24%), Positives = 127/295 (43%), Gaps = 34/295 (11%)
Query: 333 EDWEKDCPHRFRYKDLYAATKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKI--TRNS 390
+DWE + + IG G FG+VYKG G+VAVK + T +
Sbjct: 1 DDWEIP-DGQITVG------------QRIGSGSFGTVYKGKW---HGDVAVKMLNVTAPT 44
Query: 391 LQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVL 450
Q ++ F E+ L + RH N++ G+ L +V ++ SL L + +
Sbjct: 45 PQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQWCEGSSLYHHLHIIE--TKF 101
Query: 451 DWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGG 510
+ + +I + A G+ YLH + +IHRD+K +N + ++ ++GDFGLA +
Sbjct: 102 EMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWS 158
Query: 511 MPH-TTNVVGTFGYIAPELTQT---GKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVE 566
H + G+ ++APE+ + S SDV+A+GI+L E+ TG+ P + +
Sbjct: 159 GSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINN---R 215
Query: 567 WVRECHQLGRILDVADPLLNSSYVVKEMELVLKLGLMCSHKTQFRPTMRQVMRYL 621
L + S+ L+ + K RP Q++ +
Sbjct: 216 DQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAE---CLKKKRDERPLFPQILASI 267
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 212 bits (541), Expect = 6e-64
Identities = 62/226 (27%), Positives = 104/226 (46%), Gaps = 9/226 (3%)
Query: 355 FKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMRE-FAAEIESLGRLRHKNLV 413
F++ +G G G V+K +G +A K I +R E++ L +V
Sbjct: 8 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 67
Query: 414 NLHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEW 473
+G ++ + E++ GSLD +L K + + + + GL YL E+
Sbjct: 68 GFYGAFYSDGEISICMEHMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLREK- 123
Query: 474 EQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPELTQTGK 533
++HRDVKPSN L+++ +L DFG++ + VGT Y++PE Q
Sbjct: 124 -HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANSFVGTRSYMSPERLQGTH 179
Query: 534 ASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILD 579
S SD+++ G+ L+E+A GR PI D +E + C G +
Sbjct: 180 YSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAE 225
|
| >d1g9fa_ b.29.1.1 (A:) Legume lectin {Soybean (Glycine max) [TaxId: 3847]} Length = 251 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Soybean (Glycine max) [TaxId: 3847]
Score = 207 bits (528), Expect = 5e-63
Identities = 71/270 (26%), Positives = 117/270 (43%), Gaps = 33/270 (12%)
Query: 25 SQSSSFIFQGFNGGATNLSLQGAEIIKPSGALKLTNRSR------YVIGHAFYVKPIQMF 78
+++ SF + F N+ LQG I+ SG L+L +G A Y PI ++
Sbjct: 1 AETVSFSWNKFVPKQPNMILQGDAIVTSSGKLQLNKVDENGTPKPSSLGRALYSTPIHIW 60
Query: 79 DTSASPSPNASSFSTTFVFEISTPRSGRGGHGLAFLLAPSTKLPGAQPEHYLGILNSTNN 138
D + + +SF+ +F F P + R GLAF LAP +P+ + G L N
Sbjct: 61 D---KETGSVASFAASFNFTFYAPDTKRLADGLAFFLAPI----DTKPQTHAGYLGLFNE 113
Query: 139 GEPSNHILIVEFDTVNGFNDKAENQGNHVGIGINTMFSNRSEPASYYINGTDHKEEMTLE 198
E + ++ VEFDT D H+GI +N++ S ++ L
Sbjct: 114 NESGDQVVAVEFDTFRNSWDP---PNPHIGINVNSIRSIKTTS-------------WDLA 157
Query: 199 SGEPIQAWIEYDGEQKVLNVTISPAEIGKPMRPLISFGVNLTGYIKETMYVGFSASTGE- 257
+ + + I YD +L ++ + ++S V+L + E + +GFSA+TG
Sbjct: 158 NNKVAKVLITYDASTSLLVASLVYP--SQRTSNILSDVVDLKTSLPEWVRIGFSAATGLD 215
Query: 258 -KSSSHYILGWSFSLNGVAPALNVSELPKP 286
SH +L WSF+ N + N+ L
Sbjct: 216 IPGESHDVLSWSFASNLPHASSNIDPLDLT 245
|
| >d1qnwa_ b.29.1.1 (A:) Legume lectin {Furze (Ulex europaeus), UEA-II [TaxId: 3902]} Length = 237 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Furze (Ulex europaeus), UEA-II [TaxId: 3902]
Score = 206 bits (524), Expect = 1e-62
Identities = 70/254 (27%), Positives = 112/254 (44%), Gaps = 25/254 (9%)
Query: 25 SQSSSFIFQGFNGGATNLSLQGAEIIKPSGALKLTNRSRYV---IGHAFYVKPIQMFDTS 81
S SF F F N+ QG + +G L++T S+ IG A Y PIQ++D
Sbjct: 1 SDDLSFNFDKFVPNQKNIIFQGDASVSTTGVLQVTKVSKPTTTSIGRALYAAPIQIWD-- 58
Query: 82 ASPSPNASSFSTTFVFEISTPRSGRGGHGLAFLLAPSTKLPGAQPEHYLGILNSTNNGEP 141
S + +SF+T+F F + +S LAF LAP+ + + L S+++ +
Sbjct: 59 -SITGKVASFATSFSFVVKADKSDGVDG-LAFFLAPANSQIPSGSSAGMFGLFSSSDSKS 116
Query: 142 SNHILIVEFDTV-NGFNDKAENQGNHVGIGINTMFSNRSEPASYYINGTDHKEEMTLESG 200
SN I+ VEFDT + + H+GI +N++ S ++ + +G
Sbjct: 117 SNQIIAVEFDTYFGKAYNPWDPDFKHIGIDVNSIKSIKTVKWDWR-------------NG 163
Query: 201 EPIQAWIEYDGEQKVLNVTISPAEIGKPMRPLISFGVNLTGYIKETMYVGFSASTGEKS- 259
E I Y K L V +S +I+ V+L + E + VGFS G +
Sbjct: 164 EVADVVITYRAPTKSLTVCLSY--PSDGTSNIITASVDLKAILPEWVSVGFSGGVGNAAE 221
Query: 260 -SSHYILGWSFSLN 272
+H +L W F+ N
Sbjct: 222 FETHDVLSWYFTSN 235
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (525), Expect = 3e-62
Identities = 70/289 (24%), Positives = 123/289 (42%), Gaps = 30/289 (10%)
Query: 333 EDWEKDCPHRFRYKDLYAATKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQ 392
++WE + E +G G FG V+ G +VAVK + +
Sbjct: 6 DEWEVP-RETLKLV------------ERLGAGQFGEVWMGYYNG-HTKVAVKSL-KQGSM 50
Query: 393 GMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDW 452
F AE + +L+H+ LV L+ + + ++ EY+ NGSL L P G L
Sbjct: 51 SPDAFLAEANLMKQLQHQRLVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPS-GIKLTI 108
Query: 453 EQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMP 512
+ ++ IA G+ ++ E IHRD++ +N L+ ++ ++ DFGLARL +
Sbjct: 109 NKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT 165
Query: 513 HTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECH 572
+ APE G + SDV+++GILL E+ T R G
Sbjct: 166 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM--------TNP 217
Query: 573 QLGRILDVADPLLNSSYVVKEMELVLKLGLMCSHKTQFRPTMRQVMRYL 621
++ + L+ ++ +E+ +++ L + + RPT + L
Sbjct: 218 EVIQNLERGYRMVRPDNCPEELYQLMR--LCWKERPEDRPTFDYLRSVL 264
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (517), Expect = 3e-61
Identities = 61/268 (22%), Positives = 112/268 (41%), Gaps = 17/268 (6%)
Query: 355 FKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVN 414
+ IG G FG V+ G +VA+K I R +F E E + +L H LV
Sbjct: 7 LTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQ 64
Query: 415 LHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWE 474
L+G C ++ + LV+E++ +G L L + + E + + G+ E
Sbjct: 65 LYGVCLEQAPICLVFEFMEHGCLSDYLRTQRG--LFAAETLLGMCLDVCEGM---AYLEE 119
Query: 475 QVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPELTQTGKA 534
VIHRD+ N L+ ++ DFG+ R +T + +PE+ +
Sbjct: 120 ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRY 179
Query: 535 STSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSYVVKEM 594
S+ SDV+++G+L+ EV + + + + P L S++V
Sbjct: 180 SSKSDVWSFGVLMWEVFSEGKIPYENR----SNSEVVEDISTGFRLYKPRLASTHVY--- 232
Query: 595 ELVLKLGLMCSHKTQFRPTMRQVMRYLS 622
+++ + + RP +++R L+
Sbjct: 233 QIMNH---CWKERPEDRPAFSRLLRQLA 257
|
| >d1gzca_ b.29.1.1 (A:) Legume lectin {Cockspur coral tree (Erythrina crista-galli) [TaxId: 49817]} Length = 239 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Cockspur coral tree (Erythrina crista-galli) [TaxId: 49817]
Score = 200 bits (510), Expect = 1e-60
Identities = 75/259 (28%), Positives = 120/259 (46%), Gaps = 34/259 (13%)
Query: 26 QSSSFIFQGFNGGATNLSLQGAEIIKPSGALKLTNRSR------YVIGHAFYVKPIQMFD 79
++ SF F F G NL+LQGA +I SG L+LT ++ G Y KP+ M+D
Sbjct: 2 ETISFSFSEFEPGNDNLTLQGAALITQSGVLQLTKINQNGMPAWDSTGRTLYTKPVHMWD 61
Query: 80 TSASPSPNASSFSTTFVFEISTPRSGRGG-HGLAFLLAPSTKLPGAQPEHYLGILNSTNN 138
S + +SF T F F I P + GL F + P+ P Q YLG+ N++
Sbjct: 62 ---STTGTVASFETRFSFSIEQPYTRPLPADGLVFFMGPTKSKPA-QGYGYLGVFNNSKQ 117
Query: 139 GEPSNHILIVEFDTV-NGFNDKAENQGNHVGIGINTMFSNRSEPASYYINGTDHKEEMTL 197
S L VEFDT N ++ Q H+GI +N++ S +++P L
Sbjct: 118 D-NSYQTLAVEFDTFSNPWDP---PQVPHIGIDVNSIRSIKTQP-------------FQL 160
Query: 198 ESGEPIQAWIEYDGEQKVLNVTISPAEIGKPMRPLISFGVNLTGYIKETMYVGFSASTG- 256
++G+ I+YD K+L+V + I+ V++ + + + VG S +TG
Sbjct: 161 DNGQVANVVIKYDAPSKILHVVLVYP--SSGAIYTIAEIVDVKQVLPDWVDVGLSGATGA 218
Query: 257 --EKSSSHYILGWSFSLNG 273
+ + +H + WSF +
Sbjct: 219 QRDAAETHDVYSWSFQASL 237
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 202 bits (515), Expect = 1e-60
Identities = 79/306 (25%), Positives = 143/306 (46%), Gaps = 40/306 (13%)
Query: 343 FRYKDLYAATKGFKES---------EVIGIGGFGSVYKGVLPTTGGE---VAVKKITRN- 389
F ++D A + F + +VIG G FG V G L G VA+K +
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 390 SLQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSV 449
+ + R+F +E +G+ H N+++L G + ++++ E++ NGSLD+ F ++
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDS--FLRQNDGQ 124
Query: 450 LDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHG 509
Q +++GIA+G+ YL + +HRD+ N L+++ + ++ DFGL+R +
Sbjct: 125 FTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181
Query: 510 GMPHTTN----VVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVAT-GRRPI-GSGDLL 563
T + APE Q K +++SDV++YGI++ EV + G RP +
Sbjct: 182 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQD 241
Query: 564 LVEWVRECHQLGRILDVADPLLNSSYVVKEMELVLKLGLMCSHKT-QFRPTMRQVMRYLS 622
++ + + ++L +D L +L L C K RP Q++ L
Sbjct: 242 VINAIEQDYRLPPPMDCPSAL-------------HQLMLDCWQKDRNHRPKFGQIVNTL- 287
Query: 623 GEKQLR 628
+K +R
Sbjct: 288 -DKMIR 292
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (513), Expect = 1e-60
Identities = 66/272 (24%), Positives = 120/272 (44%), Gaps = 19/272 (6%)
Query: 355 FKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSL--QGMREFAAEIESLGRLRHKNL 412
++ IG G +G K + G + K++ S+ + +E+ L L+H N+
Sbjct: 6 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI 65
Query: 413 VNLHGWC--KQKNDLLLVYEYIPNGSLDTLLFK-PKDGSVLDWEQRFNIVKGIASGLLYL 469
V + + L +V EY G L +++ K K+ LD E ++ + L
Sbjct: 66 VRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKEC 125
Query: 470 HE--EWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPE 527
H + V+HRD+KP+N +D + N +LGDFGLAR+ +H VGT Y++PE
Sbjct: 126 HRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDT-SFAKAFVGTPYYMSPE 184
Query: 528 LTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNS 587
+ SD+++ G LL E+ P + + G+I + +
Sbjct: 185 QMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS--------QKELAGKIREGKFRRIPY 236
Query: 588 SYVVKEMELVLKLGLMCSHKTQFRPTMRQVMR 619
Y + E++ + M + K RP++ +++
Sbjct: 237 RYSDELNEIITR---MLNLKDYHRPSVEEILE 265
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 201 bits (512), Expect = 6e-60
Identities = 73/274 (26%), Positives = 114/274 (41%), Gaps = 27/274 (9%)
Query: 352 TKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQG---MREFAAEIESLGRLR 408
K F + IG G FG+VY VA+KK++ + Q ++ E+ L +LR
Sbjct: 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73
Query: 409 HKNLVNLHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLY 468
H N + G +++ LV EY + D L K L + + G GL Y
Sbjct: 74 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP---LQEVEIAAVTHGALQGLAY 130
Query: 469 LHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPEL 528
LH +IHRDVK N L+ +LGDFG A + M + VGT ++APE+
Sbjct: 131 LHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASI-----MAPANSFVGTPYWMAPEV 182
Query: 529 TQT---GKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLL 585
G+ DV++ GI +E+A + P+ + + + L I P L
Sbjct: 183 ILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM--------SALYHIAQNESPAL 234
Query: 586 NSSYVVKEMELVLKLGLMCSHKTQFRPTMRQVMR 619
S + + + Q RPT +++
Sbjct: 235 QSGHWSEYFRNFVD--SCLQKIPQDRPTSEVLLK 266
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 199 bits (507), Expect = 1e-59
Identities = 66/283 (23%), Positives = 112/283 (39%), Gaps = 17/283 (6%)
Query: 340 PHRFRYKDLYAATKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAA 399
P Y +G G +G VY+GV VAVK + ++++ + EF
Sbjct: 4 PSSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLK 62
Query: 400 EIESLGRLRHKNLVNLHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIV 459
E + ++H NLV L G C ++ ++ E++ G+L L + + +
Sbjct: 63 EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE-VSAVVLLYMA 121
Query: 460 KGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVG 519
I+S + YL + + IHRD+ N L+ ++ DFGL+RL
Sbjct: 122 TQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF 178
Query: 520 TFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILD 579
+ APE K S SDV+A+G+LL E+AT G L ++ +
Sbjct: 179 PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI-----------DLSQVYE 227
Query: 580 VADPLLNSSYVVKEMELVLKLGLMCSHKT-QFRPTMRQVMRYL 621
+ + E V +L C RP+ ++ +
Sbjct: 228 LLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAF 270
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (500), Expect = 1e-58
Identities = 73/272 (26%), Positives = 119/272 (43%), Gaps = 24/272 (8%)
Query: 355 FKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSL--QGMREFAAEIESLGRLRHKNL 412
K IG G F +VYKG+ T EVA ++ L + F E E L L+H N+
Sbjct: 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNI 70
Query: 413 VNLHGWC----KQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLY 468
V + K K ++LV E + +G+L T L + K V+ + + + I GL +
Sbjct: 71 VRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQF 127
Query: 469 LHEEWEQVVIHRDVKPSNALIDAE-MNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPE 527
LH +IHRD+K N I + ++GD GLA L V+GT ++APE
Sbjct: 128 LHTRTPP-IIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS---FAKAVIGTPEFMAPE 183
Query: 528 LTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNS 587
+ + K S DV+A+G+ +LE+AT P E R+ P
Sbjct: 184 MYE-EKYDESVDVYAFGMCMLEMATSEYPYS-------ECQNAAQIYRRVTSGVKPASFD 235
Query: 588 SYVVKEMELVLKLGLMCSHKTQFRPTMRQVMR 619
+ E++ +++ R +++ ++
Sbjct: 236 KVAIPEVKEIIE--GCIRQNKDERYSIKDLLN 265
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (497), Expect = 2e-58
Identities = 59/270 (21%), Positives = 113/270 (41%), Gaps = 23/270 (8%)
Query: 355 FKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVN 414
+ +G G FG V G +VA+K I S EF E + + L H+ LV
Sbjct: 6 LTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQ 63
Query: 415 LHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWE 474
L+G C ++ + ++ EY+ NG L L + + +Q + K + + YL +
Sbjct: 64 LYGVCTKQRPIFIITEYMANGCLLNYLREMR--HRFQTQQLLEMCKDVCEAMEYLESKQ- 120
Query: 475 QVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPELTQTGKA 534
+HRD+ N L++ + ++ DFGL+R + + PE+ K
Sbjct: 121 --FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKF 178
Query: 535 STSSDVFAYGILLLEVATGRRPI--GSGDLLLVEWVRECHQLGRILDVADPLLNSSYVVK 592
S+ SD++A+G+L+ E+ + + + E + + +L R ++ +
Sbjct: 179 SSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYT------ 232
Query: 593 EMELVLKLGLMCSHKT-QFRPTMRQVMRYL 621
+ C H+ RPT + ++ +
Sbjct: 233 -------IMYSCWHEKADERPTFKILLSNI 255
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (499), Expect = 2e-58
Identities = 67/269 (24%), Positives = 119/269 (44%), Gaps = 21/269 (7%)
Query: 355 FKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVN 414
+ +G G FG V+ G T VA+K + + F E + + +LRH+ LV
Sbjct: 19 LRLEVKLGQGCFGEVWMGTWNGTT-RVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQ 76
Query: 415 LHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWE 474
L+ + + +V EY+ GSL K + G L Q ++ IASG+ Y+
Sbjct: 77 LYAVV-SEEPIYIVTEYMSKGSLL-DFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN- 133
Query: 475 QVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPELTQTGKA 534
+HRD++ +N L+ + ++ DFGLARL + + APE G+
Sbjct: 134 --YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRF 191
Query: 535 STSSDVFAYGILLLEVATGRRPI--GSGDLLLVEWVRECHQLGRILDVADPLLNSSYVVK 592
+ SDV+++GILL E+ T R G + +++ V +++ + + L
Sbjct: 192 TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLH------- 244
Query: 593 EMELVLKLGLMCSHKTQFRPTMRQVMRYL 621
+L+ + + + RPT + +L
Sbjct: 245 --DLMCQ---CWRKEPEERPTFEYLQAFL 268
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (500), Expect = 3e-58
Identities = 73/292 (25%), Positives = 119/292 (40%), Gaps = 35/292 (11%)
Query: 359 EVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNLHGW 418
E IG G FG V++G G EVAVK + + AEI LRH+N++
Sbjct: 9 ESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWF-REAEIYQTVMLRHENILGFIAA 65
Query: 419 CKQKND----LLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEE-- 472
+ N L LV +Y +GSL L + + E + ASGL +LH E
Sbjct: 66 DNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT----VTVEGMIKLALSTASGLAHLHMEIV 121
Query: 473 ---WEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPH---TTNVVGTFGYIAP 526
+ + HRD+K N L+ + D GLA +D + VGT Y+AP
Sbjct: 122 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 181
Query: 527 EL------TQTGKASTSSDVFAYGILLLEVATGRRPIGSG--------DLLLVEWVRECH 572
E+ + ++ +D++A G++ E+A G DL+ + E
Sbjct: 182 EVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEM 241
Query: 573 QLGRILDVADPLLNSSYVVKE-MELVLKLGLMCSHKT-QFRPTMRQVMRYLS 622
+ P + + + E + ++ K+ C + R T ++ + LS
Sbjct: 242 RKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 293
|
| >d1g8wa_ b.29.1.1 (A:) Phytohemagglutinin-L, PHA-L, also arcelin {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 233 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Phytohemagglutinin-L, PHA-L, also arcelin species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 193 bits (492), Expect = 5e-58
Identities = 75/255 (29%), Positives = 119/255 (46%), Gaps = 35/255 (13%)
Query: 25 SQSSSFIFQGFNGGATNLSLQGAEIIKPSGALKLTNRSR------YVIGHAFYVKPIQMF 78
S F FQ FN TNL LQ + SG L+LTN + +G AFY PIQ++
Sbjct: 1 SNDIYFNFQRFNE--TNLILQRDASVSSSGQLRLTNLNGNGEPRVGSLGRAFYSAPIQIW 58
Query: 79 DTSASPSPNASSFSTTFVFEISTPRSGRGGHGLAFLLAPSTKLPGAQPEHYLGILNSTNN 138
D + + +SF+T+F F I P + GLAF L P P +LG+ + +N+
Sbjct: 59 D---NTTGTVASFATSFTFNIQVPNNAGPADGLAFALVPVGSQPK-DKGGFLGLFDGSNS 114
Query: 139 GEPSNHILIVEFDTVNGFNDKAENQGNHVGIGINTMFSNRSEPASYYINGTDHKEEMTLE 198
+ H + VEFDT+ N + H+GI +N++ S ++ +
Sbjct: 115 ---NFHTVAVEFDTLY--NKDWDPTERHIGIDVNSIRSIKTTRWDFV------------- 156
Query: 199 SGEPIQAWIEYDGEQKVLNVTISPAEIGKPMRPLISFGVNLTGYIKETMYVGFSASTGEK 258
+GE + I YD +L ++ + ++S V+L + E + VGFSA+TG
Sbjct: 157 NGENAEVLITYDSSTNLLVASLVYP--SQKTSFIVSDTVDLKSVLPEWVSVGFSATTGIN 214
Query: 259 S---SSHYILGWSFS 270
++ +L WSF+
Sbjct: 215 KGNVETNDVLSWSFA 229
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (494), Expect = 1e-57
Identities = 63/268 (23%), Positives = 110/268 (41%), Gaps = 24/268 (8%)
Query: 359 EVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNLHGW 418
+G G FG VYK T A K I S + + ++ EI+ L H N+V L
Sbjct: 18 GELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 77
Query: 419 CKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVI 478
+N+L ++ E+ G++D ++ + + L Q + K L YLH+ +I
Sbjct: 78 FYYENNLWILIEFCAGGAVDAVMLELERP--LTESQIQVVCKQTLDALNYLHDNK---II 132
Query: 479 HRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPELTQTGKA---- 534
HRD+K N L + + +L DFG++ + + +GT ++APE+ +
Sbjct: 133 HRDLKAGNILFTLDGDIKLADFGVSAKNTR-TIQRRDSFIGTPYWMAPEVVMCETSKDRP 191
Query: 535 -STSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSYVVKE 593
+DV++ GI L+E+A P + + L +I P L
Sbjct: 192 YDYKADVWSLGITLIEMAEIEPPHHELNPM--------RVLLKIAKSEPPTLAQPSRWSS 243
Query: 594 --MELVLKLGLMCSHKTQFRPTMRQVMR 619
+ + K R T Q+++
Sbjct: 244 NFKDFLKK---CLEKNVDARWTTSQLLQ 268
|
| >d1f9ka_ b.29.1.1 (A:) Legume lectin {Winged bean (Psophocarpus tetragonolobus), acidic lectin [TaxId: 3891]} Length = 234 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Winged bean (Psophocarpus tetragonolobus), acidic lectin [TaxId: 3891]
Score = 191 bits (486), Expect = 3e-57
Identities = 71/257 (27%), Positives = 110/257 (42%), Gaps = 38/257 (14%)
Query: 26 QSSSFIFQGFNGGATNLSLQGAEIIKPSGALKLTNRSR------YVIGHAFYVKPIQMFD 79
++ SF F F + L+LQ IK +G L+LT ++ G A Y +PI+++D
Sbjct: 1 ETQSFNFDHFEENSKELNLQRQASIKSNGVLELTKLTKNGVPVWKSTGRALYAEPIKIWD 60
Query: 80 TSASPSPNASSFSTTFVFEISTPRSG-RGGHGLAFLLAPSTKLPGAQPEHYLGILNSTNN 138
S + N +SF T F F I+ P + GL F + P G G
Sbjct: 61 ---STTGNVASFETRFSFNITQPYAYPEPADGLTFFMVPPNSPQG-----EDGGNLGVFK 112
Query: 139 GEPSNHILIVEFDTVNGFNDKAENQGNHVGIGINTMFSNRSEPASYYINGTDHKEEMTLE 198
++ VEFDT D Q H+GI +N++ S+++ LE
Sbjct: 113 PPEGDNAFAVEFDTFQNTWDP---QVPHIGIDVNSIVSSKTLH-------------FQLE 156
Query: 199 SGEPIQAWIEYDGEQKVLNVTISPAEIGKPMRPLISFGVNLTGYI--KETMYVGFSASTG 256
+G I+YD K+LNV ++ +S V+L E + VG SA+TG
Sbjct: 157 NGGVANVVIKYDSPTKILNVVLAF--HSVGTVYTLSNIVDLKQEFPNSEWVNVGLSATTG 214
Query: 257 EKS---SSHYILGWSFS 270
+ +H I+ WSF+
Sbjct: 215 YQKNAVETHEIISWSFT 231
|
| >d1fx5a_ b.29.1.1 (A:) Legume lectin {Furze (Ulex europaeus), UEA-I [TaxId: 3902]} Length = 240 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Furze (Ulex europaeus), UEA-I [TaxId: 3902]
Score = 191 bits (485), Expect = 5e-57
Identities = 63/252 (25%), Positives = 103/252 (40%), Gaps = 24/252 (9%)
Query: 25 SQSSSFIFQGFNGGATNLSLQGAEIIKPSGALKLTNRSR----YVIGHAFYVKPIQMFDT 80
S SF F+ F+ +LS QG + +G L+L G A Y+ PI +++
Sbjct: 1 SDDLSFKFKNFSQNGKDLSFQGNASVIETGVLQLNKVGNNLPDETGGIARYIAPIHIWN- 59
Query: 81 SASPSPNASSFSTTFVFEISTPRS-GRGGHGLAFLLAPSTKLPGAQPEHYLGILNSTNNG 139
+ +SF T+F F + T + GL F LAP P + Y G+ N T
Sbjct: 60 --CNTGELASFITSFSFFMETSANPKAATDGLTFFLAPP-DSPLRRAGGYFGLFNDTKCD 116
Query: 140 EPSNHILIVEFDTVNGFNDKAENQGNHVGIGINTMFSNRSEPASYYINGTDHKEEMTLES 199
S + VEFDT+ + + H+GI +N + S +E +
Sbjct: 117 -SSYQTVAVEFDTIGSPVNFWDPGFPHIGIDVNCVKSINAERWNKRYG-----------L 164
Query: 200 GEPIQAWIEYDGEQKVLNVTISPAEIGKPMRPLISFGVNLTGYIKETMYVGFSASTGE-K 258
I Y+ K L +++ ++ V+L + E + VGFS ST +
Sbjct: 165 NNVANVEIIYEASSKTLTASLTYP--SDQTSISVTSIVDLKEILPEWVSVGFSGSTYIGR 222
Query: 259 SSSHYILGWSFS 270
++H +L W F+
Sbjct: 223 QATHEVLNWYFT 234
|
| >d1n47a_ b.29.1.1 (A:) Legume lectin {Hairy vetch (Vicia villosa), isolectin b4 [TaxId: 3911]} Length = 233 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Hairy vetch (Vicia villosa), isolectin b4 [TaxId: 3911]
Score = 191 bits (485), Expect = 5e-57
Identities = 72/256 (28%), Positives = 111/256 (43%), Gaps = 33/256 (12%)
Query: 25 SQSSSFIFQGFNGGATNLSLQGAEIIKPSGALKLTNRSRYV-----IGHAFYVKPIQMFD 79
++S+SF F FN NL LQ ++ +G L+LT + +G A Y PI + D
Sbjct: 1 TESTSFSFTNFNPNQNNLILQEDALVNSAGTLELTAVAAGAPVPDSLGRALYAAPIHIHD 60
Query: 80 TSASPSPNASSFSTTFVFEISTPRSGRGGHGLAFLLAPSTKLPGAQPEHYLGILNSTNNG 139
+ +SF+T+F F ++ P + GLAF LAP P A +LG+ +
Sbjct: 61 -----NTTLASFTTSFSFVMAAPAAAAVADGLAFFLAPPDTQPQA-RGGFLGLFADRAHD 114
Query: 140 EPSNHILIVEFDTVNGFNDKAENQGNHVGIGINTMFSNRSEPASYYINGTDHKEEMTLES 199
S + VEFDT + D H+GI N + S ++ P +
Sbjct: 115 -ASYQTVAVEFDTYSNAWDP---NYTHIGIDTNGIESKKTTP-------------FDMVY 157
Query: 200 GEPIQAWIEYDGEQKVLNVTISPAEIGKPMRPLISFGVNLTGYIKETMYVGFSASTG--- 256
GE I Y K L ++ +S V+L + E + VGFSA+TG
Sbjct: 158 GEKANIVITYQASTKALAASLVF--PVSQTSYAVSARVDLRDILPEYVRVGFSATTGLNA 215
Query: 257 EKSSSHYILGWSFSLN 272
+H I+ WSF+++
Sbjct: 216 GVVETHDIVSWSFAVS 231
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (490), Expect = 7e-57
Identities = 67/293 (22%), Positives = 115/293 (39%), Gaps = 35/293 (11%)
Query: 355 FKESEVIGIGGFGSVYKGVLP-----TTGGEVAVKKITRNSLQGMRE-FAAEIESLGRL- 407
+ +G G FG V + VAVK + ++ RE +E++ L L
Sbjct: 25 LSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLG 84
Query: 408 RHKNLVNLHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSV---------------LDW 452
H N+VNL G C L++ EY G L L + +D + LD
Sbjct: 85 NHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDL 144
Query: 453 EQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLAR-LYDHGGM 511
E + +A G+ +L + IHRD+ N L+ ++ DFGLAR + +
Sbjct: 145 EDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNY 201
Query: 512 PHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVREC 571
N ++APE + SDV++YGI L E+ + G
Sbjct: 202 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM-------PVD 254
Query: 572 HQLGRILDVADPLLNSSYVVKEMELVLKLGLMCSHKTQFRPTMRQVMRYLSGE 624
+ +++ +L+ + EM ++K RPT +Q+++ + +
Sbjct: 255 SKFYKMIKEGFRMLSPEHAPAEMYDIMK--TCWDADPLKRPTFKQIVQLIEKQ 305
|
| >d1hqla_ b.29.1.1 (A:) Legume lectin {Griffonia simplicifolia, lectin I-b4 [TaxId: 3850]} Length = 236 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Griffonia simplicifolia, lectin I-b4 [TaxId: 3850]
Score = 189 bits (482), Expect = 1e-56
Identities = 73/254 (28%), Positives = 111/254 (43%), Gaps = 27/254 (10%)
Query: 27 SSSFIFQGFNG-GATNLSLQGAEIIKPSGALKLTNRSRYV------IGHAFYVKPIQMFD 79
S SF F F ++ QG +G L+L ++Y G A Y P+Q++D
Sbjct: 1 SVSFTFPNFWSDVEDSIIFQGDANT-TAGTLQLCKTNQYGTPLQWSAGRALYSDPVQLWD 59
Query: 80 TSASPSPNASSFSTTFVFEISTPRSGRGGHGLAFLLAPSTKLPGAQPEHYLGILNSTNNG 139
+ + + +SF T F F + +G GLAF LAP E+ ST
Sbjct: 60 ---NKTESVASFYTEFTFFLKITGNG-PADGLAFFLAPPDSDVKDAGEYLGLFNKSTATQ 115
Query: 140 EPSNHILIVEFDTVNGFNDKAENQGNHVGIGINTMFSNRSEPASYYINGTDHKEEMTLES 199
N ++ VEFDT N E H+GI +N++ S ++ + + S
Sbjct: 116 PSKNQVVAVEFDTWTNPNFP-EPSYRHIGINVNSIVSVATKRWE----------DSDIFS 164
Query: 200 GEPIQAWIEYDGEQKVLNVTISPAEIGKPMRPLISFGVNLTGYIKETMYVGFSASTGEKS 259
G+ A I YDG ++L V +S ++S V++ + E++ VG SASTG
Sbjct: 165 GKIATARISYDGSAEILTVVLSYP---DGSDYILSHSVDMRQNLPESVRVGISASTGNNQ 221
Query: 260 S-SHYILGWSFSLN 272
+ YIL W FS N
Sbjct: 222 FLTVYILSWRFSSN 235
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (484), Expect = 1e-56
Identities = 72/270 (26%), Positives = 111/270 (41%), Gaps = 27/270 (10%)
Query: 355 FKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVN 414
K + IG G FG V G G +VAVK I ++ + F AE + +LRH NLV
Sbjct: 9 LKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQ 64
Query: 415 LHGWC-KQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEW 473
L G ++K L +V EY+ GSL L + SVL + + + YL
Sbjct: 65 LLGVIVEEKGGLYIVTEYMAKGSLVDYLRS-RGRSVLGGDCLLKFSLDVCEAMEYLEGNN 123
Query: 474 EQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPELTQTGK 533
+HRD+ N L+ + A++ DFGL + + APE + K
Sbjct: 124 ---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASS----TQDTGKLPVKWTAPEALREKK 176
Query: 534 ASTSSDVFAYGILLLEVATGRRPIGSGDLL--LVEWVRECHQLGRILDVADPLLNSSYVV 591
ST SDV+++GILL E+ + R L +V V + +++ +
Sbjct: 177 FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVY------ 230
Query: 592 KEMELVLKLGLMCSHKTQFRPTMRQVMRYL 621
E++ RP+ Q+ L
Sbjct: 231 ---EVMKN---CWHLDAAMRPSFLQLREQL 254
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (486), Expect = 1e-56
Identities = 62/284 (21%), Positives = 120/284 (42%), Gaps = 26/284 (9%)
Query: 346 KDLYAATKGFKESEV-IGIGGFGSVYKGVLPTTGG--EVAVKKITRNSLQGMRE-FAAEI 401
K L+ +++ +G G FGSV +GV +VA+K + + + + E E
Sbjct: 1 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 60
Query: 402 ESLGRLRHKNLVNLHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKG 461
+ + +L + +V L G C Q L+LV E G L L ++ + ++
Sbjct: 61 QIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREE--IPVSNVAELLHQ 117
Query: 462 IASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHT--TNVVG 519
++ G+ YL E+ +HRD+ N L+ A++ DFGL++ +T +
Sbjct: 118 VSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKW 174
Query: 520 TFGYIAPELTQTGKASTSSDVFAYGILLLEVAT-GRRPI-GSGDLLLVEWVRECHQLGRI 577
+ APE K S+ SDV++YG+ + E + G++P ++ ++ + ++
Sbjct: 175 PLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECP 234
Query: 578 LDVADPLLNSSYVVKEMELVLKLGLMCSHKTQFRPTMRQVMRYL 621
+ L L+ +K + RP V + +
Sbjct: 235 PECPPELY---------ALMSD---CWIYKWEDRPDFLTVEQRM 266
|
| >d1dbna_ b.29.1.1 (A:) Legume lectin {Maackia amurensis, leukoagglutinin [TaxId: 37501]} Length = 239 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Maackia amurensis, leukoagglutinin [TaxId: 37501]
Score = 189 bits (482), Expect = 1e-56
Identities = 65/254 (25%), Positives = 106/254 (41%), Gaps = 26/254 (10%)
Query: 25 SQSSSFIFQGFNGGATNLSLQGAEIIKPSGALKLTN-----RSRYVIGHAFYVKPIQMFD 79
S SF F +L QG + +G L+LT +Y +G A Y P++++
Sbjct: 1 SDELSFTINNFVPNEADLLFQGEASVSSTGVLQLTKVENGQPQKYSVGRALYAAPVRIWG 60
Query: 80 TSASPSPNASSFSTTFVFEISTPRSGRGGHGLAFLLAPSTKLPGAQPEHYLGILNSTNNG 139
+ + + +SFST+F F + P GLAF LAP + L + +N
Sbjct: 61 ---NTTGSVASFSTSFTFVVKAPNPDITSDGLAFYLAPPDSQIPSGSVSKYLGLFNNSNS 117
Query: 140 EPSNHILIVEFDT-VNGFNDKAENQGNHVGIGINTMFSNRSEPASYYINGTDHKEEMTLE 198
+ SN I+ VEFDT D + H+GI +N + S ++ + G L
Sbjct: 118 DSSNQIVAVEFDTYFAHSYDPWDPNYRHIGIDVNGIESIKTVQWDWINGGVAFATITYLA 177
Query: 199 SGEPIQAWIEYDGEQKVLNVTISPAEIGKPMRPLISFGVNLTGYIKETMYVGFSASTGEK 258
+ + A + Y ++ V+L + E + VGFSA+TG
Sbjct: 178 PNKTLIASLVYP---------------SNQTTFSVAASVDLKEILPEWVRVGFSAATGYP 222
Query: 259 S--SSHYILGWSFS 270
+ +H +L WSF+
Sbjct: 223 TEVETHDVLSWSFT 236
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (484), Expect = 2e-56
Identities = 63/268 (23%), Positives = 111/268 (41%), Gaps = 24/268 (8%)
Query: 355 FKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSL---QGMREFAAEIESLGRLRHKN 411
F+ +G G FG+VY + +A+K + + L + E+E LRH N
Sbjct: 8 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 67
Query: 412 LVNLHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHE 471
++ L+G+ + L+ EY P G++ L K D ++ + +A+ L Y H
Sbjct: 68 ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS---KFDEQRTATYITELANALSYCH- 123
Query: 472 EWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPELTQT 531
+ VIHRD+KP N L+ + ++ DFG + T + GT Y+ PE+ +
Sbjct: 124 --SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS---RRTTLCGTLDYLPPEMIEG 178
Query: 532 GKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSYVV 591
D+++ G+L E G+ P + RI V +
Sbjct: 179 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ--------ETYKRISRV-EFTFPDFVTE 229
Query: 592 KEMELVLKLGLMCSHKTQFRPTMRQVMR 619
+L+ + + H RP +R+V+
Sbjct: 230 GARDLISR---LLKHNPSQRPMLREVLE 254
|
| >d1avba_ b.29.1.1 (A:) Phytohemagglutinin-L, PHA-L, also arcelin {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 226 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Phytohemagglutinin-L, PHA-L, also arcelin species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 189 bits (480), Expect = 2e-56
Identities = 75/254 (29%), Positives = 108/254 (42%), Gaps = 36/254 (14%)
Query: 25 SQSSSFIFQGFNGGATNLSLQGAEIIKPSGALKLTNRS---RYVIGHAFYVKPIQMFDTS 81
S +SF + FN TNL LQG + G L LTN +G AFY PIQ+ D
Sbjct: 1 SNDASFNVETFNK--TNLILQGDATVSSEGHLLLTNVKGNEEDSMGRAFYSAPIQIND-- 56
Query: 82 ASPSPNASSFSTTFVFEISTPRSGRGGHGLAFLLAPSTKLPGAQPEHYLGILNSTNNGEP 141
N +SFST F F I+ +GLAF L P P YLG+ N+TN
Sbjct: 57 -RTIDNLASFSTNFTFRINAKNIENSAYGLAFALVPVGSRPKL-KGRYLGLFNTTN---- 110
Query: 142 SNHILIVEFDTVNGFNDKAENQGNHVGIGINTMFSNRSEPASYYINGTDHKEEMTLESGE 201
+ D N + I +N++ +E ++ N +GE
Sbjct: 111 ------YDRDAHTVAVVFDTV-SNRIEIDVNSIRPIATESCNFGHN-----------NGE 152
Query: 202 PIQAWIEYDGEQKVLNVTISPAEIGKPMRPLISFGVNLTGYIKETMYVGFSASTGEKS-- 259
+ I YD + L V++ + +S V L +++ + VGFSA++G K
Sbjct: 153 KAEVRITYDSPKNDLRVSLLY--PSSEEKCHVSATVPLEKEVEDWVSVGFSATSGSKKET 210
Query: 260 -SSHYILGWSFSLN 272
+H +L WSFS N
Sbjct: 211 TETHNVLSWSFSSN 224
|
| >d1g7ya_ b.29.1.1 (A:) Legume lectin {Horse gram (Dolichos biflorus), different isoforms [TaxId: 3840]} Length = 253 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Horse gram (Dolichos biflorus), different isoforms [TaxId: 3840]
Score = 189 bits (482), Expect = 2e-56
Identities = 68/272 (25%), Positives = 118/272 (43%), Gaps = 38/272 (13%)
Query: 25 SQSSSFIFQGFNGGATNLSLQGAEIIKPSGALKLTNRSR------YVIGHAFYVKPIQMF 78
+ SF F+ FN ++ LQG + S L+LT +G AFY PIQ++
Sbjct: 1 ADIQSFSFKNFNS--SSFILQGDATV-SSSKLRLTKVKGNGLPTLSSLGRAFYSSPIQIY 57
Query: 79 DTSASPSPNASSFSTTFVFEISTPRSGRGGHGLAFLLAPSTKLPGAQPEHYLGILNSTNN 138
D + +S++T+F I P G+AF L P P + +LG+ +S
Sbjct: 58 D---KSTGAVASWATSFTANIFAPNKSSSADGIAFALVPVGSEPKS-NSGFLGVFDSDVY 113
Query: 139 GEPSNHILIVEFDTVNGFNDKAENQGNHVGIGINTMFSNRSEPASYYINGTDHKEEMTLE 198
S + VEFDT + N + H+GI +N++ S R+ L
Sbjct: 114 D-NSAQTVAVEFDTFS--NTDWDPTSRHIGIDVNSIKSIRTAS-------------WGLA 157
Query: 199 SGEPIQAWIEYDGEQKVLNVTISPAEIGKPMRPLISFGVNLTGYIKETMYVGFSASTGEK 258
+G+ + I Y+ +L ++ + ++S V++T + E + +GFSA+TG
Sbjct: 158 NGQNAEILITYNAATSLLVASLVH--PSRRTSYIVSERVDITNELPEYVSIGFSATTGLS 215
Query: 259 ---SSSHYILGWSFSLN----GVAPALNVSEL 283
+ +H +L WSF+ L+++
Sbjct: 216 EGYTETHDVLSWSFASKLPDDSTTEPLDIASY 247
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (481), Expect = 7e-56
Identities = 66/281 (23%), Positives = 123/281 (43%), Gaps = 24/281 (8%)
Query: 355 FKESEVIGIGGFGSVYKGVLPTTGGE----VAVKKITRNSLQGMR-EFAAEIESLGRLRH 409
+VIG G FG VYKG+L T+ G+ VA+K + + R +F E +G+ H
Sbjct: 9 VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSH 68
Query: 410 KNLVNLHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYL 469
N++ L G + ++++ EY+ NG+LD L + Q +++GIA+G+ YL
Sbjct: 69 HNIIRLEGVISKYKPMMIITEYMENGALDKFLREKD--GEFSVLQLVGMLRGIAAGMKYL 126
Query: 470 HEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGG--MPHTTNVVGTFGYIAPE 527
+HRD+ N L+++ + ++ DFGL+R+ + T+ + APE
Sbjct: 127 ANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPE 183
Query: 528 LTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNS 587
K +++SDV+++GI++ EV T ++ +
Sbjct: 184 AISYRKFTSASDVWSFGIVMWEVMTYGERPYWE-----------LSNHEVMKAINDGFRL 232
Query: 588 SYVVKEMELVLKLGLMCSHKT-QFRPTMRQVMRYLSGEKQL 627
+ + +L + C + RP ++ L +
Sbjct: 233 PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (482), Expect = 7e-56
Identities = 60/270 (22%), Positives = 112/270 (41%), Gaps = 21/270 (7%)
Query: 352 TKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKN 411
K + E IG G G+VY + TG EVA++++ EI + ++ N
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 412 LVNLHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHE 471
+VN ++L +V EY+ GSL ++ + D Q + + L +LH
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM----DEGQIAAVCRECLQALEFLHS 134
Query: 472 EWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPELTQT 531
VIHRD+K N L+ + + +L DFG +T +VGT ++APE+
Sbjct: 135 NQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST-MVGTPYWMAPEVVTR 190
Query: 532 GKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSYVV 591
D+++ GI+ +E+ G P + + L I P L + +
Sbjct: 191 KAYGPKVDIWSLGIMAIEMIEGEPPYLNEN--------PLRALYLIATNGTPELQNPEKL 242
Query: 592 KEM--ELVLKLGLMCSHKTQFRPTMRQVMR 619
+ + + + + R + +++++
Sbjct: 243 SAIFRDFLNR---CLDMDVEKRGSAKELLQ 269
|
| >d1v6ia_ b.29.1.1 (A:) Legume lectin {Peanut (Arachis hypogaea) [TaxId: 3818]} Length = 232 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Peanut (Arachis hypogaea) [TaxId: 3818]
Score = 187 bits (476), Expect = 9e-56
Identities = 62/248 (25%), Positives = 109/248 (43%), Gaps = 24/248 (9%)
Query: 25 SQSSSFIFQGFNGGATNLSLQGAEIIKPSGALKLTNRSRY-VIGHAFYVKPIQMFDTSAS 83
+++ SF F F+ G ++ QG + +G ++LTN ++ +G Y P++++ S
Sbjct: 1 AETVSFNFNSFSEGNPAINFQGDVTVLSNGNIQLTNLNKVNSVGRVLYAMPVRIWS---S 57
Query: 84 PSPNASSFSTTFVFEISTPRSGRGGHGLAFLLAPSTKLPGAQPEHYLGILNSTNNGEPSN 143
+ N +SF T+F FE+ + G+ F +AP A G ++ + +
Sbjct: 58 ATGNVASFLTSFSFEMKDIKDYDPADGIIFFIAPEDTQIPAG--SIGGGTLGVSDTKGAG 115
Query: 144 HILIVEFDTVNGFNDKAENQGNHVGIGINTMFSNRSEPASYYINGTDHKEEMTLESGEPI 203
H + VEFDT + +HVGI +N++ S ++ P SG +
Sbjct: 116 HFVGVEFDTYSNSEYNDPP-TDHVGIDVNSVDSVKTVP-------------WNSVSGAVV 161
Query: 204 QAWIEYDGEQKVLNVTISPAEIGKPMRPLISFGVNLTGYIKETMYVGFSASTGEKSSS-H 262
+ + YD K L+V ++ I+ V+L + E + GFSAS H
Sbjct: 162 KVTVIYDSSTKTLSVAVTN---DNGDITTIAQVVDLKAKLPERVKFGFSASGSLGGRQIH 218
Query: 263 YILGWSFS 270
I WSF+
Sbjct: 219 LIRSWSFT 226
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (482), Expect = 1e-55
Identities = 79/293 (26%), Positives = 130/293 (44%), Gaps = 36/293 (12%)
Query: 355 FKESEVIGIGGFGSVYKGVLPTTGG--EVAVKKITRN-SLQGMREFAAEIESLGRL-RHK 410
K +VIG G FG V K + G + A+K++ S R+FA E+E L +L H
Sbjct: 12 IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHP 71
Query: 411 NLVNLHGWCKQKNDLLLVYEYIPNGSLDTLLFK-------------PKDGSVLDWEQRFN 457
N++NL G C+ + L L EY P+G+L L K S L +Q +
Sbjct: 72 NIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 131
Query: 458 IVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNV 517
+A G+ YL ++ IHRD+ N L+ A++ DFGL+R + T
Sbjct: 132 FAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEV--YVKKTMG 186
Query: 518 VGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLL--LVEWVRECHQLG 575
++A E +T+SDV++YG+LL E+ + G L E + + ++L
Sbjct: 187 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLE 246
Query: 576 RILDVADPLLNSSYVVKEMELVLKLGLMCSHKTQFRPTMRQVMRYLSGEKQLR 628
+ L+ D + +L+ + K RP+ Q++ L+ + R
Sbjct: 247 KPLNCDDEVY---------DLMRQ---CWREKPYERPSFAQILVSLNRMLEER 287
|
| >d2d3sa1 b.29.1.1 (A:1-237) Legume lectin {Winged bean (Psophocarpus tetragonolobus), basic agglutinin [TaxId: 3891]} Length = 237 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Winged bean (Psophocarpus tetragonolobus), basic agglutinin [TaxId: 3891]
Score = 187 bits (475), Expect = 1e-55
Identities = 72/260 (27%), Positives = 106/260 (40%), Gaps = 37/260 (14%)
Query: 26 QSSSFIFQGFNGGATNLSLQGAEIIKPSGALKLTNRSR-----YVIGHAFYVKPIQMFDT 80
++ SF F F+ L LQ I + L+LT G A Y KP+Q++D
Sbjct: 1 KTISFNFNQFHQNEEQLKLQRDARISSNSVLELTKVVNGVPTWNSTGRALYAKPVQVWD- 59
Query: 81 SASPSPNASSFSTTFVFEISTPRSGRGGHGLAFLLAPSTKLPGAQPEHYLGILNSTNNGE 140
S + N +SF T F F I P + Y GI N +
Sbjct: 60 --STTGNVASFETRFSFSIRQPFPRPHPADGLVFFIAPPNTQTGEGGGYFGIYNPLSP-- 115
Query: 141 PSNHILIVEFDTVNGFNDKAENQGNHVGIGINTMFSNRSEPASYYINGTDHKEEMTLESG 200
+ VEFDT D Q H+GI +N++ S ++ P TL++G
Sbjct: 116 --YPFVAVEFDTFRNTWDP---QIPHIGIDVNSVISTKTVP-------------FTLDNG 157
Query: 201 EPIQAWIEYDGEQKVLNVTISPAEIGKPMRPLISFGVNLTGYIKETMYVGFSASTGEKS- 259
I+YD K+L+V + I+ V+L + E++ VGFSA+TG+ S
Sbjct: 158 GIANVVIKYDASTKILHVVLVFP--SLGTIYTIADIVDLKQVLPESVNVGFSAATGDPSG 215
Query: 260 ------SSHYILGWSFSLNG 273
+H IL WSFS +
Sbjct: 216 KQRNATETHDILSWSFSASL 235
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (476), Expect = 3e-55
Identities = 63/268 (23%), Positives = 105/268 (39%), Gaps = 18/268 (6%)
Query: 355 FKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMRE-FAAEIESLGRLRHKNLV 413
+ + +G G +G V V T VAVK + E EI L H+N+V
Sbjct: 7 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 66
Query: 414 NLHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEW 473
+G ++ N L EY G L + + + +G++YLH
Sbjct: 67 KFYGHRREGNIQYLFLEYCSGGELFDRIEPDI---GMPEPDAQRFFHQLMAGVVYLHGIG 123
Query: 474 EQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTN-VVGTFGYIAPELTQTG 532
+ HRD+KP N L+D N ++ DFGLA ++ + N + GT Y+APEL +
Sbjct: 124 ---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 180
Query: 533 K-ASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSYVV 591
+ + DV++ GI+L + G P E+ + + +P
Sbjct: 181 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYL----NPWKKIDSAP 236
Query: 592 KEMELVLKLGLMCSHKTQFRPTMRQVMR 619
L+ K + R T+ + +
Sbjct: 237 L--ALLHK---ILVENPSARITIPDIKK 259
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (478), Expect = 6e-55
Identities = 65/298 (21%), Positives = 118/298 (39%), Gaps = 40/298 (13%)
Query: 355 FKESEVIGIGGFGSVYKGVLPTTGG-----EVAVKKITRNSLQGMRE-FAAEIESLGRL- 407
+ +V+G G FG V +VAVK + + RE +E++ + +L
Sbjct: 39 LEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLG 98
Query: 408 RHKNLVNLHGWCKQKNDLLLVYEYIPNGSLDTLLFKPK--------------------DG 447
H+N+VNL G C + L++EY G L L + D
Sbjct: 99 SHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDL 158
Query: 448 SVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLAR-LY 506
+VL +E +A G+ +L + +HRD+ N L+ ++ DFGLAR +
Sbjct: 159 NVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIM 215
Query: 507 DHGGMPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVE 566
N ++APE G + SDV++YGILL E+ + G
Sbjct: 216 SDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI----- 270
Query: 567 WVRECHQLGRILDVADPLLNSSYVVKEMELVLKLGLMCSHKTQFRPTMRQVMRYLSGE 624
+++ + Y +E+ ++++ + ++ RP+ + +L +
Sbjct: 271 --PVDANFYKLIQNGFKMDQPFYATEEIYIIMQ--SCWAFDSRKRPSFPNLTSFLGCQ 324
|
| >d1fnya_ b.29.1.1 (A:) Legume lectin {Black locust (Robinia pseudoacacia) [TaxId: 35938]} Length = 237 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Black locust (Robinia pseudoacacia) [TaxId: 35938]
Score = 183 bits (466), Expect = 3e-54
Identities = 75/257 (29%), Positives = 112/257 (43%), Gaps = 30/257 (11%)
Query: 25 SQSSSFIFQGFNGGATNLSLQGAEIIKPSGALKLTN-----RSRYVIGHAFYVKPIQMFD 79
+ S SF F F L QG ++ +G L+LTN S +G A Y P Q++D
Sbjct: 1 TGSLSFSFPKFAPNQPYLINQGDALVTSTGVLQLTNVVNGVPSSKSLGRALYAAPFQIWD 60
Query: 80 TSASPSPNASSFSTTFVFEISTPRSGRGGHGLAFLLAPSTKLPGAQPEHYLGILNSTNNG 139
S + N +SF T+F F I P GLAF LAP P LGI
Sbjct: 61 ---STTGNVASFVTSFTFIIQAPNPATTADGLAFFLAPVDTQPL-DLGGMLGIFKDGYF- 115
Query: 140 EPSNHILIVEFDTVNGFNDKAENQGNHVGIGINTMFSNRSEPASYYINGTDHKEEMTLES 199
SN I+ VEFDT + + + +G H+GI +N++ S ++ P ++ +
Sbjct: 116 NKSNQIVAVEFDTFSNGDW--DPKGRHLGINVNSIESIKTVPWNWT-------------N 160
Query: 200 GEPIQAWIEYDGEQKVLNVTISPAEIGKPMRPLISFGVNLTGYIKETMYVGFSASTGEKS 259
GE +I Y+ K L ++ +I V++ + E + GFSA+TG
Sbjct: 161 GEVANVFISYEASTKSLTASLVY--PSLETSFIIDAIVDVKIVLPEWVRFGFSATTGIDK 218
Query: 260 SS---HYILGWSFSLNG 273
+ +L WSF N
Sbjct: 219 GYVQTNDVLSWSFESNL 235
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 185 bits (470), Expect = 4e-54
Identities = 70/296 (23%), Positives = 114/296 (38%), Gaps = 43/296 (14%)
Query: 355 FKESEVIGIGGFGSVYKGVLP-----TTGGEVAVKKITRNSLQGMR-EFAAEIESLGRLR 408
+ IG G FG V++ P VAVK + + M+ +F E +
Sbjct: 15 IEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFD 74
Query: 409 HKNLVNLHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSV------------------- 449
+ N+V L G C + L++EY+ G L+ L +V
Sbjct: 75 NPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGP 134
Query: 450 --LDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLAR-LY 506
L ++ I + +A+G+ YL E +HRD+ N L+ M ++ DFGL+R +Y
Sbjct: 135 PPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSRNIY 191
Query: 507 DHGGMPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVE 566
N ++ PE + +T SDV+AYG++L E+ + G E
Sbjct: 192 SADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGM--AHE 249
Query: 567 WVRECHQLGRILDVADPLLNSSYVVKEMELVLKLGLMCSHKT-QFRPTMRQVMRYL 621
V + G IL + + L +C K RP+ + R L
Sbjct: 250 EVIYYVRDGNILACPE---------NCPLELYNLMRLCWSKLPADRPSFCSIHRIL 296
|
| >d1ukga_ b.29.1.1 (A:) Legume lectin {Bloodwood tree (Pterocarpus angolensis) [TaxId: 182271]} Length = 241 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Bloodwood tree (Pterocarpus angolensis) [TaxId: 182271]
Score = 183 bits (464), Expect = 5e-54
Identities = 58/253 (22%), Positives = 109/253 (43%), Gaps = 28/253 (11%)
Query: 26 QSSSFIFQGFNGGATNLSLQGAEIIKPSGALKLTNRSR------YVIGHAFYVKPIQMFD 79
S SF F F NL QG IK + A++LT +G + + +++
Sbjct: 2 DSLSFGFPTFPSDQKNLIFQGDAQIK-NNAVQLTKTDSNGNPVASTVGRILFSAQVHLWE 60
Query: 80 TSASPSPNASSFSTTFVFEISTPRSGRGGHGLAFLLAPSTKLPGAQPEHYLGILN-STNN 138
S+S ++F + F F + +P S F+ P T +P LG+ T
Sbjct: 61 KSSS---RVANFQSQFSFSLKSPLSNGADGIAFFIAPPDTTIPSGSGGGLLGLFAPGTAQ 117
Query: 139 GEPSNHILIVEFDTV-NGFNDKAENQGNHVGIGINTMFSNRSEPASYYINGTDHKEEMTL 197
+N ++ VEFDT ++ + H+GI +N++ S ++
Sbjct: 118 NTSANQVIAVEFDTFYAQDSNTWDPNYPHIGIDVNSIRSVKTVK-------------WDR 164
Query: 198 ESGEPIQAWIEYDGEQKVLNVTISPAEIGKPMRPLISFGVNLTGYIKETMYVGFSASTGE 257
G+ + + ++ + L+V + + R +S+ V++ + E + VGFSA++GE
Sbjct: 165 RDGQSLNVLVTFNPSTRNLDVVATYS---DGTRYEVSYEVDVRSVLPEWVRVGFSAASGE 221
Query: 258 KSSSHYILGWSFS 270
+ +H + WSF+
Sbjct: 222 QYQTHTLESWSFT 234
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (466), Expect = 8e-54
Identities = 60/271 (22%), Positives = 113/271 (41%), Gaps = 23/271 (8%)
Query: 357 ESEVIGIGGFGSVYKGVLP--TTGGEVAVKKITRNSLQG--MREFAAEIESLGRLRHKNL 412
E + +G G FG+V KG VAVK + + E AE + +L + +
Sbjct: 11 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70
Query: 413 VNLHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEE 472
V + G C + +LV E G L+ L + + + + +V ++ G+ YL E
Sbjct: 71 VRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRH---VKDKNIIELVHQVSMGMKYLEES 126
Query: 473 WEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTN--VVGTFGYIAPELTQ 530
+HRD+ N L+ + A++ DFGL++ + + APE
Sbjct: 127 N---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN 183
Query: 531 TGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSYV 590
K S+ SDV+++G+L+ E + + G + ++ +L+ + + +
Sbjct: 184 YYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM--------KGSEVTAMLEKGERMGCPAGC 235
Query: 591 VKEMELVLKLGLMCSHKTQFRPTMRQVMRYL 621
+EM ++ L ++ + RP V L
Sbjct: 236 PREMYDLMN--LCWTYDVENRPGFAAVELRL 264
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (468), Expect = 1e-53
Identities = 68/274 (24%), Positives = 116/274 (42%), Gaps = 25/274 (9%)
Query: 358 SEVIGIGGFGSVYKGVLPTTGGE---VAVKKITRNSLQG-MREFAAEIESLGRLRHKNLV 413
+EVIG G FG VY G L G+ AVK + R + G + +F E + H N++
Sbjct: 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 91
Query: 414 NLHGWC-KQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEE 472
+L G C + + L+V Y+ +G L + + F + +
Sbjct: 92 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKG-----MKFL 146
Query: 473 WEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMP---HTTNVVGTFGYIAPELT 529
+ +HRD+ N ++D + ++ DFGLAR + T ++A E
Sbjct: 147 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL 206
Query: 530 QTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSY 589
QT K +T SDV+++G+LL E+ T P D+ + Q R+L Y
Sbjct: 207 QTQKFTTKSDVWSFGVLLWELMTRGAPP-YPDVNTFDITVYLLQGRRLLQ-------PEY 258
Query: 590 VVKEMELVLKLGLMCSHKT-QFRPTMRQVMRYLS 622
+ ++ L C H + RP+ +++ +S
Sbjct: 259 CPDPL---YEVMLKCWHPKAEMRPSFSELVSRIS 289
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 185 bits (470), Expect = 2e-53
Identities = 57/267 (21%), Positives = 110/267 (41%), Gaps = 17/267 (6%)
Query: 355 FKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVN 414
+ E +G G FG V++ TG A K + EI+++ LRH LVN
Sbjct: 28 YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVN 87
Query: 415 LHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWE 474
LH + N+++++YE++ G L + + + ++ ++ + GL ++HE
Sbjct: 88 LHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK--MSEDEAVEYMRQVCKGLCHMHENN- 144
Query: 475 QVVIHRDVKPSNALIDAEMNAR--LGDFGLARLYDHGGMPHTTNVVGTFGYIAPELTQTG 532
+H D+KP N + + + L DFGL D T GT + APE+ +
Sbjct: 145 --YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT--TGTAEFAAPEVAEGK 200
Query: 533 KASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSYVVK 592
+D+++ G+L + +G P G + + L + + +S++
Sbjct: 201 PVGYYTDMWSVGVLSYILLSGLSPFGGEN--------DDETLRNVKSCDWNMDDSAFSGI 252
Query: 593 EMELVLKLGLMCSHKTQFRPTMRQVMR 619
+ + + R T+ Q +
Sbjct: 253 SEDGKDFIRKLLLADPNTRMTIHQALE 279
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (459), Expect = 8e-53
Identities = 59/272 (21%), Positives = 110/272 (40%), Gaps = 20/272 (7%)
Query: 355 FKESEVIGIGGFGSVYKGVLPTTGGE---VAVKKITRNSLQGMRE-FAAEIESLGRLRHK 410
+ IG G FG V++G+ + VA+K + +RE F E ++ + H
Sbjct: 9 IELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHP 68
Query: 411 NLVNLHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLH 470
++V L G +N + ++ E G L + L K LD +++ L YL
Sbjct: 69 HIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYS--LDLASLILYAYQLSTALAYLE 125
Query: 471 EEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPELTQ 530
+ +HRD+ N L+ + +LGDFGL+R + + ++APE
Sbjct: 126 S---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESIN 182
Query: 531 TGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSYV 590
+ +++SDV+ +G+ + E+ G + +GRI + + +
Sbjct: 183 FRRFTSASDVWMFGVCMWEILMHGVKPFQGV-------KNNDVIGRIENGERLPMPPNCP 235
Query: 591 VKEMELVLKLGLMCSHKTQFRPTMRQVMRYLS 622
L+ K ++ RP ++ LS
Sbjct: 236 PTLYSLMTK---CWAYDPSRRPRFTELKAQLS 264
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (461), Expect = 1e-52
Identities = 71/311 (22%), Positives = 126/311 (40%), Gaps = 35/311 (11%)
Query: 340 PHRFRYKDLYAATK------GFKESEVIGIGGFGSVYKGVLPT-----TGGEVAVKKITR 388
P F D+Y + S +G G FG VY+GV VA+K +
Sbjct: 1 PEYFSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNE 60
Query: 389 N-SLQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDG 447
S++ EF E + ++V L G Q L++ E + G L + L +
Sbjct: 61 AASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPA 120
Query: 448 -------SVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDF 500
+ + + IA G+ YL+ +HRD+ N ++ + ++GDF
Sbjct: 121 MANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDF 177
Query: 501 GLAR-LYDHGGMPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGS 559
G+ R +Y+ + +++PE + G +T SDV+++G++L E+AT
Sbjct: 178 GMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQ 237
Query: 560 GDLLLVEWVRECHQLGRILDVADPLLNSSYVVKEMELVLKLGLMCSHKT-QFRPTMRQVM 618
G L E V G +LD D +++ +L MC + RP+ +++
Sbjct: 238 G--LSNEQVLRFVMEGGLLDKPDNCP---------DMLFELMRMCWQYNPKMRPSFLEII 286
Query: 619 RYLSGEKQLRF 629
+ E + F
Sbjct: 287 SSIKEEMEPGF 297
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (456), Expect = 2e-52
Identities = 70/277 (25%), Positives = 114/277 (41%), Gaps = 23/277 (8%)
Query: 353 KGFKESEVIGIGGFGSVYKGVLPTTGGE---VAVKKITRNSL---QGMREFAAEIESLGR 406
K + E +G G FG V +G G+ VAVK + + L + M +F E+ ++
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 407 LRHKNLVNLHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGL 466
L H+NL+ L+G + +V E P GSL L K + +A G+
Sbjct: 68 LDHRNLIRLYGVV-LTPPMKMVTELAPLGSLLDRLRKHQGH--FLLGTLSRYAVQVAEGM 124
Query: 467 LYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPH--TTNVVGTFGYI 524
YL + IHRD+ N L+ ++GDFGL R + + F +
Sbjct: 125 GYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 181
Query: 525 APELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPL 584
APE +T S +SD + +G+ L E+ T + G L +I + L
Sbjct: 182 APESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGL-------NGSQILHKIDKEGERL 234
Query: 585 LNSSYVVKEMELVLKLGLMCSHKTQFRPTMRQVMRYL 621
+++ V+ +HK + RPT + +L
Sbjct: 235 PRPEDCPQDIYNVMV--QCWAHKPEDRPTFVALRDFL 269
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (458), Expect = 2e-52
Identities = 66/270 (24%), Positives = 110/270 (40%), Gaps = 22/270 (8%)
Query: 355 FKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSL---QGMREFAAEIESLGRLRHKN 411
FK +++G G F +V T E A+K + + + + E + + RL H
Sbjct: 10 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 69
Query: 412 LVNLHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHE 471
V L+ + L Y NG L + K D I S L YLH
Sbjct: 70 FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG---SFDETCTRFYTAEIVSALEYLHG 126
Query: 472 EWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGG-MPHTTNVVGTFGYIAPELTQ 530
+ +IHRD+KP N L++ +M+ ++ DFG A++ + VGT Y++PEL
Sbjct: 127 KG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLT 183
Query: 531 TGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSYV 590
A SSD++A G ++ ++ G P +G+ E +I+ + +
Sbjct: 184 EKSACKSSDLWALGCIIYQLVAGLPPFRAGN--------EYLIFQKIIK-LEYDFPEKFF 234
Query: 591 VKEMELVLKLGLMCSHKTQFRPTMRQVMRY 620
K +LV K + R ++ Y
Sbjct: 235 PKARDLVEK---LLVLDATKRLGCEEMEGY 261
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (460), Expect = 2e-52
Identities = 64/303 (21%), Positives = 121/303 (39%), Gaps = 22/303 (7%)
Query: 355 FKESEVIGIGGFGSVYKGVLPTTGGE----VAVKKITR-NSLQGMREFAAEIESLGRLRH 409
FK+ +V+G G FG+VYKG+ G + VA+K++ S + +E E + + +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 410 KNLVNLHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYL 469
++ L G C + + L+ + +P G L L + + + + N IA G+ YL
Sbjct: 71 PHVCRLLGIC-LTSTVQLITQLMPFGCL--LDYVREHKDNIGSQYLLNWCVQIAKGMNYL 127
Query: 470 HEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLAR-LYDHGGMPHTTNVVGTFGYIAPEL 528
+ ++HRD+ N L+ + ++ DFGLA+ L H ++A E
Sbjct: 128 EDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 184
Query: 529 TQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSS 588
+ SDV++YG+ + E+ T G ++ IL+ + L
Sbjct: 185 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI--------PASEISSILEKGERLPQPP 236
Query: 589 YVVKEMELVLKLGLMCSHKTQFRPTMRQVMRYLSGEKQLRFNNDWGSIDYRQGFDEFSSR 648
++ +++ RP R+++ S + D R +
Sbjct: 237 ICTIDVYMIMV--KCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDS 294
Query: 649 TFD 651
F
Sbjct: 295 NFY 297
|
| >d1leda_ b.29.1.1 (A:) Legume lectin {West-central african legume (Griffonia simplicifolia) [TaxId: 3850]} Length = 243 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: West-central african legume (Griffonia simplicifolia) [TaxId: 3850]
Score = 178 bits (453), Expect = 2e-52
Identities = 65/256 (25%), Positives = 99/256 (38%), Gaps = 33/256 (12%)
Query: 26 QSSSFIFQGFNGG----ATNLSLQGAEIIKPSGALKLT------NRSRYVIGHAFYVKPI 75
+ +F + F T ++ G GAL+LT N R G A Y +P+
Sbjct: 2 NTVNFTYPDFWSYSLKNGTEITFLGDATR-IPGALQLTKTDANGNPVRSSAGQASYSEPV 60
Query: 76 QMFDTSASPSPNASSFSTTFVFEISTPRSGRGGHGLAFLLAPSTKLPGAQPEHYLGILNS 135
++D + A+SF T+F F + GLAF LAP +LG+
Sbjct: 61 FLWD----STGKAASFYTSFTF-LLKNYGAPTADGLAFFLAP-VDSSVKDYGGFLGLFRH 114
Query: 136 TNNGEPS-NHILIVEFDTVNGFNDKAENQGNHVGIGINTMFSNRSEPASYYINGTDHKEE 194
+PS N ++ VEFDT + H+GI +N++ S +
Sbjct: 115 ETAADPSKNQVVAVEFDTWINKDWNDPP-YPHIGIDVNSIVSVATTRWEND--------- 164
Query: 195 MTLESGEPIQAWIEYDGEQKVLNVTISPAEIGKPMRPLISFGVNLTGYIKETMYVGFSAS 254
A I YD K+L V +S ++S V+L + + + +GFSA
Sbjct: 165 -DAYGSSIATAHITYDARSKILTVLLSYE---HGRDYILSHVVDLAKVLPQKVRIGFSAG 220
Query: 255 TGEKSSSHYILGWSFS 270
G YIL W F
Sbjct: 221 VG-YDEVTYILSWHFF 235
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 177 bits (451), Expect = 1e-50
Identities = 55/267 (20%), Positives = 104/267 (38%), Gaps = 17/267 (6%)
Query: 355 FKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVN 414
+ E +G G FG V++ V TG K I EI + +L H L+N
Sbjct: 31 YDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLIN 90
Query: 415 LHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWE 474
LH + K +++L+ E++ G L + + + N ++ GL ++HE
Sbjct: 91 LHDAFEDKYEMVLILEFLSGGELFDRIAAE--DYKMSEAEVINYMRQACEGLKHMHEHS- 147
Query: 475 QVVIHRDVKPSNALIDAEMNAR--LGDFGLARLYDHGGMPHTTNVVGTFGYIAPELTQTG 532
++H D+KP N + + + + + DFGLA + + T T + APE+
Sbjct: 148 --IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVT--TATAEFAAPEIVDRE 203
Query: 533 KASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSYVVK 592
+D++A G+L + +G P D + L + ++
Sbjct: 204 PVGFYTDMWAIGVLGYVLLSGLSPFAGED--------DLETLQNVKRCDWEFDEDAFSSV 255
Query: 593 EMELVLKLGLMCSHKTQFRPTMRQVMR 619
E + + + + R T+ +
Sbjct: 256 SPEAKDFIKNLLQKEPRKRLTVHDALE 282
|
| >d1ioaa_ b.29.1.1 (A:) Phytohemagglutinin-L, PHA-L, also arcelin {Kidney bean (Phaseolus vulgaris), G02771, arcelin-5a [TaxId: 3885]} Length = 228 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Phytohemagglutinin-L, PHA-L, also arcelin species: Kidney bean (Phaseolus vulgaris), G02771, arcelin-5a [TaxId: 3885]
Score = 173 bits (439), Expect = 1e-50
Identities = 71/255 (27%), Positives = 104/255 (40%), Gaps = 40/255 (15%)
Query: 25 SQSSSFIFQGFNGGATNLSLQGAEIIKPSGALKLTNRSR------YVIGHAFYVKPIQMF 78
+ +SF F F+ L LQG I G L+LT +G AFY PIQ+
Sbjct: 1 ATETSFNFPNFHTDD-KLILQGNATISSKGQLQLTGVGSNELPRVDSLGRAFYSDPIQIK 59
Query: 79 DTSASPSPNASSFSTTFVFEISTPRSGRGGHGLAFLLAPSTKLPGAQPEHYLGILNSTNN 138
D S N +SF+T F F I +GLAF L P P + + +LG + +TNN
Sbjct: 60 D-----SNNVASFNTNFTFIIRAKNQSISAYGLAFALVPV-NSPPQKKQEFLG-IFNTNN 112
Query: 139 GEPSNHILIVEFDTVNGFNDKAENQGNHVGIGINTMFSNRSEPASYYINGTDHKEEMTLE 198
EP+ + V F+T D N + +E ++
Sbjct: 113 PEPNARTVAVVFNTFKNRID----------FDKNFIKPYVNENCDFHKY----------- 151
Query: 199 SGEPIQAWIEYDGEQKVLNVTISPAEIGKPMRPLISFGVNLTGYIKETMYVGFSASTGEK 258
+GE I YD L V + ++ +S V+L + E + VGFS ++G
Sbjct: 152 NGEKTDVQITYDSSNNDLRVFLHFT--VSQVKCSVSATVHLEKEVDEWVSVGFSPTSGLT 209
Query: 259 S---SSHYILGWSFS 270
+H +L WSFS
Sbjct: 210 EDTTETHDVLSWSFS 224
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 172 bits (438), Expect = 2e-49
Identities = 59/282 (20%), Positives = 114/282 (40%), Gaps = 22/282 (7%)
Query: 355 FKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMRE-FAAEIESLGRLRHKNLV 413
+ +V+G G F V T VA+K I + +L+G EI L +++H N+V
Sbjct: 11 YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIV 70
Query: 414 NLHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEW 473
L + L L+ + + G L + + ++ + + YLH+
Sbjct: 71 ALDDIYESGGHLYLIMQLVSGGELFDRIVEKG---FYTERDASRLIFQVLDAVKYLHDLG 127
Query: 474 EQVVIHRDVKPSNALI---DAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPELTQ 530
++HRD+KP N L D + + DFGL+++ D G + + GT GY+APE+
Sbjct: 128 ---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV--LSTACGTPGYVAPEVLA 182
Query: 531 TGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSYV 590
S + D ++ G++ + G P + + + ++ S
Sbjct: 183 QKPYSKAVDCWSIGVIAYILLCGYPPF-YDENDAKLFEQILKAEYEFDSPYWDDISDSAK 241
Query: 591 VKEMELVLKLGLMCSHKTQFRPTMRQVMR--YLSGEKQLRFN 630
+ + + + R T Q ++ +++G+ L N
Sbjct: 242 ----DFIRH---LMEKDPEKRFTCEQALQHPWIAGDTALDKN 276
|
| >d1dhkb_ b.29.1.1 (B:) Phytohemagglutinin-L, PHA-L, also arcelin {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 204 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Phytohemagglutinin-L, PHA-L, also arcelin species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 165 bits (418), Expect = 6e-48
Identities = 67/249 (26%), Positives = 97/249 (38%), Gaps = 51/249 (20%)
Query: 25 SQSSSFIFQGFNGGATNLSLQGAEIIKPSGALKLTNRSRYVIGHAFYVKPIQMFDTSASP 84
+ +SFI FN TNL LQG + +G L+L+ S + AFY PIQ+ D S
Sbjct: 1 ATETSFIIDAFNK--TNLILQGDATVSSNGNLQLSYNSYDSMSRAFYSAPIQIRD---ST 55
Query: 85 SPNASSFSTTFVFEISTPRSGRGGHGLAFLLAPSTKLPGAQPEHYLGILNSTNNGEPSNH 144
+ N +SF T F I T R GL F+L P E
Sbjct: 56 TGNVASFDTNFTMNIRTHRQANSAVGLDFVLVP-------------------VQPESKGD 96
Query: 145 ILIVEFDTVNGFNDKAENQGNHVGIGINTMFSNRSEPASYYINGTDHKEEMTLESGEPIQ 204
+ VEFDT + + I +N + + G+ +
Sbjct: 97 TVTVEFDTF----------LSRISIDVNNNDIKSVPWDVHDYD------------GQNAE 134
Query: 205 AWIEYDGEQKVLNVTISPAEIGKPMRPLISFGVNLTGYIKETMYVGFSASTGEKSSS--- 261
I Y+ KV +V++S +S V L + + + VGFSA++G S
Sbjct: 135 VRITYNSSTKVFSVSLSN--PSTGKSNNVSTTVELEKEVYDWVSVGFSATSGAYQWSYET 192
Query: 262 HYILGWSFS 270
H +L WSFS
Sbjct: 193 HDVLSWSFS 201
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (426), Expect = 7e-48
Identities = 65/291 (22%), Positives = 116/291 (39%), Gaps = 36/291 (12%)
Query: 355 FKESEVIGIGGFGSVYKGVLPTTGGE-------VAVKKITRNSLQ-GMREFAAEIESLGR 406
+ +G G FG V + VAVK + ++ + + + +E+E +
Sbjct: 15 LVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKM 74
Query: 407 L-RHKNLVNLHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSV-------------LDW 452
+ +HKN++NL G C Q L ++ EY G+L L + + L
Sbjct: 75 IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSS 134
Query: 453 EQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMP 512
+ + +A G+ YL + IHRD+ N L+ + ++ DFGLAR H
Sbjct: 135 KDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY 191
Query: 513 HTTNV-VGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVREC 571
T ++APE + SDV+++G+LL E+ T G
Sbjct: 192 KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG--------VPV 243
Query: 572 HQLGRILDVADPLLNSSYVVKEMELVLKLGLMCSHKTQFRPTMRQVMRYLS 622
+L ++L + S E+ ++++ RPT +Q++ L
Sbjct: 244 EELFKLLKEGHRMDKPSNCTNELYMMMR--DCWHAVPSQRPTFKQLVEDLD 292
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 165 bits (419), Expect = 4e-47
Identities = 52/211 (24%), Positives = 94/211 (44%), Gaps = 15/211 (7%)
Query: 355 FKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQG---MREFAAEIESLGRLRHKN 411
++ E++G GG V+ +VAVK + + + F E ++ L H
Sbjct: 9 YELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 68
Query: 412 LVNLHGWCKQKND----LLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLL 467
+V ++ + + +V EY+ +L ++ + ++ ++ L
Sbjct: 69 IVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADACQALN 125
Query: 468 YLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGG--MPHTTNVVGTFGYIA 525
+ + +IHRDVKP+N +I A ++ DFG+AR G + T V+GT Y++
Sbjct: 126 FS---HQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLS 182
Query: 526 PELTQTGKASTSSDVFAYGILLLEVATGRRP 556
PE + SDV++ G +L EV TG P
Sbjct: 183 PEQARGDSVDARSDVYSLGCVLYEVLTGEPP 213
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (421), Expect = 6e-47
Identities = 50/264 (18%), Positives = 109/264 (41%), Gaps = 20/264 (7%)
Query: 359 EVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNLHGW 418
E +G G FG V++ V ++ K + + EI L RH+N+++LH
Sbjct: 11 EDLGRGEFGIVHRCVETSSKKTYMAKFV-KVKGTDQVLVKKEISILNIARHRNILHLHES 69
Query: 419 CKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVI 478
+ +L++++E+I + + L+ + + V + L +LH +
Sbjct: 70 FESMEELVMIFEFISGLDIFERIN--TSAFELNEREIVSYVHQVCEALQFLHSHN---IG 124
Query: 479 HRDVKPSNALIDAEMNAR--LGDFGLARLYDHGGMPHTTNVVGTFGYIAPELTQTGKAST 536
H D++P N + ++ + +FG AR G Y APE+ Q ST
Sbjct: 125 HFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLF--TAPEYYAPEVHQHDVVST 182
Query: 537 SSDVFAYGILLLEVATGRRP-IGSGDLLLVEWVRECHQLGRILDVADPLLNSSYVVKEME 595
++D+++ G L+ + +G P + + ++E + + A ++ + +
Sbjct: 183 ATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAE--YTFDEEAFKEISIEAM----D 236
Query: 596 LVLKLGLMCSHKTQFRPTMRQVMR 619
V + + + + R T + ++
Sbjct: 237 FVDR---LLVKERKSRMTASEALQ 257
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (415), Expect = 2e-46
Identities = 71/299 (23%), Positives = 116/299 (38%), Gaps = 38/299 (12%)
Query: 355 FKESEVIGIGGFGSVYKGVLP-----TTGGEVAVKKITRNSLQG-MREFAAEIESLGR-L 407
K + +G G FG V + T VAVK + + R +E++ L
Sbjct: 15 LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIG 74
Query: 408 RHKNLVNLHGWCKQKND-LLLVYEYIPNGSLDTLLFKPKD-------------GSVLDWE 453
H N+VNL G C + L+++ E+ G+L T L ++ L E
Sbjct: 75 HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLE 134
Query: 454 QRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLAR-LYDHGGMP 512
+A G+ +L IHRD+ N L+ + ++ DFGLAR +Y
Sbjct: 135 HLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV 191
Query: 513 HTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECH 572
+ ++APE + SDV+++G+LL E+ + G + E+
Sbjct: 192 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC---- 247
Query: 573 QLGRILDVADPLLNSSYVVKEMELVLKLGLMCSHKT-QFRPTMRQVMRYLSGEKQLRFN 630
R L + Y EM + L C H RPT +++ +L L+ N
Sbjct: 248 ---RRLKEGTRMRAPDYTTPEM---YQTMLDCWHGEPSQRPTFSELVEHL--GNLLQAN 298
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 162 bits (411), Expect = 5e-46
Identities = 59/281 (20%), Positives = 111/281 (39%), Gaps = 32/281 (11%)
Query: 355 FKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNS--------LQGMRE-FAAEIESLG 405
++ E++G G V + + T E AVK I +Q +RE E++ L
Sbjct: 5 YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 64
Query: 406 RLR-HKNLVNLHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIAS 464
++ H N++ L + LV++ + G L L + L ++ I++ +
Sbjct: 65 KVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL---TEKVTLSEKETRKIMRALLE 121
Query: 465 GLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYI 524
+ LH+ ++HRD+KP N L+D +MN +L DFG + D G V GT Y+
Sbjct: 122 VICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK--LREVCGTPSYL 176
Query: 525 APELTQTGKA------STSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRIL 578
APE+ + D+++ G+++ + G P + L I+
Sbjct: 177 APEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK--------QMLMLRMIM 228
Query: 579 DVADPLLNSSYVVKEMELVLKLGLMCSHKTQFRPTMRQVMR 619
+ + + + + Q R T + +
Sbjct: 229 SGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (408), Expect = 4e-45
Identities = 55/223 (24%), Positives = 97/223 (43%), Gaps = 12/223 (5%)
Query: 355 FKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSL---QGMREFAAEIESLGR-LRHK 410
F +++G G FG V+ T A+K + ++ + + E L H
Sbjct: 4 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 63
Query: 411 NLVNLHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLH 470
L ++ + K +L V EY+ G L + + D + I GL +L
Sbjct: 64 FLTHMFCTFQTKENLFFVMEYLNGGDLMYHI---QSCHKFDLSRATFYAAEIILGLQFL- 119
Query: 471 EEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPELTQ 530
+ +++RD+K N L+D + + ++ DFG+ + G T GT YIAPE+
Sbjct: 120 --HSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT-FCGTPDYIAPEILL 176
Query: 531 TGKASTSSDVFAYGILLLEVATGRRPI-GSGDLLLVEWVRECH 572
K + S D +++G+LL E+ G+ P G + L +R +
Sbjct: 177 GQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDN 219
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (407), Expect = 1e-44
Identities = 66/275 (24%), Positives = 113/275 (41%), Gaps = 18/275 (6%)
Query: 355 FKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVN 414
+ +++VIG G FG VY+ L +G VA+KK+ LQ R E++ + +L H N+V
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIVR 77
Query: 415 LHGWC------KQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLY 468
L + K + L LV +Y+P + L + + L Y
Sbjct: 78 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 469 LHEEWEQVVIHRDVKPSNALIDAE-MNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAP- 526
+H + HRD+KP N L+D + +L DFG A+ G + + + Y AP
Sbjct: 138 IHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY--ICSRYYRAPE 192
Query: 527 ELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLN 586
+ ++S DV++ G +L E+ G+ GD + + V LG +N
Sbjct: 193 LIFGATDYTSSIDVWSAGCVLAELLLGQPIF-PGDSGVDQLVEIIKVLGTPTREQIREMN 251
Query: 587 SSYVVKEMELVLKLGLMCSHKTQFRPTMRQVMRYL 621
+Y + + + + P + L
Sbjct: 252 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRL 286
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 160 bits (406), Expect = 2e-44
Identities = 53/209 (25%), Positives = 87/209 (41%), Gaps = 16/209 (7%)
Query: 355 FKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQG------MREFAAEIESLGRLR 408
F +IG GGFG VY TG A+K + + ++ + +
Sbjct: 6 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 65
Query: 409 HKNLVNLHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLY 468
+V + + L + + + G L L + I GL +
Sbjct: 66 CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVF---SEADMRFYAAEIILGLEH 122
Query: 469 LHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPEL 528
+H + V++RD+KP+N L+D + R+ D GLA + VGT GY+APE+
Sbjct: 123 MHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKK---KPHASVGTHGYMAPEV 176
Query: 529 TQTGKA-STSSDVFAYGILLLEVATGRRP 556
Q G A +S+D F+ G +L ++ G P
Sbjct: 177 LQKGVAYDSSADWFSLGCMLFKLLRGHSP 205
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (400), Expect = 8e-44
Identities = 59/213 (27%), Positives = 95/213 (44%), Gaps = 7/213 (3%)
Query: 348 LYAATKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMRE-FAAEIESLGR 406
++ + IG G +G V VA+KKI+ Q + EI+ L R
Sbjct: 3 VFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLR 62
Query: 407 LRHKNLVNLHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGL 466
RH+N++ ++ + + Y+ + L+K L + + I GL
Sbjct: 63 FRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGL 122
Query: 467 LYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLY--DHGGMPHTTNVVGTFGYI 524
Y+H V+HRD+KPSN L++ + ++ DFGLAR+ DH T V T Y
Sbjct: 123 KYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYR 179
Query: 525 APELTQTGKASTSS-DVFAYGILLLEVATGRRP 556
APE+ K T S D+++ G +L E+ + R
Sbjct: 180 APEIMLNSKGYTKSIDIWSVGCILAEMLSNRPI 212
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (399), Expect = 1e-43
Identities = 61/270 (22%), Positives = 110/270 (40%), Gaps = 23/270 (8%)
Query: 358 SEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRL-RHKNLVNLH 416
S+V+G+G G V + T + A+K + Q + E+E R + ++V +
Sbjct: 17 SQVLGLGINGKVLQIFNKRTQEKFALKML-----QDCPKARREVELHWRASQCPHIVRIV 71
Query: 417 GWCK----QKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEE 472
+ + LL+V E + G L + + + + I+K I + YLH
Sbjct: 72 DVYENLYAGRKCLLIVMECLDGGELFSRIQD-RGDQAFTEREASEIMKSIGEAIQYLH-- 128
Query: 473 WEQVVIHRDVKPSNALIDAEMN---ARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPELT 529
+ HRDVKP N L ++ +L DFG A+ T T Y+APE+
Sbjct: 129 -SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY--TPYYVAPEVL 185
Query: 530 QTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSY 589
K S D+++ G+++ + G P S L R+ P S
Sbjct: 186 GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL--AISPGMKTRIRMGQYEFPNPEWSE 243
Query: 590 VVKEMELVLKLGLMCSHKTQFRPTMRQVMR 619
V +E++++++ + + R T+ + M
Sbjct: 244 VSEEVKMLIR--NLLKTEPTQRMTITEFMN 271
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (394), Expect = 2e-43
Identities = 61/204 (29%), Positives = 91/204 (44%), Gaps = 7/204 (3%)
Query: 355 FKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSL--QGMREFAAEIESLGRLRHKNL 412
F++ E IG G +G VYK TG VA+KKI ++ EI L L H N+
Sbjct: 4 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 413 VNLHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEE 472
V L +N L LV+E++ + G + + + + GL + H
Sbjct: 64 VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTG--IPLPLIKSYLFQLLQGLAFCHSH 121
Query: 473 WEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPELTQTG 532
V+HRD+KP N LI+ E +L DFGLAR + +T VV + L
Sbjct: 122 R---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCK 178
Query: 533 KASTSSDVFAYGILLLEVATGRRP 556
ST+ D+++ G + E+ T R
Sbjct: 179 YYSTAVDIWSLGCIFAEMVTRRAL 202
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (393), Expect = 3e-43
Identities = 66/283 (23%), Positives = 111/283 (39%), Gaps = 29/283 (10%)
Query: 359 EVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMRE-----FAAEIESLGRLRHKNLV 413
+ +G G F +VYK T VA+KKI ++ EI+ L L H N++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 414 NLHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEW 473
L K+++ LV++++ D + + VL + GL YLH+ W
Sbjct: 64 GLLDAFGHKSNISLVFDFMET---DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW 120
Query: 474 EQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPE-LTQTG 532
++HRD+KP+N L+D +L DFGLA+ + + T+ V T Y APE L
Sbjct: 121 ---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY-THQVVTRWYRAPELLFGAR 176
Query: 533 KASTSSDVFAYGILLLEVATGRRPI--------------GSGDLLLVEWVRECHQLGRIL 578
D++A G +L E+ + G +W C +
Sbjct: 177 MYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVT 236
Query: 579 DVADPLLNSSYVVKEMELVLK--LGLMCSHKTQFRPTMRQVMR 619
+ P + ++ L + + R T Q ++
Sbjct: 237 FKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 154 bits (390), Expect = 1e-42
Identities = 53/205 (25%), Positives = 90/205 (43%), Gaps = 13/205 (6%)
Query: 355 FKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRN---SLQGMREFAAEIESLGRLRHKN 411
F+ +G G FG V+ G A+K + + L+ + E L + H
Sbjct: 6 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 65
Query: 412 LVNLHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHE 471
++ + G + + ++ +YI G L +LL K + + V L L
Sbjct: 66 IIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEV------CLALEY 119
Query: 472 EWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPELTQT 531
+ +I+RD+KP N L+D + ++ DFG A+ T + GT YIAPE+ T
Sbjct: 120 LHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD----VTYTLCGTPDYIAPEVVST 175
Query: 532 GKASTSSDVFAYGILLLEVATGRRP 556
+ S D +++GIL+ E+ G P
Sbjct: 176 KPYNKSIDWWSFGILIYEMLAGYTP 200
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 153 bits (386), Expect = 2e-42
Identities = 69/284 (24%), Positives = 113/284 (39%), Gaps = 26/284 (9%)
Query: 355 FKESEVIGIGGFGSVYKGVLPTTGGEVAVKKI--TRNSLQGMREFAAEIESLGRLRHKNL 412
+ E IG G +G VYK G A+KKI + EI L L+H N+
Sbjct: 4 YHGLEKIGEGTYGVVYKAQNNY-GETFALKKIRLEKEDEGIPSTTIREISILKELKHSNI 62
Query: 413 VNLHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEE 472
V L+ K L+LV+E++ L L+ + + + +G+ Y H+
Sbjct: 63 VKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGG---LESVTAKSFLLQLLNGIAYCHDR 119
Query: 473 WEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPELTQTG 532
V+HRD+KP N LI+ E ++ DFGLAR + +T +V + L +
Sbjct: 120 R---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSK 176
Query: 533 KASTSSDVFAYGILLLEVATGRRP----------------IGSGDLLLVEWVRECHQLGR 576
K ST+ D+++ G + E+ G +G+ + V E +
Sbjct: 177 KYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDP 236
Query: 577 ILDVADPLLNSSYVVKEMELVLKLGLMCSHKT-QFRPTMRQVMR 619
V +PL S++ E + L R T +Q +
Sbjct: 237 NFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (380), Expect = 1e-41
Identities = 61/287 (21%), Positives = 116/287 (40%), Gaps = 29/287 (10%)
Query: 343 FRYKDLYAATKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMR------E 396
FR +++ + E +G G F V K +TG + A K I + + R +
Sbjct: 3 FRQENV---DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRED 59
Query: 397 FAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRF 456
E+ L ++H N++ LH + K D++L+ E + G L L + + L E+
Sbjct: 60 IEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEAT 116
Query: 457 NIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNAR----LGDFGLARLYDHGGMP 512
+K I +G+ YLH + H D+KP N ++ + + DFGLA D G
Sbjct: 117 EFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE- 172
Query: 513 HTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECH 572
N+ GT ++APE+ +D+++ G++ + +G P +
Sbjct: 173 -FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF--------LGDTKQE 223
Query: 573 QLGRILDVADPLLNSSYVVKEMELVLKLGLMCSHKTQFRPTMRQVMR 619
L + V + + + + + R T++ ++
Sbjct: 224 TLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (376), Expect = 3e-41
Identities = 57/242 (23%), Positives = 94/242 (38%), Gaps = 25/242 (10%)
Query: 359 EVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMRE------FAAEIESLGRLR--HK 410
++G GGFGSVY G+ + VA+K + ++ + E E+ L ++
Sbjct: 10 PLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS 69
Query: 411 NLVNLHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLH 470
++ L W ++ + +L+ E + L E + + + +
Sbjct: 70 GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA--LQEELARSFFWQVLEAVRHC- 126
Query: 471 EEWEQVVIHRDVKPSNALIDAE-MNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPELT 529
V+HRD+K N LID +L DFG L T+ GT Y PE
Sbjct: 127 --HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD---TVYTDFDGTRVYSPPEWI 181
Query: 530 QTGKA-STSSDVFAYGILLLEVATGRRP------IGSGDLLLVEWV-RECHQLGRILDVA 581
+ + S+ V++ GILL ++ G P I G + + V EC L R
Sbjct: 182 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCLAL 241
Query: 582 DP 583
P
Sbjct: 242 RP 243
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (368), Expect = 9e-40
Identities = 71/292 (24%), Positives = 115/292 (39%), Gaps = 35/292 (11%)
Query: 355 FKESEVIGIGGFGSVYKGVLPTTGGE-VAVKKITRNS------LQGMREFAAEIESLGRL 407
++ IG G +G V+K GG VA+K++ + L +RE A + L
Sbjct: 9 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIRE-VAVLRHLETF 67
Query: 408 RHKNLVNLHGWC-----KQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGI 462
H N+V L C ++ L LV+E++ L P+ G + E +++ +
Sbjct: 68 EHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPG--VPTETIKDMMFQL 125
Query: 463 ASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFG 522
GL +LH V+HRD+KP N L+ + +L DFGLAR+Y T+VV T
Sbjct: 126 LRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSF--QMALTSVVVTLW 180
Query: 523 YIAPELTQTGKASTSSDVFAYGILLLEVATGRRPI--------------GSGDLLLVEWV 568
Y APE+ +T D+++ G + E+ + G +W
Sbjct: 181 YRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 240
Query: 569 RECHQLGRILDVADPLLNSSYVVKEMELVLKLGLMCSHKT-QFRPTMRQVMR 619
R+ + +V EL L L C R + +
Sbjct: 241 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 145 bits (367), Expect = 9e-40
Identities = 55/300 (18%), Positives = 93/300 (31%), Gaps = 31/300 (10%)
Query: 359 EVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNLHGW 418
IG G FG +Y G G EVA+K + + E + ++ + W
Sbjct: 13 RKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRW 70
Query: 419 CKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVI 478
C + D ++ + SL + + + S + Y+H + I
Sbjct: 71 CGAEGDYNVMVMELLGPSL--EDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN---FI 125
Query: 479 HRDVKPSNALI---DAEMNARLGDFGLARLYDHGG------MPHTTNVVGTFGYIAPELT 529
HRDVKP N L+ + DFGLA+ Y N+ GT Y +
Sbjct: 126 HRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTH 185
Query: 530 QTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSY 589
+ S D+ + G +L+ G P E ++ + L
Sbjct: 186 LGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKG-- 243
Query: 590 VVKEMELVLKLGLMCSHKTQFRPTMRQVMRYLSGEKQLRFNN--------DWGSIDYRQG 641
E L S + +P + + + L DW + +
Sbjct: 244 YPSEFATYLN--FCRSLRFDDKPDYSYLRQLF---RNLFHRQGFSYDYVFDWNMLKFGAS 298
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (366), Expect = 1e-39
Identities = 67/269 (24%), Positives = 112/269 (41%), Gaps = 8/269 (2%)
Query: 355 FKESEVIGIGGFGSVYKGVLPTTGGEVAVKKI--TRNSLQGMREFAAEIESLGRLRHKNL 412
+++ E IG G +G+V+K T VA+K++ + EI L L+HKN+
Sbjct: 4 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNI 63
Query: 413 VNLHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEE 472
V LH L LV+E+ D D E + + + GL + H
Sbjct: 64 VRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDL---DPEIVKSFLFQLLKGLGFCHSR 120
Query: 473 WEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPELTQTG 532
V+HRD+KP N LI+ +L +FGLAR + ++ VV + L
Sbjct: 121 N---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAK 177
Query: 533 KASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSYVVK 592
STS D+++ G + E+A RP+ G+ + + R LG + P + K
Sbjct: 178 LYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYK 237
Query: 593 EMELVLKLGLMCSHKTQFRPTMRQVMRYL 621
+ + + + T R +++ L
Sbjct: 238 PYPMYPATTSLVNVVPKLNATGRDLLQNL 266
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (369), Expect = 1e-39
Identities = 52/210 (24%), Positives = 86/210 (40%), Gaps = 10/210 (4%)
Query: 355 FKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSL---QGMREFAAEIESLGRLRHKN 411
F +++G G FG V TG A+K + + + + E L RH
Sbjct: 7 FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 66
Query: 412 LVNLHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHE 471
L L + + L V EY G L L + + V E+ I S L
Sbjct: 67 LTALKYAFQTHDRLCFVMEYANGGELFFHLSRER---VFTEERARFYGAEIVSA---LEY 120
Query: 472 EWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPELTQT 531
+ V++RD+K N ++D + + ++ DFGL + G GT Y+APE+ +
Sbjct: 121 LHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-ATMKTFCGTPEYLAPEVLED 179
Query: 532 GKASTSSDVFAYGILLLEVATGRRPIGSGD 561
+ D + G+++ E+ GR P + D
Sbjct: 180 NDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 209
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (365), Expect = 3e-39
Identities = 57/216 (26%), Positives = 96/216 (44%), Gaps = 20/216 (9%)
Query: 355 FKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQG--MREFAAEIESLGRLRHKNL 412
+++ IG G FG V+K TG +VA+KK+ + + EI+ L L+H+N+
Sbjct: 12 YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENV 71
Query: 413 VNLHGWC--------KQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIAS 464
VNL C + K + LV+++ + L + +++ + +
Sbjct: 72 VNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK---FTLSEIKRVMQMLLN 128
Query: 465 GLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGG---MPHTTNVVGTF 521
GL Y+H ++HRD+K +N LI + +L DFGLAR + TN V T
Sbjct: 129 GLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTL 185
Query: 522 GYIAPELTQTGKA-STSSDVFAYGILLLEVATGRRP 556
Y PEL + D++ G ++ E+ T
Sbjct: 186 WYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPI 221
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 141 bits (357), Expect = 2e-38
Identities = 49/288 (17%), Positives = 97/288 (33%), Gaps = 27/288 (9%)
Query: 359 EVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRH-KNLVNLHG 417
IG G FG +++G +VA+K R S + E + L + N++
Sbjct: 11 RRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYY 68
Query: 418 WCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVV 477
+ ++ +LV + + D L G + K + + + +HE + +
Sbjct: 69 FGQEGLHNVLVIDLLGPSLEDLLD---LCGRKFSVKTVAMAAKQMLARVQSIHE---KSL 122
Query: 478 IHRDVKPSNALIDAEMN-----ARLGDFGLARLYD------HGGMPHTTNVVGTFGYIAP 526
++RD+KP N LI + + DFG+ + Y H N+ GT Y++
Sbjct: 123 VYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSI 182
Query: 527 ELTQTGKASTSSDVFAYGILLLEVATGR-RPIGSGDLLLVEWVRECHQLGRILDVADPLL 585
+ S D+ A G + + G G + + + + +
Sbjct: 183 NTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCA 242
Query: 586 NSSYVVKEMELVLKLGLMCSHKTQFRPTMRQVMRYLSGE-KQLRFNND 632
+E + + P + S ++L D
Sbjct: 243 GFP---EEFYKYMH--YARNLAFDATPDYDYLQGLFSKVLERLNTTED 285
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 139 bits (352), Expect = 4e-37
Identities = 53/222 (23%), Positives = 91/222 (40%), Gaps = 14/222 (6%)
Query: 355 FKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMRE---FAAEIESLGRLRHKN 411
F + +G G FG V +G A+K + + + +++ E L +
Sbjct: 43 FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 412 LVNLHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHE 471
LV L K ++L +V EY+ G + + L + I YLH
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG---RFSEPHARFYAAQIVLTFEYLHS 159
Query: 472 EWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPELTQT 531
+I+RD+KP N LID + ++ DFG A+ T + GT +APE+ +
Sbjct: 160 LD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWTLCGTPEALAPEIILS 212
Query: 532 GKASTSSDVFAYGILLLEVATGRRPI-GSGDLLLVEWVRECH 572
+ + D +A G+L+ E+A G P + + E +
Sbjct: 213 KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK 254
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (351), Expect = 5e-37
Identities = 51/205 (24%), Positives = 93/205 (45%), Gaps = 9/205 (4%)
Query: 355 FKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITR--NSLQGMREFAAEIESLGRLRHKNL 412
+++ + +G G +G+V V TG +VA+KK+ R S + E+ L +RH+N+
Sbjct: 20 YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENV 79
Query: 413 VNLHGWCKQKNDLLLVYE-YIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHE 471
+ L L + Y+ + T L K L ++ +V + GL Y+H
Sbjct: 80 IGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHA 139
Query: 472 EWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPELTQT 531
HRD+KP N ++ + ++ DFGLAR D T VV + +
Sbjct: 140 AGII---HRDLKPGNLAVNEDCELKILDFGLARQADS---EMTGYVVTRWYRAPEVILNW 193
Query: 532 GKASTSSDVFAYGILLLEVATGRRP 556
+ + + D+++ G ++ E+ TG+
Sbjct: 194 MRYTQTVDIWSVGCIMAEMITGKTL 218
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (329), Expect = 2e-34
Identities = 52/212 (24%), Positives = 98/212 (46%), Gaps = 16/212 (7%)
Query: 355 FKESEVIGIGGFGSVYKGVLPT---TGGEVAVKKITRNSL----QGMREFAAEIESLGRL 407
F+ +V+G G +G V+ + TG A+K + + ++ + E + L +
Sbjct: 26 FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 85
Query: 408 RHK-NLVNLHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGL 466
R LV LH + + L L+ +YI G L T L + + + + + +
Sbjct: 86 RQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYV------GEIV 139
Query: 467 LYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAP 526
L L + +I+RD+K N L+D+ + L DFGL++ + + GT Y+AP
Sbjct: 140 LALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAP 199
Query: 527 ELTQTGKA--STSSDVFAYGILLLEVATGRRP 556
++ + G + + D ++ G+L+ E+ TG P
Sbjct: 200 DIVRGGDSGHDKAVDWWSLGVLMYELLTGASP 231
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (330), Expect = 4e-34
Identities = 49/210 (23%), Positives = 90/210 (42%), Gaps = 19/210 (9%)
Query: 355 FKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSL--QGMREFAAEIESLGRLRHKNL 412
++ + IG G G V VA+KK++R + E+ + + HKN+
Sbjct: 19 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 78
Query: 413 VNLHGWCKQK------NDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGL 466
++L + D+ LV E + + + D E+ ++ + G+
Sbjct: 79 ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL------DHERMSYLLYQMLCGI 132
Query: 467 LYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAP 526
+LH +IHRD+KPSN ++ ++ ++ DFGLAR M T V T Y AP
Sbjct: 133 KHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM--MTPYVVTRYYRAP 187
Query: 527 ELTQTGKASTSSDVFAYGILLLEVATGRRP 556
E+ + D+++ G ++ E+ +
Sbjct: 188 EVILGMGYKENVDIWSVGCIMGEMVRHKIL 217
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 130 bits (328), Expect = 5e-34
Identities = 57/226 (25%), Positives = 89/226 (39%), Gaps = 19/226 (8%)
Query: 355 FKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLR-HKNLV 413
++ +G G + V++ + T +V VK + + + EI+ L LR N++
Sbjct: 37 YQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKK---KIKREIKILENLRGGPNII 93
Query: 414 NLHGWCKQKND--LLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHE 471
L K LV+E++ N L L + I L Y H
Sbjct: 94 TLADIVKDPVSRTPALVFEHVNNTDFKQLYQT------LTDYDIRFYMYEILKALDYCHS 147
Query: 472 EWEQVVIHRDVKPSNALIDAE-MNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPELTQ 530
++HRDVKP N +ID E RL D+GLA Y G V + + PEL
Sbjct: 148 MG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY--NVRVASRYFKGPELLV 202
Query: 531 TGKA-STSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLG 575
+ S D+++ G +L + + P G + VR LG
Sbjct: 203 DYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLG 248
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (316), Expect = 2e-32
Identities = 51/209 (24%), Positives = 93/209 (44%), Gaps = 17/209 (8%)
Query: 355 FKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRN--SLQGMREFAAEIESLGRLRHKNL 412
++ +G G +GSV TG VAVKK++R S+ + E+ L ++H+N+
Sbjct: 20 YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 79
Query: 413 VNLHGWCKQKNDL-----LLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLL 467
+ L L + + ++ L+ ++ K L + ++ I GL
Sbjct: 80 IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK----LTDDHVQFLIYQILRGLK 135
Query: 468 YLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPE 527
Y+H +IHRD+KPSN ++ + ++ DFGLAR D T V +
Sbjct: 136 YIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDD---EMTGYVATRWYRAPEI 189
Query: 528 LTQTGKASTSSDVFAYGILLLEVATGRRP 556
+ + + D+++ G ++ E+ TGR
Sbjct: 190 MLNWMHYNQTVDIWSVGCIMAELLTGRTL 218
|
| >d1nlsa_ b.29.1.1 (A:) Concanavalin A {Jack bean (Canavalia ensiformis) [TaxId: 3823]} Length = 237 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Concanavalin A species: Jack bean (Canavalia ensiformis) [TaxId: 3823]
Score = 118 bits (297), Expect = 1e-30
Identities = 34/133 (25%), Positives = 59/133 (44%), Gaps = 21/133 (15%)
Query: 142 SNHILIVEFDTV--NGFNDKAENQGNHVGIGINTMFSNRSEPASYYINGTDHKEEMTLES 199
++ I+ VE DT D + H+GI I ++ S ++ + +++
Sbjct: 1 ADTIVAVELDTYPNTDIGDPS---YPHIGIDIKSVRSKKTAKWN-------------MQN 44
Query: 200 GEPIQAWIEYDGEQKVLNVTISPAEIGKPMRPLISFGVNLTGYIKETMYVGFSASTGEKS 259
G+ A I Y+ K L+ +S +S+ V+L + E + VG SASTG
Sbjct: 45 GKVGTAHIIYNSVDKRLSAVVSYP---NADSATVSYDVDLDNVLPEWVRVGLSASTGLYK 101
Query: 260 SSHYILGWSFSLN 272
++ IL WSF+
Sbjct: 102 ETNTILSWSFTSK 114
|
| >d1nlsa_ b.29.1.1 (A:) Concanavalin A {Jack bean (Canavalia ensiformis) [TaxId: 3823]} Length = 237 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Concanavalin A species: Jack bean (Canavalia ensiformis) [TaxId: 3823]
Score = 101 bits (254), Expect = 5e-25
Identities = 33/132 (25%), Positives = 56/132 (42%), Gaps = 12/132 (9%)
Query: 13 FFFFIRLNIVAQSQSSSFIFQGFNGGATNLSLQGAEIIKPSGALKLTNRSRYV------I 66
F ++ N ++ + F+F F+ +L LQG G L+LT S +
Sbjct: 111 FTSKLKSNSTHETNALHFMFNQFSKDQKDLILQGDATTGTDGNLELTRVSSNGSPQGSSV 170
Query: 67 GHAFYVKPIQMFDTSASPSPNASSFSTTFVFEISTPRSGRGGHGLAFLLAP-STKLPGAQ 125
G A + P+ +++ S +SF TF F I +P S G+AF ++ + +P
Sbjct: 171 GRALFYAPVHIWE----SSAVVASFEATFTFLIKSPDSH-PADGIAFFISNIDSSIPSGS 225
Query: 126 PEHYLGILNSTN 137
LG+ N
Sbjct: 226 TGRLLGLFPDAN 237
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 113 bits (283), Expect = 7e-28
Identities = 47/237 (19%), Positives = 86/237 (36%), Gaps = 20/237 (8%)
Query: 359 EVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNLHGW 418
+G G F +V+ VA+K + R EI+ L R+ +
Sbjct: 19 RKLGWGHFSTVWLAKDMVNNTHVAMKIV-RGDKVYTEAAEDEIKLLQRVNDADNTKEDSM 77
Query: 419 C-------------KQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASG 465
K N + +V + G L K + + I K + G
Sbjct: 78 GANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLG 137
Query: 466 LLYLHEEWEQVVIHRDVKPSNALIDAE-MNARLGDFGLARLYDHGG-MPHTTNVVGTFGY 523
L Y+H +IH D+KP N L++ L +A L + H TN + T Y
Sbjct: 138 LDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREY 195
Query: 524 IAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDV 580
+PE+ +D+++ L+ E+ TG + + ++ + +I+++
Sbjct: 196 RSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGH--SYTKDDDHIAQIIEL 250
|
| >d1gv9a_ b.29.1.13 (A:) Carbohydrate-recognition domain of P58/ERGIC-53 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 228 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Lectin leg-like domain: Carbohydrate-recognition domain of P58/ERGIC-53 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 98.7 bits (245), Expect = 5e-24
Identities = 34/234 (14%), Positives = 62/234 (26%), Gaps = 30/234 (12%)
Query: 36 NGGATNLSLQGAEIIKPSGALKLTNRSRYVIGHAFYVKPIQMFDTSASPSPNASSFSTTF 95
+G + G I + +++ + G + ++
Sbjct: 20 DGTVPFWAHAGNAIPS-ADQIRIAPSLKSQRGSVWTKTKA-----------AFENWEVEV 67
Query: 96 VFEISTPRSGRGGHGLAFLLAPSTKLPGAQPEHYLGILNSTNNGEPSNHILIVEFDTVNG 155
T R G GLA + L G G + + + + FD+ +
Sbjct: 68 -TFRVTGRGRIGADGLAIWYTENQGLDGP----VFGSADM-------WNGVGIFFDSFDN 115
Query: 156 FNDKAENQGNHVGIGINTMFSNRSEPASYYINGTDHKEEMTLESGEPIQAWIEYDGEQKV 215
+ + N N + P++A I Y QK
Sbjct: 116 DGK---KNNPAIVVVGNNGQINYDHQNDGATQALASCQRDFRNKPYPVRAKITYY--QKT 170
Query: 216 LNVTISPAEIGKPMRPLISFGVNLTGYIKETMYVGFSASTGEKSSSHYILGWSF 269
L V I+ I + G SA+TG + H +L +
Sbjct: 171 LTVMINNGFTPDKNDYEFCA-KVENMVIPTQGHFGISAATGGLADDHDVLSFLT 223
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 89.5 bits (221), Expect = 4e-21
Identities = 28/160 (17%), Positives = 51/160 (31%), Gaps = 21/160 (13%)
Query: 359 EVIGIGGFGSVYKGVLPTTGGEVAVK----------KITRNSLQGMREFAAEIESLGRLR 408
+++G G +V+ GE VK K+ G F+ R
Sbjct: 6 KLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNE 64
Query: 409 HKNLVNLHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLY 468
+ L L G K Y + N ++ L K+ + E ++ I +
Sbjct: 65 FRALQKLQGLAVPKV-----YAWEGN-AVLMELIDAKELYRVRVENPDEVLDMILEEVAK 118
Query: 469 LHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDH 508
+ ++H D+ N L+ E + DF +
Sbjct: 119 FYHRG---IVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGE 154
|
| >d2a6va1 b.29.1.13 (A:9-226) Emp46p N-terminal domain {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 218 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Lectin leg-like domain: Emp46p N-terminal domain species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 56.5 bits (136), Expect = 1e-09
Identities = 33/247 (13%), Positives = 62/247 (25%), Gaps = 43/247 (17%)
Query: 25 SQSSSFIFQGFNGGATNLSLQGAEIIKPSGALKLTNRSRYVIGHAFYVKPIQMFDTSASP 84
S + + +L + G LT + G + + D
Sbjct: 7 SLPNLLEVTDQQKELSQWTLGDKVKL-EEGRFVLT-PGKNTKGSLWLKPEYSIKD----- 59
Query: 85 SPNASSFSTTFVFEISTPRSGRGGHGLAFLLAPSTKLPGAQPE-HYLGILNSTNNGEPSN 143
+ + + F G GLAF L + + N
Sbjct: 60 -----AMTIEWTFRSFGF-RGSTKGGLAFWLKQGNEGDSTELFGGSSKKFNG-------- 105
Query: 144 HILIVEFDTVNGFNDKAENQGNHVGIGINTMFSNRSEPASYYINGTDHKEEMTLESGEPI 203
L++ + G V +N + +S Y + +S P
Sbjct: 106 --LMILLRLDD-------KLGESVTAYLNDGTKDLDIESSPYFASCLFQ---YQDSMVPS 153
Query: 204 QAWIEYD-GEQKVLNVTISPAEIGKPMRPLISFGVNLTGYIKETMYVGFSASTGEKSSSH 262
+ Y+ + +L + + + + V G +G SA S
Sbjct: 154 TLRLTYNPLDNHLLKLQMDNRVCFQ------TRKVKFMGS--SPFRIGTSAINDASKESF 205
Query: 263 YILGWSF 269
IL
Sbjct: 206 EILKMKL 212
|
| >d2a6za1 b.29.1.13 (A:7-227) Emp47p N-terminal domain {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 221 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Lectin leg-like domain: Emp47p N-terminal domain species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 52.3 bits (125), Expect = 3e-08
Identities = 33/237 (13%), Positives = 68/237 (28%), Gaps = 42/237 (17%)
Query: 41 NLSLQGAEIIKPSGALKLTNRSRYVIGHAFYVKPIQMFDTSASPSPNASSFSTTFVFEIS 100
N ++ G + LT+ ++ G + + + D SF+ + F
Sbjct: 24 NWQTGEQASLE-EGRIVLTS-NQNSKGSLWLKQGFDLKD----------SFTMEWTFRSV 71
Query: 101 TPRSGRGGHGLAFLLAPSTKLPGAQPEHYLGILNSTNNGEPSNHILIVEFDTVNGFNDKA 160
SG+ G++F + +P + + +G L + D
Sbjct: 72 GY-SGQTDGGISFWFVQDSNIPRDKQLYNGP---VNYDG------LQLLVDNNG------ 115
Query: 161 ENQGNHVGIGINTMFSNRSEPASYYINGTDHKEEMTLESGEPIQAWIEYD-GEQKVLNVT 219
G + +N + Y +S P + YD + +L V
Sbjct: 116 -PLGPTLRGQLNDG-QKPVDKTKIYDQSFASCLMGYQDSSVPSTIRVTYDLEDDNLLKVQ 173
Query: 220 ISPAEIGKPMRPLISFGVNLTGYIKETMYVGFSASTGEKSSSHYILGW-SFSL-NGV 274
+ + V + +G +A G +++ NGV
Sbjct: 174 VDNKVC------FQTRKVRF---PSGSYRIGVTAQNGAVNNNAESFEIFKMQFFNGV 221
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 668 | |||
| d1hqla_ | 236 | Legume lectin {Griffonia simplicifolia, lectin I-b | 100.0 | |
| d1qnwa_ | 237 | Legume lectin {Furze (Ulex europaeus), UEA-II [Tax | 100.0 | |
| d1fx5a_ | 240 | Legume lectin {Furze (Ulex europaeus), UEA-I [TaxI | 100.0 | |
| d1leda_ | 243 | Legume lectin {West-central african legume (Griffo | 100.0 | |
| d1gzca_ | 239 | Legume lectin {Cockspur coral tree (Erythrina cris | 100.0 | |
| d2d3sa1 | 237 | Legume lectin {Winged bean (Psophocarpus tetragono | 100.0 | |
| d1g9fa_ | 251 | Legume lectin {Soybean (Glycine max) [TaxId: 3847] | 100.0 | |
| d1f9ka_ | 234 | Legume lectin {Winged bean (Psophocarpus tetragono | 100.0 | |
| d1dbna_ | 239 | Legume lectin {Maackia amurensis, leukoagglutinin | 100.0 | |
| d1n47a_ | 233 | Legume lectin {Hairy vetch (Vicia villosa), isolec | 100.0 | |
| d1g8wa_ | 233 | Phytohemagglutinin-L, PHA-L, also arcelin {Kidney | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1v6ia_ | 232 | Legume lectin {Peanut (Arachis hypogaea) [TaxId: 3 | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1g7ya_ | 253 | Legume lectin {Horse gram (Dolichos biflorus), dif | 100.0 | |
| d1fnya_ | 237 | Legume lectin {Black locust (Robinia pseudoacacia) | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| g1qmo.1 | 230 | Legume lectin {Field bean (Dolichos lablab), Fril | 100.0 | |
| d1ukga_ | 241 | Legume lectin {Bloodwood tree (Pterocarpus angolen | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| g2ltn.1 | 229 | Legume lectin {Garden pea (Pisum sativum) [TaxId: | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1ioaa_ | 228 | Phytohemagglutinin-L, PHA-L, also arcelin {Kidney | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1avba_ | 226 | Phytohemagglutinin-L, PHA-L, also arcelin {Kidney | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1dhkb_ | 204 | Phytohemagglutinin-L, PHA-L, also arcelin {Kidney | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1nlsa_ | 237 | Concanavalin A {Jack bean (Canavalia ensiformis) [ | 99.95 | |
| d1gv9a_ | 228 | Carbohydrate-recognition domain of P58/ERGIC-53 {R | 99.94 | |
| d1nlsa_ | 237 | Concanavalin A {Jack bean (Canavalia ensiformis) [ | 99.9 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.86 | |
| d2a6za1 | 221 | Emp47p N-terminal domain {Baker's yeast (Saccharom | 99.81 | |
| d2a6va1 | 218 | Emp46p N-terminal domain {Baker's yeast (Saccharom | 99.79 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.49 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.69 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.37 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.46 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.23 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.47 |
| >d1hqla_ b.29.1.1 (A:) Legume lectin {Griffonia simplicifolia, lectin I-b4 [TaxId: 3850]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Griffonia simplicifolia, lectin I-b4 [TaxId: 3850]
Probab=100.00 E-value=8.3e-54 Score=424.26 Aligned_cols=226 Identities=31% Similarity=0.533 Sum_probs=196.5
Q ss_pred ceeEEeCCCCCC-CCCeEEeCceeeCCCCcEEccCCC------CceEEEEEeeCceecccCCCCCCCCeeeeEEEEEEEE
Q 005940 27 SSSFIFQGFNGG-ATNLSLQGAEIIKPSGALKLTNRS------RYVIGHAFYVKPIQMFDTSASPSPNASSFSTTFVFEI 99 (668)
Q Consensus 27 ~~~f~~~~f~~~-~~~l~~~g~a~~~~~~~~~lt~~~------~~~~G~~~y~~p~~l~~~~~~~~~~~~sF~t~F~f~i 99 (668)
+++|+|++|.++ ..+|+|+|+|.+. +|.|+||+.. ..++|||+|++||+||+ +.+++++||+|+|+|.|
T Consensus 1 ~~sF~f~~F~~~~~~~l~l~G~A~~~-~~~l~LT~~~~~~~~~~~s~Gra~y~~Pv~l~~---~~t~~~asFsT~F~F~i 76 (236)
T d1hqla_ 1 SVSFTFPNFWSDVEDSIIFQGDANTT-AGTLQLCKTNQYGTPLQWSAGRALYSDPVQLWD---NKTESVASFYTEFTFFL 76 (236)
T ss_dssp CCEEEESCSCSCGGGTEEEEETCEEE-TTEEECSCBCTTSCBCSSCEEEEEESSCEECCC---STTCCCCEEEEEEEEEE
T ss_pred CEEEEeCCCCCCCcCCEEEeccEEec-CCEEEEecCCCCCcccccceEEEEECCCEEeec---CCCCceeEEEEEEEEEE
Confidence 479999999865 5689999999995 8999999754 45789999999999999 88999999999999999
Q ss_pred eCCCCCCCCCceEEEEcCCCCCCCCCCCCcccccccCCCCC-CCccEEEEEeecccCCCCCCCCCCCeeeeecCCccccc
Q 005940 100 STPRSGRGGHGLAFLLAPSTKLPGAQPEHYLGILNSTNNGE-PSNHILIVEFDTVNGFNDKAENQGNHVGIGINTMFSNR 178 (668)
Q Consensus 100 ~~~~~~~~g~GlaF~l~p~~~~~~~~~~~~lGl~~~~~~~~-~~~~~~aVEfDt~~n~~d~~~~~~~Hvgid~~s~~s~~ 178 (668)
.+. ...+||||||||+|... +.+..|++||+++..+++. ..+++|||||||++|. +.+||++||||||+|++.|.+
T Consensus 77 ~~~-~~~~gDGlAFvl~p~~~-~~~~~G~~lGl~~~~~~~~~~~~~~vAVEFDT~~n~-~~~D~~~nHIgIdvns~~s~~ 153 (236)
T d1hqla_ 77 KIT-GNGPADGLAFFLAPPDS-DVKDAGEYLGLFNKSTATQPSKNQVVAVEFDTWTNP-NFPEPSYRHIGINVNSIVSVA 153 (236)
T ss_dssp EEC-SSCCCCEEEEEEECTTC-CCCCCGGGTTTSCTTTTTCGGGCCCEEEEEECSCCS-SSCCCSSCEEEEEESSSSCSE
T ss_pred eCC-CCCCCceEEEEEeCCCC-CCCCCccccccccccccCCcccCceEEEEeeCccCC-CCCCCCCCEEEEEcCCccccc
Confidence 875 46789999999999764 3356899999999766544 5789999999999993 223499999999999999988
Q ss_pred ccCCccccCCCCCccccccCCCCcEEEEEEEeCCcceEEEEEEeCCCCCCCCcceeeeeccccccccceeeeeecccCCc
Q 005940 179 SEPASYYINGTDHKEEMTLESGEPIQAWIEYDGEQKVLNVTISPAEIGKPMRPLISFGVNLTGYIKETMYVGFSASTGEK 258 (668)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~V~~~~~~~~~p~~~~ls~~~dLs~~l~~~~~vGFsastG~~ 258 (668)
+.++. ..++.+|+.++|||+||+..++|+|+|++. +|..|+|++.+||+++|+++|||||||+||..
T Consensus 154 ~~~~~----------~~~l~~G~~~~v~I~Yd~~~~~L~V~l~~~---~~~~~~ls~~vdL~~~l~~~v~vGFSasTG~~ 220 (236)
T d1hqla_ 154 TKRWE----------DSDIFSGKIATARISYDGSAEILTVVLSYP---DGSDYILSHSVDMRQNLPESVRVGISASTGNN 220 (236)
T ss_dssp EEECC----------HHHHTSCSCEEEEEEEETTTTEEEEEEEET---TTEEEEEEEECCGGGTSCSEEEEEEEEECCSC
T ss_pred ccccc----------cccccCCCEEEEEEEEeCCCcEEEEEEecC---CCCCeeEEEEeCHHHhCCCcEEEEEEeECCCC
Confidence 87653 467889999999999999999999999975 46788999999999999999999999999974
Q ss_pred -ccceeeeccccccc
Q 005940 259 -SSSHYILGWSFSLN 272 (668)
Q Consensus 259 -~~~~~i~~w~F~~~ 272 (668)
.+.|+|++|+|+++
T Consensus 221 ~~~~h~I~sWsF~s~ 235 (236)
T d1hqla_ 221 QFLTVYILSWRFSSN 235 (236)
T ss_dssp CCEEEEEEEEEEEEE
T ss_pred CceEEEEEEeEeEec
Confidence 67799999999874
|
| >d1qnwa_ b.29.1.1 (A:) Legume lectin {Furze (Ulex europaeus), UEA-II [TaxId: 3902]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Furze (Ulex europaeus), UEA-II [TaxId: 3902]
Probab=100.00 E-value=1.5e-52 Score=417.43 Aligned_cols=227 Identities=32% Similarity=0.544 Sum_probs=200.0
Q ss_pred CceeEEeCCCCCCCCCeEEeCceeeCCCCcEEccCCC---CceEEEEEeeCceecccCCCCCCCCeeeeEEEEEEEEeCC
Q 005940 26 QSSSFIFQGFNGGATNLSLQGAEIIKPSGALKLTNRS---RYVIGHAFYVKPIQMFDTSASPSPNASSFSTTFVFEISTP 102 (668)
Q Consensus 26 ~~~~f~~~~f~~~~~~l~~~g~a~~~~~~~~~lt~~~---~~~~G~~~y~~p~~l~~~~~~~~~~~~sF~t~F~f~i~~~ 102 (668)
++++|+|++|.+++.||+|+|+|.+.++|.|+||+.. ..++|||+|++||+||+ +.+++++||+|+|+|.|.++
T Consensus 2 ~~lsF~f~~F~~~~~~l~l~GdA~i~~~g~l~LT~~~~~~~~~~G~a~y~~Pi~l~~---~~~~~~~sF~t~F~f~i~~~ 78 (237)
T d1qnwa_ 2 DDLSFNFDKFVPNQKNIIFQGDASVSTTGVLQVTKVSKPTTTSIGRALYAAPIQIWD---SITGKVASFATSFSFVVKAD 78 (237)
T ss_dssp CSEEEEESSCCTTCTTEEEEETCEECTTSCEESSCCC--CCCEEEEEEESSCEECBC---TTTCCBCEEEEEEEEECCBS
T ss_pred CcEEEEcCCCCCCCCCEEEeeceEEcCCCeEEeccCCCCccccEEEEEECCCEEecC---CCCcceeeEEEEEEEEEecC
Confidence 5799999999988889999999999888999999765 46899999999999999 88999999999999999876
Q ss_pred CCCCCCCceEEEEcCCC-CCCCCCCCCcccccccCCCCCCCccEEEEEeecccCC-CCCCCCCCCeeeeecCCccccccc
Q 005940 103 RSGRGGHGLAFLLAPST-KLPGAQPEHYLGILNSTNNGEPSNHILIVEFDTVNGF-NDKAENQGNHVGIGINTMFSNRSE 180 (668)
Q Consensus 103 ~~~~~g~GlaF~l~p~~-~~~~~~~~~~lGl~~~~~~~~~~~~~~aVEfDt~~n~-~d~~~~~~~Hvgid~~s~~s~~~~ 180 (668)
+ ..+||||||+|+|.. ..+.++.++++|+.+.. ++.+.+++|||||||++|. .+.+||++||||||+|++.|.+++
T Consensus 79 ~-~~ggdG~aF~l~p~~~~~~~~~~~~~~g~~~~~-~~~~~~~~vAVEFDT~~n~~~~~~d~~~nHvgid~ns~~s~~~~ 156 (237)
T d1qnwa_ 79 K-SDGVDGLAFFLAPANSQIPSGSSAGMFGLFSSS-DSKSSNQIIAVEFDTYFGKAYNPWDPDFKHIGIDVNSIKSIKTV 156 (237)
T ss_dssp S-SCCCCEEEEEEEETTCCCCTTCCGGGTTTCSSS-SCCTTSCCEEEEEECCCCTTTCTTSCSSCEEEEEESSSSCSEEE
T ss_pred C-CCCcceeEEEEeCCCCCCCCCCccccccccCCC-CCCCcccEEEEEeeceecCCcCCCCCCCCeEEEECCCCCccccc
Confidence 4 568999999999976 45778888899998854 3567899999999999982 244569999999999999988766
Q ss_pred CCccccCCCCCccccccCCCCcEEEEEEEeCCcceEEEEEEeCCCCCCCCcceeeeeccccccccceeeeeecccCCcc-
Q 005940 181 PASYYINGTDHKEEMTLESGEPIQAWIEYDGEQKVLNVTISPAEIGKPMRPLISFGVNLTGYIKETMYVGFSASTGEKS- 259 (668)
Q Consensus 181 ~~~~~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~V~~~~~~~~~p~~~~ls~~~dLs~~l~~~~~vGFsastG~~~- 259 (668)
+ ..+.+|+.++|||+||+..++|+|+|++.. +|..|+|++.+||+++|+++|||||||+||...
T Consensus 157 ~-------------~~~~~G~~~~v~I~Yd~~~~~L~V~l~~~~--~~~~p~ls~~vDLs~~l~~~vyvGFSasTG~~~~ 221 (237)
T d1qnwa_ 157 K-------------WDWRNGEVADVVITYRAPTKSLTVCLSYPS--DGTSNIITASVDLKAILPEWVSVGFSGGVGNAAE 221 (237)
T ss_dssp E-------------CCCCTTCCEEEEEEEEGGGTEEEEEEECTT--TCCEEEEEEECCHHHHSCSEEEEEEEEEESCGGG
T ss_pred c-------------cccCCCcEEEEEEEEcCCCcEEEEEEecCC--CCccceEEEEEChHHhCCCcEEEEEEeECCCCCC
Confidence 5 356789999999999999999999998654 788999999999999999999999999999864
Q ss_pred -cceeeeccccccc
Q 005940 260 -SSHYILGWSFSLN 272 (668)
Q Consensus 260 -~~~~i~~w~F~~~ 272 (668)
|.|+|++|+|+++
T Consensus 222 ~q~h~I~sWsF~s~ 235 (237)
T d1qnwa_ 222 FETHDVLSWYFTSN 235 (237)
T ss_dssp CBCCEEEEEEEEEE
T ss_pred ccEeEEEEeEeEEe
Confidence 8999999999874
|
| >d1fx5a_ b.29.1.1 (A:) Legume lectin {Furze (Ulex europaeus), UEA-I [TaxId: 3902]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Furze (Ulex europaeus), UEA-I [TaxId: 3902]
Probab=100.00 E-value=1.1e-52 Score=418.89 Aligned_cols=229 Identities=27% Similarity=0.412 Sum_probs=200.2
Q ss_pred CceeEEeCCCCCCCCCeEEeCceeeCCCCcEEccCCC----CceEEEEEeeCceecccCCCCCCCCeeeeEEEEEEEEeC
Q 005940 26 QSSSFIFQGFNGGATNLSLQGAEIIKPSGALKLTNRS----RYVIGHAFYVKPIQMFDTSASPSPNASSFSTTFVFEIST 101 (668)
Q Consensus 26 ~~~~f~~~~f~~~~~~l~~~g~a~~~~~~~~~lt~~~----~~~~G~~~y~~p~~l~~~~~~~~~~~~sF~t~F~f~i~~ 101 (668)
++++|+|++|++++.||+|+|+|.+.++|.|+||+.. ..++|||+|++||+||+ +.+++++||+|+|+|.|..
T Consensus 2 ~~~sF~f~~F~~~~~~l~l~G~A~~~~~g~l~LT~~~~~~~~~~~G~a~y~~Pv~l~~---~~t~~~~sF~t~F~f~i~~ 78 (240)
T d1fx5a_ 2 DDLSFKFKNFSQNGKDLSFQGNASVIETGVLQLNKVGNNLPDETGGIARYIAPIHIWN---CNTGELASFITSFSFFMET 78 (240)
T ss_dssp CEEEEEESSCCTTCSSEEEEETCEECTTSCEESCCCSSSSCSEEEEEEEESSCEECEE---TTTTEECEEEEEEEEEEEE
T ss_pred CceEEECCCCCCCCCCEEEeeeeEecCCCEEEccCCCCCCccceeEEEecCCCceeec---CCCCceeeeEEEEEEEEeC
Confidence 5789999999987789999999999888999999765 35889999999999999 8899999999999999965
Q ss_pred C-CCCCCCCceEEEEcCCCCCCCCCCCCcccccccCCCCCCCccEEEEEeecccCCCCCCCCCCCeeeeecCCccccccc
Q 005940 102 P-RSGRGGHGLAFLLAPSTKLPGAQPEHYLGILNSTNNGEPSNHILIVEFDTVNGFNDKAENQGNHVGIGINTMFSNRSE 180 (668)
Q Consensus 102 ~-~~~~~g~GlaF~l~p~~~~~~~~~~~~lGl~~~~~~~~~~~~~~aVEfDt~~n~~d~~~~~~~Hvgid~~s~~s~~~~ 180 (668)
+ +...+||||||+|+|.. .|.+..|++|||++.++ ++..+++|||||||++|..+.+||++||||||+|++.|..+.
T Consensus 79 ~~~~~~ggdG~AFvl~p~~-~~~~~~g~~lGl~~~~~-~~~~~~~vAVEFDT~~n~~~~~D~~~nHIgid~ns~~s~~~~ 156 (240)
T d1fx5a_ 79 SANPKAATDGLTFFLAPPD-SPLRRAGGYFGLFNDTK-CDSSYQTVAVEFDTIGSPVNFWDPGFPHIGIDVNCVKSINAE 156 (240)
T ss_dssp SSCGGGCCCEEEEEEECTT-CCCCBCGGGTTTBSSSC-CCGGGCCEEEEEECCCTTTSTTSCSSCEEEEEESSSSCSEEE
T ss_pred CCCCCCCCCcEEEEECCCC-CCCCCCCccccccccCC-CCccCceEEEEeeccccccccCCCCCCceEEccCCccccccc
Confidence 4 34567999999999965 46688999999998755 456789999999999984344559999999999999988776
Q ss_pred CCccccCCCCCccccccCCCCcEEEEEEEeCCcceEEEEEEeCCCCCCCCcceeeeeccccccccceeeeeecccCC-cc
Q 005940 181 PASYYINGTDHKEEMTLESGEPIQAWIEYDGEQKVLNVTISPAEIGKPMRPLISFGVNLTGYIKETMYVGFSASTGE-KS 259 (668)
Q Consensus 181 ~~~~~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~V~~~~~~~~~p~~~~ls~~~dLs~~l~~~~~vGFsastG~-~~ 259 (668)
++. ..+.+|+.++|||+||+..++|+|+|++.+ +|..|+|+..+||+.+|+++|||||||+||. ..
T Consensus 157 ~~~-----------~~~~~g~~~~v~I~Yd~~~~~L~V~l~~~~--~~~~~~ls~~vdLs~~l~~~v~vGFSasTG~~~~ 223 (240)
T d1fx5a_ 157 RWN-----------KRYGLNNVANVEIIYEASSKTLTASLTYPS--DQTSISVTSIVDLKEILPEWVSVGFSGSTYIGRQ 223 (240)
T ss_dssp ECC-----------CCCSGGGCEEEEEEEETTTTEEEEEEEETT--TTEEEEEEEECCGGGTSCSEEEEEEEEEEETTSC
T ss_pred ccc-----------cccCCCCeEEEEEEEcCCCCEEEEEEecCC--CceeeEEeEEEchHHhCCCcEEEEEEeECCCCCC
Confidence 543 456789999999999999999999999765 6778999999999999999999999999995 67
Q ss_pred cceeeeccccccc
Q 005940 260 SSHYILGWSFSLN 272 (668)
Q Consensus 260 ~~~~i~~w~F~~~ 272 (668)
|.|+|++|+|+++
T Consensus 224 ~~H~I~sWsFsst 236 (240)
T d1fx5a_ 224 ATHEVLNWYFTST 236 (240)
T ss_dssp EEEEEEEEEEEEE
T ss_pred ceEEEEEEEeEEe
Confidence 8999999999875
|
| >d1leda_ b.29.1.1 (A:) Legume lectin {West-central african legume (Griffonia simplicifolia) [TaxId: 3850]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: West-central african legume (Griffonia simplicifolia) [TaxId: 3850]
Probab=100.00 E-value=1.1e-52 Score=417.53 Aligned_cols=223 Identities=29% Similarity=0.470 Sum_probs=194.8
Q ss_pred CceeEEeCCCCCC----CCCeEEeCceeeCCCCcEEccCCC------CceEEEEEeeCceecccCCCCCCCCeeeeEEEE
Q 005940 26 QSSSFIFQGFNGG----ATNLSLQGAEIIKPSGALKLTNRS------RYVIGHAFYVKPIQMFDTSASPSPNASSFSTTF 95 (668)
Q Consensus 26 ~~~~f~~~~f~~~----~~~l~~~g~a~~~~~~~~~lt~~~------~~~~G~~~y~~p~~l~~~~~~~~~~~~sF~t~F 95 (668)
++++|+|++|.+. ..||+|+|+|.+. +|.|+||+.. .+++|||+|++||+||+ + +++++||+|+|
T Consensus 2 ~s~sF~f~~F~~~~~~~~~~l~l~G~A~~~-~g~l~LT~~~~~~~~~~~s~Gra~y~~Pv~l~~---~-t~~~asFsT~F 76 (243)
T d1leda_ 2 NTVNFTYPDFWSYSLKNGTEITFLGDATRI-PGALQLTKTDANGNPVRSSAGQASYSEPVFLWD---S-TGKAASFYTSF 76 (243)
T ss_dssp CCCEEEESCBCCTTSCTTTSEEEEETCEEE-TBEEECSCBCTTSCBCSSEEEEEEESSCEECBC---T-TSCBCEEEEEE
T ss_pred CceEEEcCCCCCCCCCCCCcEEEeeeeEEc-CCEEEeccCCCCCCccccceEEEEeCCCeEecC---C-CCcEeeEEEEE
Confidence 5789999999753 4789999999996 8999999644 35899999999999998 4 67899999999
Q ss_pred EEEEeCCCCCCCCCceEEEEcCCCCCCCCCCCCcccccccCCCCC-CCccEEEEEeecccC--CCCCCCCCCCeeeeecC
Q 005940 96 VFEISTPRSGRGGHGLAFLLAPSTKLPGAQPEHYLGILNSTNNGE-PSNHILIVEFDTVNG--FNDKAENQGNHVGIGIN 172 (668)
Q Consensus 96 ~f~i~~~~~~~~g~GlaF~l~p~~~~~~~~~~~~lGl~~~~~~~~-~~~~~~aVEfDt~~n--~~d~~~~~~~Hvgid~~ 172 (668)
+|.|.+. ...+||||||||+|... +.+..|++||+++..++++ ..+++|||||||++| ++| |++||||||+|
T Consensus 77 ~f~i~~~-~~~~gdGlAF~l~p~~~-~~~~~g~~lGl~~~~~~~~~~~~~~vAVEFDT~~n~~~~d---~~~nHVgIdvn 151 (243)
T d1leda_ 77 TFLLKNY-GAPTADGLAFFLAPVDS-SVKDYGGFLGLFRHETAADPSKNQVVAVEFDTWINKDWND---PPYPHIGIDVN 151 (243)
T ss_dssp EEEEEES-SSSCBCEEEEEEEETTC-CCCCCGGGTTTCCTTTTTCGGGCCCEEEEEECSCCGGGTC---CSSCEEEEEES
T ss_pred EEEcCCC-CCCCCCceEEEEcCCCC-CCCCCccccccccccccCCCccCcEEEEEEeCccccccCC---CCCCceEEEec
Confidence 9988765 35689999999999764 4456799999999876655 478999999999999 345 99999999999
Q ss_pred CcccccccCCccccCCCCCccccccCCCCcEEEEEEEeCCcceEEEEEEeCCCCCCCCcceeeeeccccccccceeeeee
Q 005940 173 TMFSNRSEPASYYINGTDHKEEMTLESGEPIQAWIEYDGEQKVLNVTISPAEIGKPMRPLISFGVNLTGYIKETMYVGFS 252 (668)
Q Consensus 173 s~~s~~~~~~~~~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~V~~~~~~~~~p~~~~ls~~~dLs~~l~~~~~vGFs 252 (668)
++.|..++++. ..++.+|+.++|||+||+..++|+|+|++. +|..|+|++.+||+++|+++||||||
T Consensus 152 s~~s~~~~~~~----------~~~~~~g~~~~v~I~Yd~~~~~L~V~l~~~---~~~~p~ls~~idL~~~l~~~vyvGFS 218 (243)
T d1leda_ 152 SIVSVATTRWE----------NDDAYGSSIATAHITYDARSKILTVLLSYE---HGRDYILSHVVDLAKVLPQKVRIGFS 218 (243)
T ss_dssp SSSCSEEEECC----------HHHHTSCCEEEEEEEEETTTTEEEEEEEET---TSCEEEEEEECCHHHHSCSEEEEEEE
T ss_pred Ccccccccccc----------cCCcccCceeEEEEEEECCCCEEEEEEeeC---CCCCceEEEecCHHHhcCCcEEEEEE
Confidence 99998887754 357889999999999999999999999975 56788999999999999999999999
Q ss_pred cccCCcccceeeeccccccc
Q 005940 253 ASTGEKSSSHYILGWSFSLN 272 (668)
Q Consensus 253 astG~~~~~~~i~~w~F~~~ 272 (668)
|+||. .|.|+|++|+|++.
T Consensus 219 AsTG~-~~~h~I~sWsF~s~ 237 (243)
T d1leda_ 219 AGVGY-DEVTYILSWHFFST 237 (243)
T ss_dssp EEECB-SEEEEEEEEEEEEE
T ss_pred cccCC-cceeeEEEEEEEee
Confidence 99995 69999999999875
|
| >d1gzca_ b.29.1.1 (A:) Legume lectin {Cockspur coral tree (Erythrina crista-galli) [TaxId: 49817]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Cockspur coral tree (Erythrina crista-galli) [TaxId: 49817]
Probab=100.00 E-value=8.6e-52 Score=412.04 Aligned_cols=226 Identities=33% Similarity=0.544 Sum_probs=197.1
Q ss_pred CceeEEeCCCCCCCCCeEEeCceeeCCCCcEEccCCCC------ceEEEEEeeCceecccCCCCCCCCeeeeEEEEEEEE
Q 005940 26 QSSSFIFQGFNGGATNLSLQGAEIIKPSGALKLTNRSR------YVIGHAFYVKPIQMFDTSASPSPNASSFSTTFVFEI 99 (668)
Q Consensus 26 ~~~~f~~~~f~~~~~~l~~~g~a~~~~~~~~~lt~~~~------~~~G~~~y~~p~~l~~~~~~~~~~~~sF~t~F~f~i 99 (668)
++++|+|++|+++++||+|+|+|.+.++|.|+||+... +++|||+|++||+||+ +.+++++||+|+|+|.|
T Consensus 2 ~~~sF~f~~F~~~~~nl~l~G~A~i~~~g~l~LT~~~~~~~~~~~~~Gr~~y~~Pv~l~~---~~~~~~~sFst~F~f~i 78 (239)
T d1gzca_ 2 ETISFSFSEFEPGNDNLTLQGAALITQSGVLQLTKINQNGMPAWDSTGRTLYTKPVHMWD---STTGTVASFETRFSFSI 78 (239)
T ss_dssp EEEEEEESSCCTTCTTEEEEETCEECTTSCEESSCBCTTSCBCSSCEEEEEESSCEECBC---TTTCCBCEEEEEEEEEC
T ss_pred eeEEEEeCCCCCCCCCeEEeeeeEECCCCeEEccCCCCCCcccccceEEEEeCCCeEecC---CCCCceeeEEEEEEEEE
Confidence 47899999999877899999999998889999997653 4889999999999999 88999999999999999
Q ss_pred eCCC-CCCCCCceEEEEcCCCCCCCCCCCCcccccccCCCCCCCccEEEEEeecccCCCCCCCCCCCeeeeecCCccccc
Q 005940 100 STPR-SGRGGHGLAFLLAPSTKLPGAQPEHYLGILNSTNNGEPSNHILIVEFDTVNGFNDKAENQGNHVGIGINTMFSNR 178 (668)
Q Consensus 100 ~~~~-~~~~g~GlaF~l~p~~~~~~~~~~~~lGl~~~~~~~~~~~~~~aVEfDt~~n~~d~~~~~~~Hvgid~~s~~s~~ 178 (668)
.... ...+||||||+|+|.... .+..+++||+++.... ...++.|||||||++| ..+||++||||||+|++.|..
T Consensus 79 ~~~~~~~~g~dG~aF~l~p~~~~-~~~~~g~lg~~~~~~~-~~~~~~vaVEFDT~~n--~~~d~~~~HvgI~vn~~~s~~ 154 (239)
T d1gzca_ 79 EQPYTRPLPADGLVFFMGPTKSK-PAQGYGYLGVFNNSKQ-DNSYQTLAVEFDTFSN--PWDPPQVPHIGIDVNSIRSIK 154 (239)
T ss_dssp CCCCSSSCCCEEEEEEEECSSCC-CCCCGGGTTTCSSSSC-CGGGCCEEEEEECSCC--TTSCSSSSEEEEEESSSSCSE
T ss_pred ecCCCCCCCCCeEEEEECCCCCC-CCCCcccccccccCCC-CCccceEEEEEEcccc--CCCCCCCCEEEEEECCccccc
Confidence 7553 356899999999997753 4567889999876554 3467899999999998 223499999999999999887
Q ss_pred ccCCccccCCCCCccccccCCCCcEEEEEEEeCCcceEEEEEEeCCCCCCCCcceeeeeccccccccceeeeeecccCC-
Q 005940 179 SEPASYYINGTDHKEEMTLESGEPIQAWIEYDGEQKVLNVTISPAEIGKPMRPLISFGVNLTGYIKETMYVGFSASTGE- 257 (668)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~V~~~~~~~~~p~~~~ls~~~dLs~~l~~~~~vGFsastG~- 257 (668)
+.+ .++.+|+.++|||+||+.+++|+|+|++.. +|..|+|++.+||+++|+++|||||||+||.
T Consensus 155 t~~-------------~~l~~G~~~~v~I~Yd~~~~~L~V~l~~~~--~~~~~~ls~~vdL~~~l~~~vyvGFSAsTG~~ 219 (239)
T d1gzca_ 155 TQP-------------FQLDNGQVANVVIKYDAPSKILHVVLVYPS--SGAIYTIAEIVDVKQVLPDWVDVGLSGATGAQ 219 (239)
T ss_dssp EEE-------------CCCCTTCEEEEEEEEETTTTEEEEEEECTT--TCCEEEEEEECCHHHHSCSEEEEEEEEEECSS
T ss_pred cCC-------------ccccCCCEEEEEEEEeCCCcEEEEEEecCC--CCcceeeeeEechHHhcCCcEEEEEEEEcCCC
Confidence 764 467899999999999999999999998654 7889999999999999999999999999994
Q ss_pred --cccceeeecccccccC
Q 005940 258 --KSSSHYILGWSFSLNG 273 (668)
Q Consensus 258 --~~~~~~i~~w~F~~~~ 273 (668)
..|.|+|++|+|+++.
T Consensus 220 ~~~~~~H~V~sWsF~s~l 237 (239)
T d1gzca_ 220 RDAAETHDVYSWSFQASL 237 (239)
T ss_dssp TTCCCCCEEEEEEEEEEE
T ss_pred CCCceeeEEEEEEeEeeC
Confidence 5689999999999863
|
| >d2d3sa1 b.29.1.1 (A:1-237) Legume lectin {Winged bean (Psophocarpus tetragonolobus), basic agglutinin [TaxId: 3891]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Winged bean (Psophocarpus tetragonolobus), basic agglutinin [TaxId: 3891]
Probab=100.00 E-value=1.6e-51 Score=409.19 Aligned_cols=221 Identities=34% Similarity=0.544 Sum_probs=194.1
Q ss_pred CceeEEeCCCCCCCCCeEEeCceeeCCCCcEEccCCC-----CceEEEEEeeCceecccCCCCCCCCeeeeEEEEEEEEe
Q 005940 26 QSSSFIFQGFNGGATNLSLQGAEIIKPSGALKLTNRS-----RYVIGHAFYVKPIQMFDTSASPSPNASSFSTTFVFEIS 100 (668)
Q Consensus 26 ~~~~f~~~~f~~~~~~l~~~g~a~~~~~~~~~lt~~~-----~~~~G~~~y~~p~~l~~~~~~~~~~~~sF~t~F~f~i~ 100 (668)
++++|+|++|.++++||+|+|+|.+.++|.|+||+.. .+++|||+|++||+||+ +.+++++||+|+|+|.|.
T Consensus 1 ~t~sF~f~~F~~~~~~l~l~G~A~i~~~g~l~LT~~~~~~~~~~~~G~a~y~~pi~l~~---~~~~~~~sF~t~F~f~i~ 77 (237)
T d2d3sa1 1 KTISFNFNQFHQNEEQLKLQRDARISSNSVLELTKVVNGVPTWNSTGRALYAKPVQVWD---STTGNVASFETRFSFSIR 77 (237)
T ss_dssp CEEEEEESSCCSSCTTEEEEETCEECTTSCEECSCEETTEECSSCEEEEEESSCEECBC---TTTCCBCEEEEEEEEECC
T ss_pred CeEEEEeCCCCCCCCCEEEeeeeEeCCCCeEEcCCCCCCCcccccEEEEEeCCCEEeec---CCCCceeeEEEEEEEEee
Confidence 3689999999887789999999999878899999754 46999999999999999 889999999999999997
Q ss_pred CC-CCCCCCCceEEEEcCCCCCCCCCCCCcccccccCCCCCCCccEEEEEeecccCCCCCCCCCCCeeeeecCCcccccc
Q 005940 101 TP-RSGRGGHGLAFLLAPSTKLPGAQPEHYLGILNSTNNGEPSNHILIVEFDTVNGFNDKAENQGNHVGIGINTMFSNRS 179 (668)
Q Consensus 101 ~~-~~~~~g~GlaF~l~p~~~~~~~~~~~~lGl~~~~~~~~~~~~~~aVEfDt~~n~~d~~~~~~~Hvgid~~s~~s~~~ 179 (668)
.+ +...+||||||+|+|... +.+..|++||+++.. ..+++|||||||++|.+| |++||||||+|++.|.++
T Consensus 78 ~~~~~~~g~dGlaFvl~p~~~-~~~~~gg~lG~~~~~----~~~~~vaVEFDT~~n~~d---~~~nHvgI~vns~~s~~~ 149 (237)
T d2d3sa1 78 QPFPRPHPADGLVFFIAPPNT-QTGEGGGYFGIYNPL----SPYPFVAVEFDTFRNTWD---PQIPHIGIDVNSVISTKT 149 (237)
T ss_dssp CSCCSSCCCEEEEEEEECSSC-CCCBCGGGTTTBCTT----SCCCCEEEEEECSCCTTC---CSSSEEEEEESSSSCSEE
T ss_pred cCCCCCCCCCeEEEEeCCCCc-cCCccccccccccCC----CcCceEEEEEEeecCCCC---CCCCcEEEEcCCCccccc
Confidence 54 345678999999999664 446678999998753 357899999999998656 999999999999998766
Q ss_pred cCCccccCCCCCccccccCCCCcEEEEEEEeCCcceEEEEEEeCCCCCCCCcceeeeeccccccccceeeeeecccCC--
Q 005940 180 EPASYYINGTDHKEEMTLESGEPIQAWIEYDGEQKVLNVTISPAEIGKPMRPLISFGVNLTGYIKETMYVGFSASTGE-- 257 (668)
Q Consensus 180 ~~~~~~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~V~~~~~~~~~p~~~~ls~~~dLs~~l~~~~~vGFsastG~-- 257 (668)
.. ..+.+|+.++|||+||+.+++|+|+|++.+ +|..|+++..+||+.+|+++|||||||+||.
T Consensus 150 ~~-------------~~l~~G~~~~v~I~Yd~~~~~L~V~l~~~~--~~~~~~ls~~vdL~~~l~~~vyvGFSasTG~~~ 214 (237)
T d2d3sa1 150 VP-------------FTLDNGGIANVVIKYDASTKILHVVLVFPS--LGTIYTIADIVDLKQVLPESVNVGFSAATGDPS 214 (237)
T ss_dssp EE-------------CCCCTTCEEEEEEEEETTTTEEEEEEEETT--TTEEEEEEEECCHHHHSCSEEEEEEEEEECCGG
T ss_pred cc-------------eeecCCCEEEEEEEEECCCCEEEEEEEcCC--CCcccceeeEechHHhCCCcEEEEEEeECCCCc
Confidence 54 467899999999999999999999999865 5778899999999999999999999999995
Q ss_pred -----cccceeeeccccccc
Q 005940 258 -----KSSSHYILGWSFSLN 272 (668)
Q Consensus 258 -----~~~~~~i~~w~F~~~ 272 (668)
..|.|+|++|+|+++
T Consensus 215 ~~~~~~~e~h~I~sWsFss~ 234 (237)
T d2d3sa1 215 GKQRNATETHDILSWSFSAS 234 (237)
T ss_dssp GCCTTCCCCCEEEEEEEEEE
T ss_pred cCccccceeeEEEEeEeEee
Confidence 568999999999875
|
| >d1g9fa_ b.29.1.1 (A:) Legume lectin {Soybean (Glycine max) [TaxId: 3847]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Soybean (Glycine max) [TaxId: 3847]
Probab=100.00 E-value=2.2e-51 Score=412.05 Aligned_cols=228 Identities=31% Similarity=0.516 Sum_probs=193.0
Q ss_pred CceeEEeCCCCCCCCCeEEeCceeeCCCCcEEccCCC------CceEEEEEeeCceecccCCCCCCCCeeeeEEEEEEEE
Q 005940 26 QSSSFIFQGFNGGATNLSLQGAEIIKPSGALKLTNRS------RYVIGHAFYVKPIQMFDTSASPSPNASSFSTTFVFEI 99 (668)
Q Consensus 26 ~~~~f~~~~f~~~~~~l~~~g~a~~~~~~~~~lt~~~------~~~~G~~~y~~p~~l~~~~~~~~~~~~sF~t~F~f~i 99 (668)
++++|+|++|.+++.||+|+|+|.+.++|.|+||+.. ..++|||+|++||+||+ +.+++++||+|+|+|.|
T Consensus 2 ~~~sF~f~~F~~~~~~l~l~G~A~v~~~g~l~LT~~~~~~~~~~~~~Gra~y~~Pv~l~~---~~~~~~~sf~t~f~F~i 78 (251)
T d1g9fa_ 2 ETVSFSWNKFVPKQPNMILQGDAIVTSSGKLQLNKVDENGTPKPSSLGRALYSTPIHIWD---KETGSVASFAASFNFTF 78 (251)
T ss_dssp EEEEEEESSCCC-CTTEEEEETCBCCTTC-CBCSCBC---CBCTTCEEEEEESSCEECBC---C-CCCBCEEEEEEEEEE
T ss_pred ceEEEEeCCCCCCCCCEEEeeeEEECCCCEEEecCCcCCCcccCceEEEEEeCCCEEccC---CCCccceeeEEEEEEEE
Confidence 5789999999987789999999999888999999754 35899999999999999 88999999999999999
Q ss_pred eCCCCCCCCCceEEEEcCCCCCCCCCCCCcccccccCCCCCCCccEEEEEeecccCCCCCCCCCCCeeeeecCCcccccc
Q 005940 100 STPRSGRGGHGLAFLLAPSTKLPGAQPEHYLGILNSTNNGEPSNHILIVEFDTVNGFNDKAENQGNHVGIGINTMFSNRS 179 (668)
Q Consensus 100 ~~~~~~~~g~GlaF~l~p~~~~~~~~~~~~lGl~~~~~~~~~~~~~~aVEfDt~~n~~d~~~~~~~Hvgid~~s~~s~~~ 179 (668)
...+...+||||||+|+|....+ +..+++||+++.. ...++.|||||||++|.+| |++||||||+|++.|..+
T Consensus 79 ~~~~~~~~gDGlAFvl~p~~~~~-~~~~g~lG~~~~~---~~~~~~vaVEFDT~~n~~D---~~~~Hvgi~~n~~~s~~~ 151 (251)
T d1g9fa_ 79 YAPDTKRLADGLAFFLAPIDTKP-QTHAGYLGLFNEN---ESGDQVVAVEFDTFRNSWD---PPNPHIGINVNSIRSIKT 151 (251)
T ss_dssp ECSCC--CCEEEEEEEEETTCCC-CCCGGGTTTCCTT---SCCCSCEEEEEECC-CTTS---CSSSEEEEEESSSSCSEE
T ss_pred ecCCCCCCCCceEEEEecCCCCC-CCccCccCccccc---CCCcceEEEEEecccCCCC---CCCCcEeEEecCcccccc
Confidence 98888889999999999976533 5678899998754 3457899999999998656 999999999999998776
Q ss_pred cCCccccCCCCCccccccCCCCcEEEEEEEeCCcceEEEEEEeCCCCCCCCcceeeeeccccccccceeeeeecccCCcc
Q 005940 180 EPASYYINGTDHKEEMTLESGEPIQAWIEYDGEQKVLNVTISPAEIGKPMRPLISFGVNLTGYIKETMYVGFSASTGEKS 259 (668)
Q Consensus 180 ~~~~~~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~V~~~~~~~~~p~~~~ls~~~dLs~~l~~~~~vGFsastG~~~ 259 (668)
+. +++.+|+.++|||+||+..++|+|++++.. +|..|+++..+||+.+|+++|||||||+||...
T Consensus 152 ~~-------------~~l~~g~~~~v~I~Yd~~~~~L~v~l~~~~--~~~~~~l~~~vdL~~~l~~~~yvGFSAsTG~~~ 216 (251)
T d1g9fa_ 152 TS-------------WDLANNKVAKVLITYDASTSLLVASLVYPS--QRTSNILSDVVDLKTSLPEWVRIGFSAATGLDI 216 (251)
T ss_dssp EE-------------CCCCTTCCEEEEEEEETTTTEEEEEEEEGG--GTEEEEEEEECCC-CCSCSEEEEEEEEEECSSS
T ss_pred cc-------------eEecCCCEEEEEEEEECCccEEEEEEecCC--CCcceeEEEEecchhhCCCcEEEEEEeecCCCC
Confidence 54 467899999999999999999999998653 788899999999999999999999999999765
Q ss_pred --cceeeecccccccCCCCCC
Q 005940 260 --SSHYILGWSFSLNGVAPAL 278 (668)
Q Consensus 260 --~~~~i~~w~F~~~~~~p~l 278 (668)
|.|+|++|+|+++.+++..
T Consensus 217 ~~~~h~I~sWsF~s~~~~~~~ 237 (251)
T d1g9fa_ 217 PGESHDVLSWSFASNLPHASS 237 (251)
T ss_dssp CCCEEEEEEEEEEEEECC---
T ss_pred CCceeEEEEeEeECCCCCCCc
Confidence 7899999999987654433
|
| >d1f9ka_ b.29.1.1 (A:) Legume lectin {Winged bean (Psophocarpus tetragonolobus), acidic lectin [TaxId: 3891]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Winged bean (Psophocarpus tetragonolobus), acidic lectin [TaxId: 3891]
Probab=100.00 E-value=1.9e-50 Score=401.00 Aligned_cols=221 Identities=33% Similarity=0.533 Sum_probs=192.3
Q ss_pred CceeEEeCCCCCCCCCeEEeCceeeCCCCcEEccCCC------CceEEEEEeeCceecccCCCCCCCCeeeeEEEEEEEE
Q 005940 26 QSSSFIFQGFNGGATNLSLQGAEIIKPSGALKLTNRS------RYVIGHAFYVKPIQMFDTSASPSPNASSFSTTFVFEI 99 (668)
Q Consensus 26 ~~~~f~~~~f~~~~~~l~~~g~a~~~~~~~~~lt~~~------~~~~G~~~y~~p~~l~~~~~~~~~~~~sF~t~F~f~i 99 (668)
++.||+|++|.+++.||+|+|+|.+.++|.|+||+.. .+++|||+|++||+||+ +.+++++||+|+|+|.|
T Consensus 1 ~~~SF~f~~F~~~~~~l~l~G~A~~~~~g~l~LT~~~~~~~~~~~~~Gra~y~~Pv~l~~---~~~~~~~sFsT~F~f~i 77 (234)
T d1f9ka_ 1 ETQSFNFDHFEENSKELNLQRQASIKSNGVLELTKLTKNGVPVWKSTGRALYAEPIKIWD---STTGNVASFETRFSFNI 77 (234)
T ss_dssp CEEEEEESSCCSSCTTEEEEETCEECTTSCEECSCSEETTEECCSCEEEEEESSCEECBC---TTTCCBCEEEEEEEEEE
T ss_pred CceEEEeCCCCCCCCCEEEeeeEEEcCCCEEEeecCCCCCCcccceeEEEEeCCCEEeeC---CCCCcCcceEEEEEEEE
Confidence 3689999999977789999999999878999999864 35889999999999999 88999999999999999
Q ss_pred eCCCC-CCCCCceEEEEcCCCCCCCCCCCCcccccccCCCCCCCccEEEEEeecccCCCCCCCCCCCeeeeecCCccccc
Q 005940 100 STPRS-GRGGHGLAFLLAPSTKLPGAQPEHYLGILNSTNNGEPSNHILIVEFDTVNGFNDKAENQGNHVGIGINTMFSNR 178 (668)
Q Consensus 100 ~~~~~-~~~g~GlaF~l~p~~~~~~~~~~~~lGl~~~~~~~~~~~~~~aVEfDt~~n~~d~~~~~~~Hvgid~~s~~s~~ 178 (668)
.+... ..+||||||+|+|... +.+..|+++|+++.. ..++.|||||||++|.+| |++||||||+|++.|.+
T Consensus 78 ~~~~~~~~g~dG~aF~i~p~~~-~~~~~g~~~g~~~~~----~~~~~vaVEFDT~~n~~D---p~~nHvgi~~ns~~s~~ 149 (234)
T d1f9ka_ 78 TQPYAYPEPADGLTFFMVPPNS-PQGEDGGNLGVFKPP----EGDNAFAVEFDTFQNTWD---PQVPHIGIDVNSIVSSK 149 (234)
T ss_dssp ECCCSSSCCCEEEEEEEECTTC-CCCCSGGGTTTCCSS----CCSCCEEEEEECSCCTTC---CSSSEEEEEESSSSCSE
T ss_pred ECCCCCCCccceEEEEECCCCC-CcccccccccccCCC----CccceEEEEEeccccCCC---CCCCcEeEecCCccccc
Confidence 86543 4578999999999764 556788999987653 356789999999998666 99999999999998876
Q ss_pred ccCCccccCCCCCccccccCCCCcEEEEEEEeCCcceEEEEEEeCCCCCCCCcceeeeeccccccc--cceeeeeecccC
Q 005940 179 SEPASYYINGTDHKEEMTLESGEPIQAWIEYDGEQKVLNVTISPAEIGKPMRPLISFGVNLTGYIK--ETMYVGFSASTG 256 (668)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~V~~~~~~~~~p~~~~ls~~~dLs~~l~--~~~~vGFsastG 256 (668)
+.+ +++.+|+.++|||+||+..++|+|++++.. +|..|+|++.|||+.+|+ ++|||||||+||
T Consensus 150 ~~~-------------~~l~~G~~~~v~I~Yd~~~~~l~V~l~~~~--~~~~~~ls~~idL~~~l~~~~~v~vGFSasTG 214 (234)
T d1f9ka_ 150 TLH-------------FQLENGGVANVVIKYDSPTKILNVVLAFHS--VGTVYTLSNIVDLKQEFPNSEWVNVGLSATTG 214 (234)
T ss_dssp EEE-------------CCCCTTCCEEEEEEEETTTTEEEEEEEETT--TTEEEEEEEECCHHHHSTTCSEEEEEEEEEEC
T ss_pred ccc-------------ccccCCCEEEEEEEEcCCCcEEEEEEEeCC--CCccceEEEEEcHHHhcCCCCEEEEEEEeecC
Confidence 653 568899999999999999999999999865 567789999999999997 579999999999
Q ss_pred C---cccceeeeccccccc
Q 005940 257 E---KSSSHYILGWSFSLN 272 (668)
Q Consensus 257 ~---~~~~~~i~~w~F~~~ 272 (668)
. ..|.|+|++|+|+++
T Consensus 215 ~~~~~~~~h~I~sWsF~s~ 233 (234)
T d1f9ka_ 215 YQKNAVETHEIISWSFTSS 233 (234)
T ss_dssp SSTTCCCEEEEEEEEEEEE
T ss_pred CCCCceeeeEEEEEEeEEe
Confidence 4 568899999999864
|
| >d1dbna_ b.29.1.1 (A:) Legume lectin {Maackia amurensis, leukoagglutinin [TaxId: 37501]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Maackia amurensis, leukoagglutinin [TaxId: 37501]
Probab=100.00 E-value=9.1e-50 Score=399.27 Aligned_cols=228 Identities=31% Similarity=0.514 Sum_probs=200.0
Q ss_pred CceeEEeCCCCCCCCCeEEeCceeeCCCCcEEccCCC-----CceEEEEEeeCceecccCCCCCCCCeeeeEEEEEEEEe
Q 005940 26 QSSSFIFQGFNGGATNLSLQGAEIIKPSGALKLTNRS-----RYVIGHAFYVKPIQMFDTSASPSPNASSFSTTFVFEIS 100 (668)
Q Consensus 26 ~~~~f~~~~f~~~~~~l~~~g~a~~~~~~~~~lt~~~-----~~~~G~~~y~~p~~l~~~~~~~~~~~~sF~t~F~f~i~ 100 (668)
++++|+|++|.+++.||+|+|+|.+.++|.|+||++. .+++|||+|++||+||+ +.+++++||+|+|+|.|.
T Consensus 2 ~~~sF~f~~F~~~~~~l~l~G~A~v~~~g~l~LT~~~~~~~~~~~~G~a~y~~pi~l~~---~~~~~~~sFst~F~F~i~ 78 (239)
T d1dbna_ 2 DELSFTINNFVPNEADLLFQGEASVSSTGVLQLTKVENGQPQKYSVGRALYAAPVRIWG---NTTGSVASFSTSFTFVVK 78 (239)
T ss_dssp CEEEEEESSCCTTCTTEEEEETCEECTTSCEESSCEETTEECSSCEEEEEESSCEECBC---TTTCCBCEEEEEEEEECC
T ss_pred CceEEEeCCCCCCCCCEEEeeeeEECCCCEEEccCCCCCCcccceeEEEeecCCEEccC---CCCccceEEEEEEEEEEE
Confidence 5799999999987789999999999888999999753 45789999999999999 888999999999999999
Q ss_pred CCCCCCCCCceEEEEcCCC-CCCCCCCCCcccccccCCCCCCCccEEEEEeecccC-CCCCCCCCCCeeeeecCCccccc
Q 005940 101 TPRSGRGGHGLAFLLAPST-KLPGAQPEHYLGILNSTNNGEPSNHILIVEFDTVNG-FNDKAENQGNHVGIGINTMFSNR 178 (668)
Q Consensus 101 ~~~~~~~g~GlaF~l~p~~-~~~~~~~~~~lGl~~~~~~~~~~~~~~aVEfDt~~n-~~d~~~~~~~Hvgid~~s~~s~~ 178 (668)
+.....+||||||+|+|.. ..+.++.|++||+.+..+ ++..++.+||||||++| ..+.+||+.+|||||+|++.|..
T Consensus 79 ~~~~~~~gdG~AF~l~~~~~~~~~~~~g~~lGl~~~~~-~~~~~~~~aVEfDT~~n~~~~~~d~~~~hvgid~n~~~s~~ 157 (239)
T d1dbna_ 79 APNPDITSDGLAFYLAPPDSQIPSGSVSKYLGLFNNSN-SDSSNQIVAVEFDTYFAHSYDPWDPNYRHIGIDVNGIESIK 157 (239)
T ss_dssp CSSTTSCCEEEEEEEECTTCCCCSSSCGGGTTSCSSSC-CCTTSCCEEEEEECCCCTTTCTTSCSSCEEEEEESSSSCSE
T ss_pred CCCCCCCCCCEEEEEeCCCccCCcccCccccccccccC-CCcccCeeeeEEeeeecCCCCCCCCCCceeeEEcCCccccc
Confidence 8877789999999999976 456678899999998654 45678999999999988 22335699999999999999877
Q ss_pred ccCCccccCCCCCccccccCCCCcEEEEEEEeCCcceEEEEEEeCCCCCCCCcceeeeeccccccccceeeeeecccCCc
Q 005940 179 SEPASYYINGTDHKEEMTLESGEPIQAWIEYDGEQKVLNVTISPAEIGKPMRPLISFGVNLTGYIKETMYVGFSASTGEK 258 (668)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~V~~~~~~~~~p~~~~ls~~~dLs~~l~~~~~vGFsastG~~ 258 (668)
+... .+.+|+.++|||+|++..++|.|++.+.. +|..|.|+..+||+.+|+++|||||||+||..
T Consensus 158 ~~~~-------------~~~~g~~~~~~i~y~~~~~~l~v~l~~~~--~~~~~~ls~~vdL~~~l~~~vyvGFSAsTG~~ 222 (239)
T d1dbna_ 158 TVQW-------------DWINGGVAFATITYLAPNKTLIASLVYPS--NQTTFSVAASVDLKEILPEWVRVGFSAATGYP 222 (239)
T ss_dssp EEEC-------------CCCTTCCEEEEEEEEGGGTEEEEEEEETT--TTEEEEEEEECCHHHHSCSEEEEEEEEEECSG
T ss_pred cccc-------------eEeCCceeEEEEEEcCCCCEEEEEEEecC--CCccEEEEEecchHHhcCCcEEEEEEEeCCCC
Confidence 6654 34579999999999999999999998754 67788999999999999999999999999965
Q ss_pred --ccceeeeccccccc
Q 005940 259 --SSSHYILGWSFSLN 272 (668)
Q Consensus 259 --~~~~~i~~w~F~~~ 272 (668)
.|.|+|++|+|+++
T Consensus 223 ~~~~~H~I~sWsFss~ 238 (239)
T d1dbna_ 223 TEVETHDVLSWSFTST 238 (239)
T ss_dssp GGCCCCEEEEEEEEEE
T ss_pred CCcceeEEEEEEeEEe
Confidence 57899999999864
|
| >d1n47a_ b.29.1.1 (A:) Legume lectin {Hairy vetch (Vicia villosa), isolectin b4 [TaxId: 3911]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Hairy vetch (Vicia villosa), isolectin b4 [TaxId: 3911]
Probab=100.00 E-value=9.9e-49 Score=389.48 Aligned_cols=222 Identities=32% Similarity=0.542 Sum_probs=194.5
Q ss_pred CceeEEeCCCCCCCCCeEEeCceeeCCCCcEEccCCCC-----ceEEEEEeeCceecccCCCCCCCCeeeeEEEEEEEEe
Q 005940 26 QSSSFIFQGFNGGATNLSLQGAEIIKPSGALKLTNRSR-----YVIGHAFYVKPIQMFDTSASPSPNASSFSTTFVFEIS 100 (668)
Q Consensus 26 ~~~~f~~~~f~~~~~~l~~~g~a~~~~~~~~~lt~~~~-----~~~G~~~y~~p~~l~~~~~~~~~~~~sF~t~F~f~i~ 100 (668)
++++|+|++|+++.+||+|+|+|.+.++|.|+||++.. +++|||+|++||+||+ . ..++||+|+|+|.|.
T Consensus 2 ~~~sF~f~~F~~~~~~l~l~G~A~i~~~g~i~LT~~~~~~~~~~~~G~~~y~~Pv~l~~---~--~~~~sF~t~f~f~i~ 76 (233)
T d1n47a_ 2 ESTSFSFTNFNPNQNNLILQEDALVNSAGTLELTAVAAGAPVPDSLGRALYAAPIHIHD---N--TTLASFTTSFSFVMA 76 (233)
T ss_dssp EEEEEEESSCCTTCTTEEEEETCEECTTSCEESSCBSSSSBCTTCEEEEEESSCEECBC---S--SCBCEEEEEEEEECC
T ss_pred CceEEEeCCCCCCCCCeEEecceEECCCCEEEecCCCCCCcCCCceEEEEeCCCEEccC---C--CeeeeEEEEEEEEEe
Confidence 47899999998877899999999998788999997653 5899999999999998 3 257899999999999
Q ss_pred CCCCCCCCCceEEEEcCCCCCCCCCCCCcccccccCCCCCCCccEEEEEeecccCCCCCCCCCCCeeeeecCCccccccc
Q 005940 101 TPRSGRGGHGLAFLLAPSTKLPGAQPEHYLGILNSTNNGEPSNHILIVEFDTVNGFNDKAENQGNHVGIGINTMFSNRSE 180 (668)
Q Consensus 101 ~~~~~~~g~GlaF~l~p~~~~~~~~~~~~lGl~~~~~~~~~~~~~~aVEfDt~~n~~d~~~~~~~Hvgid~~s~~s~~~~ 180 (668)
+.....+||||||+|+|....+ +..|++||+++.... +..++.|||||||++|.+| |++||||||+|++.|..+.
T Consensus 77 ~~~~~~~gDGlAF~l~~~~~~~-~~~gg~lGl~~~~~~-~~~~~~~aVefDT~~n~~d---~~~~higi~~n~~~s~~~~ 151 (233)
T d1n47a_ 77 APAAAAVADGLAFFLAPPDTQP-QARGGFLGLFADRAH-DASYQTVAVEFDTYSNAWD---PNYTHIGIDTNGIESKKTT 151 (233)
T ss_dssp CSSTTSCCEEEEEEEECTTCCC-CCCGGGTTTCSSSSC-CGGGCCEEEEEECSCCTTS---CSSCEEEEEESSSSCSEEE
T ss_pred CCCCCCCCCceEEEECCCCCCC-CCCCCccccccccCC-CCcCceEEEEEEeeecCCC---CCCCceeEccCCccccccc
Confidence 8877889999999999976544 567899999976554 4567889999999998555 9999999999999887765
Q ss_pred CCccccCCCCCccccccCCCCcEEEEEEEeCCcceEEEEEEeCCCCCCCCcceeeeeccccccccceeeeeecccC---C
Q 005940 181 PASYYINGTDHKEEMTLESGEPIQAWIEYDGEQKVLNVTISPAEIGKPMRPLISFGVNLTGYIKETMYVGFSASTG---E 257 (668)
Q Consensus 181 ~~~~~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~V~~~~~~~~~p~~~~ls~~~dLs~~l~~~~~vGFsastG---~ 257 (668)
+ +.+.+|+.++|||+||+..++|.|++.+.. +|..|.|+..+||+.+|+++|||||||+|| +
T Consensus 152 ~-------------~~l~~g~~~~v~I~Y~~~~~~l~v~l~~~~--~~~~~~ls~~vdL~~~l~~~vyvGFSAsTG~~~~ 216 (233)
T d1n47a_ 152 P-------------FDMVYGEKANIVITYQASTKALAASLVFPV--SQTSYAVSARVDLRDILPEYVRVGFSATTGLNAG 216 (233)
T ss_dssp E-------------CCCCTTSCEEEEEEEETTTTEEEEEEEETT--TTEEEEEEEECCGGGTSCSEEEEEEEEEECSSTT
T ss_pred c-------------ceecCCCEEEEEEEEcCCCeEEEEEEEeCC--CCccEEEEEEechHHhcCCcEEEEEEEecCCCCC
Confidence 4 467789999999999999999999998754 688889999999999999999999999999 4
Q ss_pred cccceeeeccccccc
Q 005940 258 KSSSHYILGWSFSLN 272 (668)
Q Consensus 258 ~~~~~~i~~w~F~~~ 272 (668)
..|.|+|++|+|+++
T Consensus 217 ~~~~H~I~sWsFss~ 231 (233)
T d1n47a_ 217 VVETHDIVSWSFAVS 231 (233)
T ss_dssp CCCCCEEEEEEEEEE
T ss_pred cccccEEEEEEeEEE
Confidence 678899999999874
|
| >d1g8wa_ b.29.1.1 (A:) Phytohemagglutinin-L, PHA-L, also arcelin {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Phytohemagglutinin-L, PHA-L, also arcelin species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=100.00 E-value=7.1e-49 Score=389.70 Aligned_cols=221 Identities=32% Similarity=0.534 Sum_probs=193.7
Q ss_pred CceeEEeCCCCCCCCCeEEeCceeeCCCCcEEccCCC------CceEEEEEeeCceecccCCCCCCCCeeeeEEEEEEEE
Q 005940 26 QSSSFIFQGFNGGATNLSLQGAEIIKPSGALKLTNRS------RYVIGHAFYVKPIQMFDTSASPSPNASSFSTTFVFEI 99 (668)
Q Consensus 26 ~~~~f~~~~f~~~~~~l~~~g~a~~~~~~~~~lt~~~------~~~~G~~~y~~p~~l~~~~~~~~~~~~sF~t~F~f~i 99 (668)
++++|+|++|+. .|++|+|||.+.++|.|+||+.. ..++|||+|++||+||+ +.++.++||+|+|+|.|
T Consensus 2 ~~~sF~f~~F~~--~nl~l~GdA~i~~~g~l~LT~~~~~~~~~~~~~G~~~y~~Pi~l~~---~~~~~~~sF~t~f~f~i 76 (233)
T d1g8wa_ 2 NDIYFNFQRFNE--TNLILQRDASVSSSGQLRLTNLNGNGEPRVGSLGRAFYSAPIQIWD---NTTGTVASFATSFTFNI 76 (233)
T ss_dssp EEEEEEESSCCG--GGEEEEETCEECTTSCEECSCCCSTTCCCTTCEEEEEESSCEECBC---TTTCCBEEEEEEEEEEC
T ss_pred CceEEECCCCCc--CcEEEeccEEECCCCEEEecCCCCCCCcccceeEEEEcCCCeEeec---CCCCceeeEEEEEEEEE
Confidence 578999999987 79999999999888999999754 35899999999999999 88899999999999999
Q ss_pred eCCCCCCCCCceEEEEcCCCCCCCCCCCCcccccccCCCCCCCccEEEEEeecccCCCCCCCCCCCeeeeecCCcccccc
Q 005940 100 STPRSGRGGHGLAFLLAPSTKLPGAQPEHYLGILNSTNNGEPSNHILIVEFDTVNGFNDKAENQGNHVGIGINTMFSNRS 179 (668)
Q Consensus 100 ~~~~~~~~g~GlaF~l~p~~~~~~~~~~~~lGl~~~~~~~~~~~~~~aVEfDt~~n~~d~~~~~~~Hvgid~~s~~s~~~ 179 (668)
.+.+...+||||||+|+|+... .+..|++||+++.. +..++.|||||||++| ..+||+++||||++|++.|..+
T Consensus 77 ~~~~~~~~gDGlAF~l~~~~~~-~g~~g~~lG~~~g~---~~~~~~vaVEFDT~~N--~~~d~~~~Hvgi~~n~~~s~~~ 150 (233)
T d1g8wa_ 77 QVPNNAGPADGLAFALVPVGSQ-PKDKGGFLGLFDGS---NSNFHTVAVEFDTLYN--KDWDPTERHIGIDVNSIRSIKT 150 (233)
T ss_dssp CCCSSCBCCEEEEEEEEETTCC-CCCCGGGTTTCCSS---CCCCCCEEEEEECSCC--TTTCCSSCEEEEEESSSSCSEE
T ss_pred ecCCCCCCCCeEEEEEecCCCC-CCcccccCCccccC---CCcccEEEEEeecccC--CCCCCCCCeEEEECCCcceeee
Confidence 9887778899999999997753 45679999998753 3467889999999998 2245999999999999988766
Q ss_pred cCCccccCCCCCccccccCCCCcEEEEEEEeCCcceEEEEEEeCCCCCCCCcceeeeeccccccccceeeeeecccCC--
Q 005940 180 EPASYYINGTDHKEEMTLESGEPIQAWIEYDGEQKVLNVTISPAEIGKPMRPLISFGVNLTGYIKETMYVGFSASTGE-- 257 (668)
Q Consensus 180 ~~~~~~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~V~~~~~~~~~p~~~~ls~~~dLs~~l~~~~~vGFsastG~-- 257 (668)
.. .++.+|+.++|||+||+..++|.|++.+.+ +|..|+++..+||+.+||++|||||||+||.
T Consensus 151 ~~-------------~~~~~g~~~~~~I~yd~~~~~l~v~l~~~~--~~~~~~l~~~vdL~~~l~~~~yvGFSAsTG~~~ 215 (233)
T d1g8wa_ 151 TR-------------WDFVNGENAEVLITYDSSTNLLVASLVYPS--QKTSFIVSDTVDLKSVLPEWVSVGFSATTGINK 215 (233)
T ss_dssp EE-------------CCCCTTCCEEEEEEEETTTTEEEEEEEETT--TTEEEEEEEECCHHHHSCSEEEEEEEEEECSST
T ss_pred cc-------------ccccCCcEEEEEEEEeCCCcEEEEEEEeCC--CCCcEEEEEEechhHcCCCcEEEEEEEEcCCCC
Confidence 54 356789999999999999999999998765 6778899999999999999999999999994
Q ss_pred -cccceeeeccccccc
Q 005940 258 -KSSSHYILGWSFSLN 272 (668)
Q Consensus 258 -~~~~~~i~~w~F~~~ 272 (668)
..|.|+|++|+|++.
T Consensus 216 ~~~~~h~I~sWsFss~ 231 (233)
T d1g8wa_ 216 GNVETNDVLSWSFASK 231 (233)
T ss_dssp TBCCCCEEEEEEEEEE
T ss_pred CCceeeEEEEEEEEEE
Confidence 557799999999874
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.5e-49 Score=412.07 Aligned_cols=267 Identities=28% Similarity=0.468 Sum_probs=201.4
Q ss_pred ccchhhHHHHhcC---------cccceeeeecCcEEEEEEEeCCCCc---EEEEEEEecC-CchhHHHHHHHHHHHhccc
Q 005940 342 RFRYKDLYAATKG---------FKESEVIGIGGFGSVYKGVLPTTGG---EVAVKKITRN-SLQGMREFAAEIESLGRLR 408 (668)
Q Consensus 342 ~f~~~el~~at~~---------f~~~~~lG~G~~g~Vy~~~~~~~~~---~vavK~~~~~-~~~~~~~f~~Ei~~l~~l~ 408 (668)
.++++++..++++ |+..++||+|+||+||+|+++.+++ .||||++... ..+..++|.+|+++|++++
T Consensus 6 ~~t~~d~~~a~~~f~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~ 85 (299)
T d1jpaa_ 6 PFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFD 85 (299)
T ss_dssp GGGSSSHHHHHHHHSCBCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCC
T ss_pred CCCHHHHHHHHhhhchhhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCC
Confidence 4566666666543 5567899999999999999876554 5899988654 3345678999999999999
Q ss_pred ccCceeEeeeecccCceEEEEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEE
Q 005940 409 HKNLVNLHGWCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNAL 488 (668)
Q Consensus 409 H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIl 488 (668)
|||||+++|+|.+.+..++|||||++|+|.+++.. ....++|.++++++.||++||.|||+ ++|+||||||+|||
T Consensus 86 HpnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~--~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHrDlKp~NIL 160 (299)
T d1jpaa_ 86 HPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQ--NDGQFTVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNIL 160 (299)
T ss_dssp CTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEE
T ss_pred CCCCccEEEEEeeCCEEEEEEEecCCCcceeeecc--ccCCCCHHHHHHHHHHHHHHHHHHhh---CCCccCccccceEE
Confidence 99999999999999999999999999999999863 34569999999999999999999999 99999999999999
Q ss_pred ECCCCCEEEEeecCceeccCCCCCc----ccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCchh
Q 005940 489 IDAEMNARLGDFGLARLYDHGGMPH----TTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVAT-GRRPIGSGDLL 563 (668)
Q Consensus 489 l~~~~~~kl~DfGla~~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~ 563 (668)
|+.++.+||+|||+++......... .....||+.|||||.+.++.++.++|||||||++|||+| |+.||......
T Consensus 161 l~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~ 240 (299)
T d1jpaa_ 161 VNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ 240 (299)
T ss_dssp ECTTCCEEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH
T ss_pred ECCCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHH
Confidence 9999999999999998765433211 223467899999999999999999999999999999998 89999754321
Q ss_pred HHHHHHHHHhcCccccccCcccCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhccCc
Q 005940 564 LVEWVRECHQLGRILDVADPLLNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSGEK 625 (668)
Q Consensus 564 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~~~ 625 (668)
+.........+. .....++ ..+..++..|++. |++||+|+||++.|+...
T Consensus 241 --~~~~~i~~~~~~------~~~~~~~----~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l 291 (299)
T d1jpaa_ 241 --DVINAIEQDYRL------PPPMDCP----SALHQLMLDCWQKDRNHRPKFGQIVNTLDKMI 291 (299)
T ss_dssp --HHHHHHHTTCCC------CCCTTCC----HHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred --HHHHHHHcCCCC------CCCccch----HHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 112222111111 1111122 3455677799987 999999999999997654
|
| >d1v6ia_ b.29.1.1 (A:) Legume lectin {Peanut (Arachis hypogaea) [TaxId: 3818]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Peanut (Arachis hypogaea) [TaxId: 3818]
Probab=100.00 E-value=1.2e-48 Score=388.56 Aligned_cols=225 Identities=28% Similarity=0.442 Sum_probs=191.3
Q ss_pred CceeEEeCCCCCCCCCeEEeCceeeCCCCcEEccCCC-CceEEEEEeeCceecccCCCCCCCCeeeeEEEEEEEEeCCCC
Q 005940 26 QSSSFIFQGFNGGATNLSLQGAEIIKPSGALKLTNRS-RYVIGHAFYVKPIQMFDTSASPSPNASSFSTTFVFEISTPRS 104 (668)
Q Consensus 26 ~~~~f~~~~f~~~~~~l~~~g~a~~~~~~~~~lt~~~-~~~~G~~~y~~p~~l~~~~~~~~~~~~sF~t~F~f~i~~~~~ 104 (668)
++++|+|++|.+++.+|+|+|+|.+.++|.|+||++. .+++|||+|++||+||+ +.+++++||+|+|+|.|.+.+.
T Consensus 2 ~~~sF~~~~F~~~~~~l~l~GdA~i~~~g~l~LT~~~~~~~~G~a~y~~Pi~l~~---~~~~~~~sf~t~f~f~i~~~~~ 78 (232)
T d1v6ia_ 2 ETVSFNFNSFSEGNPAINFQGDVTVLSNGNIQLTNLNKVNSVGRVLYAMPVRIWS---SATGNVASFLTSFSFEMKDIKD 78 (232)
T ss_dssp EEEEEEESSCCTTCTTEEEEESCEECTTSCEECSCTTSTTCEEEEEESSCEECBC---TTTCCBCEEEEEEEEEEECCSS
T ss_pred ccEEEECCCCCCCCCCEEEeeeeEEcCCCEEEeCCCCCCCceEEEEcCCCEEccC---CCCCccceeEEEEEEEeccCCC
Confidence 5789999999987788999999999888999999865 58999999999999999 8899999999999999999888
Q ss_pred CCCCCceEEEEcCCCCCCCCCCCCcccccccCCCCCCCccEEEEEeecccCCCCCCCCCCCeeeeecCCcccccccCCcc
Q 005940 105 GRGGHGLAFLLAPSTKLPGAQPEHYLGILNSTNNGEPSNHILIVEFDTVNGFNDKAENQGNHVGIGINTMFSNRSEPASY 184 (668)
Q Consensus 105 ~~~g~GlaF~l~p~~~~~~~~~~~~lGl~~~~~~~~~~~~~~aVEfDt~~n~~d~~~~~~~Hvgid~~s~~s~~~~~~~~ 184 (668)
..+||||||+|+|+....++ ++..|+.....+.+..++.|||||||++|. +.+||+++|||||+|++.|.....
T Consensus 79 ~~~gDG~AF~l~~~~~~~~~--~~~~g~~~~~~~~~~~~~~~aVEfDT~~n~-~~~d~~~~Higid~n~~~s~~~~~--- 152 (232)
T d1v6ia_ 79 YDPADGIIFFIAPEDTQIPA--GSIGGGTLGVSDTKGAGHFVGVEFDTYSNS-EYNDPPTDHVGIDVNSVDSVKTVP--- 152 (232)
T ss_dssp SBCCCEEEEEEEETTCCCCT--TCCCGGGTTTSCTTSEEEEEEEEEECSCCG-GGTCCSSCEEEEEEEESSCSEEEE---
T ss_pred CCCCCeEEEEEECCCCCCCC--CccCCcccccccCCCCCceEEEEEEeEecC-CCCCCCCccEeEeeCCcccccccc---
Confidence 88999999999997743222 223333333344456788999999999983 223499999999999988776643
Q ss_pred ccCCCCCccccccCCCCcEEEEEEEeCCcceEEEEEEeCCCCCCCCcceeeeeccccccccceeeeeecccCCc-cccee
Q 005940 185 YINGTDHKEEMTLESGEPIQAWIEYDGEQKVLNVTISPAEIGKPMRPLISFGVNLTGYIKETMYVGFSASTGEK-SSSHY 263 (668)
Q Consensus 185 ~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~V~~~~~~~~~p~~~~ls~~~dLs~~l~~~~~vGFsastG~~-~~~~~ 263 (668)
.++.+|+.++|||+||+..++|+|++++. ++..|.++..+||+.+|+++|||||||+||.. .|.|+
T Consensus 153 ----------~~~~~g~~~~v~I~Yd~~~~~L~V~~~~~---~~~~~~l~~~vdL~~~l~~~vyvGFSAsTG~~~~~~H~ 219 (232)
T d1v6ia_ 153 ----------WNSVSGAVVKVTVIYDSSTKTLSVAVTND---NGDITTIAQVVDLKAKLPERVKFGFSASGSLGGRQIHL 219 (232)
T ss_dssp ----------CCCCTTCEEEEEEEEETTTTEEEEEEECT---TSCEEEEEEECCHHHHSCSEEEEEEEEECCSSBCCEEE
T ss_pred ----------cccCCCCEEEEEEEEeCCceEEEEEEecC---CCCcceEEEEEchhhccCCcEEEEEEEECCCCCCcccE
Confidence 45678999999999999999999999864 46678899999999999999999999999964 58999
Q ss_pred eeccccccc
Q 005940 264 ILGWSFSLN 272 (668)
Q Consensus 264 i~~w~F~~~ 272 (668)
|++|+|+++
T Consensus 220 I~sWsFss~ 228 (232)
T d1v6ia_ 220 IRSWSFTST 228 (232)
T ss_dssp EEEEEEEEE
T ss_pred EEEeEeEEe
Confidence 999999875
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-49 Score=399.88 Aligned_cols=253 Identities=26% Similarity=0.416 Sum_probs=195.8
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCchhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEEec
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEYI 432 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~ 432 (668)
++|+..++||+|+||+||+|.+. +++.||||++.... ...++|.+|++++++++|||||+++|+|..++..++||||+
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~ 82 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM 82 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred HHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEec
Confidence 46888999999999999999985 57789999997654 34578999999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCCCC
Q 005940 433 PNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMP 512 (668)
Q Consensus 433 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~~~ 512 (668)
++|+|.+++.. ....++|..++.++.|||+||.|||+ ++|+||||||+||||++++.+||+|||+++........
T Consensus 83 ~~g~L~~~l~~--~~~~~~~~~~~~i~~qia~gl~~lH~---~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~ 157 (263)
T d1sm2a_ 83 EHGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT 157 (263)
T ss_dssp TTCBHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCTTCSGGGEEECGGGCEEECSCC-----------
T ss_pred CCCcHHHHhhc--cccCCCHHHHHHHHHHHHHHHHhhhc---cceeecccchhheeecCCCCeEecccchheeccCCCce
Confidence 99999999863 34669999999999999999999999 99999999999999999999999999999877655444
Q ss_pred cccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCC-CCCCCCchhHHHHHHHHHhcCccccccCcccCCcccH
Q 005940 513 HTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGR-RPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSYVV 591 (668)
Q Consensus 513 ~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~-~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 591 (668)
......||..|+|||++.++.++.++|||||||++|||+|+. .|+..... .+.........+ ...|.. ++
T Consensus 158 ~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~--~~~~~~i~~~~~---~~~p~~---~~- 228 (263)
T d1sm2a_ 158 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN--SEVVEDISTGFR---LYKPRL---AS- 228 (263)
T ss_dssp -------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCH--HHHHHHHHHTCC---CCCCTT---SC-
T ss_pred eecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCH--HHHHHHHHhcCC---CCCccc---cC-
Confidence 444567899999999999999999999999999999999954 44543321 112222222111 111211 12
Q ss_pred HHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhccC
Q 005940 592 KEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSGE 624 (668)
Q Consensus 592 ~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~~ 624 (668)
..+..++..|++. |++||+|+||+++|+..
T Consensus 229 ---~~l~~li~~cl~~~p~~Rps~~~il~~L~~i 259 (263)
T d1sm2a_ 229 ---THVYQIMNHCWKERPEDRPAFSRLLRQLAEI 259 (263)
T ss_dssp ---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---HHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 2455677789998 99999999999999864
|
| >d1g7ya_ b.29.1.1 (A:) Legume lectin {Horse gram (Dolichos biflorus), different isoforms [TaxId: 3840]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Horse gram (Dolichos biflorus), different isoforms [TaxId: 3840]
Probab=100.00 E-value=1e-48 Score=393.97 Aligned_cols=222 Identities=30% Similarity=0.544 Sum_probs=194.0
Q ss_pred CceeEEeCCCCCCCCCeEEeCceeeCCCCcEEccCCCC------ceEEEEEeeCceecccCCCCCCCCeeeeEEEEEEEE
Q 005940 26 QSSSFIFQGFNGGATNLSLQGAEIIKPSGALKLTNRSR------YVIGHAFYVKPIQMFDTSASPSPNASSFSTTFVFEI 99 (668)
Q Consensus 26 ~~~~f~~~~f~~~~~~l~~~g~a~~~~~~~~~lt~~~~------~~~G~~~y~~p~~l~~~~~~~~~~~~sF~t~F~f~i 99 (668)
...+|+|++|+. .+|+++|+|.+. ++.|+||+... .++|||+|++||+||+ +.+++++||+|+|+|.|
T Consensus 2 ~~~sF~f~~F~~--~~l~l~GdA~~~-~~~l~LT~~~~~~~~~~~~~G~a~y~~pv~l~~---~~~~~~~sF~t~F~F~i 75 (253)
T d1g7ya_ 2 DIQSFSFKNFNS--SSFILQGDATVS-SSKLRLTKVKGNGLPTLSSLGRAFYSSPIQIYD---KSTGAVASWATSFTANI 75 (253)
T ss_dssp EEEEEEESSCCS--SCEEEEETCEEE-TTEEECSCBCTTSCBCSSCEEEEEESSCEECBC---TTTCCBCEEEEEEEEEC
T ss_pred cccEEecCCCCc--ccEEEEeeeEEc-CCEEEeCCCCCCCCcccceeEEEEeCCCeEeec---CCCCceeeEEEEEEEEE
Confidence 467999999987 799999999996 78899997543 4889999999999999 88999999999999999
Q ss_pred eCCCCCCCCCceEEEEcCCCCCCCCCCCCcccccccCCCCCCCccEEEEEeecccCCCCCCCCCCCeeeeecCCcccccc
Q 005940 100 STPRSGRGGHGLAFLLAPSTKLPGAQPEHYLGILNSTNNGEPSNHILIVEFDTVNGFNDKAENQGNHVGIGINTMFSNRS 179 (668)
Q Consensus 100 ~~~~~~~~g~GlaF~l~p~~~~~~~~~~~~lGl~~~~~~~~~~~~~~aVEfDt~~n~~d~~~~~~~Hvgid~~s~~s~~~ 179 (668)
.+.....+||||||+|+|....+ +..++++|+++..+. ...++.+||||||++|. + +||+++|||||+|++.|..+
T Consensus 76 ~~~~~~~ggDGlAF~l~~~~~~~-~~~~g~lgl~~~~~~-~~~~~~vaVEFDT~~n~-~-~d~~~~Hvgi~~ns~~s~~~ 151 (253)
T d1g7ya_ 76 FAPNKSSSADGIAFALVPVGSEP-KSNSGFLGVFDSDVY-DNSAQTVAVEFDTFSNT-D-WDPTSRHIGIDVNSIKSIRT 151 (253)
T ss_dssp CCSSGGGCCCEEEEEEEETTCCC-CCCGGGTTTCSCSSC-CGGGCCEEEEEECSCCT-T-TCCSSCEEEEEESSSSCSEE
T ss_pred ecCCCCCCCCceEEEEeCCCCCC-CCCcccccccccCCC-CCcCceEEEEEeceecC-C-CCCCCCcEEEeeCCcccccc
Confidence 98877788999999999977544 456889999986553 34677899999999982 1 34999999999999998877
Q ss_pred cCCccccCCCCCccccccCCCCcEEEEEEEeCCcceEEEEEEeCCCCCCCCcceeeeeccccccccceeeeeecccC---
Q 005940 180 EPASYYINGTDHKEEMTLESGEPIQAWIEYDGEQKVLNVTISPAEIGKPMRPLISFGVNLTGYIKETMYVGFSASTG--- 256 (668)
Q Consensus 180 ~~~~~~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~V~~~~~~~~~p~~~~ls~~~dLs~~l~~~~~vGFsastG--- 256 (668)
++ ..+.+|+.++|||+||+..++|+|++++. .+|..|++++.+||+.+|+++|||||||+||
T Consensus 152 ~~-------------~~~~~g~~~~v~I~Yd~~~~~L~v~l~~~--~~~~~~~ls~~vdL~~~l~~~~yvGFSAsTG~~~ 216 (253)
T d1g7ya_ 152 AS-------------WGLANGQNAEILITYNAATSLLVASLVHP--SRRTSYIVSERVDITNELPEYVSIGFSATTGLSE 216 (253)
T ss_dssp EE-------------CCCCTTSEEEEEEEEETTTTEEEEEEEET--TTTEEEEEEEECCHHHHSCSEEEEEEEEECCSSS
T ss_pred cC-------------CCccCCCEEEEEEEEeCCcEEEEEEEecC--CCCCceEEEEEechhhcCCCcEEEEEEeEcCCCC
Confidence 54 45778999999999999999999999864 3788899999999999999999999999999
Q ss_pred Ccccceeeeccccccc
Q 005940 257 EKSSSHYILGWSFSLN 272 (668)
Q Consensus 257 ~~~~~~~i~~w~F~~~ 272 (668)
+..+.|.|++|+|+++
T Consensus 217 ~~~~~H~IlsWsF~s~ 232 (253)
T d1g7ya_ 217 GYTETHDVLSWSFASK 232 (253)
T ss_dssp SCCCCCEEEEEEEEEE
T ss_pred CcccccEEEEEEeEEe
Confidence 4679999999999874
|
| >d1fnya_ b.29.1.1 (A:) Legume lectin {Black locust (Robinia pseudoacacia) [TaxId: 35938]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Black locust (Robinia pseudoacacia) [TaxId: 35938]
Probab=100.00 E-value=1.4e-48 Score=390.30 Aligned_cols=225 Identities=33% Similarity=0.511 Sum_probs=196.6
Q ss_pred CceeEEeCCCCCCCCCeEEeCceeeCCCCcEEccCCC-----CceEEEEEeeCceecccCCCCCCCCeeeeEEEEEEEEe
Q 005940 26 QSSSFIFQGFNGGATNLSLQGAEIIKPSGALKLTNRS-----RYVIGHAFYVKPIQMFDTSASPSPNASSFSTTFVFEIS 100 (668)
Q Consensus 26 ~~~~f~~~~f~~~~~~l~~~g~a~~~~~~~~~lt~~~-----~~~~G~~~y~~p~~l~~~~~~~~~~~~sF~t~F~f~i~ 100 (668)
.++||+|++|.++++|++|+|+|.+.++|.|+||++. .+++|||+|++||+||+ +.+++++||+|+|+|.|.
T Consensus 2 ~~~sF~f~~F~~~~~~l~l~G~A~v~~~g~i~LT~~~~~~~~~~~~G~~~y~~Pi~l~~---~~~~~~~sF~t~F~F~i~ 78 (237)
T d1fnya_ 2 GSLSFSFPKFAPNQPYLINQGDALVTSTGVLQLTNVVNGVPSSKSLGRALYAAPFQIWD---STTGNVASFVTSFTFIIQ 78 (237)
T ss_dssp EEEEEEESSCCTTCTTEEEEETCEECTTSCEECSCEETTEECSSCEEEEEESSCEECBC---TTTCCBCEEEEEEEEECC
T ss_pred ceEEEEeCCCCCCCCCeEEcccEEEcCCCEEECCCCCCCCcccccEEEEEeCCCeEccc---CCCCcceeeEEEEEEEEe
Confidence 4789999999987789999999999888999999863 46899999999999999 889999999999999999
Q ss_pred CCCCCCCCCceEEEEcCCCCCCCCCCCCcccccccCCCCCCCccEEEEEeecccCCCCCCCCCCCeeeeecCCccccccc
Q 005940 101 TPRSGRGGHGLAFLLAPSTKLPGAQPEHYLGILNSTNNGEPSNHILIVEFDTVNGFNDKAENQGNHVGIGINTMFSNRSE 180 (668)
Q Consensus 101 ~~~~~~~g~GlaF~l~p~~~~~~~~~~~~lGl~~~~~~~~~~~~~~aVEfDt~~n~~d~~~~~~~Hvgid~~s~~s~~~~ 180 (668)
+.+...+||||||+|+|....+ +..++++|+++... .+..++.+||||||++|. .+||+++|||||+|++.|..+.
T Consensus 79 ~~~~~~~gDG~AF~l~~~~~~~-~~~gg~lg~~~~~~-~~~~~~~~aVefDT~~n~--~~d~~~~Higi~~n~~~s~~~~ 154 (237)
T d1fnya_ 79 APNPATTADGLAFFLAPVDTQP-LDLGGMLGIFKDGY-FNKSNQIVAVEFDTFSNG--DWDPKGRHLGINVNSIESIKTV 154 (237)
T ss_dssp CSSTTSCCEEEEEEEEETTCCC-CCCGGGTTTCC----CCTTSCCEEEEEECSCCT--TTCCSSSEEEEEESSSSCSEEE
T ss_pred cCCCCCCCCeeEEEEcCCCCCc-ccccCcccccCCCC-ccCccceEEEEecccccc--CCCCCCceEEEecCCCcccccc
Confidence 8877889999999999977533 56788999987543 345788999999999982 2459999999999999887765
Q ss_pred CCccccCCCCCccccccCCCCcEEEEEEEeCCcceEEEEEEeCCCCCCCCcceeeeeccccccccceeeeeecccC---C
Q 005940 181 PASYYINGTDHKEEMTLESGEPIQAWIEYDGEQKVLNVTISPAEIGKPMRPLISFGVNLTGYIKETMYVGFSASTG---E 257 (668)
Q Consensus 181 ~~~~~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~V~~~~~~~~~p~~~~ls~~~dLs~~l~~~~~vGFsastG---~ 257 (668)
+ .++.+|+.++|||+||+..++|.|++.+.+ ++..|+++..+||+.+|+++|||||||+|| +
T Consensus 155 ~-------------~~~~~g~~~~v~I~Y~~~~~~l~v~l~~~~--~~~~~~l~~~vdL~~~l~~~~yvGFSAsTG~~s~ 219 (237)
T d1fnya_ 155 P-------------WNWTNGEVANVFISYEASTKSLTASLVYPS--LETSFIIDAIVDVKIVLPEWVRFGFSATTGIDKG 219 (237)
T ss_dssp E-------------CCCCTTCCEEEEEEEEGGGTEEEEEEEETT--TTEEEEEEEECCHHHHSCSEEEEEEEEEECSSTT
T ss_pred c-------------ccccCCcEEEEEEEEeCCccEEEEEEEeCC--CCcceeEEEEechhhcCCCcEEEEEEEECCCCCC
Confidence 4 355689999999999999999999999865 577889999999999999999999999999 5
Q ss_pred cccceeeeccccccc
Q 005940 258 KSSSHYILGWSFSLN 272 (668)
Q Consensus 258 ~~~~~~i~~w~F~~~ 272 (668)
..|.|+|++|+|+++
T Consensus 220 ~~e~H~I~sWsF~s~ 234 (237)
T d1fnya_ 220 YVQTNDVLSWSFESN 234 (237)
T ss_dssp CCCCCEEEEEEEEEE
T ss_pred cccccEEEEeEeEEe
Confidence 568999999999985
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=8.9e-50 Score=411.26 Aligned_cols=258 Identities=26% Similarity=0.345 Sum_probs=212.4
Q ss_pred hcCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCchhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEEe
Q 005940 352 TKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEY 431 (668)
Q Consensus 352 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~ 431 (668)
.++|+..++||+|+||+||+|++..+++.||||++..+. ...++|.+|++++++++|||||+++|+|.+++..++||||
T Consensus 16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~ 94 (287)
T d1opja_ 16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 94 (287)
T ss_dssp GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeec
Confidence 457888999999999999999998889999999987654 3457899999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCCC
Q 005940 432 IPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGM 511 (668)
Q Consensus 432 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~~ 511 (668)
+++|+|.+++.. .....++|..++.++.||+.||.|||+ ++|+||||||+||||++++.+||+|||+|+.......
T Consensus 95 ~~~g~l~~~l~~-~~~~~~~~~~~~~i~~qi~~gL~yLH~---~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~ 170 (287)
T d1opja_ 95 MTYGNLLDYLRE-CNRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 170 (287)
T ss_dssp CTTCBHHHHHHH-SCTTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSS
T ss_pred ccCcchHHHhhh-ccccchHHHHHHHHHHHHHHHHHHHHH---CCcccCccccCeEEECCCCcEEEccccceeecCCCCc
Confidence 999999999963 334679999999999999999999999 9999999999999999999999999999998766554
Q ss_pred CcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCcccCCcccH
Q 005940 512 PHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSYVV 591 (668)
Q Consensus 512 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 591 (668)
.......|+..|+|||++.++.++.++|||||||++|||++|..|+...... .+ +.+....+.. +.....++
T Consensus 171 ~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~-~~-~~~~i~~~~~-----~~~~~~~~- 242 (287)
T d1opja_ 171 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-SQ-VYELLEKDYR-----MERPEGCP- 242 (287)
T ss_dssp EEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCH-HH-HHHHHHTTCC-----CCCCTTCC-
T ss_pred eeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchH-HH-HHHHHhcCCC-----CCCCccch-
Confidence 4445567899999999999999999999999999999999977776433211 11 1222222211 11111222
Q ss_pred HHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhccCc
Q 005940 592 KEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSGEK 625 (668)
Q Consensus 592 ~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~~~ 625 (668)
..+..++..|++. |++||||+||++.|+...
T Consensus 243 ---~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~ 274 (287)
T d1opja_ 243 ---EKVYELMRACWQWNPSDRPSFAEIHQAFETMF 274 (287)
T ss_dssp ---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred ---HHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 3456677799998 999999999999987653
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-48 Score=397.46 Aligned_cols=252 Identities=25% Similarity=0.328 Sum_probs=200.8
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCc-hhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEEe
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSL-QGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEY 431 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~ 431 (668)
++|+..++||+|+||+||+|+++.+++.||||++..... +..+.+.+|++++++++||||+++++++.+++..|+||||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy 84 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 84 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence 468899999999999999999999999999999976543 3446789999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCCC
Q 005940 432 IPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGM 511 (668)
Q Consensus 432 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~~ 511 (668)
+++|+|.+++.. ...+++.++..++.||+.||.|||+ ++|+||||||+|||+++++++||+|||+|+.......
T Consensus 85 ~~gg~L~~~l~~---~~~l~e~~~~~i~~qi~~al~ylH~---~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~ 158 (271)
T d1nvra_ 85 CSGGELFDRIEP---DIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 158 (271)
T ss_dssp CTTEEGGGGSBT---TTBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred cCCCcHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHH---cCCccCcccHHHEEECCCCCEEEccchhheeeccCCc
Confidence 999999999953 4569999999999999999999999 9999999999999999999999999999997654322
Q ss_pred -CcccccccCCcccCcccccCCCC-CcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCcccCCcc
Q 005940 512 -PHTTNVVGTFGYIAPELTQTGKA-STSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSY 589 (668)
Q Consensus 512 -~~~~~~~gt~~y~aPE~~~~~~~-~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 589 (668)
......+||+.|||||++.+..+ +.++||||+||++|||++|+.||.........+... ....... .+ ....
T Consensus 159 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~-~~~~~~~---~~--~~~~ 232 (271)
T d1nvra_ 159 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW-KEKKTYL---NP--WKKI 232 (271)
T ss_dssp ECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHH-HTTCTTS---TT--GGGS
T ss_pred cccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHH-hcCCCCC---Cc--cccC
Confidence 22345689999999999987776 678999999999999999999997543222211111 1111110 00 0112
Q ss_pred cHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 590 VVKEMELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 590 ~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
+ + .+..+...|++. |++|||++|++++
T Consensus 233 s-~---~~~~li~~~L~~dP~~R~t~~eil~h 260 (271)
T d1nvra_ 233 D-S---APLALLHKILVENPSARITIPDIKKD 260 (271)
T ss_dssp C-H---HHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred C-H---HHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 2 2 233455678887 9999999999763
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-48 Score=397.79 Aligned_cols=256 Identities=27% Similarity=0.417 Sum_probs=198.6
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecC--CchhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEE
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRN--SLQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYE 430 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 430 (668)
++|...++||+|+||+||+|+++ ..||||+++.. ..+..++|.+|++++++++|||||+++|++.+ +..++|||
T Consensus 8 ~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E 83 (276)
T d1uwha_ 8 GQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ 83 (276)
T ss_dssp TCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred ccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEe
Confidence 56888999999999999999873 46999998654 34566889999999999999999999999865 56899999
Q ss_pred ecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCC
Q 005940 431 YIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGG 510 (668)
Q Consensus 431 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~ 510 (668)
||++|+|.+++.. .+..++|.+++.++.||++||+|||+ ++|+||||||+||||+.++.+||+|||+|+......
T Consensus 84 y~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~gl~yLH~---~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~ 158 (276)
T d1uwha_ 84 WCEGSSLYHHLHI--IETKFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWS 158 (276)
T ss_dssp CCCEEEHHHHHHT--SCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTSSEEECCCCCSCC-----
T ss_pred cCCCCCHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHhc---CCEeccccCHHHEEEcCCCCEEEccccceeeccccC
Confidence 9999999999963 33569999999999999999999999 999999999999999999999999999998765433
Q ss_pred C-CcccccccCCcccCcccccC---CCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCcccC
Q 005940 511 M-PHTTNVVGTFGYIAPELTQT---GKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLN 586 (668)
Q Consensus 511 ~-~~~~~~~gt~~y~aPE~~~~---~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 586 (668)
. .......||+.|||||++.. +.++.++|||||||++|||+||+.||....... .+......+...... +...
T Consensus 159 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~--~~~~~~~~~~~~p~~-~~~~ 235 (276)
T d1uwha_ 159 GSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD--QIIFMVGRGYLSPDL-SKVR 235 (276)
T ss_dssp -------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH--HHHHHHHHTSCCCCG-GGSC
T ss_pred CcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHH--HHHHHHhcCCCCCcc-hhcc
Confidence 2 23345689999999999864 357899999999999999999999997543221 111112211111100 1111
Q ss_pred CcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhccC
Q 005940 587 SSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSGE 624 (668)
Q Consensus 587 ~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~~ 624 (668)
..++ ..+..++..|+.. |++|||++||+++|+..
T Consensus 236 ~~~~----~~l~~li~~cl~~dp~~RPt~~~il~~Le~l 270 (276)
T d1uwha_ 236 SNCP----KAMKRLMAECLKKKRDERPLFPQILASIELL 270 (276)
T ss_dssp TTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ccch----HHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 1222 3455667789998 99999999999999765
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-48 Score=397.83 Aligned_cols=250 Identities=23% Similarity=0.344 Sum_probs=207.7
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCchhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEEec
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEYI 432 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~ 432 (668)
++|...++||+|+||+||+|.+..+|+.||||++........+.+.+|++++++++|||||++++++.+.+..|+|||||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 47999999999999999999999899999999998766666678999999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCCCC
Q 005940 433 PNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMP 512 (668)
Q Consensus 433 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~~~ 512 (668)
++|+|.+++.+ ..+++.++..++.||+.||.|||+ ++|+||||||+|||++.++++||+|||+|+.......
T Consensus 100 ~gg~L~~~~~~----~~l~~~~~~~i~~qi~~aL~yLH~---~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~- 171 (293)
T d1yhwa1 100 AGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS- 171 (293)
T ss_dssp TTCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-
T ss_pred CCCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHH---CCCcccCCcHHHeEECCCCcEeeccchhheeeccccc-
Confidence 99999998853 359999999999999999999999 9999999999999999999999999999998764432
Q ss_pred cccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCcccCCcccHH
Q 005940 513 HTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSYVVK 592 (668)
Q Consensus 513 ~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 592 (668)
.....+||+.|+|||++.++.++.++|||||||++|||++|+.||...+... ........... . ......++
T Consensus 172 ~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~--~~~~~~~~~~~-~---~~~~~~~s-- 243 (293)
T d1yhwa1 172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR--ALYLIATNGTP-E---LQNPEKLS-- 243 (293)
T ss_dssp CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH--HHHHHHHHCSC-C---CSSGGGSC--
T ss_pred cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHH--HHHHHHhCCCC-C---CCCcccCC--
Confidence 3345689999999999999999999999999999999999999997654221 11222222111 1 11111122
Q ss_pred HHHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 593 EMELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 593 ~~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
..+..+...|+.. |++||+++|+++|
T Consensus 244 --~~~~~li~~~L~~dP~~R~s~~eil~H 270 (293)
T d1yhwa1 244 --AIFRDFLNRCLDMDVEKRGSAKELLQH 270 (293)
T ss_dssp --HHHHHHHHHHTCSSTTTSCCHHHHTTC
T ss_pred --HHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 2344556678887 9999999999874
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-48 Score=395.85 Aligned_cols=253 Identities=28% Similarity=0.435 Sum_probs=203.6
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCchhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEEec
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEYI 432 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~ 432 (668)
++|+..++||+|+||.||+|+++ ++..||||++.... ...++|.+|++++++++|||||+++|+|.+ +..++||||+
T Consensus 13 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~ 89 (272)
T d1qpca_ 13 ETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM 89 (272)
T ss_dssp GGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred HHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeC
Confidence 56888999999999999999985 57789999997654 345789999999999999999999998865 5679999999
Q ss_pred CCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCCCC
Q 005940 433 PNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMP 512 (668)
Q Consensus 433 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~~~ 512 (668)
++|+|.+++.. .....++|.++++|+.||++||.|||+ ++|+||||||+||||++++.+||+|||+|+........
T Consensus 90 ~~g~L~~~~~~-~~~~~l~~~~~~~i~~qi~~gl~~lH~---~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~ 165 (272)
T d1qpca_ 90 ENGSLVDFLKT-PSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT 165 (272)
T ss_dssp TTCBHHHHTTS-HHHHTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE
T ss_pred CCCcHHHHHhh-cCCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCccchhheeeecccceeeccccceEEccCCccc
Confidence 99999998853 223459999999999999999999999 99999999999999999999999999999988765544
Q ss_pred cccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCcccCCcccHH
Q 005940 513 HTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSYVVK 592 (668)
Q Consensus 513 ~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 592 (668)
......||+.|||||++.++.++.++|||||||++|||+||..|+...... .+.... ...+. .+.....+.
T Consensus 166 ~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~-~~~~~~-i~~~~-----~~~~p~~~~-- 236 (272)
T d1qpca_ 166 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN-PEVIQN-LERGY-----RMVRPDNCP-- 236 (272)
T ss_dssp CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH-HHHHHH-HHTTC-----CCCCCTTCC--
T ss_pred cccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCH-HHHHHH-HHhcC-----CCCCcccCh--
Confidence 445567899999999999889999999999999999999976665432111 111111 11111 111111222
Q ss_pred HHHHHHHHHhhcCCC-CCCCCCHHHHHHHhcc
Q 005940 593 EMELVLKLGLMCSHK-TQFRPTMRQVMRYLSG 623 (668)
Q Consensus 593 ~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~ 623 (668)
..+..++..|++. |++||||+||++.|+.
T Consensus 237 --~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~ 266 (272)
T d1qpca_ 237 --EELYQLMRLCWKERPEDRPTFDYLRSVLED 266 (272)
T ss_dssp --HHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred --HHHHHHHHHHcCCCHhHCcCHHHHHHHhhh
Confidence 2355667789998 9999999999998863
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-48 Score=396.40 Aligned_cols=255 Identities=25% Similarity=0.365 Sum_probs=193.4
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCC--chhHHHHHHHHHHHhcccccCceeEeeeecc--cCceEEE
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNS--LQGMREFAAEIESLGRLRHKNLVNLHGWCKQ--KNDLLLV 428 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~--~~~~~lV 428 (668)
++|++.+.||+|+||+||+|+++.+|+.||||++.... ....+.+.+|++++++++|||||++++++.+ .+.+|+|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 57899999999999999999999999999999997653 3345678999999999999999999999864 4568999
Q ss_pred EEecCCCChhhhhcCC-CCCCCccHHHHHHHHHHHHHHHHHhhhcc--CCceEecCCCCCCEEECCCCCEEEEeecCcee
Q 005940 429 YEYIPNGSLDTLLFKP-KDGSVLDWEQRFNIVKGIASGLLYLHEEW--EQVVIHRDVKPSNALIDAEMNARLGDFGLARL 505 (668)
Q Consensus 429 ~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~gL~yLH~~~--~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~ 505 (668)
||||++|+|.+++.+. ..+..+++..++.++.||+.||.|||+.. ..+|+||||||+||||+.++.+||+|||+|+.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 9999999999998532 23457999999999999999999999821 13499999999999999999999999999998
Q ss_pred ccCCCCCcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCccc
Q 005940 506 YDHGGMPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLL 585 (668)
Q Consensus 506 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 585 (668)
...... ......||+.|||||++.+..++.++|||||||++|||+||+.||...+.. +. ......+... .+
T Consensus 164 ~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~--~~-~~~i~~~~~~-----~~ 234 (269)
T d2java1 164 LNHDTS-FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK--EL-AGKIREGKFR-----RI 234 (269)
T ss_dssp C------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH--HH-HHHHHHTCCC-----CC
T ss_pred cccCCC-ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHH--HH-HHHHHcCCCC-----CC
Confidence 765332 234468999999999999999999999999999999999999999765322 11 1112222221 12
Q ss_pred CCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 586 NSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 586 ~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
...++. .+..+...|++. |++|||++|++++
T Consensus 235 ~~~~s~----~l~~li~~~L~~dp~~Rps~~ell~h 266 (269)
T d2java1 235 PYRYSD----ELNEIITRMLNLKDYHRPSVEEILEN 266 (269)
T ss_dssp CTTSCH----HHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred CcccCH----HHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 222332 344556688887 9999999999874
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-47 Score=389.04 Aligned_cols=252 Identities=25% Similarity=0.395 Sum_probs=210.5
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCchhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEEec
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEYI 432 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~ 432 (668)
++|+..++||+|+||+||+|+++ ++..||||++++... ..++|.+|++++++++||||++++|+|.+++..++||||+
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~ 81 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 81 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECC
T ss_pred HHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEcc
Confidence 57889999999999999999985 678999999987554 3478999999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCCCC
Q 005940 433 PNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMP 512 (668)
Q Consensus 433 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~~~ 512 (668)
++|+|.+++.. ....+++..+++++.|+++||.|||+ .+|+||||||+||++++++.+||+|||+++........
T Consensus 82 ~~g~l~~~~~~--~~~~~~~~~~~~i~~qi~~gl~~LH~---~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~ 156 (258)
T d1k2pa_ 82 ANGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT 156 (258)
T ss_dssp TTEEHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHH---TTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC
T ss_pred CCCcHHHhhhc--cccCCcHHHHHHHHHHHHHHHHHHhh---cCcccccccceeEEEcCCCcEEECcchhheeccCCCce
Confidence 99999999853 34568999999999999999999999 99999999999999999999999999999877665544
Q ss_pred cccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHHHhcCccccccCcccCCcccH
Q 005940 513 HTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVAT-GRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSYVV 591 (668)
Q Consensus 513 ~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 591 (668)
......||..|+|||++.++.++.++|||||||++|||+| |+.||....... ..... ..+... ..|. ...
T Consensus 157 ~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~--~~~~i-~~~~~~--~~p~---~~~- 227 (258)
T d1k2pa_ 157 SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE--TAEHI-AQGLRL--YRPH---LAS- 227 (258)
T ss_dssp CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH--HHHHH-HTTCCC--CCCT---TCC-
T ss_pred eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHH--HHHHH-HhCCCC--CCcc---ccc-
Confidence 4555679999999999999999999999999999999998 899997654322 12222 222111 1121 112
Q ss_pred HHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhcc
Q 005940 592 KEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSG 623 (668)
Q Consensus 592 ~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~ 623 (668)
..+..++..|+.. |++|||++||+++|..
T Consensus 228 ---~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 228 ---EKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp ---HHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred ---HHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 3455677789998 9999999999999853
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-48 Score=391.20 Aligned_cols=246 Identities=24% Similarity=0.370 Sum_probs=204.1
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCC---chhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEE
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNS---LQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVY 429 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 429 (668)
++|++.+.||+|+||+||+|+++.+++.||||++.+.. ....+.+.+|++++++++||||+++++++.+++..++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 46889999999999999999999999999999997532 234567899999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCC
Q 005940 430 EYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHG 509 (668)
Q Consensus 430 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~ 509 (668)
|||++|+|.+++.. ...+++.++..++.||+.||+|||+ ++|+||||||+||||+.++++||+|||+|+.....
T Consensus 86 Ey~~~g~L~~~l~~---~~~l~e~~~~~i~~qi~~al~~lH~---~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~ 159 (263)
T d2j4za1 86 EYAPLGTVYRELQK---LSKFDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 159 (263)
T ss_dssp ECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC
T ss_pred eecCCCcHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeeeeccccceecCCCCEeecccceeeecCCC
Confidence 99999999999963 3459999999999999999999999 99999999999999999999999999999876543
Q ss_pred CCCcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCcccCCcc
Q 005940 510 GMPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSY 589 (668)
Q Consensus 510 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 589 (668)
. .....||+.|||||++.+..++.++|||||||++|||++|+.||...+.. +. ........ +.+....
T Consensus 160 ~---~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~--~~-~~~i~~~~------~~~p~~~ 227 (263)
T d2j4za1 160 R---RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ--ET-YKRISRVE------FTFPDFV 227 (263)
T ss_dssp C---CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH--HH-HHHHHTTC------CCCCTTS
T ss_pred c---ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHH--HH-HHHHHcCC------CCCCccC
Confidence 2 34468999999999999989999999999999999999999999765322 11 11111111 1111122
Q ss_pred cHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 590 VVKEMELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 590 ~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
+ ++ +..+...|++. |++|||++||+++
T Consensus 228 s-~~---~~~li~~~L~~dp~~R~t~~eil~h 255 (263)
T d2j4za1 228 T-EG---ARDLISRLLKHNPSQRPMLREVLEH 255 (263)
T ss_dssp C-HH---HHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred C-HH---HHHHHHHHccCCHhHCcCHHHHHcC
Confidence 2 23 34455678887 9999999999974
|
| >d1ukga_ b.29.1.1 (A:) Legume lectin {Bloodwood tree (Pterocarpus angolensis) [TaxId: 182271]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Bloodwood tree (Pterocarpus angolensis) [TaxId: 182271]
Probab=100.00 E-value=5e-47 Score=379.94 Aligned_cols=226 Identities=26% Similarity=0.507 Sum_probs=197.3
Q ss_pred CceeEEeCCCCCCCCCeEEeCceeeCCCCcEEccCCC------CceEEEEEeeCceecccCCCCCCCCeeeeEEEEEEEE
Q 005940 26 QSSSFIFQGFNGGATNLSLQGAEIIKPSGALKLTNRS------RYVIGHAFYVKPIQMFDTSASPSPNASSFSTTFVFEI 99 (668)
Q Consensus 26 ~~~~f~~~~f~~~~~~l~~~g~a~~~~~~~~~lt~~~------~~~~G~~~y~~p~~l~~~~~~~~~~~~sF~t~F~f~i 99 (668)
++++|+|++|.+++.||+|+|+|.+. ++.|+||++. ..++|||+|++||+||+ +.+++++||+|+|+|.|
T Consensus 2 ~~~sF~f~~F~~~~~~l~l~G~A~i~-~~~i~LT~~~~~~~~~~~~~G~~~y~~Pi~l~~---~~~~~~~sF~t~F~f~i 77 (241)
T d1ukga_ 2 DSLSFGFPTFPSDQKNLIFQGDAQIK-NNAVQLTKTDSNGNPVASTVGRILFSAQVHLWE---KSSSRVANFQSQFSFSL 77 (241)
T ss_dssp CEEEEEESSCCSCCSSEEEEETCEEE-TTEEECSCBCTTSCBCSSEEEEEEESSCEECEE---TTTTEEEEEEEEEEEEE
T ss_pred ccEEEEeCCCCCCCCCEEEeeeEEEe-CCEEEeCCCCCCCCccccceEEEEeCCCeeccc---CCCCceeeeEEEEEEEE
Confidence 57999999998877899999999996 7889999754 46899999999999999 88899999999999999
Q ss_pred eCCCCCCCCCceEEEEcCCC-CCCCCCCCCcccccccCC-CCCCCccEEEEEeecccC-CCCCCCCCCCeeeeecCCccc
Q 005940 100 STPRSGRGGHGLAFLLAPST-KLPGAQPEHYLGILNSTN-NGEPSNHILIVEFDTVNG-FNDKAENQGNHVGIGINTMFS 176 (668)
Q Consensus 100 ~~~~~~~~g~GlaF~l~p~~-~~~~~~~~~~lGl~~~~~-~~~~~~~~~aVEfDt~~n-~~d~~~~~~~Hvgid~~s~~s 176 (668)
..+. ...|||+|||+.|.. ..|....|+++|+++... .+...++.+||||||++| ....++|++||||||+|++.|
T Consensus 78 ~~~~-~~~~~g~~f~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~n~~vaVEfDt~~n~~~~~~~~~~~Higid~n~~~s 156 (241)
T d1ukga_ 78 KSPL-SNGADGIAFFIAPPDTTIPSGSGGGLLGLFAPGTAQNTSANQVIAVEFDTFYAQDSNTWDPNYPHIGIDVNSIRS 156 (241)
T ss_dssp ECSS-SSCCCEEEEEEECTTCCCCTTCCGGGTTTSCGGGTTCGGGCCCEEEEEECCCCTTTCTTSCSSCEEEEEESSSSC
T ss_pred ecCC-CCCCCceEEEEeCCCCCcccccCcccccccccccccCCccCcccceeccCEecCccCCCCCCCccEeeecCCccc
Confidence 8764 567999999999855 567788889999987644 345678999999999988 223355899999999999998
Q ss_pred ccccCCccccCCCCCccccccCCCCcEEEEEEEeCCcceEEEEEEeCCCCCCCCcceeeeeccccccccceeeeeecccC
Q 005940 177 NRSEPASYYINGTDHKEEMTLESGEPIQAWIEYDGEQKVLNVTISPAEIGKPMRPLISFGVNLTGYIKETMYVGFSASTG 256 (668)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~V~~~~~~~~~p~~~~ls~~~dLs~~l~~~~~vGFsastG 256 (668)
.+... ..+.+|+.++|||+||+..++|+|++++. +|..|.+++.+||+.+|+++|||||||+||
T Consensus 157 ~~~~~-------------~~~~~g~~~~v~I~Yd~~~~~L~v~~~~~---~~~~~~l~~~vdL~~~l~~~~yvGFSAsTG 220 (241)
T d1ukga_ 157 VKTVK-------------WDRRDGQSLNVLVTFNPSTRNLDVVATYS---DGTRYEVSYEVDVRSVLPEWVRVGFSAASG 220 (241)
T ss_dssp SEEEE-------------CCCCTTCCEEEEEEEETTTTEEEEEEEET---TCCEEEEEEECCGGGTSCSEEEEEEEEEES
T ss_pred ccccc-------------cccCCCcEEEEEEEEeCCCcEEEEEEccC---CCCceEEEEEEehHHhCCCcEEEEEEEecC
Confidence 76643 45678999999999999999999999874 567788999999999999999999999999
Q ss_pred Ccccceeeeccccccc
Q 005940 257 EKSSSHYILGWSFSLN 272 (668)
Q Consensus 257 ~~~~~~~i~~w~F~~~ 272 (668)
...|.|+|++|+|+++
T Consensus 221 ~~~~~H~IlsWsFss~ 236 (241)
T d1ukga_ 221 EQYQTHTLESWSFTST 236 (241)
T ss_dssp SSCCEEEEEEEEEEEE
T ss_pred CCCceeEEEEeEEEEE
Confidence 9999999999999875
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-47 Score=394.98 Aligned_cols=252 Identities=25% Similarity=0.336 Sum_probs=204.5
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCchhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEEec
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEYI 432 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~ 432 (668)
+.|++.+.||+|+||+||+|++..++..||||++........+.|.+|++++++++|||||++++++.+.+..++|||||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 35888999999999999999999999999999998877777788999999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCCCC
Q 005940 433 PNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMP 512 (668)
Q Consensus 433 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~~~ 512 (668)
++|+|.+++.+ ....+++.++..++.||+.||.|||+ ++|+||||||+|||++.++++||+|||+|+...... .
T Consensus 92 ~~g~L~~~~~~--~~~~l~e~~~~~i~~qi~~gL~ylH~---~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~-~ 165 (288)
T d2jfla1 92 AGGAVDAVMLE--LERPLTESQIQVVCKQTLDALNYLHD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-Q 165 (288)
T ss_dssp TTEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH-H
T ss_pred CCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHH---CCEEEeecChhheeECCCCCEEEEechhhhccCCCc-c
Confidence 99999999753 23569999999999999999999999 999999999999999999999999999998654321 1
Q ss_pred cccccccCCcccCccccc-----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCcccCC
Q 005940 513 HTTNVVGTFGYIAPELTQ-----TGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNS 587 (668)
Q Consensus 513 ~~~~~~gt~~y~aPE~~~-----~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 587 (668)
......||+.|+|||++. ...++.++|||||||++|||++|+.||......- ........ .......+ .
T Consensus 166 ~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~--~~~~i~~~-~~~~~~~~---~ 239 (288)
T d2jfla1 166 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR--VLLKIAKS-EPPTLAQP---S 239 (288)
T ss_dssp HHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGG--HHHHHHHS-CCCCCSSG---G
T ss_pred cccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHH--HHHHHHcC-CCCCCCcc---c
Confidence 223468999999999884 4567899999999999999999999997543211 11111111 11111111 1
Q ss_pred cccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 588 SYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 588 ~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
..+ + .+..+...|++. |++|||++|++++
T Consensus 240 ~~s-~---~~~~li~~~L~~dp~~R~t~~ell~h 269 (288)
T d2jfla1 240 RWS-S---NFKDFLKKCLEKNVDARWTTSQLLQH 269 (288)
T ss_dssp GSC-H---HHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred cCC-H---HHHHHHHHHccCChhHCcCHHHHhcC
Confidence 112 2 344556688887 9999999999874
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-48 Score=396.01 Aligned_cols=259 Identities=25% Similarity=0.404 Sum_probs=198.9
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCC----cEEEEEEEecCCc-hhHHHHHHHHHHHhcccccCceeEeeeecccCceEE
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTG----GEVAVKKITRNSL-QGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLL 427 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~----~~vavK~~~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l 427 (668)
..|+..++||+|+||.||+|.++.++ ..||||++..... ....+|.+|++++++++|||||+++|+|.+.+..++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence 45778899999999999999986544 3699999976543 345679999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceecc
Q 005940 428 VYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYD 507 (668)
Q Consensus 428 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~ 507 (668)
||||+.+|+|.+++.. ....++|.++++++.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+++...
T Consensus 87 v~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~~i~~gl~~lH~---~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 161 (283)
T d1mqba_ 87 ITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 161 (283)
T ss_dssp EEECCTTEEHHHHHHH--TTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred EEEecccCcchhhhhc--ccccccHHHHHHHHHHHHHhhhhccc---cccccCccccceEEECCCCeEEEcccchhhccc
Confidence 9999999999998853 34569999999999999999999999 999999999999999999999999999998765
Q ss_pred CCCCC--cccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCccc
Q 005940 508 HGGMP--HTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLL 585 (668)
Q Consensus 508 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 585 (668)
..... ......||+.|||||++.++.++.++|||||||++|||++|..|+..... ..+.... ...+.. +..
T Consensus 162 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~-~~~~~~~-i~~~~~-----~~~ 234 (283)
T d1mqba_ 162 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS-NHEVMKA-INDGFR-----LPT 234 (283)
T ss_dssp ------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC-HHHHHHH-HHTTCC-----CCC
T ss_pred CCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCC-HHHHHHH-HhccCC-----CCC
Confidence 43221 22345689999999999999999999999999999999997666543211 1111122 222211 111
Q ss_pred CCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhccCcCC
Q 005940 586 NSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSGEKQL 627 (668)
Q Consensus 586 ~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~~~~~ 627 (668)
.... ...+..|+..|++. |++||+|.||++.|+.....
T Consensus 235 ~~~~----~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~ 273 (283)
T d1mqba_ 235 PMDC----PSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273 (283)
T ss_dssp CTTC----BHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred chhh----HHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence 1112 23466777899998 99999999999999865443
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-47 Score=392.09 Aligned_cols=253 Identities=23% Similarity=0.352 Sum_probs=202.5
Q ss_pred cCcccce-eeeecCcEEEEEEEeCC--CCcEEEEEEEecCCc-hhHHHHHHHHHHHhcccccCceeEeeeecccCceEEE
Q 005940 353 KGFKESE-VIGIGGFGSVYKGVLPT--TGGEVAVKKITRNSL-QGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLV 428 (668)
Q Consensus 353 ~~f~~~~-~lG~G~~g~Vy~~~~~~--~~~~vavK~~~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV 428 (668)
++|...+ +||+|+||.||+|+++. ++..||||++..... ...++|.+|++++++++|||||+++|+|.. +..|+|
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv 86 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 86 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence 4555666 49999999999998753 345799999976543 456789999999999999999999999965 468999
Q ss_pred EEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccC
Q 005940 429 YEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDH 508 (668)
Q Consensus 429 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~ 508 (668)
|||+++|+|.+++.. .+..+++.++++++.||++||+|||+ ++|+||||||+||||+.++.+||+|||+++....
T Consensus 87 mE~~~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~gL~ylH~---~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~ 161 (285)
T d1u59a_ 87 MEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGA 161 (285)
T ss_dssp EECCTTEEHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred EEeCCCCcHHHHhhc--cccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCcCchhheeeccCCceeeccchhhhcccc
Confidence 999999999999843 34579999999999999999999999 9999999999999999999999999999998765
Q ss_pred CCCC--cccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHHHhcCccccccCccc
Q 005940 509 GGMP--HTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVAT-GRRPIGSGDLLLVEWVRECHQLGRILDVADPLL 585 (668)
Q Consensus 509 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 585 (668)
.... ......||+.|+|||++..+.++.++|||||||++|||+| |+.||...... +. ......+.... .
T Consensus 162 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~--~~-~~~i~~~~~~~-----~ 233 (285)
T d1u59a_ 162 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP--EV-MAFIEQGKRME-----C 233 (285)
T ss_dssp CSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH--HH-HHHHHTTCCCC-----C
T ss_pred cccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHH--HH-HHHHHcCCCCC-----C
Confidence 4322 2234568999999999998999999999999999999998 99999764322 11 11222222111 1
Q ss_pred CCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhcc
Q 005940 586 NSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSG 623 (668)
Q Consensus 586 ~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~ 623 (668)
...++ ..+..++..|+.. |++||+|.+|++.|+.
T Consensus 234 p~~~~----~~l~~li~~cl~~~p~~RPs~~~i~~~L~~ 268 (285)
T d1u59a_ 234 PPECP----PELYALMSDCWIYKWEDRPDFLTVEQRMRA 268 (285)
T ss_dssp CTTCC----HHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred CCcCC----HHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 12222 2355677799997 9999999999998864
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-47 Score=402.12 Aligned_cols=202 Identities=29% Similarity=0.409 Sum_probs=180.2
Q ss_pred hcCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCc-hhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEE
Q 005940 352 TKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSL-QGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYE 430 (668)
Q Consensus 352 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 430 (668)
.++|+..++||+|+||+||+|++..+|+.||+|++..... ...+++.+|+.+|++++|||||+++++|.+++..++|||
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE 84 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 84 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 4689999999999999999999998999999999976533 345688999999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCC
Q 005940 431 YIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGG 510 (668)
Q Consensus 431 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~ 510 (668)
|+++|+|.+++.+ ...+++..+..++.||+.||.|||+ .++|+||||||+||||+.++++||+|||+|+......
T Consensus 85 y~~gg~L~~~l~~---~~~l~~~~~~~~~~qil~aL~yLH~--~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~ 159 (322)
T d1s9ja_ 85 HMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 159 (322)
T ss_dssp CCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH--HHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHT
T ss_pred cCCCCcHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHH--hCCEEccccCHHHeeECCCCCEEEeeCCCccccCCCc
Confidence 9999999999963 3459999999999999999999997 1489999999999999999999999999998764322
Q ss_pred CCcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCc
Q 005940 511 MPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGD 561 (668)
Q Consensus 511 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~ 561 (668)
....+||+.|+|||++.+..++.++||||+||++|||++|+.||...+
T Consensus 160 ---~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~ 207 (322)
T d1s9ja_ 160 ---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPD 207 (322)
T ss_dssp ---C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCC
T ss_pred ---cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence 234689999999999999999999999999999999999999997653
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-46 Score=383.45 Aligned_cols=245 Identities=28% Similarity=0.400 Sum_probs=195.0
Q ss_pred ccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCC--chhHHHHHHHHHHHhcccccCceeEeeeecc----cCceEEEE
Q 005940 356 KESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNS--LQGMREFAAEIESLGRLRHKNLVNLHGWCKQ----KNDLLLVY 429 (668)
Q Consensus 356 ~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~----~~~~~lV~ 429 (668)
+..++||+|+||+||+|++..++..||+|++.... ....+.|.+|++++++++|||||++++++.. ...+++||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 55678999999999999999899999999997643 3445679999999999999999999999864 34589999
Q ss_pred EecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCc--eEecCCCCCCEEEC-CCCCEEEEeecCceec
Q 005940 430 EYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQV--VIHRDVKPSNALID-AEMNARLGDFGLARLY 506 (668)
Q Consensus 430 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~--ivHrDLkp~NIll~-~~~~~kl~DfGla~~~ 506 (668)
||+++|+|.+++.+ ...+++..++.++.||++||+|||+ ++ |+||||||+||||+ +++.+||+|||+|+..
T Consensus 92 E~~~~g~L~~~l~~---~~~~~~~~~~~~~~qi~~gl~yLH~---~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~ 165 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 165 (270)
T ss_dssp ECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred eCCCCCcHHHHHhc---cccccHHHHHHHHHHHHHHHHHHHH---CCCCEEeCCcChhhceeeCCCCCEEEeecCcceec
Confidence 99999999999963 3469999999999999999999998 66 99999999999997 5789999999999864
Q ss_pred cCCCCCcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCcccC
Q 005940 507 DHGGMPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLN 586 (668)
Q Consensus 507 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 586 (668)
... .....+||+.|||||++.+ +++.++|||||||++|||++|+.||...... .. .......+.. .+.+.
T Consensus 166 ~~~---~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~-~~-~~~~i~~~~~----~~~~~ 235 (270)
T d1t4ha_ 166 RAS---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA-AQ-IYRRVTSGVK----PASFD 235 (270)
T ss_dssp CTT---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH-HH-HHHHHTTTCC----CGGGG
T ss_pred cCC---ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccH-HH-HHHHHHcCCC----CcccC
Confidence 432 2345689999999998865 6999999999999999999999999754321 11 1111111111 11111
Q ss_pred CcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 587 SSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 587 ~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
.... + .+..+...|+.. |++|||++|+++|
T Consensus 236 ~~~~-~---~~~~li~~~l~~dp~~R~s~~ell~H 266 (270)
T d1t4ha_ 236 KVAI-P---EVKEIIEGCIRQNKDERYSIKDLLNH 266 (270)
T ss_dssp GCCC-H---HHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ccCC-H---HHHHHHHHHccCCHhHCcCHHHHhCC
Confidence 1122 2 244566789887 9999999999874
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=4.4e-46 Score=393.69 Aligned_cols=252 Identities=23% Similarity=0.335 Sum_probs=208.0
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCchhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEEec
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEYI 432 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~ 432 (668)
++|.+.++||+|+||.||+|++..+|+.||||++........+.+.+|++++++++|||||++++++.+++.+|+|||||
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 105 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 105 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 57999999999999999999999899999999998877667788999999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECC--CCCEEEEeecCceeccCCC
Q 005940 433 PNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDA--EMNARLGDFGLARLYDHGG 510 (668)
Q Consensus 433 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~--~~~~kl~DfGla~~~~~~~ 510 (668)
++|+|.+++.. ....+++..+..++.||+.||.|||+ ++|+||||||+||||+. ++.+||+|||+++......
T Consensus 106 ~gg~L~~~l~~--~~~~l~e~~~~~i~~qi~~aL~ylH~---~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~ 180 (350)
T d1koaa2 106 SGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 180 (350)
T ss_dssp CSCBHHHHHTC--TTSCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS
T ss_pred CCCCHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHh---cCCeeeeechhHeeeccCCCCeEEEeecchheeccccc
Confidence 99999999853 34569999999999999999999999 99999999999999964 5789999999999876543
Q ss_pred CCcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCcccCCccc
Q 005940 511 MPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSYV 590 (668)
Q Consensus 511 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 590 (668)
. .....||+.|||||++.+..++.++|||||||++|||++|+.||...+.. +........... .++.......
T Consensus 181 ~--~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~--~~~~~i~~~~~~---~~~~~~~~~s 253 (350)
T d1koaa2 181 S--VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD--ETLRNVKSCDWN---MDDSAFSGIS 253 (350)
T ss_dssp C--EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHTCCC---SCCGGGGGCC
T ss_pred c--cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHH--HHHHHHHhCCCC---CCcccccCCC
Confidence 2 34468999999999999999999999999999999999999999754321 222222221110 0111111112
Q ss_pred HHHHHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 591 VKEMELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 591 ~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
+ .+..+...|+.. |++|||++|++++
T Consensus 254 -~---~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 254 -E---DGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp -H---HHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred -H---HHHHHHHHHccCChhHCcCHHHHhcC
Confidence 2 234555678887 9999999999997
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-47 Score=398.94 Aligned_cols=254 Identities=26% Similarity=0.360 Sum_probs=202.6
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCc-----EEEEEEEecCC-chhHHHHHHHHHHHhcc-cccCceeEeeeecccCce
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGG-----EVAVKKITRNS-LQGMREFAAEIESLGRL-RHKNLVNLHGWCKQKNDL 425 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~-----~vavK~~~~~~-~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~ 425 (668)
++|+..++||+|+||+||+|++...++ .||||++.... ......|.+|+.++.++ +|||||+++++|.+.+..
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~ 116 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI 116 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeE
Confidence 568889999999999999999865443 69999986543 34456889999999998 899999999999999999
Q ss_pred EEEEEecCCCChhhhhcCCCC--------------------CCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCC
Q 005940 426 LLVYEYIPNGSLDTLLFKPKD--------------------GSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPS 485 (668)
Q Consensus 426 ~lV~E~~~~gsL~~~l~~~~~--------------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~ 485 (668)
++|||||++|+|.++|+.... ...++|..++.++.||++||+|||+ ++|+||||||+
T Consensus 117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~---~~IiHRDlKp~ 193 (325)
T d1rjba_ 117 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAAR 193 (325)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH---TTEEETTCSGG
T ss_pred EEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCchh
Confidence 999999999999999964321 2458999999999999999999999 99999999999
Q ss_pred CEEECCCCCEEEEeecCceeccCCCCC-cccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCc--
Q 005940 486 NALIDAEMNARLGDFGLARLYDHGGMP-HTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVAT-GRRPIGSGD-- 561 (668)
Q Consensus 486 NIll~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~-- 561 (668)
|||++.++.+||+|||+|+........ ......||+.|||||++.++.++.++|||||||++|||+| |+.||....
T Consensus 194 Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~ 273 (325)
T d1rjba_ 194 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD 273 (325)
T ss_dssp GEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred ccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHH
Confidence 999999999999999999876544322 2334578999999999999999999999999999999998 899997542
Q ss_pred hhHHHHHHHHHhcCccccccCcccCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhc
Q 005940 562 LLLVEWVRECHQLGRILDVADPLLNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLS 622 (668)
Q Consensus 562 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~ 622 (668)
..+.. ....+.. +......+ ..+..++..|++. |++|||++||+++|.
T Consensus 274 ~~~~~----~~~~~~~-----~~~p~~~~----~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 274 ANFYK----LIQNGFK-----MDQPFYAT----EEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp HHHHH----HHHTTCC-----CCCCTTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHH----HHhcCCC-----CCCCCcCC----HHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 22222 1222111 11111122 2455667789987 999999999999985
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-46 Score=385.43 Aligned_cols=246 Identities=25% Similarity=0.360 Sum_probs=195.4
Q ss_pred eeeeecCcEEEEEEEeCC--CCcEEEEEEEecCC--chhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEEecCC
Q 005940 359 EVIGIGGFGSVYKGVLPT--TGGEVAVKKITRNS--LQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEYIPN 434 (668)
Q Consensus 359 ~~lG~G~~g~Vy~~~~~~--~~~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~ 434 (668)
++||+|+||+||+|.+.. .++.||||++.... ....++|.+|++++++++|||||+++|+|.. +..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 579999999999998743 44689999996542 3345789999999999999999999999965 467899999999
Q ss_pred CChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCCCCc-
Q 005940 435 GSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMPH- 513 (668)
Q Consensus 435 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~~~~- 513 (668)
|+|.+++.. ...++|.++++++.||+.||+|||+ .+|+||||||+||||+.++.+||+|||+++.........
T Consensus 92 g~L~~~l~~---~~~l~~~~~~~i~~qi~~gl~ylH~---~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~ 165 (277)
T d1xbba_ 92 GPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 165 (277)
T ss_dssp EEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEE
T ss_pred CcHHHHHhh---ccCCCHHHHHHHHHHHHHHHhhHHh---CCcccCCCcchhhcccccCcccccchhhhhhccccccccc
Confidence 999999963 3469999999999999999999999 999999999999999999999999999999775443222
Q ss_pred -ccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHHHhcCccccccCcccCCcccH
Q 005940 514 -TTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVAT-GRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSYVV 591 (668)
Q Consensus 514 -~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 591 (668)
.....||+.|||||++.++.++.++|||||||++|||+| |+.||...... + +......+.... ....++
T Consensus 166 ~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~--~-~~~~i~~~~~~~-----~p~~~~- 236 (277)
T d1xbba_ 166 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS--E-VTAMLEKGERMG-----CPAGCP- 236 (277)
T ss_dssp C----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--H-HHHHHHTTCCCC-----CCTTCC-
T ss_pred cccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHH--H-HHHHHHcCCCCC-----CCcccC-
Confidence 234578999999999999999999999999999999998 89999765322 1 112222222111 112222
Q ss_pred HHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhcc
Q 005940 592 KEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSG 623 (668)
Q Consensus 592 ~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~ 623 (668)
..+..++..|++. |++||++++|++.|+.
T Consensus 237 ---~~~~~li~~cl~~dp~~RPs~~~i~~~L~~ 266 (277)
T d1xbba_ 237 ---REMYDLMNLCWTYDVENRPGFAAVELRLRN 266 (277)
T ss_dssp ---HHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred ---HHHHHHHHHHcCCCHhHCcCHHHHHHHhhC
Confidence 2355677799997 9999999999988763
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=8.3e-46 Score=391.86 Aligned_cols=255 Identities=23% Similarity=0.313 Sum_probs=209.9
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCchhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEEec
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEYI 432 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~ 432 (668)
++|++.+.||+|+||.||+|++..+|+.||||++........+.+.+|++++++++|||||++++++.+++.+|+|||||
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 108 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 108 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 57999999999999999999998899999999998876666678899999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEEC--CCCCEEEEeecCceeccCCC
Q 005940 433 PNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALID--AEMNARLGDFGLARLYDHGG 510 (668)
Q Consensus 433 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~--~~~~~kl~DfGla~~~~~~~ 510 (668)
++|+|.+++. ..+..+++.+++.++.||+.||.|||+ .+|+||||||+||||+ .++.+||+|||+|+......
T Consensus 109 ~gg~L~~~~~--~~~~~l~e~~~~~i~~qi~~aL~ylH~---~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~ 183 (352)
T d1koba_ 109 SGGELFDRIA--AEDYKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE 183 (352)
T ss_dssp CCCBHHHHTT--CTTCCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred CCChHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccccccccccccCCCeEEEeecccceecCCCC
Confidence 9999998874 334569999999999999999999999 9999999999999998 57899999999999876543
Q ss_pred CCcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCcccCCccc
Q 005940 511 MPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSYV 590 (668)
Q Consensus 511 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 590 (668)
. .....||+.|+|||++.+..++.++||||+||++|||+||+.||...+... ....... .... ..+......+
T Consensus 184 ~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~--~~~~i~~-~~~~--~~~~~~~~~s 256 (352)
T d1koba_ 184 I--VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE--TLQNVKR-CDWE--FDEDAFSSVS 256 (352)
T ss_dssp C--EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH--HHHHHHH-CCCC--CCSSTTTTSC
T ss_pred c--eeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHh-CCCC--CCcccccCCC
Confidence 2 344579999999999999999999999999999999999999997653221 1112111 1110 1111111222
Q ss_pred HHHHHHHHHHHhhcCCC-CCCCCCHHHHHHH--hcc
Q 005940 591 VKEMELVLKLGLMCSHK-TQFRPTMRQVMRY--LSG 623 (668)
Q Consensus 591 ~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~--L~~ 623 (668)
..+..+...|++. |++|||++|++++ ++.
T Consensus 257 ----~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~ 288 (352)
T d1koba_ 257 ----PEAKDFIKNLLQKEPRKRLTVHDALEHPWLKG 288 (352)
T ss_dssp ----HHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSS
T ss_pred ----HHHHHHHHHHccCChhHCcCHHHHhcCHhhCC
Confidence 2344566688887 9999999999986 544
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.2e-46 Score=391.44 Aligned_cols=246 Identities=29% Similarity=0.401 Sum_probs=201.0
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCc---hhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEE
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSL---QGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVY 429 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 429 (668)
+.|+..+.||+|+||+||+|++..+++.||||++..... ...+.+.+|++++++++|||||++++++.+++..|+||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 358889999999999999999988999999999976543 34467899999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCC
Q 005940 430 EYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHG 509 (668)
Q Consensus 430 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~ 509 (668)
|||++|+|..++.. +..+++.+++.++.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+|+....
T Consensus 95 E~~~~g~l~~~~~~---~~~l~e~~~~~i~~qi~~aL~yLH~---~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~- 167 (309)
T d1u5ra_ 95 EYCLGSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP- 167 (309)
T ss_dssp ECCSEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-
T ss_pred EecCCCchHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHh---CCEeccCCCcceEEECCCCCEEEeecccccccCC-
Confidence 99999999877642 3569999999999999999999999 9999999999999999999999999999986543
Q ss_pred CCCcccccccCCcccCcccccC---CCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCcccC
Q 005940 510 GMPHTTNVVGTFGYIAPELTQT---GKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLN 586 (668)
Q Consensus 510 ~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 586 (668)
.....||+.|||||++.+ +.++.++|||||||++|||++|+.||...... +......... . +.+.
T Consensus 168 ----~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~--~~~~~i~~~~-~-----~~~~ 235 (309)
T d1u5ra_ 168 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM--SALYHIAQNE-S-----PALQ 235 (309)
T ss_dssp ----BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--HHHHHHHHSC-C-----CCCS
T ss_pred ----CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHH--HHHHHHHhCC-C-----CCCC
Confidence 234579999999999853 46899999999999999999999999754322 1122222211 1 1111
Q ss_pred CcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 587 SSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 587 ~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
....++ .+..+...|++. |++|||++|+++|
T Consensus 236 ~~~~s~---~~~~li~~~L~~dP~~Rpt~~ell~H 267 (309)
T d1u5ra_ 236 SGHWSE---YFRNFVDSCLQKIPQDRPTSEVLLKH 267 (309)
T ss_dssp CTTSCH---HHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred CCCCCH---HHHHHHHHHCcCChhHCcCHHHHHhC
Confidence 111122 344556688887 9999999999874
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-47 Score=390.00 Aligned_cols=255 Identities=27% Similarity=0.406 Sum_probs=197.9
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCchhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEEec
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEYI 432 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~ 432 (668)
++|++.+.||+|+||+||+|+++. ++.||||++.... ...+.|.+|+.++++++|||||+++|+|.+ +..++||||+
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~-~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~ 93 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 93 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred HHEEEeeEEeeCCCeEEEEEEECC-CCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEec
Confidence 468889999999999999999964 5679999997554 345789999999999999999999999965 5689999999
Q ss_pred CCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCCCC
Q 005940 433 PNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMP 512 (668)
Q Consensus 433 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~~~ 512 (668)
++|+|..++.. .....++|.+++.++.||+.||+|||+ .+|+||||||+||||+.++++||+|||+++........
T Consensus 94 ~~g~l~~~~~~-~~~~~l~~~~~~~i~~~i~~gl~~LH~---~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~ 169 (285)
T d1fmka3 94 SKGSLLDFLKG-ETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 169 (285)
T ss_dssp TTCBHHHHHSH-HHHTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCTTC--------
T ss_pred CCCchhhhhhh-cccccchHHHHHHHHHHHHHHHHHHhh---hheecccccceEEEECCCCcEEEcccchhhhccCCCce
Confidence 99999999853 223469999999999999999999999 99999999999999999999999999999987655544
Q ss_pred cccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCcccCCcccHH
Q 005940 513 HTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSYVVK 592 (668)
Q Consensus 513 ~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 592 (668)
......||+.|+|||++..+.++.++|||||||++|||+||..|+...... .+.........+ +......+
T Consensus 170 ~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~-~~~~~~i~~~~~------~~~~~~~~-- 240 (285)
T d1fmka3 170 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-REVLDQVERGYR------MPCPPECP-- 240 (285)
T ss_dssp ------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH-HHHHHHHHTTCC------CCCCTTSC--
T ss_pred eeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCH-HHHHHHHHhcCC------CCCCcccC--
Confidence 455567999999999999999999999999999999999977776443211 111111111111 11112222
Q ss_pred HHHHHHHHHhhcCCC-CCCCCCHHHHHHHhccCc
Q 005940 593 EMELVLKLGLMCSHK-TQFRPTMRQVMRYLSGEK 625 (668)
Q Consensus 593 ~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~~~ 625 (668)
+.+..++..|++. |++||+|++|++.|+..-
T Consensus 241 --~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~ 272 (285)
T d1fmka3 241 --ESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 272 (285)
T ss_dssp --HHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred --HHHHHHHHHHcccCHhHCcCHHHHHHHHhhhh
Confidence 3455677799998 999999999999987643
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.8e-46 Score=389.86 Aligned_cols=251 Identities=22% Similarity=0.324 Sum_probs=188.4
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCch-hHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEEe
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQ-GMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEY 431 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~ 431 (668)
+.|+..++||+|+||+||+|+++.+++.||||++.+.... ..+.+.+|++++++++|||||++++++.+++..|+||||
T Consensus 9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~ 88 (307)
T d1a06a_ 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQL 88 (307)
T ss_dssp GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence 5689999999999999999999989999999999765432 345678999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEEC---CCCCEEEEeecCceeccC
Q 005940 432 IPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALID---AEMNARLGDFGLARLYDH 508 (668)
Q Consensus 432 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~---~~~~~kl~DfGla~~~~~ 508 (668)
|++|+|.+++.. ...+++.++..++.||+.||.|||+ ++|+||||||+||++. +++.+||+|||+++....
T Consensus 89 ~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~al~ylH~---~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~ 162 (307)
T d1a06a_ 89 VSGGELFDRIVE---KGFYTERDASRLIFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP 162 (307)
T ss_dssp CCSCBHHHHHHT---CSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSTTCCEEECCC--------
T ss_pred cCCCcHHHhhhc---ccCCCHHHHHHHHHHHHHHHHhhhh---ceeeeEEecccceeecccCCCceEEEeccceeEEccC
Confidence 999999999963 3569999999999999999999999 9999999999999995 578999999999987654
Q ss_pred CCCCcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCcccCCc
Q 005940 509 GGMPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSS 588 (668)
Q Consensus 509 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 588 (668)
... ....+||+.|||||++.++.++.++|||||||++|||++|+.||....... ....... .... .+......
T Consensus 163 ~~~--~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~--~~~~i~~-~~~~--~~~~~~~~ 235 (307)
T d1a06a_ 163 GSV--LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAK--LFEQILK-AEYE--FDSPYWDD 235 (307)
T ss_dssp ------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHT-TCCC--CCTTTTTT
T ss_pred CCe--eeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHH--HHHHHhc-cCCC--CCCccccC
Confidence 432 234579999999999999999999999999999999999999997653221 1111111 1110 11111112
Q ss_pred ccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 589 YVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 589 ~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
.+ ..+..+...|+.. |++|||++|++++
T Consensus 236 ~s----~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 236 IS----DSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp SC----HHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred CC----HHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 22 2344556678887 9999999999996
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.5e-47 Score=388.24 Aligned_cols=249 Identities=25% Similarity=0.331 Sum_probs=202.2
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCC---chhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEE
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNS---LQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVY 429 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 429 (668)
++|++.+.||+|+||+||+|++..+++.||||++.+.. ....+.+.+|++++++++||||+++++++.+++..|+||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 46899999999999999999999899999999997542 234567899999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCC
Q 005940 430 EYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHG 509 (668)
Q Consensus 430 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~ 509 (668)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+ ++|+||||||+|||+++++.+||+|||+|+.+...
T Consensus 88 Ey~~gg~L~~~~~~---~~~l~e~~~~~~~~qi~~al~ylH~---~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~ 161 (288)
T d1uu3a_ 88 SYAKNGELLKYIRK---IGSFDETCTRFYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 161 (288)
T ss_dssp CCCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EccCCCCHHHhhhc---cCCCCHHHHHHHHHHHHHHHHhhcc---ccEEcCcCCccccccCCCceEEecccccceecccC
Confidence 99999999999853 3469999999999999999999999 99999999999999999999999999999987643
Q ss_pred CC-CcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCcccCCc
Q 005940 510 GM-PHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSS 588 (668)
Q Consensus 510 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 588 (668)
.. ......+||+.|+|||++.+..++.++||||+||++|||++|+.||...+.... ......... .+...
T Consensus 162 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~---~~~i~~~~~------~~p~~ 232 (288)
T d1uu3a_ 162 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLI---FQKIIKLEY------DFPEK 232 (288)
T ss_dssp --------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHTTCC------CCCTT
T ss_pred CcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHH---HHHHHcCCC------CCCcc
Confidence 32 233446899999999999999999999999999999999999999976542211 111111111 11122
Q ss_pred ccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 589 YVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 589 ~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
+.. .+..+...|+.. |++|||++|++++
T Consensus 233 ~s~----~~~~li~~~L~~dP~~R~t~~e~~~~ 261 (288)
T d1uu3a_ 233 FFP----KARDLVEKLLVLDATKRLGCEEMEGY 261 (288)
T ss_dssp CCH----HHHHHHHTTSCSSGGGSTTSGGGTCH
T ss_pred CCH----HHHHHHHHHccCCHhHCcCHHHHcCC
Confidence 222 244556688887 9999999997654
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-45 Score=381.18 Aligned_cols=251 Identities=24% Similarity=0.327 Sum_probs=204.5
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCc------hhHHHHHHHHHHHhcccccCceeEeeeecccCceE
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSL------QGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLL 426 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~ 426 (668)
+.|+..+.||+|+||+||+|+++.+|+.||||++.+... ...+.|.+|++++++++|||||++++++.+.+..|
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 89 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 579999999999999999999998999999999975432 23578999999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCC----CEEEEeecC
Q 005940 427 LVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEM----NARLGDFGL 502 (668)
Q Consensus 427 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~----~~kl~DfGl 502 (668)
+|||||++|+|.+++.. ...+++..++.++.||+.||+|||+ .+|+||||||+||+++.++ .+||+|||+
T Consensus 90 iv~E~~~gg~L~~~i~~---~~~l~~~~~~~~~~qi~~al~yLH~---~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~ 163 (293)
T d1jksa_ 90 LILELVAGGELFDFLAE---KESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL 163 (293)
T ss_dssp EEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEEcCCCccccchhcc---ccccchhHHHHHHHHHHHHHHhhhh---cceeecccccceEEEecCCCcccceEecchhh
Confidence 99999999999999953 3469999999999999999999999 9999999999999998776 499999999
Q ss_pred ceeccCCCCCcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccC
Q 005940 503 ARLYDHGGMPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVAD 582 (668)
Q Consensus 503 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d 582 (668)
++....... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...+... ....... .... ..
T Consensus 164 a~~~~~~~~--~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~--~~~~i~~-~~~~--~~ 236 (293)
T d1jksa_ 164 AHKIDFGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE--TLANVSA-VNYE--FE 236 (293)
T ss_dssp CEECTTSCB--CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHT-TCCC--CC
T ss_pred hhhcCCCcc--ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHH--HHHHHHh-cCCC--CC
Confidence 998765432 334578999999999999899999999999999999999999997653221 1111111 1110 00
Q ss_pred cccCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 583 PLLNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 583 ~~l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
+......+ ..+..+...|+.. |++|||++|++++
T Consensus 237 ~~~~~~~s----~~~~~li~~~L~~dP~~R~s~~eil~h 271 (293)
T d1jksa_ 237 DEYFSNTS----ALAKDFIRRLLVKDPKKRMTIQDSLQH 271 (293)
T ss_dssp HHHHTTSC----HHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred chhcCCCC----HHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00001111 2344566689887 9999999999984
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.7e-46 Score=387.12 Aligned_cols=260 Identities=25% Similarity=0.383 Sum_probs=207.9
Q ss_pred HhcCcccceeeeecCcEEEEEEEeC-----CCCcEEEEEEEecCCch-hHHHHHHHHHHHhcccccCceeEeeeecccCc
Q 005940 351 ATKGFKESEVIGIGGFGSVYKGVLP-----TTGGEVAVKKITRNSLQ-GMREFAAEIESLGRLRHKNLVNLHGWCKQKND 424 (668)
Q Consensus 351 at~~f~~~~~lG~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~-~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~ 424 (668)
..++|+..+.||+|+||+||+|+++ .++..||||++.....+ ..++|.+|++++++++||||++++++|...+.
T Consensus 11 p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~ 90 (301)
T d1lufa_ 11 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP 90 (301)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred CHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCc
Confidence 4567999999999999999999974 24578999999765433 45679999999999999999999999999999
Q ss_pred eEEEEEecCCCChhhhhcCCC---------------------CCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCC
Q 005940 425 LLLVYEYIPNGSLDTLLFKPK---------------------DGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVK 483 (668)
Q Consensus 425 ~~lV~E~~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLk 483 (668)
.++||||+++|+|.++++... ....++|.+++.++.||+.||+|||+ ++|+|||||
T Consensus 91 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~---~~ivHrDlK 167 (301)
T d1lufa_ 91 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLA 167 (301)
T ss_dssp CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCS
T ss_pred eEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhccc---CCeEeeEEc
Confidence 999999999999999985321 12358999999999999999999999 999999999
Q ss_pred CCCEEECCCCCEEEEeecCceeccCCCC-CcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCC-CCCCCCc
Q 005940 484 PSNALIDAEMNARLGDFGLARLYDHGGM-PHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGR-RPIGSGD 561 (668)
Q Consensus 484 p~NIll~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~-~p~~~~~ 561 (668)
|+||||+.++.+||+|||+++....... ...+...||+.|+|||++.+..++.++|||||||++|||++|. .||...+
T Consensus 168 p~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~ 247 (301)
T d1lufa_ 168 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA 247 (301)
T ss_dssp GGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred ccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCC
Confidence 9999999999999999999986644322 2233457889999999999999999999999999999999986 5676543
Q ss_pred hhHHHHHHHHHhcCccccccCcccCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhccCc
Q 005940 562 LLLVEWVRECHQLGRILDVADPLLNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSGEK 625 (668)
Q Consensus 562 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~~~ 625 (668)
.. +.... ...+.... ....+. ..+..|+..|++. |++||||.||+++|+...
T Consensus 248 ~~--e~~~~-v~~~~~~~-----~p~~~~----~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 248 HE--EVIYY-VRDGNILA-----CPENCP----LELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp HH--HHHHH-HHTTCCCC-----CCTTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred HH--HHHHH-HHcCCCCC-----CCccch----HHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 22 11122 22222221 111222 2456777899998 999999999999998764
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-45 Score=384.75 Aligned_cols=254 Identities=24% Similarity=0.385 Sum_probs=199.9
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCc----EEEEEEEecC-CchhHHHHHHHHHHHhcccccCceeEeeeecccCceEE
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGG----EVAVKKITRN-SLQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLL 427 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~----~vavK~~~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l 427 (668)
.+|+..++||+|+||+||+|++..+|+ +||+|++... ..+..++|.+|++++++++|||||+++|+|.++ ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 368999999999999999999877665 5889988653 334567899999999999999999999999764 5788
Q ss_pred EEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceecc
Q 005940 428 VYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYD 507 (668)
Q Consensus 428 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~ 507 (668)
++||+.+|+|.+++.. ....+++..+++++.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+++...
T Consensus 88 v~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~qi~~gl~yLH~---~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~ 162 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 162 (317)
T ss_dssp EEECCTTCBHHHHHHH--TSSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCCSHHHHTT
T ss_pred EEEeccCCcccccccc--cccCCCHHHHHHHHHHHHHHHHHHHH---cCcccCcchhhcceeCCCCCeEeeccccceecc
Confidence 8999999999998853 35679999999999999999999999 999999999999999999999999999999776
Q ss_pred CCCCC-cccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCch-hHHHHHHHHHhcCccccccCcc
Q 005940 508 HGGMP-HTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVAT-GRRPIGSGDL-LLVEWVRECHQLGRILDVADPL 584 (668)
Q Consensus 508 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~-~l~~~~~~~~~~~~~~~~~d~~ 584 (668)
..... ......||..|+|||++.++.++.++|||||||++|||+| |+.||..... .+...+ ..+... .
T Consensus 163 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i----~~~~~~-----~ 233 (317)
T d1xkka_ 163 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL----EKGERL-----P 233 (317)
T ss_dssp TTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHH----HHTCCC-----C
T ss_pred cccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHH----HcCCCC-----C
Confidence 54332 2334578999999999999999999999999999999998 7888875432 222222 111111 1
Q ss_pred cCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhccCc
Q 005940 585 LNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSGEK 625 (668)
Q Consensus 585 l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~~~ 625 (668)
....++ ..+..++..|++. |++||+++||+++|+...
T Consensus 234 ~p~~~~----~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~ 271 (317)
T d1xkka_ 234 QPPICT----IDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 271 (317)
T ss_dssp CCTTBC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCcccC----HHHHHHHHHhCCCChhhCcCHHHHHHHHHHHH
Confidence 111122 3355677789998 999999999999987653
|
| >d1ioaa_ b.29.1.1 (A:) Phytohemagglutinin-L, PHA-L, also arcelin {Kidney bean (Phaseolus vulgaris), G02771, arcelin-5a [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Phytohemagglutinin-L, PHA-L, also arcelin species: Kidney bean (Phaseolus vulgaris), G02771, arcelin-5a [TaxId: 3885]
Probab=100.00 E-value=1.3e-45 Score=366.22 Aligned_cols=216 Identities=33% Similarity=0.513 Sum_probs=184.4
Q ss_pred CceeEEeCCCCCCCCCeEEeCceeeCCCCcEEccCCCC------ceEEEEEeeCceecccCCCCCCCCeeeeEEEEEEEE
Q 005940 26 QSSSFIFQGFNGGATNLSLQGAEIIKPSGALKLTNRSR------YVIGHAFYVKPIQMFDTSASPSPNASSFSTTFVFEI 99 (668)
Q Consensus 26 ~~~~f~~~~f~~~~~~l~~~g~a~~~~~~~~~lt~~~~------~~~G~~~y~~p~~l~~~~~~~~~~~~sF~t~F~f~i 99 (668)
+..+|+|++|++. .+|+|+|+|.+.++|.|+||++.. .++|||+|++||+||+ +++++||+|+|+|.|
T Consensus 2 ~~~sF~f~~F~~~-~~l~l~GdA~i~~~g~l~LT~~~~~~~~~~~s~G~a~y~~Pv~l~~-----~~~~~sFst~F~f~i 75 (228)
T d1ioaa_ 2 TETSFNFPNFHTD-DKLILQGNATISSKGQLQLTGVGSNELPRVDSLGRAFYSDPIQIKD-----SNNVASFNTNFTFII 75 (228)
T ss_dssp CCCEEEESSCCTT-SSEEEEETCEECTTSCEETTCBCTTSSBCSSCBEEEEESSCEECBC-----SSCBEEEEEEEEEEC
T ss_pred ccceEEcCCCCCC-CcEEEeeeeEEcCCCEEEecCCCCCCccccceeEEEEECCceEecC-----CCceeeEEEEEEEEE
Confidence 4678999999863 579999999998789999998654 4789999999999998 357899999999999
Q ss_pred eCCCCCCCCCceEEEEcCCCCCCCCCCCCcccccccCCCCCCCccEEEEEeecccCCCCCCCCCCCeeeeecCCcccccc
Q 005940 100 STPRSGRGGHGLAFLLAPSTKLPGAQPEHYLGILNSTNNGEPSNHILIVEFDTVNGFNDKAENQGNHVGIGINTMFSNRS 179 (668)
Q Consensus 100 ~~~~~~~~g~GlaF~l~p~~~~~~~~~~~~lGl~~~~~~~~~~~~~~aVEfDt~~n~~d~~~~~~~Hvgid~~s~~s~~~ 179 (668)
.+++...+||||||+|+|+.. +.+..|+++|+++... ++..++.|||||||++|..| ++.+|+++++++..
T Consensus 76 ~~~~~~~~gDGlAF~l~~~~~-~~~~~g~~lgl~~~~~-~~~~~~~vave~dt~~n~~~---~~~~~~~~~~~~~~---- 146 (228)
T d1ioaa_ 76 RAKNQSISAYGLAFALVPVNS-PPQKKQEFLGIFNTNN-PEPNARTVAVVFNTFKNRID---FDKNFIKPYVNENC---- 146 (228)
T ss_dssp CBSCTTSCCEEEEEEEEETTC-CCCCCGGGTTTCCCSS-CCGGGCCEEEEEETTTTEEE---EEESSSSCSEEEEC----
T ss_pred ecCCCCCCCCEEEEEEeCCCC-CCCCCccccccccccC-CCCcceeEEEEecCcccccc---CCCCccceeccccc----
Confidence 998878899999999999765 3456789999988654 45678899999999987445 67777777776521
Q ss_pred cCCccccCCCCCccccccCCCCcEEEEEEEeCCcceEEEEEEeCCCCCCCCcceeeeeccccccccceeeeeecccC---
Q 005940 180 EPASYYINGTDHKEEMTLESGEPIQAWIEYDGEQKVLNVTISPAEIGKPMRPLISFGVNLTGYIKETMYVGFSASTG--- 256 (668)
Q Consensus 180 ~~~~~~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~V~~~~~~~~~p~~~~ls~~~dLs~~l~~~~~vGFsastG--- 256 (668)
...+.+|+.++|||+||+..++|+|+|++.. +|..|+|++.+||+.+|+++|||||||+||
T Consensus 147 --------------~~~~~~g~~~~v~I~Yd~~~~~l~V~l~~~~--~~~~~~ls~~vdL~~~l~~~vyvGFSAsTG~~~ 210 (228)
T d1ioaa_ 147 --------------DFHKYNGEKTDVQITYDSSNNDLRVFLHFTV--SQVKCSVSATVHLEKEVDEWVSVGFSPTSGLTE 210 (228)
T ss_dssp --------------CHHHHCSSCEEEEEEEETTTTEEEEEEEETT--TCCEEEEEEECCGGGTSCSEEEEEEEEEECSST
T ss_pred --------------ccccccCcEEEEEEEEcCCCCEEEEEEEeCC--CCceeeEEEEEchHHcCCCcEEEEEEeecCCCC
Confidence 2456689999999999999999999999754 788899999999999999999999999999
Q ss_pred Ccccceeeeccccccc
Q 005940 257 EKSSSHYILGWSFSLN 272 (668)
Q Consensus 257 ~~~~~~~i~~w~F~~~ 272 (668)
+..|.|+|++|+|++.
T Consensus 211 ~~~~~h~I~sWsFss~ 226 (228)
T d1ioaa_ 211 DTTETHDVLSWSFSSK 226 (228)
T ss_dssp TTCBCCEEEEEEEEEE
T ss_pred CCceEEEEEEEEeEEe
Confidence 5568899999999864
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-45 Score=377.98 Aligned_cols=253 Identities=22% Similarity=0.345 Sum_probs=192.4
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCC---cEEEEEEEecCCc-hhHHHHHHHHHHHhcccccCceeEeeeecccCceEEE
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTG---GEVAVKKITRNSL-QGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLV 428 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~---~~vavK~~~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV 428 (668)
++|+..+.||+|+||.||+|++..++ ..||||++..... ...+.|.+|++++++++||||++++|+|. .+..++|
T Consensus 7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~iv 85 (273)
T d1mp8a_ 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWII 85 (273)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEEE
Confidence 46888999999999999999986443 4688998865433 44567999999999999999999999996 4678999
Q ss_pred EEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccC
Q 005940 429 YEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDH 508 (668)
Q Consensus 429 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~ 508 (668)
|||+++|+|.+++.. ....+++.+++.++.||++||.|||+ ++|+||||||+||+++.++.+||+|||+++....
T Consensus 86 ~E~~~~g~l~~~~~~--~~~~l~~~~~~~~~~qi~~gl~ylH~---~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~ 160 (273)
T d1mp8a_ 86 MELCTLGELRSFLQV--RKYSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 160 (273)
T ss_dssp EECCTTEEHHHHHHH--TTTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECC---------
T ss_pred EEeccCCcHHhhhhc--cCCCCCHHHHHHHHHHHHHHhhhhcc---cCeeccccchhheeecCCCcEEEccchhheeccC
Confidence 999999999998753 34569999999999999999999999 9999999999999999999999999999998765
Q ss_pred CCCCcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCc-hhHHHHHHHHHhcCccccccCcccC
Q 005940 509 GGMPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVAT-GRRPIGSGD-LLLVEWVRECHQLGRILDVADPLLN 586 (668)
Q Consensus 509 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~-~~l~~~~~~~~~~~~~~~~~d~~l~ 586 (668)
..........||+.|+|||++.++.++.++|||||||++|||+| |+.||.... ..+...+. .+... ...
T Consensus 161 ~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~----~~~~~-----~~~ 231 (273)
T d1mp8a_ 161 STYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE----NGERL-----PMP 231 (273)
T ss_dssp ----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH----TTCCC-----CCC
T ss_pred CcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHH----cCCCC-----CCC
Confidence 55444555678999999999999999999999999999999998 899997543 22222221 12111 111
Q ss_pred CcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhccC
Q 005940 587 SSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSGE 624 (668)
Q Consensus 587 ~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~~ 624 (668)
..++ ..+..+...|+.. |++|||++||+++|+..
T Consensus 232 ~~~~----~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i 266 (273)
T d1mp8a_ 232 PNCP----PTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 266 (273)
T ss_dssp TTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCC----HHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 2222 2355666789987 99999999999998753
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-46 Score=378.19 Aligned_cols=247 Identities=31% Similarity=0.406 Sum_probs=193.1
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCchhHHHHHHHHHHHhcccccCceeEeeeecc-cCceEEEEEe
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNLHGWCKQ-KNDLLLVYEY 431 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~-~~~~~lV~E~ 431 (668)
++|+..++||+|+||.||+|.+ .|..||||+++.+. ..++|.+|++++++++||||++++|+|.+ .+.+++||||
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey 82 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 82 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred HHeEEeEEEecCCCeEEEEEEE--CCeEEEEEEECcHH--HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEec
Confidence 4577789999999999999999 47899999996543 44789999999999999999999999854 4678999999
Q ss_pred cCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCCC
Q 005940 432 IPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGM 511 (668)
Q Consensus 432 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~~ 511 (668)
+++|+|.++|.+. ....++|..+++++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 83 ~~~g~L~~~l~~~-~~~~l~~~~~~~i~~~i~~al~ylH~---~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~- 157 (262)
T d1byga_ 83 MAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ- 157 (262)
T ss_dssp CTTEEHHHHHHHH-HHHHCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred cCCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHhhcccccc---CceeccccchHhheecCCCCEeecccccceecCCCC-
Confidence 9999999999632 23458999999999999999999999 999999999999999999999999999998755422
Q ss_pred CcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCc-hhHHHHHHHHHhcCccccccCcccCCcc
Q 005940 512 PHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVAT-GRRPIGSGD-LLLVEWVRECHQLGRILDVADPLLNSSY 589 (668)
Q Consensus 512 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~-~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 589 (668)
....+|..|+|||++.++.++.++|||||||++|||+| |+.|+.... ..+.+++. .+.. +......
T Consensus 158 ---~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~----~~~~-----~~~~~~~ 225 (262)
T d1byga_ 158 ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE----KGYK-----MDAPDGC 225 (262)
T ss_dssp -------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHT----TTCC-----CCCCTTC
T ss_pred ---ccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHH----cCCC-----CCCCccC
Confidence 23467899999999999999999999999999999998 677776543 23333322 1111 1121222
Q ss_pred cHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhccC
Q 005940 590 VVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSGE 624 (668)
Q Consensus 590 ~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~~ 624 (668)
+ ..+..+...|++. |++||||.||+++|+..
T Consensus 226 ~----~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i 257 (262)
T d1byga_ 226 P----PAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 257 (262)
T ss_dssp C----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred C----HHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 2 2355667799998 99999999999999753
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.6e-44 Score=376.72 Aligned_cols=245 Identities=24% Similarity=0.336 Sum_probs=202.0
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCC---chhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEE
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNS---LQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVY 429 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 429 (668)
++|++.+.||+|+||+||+|+++.+|+.||||++.+.. ....+.+.+|+.++++++|||||++++++.+.+.+|+||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 46889999999999999999999899999999997542 234578899999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCC
Q 005940 430 EYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHG 509 (668)
Q Consensus 430 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~ 509 (668)
|||++|+|..++.. +..+++..+..++.||+.||+|||+ ++|+||||||+||||+.++.+||+|||+|+.....
T Consensus 84 E~~~gg~l~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~---~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~ 157 (316)
T d1fota_ 84 DYIEGGELFSLLRK---SQRFPNPVAKFYAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV 157 (316)
T ss_dssp CCCCSCBHHHHHHH---TSSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred eecCCccccccccc---cccccccHHHHHHHHHHHhhhhhcc---CcEEccccCchheeEcCCCCEEEecCccceEeccc
Confidence 99999999999853 4458889999999999999999998 99999999999999999999999999999986543
Q ss_pred CCCcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCcccCCcc
Q 005940 510 GMPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSY 589 (668)
Q Consensus 510 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 589 (668)
....+||+.|||||++.+..++.++||||+||++|||++|+.||...+.. +....... +.. .+....
T Consensus 158 ----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~--~~~~~i~~-~~~------~~p~~~ 224 (316)
T d1fota_ 158 ----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM--KTYEKILN-AEL------RFPPFF 224 (316)
T ss_dssp ----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH--HHHHHHHH-CCC------CCCTTS
T ss_pred ----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHH--HHHHHHHc-CCC------CCCCCC
Confidence 23468999999999999989999999999999999999999999765422 11122222 111 111122
Q ss_pred cHHHHHHHHHHHhhcCCC-CCCCC-----CHHHHHHH
Q 005940 590 VVKEMELVLKLGLMCSHK-TQFRP-----TMRQVMRY 620 (668)
Q Consensus 590 ~~~~~~~l~~l~~~C~~~-p~~RP-----s~~evl~~ 620 (668)
+. + +..+...|+.. |.+|| +++|+++|
T Consensus 225 s~-~---~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 225 NE-D---VKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp CH-H---HHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred CH-H---HHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence 22 2 33445567765 88885 99999875
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-44 Score=378.82 Aligned_cols=248 Identities=25% Similarity=0.302 Sum_probs=204.9
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCC---chhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEE
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNS---LQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVY 429 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 429 (668)
++|++.+.||+|+||.||+|+++.+++.||||++.+.. ....+.+.+|+++|++++||||+++++++.+.+.+|+||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ 84 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence 57999999999999999999999999999999997642 234577889999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCC
Q 005940 430 EYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHG 509 (668)
Q Consensus 430 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~ 509 (668)
|||++|+|.+++.+ ...+++..+..++.||+.||.|||+ ++|+||||||+||||++++.+||+|||+|+.....
T Consensus 85 ey~~gg~L~~~~~~---~~~~~e~~~~~~~~qil~al~ylH~---~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~ 158 (337)
T d1o6la_ 85 EYANGGELFFHLSR---ERVFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp ECCTTCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred eccCCCchhhhhhc---ccCCcHHHHHHHHHHHhhhhhhhhh---cCccccccCHHHeEecCCCCEEEeecccccccccC
Confidence 99999999999863 3458999999999999999999999 99999999999999999999999999999876543
Q ss_pred CCCcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCcccCCcc
Q 005940 510 GMPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSY 589 (668)
Q Consensus 510 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 589 (668)
. ......+||+.|+|||++.+..++.++||||+||++|||++|+.||...+.... . +......+ .+...+
T Consensus 159 ~-~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~--~-~~i~~~~~------~~p~~~ 228 (337)
T d1o6la_ 159 G-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL--F-ELILMEEI------RFPRTL 228 (337)
T ss_dssp T-CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH--H-HHHHHCCC------CCCTTS
T ss_pred C-cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHH--H-HHHhcCCC------CCCccC
Confidence 2 233456899999999999999999999999999999999999999976543211 1 11222211 112223
Q ss_pred cHHHHHHHHHHHhhcCCC-CCCCCC-----HHHHHHH
Q 005940 590 VVKEMELVLKLGLMCSHK-TQFRPT-----MRQVMRY 620 (668)
Q Consensus 590 ~~~~~~~l~~l~~~C~~~-p~~RPs-----~~evl~~ 620 (668)
..+ +..+...|+.. |++||+ ++|+++|
T Consensus 229 s~~----~~dli~~~L~~dP~~R~~~~~~~~~eil~H 261 (337)
T d1o6la_ 229 SPE----AKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp CHH----HHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred CHH----HHHHHHhhccCCchhhcccccccHHHHHcC
Confidence 332 33445567776 999995 8899875
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-45 Score=380.44 Aligned_cols=252 Identities=27% Similarity=0.412 Sum_probs=200.9
Q ss_pred ceeeeecCcEEEEEEEeCCCC---cEEEEEEEecC-CchhHHHHHHHHHHHhcccccCceeEeeeecc-cCceEEEEEec
Q 005940 358 SEVIGIGGFGSVYKGVLPTTG---GEVAVKKITRN-SLQGMREFAAEIESLGRLRHKNLVNLHGWCKQ-KNDLLLVYEYI 432 (668)
Q Consensus 358 ~~~lG~G~~g~Vy~~~~~~~~---~~vavK~~~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~-~~~~~lV~E~~ 432 (668)
.++||+|+||+||+|++..++ ..||||++.+. .....++|.+|++++++++||||++++|+|.+ ++..++|||||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 578999999999999986543 36999999753 44556889999999999999999999999865 56889999999
Q ss_pred CCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCCCC
Q 005940 433 PNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGMP 512 (668)
Q Consensus 433 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~~~ 512 (668)
++|+|.+++.. ....+++..+++++.|+++||.|||+ .+|+||||||+||||++++.+||+|||+++........
T Consensus 112 ~~g~l~~~~~~--~~~~~~~~~~~~i~~qia~gL~~lH~---~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~ 186 (311)
T d1r0pa_ 112 KHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD 186 (311)
T ss_dssp TTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC
T ss_pred ecCchhhhhcc--ccccchHHHHHHHHHHHHHhhhhhcc---cCcccCCccHHhEeECCCCCEEEecccchhhccccccc
Confidence 99999999863 34568899999999999999999999 99999999999999999999999999999976544322
Q ss_pred ---cccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCcccCCcc
Q 005940 513 ---HTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSY 589 (668)
Q Consensus 513 ---~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 589 (668)
......||..|+|||.+.++.++.++|||||||++|||+||+.||.... ...++........+.. .| ...
T Consensus 187 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~-~~~~~~~~i~~g~~~~---~p---~~~ 259 (311)
T d1r0pa_ 187 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV-NTFDITVYLLQGRRLL---QP---EYC 259 (311)
T ss_dssp CTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-------CHHHHHTTCCCC---CC---TTC
T ss_pred cceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCC-CHHHHHHHHHcCCCCC---Cc---ccC
Confidence 2334578999999999999999999999999999999999888886432 1222222222222111 11 111
Q ss_pred cHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhccCc
Q 005940 590 VVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSGEK 625 (668)
Q Consensus 590 ~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~~~ 625 (668)
. ..+..++..|++. |++||+|+||+++|+...
T Consensus 260 -~---~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~ 292 (311)
T d1r0pa_ 260 -P---DPLYEVMLKCWHPKAEMRPSFSELVSRISAIF 292 (311)
T ss_dssp -C---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -c---HHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 1 2455677799998 999999999999998764
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=3.6e-44 Score=366.96 Aligned_cols=251 Identities=24% Similarity=0.352 Sum_probs=203.5
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCch---------hHHHHHHHHHHHhccc-ccCceeEeeeeccc
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQ---------GMREFAAEIESLGRLR-HKNLVNLHGWCKQK 422 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---------~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~ 422 (668)
++|+..+.||+|+||+||+|++..+++.||||++.+.... ..+.+.+|+.++++++ ||||+++++++.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 5789999999999999999999889999999999765321 2346889999999997 99999999999999
Q ss_pred CceEEEEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecC
Q 005940 423 NDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGL 502 (668)
Q Consensus 423 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGl 502 (668)
+..|+|||||++|+|.+++.. ...+++.+++.++.||++||+|||+ ++|+||||||+||||+.++.+||+|||+
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~---~~~l~e~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nill~~~~~~kl~DFG~ 156 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTE---KVTLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGF 156 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred cceEEEEEcCCCchHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---cCCcccccccceEEEcCCCCeEEccchh
Confidence 999999999999999999963 3469999999999999999999999 9999999999999999999999999999
Q ss_pred ceeccCCCCCcccccccCCcccCcccccC------CCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCc
Q 005940 503 ARLYDHGGMPHTTNVVGTFGYIAPELTQT------GKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGR 576 (668)
Q Consensus 503 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~ 576 (668)
++....... .....||..|+|||++.+ ..++.++||||+||++|||++|+.||...+.... ......+.
T Consensus 157 a~~~~~~~~--~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~---~~~i~~~~ 231 (277)
T d1phka_ 157 SCQLDPGEK--LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLM---LRMIMSGN 231 (277)
T ss_dssp CEECCTTCC--BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHHTC
T ss_pred eeEccCCCc--eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHH---HHHHHhCC
Confidence 998765432 344689999999998753 3568899999999999999999999986543221 11112222
Q ss_pred cccccCcccCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 577 ILDVADPLLNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 577 ~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
.. ...+.. ..++ ..+..+...|+.. |++||+++||+++
T Consensus 232 ~~-~~~~~~-~~~s----~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 232 YQ-FGSPEW-DDYS----DTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp CC-CCTTTG-GGSC----HHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred CC-CCCccc-ccCC----HHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 11 111111 1122 2344556688887 9999999999875
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-45 Score=380.92 Aligned_cols=256 Identities=30% Similarity=0.413 Sum_probs=201.6
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCc--EEEEEEEecC-CchhHHHHHHHHHHHhcc-cccCceeEeeeecccCceEEE
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGG--EVAVKKITRN-SLQGMREFAAEIESLGRL-RHKNLVNLHGWCKQKNDLLLV 428 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~--~vavK~~~~~-~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV 428 (668)
++|+..++||+|+||.||+|+++.++. .||||++... ..+..++|.+|+++++++ +|||||+++|+|.+++..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 567888999999999999999987766 4778887654 334556899999999999 799999999999999999999
Q ss_pred EEecCCCChhhhhcCC-------------CCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCE
Q 005940 429 YEYIPNGSLDTLLFKP-------------KDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNA 495 (668)
Q Consensus 429 ~E~~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~ 495 (668)
|||+++|+|.++|+.. .....++|.++++++.||+.||.|||+ ++|+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~---~~iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhc---CCccccccccceEEEcCCCce
Confidence 9999999999999643 234679999999999999999999999 999999999999999999999
Q ss_pred EEEeecCceeccCCCCCcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCC-CCCCCchhHHHHHHHHHhc
Q 005940 496 RLGDFGLARLYDHGGMPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRR-PIGSGDLLLVEWVRECHQL 574 (668)
Q Consensus 496 kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~-p~~~~~~~l~~~~~~~~~~ 574 (668)
||+|||+++....... .....||..|+|||.+..+.++.++|||||||++|||++|.. ||...+.. +.... ...
T Consensus 167 kl~DfG~a~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~--~~~~~-i~~ 241 (309)
T d1fvra_ 167 KIADFGLSRGQEVYVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA--ELYEK-LPQ 241 (309)
T ss_dssp EECCTTCEESSCEECC--C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHHHH-GGG
T ss_pred EEcccccccccccccc--ccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHH--HHHHH-HHh
Confidence 9999999986543322 223468999999999999999999999999999999999765 56543311 11111 111
Q ss_pred CccccccCcccCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhccCc
Q 005940 575 GRILDVADPLLNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSGEK 625 (668)
Q Consensus 575 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~~~ 625 (668)
+. .+....... ..+..++.+|++. |++||+|+||+++|+...
T Consensus 242 ~~-----~~~~~~~~~----~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~ 284 (309)
T d1fvra_ 242 GY-----RLEKPLNCD----DEVYDLMRQCWREKPYERPSFAQILVSLNRML 284 (309)
T ss_dssp TC-----CCCCCTTBC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred cC-----CCCCCccCC----HHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 11 111111222 3455666789998 999999999999987653
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=3.6e-44 Score=367.63 Aligned_cols=256 Identities=23% Similarity=0.322 Sum_probs=198.6
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCc---hhHHHHHHHHHHHhcccccCceeEeeeecccC----ce
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSL---QGMREFAAEIESLGRLRHKNLVNLHGWCKQKN----DL 425 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~----~~ 425 (668)
++|++.+.||+|+||.||+|++..+++.||||++.+... +..+.|.+|++++++++||||+++++++...+ ..
T Consensus 7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~ 86 (277)
T d1o6ya_ 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP 86 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceE
Confidence 579999999999999999999988999999999976432 34567999999999999999999999987654 37
Q ss_pred EEEEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCcee
Q 005940 426 LLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARL 505 (668)
Q Consensus 426 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~ 505 (668)
|+||||+++|+|.+++.. ...+++.+++.++.||+.||.|||+ ++|+||||||+||||+.++..+|+|||.++.
T Consensus 87 ~lvmE~~~g~~L~~~~~~---~~~l~~~~~~~i~~qi~~al~~lH~---~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~ 160 (277)
T d1o6ya_ 87 YIVMEYVDGVTLRDIVHT---EGPMTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARA 160 (277)
T ss_dssp EEEEECCCEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTSCEEECCCTTCEE
T ss_pred EEEEECCCCCEehhhhcc---cCCCCHHHHHHHHHHHHHHHHHHHh---CCccCccccCcccccCccccceeehhhhhhh
Confidence 899999999999998853 3469999999999999999999999 9999999999999999999999999999986
Q ss_pred ccCCCC--CcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCc
Q 005940 506 YDHGGM--PHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADP 583 (668)
Q Consensus 506 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~ 583 (668)
...... ......+||+.|+|||++.+..++.++|||||||++|||+||+.||...... +............. .
T Consensus 161 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~--~~~~~~~~~~~~~~---~ 235 (277)
T d1o6ya_ 161 IADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV--SVAYQHVREDPIPP---S 235 (277)
T ss_dssp CC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHHCCCCCG---G
T ss_pred hccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHH--HHHHHHHhcCCCCC---c
Confidence 644322 2334568999999999999989999999999999999999999999765322 22222222221111 0
Q ss_pred ccCCcccHHHHHHHHHHHhhcCCC-CCCCC-CHHHHHHHhcc
Q 005940 584 LLNSSYVVKEMELVLKLGLMCSHK-TQFRP-TMRQVMRYLSG 623 (668)
Q Consensus 584 ~l~~~~~~~~~~~l~~l~~~C~~~-p~~RP-s~~evl~~L~~ 623 (668)
......+ ..+..+...|+.. |++|| +++++++.|..
T Consensus 236 ~~~~~~s----~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r 273 (277)
T d1o6ya_ 236 ARHEGLS----ADLDAVVLKALAKNPENRYQTAAEMRADLVR 273 (277)
T ss_dssp GTSSSCC----HHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred hhccCCC----HHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence 1111122 2344555688887 99999 89999887754
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-44 Score=373.94 Aligned_cols=258 Identities=25% Similarity=0.328 Sum_probs=193.7
Q ss_pred cCcccceeeeecCcEEEEEEEeCC-----CCcEEEEEEEecCCc-hhHHHHHHHHHHHhcc-cccCceeEeeeeccc-Cc
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPT-----TGGEVAVKKITRNSL-QGMREFAAEIESLGRL-RHKNLVNLHGWCKQK-ND 424 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~-~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~-~~ 424 (668)
++|+..++||+|+||.||+|++.. +++.||||++..... ...+++..|..++.++ +|+||+++++++.+. ..
T Consensus 13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~ 92 (299)
T d1ywna1 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 92 (299)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSC
T ss_pred HHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCe
Confidence 468889999999999999999743 346899999875433 4456788898888887 689999999998654 56
Q ss_pred eEEEEEecCCCChhhhhcCCC-------------CCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECC
Q 005940 425 LLLVYEYIPNGSLDTLLFKPK-------------DGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDA 491 (668)
Q Consensus 425 ~~lV~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~ 491 (668)
.++|||||++|+|.++++... ....++|.+++.++.||++||.|||+ ++|+||||||+||||++
T Consensus 93 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~---~~ivHrDlKp~NILl~~ 169 (299)
T d1ywna1 93 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSE 169 (299)
T ss_dssp CEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECG
T ss_pred EEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHh---CCCcCCcCCccceeECC
Confidence 899999999999999996422 13458999999999999999999999 99999999999999999
Q ss_pred CCCEEEEeecCceeccCCCC-CcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCC-CCCCCCchhHHHHHH
Q 005940 492 EMNARLGDFGLARLYDHGGM-PHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGR-RPIGSGDLLLVEWVR 569 (668)
Q Consensus 492 ~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~-~p~~~~~~~l~~~~~ 569 (668)
++++||+|||+|+....... .......||+.|+|||++.++.++.++|||||||++|||+||. .||...... +.+.
T Consensus 170 ~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~--~~~~ 247 (299)
T d1ywna1 170 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID--EEFC 247 (299)
T ss_dssp GGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS--HHHH
T ss_pred CCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHH--HHHH
Confidence 99999999999987654332 2334567999999999999999999999999999999999975 567543211 1122
Q ss_pred HHHhcCccccccCcccCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhccC
Q 005940 570 ECHQLGRILDVADPLLNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSGE 624 (668)
Q Consensus 570 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~~ 624 (668)
.....+.... ...... ..+..++..|++. |++|||++||+++|+..
T Consensus 248 ~~~~~~~~~~-----~~~~~~----~~l~~li~~cl~~dP~~Rpt~~eil~~L~~i 294 (299)
T d1ywna1 248 RRLKEGTRMR-----APDYTT----PEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 294 (299)
T ss_dssp HHHHHTCCCC-----CCTTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHhcCCCCC-----CCccCC----HHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 2222222111 111122 2355667789987 99999999999999754
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-45 Score=372.09 Aligned_cols=254 Identities=26% Similarity=0.360 Sum_probs=194.4
Q ss_pred cCcccceeeeecCcEEEEEEEeCCC-C--cEEEEEEEecC---CchhHHHHHHHHHHHhcccccCceeEeeeecccCceE
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTT-G--GEVAVKKITRN---SLQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLL 426 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~-~--~~vavK~~~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~ 426 (668)
++|+..+.||+|+||.||+|++... + ..||||++.+. ..+..++|.+|++++++++||||++++|+|.+ ...+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 5688899999999999999986432 2 36899998654 33456789999999999999999999999976 4678
Q ss_pred EEEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceec
Q 005940 427 LVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLY 506 (668)
Q Consensus 427 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~ 506 (668)
+||||+++|+|.+++.. ....+++..+++++.||++||.|||+ ++|+||||||+||+|+.++.+||+|||+++..
T Consensus 87 lv~e~~~~~~l~~~~~~--~~~~l~~~~~~~~~~qi~~gl~ylH~---~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~ 161 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRK--HQGHFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRAL 161 (273)
T ss_dssp EEEECCTTCBHHHHHHH--HGGGSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred eeeeeecCcchhhhhhc--ccCCCCHHHHHHHHHHHHHHHHHhhh---CCEeeeeecHHHhccccccceeeccchhhhhc
Confidence 99999999999998853 34569999999999999999999999 99999999999999999999999999999987
Q ss_pred cCCCCC--cccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHHHhcCccccccCc
Q 005940 507 DHGGMP--HTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVAT-GRRPIGSGDLLLVEWVRECHQLGRILDVADP 583 (668)
Q Consensus 507 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~ 583 (668)
...... ......|+..|+|||++.+..++.++|||||||++|||+| |+.||...+... ........+...+
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~--~~~~i~~~~~~~~---- 235 (273)
T d1u46a_ 162 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ--ILHKIDKEGERLP---- 235 (273)
T ss_dssp CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--HHHHHHTSCCCCC----
T ss_pred ccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHH--HHHHHHhCCCCCC----
Confidence 654332 2234467889999999999999999999999999999998 899997553221 1222222221111
Q ss_pred ccCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhcc
Q 005940 584 LLNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSG 623 (668)
Q Consensus 584 ~l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~ 623 (668)
.....+ ..+..++..|++. |++|||+.||++.|+.
T Consensus 236 -~~~~~~----~~l~~li~~cl~~dp~~RPt~~ei~~~L~~ 271 (273)
T d1u46a_ 236 -RPEDCP----QDIYNVMVQCWAHKPEDRPTFVALRDFLLE 271 (273)
T ss_dssp -CCTTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -Cccccc----HHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence 111222 2355677799998 9999999999999875
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-45 Score=376.63 Aligned_cols=261 Identities=28% Similarity=0.343 Sum_probs=198.5
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCchhHHHHHHHHHHHhcccccCceeEeeeecccC----ceEEE
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNLHGWCKQKN----DLLLV 428 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~----~~~lV 428 (668)
+.|...++||+|+||.||+|++ +|+.||||+++..... ...+..|+..+.+++||||++++++|.+.+ .+++|
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~~~-~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv 79 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchh-HHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEE
Confidence 3566778999999999999998 5889999999654322 222344566667889999999999997654 57999
Q ss_pred EEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhcc-----CCceEecCCCCCCEEECCCCCEEEEeecCc
Q 005940 429 YEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEW-----EQVVIHRDVKPSNALIDAEMNARLGDFGLA 503 (668)
Q Consensus 429 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~-----~~~ivHrDLkp~NIll~~~~~~kl~DfGla 503 (668)
||||++|+|.++|++ ..++|.++++++.|+|.||+|||+.. +++|+||||||+||||+.++.+||+|||++
T Consensus 80 ~Ey~~~g~L~~~l~~----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~ 155 (303)
T d1vjya_ 80 SDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155 (303)
T ss_dssp EECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred EecccCCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcc
Confidence 999999999999963 35999999999999999999999731 379999999999999999999999999999
Q ss_pred eeccCCCCC---cccccccCCcccCcccccCC------CCCcchhHHHHHHHHHHHHhCCCCCCCCc------------h
Q 005940 504 RLYDHGGMP---HTTNVVGTFGYIAPELTQTG------KASTSSDVFAYGILLLEVATGRRPIGSGD------------L 562 (668)
Q Consensus 504 ~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~------~~~~~sDV~S~Gvvl~elltG~~p~~~~~------------~ 562 (668)
+........ ......||+.|+|||++... .++.++|||||||++|||+||..|+.... .
T Consensus 156 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~ 235 (303)
T d1vjya_ 156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 235 (303)
T ss_dssp EEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred ccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhccccc
Confidence 987654321 23346899999999998654 25779999999999999999988774221 0
Q ss_pred hHHHHHHHHHhcCccccccCcccCCcc-cHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhccC
Q 005940 563 LLVEWVRECHQLGRILDVADPLLNSSY-VVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSGE 624 (668)
Q Consensus 563 ~l~~~~~~~~~~~~~~~~~d~~l~~~~-~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~~ 624 (668)
...+.......... .+|.+.... ..+....+..++..|+.. |++|||+.||++.|+..
T Consensus 236 ~~~~~~~~~~~~~~----~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i 295 (303)
T d1vjya_ 236 PSVEEMRKVVCEQK----LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 295 (303)
T ss_dssp CCHHHHHHHHTTSC----CCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHH
T ss_pred chHHHHHHHHhccc----cCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 11122222222111 223332222 234556788889999998 99999999999998753
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.9e-44 Score=372.36 Aligned_cols=251 Identities=20% Similarity=0.263 Sum_probs=204.0
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCchhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEEec
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEYI 432 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~ 432 (668)
++|.+.+.||+|+||+||+|.++.+++.||||++.....+ ...+.+|+++|++++|||||++++++.+.+.+|+|||||
T Consensus 5 ~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~-~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~ 83 (321)
T d1tkia_ 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFI 83 (321)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHH-HHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCccc-HHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecC
Confidence 5789999999999999999999989999999999776433 356889999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCC--CCEEEEeecCceeccCCC
Q 005940 433 PNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAE--MNARLGDFGLARLYDHGG 510 (668)
Q Consensus 433 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~--~~~kl~DfGla~~~~~~~ 510 (668)
++|+|.+++.. .+..+++.++..++.||+.||.|||+ .+|+||||||+|||++.+ ..+||+|||+++......
T Consensus 84 ~gg~L~~~i~~--~~~~l~e~~~~~i~~qi~~al~yLH~---~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~ 158 (321)
T d1tkia_ 84 SGLDIFERINT--SAFELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD 158 (321)
T ss_dssp CCCBHHHHHTS--SSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC
T ss_pred CCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHH---cCCCcccccccceeecCCCceEEEEcccchhhccccCC
Confidence 99999999953 33469999999999999999999999 999999999999999854 579999999998765433
Q ss_pred CCcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCcccCCccc
Q 005940 511 MPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSYV 590 (668)
Q Consensus 511 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 590 (668)
......+|+.|+|||...+..++.++||||+||++|||++|+.||...... +......... .. .+........
T Consensus 159 --~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~--~~~~~i~~~~-~~--~~~~~~~~~s 231 (321)
T d1tkia_ 159 --NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ--QIIENIMNAE-YT--FDEEAFKEIS 231 (321)
T ss_dssp --EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH--HHHHHHHHTC-CC--CCHHHHTTSC
T ss_pred --cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhCC-CC--CChhhccCCC
Confidence 233457899999999999999999999999999999999999999765422 1112222111 10 0110001111
Q ss_pred HHHHHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 591 VKEMELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 591 ~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
..+..+...|+.. |++||+++|++++
T Consensus 232 ----~~~~~li~~~L~~dp~~R~s~~eil~h 258 (321)
T d1tkia_ 232 ----IEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp ----HHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ----HHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 2344566688887 9999999999985
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-44 Score=375.53 Aligned_cols=259 Identities=22% Similarity=0.271 Sum_probs=198.6
Q ss_pred cCcccce-eeeecCcEEEEEEEeCCCCcEEEEEEEecCCchhHHHHHHHHHHHhcc-cccCceeEeeeecc----cCceE
Q 005940 353 KGFKESE-VIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRL-RHKNLVNLHGWCKQ----KNDLL 426 (668)
Q Consensus 353 ~~f~~~~-~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~----~~~~~ 426 (668)
++|.+.+ .||+|+||+||+|++..+++.||||+++.. ..+.+|++++.++ +|||||++++++.+ ...+|
T Consensus 11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ 85 (335)
T d2ozaa1 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 85 (335)
T ss_dssp GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEE
Confidence 5788765 599999999999999889999999998643 4567899987665 79999999999864 46789
Q ss_pred EEEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECC---CCCEEEEeecCc
Q 005940 427 LVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDA---EMNARLGDFGLA 503 (668)
Q Consensus 427 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~---~~~~kl~DfGla 503 (668)
+|||||++|+|.+++.. .....+++.++..++.||+.||.|||+ ++|+||||||+|||++. ++.+||+|||+|
T Consensus 86 ivmEy~~gg~L~~~i~~-~~~~~l~e~~~~~i~~qi~~al~ylH~---~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a 161 (335)
T d2ozaa1 86 IVMECLDGGELFSRIQD-RGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFA 161 (335)
T ss_dssp EEEECCCSEEHHHHHHS-CSCCCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EEEECCCCCcHHHHHHh-cCCCCcCHHHHHHHHHHHHHHHHHHHH---cCCcccccccccccccccccccccccccccee
Confidence 99999999999999964 234579999999999999999999999 99999999999999986 457999999999
Q ss_pred eeccCCCCCcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCch-hHHHHHHHHHhcCccccccC
Q 005940 504 RLYDHGGMPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDL-LLVEWVRECHQLGRILDVAD 582 (668)
Q Consensus 504 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~-~l~~~~~~~~~~~~~~~~~d 582 (668)
+....... .....||+.|||||++.+..++.++|||||||++|||+||+.||..... ............. .
T Consensus 162 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~------~ 233 (335)
T d2ozaa1 162 KETTSHNS--LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMG------Q 233 (335)
T ss_dssp EECCCCCC--CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSC------S
T ss_pred eeccCCCc--cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcC------C
Confidence 97765432 3445899999999999998999999999999999999999999964321 1111111111100 0
Q ss_pred cccCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHH--hccCcCCC
Q 005940 583 PLLNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRY--LSGEKQLR 628 (668)
Q Consensus 583 ~~l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~--L~~~~~~~ 628 (668)
..+.......-...+..+...|++. |++||+++|++++ +......|
T Consensus 234 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~~~ 282 (335)
T d2ozaa1 234 YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVP 282 (335)
T ss_dssp SSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTTTSSC
T ss_pred CCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCCCCCC
Confidence 1111111111123455566688887 9999999999985 54443333
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-44 Score=370.23 Aligned_cols=257 Identities=27% Similarity=0.391 Sum_probs=204.0
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCC-------cEEEEEEEecCCc-hhHHHHHHHHHHHhcc-cccCceeEeeeecccC
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTG-------GEVAVKKITRNSL-QGMREFAAEIESLGRL-RHKNLVNLHGWCKQKN 423 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~-------~~vavK~~~~~~~-~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~ 423 (668)
++|...+.||+|+||.||+|+....+ ..||||++..+.. ....++.+|...+.++ +|||||+++++|.+++
T Consensus 13 ~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~ 92 (299)
T d1fgka_ 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 92 (299)
T ss_dssp GGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCC
Confidence 46888899999999999999875433 3799999977554 4457889999999998 7999999999999999
Q ss_pred ceEEEEEecCCCChhhhhcCCC-------------CCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEEC
Q 005940 424 DLLLVYEYIPNGSLDTLLFKPK-------------DGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALID 490 (668)
Q Consensus 424 ~~~lV~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~ 490 (668)
..++||||+++|+|.+++.... ....+++.++++++.||+.||+|||+ .+|+||||||+|||++
T Consensus 93 ~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~---~~ivHrDiKp~NiLl~ 169 (299)
T d1fgka_ 93 PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVT 169 (299)
T ss_dssp SCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEC
T ss_pred eEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhh---CCEEeeeecccceeec
Confidence 9999999999999999996432 12468999999999999999999999 9999999999999999
Q ss_pred CCCCEEEEeecCceeccCCCCC-cccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHH
Q 005940 491 AEMNARLGDFGLARLYDHGGMP-HTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVAT-GRRPIGSGDLLLVEWV 568 (668)
Q Consensus 491 ~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~ellt-G~~p~~~~~~~l~~~~ 568 (668)
.++.+||+|||+++........ ......||+.|+|||++.++.++.++|||||||++|||++ |..||....... +
T Consensus 170 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~---~ 246 (299)
T d1fgka_ 170 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE---L 246 (299)
T ss_dssp TTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH---H
T ss_pred CCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHH---H
Confidence 9999999999999977654332 3345678999999999999999999999999999999998 688887554321 2
Q ss_pred HHHHhcCccccccCcccCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhccC
Q 005940 569 RECHQLGRILDVADPLLNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSGE 624 (668)
Q Consensus 569 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~~ 624 (668)
......+.... ....+. ..+..++.+|++. |++|||+.||++.|+..
T Consensus 247 ~~~i~~~~~~~-----~p~~~~----~~l~~li~~cl~~dP~~Rps~~eil~~L~~i 294 (299)
T d1fgka_ 247 FKLLKEGHRMD-----KPSNCT----NELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 294 (299)
T ss_dssp HHHHHTTCCCC-----CCSSCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHcCCCCC-----CCccch----HHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 22222222111 111222 3456777899998 99999999999999764
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.1e-43 Score=377.40 Aligned_cols=249 Identities=24% Similarity=0.295 Sum_probs=197.8
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCc---hhHHHHH---HHHHHHhcccccCceeEeeeecccCceE
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSL---QGMREFA---AEIESLGRLRHKNLVNLHGWCKQKNDLL 426 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~f~---~Ei~~l~~l~H~nIv~l~g~~~~~~~~~ 426 (668)
++|++.++||+|+||.||+|++..+|+.||||++.+... .....+. .|+++++.++|||||++++++.+.+..|
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 579999999999999999999999999999999965322 1222333 4577778888999999999999999999
Q ss_pred EEEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceec
Q 005940 427 LVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLY 506 (668)
Q Consensus 427 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~ 506 (668)
+|||||++|+|.+++.. ...+++..+..++.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+|+..
T Consensus 84 ivmE~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~aL~ylH~---~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~ 157 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQ---HGVFSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDF 157 (364)
T ss_dssp EEECCCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECSSSCEEECCCTTCEEC
T ss_pred EEEEecCCCcHHHHHHh---cccccHHHHHHHHHHHHHHHHHHHH---CCccceeeccceeEEcCCCcEEEeeeceeeec
Confidence 99999999999999963 3468899999999999999999999 99999999999999999999999999999977
Q ss_pred cCCCCCcccccccCCcccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCccc
Q 005940 507 DHGGMPHTTNVVGTFGYIAPELTQT-GKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLL 585 (668)
Q Consensus 507 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 585 (668)
.... .....||+.|+|||++.. ..++.++|||||||++|||+||+.||..........+....... .+.+
T Consensus 158 ~~~~---~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~------~~~~ 228 (364)
T d1omwa3 158 SKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM------AVEL 228 (364)
T ss_dssp SSSC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSC------CCCC
T ss_pred CCCc---ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccC------CCCC
Confidence 6533 334589999999999875 46899999999999999999999999754322111122111111 1112
Q ss_pred CCcccHHHHHHHHHHHhhcCCC-CCCCCC-----HHHHHHH
Q 005940 586 NSSYVVKEMELVLKLGLMCSHK-TQFRPT-----MRQVMRY 620 (668)
Q Consensus 586 ~~~~~~~~~~~l~~l~~~C~~~-p~~RPs-----~~evl~~ 620 (668)
...++. .+..+...|+.. |++||+ ++|+++|
T Consensus 229 ~~~~s~----~~~~li~~~L~~dP~~R~t~~~~~a~eil~H 265 (364)
T d1omwa3 229 PDSFSP----ELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 265 (364)
T ss_dssp CSSSCH----HHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred CCCCCH----HHHHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence 222232 234555678887 999999 6899875
|
| >d1avba_ b.29.1.1 (A:) Phytohemagglutinin-L, PHA-L, also arcelin {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Phytohemagglutinin-L, PHA-L, also arcelin species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=100.00 E-value=1.7e-44 Score=357.92 Aligned_cols=215 Identities=33% Similarity=0.496 Sum_probs=188.9
Q ss_pred CceeEEeCCCCCCCCCeEEeCceeeCCCCcEEccCC---CCceEEEEEeeCceecccCCCCCCCCeeeeEEEEEEEEeCC
Q 005940 26 QSSSFIFQGFNGGATNLSLQGAEIIKPSGALKLTNR---SRYVIGHAFYVKPIQMFDTSASPSPNASSFSTTFVFEISTP 102 (668)
Q Consensus 26 ~~~~f~~~~f~~~~~~l~~~g~a~~~~~~~~~lt~~---~~~~~G~~~y~~p~~l~~~~~~~~~~~~sF~t~F~f~i~~~ 102 (668)
++++|+|++|++ .|++|.|+|.+.++|.|+||+. ...++|||+|++||+||+ +.++.++||+|+|+|.|.+.
T Consensus 2 ~~~sf~f~~F~~--~nl~l~GdA~v~~~g~i~LT~~~~~~~~~~G~~~y~~Pv~l~~---~~~~~~~sF~t~f~f~i~~~ 76 (226)
T d1avba_ 2 NDASFNVETFNK--TNLILQGDATVSSEGHLLLTNVKGNEEDSMGRAFYSAPIQIND---RTIDNLASFSTNFTFRINAK 76 (226)
T ss_dssp EEEEEEESSCCG--GGEEEEETCEECTTSCEECSCSSSCCTTCEEEEEESSCEECEE---GGGTEEEEEEEEEEEEEEES
T ss_pred CceEEECCCCCc--cceeEecceEECCCCeEEccCCCCCCccceEEEEeCCCeEccc---CCCCcccceEEEEEEEEecC
Confidence 478999999987 7999999999987889999964 456899999999999999 88899999999999999998
Q ss_pred CCCCCCCceEEEEcCCCCCCCCCCCCcccccccCCCCCCCccEEEEEeecccC--CCCCCCCCCCeeeeecCCccccccc
Q 005940 103 RSGRGGHGLAFLLAPSTKLPGAQPEHYLGILNSTNNGEPSNHILIVEFDTVNG--FNDKAENQGNHVGIGINTMFSNRSE 180 (668)
Q Consensus 103 ~~~~~g~GlaF~l~p~~~~~~~~~~~~lGl~~~~~~~~~~~~~~aVEfDt~~n--~~d~~~~~~~Hvgid~~s~~s~~~~ 180 (668)
....+||||||+|+|....+ +..++++|+++. ++|||||+.| .+| +..||||||+|+..|..+.
T Consensus 77 ~~~~~gDG~aF~i~~~~~~~-g~~gg~~gl~~~----------~~v~fdt~~~~~~~d---~~~nhi~i~~n~~~s~~~~ 142 (226)
T d1avba_ 77 NIENSAYGLAFALVPVGSRP-KLKGRYLGLFNT----------TNYDRDAHTVAVVFD---TVSNRIEIDVNSIRPIATE 142 (226)
T ss_dssp STTSCCEEEEEEEEETTCCC-CCCGGGTTTCSC----------SSCCGGGCCEEEEEE---TTTTEEEEEESSSSCSEEE
T ss_pred CCCCCCceEEEEEccCCCCC-CCccccCCcccc----------ccccccceecccccc---CCCCEEEEeCCCCcccccc
Confidence 87889999999999977544 456789999763 2689999988 345 8899999999999888777
Q ss_pred CCccccCCCCCccccccCCCCcEEEEEEEeCCcceEEEEEEeCCCCCCCCcceeeeeccccccccceeeeeecccCC---
Q 005940 181 PASYYINGTDHKEEMTLESGEPIQAWIEYDGEQKVLNVTISPAEIGKPMRPLISFGVNLTGYIKETMYVGFSASTGE--- 257 (668)
Q Consensus 181 ~~~~~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~V~~~~~~~~~p~~~~ls~~~dLs~~l~~~~~vGFsastG~--- 257 (668)
+.. ..+.+|+.++|||+||+..++|+|++.+.+ +|..|.++..+||+.+|+++|||||||+||.
T Consensus 143 ~~~-----------~~~~~g~~~~v~I~Yd~~~~~L~V~l~~~~--~~~~~~~~~~vdL~~~l~~~~y~GFSAaTG~~s~ 209 (226)
T d1avba_ 143 SCN-----------FGHNNGEKAEVRITYDSPKNDLRVSLLYPS--SEEKCHVSATVPLEKEVEDWVSVGFSATSGSKKE 209 (226)
T ss_dssp ECC-----------SGGGTTCEEEEEEEEEGGGTEEEEEEEETT--TTEEEEEEEECCHHHHSCSEEEEEEEEEECSSGG
T ss_pred ccc-----------cccCCCeEEEEEEEEcCCCcEEEEEEEeCC--CCccEEEEEEecHHHccCCcEEEEEEEEcCCCCC
Confidence 654 457789999999999999999999999865 6778889999999999999999999999995
Q ss_pred cccceeeeccccccc
Q 005940 258 KSSSHYILGWSFSLN 272 (668)
Q Consensus 258 ~~~~~~i~~w~F~~~ 272 (668)
..|.|.|++|+|+++
T Consensus 210 ~~~~H~IlsWsF~s~ 224 (226)
T d1avba_ 210 TTETHNVLSWSFSSN 224 (226)
T ss_dssp GCEEEEEEEEEEEEE
T ss_pred CeeeeEEEEEEeEEe
Confidence 457899999999874
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=6.2e-44 Score=377.33 Aligned_cols=245 Identities=23% Similarity=0.292 Sum_probs=202.9
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCC---chhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEE
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNS---LQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVY 429 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 429 (668)
++|++.++||+|+||.||+|+++.+|+.||||++.+.. ....+.+.+|++++++++||||+++++++.+....++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 47999999999999999999999899999999997542 234567899999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCC
Q 005940 430 EYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHG 509 (668)
Q Consensus 430 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~ 509 (668)
||+.+|+|..++.+ ...+++.++..++.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+|+.....
T Consensus 121 e~~~~g~l~~~l~~---~~~l~e~~~~~i~~qi~~aL~yLH~---~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~ 194 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRR---IGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp ECCTTCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred ccccccchhhhHhh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCcCCHHHcccCCCCCEEeeeceeeeecccc
Confidence 99999999999953 2459999999999999999999999 99999999999999999999999999999987543
Q ss_pred CCCcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCcccCCcc
Q 005940 510 GMPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSSY 589 (668)
Q Consensus 510 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 589 (668)
.....||+.|||||++.+..++.++|||||||++|||+||+.||...+.. ........ .. +......
T Consensus 195 ----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~--~~~~~i~~-~~------~~~p~~~ 261 (350)
T d1rdqe_ 195 ----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI--QIYEKIVS-GK------VRFPSHF 261 (350)
T ss_dssp ----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHH-CC------CCCCTTC
T ss_pred ----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHH--HHHHHHhc-CC------CCCCccC
Confidence 23468999999999999999999999999999999999999999765422 11122111 11 1111222
Q ss_pred cHHHHHHHHHHHhhcCCC-CCCC-----CCHHHHHHH
Q 005940 590 VVKEMELVLKLGLMCSHK-TQFR-----PTMRQVMRY 620 (668)
Q Consensus 590 ~~~~~~~l~~l~~~C~~~-p~~R-----Ps~~evl~~ 620 (668)
.. .+..+...|+.. |.+| |+++|+++|
T Consensus 262 s~----~~~~li~~~L~~dP~kR~~~~r~t~~ell~H 294 (350)
T d1rdqe_ 262 SS----DLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp CH----HHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred CH----HHHHHHHHHhhhCHHhccccccccHHHHHcC
Confidence 22 234555578776 8888 599999874
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.7e-44 Score=370.22 Aligned_cols=261 Identities=23% Similarity=0.401 Sum_probs=209.0
Q ss_pred cCcccceeeeecCcEEEEEEEeCC-----CCcEEEEEEEecCC-chhHHHHHHHHHHHhcccccCceeEeeeecccCceE
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPT-----TGGEVAVKKITRNS-LQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLL 426 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~ 426 (668)
++|...++||+|+||+||+|++.. ++..||||++.... .+....|.+|++++++++||||++++|+|..++..+
T Consensus 20 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~ 99 (308)
T d1p4oa_ 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL 99 (308)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCE
T ss_pred HHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCcee
Confidence 567888999999999999998742 34689999997543 344567999999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhcCC-------CCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEe
Q 005940 427 LVYEYIPNGSLDTLLFKP-------KDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGD 499 (668)
Q Consensus 427 lV~E~~~~gsL~~~l~~~-------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~D 499 (668)
+||||+++|+|.+++... .....+++.++.+++.|+++||.|||+ ++|+||||||+||||++++++||+|
T Consensus 100 lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~---~~ivHrDlk~~NiLld~~~~~Kl~D 176 (308)
T d1p4oa_ 100 VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGD 176 (308)
T ss_dssp EEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCSGGGEEECTTCCEEECC
T ss_pred EEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhh---CCeeeceEcCCceeecCCceEEEee
Confidence 999999999999988532 122457999999999999999999999 9999999999999999999999999
Q ss_pred ecCceeccCCCCC-cccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCC-CCCCCCchhHHHHHHHHHhcCcc
Q 005940 500 FGLARLYDHGGMP-HTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGR-RPIGSGDLLLVEWVRECHQLGRI 577 (668)
Q Consensus 500 fGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~-~p~~~~~~~l~~~~~~~~~~~~~ 577 (668)
||+++........ ......||+.|+|||.+.++.++.++|||||||++|||+||+ .||.... ..++...... +..
T Consensus 177 FGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~--~~~~~~~i~~-~~~ 253 (308)
T d1p4oa_ 177 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS--NEQVLRFVME-GGL 253 (308)
T ss_dssp TTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC--HHHHHHHHHT-TCC
T ss_pred cccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCC--HHHHHHHHHh-CCC
Confidence 9999876543322 233447899999999999999999999999999999999985 6665432 2222222222 222
Q ss_pred ccccCcccCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhccCcCCC
Q 005940 578 LDVADPLLNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSGEKQLR 628 (668)
Q Consensus 578 ~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~~~~~~ 628 (668)
.... ..+. ..+..++..|++. |++||||+||+++|+...+..
T Consensus 254 ~~~p-----~~~~----~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~ 296 (308)
T d1p4oa_ 254 LDKP-----DNCP----DMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPG 296 (308)
T ss_dssp CCCC-----TTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTT
T ss_pred CCCc-----ccch----HHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCC
Confidence 2111 1122 3466777799998 999999999999999875433
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.8e-44 Score=368.51 Aligned_cols=257 Identities=25% Similarity=0.256 Sum_probs=194.4
Q ss_pred cceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCch-----hHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEEe
Q 005940 357 ESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQ-----GMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYEY 431 (668)
Q Consensus 357 ~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-----~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~ 431 (668)
..++||+|+||+||+|+++.+|+.||||++...... ..+.+.+|++++++++|||||++++++.+++..|+||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 368899999999999999989999999998654322 134688999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCCC
Q 005940 432 IPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGGM 511 (668)
Q Consensus 432 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~~ 511 (668)
+.++++..+.. .+..+++.++..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~~~~~~~~~~~---~~~~l~~~~~~~~~~qil~aL~~lH~---~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~ 155 (299)
T d1ua2a_ 82 METDLEVIIKD---NSLVLTPSHIKAYMLMTLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR 155 (299)
T ss_dssp CSEEHHHHHTT---CCSSCCSSHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC
T ss_pred hcchHHhhhhh---cccCCCHHHHHHHHHHHHHHHHHhhc---cceecccCCcceEEecCCCccccccCccccccCCCcc
Confidence 99887776663 34569999999999999999999999 9999999999999999999999999999987655432
Q ss_pred CcccccccCCcccCcccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCc-hhHHHHHHHHHhcCccccccCc------
Q 005940 512 PHTTNVVGTFGYIAPELTQTG-KASTSSDVFAYGILLLEVATGRRPIGSGD-LLLVEWVRECHQLGRILDVADP------ 583 (668)
Q Consensus 512 ~~~~~~~gt~~y~aPE~~~~~-~~~~~sDV~S~Gvvl~elltG~~p~~~~~-~~l~~~~~~~~~~~~~~~~~d~------ 583 (668)
.....+||+.|+|||++..+ .++.++|||||||++|||++|+.||.... ......+.+...........+.
T Consensus 156 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~ 234 (299)
T d1ua2a_ 156 -AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDY 234 (299)
T ss_dssp -CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTC
T ss_pred -cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchh
Confidence 22345799999999988654 57999999999999999999999997543 2222222222111100000000
Q ss_pred c-c--CCcccHH-----HHHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 584 L-L--NSSYVVK-----EMELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 584 ~-l--~~~~~~~-----~~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
. . ....... .-..+..+...|+.. |++|||++|+++|
T Consensus 235 ~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H 280 (299)
T d1ua2a_ 235 VTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280 (299)
T ss_dssp CCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred hhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence 0 0 0000000 012355566678776 9999999999985
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-44 Score=375.23 Aligned_cols=256 Identities=25% Similarity=0.337 Sum_probs=205.3
Q ss_pred cCcccceeeeecCcEEEEEEEeC-----CCCcEEEEEEEecCCc-hhHHHHHHHHHHHhcc-cccCceeEeeeecccCce
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLP-----TTGGEVAVKKITRNSL-QGMREFAAEIESLGRL-RHKNLVNLHGWCKQKNDL 425 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~-~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~ 425 (668)
++|+..++||+|+||.||+|++. .++..||||++..... ....+|.+|+.+++++ +|||||+++|+|.++...
T Consensus 23 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~ 102 (311)
T d1t46a_ 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPT 102 (311)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEE
Confidence 57888999999999999999863 3556899999976543 4456799999999999 699999999999999999
Q ss_pred EEEEEecCCCChhhhhcCCC---------------CCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEEC
Q 005940 426 LLVYEYIPNGSLDTLLFKPK---------------DGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALID 490 (668)
Q Consensus 426 ~lV~E~~~~gsL~~~l~~~~---------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~ 490 (668)
++|||||++|+|.++++... ....+++..+++++.||++||+|||+ ++++||||||+||+++
T Consensus 103 ~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~---~~ivHrDLKp~NIl~~ 179 (311)
T d1t46a_ 103 LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLT 179 (311)
T ss_dssp EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEE
T ss_pred EEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccccccccccc
Confidence 99999999999999996432 22358999999999999999999999 9999999999999999
Q ss_pred CCCCEEEEeecCceeccCCCC-CcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCC-CCCCc--hhHHH
Q 005940 491 AEMNARLGDFGLARLYDHGGM-PHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRP-IGSGD--LLLVE 566 (668)
Q Consensus 491 ~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p-~~~~~--~~l~~ 566 (668)
.++.+||+|||+++....... .......||+.|+|||++.++.++.++|||||||++|||+|++.| +.... ..+.+
T Consensus 180 ~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~~ 259 (311)
T d1t46a_ 180 HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYK 259 (311)
T ss_dssp TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHH
T ss_pred ccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 999999999999997765432 233456889999999999999999999999999999999995544 54332 22222
Q ss_pred HHHHHHhcCccccccCcccCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhccC
Q 005940 567 WVRECHQLGRILDVADPLLNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSGE 624 (668)
Q Consensus 567 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~~ 624 (668)
.+. .+.. +......+ ..+..|+..|++. |++||+|.||+++|++.
T Consensus 260 ~i~----~~~~-----~~~~~~~~----~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~ 305 (311)
T d1t46a_ 260 MIK----EGFR-----MLSPEHAP----AEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305 (311)
T ss_dssp HHH----HTCC-----CCCCTTSC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHh----cCCC-----CCCccccc----HHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 222 1111 11111111 3456667789987 99999999999999753
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-44 Score=371.81 Aligned_cols=247 Identities=24% Similarity=0.361 Sum_probs=201.2
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCC---chhHHHHHHHHHHHh-cccccCceeEeeeecccCceEEE
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNS---LQGMREFAAEIESLG-RLRHKNLVNLHGWCKQKNDLLLV 428 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~f~~Ei~~l~-~l~H~nIv~l~g~~~~~~~~~lV 428 (668)
++|...++||+|+||+||+|+++.+++.||||++.+.. ....+.+..|..++. .++||||+++++++.+++..|+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 47889999999999999999999999999999997542 233456777777765 68999999999999999999999
Q ss_pred EEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccC
Q 005940 429 YEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDH 508 (668)
Q Consensus 429 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~ 508 (668)
|||+++|+|.+++.. ...+++.++..++.||+.||.|||+ ++|+||||||+|||+++++++||+|||+++....
T Consensus 82 mEy~~~g~L~~~i~~---~~~~~e~~~~~~~~qi~~al~ylH~---~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~ 155 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQS---CHKFDLSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENML 155 (320)
T ss_dssp EECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EeecCCCcHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCcccceeecCCCceeccccchhhhccc
Confidence 999999999999963 3458999999999999999999999 9999999999999999999999999999986654
Q ss_pred CCCCcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCcccCCc
Q 005940 509 GGMPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPLLNSS 588 (668)
Q Consensus 509 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 588 (668)
.. .......||+.|+|||++.++.++.++|||||||++|||++|+.||...+... +........ +.+...
T Consensus 156 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~---~~~~i~~~~------~~~p~~ 225 (320)
T d1xjda_ 156 GD-AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE---LFHSIRMDN------PFYPRW 225 (320)
T ss_dssp TT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHCC------CCCCTT
T ss_pred cc-ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHH---HHHHHHcCC------CCCCcc
Confidence 33 23344689999999999999999999999999999999999999997654321 122222221 122222
Q ss_pred ccHHHHHHHHHHHhhcCCC-CCCCCCHH-HHHH
Q 005940 589 YVVKEMELVLKLGLMCSHK-TQFRPTMR-QVMR 619 (668)
Q Consensus 589 ~~~~~~~~l~~l~~~C~~~-p~~RPs~~-evl~ 619 (668)
.+ .+ +..+...|+.. |++||+++ |+++
T Consensus 226 ~s-~~---~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 226 LE-KE---AKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp SC-HH---HHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred CC-HH---HHHHHHHhcccCCCCCcCHHHHHHh
Confidence 22 22 34555578877 99999996 7765
|
| >d1dhkb_ b.29.1.1 (B:) Phytohemagglutinin-L, PHA-L, also arcelin {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Phytohemagglutinin-L, PHA-L, also arcelin species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=100.00 E-value=3.2e-43 Score=342.72 Aligned_cols=198 Identities=33% Similarity=0.502 Sum_probs=168.2
Q ss_pred CceeEEeCCCCCCCCCeEEeCceeeCCCCcEEccCCCCceEEEEEeeCceecccCCCCCCCCeeeeEEEEEEEEeCCCCC
Q 005940 26 QSSSFIFQGFNGGATNLSLQGAEIIKPSGALKLTNRSRYVIGHAFYVKPIQMFDTSASPSPNASSFSTTFVFEISTPRSG 105 (668)
Q Consensus 26 ~~~~f~~~~f~~~~~~l~~~g~a~~~~~~~~~lt~~~~~~~G~~~y~~p~~l~~~~~~~~~~~~sF~t~F~f~i~~~~~~ 105 (668)
...+|+|++|+. .||+|+|+|.+.++|.|+||++..+++|||+|++||+||+ +.+++++||+|+|+|.|.+.+..
T Consensus 2 ~~~sF~~~~F~~--~~l~l~GdA~v~~~g~i~LT~~~~~~~G~~~y~~Pi~l~~---~~~~~~~sF~t~F~f~i~~~~~~ 76 (204)
T d1dhkb_ 2 TETSFIIDAFNK--TNLILQGDATVSSNGNLQLSYNSYDSMSRAFYSAPIQIRD---STTGNVASFDTNFTMNIRTHRQA 76 (204)
T ss_dssp CCCEEEESSCCG--GGEEEESSEEECTTSCEEESSSCSSEEEEEEESSCEESEE---TTTTEECEEEEEEEEEEECCC--
T ss_pred ccceEECCCCCc--cCeeEecceEEcCCCeEEeCCCCCCCEEEEEeCCCEeccC---CCCcccccEEEEEEEEEecCCCC
Confidence 468899999987 7999999999988899999999999999999999999999 88999999999999999998777
Q ss_pred CCCCceEEEEcCCCCCCCCCCCCcccccccCCCCCCCccEEEEEeecccCCCCCCCCCCCeeeeecCCcccccccCCccc
Q 005940 106 RGGHGLAFLLAPSTKLPGAQPEHYLGILNSTNNGEPSNHILIVEFDTVNGFNDKAENQGNHVGIGINTMFSNRSEPASYY 185 (668)
Q Consensus 106 ~~g~GlaF~l~p~~~~~~~~~~~~lGl~~~~~~~~~~~~~~aVEfDt~~n~~d~~~~~~~Hvgid~~s~~s~~~~~~~~~ 185 (668)
.+||||||+++|... ...++.+||||||+. ||+++|+++........
T Consensus 77 ~~gdGlaf~~~~~~~-------------------~~~~~~~~vefDt~~----------n~~~~d~~~~~~~~~~~---- 123 (204)
T d1dhkb_ 77 NSAVGLDFVLVPVQP-------------------ESKGDTVTVEFDTFL----------SRISIDVNNNDIKSVPW---- 123 (204)
T ss_dssp -CCSEEEEEEEEC-------------------------CCEEEEEETTT----------TEEEEEETTEEEEEEEC----
T ss_pred CCCceEEEEecCCCC-------------------CCCCcEeeEeeEccc----------ccccCcccccccccccc----
Confidence 889999999998541 234568999999985 38888888865432221
Q ss_pred cCCCCCccccccCCCCcEEEEEEEeCCcceEEEEEEeCCCCCCCCcceeeeeccccccccceeeeeecccCCc---ccce
Q 005940 186 INGTDHKEEMTLESGEPIQAWIEYDGEQKVLNVTISPAEIGKPMRPLISFGVNLTGYIKETMYVGFSASTGEK---SSSH 262 (668)
Q Consensus 186 ~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~V~~~~~~~~~p~~~~ls~~~dLs~~l~~~~~vGFsastG~~---~~~~ 262 (668)
+..+.+|+.++|||+||+..++|+|++++.+ +|..+.|++.+||+.+||++|||||||+||.. .|.|
T Consensus 124 --------~~~~~~g~~~~v~I~Yd~~~~~L~V~l~~~~--~~~~~~l~~~vdL~~~l~~~~yvGFSAaTG~~~~~~e~H 193 (204)
T d1dhkb_ 124 --------DVHDYDGQNAEVRITYNSSTKVFSVSLSNPS--TGKSNNVSTTVELEKEVYDWVSVGFSATSGAYQWSYETH 193 (204)
T ss_dssp --------CGGGTTTSCEEEEEEEETTTTEEEEEEECTT--TCCEEEEEEECCCCSGGGSEEEEEEEEEECSGGGSCCEE
T ss_pred --------ccEecCCCEEEEEEEEcCCCEEEEEEEecCC--CCCceeEEEEecchhccCCcEEEEEEeecCCCCCCceee
Confidence 3567899999999999999999999999765 56678899999999999999999999999964 5779
Q ss_pred eeecccccc
Q 005940 263 YILGWSFSL 271 (668)
Q Consensus 263 ~i~~w~F~~ 271 (668)
+|++|+|++
T Consensus 194 ~IlsWsFss 202 (204)
T d1dhkb_ 194 DVLSWSFSS 202 (204)
T ss_dssp EEEEEEEEE
T ss_pred EEEEEEEEe
Confidence 999999986
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-43 Score=364.76 Aligned_cols=261 Identities=28% Similarity=0.302 Sum_probs=197.7
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCc--hhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEE
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSL--QGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYE 430 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 430 (668)
++|++.++||+|+||+||+|++..+++.||||++..... ...+.+.+|++++++++|||||++++++.+++..|+|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 579999999999999999999998999999999965432 235788999999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCC
Q 005940 431 YIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGG 510 (668)
Q Consensus 431 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~ 510 (668)
|+.++.+..... .....+++.++..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+|+......
T Consensus 82 ~~~~~~~~~~~~--~~~~~l~e~~~~~~~~qil~~L~yLH~---~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~ 156 (298)
T d1gz8a_ 82 FLHQDLKKFMDA--SALTGIPLPLIKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 156 (298)
T ss_dssp CCSEEHHHHHHH--TTTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS
T ss_pred ecCCchhhhhhh--hcccCCCHHHHHHHHHHHHHHHHHhhc---CCEEccccCchheeecccCcceeccCCcceeccCCc
Confidence 997654443332 234569999999999999999999999 999999999999999999999999999998765433
Q ss_pred CCcccccccCCcccCcccccCCC-CCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccCcc-----
Q 005940 511 MPHTTNVVGTFGYIAPELTQTGK-ASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVADPL----- 584 (668)
Q Consensus 511 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d~~----- 584 (668)
.......||+.|+|||.+.... ++.++||||+||++|||++|+.||...+..-. +.......+...+...+.
T Consensus 157 -~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~~ 234 (298)
T d1gz8a_ 157 -RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ-LFRIFRTLGTPDEVVWPGVTSMP 234 (298)
T ss_dssp -BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCCCCTTTSTTGGGST
T ss_pred -ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHH-HHHHHHhcCCCchhhcccccccc
Confidence 2234458999999999876655 58999999999999999999999976532211 111111111111100000
Q ss_pred -cC------CcccH-----HHHHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 585 -LN------SSYVV-----KEMELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 585 -l~------~~~~~-----~~~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
.. ..... .....+..+...|++. |++|||++|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 235 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp TCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 00 00000 0012344556678887 9999999999987
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-43 Score=362.59 Aligned_cols=240 Identities=23% Similarity=0.362 Sum_probs=194.7
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCc------hhHHHHHHHHHHHhccc--ccCceeEeeeecccCc
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSL------QGMREFAAEIESLGRLR--HKNLVNLHGWCKQKND 424 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------~~~~~f~~Ei~~l~~l~--H~nIv~l~g~~~~~~~ 424 (668)
++|++.++||+|+||.||+|++..+++.||||++.+... ....++.+|+.++++++ |||||++++++.+.+.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 579999999999999999999998999999999975422 12234678999999997 8999999999999999
Q ss_pred eEEEEEecCC-CChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCC-CCEEEEeecC
Q 005940 425 LLLVYEYIPN-GSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAE-MNARLGDFGL 502 (668)
Q Consensus 425 ~~lV~E~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~-~~~kl~DfGl 502 (668)
.++||||+.+ +++.+++.. +..+++.++..++.||+.||.|||+ ++|+||||||+|||++.+ +.+||+|||+
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~---~~~l~e~~~~~~~~qi~~al~~lH~---~~iiHrDiKp~NIll~~~~~~vkl~DFG~ 157 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITE---RGALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGS 157 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred EEEEEEeccCcchHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHH---CCCccccCcccceEEecCCCeEEECcccc
Confidence 9999999976 677777742 3569999999999999999999999 999999999999999855 7899999999
Q ss_pred ceeccCCCCCcccccccCCcccCcccccCCCC-CcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCcccccc
Q 005940 503 ARLYDHGGMPHTTNVVGTFGYIAPELTQTGKA-STSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVA 581 (668)
Q Consensus 503 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~ 581 (668)
|+...... .+...||+.|+|||++.+..+ +.++||||+||++|||++|+.||...+. ... ..
T Consensus 158 a~~~~~~~---~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~--------i~~-~~----- 220 (273)
T d1xwsa_ 158 GALLKDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE--------IIR-GQ----- 220 (273)
T ss_dssp CEECCSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH--------HHH-CC-----
T ss_pred ceeccccc---ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchH--------Hhh-cc-----
Confidence 98765432 344689999999999887665 5779999999999999999999975321 111 11
Q ss_pred CcccCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 582 DPLLNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 582 d~~l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
..+....+ + .+..+...|+.. |++|||++|++++
T Consensus 221 -~~~~~~~s-~---~~~~li~~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 221 -VFFRQRVS-S---ECQHLIRWCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp -CCCSSCCC-H---HHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred -cCCCCCCC-H---HHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 11112222 2 244555678887 9999999999975
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=3.5e-42 Score=354.45 Aligned_cols=200 Identities=30% Similarity=0.396 Sum_probs=172.2
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCc--hhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEE
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSL--QGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYE 430 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 430 (668)
++|+..++||+|+||+||+|+++ +++.||||++..... ...+.+.+|+.++++++||||+++++++...+..++++|
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e 80 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE 80 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEE
Confidence 57899999999999999999985 689999999976533 235789999999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCC
Q 005940 431 YIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGG 510 (668)
Q Consensus 431 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~ 510 (668)
|+.++.+..+.. ....+++.++..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||++.......
T Consensus 81 ~~~~~~~~~~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~---~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~ 154 (286)
T d1ob3a_ 81 HLDQDLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV 154 (286)
T ss_dssp CCSEEHHHHHHT---STTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred eehhhhHHHHHh---hcCCcchhhhHHHHHHHHHHHHHhcc---CcEEecCCCCceeeEcCCCCEEecccccceecccCc
Confidence 998877777764 34669999999999999999999999 999999999999999999999999999998765433
Q ss_pred CCcccccccCCcccCcccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 005940 511 MPHTTNVVGTFGYIAPELTQTG-KASTSSDVFAYGILLLEVATGRRPIGSG 560 (668)
Q Consensus 511 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDV~S~Gvvl~elltG~~p~~~~ 560 (668)
. ......+++.|+|||.+... .++.++||||+||++|||++|+.||...
T Consensus 155 ~-~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~ 204 (286)
T d1ob3a_ 155 R-KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGV 204 (286)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred c-ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCC
Confidence 2 23344689999999988654 5689999999999999999999999754
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-42 Score=355.56 Aligned_cols=203 Identities=28% Similarity=0.388 Sum_probs=170.6
Q ss_pred hcCcccceeeeecCcEEEEEEEeCCC-CcEEEEEEEecCCc--hhHHHHHHHHHHHhcc---cccCceeEeeeec-----
Q 005940 352 TKGFKESEVIGIGGFGSVYKGVLPTT-GGEVAVKKITRNSL--QGMREFAAEIESLGRL---RHKNLVNLHGWCK----- 420 (668)
Q Consensus 352 t~~f~~~~~lG~G~~g~Vy~~~~~~~-~~~vavK~~~~~~~--~~~~~f~~Ei~~l~~l---~H~nIv~l~g~~~----- 420 (668)
.++|++.++||+|+||+||+|++..+ ++.||||++..... .....+.+|+.+++.| +||||++++++|.
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 46899999999999999999998655 56799999865422 2233456777777766 7999999999985
Q ss_pred ccCceEEEEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEee
Q 005940 421 QKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDF 500 (668)
Q Consensus 421 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~Df 500 (668)
.....+++|||+.++.+..... .....+++..+..++.|++.||+|||+ ++|+||||||+|||+++++.+||+||
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~--~~~~~~~~~~~~~~~~qi~~aL~yLH~---~~ivHrDiKp~NILi~~~~~~kl~df 160 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDK--VPEPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADF 160 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHH--SCTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECSC
T ss_pred cCceEEEEEEeccCCchhhhhh--ccCCCCCHHHHHHHHHHHHHHHHHHHh---CCEEecCCCccEEEEcCCCCeeecch
Confidence 3356899999999887765553 344568999999999999999999999 99999999999999999999999999
Q ss_pred cCceeccCCCCCcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCc
Q 005940 501 GLARLYDHGGMPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGD 561 (668)
Q Consensus 501 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~ 561 (668)
|+++...... ......||+.|+|||++.+..++.++||||+||++|||++|+.||...+
T Consensus 161 g~~~~~~~~~--~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~ 219 (305)
T d1blxa_ 161 GLARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSS 219 (305)
T ss_dssp CSCCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred hhhhhhcccc--cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCC
Confidence 9988654322 2345689999999999999999999999999999999999999997653
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-41 Score=360.14 Aligned_cols=199 Identities=28% Similarity=0.390 Sum_probs=168.1
Q ss_pred CcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCchhHHHHHHHHHHHhcccccCceeEeeeeccc------CceEE
Q 005940 354 GFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVNLHGWCKQK------NDLLL 427 (668)
Q Consensus 354 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~------~~~~l 427 (668)
.|+..++||+|+||+||+|++..+++.||||++.+.... +.+|+++|++++||||++++++|... ..+++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~----~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF----KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS----CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH----HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 577789999999999999999999999999999765432 23699999999999999999998532 34789
Q ss_pred EEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCC-CEEEEeecCceec
Q 005940 428 VYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEM-NARLGDFGLARLY 506 (668)
Q Consensus 428 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~-~~kl~DfGla~~~ 506 (668)
|||||+++.+..+.........+++.++..++.||+.||+|||+ ++|+||||||+||||+.++ .+||+|||+++..
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~---~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHh---cCCcccCCCcceEEEecCCCceeEecccchhhc
Confidence 99999876555444322345679999999999999999999998 9999999999999999775 8999999999987
Q ss_pred cCCCCCcccccccCCcccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCc
Q 005940 507 DHGGMPHTTNVVGTFGYIAPELTQT-GKASTSSDVFAYGILLLEVATGRRPIGSGD 561 (668)
Q Consensus 507 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~S~Gvvl~elltG~~p~~~~~ 561 (668)
...... ....||..|+|||.+.+ ..++.++||||+||++|||++|+.||...+
T Consensus 174 ~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~ 227 (350)
T d1q5ka_ 174 VRGEPN--VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDS 227 (350)
T ss_dssp CTTSCC--CSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSS
T ss_pred cCCccc--ccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCC
Confidence 654432 33579999999998765 568999999999999999999999997653
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-41 Score=350.72 Aligned_cols=203 Identities=28% Similarity=0.397 Sum_probs=170.3
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCC--chhHHHHHHHHHHHhcccccCceeEeeeecc--------c
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNS--LQGMREFAAEIESLGRLRHKNLVNLHGWCKQ--------K 422 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~--------~ 422 (668)
++|++.++||+|+||+||+|++..+|+.||||++.... ....+++.+|+++|++++||||+++++.+.. +
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~ 89 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 89 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence 67999999999999999999998899999999985542 2345678899999999999999999998854 3
Q ss_pred CceEEEEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecC
Q 005940 423 NDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGL 502 (668)
Q Consensus 423 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGl 502 (668)
+..++||||+.++.+..... ....++...+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+
T Consensus 90 ~~~~iv~e~~~~~~~~~~~~---~~~~~~~~~~~~i~~qil~~l~~lH~---~~ivHrDlKp~NILl~~~~~~kl~dfg~ 163 (318)
T d3blha1 90 GSIYLVFDFCEHDLAGLLSN---VLVKFTLSEIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGL 163 (318)
T ss_dssp -CEEEEEECCCEEHHHHHTC---TTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTT
T ss_pred ceEEEEEeccCCCccchhhh---cccccccHHHHHHHHHHHHHHHHhcc---CCEEecCcCchheeecCCCcEEeeecce
Confidence 56899999998887765553 34568899999999999999999999 9999999999999999999999999999
Q ss_pred ceeccCCCC---CcccccccCCcccCcccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCc
Q 005940 503 ARLYDHGGM---PHTTNVVGTFGYIAPELTQTG-KASTSSDVFAYGILLLEVATGRRPIGSGD 561 (668)
Q Consensus 503 a~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~-~~~~~sDV~S~Gvvl~elltG~~p~~~~~ 561 (668)
++....... ......+||+.|+|||++.+. .++.++||||+||++|||++|+.||...+
T Consensus 164 ~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~ 226 (318)
T d3blha1 164 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNT 226 (318)
T ss_dssp CEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred eeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCC
Confidence 987653321 122335799999999998765 68999999999999999999999997543
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-40 Score=351.04 Aligned_cols=203 Identities=27% Similarity=0.363 Sum_probs=170.5
Q ss_pred hcCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCc-hhHHHHHHHHHHHhcccccCceeEeeeecccC----ceE
Q 005940 352 TKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSL-QGMREFAAEIESLGRLRHKNLVNLHGWCKQKN----DLL 426 (668)
Q Consensus 352 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~----~~~ 426 (668)
+.+|+..++||+|+||+||+|++..+|+.||||++.+... ...+.+.+|+++|++++||||+++++++.... ..+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 4579999999999999999999988999999999976543 34568899999999999999999999996543 234
Q ss_pred EEEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceec
Q 005940 427 LVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLY 506 (668)
Q Consensus 427 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~ 506 (668)
++++|+.+|+|.+++.. ..+++..+..++.||+.||+|||+ ++|+||||||+||||+.++.+||+|||+++..
T Consensus 87 ~l~~~~~~g~L~~~l~~----~~l~~~~i~~i~~qil~al~yLH~---~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~ 159 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKT----QHLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVA 159 (345)
T ss_dssp EEEEECCCEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEeecCCchhhhhhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCcceEEECCCCCEEEcccCceeec
Confidence 55566779999999953 359999999999999999999999 99999999999999999999999999999876
Q ss_pred cCCCC--CcccccccCCcccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCc
Q 005940 507 DHGGM--PHTTNVVGTFGYIAPELTQT-GKASTSSDVFAYGILLLEVATGRRPIGSGD 561 (668)
Q Consensus 507 ~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~S~Gvvl~elltG~~p~~~~~ 561 (668)
..... .......||+.|+|||++.. ..++.++||||+||++|||++|+.||...+
T Consensus 160 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~ 217 (345)
T d1pmea_ 160 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH 217 (345)
T ss_dssp CGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCC
Confidence 44322 12344679999999999855 456899999999999999999999997654
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-40 Score=352.74 Aligned_cols=198 Identities=28% Similarity=0.438 Sum_probs=167.6
Q ss_pred hcCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCC--chhHHHHHHHHHHHhcccccCceeEeeeecccC------
Q 005940 352 TKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNS--LQGMREFAAEIESLGRLRHKNLVNLHGWCKQKN------ 423 (668)
Q Consensus 352 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~------ 423 (668)
.++|++.++||+|+||+||+|++..+|+.||||++.+.. ....+.+.+|+++|++++|||||+++++|...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 357899999999999999999998899999999997543 234567889999999999999999999997654
Q ss_pred ceEEEEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCc
Q 005940 424 DLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLA 503 (668)
Q Consensus 424 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla 503 (668)
++|+||||+ +.+|..+... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+|
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~---~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a 168 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLA 168 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEecc-cccHHHHHHh----ccccHHHHHHHHHHHHHHHHHHHh---CCCcccccCcchhhcccccccccccccce
Confidence 579999999 5678777742 359999999999999999999999 99999999999999999999999999999
Q ss_pred eeccCCCCCcccccccCCcccCcccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCc
Q 005940 504 RLYDHGGMPHTTNVVGTFGYIAPELTQTG-KASTSSDVFAYGILLLEVATGRRPIGSGD 561 (668)
Q Consensus 504 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDV~S~Gvvl~elltG~~p~~~~~ 561 (668)
+..... .+...||+.|+|||++.+. .++.++||||+||++|||++|+.||...+
T Consensus 169 ~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~ 223 (346)
T d1cm8a_ 169 RQADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSD 223 (346)
T ss_dssp EECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred eccCCc----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCC
Confidence 876543 2345799999999988764 56899999999999999999999997653
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-40 Score=342.03 Aligned_cols=201 Identities=30% Similarity=0.396 Sum_probs=177.5
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCC--chhHHHHHHHHHHHhcccccCceeEeeeecccCceEEEEE
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNS--LQGMREFAAEIESLGRLRHKNLVNLHGWCKQKNDLLLVYE 430 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 430 (668)
++|++.++||+|+||+||+|++..+++.||||+++... ....+.+.+|+.++++++||||++++++|.+....++|+|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 47899999999999999999999999999999996543 2346788999999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCceeccCCC
Q 005940 431 YIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLARLYDHGG 510 (668)
Q Consensus 431 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~~~~~~ 510 (668)
++.+++|..++.. ...+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||.++......
T Consensus 82 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~q~~~aL~~lH~---~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~ 155 (292)
T d1unla_ 82 FCDQDLKKYFDSC---NGDLDPEIVKSFLFQLLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp CCSEEHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCC
T ss_pred ecccccccccccc---ccccchhHHHHHHHHHHHHHHHhhc---CCEeeecccCcccccccCCceeeeecchhhcccCCC
Confidence 9999999888753 4568999999999999999999999 999999999999999999999999999999876543
Q ss_pred CCcccccccCCcccCcccccCCC-CCcchhHHHHHHHHHHHHhCCCCCCCC
Q 005940 511 MPHTTNVVGTFGYIAPELTQTGK-ASTSSDVFAYGILLLEVATGRRPIGSG 560 (668)
Q Consensus 511 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDV~S~Gvvl~elltG~~p~~~~ 560 (668)
. ......++..|+|||.+.... ++.++||||+||++|||++|+.||...
T Consensus 156 ~-~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~ 205 (292)
T d1unla_ 156 R-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPG 205 (292)
T ss_dssp S-CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCC
T ss_pred c-cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCC
Confidence 2 233346788899999887655 689999999999999999999997544
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=3e-40 Score=340.98 Aligned_cols=258 Identities=19% Similarity=0.210 Sum_probs=200.7
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCchhHHHHHHHHHHHhcccc-cCceeEeeeecccCceEEEEEe
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRH-KNLVNLHGWCKQKNDLLLVYEY 431 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H-~nIv~l~g~~~~~~~~~lV~E~ 431 (668)
++|.+.++||+|+||+||+|++..+|+.||||++..... .+.+.+|++.++.|+| +|++.+++++......++||||
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~ 82 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL 82 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEEC
T ss_pred CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEe
Confidence 579999999999999999999988999999999865432 2456788999999975 8999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECC-----CCCEEEEeecCceec
Q 005940 432 IPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDA-----EMNARLGDFGLARLY 506 (668)
Q Consensus 432 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~-----~~~~kl~DfGla~~~ 506 (668)
+ +++|.+++.. .+..+++..+..++.|++.||.|||+ ++|+||||||+|||++. ++.+||+|||+|+..
T Consensus 83 ~-~~~l~~~~~~--~~~~~~~~~~~~i~~q~~~~l~~lH~---~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~ 156 (293)
T d1csna_ 83 L-GPSLEDLLDL--CGRKFSVKTVAMAAKQMLARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 156 (293)
T ss_dssp C-CCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred c-CCCHHHHHHh--hccchhhHHHHHHHHHHHHHHHHHHH---CCceeccCCccceeecCcccccCCceEEcccceeEEc
Confidence 9 7899998853 34569999999999999999999999 99999999999999974 567999999999987
Q ss_pred cCCCCC------cccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchh-HHHHHHHHHhcCcccc
Q 005940 507 DHGGMP------HTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLL-LVEWVRECHQLGRILD 579 (668)
Q Consensus 507 ~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~-l~~~~~~~~~~~~~~~ 579 (668)
...... ......||+.|||||++.+..++.++|||||||++|||++|+.||...... ...............
T Consensus 157 ~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~- 235 (293)
T d1csna_ 157 RDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST- 235 (293)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS-
T ss_pred ccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCC-
Confidence 543221 233457999999999999999999999999999999999999999754211 111111111110000
Q ss_pred ccCcccCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhccC
Q 005940 580 VADPLLNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSGE 624 (668)
Q Consensus 580 ~~d~~l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~~ 624 (668)
.-+.+...++ + .+..+...|+.. |++||+++.+.+.|+..
T Consensus 236 -~~~~l~~~~p-~---~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~ 276 (293)
T d1csna_ 236 -PLRELCAGFP-E---EFYKYMHYARNLAFDATPDYDYLQGLFSKV 276 (293)
T ss_dssp -CHHHHTTTSC-H---HHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred -ChHHhcCCCC-H---HHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence 0011112222 2 345555678776 99999999888877643
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=6e-40 Score=344.39 Aligned_cols=194 Identities=27% Similarity=0.377 Sum_probs=170.5
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCchhHHHHHHHHHHHhccc-ccCceeEeeeecc--cCceEEEE
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLR-HKNLVNLHGWCKQ--KNDLLLVY 429 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~--~~~~~lV~ 429 (668)
++|++.++||+|+||+||+|++..+++.||||++.... .+++.+|+++|++++ ||||+++++++.. ....++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 57999999999999999999999899999999997543 467889999999996 9999999999864 45689999
Q ss_pred EecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCC-CEEEEeecCceeccC
Q 005940 430 EYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEM-NARLGDFGLARLYDH 508 (668)
Q Consensus 430 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~-~~kl~DfGla~~~~~ 508 (668)
||+.+++|..+. +.+++..+..++.||+.||.|||+ ++|+||||||+|||++.++ .+||+|||+|+....
T Consensus 112 e~~~~~~L~~~~------~~l~e~~i~~i~~qil~aL~~LH~---~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~ 182 (328)
T d3bqca1 112 EHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 182 (328)
T ss_dssp ECCCSCBGGGTT------TSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred eecCCCcHHHHh------cCCCHHHHHHHHHHHHHHHHHHhh---cccccccccccceEEcCCCCeeeecccccceeccC
Confidence 999999997765 248999999999999999999999 9999999999999998765 589999999997765
Q ss_pred CCCCcccccccCCcccCcccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 005940 509 GGMPHTTNVVGTFGYIAPELTQTG-KASTSSDVFAYGILLLEVATGRRPIGSG 560 (668)
Q Consensus 509 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDV~S~Gvvl~elltG~~p~~~~ 560 (668)
... .....+|+.|+|||.+.+. .++.++||||+||++|||++|+.||...
T Consensus 183 ~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~ 233 (328)
T d3bqca1 183 GQE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHG 233 (328)
T ss_dssp TCC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCC
T ss_pred CCc--ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCC
Confidence 432 3345789999999997765 4799999999999999999999999765
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.5e-40 Score=342.71 Aligned_cols=258 Identities=20% Similarity=0.238 Sum_probs=192.9
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCchhHHHHHHHHHHHhcccccCcee-EeeeecccCceEEEEEe
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLVN-LHGWCKQKNDLLLVYEY 431 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~-l~g~~~~~~~~~lV~E~ 431 (668)
++|+..++||+|+||.||+|++..+++.||||++...... +++..|++++++++|+|++. +.++..+.+..++||||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~ 84 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 84 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS--CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC--HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence 4699999999999999999999889999999998765432 45788999999998776555 45555677788999999
Q ss_pred cCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECC---CCCEEEEeecCceeccC
Q 005940 432 IPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDA---EMNARLGDFGLARLYDH 508 (668)
Q Consensus 432 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~---~~~~kl~DfGla~~~~~ 508 (668)
+ +++|...+.. ....+++..+..++.|++.||+|||+ ++|+||||||+|||++. +..+||+|||+|+....
T Consensus 85 ~-~~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~---~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~ 158 (299)
T d1ckia_ 85 L-GPSLEDLFNF--CSRKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 158 (299)
T ss_dssp C-CCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred c-CCchhhhhhh--ccCCCcHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHhhccccccCCCceeeeeccCcceeccc
Confidence 9 5566666532 34569999999999999999999999 99999999999999864 55799999999998765
Q ss_pred CCC------CcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhcCccccccC
Q 005940 509 GGM------PHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEWVRECHQLGRILDVAD 582 (668)
Q Consensus 509 ~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~~~~~~~~~~~~~~~d 582 (668)
... .......||+.|||||++.+..++.++|||||||++|||++|+.||.........+........... ...
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~-~~~ 237 (299)
T d1ckia_ 159 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS-TPI 237 (299)
T ss_dssp TTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHH-SCH
T ss_pred cccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCC-CCh
Confidence 432 1234468999999999999989999999999999999999999999754221111111111000000 000
Q ss_pred cccCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHHhcc
Q 005940 583 PLLNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRYLSG 623 (668)
Q Consensus 583 ~~l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~L~~ 623 (668)
+.+...++ ..+..+...|+.. |++||++.++.+.|+.
T Consensus 238 ~~~~~~~p----~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 275 (299)
T d1ckia_ 238 EVLCKGYP----SEFATYLNFCRSLRFDDKPDYSYLRQLFRN 275 (299)
T ss_dssp HHHTTTSC----HHHHHHHHHHHHSCTTCCCCHHHHHHHHHH
T ss_pred hHhccCCC----HHHHHHHHHHccCChhHCcCHHHHHHHHHH
Confidence 11111122 2345566688876 9999999988877764
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-40 Score=348.19 Aligned_cols=252 Identities=24% Similarity=0.306 Sum_probs=198.0
Q ss_pred cCcccceeeeecCcEEEEEEEe---CCCCcEEEEEEEecCC----chhHHHHHHHHHHHhcccc-cCceeEeeeecccCc
Q 005940 353 KGFKESEVIGIGGFGSVYKGVL---PTTGGEVAVKKITRNS----LQGMREFAAEIESLGRLRH-KNLVNLHGWCKQKND 424 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~---~~~~~~vavK~~~~~~----~~~~~~f~~Ei~~l~~l~H-~nIv~l~g~~~~~~~ 424 (668)
++|+..++||+|+||+||+|.. +.+|+.||||++.+.. ....+.+.+|++++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 5699999999999999999986 3468899999986532 2234568899999999977 899999999999999
Q ss_pred eEEEEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCce
Q 005940 425 LLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLAR 504 (668)
Q Consensus 425 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~ 504 (668)
.++||||+.+|+|.+++.. ...++......++.||+.||.|||+ .+|+||||||+||+|+.++.+||+|||+++
T Consensus 104 ~~~v~e~~~~~~L~~~i~~---~~~~~e~~~~~~~~Qi~~al~~lH~---~~ivHrDiKp~Nill~~~~~vkL~DFG~a~ 177 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQ---RERFTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSK 177 (322)
T ss_dssp EEEEECCCCSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred eeeeeecccccHHHHHHHh---cccccHHHHHHHHHHHHHHHHHhhc---CCEEeccCCccceeecCCCCEEEeeccchh
Confidence 9999999999999999953 3357788999999999999999999 999999999999999999999999999998
Q ss_pred eccCCCCCcccccccCCcccCcccccCC--CCCcchhHHHHHHHHHHHHhCCCCCCCCc-hhHHHHHHHHHhcCcccccc
Q 005940 505 LYDHGGMPHTTNVVGTFGYIAPELTQTG--KASTSSDVFAYGILLLEVATGRRPIGSGD-LLLVEWVRECHQLGRILDVA 581 (668)
Q Consensus 505 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDV~S~Gvvl~elltG~~p~~~~~-~~l~~~~~~~~~~~~~~~~~ 581 (668)
..............|++.|+|||.+... .++.++|||||||+||||++|+.||.... ......+........
T Consensus 178 ~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~----- 252 (322)
T d1vzoa_ 178 EFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE----- 252 (322)
T ss_dssp ECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCC-----
T ss_pred hhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCC-----
Confidence 7755444444556899999999998754 46889999999999999999999996542 111111222111111
Q ss_pred CcccCCcccHHHHHHHHHHHhhcCCC-CCCCC-----CHHHHHHH
Q 005940 582 DPLLNSSYVVKEMELVLKLGLMCSHK-TQFRP-----TMRQVMRY 620 (668)
Q Consensus 582 d~~l~~~~~~~~~~~l~~l~~~C~~~-p~~RP-----s~~evl~~ 620 (668)
+.+....+ ..+..+...|+.. |++|| +++|+++|
T Consensus 253 -~~~~~~~s----~~~~~li~~~l~~dP~~R~s~~~~t~~eil~H 292 (322)
T d1vzoa_ 253 -PPYPQEMS----ALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 292 (322)
T ss_dssp -CCCCTTSC----HHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred -CCCcccCC----HHHHHHHHHHcccCHHHcCCCCcccHHHHHcC
Confidence 11112222 2344555688887 99999 48999874
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-39 Score=344.89 Aligned_cols=257 Identities=22% Similarity=0.220 Sum_probs=188.9
Q ss_pred cCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCC--chhHHHHHHHHHHHhcccccCceeEeeeecc------cCc
Q 005940 353 KGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNS--LQGMREFAAEIESLGRLRHKNLVNLHGWCKQ------KND 424 (668)
Q Consensus 353 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~------~~~ 424 (668)
++|++.++||+|+||+||+|.+..+|+.||||++.+.. .....++.+|+.++++++||||+++++++.. ...
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 67999999999999999999999899999999997653 3445678899999999999999999999853 367
Q ss_pred eEEEEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCce
Q 005940 425 LLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLAR 504 (668)
Q Consensus 425 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~ 504 (668)
+|+||||+.++.+. .+. ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+|++|||+++
T Consensus 97 ~~iv~Ey~~~~l~~-~~~-----~~~~~~~i~~~~~qil~gl~~LH~---~giiHrDlKP~Nil~~~~~~~kl~df~~~~ 167 (355)
T d2b1pa1 97 VYLVMELMDANLCQ-VIQ-----MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR 167 (355)
T ss_dssp EEEEEECCSEEHHH-HHT-----SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred eEEEEeccchHHHH-hhh-----cCCCHHHHHHHHHHHHHHHHHhhh---cccccccCCccccccccccceeeechhhhh
Confidence 89999999765554 442 248999999999999999999999 999999999999999999999999999988
Q ss_pred eccCCCCCcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCchhHHHH-HHHHH-----------
Q 005940 505 LYDHGGMPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDLLLVEW-VRECH----------- 572 (668)
Q Consensus 505 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~~l~~~-~~~~~----------- 572 (668)
...... ......+|+.|+|||++.+..++.++||||+||++|||++|+.||...+...... +....
T Consensus 168 ~~~~~~--~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~ 245 (355)
T d2b1pa1 168 TAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 245 (355)
T ss_dssp ---------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTS
T ss_pred cccccc--ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHh
Confidence 765433 2344578999999999999999999999999999999999999997553221111 10000
Q ss_pred --------hcC-ccc-----cccCccc---CCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHHHH
Q 005940 573 --------QLG-RIL-----DVADPLL---NSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVMRY 620 (668)
Q Consensus 573 --------~~~-~~~-----~~~d~~l---~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~ 620 (668)
... ... ....... ...........+..+...|+.. |++|||++||++|
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 246 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp CHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 000 000 0000000 0111122334566677788887 9999999999976
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-39 Score=342.30 Aligned_cols=199 Identities=27% Similarity=0.405 Sum_probs=169.0
Q ss_pred hcCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCC--chhHHHHHHHHHHHhcccccCceeEeeeeccc-----Cc
Q 005940 352 TKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNS--LQGMREFAAEIESLGRLRHKNLVNLHGWCKQK-----ND 424 (668)
Q Consensus 352 t~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~-----~~ 424 (668)
+++|++.++||+|+||+||+|++..+|+.||||++.+.. ....+.+.+|+++|++++|||||++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 467999999999999999999998899999999997653 33456788999999999999999999998533 34
Q ss_pred eEEEEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEEEeecCce
Q 005940 425 LLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARLGDFGLAR 504 (668)
Q Consensus 425 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~ 504 (668)
.+++++|+.+|+|.+++.. ..+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+|++|||++.
T Consensus 97 ~~~i~~~~~gg~L~~~~~~----~~l~e~~~~~i~~qil~aL~~LH~---~giiHrDiKp~NILi~~~~~~kl~dfg~a~ 169 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR 169 (348)
T ss_dssp CCEEEEECCSEEHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCC----
T ss_pred eEEEEEeecCCchhhhccc----ccccHHHHHHHHHHHHHHHHHHHh---CCCcccccCCccccccccccccccccchhc
Confidence 5677788889999999952 359999999999999999999999 999999999999999999999999999997
Q ss_pred eccCCCCCcccccccCCcccCcccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCc
Q 005940 505 LYDHGGMPHTTNVVGTFGYIAPELTQTG-KASTSSDVFAYGILLLEVATGRRPIGSGD 561 (668)
Q Consensus 505 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDV~S~Gvvl~elltG~~p~~~~~ 561 (668)
.... ......|+..|+|||...+. .++.++||||+||++|||++|+.||...+
T Consensus 170 ~~~~----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~ 223 (348)
T d2gfsa1 170 HTDD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 223 (348)
T ss_dssp CCTG----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred ccCc----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCC
Confidence 6543 23345789999999987665 46899999999999999999999997654
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=6.9e-35 Score=309.64 Aligned_cols=260 Identities=20% Similarity=0.224 Sum_probs=191.2
Q ss_pred CcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCchhHHHHHHHHHHHhccc-----------ccCceeEeeeeccc
Q 005940 354 GFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLR-----------HKNLVNLHGWCKQK 422 (668)
Q Consensus 354 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~-----------H~nIv~l~g~~~~~ 422 (668)
+|++.++||+|+||+||+|++..+|+.||||++++.. ...+.+.+|++++++++ |+||+++++++...
T Consensus 14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~ 92 (362)
T d1q8ya_ 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK 92 (362)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence 4999999999999999999998899999999997653 23467788999888875 57899999988644
Q ss_pred --CceEEEEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCC------
Q 005940 423 --NDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMN------ 494 (668)
Q Consensus 423 --~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~------ 494 (668)
...+++++++..+..............+++..+..++.||+.||.|||+ ..+|+||||||+||||+.++.
T Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~--~~~IvHrDlKp~NIll~~~~~~~~~~~ 170 (362)
T d1q8ya_ 93 GPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQ 170 (362)
T ss_dssp ETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH--TTCEECSCCSGGGEEEEEEETTTTEEE
T ss_pred cccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhh--hcCcccccCChhHeeeeccCcccccce
Confidence 4566777776655443333223445678999999999999999999997 378999999999999986653
Q ss_pred EEEEeecCceeccCCCCCcccccccCCcccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCch--------hHHH
Q 005940 495 ARLGDFGLARLYDHGGMPHTTNVVGTFGYIAPELTQTGKASTSSDVFAYGILLLEVATGRRPIGSGDL--------LLVE 566 (668)
Q Consensus 495 ~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvvl~elltG~~p~~~~~~--------~l~~ 566 (668)
+|++|||.+....... ....||+.|+|||++....++.++||||+||+++||++|+.||...+. .+..
T Consensus 171 ~kl~dfg~s~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~ 246 (362)
T d1q8ya_ 171 IKIADLGNACWYDEHY----TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQ 246 (362)
T ss_dssp EEECCCTTCEETTBCC----CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHH
T ss_pred eeEeeccccccccccc----ccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHH
Confidence 9999999998654322 345799999999999999999999999999999999999999964321 1111
Q ss_pred HHHHHHh-------cC-ccccccC---------cc----------cCCcccHHHHHHHHHHHhhcCCC-CCCCCCHHHHH
Q 005940 567 WVRECHQ-------LG-RILDVAD---------PL----------LNSSYVVKEMELVLKLGLMCSHK-TQFRPTMRQVM 618 (668)
Q Consensus 567 ~~~~~~~-------~~-~~~~~~d---------~~----------l~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl 618 (668)
.++.... .. ......+ .. ............+..+...|+.. |++|||++|++
T Consensus 247 ~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L 326 (362)
T d1q8ya_ 247 IIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLV 326 (362)
T ss_dssp HHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHH
T ss_pred HHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHh
Confidence 1111000 00 0000000 00 01122344556677788888887 99999999999
Q ss_pred HH
Q 005940 619 RY 620 (668)
Q Consensus 619 ~~ 620 (668)
+|
T Consensus 327 ~H 328 (362)
T d1q8ya_ 327 NH 328 (362)
T ss_dssp TC
T ss_pred cC
Confidence 86
|
| >d1nlsa_ b.29.1.1 (A:) Concanavalin A {Jack bean (Canavalia ensiformis) [TaxId: 3823]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Concanavalin A species: Jack bean (Canavalia ensiformis) [TaxId: 3823]
Probab=99.95 E-value=5.2e-29 Score=243.18 Aligned_cols=115 Identities=30% Similarity=0.434 Sum_probs=102.4
Q ss_pred CccEEEEEeecccCCCCCCCCCCCeeeeecCCcccccccCCccccCCCCCccccccCCCCcEEEEEEEeCCcceEEEEEE
Q 005940 142 SNHILIVEFDTVNGFNDKAENQGNHVGIGINTMFSNRSEPASYYINGTDHKEEMTLESGEPIQAWIEYDGEQKVLNVTIS 221 (668)
Q Consensus 142 ~~~~~aVEfDt~~n~~d~~~~~~~Hvgid~~s~~s~~~~~~~~~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~V~~~ 221 (668)
.|++|||||||++|. +.+||++||||||+|++.|.++++ +++.+|+.++|||+||+..++|+|+++
T Consensus 1 an~ivAVEFDT~~N~-~~~Dp~~nHIgIdvns~~S~~~~~-------------~~l~~G~~~~v~I~Yd~~~~~L~V~~~ 66 (237)
T d1nlsa_ 1 ADTIVAVELDTYPNT-DIGDPSYPHIGIDIKSVRSKKTAK-------------WNMQNGKVGTAHIIYNSVDKRLSAVVS 66 (237)
T ss_dssp CCCEEEEEEECSCCG-GGTCCSSCEEEEEESSSSCSEEEE-------------CCCCTTCEEEEEEEEETTTTEEEEEEE
T ss_pred CCCEEEEEEECCcCC-CCCCCCCCEEEEEeCCCCccceec-------------ccccCCCEEEEEEEEecCCcEEEEEEe
Confidence 378999999999982 223499999999999999877654 467899999999999999999999998
Q ss_pred eCCCCCCCCcceeeeeccccccccceeeeeecccCCcccceeeecccccccC
Q 005940 222 PAEIGKPMRPLISFGVNLTGYIKETMYVGFSASTGEKSSSHYILGWSFSLNG 273 (668)
Q Consensus 222 ~~~~~~p~~~~ls~~~dLs~~l~~~~~vGFsastG~~~~~~~i~~w~F~~~~ 273 (668)
+. +|..|+|++.+||+.+|+++|||||||+||...|.|+|++|+|++..
T Consensus 67 ~~---~~~~~~ls~~vdL~~~l~~~vyvGFSAsTG~~~~~h~I~sWsFsS~~ 115 (237)
T d1nlsa_ 67 YP---NADSATVSYDVDLDNVLPEWVRVGLSASTGLYKETNTILSWSFTSKL 115 (237)
T ss_dssp CT---TSCCEEEEEECCGGGTSCSEEEEEEEEECSSSCCCCEEEEEEEEEEE
T ss_pred cC---CCCCeEEEEEEChHHhCCCcEEEEEEeecCCCccceEEEEEEEEeec
Confidence 64 56778999999999999999999999999999999999999998753
|
| >d1gv9a_ b.29.1.13 (A:) Carbohydrate-recognition domain of P58/ERGIC-53 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Lectin leg-like domain: Carbohydrate-recognition domain of P58/ERGIC-53 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.94 E-value=3.9e-26 Score=225.79 Aligned_cols=212 Identities=16% Similarity=0.104 Sum_probs=142.3
Q ss_pred ceeEEeCCCCCCC---CCeEEeCceeeCCCCcEEccCCCCceEEEEEeeCceecccCCCCCCCCeeeeEEEEEEEEeCCC
Q 005940 27 SSSFIFQGFNGGA---TNLSLQGAEIIKPSGALKLTNRSRYVIGHAFYVKPIQMFDTSASPSPNASSFSTTFVFEISTPR 103 (668)
Q Consensus 27 ~~~f~~~~f~~~~---~~l~~~g~a~~~~~~~~~lt~~~~~~~G~~~y~~p~~l~~~~~~~~~~~~sF~t~F~f~i~~~~ 103 (668)
..||..+.+..++ .+..+.|+|.+. ++.|+||++..+++|+++|++|+++- +|+|+|+|.+...
T Consensus 8 ~~sf~~P~~~~~~~~~~~w~~~G~a~i~-~~~i~LT~~~~~~~G~v~~~~p~~~~-----------~F~~~f~f~~~~~- 74 (228)
T d1gv9a_ 8 KYSFKGPHLVQSDGTVPFWAHAGNAIPS-ADQIRIAPSLKSQRGSVWTKTKAAFE-----------NWEVEVTFRVTGR- 74 (228)
T ss_dssp GGCEECSSCSCTTSCBTTEEEEETCEEC-SSCEEEECSSTTCEEEEEESSCBCCS-----------SEEEEEEEEEECS-
T ss_pred EeccCCCcccCCCCCccceEEeeeEEEE-CCEEEECCCCCCCEEEEEeCCCcccc-----------CcEEEEEEeccCC-
Confidence 3456656554332 346899999996 78999999999999999999999874 4999999999865
Q ss_pred CCCCCCceEEEEcCCCCCCCCCCCCcccccccCCCCCCCccEEEEEeecccCCCCCCCCCCCeeeeecCCccccc-ccCC
Q 005940 104 SGRGGHGLAFLLAPSTKLPGAQPEHYLGILNSTNNGEPSNHILIVEFDTVNGFNDKAENQGNHVGIGINTMFSNR-SEPA 182 (668)
Q Consensus 104 ~~~~g~GlaF~l~p~~~~~~~~~~~~lGl~~~~~~~~~~~~~~aVEfDt~~n~~d~~~~~~~Hvgid~~s~~s~~-~~~~ 182 (668)
...+||||||+|+|+. +..|+.+|.. ...+-+||||||+.|.++ ++.+|+.++.|...... ..+.
T Consensus 75 ~~~ggdG~aF~i~~~~----~~~g~~~G~~-------~~~~glaVefDt~~n~~~---~~~~~~~~~~n~~~~~~~~~~~ 140 (228)
T d1gv9a_ 75 GRIGADGLAIWYTENQ----GLDGPVFGSA-------DMWNGVGIFFDSFDNDGK---KNNPAIVVVGNNGQINYDHQND 140 (228)
T ss_dssp SSCCCCEEEEEEESSC----CCEEEETTEC-------SCCEEEEEEEECCCC--------CCEEEEEEEESCCCCCHHHH
T ss_pred CCCCCCEEEEEEecCC----CCCCCccCcC-------CCCceEEEEEEcccccCC---CCCCcEEEEecCCcceeeecCC
Confidence 3568999999999865 3445666652 234568999999998555 66778888776532111 1100
Q ss_pred ccccCCCCCccccc-cCCCCcEEEEEEEeCCcceEEEEEEeCCCCCCCCcceeeeeccccccccceeeeeecccCCcccc
Q 005940 183 SYYINGTDHKEEMT-LESGEPIQAWIEYDGEQKVLNVTISPAEIGKPMRPLISFGVNLTGYIKETMYVGFSASTGEKSSS 261 (668)
Q Consensus 183 ~~~~~~~~~~~~~~-l~~g~~~~~~I~Y~~~~~~l~V~~~~~~~~~p~~~~ls~~~dLs~~l~~~~~vGFsastG~~~~~ 261 (668)
.+...... .... ...+..+++|++|+ .+.|+|++.............+..++ ...+++.+||||||+||..++.
T Consensus 141 ~~~~~~~~--~~~~~~~~~~~~~i~~~~~--~~~l~v~i~~~~~~~~~~~~~~~~~~-~~~l~~~~y~GFTAsTG~~~~~ 215 (228)
T d1gv9a_ 141 GATQALAS--CQRDFRNKPYPVRAKITYY--QKTLTVMINNGFTPDKNDYEFCAKVE-NMVIPTQGHFGISAATGGLADD 215 (228)
T ss_dssp HHHHCSEE--ECCCCBSCSSCEEEEEEEE--TTEEEEEEECSSCCCTTCCEEEEEET-TCCCCSSBEEEEEEECCSSCCE
T ss_pred Cccccccc--eeeeecCCceEEEEEEEec--CCEEEEEEeccccCCCcceeEEEEec-ccccCCCEEEEEEEeCCCCcCe
Confidence 00000000 0111 12344556666665 68899999866544444444444444 4568899999999999999999
Q ss_pred eeeeccccc
Q 005940 262 HYILGWSFS 270 (668)
Q Consensus 262 ~~i~~w~F~ 270 (668)
|.|++|.+.
T Consensus 216 H~I~s~~~~ 224 (228)
T d1gv9a_ 216 HDVLSFLTF 224 (228)
T ss_dssp EEEEEEEEE
T ss_pred EEEEEEEEE
Confidence 999999764
|
| >d1nlsa_ b.29.1.1 (A:) Concanavalin A {Jack bean (Canavalia ensiformis) [TaxId: 3823]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Concanavalin A species: Jack bean (Canavalia ensiformis) [TaxId: 3823]
Probab=99.90 E-value=1.9e-24 Score=210.71 Aligned_cols=109 Identities=28% Similarity=0.577 Sum_probs=96.2
Q ss_pred cCCceeEEeCCCCCCCCCeEEeCceeeCCCCcEEccCCC------CceEEEEEeeCceecccCCCCCCCCeeeeEEEEEE
Q 005940 24 QSQSSSFIFQGFNGGATNLSLQGAEIIKPSGALKLTNRS------RYVIGHAFYVKPIQMFDTSASPSPNASSFSTTFVF 97 (668)
Q Consensus 24 ~~~~~~f~~~~f~~~~~~l~~~g~a~~~~~~~~~lt~~~------~~~~G~~~y~~p~~l~~~~~~~~~~~~sF~t~F~f 97 (668)
..++++|+|++|.+++.||+|+|+|.+.++|.|+||+.+ ..++|||+|++||+||| + +++++||+|+|+|
T Consensus 122 esn~~~F~f~~F~~~~~nl~l~G~A~i~~~G~l~LT~~~~~~~~~~~s~Gra~y~~Pv~l~d---~-t~~~~SFsT~F~F 197 (237)
T d1nlsa_ 122 ETNALHFMFNQFSKDQKDLILQGDATTGTDGNLELTRVSSNGSPQGSSVGRALFYAPVHIWE---S-SAVVASFEATFTF 197 (237)
T ss_dssp CEEEEEEEESCCCTTCTTEEEEETCEEEETTEEESSCBCTTSCBCSSCEEEEEESSCEECCC---T-TEEEEEEEEEEEE
T ss_pred ccccceEEeeecCCCCCCEEEeeeeEecCCCcEEecCCCCCCcccCcceEEEEeCCCEEEEC---C-CCcEeeEEEEEEE
Confidence 346799999999988899999999999888999999754 45899999999999999 4 6789999999999
Q ss_pred EEeCCCCCCCCCceEEEEcCCC-CCCCCCCCCcccccccCC
Q 005940 98 EISTPRSGRGGHGLAFLLAPST-KLPGAQPEHYLGILNSTN 137 (668)
Q Consensus 98 ~i~~~~~~~~g~GlaF~l~p~~-~~~~~~~~~~lGl~~~~~ 137 (668)
.|.+++ ..+||||||||+|.. .+|.++.|+||||+|.++
T Consensus 198 ~I~~~~-~~~gdG~aF~iap~~~~~p~~~~g~~LGL~n~~n 237 (237)
T d1nlsa_ 198 LIKSPD-SHPADGIAFFISNIDSSIPSGSTGRLLGLFPDAN 237 (237)
T ss_dssp ECCCSS-SSCCCEEEEEEECTTCCCCTTCCGGGTTTCSSCC
T ss_pred EEecCC-CCCCCCEEEEEeCCCCCCCCCCCCCeeeeccCCC
Confidence 998865 568999999999964 678899999999998753
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.86 E-value=3e-22 Score=191.89 Aligned_cols=163 Identities=17% Similarity=0.162 Sum_probs=121.3
Q ss_pred ccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCc------------------hhHHHHHHHHHHHhcccccCceeEee
Q 005940 356 KESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSL------------------QGMREFAAEIESLGRLRHKNLVNLHG 417 (668)
Q Consensus 356 ~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------------------~~~~~f~~Ei~~l~~l~H~nIv~l~g 417 (668)
.+.++||+|+||+||+|++. +|+.||||+++.... ........|...+.++.|.+++..++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~ 81 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA 81 (191)
T ss_dssp EEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred hhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence 45789999999999999984 688999998753211 01133456888999999999999887
Q ss_pred eecccCceEEEEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCCEEECCCCCEEE
Q 005940 418 WCKQKNDLLLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEWEQVVIHRDVKPSNALIDAEMNARL 497 (668)
Q Consensus 418 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDLkp~NIll~~~~~~kl 497 (668)
+.. .+++|||+++..+.+ ++.....+++.|++++|+|||+ .+|+||||||+|||++++ .++|
T Consensus 82 ~~~----~~lvme~~~~~~~~~----------l~~~~~~~i~~ql~~~l~~lH~---~giiHrDiKP~NILv~~~-~~~l 143 (191)
T d1zara2 82 WEG----NAVLMELIDAKELYR----------VRVENPDEVLDMILEEVAKFYH---RGIVHGDLSQYNVLVSEE-GIWI 143 (191)
T ss_dssp EET----TEEEEECCCCEEGGG----------CCCSCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEETT-EEEE
T ss_pred ecC----CEEEEEeeccccccc----------hhhHHHHHHHHHHHHHHHHHhh---CCEEEccCChhheeeeCC-CEEE
Confidence 643 379999998765533 3345567899999999999999 999999999999999865 5899
Q ss_pred EeecCceeccCCCCCcccccccCCcccC------cccccCCCCCcchhHHHHHHHH
Q 005940 498 GDFGLARLYDHGGMPHTTNVVGTFGYIA------PELTQTGKASTSSDVFAYGILL 547 (668)
Q Consensus 498 ~DfGla~~~~~~~~~~~~~~~gt~~y~a------PE~~~~~~~~~~sDV~S~Gvvl 547 (668)
+|||+|+...+.... .|.. .|.+ .+++..++|+||..--+
T Consensus 144 iDFG~a~~~~~~~~~---------~~l~rd~~~~~~~f-~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 144 IDFPQSVEVGEEGWR---------EILERDVRNIITYF-SRTYRTEKDINSAIDRI 189 (191)
T ss_dssp CCCTTCEETTSTTHH---------HHHHHHHHHHHHHH-HHHHCCCCCHHHHHHHH
T ss_pred EECCCcccCCCCCcH---------HHHHHHHHHHHHHH-cCCCCCcccHHHHHHHH
Confidence 999999876543211 1111 1111 35678899999976443
|
| >d2a6za1 b.29.1.13 (A:7-227) Emp47p N-terminal domain {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Lectin leg-like domain: Emp47p N-terminal domain species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.81 E-value=1.4e-19 Score=176.75 Aligned_cols=198 Identities=13% Similarity=0.164 Sum_probs=128.6
Q ss_pred EEeCCCCCC---CCCeEEeCceeeCCCCcEEccCCCCceEEEEEeeCceecccCCCCCCCCeeeeEEEEEEEEeCCCCCC
Q 005940 30 FIFQGFNGG---ATNLSLQGAEIIKPSGALKLTNRSRYVIGHAFYVKPIQMFDTSASPSPNASSFSTTFVFEISTPRSGR 106 (668)
Q Consensus 30 f~~~~f~~~---~~~l~~~g~a~~~~~~~~~lt~~~~~~~G~~~y~~p~~l~~~~~~~~~~~~sF~t~F~f~i~~~~~~~ 106 (668)
|+++.+-.. ..+..+.|+|.+. ++.|+||++ .++.|.+++++|+++++ +|+++|+|.|.... ..
T Consensus 10 ~s~p~~~~~~~~~~~W~~~g~a~~~-~~~i~LTp~-~~~~G~~w~~~~i~~~~----------~f~~~~~F~i~g~~-~~ 76 (221)
T d2a6za1 10 YSLPDLINTRKVPNNWQTGEQASLE-EGRIVLTSN-QNSKGSLWLKQGFDLKD----------SFTMEWTFRSVGYS-GQ 76 (221)
T ss_dssp GCBCCCTTCCSCCTTEEEEETCEEE-TTEEESCCS-TTCEEEEEESSCEECCS----------CEEEEEEEEEESCC-SC
T ss_pred ccCCCccccccCCCccEEcceeEEE-CCEEEECCC-CCCceEEEECCccccCC----------CeEEEEEEEEeCCC-CC
Confidence 566554322 4679999999997 889999987 57889999999999987 59999999998753 56
Q ss_pred CCCceEEEEcCCCCCCCCCCCCcccccccCCCCCCCccEEEEEeecccCCCCCCCCCCCeeeeecCCcccccccCCcccc
Q 005940 107 GGHGLAFLLAPSTKLPGAQPEHYLGILNSTNNGEPSNHILIVEFDTVNGFNDKAENQGNHVGIGINTMFSNRSEPASYYI 186 (668)
Q Consensus 107 ~g~GlaF~l~p~~~~~~~~~~~~lGl~~~~~~~~~~~~~~aVEfDt~~n~~d~~~~~~~Hvgid~~s~~s~~~~~~~~~~ 186 (668)
+||||||+++++.. ....|+.+|... ...-+||||||+.| + ....|+.++.++..-........
T Consensus 77 ggdG~af~~~~~~~--~~~~g~~~G~~~-------~~~GlaV~fDt~~n--~---~~~~~~~~ndgt~~~~~~~~~~~-- 140 (221)
T d2a6za1 77 TDGGISFWFVQDSN--IPRDKQLYNGPV-------NYDGLQLLVDNNGP--L---GPTLRGQLNDGQKPVDKTKIYDQ-- 140 (221)
T ss_dssp CSCEEEEEEEECSS--SCCCCTBTTBCT-------TCEEEEEEEESCST--T---SSEEEEEEEESSSCCCGGGHHHH--
T ss_pred CCCcEEEEEEcCCC--ccccccccccCC-------CCceEEEEEECCCC--C---CCceEEEecCCCccccccCCccc--
Confidence 79999999997542 223455555522 22357999999977 3 11223344433332111111000
Q ss_pred CCCCCccccc-cCCCCcEEEEEEEeCCcc-eEEEEEEeCCCCCCCCcceeeeeccccccccceeeeeecccCCcccceee
Q 005940 187 NGTDHKEEMT-LESGEPIQAWIEYDGEQK-VLNVTISPAEIGKPMRPLISFGVNLTGYIKETMYVGFSASTGEKSSSHYI 264 (668)
Q Consensus 187 ~~~~~~~~~~-l~~g~~~~~~I~Y~~~~~-~l~V~~~~~~~~~p~~~~ls~~~dLs~~l~~~~~vGFsastG~~~~~~~i 264 (668)
... ...+. ..++...+++|.|++..+ .|.|.+... ++..++--.+-++.+|+||||+||...+.|.+
T Consensus 141 ~~~--~~~~~~~~~~~~~~~~I~y~~~~~~~l~v~id~~---------~c~~~~~v~lp~~~~~fG~SA~TG~~~~~hd~ 209 (221)
T d2a6za1 141 SFA--SCLMGYQDSSVPSTIRVTYDLEDDNLLKVQVDNK---------VCFQTRKVRFPSGSYRIGVTAQNGAVNNNAES 209 (221)
T ss_dssp CSE--EEECCCTTEEEEEEEEEEEEGGGTSEEEEEETTE---------EEEEESCCCCCSSEEEEEEEEECCSGGGCCCE
T ss_pred ccc--eeeecccCCCCCEEEEEEEecCccceEEEEecCc---------EeEEECCeecCCCCEEEEEEEccCCccCCCce
Confidence 000 01122 346778899999997655 478877421 22223322222467899999999998888886
Q ss_pred ecc
Q 005940 265 LGW 267 (668)
Q Consensus 265 ~~w 267 (668)
..+
T Consensus 210 ~~i 212 (221)
T d2a6za1 210 FEI 212 (221)
T ss_dssp EEE
T ss_pred EEE
Confidence 554
|
| >d2a6va1 b.29.1.13 (A:9-226) Emp46p N-terminal domain {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Lectin leg-like domain: Emp46p N-terminal domain species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.79 E-value=1.1e-18 Score=169.52 Aligned_cols=191 Identities=16% Similarity=0.136 Sum_probs=126.8
Q ss_pred CCeEEeCceeeCCCCcEEccCCCCceEEEEEeeCceecccCCCCCCCCeeeeEEEEEEEEeCCCCCCCCCceEEEEcCCC
Q 005940 40 TNLSLQGAEIIKPSGALKLTNRSRYVIGHAFYVKPIQMFDTSASPSPNASSFSTTFVFEISTPRSGRGGHGLAFLLAPST 119 (668)
Q Consensus 40 ~~l~~~g~a~~~~~~~~~lt~~~~~~~G~~~y~~p~~l~~~~~~~~~~~~sF~t~F~f~i~~~~~~~~g~GlaF~l~p~~ 119 (668)
.+..+.|+|.+. ++.|+||++ .++.|.++++.|+++++ +|+++|+|.|.... ..+||||||++.+..
T Consensus 22 ~~W~~~G~~~~~-~~~i~LTp~-~~~~G~~w~~~~i~~~~----------~f~i~~~F~i~g~~-~~~~dG~afw~~~~~ 88 (218)
T d2a6va1 22 SQWTLGDKVKLE-EGRFVLTPG-KNTKGSLWLKPEYSIKD----------AMTIEWTFRSFGFR-GSTKGGLAFWLKQGN 88 (218)
T ss_dssp TTEEEEETCEEE-TTEEESCCS-TTCEEEEEESSCBCCSS----------CEEEEEEEEEESCC-SCCSCEEEEEEECSC
T ss_pred CccEECCCEEEE-CCEEEECCC-CCCeeEEEeCCcccccc----------cceEEEEEEEeCCC-CCCCCcEEEEEEcCC
Confidence 679999999997 789999987 56789999999999987 69999999998763 567999999999754
Q ss_pred CCCCCCCCCcccccccCCCCCCCccEEEEEeecccCCCCCCCCCCCeeeeecCCcccccccCCccccCCCCCccccc-cC
Q 005940 120 KLPGAQPEHYLGILNSTNNGEPSNHILIVEFDTVNGFNDKAENQGNHVGIGINTMFSNRSEPASYYINGTDHKEEMT-LE 198 (668)
Q Consensus 120 ~~~~~~~~~~lGl~~~~~~~~~~~~~~aVEfDt~~n~~d~~~~~~~Hvgid~~s~~s~~~~~~~~~~~~~~~~~~~~-l~ 198 (668)
...+ .++..|..+. -.=+||||||+.| + .+||.+.+|.= +.......+..-...... ..
T Consensus 89 ~~~~--~~~~~G~~~~-------f~GlaV~fDt~~n--~-----~~~i~~~~ndG----s~~~~~~~d~~~g~c~~~~~~ 148 (218)
T d2a6va1 89 EGDS--TELFGGSSKK-------FNGLMILLRLDDK--L-----GESVTAYLNDG----TKDLDIESSPYFASCLFQYQD 148 (218)
T ss_dssp CCCC--CTBTTTBCSS-------CEEEEEEEEEETT--T-----EEEEEEEEEES----SSCCCTTTSCCSEEEECCCSS
T ss_pred cccC--CCcccccCCC-------cceEEEEEECCCC--C-----CCeEEEEeCCC----CccccccCCcccceEEecccC
Confidence 3211 1122222111 1126999999976 2 35887766531 111111111100000111 34
Q ss_pred CCCcEEEEEEEeCCcc-eEEEEEEeCCCCCCCCcceeeeeccccccccceeeeeecccCCcccceeeecccccc
Q 005940 199 SGEPIQAWIEYDGEQK-VLNVTISPAEIGKPMRPLISFGVNLTGYIKETMYVGFSASTGEKSSSHYILGWSFSL 271 (668)
Q Consensus 199 ~g~~~~~~I~Y~~~~~-~l~V~~~~~~~~~p~~~~ls~~~dLs~~l~~~~~vGFsastG~~~~~~~i~~w~F~~ 271 (668)
++.+.+++|.|+.... .++|.+. + + ++-...++.-..++.+|+||||+||...+.|.|++|++-.
T Consensus 149 ~~~~~~~~i~Y~~~~~~~l~v~id--~-----~-~c~~t~~i~lp~~~~~yfG~SA~Tg~~~d~~dIls~~~~~ 214 (218)
T d2a6va1 149 SMVPSTLRLTYNPLDNHLLKLQMD--N-----R-VCFQTRKVKFMGSSPFRIGTSAINDASKESFEILKMKLYD 214 (218)
T ss_dssp CSSCEEEEEEEEGGGTSEEEEEET--T-----E-EEEEESCCCGGGTSCBEEEEEEECCTTCCEEEEEEEEEES
T ss_pred CCCcEEEEEEEECcccceEEEEeC--C-----c-EEEEECCeecCCCCcEEEEEEECCCCCcCcEEEEEEEEEe
Confidence 6888999999987654 4677663 1 1 1111222222344679999999999999999999998753
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.49 E-value=2.2e-07 Score=91.04 Aligned_cols=149 Identities=13% Similarity=0.020 Sum_probs=104.1
Q ss_pred hHHHHhcCcccceeeeecCcEEEEEEEeCCCCcEEEEEEEecCCchhHHHHHHHHHHHhccc-ccCceeEeeeecccCce
Q 005940 347 DLYAATKGFKESEVIGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLR-HKNLVNLHGWCKQKNDL 425 (668)
Q Consensus 347 el~~at~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~ 425 (668)
++...-.+|+..+..+-+..+.||+... +++.+++|+...........+.+|...+..|. +--+.+++.++..++..
T Consensus 8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~--~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~ 85 (263)
T d1j7la_ 8 ELKKLIEKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS 85 (263)
T ss_dssp HHHHHHTTSEEEECSCCCSSSEEEEEEC--SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred HHHHhhhceEEEEcCCCCCCCcEEEEEe--CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCce
Confidence 4555556666555544444578999865 56778999987655444456778888888774 44467788888888889
Q ss_pred EEEEEecCCCChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhhcc--------------------------------
Q 005940 426 LLVYEYIPNGSLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHEEW-------------------------------- 473 (668)
Q Consensus 426 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~-------------------------------- 473 (668)
++||+++++.++.+.... ......++.++++.|+.||+..
T Consensus 86 ~lv~~~l~G~~~~~~~~~--------~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (263)
T d1j7la_ 86 NLLMSEADGVLCSEEYED--------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCEN 157 (263)
T ss_dssp EEEEECCSSEEHHHHTTT--------CSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGG
T ss_pred EEEEEecccccccccccc--------cccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhc
Confidence 999999999888665421 1123345566666666666310
Q ss_pred ------------------------CCceEecCCCCCCEEECCCCCEEEEeecCcee
Q 005940 474 ------------------------EQVVIHRDVKPSNALIDAEMNARLGDFGLARL 505 (668)
Q Consensus 474 ------------------------~~~ivHrDLkp~NIll~~~~~~kl~DfGla~~ 505 (668)
...++|+|+.|.||+++++...-|.||+.+..
T Consensus 158 ~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 158 WEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp GSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred ccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 12379999999999999876667999998753
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.69 E-value=8.7e-05 Score=71.43 Aligned_cols=131 Identities=19% Similarity=0.134 Sum_probs=85.7
Q ss_pred eeeeecCc-EEEEEEEeCCCCcEEEEEEEecCCchhHHHHHHHHHHHhcccc--cCceeEeeeecccCceEEEEEecCCC
Q 005940 359 EVIGIGGF-GSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRH--KNLVNLHGWCKQKNDLLLVYEYIPNG 435 (668)
Q Consensus 359 ~~lG~G~~-g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H--~nIv~l~g~~~~~~~~~lV~E~~~~g 435 (668)
+.+..|.. +.||+.... ++..+++|....... ..+..|.+.++.|.. -.+.++++++.+.+..++|||++++.
T Consensus 16 ~~~~~G~s~~~v~r~~~~-~~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~ 91 (255)
T d1nd4a_ 16 AQQTIGCSDAAVFRLSAQ-GRPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQ 91 (255)
T ss_dssp EECSCTTSSCEEEEEECT-TSCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSE
T ss_pred EEcCCcccCCeEEEEEeC-CCCEEEEEeCCccCH---hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecc
Confidence 34455553 679998873 466688887654432 345678888877753 34667888888888899999999887
Q ss_pred ChhhhhcCCCCCCCccHHHHHHHHHHHHHHHHHhhh--------------------------------------------
Q 005940 436 SLDTLLFKPKDGSVLDWEQRFNIVKGIASGLLYLHE-------------------------------------------- 471 (668)
Q Consensus 436 sL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~-------------------------------------------- 471 (668)
++.+.. +. ....+.++++.|.-||+
T Consensus 92 ~~~~~~--------~~---~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (255)
T d1nd4a_ 92 DLLSSH--------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAE 160 (255)
T ss_dssp ETTTSC--------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHH
T ss_pred cccccc--------cc---HHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHH
Confidence 664321 00 11222333344444441
Q ss_pred -----------ccCCceEecCCCCCCEEECCCCCEEEEeecCce
Q 005940 472 -----------EWEQVVIHRDVKPSNALIDAEMNARLGDFGLAR 504 (668)
Q Consensus 472 -----------~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~ 504 (668)
.....++|+|+.|.||+++++..+-|.||+.+.
T Consensus 161 ~~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 161 LFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp HHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 011348999999999999987667899999765
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.37 E-value=0.00027 Score=72.87 Aligned_cols=77 Identities=13% Similarity=0.014 Sum_probs=49.0
Q ss_pred ceeeeecCcEEEEEEEeCCCCcEEEEEEEecC-------CchhHHHHHHHHHHHhccc---ccCceeEeeeecccCceEE
Q 005940 358 SEVIGIGGFGSVYKGVLPTTGGEVAVKKITRN-------SLQGMREFAAEIESLGRLR---HKNLVNLHGWCKQKNDLLL 427 (668)
Q Consensus 358 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~-------~~~~~~~f~~Ei~~l~~l~---H~nIv~l~g~~~~~~~~~l 427 (668)
.+.||.|....||+.....+++.++||.-... ..........|.+.|+.+. ...+.+++.+. +...++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d--~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEc--CCCCEE
Confidence 45789999999999998777788999975321 1112233456777777663 24466666654 345689
Q ss_pred EEEecCCCC
Q 005940 428 VYEYIPNGS 436 (668)
Q Consensus 428 V~E~~~~gs 436 (668)
|||++++..
T Consensus 109 vmE~L~~~~ 117 (392)
T d2pula1 109 VMEDLSHLK 117 (392)
T ss_dssp EECCCTTSE
T ss_pred EEeccCCcc
Confidence 999997654
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.46 E-value=0.0058 Score=60.75 Aligned_cols=136 Identities=13% Similarity=0.099 Sum_probs=77.7
Q ss_pred cEEEEEEEeCCCCcEEEEEEEecCCchhHHHHHHHHHHHhcccccCce--eEee-----eecccCceEEEEEecCCCChh
Q 005940 366 FGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLV--NLHG-----WCKQKNDLLLVYEYIPNGSLD 438 (668)
Q Consensus 366 ~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv--~l~g-----~~~~~~~~~lV~E~~~~gsL~ 438 (668)
--.||+++. ++|..+++|+.+... ...+++..|...+..|....+. ..+. .....+..+.++++++|..+.
T Consensus 35 EN~vy~v~~-~dg~~~VlK~~rp~~-~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~ 112 (325)
T d1zyla1 35 ENRVYQFQD-EDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFE 112 (325)
T ss_dssp SSEEEEECC-TTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECC
T ss_pred cceeEEEEc-CCCCEEEEEEeCCCC-CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCC
Confidence 358999988 468889999986542 3446677888888888643332 1111 123345678899999864432
Q ss_pred h-----h------h-------cCC--CCCCCccH-------------------HHHHHHHHHHHHHHHHhh----hccCC
Q 005940 439 T-----L------L-------FKP--KDGSVLDW-------------------EQRFNIVKGIASGLLYLH----EEWEQ 475 (668)
Q Consensus 439 ~-----~------l-------~~~--~~~~~l~~-------------------~~~~~i~~qia~gL~yLH----~~~~~ 475 (668)
. + + ... .....+++ ..+-.+...+...+..+. +....
T Consensus 113 ~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~ 192 (325)
T d1zyla1 113 ADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTV 192 (325)
T ss_dssp SSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCC
T ss_pred CCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCc
Confidence 1 0 0 000 00111111 111112222222233332 22346
Q ss_pred ceEecCCCCCCEEECCCCCEEEEeecCcee
Q 005940 476 VVIHRDVKPSNALIDAEMNARLGDFGLARL 505 (668)
Q Consensus 476 ~ivHrDLkp~NIll~~~~~~kl~DfGla~~ 505 (668)
+++|+|+.+.|||++++ ..+.||+-++.
T Consensus 193 ~liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 193 LRLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp EECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred eeecCCCCcccEEEeCC--ceEEechhccc
Confidence 79999999999999754 56889998764
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.23 E-value=0.0083 Score=61.29 Aligned_cols=74 Identities=20% Similarity=0.166 Sum_probs=50.7
Q ss_pred ceeeeecCcEEEEEEEeCC-------CCcEEEEEEEecCCchhHHHHHHHHHHHhcccccCc-eeEeeeecccCceEEEE
Q 005940 358 SEVIGIGGFGSVYKGVLPT-------TGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNL-VNLHGWCKQKNDLLLVY 429 (668)
Q Consensus 358 ~~~lG~G~~g~Vy~~~~~~-------~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nI-v~l~g~~~~~~~~~lV~ 429 (668)
.+.|+.|-.-.+|+...+. ....|.+++.... ........|.++++.+.-.++ .++++++.+ .+|+
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~--~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~ 120 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 120 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc--chhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEE
Confidence 4678888889999998743 2345777766532 223345689999998864444 467887754 5899
Q ss_pred EecCCCCh
Q 005940 430 EYIPNGSL 437 (668)
Q Consensus 430 E~~~~gsL 437 (668)
||+++..|
T Consensus 121 efi~g~~l 128 (395)
T d1nw1a_ 121 EYIPSRPL 128 (395)
T ss_dssp CCCCEEEC
T ss_pred EEeccccC
Confidence 99987554
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.47 E-value=0.016 Score=56.98 Aligned_cols=158 Identities=11% Similarity=0.023 Sum_probs=82.4
Q ss_pred cchhhHHHHhcCccccee-----eeecCcEEEEEEEeCCCCcEEEEEEEecCCchhHHHHHHHHHHHhcccccCce--eE
Q 005940 343 FRYKDLYAATKGFKESEV-----IGIGGFGSVYKGVLPTTGGEVAVKKITRNSLQGMREFAAEIESLGRLRHKNLV--NL 415 (668)
Q Consensus 343 f~~~el~~at~~f~~~~~-----lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv--~l 415 (668)
.+.+|+.....+|...+. |..|---+.|+.+.. ++.+++|+..... ..++...|++++..|...++. ..
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~--~g~yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~p 78 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTT--KDPLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLP 78 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEES--SCCEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCB
T ss_pred CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEEC--CCcEEEEEcCCCC--CHHHHHHHHHHHHhhhhcccccccc
Confidence 345666666677765443 335555788998873 4569999986532 223445577777777543222 11
Q ss_pred eee------ecccCceEEEEEecCCCChhhh--------------hc---CC----CCCCCc-----------------c
Q 005940 416 HGW------CKQKNDLLLVYEYIPNGSLDTL--------------LF---KP----KDGSVL-----------------D 451 (668)
Q Consensus 416 ~g~------~~~~~~~~lV~E~~~~gsL~~~--------------l~---~~----~~~~~l-----------------~ 451 (668)
+-. ....+....++.+..+...... ++ .. ...... .
T Consensus 79 i~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (316)
T d2ppqa1 79 LPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEV 158 (316)
T ss_dssp CCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGT
T ss_pred ceecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhc
Confidence 111 1123345666776665433210 00 00 000000 0
Q ss_pred HHHHHHHHHHHHHHHHHhh-hccCCceEecCCCCCCEEECCCCCEEEEeecCce
Q 005940 452 WEQRFNIVKGIASGLLYLH-EEWEQVVIHRDVKPSNALIDAEMNARLGDFGLAR 504 (668)
Q Consensus 452 ~~~~~~i~~qia~gL~yLH-~~~~~~ivHrDLkp~NIll~~~~~~kl~DfGla~ 504 (668)
.......+..+...+.-.+ .....+++|+|+.+.||+++.+...-|.||+.+.
T Consensus 159 ~~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 159 EKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp STTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred chhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 0111222222222222222 1345789999999999999988777899999875
|